PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Vaur, P; Brugg, B; Mericskay, M; Li, ZL; Schmidt, MS; Vivien, D; Orset, C; Jacotot, E; Brenner, C; Duplus, E				Vaur, Pauline; Brugg, Bernard; Mericskay, Mathias; Li, Zhenlin; Schmidt, Mark S.; Vivien, Denis; Orset, Cyrille; Jacotot, Etienne; Brenner, Charles; Duplus, Eric			Nicotinamide riboside, a form of vitamin B-3, protects against excitotoxicity-induced axonal degeneration	FASEB JOURNAL			English	Article						NAD(+); NMDA; FK866; cortical neurons; NR	NAD(+) PRECURSOR; EXTRACELLULAR-PRECURSORS; ACTIVATION; MONONUCLEOTIDE; NEURONS; BIOSYNTHESIS; METABOLISM; ALZHEIMERS; EXPRESSION; PATHWAYS	NAD(+) depletion is a common phenomenon in neurodegenerative pathologies. Excitotoxicity occurs in multiple neurologic disorders and NAD(+) was shown to prevent neuronal degeneration in this process through mechanisms that remained to be determined. The activity of nicotinamide riboside (NR) in neuroprotective models and the recent description of extracellular conversion of NAD(+) to NR prompted us to probe the effects of NAD(+) and NR in protection against excitotoxicity. Here, we show that intracortical administration of NR but not NAD(+) reduces brain damage induced by NMDA injection. Using cortical neurons, we found that provision of extracellular NR delays NMDA-induced axonal degeneration (AxD) much more strongly than extracellular NAD(+). Moreover, the stronger effect of NR compared to NAD(+) depends of axonal stress since in AxD induced by pharmacological inhibition of nicotinamide salvage, both NAD(+) and NR prevent neuronal death and AxD in a manner that depends on internalization of NR. Taken together, our findings demonstrate that NR is a better neuroprotective agent than NAD(+) in excitotoxicity-induced AxD and that axonal protection involves defending intracellular NAD(+) homeostasis.	[Vaur, Pauline; Brugg, Bernard; Mericskay, Mathias; Li, Zhenlin; Jacotot, Etienne; Duplus, Eric] Univ Paris 06, CNRS, INSERM,Sorbonne Univ, UMR Adaptat Biol & Vieillissement,UMR 8256,Inst B, Paris, France; [Li, Zhenlin] Univ Paris Sud, Univ Paris Saclay, INSERM, ERL U1164, Chatenay Malabry, France; [Mericskay, Mathias] Univ Paris Sud, Univ Paris Saclay, INSERM, Unite Signalisat & Physiopathol Cardiovasc, Chatenay Malabry, France; [Schmidt, Mark S.; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Vivien, Denis; Orset, Cyrille] Univ Caen Normandie, CHU Caen, Unite INSERM 1237, GIP Cyceron, Caen, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Iowa; CHU de Caen NORMANDIE; Universite de Caen Normandie	Duplus, E (corresponding author), Univ Paris 06, CNRS, Lab Adaptat Biol & Vieillissement, UMR 8256,Neuronal Stress & Aging Team, Case Courrier 12,9 Quai St Bernard, F-75005 Paris, France.	eric.duplus@upmc.fr	orset, cyrille/A-3540-2010; Brenner, Charles/D-6339-2014; DUPLUS, Eric/F-2969-2013; MERICSKAY, Mathias/M-3477-2018	orset, cyrille/0000-0002-9139-3430; VIVIEN, DENIS/0000-0002-7636-2185; LI, Zhenlin/0000-0002-3706-4505; Brenner, Charles/0000-0002-4955-3226; Schmidt, Mark/0000-0003-4593-4096; DUPLUS, Eric/0000-0003-1954-4836; /0000-0002-5301-1569; MERICSKAY, Mathias/0000-0002-6779-092X	Ile-de-France Region DIM Cerveau et Pensee fellowship; Agence Nationale pour la Recherche (ANR) [2011-RPIB-008-001 2012-17]; Roy J. Carver Trust	Ile-de-France Region DIM Cerveau et Pensee fellowship; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Roy J. Carver Trust	The authors thank ChromaDex (Irvine, CA, USA) for kindly providing NR, and MicroBrain Biotech (Paris, France) for technical advice and microfluidic chips. Funding was provided by Ile-de-France Region DIM Cerveau et Pensee fellowship (to P.V.); by Agence Nationale pour la Recherche (ANR) Grant Neuroscreen: 2011-RPIB-008-001 2012-17 (to B.B.); and by the Roy J. Carver Trust (to C.B.). C.B. serves as a member of the scientific advisory board of ChromaDex and is cofounder of ProHealthspan, which respectively developed NR for commercialization and sells NR to consumers. The remaining authors declare no conflicts of interest.	Antenor-Dorsey JAV, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-5; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Benarroch EE, 2015, NEUROLOGY, V84, P2076, DOI 10.1212/WNL.0000000000001601; Bi J, 2012, J NEUROCHEM, V120, P334, DOI 10.1111/j.1471-4159.2011.07566.x; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; CHOI DW, 1987, J NEUROSCI, V7, P369; Chung RS, 2005, EXP NEUROL, V193, P481, DOI 10.1016/j.expneurol.2005.01.005; Cohen MS, 2012, CHEM BIOL, V19, P179, DOI 10.1016/j.chembiol.2012.01.012; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Deleglise B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071103; Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164; Fletcher RS, 2017, MOL METAB, V6, P819, DOI 10.1016/j.molmet.2017.05.011; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435; Hamity MV, 2017, PAIN, V158, P962, DOI 10.1097/j.pain.0000000000000862; Hasmann M, 2003, CANCER RES, V63, P7436; Hosie KA, 2012, ASN NEURO, V4, P47, DOI 10.1042/AN20110031; Jullienne A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-68; Kandan NM, 2013, EXP NEUROL, V246, P44, DOI 10.1016/j.expneurol.2012.06.003; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; LYON MF, 1993, P NATL ACAD SCI USA, V90, P9717, DOI 10.1073/pnas.90.20.9717; Magnifico S, 2013, FASEB J, V27, P4712, DOI 10.1096/fj.13-229781; Martire S, 2015, MECH AGEING DEV, V146, P53, DOI 10.1016/j.mad.2015.04.001; Milde S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001539; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Paxinos G, 2012, PAXINOS FRANKLINS MO; Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19749; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933; Trammell SAJ, 2016, J NUTR, V146, P957, DOI 10.3945/jn.116.230078; Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012; Verghese PB, 2011, P NATL ACAD SCI USA, V108, P19054, DOI 10.1073/pnas.1107325108; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang XW, 2014, INT J MOL SCI, V15, P20449, DOI 10.3390/ijms151120449; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Young JD, 2016, BIOCHEM SOC T, V44, P869, DOI 10.1042/BST20160038; Zhang WP, 2010, J CEREBR BLOOD F MET, V30, P1962, DOI 10.1038/jcbfm.2010.71; Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	56	52	54	3	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5440	5452		10.1096/fj.201700221RR	http://dx.doi.org/10.1096/fj.201700221RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842432				2022-12-26	WOS:000416588300027
J	Alterauge, A; Kellinghaus, M; Jackowski, C; Shved, N; Ruhli, F; Maixner, F; Zink, A; Rosendahl, W; Losch, S				Alterauge, Amelie; Kellinghaus, Manuel; Jackowski, Christian; Shved, Natallia; Ruehli, Frank; Maixner, Frank; Zink, Albert; Rosendahl, Wilfried; Loesch, Sandra			The Sommersdorf mummies-An interdisciplinary investigation on human remains from a 17th-19th century aristocratic crypt in southern Germany	PLOS ONE			English	Article							CAPUCHIN CATACOMBS; LITHUANIAN MUMMIES; SCOLIOSIS; CT; DIAGNOSIS; AGE; ATHEROSCLEROSIS; PALEORADIOLOGY; SEQUENCE; PALERMO	Sommersdorf Castle (Bavaria, Germany) is a medieval castle complex which has been inhabited by the aristocratic family von Crailsheim. The deceased were entombed in a crypt located in the parapets underneath the castle's church, resulting in mummification of the bodies. Based on the family chronicle and oral history, identities have been ascribed to the mummies. The aim of the study is therefore to test the accuracy of the historical records in comparison to archaeological, anthropological and genetic data. Today, the crypt houses eleven wooden coffins from the 17th to 19th century AD. In ten of these, mummified and scattered human remains were found. Archive records were studied in order to identify names, ancestry, titles, occupation, date of birth and death, and place of interment of the individuals. The coffins were visually inspected and dated by typo-chronology, and the mummified and scattered skeletal remains were subjected to a physical anthropological examination. In total, the crypt contains the remains of a minimum number of nine individuals, among them three adult males, five adult females and one infant. A detailed scientific examination, including prior conservation, ancient DNA analyses, and computed tomography (CT), was performed on five mummies. By means of the CT data age at death, sex, body height, pathologies, and anatomical variants were investigated. CT analysis further showed that the bodies were naturally mummified. Mitochondrial DNA analyses revealed that the tested individuals are not maternally related. In addition, health, living conditions and circumstances of death of the entombed individuals could be highlighted. Being confronted with the strengths, weaknesses and limitations of each methodological approach, probable identification was achieved in two cases.	[Alterauge, Amelie; Loesch, Sandra] Univ Bern, Inst Forens Med, Dept Phys Anthropol, Bern, Switzerland; [Alterauge, Amelie] Heidelberg Univ, Inst Pre & Protohist & Near Eastern Archaeol, Heidelberg, Germany; [Kellinghaus, Manuel; Jackowski, Christian] Univ Bern, Inst Forens Med, Bern, Switzerland; [Shved, Natallia; Ruehli, Frank] Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland; [Maixner, Frank; Zink, Albert] Eurac Res, Inst Mummy Studies, Bolzano, Italy; [Rosendahl, Wilfried] Reiss Engelhorn Museen, German Mummy Project, Mannheim, Germany	University of Bern; Ruprecht Karls University Heidelberg; University of Bern; University of Zurich; European Academy of Bozen-Bolzano	Alterauge, A (corresponding author), Univ Bern, Inst Forens Med, Dept Phys Anthropol, Bern, Switzerland.; Alterauge, A (corresponding author), Heidelberg Univ, Inst Pre & Protohist & Near Eastern Archaeol, Heidelberg, Germany.	amelie.alterauge@irm.unibe.ch	Zink, Albert/P-4024-2015; Lösch, Sandra/H-3230-2013; Maixner, Frank/AAY-7033-2020; Lösch, Sandra/AAA-9806-2021	Zink, Albert/0000-0002-1461-747X; Lösch, Sandra/0000-0003-3442-9764; Lösch, Sandra/0000-0003-3442-9764; Maixner, Frank/0000-0003-2846-8994	Karl Steinbuch Scholarship, MFG Foundation Baden-Wurttemberg	Karl Steinbuch Scholarship, MFG Foundation Baden-Wurttemberg	Financial support for AA was provided by the Karl Steinbuch Scholarship, MFG Foundation Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsadi G., 1970, HIST HUMAN LIFESPAN; Adler CP., 2000, BONE DIS MACROSCOPIC; Allam AH, 2011, JACC-CARDIOVASC IMAG, V4, P315, DOI 10.1016/j.jcmg.2011.02.002; Alterauge A., 2015, SOC HIST ARCHAEOLOGY, V48, P28; Alterauge A, 2014, ANTHR PATHWAYS FESTS, P119; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Appleby J, 2014, LANCET, V383, P1944, DOI 10.1016/S0140-6736(14)60762-5; Aturaliya S, 1999, J FORENSIC SCI, V44, P893; Aufderheide A.C., 2003, SCI STUDY MUMMIES; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Bach H, 1965, ANTHROPOL ANZ, V29, P12; Behrend J-P, 1993, EXPEDITIONEN INS UNB, P230; Bengtsson M., 2002, HYGIEA INT, V3, P53, DOI [10.3384/hygiea.1403-8668.023153, DOI 10.3384/HYGIEA.1403-8668.023153]; Biedermann JG, 1748, GESCHLECHTS REGISTER; Binder M, 2010, ARCHAEOPLUS SCHRIFTE, P42; Boyd KL, 2015, J FORENSIC SCI, V60, P363, DOI 10.1111/1556-4029.12683; Breitinger E., 1938, ANTHROPOL ANZ, V14, P249; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Brothwell D., 1981, DIGGING BONES EXCAVA; BROWN K, 1994, RADIOGRAPHICS, V14, P1247, DOI 10.1148/radiographics.14.6.7855339; Bruckner W., 1984, FRAUENGRAB 1758 KIRC, V1983, P183; Buikstra JE, 1994, ARKANSAS ARCHEOLOGIC; Caselitz P, 1998, DENTAL ANTHROPOLOGY, P203; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; Colleter R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167988; Cox M., 2001, CRYPT ARCHAEOLOGY AP; Elgenmark O., 1946, NORMAL DEV OSSIFIC C; Fehring G. P., 1967, JOHANNESKIRCHE CRAIL, P9; Fingerlin I., 1992, FORSCHUNGEN BERICHTE; Garvin HM, 2008, J FORENSIC SCI, V53, P1023, DOI 10.1111/j.1556-4029.2008.00793.x; Gill-Frerking H, 2011, 7 WORLD C MUMM STUD; Gill-Frerking H., 2015, MUMMIES WORLD ENCY M, P81; Goubitz O., 2007, STEPPING TIME ARCHAE; Grabherr S, 2009, EUR RADIOL, V19, P419, DOI 10.1007/s00330-008-1155-y; Graser H., 1990, TRIESDORFER HEFTE, V3, P1; Graw M, 2008, RESTAURIERUNG WOLFST, P27; Grieb MH., 2007, NURNBERGER KUNSTLERL; Haeusler M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168014; HAIDLE MN, 1995, INT J OSTEOARCHAEOL, V5, P359, DOI 10.1002/oa.1390050406; HILLSON S, 1996, DENT ANTHR; Jackowski C, 2008, RADIOGRAPHICS, V28, P1477, DOI 10.1148/rg.285075112; Janicki JA, 2007, PAED CHILD HEALT-CAN, V12, P771, DOI 10.1093/pch/12.9.771; Kapplinger J, 2015, SARGE FRANKISCHEN HO; Kenzler H, 2015, ARCHAEOLOGY OF DEATH IN POST-MEDIEVAL EUROPE, P148; Kilgore L, 2010, INT J OSTEOARCHAEOL, V20, P630, DOI 10.1002/oa.1085; KLEISS E, 1967, Zeitschrift fuer Morphologie und Anthropologie, V59, P204; Klocke J., 2010, MUMMIES OF THE WORLD, P251; Konin GP, 2010, AM J NEURORADIOL, V31, P1778, DOI 10.3174/ajnr.A2036; Krause D, 2004, HDB GERICHTLICHE MED, P150; Kristof LA, 2010, EUR C RAD ECR VIENN; Lee HY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-483; Lenk N., 2008, RESTAURIERUNG WOLFST, P19; Leopold D, 1998, IDENTIFIKATION UNBEK, P289; Loesch S, 2011, GESCH TRADITION MUMI, P113; Losch S, 2009, THESIS; Mann R. W., 2005, PHOTOGRAPHIC REGIONA; Mant M, 2015, INT J HIST ARCHAEOL, V19, P188, DOI 10.1007/s10761-014-0286-x; Martin Rudolf, 1914, LEHRBUCH ANTHR SYSTE; MAU H, 1982, Z ORTHOP GRENZGEB, V120, P58, DOI 10.1055/s-2008-1051576; Miles A.E.W., 1963, S SOC STUDY HUMAN BI, P191; Muller A., 2002, Z BAYERISCHE KIRCHEN, V71, P223; Mylius U., 1984, THESIS; Nerlich AG, 2015, BIOMED RES INT, V2015; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Panzer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133364; Panzer S, 2010, RADIOGRAPHICS, V30, P1123, DOI 10.1148/rg.304095174; Pap I., 1997, ACTA BIOL SZEGEDIENS, V42, P107; Petrella E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154349; Pinar G, 2013, FEMS MICROBIOL ECOL, V86, P341, DOI 10.1111/1574-6941.12165; Pinheiro J, 2006, FORENSIC ANTHROPOLOGY AND MEDICINE: COMPLEMENTARY SCIENCES FROM RECOVERY TO CAUSE OF DEATH, P85, DOI 10.1007/978-1-59745-099-7_5; Piombino-Mascali D, 2015, HOMO, V66, P420, DOI 10.1016/j.jchb.2015.01.004; Piombino-Mascali D, 2015, ANAT REC, V298, P988, DOI 10.1002/ar.23132; Piombino-Mascali D, 2014, AM J HUM BIOL, V26, P676, DOI 10.1002/ajhb.22578; Piombino-Mascali Dario, 2014, Papers on Anthropology University of Tartu, V23, P118; Preuschoft H, 1969, ANTHROPOLOGIE, V7, P55; Ramisch HK, 1964, LANDKREIS FEUCHTWANG, P21; Rechter G, 2007, ARCH FAMILIENSTIFTUN; Roberts C.A., 2007, ARCHAEOLOGY DIS; Ruhli FJ, 2004, CAN ASSOC RADIOL J, V55, P218; Saukko PJ, 2004, KNIGHTS FORENSIC PAT; Schanandore JV, 2015, THESIS; Scheuer L., 2000, DEV JUVENILE OSTEOLO; SCHMID F, 1958, Fortschr Geb Rontgenstr Nuklearmed, V89, P350; Schmitz-Esser Romedio, 2014, LEICHNAM MITTELALTER; Schnitzer A, 1843, HDB KINDERKRANKHEITE; Schultz M, 1988, ANTHR HDB VERGLEICHE, V1, P480; Schwarz R, 2015, ANTHROPOL ANZ, V72, P335, DOI 10.1127/anthranz/2015/0515; Spoerl W., 1980, RIETER KIRCHE KALBEN; Steeger W., 2003, TRAUER HOFFNUNG STER, P11; Steinheimer M., 1985, ROSSTALER HEIMATBLAT, V11, P15; STLOUKAL M, 1978, HOMO, V29, P53; Stloukal M., 1963, ANTHROPOLOGIE, V1, P35; Strobl A, 2009, GLAUBE ABERGLAUBE TO, P311; Strobl A., 2014, ENTWICKLUNG HOLZSARG, P20; Swann June, 1983, SHOES; Szikossy I, 2010, MUMMIES OF THE WORLD, P160; Tchapla A, 2004, J SEP SCI, V27, P217, DOI 10.1002/jssc.200301607; Thompson RC, 2014, GLOB HEART, V9, P187, DOI 10.1016/j.gheart.2014.03.2455; Tingle EC, 2016, DYING DEATH BURIAL C; Tyroff K., 1805, GESCHLECHTS WAPPENBE; Verwesung Schoenen D., MIKROBIELLE ABBAUPRO; Villa C, 2016, J ANAT; Villa C, 2013, AM J PHYS ANTHROPOL, V151, P158, DOI 10.1002/ajpa.22254; Villari N, 2009, RADIOGRAPHICS, V29, P2101, DOI 10.1148/rg.297085212; vom Holtz MGF, 1891, GENERALFELDZEUGMEIST; von Baron Crailsheim M, 2010, MUMMIES OF THE WORLD, P362; von Crailsheim SF, 1905, REICHSFREIHERRN CRAI; von Heyking K., 2013, THESIS; von Ow MF, 1985, JB HIST VEREINS MITT, V1984, P289; Wieczorek A., 2007, MUMIEN TRAUM EWIGEN; Wieczorek A., 2010, MUMMIES OF THE WORLD; Zech WD, 2016, LEGAL MED-TOKYO, V19, P61, DOI 10.1016/j.legalmed.2016.02.004	114	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183588	10.1371/journal.pone.0183588	http://dx.doi.org/10.1371/journal.pone.0183588			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2PY	28859116	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000408740500024
J	Laitinen, A; Bockelman, C; Hagstrom, J; Kokkola, A; Kallio, P; Haglund, C				Laitinen, Alli; Bockelman, Camilla; Hagstrom, Jaana; Kokkola, Arto; Kallio, Pauliina; Haglund, Caj			High PROX1 expression in gastric cancer predicts better survival	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; ADENOCARCINOMA; MUTATIONS; CELLS; GENE	Background PROX1 is a transcription factor involved in the development of various organs. It has also an important function in colorectal cancer progression. The aim of this study was to investigate the prognostic role of PROX1 expression in gastric cancer. Methods We evaluated PROX1 expression in gastric cancer by immunohistochemistry of tumor-tissue microarrays including tumor specimens from 283 patients who underwent surgery at Helsinki University Hospital. We investigated the association of PROX1 expression with clinicopathologic variables and patient survival. Results Cytoplasmic PROX1 reactivity was high in 56 (20.5%) and low in 217 (79.5%) cases. Low PROX1 immunostaining associated with diffuse cancer type (p = 0.002). In subgroup analysis, PROX1 was a significant marker of better prognosis in patients aged under 66 (p = 0.007), in those with intestinal cancer (p = 0.025), among men (p = 0.019), and in tumors of less than 5 cm diameter (p = 0.030). Patients with high PROX1 expression had a cancer-specific 5-year survival of 65.6% (95% CI 52.7-78.5), compared to 37.1% (95% CI 30.2-44.0) for those with low expression (p = 0.004, log-rank test). This result remained significant in multivariable analysis (HR = 0.56; 95% CI 0.35-0.90; p = 0.017). Conclusion In gastric cancer, high cytoplasmic PROX1 expression is an independent marker of better prognosis.	[Laitinen, Alli; Bockelman, Camilla; Kokkola, Arto; Haglund, Caj] Univ Helsinki, Dept Surg, Helsinki, Finland; [Laitinen, Alli; Bockelman, Camilla; Hagstrom, Jaana; Kokkola, Arto; Haglund, Caj] Helsinki Univ Hosp, Helsinki, Finland; [Laitinen, Alli; Bockelman, Camilla; Hagstrom, Jaana; Kallio, Pauliina; Haglund, Caj] Univ Helsinki, Res Programs Unit, Translat Canc Biol, Helsinki, Finland; [Hagstrom, Jaana] Univ Helsinki, Dept Pathol & Oral Pathol, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Laitinen, A (corresponding author), Univ Helsinki, Dept Surg, Helsinki, Finland.; Laitinen, A (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Laitinen, A (corresponding author), Univ Helsinki, Res Programs Unit, Translat Canc Biol, Helsinki, Finland.	alli.laitinen@helsinki.fi	Böckelman, Camilla/AFX-4447-2022; Haglund, Caj/N-1240-2019; Hagström, Jaana/G-1468-2018	Hagström, Jaana/0000-0001-6079-7881; Bockelman, Camilla/0000-0002-1628-0305; Kallio, Pauliina/0000-0001-6374-6203	Finnish Cancer Foundation; Kurt och Doris Palander Foundation; Sigrid Juselius Foundation; Martti I. Turunen Foundation; Medicinska understodsforeningen Liv och Halsa	Finnish Cancer Foundation; Kurt och Doris Palander Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Martti I. Turunen Foundation; Medicinska understodsforeningen Liv och Halsa	This study was supported by grants from the Finnish Cancer Foundation, the Kurt och Doris Palander Foundation, the Sigrid Juselius Foundation, the Martti I. Turunen Foundation, and Medicinska understodsforeningen Liv och Halsa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Elsir T, 2012, CANCER METAST REV, V31, P793, DOI 10.1007/s10555-012-9390-8; Elsir T, 2010, J NEUROPATH EXP NEUR, V69, P129, DOI 10.1097/NEN.0b013e3181ca4767; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Laerm A, 2007, J HEPATOL, V46, P89, DOI 10.1016/j.jhep.2006.07.033; Nagai H, 2003, GENE CHROMOSOME CANC, V38, P13, DOI 10.1002/gcc.10248; Park KJ, 2017, GASTRIC CANCER, V20, P104, DOI 10.1007/s10120-015-0592-y; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Roodakker KR, 2016, ONCOTARGET, V7, P72431, DOI 10.18632/oncotarget.11957; Saukkonen K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2497-5; Shimoda M, 2006, CLIN CANCER RES, V12, P6005, DOI 10.1158/1078-0432.CCR-06-0712; Skog M, 2011, BRIT J CANCER, V105, P1346, DOI 10.1038/bjc.2011.297; Taban O, 2014, ANTICANCER RES, V34, P3439; Takahashi M, 2006, NEOPLASIA, V8, P1003, DOI 10.1593/neo.06595; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Versmold B, 2007, INT J CANCER, V121, P547, DOI 10.1002/ijc.22705; Yoo J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001046; Yoshimoto T, 2007, BIOCHEM BIOPH RES CO, V359, P258, DOI 10.1016/j.bbrc.2007.05.071; Zhang B, 2016, AM J CANCER RES, V6, P2021	19	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183868	10.1371/journal.pone.0183868	http://dx.doi.org/10.1371/journal.pone.0183868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854215	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600063
J	Meng, XR; Gu, WY; Chen, YJ; Zhang, JW				Meng, Xiangrui; Gu, Wenya; Chen, Yunjie; Zhang, Jianwei			Brain MR image segmentation based on an improved active contour model	PLOS ONE			English	Article							BIAS FIELD ESTIMATION; C-MEANS ALGORITHM; LEVEL SET METHOD; AUTOMATIC SEGMENTATION; CONSTRAINT; OPTIMIZATION; MINIMIZATION; INTEGRATION; FRAMEWORK; DRIVEN	It is often a difficult task to accurately segment brain magnetic resonance (MR) images with intensity in-homogeneity and noise. This paper introduces a novel level set method for simultaneous brain MR image segmentation and intensity inhomogeneity correction. To reduce the effect of noise, novel anisotropic spatial information, which can preserve more details of edges and corners, is proposed by incorporating the inner relationships among the neighbor pixels. Then the proposed energy function uses the multivariate Student's t-distribution to fit the distribution of the intensities of each tissue. Furthermore, the proposed model utilizes Hidden Markov random fields to model the spatial correlation between neighboring pixels/voxels. The means of the multivariate Student's t-distribution can be adaptively estimated by multiplying a bias field to reduce the effect of intensity inhomogeneity. In the end, we reconstructed the energy function to be convex and calculated it by using the Split Bregman method, which allows our framework for random initialization, thereby allowing fully automated applications. Our method can obtain the final result in less than 1 second for 2D image with size 256 x 256 and less than 300 seconds for 3D image with size 256 x 256 x 171. The proposed method was compared to other state-of-the-art segmentation methods using both synthetic and clinical brain MR images and increased the accuracies of the results more than 3%.	[Meng, Xiangrui; Gu, Wenya] Nanjing Univ Informat Sci & Technol, Sch Binjiang, Nanjing, Jiangsu, Peoples R China; [Chen, Yunjie; Zhang, Jianwei] Nanjing Univ Informat Sci & Technol, Sch Math & Stat, Nanjing, Jiangsu, Peoples R China	Nanjing University of Information Science & Technology; Nanjing University of Information Science & Technology	Chen, YJ (corresponding author), Nanjing Univ Informat Sci & Technol, Sch Math & Stat, Nanjing, Jiangsu, Peoples R China.	priestcyj@nuist.edu.cn		Chen, yunjie/0000-0002-3131-2547	National Nature Science Foundation of China [61672291]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (61672291).	Ahmed MN, 2002, IEEE T MED IMAGING, V21, P193, DOI 10.1109/42.996338; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; Bresson X, 2007, J MATH IMAGING VIS, V28, P151, DOI 10.1007/s10851-007-0002-0; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Caselles V., 1995, INT J COMPUT VISION, P61; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chan TF, 2006, SIAM J APPL MATH, V66, P1632, DOI 10.1137/040615286; Chang HB, 2017, IEEE T MED IMAGING, V36, P721, DOI 10.1109/TMI.2016.2636026; Chen Y, 2012, IET COMPUT VIS, V6, P610, DOI 10.1049/iet-cvi.2011.0263; Chen YJ, 2014, MAGN RESON IMAGING, V32, P941, DOI 10.1016/j.mri.2014.05.003; Cherel M, 2015, P SPIE INT SOC OPTIC, P9413; Cong W, 2015, J MED IMAG HEALTH IN, V5, P1821, DOI 10.1166/jmihi.2015.1652; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Duan YP, 2014, IEEE IMAGE PROC, P6, DOI 10.1109/ICIP.2014.7025000; Duan YP, 2015, IEEE T IMAGE PROCESS, V24, P3927, DOI 10.1109/TIP.2015.2451957; Han Y, 2012, PATTERN RECOGN, V45, P363, DOI 10.1016/j.patcog.2011.05.002; Ji ZX, 2014, PATTERN RECOGN, V47, P2454, DOI 10.1016/j.patcog.2014.01.017; Ji ZX, 2012, APPL SOFT COMPUT, V12, P1659, DOI 10.1016/j.asoc.2012.02.010; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Lee H, 2014, EXPERT SYST APPL, V41, P2644, DOI 10.1016/j.eswa.2013.10.055; Li CY, 2013, IEEE T BIO-MED ENG, V60, P2967, DOI 10.1109/TBME.2013.2267212; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Li CM, 2014, MAGN RESON IMAGING, V32, P913, DOI 10.1016/j.mri.2014.03.010; Li CM, 2011, IEEE T IMAGE PROCESS, V20, P2007, DOI 10.1109/TIP.2011.2146190; Li CM, 2009, PROC CVPR IEEE, P218, DOI 10.1109/CVPRW.2009.5206553; Li CM, 2009, LECT NOTES COMPUT SC, V5636, P288; Liu C., 1994, THESIS; Liu G, 2013, GEOSC REM SENS S, P3730; Marquez-Neila P, 2014, IEEE T PATTERN ANAL, V36, P2, DOI 10.1109/TPAMI.2013.106; Mignotte M, 2000, IEEE T IMAGE PROCESS, V9, P1216, DOI 10.1109/83.847834; Mishra AK, 2011, IEEE T PATTERN ANAL, V33, P310, DOI 10.1109/TPAMI.2010.83; Mumford D., 1988, IMAGE UNDERSTANDING, P19; Osher S, 2001, J COMPUT PHYS, V169, P463, DOI 10.1006/jcph.2000.6636; Patil DD., 2013, IJCSMC, V2, P22; Paulinas M, 2008, INFORM TECHNOLOGY CO, V36, P278; Petitjean C, 2011, MED IMAGE ANAL, V15, P169, DOI 10.1016/j.media.2010.12.004; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P885, DOI 10.1109/42.811268; Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076; Wang L, 2015, NEUROIMAGE, V108, P160, DOI 10.1016/j.neuroimage.2014.12.042; Wang L, 2014, NEUROIMAGE, V89, P152, DOI 10.1016/j.neuroimage.2013.11.040; Wang L, 2014, NEUROIMAGE, V84, P141, DOI 10.1016/j.neuroimage.2013.08.008; Wang L, 2013, HUM BRAIN MAPP, V34, P956, DOI 10.1002/hbm.21486; Wang L, 2011, NEUROIMAGE, V58, P805, DOI 10.1016/j.neuroimage.2011.06.064; Wang L, 2010, J NEUROSCI METH, V188, P316, DOI 10.1016/j.jneumeth.2010.03.004; Wang L, 2009, SIGNAL PROCESS, V89, P2435, DOI 10.1016/j.sigpro.2009.03.014; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Wu H, 2013, IEEE T PATTERN ANAL, V35, P1298, DOI 10.1109/TPAMI.2012.207; Xie M, 2015, MED BIOL ENG COMPUT, V53, P23, DOI 10.1007/s11517-014-1198-y; Yang X, 2015, IEEE T IMAGE PROCESS, V24, P9, DOI 10.1109/TIP.2014.2372615; Zhang H, 2013, IEEE SIGNAL PROC LET, V20, P117, DOI 10.1109/LSP.2012.2230626; Zhang KH, 2016, IEEE T CYBERNETICS, V46, P546, DOI 10.1109/TCYB.2015.2409119; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhao F, 2013, NEUROCOMPUTING, V106, P115, DOI 10.1016/j.neucom.2012.10.022; Zhou X, 2016, CIRC SYST SIGNAL PR, V35, P1729, DOI 10.1007/s00034-015-0143-0	54	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183943	10.1371/journal.pone.0183943	http://dx.doi.org/10.1371/journal.pone.0183943			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854235	Green Published, gold, Green Submitted			2022-12-26	WOS:000408693600069
J	Streicher, S; Lutermann, H; Bennett, NC; Bertelsen, MF; Mohammed, OB; Manger, PR; Scantlebury, M; Ismael, K; Alagaili, AN				Streicher, S.; Lutermann, H.; Bennett, N. C.; Bertelsen, M. F.; Mohammed, O. B.; Manger, P. R.; Scantlebury, M.; Ismael, K.; Alagaili, A. N.			Living on the edge: Daily, seasonal and annual body temperature patterns of Arabian oryx in Saudi Arabia	PLOS ONE			English	Article							GAZELLA-SUBGUTTUROSA-MARICA; ARID-ZONE MAMMALS; REPRODUCTIVE SUCCESS; FOOD-CONSUMPTION; LEUCORYX; DESERT; HETEROTHERMY; BEHAVIOR; BRAIN; ACCLIMATION	Heterothermy, the ability to allow body temperature (T-b) to fluctuate, has been proposed as an adaptive mechanism that enables large ungulates to cope with the high environmental temperatures and lack of free water experienced in arid environments. By storing heat during the daytime and dissipating it during the night, arid-adapted ungulates may reduce evaporative water loss and conserve water. Adaptive heterothermy in large ungulates should be particularly pronounced in hot environments with severely limited access to free water. In the current study we investigated the effects of environmental temperature (ambient, T-a and soil, T-s) and water stress on the T-b of wild, free-ranging Arabian oryx (Oryx leucoryx) in two different sites in Saudi Arabia, Mahazat as-Sayd (MS) and Uruq Bani Ma'arid (UBM). Using implanted data loggers wet took continuous T-b readings every 10 minutes for an entire calendar year and determined the T-b amplitude as well as the heterothermy index (HI). Both differed significantly between sites but contrary to our expectations they were greater in MS despite its lower environmental temperatures and higher rainfall. This may be partially attributable to a higher activity in an unfamiliar environment for translocated animals in UBM. As expected T-b amplitude and HI were greatest during summer. Only minor sex differences were apparent that may be attributable to sex-specific investment into reproduction (e.g. male-male competition) during rut. Our results suggest that the degree of heterothermy is not only driven by extrinsic factors (e.g. environmental temperatures and water availability), but may also be affected by intrinsic factors (e.g. sex and/or behaviour).	[Streicher, S.; Lutermann, H.; Bennett, N. C.; Manger, P. R.] Univ Pretoria, Dept Zool & Entomol, Pretoria, South Africa; [Bennett, N. C.; Bertelsen, M. F.; Mohammed, O. B.; Ismael, K.; Alagaili, A. N.] King Saud Univ, Dept Zool, Coll Sci, KSU Mammals Res Chair, Riyadh, Saudi Arabia; [Bertelsen, M. F.; Manger, P. R.] Copenhagen Zoo, Ctr Zoo & Wild Anim Hlth, Frederiksberg, Denmark; [Manger, P. R.] Univ Witwatersrand, Fac Hlth Sci, Sch Anat Sci, Johannesburg, South Africa; [Scantlebury, M.] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast, Antrim, North Ireland; [Ismael, K.] Prince Saud Al Faisal Wildlife Res Ctr, At Taif, Saudi Arabia; [Alagaili, A. N.] Saudi Wildlife Author, Riyadh, Saudi Arabia	University of Pretoria; King Saud University; University of Witwatersrand; Queens University Belfast	Alagaili, AN (corresponding author), King Saud Univ, Dept Zool, Coll Sci, KSU Mammals Res Chair, Riyadh, Saudi Arabia.; Alagaili, AN (corresponding author), Saudi Wildlife Author, Riyadh, Saudi Arabia.	aziz99@gmail.com	Mohammed, Osama B/C-3226-2011; Bertelsen, Mads/AAA-5746-2022; Lutermann, Heike/A-4692-2008; Alagaili, Abdulaziz/C-4278-2018	Mohammed, Osama B/0000-0001-5457-2555; Bertelsen, Mads/0000-0001-9201-7499; Lutermann, Heike/0000-0002-7521-2302; Alagaili, Abdulaziz/0000-0002-9733-4220	National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [11-ENV1918-02]	National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia	Funded by National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Award Number 11-ENV1918-02.	AbdElGhani MM, 1997, J ARID ENVIRON, V35, P673, DOI 10.1006/jare.1996.0193; [Anonymous], 1989, ANIMAL REINTRODUCTIO; ASMODE JF, 1990, REV ECOL-TERRE VIE, V45, P295; Boyles JG, 2011, J THERM BIOL, V36, P373, DOI 10.1016/j.jtherbio.2011.07.007; Boyles JG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P115, DOI 10.1086/656724; Brigham RM, 2011, J THERM BIOL, V36, P376, DOI 10.1016/j.jtherbio.2011.08.001; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cain JW, 2006, WILDLIFE SOC B, V34, P570, DOI 10.2193/0091-7648(2006)34[570:MOTAWB]2.0.CO;2; Corp N, 1998, J ZOOL, V246, P369; Davimes JG, 2016, J BIOL RHYTHM, V31, P365, DOI 10.1177/0748730416645729; De Vos A., 1975, RODENTS DESERT ENV, P70; Degen A. A, 1997, ECOPHYSIOLOGY SMALL, P93; Fuller A, 2014, PHYSIOLOGY, V29, P159, DOI 10.1152/physiol.00049.2013; Grigg G, 2009, BIOL LETTERS, V5, P853, DOI 10.1098/rsbl.2009.0450; Henderson D.S., 1974, Oryx, V12, P347; Hetem RS, 2016, BIOL REV, V91, P187, DOI 10.1111/brv.12166; Hetem RS, 2012, ZOOLOGY, V115, P411, DOI 10.1016/j.zool.2012.04.005; Hetem RS, 2012, J EXP BIOL, V215, P3917, DOI 10.1242/jeb.074666; Hetem RS, 2012, J COMP PHYSIOL B, V182, P437, DOI 10.1007/s00360-011-0620-0; Hetem RS, 2010, J COMP PHYSIOL B, V180, P1111, DOI 10.1007/s00360-010-0480-z; Islam Zafar M., 2011, P180; Ismail K, 2011, J ARID ENVIRON, V75, P125, DOI 10.1016/j.jaridenv.2010.09.017; Kinahan AA, 2007, J THERM BIOL, V32, P47, DOI 10.1016/j.jtherbio.2006.09.002; Lease HM, 2014, J THERM BIOL, V45, P150, DOI 10.1016/j.jtherbio.2014.08.008; Louw G.N., 1982, ECOLOGY DESERT ORGAN; Macfarlane WV, 1792, S ZOOL SOC LONDON, V31, P261; Maloney SK, 2002, PFLUG ARCH EUR J PHY, V443, P437, DOI 10.1007/s004240100704; Mandaville James, 1990, FLORA E SAUDI ARABIA; MANDAVILLE JP, 1986, P ROY SOC EDINB B, V89, P147, DOI 10.1017/S0269727000008988; McKechnie AE, 2007, J EXP BIOL, V210, P97, DOI 10.1242/jeb.02615; Meigs P., 1953, REV RES ARID ZONE HY, V1, P203; Mesochina P, 2003, CR BIOL, V326, pS158, DOI 10.1016/S1631-0691(03)00053-2; Mitchell D, 2002, COMP BIOCHEM PHYS B, V131, P571, DOI 10.1016/S1096-4959(02)00012-X; Munoz-Garcia A, 2014, METHODS ECOL EVOL, V5, P141, DOI 10.1111/2041-210X.12131; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Ostrowski S, 2006, J COMP PHYSIOL B, V176, P191, DOI 10.1007/s00360-005-0040-0; Ostrowski S, 2006, J EXP BIOL, V209, P1421, DOI 10.1242/jeb.02151; Ostrowski S, 2003, J EXP BIOL, V206, P1471, DOI 10.1242/jeb.00275; Ostrowski S, 2002, J MAMMAL, V83, P665, DOI 10.1644/1545-1542(2002)083<0665:WIAFCO>2.0.CO;2; Ostrowski S, 1998, ORYX, V32, P209, DOI 10.1017/S0030605300029975; Park N, 2002, MOVEMENTS ACTIVITIES, V108, P317; Scantlebury M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036053; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; SCHMIDTNIELSEN K, 1957, AM J PHYSIOL, V188, P103, DOI 10.1152/ajplegacy.1956.188.1.103; Sempere AJ, 1996, GEN COMP ENDOCR, V101, P235, DOI 10.1006/gcen.1996.0026; Smit B, 2010, FUNCT ECOL, V24, P330, DOI 10.1111/j.1365-2435.2009.01646.x; Stewart D. R. M., 1963, East African Wildlife Journal, V1, P103; STRAUSS WM, 2003, ECOLOGICAL STUDY REI; Tear TH, 1999, BIOL CONSERV, V89, P199, DOI 10.1016/S0006-3207(98)00136-0; Tear TH, 1997, J WILDLIFE MANAGE, V61, P1142, DOI 10.2307/3802112; Williams JB, 2001, J EXP BIOL, V204, P2301; Wronski T, 2011, MAMM BIOL, V76, P506, DOI 10.1016/j.mambio.2011.01.004; Zafar-ul Islam M, 2011, ZOOL MIDDLE EAST, P125, DOI 10.1080/09397140.2011.10648904	53	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0180269	10.1371/journal.pone.0180269	http://dx.doi.org/10.1371/journal.pone.0180269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854247	Green Published, gold, Green Submitted			2022-12-26	WOS:000408693600002
J	Blazer, A; Wang, BH; Simpson, D; Kirchhoff, T; Heffron, S; Clancy, RM; Heguy, A; Ray, K; Snuderl, M; Buyon, JP				Blazer, Ashira; Wang, Binhuan; Simpson, Danny; Kirchhoff, Tomas; Heffron, Sean; Clancy, Robert M.; Heguy, Adriana; Ray, Karina; Snuderl, Matija; Buyon, Jill P.			Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients	PLOS ONE			English	Article							INTERNATIONAL COLLABORATING CLINICS; CARDIOVASCULAR-DISEASE; KIDNEY-DISEASE; APOL1; CYTOTOXICITY; NEPHROPATHY; PROTEIN; CLASSIFICATION; LOCALIZATION; RECEPTOR	Objective Atherosclerosis is exaggerated in African American (AA) systemic lupus erythematosus (SLE) patients, with doubled cardiovascular disease (CVD) risk compared to White patients. The extent to which common Apolipoprotein L1 (APOL1) risk alleles (RA) contribute to this trend is unknown. This retrospective cohort study assessed prevalent atherosclerotic disease across APOL1 genotypes in AA SLE patients. Methods One hundred thirteen AA SLE subjects were APOL1-genotyped and stratified as having: zero risk alleles, one risk allele, or two risk alleles. Chart review assessed CVD manifestations including abdominal aortic aneurysm, angina, carotid artery disease, coronary artery disease, myocardial infarction, peripheral vascular disease, stroke, and vascular calcifications. Associations between the genotypes and a composite endpoint defined as one or more CVD manifestations were calculated using logistic regression. Symptomatic atherosclerotic disease, excluding incidental vascular calcifications, was also assessed. Results The 0-risk-allele, 1-risk-allele and 2-risk-allele groups, respectively, comprised 34%, 53%, and 13% of the cohort. Respectively, 13.2%, 41.7%, and 60.0% of the 0-risk allele, 1-risk-allele, and 2-risk-allele groups met the composite endpoint of atherosclerotic CVD (p = 0.001). Adjusting for risk factors-including smoking, ESRD, BMI > 25 and hypertension-we observed an association between carrying one or more RA and atherosclerotic CVD (OR = 7.1; p = 0.002). For symptomatic disease, the OR was 3.5 (p = 0.02). In a time-to-event analysis, the proportion of subjects free from the composite primary endpoint, symptomatic atherosclerotic CVD, was higher in the 0-risk-allele group compared to the 1-risk-allele and 2-risk-allele groups (chi(2) = 6.5; p = 0.04). Conclusions Taken together, the APOL1 RAs associate with prevalent atherosclerotic CVD in this cohort of AA SLE patients, perhaps reflecting a potentiating effect of SLE on APOL1-related cardiovascular phenotypes.	[Blazer, Ashira; Clancy, Robert M.; Buyon, Jill P.] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY 10003 USA; [Wang, Binhuan] NYU, Sch Med, Dept Populat Hlth, Div Biostat, New York, NY USA; [Simpson, Danny; Kirchhoff, Tomas] NYU, Sch Med, Dept Populat Hlth, Div Genom, New York, NY USA; [Heffron, Sean] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY USA; [Heguy, Adriana; Ray, Karina] NYU, Sch Med, Genome Technol Ctr, New York, NY USA; [Snuderl, Matija] NYU, Sch Med, Dept Pathol & Neurol, New York, NY USA	New York University; New York University; New York University; New York University; New York University; New York University	Blazer, A (corresponding author), NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY 10003 USA.	ashira.blazer@nyumc.org	Heguy, Adriana/GPP-3907-2022	Buyon, Jill/0000-0002-3852-7129; Heffron, Sean/0000-0002-2692-5189; Snuderl, Matija/0000-0003-0752-0917; Blazer, Ashira/0000-0002-0386-5259; Kirchhoff, Tomas/0000-0002-9055-2364; Simpson, Danny/0000-0001-9690-3527; Wang, Binhuan/0000-0002-3435-3424	Rheumatology Research Foundation [14-A0-00-003545-01]; Rheumatology Research Foundation; NYU CTSA from the National Center for the Advancement of Translational Science (NCATS), NIH; Colton Center at New York University School of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445] Funding Source: NIH RePORTER	Rheumatology Research Foundation; Rheumatology Research Foundation; NYU CTSA from the National Center for the Advancement of Translational Science (NCATS), NIH; Colton Center at New York University School of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The corresponding author, Dr. Ashira Blazer, received a Scientist Development Award (grant number: 14-A0-00-003545-01) through the Rheumatology Research Foundation (https://www.rheumresearch.org/) for the completion of this work. Funding for this project was provided by the Rheumatology Research Foundation Scientist Development Award. This work was supported in part by the NYU CTSA grant 1UL1TR001445 from the National Center for the Advancement of Translational Science (NCATS), NIH, and The Colton Center at New York University School of Medicine. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; The authors thank Janet Nwaukoni, study coordinator, for her contributions in populating the SLE SAMPLE database and enrolling study participants. The genotyping experiment using The Infinium QC-Array-24v1.0 was performed at the New York University Cancer Institute Genomics Facility. Funding for this project was provided by the Rheumatology Research Foundation Scientist Development Award. This work was supported in part by the NYU CTSA grant 1UL1TR001445 from the National Center for the Advancement of Translational Science (NCATS), NIH, and The Colton Center at New York University School of Medicine.	Agarwal Surabhi, 2009, Curr Rheumatol Rep, V11, P241; Alenghat FJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20303; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baran Y, 2013, AM J HUM GENET, V92, P882, DOI 10.1016/j.ajhg.2013.04.023; Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Cheng DM, 2015, J LIPID RES, V56, P1583, DOI 10.1194/jlr.M059733; Dummer PD, 2015, SEMIN NEPHROL, V35, P222, DOI 10.1016/j.semnephrol.2015.04.008; Estrella MM, 2015, CLIN INFECT DIS, V60, P646, DOI 10.1093/cid/ciu765; Freedman BI, 2014, ARTHRITIS RHEUMATOL, V66, P390, DOI 10.1002/art.38220; Friedman DJ, 2011, J AM SOC NEPHROL, V22, P2098, DOI 10.1681/ASN.2011050519; Garcia MA, 2014, RHEUMATOLOGY, V53, P1431, DOI 10.1093/rheumatology/keu011; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Ines L, 2015, ARTHRIT CARE RES, V67, P1180, DOI 10.1002/acr.22539; Ito K, 2014, CIRC RES, V114, P845, DOI 10.1161/CIRCRESAHA.114.302347; Kasembeli AN, 2015, J AM SOC NEPHROL, V26, P2882, DOI 10.1681/ASN.2014050469; Khatua AK, 2015, AM J PHYSIOL-CELL PH, V309, pC22, DOI 10.1152/ajpcell.00384.2014; Kopp JB, 2015, J AM SOC NEPHROL, V26, P1443, DOI 10.1681/ASN.2013111242; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Lan XQ, 2015, EXP MOL PATHOL, V98, P491, DOI 10.1016/j.yexmp.2015.03.020; Langefeld CD, 2015, KIDNEY INT, V87, P169, DOI 10.1038/ki.2014.254; Larsen CP, 2013, J AM SOC NEPHROL, V24, P722, DOI 10.1681/ASN.2012121180; Limou S, 2014, ADV CHRONIC KIDNEY D, V21, P426, DOI 10.1053/j.ackd.2014.06.005; Lipkowitz MS, 2015, KIDNEY INT, V87, P14, DOI 10.1038/ki.2014.319; Ma LJ, 2017, J AM SOC NEPHROL, V28, P1093, DOI 10.1681/ASN.2016050567; Ma LJ, 2015, J AM SOC NEPHROL, V26, P339, DOI 10.1681/ASN.2013091017; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Mukamal KJ, 2016, ARTERIOSCL THROM VAS, V36, P398, DOI 10.1161/ATVBAHA.115.305970; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; Nieves CEF, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0571-2; Olabisi OA, 2016, P NATL ACAD SCI USA, V113, P830, DOI 10.1073/pnas.1522913113; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Petri M, 1999, J RHEUMATOL, V26, P502; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rose-John S, 2015, BEST PRACT RES CL EN, V29, P787, DOI 10.1016/j.beem.2015.07.001; Sampson MG, 2016, J AM SOC NEPHROL, V27, P814, DOI 10.1681/ASN.2014111131; Sesin CA, 2005, KIDNEY INT, V68, P110, DOI 10.1111/j.1523-1755.2005.00385.x; Vanhollebeke B, 2006, CELL MOL LIFE SCI, V63, P1937, DOI 10.1007/s00018-006-6091-x; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F	40	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0182483	10.1371/journal.pone.0182483	http://dx.doi.org/10.1371/journal.pone.0182483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850570	Green Published, gold, Green Submitted			2022-12-26	WOS:000408544200003
J	Pullicin, AJ; Penner, MH; Lim, J				Pullicin, Alexa J.; Penner, Michael H.; Lim, Juyun			Human taste detection of glucose oligomers with low degree of polymerization	PLOS ONE			English	Article							ALPHA-AMYLASE; SWEET TASTE; POLYCOSE; RECEPTOR; STARCH; T1R3; RAT; POLYSACCHARIDE; CHROMATOGRAPHY; MALTODEXTRINS	Studies have reported that some animals, including humans, can taste mixtures of glucose oligomers (i.e., maltooligosaccharides, MOS) and that their detection is independent of the known T1R2/T1R3 sweet taste receptor. In an effort to understand potential mechanisms underlying the taste perception of glucose oligomers in humans, this study was designed to investigate: 1) the variability of taste sensitivity to MOS with low degree-of-polymerization (DP), and 2) the potential role of hT1R2/T1R3 in the MOS taste detection. To address these objectives, a series of food grade, narrow-DP-range MOS were first prepared (DP 3, 3-4, 5-6, and 6-7) by fractionating disperse saccharide mixtures. Subjects were then asked to discriminate these MOS stimuli as well as glucose (DP 1) and maltose (DP 2) from blanks after the stimuli were swabbed on the tongue. All stimuli were presented at 75 mM with and without a sweet taste inhibitor (lactisole). An a-glucosidase inhibitor (acarbose) was added to all test stimuli to prevent oral digestion of glucose oligomers. Results showed that all six stimuli were detected with similar discriminability in normal tasting conditions. When the sweet receptor was inhibited, DP 1, 2, and 3 were not discriminated from blanks. In contrast, three higher-DP paired MOS stimuli (DP 3-4, 5-6, and 6-7) were discriminated from blanks at a similar degree. Overall, these results support the presence of a sweet-independent taste perception mechanism that is stimulated by MOS greater than three units.	[Pullicin, Alexa J.; Penner, Michael H.; Lim, Juyun] Oregon State Univ, Dept Food Sci & Technol, Corvallis, OR 97331 USA	Oregon State University	Lim, J (corresponding author), Oregon State Univ, Dept Food Sci & Technol, Corvallis, OR 97331 USA.	juyun.lim@oregonstate.edu	Lim, Juyun/AAR-4637-2020	Lim, Juyun/0000-0002-1781-8912				Balto AS, 2016, FOOD CHEM, V197, P872, DOI 10.1016/j.foodchem.2015.10.120; BROOKS JR, 1987, CEREAL CHEM, V64, P253; Ennis D.M., 1993, J SENSORY STUDIES, V8, P353; Galindo-Cuspinera V, 2006, NATURE, V441, P354, DOI 10.1038/nature04765; Glendinning JI, 2017, AM J PHYSIOL-REG I; Glendinning JI, 2015, AM J PHYSIOL-REG I, V309, pR552, DOI 10.1152/ajpregu.00056.2015; Green B, CHEM SENSES, V38, P655; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Lapis TJ, CHEM SENSES; Lapis TJ, 2016, CHEM SENSES, V41, P755, DOI 10.1093/chemse/bjw088; Lapis TJ, 2014, CHEM SENSES, V39, P737, DOI 10.1093/chemse/bju031; Laska M, 2001, J CHEM ECOL, V27, P1997, DOI 10.1023/A:1012286719241; Lawless H. T., 2010, SENSORY EVALUATION F; Nilsson GS, 1996, STARCH-STARKE, V48, P352, DOI 10.1002/star.19960481003; NISSENBAUM JW, 1987, NEUROSCI BIOBEHAV R, V11, P187, DOI 10.1016/S0149-7634(87)80025-8; PANGBORN RM, 1961, NATURE, V191, P810, DOI 10.1038/191810a0; ROBYT JF, 1994, CARBOHYD RES, V251, P187, DOI 10.1016/0008-6215(94)84285-X; ROBYT JF, 1970, J BIOL CHEM, V245, P3917; Sclafani A, 2004, APPETITE, V43, P1, DOI 10.1016/j.appet.2004.03.007; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P253, DOI 10.1016/S0149-7634(87)80033-7; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P197, DOI 10.1016/S0149-7634(87)80026-X; Spector AC, 2016, BEHAV EVIDENCE SELEC; Sukumaran SK, 2016, P NATL ACAD SCI USA, V113, P6035, DOI 10.1073/pnas.1520843113; Treesukosol Y, 2011, J NEUROSCI, V31, P13527, DOI 10.1523/JNEUROSCI.2179-11.2011; Treesukosol Y, 2009, AM J PHYSIOL-REG I, V296, pR855, DOI 10.1152/ajpregu.90869.2008; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; VIGORITO M, 1987, NEUROSCI BIOBEHAV R, V11, P201, DOI 10.1016/S0149-7634(87)80027-1; WHELAN WJ, 1952, NATURE, V170, P748, DOI 10.1038/170748a0; Yee KK, 2011, P NATL ACAD SCI USA, V108, P5431, DOI 10.1073/pnas.1100495108; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	31	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183008	10.1371/journal.pone.0183008	http://dx.doi.org/10.1371/journal.pone.0183008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850567	Green Published, Green Submitted, gold			2022-12-26	WOS:000408544200007
J	Abdelmaksoud, AA; Girerd, PH; Garcia, EM; Brooks, JP; Leftwich, LM; Sheth, NU; Bradley, SP; Serrano, MG; Fettweis, JM; Huang, B; Strauss, JF; Buck, GA; Jefferson, KK				Abdelmaksoud, Abdallah A.; Girerd, Philippe H.; Garcia, Erin M.; Brooks, J. Paul; Leftwich, Lauren M.; Sheth, Nihar U.; Bradley, Steven P.; Serrano, Myrna G.; Fettweis, Jennifer M.; Huang, Bernice; Strauss, Jerome F., III; Buck, Gregory A.; Jefferson, Kimberly K.			Association between statin use, the vaginal microbiome, and Gardnerella vaginalis vaginolysin-mediated cytotoxicity	PLOS ONE			English	Article							BACTERIAL-VAGINOSIS; HAEMOPHILUS VAGINALIS; RACIAL DISPARITIES; PRETERM BIRTH; HIV-INFECTION; CHOLESTEROL; LACTOBACILLI; ATORVASTATIN; ACQUISITION; WOMEN	Background Bacterial vaginosis (BV) is the leading dysbiosis of the vaginal microbiome. The pathways leading towards the development of BV are not well understood. Gardnerella vaginalis is frequently associated with BV. G. vaginalis produces the cholesterol-dependent cytolysin (CDC), vaginolysin, which can lyse a variety of human cells and is thought to play a role in pathogenesis. Because membrane cholesterol is required for vaginolysin to function, and because HMG-CoA reductase inhibitors (statins) affect not only serum levels of cholesterol but membrane levels as well, we hypothesized that statins might affect the vaginal microbiome. Methods To investigate the relationship between use of the statins and the vaginal microbiome, we analyzed 16S rRNA gene taxonomic surveys performed on vaginal samples from 133 women who participated in the Vaginal Human Microbiome Project and who were taking statins at the time of sampling, 152 women who reported high cholesterol levels but were not taking statins, and 316 women who did not report high cholesterol. To examine the effect of statins on the cytolytic effect of vaginolysin, the cholesterol-dependent cytolysin (CDC) produced by Gardnerella vaginalis, we assessed the effect of simvastatin pretreatment of VK2E6/E7 vaginal epithelial cells on vaginolysin-mediated cytotoxicity. Results The mean proportion of G. vaginalis among women taking statins was significantly lower relative to women not using statins. Women using statins had higher mean proportions of Lactobacillus crispatus relative to women with normal cholesterol levels, and higher levels of Lactobacillus jensenii relative to women with high cholesterol but not taking statins. In vitro, vaginal epithelial cells pretreated with simvastatin were relatively resistant to vaginolysin and this effect was inhibited by cholesterol. Conclusions In this cross-sectional study, statin use was associated with reduced proportions of G. vaginalis and greater proportions of beneficial lactobacilli within the vaginal microbiome. The negative association between statin use and G. vaginalis may be related to inhibition of vaginolysin function.	[Abdelmaksoud, Abdallah A.; Garcia, Erin M.; Leftwich, Lauren M.; Sheth, Nihar U.; Bradley, Steven P.; Serrano, Myrna G.; Fettweis, Jennifer M.; Huang, Bernice; Buck, Gregory A.; Jefferson, Kimberly K.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Girerd, Philippe H.; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA; [Brooks, J. Paul] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Sheth, Nihar U.] DNAnexus Inc, Mountain View, CA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Jefferson, KK (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	kimberly.jefferson@vcuhealth.org			National Institutes of Health [4UH3A1083263, P60 MD002256, U54 DE023786-01]; National Institute on Minority Health and Health Disparities [P60MD002256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health (www.nih.gov) [grants 4UH3A1083263, "The Vaginal Microbiome: Disease, Genetics and the Environment", P60 MD002256, the "VCU NIMHD Comprehensive Center of Excellence", and U54 DE023786-01 "A Multi-'omic Analysis of the Vaginal Microbiome during Pregnancy"].	Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Alcendor DJ, 2016, AM J REPROD IMMUNOL, V76, P99, DOI 10.1111/aji.12497; Amaya Rene A, 2002, J Perinatol, V22, P585, DOI 10.1038/sj.jp.7210757; Brotman RM, 2014, MENOPAUSE, V21, P450, DOI 10.1097/GME.0b013e3182a4690b; Castro J, 2013, INT J MED SCI, V10, P1193, DOI 10.7150/ijms.6304; Cheng HH, 2014, EUR REV MED PHARMACO, V18, P2294; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Cohen J, 2016, SCIENCE, V354, P157, DOI 10.1126/science.354.6309.157; Cohn JA, 2005, JAIDS-J ACQ IMM DEF, V39, P340, DOI 10.1097/01.qai.0000146599.47925.e0; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; CRISWELL BS, 1969, OBSTET GYNECOL, V33, P195; Farage MA., 2010, TXB AGING SKIN, DOI [10. 1007/978-3-540-89656-2, DOI 10.1007/978-3-540-89656-2, 10.1007/978-3-540-89656-2]; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Fettweis JM, 2011, NAT PRECED; FETTWEIS JM, 2012, BMC GENOMICS S8, V13; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fiscella K, 1996, PUBLIC HEALTH REP, V111, P104; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Graham S, 2009, J MED MICROBIOL, V58, P1382, DOI 10.1099/jmm.0.007781-0; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; Hotomi M, 2016, FOLIA MICROBIOL, V61, P375, DOI 10.1007/s12223-016-0445-z; Huett Pirje, 2016, Microbial Ecology in Health and Disease, V27, P30484, DOI 10.3402/mehd.v27.30484; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Klebanoff MA, 2005, AM J OBSTET GYNECOL, V192, P470, DOI 10.1016/j.ajog.2004.07.017; Koter M, 2002, EUR J CLIN PHARMACOL, V58, P501, DOI 10.1007/s00228-002-0507-9; Kramer MR, 2009, EPIDEMIOL REV, V31, P84, DOI 10.1093/ajerev/mxp003; Lagace-Wiens PRS, 2008, J CLIN MICROBIOL, V46, P804, DOI 10.1128/JCM.01545-07; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Mendling W, 2016, ADV EXP MED BIOL, V902, P83, DOI 10.1007/978-3-319-31248-4_6; Mirmonsef P, 2015, MENOPAUSE, V22, P702, DOI 10.1097/GME.0000000000000397; Mowla K, 2016, J CLIN DIAGN RES, V10, pOC32, DOI 10.7860/JCDR/2016/16538.7814; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; POGUE DH, 1995, J PHARMACOL EXP THER, V273, P863; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; REIMER LG, 1984, OBSTET GYNECOL, V64, P170; Tralhao AFR, 2014, POSTGRAD MED, V126, DOI 10.3810/pgm.2014.11.2832; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHEAR CL, 1992, CIRCULATION, V85, P1293, DOI 10.1161/01.CIR.85.4.1293; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Sparrow CP, 2001, ARTERIOSCL THROM VAS, V21, P115, DOI 10.1161/01.ATV.21.1.115; Statt S, 2015, AM J RESP CELL MOL, V53, P689, DOI 10.1165/rcmb.2014-0391OC; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Swidsinski A, 2011, FEMS IMMUNOL MED MIC, V61, P41, DOI 10.1111/j.1574-695X.2010.00743.x; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Verstraelen H, 2009, BMC MICROBIOL, V9; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	57	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183765	10.1371/journal.pone.0183765	http://dx.doi.org/10.1371/journal.pone.0183765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846702	Green Published, Green Submitted, gold			2022-12-26	WOS:000408438600050
J	Hanna, M; Dumas, I; Orain, M; Jacob, S; Tetu, B; Sanschagrin, F; Bureau, A; Poirier, B; Diorio, C				Hanna, Mirette; Dumas, Isabelle; Orain, Michele; Jacob, Simon; Tetu, Bernard; Sanschagrin, Francois; Bureau, Alexandre; Poirier, Brigitte; Diorio, Caroline			Association between local inflammation and breast tissue age-related lobular involution among premenopausal and postmenopausal breast cancer patients	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; GROWTH-FACTOR; RISK; EXPRESSION; CYTOKINES; ADIPOKINES; DISEASE; PLASMA; CELLS; TUMOR	Increased levels of pro-inflammatory markers and decreased levels of anti-inflammatory markers in the breast tissue can result in local inflammation. We aimed to investigate whether local inflammation in the breast tissue is associated with age-related lobular involution, a process inversely related to breast cancer risk. Levels of eleven pro-and anti-inflammatory markers were assessed by immunohistochemistry in normal breast tissue obtained from 164 pre- and postmenopausal breast cancer patients. Involution status of the breast (degree of lobular involution and the predominant lobule type) was microscopically assessed in normal breast tissue on hematoxylin-eosin stained mastectomy slides. Multivariate generalized linear models were used to assess the associations. In age-adjusted analyses, higher levels of pro-inflammatory markers IL-6, TNF-alpha, CRP, COX-2, leptin, SAA1 and IL-8; and anti-inflammatory marker IL-10, were inversely associated with the prevalence of complete lobular involution (all P <= 0.04). Higher levels of the pro-inflammatory marker COX-2 were also associated with lower prevalence of predominant type 1/no type 3 lobules in the breast, an indicator of complete involution, in age-adjusted analysis (P = 0.017). Higher tissue levels of inflammatory markers, mainly the pro-inflammatory ones, are associated with less involuted breasts and may consequently be associated with an increased risk of developing breast cancer.	[Hanna, Mirette; Dumas, Isabelle; Orain, Michele; Jacob, Simon; Tetu, Bernard; Sanschagrin, Francois; Poirier, Brigitte; Diorio, Caroline] Univ Laval, Oncol Res Unit, CHU Quebec Res Ctr, Quebec City, PQ, Canada; [Hanna, Mirette; Bureau, Alexandre; Diorio, Caroline] Univ Laval, Canc Res Ctr, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Jacob, Simon; Tetu, Bernard] Univ Laval, Dept Mol Biol Med Chem & Pathol, Canc Res Ctr, Quebec City, PQ, Canada; [Jacob, Simon; Tetu, Bernard] Univ Laval, CHU Quebec, Serv Mol Biol Med Chem & Pathol, Hop St Sacrement, Quebec City, PQ, Canada; [Jacob, Simon; Tetu, Bernard; Sanschagrin, Francois; Poirier, Brigitte; Diorio, Caroline] Hop St Sacrement, Ctr Malad Sein Deschenes Fabia, Quebec City, PQ, Canada; [Bureau, Alexandre] Univ Laval, Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [Poirier, Brigitte] Univ Laval, Canc Res Ctr, Dept Surg, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University; Laval University; Laval University	Diorio, C (corresponding author), Univ Laval, Oncol Res Unit, CHU Quebec Res Ctr, Quebec City, PQ, Canada.; Diorio, C (corresponding author), Univ Laval, Canc Res Ctr, Dept Social & Prevent Med, Quebec City, PQ, Canada.; Diorio, C (corresponding author), Hop St Sacrement, Ctr Malad Sein Deschenes Fabia, Quebec City, PQ, Canada.	Caroline.Diorio@crchudequebec.ulaval.ca		Diorio, Caroline/0000-0001-5355-7345	Canadian Breast Cancer Research Alliance [20462]; Fondation du cancer du sein du Quebec; Canadian Breast Cancer Foundation-Canadian Cancer Society Capacity Development award [703003]; FRQS Research Scholar; Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fond de recherche du Quebec Sante (FRQS); Canadian Tumor Repository Network (CTRNet)	Canadian Breast Cancer Research Alliance; Fondation du cancer du sein du Quebec; Canadian Breast Cancer Foundation-Canadian Cancer Society Capacity Development award; FRQS Research Scholar; Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fond de recherche du Quebec Sante (FRQS); Canadian Tumor Repository Network (CTRNet)	This research was supported by grants from the Canadian Breast Cancer Research Alliance (grant #20462), the Fondation du cancer du sein du Quebec and the "Banque de tissus et donnees of the Reseau de recherche sur le cancer" of the "Fond de recherche du Quebec Sante (FRQS)", associated with the Canadian Tumor Repository Network (CTRNet). CD is a recipient of The Canadian Breast Cancer Foundation-Canadian Cancer Society Capacity Development award (award #703003) and the FRQS Research Scholar.	Baer HJ, 2009, CANCER, V115, P1404, DOI 10.1002/cncr.24167; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barcellos-Hoff MH, 2000, BREAST CANCER RES, V2, P92, DOI 10.1186/bcr40; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Degnim AC, 2014, BREAST CANCER RES TR, V144, P539, DOI 10.1007/s10549-014-2896-8; Figueroa JD, 2016, BREAST CANCER RES TR, V159, P163, DOI 10.1007/s10549-016-3908-7; Figueroa JD, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju286; Ghosh K, 2010, JNCI-J NATL CANCER I, V102, P1716, DOI 10.1093/jnci/djq414; Giancotti V, 2006, CANCER LETT, V243, P145, DOI 10.1016/j.canlet.2006.01.035; Gierach GL, 2016, CANCER PREV RES, V9, P149, DOI 10.1158/1940-6207.CAPR-15-0282; Hamidullah, 2012, BREAST CANCER RES TR, V133, P11, DOI 10.1007/s10549-011-1855-x; Hanna M, 2016, MENOPAUSE J N AM MEN, V24; Hanna M, 2015, MENOPAUSE, V22, P964, DOI 10.1097/GME.0000000000000433; Henson DE, 2006, JNCI-J NATL CANCER I, V98, P1589, DOI 10.1093/jnci/djj454; Horne HN, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0678-4; Hugo HJ, 2015, J MAMMARY GLAND BIOL, V20, P109, DOI 10.1007/s10911-015-9333-4; Jinda S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3633; Kemp WL, 2008, HIGH ED SCI ENG; Lithgow D, 2005, BIOL RES NURS, V7, P118, DOI 10.1177/1099800405280823; Llanos AA, 2012, CANCER EPIDEM BIOMAR, V21, P1745, DOI 10.1158/1055-9965.EPI-12-0016; Maccio A, 2011, THESCIENTIFICWORLDJO, V11, P2020, DOI 10.1100/2011/806787; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; McKian KP, 2009, J CLIN ONCOL, V27, P5893, DOI 10.1200/JCO.2008.21.5079; Miettinen PJ, 1994, J CELL BIOL 2, V127; Milanese TR, 2006, J NATL CANCER I, V98, P1600, DOI 10.1093/jnci/djj439; Miller JA, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-18; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; Oh H, 2016, HORM CANCER-US, V7, P305, DOI 10.1007/s12672-016-0265-2; Purohit A, 2002, BREAST CANCER RES, V4, P65, DOI 10.1186/bcr425; Radisky DC, 2016, BREAST CANCER RES TR, V155, P423, DOI 10.1007/s10549-016-3691-5; Radisky DC, 2009, J MAMMARY GLAND BIOL, V14, P181, DOI 10.1007/s10911-009-9123-y; Ramakrishnan R, 2004, BREAST CANCER RES TR, V86, P259, DOI 10.1023/B:BREA.0000036899.97114.b3; Reed JR, 2010, J MAMMARY GLAND BIOL, V15, P329, DOI 10.1007/s10911-010-9188-7; RUSSO J, 1988, CANCER RES, V48, P2837; RUSSO J, 1994, CANCER EPIDEM BIOMAR, V3, P353; RUSSO J, 1989, IN VITRO CELL DEV B, V25, P643; SILBERSTEIN GB, 1990, J CELL BIOL, V110, P2209, DOI 10.1083/jcb.110.6.2209; Toomey D, 1999, IMMUNOL INVEST, V28, P29, DOI 10.3109/08820139909022721; Vierkant RA, 2009, BREAST CANCER RES TR, V117, P193, DOI 10.1007/s10549-008-0082-6; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Yang XHR, 2013, BREAST CANCER RES TR, V137, P837, DOI 10.1007/s10549-012-2380-2	42	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183579	10.1371/journal.pone.0183579	http://dx.doi.org/10.1371/journal.pone.0183579			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846716	gold, Green Published, Green Submitted			2022-12-26	WOS:000408438600039
J	Xu, FL; Ding, M; Yao, J; Shi, ZS; Wu, X; Zhang, JJ; Pang, H; Xing, JX; Xuan, JF; Wang, BJ				Xu, Feng-ling; Ding, Mei; Yao, Jun; Shi, Zhang-sen; Wu, Xue; Zhang, Jing-jing; Pang, Hao; Xing, Jia-xin; Xuan, Jin-feng; Wang, Bao-jie			Association between mitochondrial DNA variations and schizophrenia in the northern Chinese Han population	PLOS ONE			English	Article							NO EVIDENCE; RISK; SUSCEPTIBILITY; POLYMORPHISMS; HAPLOGROUPS; VARIANTS; GENETICS; SEQUENCE; GENOME; HV	To determine whether mitochondrial DNA (mtDNA) variations are associated with schizophrenia, 313 patients with schizophrenia and 326 unaffected participants of the northern Chinese Han population were included in a prospective study. Single-nucleotide polymor-phisms (SNPs) including C5178A, A10398G, G13708A, and C13928G were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Hypervariable regions I and II (HVSI and HVSII) were analyzed by sequencing. The results showed that the 4 SNPs and 11 haplotypes, composed of the 4 SNPs, did not differ significantly between patient and control groups. No significant association between haplogroups and the risk of schizophrenia was ascertained after Bonferroni correction. Drawing a conclusion, there was no evidence of an association between mtDNA (the 4 SNPs and the control region) and schizophrenia in the northern Chinese Han population.	[Xu, Feng-ling; Ding, Mei; Yao, Jun; Shi, Zhang-sen; Wu, Xue; Zhang, Jing-jing; Pang, Hao; Xing, Jia-xin; Xuan, Jin-feng; Wang, Bao-jie] China Med Univ, Sch Forens Med, Shenyang, Peoples R China	China Medical University	Wang, BJ (corresponding author), China Med Univ, Sch Forens Med, Shenyang, Peoples R China.	wangbj77@163.com	wang, jie/GRS-0942-2022; WANG, JINGYI/GSJ-1241-2022		National Natural Science Foundation of China [81373244]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 81373244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All the participants are worthy of being thanked in the study. This study was supported by National Natural Science Foundation of China(No. 81373244).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Amar S, 2007, SCHIZOPHR RES, V94, P354, DOI 10.1016/j.schres.2007.04.020; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bamne MN, 2008, SCHIZOPHRENIA BULL, V34, P458, DOI 10.1093/schbul/sbm100; Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P; Chen F, 2015, ELECTROPHORESIS, V36, P930, DOI 10.1002/elps.201400493; Chu QH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17170; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; Diop AG, 2003, ACTA TROP, V87, P149, DOI 10.1016/S0001-706X(03)00038-X; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Fachal L, 2015, AM J MED GENET B, V168, P54, DOI 10.1002/ajmg.b.32276; Fan L, 2013, MITOCHONDRION, V13, P360, DOI 10.1016/j.mito.2013.04.011; GOLDSTEIN JM, 1992, SCHIZOPHR RES, V7, P135, DOI 10.1016/0920-9964(92)90043-5; Guan FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38048; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Ishikawa K, 2008, MITOCHONDRION, V8, P339, DOI 10.1016/j.mito.2008.07.006; Jiang HG, 2014, CANCER SCI, V105, P639, DOI 10.1111/cas.12412; Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1; Kato T, 2000, AM J MED GENET, V96, P182, DOI 10.1002/(SICI)1096-8628(20000403)96:2<182::AID-AJMG12>3.3.CO;2-H; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Liou CW, 2012, DIABETES, V61, P2642, DOI 10.2337/db11-1369; LOBO A, 1986, PSYCHOL MED, V16, P135, DOI 10.1017/S0033291700002579; Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44; Mosquera-Miguel A, 2012, AM J MED GENET B, V159B, P414, DOI 10.1002/ajmg.b.32044; Nijiati M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081806; Pereira J, 2012, FORENSIC SCI INT-GEN, V6, P228, DOI 10.1016/j.fsigen.2011.05.005; Pezzotti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005356; Pietka Grzegorz, 2008, Otolaryngol Pol, V62, P158, DOI 10.1016/S0030-6657(08)70233-6; Roig B, 2007, MOL PSYCHIATR, V12, P833, DOI 10.1038/sj.mp.4001995; Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Takagi K, 2004, ATHEROSCLEROSIS, V175, P281, DOI 10.1016/j.atherosclerosis.2004.03.008; Torrell H, 2014, AM J MED GENET B, V165, P607, DOI 10.1002/ajmg.b.32264; Ueno H, 2009, MITOCHONDRION, V9, P385, DOI 10.1016/j.mito.2009.06.003; Wang GX, 2013, PSYCHIAT RES, V209, P279, DOI 10.1016/j.psychres.2013.01.001; Xu FL, 2017, MITOCHONDRIAL DNA PA, P1; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zhang W, 2014, J GENET GENOMICS, V41, P397, DOI 10.1016/j.jgg.2014.05.004; Zhou HY, 2014, GENET MOL RES, V13, P616, DOI 10.4238/2014.January.28.7; Zsurka G, 1998, BIOL PSYCHIAT, V44, P371, DOI 10.1016/S0006-3223(97)00461-7	44	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182769	10.1371/journal.pone.0182769	http://dx.doi.org/10.1371/journal.pone.0182769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846698	gold, Green Published, Green Submitted			2022-12-26	WOS:000408438600014
J	Pinheiro, DS; Santos, RD; de Brito, RB; Cruz, AHD; Ghedini, PC; Reis, AAS				Pinheiro, Denise S.; Santos, Rodrigo da S.; de Brito, Rodrigo B.; Cruz, Aline Helena da S.; Ghedini, Paulo C.; Reis, Angela A. S.			GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients	PLOS ONE			English	Article							GLUTATHIONE TRANSFERASES; ANTIOXIDANT ENZYMES; LIPID-PEROXIDATION; POLYMORPHISMS; GSTT1; GSTM1; SUSCEPTIBILITY; ANTIPSYCHOTICS; DETOXICATION; CATALYZE	Background The role of oxidative stress in schizophrenia has been demonstrated, particularly in subjects with treatment-resistant schizophrenia (TRS). In such patients, the decreased levels of antioxidants in conjunction with the increased generation of reactive oxygen species in the brain exposes the neurons to a higher risk of damage. Methods and findings We evaluated the association of deletion polymorphisms of two genes of the antioxidant Glutathione S-Transferase family, GSTT1 and GSTM1, with susceptibility to TRS. A total of 54 TRS patients (mean age 38.7 years) and 78 healthy control subjects (mean age 39.0 years) were enrolled in this study. The subjects were matched by sex, age, and smoking and alcohol consumption habits. In the case group, the frequencies of GSTT1-null and GSTM1-null genotypes were 24.1 and 51.9%, respectively, whereas for the control group, the frequencies were 12.8 and 46.2%, respectively. Analysis performed with respect to the risk of developing TRS associated with the GSTT1 and GSTM1 deletion polymorphisms, resulted in odds ratio (OR) values of 2.1 and 1.2, respectively. However, the association was not found to be significant (p = 0.1229 and p = 0.5916, respectively). The analysis performed with respect to the combined genotypes of GSTT1 and GSTM1 revealed that the double-null genotype confers a 4.6-fold increased risk of developing TRS (p = 0.0412). Conclusion The results of the present study indicate that a combination of GST deficiencies may play a role in enhanced susceptibility to TRS, and the present genotype of one of these genes may buffer the deficiency caused by the lack (null genotype) of the other. The results suggest that combined deletion polymorphisms of GSTT1 and GSTM1 can have implications in the prediction of the clinical course of the disease.	[Pinheiro, Denise S.; Santos, Rodrigo da S.; Cruz, Aline Helena da S.; Reis, Angela A. S.] Univ Fed Goias, Dept Biochem & Mol Biol, Inst Biol Sci ICB 2, Goiania, Go, Brazil; [Santos, Rodrigo da S.] Univ Fed Goias, Dept Nat Sci LEdoC, Special Acad Unit Human Sci, Goiania, Go, Brazil; [de Brito, Rodrigo B.] Bueno Med Ctr, Inst Brain, Goiania, Go, Brazil; [de Brito, Rodrigo B.; Ghedini, Paulo C.] Univ Fed Goias, Dept Pharmacol, Inst Biol Sci ICB 2, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Reis, AAS (corresponding author), Univ Fed Goias, Dept Biochem & Mol Biol, Inst Biol Sci ICB 2, Goiania, Go, Brazil.	angeladamski@gmail.com	DA SILVA, ANGELA ADAMSKI/AAJ-1403-2021; da Silva Pinheiro, Denise/Y-9276-2019	DA SILVA, ANGELA ADAMSKI/0000-0002-8281-7334; da Silva Pinheiro, Denise/0000-0001-7405-6822; Reis, AlessanRSS/0000-0001-8486-7469; da Silva Santos, Rodrigo/0000-0002-9480-4362	Fundacao de Amparo a Pesquisa do estado de Goias (FAPEG) [201310267000014]	Fundacao de Amparo a Pesquisa do estado de Goias (FAPEG)	This work was supported by grant (number: 201310267000014) from the Fundacao de Amparo a Pesquisa do estado de Goias (FAPEG - URL: http://www.fapeg.go.gov.br/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P915; Baez S, 1997, BIOCHEM J, V324, P25, DOI 10.1042/bj3240025; Boskovic M, 2011, CURR NEUROPHARMACOL, V9, P301, DOI 10.2174/157015911795596595; Burim RV, 2004, MUTAGENESIS, V19, P291, DOI 10.1093/mutage/geh034; Caspi Asaf, 2004, Dialogues Clin Neurosci, V6, P61; Colombo J, 2004, WORLD J GASTROENTERO, V10, P1240; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Gravina P, 2011, PSYCHIAT RES, V187, P454, DOI 10.1016/j.psychres.2010.10.008; Harada S, 2003, PSYCHIAT GENET, P13; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Joober R, 2002, J PSYCHIATR NEUROSCI, V27, P336; Kim SK, 2015, INT J MOL SCI, V16, P19602, DOI 10.3390/ijms160819602; Marin F, 2010, J MOL DIAGN, V12, P300, DOI 10.2353/jmoldx.2010.090076; Medina-Hernandez V, 2007, J PSYCHIATR RES, V41, P652, DOI 10.1016/j.jpsychires.2006.02.010; Mukherjee S, 1996, SCHIZOPHR RES, V19, P19, DOI 10.1016/0920-9964(95)00048-8; Nakajima S, 2015, SCHIZOPHR RES, V161, P429, DOI 10.1016/j.schres.2014.12.024; Parikh V, 2003, J PSYCHIATR RES, V37, P43, DOI 10.1016/S0022-3956(02)00048-1; Pazvantoglu O, 2009, PSYCHIAT CLIN NEUROS, V63, P693, DOI 10.1111/j.1440-1819.2009.02015.x; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Pinheiro DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076262; Raffa M, 2013, GENE, V512, P282, DOI 10.1016/j.gene.2012.10.031; Ranjekar PK, 2003, PSYCHIAT RES, V121, P109, DOI 10.1016/S0165-1781(03)00220-8; Reddy R, 2003, SCHIZOPHR RES, V62, P205, DOI 10.1016/S0920-9964(02)00407-3; Saadat M, 2007, PSYCHIAT RES, V153, P87, DOI 10.1016/j.psychres.2006.03.024; Saha S, 2005, SYSTEMATIC REV PREVA, DOI [10.1371/journal.pmed.0020141, DOI 10.1371/JOURNAL.PMED.0020141]; Salnikova LE, 2010, ASS STUDY XENOBIOTIC, V2; SeguraAguilar J, 1997, J BIOL CHEM, V272, P5727, DOI 10.1074/jbc.272.9.5727; Smythies JR, 1997, SCHIZOPHR RES, V24, P357, DOI 10.1016/S0920-9964(97)00005-4; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Teo C, 2012, PHARMACOGENET GENOM, V22, P807, DOI 10.1097/FPC.0b013e3283586c04; Yao JK, 1998, SCHIZOPHR RES	32	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183812	10.1371/journal.pone.0183812	http://dx.doi.org/10.1371/journal.pone.0183812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837637	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000127
J	Uppu, DSSM; Konai, MM; Sarkar, P; Samaddar, S; Fensterseifer, ICM; Farias, C; Krishnamoorthy, P; Shome, BR; Franco, OL; Haldar, J				Uppu, Divakara S. S. M.; Konai, Mohini M.; Sarkar, Paramita; Samaddar, Sandip; Fensterseifer, Isabel C. M.; Farias-Junior, Celio; Krishnamoorthy, Paramanandam; Shome, Bibek R.; Franco, Octavio L.; Haldar, Jayanta			Membrane-active macromolecules kill antibiotic-tolerant bacteria and potentiate antibiotics towards Gram-negative bacteria	PLOS ONE			English	Article							CATIONIC-AMPHIPHILIC POLYMERS; RESISTANCE EFFLUX PUMPS; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; KLEBSIELLA-PNEUMONIAE; ANTIBACTERIAL AGENTS; PERSISTENT INFECTIONS; MOLECULAR-MECHANISMS; BIOFILM FORMATION	Chronic bacterial biofilms place a massive burden on healthcare due to the presence of antibiotic-tolerant dormant bacteria. Some of the conventional antibiotics such as erythromycin, vancomycin, linezolid, rifampicin etc. are inherently ineffective against Gram-negative bacteria, particularly in their biofilms. Here, we report membrane-active macromolecules that kill slow dividing stationary-phase and antibiotic tolerant cells of Gram-negative bacteria. More importantly, these molecules potentiate antibiotics (erythromycin and rifampicin) to biofilms of Gram-negative bacteria. These molecules eliminate planktonic bacteria that are liberated after dispersion of biofilms (dispersed cells). The membrane-active mechanism of these molecules forms the key for potentiating the established antibiotics. Further, we demonstrate that the combination of macromolecules and antibiotics significantly reduces bacterial burden in mouse burn and surgical wound infection models caused by Acinetobacter baumannii and Carbapenemase producing Klebsiella pneumoniae (KPC) clinical isolate respectively. Colistin, a well-known antibiotic targeting the lipopolysaccharide (LPS) of Gram-negative bacteria fails to kill antibiotic tolerant cells and dispersed cells (from biofilms) and bacteria develop resistance to it. On the contrary, these macromolecules prevent or delay the development of bacterial resistance to known antibiotics. Our findings emphasize the potential of targeting the bacterial membrane in antibiotic potentiation for disruption of biofilms and suggest a promising strategy towards developing therapies for topical treatment of Gram-negative infections.	[Uppu, Divakara S. S. M.; Konai, Mohini M.; Sarkar, Paramita; Samaddar, Sandip; Haldar, Jayanta] JNCASR, New Chem Unit, Chem Biol & Med Chem Lab, Bangalore, Karnataka, India; [Fensterseifer, Isabel C. M.; Franco, Octavio L.] Ctr Anal Proteom & Bioquim, Posgrad Ciencias Genom & Biotecnol UC, Brasilia, DF, Brazil; [Fensterseifer, Isabel C. M.; Franco, Octavio L.] Univ Brasilia, Mol Pathol Postgrad Program, Brasilia, DF, Brazil; [Farias-Junior, Celio] Lacen, Lab Cent, Brasilia, DF, Brazil; [Krishnamoorthy, Paramanandam; Shome, Bibek R.] ICAR Natl Inst Vet Epidemiol & Dis Informat NIVED, Bengaluru, Karnataka, India; [Franco, Octavio L.] Univ Catolica Dom Bosco, Posgrad Biotecnol, S Inova Biotech, Campo Grande, Brazil; [Uppu, Divakara S. S. M.] SMART, ID IRG, Singapore, Singapore	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Universidade de Brasilia; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Veterinary Epidemiology & Disease Informatics; Universidade Catolica Dom Bosco (UCDB); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Haldar, J (corresponding author), JNCASR, New Chem Unit, Chem Biol & Med Chem Lab, Bangalore, Karnataka, India.	jayanta@jncasr.ac.in	Krishnamoorthy, Paramanandham/ABC-3793-2021; Franco, Octavio L/T-3020-2017; Uppu, Divakara SSM/U-1848-2019	Krishnamoorthy, Paramanandham/0000-0001-7495-1333; Uppu, Divakara SSM/0000-0002-7271-9538; Sarkar, Paramita/0000-0001-6917-3493; Samaddar, Sandip/0000-0002-2653-9050; Franco, Octavio/0000-0001-9546-0525; Shome, Bibek/0000-0003-4741-7076	Sheikh Saqr laboratory at JNCASR; CNPQ; CAPES; FAPDF; FUNDECT	Sheikh Saqr laboratory at JNCASR; CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	SS is funded by the Sheikh Saqr laboratory at JNCASR for post-doctoral fellowship. Brazillian group was granted by CNPQ, CAPES, FAPDF and FUNDECT. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Amato SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00070; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barraud N, 2012, ANGEW CHEM INT EDIT, V51, P9057, DOI 10.1002/anie.201202414; Baugh S, 2012, J ANTIMICROB CHEMOTH, V67, P2409, DOI 10.1093/jac/dks228; Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Brauner A, 2016, NAT REV MICROBIOL, V14, P320, DOI 10.1038/nrmicro.2016.34; Cameron A, 2014, BIOPOLYMERS, V102, P88, DOI 10.1002/bip.22423; Chua SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5462; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cox G, 2014, J ANTIMICROB CHEMOTH, V69, P1844, DOI 10.1093/jac/dku057; de la Fuente-Nunez C, 2015, CHEM BIOL, V22, P196, DOI 10.1016/j.chembiol.2015.01.002; Dhal PK, 2009, ADV DRUG DELIVER REV, V61, P1121, DOI 10.1016/j.addr.2009.05.004; Eckert R, 2006, ANTIMICROB AGENTS CH, V50, P3833, DOI 10.1128/AAC.00509-06; Fensterseifer ICM, 2015, PEPTIDES, V63, P38, DOI 10.1016/j.peptides.2014.10.019; Flemming K, 2009, J ANTIMICROB CHEMOTH, V63, P136, DOI 10.1093/jac/dkn464; Ganewatta MS, 2015, POLYMER, V63, pA1, DOI 10.1016/j.polymer.2015.03.007; Giano MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5095; Gill EE, 2015, CHEM BIOL DRUG DES, V85, P56, DOI 10.1111/cbdd.12478; Goldberg K, 2013, FASEB J, V27, P3818, DOI 10.1096/fj.13-227942; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harris TL, 2014, ACS CHEM BIOL, V9, P122, DOI 10.1021/cb400490k; Hoque J, 2015, CHEM COMMUN, V51, P13670, DOI 10.1039/c5cc05159b; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Jennings MC, 2014, CHEMBIOCHEM, V15, P2211, DOI 10.1002/cbic.201402254; Kaneti G, 2015, BIOCH BIOPHYS ACTA; Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036; Kim JS, 2011, ANTIMICROB AGENTS CH, V55, P5380, DOI 10.1128/AAC.00708-11; Kim W, 2016, FUTURE MED CHEM, V8, P257, DOI 10.4155/fmc.15.189; Konai MM, 2015, BIOCONJUGATE CHEM, V26, P2442, DOI 10.1021/acs.bioconjchem.5b00494; Lebeaux D, 2013, PATHOGENS, V2, P288, DOI 10.3390/pathogens2020288; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li J, 2015, J CONTROL RELEASE; Li Y, 2013, ANGEW CHEM INT EDIT, V52, P674, DOI 10.1002/anie.201206053; LIPNICK RL, 1995, FOOD CHEM TOXICOL, V33, P223, DOI 10.1016/0278-6915(94)00136-C; Liu RH, 2015, J AM CHEM SOC, V137, P2183, DOI 10.1021/ja512567y; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; McGrath DM, 2013, P NATL ACAD SCI USA, V110, P3477, DOI 10.1073/pnas.1221924110; McLeod GI, 1996, J BACTERIOL, V178, P3683, DOI 10.1128/jb.178.13.3683-3688.1996; Mohammad H, 2015, J ANTIBIOT, V68, P259, DOI 10.1038/ja.2014.142; Niu YH, 2012, J MED CHEM, V55, P4003, DOI 10.1021/jm300274p; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; O'Shea MK, 2012, INT J ANTIMICROB AG, V39, P363, DOI 10.1016/j.ijantimicag.2012.01.018; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Ooi N, 2010, J ANTIMICROB CHEMOTH, V65, P72, DOI 10.1093/jac/dkp409; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Pan JC, 2013, BIOORG MED CHEM LETT, V23, P4648, DOI 10.1016/j.bmcl.2013.06.011; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Pieri C, 2014, J MED CHEM, V57, P4263, DOI 10.1021/jm500194e; Pu YY, 2017, DRUG RESIST UPDATE, V30, P7, DOI 10.1016/j.drup.2016.11.002; Pu YY, 2016, MOL CELL, V62, P284, DOI 10.1016/j.molcel.2016.03.035; Rahim NA, 2015, J ANTIMICROB CHEMOTH, V70, P2589, DOI 10.1093/jac/dkv135; Ribeiro SM, 2015, ANTIMICROB AGENTS CH, V59, P3906, DOI 10.1128/AAC.00092-15; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Schmidt NW, 2014, ACS NANO, V8, P8786, DOI 10.1021/nn502201a; Sgolastra F, 2013, ACCOUNTS CHEM RES, V46, P2977, DOI 10.1021/ar400066v; Sharma A, 2015, CHEM-EUR J, V21, P3540, DOI 10.1002/chem.201404650; Soon RL, 2011, J ANTIMICROB CHEMOTH, V66, P126, DOI 10.1093/jac/dkq422; Takahashi H, 2013, MACROMOL BIOSCI, V13, P1285, DOI 10.1002/mabi.201300126; Uppu DSSM, 2016, CHEM COMMUN, V52, P4644, DOI 10.1039/c5cc09930g; Uppu DSSM, 2016, BIOMACROMOLECULES, V17, P862, DOI 10.1021/acs.biomac.5b01567; Uppu DSSM, 2016, BIOMATERIALS, V74, P131, DOI 10.1016/j.biomaterials.2015.09.042; Uppu DSSM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119422; Uppu DSSM, 2013, CHEM COMMUN, V49, P9389, DOI 10.1039/c3cc43751e; Vaara M, 2010, ANTIMICROB AGENTS CH, V54, P3341, DOI 10.1128/AAC.01439-09; Xiong M, 2015, P NATL ACAD SCI USA, V112, P13155, DOI 10.1073/pnas.1507893112; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	73	25	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183263	10.1371/journal.pone.0183263	http://dx.doi.org/10.1371/journal.pone.0183263			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837596	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000055
J	Cho, S; Tripathi, A; Chlipala, G; Green, S; Lee, H; Chang, EB; Jeong, H				Cho, Sungjoon; Tripathi, Ashutosh; Chlipala, George; Green, Stefan; Lee, Hyunwoo; Chang, Eugene B.; Jeong, Hyunyoung			Fructose diet alleviates acetaminophen-induced hepatotoxicity in mice	PLOS ONE			English	Article							INDUCED LIVER-INJURY; GLUTATHIONE METABOLISM; AMINO-ACID; TOXICITY; CYP2E1; MICROBIOTA; PROTECTION; FAILURE; SYSTEM; GENE	Acetaminophen (APAP) is a commonly used analgesic and antipyretic that can cause hepatotoxicity due to production of toxic metabolites via cytochrome P450 (Cyp) 1a2 and Cyp2e1. Previous studies have shown conflicting effects of fructose (the major component in Western diet) on the susceptibility to APAP-induced hepatotoxicity. To evaluate the role of fructose-supplemented diet in modulating the extent of APAP-induced liver injury, male C57BL/6J mice were given 30% (w/v) fructose in water (or regular water) for 8 weeks, followed by oral administration of APAP. APAP-induced liver injury (determined by serum levels of liver enzymes) was decreased by two-fold in mice pretreated with fructose. Fructose-treated mice exhibited (similar to 1.5 fold) higher basal glutathione levels and (similar to 2 fold) lower basal (mRNA and activity) levels of Cyp1a2 and Cyp2e1, suggesting decreased bioactivation of APAP and increased detoxification of toxic metabolite in fructose-fed mice. Hepatic mRNA expression of heat shock protein 70 was also found increased in fructose-fed mice. Analysis of bacterial 16S rRNA gene amplicons from the cecal samples of vehicle groups showed that the fructose diet altered gut bacterial community, leading to increased a-diversity. The abundance of several bacterial taxa including the genus Anaerostipes was found to be significantly correlated with the levels of hepatic Cyp2e1, Cyp1a2 mRNA, and glutathione. Together, these results suggest that the fructose-supplemented diet decreases APAP-induced liver injury in mice, in part by reducing metabolic activation of APAP and inducing detoxification of toxic metabolites, potentially through altered composition of gut microbiota.	[Cho, Sungjoon; Tripathi, Ashutosh; Lee, Hyunwoo; Jeong, Hyunyoung] Univ Illinois, Coll Pharm, Dept Biopharmaceut Sci, Chicago, IL USA; [Chlipala, George; Green, Stefan] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Chang, Eugene B.] Univ Chicago, Gastroenterol Sect, Knapp Ctr Biomed Discovery, Chicago, IL USA; [Jeong, Hyunyoung] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jeong, H (corresponding author), Univ Illinois, Coll Pharm, Dept Biopharmaceut Sci, Chicago, IL USA.; Jeong, H (corresponding author), Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA.	yjeong@uic.edu		Jeong, Hyunyoung/0000-0001-7769-7676; Green, Stefan/0000-0003-2781-359X; Chlipala, George/0000-0003-0203-3191	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health [DK47722, DK42086]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust to Hyunyoung Jeong and Eugene Chang (http://www.chicagabiomedicalconsortium.org/awards/funded_awards), as well as National Institutes of Health (DK47722 and DK42086 to Eugene Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON GM, 1989, BIOCHEM PHARMACOL, V38, P3323, DOI 10.1016/0006-2952(89)90630-8; Allen-Vercoe E, 2012, ANAEROBE, V18, P523, DOI 10.1016/j.anaerobe.2012.09.002; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Botta D, 2006, J BIOL CHEM, V281, P28865, DOI 10.1074/jbc.M605143200; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Cover C, 2006, TOXICOL APPL PHARM, V216, P98, DOI 10.1016/j.taap.2006.04.010; Di Luccia B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134893; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Felmlee MA, 2008, DRUG METAB DISPOS, V36, P435, DOI 10.1124/dmd.107.018838; Fisher FM, 2017, MOL METAB, V6, P14, DOI 10.1016/j.molmet.2016.11.008; Fisher JE, 2013, J SURG RES, V180, P147, DOI 10.1016/j.jss.2012.11.051; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Gregory B, 2010, J INVEST MED, V58, P707, DOI 10.231/JIM.0b013e3181db8764; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hojo I, 2000, XENOBIOTICA, V30, P933, DOI 10.1080/004982500433345; HUANG CS, 1993, J BIOL CHEM, V268, P20578; Iizuka K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020181; Ishida K, 1995, EXP TOXICOL PATHOL, V47, P509, DOI 10.1016/S0940-2993(11)80338-6; Jena PK, 2014, APPL BIOCHEM BIOTECH, V172, P3810, DOI 10.1007/s12010-014-0772-y; Kennedy K, 2014, APPL ENVIRON MICROB, V80, P5717, DOI 10.1128/AEM.01451-14; Krasniak AE, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00314; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lee WM, 2004, HEPATOLOGY, V40, P6, DOI 10.1002/hep.20293; LIU SY, 1995, DNA CELL BIOL, V14, P285, DOI 10.1089/dna.1995.14.285; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Mardinoglu A, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156487; McConnachie LA, 2007, TOXICOL SCI, V99, P628, DOI 10.1093/toxsci/kfm165; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; MOURELLE M, 1991, BIOCHEM PHARMACOL, V41, P1831, DOI 10.1016/0006-2952(91)90121-K; Nourjah P, 2006, PHARMACOEPIDEM DR S, V15, P398, DOI 10.1002/pds.1191; PATTEN CJ, 1993, CHEM RES TOXICOL, V6, P511, DOI 10.1021/tx00034a019; Payne AN, 2012, OBES REV, V13, P799, DOI 10.1111/j.1467-789X.2012.01009.x; PRESCOTT LF, 1981, BRIT J CLIN PHARMACO, V12, P149; Saito C, 2010, TOXICOL APPL PHARM, V246, P8, DOI 10.1016/j.taap.2010.04.015; Salminen WF, 1998, J PHARMACOL EXP THER, V286, P519; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Schmidt LE, 2002, HEPATOLOGY, V35, P876, DOI 10.1053/jhep.2002.32148; Schwiertz A, 2002, SYST APPL MICROBIOL, V25, P46, DOI 10.1078/0723-2020-00096; Selwyn FP, 2015, TOXICOL SCI, V147, P84, DOI 10.1093/toxsci/kfv110; Sener G, 2005, J APPL TOXICOL, V25, P20, DOI 10.1002/jat.1012; Shayiq RM, 1999, HEPATOLOGY, V29, P451, DOI 10.1002/hep.510290241; Softic S, 2016, DIGEST DIS SCI, V61, P1282, DOI 10.1007/s10620-016-4054-0; Su GL, 2005, HEPATOLOGY, V41, P187, DOI 10.1002/hep.20533; Tillman EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107206; Tolson JK, 2006, TOXICOL APPL PHARM, V210, P157, DOI 10.1016/j.taap.2005.10.001; WALKER RM, 1982, CAN J PHYSIOL PHARM, V60, P399, DOI 10.1139/y82-058; Welch KD, 2006, CHEM RES TOXICOL, V19, P223, DOI 10.1021/tx050285z; Wolf KK, 2007, DRUG METAB DISPOS, V35, P1223, DOI 10.1124/dmd.107.014738; Xu JJ, 2008, FEBS LETT, V582, P1276, DOI 10.1016/j.febslet.2008.01.063; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhou SF, 2009, CURR DRUG METAB, V10, P713, DOI 10.2174/138920009789895552	61	8	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182977	10.1371/journal.pone.0182977	http://dx.doi.org/10.1371/journal.pone.0182977			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832650	Green Submitted, gold, Green Published			2022-12-26	WOS:000408355800039
J	Giacoppo, S; Thangavelu, SR; Diomede, F; Bramanti, P; Conti, P; Trubiani, O; Mazzon, E				Giacoppo, Sabrina; Thangavelu, Soundara Rajan; Diomede, Francesca; Bramanti, Placido; Conti, Pio; Trubiani, Oriana; Mazzon, Emanuela			Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37	FASEB JOURNAL			English	Article						inflammation; EAE; hPDLSC secretome; eperimental autoimmune ensephalomyelitis	MESENCHYMAL STEM-CELL; TRAUMATIC BRAIN-INJURY; IN-VITRO; CORTICAL-NEURONS; OXIDATIVE STRESS; MOUSE MODEL; AUTOPHAGY; APOPTOSIS; FAMILY; INTERLEUKIN-37	Recent research has widely investigated the anti-inflammatory effects of mesenchymal stem cells and their secretory products, termed the secretome, in the treatment of multiple sclerosis (MS). The present study examined the capacity of the conditioned medium (CM) from human periodontal ligament stem cells (hPLSCs) under hypoxia (H-hPDLSCs-CM) to suppress experimental autoimmune encephalomyelitis (EAE), a murine model of MS. To induce EAE, female C57BL/6 mice were immunized with myelin oligodendroglial glycoprotein peptide35-55. At the onset of symptoms, H-hPDLSCs-CM was infused via the tail vein of mice. Our results demonstrate the efficacy of H-hPDLSCs-CM treatment in diminishing clinical and histologic disease score. A key finding from this study is the marked expression of anti-inflammatory cytokine IL-37, paralleledby the suppression of proinflammatory cytokines in mice with EAE that were treated with H-hPDLSCs-CM. In addition, a consequent modulation of oxidative stress, autophagic, and apoptotic markers was observed in mice with EAE after hPDLSCsCM administration. In addition, to provide additional evidence of the molecular mechanisms that underlie H-hPDLSCs-CM, we investigated its therapeutic action in scratch injury-exposed NSC-34 neurons, an in vitro model of injury. This model reproduces severe inflammation and oxidative stress conditions as observed after EAE damage. In vitro results corroborate the ability of hPDLSCs-CM to modulate inflammatory, oxidative stress, and apoptotic pathways. Taken together, our findings suggest H-hPDLSCs-CM as a new pharmacologic opportunity for the management of MS.	[Giacoppo, Sabrina; Thangavelu, Soundara Rajan; Bramanti, Placido; Mazzon, Emanuela] IRCCS, Ctr Neurolesi Bonino Pulejo, Via Prov Palermo, I-98124 Messina, Italy; [Diomede, Francesca; Trubiani, Oriana] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Stem Cells & Regenerat Med Lab, Chieti, Italy; [Conti, Pio] Univ G dAnnunzio, Immunol Div, Postgrad Med Sch, Chieti, Italy	IRCCS Bonino Pulejo; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Mazzon, E (corresponding author), IRCCS, Ctr Neurolesi Bonino Pulejo, Via Prov Palermo, I-98124 Messina, Italy.	emazzon.irccs@gmail.com	Diomede, Francesca/AAL-6840-2020; Gao, Jing/M-8264-2018; Mazzon, Emanuela/AAL-4334-2020; Rajan, Thangavelu Soundara/J-9840-2016; Bramanti, Placido/K-5117-2016	Diomede, Francesca/0000-0002-0384-6509; Rajan, Thangavelu Soundara/0000-0001-8728-6176; mazzon, emanuela/0000-0002-5073-717X				Ahmed NEB, 2016, SCI REP-UK, V6, DOI 10.1038/srep35476; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Bulau AM, 2014, P NATL ACAD SCI USA, V111, P2650, DOI 10.1073/pnas.1324140111; Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P84; Carinci F, 2016, J BIOL REG HOMEOS AG, V30, P945; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; DINARELLO CA, 1986, YALE J BIOL MED, V59, P97; Dulamea A, 2015, J Med Life, V8, P24; Farrokhi M, 2015, ACTA NEUROL BELG, V115, P609, DOI 10.1007/s13760-015-0491-3; Feng XD, 2017, BOSNIAN J BASIC MED, V17, P95, DOI 10.17305/bjbms.2017.1696; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Giacoppo S, 2017, ARCH IMMUNOL THER EX, V65, P363, DOI 10.1007/s00005-017-0460-z; Giacoppo S, 2017, FITOTERAPIA, V116, P77, DOI 10.1016/j.fitote.2016.11.010; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Haque N, 2013, SCI WORLD J, DOI 10.1155/2013/632972; Imaeda H, 2013, CLIN EXP IMMUNOL, V172, P410, DOI 10.1111/cei.12061; Jarmalaviciute A, 2016, NEURAL REGEN RES, V11, P904, DOI 10.4103/1673-5374.184480; Khwanraj K, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/8716016; Kumar S, 2013, NEUROBIOL DIS, V56, P131, DOI 10.1016/j.nbd.2013.04.005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li JH, 2008, J ENDOCRINOL INVEST, V31, P103, DOI 10.1007/BF03345575; Li SZ, 2015, P NATL ACAD SCI USA, V112, P2497, DOI 10.1073/pnas.1424626112; Li TT, 2017, MOL IMMUNOL, V87, P132, DOI 10.1016/j.molimm.2017.04.010; Liu JJ, 2015, STEM CELLS, V33, P627, DOI 10.1002/stem.1909; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Ma YH, 2012, NEUROSCI LETT, V510, P14, DOI 10.1016/j.neulet.2011.12.061; Madrigal M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0260-8; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Meamar Rokhsareh, 2016, Adv Biomed Res, V5, P46, DOI 10.4103/2277-9175.178791; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Merino-Gonzalez C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00024; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Paschalidis N, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-33; Payette DJ, 2008, INT J CLIN EXP PATHO, V1, P44; Rajan TS, 2017, J CELL BIOCHEM, V118, P1531, DOI 10.1002/jcb.25815; Rajan TS, 2017, J CELL BIOCHEM, V118, P819, DOI 10.1002/jcb.25757; Rajan TS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38743; Rajan TS, 2016, EXP CELL RES, V349, P152, DOI 10.1016/j.yexcr.2016.10.008; Rodrigues DH, 2010, J NEUROIMMUNOL, V222, P90, DOI 10.1016/j.jneuroim.2010.02.016; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sarvar DP, 2016, ADV PHARM BULL, V6, P293, DOI 10.15171/apb.2016.041; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477; Sharpe PT, 2016, DEVELOPMENT, V143, P2273, DOI 10.1242/dev.134189; Song LJ, 2013, J CLIN IMMUNOL, V33, P111, DOI 10.1007/s10875-012-9791-z; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Teng X, 2014, J IMMUNOL, V192, P1815, DOI 10.4049/jimmunol.1300047; Tete S, 2012, INT J IMMUNOPATH PH, V25, P31, DOI 10.1177/039463201202500105; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025; Vertelov G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt153; Wahl SE, 2014, J NEUROSCI, V34, P4453, DOI 10.1523/JNEUROSCI.4311-13.2014; Weber MS, 2012, CURR PHARM DESIGN, V18, P209; Wu TT, 2016, INT J BIOL SCI, V12, P884, DOI 10.7150/ijbs.15194; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Yang LB, 2015, APMIS, V123, P1025, DOI 10.1111/apm.12467; Yeo RWY, 2013, ADV DRUG DELIVER REV, V65, P336, DOI 10.1016/j.addr.2012.07.001; Yu J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt234; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhuang XY, 2017, IMMUN INFLAMM DIS, V5, P373, DOI 10.1002/iid3.159	64	63	64	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5592	5608		10.1096/fj.201700524R	http://dx.doi.org/10.1096/fj.201700524R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842429	Green Published			2022-12-26	WOS:000416588300039
J	Kaczmarczyk, A; Allahverdi, A; Brouwer, TB; Nordenskiold, L; Dekker, NH; van Noort, J				Kaczmarczyk, Artur; Allahverdi, Abdollah; Brouwer, Thomas B.; Nordenskiold, Lars; Dekker, Nynke H.; van Noort, John			Single-molecule force spectroscopy on histone H4 tail-cross-linked chromatin reveals fiber folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-SEQUENCE; IN-VIVO; TRANSCRIPTION; NUCLEOSOMES; COMPACTION; OCTAMER; EM	The eukaryotic genome is highly compacted into a protein-DNA-complex called chromatin. The cell controls access of transcriptional regulators to chromosomal DNA via several mechanisms that act on chromatin-associated proteins and provide a rich spectrum of epigenetic regulation. Elucidating the mechanisms that fold chromatin fibers into higher-order structures is therefore key to understanding the epigenetic regulation of DNA accessibility. Here, using histone H4-V21C and histone H2A-E64C mutations, we employed single-molecule force spectroscopy to measure the unfolding of individual chromatin fibers that are reversibly cross-linked through the histone H4 tail. Fibers with covalently linked nucleosomes featured the same folding characteristics as fibers containing wild-type histones but exhibited increased stability against stretching forces. By stabilizing the secondary structure of chromatin, we confirmed a nucleosome repeat length (NRL)-dependent folding. Consistent with previous crystallographic and cryo-EM studies, the obtained force-extension curves on arrays with 167-bp NRLs best supported an underlying structure consisting of zig-zag, two-start fibers. For arrays with 197-bp NRLs, we previously inferred solenoidal folding, which was further corroborated by force-extension curves of the cross-linked fibers. The different unfolding pathways exhibited by these two types of arrays and reported here extend our understanding of chromatin structure and its potential roles in gene regulation. Importantly, these findings imply that chromatin compaction by nucleosome stacking protects nucleosomal DNA from external forces up to 4 piconewtons.	[Kaczmarczyk, Artur; Brouwer, Thomas B.; van Noort, John] Leiden Univ, Huygens Kamerlingh Onnes Lab, Niels Bohrweg 2, NL-2333 CA Leiden, Netherlands; [Dekker, Nynke H.] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Van der Maasweg 9, NL-2629 HZ Delft, Netherlands; [Allahverdi, Abdollah; Nordenskiold, Lars] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Allahverdi, Abdollah] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, POB 14115-175, Tehran, Iran	Leiden University; Leiden University - Excl LUMC; Delft University of Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tarbiat Modares University	van Noort, J (corresponding author), Leiden Univ, Huygens Kamerlingh Onnes Lab, Niels Bohrweg 2, NL-2333 CA Leiden, Netherlands.	noort@physics.leidenuniv.nl	van Noort, John/B-1242-2008; Allahverdi, Abdollah/AAE-1244-2022; NORDENSKIÖLD, LARS/ABD-4725-2020	van Noort, John/0000-0002-9094-5598; NORDENSKIÖLD, LARS/0000-0002-3681-209X; Kaczmarczyk, Artur/0000-0002-2100-2780	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program, by NWO-VICI Research Program Project [680-47-616]; Singapore Ministry of Education Academic Research Fund through Tier 3 Grant [MOE2012-T3-1001]; Singapore Agency for Science Technology and Research through Biomedical Research Council Grant [10/1/22/19/666]	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program, by NWO-VICI Research Program Project; Singapore Ministry of Education Academic Research Fund through Tier 3 Grant(Ministry of Education, Singapore); Singapore Agency for Science Technology and Research through Biomedical Research Council Grant	This work was supported by the Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program, by NWO-VICI Research Program Project 680-47-616; the Singapore Ministry of Education Academic Research Fund through Tier 3 Grant MOE2012-T3-1001; and the Singapore Agency for Science Technology and Research through Biomedical Research Council Grant 10/1/22/19/666. The authors declare that they have no conflicts of interest with the contents of this article.	Allahverdi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08512; Ricci MA, 2015, CELL, V160, P1145, DOI 10.1016/j.cell.2015.01.054; Bednar J, 1999, MOL CELL, V4, P377, DOI 10.1016/S1097-2765(00)80339-1; Chen QM, 2017, J MOL BIOL, V429, P2075, DOI 10.1016/j.jmb.2017.03.016; Chien FT, 2009, CURR PHARM BIOTECHNO, V10, P474, DOI 10.2174/138920109788922128; Clark DJ, 2010, J BIOMOL STRUCT DYN, V27, P781, DOI 10.1080/073911010010524945; Claudet C, 2005, J BIOL CHEM, V280, P19958, DOI 10.1074/jbc.M500121200; Correll SJ, 2012, EMBO J, V31, P2416, DOI 10.1038/emboj.2012.80; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Flaus A, 2011, FRONT LIFE SCI, V5, P5, DOI 10.1080/21553769.2012.702667; Gilbert Nick, 2005, Briefings in Functional Genomics & Proteomics, V4, P129, DOI 10.1093/bfgp/4.2.129; Grigoryev SA, 2012, NUCLEUS-PHILA, V3, P493, DOI 10.4161/nucl.22168; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Koslover EF, 2010, BIOPHYS J, V99, P3941, DOI 10.1016/j.bpj.2010.10.024; Kruithof M, 2008, BIOPHYS J, V94, P2343, DOI 10.1529/biophysj.107.121673; Langowski J, 2006, COMPUTATIONAL STUDIE, P605; Li W, 2016, MOL CELL, V64, P120, DOI 10.1016/j.molcel.2016.08.024; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maeshima K, 2016, CURR OPIN GENET DEV, V37, P36, DOI 10.1016/j.gde.2015.11.006; Maeshima K, 2010, CURR OPIN CELL BIOL, V22, P291, DOI 10.1016/j.ceb.2010.03.001; Meng H, 2015, NUCLEIC ACIDS RES, V43, P3578, DOI 10.1093/nar/gkv215; Nikitina T., 2017, BIORXIV, DOI [10.1101/104083, DOI 10.1101/104083]; Norouzi D, 2015, AIMS BIOPHYS, V2, P613, DOI 10.3934/biophy.2015.4.613; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schlick T, 2012, J BIOL CHEM, V287, P5183, DOI 10.1074/jbc.R111.305763; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Tompitak M, 2017, BIOPHYS J, V112, P505, DOI 10.1016/j.bpj.2016.12.041; Victor JM, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-21; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	37	25	25	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17506	17513		10.1074/jbc.M117.791830	http://dx.doi.org/10.1074/jbc.M117.791830			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28855255	Green Published, hybrid			2022-12-26	WOS:000414009300030
J	Bove-Fenderson, E; Urano, R; Straub, JE; Harris, DA				Bove-Fenderson, Erin; Urano, Ryo; Straub, John E.; Harris, David A.			Cellular prion protein targets amyloid-beta fibril ends via its C-terminal domain to prevent elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (AB); neurodegeneration; prion; protein aggregation	GLUTAMATE-RECEPTOR 5; A-BETA; MICROSCOPIC MECHANISMS; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; LAG PHASE; OLIGOMERS; IMPAIRMENT; TOXICITY; OCCURS	Oligomeric forms of the amyloid- (A) peptide are thought to represent the primary synaptotoxic species underlying the neurodegenerative changes seen in Alzheimer's disease. It has been proposed that the cellular prion protein (PrPC) functions as a cell-surface receptor, which binds to A oligomers and transduces their toxic effects. However, the molecular details of the PrPC-A interaction remain uncertain. Here, we investigated the effect of PrPC on polymerization of A under rigorously controlled conditions in which A converts from a monomeric to a fibrillar state via a series of kinetically defined steps. We demonstrated that PrPC specifically inhibited elongation of A fibrils, most likely by binding to the ends of growing fibrils. Surprisingly, this inhibitory effect required the globular C-terminal domain of PrPC, which has not been previously implicated in interactions with A. Our results suggest that PrPC recognizes structural features common to both A oligomers and fibril ends and that this interaction could contribute to the neurotoxic effect of A aggregates. Additionally, our results identify the C terminus of PrPC as a new and potentially more druggable molecular target for treating Alzheimer's disease.	[Bove-Fenderson, Erin; Harris, David A.] Boston Univ, Dept Biochem, Sch Med, K225,72 E Concord St, Boston, MA 02118 USA; [Urano, Ryo; Straub, John E.] Boston Univ, Dept Chem, Boston, MA 02215 USA	Boston University; Boston University	Harris, DA (corresponding author), Boston Univ, Dept Biochem, Sch Med, K225,72 E Concord St, Boston, MA 02118 USA.	daharris@bu.edu	URANO, Ryo/AAG-8623-2020	URANO, Ryo/0000-0003-1417-5074; Harris, David/0000-0002-6985-5790	National Institutes of Health (NIH) [R01 NS065244]; National Science Foundation [CHE-1362524]; NIH [R01 GM107703]; National Research Service Award Fellowship [5F31NS090747]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065244, F31NS090747] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) Grant R01 NS065244 (to D. A. H.), National Science Foundation Grant CHE-1362524 and NIH Grant R01 GM107703 (to J. E. S.), and National Research Service Award Fellowship 5F31NS090747 (to E. B-F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arosio P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10948; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Arosio P, 2014, J AM CHEM SOC, V136, P219, DOI 10.1021/ja408765u; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Biasini E, 2012, FUTURE MED CHEM, V4, P1655, DOI [10.4155/FMC.12.114, 10.4155/fmc.12.114]; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608918; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608917; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Haas LT, 2016, J BIOL CHEM, V291, P17112, DOI 10.1074/jbc.M116.720664; Haas LT, 2014, J BIOL CHEM, V289, P28460, DOI 10.1074/jbc.M114.584342; Halfmann R., 2008, J VIS EXP, V10; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Liu P, 2015, CELL REP, V11, P1760, DOI 10.1016/j.celrep.2015.05.021; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; McDonald AJ, 2014, J BIOL CHEM, V289, P803, DOI 10.1074/jbc.M113.502351; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Slapsak U, 2016, J BIOL CHEM, V291, P21857, DOI 10.1074/jbc.M116.743435; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Wu B, 2017, ELIFE, V6, DOI 10.7554/eLife.23473; Xu LQ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0410	49	23	23	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16858	16871		10.1074/jbc.M117.789990	http://dx.doi.org/10.1074/jbc.M117.789990			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842494	Green Published, hybrid			2022-12-26	WOS:000413140600008
J	Wu, XS; Huang, YH; Kaas, Q; Harvey, PJ; Wang, CK; Tae, HS; Adams, DJ; Craik, DJ				Wu, Xiaosa; Huang, Yen-Hua; Kaas, Quentin; Harvey, Peta J.; Wang, Conan K.; Tae, Han-Shen; Adams, David J.; Craik, David J.			Backbone cyclization of analgesic conotoxin GeXIVA facilitates direct folding of the ribbon isomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug design; nicotinic acetylcholine receptors (nAChR); peptide chemical synthesis; peptide conformation; protein folding; conotoxin; cyclization; oxidative folding; stability	NICOTINIC ACETYLCHOLINE-RECEPTORS; CHAIN DES-(B30) INSULIN; ALPHA-O-CONOTOXIN; NEUROPATHIC PAIN; CHEMICAL-SYNTHESIS; CALCIUM-CHANNELS; GABA(B) RECEPTOR; CYCLIC-PEPTIDES; SENSORY NEURONS; STABILITY	Conotoxin GeXIVA inhibits the 910 nicotinic acetylcholine receptor (nAChR) and is analgesic in animal models of pain. -Conotoxins have four cysteines that can have three possible disulfide connectivities: globular (Cys(I)-Cys(III) and Cys(II)-Cys(IV)), ribbon (Cys(I)-Cys(IV) and Cys(II)-Cys(III)), or bead (Cys(I)-Cys(II) and Cys(III)-Cys(IV)). Native -conotoxins preferably adopt the globular connectivity, and previous studies of -conotoxins have focused on the globular isomers as the ribbon and bead isomers typically have lower potency at nAChRs than the globular form. A recent report showed that the bead and ribbon isomers of GeXIVA are more potent than the globular isomer, with low nanomolar half-maximal inhibitory concentrations (IC50). Despite this high potency, the therapeutic potential of GeXIVA is limited, because like most peptides, it is susceptible to proteolytic degradation and is challenging to synthesize in high yield. Here we used backbone cyclization as a strategy to improve the folding yield as well as increase the serum stability of ribbon GeXIVA while preserving activity at the 910 nAChR. Specifically, cyclization of ribbon GeXIVA with a two-residue linker maintained the biological activity at the human 910 nAChR and improved stability in human serum. Short linkers led to selective formation of the ribbon disulfide isomer without requiring orthogonal protection. Overall, this study highlights the value of backbone cyclization in directing folding, improving yields, and stabilizing conotoxins with therapeutic potential.	[Wu, Xiaosa; Huang, Yen-Hua; Kaas, Quentin; Harvey, Peta J.; Wang, Conan K.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Tae, Han-Shen; Adams, David J.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia	University of Queensland; University of Wollongong	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Adams, David John/K-3578-2019; Wang, Conan K/D-1481-2010; Tae, Han-Shen/AAA-1904-2020; Wu, Xiaosa/ABD-1866-2020; Craik, David/B-1695-2010; Huang, Yen-Hua/J-9056-2014; harvey, peta/D-2048-2017; Kaas, Quentin/J-8727-2014; Wu, Xiaosa/C-8000-2017	Adams, David John/0000-0002-7030-2288; Wang, Conan K/0000-0002-7973-7632; Tae, Han-Shen/0000-0001-8961-7194; Craik, David/0000-0003-0007-6796; Huang, Yen-Hua/0000-0001-6937-2660; harvey, peta/0000-0003-4735-6242; Kaas, Quentin/0000-0001-9988-6152; Wu, Xiaosa/0000-0002-1733-9639	Australian Research Council [DP150103990];  [FL150100146]	Australian Research Council(Australian Research Council); 	This work was supported by Australian Research Council Grant DP150103990. The authors declare that they have no conflicts of interest with the contents of this article.; Australian Research Council Australian Laureate Fellow supported by Grant FL150100146. To whom correspondence should be addressed. Tel.: 61-7-33462019; Fax: 61-7-33462101; E-mail: d.craik@imb.uq.edu.au.	Akcan M, 2015, RSC DRUG DISCOV, V42, P275; Akcan M, 2011, J MED CHEM, V54, P782, DOI 10.1021/jm101018r; Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Armishaw CJ, 2011, ANTIOXID REDOX SIGN, V14, P65, DOI 10.1089/ars.2010.3458; Armishaw CJ, 2010, BIOPOLYMERS, V94, P307, DOI 10.1002/bip.21360; Bulaj G, 2008, ANTIOXID REDOX SIGN, V10, P141, DOI 10.1089/ars.2007.1856; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Callaghan B, 2010, CHANNELS, V4, P51, DOI 10.4161/chan.4.1.10281; Carstens BB, 2016, BIOPOLYMERS, V106, P864, DOI 10.1002/bip.22848; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheneval O, 2014, J ORG CHEM, V79, P5538, DOI 10.1021/jo500699m; Clark RJ, 2012, TOXICON, V59, P446, DOI 10.1016/j.toxicon.2010.12.003; Clark RJ, 2012, METHOD ENZYMOL, V503, P57, DOI 10.1016/B978-0-12-396962-0.00003-3; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Clark RJ, 2005, P NATL ACAD SCI USA, V102, P13767, DOI 10.1073/pnas.0504613102; Colloca L, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.2; Conibear AC, 2014, ANGEW CHEM INT EDIT, V53, P10612, DOI 10.1002/anie.201402167; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Cruccu G, 2007, CURR OPIN NEUROL, V20, P531; Dekan Z, 2012, ORG BIOMOL CHEM, V10, P5791, DOI 10.1039/c2ob25133g; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Gyanda R, 2013, J PEPT SCI, V19, P16, DOI 10.1002/psc.2467; Halai R, 2011, J MED CHEM, V54, P6984, DOI 10.1021/jm201060r; Halai R, 2009, NAT PROD REP, V26, P526, DOI 10.1039/b819311h; Hemu X, 2013, BIOPOLYMERS, V100, P492, DOI 10.1002/bip.22308; Hua QX, 2008, J BIOL CHEM, V283, P14703, DOI 10.1074/jbc.M800313200; Ikeya T, 2006, MAGN RESON CHEM, V44, pS152, DOI 10.1002/mrc.1815; Jain KK, 2000, EXPERT OPIN INV DRUG, V9, P2403, DOI 10.1517/13543784.9.10.2403; Jensen JE, 2012, MAR DRUGS, V10, P1511, DOI 10.3390/md10071511; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Koval L, 2011, INT J BIOCHEM CELL B, V43, P516, DOI 10.1016/j.biocel.2010.12.003; Kwon S, 2016, BIOTECHNOL BIOENG, V113, P2202, DOI 10.1002/bit.25993; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Li XD, 2016, PROG NEURO-PSYCHOPH, V66, P112, DOI 10.1016/j.pnpbp.2015.12.005; Lovelace ES, 2006, J MED CHEM, V49, P6561, DOI 10.1021/jm060299h; Lovelace ES, 2011, ANTIOXID REDOX SIGN, V14, P87, DOI 10.1089/ars.2009.3068; Luo SL, 2015, P NATL ACAD SCI USA, V112, pE4026, DOI 10.1073/pnas.1503617112; Luo SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054648; MARKUSSEN J, 1985, INT J PEPT PROT RES, V25, P431; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Mohammadi SA, 2015, TOXINS, V7, P3916, DOI 10.3390/toxins7103916; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Peng HS, 2004, LIFE SCI, V76, P263, DOI 10.1016/j.lfs.2004.05.031; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Scanlon MJ, 1997, STRUCTURE, V5, P1585, DOI 10.1016/S0969-2126(97)00307-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; STATES DJ, 1984, J MOL BIOL, V174, P411, DOI 10.1016/0022-2836(84)90345-0; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Thal DM, 2016, NATURE, V531, P335, DOI 10.1038/nature17188; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Verdes A, 2016, INTEGR COMP BIOL, V56, pE230; Wang CK, 2015, J PHYS CHEM B, V119, P15821, DOI 10.1021/acs.jpcb.5b11085; Wang T, 2016, CURR TOP MED CHEM, V16, P901, DOI [10.2174/1568026615666150825142002, 10.2174/1568026615666150701114831]; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P1483, DOI 10.1021/bi011893q; WEISSMAN JS, 1992, CELL, V71, P841, DOI 10.1016/0092-8674(92)90559-U; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wu CH, 2011, CLIN CANCER RES, V17, P3533, DOI 10.1158/1078-0432.CCR-10-2434; Wu XS, 2016, EUR J ORG CHEM, V2016, P3462, DOI 10.1002/ejoc.201600402; Wu XS, 2013, MAR DRUGS, V11, P3537, DOI 10.3390/md11093537; Xu SQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14261; Yu RL, 2013, J MED CHEM, V56, P3557, DOI 10.1021/jm400041h; Zaykov AN, 2014, ACS CHEM BIOL, V9, P683, DOI 10.1021/cb400792s	76	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17101	17112		10.1074/jbc.M117.808386	http://dx.doi.org/10.1074/jbc.M117.808386			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28851841	Green Published, hybrid			2022-12-26	WOS:000413140600029
J	Yao, PB; Sun, HS; Xu, C; Chen, TQ; Zou, B; Jiang, P; Du, WJ				Yao, Pengbo; Sun, Huishan; Xu, Chang; Chen, Taiqi; Zou, Bing; Jiang, Peng; Du, Wenjing			Evidence for a direct cross-talk between malic enzyme and the pentose phosphate pathway via structural interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; metabolism; pentose phosphate pathway (PPP); protein cross-linking; protein-protein interaction; 6PGD; NADPH; conformational simulation; malic enzyme	6-PHOSPHOGLUCONATE DEHYDROGENASE; TUMOR-GROWTH; CELL-PROLIFERATION; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; 6-AMINONICOTINAMIDE; INHIBITION; P53	Recent studies have revealed that the oxidative pentose phosphate pathway (PPP), malic enzyme (ME), and folate metabolism are the three major routes for generating cellular NADPH, a key cofactor involved in redox control and reductive biosynthesis. Many tumor cells exhibit altered NADPH metabolism to fuel their rapid proliferation. However, little is known about how NADPH metabolism is coordinated in tumor cells. Here we report that ME1 increases the PPP flux by forming physiological complexes with 6-phosphogluconate dehydrogenase (6PGD). We found that ME1 and 6PGD form a hetero-oligomer that increases the capability of 6PGD to bind its substrate 6-phosphogluconate. Through activating 6PGD, ME1 enhances NADPH generation, PPP flux, and tumor cell growth. Interestingly, although ME1 could bind either the dimer-defect mutant 6PGD (K294R) or the NADP(+)-binding defect 6PGD mutants, only 6PGD (K294R) activity was induced by ME1. Thus, ME1/6PGD hetero-complexes may mimic the active oligomer form of 6PGD. Together, these findings uncover a direct cross-talk mechanism between ME1 and PPP, may reveal an alternative model for signaling transduction via protein conformational simulation, and pave the way for better understanding how metabolic pathways are coordinated in cancer.	[Yao, Pengbo; Xu, Chang; Chen, Taiqi; Zou, Bing; Jiang, Peng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Huishan; Du, Wenjing] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Sun, Huishan; Du, Wenjing] Chinese Acad Med Sci, Sch Basic Med, Beijing 100005, Peoples R China; [Sun, Huishan; Du, Wenjing] Peking Union Med Coll, Beijing 100005, Peoples R China	Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jiang, P (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Du, WJ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China.	pengjiang@tsinghua.edu.cn; wenjingdu@ibms.pumc.edu.cn		Jiang, Peng/0000-0002-4218-0092	1000 Talents Program for Young Scholars; Tsinghua-Peking Center for Life Sciences; National Natural Science Foundation of China [31571470, 81672766]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-4-002]; State Key Laboratory Special Fund [2060204]; Peking Union College "Union Youth Fund" [3332016045]	1000 Talents Program for Young Scholars; Tsinghua-Peking Center for Life Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences (CIFMS); State Key Laboratory Special Fund; Peking Union College "Union Youth Fund"	This work was supported by the 1000 Talents Program for Young Scholars, the Tsinghua-Peking Center for Life Sciences, and National Natural Science Foundation of China (31571470; to P. J.) and CAMS Innovation Fund for Medical Sciences (CIFMS) (2016-I2M-4-002), National Natural Science Foundation of China (81672766), State Key Laboratory Special Fund (2060204), Peking Union College "Union Youth Fund" (3332016045), and the 1000 Talents Program for Young Scholars (to W. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Berg J, 2006, BIOCHEMISTRY-US, P577; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Du WJ, 2013, NAT CELL BIOL, V15, P991, DOI 10.1038/ncb2789; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsieh JY, 2014, BBA-PROTEINS PROTEOM, V1844, P1773, DOI 10.1016/j.bbapap.2014.06.019; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; KOHLER E, 1970, FEBS LETT, V6, P225, DOI 10.1016/0014-5793(70)80063-1; LANGE K, 1970, N-S ARCH PHARMAKOL, V267, P177, DOI 10.1007/BF00999399; Lin RT, 2015, NAT CELL BIOL, V17, P1484, DOI 10.1038/ncb3255; Liu L, 2016, NAT CHEM BIOL, V12, P345, DOI [10.1038/NCHEMBIO.2047, 10.1038/nchembio.2047]; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Shan CL, 2014, MOL CELL, V55, P552, DOI 10.1016/j.molcel.2014.06.020; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609	16	21	24	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17113	17120		10.1074/jbc.M117.810309	http://dx.doi.org/10.1074/jbc.M117.810309			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28848047	hybrid, Green Published			2022-12-26	WOS:000413140600030
J	Cao, XY; Hu, XZ; Zhang, XJ; Gao, SJ; Ding, CJ; Feng, YG; Bao, WH				Cao, Xiaoyong; Hu, Xiuzhen; Zhang, Xiaojin; Gao, Sujuan; Ding, Changjiang; Feng, Yonge; Bao, Weihua			Identification of metal ion binding sites based on amino acid sequences	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; PROTEIN-STRUCTURE; PREDICTION; CLASSIFICATION; RECOGNITION; RESIDUES	The identification of metal ion binding sites is important for protein function annotation and the design of new drug molecules. This study presents an effective method of analyzing and identifying the binding residues of metal ions based solely on sequence information. Ten metal ions were extracted from the BioLip database: Zn2+, Cu2+, Fe2+, Fe3+, Ca2+, Mg2+, Mn2+, Na+, K+ and Co2+. The analysis showed that Zn2+, Cuv, Fe2+, Fe3+, and Co2+ were sensitive to the conservation of amino acids at binding sites, and promising results can be achieved using the Position Weight Scoring Matrix algorithm, with an accuracy of over 79.9% and a Matthews correlation coefficient of over 0.6. The binding sites of other metals can also be accurately identified using the Support Vector Machine algorithm with multifeature parameters as input. In addition, we found that Ca2+ was insensitive to hydrophobicity and hydrophilicity information and Mn2+ was insensitive to polarization charge information. An online server was constructed based on the framework of the proposed method and is freely available at http://60.31.198.140: 8081/metal/HomePage/HomePage.html.	[Cao, Xiaoyong; Hu, Xiuzhen; Zhang, Xiaojin; Gao, Sujuan; Ding, Changjiang; Bao, Weihua] Inner Mongolia Univ Technol, Coll Sci, Hohhot 010051, Peoples R China; [Gao, Sujuan; Feng, Yonge] Inner Mongolia Agr Univ, Coll Sci, Hohhot 010021, Peoples R China	Inner Mongolia University of Technology; Inner Mongolia Agricultural University	Hu, XZ (corresponding author), Inner Mongolia Univ Technol, Coll Sci, Hohhot 010051, Peoples R China.	hxz@imut.edu.cn			National Natural Science Foundation of China [31260203, 51467015]; Natural Science Foundation of the Inner Mongolia of China [2016MS0378]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Inner Mongolia of China	This work was supported by National Natural Science Foundation of China (31260203, 51467015) and Natural Science Foundation of the Inner Mongolia of China (2016MS0378).	Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; Babor M, 2008, PROTEINS, V70, P208, DOI 10.1002/prot.21587; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chauhan JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-301; Chauhan JS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-434; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; Chen YL, 2007, J THEOR BIOL, V245, P775, DOI 10.1016/j.jtbi.2006.11.010; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Degtyarenko K, 2000, BIOINFORMATICS, V16, P851, DOI 10.1093/bioinformatics/16.10.851; Deng H, 2006, PROTEINS, V64, P34, DOI 10.1002/prot.20973; Dong QW, 2009, BIOINFORMATICS, V25, P2655, DOI 10.1093/bioinformatics/btp500; Ebert JC, 2008, PROTEIN SCI, V17, P54, DOI 10.1110/ps.073138508; Feng Z, 2014, BIOMED RES INT, V2014, P871; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Hu X, 2016, BIOINFORMATICS, V32, P3694, DOI 10.1093/bioinformatics/btw637; Hu XZ, 2008, J COMPUT CHEM, V29, P1867, DOI 10.1002/jcc.20929; IBERS JA, 1980, SCIENCE, V209, P223, DOI 10.1126/science.7384796; Jiang Z, 2015, GENETICS MOL RES GMR, V15; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Levy R, 2011, HUM MUTAT, V32, P1309, DOI 10.1002/humu.21573; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin CT, 2005, INT J NEURAL SYST, V15, P71, DOI 10.1142/S0129065705000116; Lin HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S13; Liu L, 2012, PROTEIN PEPTIDE LETT, V19, P439, DOI 10.2174/092986612799789378; Lu C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034833, 10.1371/journal.pone.0038332]; Moult J, 2016, PROTEINS, V84, P4, DOI 10.1002/prot.25064; Panek J, 2005, PROTEINS, V58, P923, DOI 10.1002/prot.20356; Passerini A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-39; REIF DW, 1992, FREE RADICAL BIO MED, V12, P417, DOI 10.1016/0891-5849(92)90091-T; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Sobolev V, 2013, ISR J CHEM, V53, P166, DOI 10.1002/ijch.201200084; Sodhi JS, 2004, J MOL BIOL, V342, P307, DOI 10.1016/j.jmb.2004.07.019; TAINER JA, 1991, CURR OPIN BIOTECH, V2, P582, DOI 10.1016/0958-1669(91)90084-I; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Vapnik V. N., 2000, NATURE STAT LEARNING, P123, DOI [10.1007/978-1-4757-3264-1_6, DOI 10.1007/978-1-4757-3264-1_6]; Wu ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003400; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang JY, 2013, NUCLEIC ACIDS RES, V41, pD1096, DOI 10.1093/nar/gks966; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	45	28	28	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183756	10.1371/journal.pone.0183756	http://dx.doi.org/10.1371/journal.pone.0183756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854211	Green Published, gold, Green Submitted			2022-12-26	WOS:000408693600057
J	Stewart, JAE; Wright, DH; Heckman, KA				Stewart, Joseph A. E.; Wright, David H.; Heckman, Katherine A.			Apparent climate-mediated loss and fragmentation of core habitat of the American pika in the Northern Sierra Nevada, California, USA	PLOS ONE			English	Article							OCHOTONA-PRINCEPS; GREAT-BASIN; RANGE BOUNDARIES; FECAL PELLETS; PATTERNS; POPULATION; CONSERVATION; BIOGEOGRAPHY; RADIOCARBON; DISPERSAL	Contemporary climate change has been widely documented as the apparent cause of range contraction at the edge of many species distributions but documentation of climate change as a cause of extirpation and fragmentation of the interior of a species' core habitat has been lacking. Here, we report the extirpation of the American pika (Ochotona princeps), a temperature-sensitive small mammal, from a 165-km(2) area located within its core habitat in California's Sierra Nevada mountains. While sites surrounding the area still maintain pikas, radiocarbon analyses of pika fecal pellets recovered within this area indicate that former patch occupancy ranges from before 1955, the beginning of the atmospheric spike in radiocarbon associated with above ground atomic bomb testing, to c. 1991. Despite an abundance of suitable rocky habitat climate warming appears to have precipitated their demise. Weather station data reveal a 1.9 degrees C rise in local temperature and a significant decline in snowpack over the period of record, 1910-2015, pushing pika habitat into increasingly tenuous climate conditions during the period of extirpation. This is among the first accounts of an apparently climate-mediated, modern extirpation of a species from an interior portion of its geographic distribution, resulting in habitat fragmentation, and is the largest area yet reported for a modern-era pika extirpation. Our finding provides empirical support to model projections, indicating that even core areas of species habitat are vulnerable to climate change within a timeframe of decades.	[Stewart, Joseph A. E.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Stewart, Joseph A. E.; Wright, David H.] Calif Dept Fish & Wildlife, Rancho Cordova, CA USA; [Heckman, Katherine A.] US Forest Serv, USDA, Northern Res Stn, Lawrence Livermore Natl Lab, Livermore, CA USA	University of California System; University of California Santa Cruz; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Stewart, JAE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.; Stewart, JAE (corresponding author), Calif Dept Fish & Wildlife, Rancho Cordova, CA USA.	jaes@ucsc.edu	Stewart, Joseph/AAA-4647-2020	Stewart, Joseph/0000-0001-5915-6892	State Wildlife Grant; Tahoe National Forest; Radiocarbon Collaborative - USDA Forest Service Northern Research Station; Radiocarbon Collaborative - University of California, Irvine; Ecology and Evolutionary Biology Department at the University of California, Santa Cruz	State Wildlife Grant; Tahoe National Forest; Radiocarbon Collaborative - USDA Forest Service Northern Research Station; Radiocarbon Collaborative - University of California, Irvine; Ecology and Evolutionary Biology Department at the University of California, Santa Cruz	Funding was provided by a State Wildlife Grant awarded to the California Department of Fish and Wildlife, by Tahoe National Forest, by the Radiocarbon Collaborative, which is jointly supported by the USDA Forest Service Northern Research Station and the University of California, Irvine, and by the Ecology and Evolutionary Biology Department at the University of California, Santa Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou JT, 2009, J APPL METEOROL CLIM, V48, P1527, DOI 10.1175/2009JAMC2062.1; Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Beever EA, 2008, WEST N AM NATURALIST, V68, P8, DOI 10.3398/1527-0904(2008)68[8:APOPIN]2.0.CO;2; Beever EA, 2016, J MAMMAL, V97, P1495, DOI 10.1093/jmammal/gyw128; Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Beever EA, 2010, ECOL APPL, V20, P164, DOI 10.1890/08-1011.1; Bhattacharyya S, 2015, PLANT ECOL DIVERS, V8, P781, DOI 10.1080/17550874.2015.1121520; Bowerman ND, 2011, QUATERNARY SCI REV, V30, P1067, DOI 10.1016/j.quascirev.2010.10.014; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Castillo JA, 2016, ECOL APPL, V26, P1660, DOI 10.1890/15-1452.1; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; DAVIS JC, 1990, NUCL INSTRUM METH B, V52, P269, DOI 10.1016/0168-583X(90)90419-U; Erb LP, 2011, ECOLOGY, V92, P1730, DOI 10.1890/11-0175.1; FLINT LE, 2012, ECOL PROCESS, V1, pNIL6, DOI DOI 10.1186/2192-1709-1-2; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Goosse H, 2005, QUATERNARY SCI REV, V24, P1345, DOI 10.1016/j.quascirev.2004.12.009; Grayson DK, 2005, J BIOGEOGR, V32, P2103, DOI 10.1111/j.1365-2699.2005.01341.x; Grayson DK, 2006, QUATERNARY SCI REV, V25, P2964, DOI 10.1016/j.quascirev.2006.03.004; HAFNER DJ, 1993, QUATERNARY RES, V39, P373, DOI 10.1006/qres.1993.1044; HAFNER DJ, 1994, ARCTIC ALPINE RES, V26, P375, DOI 10.2307/1551799; HAFNER DJ, 1995, J MAMMAL, V76, P302, DOI 10.2307/1382343; Harte J, 2004, NATURE, V430, DOI 10.1038/nature02718; Hua Q, 2013, RADIOCARBON, V55, P2059, DOI 10.2458/azu_js_rc.v55i2.16177; Jeffress MR, 2013, ECOL APPL, V23, P864, DOI 10.1890/12-0979.1; Koch J, 2014, HOLOCENE, V24, P1639, DOI 10.1177/0959683614551214; MACARTHUR RA, 1974, CAN J ZOOL, V52, P353, DOI 10.1139/z74-042; MACARTHUR RA, 1973, CAN J ZOOL, V51, P11, DOI 10.1139/z73-002; Manning T, 2011, WEST N AM NATURALIST, V71, P106, DOI 10.3398/064.071.0114; Mccain CM, 2014, GLOBAL CHANGE BIOL, V20, P1760, DOI 10.1111/gcb.12499; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Millar CI, 2014, ECOL APPL, V24, P1748, DOI 10.1890/13-0520.1; Morelli TL, 2012, P ROY SOC B-BIOL SCI, V279, P4279, DOI 10.1098/rspb.2012.1301; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Moyer-Horner L, 2015, ECOL EVOL, V5, pS810, DOI 10.1002/ece3.1848; Nichols LB, 2010, WEST N AM NATURALIST, V70, P500; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Peacock MM, 1997, BEHAV ECOL, V8, P340, DOI 10.1093/beheco/8.3.340; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Robson KM, 2016, J MAMMAL, V97, P464, DOI 10.1093/jmammal/gyv191; Rodhouse TJ, 2010, J MAMMAL, V91, P1287, DOI 10.1644/09-MAMM-A-334.1; Rodriguez A, 2002, ECOGRAPHY, V25, P314, DOI 10.1034/j.1600-0587.2002.250308.x; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Rowe K. C., 2014, P ROYAL SOC B, V282; Sahanatien V, 2012, ANIM CONSERV, V15, P397, DOI 10.1111/j.1469-1795.2012.00529.x; Schwalm D, 2016, GLOBAL CHANGE BIOL, V22, P1572, DOI 10.1111/gcb.13189; SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464; Southon J, 2004, RADIOCARBON, V46, P41, DOI 10.1017/S0033822200039333; Stewart JAE, 2015, J BIOGEOGR, V42, P880, DOI 10.1111/jbi.12466; Stewart JAE, 2012, WILDLIFE SOC B, V36, P759, DOI 10.1002/wsb.220; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Tapper S., 1973, SPATIAL ORG PIKAS OC; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Thorne JH, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00300.1; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; TYSER RW, 1980, AM MIDL NAT, V104, P32, DOI 10.2307/2424955; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; Varner J, 2016, BEHAV PROCESS, V125, P63, DOI 10.1016/j.beproc.2016.01.009; Varner J, 2014, J MAMMAL, V95, P72, DOI 10.1644/13-MAMM-A-099.1; VOGEL JS, 1987, NUCL INSTRUM METH B, V29, P50, DOI 10.1016/0168-583X(87)90202-3; Wilkening JL, 2011, QUATERN INT, V235, P77, DOI 10.1016/j.quaint.2010.05.004; Wilson RJ, 2004, NATURE, V432, P393, DOI 10.1038/nature03031; Wunder Bruce A., 1992, P83	71	24	24	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0181834	10.1371/journal.pone.0181834	http://dx.doi.org/10.1371/journal.pone.0181834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854268	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600008
J	Wang, L; Zhang, Y; Wang, W; Zhu, Y; Chen, Y; Tian, B				Wang, Li; Zhang, Yi; Wang, Weiguo; Zhu, Yunjie; Chen, Yang; Tian, Bole			Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs)	PLOS ONE			English	Article							PANCREATIC-CANCER; MUTANT P53; POOR-PROGNOSIS; MESSENGER-RNA; PROTEIN 78; CHEMORESISTANCE; GRP78; EXPRESSION; INVASION; TRANSCRIPTION	Background Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with poor survival rates. The presence of cancer stem-like cells (CSCs) is believed to be among the underlying reasons for the aggressiveness of PDAC, which contributes to chemoresistance and recurrence. However, the mechanisms that induce chemoresistance and inhibit apoptosis remain largely unknown. Methods We used serum-free medium to enrich CSCs from panc-1 human pancreatic cancer cells and performed sphere formation testing, flow cytometry, quantitative reverse transcription polymerase chain reaction (RT-qPCR) and semi-quantitative western blotting to confirm the stemness of panc-1 CSCs. Hallmarks of endoplasmic reticulum (ER) stress, including IRE1, PERK, ATF4, ATF6a, GRP78 and uPA expression, were detected after gemcitabine treatment. Effects of gemcitabine-induced uPA expression on cell invasion, sphere formation, colony formation and gemcitabine sensitivity were detected. Electrophoretic mobility shift assays (EMSAs) and RNA-immunoprecipitation (RIP) were performed to detect interaction between the uPA mRNA 3'-UTR and mutant p53-R273H expressed by panc-1 CSCs. The effects of upregulated uPA by gemcitabine on apoptosis were detected by Annexin V-FITC/PI staining, and the impact of uPA on small molecule CP-31398-restored mutant p53 transcriptional activity was measured by a luciferase reporter assay. Results Enriched panc-1 CSCs expressing high levels of CD44 and CD133 also produced significantly higher amounts of Oct4 and Nanog. Compared with panc-1 cells, panc-1 CSCs presented chemoresistance to gemcitabine. ER stress gene detections demonstrated effects of gemcitabine-induced ER stress on both the pro-apoptotic and pro-survival branches. ER stress-induced ATF6a upregulated level of uPA by transcriptionally activating GRP78. Gemcitabine-induced uPA promoted invasion, sphere formation and colony formation and attenuated apoptosis induced by gemcitabine in panc-1 CSCs, depending on interaction with mutant p53-R273H. Upregulation of uPA abolished CP-31398-mediated restoration of mutant p53 transcriptional activity in panc-1 CSCs. Conclusion Gemcitabine treatment induced ER stress and promoted mutant p53-R273H stabilization via transcriptionally activated uPA which may contribute to chemoresistance to gemcitabine. Notably, upregulation of uPA by gemcitabine treatment may lead to the failure of CP-31398; thus, a novel strategy for modulating mutant p53 function needs to be developed.	[Wang, Li; Zhang, Yi; Wang, Weiguo; Zhu, Yunjie; Chen, Yang; Tian, Bole] Sichuan Univ, West China Hosp, Dept Pancreat Surg, Chengdu, Sichuan, Peoples R China	Sichuan University	Tian, B (corresponding author), Sichuan Univ, West China Hosp, Dept Pancreat Surg, Chengdu, Sichuan, Peoples R China.	tianbole@163.com	王, 力/AAJ-5005-2020		National Natural Science Foundation of China [30872528, 81371585]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by two National Natural Science Foundation of China (grant number: 30872528 and 81371585). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Asuthkar S, 2013, MOL BIOL CELL, V24, P2620, DOI 10.1091/mbc.E12-04-0306; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bhandary YP, 2013, AM J PATHOL, V183, P131, DOI 10.1016/j.ajpath.2013.03.022; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen H, 2009, BRIT J CANCER, V101, P432, DOI 10.1038/sj.bjc.6605185; Cheng SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122270; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dhayat S, 2015, PLOS ONE, V10; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Fujimoto A, 2016, ONCOTARGET, V7, P51854, DOI 10.18632/oncotarget.10126; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gungor C, 2014, BRIT J PHARMACOL, V171, P849, DOI 10.1111/bph.12401; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; Kato T, 2012, BIOCHEM BIOPH RES CO, V417, P966, DOI 10.1016/j.bbrc.2011.12.047; Khanna A, 2011, CELL MOL BIOL LETT, V16, P101, DOI 10.2478/s11658-010-0043-z; Lee HJ, 2010, J THORAC ONCOL, V5, P649, DOI 10.1097/JTO.0b013e3181d5e554; Lei P, 2008, MOL CANCER THER, V7, P3363, DOI 10.1158/1535-7163.MCT-08-0439; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li M, MOL CELL BIOL, V20, P5096; Li XM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-8; Li YW, 2013, CANCER LETT, V338, P94, DOI 10.1016/j.canlet.2012.03.018; Li ZW, 2014, BMB REP, V47, P445, DOI 10.5483/BMBRep.2014.47.8.211; Li ZW, 2013, INT J BIOCHEM CELL B, V45, P987, DOI 10.1016/j.biocel.2013.02.002; Li ZW, 2012, BBA-REV CANCER, V1826, P13, DOI 10.1016/j.bbcan.2012.02.001; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Lonardo E, 2010, MOL ONCOL, V4, P431, DOI 10.1016/j.molonc.2010.06.002; Moriyama T, 2010, CANCER-AM CANCER SOC, V116, P3357, DOI 10.1002/cncr.25121; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Niu DG, 2015, ONCOTARGET, V6, P3963, DOI 10.18632/oncotarget.2894; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Perri ER, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00080; Pluquet O, 2015, AM J PHYSIOL-CELL PH, V308, pC415, DOI 10.1152/ajpcell.00334.2014; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Riley KJL, 2007, RNA, V13, P1825, DOI 10.1261/rna.673407; Shetty P, 2008, AM J RESP CELL MOL, V39, P364, DOI 10.1165/rcmb.2007-0406OC; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegelin MD, 2012, EXPERT OPIN THER TAR, V16, P801, DOI 10.1517/14728222.2012.703655; Slomiany MG, 2009, CLIN CANCER RES, V15, P7593, DOI 10.1158/1078-0432.CCR-09-2317; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Sun Q, 2012, MOL BIOL REP, V39, P6753, DOI 10.1007/s11033-012-1500-8; Tan BS, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.191; Tang XW, 2007, J CLIN INVEST, V117, P3753, DOI 10.1172/JCI32481; URANO F, 2000, SCIENCE, V287, P664, DOI [DOI 10.1126/SCIENCE.287.5453.664, 10.1126/science.287.5453.664, DOI 10.1126/science.287.5453.664]; Wang GH, 2010, AM J TRANSL RES, V2, P65; Wang WG, 2003, MOL CELL BIOL, V23, P2171, DOI 10.1128/MCB.23.6.2171-2181.2003; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Xu JM, 2010, CANCER RES, V70, P6566, DOI 10.1158/0008-5472.CAN-10-0942; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang J, 2006, CLIN EXP METASTAS, V23, P401, DOI 10.1007/s10585-006-9051-9; Zheng HC, 2008, HUM PATHOL, V39, P1042, DOI 10.1016/j.humpath.2007.11.009	57	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184110	10.1371/journal.pone.0184110	http://dx.doi.org/10.1371/journal.pone.0184110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854261	gold, Green Submitted, Green Published			2022-12-26	WOS:000408693600084
J	Jantaruk, P; Roytrakul, S; Sitthisak, S; Kunthalert, D				Jantaruk, Pornpimon; Roytrakul, Sittiruk; Sitthisak, Sutthirat; Kunthalert, Duangkamol			Potential role of an antimicrobial peptide, KLK in inhibiting lipopolysaccharide-induced macrophage inflammation	PLOS ONE			English	Article							CELL-SURFACE CALRETICULIN; IMMUNE-RESPONSES; ACTIVATION; LL-37	Antimicrobial peptides (AMPs) are attractive alternatives to antibiotics. Due to their immune modulatory properties, AMPs are at present emerging as promising agents for controlling inflammatory-mediated diseases. In this study, anti-inflammatory potential of an antimicrobial peptide, KLK (KLKLLLLLKLK) and its analogs was evaluated in lipopolysaccharide (LPS)-induced RAW 264.7 macrophages. The results herein demonstrated that KLK peptide as well as its analogs significantly inhibited the pro-inflammatory mediator nitric oxide (NO), interleukin-1 beta (IL-1 beta)and tumor necrosis factor-alpha (TNF-alpha) production in LPS-stimulated RAW 264.7 macrophages in dose-dependent manners, and such inhibitory effects were not due to direct cytotoxicity. When considering inhibition potency, KLK among the test peptides exhibited the most effective activity. The inhibitory activity of KLK peptide also extended to include suppression of LPS-induced production of prostaglandin E-2 (PGE(2)). KLK significantly decreased mRNA and protein expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) as well as mRNA expression of IL-1 beta and TNF-alpha. Moreover, KLK inhibited nuclear translocation of nuclear factor-kappa B (NF-kappa B) p65 and blocked degradation and phosphorylation of inhibitor of kappa B (I kappa B). Taken together, these results suggested that the KLK peptide inhibited inflammatory response through the down-regulation of NF-kappa B mediated activation in macrophages. Since peptide analogs with different amino acid sequences and arrangement were investigated for their anti-inflammatory activities, the residues/ structures required for activity were also discussed. Our findings therefore proved antiinflammatory potential of the KLK peptide and provide direct evidence for therapeutic application of KLK as a novel anti-inflammatory agent.	[Jantaruk, Pornpimon; Sitthisak, Sutthirat; Kunthalert, Duangkamol] Naresuan Univ, Dept Microbiol & Parasitol, Fac Med Sci, Phitsanulok, Thailand; [Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Genome Inst, Thailand Sci Pk, Pathum Thani, Thailand; [Kunthalert, Duangkamol] Naresuan Univ, Ctr Excellence Med Biotechnol, Fac Med Sci, Phitsanulok, Thailand	Naresuan University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Naresuan University	Kunthalert, D (corresponding author), Naresuan Univ, Dept Microbiol & Parasitol, Fac Med Sci, Phitsanulok, Thailand.; Kunthalert, D (corresponding author), Naresuan Univ, Ctr Excellence Med Biotechnol, Fac Med Sci, Phitsanulok, Thailand.	kunthalertd@yahoo.com	Sitthisak, Sutthirat/ABF-4922-2021; Sitthisak, Sutthirat/AAF-9383-2020	Sitthisak, Sutthirat/0000-0003-4992-7635; Roytrakul, Sittiruk/0000-0003-3696-8390	National Research Council of Thailand through the Annual Research Fund of Naresuan University [R2558B014]	National Research Council of Thailand through the Annual Research Fund of Naresuan University	This work was supported by the National Research Council of Thailand through the Annual Research Fund of Naresuan University (Academic year 2015; grant number R2558B014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZBRAVO J, 1994, BIOCHEM J, V302, P535, DOI 10.1042/bj3020535; Cao LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040135; Chan LY, 2013, CHEMBIOCHEM, V14, P617, DOI 10.1002/cbic.201300034; Cho JH, 1999, EUR J BIOCHEM, V266, P878, DOI 10.1046/j.1432-1327.1999.00920.x; Cho JH, 2001, CELL STRESS CHAPERON, V6, P148, DOI 10.1379/1466-1268(2001)006<0148:AOHMCL>2.0.CO;2; Cho YS, 2011, PROCESS BIOCHEM, V46, P465, DOI 10.1016/j.procbio.2010.09.019; Chu HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126390; Cochain C, 2017, PFLUG ARCH EUR J PHY, V469, P485, DOI 10.1007/s00424-017-1941-y; da Silva FP, 2012, PEPTIDES, V36, P308, DOI 10.1016/j.peptides.2012.05.014; Fabisiak A, 2016, PHARMACOL REP, V68, P802, DOI 10.1016/j.pharep.2016.03.015; Fritz JH, 2004, VACCINE, V22, P3274, DOI 10.1016/j.vaccine.2004.03.007; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gupta K, 2015, ONCOTARGET, V6, P28573, DOI 10.18632/oncotarget.5611; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Jung HJ, 2015, MOL CELLS, V38, P273, DOI 10.14348/molcells.2015.2320; Kang HK, 2017, J MICROBIOL, V55, P1, DOI 10.1007/s12275-017-6452-1; Khara JS, 2017, ACTA BIOMATER, V57, P103, DOI 10.1016/j.actbio.2017.04.032; Kim JK, 2011, J BIOL CHEM, V286, P41296, DOI 10.1074/jbc.M111.269225; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Lear S, 2016, J COMPUT AID MOL DES, V30, P271, DOI 10.1007/s10822-016-9902-7; Lee J, 2014, BMB REP, V47, P625, DOI 10.5483/BMBRep.2014.47.11.262; Lee JY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2014.11.03; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagaoka I, 2002, CLIN DIAGN LAB IMMUN, V9, P972, DOI 10.1128/CDLI.9.5.972-982.2002; Nakajima Y, 1997, FEBS LETT, V415, P64, DOI 10.1016/S0014-5793(97)01101-0; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Rosenfeld Y, 2010, BIOCHEMISTRY-US, V49, P853, DOI 10.1021/bi900724x; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Scott A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026525; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; Shim DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126871; Sun L, 2013, MOD CHEM APPL, V1, pe103, DOI DOI 10.4172/2329-6798.1000E103; Tsai WC, 2016, J APPL MICROBIOL, V121, P952, DOI 10.1111/jam.13203; Udalova IA, 2016, NAT REV RHEUMATOL, V12, P472, DOI 10.1038/nrrheum.2016.91; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang YF, 2011, MOL THER, V19, P1849, DOI 10.1038/mt.2011.82; Yousif AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126172; Zhang Q, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00071	42	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183852	10.1371/journal.pone.0183852	http://dx.doi.org/10.1371/journal.pone.0183852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850608	gold, Green Published, Green Submitted			2022-12-26	WOS:000408544200033
J	Jimenez, C; Andreou, V; Evriviadou, M; Munkes, B; Hadjioannou, L; Petrou, A; Abu Alhaija, R				Jimenez, Carlos; Andreou, Vasilis; Evriviadou, Marina; Munkes, Britta; Hadjioannou, Louis; Petrou, Antonis; Abu Alhaija, Rana			Epibenthic communities associated with unintentional artificial reefs (modern shipwrecks) under contrasting regimes of nutrients in the Levantine Sea (Cyprus and Lebanon)	PLOS ONE			English	Article							FOULING COMMUNITIES; FISH ASSEMBLAGES; MARINE; CORAL; TEMPERATURE; RECRUITMENT; SETTLEMENT	Artificial reefs, in the Eastern Mediterranean (Cyprus,) became a popular and frequently used tool, in fisheries and biodiversity conservation management. Even though evaluation studies about the efficacy of artificial reefs are plentiful in the rest of the Mediterranean (Central and Western), in the Eastern Basin they are largely absent. As the Eastern part of the Mediterranean Sea is characterised by unique physical parameters, the necessity to study artificial reefs under these contrasting regimes increases. The epibenthic communities of two unintentional artificial reefs (modern shipwrecks) in Cyprus (Zenobia) and Lebanon (Alice-B) were evaluated in 2010. Both shipwrecks are at similar depth, type of sea bottom, made of the same material (steel) and were sunk approximately the same period of time. However, Alice-B shipwreck off the coast of Lebanon is constantly exposed to higher levels of nutrients than Zenobia in Cyprus. Significant dissimilarities were observed in the composition, percentage of benthic cover of predominant taxonomic groups and development of the epibenthic communities. Differences in physical and chemical parameters between sides lay mainly in the nutrient and thermal regimes affecting the shipwrecks and most likely bring about the differences in the observed community structure. The results of this study suggest that epibenthic communities could be highly impacted by eutrophication caused by anthropogenic activities, leading to less biodiverse	[Jimenez, Carlos; Andreou, Vasilis; Hadjioannou, Louis; Petrou, Antonis; Abu Alhaija, Rana] Enalia Physis Environm Res Ctr ENALIA, Acropoleos 2, Nicosia, Cyprus; [Jimenez, Carlos; Evriviadou, Marina; Abu Alhaija, Rana] Cyprus Inst, Energy Environm & Water Res Ctr, Nicosia, Cyprus; [Munkes, Britta] Helmholtz Ctr Ocean Res GEOMAR, Expt Ecol Dept, Dusternbrooker Weg 20, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Jimenez, C (corresponding author), Enalia Physis Environm Res Ctr ENALIA, Acropoleos 2, Nicosia, Cyprus.; Jimenez, C (corresponding author), Cyprus Inst, Energy Environm & Water Res Ctr, Nicosia, Cyprus.	c.jimenez@enaliaphysis.org.cy	Jimenez, Carlos/AAJ-7275-2020; Hadjioannou, Louis/F-3272-2018	Jimenez, Carlos/0000-0003-3413-6662; Hadjioannou, Louis/0000-0001-5864-5467	AP Marine Environmental Consultancy Ltd.; TEMPUS (Germany-Lebanon)	AP Marine Environmental Consultancy Ltd.; TEMPUS (Germany-Lebanon)	This study was funded in part by AP Marine Environmental Consultancy Ltd., TEMPUS Program (Germany-Lebanon), and Mr. Nick Galea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDIZZONE GD, 1989, B MAR SCI, V44, P592; Arnott J, 2014, BIOFOULING, V30, P1045, DOI 10.1080/08927014.2014.967687; Baird AH, 2003, MAR ECOL PROG SER, V252, P289, DOI 10.3354/meps252289; Barnard A, 2015, NY TIMES; BAYNES TW, 1989, B MAR SCI, V44, P545; Borum J, 1996, OIKOS, V76, P406, DOI 10.2307/3546213; Boynton W.R., 1982, ESTUARINE COMP, P69, DOI DOI 10.1016/B978-0-12-404070-0.50011-9; Burt J, 2009, J EXP MAR BIOL ECOL, V373, P72, DOI 10.1016/j.jembe.2009.03.009; Canning-Clode J, 2008, MAR ECOL-EVOL PERSP, V29, P115, DOI 10.1111/j.1439-0485.2007.00210.x; Cheminee A, 2013, J EXP MAR BIOL ECOL, V442, P70, DOI 10.1016/j.jembe.2013.02.003; Colella S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155756; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Consoli P, 2015, J MAR BIOL ASSOC UK, V95, P17, DOI 10.1017/S0025315414000940; Dobretsov S, 2009, BIOFOULING, V25, P413, DOI 10.1080/08927010902853516; Fabi G, 2011, BRAZ J OCEANOGR, V59, P155, DOI 10.1590/S1679-87592011000300017; Fernandez-Marquez D, 2010, 16 S IB EST BIOL MAR, P6; Fowler AM, 2012, MAR BIOL, V159, P2787, DOI 10.1007/s00227-012-2039-x; Gamfeldt L, 2015, OIKOS, V124, P252, DOI 10.1111/oik.01549; Haines-Young J., 2016, AL ARABIYA ENGLISH; Harrison P.L., 2000, 9 INT COR REEF S, V1, P409; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Humanes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161616; Jennings S, 1997, MAR ECOL PROG SER, V146, P109, DOI 10.3354/meps146109; Jensen A, 2002, ICES J MAR SCI, V59, pS3, DOI 10.1006/jmsc.2002.1298; Jimenez C, 2016, REG ENVIRON CHANGE, V16, P1963, DOI 10.1007/s10113-014-0729-2; Jimenez C, 2017, WATER-SUI, V9, DOI 10.3390/w9010011; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; Kersting DK, 2015, SCI REP-UK, V5, DOI 10.1038/srep18635; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Malak A. D., 2011, OVERVIEW CONSERVATIO; Moreno I, 2004, JOURNAL OF COASTAL R, V39, P1843; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; Park SR, 2011, ESTUAR COAST SHELF S, V91, P163, DOI 10.1016/j.ecss.2010.10.013; Perkol-Finkel S, 2007, J EXP MAR BIOL ECOL, V340, P25, DOI 10.1016/j.jembe.2006.08.008; Perkol-Finkel S, 2006, MAR ENVIRON RES, V61, P121, DOI 10.1016/j.marenvres.2005.08.001; Perkol-Finkel S, 2005, MAR ENVIRON RES, V59, P79, DOI 10.1016/j.marenvres.2004.03.122; Pickering H, 1997, FISH RES, V31, P39, DOI 10.1016/S0165-7836(97)00019-2; Relini G, 2000, ARTIFICIAL REEFS IN EUROPEAN SEAS, P129; Sala E, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P170; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; Santos LN, 2011, ECOL APPL, V21, P251, DOI 10.1890/09-1283.1; Walker SJ, 2007, MAR ECOL-EVOL PERSP, V28, P435, DOI 10.1111/j.1439-0485.2007.00193.x; Zenetos A, 2002, MEDITERRANEAN SEA	43	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0182486	10.1371/journal.pone.0182486	http://dx.doi.org/10.1371/journal.pone.0182486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850572	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000408544200004
J	Maruko, I; Koizumi, H; Hasegawa, T; Arakawa, H; Iida, T				Maruko, Ichiro; Koizumi, Hideki; Hasegawa, Taiji; Arakawa, Hisaya; Iida, Tomohiro			Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy	PLOS ONE			English	Article							TERM-FOLLOW-UP; PHOTODYNAMIC THERAPY; PHOTOCOAGULATION	Purpose To compare the efficacy of the subthreshold micropulse laser (SML) to conventional laser (CL) in treating focal leakages of the retinal pigment epithelium (RPE) in the eyes with central serous chorioretinopathy (CSC). Methods Twenty-nine eyes of 28 patients with CSC and typical focal leakage were treated with CL or SML. Both treatments were made with a 577 nm yellow laser (CL: NIDEK MC-500, SML: IRIDEX IQ577). The percentage of eyes with a complete resolution, the distance of the laser burns from the fovea, and injury of the RPE after treatment were studied. Results A complete resolution was seen in 10 of 15 eyes (66.7%) after CL and 9 of 14 eyes (64.3%) after SML (P = 0.89). The average distance from the foveal center to the leakage point was 1282 +/- 596 mu m for eyes treated with CL and 1271 +/- 993 mu m for eyes treated with SML (P = 0.4). Only three eyes treated with SML had treatment sites within 500 ae m of the fovea. RPE damage determined by fundus autofluorescence was found in all eyes treated with CL and only one eye treated with SML (P <.01). Conclusions SML achieved equivalent therapeutic effects as CL but without RPE damage in eyes with CSC.	[Maruko, Ichiro; Koizumi, Hideki; Hasegawa, Taiji; Arakawa, Hisaya; Iida, Tomohiro] Tokyo Womens Med Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University	Maruko, I (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan.	imaruko@twmu.ac.jp	Hasegawa, Taiji/ABG-8260-2021; Maruko, Ichiro/AFP-1311-2022	Maruko, Ichiro/0000-0001-5647-6372	JSPS KAKENHI [JP16K11274]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Dr. Maruko reports grants from JSPS KAKENHI (Grant Number JP16K11274), grants and personal fees from Novartis Pharma K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., personal fees from NIDEK Co., Ltd., outside the submitted work. Dr. Koizumi reports grants and personal fees from Novartis Pharma K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., personal fees from HOYA Corp., personal fees from Canon Inc., personal fees from Wakamoto Pharmaceutical Co., Ltd., personal fees from NIDEK Co., Ltd., outside the submitted work;. Dr. Hasegawa has nothing to disclose. Dr. Arakawa has nothing to disclose. Dr. lida reports grants and personal fees from Novartis Pharma K.K. (Japan), personal fees from Bayer Yakuhin, Ltd. (Japan), grants and personal fees from Santen Pharmaceutical Co., Ltd. (japan), grants from Nidek, research support from Chuosangyo (Japan), outside the submitted work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elhamid AH, 2015, CLIN OPHTHALMOL, V9, P2277, DOI 10.2147/OPTH.S87499; Chan WM, 2008, OPHTHALMOLOGY, V115, P1756, DOI 10.1016/j.ophtha.2008.04.014; Chan WM, 2008, RETINA-J RET VIT DIS, V28, P85, DOI 10.1097/IAE.0b013e318156777f; Chen SN, 2008, OPHTHALMOLOGY, V115, P2229, DOI 10.1016/j.ophtha.2008.08.026; FICKER L, 1988, BRIT J OPHTHALMOL, V72, P829, DOI 10.1136/bjo.72.11.829; GARTNER J, 1987, DOC OPHTHALMOL, V66, P19, DOI 10.1007/BF00144736; Gass J., 1967, AM J OPHTHALMOL, V63, P1; Inagaki K, 2015, JPN J OPHTHALMOL, V59, P21, DOI 10.1007/s10384-014-0361-1; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Klais CM, 2006, RETINA, V2, P1135, DOI DOI 10.1016/B978-0-323-02598-0.50069-02-S2.0-84917282576; Koss MJ, 2012, EYE, V26, P307, DOI 10.1038/eye.2011.282; Lanzetta P, 2008, EUR J OPHTHALMOL, V18, P934, DOI 10.1177/112067210801800613; Lim JI, 1999, SURV OPHTHALMOL, V44, P95, DOI 10.1016/S0039-6257(99)00077-6; Ozmert E, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/3513794; Piccolino FC, 2003, RETINA-J RET VIT DIS, V23, P752, DOI 10.1097/00006982-200312000-00002; ROBERTSON DM, 1983, AM J OPHTHALMOL, V95, P457, DOI 10.1016/0002-9394(83)90265-9; Salehi M, 2015, COCHRANE DATABASE SY; Scholz P, 2016, EYE, V30, P1371, DOI 10.1038/eye.2016.142; Scholz P, 2017, ADV THER, V34, P1528, DOI 10.1007/s12325-017-0559-y; Yadav NK, 2015, EYE, V29, P258, DOI 10.1038/eye.2014.315; Yannuzzi LA, 2003, RETINA-J RET VIT DIS, V23, P288, DOI 10.1097/00006982-200306000-00002; Yap EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P689, DOI 10.1001/archopht.1996.01100130681007	22	26	27	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0184112	10.1371/journal.pone.0184112	http://dx.doi.org/10.1371/journal.pone.0184112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850595	Green Submitted, gold, Green Published			2022-12-26	WOS:000408544200058
J	Aguilar, C; Chossat, P; Krupa, M; Lavigne, F				Aguilar, Carlos; Chossat, Pascal; Krupa, Martin; Lavigne, Frederic			Latching dynamics in neural networks with synaptic depression	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; LONG-TERM-MEMORY; MONKEY INFEROTEMPORAL CORTEX; SEMANTIC PRIMING SHIFT; PREFRONTAL CORTEX; ASSOCIATIVE MEMORY; PYRAMIDAL NEURONS; CORTICAL NETWORK; WORKING-MEMORY; ABSTRACT RULES	Prediction is the ability of the brain to quickly activate a target concept in response to a related stimulus (prime). Experiments point to the existence of an overlap between the populations of the neurons coding for different stimuli, and other experiments show that prime-target relations arise in the process of long term memory formation. The classical modelling paradigm is that long term memories correspond to stable steady states of a Hopfield network with Hebbian connectivity. Experiments show that short term synaptic depression plays an important role in the processing of memories. This leads naturally to a computational model of priming, called latching dynamics; a stable state (prime) can become unstable and the system may converge to another transiently stable steady state (target). Hopfield network models of latching dynamics have been studied by means of numerical simulation, however the conditions for the existence of this dynamics have not been elucidated. In this work we use a combination of analytic and numerical approaches to confirm that latching dynamics can exist in the context of a symmetric Hebbian learning rule, however lacks robustness and imposes a number of biologically unrealistic restrictions on the model. In particular our work shows that the symmetry of the Hebbian rule is not an obstruction to the existence of latching dynamics, however fine tuning of the parameters of the model is needed.	[Aguilar, Carlos; Lavigne, Frederic] Univ Nice Sophia Antipolis, CNRS, UMR 7320, F-06357 Nice, France; [Chossat, Pascal; Krupa, Martin] Univ Nice Sophia Antipolis, UMR CNRS UNS 7351, Lab JA Dieudonne, F-06108 Nice, France; [Chossat, Pascal; Krupa, Martin] Inria Sophia Antipolis, MathNeuro Team, F-06902 Valbonne, France; [Krupa, Martin] Univ Coll Cork, Dept Appl Math, Cork, Ireland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University College Cork	Krupa, M (corresponding author), Univ Nice Sophia Antipolis, UMR CNRS UNS 7351, Lab JA Dieudonne, F-06108 Nice, France.; Krupa, M (corresponding author), Inria Sophia Antipolis, MathNeuro Team, F-06902 Valbonne, France.; Krupa, M (corresponding author), Univ Coll Cork, Dept Appl Math, Cork, Ireland.	maciej.krupa@inria.fr		Krupa, Maciej (Martin)/0000-0001-9330-4705	European Research Council [227747]	European Research Council(European Research Council (ERC)European Commission)	Our work was funded in part by European Research Council Advanced Grant NerVi number 227747, https://erc.europa.eu/advanced-grants. There was no additional external funding received for this study.	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Amit DJ, 2003, CEREB CORTEX, V13, P435, DOI 10.1093/cercor/13.5.435; AMIT DJ, 1994, J NEUROSCI, V14, P6435; Bick C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.218101; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brothers T, 2015, COGNITION, V136, P135, DOI 10.1016/j.cognition.2014.10.017; Brunel N, 1996, NEURAL COMPUT, V8, P1677, DOI 10.1162/neco.1996.8.8.1677; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Brunel N, 2016, NAT NEUROSCI, V19, P749, DOI 10.1038/nn.4286; Brunel N, 2009, J COGNITIVE NEUROSCI, V21, P2300, DOI 10.1162/jocn.2008.21156; BUHMANN J, 1989, PHYS REV A, V39, P2689, DOI 10.1103/PhysRevA.39.2689; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Chapeton J, 2012, P NATL ACAD SCI USA, V109, pE3614, DOI 10.1073/pnas.1211467109; Chaudhuri R, 2016, NAT NEUROSCI, V19, P394, DOI 10.1038/nn.4237; Chossat P., 2016, J NONLINEAR SCI, V28, P471; Clopath C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002919; Clopath C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002448; Cortes JM, 2006, NEURAL COMPUT, V18, P614, DOI 10.1162/089976606775623342; Cree GS, 2003, J EXP PSYCHOL GEN, V132, P163, DOI 10.1037/0096-3445.132.2.163; DARK VJ, 1988, MEM COGNITION, V16, P299, DOI 10.3758/BF03197040; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; DeLong KA, 2014, LANG LINGUIST COMPAS, V8, P631, DOI 10.1111/lnc3.12093; DeLong KA, 2014, NEUROPSYCHOLOGIA, V61, P150, DOI 10.1016/j.neuropsychologia.2014.06.016; Ding N, 2016, NAT NEUROSCI, V19, P158, DOI 10.1038/nn.4186; Erickson CA, 1999, J NEUROSCI, V19, P10404; Fiete I, 2014, BINARY HOPFIELD NETW; Fujimichi R, 2010, EUR J NEUROSCI, V32, P659, DOI 10.1111/j.1460-9568.2010.07320.x; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HERRMANN M, 1993, BIOL CYBERN, V68, P455, DOI 10.1007/BF00198778; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; HORN D, 1989, PHYS REV A, V40, P1036, DOI 10.1103/PhysRevA.40.1036; Huber DE, 2003, COGNITIVE SCI, V27, P403, DOI 10.1016/S0364-0213(03)00012-0; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Hutchison KA, 2003, PSYCHON B REV, V10, P785, DOI 10.3758/BF03196544; Hutchison KA, 2014, J EXP PSYCHOL LEARN, V40, P844, DOI 10.1037/a0035781; Ison MJ, 2015, NEURON, V87, P220, DOI 10.1016/j.neuron.2015.06.016; Johnson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050276; KAWAMOTO AH, 1985, ACTA PSYCHOL, V59, P35, DOI 10.1016/0001-6918(85)90041-1; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Kropff Emilio, 2007, Natural Computing, V6, P169, DOI 10.1007/s11047-006-9019-3; Krupa M, 1997, NONLINEAR SCI, V7, P129; Kutas M., 2011, PREDICTIONBRAIN US, P190, DOI DOI 10.1093/ACPROF:OSO/9780195395518.003.0065; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lavigne F, 2000, ACTA PSYCHOL, V104, P191, DOI 10.1016/S0001-6918(00)00020-2; Lavigne F, 2008, NEUROPSYCHOLOGIA, V46, P3074, DOI 10.1016/j.neuropsychologia.2008.06.019; Lavigne F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00842; Lavigne F, 2013, ADV COGN PSYCHOL, V9, P1, DOI 10.2478/v10053-008-0126-9; Lavigne F, 2012, COGN NEURODYNAMICS, V6, P467, DOI 10.1007/s11571-012-9206-0; Lavigne F, 2011, J COGNITIVE NEUROSCI, V23, P1447, DOI 10.1162/jocn.2010.21504; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lerner I, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00314; Lerner I, 2012, COGNITIVE SCI, V36, P1339, DOI 10.1111/cogs.12007; Lerner I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040663; Luka BJ, 2014, BRAIN LANG, V135, P115, DOI 10.1016/j.bandl.2014.06.001; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Marro J, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/02/P02017; Marro J, 2007, NEURAL NETWORKS, V20, P230, DOI 10.1016/j.neunet.2006.11.005; MASON A, 1991, J NEUROSCI, V11, P72; MASSON MEJ, 1995, J EXP PSYCHOL LEARN, V21, P3, DOI 10.1037/0278-7393.21.1.3; Masson MEJ, 1991, DISTRIBUTED MEMORY M; McDonald SA, 2003, PSYCHOL SCI, V14, P648, DOI 10.1046/j.0956-7976.2003.psci_1480.x; McRae K, 2005, BEHAV RES METHODS, V37, P547, DOI 10.3758/BF03192726; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; Meyer DE, 2014, SCIENCE, V345, P523, DOI 10.1126/science.345.6196.523-b; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Miller P, 2006, CHAOS, V16, DOI 10.1063/1.2208923; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Moss H. E., 1994, Connection Science, V6, P413, DOI 10.1080/09540099408915732; Muhammad R, 2006, J COGNITIVE NEUROSCI, V18, P974, DOI 10.1162/jocn.2006.18.6.974; Naya Y, 2003, EUR J NEUROSCI, V18, P2915, DOI 10.1111/j.1460-9568.2003.03020.x; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Neely J. H., 1991, BASIC PROCESSES READ, P264; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; Plaut D.C., 1995, P 17 ANN C COGN SCI, P37; Plaut DC, 2000, PSYCHOL REV, V107, P786, DOI 10.1037//0033-295X.107.4.786; Quiroga R. Quian, 2010, PSYCHOL REV, V117, P291, DOI [10.1037/a0016917, DOI 10.1037/A0016917]; Quiroga RQ, 2016, NEUROPSYCHOLOGIA, V83, P227, DOI 10.1016/j.neuropsychologia.2015.12.016; Quiroga RQ, 2012, NAT REV NEUROSCI, V13, P587, DOI 10.1038/nrn3251; Rabinovich MI, 2012, PHYS LIFE REV, V9, P51, DOI 10.1016/j.plrev.2011.11.002; Rainer G, 1999, J NEUROSCI, V19, P5493; Ranganath C, 2005, CURR OPIN NEUROBIOL, V15, P175, DOI 10.1016/j.conb.2005.03.017; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rolls E.T., 2010, NOISY BRAIN STOCHAST; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; Russo E, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015008; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SIK A, 1995, J NEUROSCI, V15, P6651; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SPENCE DP, 1990, J PSYCHOLINGUIST RES, V19, P317, DOI 10.1007/BF01074363; Tamura H, 2001, CEREB CORTEX, V11, P384, DOI 10.1093/cercor/11.5.384; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Torres JJ, 2007, NEURAL COMPUT, V19, P2739, DOI 10.1162/neco.2007.19.10.2739; Torres JJ, 2008, NEURAL NETWORKS, V21, P1272, DOI 10.1016/j.neunet.2008.07.002; Treves A, 2005, COGN NEUROPSYCHOL, V22, P276, DOI 10.1080/02643290442000329; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks M. V., 1990, Modern Physics Letters B, V4, P259, DOI 10.1142/S0217984990000325; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Van Petten C, 2014, INT J PSYCHOPHYSIOL, V94, P407, DOI 10.1016/j.ijpsycho.2014.10.012; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Weinberger NM, 1998, NEUROBIOL LEARN MEM, V70, P226, DOI 10.1006/nlme.1998.3850; Willems R. M., 2015, CEREB CORTEX; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Yakovlev V, 1998, NAT NEUROSCI, V1, P310, DOI 10.1038/1131; Yoshida M, 2003, P NATL ACAD SCI USA, V100, P4257, DOI 10.1073/pnas.0736457100; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	122	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183710	10.1371/journal.pone.0183710	http://dx.doi.org/10.1371/journal.pone.0183710			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846727	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600047
J	Ivanicova, Z; Valarik, M; Pankova, K; Travnivkova, M; Dolezel, J; Safar, J; Milec, Z				Ivanicova, Zuzana; Valarik, Miroslav; Pankova, Katerina; Travnivkova, Martina; Dolezel, Jaroslav; Safar, Jans; Milec, Zbynek			Heritable heading time variation in wheat lines with the same number of Ppd-B1 gene copies	PLOS ONE			English	Article							COPY NUMBER; DNA METHYLATION; FLOWERING TIME; SE GENE; VERNALIZATION; EARLINESS; REGION; LOCUS; PARAMUTATION; SEQUENCE	The ability of plants to identify an optimal flowering time is critical for ensuring the production of viable seeds. The main environmental factors that influence the flowering time include the ambient temperature and day length. In wheat, the ability to assess the day length is controlled by photoperiod (Ppd) genes. Due to its allohexaploid nature, bread wheat carries the following three Ppd-1 genes: Ppd-A1, Ppd-B1 and Ppd-D1. While photoperiod (in) sensitivity controlled by Ppd-A1 and Ppd-D1 is mainly determined by sequence changes in the promoter region, the impact of the Ppd-B1 alleles on the heading time has been linked to changes in the copy numbers (and possibly their methylation status) and sequence changes in the promoter region. Here, we report that plants with the same number of Ppd-B1 copies may have different heading times. Differences were observed among F-7 lines derived from crossing two spring hexaploid wheat varieties. Several lines carrying three copies of Ppd-B1 headed 16 days later than other plants in the population with the same number of gene copies. This effect was associated with changes in the gene expression level and methylation of the Ppd-B1 gene.	[Ivanicova, Zuzana; Valarik, Miroslav; Dolezel, Jaroslav; Safar, Jans; Milec, Zbynek] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Slechtitelu 31, Olomouc, Czech Republic; [Pankova, Katerina; Travnivkova, Martina] Crop Res Inst, Drnovska 507, Prague, Czech Republic; [Travnivkova, Martina] Czech Univ Life Sci Prague, Kamycka 129, Prague 6, Czech Republic	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Czech Crop Research Institute (CRI); Czech University of Life Sciences Prague	Milec, Z (corresponding author), Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Slechtitelu 31, Olomouc, Czech Republic.	milec@ueb.cas.cz	Dolezel, Jaroslav/B-7716-2008; Safar, Jan/G-1038-2014; Milec, Zbynek/F-8655-2014; Valárik, Miroslav/F-6129-2014	Dolezel, Jaroslav/0000-0002-6263-0492; Valárik, Miroslav/0000-0003-0143-6853; Milec, Zbynek/0000-0003-4724-9519	Ministry of Education, Youth and Sports of the Czech Republic [L01204]; Czech Science Foundation [P501-12-G090]; Ministry of Agriculture of the Czech Republic [MZE OR R00417]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic (award L01204 from the National Program of Sustainability I), Czech Science Foundation (grant no. P501-12-G090) and supported by Ministry of Agriculture of the Czech Republic, Project No. MZE OR R00417. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Bullrich L, 2002, THEOR APPL GENET, V105, P585, DOI 10.1007/s00122-002-0982-5; Cane K, 2013, CROP PASTURE SCI, V64, P100, DOI 10.1071/CP13086; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Della Vedova CB, 2004, PLANT CELL, V16, P1358, DOI 10.1105/tpc.160630; Diallo AO, 2012, MOL GENET GENOMICS, V287, P575, DOI 10.1007/s00438-012-0701-0; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Dumas M, 2008, J DRUGS DERMATOLOG S, V6, P20; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Force A, 1999, AM ZOOL, V39, p78A; Francia E, 2016, PLANT MOL BIOL, V92, P161, DOI 10.1007/s11103-016-0505-4; Giorgi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057994; Henderson IR, 2010, EPIGENETICS-US, V5, P47, DOI 10.4161/epi.5.1.10560; Herman JJ, 2014, EVOLUTION, V68, P632, DOI 10.1111/evo.12324; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ivanicova Z, 2016, NEW BIOTECHNOL, V33, P718, DOI 10.1016/j.nbt.2016.01.008; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Kiss T, 2014, MOL BREEDING, V34, P297, DOI 10.1007/s11032-014-0034-2; Lewis S, 2008, J EXP BOT, V59, P3595, DOI 10.1093/jxb/ern209; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Milec Z, 2012, MOL BREEDING, V30, P317, DOI 10.1007/s11032-011-9621-7; Newell-Price J, 2000, TRENDS ENDOCRIN MET, V11, P142, DOI 10.1016/S1043-2760(00)00248-4; Nishida H, 2013, MOL BREEDING, V31, P27, DOI 10.1007/s11032-012-9765-0; Nitcher R, 2013, MOL GENET GENOMICS, V288, P261, DOI 10.1007/s00438-013-0746-8; Piepho HP, 2000, GENETICS, V156, P2043; Pilu R, 2015, SEMIN CELL DEV BIOL, V44, P2, DOI 10.1016/j.semcdb.2015.08.015; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Simkova H, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-237, 10.1186/1471-2164-9-294]; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sun H, 2014, NEW PHYTOL, V204, P682, DOI 10.1111/nph.12948; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Valarik M, 2006, THEOR APPL GENET, V112, P945, DOI 10.1007/s00122-005-0198-6; Wurschum T, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0258-0; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang X, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/05/P05014; Zmienko A, 2014, THEOR APPL GENET, V127, P1, DOI 10.1007/s00122-013-2177-7	41	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183745	10.1371/journal.pone.0183745	http://dx.doi.org/10.1371/journal.pone.0183745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846721	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600048
J	Zhang, SQ; Zeng, N; Alowayed, N; Singh, Y; Cheng, AC; Lang, F; Salker, MS				Zhang, Shaqiu; Zeng, Ni; Alowayed, Nour; Singh, Yogesh; Cheng, Anchun; Lang, Florian; Salker, Madhuri S.			Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells	PLOS ONE			English	Article							DOMAIN-CONTAINING 2; STEM-CELLS; GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; STEM/STROMAL CELLS; PROTEIN MODULE; CANCER-CELLS; GALECTIN-1; EXPRESSION; TUMORIGENESIS	The cause of death among the majority of endometrial cancer patients involves migration of cancer cells within the peritoneal cavity and subsequent implantation of cancer spheroids into neighbouring organs. It is, thereby, important to identify factors that mediate metastasis. Cell adhesion and migration are modified by the mesenchymal stem cell (MSC) marker Sushi domain containing 2 (SUSD2), a type I transmembrane protein that participates in the orchestration of cell adhesion and migration through interaction with its partner Galactosidase-binding soluble-1 (LGALS1). MSCs have emerged as attractive targets in cancer therapy. Human endometrial adenocarcinoma (Ishikawa) cells were treated with TGF beta (10 ng/ml) for 72h. SUSD2, LGALS1 and MKI67 transcript levels were quantified using qRT-PCR. The proportion of SUSD2 positive (SUSD2+) cells and SMAD2/3 abundance were quantified by FACS and Western blotting, respectively. Senescent cells were identified with beta-galactosidase staining; cell cycle and cell death were quantified using Propidium Iodide staining. Treatment of endometrial cancer cells (Ishikawa cells) with TGF beta (10 ng/ml) significantly decreased SUSD2 transcript levels and the proportion of SUSD2 positive cells. Silencing of SUSD2 using siRNA resulted in senescence and cell death of Ishikawa cells via activation of SMAD2/3. These findings suggest that SUSD2 counteracts senescence and cell death and is thus a potential chemotherapeutic target in human endometrial cancer.	[Zhang, Shaqiu; Cheng, Anchun] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu, Sichuan, Peoples R China; [Zhang, Shaqiu; Zeng, Ni; Alowayed, Nour; Singh, Yogesh] Tubingen Univ, Dept Internal Med 3, Tubingen, Germany; [Singh, Yogesh] Tubingen Univ, Inst Med Genet & Appl Genom, Tubingen, Germany; [Lang, Florian; Salker, Madhuri S.] Tubingen Univ, Dept Physiol 1, Tubingen, Germany; [Salker, Madhuri S.] Univ Hosp Tubingen, Res Inst Womens Hlth, Tubingen, Germany	Sichuan Agricultural University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Lang, F (corresponding author), Tubingen Univ, Dept Physiol 1, Tubingen, Germany.	florian.lang@uni-tuebingen.de	; Singh, Yogesh/T-8230-2017	Salker, Madhuri Sonal/0000-0002-7939-289X; Singh, Yogesh/0000-0001-6919-6273				Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Burke W. M., 2014, GYNECOL ONCOL, V134, P385, DOI DOI 10.1016/J.YGYN0.2014.05.018; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cheng YY, 2016, TUMOR BIOL, V37, P9919, DOI 10.1007/s13277-015-4734-y; Ciccarelli FD, 2002, TRENDS BIOCHEM SCI, V27, P113, DOI 10.1016/S0968-0004(01)02049-7; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duraisamy S, 2006, GENE, V373, P28, DOI 10.1016/j.gene.2005.12.021; Gargett CE, 2016, HUM REPROD UPDATE, V22, P137, DOI 10.1093/humupd/dmv051; Gurung S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15042; Horbelt D, 2012, INT J BIOCHEM CELL B, V44, P469, DOI 10.1016/j.biocel.2011.12.013; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Itoh S, 2000, NUCLEIC ACIDS RES, V28, P4291, DOI 10.1093/nar/28.21.4291; Jeschke U, 2009, J HISTOCHEM CYTOCHEM, V57, P871, DOI 10.1369/jhc.2009.952085; Kadoya T, 2005, CURR DRUG TARGETS, V6, P375, DOI 10.2174/1389450054022007; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Letouzey V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127531; Liu XR, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0286-5; Luo K., 2017, COLD SPRING HARBOR P, V9; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Murakami K, 2014, ENDOCRINOLOGY, V155, P4542, DOI 10.1210/en.2014-1370; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Pan W, 2014, SCI REP-UK, V4, DOI 10.1038/srep06812; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rajaraman G, 2013, TISSUE ENG PART C-ME, V19, DOI 10.1089/ten.tec.2011.0718; Salker MS, 2016, CELL PHYSIOL BIOCHEM, V39, P1295, DOI 10.1159/000447834; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Shany S, 2016, ANTICANCER RES, V36, P6225, DOI 10.21873/anticanres.11216; Sheets JN, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.64; Sivasubramaniyan K, 2013, STEM CELLS DEV, V22, P1944, DOI 10.1089/scd.2012.0584; Su K, 2014, ACTA BIOMATER, V10, P5012, DOI 10.1016/j.actbio.2014.08.031; Sugahara T, 2007, CANCER SCI, V98, P900, DOI 10.1111/j.1349-7006.2007.00466.x; Sugahara T, 2007, CANCER SCI, V98, P909, DOI 10.1111/j.1349-7006.2007.00467.x; Tian H, 2016, ONCOL REP, V36, P1361, DOI 10.3892/or.2016.4942; Ulrich D, 2014, HUM REPROD, V29, P1895, DOI 10.1093/humrep/deu159; Watson AP, 2013, MOL CANCER RES, V11, P74, DOI 10.1158/1541-7786.MCR-12-0501-T; Wu JF, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-21; Wu SQ, 2009, EXP CELL RES, V315, P3099, DOI 10.1016/j.yexcr.2009.09.009; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yagi Hiroshi, 2013, Frontiers in Genetics, V4, P261, DOI 10.3389/fgene.2013.00261; Yu AL, 2010, INVEST OPHTH VIS SCI, V51, P5718, DOI 10.1167/iovs.10-5679	52	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183681	10.1371/journal.pone.0183681	http://dx.doi.org/10.1371/journal.pone.0183681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841682	Green Published, Green Submitted, gold			2022-12-26	WOS:000408370700050
J	Kim, ES; Kim, SY; Koh, M; Lee, HM; Kim, K; Jung, J; Kim, HS; Moon, WK; Hwang, S; Moon, A				Kim, E-S; Kim, S. Y.; Koh, M.; Lee, H-M; Kim, K.; Jung, J.; Kim, H. S.; Moon, W. K.; Hwang, S.; Moon, A.			C-reactive protein binds to integrin alpha 2 and Fc gamma receptor I, leading to breast cell adhesion and breast cancer progression	ONCOGENE			English	Article							EPITHELIAL-CELLS; H-RAS; INVASIVE PHENOTYPE; ACUTE APPENDICITIS; TUMOR-GROWTH; EXPRESSION; PAXILLIN; KINASE; METASTASIS; INTERLEUKIN-6	C-reactive protein (CRP) is an acute phase protein synthesized upon the inflammatory responses, associated with breast cancer. The process of tumor cell invasion and metastasis involves the adherence of cells to the extracellular matrix via integrin as a receptor for matrix molecules. The present study investigated the role of CRP in the adhesive phenotype of breast cells and the underlying mechanisms. Here, we first showed that CRP induces adhesion of MCF10A human breast epithelial cells through the activation of integrin alpha 2 signaling. Expression of integrin alpha 2 was induced by CRP in which transcription factors c-fos and SP1 may be involved. Binding of CRP with integrin alpha 2 leads to the activation of focal adhesion kinase (FAK), paxillin and ERKs. CRP also binds to an Fc gamma receptor Fc gamma receptor I (Fc gamma RI), and induces activation of paxillin, FAK and ERKs. Integrin alpha 2 and FAK have crucial roles in the adhesive and invasive phenotypes as well as MMP-9 upregulation induced by CRP in MCF10A cells. Treatment with an inflammatory lipid sphingosine-1-phosphate induced CRP, which may be secreted and exert an autocrine effect by binding to Fc gamma RI and integrin alpha 2. Involvement of CRP in adhesion, invasion, anchorage-independent growth and upregulation of integrin alpha 2, paxillin and FAK was observed in MDA-MB-231 triple-negative human breast cancer (TNBC) cells. Using an in vivo invasion model and an orthotopic mouse tumor model with MDA-MB-231 cells, we showed that CRP has an important role in intravasation and tumor growth in vivo, demonstrating the in vivo relevance of our in vitro results. The present study elucidates a critical molecular basis between CRP, integrin alpha 2 and Fc gamma RI pathways in MCF10A breast cells and MDA-MB-231 TNBC cells, thereby providing useful information on CRP-induced aggressiveness of breast cells in the inflammatory microenvironment.	[Kim, E-S; Kim, S. Y.; Koh, M.; Lee, H-M; Kim, K.; Jung, J.; Moon, A.] Duksung Womens Univ, Coll Pharm, Duksung Innovat Drug Ctr, Seoul 132714, South Korea; [Kim, H. S.; Moon, W. K.] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Hwang, S.] Hanyang Univ, Coll Med, Seoul, South Korea	Duksung Women's University; Seoul National University (SNU); Seoul National University Hospital; Hanyang University	Moon, A (corresponding author), Duksung Womens Univ, Coll Pharm, Duksung Innovat Drug Ctr, Seoul 132714, South Korea.	armoon@duksung.ac.kr			Priority Research Centers Program [2016R1A6A1A03007648]; Bio & Medical Technology Development Program [2015M3A9B6074045]; Basic Science Program of the NRF - Korean government [2014R1A6A3A01059908]	Priority Research Centers Program; Bio & Medical Technology Development Program; Basic Science Program of the NRF - Korean government	The present study was supported by Priority Research Centers Program (no. 2016R1A6A1A03007648), the Bio & Medical Technology Development Program (no. 2015M3A9B6074045) and Basic Science Program (no. 2014R1A6A3A01059908) of the NRF funded by the Korean government.	Allin KH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2891; AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bartolome RA, 2014, ONCOGENE, V33, P1658, DOI 10.1038/onc.2013.117; Bendas G, 2012, INT J CELL BIOL, V2012; Cance WG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.120pe22; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chi M, 2002, J IMMUNOL, V168, P1413, DOI 10.4049/jimmunol.168.3.1413; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; DEPRAETERE S, 1991, AGENTS ACTIONS, V34, P369, DOI 10.1007/BF01988730; Fujita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093738; Galon J, 1996, J IMMUNOL, V157, P1184; Golubovskaya VM, 2012, CARCINOGENESIS, V33, P1004, DOI 10.1093/carcin/bgs120; Guo Yan, 2014, Biomed Res Int, V2014, P248090, DOI 10.1155/2014/248090; GURLEYIK E, 1995, DIS COLON RECTUM, V38, P1270, DOI 10.1007/BF02049151; Haimovich B, 1996, J BIOL CHEM, V271, P16332, DOI 10.1074/jbc.271.27.16332; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hojilla CV, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1980; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Hwang HS, 2015, BMB REP, V48, P407, DOI 10.5483/BMBRep.2015.48.7.050; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ibaragi S, 2011, ANTICANCER RES, V31, P1307; INDIK ZK, 1994, EXP HEMATOL, V22, P599; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kim ES, 2014, ONCOGENE, V33, P3583, DOI 10.1038/onc.2013.319; Kim ES, 2011, J CELL SCI, V124, P2220, DOI 10.1242/jcs.076794; Kim KM, 2017, INT J NANOMED, V12, P1917, DOI 10.2147/IJN.S132043; Kim MS, 2003, CANCER RES, V63, P5454; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Koh M, 2015, INT J CANCER, V136, pE508, DOI 10.1002/ijc.29154; KOUKOULIS GK, 1993, J SUBMICR CYTOL PATH, V25, P285; Lee HM, 2016, BIOMOL THER, V24, P62, DOI 10.4062/biomolther.2015.172; MAEMURA M, 1995, CLIN EXP METASTAS, V13, P223, DOI 10.1007/BF00133478; Maric G, 2015, ONCOGENE, V34, P5494, DOI 10.1038/onc.2015.8; Mego M, 2010, NAT REV CLIN ONCOL, V7, P693, DOI 10.1038/nrclinonc.2010.171; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Mira E, 2002, CLIN EXP METASTAS, V19, P313, DOI 10.1023/A:1015563031769; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Moon A, 2000, INT J CANCER, V85, P176, DOI 10.1002/(SICI)1097-0215(20000115)85:2<176::AID-IJC5>3.0.CO;2-E; Ortiz-Stern A, 2003, IMMUNOL LETT, V90, P137, DOI 10.1016/j.imlet.2003.08.004; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Platz Elizabeth A., 2004, Journal of Urology, V171, pS36, DOI 10.1097/01.ju.0000108131.43160.77; Qu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131285; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Ravishankaran P, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-18; Ridker PM, 2016, CIRC RES, V118, P145, DOI 10.1161/CIRCRESAHA.115.306656; Rodriguez-Sanjuan JC, 1999, DIS COLON RECTUM, V42, P1325, DOI 10.1007/BF02234223; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; Sawhney RS, 2003, J BIOL CHEM, V278, P19861, DOI 10.1074/jbc.M213162200; Schaller MD, 2004, J CELL BIOL, V166, P157, DOI 10.1083/jcb.200406151; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; SOULE HD, 1990, CANCER RES, V50, P6075; Tsaur I, 2012, BRIT J CANCER, V107, P847, DOI 10.1038/bjc.2012.313; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Venugopal SK, 2005, AM J PATHOL, V166, P1265, DOI 10.1016/S0002-9440(10)62345-0; WENG ZG, 1993, J BIOL CHEM, V268, P14956; Woollard KJ, 2005, INFLAMM RES, V54, P485, DOI 10.1007/s00011-005-1382-5; Yang CQ, 2003, CANCER RES, V63, P8312; Yang J, 2007, CANCER CELL, V12, P252, DOI 10.1016/j.ccr.2007.08.008; Ye JP, 1996, MOL CELL BIOL, V16, P6178; Yoshimura K, 2009, CANCER RES, V69, P7320, DOI 10.1158/0008-5472.CAN-09-0315; YOUNG B, 1991, PATHOLOGY, V23, P118, DOI 10.3109/00313029109060809; Zou Cai-Yan, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P386; ZUTTER MM, 1994, J BIOL CHEM, V269, P463	67	20	20	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					28	38		10.1038/onc.2017.298	http://dx.doi.org/10.1038/onc.2017.298			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28846105				2022-12-26	WOS:000422625000004
J	Li, Y; Sun, H; Zhang, C; Liu, J; Zhang, H; Fan, F; Everley, RA; Ning, X; Sun, Y; Hu, J; Liu, J; Zhang, J; Ye, W; Qiu, X; Dai, S; Liu, B; Xu, H; Fu, S; Gygi, SP; Zhou, C				Li, Y.; Sun, H.; Zhang, C.; Liu, J.; Zhang, H.; Fan, F.; Everley, R. A.; Ning, X.; Sun, Y.; Hu, J.; Liu, J.; Zhang, J.; Ye, W.; Qiu, X.; Dai, S.; Liu, B.; Xu, H.; Fu, S.; Gygi, S. P.; Zhou, C.			Identification of translationally controlled tumor protein in promotion of DNA homologous recombination repair in cancer cells by affinity proteomics	ONCOGENE			English	Article							DAMAGE RESPONSE; ATM ACTIVATION; THERAPEUTIC TARGET; TCTP; MECHANISM; ALPHA; SERTRALINE; INHIBITION; INTERACTS; PATHWAYS	Translationally controlled tumor protein (TCTP) has been implicated in the regulation of apoptosis, DNA repair and drug resistance. However, the underlying molecular mechanisms are poorly defined. To better understand the molecular mechanisms underlying TCTP involved in cellular processes, we performed an affinity purification-based proteomic profiling to identify proteins interacting with TCTP in human cervical cancer HeLa cells. We found that a group of proteins involved in DNA repair are enriched in the potential TCTP interactome. Silencing TCTP by short hairpin RNA in breast carcinoma MCF-7 cells leads to the declined repair efficiency for DNA double-strand breaks on the GFP-Pem1 reporter gene by homologous recombination, the persistent activation and the prolonged retention of gamma H2AX and Rad51 foci following ionizing radiation. Reciprocal immunoprecipitations indicated that TCTP forms complexes with Rad51 in vivo, and the stability maintenance of Rad51 requires TCTP in MCF-7 cells under normal cell culture conditions. Moreover, inactivation of TCTP by sertraline treatment enhances UVC irradiation-induced apoptosis in MCF-7 cells, and causes sensitization to DNA-damaging drug etoposide and DNA repair inhibitor olaparib. Thus, we have identified an important role of TCTP in promoting DNA double-stand break repair via facilitating DNA homologous recombination processes and highlighted the great potential of TCTP as a drug target to enhance conventional chemotherapy for cancer patients with high levels of TCTP expression.	[Li, Y.; Sun, H.; Liu, J.; Zhang, H.; Fan, F.; Ning, X.; Sun, Y.; Hu, J.; Fu, S.; Zhou, C.] Harbin Med Univ, Lab Med Genet, 157 Baojian Rd, Harbin 150081, Heilongjiang, Peoples R China; [Zhang, C.; Liu, J.; Zhang, J.; Ye, W.; Qiu, X.] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Everley, R. A.; Gygi, S. P.] Harvard Med Sch, Dept Cell Biol, Boston, MA USA; [Dai, S.; Liu, B.] Harbin Med Univ, Tumor Hosp, Harbin, Heilongjiang, Peoples R China; [Xu, H.] Dalian Med Univ, Affiliated Hosp 1, Dept Clin Lab, Dalian, Peoples R China	Harbin Medical University; Harbin Medical University; Harvard University; Harvard Medical School; Harbin Medical University; Dalian Medical University	Zhou, C (corresponding author), Harbin Med Univ, Lab Med Genet, 157 Baojian Rd, Harbin 150081, Heilongjiang, Peoples R China.	Chunshuizhou@163.com			National Natural Science Foundation of China [81272582, 31600662]; National Institutes of Health, USA	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Professor Vera Gorbunova of the University of Rochester for providing the GFP-Pem1 reporter plasmid and CMV-HA-I-Sce I expression plasmid for detection of HR. We also thank Drs Bo Zhai, Willi Haas of SPG lab for their assistance and advice, and Dr Noah Dephoure's critical comments on manuscript writing. YL, HS, JL, HZ and CZ are supported by Grant No. 81272582 from the National Natural Science Foundation of China, HX is supported by Grant No. 31600662 from the National Natural Science Foundation of China. RAE and SPG are supported by National Institutes of Health, USA.	Acunzo J, 2014, CANCER TREAT REV, V40, P760, DOI 10.1016/j.ctrv.2014.02.007; Aglipay JA, 2006, J BIOL CHEM, V281, P9710, DOI 10.1074/jbc.M510332200; Amson R, 2013, TRENDS CELL BIOL, V23, P37, DOI 10.1016/j.tcb.2012.10.002; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Baylot V, 2012, MOL THER, V20, P2244, DOI 10.1038/mt.2012.155; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cucchi U, 2010, ANTICANCER RES, V30, P4973; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gachet Y, 1999, J CELL SCI, V112, P1257; Gnanasekar M, 2009, BIOCHEM BIOPH RES CO, V386, P333, DOI 10.1016/j.bbrc.2009.06.028; Gunaratne J, 2011, J BIOL CHEM, V286, P18093, DOI 10.1074/jbc.M111.221184; Hong ST, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3986; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Katsogiannou M, 2014, MOL CELL PROTEOMICS, V13, P3585, DOI 10.1074/mcp.M114.041228; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Li TY, 2016, ONCOTARGET, V7, P11838, DOI 10.18632/oncotarget.7864; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu JM, 2001, ONCOGENE, V20, P336, DOI 10.1038/sj.onc.1204098; Low LH, 2015, J BIOL CHEM, V290, P7141, DOI 10.1074/jbc.M114.613687; Lu GQ, 2016, P NATL ACAD SCI USA, V113, P1256, DOI 10.1073/pnas.1521597113; Lucibello M, 2015, ONCOTARGET, V6, P5275, DOI 10.18632/oncotarget.2971; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mao ZY, 2012, P NATL ACAD SCI USA, V109, P11800, DOI 10.1073/pnas.1200583109; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Seo EJ, 2016, ONCOTARGET, V7, P16818, DOI 10.18632/oncotarget.7605; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Sinha P, 2000, ELECTROPHORESIS, V21, P3048, DOI 10.1002/1522-2683(20000801)21:14<3048::AID-ELPS3048>3.0.CO;2-W; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Wang LF, 2016, NEUROPSYCH DIS TREAT, V12, P1127, DOI 10.2147/NDT.S106562; Woodhouse BC, 2008, DNA REPAIR, V7, P932, DOI 10.1016/j.dnarep.2008.03.017; Xu H, 2015, J PROTEOME RES, V14, P2480, DOI 10.1021/acs.jproteome.5b00004; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhang D, 2002, J BIOL CHEM, V277, P37430, DOI 10.1074/jbc.M207413200; Zhang J, 2012, P NATL ACAD SCI USA, V109, pE926, DOI 10.1073/pnas.1106300109; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	51	11	12	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 14	2017	36	50					6839	6849		10.1038/onc.2017.289	http://dx.doi.org/10.1038/onc.2017.289			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FQ0JM	28846114	hybrid, Green Published			2022-12-26	WOS:000418041800001
J	Jang, KK; Lee, ZW; Kim, B; Jung, YH; Han, HJ; Kim, MH; Kim, BS; Choi, SH				Jang, Kyung Ku; Lee, Zee-Won; Kim, Bityeoul; Jung, Young Hyun; Han, Ho Jae; Kim, Myung Hee; Kim, Byoung Sik; Choi, Sang Ho			Identification and characterization of Vibrio vulnificus plpA encoding a phospholipase A(2) essential for pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; microbial pathogenesis; Phospholipase A; transcription factor; virulence factor; CRP; HlyU; PlpA; Vibrio vulnificus	VIRULENCE GENE-EXPRESSION; SENSING MASTER REGULATOR; GRAM-NEGATIVE BACTERIA; AMP RECEPTOR PROTEIN; NECROTIC CELL-DEATH; CYCLIC-AMP; GLOBAL REGULATOR; BINDING PROTEIN; HEMOLYSIN; TRANSCRIPTION	The marine bacterium Vibrio vulnificus causes food-borne diseases, which may lead to life-threatening septicemia in some individuals. Therefore, identifying virulence factors in V. vulnificus is of high priority. We performed a transcriptome analysis on V. vulnificus after infection of human intestinal HT29-methotrexate cells and found induction of plpA, encoding a putative phospholipase, VvPlpA. Bioinformatics, biochemical, and genetic analyses demonstrated that VvPlpA is a phospholipase A(2) secreted in a type II secretion system-dependent manner. Compared with the wild type, the plpA mutant exhibited reduced mortality, systemic infection, and inflammation in mice as well as low cytotoxicity toward the human epithelial INT-407 cells. Moreover, plpA mutation attenuated the release of actin and cytosolic cyclophilin A from INT-407 cells, indicating that VvPlpA is a virulence factor essential for causing lysis and necrotic death of the epithelial cells. plpA transcription was growth phase-dependent, reaching maximum levels during the early stationary phase. Also, transcription factor HlyU and cAMP receptor protein (CRP) mediate additive activation and host-dependent induction of plpA. Molecular biological analyses revealed that plpA expression is controlled via the promoter, P-plpA, and that HlyU and CRP directly bind to P-plpA upstream sequences. Taken together, this study demonstrated that VvPlpA is a type II secretion system-dependent secretory phospholipase A(2) regulated by HlyU and CRP and is essential for the pathogenicity of V. vulnificus.	[Jang, Kyung Ku; Lee, Zee-Won; Kim, Bityeoul; Choi, Sang Ho] Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Ctr Food Safety & Toxicol, Dept Agr Biotechnol, Seoul 08826, South Korea; [Jung, Young Hyun; Han, Ho Jae] Seoul Natl Univ, Coll Vet Med, PLUS Creat Vet Res Ctr BK21, Dept Vet Physiol,Res Inst Vet Med, Seoul 08826, South Korea; [Kim, Myung Hee; Kim, Byoung Sik] Korea Res Inst Biosci & Biotechnol, Metab Regulat Res Ctr, Infect & Immun Res Lab, Daejeon 34141, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, SH (corresponding author), Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Ctr Food Safety & Toxicol, Dept Agr Biotechnol, Seoul 08826, South Korea.; Kim, BS (corresponding author), Korea Res Inst Biosci & Biotechnol, Metab Regulat Res Ctr, Infect & Immun Res Lab, Daejeon 34141, South Korea.	bskim@kribb.re.kr; choish@snu.ac.kr	Kim, Byoungsik/AAE-6239-2021; Jang, Kyungku/GLT-4101-2022	Jang, Kyungku/0000-0002-0403-1256; Choi, Sang Ho/0000-0003-3865-1039; Lee, Zee-Won/0000-0003-0376-1860; Kim, Byoung Sik/0000-0001-9820-6071	National Research Foundation from Ministry of Science, ICT, and Future Planning [2015R1A2A1A13001654]; R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea	National Research Foundation from Ministry of Science, ICT, and Future Planning; R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea	This work was supported by National Research Foundation Mid-career Researcher Program Grant 2015R1A2A1A13001654 from the Ministry of Science, ICT, and Future Planning and the R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea (to S. H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Bisharat N, 2013, MICROBIOL-SGM, V159, P1878, DOI 10.1099/mic.0.067900-0; Browning DF, 2016, NAT REV MICROBIOL, V14, P638, DOI 10.1038/nrmicro.2016.103; Cameron ADS, 2006, NUCLEIC ACIDS RES, V34, P6001, DOI 10.1093/nar/gkl734; Choi HK, 2002, J BIOL CHEM, V277, P47292, DOI 10.1074/jbc.M206893200; Christofferson DE, 2010, CELL DEATH DIFFER, V17, P1942, DOI 10.1038/cdd.2010.123; de los Reyes-Gavilan CG, 2011, RES MICROBIOL, V162, P514, DOI 10.1016/j.resmic.2011.03.009; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Fang FC, 2016, CELL HOST MICROBE, V20, P133, DOI 10.1016/j.chom.2016.07.009; Gavin HE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006119; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Green J, 2014, VIRULENCE, V5, P794, DOI 10.4161/viru.27794; Green J, 2014, CURR OPIN MICROBIOL, V18, P1, DOI 10.1016/j.mib.2014.01.003; Hering NA, 2011, LAB INVEST, V91, P310, DOI 10.1038/labinvest.2010.180; Horseman MA, 2011, INT J INFECT DIS, V15, pE157, DOI 10.1016/j.ijid.2010.11.003; Jang KK, 2016, J BIOL CHEM, V291, P5774, DOI 10.1074/jbc.M115.685321; Jeong HG, 2008, J BACTERIOL, V190, P3768, DOI 10.1128/JB.00058-08; Jeong HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002581; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim BS, 2015, MBIO, V6, DOI 10.1128/mBio.00324-15; Kim BS, 2011, J BIOL CHEM, V286, P40889, DOI 10.1074/jbc.M111.300988; Kim JA, 2015, MOL MICROBIOL, V97, P330, DOI 10.1111/mmi.13028; Kim SM, 2012, MICROBIOL-SGM, V158, P2017, DOI 10.1099/mic.0.059071-0; Kim S, 2014, MOL MICROBIOL, V93, P992, DOI 10.1111/mmi.12712; Kim Y, 2010, J BIOL CHEM, V285, P14020, DOI 10.1074/jbc.M109.100248; Kim YR, 2013, J INFECT DIS, V207, P1406, DOI 10.1093/infdis/jis746; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Kirk JS, 2015, ONCOTARGET, V6, P3136, DOI 10.18632/oncotarget.3077; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Lee HJ, 2013, MOL MICROBIOL, V88, P813, DOI 10.1111/mmi.12224; Lee KE, 2007, J MICROBIOL BIOTECHN, V17, P234; Lee SE, 2004, BIOCHEM BIOPH RES CO, V324, P86, DOI 10.1016/j.bbrc.2004.09.020; Lee SJ, 2016, INT J MED MICROBIOL, V306, P10, DOI 10.1016/j.ijmm.2015.10.006; LEIBOVICI L, 1995, JAMA-J AM MED ASSOC, V274, P807, DOI 10.1001/jama.274.10.807; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Li L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-271; Li L, 2011, J BACTERIOL, V193, P4779, DOI 10.1128/JB.01033-10; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lim JG, 2014, J BIOL CHEM, V289, P36263, DOI 10.1074/jbc.M114.611020; Lim JG, 2014, INFECT IMMUN, V82, P569, DOI 10.1128/IAI.01141-13; Lim MS, 2011, J BACTERIOL, V193, P3722, DOI 10.1128/JB.00314-11; Liu MQ, 2011, J BACTERIOL, V193, P6895, DOI 10.1128/JB.05950-11; Liu MQ, 2009, MOL MICROBIOL, V72, P491, DOI 10.1111/j.1365-2958.2009.06664.x; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NouriSorkhabi MH, 1996, COMP BIOCHEM PHYS B, V113, P221, DOI 10.1016/0305-0491(95)02011-X; Oh MH, 2009, INFECT IMMUN, V77, P1208, DOI 10.1128/IAI.01006-08; Oliver JD, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.VE-0001-2014; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phillips KE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006053; Rahman MS, 2010, J BACTERIOL, V192, P3294, DOI 10.1128/JB.00155-10; Rock JL, 2006, INFECT IMMUN, V74, P2777, DOI 10.1128/IAI.74.5.2777-2786.2006; Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Takahashi M, 2002, ATHEROSCLEROSIS, V161, P387, DOI 10.1016/S0021-9150(01)00674-8; Tian XC, 2010, J VIROL, V84, P3373, DOI 10.1128/JVI.02555-09; Virtanen JA, 1998, P NATL ACAD SCI USA, V95, P4964, DOI 10.1073/pnas.95.9.4964; Walthers D, 2011, J BIOL CHEM, V286, P1895, DOI 10.1074/jbc.M110.164962; WILLIAMS SG, 1993, MOL MICROBIOL, V9, P751, DOI 10.1111/j.1365-2958.1993.tb01735.x; Williams TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114376; WRIGHT AC, 1990, INFECT IMMUN, V58, P1769, DOI 10.1128/IAI.58.6.1769-1773.1990; Xie DL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181454; Yonezawa K, 2010, INT J LAB HEMATOL, V32, P598, DOI 10.1111/j.1751-553X.2010.01227.x; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	67	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17129	17143		10.1074/jbc.M117.791657	http://dx.doi.org/10.1074/jbc.M117.791657			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28855258	Green Published, hybrid			2022-12-26	WOS:000413140600032
J	Martinac, AD; Bavi, N; Bavi, O; Martinac, B				Martinac, Adam D.; Bavi, Navid; Bavi, Omid; Martinac, Boris			Pulling MscL open via N-terminal and TM1 helices: A computational study towards engineering an MscL nanovalve	PLOS ONE			English	Article							OPEN-CHANNEL STRUCTURE; MECHANOSENSITIVE CHANNEL; MOLECULAR-DYNAMICS; LARGE-CONDUCTANCE; GATING MECHANISM; PORE-SIZE; ELEMENT; WATER	There are great opportunities in the manipulation of bacterial mechanosensitive (MS) ion channels for specific and targeted drug delivery purposes. Recent research has shown that these ion channels have the potential to be converted into nanovalves through clever use of magnetic nanoparticles and magnetic fields. Using a combination of molecular dynamics (MD) simulations and the finite element (FE) modelling, this study investigates the theoretical feasibility of opening the MscL channel (MS channel of large conductance of E.coli) by applying mechanical force directly to its N-terminus. This region has already been reported to function as a major mechanosensor in this channel. The stress-strain behaviour of each MscL helix was obtained using all atom MD simulations. Using the same method, we simulated two models, the wild-type (WT) MscL and the G22N mutant MscL, both embedded in a POPE lipid bilayer. In addition to indicating the main interacting residues at the hydrophobic pore, their pairwise interaction energies were monitored during the channel gating. We implemented these inputs into our FE model of MscL using curve-fitting codes and continuum mechanics equations. In the FE model, the channel could be fully opened via pulling directly on the N-terminus and bottom of TM1 by mutating dominant van der Waals interactions in the channel pore; otherwise the stress generated on the channel protein can irreversibly unravel the N-secondary structure. This is a significant finding suggesting that applying force in this manner is sufficient to open an MscL nanovalve delivering various drugs used, for example, in cancer chemotherapy. More importantly, the FE model indicates that to fully operate an MscL nanovalve by pulling directly on the N-terminus and bottom of TM1, gain-of-function (GOF) mutants (e.g., G22N MscL) would have to be employed rather than the WT MscL channel.	[Martinac, Adam D.; Bavi, Navid; Martinac, Boris] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia; [Bavi, Navid; Martinac, Boris] Univ New South Wales, St Vincents Clin Sch, Fac Med, Darlinghurst, NSW, Australia; [Bavi, Omid] Univ Tehran, Dept Phys, Tehran, Iran	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of Tehran	Martinac, B (corresponding author), Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia.; Martinac, B (corresponding author), Univ New South Wales, St Vincents Clin Sch, Fac Med, Darlinghurst, NSW, Australia.	b.martinac@victorchang.edu.au	Bavi, Omid/L-9086-2018; Bavi, Omid/CAA-9972-2022; Martinac, Boris/A-7178-2018; Bavi, Navid/AAU-4729-2021	Bavi, Omid/0000-0003-3539-0849; Bavi, Omid/0000-0003-3539-0849; Martinac, Boris/0000-0001-8422-7082; Bavi, Navid/0000-0001-7040-0710	Australian Government; University International Postgraduate Award (UIPA) from the University of New South Wales; Australian Research Council; National Health and Medical Research Council of Australia; Office of Health and Medical Research, NSW State Government	Australian Government(Australian GovernmentCGIAR); University International Postgraduate Award (UIPA) from the University of New South Wales; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Office of Health and Medical Research, NSW State Government	The authors would like to acknowledge Dr. Adam Hill and CSIRO for computing facilities and National Computational Infrastructure NCI, which are supported by the Australian Government. We thank Dr. Dr S. Mehdi Vaez Allaei for providing O.B. access to computational facilities. N.B. has been supported by a University International Postgraduate Award (UIPA) from the University of New South Wales. This project was supported by the Australian Research Council and Principal Research Fellowship to B.M. from the National Health and Medical Research Council of Australia. This work was also supported in part by funds from the Office of Health and Medical Research, NSW State Government.; The authors would like to acknowledge Dr. Adam Hill and CSIRO for computing facilities and National Computational Infrastructure NCI, which are supported by the Australian Government. We thank Dr. Dr. S. Mehdi Vaez Allaei for providing O.B. access to computational facilities.	Anishkin A, 2004, BIOPHYS J, V86, P2883, DOI 10.1016/S0006-3495(04)74340-4; Anishkin A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454120; Anishkin A, 2017, CHANNELS, P1; [Anonymous], 2016, CURRENT TOPICS MEMBR; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; Bathe M, 2008, PROTEINS, V70, P1595, DOI 10.1002/prot.21708; Bavi N, 2016, CHANNELS; Bavi N, 2017, CHANNELS, V11, P91, DOI 10.1080/19336950.2016.1224624; Bavi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11984; Bavi N, 2013, PROC SPIE, V8793, DOI 10.1117/12.2030203; Bavi O, 2016, MEMBRANES-BASEL, V6, DOI 10.3390/membranes6010014; Bavi O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150578; Bavi O, 2014, CHANNELS, V8, P344, DOI 10.4161/chan.29572; Beckstein O, 2003, P NATL ACAD SCI USA, V100, P7063, DOI 10.1073/pnas.1136844100; Biasini M., 2014, NUCL ACIDS RES; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Chatzieleftheriou S, 2016, J CHEM INF MODEL, V56, P1963, DOI 10.1021/acs.jcim.6b00356; Chen X, 2008, BIOPHYS J, V95, P563, DOI 10.1529/biophysj.107.128488; Corry B, 2010, J GEN PHYSIOL, V136, P483, DOI 10.1085/jgp.200910376; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Evans E, 2013, FARADAY DISCUSS, V161, P591, DOI 10.1039/c2fd20127e; Grubmuller H., 1996, SOLVATE PROGRAM CREA; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Iscla I, 2013, BIOSENSORS-BASEL, V3, P171, DOI 10.3390/bios3010171; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kocer A, 2005, SCIENCE, V309, P755, DOI 10.1126/science.1114760; Kocer A, 2015, CURR OPIN CHEM BIOL, V29, P120, DOI 10.1016/j.cbpa.2015.10.006; Kocer A, 2012, BIOSENS BIOELECTRON, V38, P1, DOI 10.1016/j.bios.2012.05.013; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Liu WK, 2006, COMPUT METHOD APPL M, V195, P1722, DOI 10.1016/j.cma.2005.05.049; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Mondalek Fadee G, 2006, J Nanobiotechnology, V4, P4, DOI 10.1186/1477-3155-4-4; Nakayama Y, 2015, EUR BIOPHYS J BIOPHY, V44, P647, DOI 10.1007/s00249-015-1059-0; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sawada Y, 2015, EUR BIOPHYS J BIOPHY, V44, P531, DOI 10.1007/s00249-015-1065-2; Sawada Y, 2012, CHANNELS, V6, P317, DOI 10.4161/chan.21895; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Vanegas JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113947; Wahajuddin, 2012, INT J NANOMED, V7, P3445, DOI 10.2147/IJN.S30320; Wang Y, 2014, ELIFE, V3, DOI 10.7554/eLife.01834; Yang LM, 2012, ACS NANO, V6, P1134, DOI 10.1021/nn203703j; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Zhu LD, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8792548	52	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183822	10.1371/journal.pone.0183822	http://dx.doi.org/10.1371/journal.pone.0183822			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859093	Green Published, gold			2022-12-26	WOS:000408740500037
J	Debaud, C; Salga, M; Begot, L; Holy, X; Chedik, M; de l'Escalopier, N; Torossian, F; Levesque, JP; Lataillade, JJ; Le Bousse-Kerdiles, MC; Genet, F				Debaud, Charlotte; Salga, Marjorie; Begot, Laurent; Holy, Xavier; Chedik, Malha; de l'Escalopier, Nicolas; Torossian, Frederic; Levesque, Jean-Pierre; Lataillade, Jean-Jacques; Le Bousse-Kerdiles, Marie-Caroline; Genet, Francois			Peripheral denervation participates in heterotopic ossification in a spinal cord injury model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SUBSTANCE-P; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; BONE-FORMATION; INFLAMMATION; REGENERATION; IMPACT; DEGENERATION; EXPRESSION	We previously reported the development of a new acquired neurogenic HO (NHO) mouse model, combining spinal cord transection (SCI) and chemical muscle injury. Pathological mechanisms responsible for ectopic osteogenesis after central neurological damage are still to be elucidated. In this study, we first hypothesized that peripheral nervous system (PNS) might convey pathological signals from injured spinal cord to muscles in NHO mouse model. Secondly, we sought to determine whether SCI could lead to intramuscular modifications of BMP2 signaling pathways. Twenty one C57Bl6 mice were included in this protocol. Bilateral cardiotoxin (CTX) injection in hamstring muscles was associated with a two-stage surgical procedure, combining thoracic SCI with unilateral peripheral denervation. Volumes of HO (Bone Volume, BV) were measured 28 days after surgery using micro-computed tomography imaging techniques and histological analyses were made to confirm intramuscular osteogenesis. Volume comparisons were conducted between right and left hind limb of each animal, using a Wilcoxon signed rank test. Quantitative polymerase chain reaction (qPCR) was performed to explore intra muscular expression of BMP2, Alk3 and Id1. Nineteen mice survive the complete SCI and peripheral denervation procedure. When CTX injections were done right after surgery (n = 7), bilateral HO were detected in all animals after 28 days. Micro-CT measurements showed significantly increased BV in denervated paws (1.47 mm3 +/- 0.5) compared to contralateral sides (0.56 mm3 +/-0.4), p = 0.03. When peripheral denervation and CTX injections were performed after sham SCI surgery (n = 6), bilateral HO were present in three mice at day 28. Quantitative PCR analyses showed no changes in intra muscular BMP2 expression after SCI as compared to control mice (shamSCI). Peripheral denervation can be reliably added to spinal cord transection in NHO mouse model. This new experimental design confirms that neuro inflammatory mechanisms induced by central or peripheral nervous system injury plays a key role in triggering ectopic osteogenesis.	[Debaud, Charlotte] Hop Europeen Georges Pompidou, APHP, Spine Div, Dept Orthopaed Surg, Paris, France; [Debaud, Charlotte; Salga, Marjorie; Chedik, Malha; Genet, Francois] Univ Versailles St Quentin Yvelines, INSERM, U1179, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France; [Salga, Marjorie; Genet, Francois] Hop Raymond Poincare, APHP, CIC IT 1429, Rehabil Serv, Garches, France; [Begot, Laurent; Holy, Xavier] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [de l'Escalopier, Nicolas] Hop Instruct Armees PERCY, Dept Orthopaed Surg, Clamart, France; [Torossian, Frederic; Le Bousse-Kerdiles, Marie-Caroline] Univ Paris Sud, Hop Paul Brousse, APHP, INSERM,UMR S MD 1197, Villejuif, France; [Levesque, Jean-Pierre] Univ Queensland, Mater Res Inst, Blood & Bone Dis Program, Woolloongabba, Qld, Australia; [Levesque, Jean-Pierre] Univ Queensland, Sch Med, Herston, Qld, Australia; [Lataillade, Jean-Jacques] Univ Paris Sud, Ecole Val de Grace, IRBA CTSA HIA Percy, Unite Mixte Inserm SSA 1197, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Mater Research; University of Queensland; University of Queensland; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Debaud, C (corresponding author), Hop Europeen Georges Pompidou, APHP, Spine Div, Dept Orthopaed Surg, Paris, France.; Debaud, C (corresponding author), Univ Versailles St Quentin Yvelines, INSERM, U1179, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France.	charlotte.debaud@aphp.fr	Levesque, Jean-Pierre/C-5426-2011; Le Bousse-Kerdiles, Marie-Caroline/Q-4029-2018	Levesque, Jean-Pierre/0000-0002-7299-6025; de l'Escalopier, Nicolas/0000-0001-6333-7311; Le Bousse-Kerdiles, Marie-Caroline/0000-0003-0863-5222				Anthonissen J, 2014, ACTA ORTHOP BELG, V80, P2; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; AVELLINO AM, 1995, EXP NEUROL, V136, P183, DOI 10.1006/exnr.1995.1095; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Cadosch D, 2010, ANZ J SURG, V80, P542, DOI 10.1111/j.1445-2197.2010.05268.x; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; David S, 2012, INT REV NEUROBIOL, V106, P127, DOI 10.1016/B978-0-12-407178-0.00006-5; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Genet F, 2015, SPINAL CORD, V53, P340, DOI 10.1038/sc.2015.20; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; Genet F, 2015, BRAIN INJURY, V29, P866, DOI 10.3109/02699052.2015.1005133; Genet F, 2015, J PATHOL, V236, P229, DOI 10.1002/path.4519; Genet F, 2012, J HEAD TRAUMA REHAB, V27, P443, DOI 10.1097/HTR.0b013e31822b54ba; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; GEPPETTI P, 1995, CAN J PHYSIOL PHARM, V73, P843, DOI 10.1139/y95-115; Glaser DL, 2003, J BONE JOINT SURG AM, V85A, P2332, DOI 10.2106/00004623-200312000-00010; Gonda K, 2000, J BONE MINER RES, V15, P1056, DOI 10.1359/jbmr.2000.15.6.1056; Gong LL, 2016, BIOCHEM BIOPH RES CO, V478, P206, DOI 10.1016/j.bbrc.2016.07.067; Han B, CDC42 PROMOTES SCHWA; Hannallah D, 2004, J BONE JOINT SURG AM, V86A, P80, DOI 10.2106/00004623-200401000-00013; HARAN M, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003321.PUB3; Hayashi C, 2009, J CELL PHYSIOL, V220, P1, DOI 10.1002/jcp.21760; Hino K, 2015, P NATL ACAD SCI USA, V112, P15438, DOI 10.1073/pnas.1510540112; Kan LX, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/309287; Kan LX, 2011, J CELL BIOCHEM, V112, P2759, DOI 10.1002/jcb.23259; Kan LX, 2004, AM J PATHOL, V165, P1107, DOI 10.1016/S0002-9440(10)63372-X; Kim KT, 2015, SPINE J, V15, P2055, DOI 10.1016/j.spinee.2015.04.032; Leonard AV, 2014, SPINAL CORD, V52, P17, DOI 10.1038/sc.2013.136; Li XL, 2006, ANN NY ACAD SCI, V1068, P26, DOI 10.1196/annals.1346.006; Liu PT, 2017, DIS MODEL MECH, V10, P53, DOI 10.1242/dmm.026880; Ma CHE, 2011, J NEUROSCI, V31, P18391, DOI 10.1523/JNEUROSCI.4550-11.2011; Ma WH, 2015, BRAZ J MED BIOL RES, V48, P299, DOI 10.1590/1414-431X20144226; Nazarian A, 2008, NEUROSCIENCE, V152, P119, DOI 10.1016/j.neuroscience.2007.11.037; Peng HR, 2001, MOL THER, V4, P95, DOI 10.1006/mthe.2001.0423; Qin J, 2016, NEURAL REGEN RES, V11, P1165, DOI 10.4103/1673-5374.187059; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Sakaguchi S, 2014, INT J BIOCHEM CELL B, V54, P272, DOI 10.1016/j.biocel.2014.05.032; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Salga M, 2015, SKELETAL RADIOL, V44, P233, DOI 10.1007/s00256-014-2003-6; Salisbury E, 2011, J CELL BIOCHEM, V112, P2748, DOI 10.1002/jcb.23225; Schwab JM, 2014, EXP NEUROL AOUT, P121; Shehab D, 2002, J NUCL MED, V43, P346; Shono Jun-ichi, 2013, Anim Sci J, V84, P744, DOI 10.1111/asj.12105; Shore EM, 2008, BONE, V43, P427, DOI 10.1016/j.bone.2008.05.013; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; Stangenberg L, 2014, P NATL ACAD SCI USA, V111, P11419, DOI 10.1073/pnas.1410854111; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	53	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182454	10.1371/journal.pone.0182454	http://dx.doi.org/10.1371/journal.pone.0182454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854256	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600010
J	Seike, K; Shirai, K; Murakami-Sugihara, N				Seike, Koji; Shirai, Kotaro; Murakami-Sugihara, Naoko			Using tsunami deposits to determine the maximum depth of benthic burrowing	PLOS ONE			English	Article							TOHOKU-OKI TSUNAMI; SENDAI BAY; PACIFIC COAST; BIOTURBATION; SEDIMENTS; MACARONICHNUS; BICHORDITES; EVALUATE; SHELF; JAPAN	The maximum depth of sediment biomixing is directly related to the vertical extent of post-depositional environmental alteration in the sediment; consequently, it is important to determine the maximum burrowing depth. This study examined the maximum depth of bioturbation in a natural marine environment in Funakoshi Bay, northeastern Japan, using observations of bioturbation structures developed in an event layer (tsunami deposits of the 2011 Tohoku-Oki earthquake) and measurements of the radioactive cesium concentrations in this layer. The observations revealed that the depth of bioturbation (i.e., the thickness of the biomixing layer) ranged between 11 and 22 cm, and varied among the sampling sites. In contrast, the radioactive cesium concentrations showed that the processing of radioactive cesium in coastal environments may include other pathways in addition to bioturbation. The data also revealed the nature of the bioturbation by the heart urchin Echinocardium cordatum (Echinoidea: Loveniidae), which is one of the important ecosystem engineers in seafloor environments. The maximum burrowing depth of E. cordatum in Funakoshi Bay was 22 cm from the seafloor surface.	[Seike, Koji; Shirai, Kotaro; Murakami-Sugihara, Naoko] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	University of Tokyo	Seike, K (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	seike@aori.u-tokyo.ac.jp	Seike, Koji/G-1050-2012; Shirai, Kotaro/B-5758-2012	Seike, Koji/0000-0002-6938-0350; Shirai, Kotaro/0000-0003-3922-5971	JSPS KAKENHI [JP16781047]; Tohoku Ecosystem Associated Marine Sciences (TEAMS) grant from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Atmosphere and Ocean Research Institute (AORI); University of Tokyo; cooperative research program of the Center for Advanced Marine Core Research (CMCR), Kochi University [14B024]; joint research program of the Institute for Cosmic Ray Research (ICRR), the University of Tokyo	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tohoku Ecosystem Associated Marine Sciences (TEAMS) grant from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Atmosphere and Ocean Research Institute (AORI); University of Tokyo; cooperative research program of the Center for Advanced Marine Core Research (CMCR), Kochi University; joint research program of the Institute for Cosmic Ray Research (ICRR), the University of Tokyo	This study was partly supported by JSPS KAKENHI Grant Number JP16781047 awarded to Kotaro Shirai (http://www.jsps.go.jp/english/e-grants/index.html) and by Tohoku Ecosystem Associated Marine Sciences (TEAMS) grant (http://www.i-teams.jp/e/about/) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT). This study was also supported through the cooperative program of the Atmosphere and Ocean Research Institute (AORI), the University of Tokyo, and the cooperative research program of the Center for Advanced Marine Core Research (CMCR), Kochi University (number 14B024), and was also supported by the joint research program of the Institute for Cosmic Ray Research (ICRR), the University of Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2015, MAR ENVIRON RES, V112, P86, DOI 10.1016/j.marenvres.2015.09.011; Bradshaw C, 2006, ESTUAR COAST SHELF S, V66, P123, DOI 10.1016/j.ecss.2005.08.002; BROMLEY R G, 1975, Bulletin of the Geological Society of Denmark, V24, P261; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; D'Alessandro A, 2007, SOC SEDIMENT GEOL SP, V88, P213; de Gibert JM, 2008, PALAEOGEOGR PALAEOCL, V270, P299, DOI 10.1016/j.palaeo.2008.01.031; Enderlein P, 2004, SARSIA, V89, P190, DOI 10.1080/00364820410006367; Gingras MK, 2008, AQUAT BIOL, V2, P255, DOI 10.3354/ab00055; Goto R, 2017, J OCEANOGR, V73, P103, DOI 10.1007/s10872-016-0380-2; Green MA, 2002, DEEP-SEA RES PT II, V49, P4627, DOI 10.1016/S0967-0645(02)00132-7; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Ikehara K, 2014, MAR GEOL, V358, P120, DOI 10.1016/j.margeo.2014.11.004; Kanaya G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135125; KANAZAWA K, 1992, PALAEONTOLOGY, V35, P733; KOTAKE N, 1993, PALAIOS, V8, P544, DOI 10.2307/3515031; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Kubota K, 2017, PALAEOGEOGR PALAEOCL, V465, P307, DOI 10.1016/j.palaeo.2016.05.016; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Lohrer AM, 2005, J EXP MAR BIOL ECOL, V321, P155, DOI 10.1016/j.jembe.2005.02.002; Lohrer AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10349; Lohrer AM, 2013, ECOLOGY, V94, P136, DOI 10.1890/11-1779.1; Mori N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049210; NARA M, 1995, LETHAIA, V28, P171, DOI 10.1111/j.1502-3931.1995.tb01610.x; Nara Masakazu, 2014, Spanish Journal of Palaeontology, V29, P191; NICHOLS D, 1959, PHILOS T ROY SOC B, V242, P347, DOI 10.1098/rstb.1959.0007; Oguri K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01915; Owen G, 1996, SEDIMENTOLOGY, V43, P279, DOI 10.1046/j.1365-3091.1996.d01-5.x; PEMBERTON GS, 1976, SCIENCE, V192, P790, DOI 10.1126/science.192.4241.790; Sawai Y., 2012, Jour Geol Soc Japan, V118, P535, DOI [10.1016/j.sedgeo.2012.08.012, DOI 10.5575/geosoc.2012.0063, 10.5575/geosoc.2012.0063]; SCHINNER GO, 1993, MAR ECOL-P S Z N I, V14, P129, DOI 10.1111/j.1439-0485.1993.tb00371.x; Seike K, 2017, ISL ARC, V26, DOI 10.1111/iar.12174; Seike K, 2016, J OCEANOGR, V72, P141, DOI 10.1007/s10872-015-0297-1; Seike K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065417; Seike K, 2011, PALAEOGEOGR PALAEOCL, V311, P224, DOI 10.1016/j.palaeo.2011.08.023; Seike K, 2009, PALAIOS, V24, P799, DOI 10.2110/palo.2009.p09-007r; Tamura T, 2015, J QUATERNARY SCI, V30, P293, DOI 10.1002/jqs.2786; The 2011 Tohoku Earthquake Tsunami Joint Survey Group (TETJSG), 2011, J JAPAN SOC CIVIL B, V67, P63, DOI DOI 10.2208/KAIGAN.67.63; Uchman A., 1995, BERINGERIA, V15, P3, DOI DOI 10.1016/0031-0182(81)90053-5; Uchman Alfred, 1995, Palaeontologische Zeitschrift, V69, P503; WETZEL A, 1986, GEOLOGY, V14, P234, DOI 10.1130/0091-7613(1986)14<234:SCTTFP>2.0.CO;2; Wetzel A, 2008, PALAIOS, V23, P601, DOI 10.2110/palo.2007.p07-096r; Wetzel A, 2009, SEDIMENTOLOGY, V56, P1992, DOI 10.1111/j.1365-3091.2009.01066.x; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Yoshikawa S, 2015, GEO-MAR LETT, V35, P315, DOI 10.1007/s00367-015-0409-3; Ziebis W, 1996, NATURE, V382, P619, DOI 10.1038/382619a0	45	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182753	10.1371/journal.pone.0182753	http://dx.doi.org/10.1371/journal.pone.0182753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854254	Green Submitted, gold, Green Published			2022-12-26	WOS:000408693600016
J	Howing, T; Dann, M; Hoefle, C; Huckelhoven, R; Gietl, C				Hoewing, Timo; Dann, Marcel; Hoefle, Caroline; Hueckelhoven, Ralph; Gietl, Christine			Involvement of Arabidopsis thaliana endoplasmic reticulum KDEL-tailed cysteine endopeptidase 1 (AtCEP1) in powdery mildew-induced and AtCPR5-controlled cell death	PLOS ONE			English	Article							CASTOR BEAN ENDOSPERM; TRIGGERED IMMUNITY; SALICYLIC-ACID; RESISTANCE; CPR5; DEFENSE; RICINOSOMES; EXPRESSION; PROTEASES; RESPONSES	Programmed cell death (PCD) is a prerequisite for successful development and it limits the spread of biotrophic pathogens in a rapid hypersensitive response at the site of infection. KDEL-tailed cysteine endopeptidases (KDEL CysEP) are a subgroup of papain-type cysteine endopeptidases expressed in tissues undergoing PCD. In Arabidopsis, three KDEL CysEPs (AtCEP1, AtCEP2, and AtCEP3) are expressed. We have previously shown that AtCEP1 is a factor of basal resistance to powdery mildew caused by the biotrophic ascomycete Erysiphe cruciferarum, and is expressed in spatiotemporal association with the late fungal development on Arabidopsis leaves. The endoplasmic reticulum-localized proenzyme of AtCEP1 was further visualized at the haustorial complex encased with callose. The AtCPR5 gene (CONSTITUTIVE EXPRESSION OF PR GENES 5) is a regulator of expression of pathogenesis related genes. Loss of AtCPR5 leads to spontaneous expression of chlorotic lesions which was associated with enhanced expression of AtCEP1. We used the atcpr5-2 mutant plants and the atcep1 atcpr5-2 double mutants harboring a non-functional reporter (PCEP1:: pre-pro-3xHA-EGFP-KDEL) for visualization of AtCEP1 promoter activity. We found the specific up-regulation of AtCEP1 in direct neighborhood of spreading leaf lesions thus likely representing cells undergoing PCD. Furthermore, we found a strong resistance of atcpr5 mutant plants against infection with E. cruciferarum. Loss of AtCEP1 had no obvious influence on the strong resistance of atcpr5-2 mutant plants against infection with E. cruciferarum. However, the area of necrotic leaf lesions associated with E. cruciferarum colonies was significantly larger in atcpr5-2 as compared to atcep1 atcpr5-2 double mutant plants. The presence of AtCEP1 thus contributes to AtCPR5-controlled PCD at the sites of powdery mildew infection.	[Hoewing, Timo; Dann, Marcel; Gietl, Christine] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Lehrstuhl Bot, Freising Weihenstephan, Germany; [Hoefle, Caroline; Hueckelhoven, Ralph] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Lehrstuhl Phytopathol, Freising Weihenstephan, Germany; [Dann, Marcel] Ludwig Maximilians Univ Munchen, Dept Biol 1, Lehrstuh Bot Mol Biol Pflanzen, Planegg Martinsried, Germany	Technical University of Munich; Technical University of Munich; University of Munich	Gietl, C (corresponding author), Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Lehrstuhl Bot, Freising Weihenstephan, Germany.	christine.gietl@wzw.tum.de	Huckelhoven, Ralph/H-6676-2013	Huckelhoven, Ralph/0000-0001-5632-5451	Deutsche Forschungsgemeinschaft [SFB924]; Technische Universitat Munchen within the funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Technische Universitat Munchen within the funding programme Open Access Publishing	This work was supported by grants from the Deutsche Forschungsgemeinschaft [SFB924 to CG (A07) and RH (B08)] and by the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beers EP, 2004, PHYTOCHEMISTRY, V65, P43, DOI 10.1016/j.phytochem.2003.09.005; Boch J, 1998, MOL PLANT MICROBE IN, V11, P1196, DOI 10.1094/MPMI.1998.11.12.1196; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Bowling SA, 1994, MUTATION ARABIDOPSIS; Brininstool G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-58; Clarke JD, 2001, PLANT J, V26, P409, DOI 10.1046/j.1365-313X.2001.2641041.x; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Dickman MB, 2013, ANNU REV PHYTOPATHOL, V51, P543, DOI 10.1146/annurev-phyto-081211-173027; Eichmann R, 2008, J PLANT PHYSIOL, V165, P5, DOI 10.1016/j.jplph.2007.05.004; Eichmann R, 2006, MOL PLANT PATHOL, V7, P543, DOI 10.1111/j.1364-3703.2006.00359.X; Fendrych M, 2014, CURR BIOL, V24, P931, DOI 10.1016/j.cub.2014.03.025; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Helm M, 2008, AM J BOT, V95, P1049, DOI 10.3732/ajb.2007404; Hierl G, 2014, PLANT MOL BIOL, V84, P605, DOI 10.1007/s11103-013-0157-6; Hierl G, 2012, PHYSIOL PLANTARUM, V145, P103, DOI 10.1111/j.1399-3054.2012.01580.x; Howing T, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00058; Kirik V, 2001, CURR BIOL, V11, P1891, DOI 10.1016/S0960-9822(01)00590-5; Koh S, 2005, PLANT J, V44, P516, DOI 10.1111/j.1365-313X.2005.02545.x; LECKIE CP, 1995, NEW PHYTOL, V131, P211, DOI 10.1111/j.1469-8137.1995.tb05722.x; Maekawa T, 2012, P NATL ACAD SCI USA, V109, P20119, DOI 10.1073/pnas.1218059109; Micali CO, 2011, CELL MICROBIOL, V13, P210, DOI 10.1111/j.1462-5822.2010.01530.x; Misas-Villamil JC, 2016, NEW PHYTOL, V212, P902, DOI 10.1111/nph.14117; Nakano RT, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00073; Orjuela J, 2013, MOL PLANT MICROBE IN, V26, P1455, DOI 10.1094/MPMI-05-13-0127-R; Lopez-Fernandez MP, 2015, J INTEGR PLANT BIOL, V57, P996, DOI 10.1111/jipb.12367; Rasband, 2018, IMAGE J; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Schmid M, 1999, P NATL ACAD SCI USA, V96, P14159, DOI 10.1073/pnas.96.24.14159; Schmid M, 1998, PLANTA, V206, P466, DOI 10.1007/s004250050423; Schmid M, 2001, P NATL ACAD SCI USA, V98, P5353, DOI 10.1073/pnas.061038298; Senatore A, 2009, PLANT PHYSIOL, V149, P775, DOI 10.1104/pp.108.132720; Than ME, 2004, J MOL BIOL, V336, P1103, DOI 10.1016/j.jmb.2003.12.075; Toyooka K, 2000, J CELL BIOL, V148, P453, DOI 10.1083/jcb.148.3.453; Wang S, 2014, CELL HOST MICROBE, V16, P787, DOI 10.1016/j.chom.2014.10.005; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Zhang DD, 2014, PLANT CELL, V26, P2939, DOI 10.1105/tpc.114.127282; Zhou LZ, 2016, PLANT REPROD, V29, P265, DOI 10.1007/s00497-016-0288-4; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	38	12	12	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183870	10.1371/journal.pone.0183870	http://dx.doi.org/10.1371/journal.pone.0183870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846731	Green Published, Green Submitted, gold			2022-12-26	WOS:000408438600053
J	Su, JB; Yang, XH; Zhang, XL; Cai, HL; Huang, HY; Zhao, LH; Xu, F; Chen, T; Cheng, XB; Wang, XQ; Lu, Y				Su, Jian-bin; Yang, Xiao-hua; Zhang, Xiu-lin; Cai, Hong-li; Huang, Hai-yan; Zhao, Li-hua; Xu, Feng; Chen, Tong; Cheng, Xing-bo; Wang, Xue-qin; Lu, Yan			The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes	PLOS ONE			English	Article							ACUTE GLUCOSE FLUCTUATIONS; OXIDATIVE STRESS; RISK-FACTORS; DISPERSION; MORTALITY; DURATION; DISEASE; CARDIOMYOPATHY; POPULATION; PREVALENCE	Objectives Prolonged heart rate-corrected QT(QTc) interval is related to ventricular arrhythmia and cardiovascular mortality, with considerably high prevalence of type 2 diabetes. Additionally, long-term glycaemic variability could be a significant risk factor for diabetic complications in addition to chronic hyperglycaemia. We compared the associations of long-term glycaemic variability versus sustained chronic hyperglycaemia with the QTc interval among type 2 diabetes patients. Methods In this cross-sectional study, 2904 type 2 diabetes patients were recruited who had undergone at least four fasting plasma glucose (FPG) and 2-hour postprandial plasma glucose (PPG) measurements (at least once for every 3 months, respectively) during the preceding year. Long-term glycaemic variabilities of FPG and 2-hour PPG were assessed by their standard deviations (SD-FPG and SD-PPG, respectively), and chronic fasting and postprandial hyperglycaemia were assessed by their means (M-FPG and M-PPG, respectively). HbA1c was also determined upon enrolment to assess current overall glycaemic control. QTc interval was estimated from resting 12-lead electrocardiograms, and more than 440 ms was considered abnormally prolonged. Results Patients with prolonged QTc interval (>= 440 ms) had greater M-FPG, M-PPG, SD-PPG and HbA1c than those with normal QTc interval but comparable SD-FPG. QTc interval was correlated with M-FPG, M-PPG, SD-PPG and HbA1c (r = 0.133, 0.153, 0.245 and 0.207, respectively, p = 0.000) but not with SD-FPG (r = 0.024, p = 0.189). After adjusting for metabolic risk factors via multiple linear regression analysis, SD-PPG, M-PPG and HbA1c (t = 12.16, 2.69 and 10.16, respectively, p = 0.000) were the major independent contributors to the increased QTc interval. The proportion of prolonged QTc interval increased significantly from 10.9% to 14.2% to 26.6% for the first (T1) to second (T2) to third (T3) tertiles of SD-PPG. After adjusting via multiple logistic regression analysis, the odd ratios of prolonged QTc interval of the T2 and T3 versus the T1 of SD-PPG were 1.15 (95% CI, 0.821.60) and 2.62 (1.923.57), respectively. Conclusions Increased long-term variability of PPG is a strong independent risk factor for prolonged QTc interval in type 2 diabetes patients, in addition to long-term postprandial hyperglycaemia and current HbA1c.	[Su, Jian-bin; Yang, Xiao-hua; Cheng, Xing-bo; Lu, Yan] Soochow Univ, Dept Endocrinol, Affiliated Hosp 1, Suzhou, Peoples R China; [Su, Jian-bin; Huang, Hai-yan; Zhao, Li-hua; Xu, Feng; Wang, Xue-qin] Nantong Univ, Dept Endocrinol, Affiliated Hosp 2, Nantong, Peoples R China; [Yang, Xiao-hua] Nantong Univ, Dept Endocrinol, Affiliated Haian Hosp, Nantong, Haian, Peoples R China; [Zhang, Xiu-lin; Chen, Tong] Nantong Univ, Dept Clin Lab, Affiliated Hosp 2, Nantong, Peoples R China; [Cai, Hong-li] Nantong Univ, Dept Geriatr, Affiliated Hosp 2, Nantong, Peoples R China	Soochow University - China; Nantong University; Nantong University; Nantong University; Nantong University	Cheng, XB; Lu, Y (corresponding author), Soochow Univ, Dept Endocrinol, Affiliated Hosp 1, Suzhou, Peoples R China.; Wang, XQ (corresponding author), Nantong Univ, Dept Endocrinol, Affiliated Hosp 2, Nantong, Peoples R China.	xingbo1107@sohu.com; wangxueqin@medmail.com.cn; lucia1817@163.com	Su, Jian-bin/R-9181-2017	Su, Jian-bin/0000-0002-2138-0263	Scientific Research Program of Nantong [MS22015065]; Scientific Research Program of Health and Planning Commission of Jiangsu [H201553]; Scientific and Educational Program for Health Care Prosperity of Jiangsu (Young Medical Talents Project) [QNRC2016408]	Scientific Research Program of Nantong; Scientific Research Program of Health and Planning Commission of Jiangsu; Scientific and Educational Program for Health Care Prosperity of Jiangsu (Young Medical Talents Project)	The study was funded by the Scientific Research Program of Nantong (MS22015065), http://www.ntkj.gov.cn/; the Scientific Research Program of Health and Planning Commission of Jiangsu (H201553), http://www.jswst.gov.cn/jsswshjhsywyh/index.html;and the Scientific and Educational Program for Health Care Prosperity of Jiangsu (Young Medical Talents Project: QNRC2016408), http://www.jswst.gov.cn/jsswshjhsywyh/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cardoso C, 2001, INT J CARDIOL, V79, P253, DOI 10.1016/S0167-5273(01)00443-0; Cavalot F, 2011, DIABETES CARE, V34, P2237, DOI 10.2337/dc10-2414; Ceriello A, 2010, DIABETIC MED, V27, P862, DOI 10.1111/j.1464-5491.2010.02967.x; Chang CM, 2012, ACTA DIABETOL, V49, pS171, DOI 10.1007/s00592-012-0398-x; Colette C, 2007, HORM METAB RES, V39, P683, DOI 10.1055/s-2007-985157; Cox AJ, 2014, DIABETES CARE, V37, P1454, DOI 10.2337/dc13-1257; Festa A, 2000, AM J CARDIOL, V86, P1117, DOI 10.1016/S0002-9149(00)01170-X; Gao X, 2012, CHINESE MED J-PEKING, V125, P4167, DOI 10.3760/cma.j.issn.0366-6999.2012.23.002; Gastaldelli A, 2000, AM J PHYSIOL-REG I, V279, pR2022, DOI 10.1152/ajpregu.2000.279.6.R2022; Guo XF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005568; Jun JE, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0233-0; Klonoff DC, 2011, J CLIN ENDOCR METAB, V96, P2968, DOI 10.1210/jc.2010-2756; Lin CC, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0165-7; Lin CC, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.04.015; Lin CC, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.027; Lin YC, 2012, AM J PHYSIOL-HEART C, V302, pH1013, DOI 10.1152/ajpheart.00837.2011; Marfella R, 2000, DIABETOLOGIA, V43, P571, DOI 10.1007/s001250051345; Meek S, 2002, BRIT MED J, V324, P415, DOI 10.1136/bmj.324.7334.415; Mizamtsidi M, 2016, EUR J CLIN INVEST, V46, P947, DOI 10.1111/eci.12673; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Monnier L, 2015, DIABETES METAB, V41, pS9; Monnier L, 2009, DIABETES-METAB RES, V25, P393, DOI 10.1002/dmrr.962; Ninkovic VM, 2016, ACTA DIABETOL, V53, P737, DOI 10.1007/s00592-016-0864-y; Ohara M, 2016, DIABETES RES CLIN PR, V122, P62, DOI 10.1016/j.diabres.2016.09.025; Omran J, 2016, OBES REV, V17, P520, DOI 10.1111/obr.12390; Pickham D, 2014, J CARDIOVASC NURS, V29, P264, DOI 10.1097/JCN.0b013e31827f174c; Sartore G, 2013, ACTA DIABETOL, V50, P437, DOI 10.1007/s00592-013-0459-9; Shah MS, 2016, CIRC RES, V118, P1808, DOI 10.1161/CIRCRESAHA.116.306923; Stettler C, 2007, DIABETOLOGIA, V50, P186, DOI 10.1007/s00125-006-0483-1; Strohmer B, 2005, J INTERN MED, V257, P238, DOI 10.1111/j.1365-2796.2004.01436.x; Su G, 2013, DIABETES CARE, V36, P1026, DOI 10.2337/dc12-0925; Su G, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-19; Subbalakshmi NK, 2010, DIABETES RES CLIN PR, V88, P265, DOI 10.1016/j.diabres.2010.03.001; Szabo Z, 2005, CAN J CARDIOL, V21, P847; Takao T, 2011, DIABETES RES CLIN PR, V91, pE40, DOI 10.1016/j.diabres.2010.10.009; Tanaka K, 2014, HEART VESSELS, V29, P256, DOI 10.1007/s00380-013-0356-8; Targher G, 2014, NUTR METAB CARDIOVAS, V24, P663, DOI 10.1016/j.numecd.2014.01.005; Tarquini R, 2011, ACTA DIABETOL, V48, P173, DOI 10.1007/s00592-010-0180-x; Thomakos P, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/329189; Torimoto K, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-1; Veglio M, 2002, J INTERN MED, V251, P317, DOI 10.1046/j.1365-2796.2002.00955.x; Xu F, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-139	45	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183055	10.1371/journal.pone.0183055	http://dx.doi.org/10.1371/journal.pone.0183055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846720	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600022
J	Benhalevy, D; Biran, I; Bochkareva, ES; Sorek, R; Bibi, E				Benhalevy, Daniel; Biran, Ido; Bochkareva, Elena S.; Sorek, Rotem; Bibi, Eitan			Evidence for a cytoplasmic pool of ribosome-free mRNAs encoding inner membrane proteins in Escherichia coli	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; SINGLE STRANDS BIND; LARGE GENE LISTS; SHOCK PROTEIN; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; CSPA-FAMILY; RECEPTOR; TRANSLATION; CHAPERONES	Translation-independent mRNA localization represents an emerging concept in cell biology. In Escherichia coli, mRNAs encoding integral membrane proteins (MPRs) are targeted to the membrane where they are translated by membrane associated ribosomes and the produced proteins are inserted into the membrane co-translationally. In order to better understand aspects of the biogenesis and localization of MPRs, we investigated their subcellular distribution using cell fractionation, RNA-seq and qPCR. The results show that MPRs are overrepresented in the membrane fraction, as expected, and depletion of the signal recognition particle-receptor, FtsY reduced the amounts of all mRNAs on the membrane. Surprisingly, however, MPRs were also found relatively abundant in the soluble ribosome-free fraction and their amount in this fraction is increased upon overexpression of CspE, which was recently shown to interact with MPRs. CspE also conferred a positive effect on the membrane-expression of integral membrane proteins. We discuss the possibility that the effects of CspE overexpression may link the intriguing subcellular localization of MPRs to the cytosolic ribosome-free fraction with their translation into membrane proteins and that the ribosome-free pool of MPRs may represent a stage during their targeting to the membrane, which precedes translation.	[Benhalevy, Daniel; Biran, Ido; Bochkareva, Elena S.; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, Rehovot, Israel; [Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, Rehovot, Israel.	e.bibi@weizmann.ac.il	Benhalevy, Daniel/AGG-5321-2022	Benhalevy, Daniel/0000-0001-6998-1933; Bibi, Eitan/0000-0003-3700-2707	Israel Science Foundation [541/15]; Minerva Foundation; Pasteur-Weizmann center; Federal German Ministry for Education and Research	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Pasteur-Weizmann center; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Israel Science Foundation research grant (541/15), the Minerva Foundation with funding from the Federal German Ministry for Education and Research and by the Pasteur-Weizmann center to EB.; We thank Dr. Shlomi Dagan for writing Matlab scripts and Dr. Ester Feldmesser from the Bioinformatics and Biological Computing Unit at the Weizmann Institute of Science, for help in the clustering analysis. We also thank Drs. Hajime Tokuda and Hans-Georg Koch for sharing antibodies. This work was supported by the Israel Science Foundation research grant (541/15), the Minerva Foundation with funding from the Federal German Ministry for Education and Research and by the Pasteur-Weizmann center for non-coding RNA research. E.B. holds the Jerome A., Freda, and Edward M. Siegel professorial Chair.	Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Benhalevy D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134413; Bercovich-Kinori A, 2015, J CELL SCI, V128, P1444, DOI 10.1242/jcs.166116; Bibi E, 2012, TRENDS BIOCHEM SCI, V37, P1, DOI 10.1016/j.tibs.2011.09.004; Bibi E, 2011, BBA-BIOMEMBRANES, V1808, P841, DOI 10.1016/j.bbamem.2010.07.025; Blaha G, 2002, BIOPHYS CHEM, V96, P153, DOI 10.1016/S0301-4622(02)00021-2; Burk J, 2009, J BACTERIOL, V191, P7017, DOI 10.1128/JB.00208-09; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; Dar D, 2016, SCIENCE, V352, DOI 10.1126/science.aad9822; du Plessis DJ, 2010, BIOCHIM BIOPHYS ACTA, DOI [10.1074/ibc.M109.081935, DOI 10.1074/ibc.M109.081935]; Elvekrog MM, 2015, CURR OPIN CHEM BIOL, V29, P79, DOI 10.1016/j.cbpa.2015.09.016; Erez E, 2010, J BIOL CHEM, V285, P40508, DOI 10.1074/jbc.M110.140921; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gerst JE, 2008, TRENDS CELL BIOL, V18, P68, DOI 10.1016/j.tcb.2007.11.005; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jansen RP, 2014, TRENDS GENET, V30, P408, DOI 10.1016/j.tig.2014.07.002; Jiang WN, 1997, J BIOL CHEM, V272, P196; Kraut-Cohen J, 2013, MOL BIOL CELL, V24, P3069, DOI 10.1091/mbc.E13-01-0038; Lange C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168143; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044; Moffitt JR, 2016, ELIFE, V5, DOI 10.7554/eLife.13065; Morgan HP, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm040; Muller C, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5020019; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Phadtare S, 1999, MOL MICROBIOL, V33, P1004, DOI 10.1046/j.1365-2958.1999.01541.x; Phadtare S, 2001, J BACTERIOL, V183, P1205, DOI 10.1128/JB.183.4.1205-1214.2001; Phadtare S, 2005, NUCLEIC ACIDS RES, V33, P5583, DOI 10.1093/nar/gki859; Phadtare S, 2010, RNA BIOL, V7, P788, DOI 10.4161/rna.7.6.13482; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Rodnina MV, 2016, J MOL BIOL, V428, P2165, DOI 10.1016/j.jmb.2016.03.022; Sachs R, 2012, RNA, V18, P65, DOI 10.1261/rna.02809212; Schuwirth BS, 2006, NAT STRUCT MOL BIOL, V13, P879, DOI 10.1038/nsmb1150; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Shenhar Y, 2012, ENV MICROBIOL REP, V4, P532, DOI 10.1111/j.1758-2229.2012.00358.x; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Von Konig K., 2003, THESIS; Wickstrom D, 2011, J BIOL CHEM, V286, P4598, DOI 10.1074/jbc.M109.081935; Wild K, 2016, J MOL BIOL; Yosef I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009130	55	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183862	10.1371/journal.pone.0183862	http://dx.doi.org/10.1371/journal.pone.0183862			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841711	gold, Green Published, Green Submitted			2022-12-26	WOS:000408370700064
J	Lopez-Pascual, J; Page, A; Serra-Ano, P				Lopez-Pascual, Juan; Page, Alvaro; Serra-Ano, Pilar			Dynamic thoracohumeral kinematics are dependent upon the etiology of the shoulder injury	PLOS ONE			English	Article							ROTATOR CUFF TEARS; MOTOR VARIABILITY; MUSCLE-ACTIVITY; PAIN; IMPINGEMENT; RHYTHM; ARTHROPLASTY; RELIABILITY; DISORDERS; SYMPTOMS	Obtaining kinematic patterns that depend on the shoulder injury may be important when planning rehabilitation. The main goal of this study is to explore whether the kinematic patterns of continuous and repetitive shoulder elevation motions are different according to the type of shoulder injury in question, specifically tendinopathy or rotator cuff tear, and to analyze the influence of the load handled during its assessment. For this purpose, 19 individuals with tendinopathy and 9 with rotator cuff tear performed a repetitive scaption movement that was assessed with stereophotogrammetry. Furthermore, static range of motion (ROM) and isometric strength were evaluated with a goniometer and a dynamometer, respectively. Dynamic measurements of maximum elevation (Emax), variablility of the maximum angle (VMA), maximum angular velocity (Velmax), and time to maximum velocity (tmaxvel) were found to be significantly different between the tendinopathy group (TG) and the rotator cuff tear group (RTCG). No differences were found in the ROM assessed with goniometry and the isometric strength. The effect of increasing the load placed in the hand during the scaption movement led to significant differences in Emax, VMA, tmaxvel and repeatability. Therefore, only the dynamic variables showed sufficient capability of detecting differences in functional performance associated with structural shoulder injury. The differences observed in the kinematic variables between patients with tendinopathy and rotator cuff tear seem to be related to alterations in thoracohumeral rhythm and neuromuscular control. Kinematic analysis may contribute to a better understanding of the functional impact of shoulder injuries, which would help in the assessment and treatment of shoulder pain.	[Lopez-Pascual, Juan] Univ Politecn Valencia, Inst Biomecan Valencia, Valencia, Spain; [Page, Alvaro] Univ Politecn Valencia, Dept Fis Aplicada, Valencia, Spain; [Page, Alvaro] CIBER BBN, Grp Tecnol Sanitaria, IBV, Valencia, Spain; [Serra-Ano, Pilar] Univ Valencia, Dept Fisioterapia, Valencia, Spain	Instituto de Biomecanica de Valencia (IBV); Universitat Politecnica de Valencia; Universitat Politecnica de Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Valencia	Serra-Ano, P (corresponding author), Univ Valencia, Dept Fisioterapia, Valencia, Spain.	pilar.serra@uv.es	Serra-Añó, Pilar/L-6085-2014	Serra-Añó, Pilar/0000-0002-0743-3445; Lopez Pascual, Juan/0000-0002-6641-0200	Spanish Government; Secretaria de Estado de Investigacion, Desarrollo e Innovacion; EU FEDER funds [DPI2013-44227-R]	Spanish Government(Spanish GovernmentEuropean Commission); Secretaria de Estado de Investigacion, Desarrollo e Innovacion; EU FEDER funds(European Commission)	This work was funded by the Spanish Government, Secretaria de Estado de Investigacion, Desarrollo e Innovacion, and co-financed by EU FEDER funds (Grant DPI2013-44227-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allom R, 2009, J BONE JOINT SURG BR, V91B, P367, DOI 10.1302/0301-620X.91B3.20714; Bergsma A, 2014, ARCH PHYS MED REHAB, V95, P1731, DOI 10.1016/j.apmr.2014.03.033; Brown LE, 2001, J EXERC PHYSL ONLINE, V4, DOI DOI 10.4236/JEP.2013.46A001; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; CLARK JE, 1993, CHILD DEV, V64, P1143, DOI 10.1111/j.1467-8624.1993.tb04192.x; Dabholkar A, 2015, INT J HLTH SCI RES I, V5, P232; Reyes-Guzman ADL, 2014, CLIN BIOMECH, V29, P719, DOI 10.1016/j.clinbiomech.2014.06.013; de Toledo JM, 2012, CLIN BIOMECH, V27, P793, DOI 10.1016/j.clinbiomech.2012.04.009; Duhamel A, 2004, GAIT POSTURE, V20, P204, DOI 10.1016/j.gaitpost.2003.09.010; Dunn WR, 2014, SHOULDER ARTHROSCOPY, P585; Garofalo P, 2009, MED BIOL ENG COMPUT, V47, P475, DOI 10.1007/s11517-009-0454-z; Gates DH, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.015487; Gausden EB, 2017, J SHOULDER ELB SURG, V26, P331, DOI 10.1016/j.jse.2016.07.013; Hebert LJ, 2002, ARCH PHYS MED REHAB, V83, P60, DOI 10.1053/apmr.2002.27471; Jaspers E, 2011, GAIT POSTURE, V33, P279, DOI 10.1016/j.gaitpost.2010.11.021; KANEKO K, 1995, CLIN IMAG, V19, P8, DOI 10.1016/0899-7071(94)00024-7; Karduna AR, 2001, J BIOMECH ENG-T ASME, V123, P184, DOI 10.1115/1.1351892; Kwon YW, 2012, J SHOULDER ELB SURG, V21, P1184, DOI 10.1016/j.jse.2011.07.031; Laudner KG, 2006, J ORTHOP SPORT PHYS, V36, P485, DOI 10.2519/jospt.2006.2146; Li XT, 2016, J BIOMECH, V49, P2806, DOI 10.1016/j.jbiomech.2016.06.018; Lopez-Pascual J, 2016, J BIOMECH, V49, P502, DOI 10.1016/j.jbiomech.2015.12.045; Lowe CJM, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-228; Ludewig PM, 2003, OCCUP ENVIRON MED, V60, P841, DOI 10.1136/oem.60.11.841; Ludewig PM, 2000, PHYS THER, V80, P276, DOI 10.1093/ptj/80.3.276; Madeleine P, 2008, EXP BRAIN RES, V185, P689, DOI 10.1007/s00221-007-1199-2; Meana-Riera M., 2008, BIOMECANICA BASES NE, P489; Mell AG, 2005, J SHOULDER ELB SURG, V14, p58S, DOI 10.1016/j.jse.2004.09.018; Page A, 2006, MED BIOL ENG COMPUT, V44, P1113, DOI 10.1007/s11517-006-0124-3; Page A, 2006, J BIOMECH, V39, P2526, DOI 10.1016/j.jbiomech.2005.07.032; PATTE D, 1990, CLIN ORTHOP RELAT R, P81; Pribicevic M., 2012, EPIDEMIOLOGY SHOULDE; Reese N., 2016, JOINT RANGE MOTION M; Rice IM, 2014, ARCH PHYS MED REHAB, V95, P699, DOI 10.1016/j.apmr.2013.11.005; Robert-Lachaine X, 2015, COMPUT METHOD BIOMEC, V18, P249, DOI 10.1080/10255842.2013.792810; Scibek JS, 2008, J SHOULDER ELB SURG, V17, P172, DOI 10.1016/j.jse.2007.05.010; Scibek Jason S., 2010, Journal of Musculoskeletal Research, V13, P23, DOI 10.1142/S0218957710002429; Scibek JS, 2009, J ATHL TRAINING, V44, P148, DOI 10.4085/1062-6050-44.2.148; Srinivasan D, 2012, CLIN BIOMECH, V27, P979, DOI 10.1016/j.clinbiomech.2012.08.007; Struyf F, 2014, J ELECTROMYOGR KINES, V24, P277, DOI 10.1016/j.jelekin.2013.12.002; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; van der Heijden GJMG, 1999, BEST PRACT RES CL RH, V13, P287, DOI 10.1053/berh.1999.0021; VANDERHELM FCT, 1995, J BIOMECH ENG-T ASME, V117, P27, DOI 10.1115/1.2792267; Vidt ME, 2016, J BIOMECH, V49, P611, DOI 10.1016/j.jbiomech.2016.01.029; Walton MJ, 2007, J SHOULDER ELB SURG, V16, P285, DOI 10.1016/j.jse.2006.08.002; Wickham J, 2010, J ELECTROMYOGR KINES, V20, P212, DOI 10.1016/j.jelekin.2009.06.004	45	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183954	10.1371/journal.pone.0183954	http://dx.doi.org/10.1371/journal.pone.0183954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841697	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700071
J	Martinez-Granados, L; Serrano, M; Gonzalez-Utor, A; Ortiz, N; Badajoz, V; Olaya, E; Prados, N; Boada, M; Castilla, JA				Martinez-Granados, Luis; Serrano, Maria; Gonzalez-Utor, Antonio; Ortiz, Nereyda; Badajoz, Vicente; Olaya, Enrique; Prados, Nicolas; Boada, Montse; Castilla, Jose A.		Special Interest Grp Quality	Inter-laboratory agreement on embryo classification and clinical decision: Conventional morphological assessment vs. time lapse	PLOS ONE			English	Article							EXTERNAL QUALITY-CONTROL; IMPLANTATION; MORPHOKINETICS; SELECTION; MODEL; PREDICTION; ALGORITHM	The aim of this study is to determine inter-laboratory variability on embryo assessment using time-lapse platform and conventional morphological assessment. This study compares the data obtained from a pilot study of external quality control (EQC) of time lapse, performed in 2014, with the classical EQC of the Spanish Society for the Study of Reproductive Biology (ASEBIR) performed in 2013 and 2014. In total, 24 laboratories (8 using EmbryoScope (TM), 15 using Primo Vision (TM) and one with both platforms) took part in the pilot study. The clinics that used EmbryoScope (TM) analysed 31 embryos and those using Primo Vision (TM) analysed 35. The classical EQC was implemented by 39 clinics, based on an analysis of 25 embryos per year. Both groups were required to evaluate various qualitative morphological variables (cell fragmentation, the presence of vacuoles, blastomere asymmetry and multinucleation), to classify the embryos in accordance with ASEBIR criteria and to stipulate the clinical decision taken. In the EQC time-lapse pilot study, the groups were asked to determine, as well as the above characteristics, the embryo development times, the number, opposition and size of pronuclei, the direct division of 1 into 3 cells and/or of 3 into 5 cells and false divisions. The degree of agreement was determined by calculating the intra-class correlation coefficients and the coefficient of variation for the quantitative variables and the Gwet index for the qualitative variables. For both EmbryoScope (TM) and Primo Vision (TM), two periods of greater inter-laboratory variability were observed in the times of embryo development events. One peak of variability was recorded among the laboratories addressing the first embryo events (extrusion of the second polar body and the appearance of pronuclei); the second peak took place between the times corresponding to the 8-cell and morula stages. In most of the qualitative variables analysed regarding embryo development, there was almost-perfect inter-laboratory agreement among conventional morphological assessment (CMA), EmbryoScope (TM) and Primo Vision (TM), except for false divisions, vacuoles and asymmetry (users of all methods) and multinucleation (users of Primo Vision (TM)), where the degree of agreement was lower. The inter-laboratory agreement on embryo classification according to the ASEBIR criteria was moderate-substantial (Gwet 0.41-0.80) for the laboratories using CMA and EmbryoScope (TM), and fair-moderate (Gwet 0.21-0.60) for those using Primo Vision (TM). The inter-laboratory agreement for clinical decision was moderate (Gwet 0.41-0.60) on day 5 for CMA users and almost perfect (Gwet 0.81-1) for time-lapse users. In conclusion, time-lapse technology does not improve inter-laboratory agreement on embryo classification or the analysis of each morphological variable. Moreover, depending on the time-lapse platform used, inter-laboratory agreement may be lower than that obtained by CMA. However, inter-laboratory agreement on clinical decisions is improved with the use of time lapse, regardless of the platform used.	[Martinez-Granados, Luis; Castilla, Jose A.] Hosp Univ Virgen Nieves, IIBG, UGC Lab Clin, U Reprod, Granada, Spain; [Martinez-Granados, Luis; Castilla, Jose A.] Hosp Univ Virgen Nieves, IIBG, UGC Obstetricia & Ginecol, U Reprod, Granada, Spain; [Serrano, Maria] Clin IFEM, Cordoba, Spain; [Gonzalez-Utor, Antonio] Ctr MasVida Reprod, Seville, Spain; [Ortiz, Nereyda] Inst Europeo Fertilidad, Madrid, Spain; [Badajoz, Vicente] Ginefiv, Madrid, Spain; [Olaya, Enrique] Clin Tambre, Madrid, Spain; [Prados, Nicolas] IVI, Seville, Spain; [Boada, Montse] Womens Hlth Dexeus, Barcelona, Spain; [Castilla, Jose A.] CEIFER Biobanco, Granada, Spain; [Castilla, Jose A.] Univ Granada, Fac Med, Dept Anat & Embriol Humana, Granada, Spain	Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; University of Granada	Martinez-Granados, L (corresponding author), Hosp Univ Virgen Nieves, IIBG, UGC Lab Clin, U Reprod, Granada, Spain.; Martinez-Granados, L (corresponding author), Hosp Univ Virgen Nieves, IIBG, UGC Obstetricia & Ginecol, U Reprod, Granada, Spain.	Luismargra@gmail.com	Castilla, jose antonio/ABF-8754-2021; Prados, Nicolas/P-1554-2016	Castilla, jose antonio/0000-0003-2185-565X; Prados, Nicolas/0000-0002-7888-2125				Ahlstrom A, 2016, REPROD BIOMED ONLINE, V33, P61, DOI 10.1016/j.rbmo.2016.03.008; Castilla JA, 2010, REPROD BIOMED ONLINE, V20, P68, DOI 10.1016/j.rbmo.2009.09.033; Aparicio-Ruiz B, 2016, FERTIL STERIL, V106, P1379, DOI 10.1016/j.fertnstert.2016.07.1117; Arce JC, 2006, HUM REPROD, V21, P2141, DOI 10.1093/humrep/del106; ASEBIR, 2008, CUAD EMBR CLIN 2 CRI; Basile N, 2015, HUM REPROD, V30, P276, DOI 10.1093/humrep/deu331; Chavez SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2249; Ciray HN, 2014, HUM REPROD, V29, P2650, DOI 10.1093/humrep/deu278; Conaghan J, 2013, FERTIL STERIL, V100, P412, DOI 10.1016/j.fertnstert.2013.04.021; de los Santos MJ, 2013, FERTIL STERIL, V100, P402, DOI 10.1016/j.fertnstert.2013.03.044; De los Santos MJ, 2016, HUM REPROD, V31, P685, DOI 10.1093/humrep/dew016; Diamond MP, 2015, J ASSIST REPROD GEN, V32, P61, DOI 10.1007/s10815-014-0366-1; Gardner DK, 2016, MOL HUM REPROD, V22, P704, DOI 10.1093/molehr/gaw057; Hardarson T, 2002, Reprod Biomed Online, V5, P36; Harper J, 2012, HUM REPROD, V27, P303, DOI 10.1093/humrep/der414; Kieslinger DC, 2016, HUM REPROD, V31, P2450, DOI 10.1093/humrep/dew207; Kirkegaard K, 2015, FERTIL STERIL, V103, P323, DOI 10.1016/j.fertnstert.2014.11.003; Kirkegaard K, 2014, REPROD BIOMED ONLINE, V29, P156, DOI 10.1016/j.rbmo.2014.04.011; Kirkegaard K, 2013, FERTIL STERIL, V99, P738, DOI 10.1016/j.fertnstert.2012.11.028; Kirkegaard K, 2012, HUM REPROD, V27, P1277, DOI 10.1093/humrep/des079; Liu YH, 2016, FERTIL STERIL, V105, P656, DOI 10.1016/j.fertnstert.2015.11.003; Lundin K, 2015, REPROD BIOMED ONLINE, V31, P459, DOI 10.1016/j.rbmo.2015.06.026; Mastenbroek S, 2011, HUM REPROD, V26, P964, DOI 10.1093/humrep/der050; Meseguer M, 2011, HUM REPROD, V26, P2658, DOI 10.1093/humrep/der256; Milewski R, 2015, J ASSIST REPROD GEN, V32, P571, DOI 10.1007/s10815-015-0440-3; Molder A, 2015, CYTOM PART A, V87A, P119, DOI 10.1002/cyto.a.22611; Petersen BM, 2016, HUM REPROD, V31, P2231, DOI 10.1093/humrep/dew188; Rubio I, 2012, FERTIL STERIL, V98, P1458, DOI 10.1016/j.fertnstert.2012.07.1135; de Assin RR, 2009, REPROD BIOMED ONLINE, V19, P824, DOI 10.1016/j.rbmo.2009.09.026; Sundvall L, 2013, HUM REPROD, V28, P3215, DOI 10.1093/humrep/det366; VerMilyea MD, 2014, REPROD BIOMED ONLINE, V29, P729, DOI 10.1016/j.rbmo.2014.09.005; Wirka KA, 2014, FERTIL STERIL, V101, P1637, DOI 10.1016/j.fertnstert.2014.02.050	32	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183328	10.1371/journal.pone.0183328	http://dx.doi.org/10.1371/journal.pone.0183328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841654	gold, Green Published, Green Submitted			2022-12-26	WOS:000408370700024
J	Akshaya, KM; Shivalli, S				Akshaya, Kibballi Madhukeshwar; Shivalli, Siddharudha			Birth preparedness and complication readiness among the women beneficiaries of selected rural primary health centers of Dakshina Kannada district, Karnataka, India	PLOS ONE			English	Article							NEPAL	Introduction Birth preparedness and complication readiness (BPCR) is a strategy to promote timely use of skilled maternal and neonatal care during childbirth. According to World Health Organization, BPCR should be a key component of focused antenatal care. Dakshina Kannada, a coastal district of Karnataka state, is categorized as a high-performing district (institutional delivery rate > 25%) under the National Rural Health Mission. However, a substantial proportion of women in the district experience complications during pregnancy (58.3%), childbirth (45.7%), and postnatal (17.4%) period. There is a paucity of data on BPCR practice and the factors associated with it in the district. Exploring this would be of great use in the evidence-based fine-tuning of ongoing maternal and child health interventions. Objective To assess BPCR practice and the factors associated with it among the beneficiaries of two rural Primary Health Centers (PHCs) of Dakshina Kannada district, Karnataka, India. Methods A facility-based cross-sectional study was conducted among 217 pregnant (> 28 weeks of gestation) and recently delivered (in the last 6 months) women in two randomly selected PHCs from June - September 2013. Exit interviews were conducted using a pre-designed semi-structured interview schedule. Information regarding socio-demographic profile, obstetric variables, and knowledge of key danger signs was collected. BPCR included information on five key components: identified the place of delivery, saved money to pay for expenses, mode of transport identified, identified a birth companion, and arranged a blood donor if the need arises. In this study, a woman who recalled at least two key danger signs in each of the three phases, i.e., pregnancy, childbirth, and postpartum (total six) was considered as knowledgeable on key danger signs. Optimal BPCR practice was defined as following at least three out of five key components of BPCR. Outcome measures Proportion, Odds ratio, and adjusted Odds ratio (adj OR) for optimal BPCR practice. Results A total of 184 women completed the exit interview (mean age: 26.9 +/- 3.9 years). Optimal BPCR practice was observed in 79.3% (95% CI: 73.5-85.2%) of the women. Multivariate logistic regression revealed that age > 26 years (adj OR = 2.97; 95% CI: 1.15-7.7), economic status of above poverty line (adj OR = 4.3; 95% CI: 1.12-16.5), awareness of minimum two key danger signs in each of the three phases, i.e., pregnancy, childbirth, and postpartum (adj OR = 3.98; 95% CI: 1.4-11.1), preference to private health sector for antenatal care/delivery (adj OR = 2.9; 95% CI: 1.1-8.01), and woman's discussion about the BPCR with her family members (adj OR = 3.4; 95% CI: 1.1-10.4) as the significant factors associated with optimal BPCR practice. Conclusion In this study population, BPCR practice was better than other studies reported from India. Healthcare workers at the grassroots should be encouraged to involve women's family members while explaining BPCR and key danger signs with a special emphasis on young (<26 years) and economically poor women. Ensuring a reinforcing discussion between woman and her family members may further enhance the BPCR practice.	[Akshaya, Kibballi Madhukeshwar] Yenepoya Univ, Yenepoya Med Coll, Dept Community Med, Mangaluru, Karnataka, India; [Shivalli, Siddharudha] Yenepoya Univ, Yenepoya Med Coll, Dept Publ Hlth, Mangaluru, Karnataka, India; [Shivalli, Siddharudha] TEPHINET, Southeast Asia Reg Off SEARO, Decatur, GA USA	Yenepoya (Deemed to be University); Yenepoya (Deemed to be University)	Shivalli, S (corresponding author), Yenepoya Univ, Yenepoya Med Coll, Dept Publ Hlth, Mangaluru, Karnataka, India.; Shivalli, S (corresponding author), TEPHINET, Southeast Asia Reg Off SEARO, Decatur, GA USA.	shivalli.bhu@gmail.com	Shivalli, Siddharudha/AAU-3907-2020; Akshaya, Kibballi Madhukeshwar/AAE-3352-2021	Shivalli, Siddharudha/0000-0003-1454-7114				Acharya Anita Shankar, 2015, Indian J Community Med, V40, P127, DOI 10.4103/0970-0218.153881; Acsadi GT, 1991, SOCIAL CULTURAL FACT, P73; Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; August F, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.26922; Bintabara D, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0041-8; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Debelew GT, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.272.4244; Ekabua John E, 2011, ISRN Obstet Gynecol, V2011, P560641, DOI 10.5402/2011/560641; Govt. of India (Sample Registration System), MAT MORT IND 1997 20; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; JHPIEGO, 2004, MAT NEON HLTH MON BI; Karkee R, 2013, MIDWIFERY, V29, P1206, DOI 10.1016/j.midw.2013.05.002; Kaso M, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-55; Lwanga SK., 1991, SAMPLE SIZE DETERMIN, P25; Malik Geeta, 2009, Nurs J India, V100, P88; Markos D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-282; Mazumdar R, AL AMEEN J MED SCI, V7, P52; Mukhopadhyay Dipta Kanti, 2013, Indian J Public Health, V57, P147, DOI 10.4103/0019-557X.119827; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Mutiso S M, 2008, East Afr Med J, V85, P275; Nandan D, 2009, STUDY ASSESSING BIRT; Nawal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060957; Odimegwu Clifford, 2005, Afr J Reprod Health, V9, P59; Pembe AB, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-12; Shetty N., DAKSHINA KANNADA DIS; Sookhoo D., 2009, SOCIAL CONTEXT BIRTH, P85; Soubeiga D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-129; stergren P-O, 2011, REPROD HLTH, V8, P33; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Timsa L, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.23969; World Health Organization, 2010, WORK IND FAM COMM IM; World Health Organization, 2015, WORLD REP AG HLTH, P3; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735	33	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183739	10.1371/journal.pone.0183739	http://dx.doi.org/10.1371/journal.pone.0183739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837683	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000408365000108
J	Gao, LY; Chen, B; Li, JH; Yang, F; Cen, XC; Liao, ZB; Long, X				Gao, Liyang; Chen, Bing; Li, Jinhong; Yang, Fan; Cen, Xuecheng; Liao, Zhuangbing; Long, Xiao'ao			Wnt/beta-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms	PLOS ONE			English	Article							BETA-CATENIN; WNT; EXPRESSION; GROWTH; INVASION; TARGET; ANGIOGENESIS; FIBRONECTIN; LAMININ; MARKER	The Wnt signaling pathway is necessary for the development of the central nervous system and is associated with tumorigenesis in various cancers. However, the mechanism of the Wnt signaling pathway in glioma cells has yet to be elucidated. Small-molecule Wnt modulators such as ICG-001 and AZD2858 were used to inhibit and stimulate the Wnt/beta-catenin signaling pathway. Techniques including cell proliferation assay, colony formation assay, Matrigel cell invasion assay, cell cycle assay and Genechip microarray were used. Gene Ontology Enrichment Analysis and Gene Set Enrichment Analysis have enriched many biological processes and signaling pathways. Both the inhibiting and stimulating Wnt/beta-catenin signaling pathways could influence the cell cycle, moreover, reduce the proliferation and survival of U87 glioma cells. However, Affymetrix expression microarray indicated that biological processes and networks of signaling pathways between stimulating and inhibiting the Wnt/beta-catenin signaling pathway largely differ. We propose that Wnt/beta-catenin signaling pathway might prove to be a valuable therapeutic target for glioma.	[Gao, Liyang] Ningxia Univ, Sch Life Sci, Yinchuan, Peoples R China; [Gao, Liyang] Guangdong Med Univ, Affiliated Hosptial, Stem Cell Res & Cellular Therapy Ctr, Zhanjiang, Peoples R China; [Chen, Bing; Li, Jinhong; Yang, Fan; Cen, Xuecheng; Liao, Zhuangbing; Long, Xiao'ao] Guangdong Med Univ, Affiliated Hosp, Dept Neurosurg, Zhanjiang, Peoples R China	Ningxia University; Guangdong Medical University; Guangdong Medical University	Gao, LY (corresponding author), Ningxia Univ, Sch Life Sci, Yinchuan, Peoples R China.; Gao, LY (corresponding author), Guangdong Med Univ, Affiliated Hosptial, Stem Cell Res & Cellular Therapy Ctr, Zhanjiang, Peoples R China.; Chen, B (corresponding author), Guangdong Med Univ, Affiliated Hosp, Dept Neurosurg, Zhanjiang, Peoples R China.	pandarun@aliyun.com; 13702878900@139.com			Major Innovation Projects of Building First-class Universities in China's Western Region [ZKZD2017001]	Major Innovation Projects of Building First-class Universities in China's Western Region	This study was supported by the Major Innovation Projects of Building First-class Universities in China's Western Region (ZKZD2017001). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6853; An SM, 2013, ACTA PHARMACOL SIN, V34, P777, DOI 10.1038/aps.2013.64; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Cao P, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1495-3; Chen DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087281; Duan R, 2015, ONCOTARGET, V6, P27778, DOI 10.18632/oncotarget.4813; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Evans DGR, 2009, GENET MED, V11, P599, DOI 10.1097/GIM.0b013e3181ac9a27; Fenstermaker RA, 2016, CANCER IMMUNOL IMMUN, V65, P1339, DOI 10.1007/s00262-016-1890-x; Gao J, 2015, INT J CLIN EXP PATHO, V8, P10130; Gu XF, 2014, NEURO-ONCOLOGY, V16, P217, DOI 10.1093/neuonc/not194; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Herbst Andreas, 2007, Methods Mol Biol, V361, P63; Hu JX, 2010, J AM STAT ASSOC, V105, P1215, DOI 10.1198/jasa.2010.tm09329; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Iacopino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105166; Katz LH, 2013, EXPERT OPIN THER TAR, V17, P743, DOI 10.1517/14728222.2013.782287; KAVINSKY CJ, 1979, J SUPRAMOL STR CELL, V11, P269, DOI 10.1002/jss.400110216; Kingdom U, 2008, OCT4 SPLICED VARIANT, P3068; Kingsmore KM, 2016, INTEGR BIOL; Lathia JD, 2012, ANN NEUROL, V72, P766, DOI 10.1002/ana.23674; Lee KH, 2010, P NATL ACAD SCI USA, V107, P69, DOI 10.1073/pnas.0909734107; Li QF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-302; LIESI P, 1984, MED BIOL, V62, P163; Lu JM, 2009, BIOORG MED CHEM LETT, V19, P3825, DOI 10.1016/j.bmcl.2009.04.040; Ma Q, 2015, ONCOTARGET, V6, P35851, DOI 10.18632/oncotarget.5323; Maguschak K, 2012, J NEUROIMMUNE PHARM; Maiese K, 2008, PHARMACOL THERAPEUT, V118, P58, DOI 10.1016/j.pharmthera.2008.01.004; Mulligan KA, 2012, J NEUROIMMUNE PHARM, V7, P774, DOI 10.1007/s11481-012-9404-x; Nagaraj AB, 2015, ONCOTARGET, V6, P23720, DOI 10.18632/oncotarget.4690; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; ORourke NA, 1997, DEVELOPMENT, V124, P997; OSADA T, 1995, BRAIN RES, V683, P254, DOI 10.1016/0006-8993(95)00336-O; Payne LS, 2013, MOL CANCER RES, V11, P1129, DOI 10.1158/1541-7786.MCR-13-0236; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Qiu B, 2012, INT J MOL SCI, V13, P9142, DOI 10.3390/ijms13079142; RAMPAZZO E, 2013, CELL DEATH DIS, V4; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; Seidel C, 2007, MOL CARCINOGEN, V46, P865, DOI 10.1002/mc.20317; Thacker PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120045; Wang DY, 2015, ONCOL LETT, V9, P2603, DOI 10.3892/ol.2015.3079; Wang HD, 2016, ONCOL LETT, V11, P678, DOI 10.3892/ol.2015.3917; Wang K, 2013, NEURO-ONCOLOGY, V15, P578, DOI 10.1093/neuonc/not004; Wang Lei, 2016, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V32, P789; Wiranowska M, 2010, INT J CANCER, V127, P532, DOI 10.1002/ijc.25085; XU TA, 1995, DEVELOPMENT, V121, P1053; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhao P, 2015, ONCOTARGET, V6, P31901, DOI 10.18632/oncotarget.5043	50	51	51	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181346	10.1371/journal.pone.0181346	http://dx.doi.org/10.1371/journal.pone.0181346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837560	Green Submitted, Green Published, gold			2022-12-26	WOS:000408365000006
J	Hull, WW; Bourdeau, PE				Hull, Wesley W.; Bourdeau, Paul E.			Can crabs kill like a keystone predator? A field-test of the effects of crab predation on mussel mortality on a northeast Pacific rocky shore	PLOS ONE			English	Article							COMMUNITY STATES; MYTILUS-EDULIS; WAVE-EXPOSURE; SIZE; COMPLEXITY; PATTERNS; STRESS; LEVEL; GULF	Predation can strongly influence community structure and ecosystem function, so the loss of key predators can have dramatic ecological consequences, unless other predatory species in the system are capable of playing similar ecological roles. In light of the recent outbreak of sea star wasting disease (SSWD) and subsequent depletion of west coast sea star populations, including those of the keystone predator Pisaster ochraceus, we examined whether large mobile crabs could play a role as predators on mussels (Mytilus californianus) on a rocky shore in Northern California. Using a combination of sea star removal and predator exclusion cages we found that mussel mortality was 43-294 times greater in uncaged treatments versus caged treatments. Mortality on uncaged mussels at low tidal elevations was due to predation by large mobile crabs (Cancer productus and Romaleon antennarium); confirmed by the presence of mussel shell fragments and documented attacks on wax snail replicas. Laboratory feeding assays indicated that crabs, on a per unit biomass basis, can consume almost twenty-five times as many mussels per day than sea stars, which together with the results of our field experiment, suggest that large predatory crabs could play an important role in maintaining ecosystem function through their predation on mussels on rocky shores where P. ochraceus are rare, absent, or have been depleted by SSWD.	[Hull, Wesley W.; Bourdeau, Paul E.] Humboldt State Univ, Telonicher Marine Lab, Trinidad, CA 95570 USA; [Hull, Wesley W.; Bourdeau, Paul E.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt; California State University System; California State Polytechnic University, Humboldt	Bourdeau, PE (corresponding author), Humboldt State Univ, Telonicher Marine Lab, Trinidad, CA 95570 USA.; Bourdeau, PE (corresponding author), Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA.	peb112@humboldt.edu	Bourdeau, Paul/AAA-3551-2019	Bourdeau, Paul/0000-0002-8927-1899	Humboldt Marine and Coastal Sciences Institute Undergraduate Student Research Award; Humboldt State University Research, Scholarly, and Creative Activities Research Grant; Humboldt State University; California State University Council on Ocean Affairs, Science & Technology (CSU-COAST) Grant Development Program	Humboldt Marine and Coastal Sciences Institute Undergraduate Student Research Award; Humboldt State University Research, Scholarly, and Creative Activities Research Grant; Humboldt State University; California State University Council on Ocean Affairs, Science & Technology (CSU-COAST) Grant Development Program	Funding was provided by a Humboldt Marine and Coastal Sciences Institute Undergraduate Student Research Award to WWH and by a Humboldt State University Research, Scholarly, and Creative Activities Research Grant to PEB. Additional funding was provided by a Humboldt State University Sponsored Programs Foundation Incentives Program Grant to PEB. PEB acknowledges support from The California State University Council on Ocean Affairs, Science & Technology (CSU-COAST) Grant Development Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the director and staff of the Humboldt State University Telonicher Marine Laboratory for logistical support, as well as volunteers from the Phenotype Environment Biodiversity Lab who helped with field work. We thank both T. Flagor and J. Paulsen for field and lab assistance. We also thank T. McClure for his assistance in creating our map. Mussels, crabs, and sea stars were collected by the authors under scientific collecting permit # SCP 10571 issued to PEB from the California Department of Fish and Wildlife. Two anonymous reviewers provided constructive criticism on earlier versions of this manuscript. Funding was provided by a Humboldt Marine and Coastal Sciences Institute Undergraduate Student Research Award to WWH and by a Humboldt State University Research, Scholarly, and Creative Activities Research Grant to PEB. Additional funding was provided by a Humboldt State University Sponsored Programs Foundation Incentives Program Grant to PEB. PEB acknowledges support from The California State University Council on Ocean Affairs, Science & Technology (CSU-COAST) Grant Development Program. This work conforms to the legal requirements of the country in which it was carried out and to accepted international ethical standards, including those relating to conservation and animal welfare. This is a contribution of the Humboldt State University Telonicher Marine Laboratory and the Humboldt Marine and Coastal Sciences Institute. This manuscript is dedicated to the memory of Lynn K. Hull.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bertness MD, 2002, ECOLOGY, V83, P3434, DOI 10.1890/0012-9658(2002)083[3434:DASCSE]2.0.CO;2; Bertness MD, 2004, ECOLOGY, V85, P1321, DOI 10.1890/02-0636; Boulding EG, 1999, J EXP MAR BIOL ECOL, V232, P217, DOI 10.1016/S0022-0981(98)00117-8; Bourdeau PE, 2009, ECOLOGY, V90, P1659, DOI 10.1890/08-1653.1; BRETT JR, 1979, CAN J ZOOL, V57, P658, DOI 10.1139/z79-078; Carroll JC, 1989, US FISH WILD1 SERV B, V82; Coverdale TC, 2013, FRONT ECOL ENVIRON, V11, P69, DOI 10.1890/120130; Denny MW, 2011, J EXP MAR BIOL ECOL, V400, P175, DOI 10.1016/j.jembe.2011.02.006; DENNY MW, 1983, LIMNOL OCEANOGR, V28, P1269, DOI 10.4319/lo.1983.28.6.1269; EBLING FJ, 1964, J ANIM ECOL, V33, P73, DOI 10.2307/2349; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Errington PL, 1967, PREDATION LIFE; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; HALDORSON L, 1979, COPEIA, P567; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Helmuth BST, 2001, BIOL BULL-US, V201, P374, DOI 10.2307/1543615; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Jenkinson RS, 2017, BASELINE MONITORING; Jurgens LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37573; KITCHING JA, 1959, J ANIM ECOL, V28, P331, DOI 10.2307/2087; Krenz C, 2007, THESIS; Mazerolle MJ, 2016, AICCMODAVG MODEL SEL; Menge BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153994; MILLER B, 1994, CONSERV BIOL, V8, P677, DOI 10.1046/j.1523-1739.1994.08030677.x; Miller LP, 2007, J EXP MAR BIOL ECOL, V344, P215, DOI 10.1016/j.jembe.2007.01.005; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; Nummi P, 2014, AQUAT CONSERV, V24, P623, DOI 10.1002/aqc.2437; Opermanis O, 2005, ACTA U LATVIENSIS, V691, P17; Oug Eivind, 2011, Marine Biodiversity, V41, P467, DOI 10.1007/s12526-010-0068-6; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1976, ECOLOGY, V57, P858, DOI 10.2307/1941053; PALUMBI SR, 1984, J EXP MAR BIOL ECOL, V81, P171, DOI 10.1016/0022-0981(84)90004-2; Robinson EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021025; ROBLES C, 1989, J NAT HIST, V23, P1041, DOI 10.1080/00222938900770951; ROBLES C, 1990, ECOLOGY, V71, P1564, DOI 10.2307/1938292; Rogers TL, 2013, MAR BIOL, V160, P853, DOI 10.1007/s00227-012-2139-7; SCHMITT RJ, 1984, OECOLOGIA, V63, P6, DOI 10.1007/BF00379778; SEED R, 1969, OECOLOGIA, V3, P317, DOI 10.1007/BF00390381; SPIGHT TM, 1974, ECOLOGY, V55, P712, DOI 10.2307/1934409; SUCHANEK TH, 1981, OECOLOGIA, V50, P143, DOI 10.1007/BF00348028; Tyler Cl, 2014, J MAR BIOL ASSOC UK, V95, P361, DOI DOI 10.1017/S0025315414001210; Walker B. H., 1992, Conservation Biology, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Yamada SB, 1996, J EXP MAR BIOL ECOL, V204, P59, DOI 10.1016/0022-0981(96)02579-8	48	9	9	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183064	10.1371/journal.pone.0183064	http://dx.doi.org/10.1371/journal.pone.0183064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837597	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000045
J	Mazur, M; Gladkowski, W; Srcek, VG; Radosevic, K; Maciejewska, G; Wawrzenczyk, C				Mazur, Marcelina; Gladkowski, Witold; Srcek, Visnja Gaurina; Radosevic, Kristina; Maciejewska, Gabriela; Wawrzenczyk, Czeslaw			Regio- and enantioselective microbial hydroxylation and evaluation of cytotoxic activity of beta-cyclocitral-derived halolactones	PLOS ONE			English	Article							BICYCLIC GAMMA-LACTONES; CYCLOHEXANE SYSTEM; ABSIDIA-COERULEA; FUNGAL STRAINS; TRANSFORMATION; BIOTRANSFORMATION; RING; OXIDATION; CULTURES	Three beta-cyclocitral-derived halolactones, which exhibit antifeedant activity towards storage product pests, were subjected to microbial transformation processes. Among the thirty tested strains of filamentous fungi and yeast, the most effective biocatalysts were Absidia cylindrospora AM336, Mortierella isabellina AM212 and Mortierella vinaceae AM149. As a result of regio- and enantioselective hydroxylation four new oxygenated derivatives were obtained. Regardless of the biocatalyst applied, the alpha-iodo- and delta-bromo-gamma-lactones were hydroxylated in an inactivated position C-5 of cyclohexane ring. The analogous transformation of chlorolactone was observed in Mortierella isabellina AM212 culture but in the case of two other biocatalysts the hydroxy group was introduced at C-3 position. All obtained hydroxylactones were enantiomerically pure (ee = 100%) or enriched (ee = 50%). The highest enantioselectivity of hydroxylation was observed for M. isabellina AM212. The cytotoxic activity of halolactones was also examined by WST-1 assay wherein tested compounds did not exhibit significant effect on the viability of tumor HeLa and normal CHO-K1 cells.	[Mazur, Marcelina; Gladkowski, Witold; Wawrzenczyk, Czeslaw] Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland; [Srcek, Visnja Gaurina; Radosevic, Kristina] Univ Zagreb, Fac Food Technol & Biotechnol, Zagreb, Croatia; [Maciejewska, Gabriela] Wroclaw Univ Technol, Cent Lab Instrumental Anal, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; University of Zagreb; Wroclaw University of Science & Technology	Mazur, M (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland.	marcelina.mazur@upwr.edu.pl	Gładkowski, Witold/A-5750-2017; Srcek, Visnja Gaurina/ABB-6821-2020; Radošević, Kristina/AAE-7909-2021; Mazur, Marcelina/AAC-4794-2020	Gładkowski, Witold/0000-0002-3271-779X; Srcek, Visnja Gaurina/0000-0001-6591-3810; Mazur, Marcelina/0000-0002-6192-5248; Radosevic, Kristina/0000-0001-5156-1893	Ministry of Science and Higher Education, Poland [B010/00031/16]; Wroclaw Centre of Biotechnology, programme the Leading National Research Centre (KNOW)	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Wroclaw Centre of Biotechnology, programme the Leading National Research Centre (KNOW)	This work was financially supported by Ministry of Science and Higher Education, Poland (grant number B010/00031/16). Publication supported by Wroclaw Centre of Biotechnology, programme the Leading National Research Centre (KNOW) for years 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnoch RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114945; Borges KB, 2009, TETRAHEDRON-ASYMMETR, V20, P385, DOI 10.1016/j.tetasy.2009.02.009; Chen GT, 2016, J MOL CATAL B-ENZYM, V123, P154, DOI 10.1016/j.molcatb.2015.11.015; Chen XL, 2014, ENZYME MICROB TECH, V66, P28, DOI 10.1016/j.enzmictec.2014.08.002; Dai JG, 2003, TETRAHEDRON LETT, V44, P1091, DOI 10.1016/S0040-4039(02)02714-4; Dai SY, 2010, TETRAHEDRON, V66, P6919, DOI 10.1016/j.tet.2010.06.039; Gadkowski W, 2013, TETRAHEDRON, V69, P10414, DOI DOI 10.1016/j.tet.2013.09.094; Gladkowski W, 2006, J MOL CATAL B-ENZYM, V39, P31, DOI 10.1016/j.molcatb.2006.01.023; Gladkowski W, 2004, J MOL CATAL B-ENZYM, V29, P13, DOI 10.1016/j.molcarb.2003.10.012; Gladkowski W, 2007, J MOL CATAL B-ENZYM, V49, P79, DOI 10.1016/j.molcatb.2007.08.006; Gladkowski W, 2015, EUR J ORG CHEM, V2015, P605, DOI 10.1002/ejoc.201403343; Gladkowski W, 2011, ENZYME MICROB TECH, V48, P326, DOI 10.1016/j.enzmictec.2010.12.007; Gliszczynska A, 2016, CATAL COMMUN, V80, P39, DOI 10.1016/j.catcom.2016.03.018; Gnitka R, 2015, PHYTOCHEM LETT, V13, P41; Grabarczyk M, 2014, J MOL CATAL B-ENZYM, V102, P195, DOI 10.1016/j.molcatb.2014.02.012; Grabarczyk M, 2012, MOLECULES, V17, P9741, DOI 10.3390/molecules17089741; Grotowska AK, 2002, J MOL CATAL B-ENZYM, V19, P203, DOI 10.1016/S1381-1177(02)00168-6; Grudniewska A, 2013, MOLECULES, V18, P2778, DOI 10.3390/molecules18032778; Han F, 2016, PHYTOCHEM LETT, V18, P136, DOI 10.1016/j.phytol.2016.10.002; Heidary M, 2016, J MOL CATAL B-ENZYM, V126, P32, DOI 10.1016/j.molcatb.2016.01.007; Janeczko T, 2014, J MOL CATAL B-ENZYM, V109, P47, DOI 10.1016/j.molcatb.2014.08.006; Khan N, 2014, ORIENT J CHEM, V30, P941; Mao S, J MOL CATAL B; Martinez A, 2015, PHYTOCHEMISTRY, V117, P500, DOI 10.1016/j.phytochem.2015.07.020; Mazur M, 2015, J BIOSCI BIOENG, V119, P72, DOI 10.1016/j.jbiosc.2014.06.007; Mazur M, 2014, PEST MANAG SCI, V70, P286, DOI 10.1002/ps.3557; Milecka-Tronina N, 2014, BIOORGAN MED CHEM, V22, P883, DOI 10.1016/j.bmc.2013.11.050; Pawlak A, 2017, CHEM-BIOL INTERACT, V261, P18, DOI 10.1016/j.cbi.2016.11.013; Qiao LR, 2014, TETRAHEDRON, V70, P3560, DOI 10.1016/j.tet.2014.04.011; Rivero CW, 2015, PROCESS BIOCHEM, V50, P935, DOI 10.1016/j.procbio.2015.03.015; Roiban GD, 2013, TETRAHEDRON, V69, P5306, DOI 10.1016/j.tet.2013.04.132; Siddiqui M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171476; Solano DM, 2012, BIORESOURCE TECHNOL, V115, P196, DOI 10.1016/j.biortech.2011.11.131; Winska K, J SAUDI CHEM SOC; Yi-Qing W, 2016, CHIN J NAT MED, V14, P939; Zhang BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037641; Zhang RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083586	37	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183429	10.1371/journal.pone.0183429	http://dx.doi.org/10.1371/journal.pone.0183429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837605	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000066
J	Li, H; Yang, DX; Ning, SL; Xu, YH; Yang, F; Yin, RS; Feng, TH; Han, SQ; Guo, L; Zhang, PJ; Qu, WJ; Guo, RB; Song, C; Xiao, P; Zhou, CJ; Xu, ZG; Sun, JP; Yu, X				Li, Hui; Yang, Duxiao; Ning, Shanglei; Xu, Yinghui; Yang, Fan; Yin, Rusha; Feng, Taihu; Han, Shouqing; Guo, Lu; Zhang, Pengju; Qu, Wenjie; Guo, Renbo; Song, Chen; Xiao, Peng; Zhou, Chengjun; Xu, Zhigang; Sun, Jin-Peng; Yu, Xiao			Switching of the substrate specificity of protein tyrosine phosphatase N12 by cyclin-dependent kinase 2 phosphorylation orchestrating 2 oncogenic pathways	FASEB JOURNAL			English	Article						HER2; PAK1; breast cancer; migration; therapy	NONRECEPTOR TYPE 12; CELL LUNG-CANCER; BREAST-CANCER; PTP-PEST; VHR PHOSPHATASE; GROWTH-FACTOR; MIGRATION; ACTIVATION; DEPHOSPHORYLATION; AUTOIMMUNITY	The protein tyrosine phosphatase nonreceptor type 12 (PTPN12) is a multifunctional protein and has elicited much research attention because its decreased protein level has been associated with poor prognosis of several types of cancers. Recently, we have solved the crystal structure of the phosphatase domain of PTPN12, which disclosed a specific PTPN12-insert-loop harboring a cyclin-dependent kinase 2 (CDK2) phosphorylation site. However, the functional significance of this phosphorylation is undefined. In the present study, we found that S19 site phosphorylation of PTPN12 by CDK2 discharged its antitumor activity by down-regulation of its inhibitory role in cell migration, but not affecting its other regulatory functions. Phosphorylation of PTPN12 at the S19 site changed its substrate interface, and by doing so, selectively decreased its activity toward the human epidermal growth factor receptor 2 (HER2)-pY(1196) site, but not otherHER2 phosphorylation sites or other known PTPN12 substrates. Afurther in-depth mechanism study revealed that the phosphorylation of PTPN12 byCDK2 impaired recruitment of the serine/threonine-protein kinase 1 (PAK1) to HER2, resulted in the blockade of the HER2-pY(1196)-PAK1-T-423 signaling pathway, thus increased tumor cell motility. Taken together, our results identified a new phosphorylation-based substrate recognition mechanism of PTPN12 by CDK2, which orchestrated signaling crosstalk between the oncogenic CDK2 and HER2 pathways. The newly identified governing mechanism of the substrate selectivity of a particular phosphatase was previously unappreciated and exemplifies howa phospho-network is precisely controlled in different cellular contexts.	[Li, Hui; Yang, Fan; Yin, Rusha; Feng, Taihu; Han, Shouqing; Qu, Wenjie; Guo, Renbo; Yu, Xiao] Shandong Univ, Sch Med, Key Lab Expt Teratol, Minist Educ, Jinan, Shandong, Peoples R China; [Li, Hui; Yang, Fan; Yin, Rusha; Feng, Taihu; Han, Shouqing; Qu, Wenjie; Guo, Renbo; Yu, Xiao] Shandong Univ, Sch Med, Dept Physiol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Yang, Duxiao; Zhang, Pengju; Xiao, Peng; Sun, Jin-Peng] Shandong Univ, Sch Med, Dept Mol Biol & Biochem, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Li, Hui; Zhou, Chengjun] Shangdong Univ, Hosp 2, Jinan, Shandong, Peoples R China; [Ning, Shanglei] Shangdong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China; [Ning, Shanglei] Shangdong Univ, Sch Life Sci, Jinan, Shandong, Peoples R China; [Xu, Yinghui] Jilin Univ, Hosp 1, Canc Ctr, Jilin, Jilin, Peoples R China; [Ning, Shanglei] Peking Univ, Ctr Quantitat Biol, Beijing, Peoples R China; [Sun, Jin-Peng] Duke Univ, Sch Med, Durham, NC USA	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Jilin University; Peking University; Duke University	Yu, X (corresponding author), Shandong Univ, Sch Med, Dept Physiol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Sun, JP (corresponding author), Shandong Univ, Sch Med, Dept Mol Biol & Biochem, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	sunjinpeng@sdu.edu.cn; yuxiao@sdu.edu.cn	sun, Jinpeng/AAR-9196-2020		National Key Basic Research Program of China [2013CB967700]; National Natural Science Foundation of China [31270857, 31471102, 31470789]; Shandong Natural Science Fund for Distinguished Young Scholars [JQ201320, JQ201517]; Fundamental Research Funds of Shandong University [2014JC029]; China Postdoctoral Science Foundation [2015M582082]; Shandong Natural Science Fund [ZR2016CQ07, ZR2015HM036]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Fundamental Research Funds of Shandong University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong Natural Science Fund	The authors thank Dr. Debo Zou (Shangdon Provincial Qianofoshan Hospital, Jinan, China) for help in GST pull-down experiments. This work was supported by Grant 2013CB967700 from the National Key Basic Research Program of China (to X.Y.); Grants 31270857 and 31471102 (to X.Y) and 31470789 (to J.-P.S.) from the National Natural Science Foundation of China; Grants JQ201320 (to X.Y.) and JQ201517 (to J.-P.) from the Shandong Natural Science Fund for Distinguished Young Scholars; Grant 2014JC029 (to X.Y. and Z.X.) from the Fundamental Research Funds of Shandong University, Grant 2015M582082 (to P.X.) from the China Postdoctoral Science Foundation; Grant ZR2016CQ07 (to P.X.) from the Shandong Natural Science Fund; and Grant ZR2015HM036 (to C.Z.) from the Shandong Natural Science Fund. The authors declare no conflicts of interest.	Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010; Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; Cao X, 2015, ONCOTARGET, V6, P11704, DOI 10.18632/oncotarget.3588; Chellaiah MA, 2009, J CELL PHYSIOL, V220, P382, DOI 10.1002/jcp.21777; Chen KE, 2015, STRUCTURE, V23, P653, DOI 10.1016/j.str.2015.01.017; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Dai XZ, 2013, J CLIN INVEST, V123, P2024, DOI 10.1172/JCI66963; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; De Robertis M, 2017, CLIN CANCER RES, V23, P159, DOI 10.1158/1078-0432.CCR-16-0709; GARTON AJ, 1994, EMBO J, V13, P3763, DOI 10.1002/j.1460-2075.1994.tb06687.x; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Gu LQ, 2010, CLIN ENDOCRINOL, V72, P248, DOI 10.1111/j.1365-2265.2009.03617.x; Harris IS, 2014, ONCOGENE, V33, P1047, DOI 10.1038/onc.2013.24; Hu SH, 2015, CANCER RES, V75, P2029, DOI 10.1158/0008-5472.CAN-14-1494; Kang TH, 2006, NAT CELL BIOL, V8, P863, DOI 10.1038/ncb1447; Karakas C, 2016, AM J PATHOL, V186, P1900, DOI 10.1016/j.ajpath.2016.02.024; Kim SJ, 2012, ANN ONCOL, V23, P891, DOI 10.1093/annonc/mdr340; Kim SJ, 2014, CANCER LETT, V355, P217, DOI 10.1016/j.canlet.2014.08.042; Kumar SK, 2015, BLOOD, V125, P443, DOI 10.1182/blood-2014-05-573741; Lane HA, 2001, ANN ONCOL, V12, P21, DOI 10.1023/A:1011155606333; Li H, 2016, CELL REP, V15, P1345, DOI 10.1016/j.celrep.2016.04.016; Li J, 2015, MOL CELL BIOL, V35, P4069, DOI 10.1128/MCB.00741-15; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043631; Maine CJ, 2016, P NATL ACAD SCI USA, V113, pE7231, DOI 10.1073/pnas.1603738113; Mendoza N, 2003, CANCER RES, V63, P1020; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Qu XH, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0666-y; Rhee I, 2014, MOL CELL BIOL, V34, P888, DOI 10.1128/MCB.01369-13; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rojas M, 2014, P NATL ACAD SCI USA, V111, pE1344, DOI 10.1073/pnas.1400129111; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Shanley TP, 2001, J IMMUNOL, V166, P966, DOI 10.4049/jimmunol.166.2.966; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sood S, 2016, J IMMUNOL, V197, P429, DOI 10.4049/jimmunol.1502656; Souza CM, 2012, J BIOL CHEM, V287, P43180, DOI 10.1074/jbc.M112.387456; Streit S, 2006, CANCER GENET CYTOGEN, V170, P48, DOI 10.1016/j.cancergencyto.2006.05.013; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Wang HM, 2014, CELL RES, V24, P1067, DOI 10.1038/cr.2014.99; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wu MQ, 2013, ASIAN PAC J CANCER P, V14, P287, DOI 10.7314/APJCP.2013.14.1.287; Yamasaki F, 2007, MOL CANCER THER, V6, P2168, DOI 10.1158/1535-7163.MCT-06-0514; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zheng YH, 2011, MOL CELL BIOL, V31, P4258, DOI 10.1128/MCB.05547-11; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	49	6	6	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					73	82		10.1096/fj.201700418R	http://dx.doi.org/10.1096/fj.201700418R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28842430				2022-12-26	WOS:000419172700009
J	Kwun, HJ; Wendzicki, JA; Shuda, Y; Moore, PS; Chang, Y				Kwun, H. J.; Wendzicki, J. A.; Shuda, Y.; Moore, P. S.; Chang, Y.			Merkel cell polyomavirus small T antigen induces genome instability by E3 ubiquitin ligase targeting	ONCOGENE			English	Article							CENTROSOME OVERDUPLICATION; CHROMOSOMAL INSTABILITY; PROMOTES TUMORIGENESIS; HUMAN PAPILLOMAVIRUSES; MEDIATED DEGRADATION; BINDING PROTEIN-1; E7 ONCOPROTEINS; CYCLE CONTROL; CANCER; ANEUPLOIDY	The formation of a bipolar mitotic spindle is an essential process for the equal segregation of duplicated DNA into two daughter cells during mitosis. As a result of deregulated cellular signaling pathways, cancer cells often suffer a loss of genome integrity that might etiologically contribute to carcinogenesis. Merkel cell polyomavirus (MCV) small T (sT) oncoprotein induces centrosome overduplication, aneuploidy, chromosome breakage and the formation of micronuclei by targeting cellular ligases through a sT domain that also inhibits MCV large T oncoprotein turnover. These results provide important insight as to how centrosome number and chromosomal stability can be affected by the E3 ligase targeting capacity of viral oncoproteins such as MCV sT, which may contribute to Merkel cell carcinogenesis.	[Kwun, H. J.; Wendzicki, J. A.; Shuda, Y.; Moore, P. S.; Chang, Y.] Univ Pittsburgh, Canc Virol Program, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Moore, PS; Chang, Y (corresponding author), Univ Pittsburgh, Canc Inst, Canc Virol Program, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	psm9@pitt.edu; yc70@pitt.edu	Kwun, Hyun Jin/F-5511-2011; Chang, Yuan/F-4146-2011; Moore, Patrick S./F-3960-2011; Kwun, Hyun Jin/AAH-2706-2020; Kwun, Hyun jin/AAJ-3365-2020; Moore, Patrick/GVR-8294-2022	Kwun, Hyun Jin/0000-0002-8926-746X; Chang, Yuan/0000-0003-1125-4041; Moore, Patrick S./0000-0002-8132-858X; Kwun, Hyun jin/0000-0002-8926-746X; 	comprehensive Masonic Cancer Center [P30CA077598]; National Institutes of Health (NIH) [CA136363, CA120726]; NIH [T32AI049820]; UPCI Animal and Cytometry Facilities [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA077598, P30CA047904, R33CA120726, R01CA136363, R35CA197463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049820] Funding Source: NIH RePORTER	comprehensive Masonic Cancer Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UPCI Animal and Cytometry Facilities; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Gutian Xiao for providing the HA-beta TrCP plasmid, Bert Vogelstein for providing the HCT116 cells, and Megan Lambert and Robin Frederick for assistance in mouse studies, and Meredith Monk for help with the manuscript. The cytogenetic analyses were performed in the Cytogenomics Shared Resource at the University of Minnesota with support from the comprehensive Masonic Cancer Center grant P30CA077598. This study was supported by National Institutes of Health (NIH) grants CA136363 and CA120726 to PSM and YC, who are also supported as American Cancer Society Research Professors. Additional support was provided by the NIH grant T32AI049820 to JAW as a predoctoral trainee. This project used the UPCI Animal and Cytometry Facilities that are supported in part by award P30CA047904.	Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Busam KJ, 2009, AM J SURG PATHOL, V33, P1378, DOI 10.1097/PAS.0b013e3181aa30a5; Chi YH, 2007, J CELL BIOCHEM, V102, P531, DOI 10.1002/jcb.21484; Cizmecioglu O, 2012, J CELL SCI, V125, P981, DOI 10.1242/jcs.095075; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Desmaze C, 2003, CANCER LETT, V194, P173, DOI 10.1016/S0304-3835(02)00704-8; Duensing A, 2008, VIROLOGY, V372, P157, DOI 10.1016/j.virol.2007.10.030; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Duensing S, 2002, ONCOGENE, V21, P6241, DOI 10.1038/sj.onc.1205709; Fang X, 2011, SEMIN CELL DEV BIOL, V22, P595, DOI 10.1016/j.semcdb.2011.03.002; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Iarmarcovai G, 2008, MUTAT RES-REV MUTAT, V658, P215, DOI 10.1016/j.mrrev.2007.10.001; Knight LM, 2015, J VIROL, V89, P35, DOI 10.1128/JVI.02317-14; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Korzeniewski N, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-61; Kwun HJ, 2015, J VIROL, V89, P4191, DOI 10.1128/JVI.00157-15; Kwun HJ, 2013, CELL HOST MICROBE, V14, P125, DOI 10.1016/j.chom.2013.06.008; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Lau AW, 2012, FRONT BIOSCI-LANDMRK, V17, P2197, DOI 10.2741/4045; Li M, 2009, J CELL BIOL, V185, P983, DOI 10.1083/jcb.200904020; Liu BY, 2005, P NATL ACAD SCI USA, V102, P63, DOI 10.1073/pnas.0406424101; Martin-Lluesma S, 2008, HEPATOLOGY, V48, P1467, DOI 10.1002/hep.22542; Miron K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8094; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Pan HY, 2004, CANCER RES, V64, P4064, DOI 10.1158/0008-5472.CAN-04-0657; Peel Nina, 2013, Worm, V2, pe22497, DOI 10.4161/worm.22497; Peloponese JM, 2005, P NATL ACAD SCI USA, V102, P18974, DOI 10.1073/pnas.0506659103; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rodig SJ, 2012, J CLIN INVEST, V122, P4645, DOI 10.1172/JCI64116; Sahi H, 2014, APMIS, V122, P1157, DOI 10.1111/apm.12274; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142329; Shuda M, 2015, P NATL ACAD SCI USA, V112, P5875, DOI 10.1073/pnas.1505787112; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Verhaegen ME, 2015, J INVEST DERMATOL, V135, P1415, DOI 10.1038/jid.2014.446; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; White EA, 2012, P NATL ACAD SCI USA, V109, pE260, DOI 10.1073/pnas.1116776109; Witt KL, 2008, MUTAT RES-GEN TOX EN, V649, P101, DOI 10.1016/j.mrgentox.2007.08.004; Yun C, 2004, MOL CANCER RES, V2, P159	50	27	27	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 7	2017	36	49					6784	6792		10.1038/onc.2017.277	http://dx.doi.org/10.1038/onc.2017.277			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FP0IK	28846109	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000417282500004
J	Di Pasquale, A; McCann, RS; Maire, N				Di Pasquale, Aurelio; McCann, Robert S.; Maire, Nicolas			Assessing the population coverage of a health demographic surveillance system using satellite imagery and crowd-sourcing	PLOS ONE			English	Article							WORLD	Remotely sensed data can serve as an independent source of information about the location of residential structures in areas under demographic and health surveillance. We report on results obtained combining satellite imagery, imported from Bing, with location data routinely collected using the built-in GPS sensors of tablet computers, to assess completeness of population coverage in a Health and Demographic Surveillance System in Malawi. The Majete Malaria Project Health and Demographic Surveillance System, in Malawi, started in 2014 to support a project with the aim of studying the reduction of malaria using an integrated control approach by rolling out insecticide treated nets and improved case management supplemented with house improvement and larval source management. In order to support the monitoring of the trial a Health and Demographic Surveillance System was established in the area that surrounds the Majete Wildlife Reserve (1600 km2), using the OpenHDS data system. We compared house locations obtained using GPS recordings on mobile devices during the demographic surveillance census round with those acquired from satellite imagery. Volunteers were recruited through the crowdcrafting. org platform to identify building structures on the images, which enabled the compilation of a database with coordinates of potential residences. For every building identified on these satellite images by the volunteers (11,046 buildings identified of which 3424 (ca. 30%) were part of the censused area), we calculated the distance to the nearest house enumerated on the ground by fieldworkers during the census round of the HDSS. A random sample of buildings (85 structures) identified on satellite images without a nearby location enrolled in the census were visited by a fieldworker to determine how many were missed during the baseline census survey, if any were missed. The findings from this ground-truthing effort suggest that a high population coverage was achieved in the census survey, however the crowd-sourcing did not locate many of the inhabited structures (52.3% of the 6543 recorded during the census round). We conclude that using auxiliary data can play a useful role in quality assurance in population based health surveillance, but improved algorithms would be needed if crowd-sourced house locations are to be used as the basis of population databases.	[Di Pasquale, Aurelio; Maire, Nicolas] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Di Pasquale, Aurelio; Maire, Nicolas] Univ Basel, Basel, Switzerland; [McCann, Robert S.] Wageningen Univ & Res Ctr, Lab Entomol, Wageningen, Netherlands	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Wageningen University & Research	Di Pasquale, A (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.; Di Pasquale, A (corresponding author), Univ Basel, Basel, Switzerland.	aurelio.dipasquale@unibas.ch		McCann, Robert/0000-0002-2195-6461	Dioraphte Foundation	Dioraphte Foundation	Majete Malaria Project is funded by Dioraphte Foundation (www.dioraphte.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokwa Y, 2009, COMPUTER, V42, P97, DOI 10.1109/MC.2009.328; [Anonymous], 2014, FORM C PROF DR IR WT; [Anonymous], 2016, INDEPTH RESOURCE KIT; Bordag S., 2016, BILDVERARBEITUNG MED, P1; Di Pasquale A., 2017, SWISSTPH OPENHDS SER; Di Pasquale A., 2017, SWISSTPH OPENHDS TAB; Doan A, 2011, COMMUN ACM, V54, P86, DOI 10.1145/1924421.1924442; Elwood S, 2008, GEOJOURNAL, V72, P173, DOI 10.1007/s10708-008-9186-0; Estelles-Arolas E, 2012, J INF SCI, V38, P189, DOI 10.1177/0165551512437638; Goodchild MF, 2017, CITIZENS VOLUNTARY S; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; Hartung C, 2010, P 4 ACM IEEE INT C I, DOI [DOI 10.1145/2369220.2369236, 10.1145/2369220.2369236]; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Heipke C, 2010, ISPRS J PHOTOGRAMM, V65, P550, DOI 10.1016/j.isprsjprs.2010.06.005; Homan Tobias, 2015, BMC Res Notes, V8, P397, DOI 10.1186/s13104-015-1373-8; Hudson-Smith A, 2009, SOC SCI COMPUT REV, V27, P524, DOI 10.1177/0894439309332299; Hussain M, 2013, ISPRS J PHOTOGRAMM, V80, P91, DOI 10.1016/j.isprsjprs.2013.03.006; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; LTD S, ULT CROWDS FRAM PYBO; Nicolas Daniel Gonza A lez, 2017, SWISSTPH APP RURAL G; Sankoh O, 2012, INT J EPIDEMIOL, V41, P579, DOI 10.1093/ije/dys081; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Scifabric CrowdcraftingEn, 2013, RUR GEOL; Seltzer E, 2013, J PLAN LIT, V28, P3, DOI 10.1177/0885412212469112; Shannon HS, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-5; Simperl E., 2015, LIBER Q, V25; Stark H.-J., 2008, CROWDSOURCING GEODAT; Surowiecki James, 2004, WISDOM CROWDS; SwissTPH/ openhds: 1. 5 Stable, SWISSTPH OP 1 5 STAB; Ward D, 2000, PROF GEOGR, V52, P371, DOI 10.1111/0033-0124.00232	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183661	10.1371/journal.pone.0183661	http://dx.doi.org/10.1371/journal.pone.0183661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859109	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500028
J	Nasvall, J				Nasvall, Joakim			Direct and Inverted Repeat stimulated excision (DIRex): Simple, single-step, and scar-free mutagenesis of bacterial genes	PLOS ONE			English	Article							ESCHERICHIA-COLI; RECOMBINATION; DELETION; TRANSDUCTION; EVOLUTION; PRECISE; SYSTEM	The need for generating precisely designed mutations is common in genetics, biochemistry, and molecular biology. Here, I describe a new. Red recombineering method (Direct and Inverted Repeat stimulated excision; DIRex) for fast and easy generation of single point mutations, small insertions or replacements as well as deletions of any size, in bacterial genes. The method does not leave any resistance marker or scar sequence and requires only one transformation to generate a semi-stable intermediate insertion mutant. Spontaneous excision of the intermediate efficiently and accurately generates the final mutant. In addition, the intermediate is transferable between strains by generalized transductions, enabling transfer of the mutation into multiple strains without repeating the recombineering step. Existing methods that can be used to accomplish similar results are either (i) more complicated to design, (ii) more limited in what mutation types can be made, or (iii) require expression of extrinsic factors in addition to. Red. I demonstrate the utility of the method by generating several deletions, small insertions/replacements, and single nucleotide exchanges in Escherichia coli and Salmonella enterica. Furthermore, the design parameters that influence the excision frequency and the success rate of generating desired point mutations have been examined to determine design guidelines for optimal efficiency.	[Nasvall, Joakim] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University	Nasvall, J (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	joakim.nasvall@imbim.uu.se	Näsvall, Joakim/F-8750-2018	Näsvall, Joakim/0000-0002-6831-3105	Swedish Research Council (Vetenskapsradet) [2014-4479]; Swedish Research Foundation (VR)	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Research Foundation (VR)(Swedish Research Council)	This study was supported by the Swedish Research Council (Vetenskapsradet; https://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html; grant number 2014-4479 to J.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by grants from the Swedish Research Foundation (VR). I am very grateful to Anna Knoppel, Herve Nicoloff, Dan I. Andersson and Erik Gullberg for critical reading and helpful comments on this manuscript.	Blank K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015763; Bzymek M, 2001, GENETICS, V158, P527; COLLINS J, 1980, COLD SPRING HARB SYM, V45, P409, DOI 10.1101/SQB.1981.045.01.055; COLLINS J, 1982, GENE, V19, P139, DOI 10.1016/0378-1119(82)90198-6; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Freiflder D., 1994, MICROBIAL GENETICS; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; IKEDA H, 1965, J MOL BIOL, V14, P85, DOI 10.1016/S0022-2836(65)80232-7; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Knoppel A, 2016, MOL BIOL EVOL; Koskiniemi S, 2011, MOL MICROBIOL, V80, P1464, DOI 10.1111/j.1365-2958.2011.07657.x; Li XT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1075; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Nair NU, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn943; Nasvall J, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1078; Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521; Nyerges A, 2016, P NATL ACAD SCI USA, V113, P2502, DOI 10.1073/pnas.1520040113; Quan S, 2015, G3-GENES GENOM GENET, V5, P2555, DOI 10.1534/g3.115.022301; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Subramanian K, 2003, NUCLEIC ACIDS RES, V31, P1585, DOI 10.1093/nar/gkg266; SWARTZMAN E, 1990, J BACTERIOL, V172, P6797, DOI 10.1128/jb.172.12.6797-6802.1990; Tear CJY, 2015, APPL BIOCHEM BIOTECH, V175, P1858, DOI 10.1007/s12010-014-1402-4; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Wang HL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1339; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184126	10.1371/journal.pone.0184126	http://dx.doi.org/10.1371/journal.pone.0184126			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854250	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600087
J	Puthenparampil, M; Federle, L; Poggiali, D; Miante, S; Signori, A; Pilotto, E; Rinaldi, F; Perini, P; Sormani, MP; Midena, E; Gallo, P				Puthenparampil, Marco; Federle, Lisa; Poggiali, Davide; Miante, Silvia; Signori, Alessio; Pilotto, Elisabetta; Rinaldi, Francesca; Perini, Paola; Sormani, Maria Pia; Midena, Edoardo; Gallo, Paolo			Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis	PLOS ONE			English	Article							DOUBLE INVERSION-RECOVERY; GREY-MATTER ATROPHY; VISUAL PATHWAY; AXONAL DEGENERATION; CORTICAL PATHOLOGY; RADIATION-DAMAGE; LESIONS; ONSET; MRI; DEMYELINATION	Objective Increasing evidence suggest that neuronal damage is an early and diffuse feature of Multiple Sclerosis (MS) pathology. Analysis of the optic pathway may help to clarify the mechanisms involved in grey matter damage in MS. Purpose of our study was to investigate the relationship between inflammation and neurodegeneration and to achieve evidence of trans-synaptic degeneration in the optic pathway in MS at clinical onset. Methods 50 clinically isolated syndromes/early relapse-onset MS (CIS/eRRMS) with mean disease duration of 4.0 +/- 3.5 months, 28 MRI healthy controls (HC) and 31 OCT-HC were studied. Ten patients had optic neuritis at presentation (MSON+), 40 presented with other symptoms (MSON-). MRI examination included 3D-T1, 3D-FLAIR and 3D-DIR sequences. Global cortical thickness (gCTh), pericalcarin CTh (pCTh) and white matter volume (WMV) were analysed by means of Freesurfer on 3D-T1 scans. Optic radiation morphology (OR) and volume (ORV) were reconstructed on the base of the Julich's Atlas. White matter lesion volume (WMLV), OR-WMLV and percent WM damage (WMLV/WMV = WMLV% and OR-WMLV/ORV = ORWMLV%) were obtained by 3D-FLAIR image segmentation. 3D-DIR sequences were applied to identify inflammatory lesions of the optic nerve. Optic coherence tomography (OCT) protocol included the analysis of global peripapillary retinal nerve fiber layer (g-RNFL) and the 6 fundus oculi's sectors (temporal, T-RNFL; temporal superior, TS-RNFL; nasal superior, NS-RNFL; nasal, N-RNFL; nasal inferior, NI-RNFL, temporal inferior, TI-RNFL). The retina of both eyes was analyzed. The eyes of ON+ were further divided into affected (aON+) or not (naON+). Results No difference in CTh was found between CIS/eRRMS and HC, and between MSON+ and MSON-. Moreover, MSON+ and MSON- did not differ for any WM lesion load parameter. The most significant correlations between RNFL thickness and optic radiation WM pathology were found in MSON+. In these patients, the temporal RNFL inversely correlated to ipsilateral optic radiation WM lesion load (T-RNFL: r -0.7, p<0.05; TS-RNFL: r -0.7, p<0.05), while nasal RNFL inversely correlated to contralateral optic radiation WM lesion load (NI: r -0.8, p<0.01; NS-RNFL: r -0.8, p<0.01). Conclusions Our findings suggest that in MSON+ the optic pathway is site of a diffuse pathological process that involves both directly and via trans-synaptic degeneration the RNFL.	[Puthenparampil, Marco; Federle, Lisa; Poggiali, Davide; Miante, Silvia; Rinaldi, Francesca; Perini, Paola; Gallo, Paolo] Univ Hosp, Med Sch, Dept Neurosci DNS, Multiple Sclerosis Ctr, Padua, Italy; [Signori, Alessio; Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci, Sect Biostat, Genoa, Italy; [Pilotto, Elisabetta; Midena, Edoardo] Univ Hosp, Med Sch, Dept Neurosci DNS, Ophthalmol Unit, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Genoa; University of Padua; Azienda Ospedaliera - Universita di Padova	Puthenparampil, M (corresponding author), Univ Hosp, Med Sch, Dept Neurosci DNS, Multiple Sclerosis Ctr, Padua, Italy.	marco.puthenparampil@studenti.unipd.it	Sormani, Maria Pia/ABH-8756-2020; Puthenparampil, Marco/AAC-6398-2022; Midena, Edoardo/AAB-6010-2020; Poggiali, Davide/AAR-2478-2020; Signori, Alessio/L-3081-2016	Puthenparampil, Marco/0000-0002-2313-8462; Poggiali, Davide/0000-0002-2894-0825; Signori, Alessio/0000-0001-6289-9144; SORMANI, MARIA PIA/0000-0001-6892-104X	Italian Minister of Public Health [GR-2010-2313255]	Italian Minister of Public Health	This research was supported by grants from the Italian Minister of Public Health, Project GR-2010-2313255.	Balk LJ, 2015, J NEUROL NEUROSUR PS, V86, P419, DOI 10.1136/jnnp-2014-308189; BROWNELL B, 1962, J NEUROL NEUROSUR PS, V25, P315, DOI 10.1136/jnnp.25.4.315; Calabrese M, 2007, J NEUROL, V254, P1212, DOI 10.1007/s00415-006-0503-6; Calabrese M, 2015, NAT REV NEUROSCI, V16, P147, DOI 10.1038/nrn3900; Calabrese M, 2012, MULT SCLER J, V18, P174, DOI 10.1177/1352458511418550; Chard DT, 2004, MULT SCLER J, V10, P387, DOI 10.1191/1352458504ms1050oa; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Ciccarelli O, 2005, HUM BRAIN MAPP, V25, P308, DOI 10.1002/hbm.20101; Dalton CM, 2004, BRAIN, V127, P1101, DOI 10.1093/brain/awh126; Dasenbrock HH, 2011, J NEUROIMAGING, V21, pe41, DOI 10.1111/j.1552-6569.2010.00468.x; Dziedzic T, 2010, BRAIN PATHOL, V20, P976, DOI 10.1111/j.1750-3639.2010.00401.x; Enzinger C, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.194; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; Hadhoum N, 2016, MULT SCLER J, V22, P649, DOI 10.1177/1352458515598021; Hodel J, 2014, EUR RADIOL, V24, P3069, DOI 10.1007/s00330-014-3342-3; Jonkman LE, 2015, J NEUROL, V262, P1074, DOI 10.1007/s00415-015-7689-4; Klistorner A, 2014, NEUROLOGY, V82, P2165, DOI 10.1212/WNL.0000000000000522; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Martinez-Lapiscina EH, 2014, MULT SCLER J, V20, P1678, DOI 10.1177/1352458514542862; Mitjana R, 2014, MULT SCLER J, V20, P1471, DOI 10.1177/1352458514526083; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Raz N, 2015, MULT SCLER J, V21, P562, DOI 10.1177/1352458514551452; Rocca MA, 2013, MULT SCLER J, V19, P1610, DOI 10.1177/1352458513485146; Rossi S, 2012, ANN NEUROL, V71, P76, DOI 10.1002/ana.22512; Scheel M, 2014, MULT SCLER J, V20, P1904, DOI 10.1177/1352458514535128; Schippling S, 2015, MULT SCLER J, V21, P163, DOI 10.1177/1352458514538110; Seppi D, 2014, J NEUROIMMUNOL, V270, P56, DOI 10.1016/j.jneuroim.2014.02.014; Sepulcre J, 2009, ARCH NEUROL-CHICAGO, V66, P173, DOI 10.1001/archneurol.2008.562; Sinnecker T, 2015, EUR RADIOL, V25, P122, DOI 10.1007/s00330-014-3358-8; Steenwijk MD, 2014, RADIOLOGY, V272, P832, DOI 10.1148/radiol.14132708; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502	37	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183957	10.1371/journal.pone.0183957	http://dx.doi.org/10.1371/journal.pone.0183957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850630	Green Published, Green Submitted, gold			2022-12-26	WOS:000408544200048
J	Soto-Rojas, C; Suazo-Ortuno, I; Laos, JAM; Alvarado-Diaz, J				Soto-Rojas, Carlos; Suazo-Ortuno, Ireri; Montoya Laos, Jose Arturo; Alvarado-Diaz, Javier			Habitat quality affects the incidence of morphological abnormalities in the endangered salamander Ambystoma ordinarium	PLOS ONE			English	Article							AMPHIBIAN MALFORMATIONS; ULTRAVIOLET-RADIATION; LIFE-HISTORY; RANA-PIPIENS; INFECTION; RISK; HEALTH; INJURY; FROGS; ORGANISMS	Identification of early warning signals previous to the occurrence of population decline or extinction is a major challenge for the conservation of animal species. Prevalence of morphological abnormalities in a population can be one of these signals. We registered morphological abnormalities in the salamander Ambystoma ordinarium. We also evaluated the relation between habitat quality and the prevalence of abnormalities in this species. We used scores from rapid bioassessment protocols (RBPs) to assess the habitat quality of streams inhabited by A. ordinarium. A preliminary survey indicated that of 29 streams where this species has been historically registered, 13 might have few or no A. ordinarium. The association between habitat quality and the incidence of morphological abnormalities was evaluated in these 16 streams. Of 502 sampled individuals, 224 (44.62%) had at least one body abnormality. Of the 224 individuals with body abnormalities, 84 (37.5%) presented more than one abnormality. Of a total of 5,522 evaluated morphological characters, 344 (6.74%) were abnormal. Partial loss of gills and missing digits were the most frequent abnormalities. Results of a binomial logistic regression indicated that the probability of a character of an individual to be abnormal was significantly associated with habitat quality; as the levels of the quality of the habitat increased, the prevalence of morphological abnormalities decreased. These results suggest that RBPs are a quick and useful method for assessing the habitat quality of streams inhabited by A. ordinarium. Given that RBPs provide rapid and cost-effective assessments of the ecological health of aquatic ecosystems, it will be important to test if the RBPs protocols can be used to rapidly assess habitat quality for other species of stream amphibians. The negative association between habitat quality and the prevalence of morpohological abnormalities that we found indicates that habitat condition plays an important role in the high number of abnormalities registered in A. ordinarium. Therefore, our results suggest that one of the several negative effects of habitat degradation on amphibians is an increase in the frequency of morphological abnormalities with marked consequences for the survival and general fitness of aquatic amphibians.	[Soto-Rojas, Carlos; Suazo-Ortuno, Ireri; Alvarado-Diaz, Javier] Univ Michoacana, Inst Invest Recursos Nat, Morelia, Michoacan, Mexico; [Montoya Laos, Jose Arturo] Univ Sonora, Dept Matemat, Col Ctr, Hermosillo, Sonora, Mexico	Universidad Michoacana de San Nicolas de Hidalgo; Universidad de Sonora	Suazo-Ortuno, I (corresponding author), Univ Michoacana, Inst Invest Recursos Nat, Morelia, Michoacan, Mexico.	ireri.suazo@gmail.com	Suazo-Ortuño, Ireri/AAO-9826-2020		Programa Nacional de Becas del Consejo Nacional de Ciencia y Tecnologia [239254]; Secretaria de Educacion Kiblica/Consejo Nacional de Ciencia y Tecnologia Ciencia Basica [2015-259173]	Programa Nacional de Becas del Consejo Nacional de Ciencia y Tecnologia; Secretaria de Educacion Kiblica/Consejo Nacional de Ciencia y Tecnologia Ciencia Basica	This study was part of the project "Efecto de la calidad del agua sobre parametros poblacionales, fisiologicos y morfologicos de la salamandra de montana (Ambystoma ordinarium)" Secretaria de Educacion Kiblica/Consejo Nacional de Ciencia y Tecnologia Ciencia Basica 2015-259173. The results of this study are part of the Ph.D. thesis of the principal author, under the direction of ISO. CSR thanks the financial support of Programa Nacional de Becas del Consejo Nacional de Ciencia y Tecnologia No. 239254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON J D, 1971, Herpetologica, V27, P165; Andrews K. M., 2006, US DEP TRANSPORTATIO; Ankley GT, 2000, CAN J ZOOL, V78, P1092, DOI 10.1139/cjz-78-6-1092; Ankley GT, 2004, ECOTOX ENVIRON SAFE, V58, P7, DOI 10.1016/j.ecoenv.2004.01.004; Ankley GT, 2002, ENVIRON SCI TECHNOL, V36, P2853, DOI 10.1021/es011195t; [Anonymous], 1999, RAPID BIOASSESSMENT; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Bendik NF, 2013, J ZOOL, V290, P35, DOI 10.1111/jzo.12009; Blaustein AR, 2003, FRONT ECOL ENVIRON, V1, P87, DOI 10.1890/1540-9295(2003)001[0087:TCODA]2.0.CO;2; Bowerman J, 2010, ECOLOGY, V91, P242, DOI 10.1890/08-1687.1; Burggren Warren W., 1992, P467; Burkhart JG, 2000, ENVIRON HEALTH PERSP, V108, P83, DOI 10.2307/3454299; Eaton BR, 2004, J HERPETOL, V38, P283, DOI 10.1670/95-03N; Garcia-Garrido Pedro, 2016, Mesoamerican Herpetology, V3, P461; Gardiner DM, 1999, J EXP ZOOL, V284, P207, DOI 10.1002/(SICI)1097-010X(19990701)284:2<207::AID-JEZ10>3.0.CO;2-B; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Harding J.S., 2009, STREAM HABITAT ASSES; HARRIS RN, 1989, AM NAT, V134, P835, DOI 10.1086/285016; Hoppe David M., 2000, Journal of the Iowa Academy of Science, V107, P86; Johnson PTJ, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P124; Johnson PTJ, 2006, ECOLOGY, V87, P2227, DOI 10.1890/0012-9658(2006)87[2227:AITISE]2.0.CO;2; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Johnson PTJ, 2004, ADV PARASIT, V57, P191, DOI 10.1016/S0065-308X(04)57003-3; Johnson PTJ, 2002, ECOL MONOGR, V72, P151, DOI 10.1890/0012-9615(2002)072[0151:PROILT]2.0.CO;2; Johnson PTJ, 2001, HERPETOLOGICA, V57, P336; Johnstone CP, 2010, J MAMMAL, V91, P1332, DOI 10.1644/10-MAMM-A-034.1; Kaczmarski M, 2016, ENVIRON SCI POLLUT R, V23, P21940, DOI 10.1007/s11356-016-7297-6; Kang Changku, 2016, Journal of Ecology and Environment, V39, P11, DOI 10.5141/ecoenv.2016.002; Kie JG, 1988, PSW106 USDA FOR SERV; Martinez-Silvestre Albert, 2014, Herpetology Notes, V7, P277; MEYERROCHOW VB, 1988, ZOOL ANZ, V221, P70; Ousterhout BH, 2015, J ANIM ECOL, V84, P914, DOI 10.1111/1365-2656.12344; Pinto HA, 2013, J PARASITOL, V99, P914, DOI 10.1645/GE-3214.1; Pokhrel LR, 2013, ETHOL ECOL EVOL, V25, P214, DOI 10.1080/03949370.2013.767858; R Core Team, R LANG ENV STAT COMP; Reeves MK, 2008, ENVIRON HEALTH PERSP, V116, P1009, DOI 10.1289/ehp.10963; Reeves MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077467; Ruiz-Martinez L, 2014, SALAMANDRA, V50, P63; Schotthoefer AM, 2003, J PARASITOL, V89, P475, DOI 10.1645/0022-3395(2003)089[0475:ROTSTL]2.0.CO;2; SEMLITSCH RD, 1989, OECOLOGIA, V81, P100, DOI 10.1007/BF00377017; SESSIONS SK, 1990, J EXP ZOOL, V254, P38, DOI 10.1002/jez.1402540107; SHAFFER HB, 1993, SYST BIOL, V42, P508, DOI 10.2307/2992486; Shulse CD, 2014, HYDROBIOLOGIA, V723, P131, DOI 10.1007/s10750-013-1502-0; Soto RC, 2012, THESIS; Taylor B, 2005, ENVIRON HEALTH PERSP, V113, P1497, DOI 10.1289/ehp.7585; Thompson S, 2014, REGENERATION, V1, P27, DOI 10.1002/reg2.17; Weisrock DW, 2006, MOL ECOL, V15, P2489, DOI 10.1111/j.1365-294X.2006.02961.x; Wells KD, 2007, COMPETITION PREDATIO, P776; Winandy L, 2011, BEHAV RES METHODS, V43, P568, DOI 10.3758/s13428-011-0058-z; Wu W, 2014, ENVIRON MONIT ASSESS, V186, P3701, DOI 10.1007/s10661-014-3651-7	51	11	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183573	10.1371/journal.pone.0183573	http://dx.doi.org/10.1371/journal.pone.0183573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846723	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600038
J	Bailly, C; Leforestier, R; Campion, L; Thebaud, E; Moreau, A; Kraeber-Bodere, F; Carlier, T; Bodet-Milin, C				Bailly, Clement; Leforestier, Rodolphe; Campion, Loic; Thebaud, Estelle; Moreau, Anne; Kraeber-Bodere, Francoise; Carlier, Thomas; Bodet-Milin, Caroline			Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma	PLOS ONE			English	Article							F-18-FDG PET/CT; BONE SARCOMAS; TUMOR VOLUME; SOLID TUMORS; SURVIVAL; CHILDREN; CRITERIA; RECIST; MRI	Purpose The objective of this retrospective work was to evaluate the prognostic value on histological response and survival of quantitative indices derived from FDG-PET performed before and after chemotherapy (CHT), in a homogeneous pediatric Ewing sarcoma (EWS) and Osteosarcoma (OST) population. Methods Thirty-one patients with EWS and 31 with OST were included. All patients were treated with neoadjuvant CHT, and underwent surgery for local control. All patients had FDG-PET at diagnosis and after CHT, prior to surgery. Several parameters were evaluated: SUVmax, SUVpeak, SUVmean, metabolic tumor volume, total lesion glycolysis, 7 textural features and 3 shape features (SF). The segmentation was performed using an adaptive approach. Results were compared to histopathological regression of the resected tumor and to clinical follow-up for survival evaluation. Results For EWS, univariate analysis did not highlight any prognostic value on histological response, or survival regardless of all the considered metrics. For OST, only one of the SF, namely elongation, was significantly associated with PFS and OS on both univariate and multivariate analysis (PFS: p = 0.019, HR = 5.583; OS: p = 0.0062, HR = 7.113). Conclusion Only elongation determined on initial FDG-PET has a potential interest as a prognostic factor of PFS and OS in pediatric OST patients. Unlike recent studies of the literature realized in adult population, all the metrics reveal limited additional prognostic value in pediatric EWS patients. This seems to reinforce the question of whether children experience different sub-types of the same pathologies than older patients, with different outcomes.	[Bailly, Clement; Leforestier, Rodolphe; Kraeber-Bodere, Francoise; Carlier, Thomas; Bodet-Milin, Caroline] Univ Hosp, Dept Nucl Med, Nantes, France; [Bailly, Clement; Kraeber-Bodere, Francoise; Carlier, Thomas; Bodet-Milin, Caroline] Univ Nantes, Nantes Angers Canc Res Ctr CRCNA, CNRS,INSERM, UMR892,UMR6299, Nantes, France; [Campion, Loic] ICO Rene Gauducheau Canc Ctr, Biometr Dept, St Herblain, France; [Thebaud, Estelle] Univ Hosp, Dept Pediat Oncol, Nantes, France; [Moreau, Anne] Univ Hosp, Dept Pathol, Nantes, France	Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Bodet-Milin, C (corresponding author), Univ Hosp, Dept Nucl Med, Nantes, France.; Bodet-Milin, C (corresponding author), Univ Nantes, Nantes Angers Canc Res Ctr CRCNA, CNRS,INSERM, UMR892,UMR6299, Nantes, France.	caroline.milin@chu-nantes.fr	Campion, Loic/K-4726-2015; Leforestier, Rodolphe/C-1321-2018; Bodet-Milin, Caroline/F-7721-2013; Bailly, Clément/AAX-9022-2020; Carlier, Thomas/L-2924-2015; Kraeber-Bodéré, Françoise/F-7143-2013; Leforestier, Rodolphe/AAC-5304-2022	Campion, Loic/0000-0003-4903-0908; Leforestier, Rodolphe/0000-0001-7492-0537; Bodet-Milin, Caroline/0000-0002-8219-3592; Bailly, Clément/0000-0001-8313-3287; Kraeber-Bodéré, Françoise/0000-0002-3417-0759; Leforestier, Rodolphe/0000-0001-7492-0537	French National Agency for Research [ANR-11-LABX-0018-01]	French National Agency for Research(French National Research Agency (ANR))	This work was supported by a grant from the French National Agency for Research called Investissementsd' Avenir no ANR-11-LABX-0018-01. The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the French National Agency for Research called Investissementsd' Avenir no ANR-11-LABX-0018-01.	Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bailly C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159984; Bielack S, 2013, MINERVA PEDIATR, V65, P125; Byun BH, 2014, EUR J NUCL MED MOL I, V41, P1553, DOI 10.1007/s00259-014-2746-2; Byun BH, 2013, J NUCL MED, V54, P1725, DOI 10.2967/jnumed.112.117697; Carlier T, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00018; Costelloe CM, 2009, J NUCL MED, V50, P340, DOI 10.2967/jnumed.108.058461; Cotterill SJ, 2000, J CLIN ONCOL, V18, P3108, DOI 10.1200/JCO.2000.18.17.3108; Denecke T, 2010, EUR J NUCL MED MOL I, V37, P1842, DOI 10.1007/s00259-010-1484-3; Duchman KR, 2015, CANCER EPIDEMIOL, V39, P189, DOI 10.1016/j.canep.2014.12.012; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Franzius C, 2002, J NUCL MED, V43, P1012; Gaston LL, 2011, SKELETAL RADIOL, V40, P1007, DOI 10.1007/s00256-011-1096-4; Guimarães Júlio Brandão, 2015, Radiol Bras, V48, P175, DOI 10.1590/0100-3984.2013.1887; HaDuong JH, 2015, PEDIATR CLIN N AM, V62, P179, DOI 10.1016/j.pcl.2014.09.012; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hawkins DS, 2002, CANCER, V94, P3277, DOI 10.1002/cncr.10599; Janeway KA, 2012, CANCER-AM CANCER SOC, V118, P4597, DOI 10.1002/cncr.27414; Kolb EA, 2003, J CLIN ONCOL, V21, P3423, DOI 10.1200/JCO.2003.10.033; Leavey PJ, 2014, PEDIATR BLOOD CANCER, V61, P2149, DOI 10.1002/pbc.25214; Li HT, 2012, SURG ONCOL, V21, pE165, DOI 10.1016/j.suronc.2012.07.002; Guerra JLL, 2012, CLIN TRANSL ONCOL, V14, P294, DOI 10.1007/s12094-012-0798-y; Luetke A, 2014, CANCER TREAT REV, V40, P523, DOI 10.1016/j.ctrv.2013.11.006; Meyer JS, 2008, PEDIATR BLOOD CANCER, V51, P163, DOI 10.1002/pbc.21596; Nair, 2000, Clin Positron Imaging, V3, P79, DOI 10.1016/S1095-0397(00)00037-6; O'Sullivan F, 2011, IEEE T MED IMAGING, V30, P2059, DOI 10.1109/TMI.2011.2160984; Ozaki T, 2015, J ORTHOP SCI, V20, P250, DOI 10.1007/s00776-014-0687-z; Palmerini E, 2016, EUR J NUCL MED MOL I; Quartuccio N, 2015, AM J ROENTGENOL, V204, P153, DOI 10.2214/AJR.14.12932; Raciborska A, 2016, CLIN TRANSL ONCOL, V18, P189, DOI 10.1007/s12094-015-1351-6; SALZERKUNTSCHIK M, 1983, J CANCER RES CLIN, V106, P21, DOI 10.1007/BF00625047; Vauclin S, 2009, PHYS MED BIOL, V54, P6901, DOI 10.1088/0031-9155/54/22/010; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Williams RF, 2016, SURG CLIN N AM, V96, P1107, DOI 10.1016/j.suc.2016.05.012	34	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183841	10.1371/journal.pone.0183841	http://dx.doi.org/10.1371/journal.pone.0183841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841702	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700061
J	Lee, SY; Shin, YR; Park, HJ; Rho, MH; Chung, EC				Lee, So-Yeon; Shin, Yu Ri; Park, Hee Jin; Rho, Myung Ho; Chung, Eun Chul			Usefulness of multiecho fast field echo MRI in the evaluation of ossification of the posterior longitudinal ligament and dural ossification of the cervical spine	PLOS ONE			English	Article								Objectives The diagnosis of ossification of the posterior longitudinal ligament (OPLL) on magnetic resonance imaging (MRI) is challenging. The purpose of this study is to evaluate the usefulness of the multiecho fast field echo (mFFE) MRI in the detection of ossification of the posterior longitudinal ligament and dural ossification (DO) of the cervical spine. Methods Sixty-three patients who underwent MRI with mFFE and CT for cervical spine were retrospectively evaluated. The presence of OPLL and DO on MR images was assessed by two independent readers. The sensitivity, specificity, and accuracy of MRI for detecting OPLL and DO were determined using CT as a reference standard. Image contrast ratios were obtained between the OPLL and perilesional structures on each sequence. Results There were 31 patients with OPLL and 13 DO lesions. The mean sensitivity, specificity, and accuracy of both readers were 94%, 81%, 88% for OPLL and 92%, 81%, 86% for DO, respectively. The contrast ratios for OPLL and intervertebral disc, spinal cord and cerebrospinal fluid were significantly superior on mFFE images, whereas those for OPLL and bone marrow were significantly inferior on mFFE images than those of T1-and T2-weighted images (p <= 0.016). Conclusions MRI with mFFE may be sufficient for the assessment of OPLL and DO, with good contrasts between OPLL and intervertebral disc, spinal cord, and cerebrospinal fluid.	[Lee, So-Yeon; Park, Hee Jin; Rho, Myung Ho; Chung, Eun Chul] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea; [Shin, Yu Ri] Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiol, Coll Med, Incheon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea	Park, HJ (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea.	radiology12@paran.com		Lee, So-Yeon/0000-0002-0109-0998				Chang H, 2010, CLIN ORTHOP SURG, V2, P8, DOI 10.4055/cios.2010.2.1.8; Dorenbeck U, 2004, NEURORADIOLOGY, V46, P306, DOI 10.1007/s00234-004-1175-5; Held P, 2001, EUR J RADIOL, V38, P64, DOI 10.1016/S0720-048X(00)00253-9; Hida Kazutoshi, 1997, Neurologia Medico-Chirurgica, V37, P173, DOI 10.2176/nmc.37.173; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee SY, 2008, AM J ROENTGENOL, V191, P81, DOI 10.2214/AJR.07.2945; Li H, 2011, SPINE J, V11, P1049, DOI 10.1016/j.spinee.2011.09.008; Min JH, 2007, J NEUROSURG-SPINE, V6, P309, DOI 10.3171/spi.2007.6.4.4; Mizuno J, 2005, J NEUROSURG-SPINE, V2, P425, DOI 10.3171/spi.2005.2.4.0425; OTAKE S, 1992, AM J NEURORADIOL, V13, P1059; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; YAMASHITA Y, 1990, RADIOLOGY, V175, P843, DOI 10.1148/radiology.175.3.2111569	12	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183744	10.1371/journal.pone.0183744	http://dx.doi.org/10.1371/journal.pone.0183744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841680	Green Published, Green Submitted, gold			2022-12-26	WOS:000408370700055
J	Campos, R; Monica, FZ; Rodrigues, RL; Rojas-Moscoso, JA; Moreno, RA; Cogo, JC; de Oliveira, MA; Antunes, E; De Nucci, G				Campos, Rafael; Monica, Fabiola Z.; Rodrigues, Renata Lopes; Rojas-Moscoso, Julio Alejandro; Moreno, Ronilson Agnaldo; Cogo, Jose Carlos; de Oliveira, Marco Antonio; Antunes, Edson; De Nucci, Gilberto			Tetrodotoxin-insensitive electrical field stimulation-induced contractions on Crotalus durissus terrificus corpus cavernosum	PLOS ONE			English	Article							RESISTANT SODIUM-CHANNELS; PENILE ERECTION; NITRIC-OXIDE; CATECHOLAMINE UPTAKE; SMOOTH-MUSCLE; RELAXATION; RABBIT; DRUGS; DYSFUNCTION; MECHANISMS	Reptiles are the first amniotes to develop an intromitent penis, however until now the mechanisms involved in the electrical field stimulation-induced contraction on corpora cavernosa isolated from Crotalus durissus terrificus were not investigated. Crotalus and rabbit corpora cavernosa were mounted in 10 mL organ baths for isometric tension recording. Electrical field stimulation (EFS)-induced contractions were performed in presence/absence of phentolamine (10 mu M), guanethidine (30 mu M), tetrodotoxin (1 mu M and 1mM), A-803467 (10 mu M), 3-iodo-L-Tyrosine (1 mM), salsolinol (3 mu M) and a modified Krebs solution (equimolar substitution of NaCl by N-methyl-D-glucamine). Immuno-histochemistry for tyrosine hydroxylase was also performed. Electrical field stimulation (EFS; 8 Hz and 16 Hz) caused contractions in both Crotalus and rabbit corpora cavernosa. The contractions were abolished by previous incubation with either phentolamine or guanethidine. Tetrodotoxin (1 mu M) also abolished the EFS-induced contractions of rabbit CC, but did not affect EFS-induced contractions of Crotalus CC. Addition of A-803467 (10 mu M) did not change the EFS-induced contractions of Crotalus CC but abolished rabbit CC contractions. 3-iodo-L-Tyrosine and salsolinol had no effect on EFS-induced contractions of Crotalus CC and Rabbit CC. Replacement of NaCl by N-Methyl-D-glucamine (NMDG) abolished EFS-induced contractions of rabbit CC, but did not affect Crotalus CC. The presence of tyrosine hydroxylase was identified in endothelial cells only of Crotalus CC. Since the EFS-induced contractions of Crotalus CC is dependent on catecholamine release, insensitive to TTX, insensitive to A803467 and to NaCl replacement, it indicates that the source of cathecolamine is unlikely to be from adrenergic terminals. The finding that tyrosine hydroxylase is present in endothelial cells suggests that these cells can modulate Crotalus CC tone.	[Campos, Rafael; Monica, Fabiola Z.; Rodrigues, Renata Lopes; Rojas-Moscoso, Julio Alejandro; de Oliveira, Marco Antonio; Antunes, Edson; De Nucci, Gilberto] Univ Estadual Campinas, UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, Brazil; [Moreno, Ronilson Agnaldo] FACISB, Fac Hlth Sci, Dept Pharmacol, Barretos, Brazil; [Cogo, Jose Carlos; De Nucci, Gilberto] Brazil Univ, Fac Med Sci, Fernando Polis, Brazil; [De Nucci, Gilberto] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo	Campos, R (corresponding author), Univ Estadual Campinas, UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, Brazil.	rafaelcampos.vet@gmail.com	Monica, Fabiola Zakia/B-4191-2013; De Nucci, Gilberto/J-5990-2012; Campos, Rafael/F-2471-2017	Monica, Fabiola Zakia/0000-0002-8449-6677; De Nucci, Gilberto/0000-0002-4346-7941; Campos, Rafael/0000-0002-9816-2061	Fundacao de amparo a pesquisa do estado de Sao Paulo (FAPESP) [2011/11828-4]; Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq) [140731/2013-0]	Fundacao de amparo a pesquisa do estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de amparo a pesquisa do estado de Sao Paulo (FAPESP; 2011/11828-4) (GDN) http://www.fapesp.br/ and by Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq; 140731/2013-0) (RMC) http://cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; BARNETT A, 1968, BRIT J PHARMACOL, V34, P484, DOI 10.1111/j.1476-5381.1968.tb08476.x; BOSSU JL, 1984, NEUROSCI LETT, V51, P241, DOI 10.1016/0304-3940(84)90558-5; BRINDLEY GS, 1983, BRIT J PSYCHIAT, V143, P332, DOI 10.1192/bjp.143.4.332; BRINDLEY GS, 1986, BRIT J PHARMACOL, V87, P495, DOI 10.1111/j.1476-5381.1986.tb10191.x; Broderick G, 1991, IN VITRO CONTRACTILE, P515; BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650; Capel RO, 2011, J SEX MED, V8, P1616, DOI 10.1111/j.1743-6109.2011.02246.x; COYLE JT, 1969, J PHARMACOL EXP THER, V170, P221; DAIL WG, 1987, J AUTON PHARMACOL, V7, P287, DOI 10.1111/j.1474-8673.1987.tb00157.x; De Oliveira JF, 2003, UROLOGY, V62, P581, DOI 10.1016/S0090-4295(03)00462-X; Dean RC, 2005, UROL CLIN N AM, V32, P379, DOI 10.1016/j.ucl.2005.08.007; Estancial CS, 2015, BJU INT, V116, P657, DOI 10.1111/bju.13105; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Geffeney SL, 2005, NATURE, V434, P759, DOI 10.1038/nature03444; Gratzke C, 2010, EUR UROL, V57, P342, DOI 10.1016/j.eururo.2008.12.024; Hedlund P, 1999, BRIT J PHARMACOL, V127, P349, DOI 10.1038/sj.bjp.0702556; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOLMQUIST F, 1992, J PHYSIOL-LONDON, V449, P295, DOI 10.1113/jphysiol.1992.sp019087; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; IGNARRO LJ, 1990, BIOCHEM BIOPH RES CO, V170, P843, DOI 10.1016/0006-291X(90)92168-Y; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; McGaraughty S, 2008, J PHARMACOL EXP THER, V324, P1204, DOI 10.1124/jpet.107.134148; Neurophysiology J., 1978, NEUROPHYSIOLOGY, V41; Okamura T, 1998, AM J PHYSIOL-HEART C, V274, pH1075, DOI 10.1152/ajpheart.1998.274.4.H1075; Raymond Huey WM, 2002, SCIENCE, V297, P64; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; Sorriento D, 2012, HYPERTENSION, V60, P129, DOI 10.1161/HYPERTENSIONAHA.111.189605	28	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183766	10.1371/journal.pone.0183766	http://dx.doi.org/10.1371/journal.pone.0183766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837636	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000116
J	Deng, C; Wu, CZ; Lyu, NC; Huang, Z				Deng, Chao; Wu, Chaozhong; Lyu, Nengchao; Huang, Zhen			Driving style recognition method using braking characteristics based on hidden Markov model	PLOS ONE			English	Article							PREDICTION; SYSTEMS	Since the advantage of hidden Markov model in dealing with time series data and for the sake of identifying driving style, three driving style (aggressive, moderate and mild) are modeled reasonably through hidden Markov model based on driver braking characteristics to achieve efficient driving style. Firstly, braking impulse and the maximum braking unit area of vacuum booster within a certain time are collected from braking operation, and then general braking and emergency braking characteristics are extracted to code the braking characteristics. Secondly, the braking behavior observation sequence is used to describe the initial parameters of hidden Markov model, and the generation of the hidden Markov model for differentiating and an observation sequence which is trained and judged by the driving style is introduced. Thirdly, the maximum likelihood logarithm could be implied from the observable parameters. The recognition accuracy of algorithm is verified through experiments and two common pattern recognition algorithms. The results showed that the driving style discrimination based on hidden Markov model algorithm could realize effective discriminant of driving style.	[Deng, Chao; Wu, Chaozhong; Lyu, Nengchao] Wuhan Univ Technol, Intelligent Transportat Syst Res Ctr, Wuhan, Hubei, Peoples R China; [Deng, Chao; Wu, Chaozhong; Lyu, Nengchao] Wuhan Univ Technol, Engn Res Ctr Transportat Safety, Wuhan, Hubei, Peoples R China; [Deng, Chao; Wu, Chaozhong; Lyu, Nengchao] Wuhan Univ Technol, Natl Engn Res Ctr Water Transport Safety, Wuhan, Hubei, Peoples R China; [Huang, Zhen] Wuhan Univ Technol, Sch Automat, Wuhan, Hubei, Peoples R China	Wuhan University of Technology; Wuhan University of Technology; National Engineering Research Center for Water Transport Safety; Wuhan University of Technology; Wuhan University of Technology	Lyu, NC (corresponding author), Wuhan Univ Technol, Intelligent Transportat Syst Res Ctr, Wuhan, Hubei, Peoples R China.; Lyu, NC (corresponding author), Wuhan Univ Technol, Engn Res Ctr Transportat Safety, Wuhan, Hubei, Peoples R China.; Lyu, NC (corresponding author), Wuhan Univ Technol, Natl Engn Res Ctr Water Transport Safety, Wuhan, Hubei, Peoples R China.	lvnengchao@163.com			National Nature Science Foundation of China [51678460, U1664262]; Fundamental Research Funds for the Central Universities [2017-JL-003]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Nature Science Foundation of China (No. 51678460, No. U1664262) and the Fundamental Research Funds for the Central Universities (No. 2017-JL-003). The National Nature Science Foundation of China supported the data collection and analysis in this manuscript, and the Fundamental Research Funds for the Central Universities supported the preparation of this manuscript.	Bolovinou A., 2014, P 6 INT C AD SELF AD, P73; Chao Deng, 2016, CICTP 2016. Green and Multimodal Transportation and Logistics. Proceedings of the 16th COTA International Conference of Transportation Professionals, P308; Chen M, 2008, IEEE INT CONF ROBOT, P2019, DOI 10.1109/ROBOT.2008.4543503; Cheng H, 2015, J ECONOMETRICS, V187, P312; Demcenko A, 2008, P IEEE INT VEH S, P1181; Ding C, 2015, ACCIDENT ANAL PREV, V85, P58, DOI 10.1016/j.aap.2015.08.024; Gmbh RB, 2011, AUTOMOTIVE HDB, P89; Huang PF, 2007, INT J NEURAL SYST, V17, P467, DOI 10.1142/S0129065707001305; ITAKURA F, 1975, IEEE T ACOUST SPEECH, VAS23, P67, DOI 10.1109/TASSP.1975.1162641; Jing Zhong, 2010, Proceedings 2010 Sixth International Conference on Natural Computation (ICNC 2010), P832, DOI 10.1109/ICNC.2010.5583250; Jung EJ, 2016, STRUCT EQU MODELING, V23, P567, DOI 10.1080/10705511.2015.1138092; Limpert R, 1999, BRAKING          DEC, P61; Lu GQ, 2015, TRANSPORT RES A-POL, V73, P39, DOI 10.1016/j.tra.2015.01.001; Lu GQ, 2012, SAFETY SCI, V50, P1898, DOI 10.1016/j.ssci.2012.05.007; Ma XS, 2018, IEEE J-STARS, V11, P743, DOI 10.1109/JSTARS.2017.2768059; MacAdam C, 1998, VEHICLE SYST DYN, V29, P143, DOI 10.1080/00423119808969557; Matisic, 2016, INT MULTIDISCIPLINAR, V7, P13; Meiring GAM, 2015, SENSORS-BASEL, V15, P30653, DOI 10.3390/s151229822; Meng XN, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-3, P274, DOI 10.1109/ROBIO.2006.340166; Murphey YL, 2009, CIVVS: 2009 IEEE WORKSHOP ON COMPUTATIONAL INTELLIGENCE IN VEHICLES AND VEHICULAR SYSTEMS, P23; Murphy K. P., 2002, PROBAB GRAPH MODELS, V13, P303; Nikolic M, 2016, 2016 24TH TELECOMMUNICATIONS FORUM (TELFOR), P691; Oliver N, 2000, PROCEEDINGS OF THE IEEE INTELLIGENT VEHICLES SYMPOSIUM 2000, P7, DOI 10.1109/IVS.2000.898310; Ou YS, 2009, J INTELL ROBOT SYST, V55, P39, DOI 10.1007/s10846-008-9292-8; Pentland A, 1999, NEURAL COMPUT, V11, P229, DOI 10.1162/089976699300016890; Qian H., 2010, J ROBOTICS, V2010, P1; Sebald DJ, 2000, IEEE T SIGNAL PROCES, V48, P3217, DOI 10.1109/78.875477; Trafalis TB, 2000, IEEE IJCNN, P348, DOI 10.1109/IJCNN.2000.859420; Wang JQ, 2013, IEEE T INTELL TRANSP, V14, P1, DOI 10.1109/TITS.2012.2205143; [王琳虹 Wang Linhong], 2014, [哈尔滨工业大学学报, Journal of Harbin Institute of Technology], V46, P102; Wu X, 2008, INT J INFORM ACQUISI, V5, P1; Xu L, 2015, IEEE T INTELL TRANSP, V16, P2522, DOI 10.1109/TITS.2015.2409870; Yang F, 2015, MATHEMATICS, V11, P53; Zhang JP, 2011, IEEE T INTELL TRANSP, V12, P1624, DOI 10.1109/TITS.2011.2158001	34	21	23	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182419	10.1371/journal.pone.0182419	http://dx.doi.org/10.1371/journal.pone.0182419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837580	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000017
J	Hippmann, AA; Schuback, N; Moon, KM; McCrow, JP; Allen, AE; Foster, LJ; Green, BR; Maldonado, MT				Hippmann, Anna A.; Schuback, Nina; Moon, Kyung-Mee; McCrow, John P.; Allen, Andrew E.; Foster, Leonard J.; Green, Beverley R.; Maldonado, Maria T.			Contrasting effects of copper limitation on the photosynthetic apparatus in two strains of the open ocean diatom Thalassiosira oceanica	PLOS ONE			English	Article							FUCOXANTHIN-CHLOROPHYLL PROTEINS; PHAEODACTYLUM-TRICORNUTUM; ELECTRON-TRANSPORT; CARBON FIXATION; MARINE DIATOMS; SPRING BLOOM; IRON STRESS; HIGH-LIGHT; CHLAMYDOMONAS; EXPRESSION	There is an intricate interaction between iron (Fe) and copper (Cu) physiology in diatoms. However, strategies to cope with low Cu are largely unknown. This study unveils the comprehensive restructuring of the photosynthetic apparatus in the diatom Thalassiosira oceanica (CCMP1003) in response to low Cu, at the physiological and proteomic level. The restructuring results in a shift from light harvesting for photochemistry-and ultimately for carbon fixation-to photoprotection, reducing carbon fixation and oxygen evolution. The observed decreases in the physiological parameters F-v/F-m, carbon fixation, and oxygen evolution, concomitant with increases in the antennae absorption cross section (sigma(PSII)), non-photochemical quenching (NPQ) and the conversion factor (phi(e:C)/eta(PSII)) are in agreement with well documented cellular responses to low Fe. However, the underlying proteomic changes due to low Cu are very different from those elicited by low Fe. Low Cu induces a significant four-fold reduction in the Cu-containing photosynthetic electron carrier plastocyanin. The decrease in plastocyanin causes a bottleneck within the photosynthetic electron transport chain (ETC), ultimately leading to substantial stoichiometric changes. Namely, 2-fold reduction in both cytochrome b(6)f complex (cytb(6)f) and photosystem II (PSII), no change in the Fe-rich PSI and a 40- and 2-fold increase in proteins potentially involved in detoxification of reactive oxygen species (ferredoxin and ferredoxin: NADP(+) reductase, respectively). Furthermore, we identify 48 light harvesting complex (LHC) proteins in the publicly available genome of T. oceanica and provide proteomic evidence for 33 of these. The change in the LHC composition within the antennae in response to low Cu underlines the shift from photochemistry to photoprotection in T. oceanica (CCMP1003). Interestingly, we also reveal very significant intra-specific strain differences. Another strain of T. oceanica (CCMP 1005) requires significantly higher Cu concentrations to sustain both its maximal and minimal growth rate compared to CCMP 1003. Under low Cu, CCMP 1005 decreases its growth rate, cell size, Chla and total protein per cell. We argue that the reduction in protein per cell is the main strategy to decrease its cellular Cu requirement, as none of the other parameters tested are affected. Differences between the two strains, as well as differences between the well documented responses to low Fe and those presented here in response to low Cu are discussed.	[Hippmann, Anna A.; Schuback, Nina; Maldonado, Maria T.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [McCrow, John P.; Allen, Andrew E.] J Craig Venter Inst, Dept Microbial & Environm Genom, La Jolla, CA USA; [Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; J. Craig Venter Institute; University of British Columbia	Hippmann, AA; Maldonado, MT (corresponding author), Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC, Canada.	ahippman@eoas.ubc.ca; mmaldonado@eoas.ubc.ca	Green, Beverley R./AAJ-5199-2021; Allen, Andrew E/C-4896-2012	Green, Beverley R./0000-0002-4021-9387; Allen, Andrew E/0000-0001-5911-6081; McCrow, John/0000-0002-7014-5040; Hippmann, Anna/0000-0002-9495-7414	National Sciences and Engineering Research Council of Canada (NSERC)	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by grants to MTM and LJF from the National Sciences and Engineering Research Council of Canada (NSERC), http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Annett AL, 2008, LIMNOL OCEANOGR, V53, P2451, DOI 10.4319/lo.2008.53.6.2451; [Anonymous], 2015, RSTUDIO INT DEV ENV; Arar EJ, 1997, 4450 US EPA, P132; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bailleul B, 2015, NATURE, V524, P366, DOI 10.1038/nature14599; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BRAND LE, 1983, LIMNOL OCEANOGR, V28, P1182, DOI 10.4319/lo.1983.28.6.1182; Bruland K. W., 1983, Trace Metals in Sea Water. Proceedings of the NATO Advanced Research Institute, P395; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chen G, 2016, LIMNOL OCEANOGR; Claquin P, 2004, EUR J PHYCOL, V39, P33, DOI 10.1080/0967026032000157165; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fredrickson KA, 2011, J PHYCOL, V47, P25, DOI 10.1111/j.1529-8817.2010.00942.x; Gao QM, 2014, CELL REP, V9, P1681, DOI 10.1016/j.celrep.2014.10.069; GEIDER RJ, 1993, J PHYCOL, V29, P755, DOI 10.1111/j.0022-3646.1993.00755.x; Goss R, 2005, BIOCHEMISTRY-US, V44, P4028, DOI 10.1021/bi047464k; Goss R, 2007, BBA-BIOMEMBRANES, V1768, P67, DOI 10.1016/j.bbamem.2006.06.006; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Goss R, 2009, J PLANT PHYSIOL, V166, P1839, DOI 10.1016/j.jplph.2009.05.017; Green Beverley R., 2003, Advances in Photosynthesis and Respiration, V13, P129; Green Beverley R., 2007, P37; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Grouneva I, 2011, J PROTEOME RES, V10, P5338, DOI 10.1021/pr200600f; Gruber A, 2015, PLANT J, V81, P519, DOI 10.1111/tpj.12734; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gundermann K, 2014, ADV PHOTOSYNTH RESP, V39, P21, DOI 10.1007/978-94-017-8742-0_2; Guo J, 2015, PROTIST, V166, P58, DOI 10.1016/j.protis.2014.11.006; Guo J, 2012, J PHYCOL, V48, P312, DOI 10.1111/j.1529-8817.2012.01133.x; Guo JA, 2010, J PHYCOL, V46, P1218, DOI 10.1111/j.1529-8817.2010.00911.x; Hall T., 2013, IBIS BIOSCIENCES; Harvey EL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01277; Helliwell KE, 2015, ISME J, V9, P1446, DOI 10.1038/ismej.2014.230; Hoffman GE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-101; Ikeda Y, 2013, BBA-BIOENERGETICS, V1827, P529, DOI 10.1016/j.bbabio.2013.02.003; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katoh K, 2016, BIOINFORMATICS, V32, P1933, DOI 10.1093/bioinformatics/btw108; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kern J, 2009, ADV PHOTOSYNTH RESP, V30, P203; Kim JH, 2015, J PHYCOL, V51, P159, DOI 10.1111/jpy.12263; KITAJIMA M, 1975, BIOCHIM BIOPHYS ACTA, V376, P105, DOI 10.1016/0005-2728(75)90209-1; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Kremp A, 2012, ECOL EVOL, V2, P1195, DOI 10.1002/ece3.245; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; Kropat J, 2015, P NATL ACAD SCI USA, V112, P2644, DOI 10.1073/pnas.1422492112; LaRoche J, 1996, NATURE, V382, P802; Lavaud J, 2002, PHOTOSYNTH RES, V74, P51, DOI 10.1023/A:1020890625141; Lebret K, 2012, ENVIRON MICROBIOL, V14, P2395, DOI 10.1111/j.1462-2920.2012.02769.x; Lefebvre SC, 2010, J PHYCOL, V46, P123, DOI 10.1111/j.1529-8817.2009.00793.x; Lelong A, 2013, LIMNOL OCEANOGR, V58, P613, DOI 10.4319/lo.2013.58.2.0613; Lennon AM, 2003, PLANTA, V218, P254, DOI 10.1007/s00425-003-1111-7; LEWIS MR, 1983, MAR ECOL PROG SER, V13, P99, DOI 10.3354/meps013099; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Lin YH, 2013, INT J MOL SCI, V14, P20913, DOI 10.3390/ijms141020913; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lomas MW, 2000, J PHYCOL, V36, P903, DOI 10.1046/j.1529-8817.2000.99029.x; Lombardi AT, 2011, PHOTOSYNTH RES, V108, P77, DOI 10.1007/s11120-011-9655-z; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Lommer M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-718; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; Maldonado MT, 2006, LIMNOL OCEANOGR, V51, P1729, DOI 10.4319/lo.2006.51.4.1729; Maldonado MT, 1999, DEEP-SEA RES PT II, V46, P2447, DOI 10.1016/S0967-0645(99)00071-5; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Maldonado MT, 2001, J PHYCOL, V37, P298, DOI 10.1046/j.1529-8817.2001.037002298.x; Malkin, 2015, PHYTOTOOLS PHYTOPLAN; Marchetti A, 2016, DEVEL APPL PHYCOL, V6, P233, DOI 10.1007/978-3-319-24945-2_11; Marchetti A, 2009, NATURE, V457, P467, DOI 10.1038/nature07539; McKew BA, 2013, NEW PHYTOL, V200, P74, DOI 10.1111/nph.12373; Menden-Deuer S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0031; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; MERCHANT S, 1991, EMBO J, V10, P1383, DOI 10.1002/j.1460-2075.1991.tb07658.x; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; Mock T, 2017, NATURE, V541, P536, DOI 10.1038/nature20803; Moniz MBJ, 2010, PROTIST, V161, P7, DOI 10.1016/j.protis.2009.07.001; Moniz MBJ, 2009, MOL ECOL RESOUR, V9, P65, DOI 10.1111/j.1755-0998.2009.02633.x; Moore JK, 2008, BIOGEOSCIENCES, V5, P631, DOI 10.5194/bg-5-631-2008; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Nagao R, 2013, PHOTOSYNTH RES, V117, P281, DOI 10.1007/s11120-013-9903-5; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Orsini L, 2004, MAR ECOL PROG SER, V271, P87, DOI 10.3354/meps271087; Oxborough K, PHOTOSYNTHESIS RES, V54, P135; Page RD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0602S01; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parker MS, 2005, J PHYCOL, V41, P1142, DOI 10.1111/j.1529-8817.2005.00139.x; Peers G, 2006, NATURE, V441, P341, DOI 10.1038/nature04630; Peers G, 2005, LIMNOL OCEANOGR, V50, P1149, DOI 10.4319/lo.2005.50.4.1149; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrou K, 2014, MAR BIOL, V161, P925, DOI 10.1007/s00227-014-2392-z; Prasil O, 1996, PHOTOSYNTH RES, V48, P395, DOI 10.1007/BF00029472; Premvardhan L, 2010, BBA-BIOENERGETICS, V1797, P1647, DOI 10.1016/j.bbabio.2010.05.002; PRICE N M, 1988, Biological Oceanography, V6, P443; R Core Team, 2013, LANG ENV STAT COMP; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Raven JA, 2004, NEW PHYTOL, V162, P45, DOI 10.1111/j.1469-8137.2004.01022.x; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; RICHARDSON K, 1983, NEW PHYTOL, V93, P157, DOI 10.1111/j.1469-8137.1983.tb03422.x; Rodriguez RE, 2007, PLANT PHYSIOL, V143, P639, DOI 10.1104/pp.106.090449; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Rynearson TA, 2006, LIMNOL OCEANOGR, V51, P1249, DOI 10.4319/lo.2006.51.3.1249; Schmieder R, 2012, BIOINFORMATICS, V28, P433, DOI 10.1093/bioinformatics/btr669; Schuback N, 2016, BIOGEOSCIENCES, V13, P1019, DOI 10.5194/bg-13-1019-2016; Schuback N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133235; Semeniuk D. M., 2014, COPPER NUTR TRANSPOR; Semeniuk DM, 2009, DEEP-SEA RES PT I, V56, P1130, DOI 10.1016/j.dsr.2009.03.003; Sommer F, 2010, PLANT CELL, V22, P4098, DOI 10.1105/tpc.110.080069; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; SUNDA WG, 1991, NATURE, V351, P55, DOI 10.1038/351055a0; Taddei L, 2016, J EXP BOT, V67, P3939, DOI 10.1093/jxb/erw198; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Westall, 1976, MINEQL COMPUTER PROG; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wu JF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001453; Yamori W, 2016, ANNU REV PLANT BIOL, V67, P81, DOI 10.1146/annurev-arplant-043015-112002; Zamzow H, 1998, ANAL CHIM ACTA, V377, P133, DOI 10.1016/S0003-2670(98)00618-7; Zhu SH, 2010, J PHYCOL, V46, P974, DOI 10.1111/j.1529-8817.2010.00884.x; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003; Zhu Y, 2016, J OCEANOGR, V72, P761, DOI 10.1007/s10872-016-0370-4	136	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181753	10.1371/journal.pone.0181753	http://dx.doi.org/10.1371/journal.pone.0181753			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837661	Green Submitted, Green Published, gold			2022-12-26	WOS:000408365000011
J	Kudumala, SR; Penserga, T; Borner, J; Slipchuk, O; Kakad, P; Lee, LH; Qureshi, A; Pielage, J; Godenschwege, TA				Kudumala, Sirisha R.; Penserga, Tyrone; Boerner, Jana; Slipchuk, Olesya; Kakad, Priyanka; Lee, LaTasha H.; Qureshi, Aater; Pielage, Jan; Godenschwege, Tanja A.			Lissencephaly-1 dependent axonal retrograde transport of L1-type CAM Neuroglian in the adult drosophila central nervous system	PLOS ONE			English	Article							ADHESION MOLECULE L1; LONG-TERM POTENTIATION; CENTRAL-SYNAPSE FORMATION; GIANT-FIBER SYSTEM; FLUORESCENT PROTEINS; ORGANELLE TRANSPORT; IN-VIVO; CHROMOPHORE MATURATION; NUCLEAR TRANSLOCATION; DYNACTIN INTERACTION	Here, we established the Drosophila Giant Fiber neurons (GF) as a novel model to study axonal trafficking of L1-type Cell Adhesion Molecules (CAM) Neuroglian (Nrg) in the adult CNS using live imaging. L1-type CAMs are well known for their importance in nervous system development and we previously demonstrated a role for Nrg in GF synapse formation. However, in the adult they have also been implicated in synaptic plasticity and regeneration. In addition, to its canonical role in organizing cytoskeletal elements at the plasma membrane, vertebrate L1CAM has also been shown to regulate transcription indirectly as well as directly via its import to the nucleus. Here, we intend to determine if the sole L1CAM homolog Nrg is retrogradley transported and thus has the potential to relay signals from the synapse to the soma. Live imaging of c-terminally tagged Nrg in the GF revealed that there are at least two populations of retrograde vesicles that differ in speed, and either move with consistent or varying velocity. To determine if endogenous Nrg is retrogradely transported, we inhibited two key regulators, Lissencephaly-1 (Lis1) and Dynactin, of the retrograde motor protein Dynein. Similar to previously described phenotypes for expression of poisonous sub-units of Dynactin, we found that developmental knock down of Lis1 disrupted GF synaptic terminal growth and that Nrg vesicles accumulated inside the stunted terminals in both mutant backgrounds. Moreover, post mitotic Lis1 knock down in mature GFs by either RNAi or Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) induced mutations, resulted in normal length terminals with fully functional GF synapses which also exhibited severe accumulation of endogenous Nrg vesicles. Thus, our data suggests that accumulation of Nrg vesicles is due to failure of retrograde transport rather than a failure of terminal development. Together with the finding that post mitotic knock down of Lis1 also disrupted retrograde transport of tagged Nrg vesicles in GF axons, it demonstrates that endogenous Nrg protein is transported from the synapse to the soma in the adult central nervous system in a Lis1-dependent manner.	[Kudumala, Sirisha R.; Penserga, Tyrone; Boerner, Jana; Slipchuk, Olesya; Kakad, Priyanka; Lee, LaTasha H.; Godenschwege, Tanja A.] Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL 33458 USA; [Qureshi, Aater] Florida Atlantic Univ, Harriet L Wilkes Honors Coll, Jupiter, FL USA; [Pielage, Jan] Tech Univ Kaiserslautern, Div Zool Neurobiol, Dept Biol, Kaiserslautern, Germany	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; University of Kaiserslautern	Godenschwege, TA (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL 33458 USA.	godensch@fau.edu	; Godenschwege, Tanja/A-2830-2010	Pielage, Jan/0000-0002-5115-5884; Godenschwege, Tanja/0000-0003-3322-4134	National Institute for Neurological Disease and Stroke [R15NS090043]; National Institute of Child Health And Human Development [R01HD050725]; Jupiter Life Sciences Initiative; Division of Research- Florida Atlantic University; College of Science- Florida Atlantic University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS090043] Funding Source: NIH RePORTER	National Institute for Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health And Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Jupiter Life Sciences Initiative; Division of Research- Florida Atlantic University; College of Science- Florida Atlantic University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute for Neurological Disease and Stroke, https://www.ninds.nih.gov/, (R15NS090043) to TAG; the National Institute of Child Health And Human Development, https://www.nichd.nih.gov/Pages/index.aspx, (R01HD050725) to TAG; Jupiter Life Sciences Initiative, http://www.fau.edu/jlsi/, TAG and SRK; Division of Research- Florida Atlantic University, http://www.fau.edu/research/, TAG; College of Science- Florida Atlantic University, http://www.science.fau.edu/, TAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2012, J BIOL CHEM, V287, P32312, DOI 10.1074/jbc.M112.374322; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; Allen MJ, 1999, J NEUROSCI, V19, P9374; Allen MJ, 1998, J COMP NEUROL, V397, P519, DOI 10.1002/(SICI)1096-9861(19980810)397:4<519::AID-CNE5>3.0.CO;2-4; Allen MJ, 2010, COLD SPRING HARBOR P, V2010; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Bliss T, 2000, CURR BIOL, V10, P1607, DOI 10.1016/S0960-9822(00)00865-4; Boerner J, 2011, JOVE-J VIS EXP, DOI 10.3791/3080; Boerner J, 2010, J NEUROGENET, V24, P158, DOI 10.3109/01677063.2010.489624; Chen QY, 2005, SCHIZOPHR RES, V73, P269, DOI 10.1016/j.schres.2004.06.001; Chen XQ, 2012, CELL RES, V22, P677, DOI 10.1038/cr.2011.197; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Chiba K, 2014, MOL BIOL CELL, V25, P3569, DOI 10.1091/mbc.E14-06-1111; Clague MJ, 2016, CURR BIOL, V26, pR332, DOI 10.1016/j.cub.2016.03.001; Costantini LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8670; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Dix CI, 2013, J CELL BIOL, V202, P479, DOI 10.1083/jcb.201211052; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Enneking EM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001537; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Garcia-Alonso L, 2000, NEURON, V28, P741, DOI 10.1016/S0896-6273(00)00150-1; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Godenschwege TA, 2009, J NEUROGENET, V23, P147, DOI 10.1080/01677060802441380; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; Hebisch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Islam R, 2003, DEVELOPMENT, V130, P2051, DOI 10.1242/dev.00415; Itoh K, 2005, MOL CELL NEUROSCI, V29, P245, DOI 10.1016/j.mcn.2005.02.014; Jacobs K, 2000, DEVELOPMENT, V127, P5203; Janssens K, 2014, NEUROBIOL DIS, V65, P211, DOI 10.1016/j.nbd.2014.01.021; Kalinovsky A, 2004, CURR OPIN NEUROBIOL, V14, P272, DOI 10.1016/j.conb.2004.05.011; Kiefel H, 2011, TRENDS MOL MED, V17, P178, DOI 10.1016/j.molmed.2010.11.005; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Kristiansen LV, 2005, MOL CELL NEUROSCI, V28, P141, DOI 10.1016/j.mcn.2004.09.003; Kudumala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076974; Lee LH, 2015, MOL CELL NEUROSCI, V64, P24, DOI 10.1016/j.mcn.2014.11.002; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Liu Z, 1999, DEVELOPMENT, V126, P4477; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Lorenzo DN, 2014, J CELL BIOL, V207, P735, DOI 10.1083/jcb.201407063; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Lutz D, 2013, J NEUROCHEMISTRY; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Macdonald PJ, 2012, ANAL BIOCHEM, V421, P291, DOI 10.1016/j.ab.2011.10.040; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Medioni C, 2015, NAT PROTOC, V10, P574, DOI 10.1038/nprot.2015.034; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Moughamian AJ, 2013, J NEUROSCI, V33, P13190, DOI 10.1523/JNEUROSCI.0935-13.2013; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nikonenko AG, 2006, EUR J NEUROSCI, V23, P1839, DOI 10.1111/j.1460-9568.2006.04710.x; Pandey JP, 2011, J NEUROSCI, V31, P17207, DOI 10.1523/JNEUROSCI.4108-11.2011; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Poltorak M, 1997, BRAIN RES, V751, P152, DOI 10.1016/S0006-8993(97)00023-1; Port F, 2015, G3-GENES GENOM GENET, V5, P1493, DOI 10.1534/g3.115.019083; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Sakurai T, 2012, MOL CELL NEUROSCI, V49, P351, DOI 10.1016/j.mcn.2011.12.002; Salinas PC, 2005, BIOCHEM SOC T, V33, P1295, DOI 10.1042/BST0331295; Sanyal S, 2004, NEURON, V41, P845, DOI 10.1016/S0896-6273(04)00152-7; Sayama K, 2010, J BIOL CHEM, V285, P30042, DOI 10.1074/jbc.M110.106484; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schmieg N, 2014, SEMIN CELL DEV BIOL, V27, P32, DOI 10.1016/j.semcdb.2013.10.004; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shao CY, 2013, TRAFFIC, V14, P785, DOI 10.1111/tra.12070; Siegenthaler D, 2015, J CELL BIOL, V208, P1003, DOI 10.1083/jcb.201407131; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Sinadinos C, 2009, NEUROBIOL DIS, V34, P389, DOI 10.1016/j.nbd.2009.02.012; Smith RB, 2012, J CELL SCI, V125, P3752, DOI 10.1242/jcs.094292; Soares L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06199; Uthaman SB, THE STICKY SYNAPSE, P247; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; von Reyn CR, 2014, NAT NEUROSCI, V17, P962, DOI 10.1038/nn.3741; Wang SS, 2013, MOL BIOL CELL, V24, P3522, DOI 10.1091/mbc.E13-05-0283; White JA, 2015, HUM MOL GENET, V24, P7182, DOI 10.1093/hmg/ddv415; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamasaki M, 1997, NEUROPEDIATRICS, V28, P175, DOI 10.1055/s-2007-973696; Yi JY, 2011, J CELL BIOL, V195, P193, DOI 10.1083/jcb.201104076; Zala D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060162; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010	95	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183605	10.1371/journal.pone.0183605	http://dx.doi.org/10.1371/journal.pone.0183605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837701	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000086
J	Vidorreta, M; Wang, Z; Chang, YLV; Wolk, DA; Fernandez-Seara, MA; Detre, JA				Vidorreta, Marta; Wang, Ze; Chang, Yulin V.; Wolk, David A.; Fernandez-Seara, Maria A.; Detre, John A.			Whole-brain background-suppressed pCASL MRI with 1D-accelerated 3D RARE Stack-Of-Spirals readout	PLOS ONE			English	Article							PERFUSION MRI; INVERSION; SIGNAL; BLOOD; COIL; CASL; 3T	Arterial Spin Labeled (ASL) perfusion MRI enables non-invasive, quantitative measurements of tissue perfusion, and has a broad range of applications including brain functional imaging. However, ASL suffers from low signal-to-noise ratio (SNR), limiting image resolution. Acquisitions using 3D readouts are optimal for background-suppression of static signals, but can be SAR intensive and typically suffer from through-plane blurring. In this study, we investigated the use of accelerated 3D readouts to obtain whole-brain, high-SNR ASL perfusion maps and reduce SAR deposition. Parallel imaging was implemented along the partition-encoding direction in a pseudo-continuous ASL sequence with background-suppression and 3D RARE Stack-Of-Spirals readout, and its performance was evaluated in three small cohorts. First, both non-accelerated and two-fold accelerated single-shot versions of the sequence were evaluated in healthy volunteers during a motor-photic task, and the performance was compared in terms of temporal SNR, GM-WM contrast, and statistical significance of the detected activation. Secondly, single-shot 1D-accelerated imaging was compared to a two-shot accelerated version to assess benefits of SNR and spatial resolution for applications in which temporal resolution is not paramount. Third, the efficacy of this approach in clinical populations was assessed by applying the single-shot 1D-accelerated version to a larger cohort of elderly volunteers. Accelerated data demonstrated the ability to detect functional activation at the subject level, including cerebellar activity, without loss in the perfusion signal temporal stability and the statistical power of the activations. The use of acceleration also resulted in increased GM-WM contrast, likely due to reduced through-plane partial volume effects, that were further attenuated with the use of two-shot readouts. In a clinical cohort, image quality remained excellent, and expected effects of age and sex on cerebral blood flow could be detected. The sequence is freely available upon request for academic use and could benefit a broad range of cognitive and clinical neuroscience research.	[Vidorreta, Marta; Chang, Yulin V.; Wolk, David A.; Detre, John A.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Vidorreta, Marta; Chang, Yulin V.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Wang, Ze] Temple Univ, Dept Radiol, Philadelphia, PA 19122 USA; [Wang, Ze] Hangzhou Normal Univ, Ctr Cognit & Brain Disorder, Hangzhou, Zhejiang, Peoples R China; [Fernandez-Seara, Maria A.] Univ Navarra Clin, Dept Radiol, Navarra, Spain	University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Hangzhou Normal University; University of Navarra	Detre, JA (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	detre@mail.med.upenn.edu	Fernandez-Seara, Maria A./K-1246-2014	Fernandez-Seara, Maria A./0000-0001-8536-6295	National Institutes of Health [P41EB015893, MH080729, R01 AG040271]; National Natural Science Foundation of China [81471644]; Hangzhou Innovation Seed Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040271, P30AG010124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou Innovation Seed Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has was supported by the National Institutes of Health (http://www.nih.gov/), grants no. P41EB015893, MH080729, and R01 AG040271, by National Natural Science Foundation of China (http://www.nsfc.gov.cn/), grant no. 81471644, and Hangzhou Innovation Seed Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Buxton RB, 2009, INTRO FUNCTIONAL MAG, P101; Chang Y V., 2016, MAGN RESON MED; Chen JJ, 2009, MAGN RESON MED, V61, P249, DOI 10.1002/mrm.21858; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Duhamel G, 2004, P INT SOC MAGN RES M, P10909; Feinberg DA, 2009, P INT SOC MAGN RES M, P59223; Fernandez-Seara MA, 2005, MAGN RESON MED, V54, P1241, DOI 10.1002/mrm.20674; Frackowiak R.S.J., 2004, HUMAN BRAIN FUNCTION, V2nd ed, P793, DOI [10.1016/B978-012264841-0/50042-1, DOI 10.1016/B978-012264841-0/50042-1]; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; HAACKE EM, 1991, J MAGN RESON, V92, P126, DOI 10.1016/0022-2364(91)90253-P; KAUFMAN L, 1989, RADIOLOGY, V173, P265, DOI 10.1148/radiology.173.1.2781018; Kessler RM, 2003, NEUROBIOL AGING, V24, pS21, DOI 10.1016/S0197-4580(03)00047-2; NUTTALL AH, 1981, IEEE T ACOUST SPEECH, V29, P84, DOI 10.1109/TASSP.1981.1163506; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Robison RK, 2010, MAGN RESON MED, V63, P1683, DOI 10.1002/mrm.22327; Talagala SL, 2004, MAGNET RESON MED, V52, P131, DOI 10.1002/mrm.20124; Vidorreta M, 2015, P INT SOC MAGN RES M, P269; Vidorreta M, 2014, NMR BIOMED, V27, P1387, DOI 10.1002/nbm.3201; Vidorreta M, 2013, NEUROIMAGE, V66, P662, DOI 10.1016/j.neuroimage.2012.10.087; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang Z, 2005, MAGN RESON MED, V54, P732, DOI 10.1002/mrm.20574; Wang Z, 2012, MAGN RESON IMAGING, V30, P1409, DOI 10.1016/j.mri.2012.05.004; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Ye FQ, 2000, MAGN RESON MED, V44, P92, DOI 10.1002/1522-2594(200007)44:1<92::AID-MRM14>3.0.CO;2-M; Zhao JM, 2007, MAGN RESON MED, V58, P592, DOI 10.1002/mrm.21342; Zhao L, 2015, NEUROIMAGE, V121, P205, DOI 10.1016/j.neuroimage.2015.07.018	29	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183762	10.1371/journal.pone.0183762	http://dx.doi.org/10.1371/journal.pone.0183762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837640	Green Submitted, gold, Green Published			2022-12-26	WOS:000408365000115
J	Ajayi, IE; Mills, PC				Ajayi, Itopa E.; Mills, Paul C.			Effects of the hippocampus on the motor expression of augmented breaths	PLOS ONE			English	Article							PERIAQUEDUCTAL GRAY; RESPIRATORY VARIABILITY; ANESTHETIZED RATS; SIGH RATE; FREQUENCY; HYPOXIA; CATS; FACILITATION; MODULATION; INCREASES	Augmented breaths, also known as sighs, constitute the normal repertoire of breathing in freely behaving humans and animals. The breaths are believed to be generated by neurones in the preBotzinger complex but under modulatory influence from higher brain centres, particularly in the limbic system due to the strong correlations between the expression of emotional behaviours such as anxiety and the occurrence of augmented breaths. The current study examines the role of the hippocampus in the motor expression of augmented breaths, and also examines the characteristics of eupneic breaths surrounding a sigh before and after stimulating the hippocampus in urethane anaesthetised Sprague-Dawley rats. Neurochemical microstimulation using the excitatory amino acid, D, L-Homocysteic acid, was used to locate areas in the hippocampus with the potential to modulated the motor expression of augmented breaths. The CA1 neurone cluster of the ventral hippocampus was found to completely suppress the expression of augmented breaths without affecting the intrinsic properties of the breaths. A similar neurone cluster, but in the dorsal field of the hippocampus, was also investigated and found to have no effects over the expression of augmented breaths. The data supports the hypothesis that there is a structural or functional relationship between neurones of the ventral hippocampus and brainstem nuclei that control augmented breaths. The implications of these findings in the context of behaviours are discussed but with due consideration of experimental conditions.	[Ajayi, Itopa E.; Mills, Paul C.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia	University of Queensland	Ajayi, IE (corresponding author), Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia.	mailitopa@gmail.com			International Postgraduate Research Scholarship (IPRS); Australian Postgraduate Award (APA); Asia-Pacific Centre for Neuromodulation research top-up scholarship	International Postgraduate Research Scholarship (IPRS)(Australian Government); Australian Postgraduate Award (APA)(Australian Government); Asia-Pacific Centre for Neuromodulation research top-up scholarship	Itopa Ajayi was supported by the International Postgraduate Research Scholarship (IPRS), Australian Postgraduate Award (APA), and Asia-Pacific Centre for Neuromodulation research top-up scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; BARNES GE, 1985, J ABNORM PSYCHOL, V94, P64, DOI 10.1037/0021-843X.94.1.64; Bell HJ, 2010, RESP PHYSIOL NEUROBI, V171, P201, DOI 10.1016/j.resp.2010.04.002; Bell HJ, 2009, AM J PHYSIOL-REG I, V296, pR334, DOI 10.1152/ajpregu.90680.2008; CARRIVE P, 1993, BEHAV BRAIN RES, V58, P27, DOI 10.1016/0166-4328(93)90088-8; CHERNIACK NS, 1981, ACTA PHYSIOL SCAND, V111, P349, DOI 10.1111/j.1748-1716.1981.tb06747.x; Chou TC, 2003, J NEUROSCI, V23, P10691; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Cohen G, 1996, J PHYSIOL-LONDON, V490, P551, DOI 10.1113/jphysiol.1996.sp021166; Davenport P. W., 2004, 33 M SOC NEUR SAN DI, P23; DAVIS GM, 1994, PEDIATR PULM, V17, P26, DOI 10.1002/ppul.1950170106; DUFFIN J, 1972, BRAIN RES, V39, P235, DOI 10.1016/0006-8993(72)90798-6; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Floyd NS, 2000, J COMP NEUROL, V422, P556, DOI 10.1002/1096-9861(20000710)422:4<556::AID-CNE6>3.0.CO;2-U; FRIES W, 1974, EXP BRAIN RES, V21, P441; FRYSINGER RC, 1989, ELECTROEN CLIN NEURO, V72, P463, DOI 10.1016/0013-4694(89)90222-8; Gaytan SP, 1998, BRAIN RES BULL, V47, P625, DOI 10.1016/S0361-9230(98)00125-7; Golder FJ, 2005, NEUROSCI LETT, V373, P89, DOI 10.1016/j.neulet.2004.09.063; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; INGRAM RH, 1990, LUNG, V168, P237, DOI 10.1007/BF02719700; Janssens T, 2013, CLIN EXP ALLERGY, V43, P1000, DOI 10.1111/cea.12138; Li P, 2016, NATURE, V530, P293, DOI 10.1038/nature16964; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; LOVICK TA, 1993, BEHAV BRAIN RES, V58, P19, DOI 10.1016/0166-4328(93)90087-7; MARSHALL JM, 1988, J PHYSIOL-LONDON, V400, P15, DOI 10.1113/jphysiol.1988.sp017107; MATHEW OP, 1988, PEDIATR PULM, V4, P134, DOI 10.1002/ppul.1950040303; Matsumoto S, 1997, LUNG, V175, P175, DOI 10.1007/PL00007565; MEAD J, 1959, J APPL PHYSIOL, V14, P669, DOI 10.1152/jappl.1959.14.5.669; Moore J, 2012, RESP PHYSIOL NEUROBI, V180, P105, DOI 10.1016/j.resp.2011.10.016; OREM J, 1993, J APPL PHYSIOL, V74, P761, DOI 10.1152/jappl.1993.74.2.761; Pagliardini S, 2012, J NEUROSCI, V32, P11259, DOI 10.1523/JNEUROSCI.0948-12.2012; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Poe GR, 1996, NEUROSCIENCE, V72, P39, DOI 10.1016/0306-4522(95)00525-0; Ramirez JM, 2014, PROG BRAIN RES, V209, P91, DOI 10.1016/B978-0-444-63274-6.00006-0; Reynolds CR, 2008, ADV EXP MED BIOL, V605, P274; REYNOLDS LB, 1962, J APPL PHYSIOL, V17, P683, DOI 10.1152/jappl.1962.17.4.683; Shahan CP, 2004, ANN M SOC NEUR 2004; Sody Abby Naimer, 2008, J Fam Pract, V57, pE1; Soltysik S, 2005, PHYSIOL BEHAV, V85, P598, DOI 10.1016/j.physbeh.2005.06.008; SZEREDAPRZESTASZEWSKA M, 1992, EXP PHYSIOL, V77, P109, DOI 10.1113/expphysiol.1992.sp003565; Vlemincx E, 2017, BIOL PSYCHOL, V125, P163, DOI 10.1016/j.biopsycho.2017.03.005; Vlemincx E, 2013, BIOL PSYCHOL, V93, P24, DOI 10.1016/j.biopsycho.2012.12.001; Wuyts R, 2011, INT J PSYCHOPHYSIOL, V82, P175, DOI 10.1016/j.ijpsycho.2011.07.021; ZHANG SP, 1994, J NEUROPHYSIOL, V72, P1337, DOI 10.1152/jn.1994.72.3.1337	44	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183619	10.1371/journal.pone.0183619	http://dx.doi.org/10.1371/journal.pone.0183619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832663	Green Published, Green Submitted, gold			2022-12-26	WOS:000408355800073
J	Mabuchi, F; Mabuchi, N; Sakurada, Y; Yoneyama, S; Kashiwagi, K; Iijima, H; Yamagata, Z; Takamoto, M; Aihara, M; Iwata, T; Kawase, K; Shiga, Y; Nishiguchi, KM; Nakazawa, T; Ozaki, M; Araie, M				Mabuchi, Fumihiko; Mabuchi, Nakako; Sakurada, Yoichi; Yoneyama, Seigo; Kashiwagi, Kenji; Iijima, Hiroyuki; Yamagata, Zentaro; Takamoto, Mitsuko; Aihara, Makoto; Iwata, Takeshi; Kawase, Kazuhide; Shiga, Yukihiro; Nishiguchi, Koji M.; Nakazawa, Toru; Ozaki, Mineo; Araie, Makoto		Japan Glaucoma Soc Omics Grp J	Additive effects of genetic variants associated with intraocular pressure in primary open-angle glaucoma	PLOS ONE			English	Article							TO-DISC RATIO; GENOME-WIDE ASSOCIATION; COMMON VARIANTS; RISK-FACTORS; FAMILY-HISTORY; POPULATION; HERITABILITY; PREVALENCE; EYE; SUSCEPTIBILITY	To investigate the association between the additive effects of genetic variants associated with intraocular pressure (IOP) and IOP, vertical cup-to-disc ratio (VCDR), and high tension glaucoma (HTG) or normal tension glaucoma (NTG) as phenotypic features of primary open-angle glaucoma (POAG), and to evaluate the clinical usefulness of the additive effects of IOP-related genetic variants for predicting IOP elevation, Japanese patients with HTG (n = 255) and NTG (n = 261) and 246 control subjects were genotyped for nine IOP-related genetic variants near CAV2, GAS7, GLCCI1/ICA1, ABCA1, ARHGEF12, FAM125B, FNDC3B, ABO, and PTPRJ/AGBL2. The total number of risk alleles of these genetic variants was calculated for each participant as a genetic risk score (GRS), and the association between the GRS and the maximum IOP, mean VCDR, and phenotype (HTG or NTG) of POAG was evaluated. As the GRS increased, the maximum IOP (P = 0.012) and VCDR (P = 0.010) significantly increased. The GRS (9.1 +/- 1.9) in patients with HTG was significantly higher (P = 0.011) than that (8.7 +/- 1.8) in control subjects. The patients with GRS >= 12 as a cut-off value had a 2.54 times higher (P = 0.0085) risk on HTG (maximum IOP >= 22mmHg) compared with all patients. The IOP-related GRS approach substantiated that the IOP and VCDR were increased by the additive effects of IOP-related genetic variants in POAG. The high IOP-related GRS in patients with HTG but not NTG shows that there are differences in the genetic background between HTG and NTG and supports the notion that the phenotype (HTG or NTG) in patients with POAG depends on the additive effects of IOP-related genetic variants. The above-mentioned cut-off value of IOP-related GRS may be clinically useful for predicting the risk of IOP elevation.	[Mabuchi, Fumihiko; Mabuchi, Nakako; Sakurada, Yoichi; Yoneyama, Seigo; Kashiwagi, Kenji; Iijima, Hiroyuki] Univ Yamanashi, Dept Ophthalmol, Fac Med, Yamanashi, Japan; [Yamagata, Zentaro] Univ Yamanashi, Dept Hlth Sci, Fac Med, Yamanashi, Japan; [Takamoto, Mitsuko] Tokyo Metropolitan Police Hosp, Dept Ophthalmol, Tokyo, Japan; [Aihara, Makoto] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Iwata, Takeshi] Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo, Japan; [Kawase, Kazuhide] Gifu Univ Hosp, Gifu, Japan; [Shiga, Yukihiro; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Nishiguchi, Koji M.; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi, Japan; [Ozaki, Mineo] Ozaki Eye Hosp, Miyazaki, Japan; [Araie, Makoto] Kanto Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Tokyo, Japan	University of Yamanashi; University of Yamanashi; University of Tokyo; Gifu University; Tohoku University; Tohoku University; Tohoku University	Mabuchi, F (corresponding author), Univ Yamanashi, Dept Ophthalmol, Fac Med, Yamanashi, Japan.	fmabuchi@yamanashi.ac.jp		Mabuchi, Fumihiko/0000-0003-0927-3868	Japan Society for the Promotion of Science (JSPS; KAKENHI [15K10861]; Grants-in-Aid for Scientific Research [15K10861] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	FM has been supported in part by Japan Society for the Promotion of Science (JSPS, URLs http://www.jsps.go.jp) KAKENHI Grant Number 15K10861. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1989, AM J OPHTHALMOL, V108, P485, DOI 10.1016/0002-9394(89)90423-6; Balasubbu S, 2012, INVEST OPHTH VIS SCI, V53, P1861, DOI 10.1167/iovs.11-8602; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Carbonaro F, 2008, BRIT J OPHTHALMOL, V92, P1125, DOI 10.1136/bjo.2007.133272; Chang TC, 2005, OPHTHALMOLOGY, V112, P1186, DOI 10.1016/j.ophtha.2005.03.006; Charlesworth J, 2010, INVEST OPHTH VIS SCI, V51, P3509, DOI 10.1167/iovs.09-4786; Chen YH, 2015, INVEST OPHTH VIS SCI, V56, P2595, DOI 10.1167/iovs.14-16269; Chen YH, 2014, NAT GENET, V46, P1115, DOI 10.1038/ng.3078; Donnelly P, 2013, HUM MOL GENET, V22, P4653, DOI 10.1093/hmg/ddt293; Freeman EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055573; Gharahkhani P, 2014, NAT GENET, V46, P1120, DOI 10.1038/ng.3079; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2035, DOI 10.1001/jama.2013.5099; Hysi PG, 2014, NAT GENET, V46, P1126, DOI 10.1038/ng.3087; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jiao XD, 2009, P NATL ACAD SCI USA, V106, P17105, DOI 10.1073/pnas.0907564106; Keltner JL, 2006, OPHTHALMOLOGY, V113, P1603, DOI 10.1016/j.ophtha.2006.05.061; Kim NR, 2014, JAMA OPHTHALMOL, V132, P278, DOI 10.1001/jamaophthalmol.2013.7612; Klein BEK, 2004, INVEST OPHTH VIS SCI, V45, P59, DOI 10.1167/iovs.03-0516; Lee MK, 2012, OPHTHALMOLOGY, V119, P450, DOI 10.1016/j.ophtha.2011.09.016; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Liu YT, 2010, P NATL ACAD SCI USA, V107, pE61, DOI 10.1073/pnas.0913838107; Mabuchi F, 2015, AM J OPHTHALMOL, V159, P437, DOI 10.1016/j.ajo.2014.11.023; Mabuchi F, 2010, P NATL ACAD SCI USA, V107, pE90, DOI 10.1073/pnas.0914903107; Micheal S, 2014, MOL VIS, V20, P1471; Miglior S, 2007, OPHTHALMOLOGY, V114, P3, DOI 10.1016/j.ophtha.2006.05.075; Nag A, 2014, HUM MOL GENET, V23, P3343, DOI 10.1093/hmg/ddu050; Ramdas WD, 2011, OPHTHALMOLOGY, V118, P2389, DOI 10.1016/j.ophtha.2011.05.040; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ramdas WD, 2011, J MED GENET, V48, P190, DOI 10.1136/jmg.2010.083337; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Scheetz TE, 2016, OPHTHALMOLOGY; Springelkamp H, 2015, HUM MOL GENET, V24, P2689, DOI 10.1093/hmg/ddv027; Springelkamp H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5883; Sun J, 2012, EYE, V26, P283, DOI 10.1038/eye.2011.243; Tham YC, 2015, OPHTHALMOLOGY, V122, P1149, DOI 10.1016/j.ophtha.2015.01.024; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; TIELSCH JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P69, DOI 10.1001/archopht.1994.01090130079022; van Koolwijk LME, 2007, INVEST OPHTH VIS SCI, V48, P3669, DOI 10.1167/iovs.06-1519; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Weih LM, 2001, OPHTHALMOLOGY, V108, P1966, DOI 10.1016/S0161-6420(01)00799-0; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640	41	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183709	10.1371/journal.pone.0183709	http://dx.doi.org/10.1371/journal.pone.0183709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832686	Green Published, gold			2022-12-26	WOS:000408355800090
J	Sabharwal, S; Verhulst, S; Guirguis, G; Kark, JD; Labat, C; Roche, NE; Martimucci, K; Patel, K; Heller, DS; Kimura, M; Chuang, D; Chuang, A; Benetos, A; Aviv, A				Sabharwal, Sanjeev; Verhulst, Simon; Guirguis, George; Kark, Jeremy D.; Labat, Carlos; Roche, Natalie E.; Martimucci, Kristina; Patel, Krunal; Heller, Debra S.; Kimura, Masayuki; Chuang, Donald; Chuang, Anne; Benetos, Athanase; Aviv, Abraham			Telomere length dynamics in early life: the blood-and-muscle model	FASEB JOURNAL			English	Article						fetus; children; leukocytes	METAANALYSIS; ASSOCIATION; CANCER; RISK; TISSUES; DISEASE	Telomere length (TL) trajectories in somatic tissues during human growth and development are poorly understood. We examined a blood-and-muscle model during early life, focusing on TL trajectories in leukocytes, representing the highly proliferative hematopoietic system, and skeletal muscle, a minimally proliferative tissue. Leukocyte TL (LTL) and skeletal muscle TL (MTL) were measured in 28 fetuses and 73 children. LTL and MTL were highly variable across individuals (SD: fetal LTL = 0.72 kb, MTL = 0.72 kb; children LTL = 0.81 kb, MTL = 0.82 kb) but were highly correlated within individuals (fetuses, r = 0.76, P < 0.0001; children, r = 0.87, P < 0.0001). LTL was shorter than MTL in fetuses (10.63 vs. 11.01 kb; P = 0.0004) and children (8.46 vs. 9.40 kb; < 0.0001). The LTL-MTL gap was smaller in fetuses than children. TL in children was inversely correlated with body mass index (BMI) (LTL: 20.047 6 0.016 kb/BMI, P < 0.005; MTL: -0.037 +/- 0.017 kb/BMI, P = 0.03). We conclude that variations in TL across adults and differences in TL between somatic tissues are largely established in early life. Because TL plays a significant role in aging-related diseases, insight into the factors that fashion TL in somatic tissues during early development should contribute to an understanding of the relationship of TL with these disease and longevity in humans.	[Sabharwal, Sanjeev] State Univ New Jersey, Rutgers New Jersey Med Sch, Dept Orthoped, Newark, NJ USA; [Guirguis, George; Roche, Natalie E.; Martimucci, Kristina; Patel, Krunal] State Univ New Jersey, Rutgers New Jersey Med Sch, Dept Obstet Gynecol & Womens Hlth, Newark, NJ USA; [Heller, Debra S.] State Univ New Jersey, Rutgers New Jersey Med Sch, Dept Pathol, Newark, NJ USA; [Kimura, Masayuki; Chuang, Donald; Chuang, Anne; Aviv, Abraham] State Univ New Jersey, Rutgers New Jersey Med Sch, Ctr Human Dev & Aging, Newark, NJ USA; [Verhulst, Simon] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Kark, Jeremy D.] Hebrew Univ Jerusalem, Hadassah Sch Publ Hlth & Community Med, Jerusalem, Israel; [Benetos, Athanase] INSERM, UMR S1116, Paris, France; [Benetos, Athanase] Univ Lorraine, CHRU Nancy, Dept Geriatr Med, Nancy, France	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Groningen; Hebrew University of Jerusalem; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Universite de Lorraine	Aviv, A (corresponding author), Rutgers New Jersey Med Sch, Ctr Human Dev & Aging, Room F-464 MSB,185 South Orange Ave, Newark, NJ 07103 USA.	avivab@njms.rutgers.edu	Verhulst, Simon/B-1613-2009; Labat, Carlos/F-7492-2010; Verhulst, Simon/S-3404-2019	Verhulst, Simon/0000-0002-1143-6868; Labat, Carlos/0000-0002-5275-3405; Verhulst, Simon/0000-0002-1143-6868	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [R01HL116446]; NHLBI [R01HL13840]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD071180]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071180] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116446] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grant R01HL116446 (Leukocyte Telomere Length and Cardiovascular Disease in the Jackson Heart Study), NHLBI Grant R01HL13840 (Telomeres and Female Fecundity), and NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R01HD071180 (Determinants of Leukocyte Telomere Length at Birth) (all to A. A.) The authors declare no conflicts of interest.	Anic GM, 2013, CANCER EPIDEMIOL, V37, P434, DOI 10.1016/j.canep.2013.02.010; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Aviv A, 2015, EPIDEMIOLOGY, V26, P295, DOI 10.1097/EDE.0000000000000280; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Benetos A, 2013, AGING CELL, V12, P615, DOI 10.1111/acel.12086; Benetos A, 2011, AGING CELL, V10, P991, DOI 10.1111/j.1474-9726.2011.00744.x; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; D'Mello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Factor-Litvak P, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3927; Fyhrquist F, 2013, NAT REV CARDIOL, V10, P274, DOI 10.1038/nrcardio.2013.30; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Hjelmborg JB, 2015, J MED GENET, V52, P297, DOI 10.1136/jmedgenet-2014-102736; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Iles MM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju267; Julin B, 2015, BRIT J CANCER, V112, P769, DOI 10.1038/bjc.2014.640; Kimura M, 2010, NAT PROTOC, V5, P1596, DOI 10.1038/nprot.2010.124; Muezzinler A, 2014, OBES REV, V15, P192, DOI 10.1111/obr.12126; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Seow WJ, 2014, CANCER RES, V74, P4090, DOI 10.1158/0008-5472.CAN-14-0459; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Stone RC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006144; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; Ulaner GA, 1997, MOL HUM REPROD, V3, P769, DOI 10.1093/molehr/3.9.769; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Verhulst S, 2015, INT J EPIDEMIOL, V44, P1683, DOI 10.1093/ije/dyv166; Walsh KM, 2015, NEURO-ONCOLOGY, V17, P1445, DOI 10.1093/neuonc/nov082; Wright WE, 1996, DEV GENET, V18, P173	31	36	36	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					529	534		10.1096/fj.201700630R	http://dx.doi.org/10.1096/fj.201700630R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855279	Green Published, Green Submitted			2022-12-26	WOS:000419172700046
J	Shen, ZF; Chen, Y; Hong, LJ; Cui, ZT; Yang, HP; He, XB; Shi, Y; Shi, LG; Han, F; Zhou, NM				Shen, Zhangfei; Chen, Yu; Hong, Lingjuan; Cui, Zhenteng; Yang, Huipeng; He, Xiaobai; Shi, Ying; Shi, Liangen; Han, Feng; Zhou, Naiming			BNGR-A25L and-A27 are two functional G protein-coupled receptors for CAPA periviscerokinin neuropeptides in the silkworm Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; ANTIDIURETIC-HORMONE; INSECT NEUROPEPTIDES; NEUROHORMONE GPCRS; SIGNALING PATHWAY; MOLECULAR-CLONING; TOBACCO HAWKMOTH; ACTIVATION; PEPTIDES; EXPRESSION	CAPA peptides, such as periviscerokinin (PVK), are insect neuropeptides involved in many signaling pathways controlling, for example, metabolism, behavior, and reproduction. They are present in a large number of insects and, together with their cognate receptors, are important for research into approaches for improving insect control. However, the CAPA receptors in the silkworm (Bombyx mori) insect model are unknown. Here, we cloned cDNAs of two putative CAPA peptide receptor genes, BNGR-A27 and -A25, from the brain of B. mori larvae. We found that the predicted BNGR-A27 ORF encodes 450 amino acids and that one BNGRA-25 splice variant encodes a full-length isoform (BNGR-A25L) of 418 amino acid residues and another a short isoform (BNGRA-25S) of 341 amino acids with a truncated C-terminal tail. Functional assays indicated that both BNGR-A25L and -A27 are activated by the PVK neuropeptides Bom-CAPA-PVK-1 and -PVK-2, leading to a significant increase in cAMP-response element-controlled luciferase activity and Ca2+ mobilization in a G(q) inhibitor-sensitive manner. In contrast, BNGR-A25S was not significantly activated in response to the PVK peptides. Moreover, Bom-CAPA-PVK-1 directly bound to BNGR-A25L and -A27, but not BNGR-A25S. Of note, CAPA-PVK-mediated ERK1/2 phosphorylation and receptor internalization confirmed that BNGR-A25L and -A27 are two canonical receptors for Bombyx CAPA-PVKs. However, BNGR-A25S alone is a nonfunctional receptor but serves as a dominant-negative protein for BNGR-A25L. These results provide evidence that BNGR-A25L and -A27 are two functional G(q)-coupled receptors for Bombyx CAPA-PVKs, enabling the further elucidation of the endocrinological roles of Bom-CAPA-PVKs and their receptors in insect biology.	[Shen, Zhangfei; Yang, Huipeng; He, Xiaobai; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Inst Biochem, Coll Life Sci, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Shen, Zhangfei; Cui, Zhenteng; Shi, Liangen] Zhejiang Univ, Dept Econ Zool, Coll Anim Sci, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Hong, Lingjuan; Han, Feng] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Huipeng] CAAS, Inst Apicultural Res, Beijing 100093, Peoples R China; [He, Xiaobai] Jiangsu Univ Sci & Technol, Coll Biotechnol, Zhenjiang 212018, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Jiangsu University of Science & Technology	Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Zijingang Campus,866 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zhounaiming@zju.edu.cn	Zhou, Naiming/AHC-1121-2022	shen, zhangfei/0000-0002-3707-2265	Ministry of Science and Technology of China [2012CB910402]; National Natural Science Foundation of China [31272375, 31572462, 31072090]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2012CB910402 and National Natural Science Foundation of China Grants 31272375, 31572462, and 31072090. The authors declare that they have no conflicts of interest with the contents of this article.	Altstein M., 2013, HDB BIOL ACTIVE PEPT, P255, DOI DOI 10.1016/B978-0-12-385095-9.00037-3; Caers Jelle, 2012, Front Endocrinol (Lausanne), V3, P151, DOI 10.3389/fendo.2012.00151; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Christie AE, 2015, GEN COMP ENDOCR, V213, P90, DOI 10.1016/j.ygcen.2015.02.003; Cordoba-Chacon J, 2010, CELL MOL LIFE SCI, V67, P1147, DOI 10.1007/s00018-009-0240-y; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Davies SA, 1997, AM J PHYSIOL-REG I, V273, pR823, DOI 10.1152/ajpregu.1997.273.2.R823; Deng XY, 2014, INSECT BIOCHEM MOLEC, V45, P77, DOI 10.1016/j.ibmb.2013.12.007; Durocher Y, 2000, ANAL BIOCHEM, V284, P316, DOI 10.1006/abio.2000.4698; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Fan Y, 2010, INSECT BIOCHEM MOLEC, V40, P581, DOI 10.1016/j.ibmb.2010.05.005; Fan YZ, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/173865; Gondalia K., 2016, IXODES SCAPULARIS PE, V86, P42; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Huang HS, 2010, BIOCHEMISTRY-US, V49, P10862, DOI 10.1021/bi1014425; HUESMANN GR, 1995, FEBS LETT, V371, P311, DOI 10.1016/0014-5793(95)00929-4; Iversen A, 2002, BIOCHEM BIOPH RES CO, V299, P628, DOI 10.1016/S0006-291X(02)02709-2; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Jiang HB, 2014, SCI REP-UK, V4, DOI 10.1038/srep06800; Jiang X, 2016, INSECT BIOCHEM MOLEC, V75, P78, DOI 10.1016/j.ibmb.2016.06.005; Kapustin Y., 2004, 8 ANN INT C RECOMB 2, P741; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Kean L, 2002, AM J PHYSIOL-REG I, V282, pR1297, DOI 10.1152/ajpregu.00584.2001; Kumari P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13416; Lee HJ, 2008, PIGM CELL MELANOMA R, V21, P415, DOI 10.1111/j.1755-148X.2008.00478.x; Lee Jae Min, 2012, Front Endocrinol (Lausanne), V3, P6, DOI 10.3389/fendo.2012.00006; Li G, 2010, J BIOL CHEM, V285, P22605, DOI 10.1074/jbc.M109.087213; Liu Xiaoguang, 2012, Int J Pept, V2012, P640359, DOI 10.1155/2012/640359; Lu ZG, 2015, J CLIN INVEST, V125, P2626, DOI 10.1172/JCI81070; MacPherson MR, 2001, AM J PHYSIOL-CELL PH, V280, pC394, DOI 10.1152/ajpcell.2001.280.2.C394; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; MASLER EP, 1993, ARCH INSECT BIOCHEM, V22, P87, DOI 10.1002/arch.940220109; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; ODonnell M. J., 1996, J EXP BIOL, V199; Oladosu FA, 2015, MAYO CLIN PROC, V90, P1135, DOI 10.1016/j.mayocp.2015.06.010; Olsen SS, 2007, BIOCHEM BIOPH RES CO, V362, P245, DOI 10.1016/j.bbrc.2007.06.190; Paluzzi JP, 2008, ENDOCRINOLOGY, V149, P4638, DOI 10.1210/en.2008-0353; Paluzzi JP, 2010, P NATL ACAD SCI USA, V107, P10290, DOI 10.1073/pnas.1003666107; Paluzzi JP, 2010, MOL CELL ENDOCRINOL, V317, P53, DOI 10.1016/j.mce.2009.11.004; Paluzzi JP, 2006, J EXP BIOL, V209, P907, DOI 10.1242/jeb.02083; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Pollock VP, 2004, J EXP BIOL, V207, P4135, DOI 10.1242/jeb.01255; Pollock VP, 2003, J EXP BIOL, V206, P901, DOI 10.1242/jeb.00189; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Rosay P, 1997, J CELL SCI, V110, P1683; Rosenkilde C, 2003, BIOCHEM BIOPH RES CO, V309, P485, DOI 10.1016/j.bbrc.2003.08.022; Schooley D.A., 2012, INSECT ENDOCRINOLOGY, P366, DOI DOI 10.1016/B978-0-12-384749-2.10009-3; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Terhzaz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029897; TUBLITZ NJ, 1985, J EXP BIOL, V116, P395; Veenstra JA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00454; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wegener C, 2000, J NEUROPHYSIOL, V84, P3056, DOI 10.1152/jn.2000.84.6.3056; Wise Helen, 2012, J Mol Signal, V7, P13, DOI 10.1186/1750-2187-7-13; Woodley Louise, 2002, Briefings in Functional Genomics & Proteomics, V1, P266, DOI 10.1093/bfgp/1.3.266; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yang HP, 2013, INSECT BIOCHEM MOLEC, V43, P1028, DOI 10.1016/j.ibmb.2013.08.011; Yang JW, 2013, J BIOL CHEM, V288, P11662, DOI 10.1074/jbc.M112.441675; Yang YL, 2015, INSECT BIOCHEM MOLEC, V60, P13, DOI 10.1016/j.ibmb.2015.02.010; Yang YL, 2013, GEN COMP ENDOCR, V194, P142, DOI 10.1016/j.ygcen.2013.09.001	69	9	9	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16554	16570		10.1074/jbc.M117.803445	http://dx.doi.org/10.1074/jbc.M117.803445			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842502	hybrid, Green Published			2022-12-26	WOS:000412414800017
J	Kasianov, NS; Belousova, IA; Pavlushin, SV; Dubovskiy, IM; Podgwaite, JD; Martemyanov, VV; Bakhvalov, SA				Kasianov, Nikita S.; Belousova, Irina A.; Pavlushin, Sergey V.; Dubovskiy, Ivan M.; Podgwaite, John D.; Martemyanov, Vyacheslav V.; Bakhvalov, Stanislav A.			The activity of phenoloxidase in haemolymph plasma is not a predictor of Lymantria dispar resistance to its baculovirus	PLOS ONE			English	Article							NUCLEAR-POLYHEDROSIS-VIRUS; GYPSY-MOTH; VERTICAL TRANSMISSION; DISEASE RESISTANCE; MANDUCA-SEXTA; ARMIGERES SUBALBATUS; CYTOTOXIC MOLECULES; IMMUNE FUNCTION; LIFE-HISTORY; INSECT VIRUS	Host innate immunity is one of the factors that determines the resistance of insects to their entomopathogens. In the research reported here we studied whether or not phenoloxidase (PO), a key enzyme in the melanogenesis component of humoral immunity of insects, plays a role in the protection of Lymantria dispar larvae from infection by L. dispar multiple nucleopolyhedrovirus. We studied two types of viral infection: overt and covert. The following lines of investigation were tested: i) the intravital individual estimation of baseline PO activity in haemolymph plasma followed by virus challenging; ii) the specific inhibition of PO activity in vivo by peroral treatment of infected larvae with phenylthiourea (PTU), a competitive inhibitor of PO; iii) the evaluation of PO activity in the haemolymph plasma after larval starvation. Starvation is a stress that activates the covert infection to an overt form. All of these experiments did not show a relationship between PO activity in haemolymph plasma of L. dispar larvae and larval susceptibility to baculovirus. Moreover, starvation-induced activation of covert viral infection to an overt form occurred in 70 percent of virus-carrying larvae against the background of a dramatic increase of PO activity in haemolymph plasma in the insects studied. Our conclusion is that in L. dispar larvae PO activity is not a predictor of host resistance to baculovirus.	[Kasianov, Nikita S.; Belousova, Irina A.; Pavlushin, Sergey V.; Martemyanov, Vyacheslav V.] RAS, SB, Lab Ecol Parasitol, Inst Systemat & Ecol Anim, Novosibirsk, Russia; [Kasianov, Nikita S.] Novosibirsk Natl Res State Univ, Dept Nat Sci, Novosibirsk, Russia; [Belousova, Irina A.] Irkutsk State Univ, Inst Biol, Irkutsk, Russia; [Dubovskiy, Ivan M.; Bakhvalov, Stanislav A.] RAS, SB, Inst Systemat & Ecol Anim, Lab Insect Pathol, Novosibirsk, Russia; [Dubovskiy, Ivan M.] Novosibirsk State Agr Univ, Novosibirsk, Russia; [Podgwaite, John D.] US Forest Serv, Northern Res Stn, USDA, Hamden, CT USA; [Martemyanov, Vyacheslav V.] Natl Res Tomsk State Univ, Inst Biol, Tomsk, Russia	Russian Academy of Sciences; Novosibirsk State University; Irkutsk State University; Russian Academy of Sciences; Novosibirsk State Agrarian University; United States Department of Agriculture (USDA); United States Forest Service; Tomsk State University	Martemyanov, VV (corresponding author), RAS, SB, Lab Ecol Parasitol, Inst Systemat & Ecol Anim, Novosibirsk, Russia.; Martemyanov, VV (corresponding author), Natl Res Tomsk State Univ, Inst Biol, Tomsk, Russia.	martemyanov79@yahoo.com	Dubovskiy, Ivan/B-8252-2008; Martemyanov, Vyacheslav/Q-7466-2016; Pavlushin, Sergey/AAH-5329-2019; Belousova, Irina A/L-3280-2017	Dubovskiy, Ivan/0000-0001-9691-3960; Pavlushin, Sergey/0000-0002-4210-0662; Martemyanov, Vyacheslav/0000-0002-7061-3772	Civilian Research and Development Foundation [RUB1-2922-NO-07]; Russian foundation for basic research [08-04-91116, 15-04-08197]; Russian Science Foundation [15-14-10014]	Civilian Research and Development Foundation; Russian foundation for basic research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The work was supported by Civilian Research and Development Foundation (RUB1-2922-NO-07); and Russian foundation for basic research (08-04-91116 and 15-04-08197). The study of PO inhibition by PTU was supported by the Russian Science Foundation (grant Nr 15-14-10014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHIDA M, 1995, P NATL ACAD SCI USA, V92, P10698, DOI 10.1073/pnas.92.23.10698; Bakhvalov SA, 2010, FACTORS ECOLOGICAL M; Bell RA., 1981, USDA TECH B, P599; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Boots M, 2012, P ROY SOC B-BIOL SCI, V279, P4009, DOI 10.1098/rspb.2012.1073; Brivio MF, 2002, EXP PARASITOL, V101, P149, DOI 10.1016/S0014-4894(02)00111-X; Burden JP, 2003, ECOL LETT, V6, P524, DOI 10.1046/j.1461-0248.2003.00459.x; Burden JP, 2002, MOL ECOL, V11, P547, DOI 10.1046/j.0962-1083.2001.01439.x; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cory JS, 2015, CURR OPIN INSECT SCI, V8, P130, DOI 10.1016/j.cois.2015.01.007; Cory JS, 2003, ANNU REV ECOL EVOL S, V34, P239, DOI 10.1146/annurev.ecolsys.34.011802.132402; DOANE CC, 1969, J INVERTEBR PATHOL, V14, P199, DOI 10.1016/0022-2011(69)90107-4; Doane ChC, 1981, GYPSY MOTH RES ITEGR; Dubovskiy IM, 2016, ISJ-INVERT SURVIV J, V13, P229; Felton G.W., 1995, OXIDATIVE STRESS ANT, P356, DOI DOI 10.1007/978-1-4615-9689-9_10; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; Fuxa JR, 1999, J INVERTEBR PATHOL, V74, P149, DOI 10.1006/jipa.1999.4869; GIESE RL, 1979, ENTOMOL NEWS, V90, P1; Gorman MJ, 2007, INSECT BIOCHEM MOLEC, V37, P1327, DOI 10.1016/j.ibmb.2007.08.006; Hughes DS, 1997, J GEN VIROL, V78, P1801, DOI 10.1099/0022-1317-78-7-1801; Hung SY, 1996, J INVERTEBR PATHOL, V67, P35, DOI 10.1006/jipa.1996.0006; Ilyinykh AV, 2012, ZH OBSHCH BIOL, V73, P389; Ji CY, 2004, J BIOL CHEM, V279, P34101, DOI 10.1074/jbc.M404584200; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Karl I, 2011, GLOBAL CHANGE BIOL, V17, P676, DOI 10.1111/j.1365-2486.2010.02277.x; Katsuma S, 2015, APPL ENTOMOL ZOOL, V50, P57, DOI 10.1007/s13355-014-0304-9; Komarov DA, 2009, APPL MAGN RESON, V35, P495, DOI 10.1007/s00723-009-0180-6; Kong HL, 2013, INT J PEST MANAGE, V59, P174, DOI 10.1080/09670874.2013.807957; Kukan B, 1999, J INVERTEBR PATHOL, V74, P103, DOI 10.1006/jipa.1999.4873; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Liu CT, 1997, PARASITOLOGY, V115, P57, DOI 10.1017/S0031182097001108; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Lu AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00252; Martemyanov VV, 2017, J INVERTEBR PATHOL, V146, P41, DOI 10.1016/j.jip.2017.04.004; Martemyanov V. V., 2014, Evraziatskii Entomologicheskii Zhurnal, V13, P494; Martemyanov VV, 2009, RUSS J ECOL+, V40, P434, DOI 10.1134/S1067413609060095; Martemyanov VV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130988; Martemyanov VV, 2012, ARTHROPOD-PLANT INTE, V6, P507, DOI 10.1007/s11829-012-9202-7; McNeil J, 2010, J INSECT PHYSIOL, V56, P1167, DOI 10.1016/j.jinsphys.2010.03.020; Meister M, 2000, CURR TOP MICROBIOL, V248, P17; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; PericMataruga V, 1997, J INSECT PHYSIOL, V43, P101, DOI 10.1016/S0022-1910(96)00018-2; PODGWAITE JD, 1986, ADV VIRUS RES, V31, P293, DOI 10.1016/S0065-3527(08)60266-3; PODGWAITE JD, 1979, ENVIRON ENTOMOL, V8, P528, DOI 10.1093/ee/8.3.528; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Ryazanova AD, 2012, J ENZYM INHIB MED CH, V27, P78, DOI 10.3109/14756366.2011.576010; Saejeng A, 2010, J INSECT PHYSIOL, V56, P1232, DOI 10.1016/j.jinsphys.2010.03.025; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; Shelby KS, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_13.1; Shelby KS, 2000, J INVERTEBR PATHOL, V75, P218, DOI 10.1006/jipa.2000.4925; Shiao SH, 2001, INSECT MOL BIOL, V10, P315, DOI 10.1046/j.0962-1075.2001.00268.x; Shikano I, 2015, ECOL ENTOMOL, V40, P620, DOI 10.1111/een.12235; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Sparks WO, 2008, INSECT IMMUNOLOGY, P209, DOI 10.1016/B978-012373976-6.50011-2; STOLTZ DB, 1983, EXPERIENTIA, V39, P1022, DOI 10.1007/BF01989783; Sugumaran M, 1998, ARCH BIOCHEM BIOPHYS, V353, P207, DOI 10.1006/abbi.1998.0653; Triggs AM, 2012, FUNCT ECOL, V26, P1409, DOI 10.1111/j.1365-2435.2012.02051.x; van Frankenhuyzen K., 2007, FIELD MANUAL TECHNIQ, V2nd edition, P481; Vilaplana L, 2010, EVOL ECOL, V24, P147, DOI 10.1007/s10682-009-9296-2; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; Yang SY, 2007, ANN ZOOL FENN, V44, P89; Zhao PC, 2011, INSECT BIOCHEM MOLEC, V41, P645, DOI 10.1016/j.ibmb.2011.04.006	65	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183940	10.1371/journal.pone.0183940	http://dx.doi.org/10.1371/journal.pone.0183940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854240	gold, Green Submitted, Green Published			2022-12-26	WOS:000408693600068
J	Persson, HC; Tornbom, K; Sunnerhagen, KS; Tornbom, M				Persson, Hanna C.; Tornbom, Karin; Sunnerhagen, Katharina S.; Tornbom, Marie			Consequences and coping strategies six years after a subarachnoid hemorrhage - A qualitative study	PLOS ONE			English	Article							OF-LIFE; RECOVERY; OUTCOMES; DETERMINANTS; SYMPTOMS	Background After a subarachnoid haemorrhage (SAH), continuing impairment is common and may impact the person's life. There is a lack of knowledge regarding long-term consequences experienced. Purpose To explore experiences of the care and rehabilitation as well as the consequences and strategies used to cope with everyday life six years post SAH. Methods An explorative interview study with a qualitative design. Individual interviews, with open ended questions, using an interview guide were performed with sixteen participants (mean age 63, 8 men, 8 women) six years post SAH. Data was analyzed according to a descriptive thematic analysis, and themes were discovered inductively. Results Two major themes from the analysis, both including four sub-themes, were identified; these themes were consequences of the SAH and coping strategies. Participants were grateful to have survived the SAH and most were satisfied with their acute medical care. If discharged directly from the neurosurgical unit participants can feel abandoned. In contrast, participants who were referred to a rehabilitation clinic felt supported and informed. Cognitive problems, such as impaired memory and mental fatigue, were reported as still present six years post SAH. Coping strategies were; receiving support from family, society, employers, or technical equipment. At work, talking to colleagues and to taking breaks were common. Participants described hiding their symptoms from employers and friends, as well as trying to continue doing tasks in the same manner as prior to the SAH. If this was not possible, some refrained from doing these tasks. They went through a mourning process, fear, and worries. Conclusions Participants reported several long-term consequences which impacted on their daily lives post SAH, and different coping strategies were used to cope with these problems. Participants reported lack of awareness regarding the consequences of SAH and stressed the importance of structured multidisciplinary follow-ups, which mostly is missing.	[Persson, Hanna C.; Tornbom, Karin; Sunnerhagen, Katharina S.; Tornbom, Marie] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden	University of Gothenburg	Persson, HC (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden.	hanna.persson@neuro.gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Persson, Hanna C/0000-0001-8633-3292	Norrbacka Eugenia Foundation [853/16]; Swedish National Stroke Association; Swedish Brain Foundation; Swedish Heart and Lung Foundation; Local Research and Development Board for Gothenburg and Sodra Bohuslan [VGFOUGSB-676251]; Greta and Einar Asker's Foundation; Hjalmar Svensson's Research Foundation [HJSV2016025]; Norrbacka Eugenia Foundation; Local Research and Development Board for Gothenburg and Sodra Bohuslan; Hjalmar Svensson's Research Foundation	Norrbacka Eugenia Foundation; Swedish National Stroke Association; Swedish Brain Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Local Research and Development Board for Gothenburg and Sodra Bohuslan; Greta and Einar Asker's Foundation; Hjalmar Svensson's Research Foundation; Norrbacka Eugenia Foundation; Local Research and Development Board for Gothenburg and Sodra Bohuslan; Hjalmar Svensson's Research Foundation	This work was supported by the Norrbacka Eugenia Foundation, grant number: 853/16, http://www.norrbacka-eugenia.se/; the Swedish National Stroke Association, www.strokeforbundet.se; the Swedish Brain Foundation, http://www.hjarnfonden.se/; The Swedish Heart and Lung Foundation, https://www.hjart-lungfonden.se/; the Local Research and Development Board for Gothenburg and Sodra Bohuslan, grant number: VGFOUGSB-676251 https://www.researchweb.org/is/gsb/ansokan/676251; the Greta and Einar Asker's Foundation, https://stiftelsemedel.se/greta-och-einar-askers-stiftelse/; and the Hjalmar Svensson's Research Foundation, grant number: HJSV2016025, http://www.gu.se/digitalAssets/1473/1473973_annons-handlanden-hjalmar-svensson-och-herman-svensson-2014.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded in parts by the Norrbacka Eugenia Foundation, the Swedish National Stroke Association, the Swedish Brain Foundation, The Swedish Heart and Lung Foundation, the Local Research and Development Board for Gothenburg and Sodra Bohuslan, the Greta and Einar Asker's Foundation and the Hjalmar Svensson's Research Foundation.	Ackermark PY, 2017, EUR J PHYS REHAB MED, V53, P98, DOI 10.23736/S1973-9087.16.04202-7; Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Boerboom W, 2017, DISABIL REHABIL, V39, P928, DOI 10.3109/09638288.2016.1172671; BRANDTSTADTER J, 1990, PSYCHOL AGING, V5, P58, DOI 10.1037/0882-7974.5.1.58; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Ch'ng AM, 2008, J HEALTH PSYCHOL, V13, P1136, DOI 10.1177/1359105308095967; Chahal N, 2011, NEUROEPIDEMIOLOGY, V37, P31, DOI 10.1159/000328647; Greebe P, 2010, J NEUROL, V257, P2059, DOI 10.1007/s00415-010-5660-y; Hedlund M, 2010, ACTA NEUROCHIR, V152, P1375, DOI 10.1007/s00701-010-0673-y; Hedlund M, 2010, J CLIN NURS, V19, P1578, DOI 10.1111/j.1365-2702.2009.02940.x; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jarvis Anne, 2002, Br J Nurs, V11, P1430; Lazarus R.S., 1984, EMOTION ADAPTATION; Lo Buono V, 2015, J HLTH PSYCHOL; Luker J, 2015, ARCH PHYS MED REHAB, V96, P1698, DOI 10.1016/j.apmr.2015.03.017; Ogden JA, 1997, NEUROSURGERY, V41, P25, DOI 10.1097/00006123-199707000-00008; Passier PECA, 2013, QUAL LIFE RES, V22, P1027, DOI 10.1007/s11136-012-0236-1; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Persson HC, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-162; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Sarre S, 2014, DISABIL REHABIL, V36, P716, DOI 10.3109/09638288.2013.814724; Thompson JN, 2011, NEUROPSYCHOL REHABIL, V21, P92, DOI 10.1080/09602011.2010.529748; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Visser-Meily JMA, 2013, CEREBROVASC DIS, V36, P126, DOI 10.1159/000353642; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277; Vogelsang AC, 2004, J ADV NURS, V48, P551, DOI 10.1111/j.1365-2648.2004.03243.x; Wesali S, 2015, CLIN NEUROL NEUROSUR, V138, P52, DOI 10.1016/j.clineuro.2015.07.020	29	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0181006	10.1371/journal.pone.0181006	http://dx.doi.org/10.1371/journal.pone.0181006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF1XX	28854198	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600004
J	Solazzo, C; Fitzhugh, W; Kaplan, S; Potter, C; Dyer, JM				Solazzo, Caroline; Fitzhugh, William; Kaplan, Susan; Potter, Charles; Dyer, Jolon M.			Molecular markers in keratins from Mysticeti whales for species identification of baleen in museum and archaeological collections	PLOS ONE			English	Article							BOWHEAD WHALES; PHYLOGENETIC-RELATIONSHIPS; DNA; MITOCHONDRIAL; SPECIMENS; BONE; EXPLOITATION; ARTIFACTS; ORIGINS; PROMISE	Baleen has been harvested by indigenous people for thousands of years, as well as collected by whalers as an additional product of commercial whaling in modern times. Baleen refers to the food-filtering system of Mysticeti whales; a full baleen rack consists of dozens of plates of a tough and flexible keratinous material that terminate in bristles. Due to its properties, baleen was a valuable raw material used in a wide range of artefacts, from implements to clothing. Baleen is not widely used today, however, analyses of this biomolecular tissue have the potential to contribute to conservation efforts, studies of genetic diversity and a better understanding of the exploitation and use of Mysticeti whales in past and recent times. Fortunately, baleen is present in abundance in museum natural history collections. However, it is often difficult or impossible to make a species identification of manufactured or old baleen. Here, we propose a new tool for biomolecular identification of baleen based on its main structural component alpha-keratin (the same protein that makes up hair and fingernails). With the exception of minke whales, alpha-keratin sequences are not yet known for baleen whales. We therefore used peptide mass fingerprinting to determine peptidic profiles in well documented baleen and evaluated the possibility of using this technique to differentiate species in baleen samples that are not adequately identified or are unidentified. We examined baleen from ten different species of whales and determined molecular markers for each species, including species-specific markers. In the case of the Bryde's whales, differences between specimens suggest distinct species or sub-species, consistent with the complex phylogeny of the species. Finally, the methodology was applied to 29 fragments of baleen excavated from archaeological sites in Labrador, Canada (representing 1500 years of whale use by prehistoric people), demonstrating a dominance of bowhead whale (Balaena mysticetus) in the archaeological assemblage and the successful application of the peptide mass fingerprinting technique to identify the species of whale in unidentified and partially degraded samples.	[Solazzo, Caroline] Smithsonian Inst, Museum Conservat Inst, Museum Support Ctr, Suitland, MD 20746 USA; [Fitzhugh, William] Smithsonian Inst, Arctic Studies Ctr, Natl Museum Nat Hist, Dept Anthropol MRC 112, Washington, DC 20560 USA; [Kaplan, Susan] Bowdoin Coll, Peary MacMillan Arctic Museum, Brunswick, ME 04011 USA; [Kaplan, Susan] Bowdoin Coll, Arctic Studies Ctr, Brunswick, ME 04011 USA; [Potter, Charles] Smithsonian Inst, Dept Vertebrate Zool, Div Mammals, Natl Museum Nat Hist, MRC 108, Washington, DC 20560 USA; [Dyer, Jolon M.] AgResearch, Food & Biobased Prod, Lincoln Res Ctr, Christchurch, New Zealand	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; Bowdoin College; Bowdoin College; Smithsonian Institution; Smithsonian National Museum of Natural History; AgResearch - New Zealand	Solazzo, C (corresponding author), Smithsonian Inst, Museum Conservat Inst, Museum Support Ctr, Suitland, MD 20746 USA.	solazzoc@si.edu	Solazzo, Caroline/F-1750-2018	Solazzo, Caroline/0000-0001-5092-0807; Dyer, Jolon/0000-0002-7220-6062	Burch Fellowship in Theoretical Medicine and Affiliated Sciences (Smithsonian Institution)	Burch Fellowship in Theoretical Medicine and Affiliated Sciences (Smithsonian Institution)	The analytical work was supported by a Burch Fellowship in Theoretical Medicine and Affiliated Sciences (Smithsonian Institution). Caroline Solazzo-2014 recipient: https://www.smithsonianofi.com/fellowship-opportunities/george-e-burch-fellowship/. The funder provided support in the form of salaries for authors [CS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Jolon Dyer employed at the company AgResearch Ltd served as adviser and contributed to the preparation of the manuscript.	Agnarsson I, 2008, MOL PHYLOGENET EVOL, V48, P964, DOI 10.1016/j.ympev.2008.05.046; Aguilar A., 1986, Reports of the International Whaling Commission Special Issue, P191; BARKHAM SH, 1984, ARCTIC, V37, P515; Barnes RH, 1974, LAMALERAP WHALING VI, P137; Bentaleb I, 2011, MAR ECOL PROG SER, V438, P285, DOI 10.3354/meps09269; Berta A, 2015, EVOLUTIONARY BIOL; Best PB, 2001, MAR ECOL PROG SER, V220, P277, DOI 10.3354/meps220277; Bi K, 2013, MOL ECOL, V22, P6018, DOI 10.1111/mec.12516; Brandt LO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106875; Buckley M, 2014, J ARCHAEOL SCI, V41, P631, DOI 10.1016/j.jas.2013.08.021; Buckley M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2671; Buerki S, 2016, BIOL J LINN SOC, V117, P5, DOI 10.1111/bij.12721; Casas-Marce M, 2010, MOL ECOL RESOUR, V10, P502, DOI 10.1111/j.1755-0998.2009.02784.x; Clark J. G. D., 1947, Antiquity, V21, P84; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Coltrain JB, 2004, J ARCHAEOL SCI, V31, P39, DOI 10.1016/j.jas.2003.06.003; Cumbaa SL., 1986, REPORTS INT WHALING, V10, P187; Cunliffe EA, 2016, INT J OSTEOARCHAEOL, V26, P384, DOI 10.1002/oa.2427; Cunliffe EA, 2014, WHALES WHALE BONE TE; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Eastop D, 2005, SCI ANAL ANCIENT HIS, P161; Evans S, 2016, J ARCHAEOL SCI-REP, V6, P757, DOI 10.1016/j.jasrep.2015.10.025; FITZHUGH W, 1980, ARCTIC, V33, P585; Fordyce RE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2645; Fudge Douglas S., 2009, Aquatic Mammals, V35, P226, DOI 10.1578/AM.35.2.2009.226; Galimberti A, 2015, HYSTRIX, V26, P13, DOI 10.4404/hystrix-26.1-11347; Gardiner M., 1997, ARCHAEOL J, V154, P173, DOI DOI 10.1080/00665983.1997.11078787; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Guschanski K, 2013, SYST BIOL, V62, P539, DOI 10.1093/sysbio/syt018; Hatch LT, 2006, MOL PHYLOGENET EVOL, V41, P12, DOI 10.1016/j.ympev.2006.05.023; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holmes MW, 2016, MOL ECOL, V25, P864, DOI 10.1111/mec.13529; Hunt KE, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow014; Hunt KE, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou030; Jackson JA, 2009, MOL BIOL EVOL, V26, P2427, DOI 10.1093/molbev/msp169; JORDAN RH, 1980, ARCTIC, V33, P607; Junge GCA, 1950, ZOOLOGISCHE VERHANDE, V9, P3; KAPLAN SA, 1980, ARCTIC, V33, P646; Kimura T, 1997, MAR MAMMAL SCI, V13, P495, DOI 10.1111/j.1748-7692.1997.tb00657.x; Lauffenburger J A, 1993, J AM INT CONSERV, V32, P213, DOI DOI 10.1179/019713693806124910; Lee M., 1998, BALEEN BASKETRY N AL; Lindquist O., 1994, DOLPHINS PORPOISES E; Loring S., 1998, ETUDES INUIT STUDIES, V22, P53; Marx FG, 2015, R SOC OPEN SCI, V2; McCartney Allen P., 1993, Polar Record, V29, P1; McCartney AP, 1984, HIST NATIVE WHALING; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; McLeod BA, 2008, ARCTIC, V61, P61; McMillan AD, 2015, BC STUDIES, V187, P229, DOI DOI 10.14288/BCS.V0I187.186163; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SE, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0339; Monks GG, 2001, ARCTIC ANTHROPOL, V38, P60; Monks GG, 2001, INT J OSTEOARCHAEOL, V11, P136, DOI 10.1002/oa.552; Morin PA, 2007, MOL ECOL NOTES, V7, P404, DOI 10.1111/j.1471-8286.2007.01699.x; Morin PA, 2007, MOL ECOL NOTES, V7, P937, DOI 10.1111/j.1471-8286.2007.01804.x; Mulville J, 2002, INT J OSTEOARCHAEOL, V12, P34, DOI 10.1002/oa.611; Nachman MW, 2013, MOL ECOL, V22, P5966, DOI 10.1111/mec.12563; Nishida S, 2007, ZOOL SCI, V24, P723, DOI 10.2108/zsj.24.723; O'Connor S, 2015, STUD CONSERV, V60, P393, DOI 10.1179/2047058414Y.0000000134; Olsen O, 1913, P ZOOL SOC LOND, V1913, P1073; Omura H., 1986, Reports of the International Whaling Commission Special Issue, P35; Rastogi T, 2004, CAN J ZOOL, V82, P1647, DOI 10.1139/Z04-146; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P82; Reeves RR, 2002, MAMMAL REV, V32, P71, DOI 10.1046/j.1365-2907.2002.00100.x; REEVES RR, 1999, MAR FISH REV, V61, P1; Reilly SB, 2008, IUCN RED LIST THREAT; Reilly SB, 2012, IUCN RED LIST THREAT; Rijkelijkhuizen M, 2009, INT J HIST ARCHAEOL, V13, P409, DOI 10.1007/s10761-009-0091-0; Rosenbaum HC, 2000, MOL ECOL, V9, P1793, DOI 10.1046/j.1365-294x.2000.01066.x; Rosenbaum HC, 2000, CONSERV BIOL, V14, P1837, DOI 10.1111/j.1523-1739.2000.99310.x; Rychel AL, 2004, MOL PHYLOGENET EVOL, V32, P892, DOI 10.1016/j.ympev.2004.02.020; Sasaki T, 2006, MOL PHYLOGENET EVOL, V41, P40, DOI 10.1016/j.ympev.2006.03.032; Savelle JM, 1997, J ARCHAEOL SCI, V24, P869, DOI 10.1006/jasc.1996.0167; Scarff J. E., 1986, REP INT WHAL COMMN S, V10, P43; Seersholm FV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13389; Sinding MHS, 2016, J ARCHAEOL SCI-REP, V10, P345, DOI 10.1016/j.jasrep.2016.11.001; Sinding MHS, 2012, J ARCHAEOL SCI, V39, P3750, DOI 10.1016/j.jas.2012.06.020; Solazzo C, 2014, J ARCHAEOL SCI, V49, P524, DOI 10.1016/j.jas.2014.06.009; Solazzo C, 2013, RAPID COMMUN MASS SP, V27, P2685, DOI 10.1002/rcm.6730; Speller C, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0332; Szewciw LJ, 2010, P ROY SOC B-BIOL SCI, V277, P2597, DOI 10.1098/rspb.2010.0399; Taylor HR, 2012, MOL ECOL RESOUR, V12, P377, DOI 10.1111/j.1755-0998.2012.03119.x; TAYLOR JG, 1988, ARCTIC ANTHROPOL, V25, P120; Wada S, 2003, NATURE, V426, P278, DOI 10.1038/nature02103; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wellman HP, 2016, JICA, P1; Whitridge P, 2002, INT J OSTEOARCHAEOL, V12, P65, DOI 10.1002/oa.613; Wiseman N, 2011, MAR MAMMAL SCI, V27, pE253, DOI 10.1111/j.1748-7692.2010.00454.x; Yamaura K, 1998, ARCTIC ANTHROPOL, V35, P321; Yesner DR, 1998, ARCTIC ANTHROPOL, V35, P204; Young S., 2012, COMP ANATOMY BALEEN; Young S, 2015, ANAT REC, V298, P703, DOI 10.1002/ar.23108	93	23	23	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183053	10.1371/journal.pone.0183053	http://dx.doi.org/10.1371/journal.pone.0183053			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF1XX	28854252	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600028
J	Mwau, M; Bwana, P; Kithinji, L; Ogollah, F; Ochieng, S; Akinyi, C; Adhiambo, M; Ogumbo, F; Sirengo, M; Boeke, C				Mwau, Matilu; Bwana, Priska; Kithinji, Lucy; Ogollah, Francis; Ochieng, Samuel; Akinyi, Catherine; Adhiambo, Maureen; Ogumbo, Fred; Sirengo, Martin; Boeke, Caroline			Mother-to-child transmission of HIV in Kenya: A cross-sectional analysis of the national database over nine years	PLOS ONE			English	Article							EARLY INFANT DIAGNOSIS; RANDOMIZED CONTROLLED-TRIAL; HEALTH SYSTEM; PREVENTION; WOMEN; RISK; CARE; INFECTION; DELIVERY; COMMUNITY	Objective To describe factors associated with mother-to-child HIV transmission (MTCT) in Kenya and identify opportunities to increase testing/care coverage. Design Cross-sectional analysis of national early infant diagnosis (EID) database. Methods 365,841 Kenyan infants were tested for HIV from January 2007-July 2015 and results, demographics, and treatment information were entered into a national database. HIV risk factors were assessed using multivariable logistic regression. Results 11.1% of infants tested HIV positive in 2007 - 2010 and 6.9% in 2014 - 2015. Greater odds of infection were observed in females (OR: 1.08; 95% CI: 1.05 - 1.11), older children (18 - 24 months vs. 6 weeks-2 months: 4.26; 95% CI: 3.87 - 4.69), infants whose mothers received no PMTCT intervention (vs. HAART OR: 1.92; 95% CI: 1.79 - 2.06), infants receiving no prophylaxis (vs. nevirapine for 6 weeks OR: 2.76; 95% CI: 2.51 - 3.05), and infants mixed breastfed (vs. exclusive breastfeeding OR: 1.39; 95% CI: 1.30 - 1.49). In 2014 - 2015, 9.1% of infants had mothers who were not on treatment during pregnancy, 9.8% were not on prophylaxis, and 7.0% were mixed breastfed. Infants exposed to all three risky practices had a sevenfold higher odds of HIV infection compared to those exposed to recommended practices. The highest yield of HIV-positive infants were found through targeted testing of symptomatic infants in pediatric/outpatient departments (>15%); still, most infected infants were identified through PMTCT programs. Conclusion Despite impressive gains in Kenya's PMTCT program, some HIV-infected infants present late and are not benefitting from PMTCT best practices. Efforts to identify these early and enforce evidence-based practice for PMTCT should be scaled up. Infant testing should be expanded in pediatric/outpatient departments, given high yields in these portals.	[Mwau, Matilu; Akinyi, Catherine; Adhiambo, Maureen; Ogumbo, Fred] Kenya Govt Med Res Ctr, Ctr Infect & Parasit Dis Control Res, Busia, Kenya; [Mwau, Matilu; Bwana, Priska; Kithinji, Lucy; Ogollah, Francis; Ochieng, Samuel] Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya; [Sirengo, Martin] Minist Hlth, Natl AIDS & STIs Control Program, Nairobi, Kenya; [Boeke, Caroline] Clinton Hlth Access Initiat, Boston, MA USA	Kenya Medical Research Institute; Kenya Medical Research Institute	Mwau, M (corresponding author), Kenya Govt Med Res Ctr, Ctr Infect & Parasit Dis Control Res, Busia, Kenya.; Mwau, M (corresponding author), Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya.	mmwau@kemri.org	Ogumbo, Fredrick/AAO-6964-2021	Ogumbo, Fredrick/0000-0002-5699-5591	Centers for Disease Control and Prevention (CDC); USAID/PEPFAR; UNITAID; Hewlett-Packard	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID/PEPFAR(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UNITAID; Hewlett-Packard	The authors wish to thank the Centers for Disease Control and Prevention (CDC), USAID/PEPFAR, and UNITAID for funding HIV diagnostics in Kenya. The IT infrastructure was funded by Hewlett-Packard. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the Centers for Disease Control and Prevention (CDC), USAID/PEPFAR, and UNITAID for funding HIV diagnostics in Kenya, as well as the Clinton Health Access Initiative for technical support.	Ambia J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20309; [Anonymous], 2000, BMJ, V320, P14681; [Anonymous], 2016, THAIL IS 1 COUNTR AS; [Anonymous], 2014, KENYA AIDS RESP PROG; Becquet R, 2008, PREV MED, V47, P27, DOI 10.1016/j.ypmed.2007.11.014; Biggar RJ, 2006, JAIDS-J ACQ IMM DEF, V41, P509, DOI 10.1097/01.qai.0000191283.85578.46; Bosire R, 2016, BREASTFEED MED, V11, P56, DOI 10.1089/bfm.2015.0071; Brahmbhatt H, 2009, J PEDIAT INF DIS-GER, V4, P275, DOI 10.3233/JPI-2009-0168; Chang J, 2014, J VIROL METHODS, V204, P25, DOI 10.1016/j.jviromet.2014.03.010; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Dillabaugh LL, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/602120; Finocchario-Kessler S, 2014, AIDS, V28, pS313, DOI 10.1097/QAD.0000000000000332; Fowler MG, 2008, PLOS MED, V5, P359, DOI 10.1371/journal.pmed.0050063; Galli L, 2005, JAIDS-J ACQ IMM DEF, V40, P479, DOI 10.1097/01.qai.0000164247.49098.0e; Goggin K, 2016, AIDS BEHAV, V20, P2141, DOI 10.1007/s10461-016-1404-z; Goldstein M, 2013, AM ECON J-APPL ECON, V5, P58, DOI 10.1257/app.5.2.58; Hassan AS, 2012, AIDS BEHAV, V16, P5, DOI 10.1007/s10461-010-9877-7; IATT, 2016, INT TASK TEAM PREV T; Jennings L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1131; Kageha S, 2012, J TROP PEDIATRICS, V58, P247, DOI 10.1093/tropej/fmr076; Kinuthia J, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0467-6; KNBS, 2014, KENYA DEM HLTH SURV; Lofgren SM, 2009, AIDS, V23, P2459, DOI 10.1097/QAD.0b013e328331f702; Lowther K, 2016, AIDS CARE, V28, P60, DOI 10.1080/09540121.2016.1146214; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Ministry of Health Government of Kenya, 2012, GUIDELINES PREVENTIO, V4th ed; Mushamiri I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1358-5; NASCOP, 2015, KENYA HIV TEST SERV; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Obermeyer CM, 2013, TROP MED INT HEALTH, V18, P1110, DOI 10.1111/tmi.12155; Odeny BM, 2016, BREASTFEED MED, V11, P252, DOI 10.1089/bfm.2016.0014; Okanda JO, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-280; Onono M, 2015, AIDS PATIENT CARE ST, V29, P204, DOI 10.1089/apc.2014.0181; Piwoz EG, 2005, AIDS, V19, P1719, DOI 10.1097/01.aids.0000184745.12338.21; Rustagi AS, 2016, J ACQUIR IMMUNE DEFI; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Turan JM, 2015, JAIDS-J ACQ IMM DEF, V69, pe172, DOI 10.1097/QAI.0000000000000678; UNAIDS/WHO, 2013, UNAIDS REP GLOB AIDS; Wise J, 2001, BRIT MED J, V322, P511; World Health Organization, 2016, CONS GUID US ANT DRU	41	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183860	10.1371/journal.pone.0183860	http://dx.doi.org/10.1371/journal.pone.0183860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE9SU	28850581	gold, Green Published, Green Submitted			2022-12-26	WOS:000408544200035
J	van den Hoogenhof, MMG; van der Made, I; Beqqali, A; de Groot, NE; Damanafshan, A; van Oort, RJ; Pinto, YM; Creemers, EE				van den Hoogenhof, Maarten M. G.; van der Made, Ingeborg; Beqqali, Abdelaziz; de Groot, Nina E.; Damanafshan, Amin; van Oort, Ralph J.; Pinto, Yigal M.; Creemers, Esther E.			The RNA-binding protein Rbm38 is dispensable during pressure overload-induced cardiac remodeling in mice	PLOS ONE			English	Article							REGULATES P63 EXPRESSION; MESSENGER-RNA; P53 FAMILY; DILATED CARDIOMYOPATHY; TARGET; RNPC1; STABILITY; HEART; RBM24; DYSFUNCTION	The importance of tightly controlled alternative pre-mRNA splicing in the heart is emerging. The RNA binding protein Rbm24 has recently been identified as a pivotal cardiac splice factor, which governs sarcomerogenesis in the heart by controlling the expression of alternative protein isoforms. Rbm38, a homolog of Rbm24, has also been implicated in RNA processes such as RNA splicing, RNA stability and RNA translation, but its function in the heart is currently unknown. Here, we investigated the role of Rbm38 in the healthy and diseased adult mouse heart. In contrast to the heart- and skeletal muscle-enriched protein Rbm24, Rbm38 appears to be more broadly expressed. We generated somatic Rbm38 -/- mice and show that global loss of Rbm38 results in hematopoietic defects. Specifically, Rbm38 -/- mice were anemic and displayed enlarged spleens with extramedullary hematopoiesis, as has been shown earlier. The hearts of Rbm38 -/- mice were mildly hypertrophic, but cardiac function was not affected. Furthermore, Rbm38 deficiency did not affect cardiac remodeling (i.e. hypertrophy, LV dilation and fibrosis) or performance (i.e. fractional shortening) after pressure-overload induced by transverse aorta constriction. To further investigate molecular consequences of Rbm38 deficiency, we examined previously identified RNA stability, splicing, and translational targets of Rbm38. We found that stability targets p21 and HuR, splicing targets Mef2d and Fgfr2, and translation target p53 were not altered, suggesting that these Rbm38 targets are tissue-specific or that Rbm38 deficiency may be counteracted by a redundancy mechanism. In this regard, we found a trend towards increased Rbm24 protein expression in Rbm38 -/- hearts. Overall, we conclude that Rbm38 is critical in hematopoiesis, but does not play a critical role in the healthy and diseased heart.	[van den Hoogenhof, Maarten M. G.; van der Made, Ingeborg; Beqqali, Abdelaziz; de Groot, Nina E.; Damanafshan, Amin; van Oort, Ralph J.; Pinto, Yigal M.; Creemers, Esther E.] Acad Med Ctr, Dept Expt Cardiol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Creemers, EE (corresponding author), Acad Med Ctr, Dept Expt Cardiol, Amsterdam, Netherlands.	e.e.creemers@amc.uva.nl	Beqqali, Abdelaziz/F-8568-2013	Beqqali, Abdelaziz/0000-0003-1390-5821; van den Hoogenhof, Maarten/0000-0003-2768-3457; , yigal/0000-0002-2836-571X; Creemers, Esther/0000-0002-9001-3854	AMC; Netherlands Organization for Scientific Research [NWO-836.12.002, NWO-821.02.021]; Netherlands Cardiovascular Research Initiative [CVON-ARENA-2011-11]	AMC; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Cardiovascular Research Initiative	This work was supported an AMC PhD Fellowship (MMGvdH) and by grants from the Netherlands Organization for Scientific Research (NWO-836.12.002 and NWO-821.02.021) (EEC, YMP) and the Netherlands Cardiovascular Research Initiative (CVON-ARENA-2011-11) (YMP). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dominguez JR, 2016, BLOOD; Anyanful A, 2004, J CELL BIOL, V167, P639, DOI 10.1083/jcb.200407085; Asaumi Y, 2007, CIRCULATION, V115, P2022, DOI 10.1161/CIRCULATIONAHA.106.659037; Beqqali A, 2016, CARDIOVASC RES, V112, P452, DOI 10.1093/cvr/cvw192; Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Cho SJ, 2015, ONCOTARGET, V6, P305, DOI 10.18632/oncotarget.2786; Cho SJ, 2012, J BIOL CHEM, V287, P14535, DOI 10.1074/jbc.M111.326827; Heinicke LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078031; Jiang YQ, 2014, J BIOL CHEM, V289, P3164, DOI 10.1074/jbc.M113.524413; Kuroyanagi H, 2007, MOL CELL BIOL, V27, P8612, DOI 10.1128/MCB.01508-07; Leveille N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1519; Li DX, 2010, CTS-CLIN TRANSL SCI, V3, P90, DOI 10.1111/j.1752-8062.2010.00198.x; Medzikovic L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15404; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Ogino A, 2010, J AM COLL CARDIOL, V56, P1949, DOI 10.1016/j.jacc.2010.04.068; Poon KL, 2012, CARDIOVASC RES, V94, P418, DOI 10.1093/cvr/cvs095; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruiz-Villalba A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00043-9; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; TERWELLE HF, 1988, J MOL CELL CARDIOL, V20, P435, DOI 10.1016/S0022-2828(88)80135-4; Tijsen AJ, 2014, CARDIOVASC RES, V104, P61, DOI 10.1093/cvr/cvu184; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; van den Hoogenhof MMG, 2016, CIRC RES, V118, P454, DOI 10.1161/CIRCRESAHA.115.307872; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Weeland CJ, 2015, J MOL CELL CARDIOL, V81, P107, DOI 10.1016/j.yjmcc.2015.02.008; Xu ES, 2014, MOL CANCER RES, V12, P359, DOI 10.1158/1541-7786.MCR-13-0526; Xue JQ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-322; Yan W, 2017, ONCOTARGET; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Yang JW, 2014, DEV CELL, V31, P87, DOI 10.1016/j.devcel.2014.08.025; Zhang J, 2014, P NATL ACAD SCI USA, V111, P18637, DOI 10.1073/pnas.1415607112; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107; Zhang M, 2013, GENE DEV, V27, P2246, DOI 10.1101/gad.221739.113	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0184093	10.1371/journal.pone.0184093	http://dx.doi.org/10.1371/journal.pone.0184093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850611	Green Published, gold, Green Submitted			2022-12-26	WOS:000408544200054
J	Lee, B; Song, T; Lee, K; Kim, J; Berggren, PO; Ryu, SH; Jo, J				Lee, Boah; Song, Taegeun; Lee, Kayoung; Kim, Jaeyoon; Berggren, Per-Olof; Ryu, Sung Ho; Jo, Junghyo			Insulin modulates the frequency of Ca2+ oscillations in mouse pancreatic islets	PLOS ONE			English	Article							BETA-CELLS; SECRETION; GLUCOSE; ENTRAINMENT; LANGERHANS; RECEPTOR; CALCIUM; SINGLE; SYNCHRONIZATION; DESENSITIZATION	Pancreatic islets can adapt to oscillatory glucose to produce synchronous insulin pulses. Can islets adapt to other oscillatory stimuli, specifically insulin? To answer this question, we stimulated islets with pulses of exogenous insulin and measured their Ca2+ oscillations. We observed that sufficiently high insulin (>500 nM) with an optimal pulse period (similar to 4 min) could make islets to produce synchronous Ca2+ oscillations. Glucose and insulin, which are key stimulatory factors of islets, modulate islet Ca2+ oscillations differently. Glucose increases the active-to-silent ratio of phases, whereas insulin increases the period of the oscillation. To examine the dual modulation, we adopted a phase oscillator model that incorporated the phase and frequency modulations. This mathematical model showed that out-of-phase oscillations of glucose and insulin were more effective at synchronizing islet Ca2+ oscillations than in-phase stimuli. This finding suggests that a phase shift in glucose and insulin oscillations can enhance inter-islet synchronization.	[Lee, Boah] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Gyeongbuk, South Korea; [Song, Taegeun; Jo, Junghyo] Asia Pacific Ctr Theoret Phys, Pohang, Gyeongbuk, South Korea; [Lee, Kayoung; Kim, Jaeyoon; Berggren, Per-Olof; Ryu, Sung Ho] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeongbuk, South Korea; [Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Jo, Junghyo] Pohang Univ Sci & Technol, Dept Phys, Pohang, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Asia Pacific Center for Theoretical Physics; Pohang University of Science & Technology (POSTECH); Karolinska Institutet; Pohang University of Science & Technology (POSTECH)	Jo, J (corresponding author), Asia Pacific Ctr Theoret Phys, Pohang, Gyeongbuk, South Korea.; Jo, J (corresponding author), Pohang Univ Sci & Technol, Dept Phys, Pohang, Gyeongbuk, South Korea.	jojunghyo@apctp.org		Berggren, Per-Olof/0000-0001-8991-413X; Song, Taegeun/0000-0002-1511-6626	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03932264]; Max Planck Society; Korean Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City; NRF - Ministry of Science, ICT & Future Planning [2016K1A1A2912722]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Max Planck Society(Max Planck Society); Korean Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City; NRF - Ministry of Science, ICT & Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF, www.nrf.re.kr), funded by the Ministry of Education (2016R1D1A1B03932264), the Max Planck Society, and the Korean Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City (J.J.), and by the NRF funded by the Ministry of Science, ICT & Future Planning (2016K1A1A2912722) (S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2016R1D1A 1B03932264), the Max Planck Society, and the Korean Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City (J.J.), and by the NRF funded by the Ministry of Science, ICT & Future Planning (2016K1A1A2912722) (S.R.).	Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Barbosa RM, 1998, J PHYSIOL-LONDON, V510, P135, DOI 10.1111/j.1469-7793.1998.135bz.x; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; BERGGREN PO, 1993, ADV EXP MED BIOL, V334, P25; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Braun M, 2012, DIABETES OBES METAB, V14, P143, DOI 10.1111/j.1463-1326.2012.01642.x; Dhumpa R, 2015, INTEGR BIOL-UK, V7, P1061, DOI 10.1039/c5ib00156k; Dhumpa R, 2014, BIOPHYS J, V106, P2275, DOI 10.1016/j.bpj.2014.04.015; Gilon P, 2002, DIABETES, V51, pS144, DOI 10.2337/diabetes.51.2007.S144; Goldbeter A., 1996, BIOCH OSCILLATIONS C, Vxxiv; HOM FG, 1981, AM J PHYSIOL, V240, pE1, DOI 10.1152/ajpendo.1981.240.1.E1; Hussain MA, 1999, EUR J ENDOCRINOL, V141, P95, DOI 10.1530/eje.0.1410095; Jimenez-Feltstrom J, 2004, REGUL PEPTIDES, V122, P109, DOI 10.1016/j.regpep.2004.06.004; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; KARLSSON FA, 1979, P NATL ACAD SCI USA, V76, P809, DOI 10.1073/pnas.76.2.809; Khan FA, 2001, DIABETES, V50, P2192, DOI 10.2337/diabetes.50.10.2192; Koh DS, 2012, J MOL NEUROSCI, V48, P429, DOI 10.1007/s12031-012-9752-2; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Lee B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172901; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; LI YX, 1992, BIOPHYS J, V61, P161, DOI 10.1016/S0006-3495(92)81824-6; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; McKenna JP, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005143; Nunemaker CS, 2006, BIOPHYS J, V91, P2082, DOI 10.1529/biophysj.106.087296; Pedersen MG, 2013, BIOPHYS J, V105, P29, DOI 10.1016/j.bpj.2013.05.036; Press WH., 2002, NUMERICAL RECIPES C, V2; Rhodes CJ, 2013, DIABETES, V62, P2157, DOI 10.2337/db13-0246; Rosenblum R, 2001, NEUROINFORMATICS NEU, P279; SHINOMOTO S, 1986, PROG THEOR PHYS, V75, P1105, DOI 10.1143/PTP.75.1105; STURIS J, 1991, J CLIN INVEST, V87, P439, DOI 10.1172/JCI115015; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Zarkovic M, 2004, AM J PHYSIOL-ENDOC M, V287, pE340, DOI 10.1152/ajpendo.00069.2004; Zhang XY, 2011, AM J PHYSIOL-ENDOC M, V301, pE742, DOI 10.1152/ajpendo.00248.2011	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183569	10.1371/journal.pone.0183569	http://dx.doi.org/10.1371/journal.pone.0183569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846705	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600036
J	Schmuckli-Maurer, J; Reber, V; Wacker, R; Bindschedler, A; Zakher, A; Heussler, VT				Schmuckli-Maurer, Jacqueline; Reber, Vera; Wacker, Rahel; Bindschedler, Annina; Zakher, Anthony; Heussler, Volker Theo			Inverted recruitment of autophagy proteins to the Plasmodium berghei parasitophorous vacuole membrane	PLOS ONE			English	Article							TOXOPLASMA-GONDII; HOST HEPATOCYTES; LIVER STAGE; UBIQUITIN; DEGRADATION; OPTINEURIN; CELLS; LC3; RECEPTORS; BINDING	Selective autophagy and related mechanisms can act as variable defense mechanisms against pathogens and can therefore be considered as intracellular immune responses. When in hepatocytes, Plasmodium parasites reside in a parasitophorous vacuole (PV) and the PV membrane (PVM) is the main contact site between host cell and parasite. Early in infection, the PVM is directly labeled with host cell autophagy proteins LC3B and p62 (nucleoporin 62). We investigated the recruitment of different selective autophagy receptors and could show that mainly p62 and NBR1 (neighbour of BRCA1 gene 1) and to a lesser extent NDP52 (nuclear dot protein 52) associate with the PVM. To investigate the recruitment of these receptors to the PVM in Plasmodium-infected cells, we generated LC3B knock out HeLa cells. In these cell lines, autophagosome formation and autophagic flux are not different to those in WT cells. Unexpectedly, p62 and NBR1 recruitment to the PVM was strongly impaired in LC3B-negative host cells, suggesting that LC3B recruits both receptors to the PVM of Plasmodium parasites. We also noticed that LC3B recruited ubiquitin to the PVM. This indicates that, in comparison to classical selective autophagy, in P. berghei-infected cells the order of membrane labeling with autophagy proteins appears to be inverted from canonical ubiquitin-receptor-LC3B recruitment to LC3B-receptor and possibly ubiquitin.	[Schmuckli-Maurer, Jacqueline; Reber, Vera; Wacker, Rahel; Bindschedler, Annina; Zakher, Anthony; Heussler, Volker Theo] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Wacker, Rahel] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland	University of Bern; University of Bern	Schmuckli-Maurer, J (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	jacqueline.schmuckli@izb.unibe.ch	Heussler, Volker/H-9322-2019	Heussler, Volker/0000-0001-8028-9825; Bindschedler, Annina/0000-0003-0336-0864	Schweizerischer Nationalfond [310030_159519]	Schweizerischer Nationalfond	Funded by Schweizerischer Nationalfond, grant 310030_159519 to VTH, www.snf.ch.EviMalaR EU consortium to VTH and RW, www.evimalar.org.	Agop-Nersesian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02156-7; Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Bano N, 2007, INT J PARASITOL, V37, P1329, DOI 10.1016/j.ijpara.2007.04.005; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Burda PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004760; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hanson KK, 2014, BIOL OPEN, V3, P103, DOI 10.1242/bio.20136833; Isakson P, 2013, AUTOPHAGY, V9, P1955, DOI 10.4161/auto.26085; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Khaminets A., 2015, TRENDS CELL BIOL; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Muniz-Feliciano L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003809; Nguyen TN, 2016, J CELL BIOL; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Prado M, 2015, AUTOPHAGY, V11, P1561, DOI 10.1080/15548627.2015.1067361; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Sturm A, 2007, MED MICROBIOL IMMUN, V196, P127, DOI 10.1007/s00430-007-0044-3; Thieleke-Matos C, 2016, CELL MICROBIOL, V18, P437, DOI 10.1111/cmi.12524; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Wacker R, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12754; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	47	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183797	10.1371/journal.pone.0183797	http://dx.doi.org/10.1371/journal.pone.0183797			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841718	Green Published, gold			2022-12-26	WOS:000408370700058
J	Wessel, O; Braaen, S; Alarcon, M; Haatveit, H; Roos, N; Markussen, T; Tengs, T; Dahle, MK; Rimstad, E				Wessel, Oystein; Braaen, Stine; Alarcon, Marta; Haatveit, Hanne; Roos, Norbert; Markussen, Turhan; Tengs, Torstein; Dahle, Maria K.; Rimstad, Espen			Infection with purified Piscine orthoreovirus demonstrates a causal relationship with heart and skeletal muscle inflammation in Atlantic salmon	PLOS ONE			English	Article							PANCREAS DISEASE; REOVIRUS PRV; SALAR L.; RESPONSES; OUTBREAK; NUMBER; HSMI	Viral diseases pose a significant threat to the productivity in aquaculture. Heart-and skeletal muscle inflammation (HSMI) is an emerging disease in Atlantic salmon (Salmo salar) farming. HSMI is associated with Piscine orthoreovirus (PRV) infection, but PRV is ubiquitous in farmed Atlantic salmon and thus present also in apparently healthy individuals. This has brought speculations if additional etiological factors are required, and experiments focusing on the causal relationship between PRV and HSMI are highly warranted. A major bottleneck in PRV research has been the lack of cell lines that allow propagation of the virus. To bypass this, we propagated PRV in salmon, bled the fish at the peak of the infection, and purified virus particles from blood cells. Electron microscopy, western blot and high-throughput sequencing all verified the purity of the viral particles. Purified PRV particles were inoculated into naive Atlantic salmon. The purified virus replicated in inoculated fish, spread to naive cohabitants, and induced histopathological changes consistent with HSMI. PRV specific staining was demonstrated in the pathological lesions. A dose-dependent response was observed; a high dose of virus gave earlier peak of the viral load and development of histopathological changes compared to a lower dose, but no difference in the severity of the disease. The experiment demonstrated that PRV can be purified from blood cells, and that PRV is the etiological agent of HSMI in Atlantic salmon.	[Wessel, Oystein; Braaen, Stine; Haatveit, Hanne; Markussen, Turhan; Rimstad, Espen] Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway; [Alarcon, Marta] Norwegian Vet Inst, Harstad, Norway; [Roos, Norbert] Univ Oslo, Dept Biosci, Oslo, Norway; [Tengs, Torstein] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway; [Dahle, Maria K.] Norwegian Vet Inst, Oslo, Norway	Norwegian University of Life Sciences; Norwegian Veterinary Institute; University of Oslo; Norwegian University of Life Sciences; Norwegian Veterinary Institute	Wessel, O (corresponding author), Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway.	oystein.wessel@nmbu.no	Dahle, Maria K/AAK-5130-2021	Dahle, Maria K/0000-0003-0380-084X; Wessel, Oystein/0000-0002-0811-7305	Research Council of Norway [237315/E40, 245286]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway Grant No. 237315/E40 and 245286 (http://www.forskningsradet.no/en/Home_page/1177315753906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Attoui H., 2012, VIRUS TAXONOMY, P541, DOI [DOI 10.1016/B978-0-12-384684-6.00051-3, 10.1016/B978-0-12-384684-6.00051-3]; Berard A, 2009, CURRENT PROTOCOLS MI; BRUNER R, 1965, BIOCHIM BIOPHYS ACTA, V108, P18, DOI 10.1016/0005-2787(65)90104-8; Collet B, 2014, DEV COMP IMMUNOL, V43, P160, DOI 10.1016/j.dci.2013.08.017; Dahle MK, 2015, FISH SHELLFISH IMMUN, V45, P780, DOI 10.1016/j.fsi.2015.05.049; Di Cicco E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171471; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Garseth AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082202; Garver KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146229; Godoy MG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0554-y; Haatveit HM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030049; Johansen LH, 2015, FISH SHELLFISH IMMUN, V46, P612, DOI 10.1016/j.fsi.2015.07.023; Key T, 2013, J GEN VIROL, V94, P1039, DOI 10.1099/vir.0.048637-0; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kongtorp RT, 2006, J FISH DIS, V29, P233, DOI 10.1111/j.1365-2761.2006.00710.x; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Lund M, 2016, VET RES, V47, DOI 10.1186/s13567-016-0389-y; Markussen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070075; Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; Mendez II, 2000, J VIROL METHODS, V90, P59, DOI 10.1016/S0166-0934(00)00217-2; Nibert ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068607; Olsen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131638; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Siah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141475; Takano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165424; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Walker PJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010022; Wessel O, 2015, VET RES, V46	38	70	72	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183781	10.1371/journal.pone.0183781	http://dx.doi.org/10.1371/journal.pone.0183781			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841684	Green Published, gold			2022-12-26	WOS:000408370700057
J	Liao, LE; Kowal, S; Cardenas, DA; Beauchemin, CAA				Liao, Laura E.; Kowal, Szymon; Cardenas, Daniel A.; Beauchemin, Catherine A. A.			Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors	PLOS ONE			English	Article							CELL-CULTURE; RESISTANCE; HIV-1; REPLICATION; FAVIPIRAVIR; GENERATION; CLEARANCE; LACKING; HUMANS	Mathematical models (MMs) have been used to study the kinetics of influenza A virus infections under antiviral therapy, and to characterize the efficacy of antivirals such as neuraminidase inhibitors (NAIs). NAIs prevent viral neuraminidase from cleaving sialic acid receptors that bind virus progeny to the surface of infected cells, thereby inhibiting their release, suppressing infection spread. When used to study treatment with NAIs, MMs represent viral release implicitly as part of viral replication. Consequently, NAIs in such MMs do not act specifically and exclusively on virus release. We compared a MM with an explicit representation of viral release (i.e., distinct from virus production) to a simple MM without explicit release, and investigated whether parameter estimation and the estimation of NAI efficacy were affected by the use of a simple MM. Since the release rate of influenza A virus is not well-known, a broad range of release rates were considered. If the virus release rate is greater than similar to 0.1 h(-1), the simple MM provides accurate estimates of infection parameters, but underestimates NAI efficacy, which could lead to underdosing and the emergence of NAI resistance. In contrast, when release is slower than similar to 0.1 h(-1), the simple MM accurately estimates NAI efficacy, but it can significantly overestimate the infectious lifespan (i.e., the time a cell remains infectious and producing free virus), and it will significantly underestimate the total virus yield and thus the likelihood of resistance emergence. We discuss the properties of, and a possible lower bound for, the influenza A virus release rate.	[Liao, Laura E.; Kowal, Szymon; Cardenas, Daniel A.; Beauchemin, Catherine A. A.] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Beauchemin, Catherine A. A.] RIKEN, Interdisciplinary Theoret & Math Sci iTHES, iTHEMS Res Grp, Wako, Saitama, Japan	Toronto Metropolitan University; RIKEN	Beauchemin, CAA (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.; Beauchemin, CAA (corresponding author), RIKEN, Interdisciplinary Theoret & Math Sci iTHES, iTHEMS Res Grp, Wako, Saitama, Japan.	cbeau@ryerson.ca	Beauchemin, Catherine AA/G-4619-2011	Beauchemin, Catherine AA/0000-0003-0599-0069; Liao, Laura/0000-0001-6069-2633; Cardenas, Daniel/0000-0002-9785-0858	Natural Sciences and Engineering Research Council of Canada [355837-2013]; Ministry of Research and Innovation and Science of the Government of Ontario [ER13-09-040]; Interdisciplinary Theoretical and Mathematical Sciences (iTHES); Ontario Graduate Scholarship from Government of Ontario; Doctoral Canadian Graduate Scholarship (CGS-D) from Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministry of Research and Innovation and Science of the Government of Ontario; Interdisciplinary Theoretical and Mathematical Sciences (iTHES); Ontario Graduate Scholarship from Government of Ontario; Doctoral Canadian Graduate Scholarship (CGS-D) from Natural Sciences and Engineering Research Council of Canada	This work was supported in part by Discovery Grant 355837-2013 from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca), and by Early Researcher Award ER13-09-040 from the Ministry of Research and Innovation and Science of the Government of Ontario (www.ontario.ca/page/early-researcher-awards), both awarded to CAAB, and by the Interdisciplinary Theoretical and Mathematical Sciences (iTHES, ithes.riken.jp; iTHEMS, ithems.riken.jp) research programmes at RIKEN (CAAB). Additional support in the form of an Ontario Graduate Scholarship from the Government of Ontario (www.osap.gov.on.ca) (LEL), a Michael Smith Foreign Study Supplement and a Doctoral Canadian Graduate Scholarship (CGS-D) from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) were awarded to LEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; Beauchemin CAA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S7; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; DANIELS PU, 1989, FEBS LETT, V244, P57, DOI 10.1016/0014-5793(89)81161-5; Dobrovolny HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057088; Dobrovolny HM, 2011, J THEOR BIOL, V269, P234, DOI 10.1016/j.jtbi.2010.10.017; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Gubareva LV, 2002, J GEN VIROL, V83, P2683, DOI 10.1099/0022-1317-83-11-2683; Handel A, 2007, PLOS COMPUT BIOL, V3, P2456, DOI 10.1371/journal.pcbi.0030240; Handel A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1083; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Holder BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014767; Holder BP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S10; Holder BP, 2011, AUTOIMMUNITY, V44, P282, DOI 10.3109/08916934.2011.523267; Hoopes JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029778; Hughes MT, 2000, J VIROL, V74, P5206, DOI 10.1128/JVI.74.11.5206-5212.2000; Iwami S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00319; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; KUNDU A, 1994, J VIROL, V68, P1812, DOI 10.1128/JVI.68.3.1812-1818.1994; Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Mitchell H, 2011, J VIROL, V85, P1125, DOI 10.1128/JVI.01722-10; Nunes-Correia I, 1999, BIOCHEMISTRY-US, V38, P1095, DOI 10.1021/bi9812524; Paradis EG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126115; Perelson AS, 2012, J INFECT DIS, V205, P1642, DOI 10.1093/infdis/jis265; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pinilla LT, 2012, J VIROL, V86, P10651, DOI 10.1128/JVI.07244-11; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Simon PF, 2016, SCI REP-UK, V6, DOI 10.1038/srep24154; Tarbet EB, 2014, ARCH VIROL, V159, P1279, DOI 10.1007/s00705-013-1922-1; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; Weinstock DM, 2006, JAMA-J AM MED ASSOC, V295, P934, DOI 10.1001/jama.295.8.934; World Health Organization, 2016, INFL SEAS, P211	35	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183621	10.1371/journal.pone.0183621	http://dx.doi.org/10.1371/journal.pone.0183621			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837615	gold, Green Submitted, Green Published			2022-12-26	WOS:000408365000089
J	Ratnasari, N; Nurdjanah, S; Sadewa, AH; Hakimi, M; Yano, Y				Ratnasari, Neneng; Nurdjanah, Siti; Sadewa, Ahmad Hamim; Hakimi, Mohammad; Yano, Yoshihiko			Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; ANGIOGENESIS; EXPRESSION	Background The VEGF gene polymorphism rs699947 related to clinical pathology, mortality, and recurrence of HCC. Few studies mentioned an association between VEGF gene polymorphisms with illness progression in chronic liver disease. We aimed to explore differences of VEGF gene polymorphism rs699947 in chronic hepatitis, liver cirrhosis and hepatocellular carcinoma patients in Indonesian population. Methods A cross-sectional study with consecutive sampling and without matching was performed during a 3 years period (2011-2014) at Dr. Sardjito General Hospital Yogyakarta, Indonesia. Blood DNA was sequenced from 123 subjects with chronic liver diseases [39 chronic hepatitis (CH), 39 liver cirrhosis (LC), and 45 hepatocellular carcinoma (HCC)]. 59 healthy subjects also participated. Using isolated VEGF genes for specific primers for rs699947, blood samples were examined by targeting DNA sequences with Applied Bio systems. All data were analyzed using STATA version 11.0 with significance level at P<0.05. Results The mean of age in HCC and LC subjects were older than in CH and healthy (P value <0.05); there were more males in LC, HCC and the healthy groups but not in CH (P>0.05). HBV was the dominant etiology in HCC, LC, and CH besides HCV and non HBV-HCV (P<0.05). There were significant differences in the SNP -2578 distributions of allele C compared to allele A in all subjects (healthy vs. LC, and HCC; LC vs. CH (P<0.05), but no significant difference A>C vs. C>C, and genotypes distribution. Proportion of SNP -2578 A>C vs. C>C CH 1.8:1; HCC 1.4:1; healthy 1.7:1; but its proportion in LC was inversed (1:1.2). Genotype A was low in all subjects (5%-11%). Significant difference of allele distribution was found in healthy vs. LC, and HCC; CH vs. LC. Based on HWE analyses, distribution of allele C was dominant. There were not significant differences in deletion, insertion-deletion at -2547 until -2526, and haplotype (Ht) CCGACCCC (P>0.05). The OR analyses of allele and SNP showed that allele A can be a predictor of disease progression in LC to HCC (OR 2.26) and healthy to LC (OR 1.65); and SNP A>C also can be a predictor in healthy to HCC (OR 1.41) and CH (OR 1.14). Conclusion The occurrence of allele A and SNP A>C VEGF gene (-2578) might predict illness progression from healthy to CH, LC or HCC and LC to HCC.	[Ratnasari, Neneng; Nurdjanah, Siti] Gadjah Mada Univ, Dr Sardjito Hosp, Fac Med, Dept Internal Med, Yogyakarta, Indonesia; [Sadewa, Ahmad Hamim] Gadjah Mada Univ, Fac Med, Dept Biochem, Yogyakarta, Indonesia; [Hakimi, Mohammad] Gadjah Mada Univ, Fac Med, Dept Publ Hlth, Yogyakarta, Indonesia; [Yano, Yoshihiko] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Kobe, Hyogo, Japan	Central General Hospital Dr. Sardjito; Gadjah Mada University; Gadjah Mada University; Gadjah Mada University; Kobe University	Ratnasari, N (corresponding author), Gadjah Mada Univ, Dr Sardjito Hosp, Fac Med, Dept Internal Med, Yogyakarta, Indonesia.	nenengratnasari@yahoo.com	Ahmad Hamim, Sadewa/GPC-7031-2022; Ratnasari, Neneng/GLN-5795-2022; Hakimi, Mohammad/GOV-6587-2022	Ahmad Hamim, Sadewa/0000-0002-3514-6646; Ratnasari, Neneng/0000-0003-1323-2233				Cha C, 2005, BEST PRACT RES CL GA, V19, P25, DOI 10.1016/j.bpg.2004.11.005; Chen JA, 2010, HEPATOL INT, V4, P537, DOI 10.1007/s12072-010-9192-4; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; Coulon S, 2011, LIVER INT, V31, P146, DOI 10.1111/j.1478-3231.2010.02369.x; Elpek GO, 2015, WORLD J HEPATOL, V7, P377, DOI 10.4254/wjh.v7.i3.377; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Heriyanto DS, 2012, J MED VIROL, V84, P44, DOI 10.1002/jmv.22266; Hong TT, 2012, MOL BIOL REP, V39, P5283, DOI 10.1007/s11033-011-1326-9; Jin QR, 2005, CLIN CANCER RES, V11, P3647, DOI 10.1158/1078-0432.CCR-04-1803; Juniastuti, 2013, BIOMED REP, V1, P522, DOI 10.3892/br.2013.106; Kew MC, 1997, YALE J BIOL MED, V70, P119; Kong SY, 2007, HEPATOLOGY, V46, P446, DOI 10.1002/hep.21720; Korpanty G, 2010, J ONCOL, V2010, DOI 10.1155/2010/652320; Lai WK, 2005, J HEPATOL, V42, P7, DOI 10.1016/j.jhep.2004.11.008; Liu L, 2011, J CANCER RES CLIN, V137, P1027, DOI 10.1007/s00432-010-0966-9; Mendez-Sanchez N, 2008, ANN HEPATOL, V7, P46; Mohammadi Mojgan, 2003, Human Immunology, V64, pS125, DOI 10.1016/j.humimm.2003.08.234; Murakami Y, 2005, GUT, V54, P1162, DOI 10.1136/gut.2004.054452; Ratnasari N, 2016, ARAB J GASTROENTEROL, V17, P61, DOI 10.1016/j.ajg.2016.06.005; Rosmorduc O, 1999, AM J PATHOL, V155, P1065, DOI 10.1016/S0002-9440(10)65209-1; Sakakura C, 1999, BRIT J CANCER, V80, P2034, DOI 10.1038/sj.bjc.6690638; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Shahbazi M, 2002, J AM SOC NEPHROL, V13, P260, DOI 10.1681/ASN.V131260; Tamori A, 2005, CLIN CANCER RES, V11, P5821, DOI 10.1158/1078-0432.CCR-04-2055; Wu LM, 2009, ARCH MED RES, V40, P565, DOI 10.1016/j.arcmed.2009.07.011; Wu XP, 2013, INT J CANCER, V133, P1085, DOI 10.1002/ijc.28109	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183503	10.1371/journal.pone.0183503	http://dx.doi.org/10.1371/journal.pone.0183503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837651	gold, Green Submitted, Green Published			2022-12-26	WOS:000408365000073
J	Lee, J; Tam, H; Adler, L; Ilstad-Minnihan, A; Macaubas, C; Mellins, ED				Lee, Justin; Tam, Hanson; Adler, Lital; Ilstad-Minnihan, Alexandra; Macaubas, Claudia; Mellins, Elizabeth D.			The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INVARIANT CHAIN; HLA-DR; CD14(++)CD16(+) MONOCYTES; DENDRITIC CELLS; MACROPHAGES; EXPRESSION; COMPLEXES; DM; DIFFERENTIATION	Monocytes play a critical role in the innate and adaptive immune systems, performing phagocytosis, presenting antigen, and producing cytokines. They are a heterogeneous population that has been divided in humans into classical, intermediate, and non-classical subsets, but the roles of these subsets are incompletely understood. In this study, we investigated the expression patterns of MHC class II (MHCII) and associated molecules and find that the intermediate monocytes express the highest levels of the MHC molecules, HLA-DR (tested in n = 30 samples), HLA-DP (n = 30), and HLA-DQ (n = 10). HLA-DM (n = 30), which catalyzes the peptide exchange on the MHC molecules, is also expressed at the highest levels in intermediate monocytes. To measure HLA-DM function, we measured levels of MHCII-bound CLIP (class II invariant chain peptide, n = 23), which is exchanged for other peptides by HLA-DM. We calculated CLIP: MHCII ratios to normalize CLIP levels to MHCII levels, and found that intermediate monocytes have the lowest CLIP: MHCII ratio. We isolated the different monocyte subsets (in a total of 7 samples) and analyzed their responses to selected cytokines as model of monocyte activation: two M1-polarizing cytokines (IFN., GM-CSF), an M2-polarizing cytokine (IL-4) and IL-10. Classical monocytes exhibit the largest increases in class II pathway expression in response to stimulatory cytokines (IFN., GM-CSF, IL-4). All three subsets decrease HLA-DR levels after IL-10 exposure. Our findings argue that intermediate monocytes are the most efficient constitutive antigen presenting subset, that classical monocytes are recruited into an antigen presentation role during inflammatory responses and that IL-10 negatively regulates this function across all subsets.	[Lee, Justin; Tam, Hanson; Adler, Lital; Ilstad-Minnihan, Alexandra; Macaubas, Claudia; Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Program Immunol, Stanford, CA 94305 USA; [Lee, Justin] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Macaubas, C; Mellins, ED (corresponding author), Stanford Univ, Dept Pediat, Program Immunol, Stanford, CA 94305 USA.	macaubas@stanford.edu; mellins@stanford.edu		Mellins, Elizabeth/0000-0003-2577-139X; Tam, Hanson/0000-0001-5772-0680; Macaubas, Claudia/0000-0002-5472-8086	National Institutes of Health (NIH) [R01 AR066551]; Shriners Hospital [85100]; Cure JM Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital; Cure JM Foundation	This work was supported by National Institutes of Health (NIH) R01 AR066551 to EDM; Shriners Hospital Grant 85100 to EDM; and Cure JM Foundation to EDM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles D, 2012, CYTOM PART A, V81A, P823, DOI 10.1002/cyto.a.22104; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Cao ZA, 2000, EUR J IMMUNOL, V30, P2604, DOI 10.1002/1521-4141(200009)30:9<2604::AID-IMMU2604>3.0.CO;2-6; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Fromm SV, 2001, J INTERF CYTOK RES, V21, P199, DOI 10.1089/107999001750169790; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gren ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144351; HERSHMAN MJ, 1989, CLIN EXP IMMUNOL, V77, P67; Hijdra D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00339; Hornell TMC, 2003, J IMMUNOL, V171, P2374, DOI 10.4049/jimmunol.171.5.2374; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Lachmann G, 2017, INT J MED SCI, V14, P367, DOI 10.7150/ijms.18288; LAH TT, 1995, FEBS LETT, V363, P85; Liu BY, 2015, J IMMUNOL, V194, P5150, DOI 10.4049/jimmunol.1402409; MALEFYT RD, 1991, J EXP MED, V174, P915; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; Muczynski KA, 1998, J IMMUNOL, V160, P3207; Mukherjee R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13886; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Reading JL, 2015, MOL THER, V23, P1783, DOI 10.1038/mt.2015.131; Sanchez-Torres C, 2001, INT IMMUNOL, V13, P1571, DOI 10.1093/intimm/13.12.1571; Semnani RT, 2014, INFECT IMMUN, V82, P4438, DOI 10.1128/IAI.01973-14; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Spies C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144003; Sprangers S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1475435; Stang E, 1998, J IMMUNOL, V160, P4696; Stansfield BK, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0040-3; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Thomas G.D., 2017, ARTERIOSCLER THROMB; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; van Lith M, 2010, J BIOL CHEM, V285, P40800, DOI 10.1074/jbc.M110.148155; WATSON AJ, 1983, NATURE, V304, P358, DOI 10.1038/304358a0; Wicks IP, 2016, NAT REV RHEUMATOL, V12, P37, DOI 10.1038/nrrheum.2015.161; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Ziegler-Heitbrock L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00423	44	50	53	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183594	10.1371/journal.pone.0183594	http://dx.doi.org/10.1371/journal.pone.0183594			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832681	Green Submitted, Green Published, gold			2022-12-26	WOS:000408355800068
J	Stiegler, SC; Rubbelke, M; Korotkov, VS; Weiwad, M; John, C; Fischer, G; Sieber, SA; Sattler, M; Buchner, J				Stiegler, Sandrine C.; Ruebbelke, Martin; Korotkov, Vadim S.; Weiwad, Matthias; John, Christine; Fischer, Gunter; Sieber, Stephan A.; Sattler, Michael; Buchner, Johannes			A chemical compound inhibiting the Aha1-Hsp90 chaperone complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; biophysics; heat shock protein 90 (Hsp90); molecular chaperone; protein folding; co-chaperones	TRANSMEMBRANE CONDUCTANCE REGULATOR; GLUCOCORTICOID-RECEPTOR FUNCTION; CLIENT PROTEIN-ACTIVATION; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; CYSTIC-FIBROSIS; COCHAPERONE AHA1; ATPASE ACTIVITY; MINERALOCORTICOID RECEPTOR; CONFORMATIONAL-CHANGES	The eukaryotic Hsp90 chaperone machinery comprises many co-chaperones and regulates the conformation of hundreds of cytosolic client proteins. Therefore, it is not surprising that the Hsp90 machinery has become an attractive therapeutic target for diseases such as cancer. The compounds used so far to target this machinery affect the entire Hsp90 system. However, it would be desirable to achieve a more selective targeting of Hsp90-co-chaperone complexes. To test this concept, in this-proof-of-principle study, we screened for modulators of the interaction between Hsp90 and its co-chaperone Aha1, which accelerates the ATPase activity of Hsp90. A FRET-based assay that monitored Aha1 binding to Hsp90 enabled identification of several chemical compounds modulating the effect of Aha1 on Hsp90 activity. We found that one of these inhibitors can abrogate the Aha1-induced ATPase stimulation of Hsp90 without significantly affecting Hsp90 ATPase activity in the absence of Aha1. NMR spectroscopy revealed that this inhibitory compound binds the N-terminal domain of Hsp90 close to its ATP-binding site and overlapping with a transient Aha1-interaction site. We also noted that this inhibitor does not dissociate the Aha1-Hsp90 complex but prevents the specific interaction with the N-terminal domain of Hsp90 required for catalysis. In consequence, the inhibitor affected the activation and processing of Hsp90-Aha1-dependent client proteins in vivo. We conclude that it is possible to abrogate a specific co-chaperone function of Hsp90 without inhibiting the entire Hsp90 machinery. This concept may also hold true for other co-chaperones of Hsp90.	[Stiegler, Sandrine C.; Ruebbelke, Martin; Korotkov, Vadim S.; John, Christine; Sieber, Stephan A.; Sattler, Michael; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany; [Weiwad, Matthias; Fischer, Gunter] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany; [Ruebbelke, Martin; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Weiwad, Matthias] Martin Luther Univ Halle Wittenberg, Inst Biochem, Weinbergweg 22, D-06120 Halle, Germany; [Fischer, Gunter] Max Planck Inst Biophys Chem Goettingen, Weinbergweg 22, D-06120 Halle, Germany	Technical University of Munich; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Martin Luther University Halle Wittenberg	Buchner, J (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany.	johannes.buchner@tum.de	Buchner, Johannes/A-2651-2010; Sattler, Michael/A-2407-2012	Sattler, Michael/0000-0002-1594-0527; Buchner, Johannes/0000-0003-1282-7737	BMBF [ProNet T3]; Deutsche Forschungsgemeinschaft [SFB 1035]; Studienstiftung des deutschen Volkes	BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	This work was supported by a grant from the BMBF Project ProNet T3 (to J. B.), Deutsche Forschungsgemeinschaft Grant SFB 1035 (to J. B., M. S., and S. A. S.), and a doctoral scholarship from the Studienstiftung des deutschen Volkes (to S. C. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Amaral MD, 2006, J INHERIT METAB DIS, V29, P477, DOI 10.1007/s10545-006-0251-x; Bamberger CM, 1997, MOL CELL ENDOCRINOL, V131, P233, DOI 10.1016/S0303-7207(97)00115-9; Brodsky JL, 1998, BIOCHEMISTRY-US, V37, P18045, DOI 10.1021/bi980900g; Bruner KL, 1997, RECEPT SIGNAL TRANS, V7, P85; Buchner J, 1998, METHOD ENZYMOL, V290, P418, DOI 10.1016/S0076-6879(98)90035-0; Burlison JA, 2006, ORG LETT, V8, P4855, DOI 10.1021/ol061918j; Chong P. A., 2013, COLD SPRING HARB PER, V3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunn DM, 2015, CELL REP, V12, P1006, DOI 10.1016/j.celrep.2015.07.004; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Eskew JD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-468; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Ihrig V, 2017, SLAS DISCOV, V22, P923, DOI 10.1177/2472555216688312; Johnson JL, 2000, MOL CELL BIOL, V20, P3027, DOI 10.1128/MCB.20.9.3027-3036.2000; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2013, NAT STRUCT MOL BIOL, V20, P326, DOI 10.1038/nsmb.2502; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lin TY, 2008, EXP HEMATOL, V36, P1266, DOI 10.1016/j.exphem.2008.05.001; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; PIND S, 1994, J BIOL CHEM, V269, P12784; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Ratzke C, 2012, J MOL BIOL, V423, P462, DOI 10.1016/j.jmb.2012.07.026; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Rosenhagen MC, 2001, BIOL CHEM, V382, P499, DOI 10.1515/BC.2001.063; Sahasrabudhe P, 2017, MOL CELL, V67, P947, DOI 10.1016/j.molcel.2017.08.004; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Skinner SP, 2016, J BIOMOL NMR, V66, P111, DOI 10.1007/s10858-016-0060-y; Smale S. T., 2010, COLD SPRING HARB PRO, V5, P5423, DOI DOI 10.1101/PDB.PROT5423; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; SUSEK RE, 1990, MOL CELL BIOL, V10, P6362, DOI 10.1128/MCB.10.12.6362; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zierer BK, 2014, ANGEW CHEM INT EDIT, V53, P12257, DOI 10.1002/anie.201406578	65	25	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17073	17083		10.1074/jbc.M117.797829	http://dx.doi.org/10.1074/jbc.M117.797829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28851842	hybrid, Green Published			2022-12-26	WOS:000413140600026
J	Haertle, L; Maierhofer, A; Bock, J; Lehnen, H; Bottcher, Y; Bluher, M; Schorsch, M; Potabattula, R; El Hajj, N; Appenzeller, S; Haaf, T				Haertle, Larissa; Maierhofer, Anna; Boeck, Julia; Lehnen, Harald; Boettcher, Yvonne; Blueher, Matthias; Schorsch, Martin; Potabattula, Ramya; El Hajj, Nady; Appenzeller, Silke; Haaf, Thomas			Hypermethylation of the non-imprinted maternal MEG3 and paternal MEST alleles is highly variable among normal individuals	PLOS ONE			English	Article							DNA METHYLATION; DEVELOPMENTAL ORIGINS; HUMAN PEG1/MEST; EXPRESSION; GENE; TISSUE; IGF2; EPIGENETICS; MECHANISMS; EXPOSURE	Imprinted genes show parent-specific activity (functional haploidy), which makes them particularly vulnerable to epigenetic dysregulation. Here we studied the methylation profiles of oppositely imprinted genes at single DNA molecule resolution by two independent parental allele-specific deep bisulfite sequencing (DBS) techniques. Using Roche (GSJunior) next generation sequencing technology, we analyzed the maternally imprinted MEST promoter and the paternally imprinted MEG3 intergenic (IG) differentially methylated region (DMR) in fetal cord blood, adult blood, and visceral adipose tissue. Epimutations were defined as paternal or maternal alleles with >50% aberrantly (de) methylated CpG sites, showing the wrong methylation imprint. The epimutation rates (range 2-66%) of the paternal MEST and the maternal MEG3 IG DMR allele, which should be completely unmethylated, were significantly higher than those (0-15%) of the maternal MEST and paternal MEG3 alleles, which are expected to be fully methylated. This hypermethylation of the non-imprinted allele (HNA) was independent of parental origin. Very low epimutation rates in sperm suggest that HNA occurred after fertilization. DBS with Illumina (MiSeq) technology confirmed HNA for the MEST promoter and the MEG3 IG DMR, and to a lesser extent, for the paternally imprinted secondary MEG3 promoter and the maternally imprinted PEG3 promoter. HNA leads to biallelic methylation of imprinted genes in a considerable proportion of normal body cells (somatic mosaicism) and is highly variable between individuals. We propose that during development and differentiation maintenance of differential methylation at most imprinting control regions may become to some extent redundant. The accumulation of stochastic and environmentally-induced methylation errors on the non-imprinted allele may increase epigenetic diversity between cells and individuals.	[Haertle, Larissa; Maierhofer, Anna; Boeck, Julia; Potabattula, Ramya; El Hajj, Nady; Haaf, Thomas] Julius Maximilians Univ, Inst Human Genet, Wurzburg, Germany; [Lehnen, Harald] Municipal Clin, Dept Gynecol & Obstet, Monchengladbach, Germany; [Boettcher, Yvonne; Blueher, Matthias] Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany; [Boettcher, Yvonne] Univ Oslo, Inst Clin Med, Lorenskog, Norway; [Schorsch, Martin] Fertil Ctr, Wiesbaden, Germany; [Appenzeller, Silke] Julius Maximilians Univ, Core Unit Syst Med, Wurzburg, Germany; [Appenzeller, Silke] Julius Maximilians Univ, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany	University of Wurzburg; University of Oslo; University of Wurzburg; University of Wurzburg	Haaf, T (corresponding author), Julius Maximilians Univ, Inst Human Genet, Wurzburg, Germany.	thomas.haaf@uni-wuerzburg.de		Haertle, Larissa/0000-0002-3927-9163; Appenzeller, Silke/0000-0002-5472-8692; Potabattula, Ramya/0000-0002-2858-8104; El Hajj, Nady/0000-0003-3420-8531	Wuerzburg Human Genetics Institute	Wuerzburg Human Genetics Institute	There was no grant support. The study was funded by revenues of the Wuerzburg Human Genetics Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Beygo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076953; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Eggermann T, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0143-8; El Hajj N, 2014, REPRODUCTION, V148, pR111, DOI 10.1530/REP-14-0334; El Hajj N, 2013, DIABETES, V62, P1320, DOI 10.2337/db12-0289; el Hajj N, 2013, FERTIL STERIL, V99, P632, DOI 10.1016/j.fertnstert.2012.12.044; Engel N, 2006, HUM MOL GENET, V15, P2945, DOI 10.1093/hmg/ddl237; Estill MS, 2016, FERTIL STERIL, V106, P629, DOI 10.1016/j.fertnstert.2016.05.006; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Geuns E, 2007, EUR J HUM GENET, V15, P352, DOI 10.1038/sj.ejhg.5201759; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Harris RA, 2013, EPIGENETICS-US, V8, P157, DOI 10.4161/epi.23438; del Pozo CH, 2010, OBESITY, V18, P897, DOI 10.1038/oby.2009.374; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Kamei Y, 2007, FEBS LETT, V581, P91, DOI 10.1016/j.febslet.2006.12.002; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Kelsey G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0336; Kim H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv632; Kosaki K, 2000, AM J HUM GENET, V66, P309, DOI 10.1086/302712; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kuhtz J, 2014, HUM REPROD, V29, P1995, DOI 10.1093/humrep/deu155; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Massah S, 2015, CRIT REV BIOCHEM MOL, V50, P337, DOI 10.3109/10409238.2015.1064350; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Murphy SK, 2003, HUM MUTAT, V22, P92, DOI 10.1002/humu.10237; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Rahmann S, 2013, PEERJ PREPRINTS, V1; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Rancourt RC, 2013, FASEB J, V27, P3335, DOI 10.1096/fj.12-225284; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2003, J PHYSIOL-LONDON, V547, P35, DOI 10.1113/jphysiol.2002.033274; Riesewijk AM, 1997, GENOMICS, V42, P236, DOI 10.1006/geno.1997.4731; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Montfoort APA, 2012, HUM REPROD UPDATE, V18, P171, DOI 10.1093/humupd/dmr047; Warnecke PM, 1997, NUCLEIC ACIDS RES, V25, P4422, DOI 10.1093/nar/25.21.4422; Weber M, 2001, MECH DEVELOP, V101, P133, DOI 10.1016/S0925-4773(00)00573-6; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Zhang X, 2010, ENDOCRINOLOGY, V151, P939, DOI 10.1210/en.2009-0657	57	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184030	10.1371/journal.pone.0184030	http://dx.doi.org/10.1371/journal.pone.0184030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854270	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600078
J	Tanaka, T; Watanabe, S; Takahashi, M; Sato, K; Saida, Y; Baba, J; Arita, M; Sato, M; Ohtsubo, A; Shoji, S; Nozaki, K; Ichikawa, K; Kondo, R; Aoki, N; Ohshima, Y; Sakagami, T; Abe, T; Moro, H; Koya, T; Tanaka, J; Kagamu, H; Yoshizawa, H; Kikuchi, T				Tanaka, Tomohiro; Watanabe, Satoshi; Takahashi, Miho; Sato, Ko; Saida, Yu; Baba, Junko; Arita, Masashi; Sato, Miyuki; Ohtsubo, Aya; Shoji, Satoshi; Nozaki, Koichiro; Ichikawa, Kosuke; Kondo, Rie; Aoki, Nobumasa; Ohshima, Yasuyoshi; Sakagami, Takuro; Abe, Tetsuya; Moro, Hiroshi; Koya, Toshiyuki; Tanaka, Junta; Kagamu, Hiroshi; Yoshizawa, Hirohisa; Kikuchi, Toshiaki			Transfer of in vitro-expanded naive T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells	PLOS ONE			English	Article							ADOPTIVE IMMUNOTHERAPY; PROLIFERATION; NEOANTIGENS; SENSITIVITY; BIOMARKERS; BLOCKADE; SINKS	The adoptive transfer of effector T cells combined with lymphodepletion has demonstrated promising antitumor effects in mice and humans, although the availability of tumor-specific T cells is limited. We and others have also demonstrated that the transfer of polyclonal naive T cells induces tumor-specific effector T cells and enhances antitumor immunity after lymphodepletion. Because tumors have been demonstrated to induce immunosuppressive networks and regulate the function of T cells, obtaining a sufficient number of fully functional naive T cells that are able to differentiate into tumor-specific effector T cells remains difficult. To establish culture methods to obtain a large number of polyclonal T cells that are capable of differentiating into tumor-specific effector T cells, naive T cells were activated with anti-CD3 mAbs in vitro. These cells were stimulated with IL-2 and IL-7 for the CD8 subset or with IL-7 and IL-23 for the CD4 subset. Transfer of these hyperexpanded T cells after lymphodepletion showed significant antitumor efficacy, and tumor-specific effector T cells were primed from these expanded T cells in tumor-bearing hosts. Moreover, these ex vivo-D expanded T cells maintained T cell receptor diversity and showed long-term persistence of memory against specific tumors. Further analyses revealed that combination therapy consisting of vaccination with dendritic cells that were co-cultured with irradiated whole tumor cells and the transfer of ex vivo D expanded T cells significantly enhanced antitumor immunity. These results indicate that the transfer of ex vivo D expanded polyclonal T cells can be combined with other immunotherapies and augment antitumor effects.	[Tanaka, Tomohiro; Watanabe, Satoshi; Takahashi, Miho; Sato, Ko; Saida, Yu; Baba, Junko; Arita, Masashi; Sato, Miyuki; Ohtsubo, Aya; Shoji, Satoshi; Nozaki, Koichiro; Ichikawa, Kosuke; Kondo, Rie; Aoki, Nobumasa; Ohshima, Yasuyoshi; Sakagami, Takuro; Abe, Tetsuya; Moro, Hiroshi; Koya, Toshiyuki; Tanaka, Junta; Kikuchi, Toshiaki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, Niigata, Niigata, Japan; [Kagamu, Hiroshi] Saitama Int Med Ctr, Resp Med, Saitama, Japan; [Yoshizawa, Hirohisa] Niigata Univ, Med & Dent Hosp, Biosci Med Res Ctr, Niigata, Niigata, Japan	Niigata University; Niigata University	Watanabe, S (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, Niigata, Niigata, Japan.	satoshi7@med.niigata-u.ac.jp	Tanaka, Junta/GPW-9381-2022	Tanaka, Junta/0000-0001-9907-8147; Moro, Hiroshi/0000-0003-4588-5845	Japan Society for the Promotion of Science [JP15K09168]; Grants-in-Aid for Scientific Research [15K09168] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supproted by Japan Society for the Promotion of Science KAKENHI Grant Number JP15K09168 to SW. http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba J, 2012, BLOOD, V120, P2417, DOI 10.1182/blood-2012-02-411124; Baccala R, 2005, TRENDS IMMUNOL, V26, P5, DOI 10.1016/j.it.2004.11.006; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Camisaschi C, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040038; Devaud C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25961; Dummer W, 2002, J CLIN INVEST, V110, P185, DOI 10.1172/JCI200215175; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Haabeth OAW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00174; Klebanoff CA, 2005, TRENDS IMMUNOL, V26, P111, DOI 10.1016/j.it.2004.12.003; Klebanoff CA, 2016, NAT MED, V22, P26, DOI 10.1038/nm.4015; Manson G, 2016, ANN ONCOL, V27, P1199, DOI 10.1093/annonc/mdw181; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; NORTH RJ, 1982, J EXP MED, V155, P1063, DOI 10.1084/jem.155.4.1063; NORTH RJ, 1984, CANCER IMMUNOL IMMUN, V16, P175; Papaioannou NE, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.04.01; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Riaz N, 2016, INT IMMUNOL, V28, P411, DOI 10.1093/intimm/dxw019; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Saida Y, 2015, J IMMUNOL, V195, P726, DOI 10.4049/jimmunol.1401468; SHU S, 1985, CANCER RES, V45, P1657; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Turcotte Simon, 2011, Adv Surg, V45, P341; Wang LX, 2007, BLOOD, V109, P4865, DOI 10.1182/blood-2006-09-045245; Wang Li-Xin, 2004, J Transl Med, V2, P41, DOI 10.1186/1479-5876-2-41; Wang LX, 2005, CANCER RES, V65, P9547, DOI 10.1158/0008-5472.CAN-05-1175; Watanabe S, 2003, J IMMUNOL, V171, P5828, DOI 10.4049/jimmunol.171.11.5828; Watanabe S, 2008, J IMMUNOL, V181, P3291, DOI 10.4049/jimmunol.181.5.3291; Whiteside T., 2004, CANC IMMUNOLOGY IMMU, V53; Williams KA, 2007, SEMIN IMMUNOL, V19, P318, DOI 10.1016/j.smim.2007.10.004; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; YOSHIZAWA H, 1991, J IMMUNOL, V147, P729; Zheng RX, 2007, CANCER TREAT RES, P223	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183976	10.1371/journal.pone.0183976	http://dx.doi.org/10.1371/journal.pone.0183976			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854279	gold, Green Submitted, Green Published			2022-12-26	WOS:000408693600072
J	Buchakjian, MR; Merritt, NM; Moose, DL; Dupuy, AJ; Tanas, MR; Henry, MD				Buchakjian, Marisa R.; Merritt, Nicole M.; Moose, Devon L.; Dupuy, Adam J.; Tanas, Munir R.; Henry, Michael D.			A Trp53 (fl/fl) Pten (fl/fl) mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging	PLOS ONE			English	Article							SOFT-TISSUE SARCOMAS; TUMOR-SUPPRESSOR; P53; PROGRESSION; DEFICIENT; CANCER; GENE; MICE	Genetic mouse models of soft tissue sarcoma provide critical insights into disease pathophysiology, which are oftentimes unable to be extracted from human tumor samples or xenograft models. In this study we describe a mouse model of soft tissue sarcoma mediated by adenoviral-Cre recombinase injection into Trp53 (fl/fl) /Pten (fl/fl) lox-stop-lox luciferase mice. Injection of adenovirus expressing Cre recombinase, either subcutaneously or intramuscularly in two experimental groups, results in viral infection and gene recombination with 100% penetrance within the first 24 hours following injection. Luciferase expression measured by real-time bioluminescence imaging increases over time, with an initial robust increase following viral injection, followed by a steady rise over the next several weeks as primary tumors develop and grow. Intramuscular injections were more commonly associated with evidence of systemic viral distribution than subcutaneous injections. All mice developed soft tissue sarcomas at the primary injection site, with histological examination identifying 93% of tumors as invasive pleomorphic sarcomas based on microscopic morphology and immunohistochemical expression of sarcoma markers. A lymphocytic infiltrate was present in 64% of the sarcomas in this immunocompetent model and 71% of tumors expressed PDL1. This is the first report of a viral-Cre mediated Trp53/Pten mouse model of undifferentiated pleomorphic sarcoma. The bioluminescence imaging feature, along with high penetrance of the model and its immunological characteristics, makes it suited for pre-clinical studies of soft tissue sarcoma.	[Buchakjian, Marisa R.] Univ Iowa Hosp & Clin, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Buchakjian, Marisa R.; Moose, Devon L.; Henry, Michael D.] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA USA; [Buchakjian, Marisa R.; Dupuy, Adam J.; Tanas, Munir R.; Henry, Michael D.] Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Merritt, Nicole M.; Tanas, Munir R.; Henry, Michael D.] Univ Iowa Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA; [Dupuy, Adam J.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Tanas, MR (corresponding author), Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.; Tanas, MR (corresponding author), Univ Iowa Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA.	munir-tanas@uiowa.edu		Buchakjian, Marisa/0000-0001-8261-1566; Moose, Devon/0000-0002-1694-3981; Dupuy, Adam/0000-0002-8561-4911; Tanas, Munir/0000-0002-6779-2642; Henry, Michael/0000-0002-7871-245X	University of Iowa Sarcoma Foundation; Veterans Health Administration Merit Review Program [1 I01 BX003644-01]; University of Iowa Sarcoma Research Program;  [P30 CA086862]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003644] Funding Source: NIH RePORTER	University of Iowa Sarcoma Foundation; Veterans Health Administration Merit Review Program; University of Iowa Sarcoma Research Program; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	A portion of this work was funded by a pilot grant from the University of Iowa Sarcoma Foundation. This study was also funded by a grant from the Veterans Health Administration Merit Review Program (1 I01 BX003644-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Core facilities used in these studies were supported by P30 CA086862. This work was supported by a grant from the Veterans Health Administration Merit Review Program (1 I01 BX003644-01) to MRT and pilot grant funding from the University of Iowa Sarcoma Research Program to MDH. We would like to thank Allyn M. Lambertz and Georgina Ofori-Amanfo for assistance with tissue processing and immunohistochemical staining. We would also like to thank Rebecca D. Dodd for her careful reading and thoughtful insight into the manuscript.	Balar AV, 2017, CANCER IMMUNOL IMMUN, V1, P1; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Borden EC, 2003, CLIN CANCER RES, V9, P1941; Collini P, 2009, SEMIN ONCOL, V36, P324, DOI 10.1053/j.seminoncol.2009.06.007; Demicco EG, 2012, ADV ANAT PATHOL, V19, P170, DOI 10.1097/PAP.0b013e318253462f; Dodd Rebecca D, 2015, Methods Mol Biol, V1267, P283, DOI 10.1007/978-1-4939-2297-0_13; Dodd RD, 2010, DIS MODEL MECH, V3, P557, DOI 10.1242/dmm.005223; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Edinger M, 2002, EUR J CANCER, V38, P2128, DOI 10.1016/S0959-8049(02)00410-0; El Hilali N, 2002, LAB INVEST, V82, P1563, DOI 10.1097/01.LAB.0000036877.36379.1F; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guijarro MV, 2013, AM J PATHOL, V182, P2015, DOI 10.1016/j.ajpath.2013.02.035; Ito M, 2011, CLIN CANCER RES, V17, P416, DOI 10.1158/1078-0432.CCR-10-2050; Kawaguchi K, 2005, HUM PATHOL, V36, P357, DOI 10.1016/j.humpath.2005.01.017; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Marino S, 2000, GENE DEV, V14, P994; Matushansky I, 2009, EXPERT REV ANTICANC, V9, P1135, DOI [10.1586/era.09.76, 10.1586/ERA.09.76]; Mito JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008075; Puzio-Kuter AM, 2015, CELL DEATH DIFFER, V22, P1785, DOI 10.1038/cdd.2015.27; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Sachdeva M, 2016, J CLIN INVEST, V126, P1606, DOI 10.1172/JCI86573; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Sim H, 2011, CANCER RES, V71, P686, DOI 10.1158/0008-5472.CAN-10-2666; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sorrell AD, 2013, MOL DIAGN THER, V17, P31, DOI 10.1007/s40291-013-0020-0; Svensson RU, 2011, AM J PATHOL, V179, P502, DOI 10.1016/j.ajpath.2011.03.014; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087	28	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183469	10.1371/journal.pone.0183469	http://dx.doi.org/10.1371/journal.pone.0183469			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841687	gold, Green Published, Green Submitted			2022-12-26	WOS:000408370700034
J	Syranidou, E; Karkanorachaki, K; Amorotti, F; Repouskou, E; Kroll, K; Kolvenbach, B; Corvini, PFX; Fava, F; Kalogerakis, N				Syranidou, Evdokia; Karkanorachaki, Katerina; Amorotti, Filippo; Repouskou, Eftychia; Kroll, Kevin; Kolvenbach, Boris; Corvini, Philippe F-X; Fava, Fabio; Kalogerakis, Nicolas			Development of tailored indigenous marine consortia for the degradation of naturally weathered polyethylene films	PLOS ONE			English	Article							LOW-DENSITY POLYETHYLENE; MICROBIAL-DEGRADATION; PLASTIC DEBRIS; BIODEGRADATION; MICROPLASTICS; BACTERIA; ENVIRONMENT; COMMUNITY; ABUNDANCE; COLONIZATION	This study investigated the potential of bacterial-mediated polyethylene (PE) degradation in a two-phase microcosm experiment. During phase I, naturally weathered PE films were incubated for 6 months with the indigenous marine community alone as well as bioaugmented with strains able to grow in minimal medium with linear low-density polyethylene (LLDPE) as the sole carbon source. At the end of phase I the developed biofilm was harvested and re-inoculated with naturally weathered PE films. Bacteria from both treatments were able to establish an active population on the PE surfaces as the biofilm community developed in a time dependent way. Moreover, a convergence in the composition of these communities was observed towards an efficient PE degrading microbial network, comprising of indigenous species. In acclimated communities, genera affiliated with synthetic (PE) and natural (cellulose) polymer degraders as well as hydrocarbon degrading bacteria were enriched. The acclimated consortia (indigenous and bioaugmented) reduced more efficiently the weight of PE films in comparison to non-acclimated bacteria. The SEM images revealed a dense and compact biofilm layer and signs of bio-erosion on the surface of the films. Rheological results suggest that the polymers after microbial treatment had wider molecular mass distribution and a marginally smaller average molar mass suggesting biodegradation as opposed to abiotic degradation. Modifications on the surface chemistry were observed throughout phase II while the FTIR profiles of microbially treated films at month 6 were similar to the profiles of virgin PE. Taking into account the results, we can suggest that the tailored indigenous marine community represents an efficient consortium for degrading weathered PE plastics.	[Syranidou, Evdokia; Karkanorachaki, Katerina; Amorotti, Filippo; Kalogerakis, Nicolas] Tech Univ Crete, Sch Environm Engn, Khania, Greece; [Amorotti, Filippo; Fava, Fabio] Univ Bologna, Dept Civil Chem Environm & Mat Engn DICAM, Bologna, Italy; [Repouskou, Eftychia] Tech Univ Crete, Sch Mineral Resources Engn, Khania, Greece; [Kroll, Kevin; Kolvenbach, Boris; Corvini, Philippe F-X] FHNW, Sch Life Sci, Inst Ecopreneurship, Muttenz, Switzerland	Technical University of Crete; University of Bologna; Technical University of Crete; FHNW University of Applied Sciences & Arts Northwestern Switzerland	Kalogerakis, N (corresponding author), Tech Univ Crete, Sch Environm Engn, Khania, Greece.	nicolas.kalogerakis@enveng.tuc.gr	Syranidou, Evdokia/AAO-4883-2020; KALOGERAKIS, Nicolas/AAC-8528-2019; Kalogerakis, Nicolas/C-9254-2009	KALOGERAKIS, Nicolas/0000-0001-7033-0302; Kalogerakis, Nicolas/0000-0001-7033-0302; Syranidou, Evdokia/0000-0002-1971-3807; Karkanorachaki, Katerina/0000-0002-2560-712X; FAVA, FABIO/0000-0001-9283-0420; Amorotti, Filippo/0000-0003-3819-2565; Kolvenbach, Boris/0000-0003-3491-9026	European Union FP-7 project BIOCLEAN [312100]	European Union FP-7 project BIOCLEAN	Funding by the European Union FP-7 project BIOCLEAN (grant agreement No. 312100) is highly appreciated (www.biocleanproject.eu).; Funding by the European Union FP-7 project BIOCLEAN (grant agreement No. 312100) is highly appreciated. We thank S. Costanzo and D. Parisi (FORTH, Heraklion, Greece) for the rheological measurements and C. Chatzidoukas (Chemical Eng. Dept., AUTh, Greece) for the FTIR measurements.	Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Antoniou E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00274; Artham T, 2009, INT BIODETER BIODEGR, V63, P884, DOI 10.1016/j.ibiod.2009.03.003; Balasubramanian V, 2010, LETT APPL MICROBIOL, V51, P205, DOI 10.1111/j.1472-765X.2010.02883.x; Bonhomme S, 2003, POLYM DEGRAD STABIL, V81, P441, DOI 10.1016/S0141-3910(03)00129-0; Bryant JA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00024-16; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Costanzo S, 2016, MACROMOLECULES, V49, P7054, DOI 10.1021/acs.macromol.6b01311; Cozar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121762; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; da Costa JP, 2016, SCI TOTAL ENVIRON, V566, P15, DOI 10.1016/j.scitotenv.2016.05.041; Das MP, 2015, 3 BIOTECH, V5, P81, DOI 10.1007/s13205-014-0205-1; Dealy J. M., 2018, STRUCTURE RHEOLOGY M, DOI DOI 10.3139/9781569906125; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Fazey FMC, 2016, ENVIRON POLLUT, V210, P354, DOI 10.1016/j.envpol.2016.01.026; Fontanella S, 2010, POLYM DEGRAD STABIL, V95, P1011, DOI 10.1016/j.polymdegradstab.2010.03.009; Gilan I, 2004, APPL MICROBIOL BIOT, V65, P97, DOI 10.1007/s00253-004-1584-8; Goldstein MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080020; Hadad D, 2005, J APPL MICROBIOL, V98, P1093, DOI 10.1111/j.1365-2672.2005.02553.x; Harrison JP, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0232-4; Harshvardhan K, 2013, MAR POLLUT BULL, V77, P100, DOI 10.1016/j.marpolbul.2013.10.025; Hwang SJ, 1999, J PLANKTON RES, V21, P699, DOI 10.1093/plankt/21.4.699; Jin CE, 2017, INT BIODETER BIODEGR, V118, P27, DOI 10.1016/j.ibiod.2017.01.020; Kalogerakis N, 2017, FRONT MAR SCI, P4; Koutny M, 2006, POLYM DEGRAD STABIL, V91, P1495, DOI 10.1016/j.polymdegradstab.2005.10.007; Kowalczyk A, 2016, ENVIRON SCI POLLUT R, V23, P11349, DOI 10.1007/s11356-016-6563-y; Kowalski N, 2016, MAR POLLUT BULL, V109, P310, DOI 10.1016/j.marpolbul.2016.05.064; Lee JW, 2008, J MICROBIOL, V46, P174, DOI 10.1007/s12275-008-0032-3; Lo YC, 2009, ENZYME MICROB TECH, V44, P417, DOI 10.1016/j.enzmictec.2009.03.002; Lobelle D, 2011, MAR POLLUT BULL, V62, P197, DOI 10.1016/j.marpolbul.2010.10.013; Lucas N, 2008, CHEMOSPHERE, V73, P429, DOI 10.1016/j.chemosphere.2008.06.064; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nauendorf A, 2016, MAR POLLUT BULL, V103, P168, DOI 10.1016/j.marpolbul.2015.12.024; Nie Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04968; Nkem BM, 2016, MAR POLLUT BULL, V107, P261, DOI 10.1016/j.marpolbul.2016.03.060; Pathak VM, 2017, BIORESOUR BIOPROCESS, V4, DOI 10.1186/s40643-017-0145-9; Perez-de-Mora A, 2011, MICROB ECOL, V62, P959, DOI 10.1007/s00248-011-9858-z; Plastics Europe, 2015, PLAST FACTS 2014 201; Prieto A, 2016, MICROB BIOTECHNOL, V9, P652, DOI 10.1111/1751-7915.12393; R Core Team, 2020, R LANG ENV STAT COMP; Raghul SS, 2014, INT J ENVIRON SCI TE, V11, P1827, DOI 10.1007/s13762-013-0335-8; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Reisser J, 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0100289; Restrepo-Florez JM, 2014, INT BIODETER BIODEGR, V88, P83, DOI 10.1016/j.ibiod.2013.12.014; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Roy PK, 2008, POLYM DEGRAD STABIL, V93, P1917, DOI 10.1016/j.polymdegradstab.2008.07.016; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Santos RG, 2016, ENVIRON POLLUT, V214, P585, DOI 10.1016/j.envpol.2016.04.024; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sen SK, 2015, J ENVIRON CHEM ENG, V3, P462, DOI 10.1016/j.jece.2015.01.003; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Shannon CE, 2002, MATH THEORY COMMUNIC; Sivan A, 2011, CURR OPIN BIOTECH, V22, P422, DOI 10.1016/j.copbio.2011.01.013; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Sudhakar M, 2008, INT BIODETER BIODEGR, V61, P203, DOI 10.1016/j.ibiod.2007.07.011; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thompson RC, 2009, PHILOS T R SOC B, V364, P1973, DOI 10.1098/rstb.2009.0054; Tribedi P., 2015, BIORESOUR BIOPROCESS, V2, P14, DOI [10.1186/s40643-015-0044-x, DOI 10.1186/S40643-015-0044-X]; Tribedi P, 2013, ENVIRON SCI POLLUT R, V20, P4146, DOI 10.1007/s11356-012-1378-y; Tubau X, 2015, PROG OCEANOGR, V134, P379, DOI 10.1016/j.pocean.2015.03.013; Wang JD, 2016, MAR ENVIRON RES, V113, P7, DOI 10.1016/j.marenvres.2015.10.014; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; ZERBI G, 1989, POLYMER, V30, P2324, DOI 10.1016/0032-3861(89)90269-3; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	68	53	55	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183984	10.1371/journal.pone.0183984	http://dx.doi.org/10.1371/journal.pone.0183984			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841722	gold, Green Submitted, Green Published			2022-12-26	WOS:000408370700073
J	Leiva, JA; Nkedi-Kizza, P; Morgan, KT; Kadyampakeni, DM				Leiva, Jorge A.; Nkedi-Kizza, Peter; Morgan, Kelly T.; Kadyampakeni, Davie M.			Imidacloprid transport and sorption nonequilibrium in single and multilayered columns of Immokalee fine sand	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; NEONICOTINOID INSECTICIDE; PESTICIDE TRANSPORT; LEACHING BEHAVIOR; SOILS; CITRUS; KINETICS; THIAMETHOXAM; DEGRADATION; EQUILIBRIA	Imidacloprid (IMD) is a neonicotinoid pesticide soil-drenched to many crops to control piercing-sucking insects such as the Asian citrus psyllid (ACP). Neonicotinoids are persistent in the environment and transport analyses are helpful estimate leaching potential from soils that could result in groundwater pollution. The objective of this study was to analyze IMD breakthrough under saturated water flow in soil columns packed with three horizons (A, E, Bh) of Immokalee Fine Sand (IFS). Also, we used the dimensionless form of the convective-dispersive model (CD-Model) to compare the optimized transport parameters from each column experiment (retardation factor, R; fraction of instantaneous-to-total retardation, beta; and mass transfer coefficient, omega) with the parameters obtained from sorption batch equilibria and sorption kinetics. The tracer (Cl-) breakthrough curves (BTCs) were symmetrical and properly described by the CD-Model. IMD BTCs from A, Bh, and multilayered [A+E+Bh] soil columns showed steep fronts and tailing that were well described by the one-site nonequilibrium (OSNE) model, which was an evidence of non-ideal transport due to IMD mass transfer into the soil organic matter. In general, IMD was weakly-sorbed in the A and Bh horizons (R values of 3.72 +/- 0.04 and 3.08 +/- 0.07, respectively), and almost no retardation was observed in the E horizon (R = 1.20 +/- 0.02) due to its low organic matter content (0.3%). Using the HYDRUS-1D package, optimized parameters (R, beta, omega) from the individual columns successfully simulated IMD transport in a multilayered column mimicking an IFS soil profile. These column studies and corresponding simulations agreed with previous findings from batch sorption equilibria and kinetics experiments, where IMD showed one-site kinetic mass transfer between soil surfaces and soil solution. Ideally, sandy soils should be maintained unsaturated by crop irrigation systems and rainfall monitoring during and after soil-drench application. The unsaturated soil will increase IMD retardation factors and residence time for plant uptake, lowering leaching potential from soil layers with low sorption capacity, such as the E horizon.	[Leiva, Jorge A.; Nkedi-Kizza, Peter] Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA; [Morgan, Kelly T.] UF IFAS Southwest Florida Res & Educ Ctr, Immokalee, FL USA; [Kadyampakeni, Davie M.] UF IFAS Citrus Res & Educ Ctr, Lake Alfred, FL USA	State University System of Florida; University of Florida	Leiva, JA (corresponding author), Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA.	jorge.leiva@ufl.edu		Leiva-Sanabria, Jorge-Armando/0000-0001-7255-2726	United States Department of Agriculture; University of Florida Open Access Publishing Fund; United States Department of Agriculture; University of Florida Open Access Publishing Fund	United States Department of Agriculture(United States Department of Agriculture (USDA)); University of Florida Open Access Publishing Fund; United States Department of Agriculture(United States Department of Agriculture (USDA)); University of Florida Open Access Publishing Fund	This work was supported by the United States Department of Agriculture to PN and KTM. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi EP, 2009, J CONTAM HYDROL, V107, P58, DOI 10.1016/j.jconhyd.2009.04.001; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; BRUSSEAU ML, 1989, WATER RESOUR RES, V25, P1971, DOI 10.1029/WR025i009p01971; BRUSSEAU ML, 1991, SSSA SPEC PUBL, V27, P281; Brusseau ML, 1998, PHYSICAL NONEQUILIBR, P63; Buckingham SD, 1997, J EXP BIOL, V200, P2685; Choquette AF, 2009, WATER QUALITY EVALUA; Choquette AF, 2014, PESTICIDES NITRATE G; Fernandez-Bayo JD, 2008, J AGR FOOD CHEM, V56, P5266, DOI 10.1021/jf8004349; Fernandez-Bayo JD, 2015, J ENVIRON SCI HEAL B, V50, P190, DOI 10.1080/03601234.2015.982423; Flint AL, 2002, 2 1 BULK DENSITY LIN, P201; Flores-Cespedes F, 2002, J ENVIRON QUAL, V31, P880, DOI 10.2134/jeq2002.0880; Flury M, 1996, J ENVIRON QUAL, V25, P25, DOI 10.2134/jeq1996.00472425002500010005x; Fossen M., 2006, ENV FATE IMIDACLOPRI, P16; Gervais J.A., 2010, IMIDACLOPRID TECHNIC; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gupta S, 2002, B ENVIRON CONTAM TOX, V68, P502, DOI 10.1007/s001280283; Gupta S, 2008, B ENVIRON CONTAM TOX, V80, P431, DOI 10.1007/s00128-008-9420-y; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Kadyampakeni DM, 2014, SOIL SCI SOC AM J, V78, P1351, DOI 10.2136/sssaj2014.02.0054; Kadyampakeni DM, 2014, SOIL SCI SOC AM J, V78, P645, DOI 10.2136/sssaj2013.07.0319; Karmakar R, 2006, B ENVIRON CONTAM TOX, V76, P400, DOI 10.1007/s00128-006-0935-9; Katagi T, 2013, REV ENVIRON CONTAM T, V221, P1, DOI 10.1007/978-1-4614-4448-0_1; Katayama A, 2010, REV ENVIRON CONTAM T, V203, P1, DOI 10.1007/978-1-4419-1352-4_1; Krischik V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119133; Kuntz D, 2009, J HYDROL, V369, P225, DOI 10.1016/j.jhydrol.2009.02.006; Kurwadkar S, 2014, J CONTAM HYDROL, V170, P86, DOI 10.1016/j.jconhyd.2014.09.009; Leiva JA, 2014, IMIDACLOPRID FATE TR; Leiva JA, 2015, J AGR FOOD CHEM, V63, P4915, DOI 10.1021/acs.jafc.5b00532; Ma LW, 2005, SOIL SCI SOC AM J, V69, P318, DOI 10.2136/sssaj2005.0318; Markus F, 1998, ACS SYM SER, V699, P65; Muwamba A., 2012, NITROGEN PHOSPHORUS; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nkedi Kizza P, 1984, WATER RESOUR RES, P20; Nkedi-Kizza P, 2006, J ENVIRON QUAL, V35, P268, DOI 10.2134/jeq2005.0140; Nzengung VA, 1997, ENVIRON SCI TECHNOL, V31, P1470, DOI 10.1021/es960720z; OBREZA T.A, 2008, NUTR FLORIDA CITRUS; Qureshi JA, 2007, PROC FL STATE HORTIC, V120, P110; Qureshi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112331; Qureshi JA, 2010, CROP PROT, V29, P860, DOI 10.1016/j.cropro.2010.04.013; Radcliffe D.E., 2010, SOIL PHYS HYDRUS MOD; Selim HM, 2010, SOIL SCI, V175, P375, DOI 10.1097/SS.0b013e3181ebc9a2; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Simunek J., 2002, METHODS SOIL ANAL 1, P139, DOI [10.2136/sssabookser5.4.c7, DOI 10.2136/SSSABOOKSER5.4.C7]; Simunek J, 2008, VADOSE ZONE J, V7, P587, DOI 10.2136/vzj2007.0077; Simunek J, 2008, VADOSE ZONE J, V7, P782, DOI 10.2136/vzj2007.0074; SKAGGS TH, 2002, METHODS SOIL ANAL 4, P1353, DOI DOI 10.2136/SSSABOOKSER5.4.C56; Skaggs TH, 2002, SSSA BOOK SERIES, P1381; Soil Survey S, 2014, KEYS SOIL TAXONOMY; USDA-NRCS, 1998, SOIL SURV COLL COUNT; [USEPA Office of Prevention PaTS], 2008, TRANSP TRANSF TEST G; USEPA (United States Environmental Protection Agency), 1983, METH CHEM AN WAT WAS; van Genuchten MT, 2012, T ASABE, V55, P1353; van Genuchten MT, 2014, PROGR SOIL SCI, P349, DOI 10.1007/978-3-319-06013-2_15; VANGENUCHTEN MT, 1989, SOIL SCI SOC AM J, V53, P1303, DOI 10.2136/sssaj1989.03615995005300050001x; Wang DJ, 2015, VADOSE ZONE J, V14, DOI 10.2136/vzj2015.01.0007; Wauchope RD, 2002, PEST MANAG SCI, V58, P419, DOI 10.1002/ps.489; Wettstein FE, 2016, J AGR FOOD CHEM, V64, P6407, DOI 10.1021/acs.jafc.6b02619; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	60	18	18	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183767	10.1371/journal.pone.0183767	http://dx.doi.org/10.1371/journal.pone.0183767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837702	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000117
J	Pols, DHJ; Nielen, MMJ; Bohnen, AM; Korevaar, JC; Bindels, PJE				Pols, David H. J.; Nielen, Mark M. J.; Bohnen, Arthur M.; Korevaar, Joke C.; Bindels, Patrick J. E.			Atopic children and use of prescribed medication: A comprehensive study in general practice	PLOS ONE			English	Article							DISEASES; ASTHMA; LIFE; COMORBIDITY; SYMPTOMS	Purpose A comprehensive and representative nationwide general practice database was explored to study associations between atopic disorders and prescribed medication in children. Method All children aged 0-18 years listed in the NIVEL Primary Care Database in 2014 were selected. Atopic children with atopic eczema, asthma and allergic rhinitis (AR) were matched with controls (not diagnosed with any of these disorders) within the same general practice on age and gender. Logistic regression analyses were performed to study the differences in prescribed medication between both groups by calculating odds ratios (OR); 93 different medication groups were studied. Results A total of 45,964 children with at least one atopic disorder were identified and matched with controls. Disorder-specific prescriptions seem to reflect evidence-based medicine guidelines for atopic eczema, asthma and AR. However, these disorder-specific prescriptions were also prescribed for children who were not registered as having that specific disorder. For eczema-related medication, about 3.7-8.4% of the children with non-eczematous atopic morbidity received these prescriptions, compared to 1.4-3.5% of the non-atopic children. The same pattern was observed for anti-asthmatics (having non-asthmatic atopic morbidity: 0.8-6.2% vs. controls: 0.3-2.1%) and AR-related medication (having non-AR atopic morbidity: 4.7-12.5% vs. controls: 2.8-3.1%). Also, non-atopic related medication, such as laxatives and antibiotics were more frequently prescribed for atopic children. Conclusions The present study shows that atopic children received more prescriptions, compared to non-atopic children. Non-atopic controls frequently received specific prescriptions for atopic disorders. This indicates that children with atopic disorders need better monitoring by their GP.	[Pols, David H. J.; Bohnen, Arthur M.; Bindels, Patrick J. E.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [Nielen, Mark M. J.; Korevaar, Joke C.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Netherlands Institute for Health Services Research	Pols, DHJ (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands.	d.pols@erasmusmc.nl	Bohnen, Arthur M/F-7814-2011					Bindels PJ, 2014, HUISARTS WET, V57, P70; Chen WJ, 2016, EUR RESPIR J, V48, P1584, DOI 10.1183/13993003.01141-2016; Dirven-Meijer PCDKC., 2014, HUISARTS WET, V57, P240; Hoskin-Parr L, 2013, PEDIAT ALLERG IMM-UK, V24, P762, DOI 10.1111/pai.12153; Hupkens C, 2013, ONGEVEER DRIE KWART; Lamberts H, 2002, FAM PRACT, V19, P433, DOI 10.1093/fampra/19.5.433; Mai X, 2009, ALLERGY, V64, P21; Mulder B, 2016, EUR J CLIN PHARMACOL, V72, P73, DOI 10.1007/s00228-015-1940-x; Nielen MMJ, 2012, ACCOUNTABILITY INCID; Pols DHJ, 2016, SCAND J PRIM HEALTH, V34, P143, DOI 10.3109/02813432.2016.1160629; Pols DHJ, 2017, NPJ PRIM CARE RESP M, V27, DOI 10.1038/s41533-017-0025-y; Powell N, 2007, POSTGRAD MED J, V83, P182, DOI 10.1136/pgmj.2006.049585; Sachs APE, 2006, HUISARTS WET, V49, P254; Skvorc HM, 2011, ALLERGY, V66, P553; Van Limbergen J, 2009, INFLAMM BOWEL DIS, V15, P1492, DOI 10.1002/ibd.20926	15	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182664	10.1371/journal.pone.0182664	http://dx.doi.org/10.1371/journal.pone.0182664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837578	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000023
J	Seebacher, V; Aust, S; D'Andrea, D; Grimm, C; Reiser, E; Tiringer, D; Von Mersi, H; Polterauer, S; Reinthaller, A; Helmy-Bader, S				Seebacher, Veronika; Aust, Stefanie; D'Andrea, David; Grimm, Christoph; Reiser, Elisabeth; Tiringer, Denise; Von Mersi, Hannah; Polterauer, Stephan; Reinthaller, Alexander; Helmy-Bader, Samir			Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen	PLOS ONE			English	Article							PREOPERATIVE DIAGNOSIS; MENOPAUSAL STATUS; CA 125; BENIGN; RISK; MULTICENTER; ULTRASOUND; SURGERY; MODELS; DISTINGUISH	Objective To develop a tool for individualized risk estimation of presence of cancer in women with adnexal masses, and to assess the added value of plasma fibrinogen. Study design We performed a retrospective analysis of a prospectively maintained database of 906 patients with adnexal masses who underwent cystectomy or oophorectomy. Uni- and multivariate logistic regression analyses including pre-operative plasma fibrinogen levels and established predictors were performed. A nomogram was generated to predict the probability of ovarian cancer. Internal validation with split-sample analysis was performed. Decision curve analysis (DCA) was then used to evaluate the clinical net benefit of the prediction model. Results Ovarian cancer including borderline tumours was found in 241 (26.6%) patients. In multivariate analysis, elevated plasma fibrinogen, elevated CA-125, suspicion for malignancy on ultrasound, and postmenopausal status were associated with ovarian cancer and formed the basis for the nomogram. The overall predictive accuracy of the model, as measured by AUC, was 0.91 (95% CI 0.87 +/- 0.94). DCA revealed a net benefit for using this model for predicting ovarian cancer presence compared to a strategy of treat all or treat none. Conclusion We confirmed the value of plasma fibrinogen as a strong predictor for ovarian cancer in a large cohort of patients with adnexal masses. We developed a highly accurate multivariable model to help in the clinical decision-making regarding the presence of ovarian cancer. This model provided net benefit for a wide range of threshold probabilities. External validation is needed before a recommendation for its use in routine practice can be given.	[Seebacher, Veronika; Aust, Stefanie; Grimm, Christoph; Reiser, Elisabeth; Tiringer, Denise; Von Mersi, Hannah; Polterauer, Stephan; Reinthaller, Alexander; Helmy-Bader, Samir] Med Univ Vienna, Ctr Comprehens Canc, Gynecol Canc Unit, Dept Gynecol & Gynecol Oncol, Vienna, Austria; [D'Andrea, David] Med Univ Vienna, Dept Urol, Vienna, Austria; [Polterauer, Stephan; Reinthaller, Alexander] Karl Landsteiner Inst Gen Gynecol & Expt Gynecol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Grimm, C (corresponding author), Med Univ Vienna, Ctr Comprehens Canc, Gynecol Canc Unit, Dept Gynecol & Gynecol Oncol, Vienna, Austria.	christoph.grimm@meduniwien.ac.at	Polterauer, Stephan/AAG-1331-2021; Grimm, Christoph/GSJ-3020-2022	Polterauer, Stephan/0000-0002-9649-4505; Grimm, Christoph/0000-0003-2948-8129; D'Andrea, David/0000-0003-1625-1077; Aust, stefanie/0000-0002-6760-949X				Alcazar JL, 2005, HUM REPROD, V20, P3231, DOI 10.1093/humrep/dei206; Bast RC, 2012, INT J GYNECOL CANCER, V22, pS5, DOI 10.1097/IGC.0b013e318251c97d; Bristow RE, 2013, GYNECOL ONCOL, V128, P252, DOI 10.1016/j.ygyno.2012.11.022; Buys SS, 2005, AM J OBSTET GYNECOL, V193, P1630, DOI 10.1016/j.ajog.2005.05.005; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Dearking AC, 2007, OBSTET GYNECOL, V110, P841, DOI 10.1097/01.AOG.0000267198.25223.bc; Dodge JE, 2012, GYNECOL ONCOL, V126, P157, DOI 10.1016/j.ygyno.2012.03.048; Engelen MJA, 2006, CANCER-AM CANCER SOC, V106, P589, DOI 10.1002/cncr.21616; Engelen MJA, 2000, GYNECOL ONCOL, V78, P16, DOI 10.1006/gyno.2000.5811; Feng Z, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2070-2; Gotlieb WH, 2000, AM J OBSTET GYNECOL, V183, P541, DOI 10.1067/mob.2000.105940; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Hefler-Frischmuth K, 2015, GYNECOL ONCOL, V136, P567, DOI 10.1016/j.ygyno.2014.12.041; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Kaijser J, 2013, GYNECOL ONCOL, V130, P398, DOI 10.1016/j.ygyno.2013.04.472; Kaijser J, 2014, HUM REPROD UPDATE, V20, P449, DOI 10.1093/humupd/dmt059; Ma CQ, 2016, ONCOTARGETS THER, V9, P4917, DOI 10.2147/OTT.S107445; Moore LE, 2012, CANCER-AM CANCER SOC, V118, P91, DOI 10.1002/cncr.26241; Moore RG, 2011, OBSTET GYNECOL, V118, P280, DOI 10.1097/AOG.0b013e318224fce2; Nolen BM, 2013, MOL DIAGN THER, V17, P139, DOI 10.1007/s40291-013-0027-6; Polterauer S, 2009, ONCOLOGIST, V14, P979, DOI 10.1634/theoncologist.2009-0079; Polterauer S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.008; Qiu J, 2012, J OBSTET GYNAECOL RE, V38, P651, DOI 10.1111/j.1447-0756.2011.01780.x; Seebacher V, 2010, BRIT J CANCER, V102, P952, DOI 10.1038/sj.bjc.6605547; Sevinc A, 2007, LANCET ONCOL, V8, P1054, DOI 10.1016/S1470-2045(07)70357-1; Shariat FS, 2008, BJUI, V103, P492; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Timmerman D, 2008, ULTRASOUND OBST GYN, V31, P681, DOI 10.1002/uog.5365; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Timmerman D, 1999, ULTRASOUND OBST GYN, V13, P17, DOI 10.1046/j.1469-0705.1999.13010017.x; Timmerman D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6839; Tingulstad S, 1996, BRIT J OBSTET GYNAEC, V103, P826, DOI 10.1111/j.1471-0528.1996.tb09882.x; Ueland FR, 2011, OBSTET GYNECOL, V117, P1289, DOI 10.1097/AOG.0b013e31821b5118; Van Calster B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5920; Van Gorp T, 2011, BRIT J CANCER, V104, P863, DOI 10.1038/sj.bjc.6606092; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Woo YL, 2012, GYNECOL ONCOL, V126, P286, DOI 10.1016/j.ygyno.2012.04.012	40	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182383	10.1371/journal.pone.0182383	http://dx.doi.org/10.1371/journal.pone.0182383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837575	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000016
J	Esakky, P; Hansen, DA; Drury, AM; Felder, P; Cusumano, A; Moley, KH				Esakky, Prabagaran; Hansen, Deborah A.; Drury, Andrea M.; Felder, Paul; Cusumano, Andrew; Moley, Kelle H.			Testicular cells exhibit similar molecular responses to cigarette smoke condensate ex vivo and in vivo	FASEB JOURNAL			English	Article						germ cells; explant; neonatal; offspring; marker proteins	MOUSE FETAL TESTIS; SPERM FERTILIZING-CAPACITY; GENE-EXPRESSION; NUCLEAR ANTIGEN; SERTOLI-CELLS; SEMEN QUALITY; LEYDIG-CELLS; GERM; EXPOSURE; NICOTINE	Male exposure to cigarette smoke is associated with seminal defects and with congenital anomalies and childhood cancers in offspring. In mice, paternal exposure to cigarette smoke condensate (CSC) causes molecular defects in germcells and phenotypic effects in their offspring. Hereweused an ex vivo testicular explantmodel and in vivo exposure to determine the concentration atwhichCSCimpairs spermatogenesis and offspring development. We explanted testis tissue at postnatal day (P) 5.5 and cultured it until P11.5. Assessment of growth parameters by analyzing expression of cell-specificmarkers revealed that the explant systemmaintained structural and functional integrity. We exposed the P5.5 to -11.5 explants to various concentrations (40-160 mu g/ml) of CSC and confirmed that nicotine intheCSCwasmetabolizedto cotinine. We assessedvarious growthanddifferentiationparameters, aswell as testosterone production, and observed thatmany spermatogenesis featureswere impaired at 160 mu g/ml CSC. The same parameters were impaired by a similar CSC concentration in vivo. Finally, females mated to males that were exposed to 160 mu g/mlCSCneonatally had increased rates of pup resorption. Weconclude thatmale exposure toCSC impairs offspring development and that the concentration atwhich CSC impairs spermatogenesis is similar in vivo andex vivo. Given that the concentrations of CSC we used contained similardoses ofnicotine as human smokers are exposed to, we argue that our modelmimics human male reproductive effects of smoking.	[Esakky, Prabagaran; Hansen, Deborah A.; Drury, Andrea M.] US Dept Vet Affairs Med Ctr, Reasearch & Dev, St Louis, MO USA; [Esakky, Prabagaran; Drury, Andrea M.; Felder, Paul; Cusumano, Andrew; Moley, Kelle H.] Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 South Euclid Ave,Campus Box 8064, St Louis, MO 63110 USA	Washington University (WUSTL)	Esakky, P; Moley, KH (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 South Euclid Ave,Campus Box 8064, St Louis, MO 63110 USA.	prabagaran.esakky@wustl.edu; moleyk@wustl.edu			U.S. Department of Veterans Affairs, Veterans Health Administration, Biomedical Laboratory Research and Development [I01BX007080]	U.S. Department of Veterans Affairs, Veterans Health Administration, Biomedical Laboratory Research and Development	The authors thank Dr. Deborah Frank (Washington University School of Medicine) for comments. This work was supported, in part, by the U.S. Department of Veterans Affairs, Veterans Health Administration, Biomedical Laboratory Research and Development (Award I01BX007080 to D.A.H.). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the U.S. government. The authors declare no conflicts of interest.	Aydos K, 2001, BJU INT, V88, P622, DOI 10.1046/j.1464-4096.2001.02384.x; Baker PJ, 1999, EUR J BIOCHEM, V260, P911, DOI 10.1046/j.1432-1327.1999.00245.x; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Benowitz NL, 2013, TOB CONTROL, V22, P14, DOI 10.1136/tobaccocontrol-2012-050860; Bruin JE, 2010, TOXICOL SCI, V116, P364, DOI 10.1093/toxsci/kfq103; Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; De Rooij DG, 2000, J ANDROL, V21, P776; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Esakky P, 2016, REPROD TOXICOL, V65, P283, DOI 10.1016/j.reprotox.2016.08.017; Esakky P, 2013, REPROD SCI, V20, P238, DOI 10.1177/1933719112452939; Esakky P, 2012, REPROD TOXICOL, V34, P665, DOI 10.1016/j.reprotox.2012.10.005; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Hallmark N, 2007, ENVIRON HEALTH PERSP, V115, P390, DOI 10.1289/ehp.9490; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; Hansen DA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108845; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; Holloway AC, 2006, ENDOCRINE, V30, P213, DOI 10.1385/ENDO:30:2:213; Jana K, 2010, TOXICOL SCI, V116, P647, DOI 10.1093/toxsci/kfq149; Jarvis S, 2005, HUM REPROD, V20, P108, DOI 10.1093/humrep/deh565; Kapawa A, 2004, ANDROLOGIA, V36, P57, DOI 10.1111/j.1439-0272.2004.00605.x; KLONOFFCOHEN HS, 1995, JAMA-J AM MED ASSOC, V273, P795, DOI 10.1001/jama.273.10.795; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kyronlahti A, 2011, MOL CELL ENDOCRINOL, V333, P85, DOI 10.1016/j.mce.2010.12.019; Lambrot R, 2006, BIOCHIMIE, V88, P1831, DOI 10.1016/j.biochi.2006.09.022; LAZUTKA F A, 1969, Gigiena i Sanitariya, V34, P30; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; Livera G, 2000, BIOL REPROD, V62, P1303, DOI 10.1095/biolreprod62.5.1303; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; Mayer B, 2014, ARCH TOXICOL, V88, P5, DOI 10.1007/s00204-013-1127-0; Meeker JD, 2007, AM J EPIDEMIOL, V166, P571, DOI 10.1093/aje/kwm128; Mostafa T, 2010, J ADV RES, V1, P179, DOI 10.1016/j.jare.2010.05.002; Muczynski V, 2012, TOXICOL APPL PHARM, V261, P97, DOI 10.1016/j.taap.2012.03.016; Nagano R, 2000, ANAT REC, V258, P210; Neal MS, 2005, HUM REPROD, V20, P2531, DOI 10.1093/humrep/dei080; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Olaso R, 2000, J ANDROL, V21, P497, DOI 10.1002/j.1939-4640.2000.tb02114.x; PACIFICI R, 1993, THER DRUG MONIT, V15, P358, DOI 10.1097/00007691-199310000-00002; PATTERSON TR, 1990, LIFE SCI, V46, P265, DOI 10.1016/0024-3205(90)90032-M; Pourimand G, 2004, BJU INT, V94, P1310, DOI 10.1111/j.1464-410X.2004.05162.x; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1400, DOI 10.1016/j.fertnstert.2012.07.1146; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P188, DOI 10.1093/humrep/del364; Rodgman A., 2013, CHEM COMPONENTS TOBA, V2nd; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130171; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Schane RE, 2010, CIRCULATION, V121, P1518, DOI 10.1161/CIRCULATIONAHA.109.904235; Seccareccia F, 2003, EUR J EPIDEMIOL, V18, P487, DOI 10.1023/A:1024672522802; SOFIKITIS N, 1995, J UROLOGY, V154, P1030, DOI 10.1016/S0022-5347(01)66968-4; Stanley JL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096198; Staub C, 2001, J ANDROL, V22, P911; Steger K, 1998, MOL HUM REPROD, V4, P227, DOI 10.1093/molehr/4.3.227; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; VICIAN M, 1968, EXPERIENTIA, V24, P511; Vine MF, 1996, INT J ANDROL, V19, P323, DOI 10.1111/j.1365-2605.1996.tb00523.x; Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279; ZHANG J, 1992, INT J EPIDEMIOL, V21, P273, DOI 10.1093/ije/21.2.273; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	60	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					63	72		10.1096/fj.201700405R	http://dx.doi.org/10.1096/fj.201700405R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28842431				2022-12-26	WOS:000419172700008
J	Yamaleyeva, LM; Sun, Y; Bledsoe, T; Hoke, A; Gurley, SB; Brosnihan, KB				Yamaleyeva, Liliya M.; Sun, Yao; Bledsoe, Tiffaney; Hoke, Asia; Gurley, Susan B.; Brosnihan, K. Bridget			Photoacoustic imaging for in vivo quantification of placental oxygenation in mice	FASEB JOURNAL			English	Article						placental hypoxia; oxygen saturation; hypertensive pregnancy; HIF-1 alpha; fetal growth restriction	PREGNANCY; HYPOXIA; RATS; BIOMEDICINE; CIRCULATION; TOMOGRAPHY; MICROSCOPY; ARTERY; ACE2	Accurate analysis of placental and fetal oxygenation is critical during pregnancy. Photoacoustic imaging (PAI) combines laser technology with ultrasound in real time. We tested the sensitivity and accuracy of PAI for analysis of placental and fetal oxygen saturation (sO(2)) inmice. The placental labyrinth (L) had a higher sO(2) than the junctional zone plus decidua region (JZ+D) inC57Bl/6mice. ChangingmaternalO(2) from 100 to 20% inC57Bl/6mice lowered sO(2) in these regions. C57Bl/6 mice were treated with the NO synthase inhibitor L-N-G-nitroarginine methyl ester (L-NAME) from gestational day (GD) 11 to GD18 to induce hypertension. L-NAME decreased sO2 in L and JZ+DatGD14 and GD18 in associationwith fetal growth restriction and higher blood pressure. Hypoxia-inducible factor 1 alpha immunostaining was higher in L-NAME vs. control mice at GD14. Fetal sO(2) levels were similar between L-NAME and controlmice atGD14 and GD18. In contrast to untreated C57Bl/6, L-NAMEdecreased placental sO(2) at GD14 and GD18 vs. GD10 or GD12. Placental sO(2) was lower in fetal growth restriction in an angiotensin-converting enzyme 2 knockout mouse model characterized by placental hypoxia. On phantom studies, patterns of sO(2) measured directly correlated with those measured by PAI. In summary, PAI enables the detection of placental and fetal oxygenation during normal and pathologic pregnancies in mice.	[Yamaleyeva, Liliya M.; Bledsoe, Tiffaney; Hoke, Asia; Brosnihan, K. Bridget] Wake Forest Sch Med, Dept Surg Hypertens & Vasc Res, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Sun, Yao] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27157 USA; [Gurley, Susan B.] Durham Vet Affairs Med Ctr, Dept Med, Div Nephrol, Durham, NC USA; [Gurley, Susan B.] Duke Univ, Med Ctr, Durham, NC USA	Wake Forest University; Wake Forest University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Yamaleyeva, LM (corresponding author), Wake Forest Sch Med, Dept Surg Hypertens & Vasc Res, Med Ctr Blvd, Winston Salem, NC 27157 USA.	lyamaley@wakehealth.edu			U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [R21 HD086357]; American Heart Association [13SDG17390009]; NIH Office of Research Infrustructure Programs (ORIP) /OD-High End Instrumentation Grant [S10 OD012330]; NIH Excellence in Cardiovascular Sciences Summer Research Program Grant [5R25HL092618]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD086357] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092618] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012330] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; American Heart Association(American Heart Association); NIH Office of Research Infrustructure Programs (ORIP) /OD-High End Instrumentation Grant; NIH Excellence in Cardiovascular Sciences Summer Research Program Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge the assistance of the Preclinical Ultrasound and Photoacoustics Imaging Core and Virtual Microscopy Core of the Wake Forest School of Medicine. The authors also acknowledge the editorial assistance of Karen Klein (Wake Forest Clinical and Translational Science Institute). This work was supported by U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R21 HD086357 (to L.M.Y.), American Heart Association Grant 13SDG17390009 (to L.M.Y.), in part by NIH Office of Research Infrustructure Programs (ORIP) /OD-High End Instrumentation Grant S10 OD012330 (to K.B.B.), and by NIH Excellence in Cardiovascular Sciences Summer Research Program Grant 5R25HL092618. The authors declare no conflicts of interest.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Arthuis CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169850; Bharadwaj MS, 2011, HYPERTENSION, V58, P852, DOI 10.1161/HYPERTENSIONAHA.111.179358; Chalouhi GE, 2011, SEMIN FETAL NEONAT M, V16, P22, DOI 10.1016/j.siny.2010.09.001; Chung E, 2013, CARDIOVASC RES, V100, P402, DOI 10.1093/cvr/cvt208; Cuffe JSM, 2014, J PHYSIOL-LONDON, V592, P3127, DOI 10.1113/jphysiol.2014.272856; Heazell AEP, 2015, PLACENTA, V36, pS20, DOI 10.1016/j.placenta.2014.12.017; KAUR J, 2012, ANN BIOL RES, V3, P4845; Laufer J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061220; Li CH, 2009, PHYS MED BIOL, V54, pR59, DOI 10.1088/0031-9155/54/19/R01; LI H, 2015, SCI REP UK, V5; Lindsey SH, 2013, AM J PHYSIOL-ENDOC M, V305, pE113, DOI 10.1152/ajpendo.00649.2012; Maslov K, 2008, OPT LETT, V33, P929, DOI 10.1364/OL.33.000929; Nguyen DH, 2013, CANCERINCYTES, V2, DOI DOI 10.1038/PROTEX.2013.097; Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008; Rich LJ, 2015, RADIOLOGY, V275, P110, DOI 10.1148/radiol.14140654; Smith LM, 2016, SHOCK, V46, P527, DOI 10.1097/SHK.0000000000000644; Tiboni GM, 2003, PEDIATR RES, V54, P69, DOI 10.1203/01.PDR.0000069840.78984.76; Tsukimori K, 2008, AM J HYPERTENS, V21, P477, DOI 10.1038/ajh.2007.80; Valdes G, 2011, INTEGR BLOOD PRESS C, V4, P45, DOI 10.2147/IBPC.S8393; VisualSonics Inc, 2011, APPL NOT PLANC IM VE; World Health Organization, 2016, ORLD HLTH STAT 2016; Xia WF, 2015, LECT NOTES COMPUT SC, V9349, P371, DOI 10.1007/978-3-319-24553-9_46; Xu MH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2195024; Yamaleyeva LM, 2015, AM J PHYSIOL-ENDOC M, V309, pE84, DOI 10.1152/ajpendo.00596.2014; Yamaleyeva LM, 2012, J CARDIOVASC PHARM, V59, P529, DOI 10.1097/FJC.0b013e31824dd15b; Yamaleyeva LM, 2012, AM J PHYSIOL-RENAL, V302, pF1374, DOI 10.1152/ajprenal.00656.2011; Yao JJ, 2014, PHOTOACOUSTICS, V2, P87, DOI 10.1016/j.pacs.2014.04.002; Yao JJ, 2011, CONTRAST MEDIA MOL I, V6, P332, DOI 10.1002/cmmi.443; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941	30	18	19	4	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5520	5529		10.1096/fj.201700047RR	http://dx.doi.org/10.1096/fj.201700047RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842425	Green Published			2022-12-26	WOS:000416588300033
J	Bruder, LM; Gruninger, RJ; Cleland, CP; Mosimann, SC				Bruder, Lisza M.; Gruninger, Robert J.; Cleland, Colyn P.; Mosimann, Steven C.			Bacterial PhyA protein-tyrosine phosphatase-like myo-inositol phosphatases in complex with the Ins(1,3,4,5)P-4 and Ins(1,4,5)P-3 second messengers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL POLYPHOSPHATASE; STRUCTURAL-ANALYSIS; SECRETED PROTEIN; HEXAKISPHOSPHATE; PHYTASE; STEREOSPECIFICITY; SPECIFICITY; VIRULENCE; QUALITY; BINDING	myo-Inositol phosphates (IPs) are important bioactive molecules that have multiple activities within eukaryotic cells, including well-known roles as second messengers and cofactors that help regulate diverse biochemical processes such as transcription and hormone receptor activity. Despite the typical absence of IPs in prokaryotes, many of these organisms express IPases (or phytases) that dephosphorylate IPs. Functionally, these enzymes participate in phosphate-scavenging pathways and in plant pathogenesis. Here, we determined the X-ray crystallographic structures of two catalytically inactive mutants of protein-tyrosine phosphatase like myo-inositol phosphatases (PTPLPs) from the non-pathogenic bacteria Selenomonas ruminantium (PhyAsr) and Mitsuokella multacida (PhyAmm) in complex with the known eukaryotic second messengers Ins(1,3,4,5)P-4 and Ins(1,4,5)P-3. Both enzymes bound these less-phosphorylated IPs in a catalytically competent manner, suggesting that IP hydrolysis has a role in plant pathogenesis. The less-phosphorylated IP binding differed in both the myo-inositol ring position and orientation when compared with a previously determined complex structure in the presence of myoinositol-1,2,3,4,5,6-hexakisphosphate (InsP(6) or phytate). Further, we have demonstrated that PhyAsr and PhyAmm have different specificities for Ins(1,2,4,5,6)P-5, have identified structural features that account for this difference, and have shown that the absence of these features results in a broad specificity toward Ins(1,2,4,5,6) P5. These features are main-chain conformational differences in loops adjacent to the active site that include the extended loop prior to the penultimate helix, the extended Omega-loop, and a beta-hairpin turn of the Phy-specific domain.	[Bruder, Lisza M.; Cleland, Colyn P.; Mosimann, Steven C.] Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada; [Gruninger, Robert J.] Agr & Agri Foods Canada, Lethbridge Res Ctr, Lethbridge, AB T1J 4B1, Canada	University of Lethbridge	Mosimann, SC (corresponding author), Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada.	steven.mosimann@uleth.ca			National Science and Engineering Research Council of Canada (NSERC); NSERC; Alberta Innovates-Technology Futures studentship	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates-Technology Futures studentship	This work was supported by Discovery Grants from the National Science and Engineering Research Council of Canada (NSERC) (to S.C.M.), NSERC studentships (to L.M.B. and R.J.G.), and an Alberta Innovates-Technology Futures studentship (to L.M.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ariza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065062; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Blaabjerg K, 2010, J CHROMATOGR B, V878, P347, DOI 10.1016/j.jchromb.2009.11.046; Bretz JR, 2003, MOL MICROBIOL, V49, P389, DOI 10.1046/j.1365-2958.2003.03616.x; Chatterjee S, 2003, MOL PLANT MICROBE IN, V16, P973, DOI 10.1094/MPMI.2003.16.11.973; Chen LJ, 1999, APPL ENVIRON MICROB, V65, P4559; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; GAWLER DJ, 1990, BIOCHEM J, V272, P519, DOI 10.1042/bj2720519; Gillaspy GE, 2011, NEW PHYTOL, V192, P823, DOI 10.1111/j.1469-8137.2011.03939.x; Gruninger RJ, 2008, FEBS J, V275, P3783, DOI 10.1111/j.1742-4658.2008.06524.x; Gruninger RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094403; Gruninger RJ, 2012, J BIOL CHEM, V287, P9722, DOI 10.1074/jbc.M111.309872; Gruninger RJ, 2009, J MOL BIOL, V392, P75, DOI 10.1016/j.jmb.2009.05.079; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Lee DC, 2003, J BIOL CHEM, V278, P31412, DOI 10.1074/jbc.M213154200; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Majerus PW, 2008, ADV ENZYME REGUL, V48, P10, DOI 10.1016/j.advenzreg.2008.04.001; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Mullaney EJ, 2000, ADV APPL MICROBIOL, V47, P157, DOI 10.1016/S0065-2164(00)47004-8; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Puhl AA, 2008, BIOCHEM CELL BIOL, V86, P322, DOI 10.1139/o08-095; Puhl AA, 2008, INT J BIOCHEM CELL B, V40, P2053, DOI 10.1016/j.biocel.2008.02.003; Puhl AA, 2007, PROTEIN SCI, V16, P1368, DOI 10.1110/ps.062738307; Puhl AA, 2009, APPL MICROBIOL BIOT, V82, P95, DOI 10.1007/s00253-008-1734-5; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Weber S, 2014, J BIOL CHEM, V289, P34175, DOI 10.1074/jbc.M114.592568; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	36	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17302	17311		10.1074/jbc.M117.787853	http://dx.doi.org/10.1074/jbc.M117.787853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28848052	hybrid, Green Published			2022-12-26	WOS:000414009300013
J	Mobbs, JI; Illing, PT; Dudek, NL; Brooks, AG; Baker, DG; Purcell, AW; Rossjohn, J; Vivian, JP				Mobbs, Jesse I.; Illing, Patricia T.; Dudek, Nadine L.; Brooks, Andrew G.; Baker, Daniel G.; Purcell, Anthony W.; Rossjohn, Jamie; Vivian, Julian P.			The molecular basis for peptide repertoire selection in the human leukocyte antigen (HLA) C*06:02 molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; NATURAL-KILLER; PSORIATIC-ARTHRITIS; COMPLEX; EPITOPE; SUSCEPTIBILITY; ASSOCIATIONS; RECOGNITION; REFINEMENT; EXPRESSION	Human leukocyte antigen (HLA)-C*06:02 is identified as the allele associated with the highest risk for the development of the autoimmune skin disease psoriasis. However, the diversity and mode of peptide presentation by the HLA-C*06:02 molecule remains unclear. Here, we describe the endogenous peptide repertoire of similar to 3,000 sequences for HLA-C*06:02 that defines the peptide-binding motif for this HLA allomorph. We found that HLA-C*06:02 predominantly presents nonamer peptides with dominant arginine anchors at the P2 and P7 positions and a preference for small hydrophobic residues at the C terminus (P Omega). To determine the structural basis of this selectivity, we determined crystal structures of HLA-C*06:02 in complex with two self-peptides (ARTELYRSL and ARFNDLRFV) and an analogue of a melanocyte autoantigen (ADAMTSL5, VRSRR-abu-LRL) implicated in psoriasis. These structures revealed that HLA-C*06:02 possesses a deep peptide-binding groove comprising two electronegative Band E-pockets that coincide with the preference for P2 and P7 arginine anchors. The ADAMTSL5 autoantigen possessed a P7-Leu instead of the P7-Arg residue, but nevertheless was accommodated within the HLA-C*06:02 antigen-binding cleft. Collectively, our results provide the structural basis for understanding peptide repertoire selection in HLA-C*06:02.	[Mobbs, Jesse I.; Illing, Patricia T.; Dudek, Nadine L.; Purcell, Anthony W.; Rossjohn, Jamie; Vivian, Julian P.] Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia; [Mobbs, Jesse I.; Illing, Patricia T.; Dudek, Nadine L.; Purcell, Anthony W.; Rossjohn, Jamie; Vivian, Julian P.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Brooks, Andrew G.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Baker, Daniel G.] Janssen Res & Dev LLC, Philadelphia, PA 19044 USA; [Rossjohn, Jamie; Vivian, Julian P.] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; University of Melbourne; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Monash University; Cardiff University	Purcell, AW; Rossjohn, J; Vivian, JP (corresponding author), Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia.; Purcell, AW; Rossjohn, J; Vivian, JP (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Rossjohn, J; Vivian, JP (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales.	Anthony.purcell@monash.edu; Jamie.rossjohn@monash.edu; Julian.vivian@monash.edu	Purcell, Anthony/AAH-1942-2019; Illing, Patricia/AAP-6045-2021; Rossjohn, Jamie/F-9032-2013	Purcell, Anthony/0000-0003-0532-8331; Illing, Patricia/0000-0002-3870-0796; Rossjohn, Jamie/0000-0002-2020-7522; Brooks, Andrew/0000-0002-4085-9683; Mobbs, Jesse/0000-0001-6979-1427; Vivian, Julian/0000-0002-9400-4437	Janssen Pty. Ltd.; Australian National Health and Medical Research Council (NHMRC); NHMRC [1044215]; NMHRC [1072159]; Australian Research Council (ARC); ARC	Janssen Pty. Ltd.; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NMHRC; Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council)	This work was supported by Janssen Pty. Ltd., the Australian National Health and Medical Research Council (NHMRC), grants from the Australian Research Council (ARC) (to J. R., and A. W. P.), a ARC Laureate fellowship (to J.R.), NHMRC Senior Research Fellowship 1044215 (to A. W. P.), and NMHRC early career fellowship 1072159 (to P. T. I.). D .G. B. is an employee of Janssen Pty Ltd., which provided support for this work.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arakawa A, 2015, J EXP MED, V212, P2203, DOI 10.1084/jem.20151093; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Badrinath S, 2012, HAEMATOL-HEMATOL J, V97, P98, DOI 10.3324/haematol.2011.046037; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blais ME, 2011, IMMUNOLOGY, V133, P1, DOI 10.1111/j.1365-2567.2011.03422.x; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Cai YH, 2012, CELL MOL IMMUNOL, V9, P302, DOI 10.1038/cmi.2012.15; Chang JCC, 1997, ARCH DERMATOL, V133, P703, DOI 10.1001/archderm.133.6.703; CHANG JCC, 1994, P NATL ACAD SCI USA, V91, P9282, DOI 10.1073/pnas.91.20.9282; Chen B., 2017, MOL MED REP; Choo JAL, 2014, J VIROL, V88, P10613, DOI 10.1128/JVI.00855-14; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dudek NL, 2014, VITAM HORM, V95, P115, DOI 10.1016/B978-0-12-800174-5.00005-3; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dunphy SE, 2017, CLIN IMMUNOL, V177, P43, DOI 10.1016/j.clim.2015.10.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fan QR, 1999, J EXP MED, V190, P113, DOI 10.1084/jem.190.1.113; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Gudjonsson JE, 2003, BRIT J DERMATOL, V148, P233, DOI 10.1046/j.1365-2133.2003.05115.x; Gudmundsdottir AS, 1999, CLIN EXP IMMUNOL, V117, P580; Harden JL, 2015, J AUTOIMMUN, V64, P66, DOI 10.1016/j.jaut.2015.07.008; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Johnston A, 2004, CLIN EXP IMMUNOL, V138, P83, DOI 10.1111/j.1365-2249.2004.00600.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaur G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15924; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Kim SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037338; Kraemer T, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/346714; Kunze-Schumacher H., 2014, J IMMUNOL RES, V2014, DOI DOI 10.1155/2014/246171; Lande R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6621; Luszczek W, 2004, HUM IMMUNOL, V65, P758, DOI 10.1016/j.humimm.2004.05.008; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCCUTCHEON JA, 1995, J EXP MED, V181, P2085, DOI 10.1084/jem.181.6.2085; MCFADDEN J, 1991, BRIT J DERMATOL, V125, P443, DOI 10.1111/j.1365-2133.1991.tb14769.x; McGinty JW, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0657-7; Minos E, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0429-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; PARHAM P, 1995, IMMUNOL REV, V143, P141, DOI 10.1111/j.1600-065X.1995.tb00674.x; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Rasmussen M, 2014, J IMMUNOL, V193, P4790, DOI 10.4049/jimmunol.1401689; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Schittenhelm RB, 2014, TISSUE ANTIGENS, V83, P174, DOI 10.1111/tan.12282; Schittenhelm RB, 2015, ARTHRITIS RHEUMATOL, V67, P702, DOI 10.1002/art.38963; Scull KE, 2012, MOL IMMUNOL, V51, P136, DOI 10.1016/j.molimm.2012.02.117; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; Valdimarsson H, 2009, TRENDS IMMUNOL, V30, P494, DOI 10.1016/j.it.2009.07.008; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Vollmer S, 2001, J INVEST DERMATOL, V117, P1296, DOI 10.1046/j.0022-202x.2001.01494.x; Webb AI, 2004, J BIOL CHEM, V279, P23438, DOI 10.1074/jbc.M314066200; Winchester R, 2012, ARTHRITIS RHEUM-US, V64, P1134, DOI 10.1002/art.33415	66	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17203	17215		10.1074/jbc.M117.806976	http://dx.doi.org/10.1074/jbc.M117.806976			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28855257	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000414009300005
J	Zhuang, XL; Watts, NR; Palmer, IW; Kaufman, JD; Dearborn, AD; Trenbeath, JL; Eren, E; Steven, AC; Rader, C; Wingfield, PT				Zhuang, Xiaolei; Watts, Norman R.; Palmer, Ira W.; Kaufman, Joshua D.; Dearborn, Altaira D.; Trenbeath, Joni L.; Eren, Elif; Steven, Alasdair C.; Rader, Christoph; Wingfield, Paul T.			Chimeric rabbit/human Fab antibodies against the hepatitis B e-antigen and their potential applications in assays, characterization, and therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS E-ANTIGEN; CORE ANTIGEN; PRECORE PROTEIN; ESCHERICHIA-COLI; PHAGE DISPLAY; HIV-1 REV; IN-VITRO; MONOCLONAL-ANTIBODIES; SURFACE-ANTIGEN; GENERATION	Hepatitis B virus (HBV) infection afflicts millions worldwide, causing cirrhosis and liver cancer. HBV e-antigen (HBeAg), a clinical marker for disease severity, is a soluble variant of the viral capsid protein. HBeAg is not required for viral replication but is implicated in establishing immune tolerance and chronic infection. The structure of recombinant e-antigen (rHBeAg) was recently determined, yet to date, the exact nature and quantitation of HBeAg still remain uncertain. Here, to further characterize HBeAg, we used phage display to produce a panel of chimeric rabbit/human monoclonal antibody fragments (both Fab and scFv) against rHBeAg. Several of the Fab/scFv, expressed in Escherichia coli, had unprecedentedly high binding affinities (K-d similar to 10(-12) M) and high specificity. We used Fab/scFv in the context of an enzyme-linked immunosorbent assay (ELISA) for HBeAg quantification, which we compared with commercially available kits and verified with seroconversion panels, the WHO HBeAg standard, rHBeAg, and patient plasma samples. We found that the specificity and sensitivity are superior to those of existing commercial assays. To identify potential fine differences between rHBeAg and HBeAg, we used these Fabs in microscale immunoaffinity chromatography to purify HBeAg from individual patient plasmas. Western blotting and MS results indicated that rHBeAg and HBeAg are essentially structurally identical, although HBeAg from different patients exhibits minor carboxyl-terminal heterogeneity. We discuss several potential applications for the humanized Fab/scFv.	[Zhuang, Xiaolei; Watts, Norman R.; Palmer, Ira W.; Kaufman, Joshua D.; Dearborn, Altaira D.; Wingfield, Paul T.] NIAMS, Prot Express Lab, NIH, Bldg 6B,Rm 1B 130,9000 Rockville Pike, Bethesda, MD 20892 USA; [Eren, Elif; Steven, Alasdair C.] NIAMS, Lab Struct Biol Res, NIH, Bethesda, MD 20892 USA; [Trenbeath, Joni L.] Warren Grant Magnuson Clin Ctr, Dept Transfus Med, NIH, Bethesda, MD 20892 USA; [Rader, Christoph] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; Scripps Research Institute	Wingfield, PT (corresponding author), NIAMS, Prot Express Lab, NIH, Bldg 6B,Rm 1B 130,9000 Rockville Pike, Bethesda, MD 20892 USA.	wingfiep@mail.nih.gov		Eren, Elif/0000-0002-7942-4943; Rader, Christoph/0000-0001-9955-3454; Dearborn, Altaira/0000-0003-0463-5233; Wingfield, Paul/0000-0002-9515-4752	Intramural Research Program of the NIAMS; Center for Cancer Research of the NCI, National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027002] Funding Source: NIH RePORTER	Intramural Research Program of the NIAMS; Center for Cancer Research of the NCI, National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Intramural Research Program of the NIAMS, and the Center for Cancer Research of the NCI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baumeister MA, 2000, J MED VIROL, V60, P256, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt;256::AID-JMV2&gt;3.0.CO;2-H; Bereszczak JZ, 2013, J AM CHEM SOC, V135, P6504, DOI 10.1021/ja402023x; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Brunetto MR, 2010, J HEPATOL, V52, P475, DOI 10.1016/j.jhep.2009.12.020; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Chen GF, 2017, LIVER INT, V37, P59, DOI 10.1111/liv.13309; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; COHEN BJ, 1982, NATURE, V296, P677, DOI 10.1038/296677a0; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; DiMattia MA, 2016, STRUCTURE, V24, P1068, DOI 10.1016/j.str.2016.04.015; DiMattia MA, 2013, STRUCTURE, V21, P133, DOI 10.1016/j.str.2012.10.017; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Duriez M, 2008, J BIOL CHEM, V283, P32352, DOI 10.1074/jbc.M807178200; Duriez M, 2014, VIROLOGY, V462, P273, DOI 10.1016/j.virol.2014.06.013; FERNANDO SA, 1992, J IMMUNOL METHODS, V151, P47; FERNS RB, 1984, J GEN VIROL, V65, P899, DOI 10.1099/0022-1317-65-5-899; Hofer T, 2007, J IMMUNOL METHODS, V318, P75, DOI 10.1016/j.jim.2006.10.007; HOWARD CR, 1979, J MED VIROL, V4, P303, DOI 10.1002/jmv.1890040408; Hu DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129125; IMAI M, 1982, J IMMUNOL, V128, P69; Ito K, 2009, J VIROL, V83, P3507, DOI 10.1128/JVI.02348-08; Kimura T, 2005, J BIOL CHEM, V280, P21713, DOI 10.1074/jbc.M501564200; King TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101904; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liaw YF, 2009, HEPATOL INT, V3, P425, DOI 10.1007/s12072-009-9140-3; MACKAY P, 1981, J MED VIROL, V8, P237, DOI 10.1002/jmv.1890080404; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Maini MK, 2017, NAT REV GASTRO HEPAT, V14, P71, DOI 10.1038/nrgastro.2016.196; Messageot F, 2003, J BIOL CHEM, V278, P891, DOI 10.1074/jbc.M207634200; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; MURRAY K, 1984, EMBO J, V3, P645, DOI 10.1002/j.1460-2075.1984.tb01861.x; MURRAY K, 1987, J MED VIROL, V23, P101, DOI 10.1002/jmv.1890230202; NEURATH AR, 1979, J GEN VIROL, V42, P493, DOI 10.1099/0022-1317-42-3-493; Nguyen T, 2009, HEPATOL INT, V3, pS5, DOI 10.1007/s12072-009-9149-7; OU JH, 1986, P NATL ACAD SCI USA, V83, P1578, DOI 10.1073/pnas.83.6.1578; Popkov M, 2004, J IMMUNOL METHODS, V288, P149, DOI 10.1016/j.jim.2004.03.005; Rader C, 1997, CURR OPIN BIOTECH, V8, P503, DOI 10.1016/S0958-1669(97)80075-4; Rader Christoph, 2009, V525, P101, DOI 10.1007/978-1-59745-554-1_5; Stahl SJ, 2014, METHODS MOL BIOL, V1131, P549, DOI 10.1007/978-1-62703-992-5_35; Stahl SJ, 2010, J MOL BIOL, V397, P697, DOI 10.1016/j.jmb.2010.01.061; STANDRING DN, 1988, P NATL ACAD SCI USA, V85, P8405, DOI 10.1073/pnas.85.22.8405; Steven AC, 2005, ADV VIRUS RES, V64, P125, DOI 10.1016/S0065-3527(05)64005-5; TAKAHASHI K, 1983, J IMMUNOL, V130, P2903; Tong SP, 2016, J HEPATOL, V64, pS4, DOI 10.1016/j.jhep.2016.01.027; Vanlandschoot P, 2003, TRENDS IMMUNOL, V24, P144, DOI 10.1016/S1471-4906(03)00026-7; Venkatakrishnan B, 2016, ANNU REV VIROL, V3, P429, DOI 10.1146/annurev-virology-110615-042238; Volkers M, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-28; Walsh R, 2012, YONSEI MED J, V53, P875, DOI 10.3349/ymj.2012.53.5.875; Watts NR, 2011, J MOL BIOL, V409, P202, DOI 10.1016/j.jmb.2011.03.049; Watts NR, 2010, J MOL BIOL, V398, P530, DOI 10.1016/j.jmb.2010.03.026; Weber J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.23; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; WINGFIELD PT, 1987, YEAST, V3, P43, DOI 10.1002/yea.320030107; Wu WM, 2013, J STRUCT BIOL, V181, P53, DOI 10.1016/j.jsb.2012.10.004; Xun YH, 2013, INT J MOL MED, V31, P369, DOI 10.3892/ijmm.2012.1210; Ying TL, 2012, J BIOL CHEM, V287, P19399, DOI 10.1074/jbc.M112.368647	56	5	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16760	16772		10.1074/jbc.M117.802272	http://dx.doi.org/10.1074/jbc.M117.802272			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842495	Green Published, hybrid			2022-12-26	WOS:000412414800034
J	Maxson, T; Taylor-Howell, CL; Minogue, TD				Maxson, Tucker; Taylor-Howell, Cheryl L.; Minogue, Timothy D.			Semi-quantitative MALDI-TOF for antimicrobial susceptibility testing in Staphylococcus aureus	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; LASER-DESORPTION/IONIZATION-TIME; RAPID DETECTION; ANTIBIOTIC-RESISTANCE; TOOL; MS	Antibiotic resistant bacterial infections are a significant problem in the healthcare setting, in many cases requiring the rapid administration of appropriate and effective antibiotic therapy. Diagnostic assays capable of quickly and accurately determining the pathogen resistance profile are therefore crucial to initiate or modify care. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) is a standard method for species identification in many clinical microbiology laboratories and is well positioned to be applied towards antimicrobial susceptibility testing. One recently reported approach utilizes semi-quantitative MALDI-TOF MS for growth rate analysis to provide a resistance profile independent of resistance mechanism. This method was previously successfully applied to Gram-negative pathogens and mycobacteria; here, we evaluated this method with the Gram-positive pathogen Staphylococcus aureus. Specifically, we used 35 strains of S. aureus and four antibiotics to optimize and test the assay, resulting in an overall accuracy rate of 95%. Application of the optimized assay also successfully determined susceptibility from mock blood cultures, allowing both species identification and resistance determination for all four antibiotics within 3 hours of blood culture positivity.	[Maxson, Tucker; Taylor-Howell, Cheryl L.; Minogue, Timothy D.] US Army, Med Res Inst Infect Dis, Diagnost Syst Div, Ft Detrick, MD 21702 USA		Minogue, TD (corresponding author), US Army, Med Res Inst Infect Dis, Diagnost Syst Div, Ft Detrick, MD 21702 USA.	timothy.d.minogue.civ@mail.mil						Angeletti S., 2016, J MICROBIOL METHODS; Camara JE, 2007, ANAL BIOANAL CHEM, V389, P1633, DOI 10.1007/s00216-007-1558-7; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Clinical and Laboratory Standard Institute, 2007, M100S17 CLSI; Clinical and Laboratory Standards Institute, 2016, M100S26 CLSI, VM100-S26; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; De Carolis E, 2014, J INFECT DEV COUNTR, V8, P1081, DOI 10.3855/jidc.3623; Griffin PM, 2012, J CLIN MICROBIOL, V50, P2918, DOI 10.1128/JCM.01000-12; Hiramatsu K, 2014, J GLOB ANTIMICROB RE, V2, P213, DOI 10.1016/j.jgar.2014.04.006; Hrabak J, 2013, CLIN MICROBIOL REV, V26, P103, DOI 10.1128/CMR.00058-12; Jung JS, 2014, EUR J CLIN MICROBIOL, V33, P949, DOI 10.1007/s10096-013-2031-5; Jung JS, 2016, J CLIN MICROBIOL, V54, P2820, DOI 10.1128/JCM.01131-16; Kostrzewa M, 2013, PROTEOM CLIN APPL, V7, P767, DOI 10.1002/prca.201300042; Lange C, 2014, J CLIN MICROBIOL, V52, P4155, DOI 10.1128/JCM.01872-14; Malani AN, 2013, AM J INFECT CONTROL, V41, P145, DOI 10.1016/j.ajic.2012.02.021; Oviano M, 2017, J ANTIMICROB CHEMOTH; Oviano M, 2017, J ANTIMICROB CHEMOTH, V72, P1074, DOI 10.1093/jac/dkw552; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Sakarikou C, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0952-3; Sparbier K, 2016, METHODS, V104, P48, DOI 10.1016/j.ymeth.2016.01.008; Sparbier K, 2013, J CLIN MICROBIOL, V51, P3741, DOI 10.1128/JCM.01536-13; Wang MC, 2015, J MICROBIOL IMMUNOL, V48, P419, DOI 10.1016/j.jmii.2013.10.006	23	23	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183899	10.1371/journal.pone.0183899	http://dx.doi.org/10.1371/journal.pone.0183899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859120	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500045
J	Scheper, V; Hessler, R; Hutten, M; Wilk, M; Jolly, C; Lenarz, T; Paasche, G				Scheper, Verena; Hessler, Roland; Huetten, Mareike; Wilk, Maciej; Jolly, Claude; Lenarz, Thomas; Paasche, Gerrit			Local inner ear application of dexamethasone in cochlear implant models is safe for auditory neurons and increases the neuroprotective effect of chronic electrical stimulation	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; TRAUMA-INDUCED HEARING; INTRATYMPANIC DEXAMETHASONE; NEUROTROPHIC FACTOR; CONSERVES HEARING; MENIERES-DISEASE; DOUBLE-BLIND; SURVIVAL; NERVE; PROTECTION	Dexamethasone (DEX) can reduce fibrous tissue growth as well as loss of residual hearing which may occur after cochlear implantation. Little is known about the effect of local inner ear DEX treatment on the spiral ganglion neurons (SGN), which are the target of the electrical stimulation with a cochlear implant (CI). Three different clinically relevant strategies of DEX-delivery into the inner ear were used. DEX was either eluted from the electrode carriers' silicone, released from a reservoir by passive diffusion, or actively applied using a pump based system. The effect of the locally applied DEX on SGN density, size and function was evaluated. DEX did not affect the SGN density compared to the relevant control groups. Simultaneously applied with chronic electrical stimulation (ES), DEX increased the neuroprotective effect of ES in the basal region and the hearing threshold tended to decrease. The EABR thresholds did not correlate with the relevant SGN density. When correlating the SGN number with fibrosis, no dependency was observed. DEX concentrations as applied in these animal models are safe for inner ear delivery in terms of their effect on SGN density. Additionally, DEX tends to improve the neuroprotective effect of chronic electrical stimulation by increasing the number of surviving neurons. This is an important finding in regard to clinical applications of DEX for local treatment of the inner ear in view of cochlear implantation and other applications.	[Scheper, Verena; Huetten, Mareike; Wilk, Maciej; Lenarz, Thomas; Paasche, Gerrit] Hannover Med Sch MHH, Dept Otolaryngol, Hannover, Germany; [Scheper, Verena; Lenarz, Thomas; Paasche, Gerrit] German Res Fdn, Cluster Excellence Hearing4all, Hannover, Germany; [Hessler, Roland; Jolly, Claude] MED EL Innsbruck, Res & Dev, Innsbruck, Austria	Hannover Medical School; German Research Foundation (DFG)	Scheper, V (corresponding author), Hannover Med Sch MHH, Dept Otolaryngol, Hannover, Germany.; Scheper, V (corresponding author), German Res Fdn, Cluster Excellence Hearing4all, Hannover, Germany.	scheper.verena@mh-hannover.de	Scheper, Verena/J-4298-2019	Scheper, Verena/0000-0001-8618-8793	European Community 6th Framework Programme (NANOEAR) [26556]; 5th Framework Programme (BIOEAR) [QLG3-CT-2002-01563]; 7th Framework Programme (NeuEar) [304930]; MED-EL Corporation; EC; MEDEL Corporation	European Community 6th Framework Programme (NANOEAR); 5th Framework Programme (BIOEAR); 7th Framework Programme (NeuEar); MED-EL Corporation; EC(European CommissionEuropean Commission Joint Research Centre); MEDEL Corporation	This study was supported by the European Community 6th Framework Programme (Project reference: 26556; Funded under: FP6-NMP; Project acronym: NANOEAR), the 5th Framework Programme (Project reference: QLG3-CT-2002-01563; Funded under: FP5-LIFE QUALITY; Project acronym: BIOEAR), the 7th Framework Programme (Project reference: 304930; Funded under: FP7-HEALTH, Project acronym: NeuEar), and MED-EL Corporation. The APC fee for this article has been funded by the EC FP7 Post-Grant Open Access Pilot. The funders provided support in the form of salaries for authors [RH and CJ from MEDEL Corporation; VS, MH and MW from the EC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. Besides of the financial support, the funding sources had no leading part in the studies. No editorial support was received in the preparation of the manuscript.	Albu S, 2016, AM J OTOLARYNG, V37, P225, DOI 10.1016/j.amjoto.2015.12.007; Al Attrache NA, 2016, J INT ADV OTOL, V12, P92, DOI 10.5152/iao.2016.2177; Bas DB, 2015, EUR J PAIN, V19, P260, DOI 10.1002/ejp.544; Bas E, 2016, HEARING RES, V337, P12, DOI 10.1016/j.heares.2016.02.003; Berjis Nezamoddin, 2016, Adv Biomed Res, V5, P111, DOI 10.4103/2277-9175.184277; Braun S, 2011, ORL-J OTO-RHIN-LARYN, V73, P219, DOI 10.1159/000329791; Ceschi P., 2013, DEV POLYMERIC COATIN; Chirtes F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925485; Connolly TM, 2011, AUDIOL NEURO-OTOL, V16, P137, DOI 10.1159/000314757; Dixon WG, 2012, ANN RHEUM DIS, V71, P1761, DOI 10.1136/annrheumdis-2012-202021; Douchement D, 2015, Cochlear Implants Int, V16, P195, DOI 10.1179/1754762813Y.0000000053; Elzayat S, 2016, ORL J OTO-RHINO-LARY, V78, P159, DOI 10.1159/000445774; Erdur O, 2014, EUR ARCH OTO-RHINO-L, V271, P1431, DOI 10.1007/s00405-013-2594-x; Eshraghi AA, 2007, OTOL NEUROTOL, V28, P842, DOI 10.1097/MAO.0b013e31805778fc; Fayad JN, 2006, LARYNGOSCOPE, V116, P1310, DOI 10.1097/01.mlg.0000227176.09500.28; Hahn HL, 1990, GLUKOKORTIKOIDE BEI; HALL RD, 1990, HEARING RES, V49, P155, DOI 10.1016/0378-5955(90)90102-U; Hansen MR, 2001, J NEUROSCI, V21, P2256, DOI 10.1523/JNEUROSCI.21-07-02256.2001; Hargunani CA, 2006, OTOL NEUROTOL, V27, P564, DOI 10.1097/00129492-200606000-00021; Hegarty JL, 1997, J NEUROSCI, V17, P1959; Heinrich UR, 2016, LARYNGOSCOPE, V126, pE29, DOI 10.1002/lary.25345; Honeder C, 2015, LARYNGOSCOPE, V125, pE149, DOI 10.1002/lary.25011; Hutten M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104564; Kanzaki S, 2002, J COMP NEUROL, V454, P350, DOI 10.1002/cne.10480; Konerding WS, 2017, HEARING RES, V350, P110, DOI 10.1016/j.heares.2017.04.013; Kuthubutheen J, 2015, HEARING RES, V327, P257, DOI 10.1016/j.heares.2015.06.010; Lambert PR, 2012, OTOL NEUROTOL, V33, P1257, DOI 10.1097/MAO.0b013e318263d35d; Leake PA, 1999, J COMP NEUROL, V412, P543, DOI 10.1002/(SICI)1096-9861(19991004)412:4<543::AID-CNE1>3.0.CO;2-3; LEAKE PA, 1991, HEARING RES, V54, P251, DOI 10.1016/0378-5955(91)90120-X; Leake PA, 2013, JARO-J ASSOC RES OTO, V14, P187, DOI 10.1007/s10162-013-0372-5; Lenarz T, 2015, OXID STRESS APPL BAS, P423, DOI 10.1007/978-3-319-13473-4_20; Liu Y, 2015, HEARING RES, V327, P89, DOI 10.1016/j.heares.2015.04.019; Maini S, 2009, AUDIOL NEURO-OTOL, V14, P402, DOI 10.1159/000241897; Maruyama J, 2007, NEUROBIOL DIS, V25, P309, DOI 10.1016/j.nbd.2006.09.012; Meyer H, 2012, INT J NANOMED, V7, P2449, DOI 10.2147/IJN.S29712; Miller AL, 2003, BRAIN RES, V966, P218, DOI 10.1016/S0006-8993(02)04170-7; Miller J M, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P57; Mitchell A, 1997, HEARING RES, V105, P30, DOI 10.1016/S0378-5955(96)00202-X; Piu F, 2011, OTOL NEUROTOL, V32, P171, DOI 10.1097/MAO.0b013e3182009d29; Plontke SK, 2009, LARYNGOSCOPE, V119, P359, DOI 10.1002/lary.20074; Rajan GP, 2012, LARYNGOSCOPE, V122, P190, DOI 10.1002/lary.22142; Ramekers D, 2014, JARO-J ASSOC RES OTO, V15, P187, DOI 10.1007/s10162-013-0440-x; Roehm Pamela C, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P294, DOI 10.1097/01.moo.0000180919.68812.b9; Scheper V, 2009, J NEUROSCI RES, V87, P1389, DOI 10.1002/jnr.21964; Semaan Maroun T, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P301, DOI 10.1097/01.moo.0000186335.44206.1c; Shepherd RK, 2008, HEARING RES, V242, P100, DOI 10.1016/j.heares.2007.12.005; Shirwany NA, 1998, AM J OTOL, V19, P230; Stathopoulos Dimitra, 2014, Cochlear Implants Int, V15, P254, DOI 10.1179/1754762813Y.0000000054; TENCATE WJF, 1993, LARYNGOSCOPE, V103, P865; Vivero RJ, 2008, LARYNGOSCOPE, V118, P2028, DOI 10.1097/MLG.0b013e31818173ec; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Wei L, 2004, ANN INTERN MED, V141, P764, DOI 10.7326/0003-4819-141-10-200411160-00007; Wilk M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147552; Worsoe L, 2010, OTOL NEUROTOL, V31, P394, DOI 10.1097/MAO.0b013e3181d2796c; Wrzeszcz A, 2013, HEARING RES, V306, P145, DOI 10.1016/j.heares.2013.08.002; Xu HX, 2012, ACTA OTO-LARYNGOL, V132, P482, DOI 10.3109/00016489.2011.647361; Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1; Yamagata T, 2004, J NEUROSCI RES, V78, P75, DOI 10.1002/jnr.20239	58	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183820	10.1371/journal.pone.0183820	http://dx.doi.org/10.1371/journal.pone.0183820			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859106	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500036
J	Pereira, AAL; Morelli, MP; Overman, M; Kee, B; Fogelman, D; Vilar, E; Shureiqi, I; Raghav, K; Eng, C; Manuel, S; Crosby, S; Wolff, RA; Banks, K; Lanman, R; Talasaz, A; Kopetz, S; Van Morris,				Pereira, Allan A. Lima; Morelli, Maria Pia; Overman, Michael; Kee, Bryan; Fogelman, David; Vilar, Eduardo; Shureiqi, Imad; Raghav, Kanwal; Eng, Cathy; Manuel, Shanequa; Crosby, Shadarra; Wolff, Robert A.; Banks, Kimberly; Lanman, Richard; Talasaz, AmirAli; Kopetz, Scott; Van Morris			Clinical utility of circulating cell-free DNA in advanced colorectal cancer	PLOS ONE			English	Article							TUMOR DNA; LUNG-CANCER; PERSONALIZED MEDICINE; LIQUID BIOPSIES; BREAST-CANCER; MUTATIONS; HETEROGENEITY; THERAPY; PLASMA; QUANTIFICATION	Background Circulating cell-free DNA (cfDNA) isolated from the plasma of cancer patients (pts) has been shown to reflect the genomic mutation profile of the tumor. However, physician and patient assessment of clinical utility of these assays in patients with metastatic colorectal cancer (mCRC) has not been previously described. Methods Patients were prospectively consented to a prospective genomic matching protocol (Assessment of Targeted Therapies Against Colorectal Cancer [ATTACC]), with collection of blood for cfDNA extraction and sequencing of a 54-gene panel in a CLIA-certified lab. Formalin-fixed, paraffin-embedded (FFPE) tissue from prior resections or biopsies underwent 50-gene sequencing. Results from both assays were returned to the treating physicians for patient care and clinical trial selection. Follow-up surveys of treating physicians and chart reviews assessed clinical utility. Results 128 mCRC pts were enrolled between 6/2014 and 1/2015. Results were returned in median of 13 and 26 days for cfDNA and FFPE sequencing, respectively. With cfDNA sequencing, 78% (100/128) of samples had a detectable somatic genomic alteration. 50% of cfDNA cases had potentially actionable alterations, and 60% of these could be genomically matched to at least one clinical trial in our institution. 50% (15/30) of these pts enrolled onto an identified matched trial. Physicians reported that the cfDNA testing improved the quality of care they could provide in 73% of the cases, and that 89% of pts reported greater satisfaction with the efforts to personalize experimental therapeutic agents. Conclusions cfDNA sequencing can provide timely information on potentially actionable mutations and amplifications, thereby facilitating clinical trial enrollment and improving the perceived quality of care.	[Pereira, Allan A. Lima; Morelli, Maria Pia; Overman, Michael; Kee, Bryan; Fogelman, David; Shureiqi, Imad; Raghav, Kanwal; Eng, Cathy; Manuel, Shanequa; Crosby, Shadarra; Wolff, Robert A.; Kopetz, Scott; Van Morris] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Vilar, Eduardo] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Banks, Kimberly; Lanman, Richard; Talasaz, AmirAli] Guardant Hlth, Redwood City, CA USA; [Morelli, Maria Pia] NCI, Ctr Canc Res, Bethesda, MD 20892 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Van Morris, (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA.	vkmorris@mdanderson.org	Lanman, Richard B/D-8290-2016; Shureiqi, imad/T-6214-2019; Kopetz, Scott/AAC-1387-2019; Pereira, Allan/N-7773-2016	Lanman, Richard B/0000-0001-8122-4329; Kopetz, Scott/0000-0001-9647-3416; Pereira, Allan/0000-0002-8573-7364; Eng, Cathy/0000-0003-2335-0612; Shureiqi, Imad/0000-0003-2019-938X	NATIONAL CANCER INSTITUTE [P30CA016672, K12CA088084] Funding Source: NIH RePORTER; NCI NIH HHS [K12 CA088084] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allegra CJ, 2016, J ONCOL PRACT, V12, P180, DOI 10.1200/JOP.2015.007898; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Booth CM, 2016, ANN SURG ONCOL, V23, P1057, DOI 10.1245/s10434-015-4979-0; Carpinetti P, 2015, ONCOTARGET, V6, P38360, DOI 10.18632/oncotarget.5256; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Mattos-Arruda L, 2014, ANN ONCOL, V25, P1729, DOI 10.1093/annonc/mdu239; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goyal L, 2017, CANC DISCOV; Gray SW, 2014, J CLIN ONCOL, V32, P1317, DOI 10.1200/JCO.2013.52.4298; Hong DS, 2016, CANCER DISCOV, V6, P1352, DOI 10.1158/2159-8290.CD-16-0050; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; Lebofsky R, 2015, MOL ONCOL, V9, P783, DOI 10.1016/j.molonc.2014.12.003; Liang DH, 2016, BREAST CANCER RES TR, V155, P139, DOI 10.1007/s10549-015-3635-5; Marchetti A, 2015, J THORAC ONCOL, V10, P1437, DOI 10.1097/JTO.0000000000000643; Meric-Bernstam F, 2015, J CLIN ONCOL, V33, P2753, DOI 10.1200/JCO.2014.60.4165; Morelli MP, 2015, ANN ONCOL, V26, P731, DOI 10.1093/annonc/mdv005; Morris VK, 2017, LANCET ONCOL, V18, P446, DOI 10.1016/S1470-2045(17)30104-3; Overman MJ, 2016, ANN ONCOL, V27, P1068, DOI 10.1093/annonc/mdw073; Piotrowska Z, 2016, J THORAC ONCOL, V11, pE95, DOI 10.1016/j.jtho.2016.03.020; Raghav K, 2016, ONCOTARGET, V7, P54627, DOI 10.18632/oncotarget.10559; Rozenblum AB, 2017, J THORAC ONCOL, V12, P258, DOI 10.1016/j.jtho.2016.10.021; Russo M, 2016, CANCER DISCOV, V6, P147, DOI 10.1158/2159-8290.CD-15-1283; Sacher A.G., 2016, JAMA ONCOL; Sartore-Bianchi A, 2016, LANCET ONCOL, V17, P738, DOI 10.1016/S1470-2045(16)00150-9; Schwaederle M, 2016, CLIN CANCER RES, V22, P5497, DOI 10.1158/1078-0432.CCR-16-0318; Schwaederle M, 2016, ONCOTARGET, V7, P9707, DOI 10.18632/oncotarget.7110; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Spindler KG, 2013, BRIT J CANCER, V109, P3067, DOI 10.1038/bjc.2013.633; Thompson JC, 2016, CLIN CANCER RES, V22, P5772, DOI 10.1158/1078-0432.CCR-16-1231; Tie J, 2015, ANN ONCOL, V26, P1715, DOI 10.1093/annonc/mdv177; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Vallee A, 2016, LUNG CANCER, V91, P73, DOI 10.1016/j.lungcan.2015.11.008; van der Vaart M, 2008, ANN NY ACAD SCI, V1137, P18, DOI 10.1196/annals.1448.022; Verwaal VJ, 2008, ANN SURG ONCOL, V15, P2426, DOI 10.1245/s10434-008-9966-2; Villaflor V, 2016, ONCOTARGET, V7, P66880, DOI 10.18632/oncotarget.11801; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	41	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183949	10.1371/journal.pone.0183949	http://dx.doi.org/10.1371/journal.pone.0183949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850629	Green Published, gold, Green Submitted			2022-12-26	WOS:000408544200046
J	Tan, TL; Cheong, SA				Tan, Teck Liang; Cheong, Siew Ann			Statistical complexity is maximized in a small-world brain	PLOS ONE			English	Article							INTEGRATE-AND-FIRE; SELF-ORGANIZED CRITICALITY; SPIKING NEURONS; SYNAPTIC INPUT; NETWORKS; MODEL; CHAOS; PLASTICITY; EDGE	In this paper, we study a network of Izhikevich neurons to explore what it means for a brain to be at the edge of chaos. To do so, we first constructed the phase diagram of a single Izhikevich excitatory neuron, and identified a small region of the parameter space where we find a large number of phase boundaries to serve as our edge of chaos. We then couple the outputs of these neurons directly to the parameters of other neurons, so that the neuron dynamics can drive transitions from one phase to another on an artificial energy landscape. Finally, we measure the statistical complexity of the parameter time series, while the network is tuned from a regular network to a random network using the Watts-Strogatz rewiring algorithm. We find that the statistical complexity of the parameter dynamics is maximized when the neuron network is most small-world-like. Our results suggest that the small-world architecture of neuron connections in brains is not accidental, but may be related to the information processing that they do.	[Tan, Teck Liang; Cheong, Siew Ann] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, 21 Nanyang Link, Singapore 637371, Singapore; [Tan, Teck Liang; Cheong, Siew Ann] Nanyang Technol Univ, Complex Inst, Block 2 Innovat Ctr,Level 2 Unit 245, Singapore 637723, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, TL (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, 21 Nanyang Link, Singapore 637371, Singapore.; Tan, TL (corresponding author), Nanyang Technol Univ, Complex Inst, Block 2 Innovat Ctr,Level 2 Unit 245, Singapore 637723, Singapore.	S130004@e.ntu.edu.sg	Cheong, Siew Ann/B-6991-2011	Cheong, Siew Ann/0000-0002-8589-6699				ABBOTT LF, 1990, LECT NOTES PHYS, V368, P5; Abbott LF, 1999, BRAIN RES BULL, V50, P303, DOI 10.1016/S0361-9230(99)00161-6; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bak P., 1996, NATURE WORKS, P1, DOI [10.1007/978-1-4757-5426-1, 10.1007/978-1-4757-5426-1_1, DOI 10.1007/978-1-4757-5426-1_1]; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Brunel N, 2007, BIOL CYBERN, V97, P337, DOI 10.1007/s00422-007-0190-0; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burkitt AN, 2006, BIOL CYBERN, V95, P97, DOI 10.1007/s00422-006-0082-8; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Chialvo DR, 1999, NEUROSCIENCE, V90, P1137, DOI 10.1016/S0306-4522(98)00472-2; Chialvo DR, 2008, ARXIV08040032; Crutchfield JP, 2012, NAT PHYS, V8, P17, DOI 10.1038/nphys2190; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; Crutchfield JP, 1988, COMPUTATION ONSET CH; Feldman DP, 1998, PHYS LETT A, V238, P244, DOI 10.1016/S0375-9601(97)00855-4; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Guo D, 2016, SCI REP, P6; Guo DQ, 2010, IEEE T NEURAL NETWOR, V21, P895, DOI 10.1109/TNN.2010.2044419; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich E.M., 2008, SIAM REV, V50, P397; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Legenstein R, 2007, NEURAL NETWORKS, V20, P323, DOI 10.1016/j.neunet.2007.04.017; Lopez-Ruiz R., 2002, NLIN0205033 ARXIV; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Newman MEJ, 1999, PHYS REV E, V60, P7332, DOI 10.1103/PhysRevE.60.7332; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Touboul J, 2008, SIAM J APPL MATH, V68, P1045, DOI 10.1137/070687268; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Turcotte DL, 1999, REP PROG PHYS, V62, P1377, DOI 10.1088/0034-4885/62/10/201; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	44	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183918	10.1371/journal.pone.0183918	http://dx.doi.org/10.1371/journal.pone.0183918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850587	gold, Green Published			2022-12-26	WOS:000408544200042
J	Hyun, J; Lim, DH; Eo, DR; Hwang, S; Chung, ES; Chung, TY				Hyun, Joo; Lim, Dong Hui; Eo, Doo Ri; Hwang, Sungsoon; Chung, Eui-Sang; Chung, Tae-Young			A comparison of visual outcome and rotational stability of two types of toric implantable collamer lenses (TICL): V4 versus V4c	PLOS ONE			English	Article							PHAKIC INTRAOCULAR-LENS; HIGH MYOPIC ASTIGMATISM; CENTRAL HOLE; CLINICAL-OUTCOMES; PUPILLARY BLOCK; AXIS ALIGNMENT; GLAUCOMA; BIOMETRY; MODERATE; EYES	Purpose To compare the efficacy and rotational stability after implantation of two types of toric implantable collamer lenses (Toric ICL (TM)(TICL);V4 and V4c, STAAR Surgical Co.) Study design Retrospective case series. Methods This retrospective study evaluated total 48 eyes of 48 patients who underwent the implantation with V4 and V4c TICL with a central hole; A twenty-four eyes of 24 patients with V4 TICL and 24 eyes of 24 patients with V4c TICL with a central hole. Visual acuity, manifest refraction, and intraocular pressure were evaluated before and after surgery. Rotational stability (disparity between the intended axis and achieved axis) was assessed in both groups using digital anterior segment photographs, and vector analysis was also performed. Results Uncorrected visual acuity improved in both groups without significant difference (P = .111). There were no statistical differences between two groups in postoperative SE and cylindrical errors (P = .067 and .384, respectively). The mean value of rotation was 4.17 +/- 3.31 degrees and 3.39 +/- 2.36 degrees in the V4 and V4c TICL groups, respectively without significant difference (P = .364). Vector analysis of astigmatic correction showed no significant diffrence between two groups. Conclusion V4 and V4c TICL have similar efficacy with regard to visual acuity and refractive outcomes and rotational stability.	[Hyun, Joo; Lim, Dong Hui; Eo, Doo Ri; Hwang, Sungsoon; Chung, Tae-Young] Sungkyunkwan Univ, Samsung Med Ctr, Dept Ophthalmol, Sch Med, Seoul, South Korea; [Hyun, Joo] Saevit Eye Hosp, Dept Ophthalmol, Goyang, South Korea; [Lim, Dong Hui] Catholic Univ Korea, Dept Prevent Med, Coll Med, Seoul, South Korea; [Chung, Eui-Sang] Rhees Eye Hosp, Daejeon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea	Chung, TY (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Ophthalmol, Sch Med, Seoul, South Korea.	tychung@skku.edu		Hyun, Joo/0000-0003-0830-807X; Chung, Tae-Young/0000-0002-7291-822X				Alfonso JF, 2014, J CATARACT REFR SURG, V40, P1155, DOI 10.1016/j.jcrs.2013.11.034; Alfonso JF, 2013, J CATARACT REFR SURG, V39, P915, DOI 10.1016/j.jcrs.2013.01.036; Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; Bylsma SS, 2002, J CATARACT REFR SURG, V28, P2222, DOI 10.1016/S0886-3350(02)01303-2; Choi KH, 2007, J REFRACT SURG, V23, P362; Choi SH, 2011, J REFRACT SURG, V27, P91, DOI 10.3928/1081597X-20100414-01; Chung TY, 2009, J REFRACT SURG, V25, P251, DOI 10.3928/1081597X-20090301-03; Gonzalez-Lopez F, 2013, J CATARACT REFR SURG, V39, P1859, DOI 10.1016/j.jcrs.2013.06.020; Hashem AN, 2009, J REFRACT SURG, V25, pS939, DOI 10.3928/1081597X-20090915-08; HOFFER KJ, 1980, AM J OPHTHALMOL, V90, P360, DOI 10.1016/S0002-9394(14)74917-7; Huseynova T, 2014, AM J OPHTHALMOL, V157, P1136, DOI 10.1016/j.ajo.2014.01.032; Kamiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056453; Lee DH, 2012, OPHTHALMOLOGY, V119, P272, DOI 10.1016/j.ophtha.2011.07.047; Lee SY, 2011, EYE, V25, P1409, DOI 10.1038/eye.2011.176; Lim DH, 2014, AM J OPHTHALMOL, V158, P447, DOI 10.1016/j.ajo.2014.06.005; Lim DH, 2014, AM J OPHTHALMOL, V157, P135, DOI 10.1016/j.ajo.2013.09.004; Mori T, 2012, J CATARACT REFR SURG, V38, P568, DOI 10.1016/j.jcrs.2011.11.028; Park SC, 2009, J REFRACT SURG, V25, P403, DOI 10.3928/1081597X-20090422-01; Sanders DR, 2007, OPHTHALMOLOGY, V114, P54, DOI 10.1016/j.ophtha.2006.08.049; Sheng XL, 2012, INT J OPHTHALMOL-CHI, V5, P459, DOI 10.3980/j.issn.2222-3959.2012.04.10; Shimizu K, 2012, BRIT J OPHTHALMOL, V96, P409, DOI 10.1136/bjophthalmol-2011-300148; Smallman DS, 2004, J CATARACT REFR SURG, V30, P905, DOI 10.1016/j.jcrs.2003.09.019; Till JS, 2002, J CATARACT REFR SURG, V28, P295, DOI 10.1016/S0886-3350(01)01035-5; Vetter JM, 2006, J CATARACT REFR SURG, V32, P1065, DOI 10.1016/j.jcrs.2006.02.028	24	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183335	10.1371/journal.pone.0183335	http://dx.doi.org/10.1371/journal.pone.0183335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846701	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600024
J	Dessauer, CW				Dessauer, Carmen W.			Shining a light on GPCR complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEIN-COUPLED RECEPTOR; CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; RHODOPSIN; TRANSDUCIN	The G protein-coupled receptor (GPCR) signaling pathways mediating information exchange across the cell membrane are central to a variety of biological processes and therapeutic strategies, but visualizing the molecular-level details of this exchange has been difficult for all but a few GPCR-G protein complexes. A study by Gao et al. now reports new strategies and tools to obtain receptor complexes in a near-native state, revealing insights into the gross conformational features of rhodopsin-transducin interactions and setting the stage for future studies.	[Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Dessauer, CW (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	carmen.w.dessauer@uth.tmc.edu			National Institutes of Health [GM60419, NS091759]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants GM60419 and NS091759. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Gao Y, 2017, J BIOL CHEM, V292, P14280, DOI 10.1074/jbc.M117.797100; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394	10	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14290	14291		10.1074/jbc.H117.797100	http://dx.doi.org/10.1074/jbc.H117.797100			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28842475	Green Published, hybrid			2022-12-26	WOS:000408439800033
J	Prieto, LM; McPhee, CF; Rojas, P; Mazariegos, D; Munoz, E; Mellado, MJ; Holguin, A; Navarro, ML; Gonzalez-Tome, M; Ramos, JT				Prieto, Luis M.; Fernandez McPhee, Carolina; Rojas, Patricia; Mazariegos, Diana; Munoz, Eloy; Jose Mellado, Maria; Holguin, Africa; Luisa Navarro, Maria; Isabel Gonzalez-Tome, Maria; Tomas Ramos, Jose		Madrid Cohort HIV-Infected Mother	Pregnancy outcomes in perinatally HIV-infected young women in Madrid, Spain: 2000-2015	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; FOR-GESTATIONAL-AGE; LOW RATES; ADOLESCENTS; COHORT; RISK; MORTALITY; IRELAND; BORN; UK	Background An increasing number of perinatally HIV-infected women (PHIV) are reaching adulthood and becoming pregnant. Most PHIV women have been exposed to a high number of antiretroviral regimens, and they may have difficulties to achieve viral suppression. Psychosocial problems are not uncommon and could be an important barrier for treatment adherence. The effects of chronic HIV infection and long-term exposure to antiretroviral treatment of PHIV women cause concerns on the developing fetus. The aims of this study were to describe the prevention of mother-to-child transmission strategies in PHIV women and the infant outcomes in the Madrid Cohort of HIV-infected mother-infant pairs. Methods All PHIV pregnant women registered in the Cohort that gave birth from 2000 to 2015 were included in the study. Results Twenty-eight pregnancies in twenty-two perinatally infected women were registered. Most women were Caucasian and heavily treatment-experienced. Nine cases (32.1%) were at high risk of HIV mother-to-child transmission. Maternal HIV-1 viral load was detectable close to delivery in four women (14.3%). The management of these cases was described, and the treatment strategies were discussed. None of the newborns acquired HIV infection. Eight infants (28.6%) were small for gestational age. Conclusions This study included a large series of pregnancies among PHIV women attended according to a youth-centered care model. The challenges in the management of this population by health-care providers were described. Specific strategies to minimize perinatal transmission risks should be addressed in future collaborative studies.	[Prieto, Luis M.] Hosp Univ Getafe, Paediat Dept, Madrid, Spain; [Fernandez McPhee, Carolina; Luisa Navarro, Maria] Hosp Gen Univ Gregorio Maranon, Paediat Dept, Infect Dis Unit, Madrid, Spain; [Rojas, Patricia; Holguin, Africa] Hosp Ramon & Cajal IRYCIS, HIV Mol Epidemiol Lab 1, Microbiol & Parasitol Dept, Madrid, Spain; [Rojas, Patricia; Holguin, Africa] CIBER ESP, Madrid, Spain; [Mazariegos, Diana; Tomas Ramos, Jose] Hosp Clin Univ San Carlos, Paediat Dept, Madrid, Spain; [Munoz, Eloy] Hosp Univ 12 Octubre, Obstet & Ginecol Dept, Madrid, Spain; [Jose Mellado, Maria] Hosp Univ La Paz, Paediat Dept, Trop & Infect Dis Unit, Madrid, Spain; [Isabel Gonzalez-Tome, Maria] Hosp Univ 12 Octubre, Paediat Dept, Infect Dis Unit, Madrid, Spain	Hospital Universitario de Getafe; General University Gregorio Maranon Hospital; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario 12 de Octubre; Hospital Universitario La Paz; Hospital Universitario 12 de Octubre	Prieto, LM (corresponding author), Hosp Univ Getafe, Paediat Dept, Madrid, Spain.	lmprieto.hugf@salud.madrid.org	Holguín, Africa/AAF-9001-2021; Prieto, Luis Enrique/HFZ-7903-2022; Roa, Miguel Angel/D-1088-2016	Holguín, Africa/0000-0002-1330-8050; Roa, Miguel Angel/0000-0003-1933-3000; Mellado Pena, Maria Jose/0000-0003-2251-9666; , Patricia/0000-0001-6935-0066				Albright JN, 2014, AIDS PATIENT CARE ST, V28, P587, DOI 10.1089/apc.2014.0162; [Anonymous], 2013, AIDS, V27, P2312, DOI 10.1097/QAD.0b013e32836378e4; [Anonymous], 2010, EST ESP CREC; Badell Martina L, 2012, AIDS Res Treat, V2012, P418630, DOI 10.1155/2012/418630; Badell Martina L, 2013, Infect Dis Obstet Gynecol, V2013, P301763, DOI 10.1155/2013/301763; Byrne L, 2015, J INT AIDS SOC, V17, P19693; Calitri C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-277; Croucher AP, 2013, SEX TRANSM INFECT, V89, P392, DOI 10.1136/sextrans-2012-050831; Cruz MLS, 2010, AIDS, V24, P2727, DOI 10.1097/QAD.0b013e32833e50d4; Echenique M, 2017, AIDS CARE, V29, P372, DOI 10.1080/09540121.2016.1220483; Elgalib A, 2011, HIV MED, V12, P118, DOI 10.1111/j.1468-1293.2010.00878.x; EUROCAT, EUR SURV CONG AN; Fish R, 2014, HIV MED, V15, P239, DOI 10.1111/hiv.12091; Garcia-Subirats I, 2011, MATERN CHILD HLTH J, V15, P561, DOI 10.1007/s10995-010-0614-7; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Hernandez S, 2016, J CELL MOL MED; de Jose MI, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-2; Jao J, 2015, AIDS, V29, P111, DOI 10.1097/QAD.0000000000000501; Jao J, 2012, AIDS, V26, P855, DOI 10.1097/QAD.0b013e328351f6ef; Kenny J, 2012, HIV MED, V13, P304, DOI 10.1111/j.1468-1293.2011.00967.x; Lall P, 2015, J INT AIDS SOC, V18, P41, DOI 10.7448/IAS.18.2.19393; Lopez M, 2016, J INFECT DIS, V213, P343, DOI 10.1093/infdis/jiv416; Prieto LM, 2012, PEDIATR INFECT DIS J, V31, P1053, DOI 10.1097/INF.0b013e31826fe968; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Medin G, 2016, AIDS CARE, V28, P124, DOI 10.1080/09540121.2015.1071768; Millery M, 2012, J ASSOC NURSE AIDS C, V23, DOI 10.1016/j.jana.2011.05.008; Palladino C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096307; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625; Taha TE, 2005, PEDIATRICS, V115, pE167, DOI 10.1542/peds.2004-1590; Thorne C, 2004, AIDS, V18, P344, DOI [10.1097/00002030-200401230-00033, 10.1097/01.aids.0000111440.91384.30]; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; Townsend CL, 2014, AIDS, V28, P1049, DOI 10.1097/QAD.0000000000000212; Tubiana R, 2010, CLIN INFECT DIS, V50, P585, DOI 10.1086/650005; Warszawski J, 2008, AIDS, V22, P289, DOI 10.1097/QAD.0b013e3282f3d63c; Writing group for the Kids to Adults Working Group and Data Management and Harmonisation Group in EuroCoord, 2016, CHILDREN AND YOUNG P, V21	36	11	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183558	10.1371/journal.pone.0183558	http://dx.doi.org/10.1371/journal.pone.0183558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841701	Green Published, Green Submitted, gold			2022-12-26	WOS:000408370700042
J	Teixeira-Coelho, F; Fonseca, CG; Barbosa, NHS; Vaz, FF; Cordeiro, LMD; Coimbra, CC; Pires, W; Soares, DD; Wanner, SP				Teixeira-Coelho, Francisco; Fonseca, Cletiana Goncalves; Santos Barbosa, Nicolas Henrique; Vaz, Filipe Ferreira; de Souza Cordeiro, Leticia Maria; Coimbra, Candido Celso; Pires, Washington; Soares, Danusa Dias; Wanner, Samuel Penna			Effects of manipulating the duration and intensity of aerobic training sessions on the physical performance of rats	PLOS ONE			English	Article							SKELETAL-MUSCLE; RUNNING ECONOMY; EXERCISE PERFORMANCE; ANAEROBIC THRESHOLD; ENDURANCE EXERCISE; OXYGEN-UPTAKE; CAPACITY; VO2MAX; INTERVAL; ADAPTATIONS	This study investigated the effects of manipulating the load components of aerobic training sessions on the physical performance of rats. To achieve this purpose, adult male Wistar rats were divided into four groups: an untrained control (CON) group and training groups with a predominant overload in intensity (INT) or duration (DUR) or alternating and similar overloads in intensity and duration (ID). Prior to, during, and after 8 weeks of the control or training protocols, the performance of the rats (evaluated by their workload) was determined during fatiguing, incremental-speed treadmill running. Two additional incremental running tests were performed prior to and at the end of the protocols to measure the peak rate of oxygen consumption (VO2peak). As expected, the rats in the trained groups exhibited increased performance, whereas the untrained rats showed stable performance throughout the 8 weeks. Notably, the performance gain exhibited by the DUR rats reached a plateau after the 4 th week. This plateau was not present in the INT or ID rats, which exhibited increased performance at the end of training protocol compared with the DUR rats. None of the training protocols changed the VO2peak values; however, these values were attained at faster speeds, which indicated increased running economy. In conclusion, our findings demonstrate that the training protocols improved the physical performance of rats, likely resulting from enhanced running economy. Furthermore, compared with overload in duration, overload in the intensity of training sessions was more effective at inducing performance improvements across the 8 weeks of the study.	[Teixeira-Coelho, Francisco; Fonseca, Cletiana Goncalves; Santos Barbosa, Nicolas Henrique; Vaz, Filipe Ferreira; de Souza Cordeiro, Leticia Maria; Pires, Washington; Soares, Danusa Dias; Wanner, Samuel Penna] Univ Fed Minas Gerais, Sch Phys Educ Physiotherapy & Occupat Therapy, Exercise Physiol Lab, Belo Horizonte, MG, Brazil; [Teixeira-Coelho, Francisco] Teacher Format Ctr, Amargosa, BA, Brazil; [Teixeira-Coelho, Francisco] Univ Fed Reconcavo Bahia, Amargosa, BA, Brazil; [Coimbra, Candido Celso] Univ Fed Minas Gerais, Inst Biol Sci, Lab Endocrinol & Metab, Belo Horizonte, MG, Brazil; [Pires, Washington] Univ Fed Juiz De Fora, Inst Life Sci, Dept Phys Educ, Governador Valadares, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Reconcavo da Bahia; Universidade Federal de Minas Gerais; Universidade Federal de Juiz de Fora	Wanner, SP (corresponding author), Univ Fed Minas Gerais, Sch Phys Educ Physiotherapy & Occupat Therapy, Exercise Physiol Lab, Belo Horizonte, MG, Brazil.	samuelwanner@ufmg.br	Soares, Danusa/H-1385-2012; Soares, Danusa/AAW-1915-2021; Wanner, Samuel P./F-9654-2012	Soares, Danusa/0000-0002-5705-8890; Wanner, Samuel P./0000-0002-4659-1032; de Souza Cordeiro, Leticia Maria/0000-0003-2115-2102	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473737/2013-2]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-01946-14]; FAPEMIG [BPD 00555-14]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPEMIG	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was funded by the following agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant number 473737/2013-2) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG; grant number APQ-01946-14). LMSC was a recipient of a post-doc fellowship from FAPEMIG (grant number BPD 00555-14). CGF was recipient of a PhD fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), whereas NHSB was a recipient of an undergraduate fellowship from FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Carvalho JF, 2005, COMP BIOCHEM PHYS A, V140, P409, DOI 10.1016/j.cbpb.2004.12.002; Cheilleachair NJN, 2017, J SPORT SCI, V35, P1052, DOI 10.1080/02640414.2016.1209539; CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010; COSTILL DL, 1991, MED SCI SPORT EXER, V23, P371; Damasceno WC, 2015, NEUROSCI LETT, V590, P193, DOI 10.1016/j.neulet.2015.01.082; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; de Araujo GG, 2015, PHYSIOL RES, V64, P209, DOI 10.33549/physiolres.932693; Drummond LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155919; Fiskerstrand A, 2004, SCAND J MED SCI SPOR, V14, P303, DOI 10.1046/j.1600-0838.2003.370.x; Franch J, 1998, MED SCI SPORT EXER, V30, P1250, DOI 10.1097/00005768-199808000-00011; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Ingham SA, 2008, MED SCI SPORT EXER, V40, P579, DOI [10.1249/mss.0b013e31815ecc6a, 10.1249/MSS.0b013e31815ecc6a]; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Kemi OJ, 2005, CARDIOVASC RES, V67, P161, DOI 10.1016/j.cardiores.2005.03.010; Kunstetter AC, 2014, BRAZ J MED BIOL RES, V47, P679, DOI 10.1590/1414-431X20143561; LAMBERT MI, 1989, J APPL PHYSIOL, V66, P1620, DOI 10.1152/jappl.1989.66.4.1620; Laursen PB, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01184.x; Londeree BR, 1997, MED SCI SPORT EXER, V29, P837, DOI 10.1097/00005768-199706000-00016; Marton O, 2015, PFLUG ARCH EUR J PHY, V467, P779, DOI 10.1007/s00424-014-1554-7; Mclaughlin JE, 2010, MED SCI SPORT EXER, V42, P991, DOI 10.1249/MSS.0b013e3181c0669d; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Moreira JBN, 2013, J APPL PHYSIOL, V114, P1029, DOI 10.1152/japplphysiol.00760.2012; PATE RR, 1984, SPORTS MED, V1, P87, DOI 10.2165/00007256-198401020-00001; PICA AJ, 1982, MED SCI SPORT EXER, V14, P249; PILIS W, 1993, COMP BIOCHEM PHYS A, V106, P285, DOI 10.1016/0300-9629(93)90513-4; Primola-Gomes TN, 2009, J APPL PHYSIOL, V107, P593, DOI 10.1152/japplphysiol.91218.2008; Rabelo PCR, 2015, BRAIN RES BULL, V112, P7, DOI 10.1016/j.brainresbull.2015.01.006; SALTIN B, 1969, SCAND J CLIN LAB INV, V24, P323, DOI 10.3109/00365516909080169; Santiago HP, 2016, CLIN EXP PHARMACOL P, V43, P116, DOI 10.1111/1440-1681.12507; Saunders PU, 2004, SPORTS MED, V34, P465, DOI 10.2165/00007256-200434070-00005; Skinner JS, 1985, J APPL PHYSIOL, V2001, P1770; Soya H, 2007, NEUROSCI RES, V58, P341, DOI 10.1016/j.neures.2007.04.004; TAYLOR CR, 1981, RESP PHYSIOL, V44, P25, DOI 10.1016/0034-5687(81)90075-X; Wanner SP, 2007, BRAIN RES BULL, V73, P28, DOI 10.1016/j.brainresbull.2007.03.004; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Zoladz JA, 2016, PFLUG ARCH EUR J PHY, V468, P1709, DOI 10.1007/s00424-016-1867-9	43	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183763	10.1371/journal.pone.0183763	http://dx.doi.org/10.1371/journal.pone.0183763			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841706	Green Published, Green Submitted, gold			2022-12-26	WOS:000408370700056
J	Surachat, K; Sangket, U; Deachamag, P; Chotigeat, W				Surachat, Komwit; Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan			In silico analysis of protein toxin and bacteriocins from Lactobacillus paracasei SD1 genome and available online databases	PLOS ONE			English	Article							SWISS-MODEL REPOSITORY; LACTIC-ACID BACTERIA; WEB-BASED RESOURCE; RHAMNOSUS GG; TRNASCAN-SE; MUTANS STREPTOCOCCI; MICROBIAL GENOMES; SAFETY ASSESSMENT; RAPID ANNOTATION; GASSERICIN-A	Lactobacillus paracasei SD1 is a potential probiotic strain due to its ability to survive several conditions in human dental cavities. To ascertain its safety for human use, we therefore performed a comprehensive bioinformatics analysis and characterization of the bacterial protein toxins produced by this strain. We report the complete genome of Lactobacillus paracasei SD1 and its comparison to other Lactobacillus genomes. Additionally, we identify and analyze its protein toxins and antimicrobial proteins using reliable online database resources and establish its phylogenetic relationship with other bacterial genomes. Our investigation suggests that this strain is safe for human use and contains several bacteriocins that confer health benefits to the host. An in silico analysis of protein-protein interactions between the target bacteriocins and the microbial proteins gtfB and luxS of Streptococcus mutans was performed and is discussed here.	[Surachat, Komwit; Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan] Prince Songkla Univ, Dept Mol Biotechnol & Bioinformat, Fac Sci, Hat Yai 90112, Songkhla, Thailand; [Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan] Prince Songkla Univ, Ctr Genom & Bioinformat Res, Fac Sci, Hat Yai 90112, Songkhla, Thailand; [Surachat, Komwit] Prince Songkla Univ, Fac Sci, Informat & Commun Technol Programme, Hat Yai 90112, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University; Prince of Songkla University	Chotigeat, W (corresponding author), Prince Songkla Univ, Dept Mol Biotechnol & Bioinformat, Fac Sci, Hat Yai 90112, Songkhla, Thailand.; Chotigeat, W (corresponding author), Prince Songkla Univ, Ctr Genom & Bioinformat Res, Fac Sci, Hat Yai 90112, Songkhla, Thailand.	wilaiwan58@hotmail.com	Surachat, Komwit/AAX-3087-2020	Surachat, Komwit/0000-0001-7793-7561	Department of Molecular Biotechnology and Bioinformatics, Information Communication Technology Program; Center for Genomics and Bioinformatics Research of Faculty of Science, Prince of Songkla University	Department of Molecular Biotechnology and Bioinformatics, Information Communication Technology Program; Center for Genomics and Bioinformatics Research of Faculty of Science, Prince of Songkla University	The study was supported by Department of Molecular Biotechnology and Bioinformatics, Information Communication Technology Program, and Center for Genomics and Bioinformatics Research of Faculty of Science, Prince of Songkla University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2014, PAK J PHARM SCI, V27, P1523; Aktas B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145784; [Anonymous], 2006, PROB FOOD HLTH NUTR; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bi DX, 2012, NUCLEIC ACIDS RES, V40, pD621, DOI 10.1093/nar/gkr846; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Borrero J, 2011, J BIOTECHNOL, V156, P76, DOI 10.1016/j.jbiotec.2011.07.038; Cai H, 2009, GENOME BIOL EVOL, V1, P239, DOI 10.1093/gbe/evp019; Chakraborty A, 2012, NUCLEIC ACIDS RES, V40, pD615, DOI 10.1093/nar/gkr942; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Ciandrini E, 2016, APPL MICROBIOL BIOT, V100, P6767, DOI 10.1007/s00253-016-7531-7; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; da Cunha LR, 2012, GUT MICROBES, V3, P15, DOI 10.4161/gmic.19489; Davis CD, 2009, J NUTR BIOCHEM, V20, P743, DOI 10.1016/j.jnutbio.2009.06.001; de Jong A, 2006, NUCLEIC ACIDS RES, V34, pW273, DOI 10.1093/nar/gkl237; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Devine Deirdre A, 2009, J Oral Microbiol, V1, DOI 10.3402/jom.v1i0.1949; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gabrielsen C, 2014, APPL ENVIRON MICROB, V80, P6854, DOI 10.1128/AEM.02284-14; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hammami R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-89; Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22; Hu CB, 2010, APPL ENVIRON MICROB, V76, P4542, DOI 10.1128/AEM.02264-09; Hunt M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0849-0; Husain S, 2008, CURR MICROBIOL, V57, P331, DOI 10.1007/s00284-008-9198-5; Hynonen U, 2013, APPL MICROBIOL BIOT, V97, P5225, DOI 10.1007/s00253-013-4962-2; Ito Y, 2009, APPL ENVIRON MICROB, V75, P6340, DOI 10.1128/AEM.00195-09; Jiang QR, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0759-7; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kaushik JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008099; Kawai Y, 1998, BIOSCI BIOTECH BIOCH, V62, P887, DOI 10.1271/bbb.62.887; Kawai Y, 2004, CURR PROTEIN PEPT SC, V5, P393, DOI 10.2174/1389203043379549; Kawai Y, 2004, APPL ENVIRON MICROB, V70, P2906, DOI 10.1128/AEM.70.5.2906-2911.2004; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kuo YC, 2013, APPL MICROBIOL BIOT, V97, P237, DOI 10.1007/s00253-012-4149-2; Kwak Shin-Hye, 2014, J Cancer Prev, V19, P253, DOI 10.15430/JCP.2014.19.4.253; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Nakamura K, 2013, ANIM SCI J, V84, P144, DOI 10.1111/j.1740-0929.2012.01048.x; Niers LEM, 2007, CLIN EXP IMMUNOL, V149, P344, DOI 10.1111/j.1365-2249.2007.03421.x; Olson Nathan D, 2015, Biomol Detect Quantif, V3, P17, DOI 10.1016/j.bdq.2015.01.004; Ouwehand AC, 2004, CLIN INFECT DIS, V39, P1858, DOI 10.1086/425741; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pan T, 2014, BENEF MICROBES, V5, P315, DOI 10.3920/BM2013.0041; Pandey N, 2013, WORLD J MICROB BIOT, V29, P1977, DOI 10.1007/s11274-013-1368-3; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Ritthagol W, 2014, CLEFT PALATE-CRAN J, V51, P257, DOI 10.1597/12-243; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Senan S, 2015, PROBIOTICS ANTIMICRO, V7, P249, DOI 10.1007/s12602-015-9199-1; Songisepp E, 2012, J DAIRY SCI, V95, P5495, DOI 10.3168/jds.2011-4756; Tapiovaara L, 2014, INT J PEDIATR OTORHI, V78, P1637, DOI 10.1016/j.ijporl.2014.07.011; Teanpaisan R, 2014, CLIN ORAL INVEST, V18, P857, DOI 10.1007/s00784-013-1057-5; Terai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128657; Tsai YT, 2012, APPL MICROBIOL BIOT, V96, P853, DOI 10.1007/s00253-012-4407-3; Vesterlund S, 2007, INT J FOOD MICROBIOL, V116, P325, DOI 10.1016/j.ijfoodmicro.2007.02.002; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wang S, 2016, NUCLEIC ACIDS RES, V44, pW430, DOI 10.1093/nar/gkw306; Wannun P, 2014, ANAEROBE, V27, P17, DOI 10.1016/j.anaerobe.2014.03.001; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Yang Jianyi, 2015, Curr Protoc Bioinformatics, V52, DOI 10.1002/0471250953.bi0508s52; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yli-Knuuttila H, 2006, ORAL MICROBIOL IMMUN, V21, P129, DOI 10.1111/j.1399-302X.2006.00258.x; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhang ZY, 2012, INT J FOOD MICROBIOL, V153, P166, DOI 10.1016/j.ijfoodmicro.2011.11.003; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	92	20	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183548	10.1371/journal.pone.0183548	http://dx.doi.org/10.1371/journal.pone.0183548			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837656	gold, Green Submitted, Green Published			2022-12-26	WOS:000408365000078
J	Chen, JC; Peng, C; Lei, L; Zhang, JL; Zeng, WQ; Chen, X				Chen, Junchen; Peng, Cong; Lei, Li; Zhang, Jianglin; Zeng, Weiqi; Chen, Xiang			Nuclear envelope-distributed CD147 interacts with and inhibits the transcriptional function of RING1 and promotes melanoma cell motility	PLOS ONE			English	Article							MATRIX GLA PROTEIN; EXPRESSION; CANCER; EMMPRIN; PROGRESSION; RESISTANCE; ABCG2; CDNA	Melanoma accounts for nearly 80% of all deaths associated with skin cancer. CD147 plays a very important role in melanoma progression and the expression level may correlate with tumor malignancy. RING1 can bind DNA and act as a transcriptional repressor, play an important role in the aggressive phenotype in melanoma. The interactions between CD147 and RING1 were identified with a yeast two-hybrid and RING1 interacted with CD147 through the transmembrane domain. RING1 inhibits CD147's capability promoting melanoma cell migration. In conclusion, the study identified novel interactions between CD147 and RING1, recovered CD147 nuclear envelope distribution in melanoma cells, and suggested a new mechanism underlying how cytoplasmic CD147 promotes melanoma development.	[Chen, Junchen; Peng, Cong; Lei, Li; Zhang, Jianglin; Zeng, Weiqi; Chen, Xiang] Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [Chen, Junchen; Peng, Cong; Lei, Li; Zhang, Jianglin; Zeng, Weiqi; Chen, Xiang] Cent South Univ, Hunan Key Lab Skin Canc & Psoriasis, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zeng, WQ; Chen, X (corresponding author), Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China.; Zeng, WQ; Chen, X (corresponding author), Cent South Univ, Hunan Key Lab Skin Canc & Psoriasis, Changsha, Hunan, Peoples R China.	Weiqizeng@gmail.com; chenxiangck@126.com		Jianglin, Zhang/0000-0003-0434-1729	National Natural Science Key Foundation of China [81430075]; International Cooperation and Exchanges National Natural Science Foundation of China [81620108024]; National Natural Science Foundation of China [81572677]	National Natural Science Key Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchanges National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 81430075 from the National Natural Science Key Foundation of China (Xiang Chen), grant 81620108024 from International Cooperation and Exchanges National Natural Science Foundation of China (Xiang Chen), and grant 81572677 from the National Natural Science Foundation of China (Weiqi Zeng). http://www.nsfc.gov.cn.	Agrawal SM, 2011, BBA-MOL BASIS DIS, V1812, P213, DOI 10.1016/j.bbadis.2010.07.018; [Anonymous], 2007, J INVEST DERMATOL, V127, P1516; BARTELS H, 1975, CHEMOTHERAPY, V21, P1, DOI 10.1159/000221838; Basigin Takashi M., 2015, J BIOCH, V159, P481; Bi XC, 2011, CLIN INVEST MED, V34, pE358; BISWAS C, 1995, CANCER RES, V55, P434; Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; CANCELA L, 1990, J BIOL CHEM, V265, P15040; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; CHEN L, 1990, ONCOGENE, V5, P1391; Chen Y, 2003, CANCER RES, V63, P1927; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Ferlay J, 2015, EUR J CANCER, V51, P1201, DOI 10.1016/j.ejca.2015.05.004; Gabison EE, 2009, PROG RETIN EYE RES, V28, P19, DOI 10.1016/j.preteyeres.2008.11.001; Grass GD, 2014, ADV CANCER RES, V123, P351, DOI 10.1016/B978-0-12-800092-2.00013-7; Hough CD, 2001, CANCER RES, V61, P3869; Huang XQ, 2014, INT J CLIN EXP PATHO, V7, P1651; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ke X, 2014, HEPATOL INT, V8, P405, DOI 10.1007/s12072-014-9536-6; Knutti N, 2015, FEBS J, V282, P4187, DOI 10.1111/febs.13414; Korn EL, 2008, J CLIN ONCOL, V26, P527, DOI 10.1200/JCO.2007.12.7837; Lescaille G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-115; LEVEDAKOU EN, 1992, INT J CANCER, V52, P534, DOI 10.1002/ijc.2910520406; Liao CG, 2011, MOL CELL BIOL, V31, P2591, DOI 10.1128/MCB.05160-11; Long TT, 2013, CANCER LETT, V339, P93, DOI 10.1016/j.canlet.2013.07.019; Luo Z, 2014, CURR MOL MED, V14, P1252, DOI 10.2174/1566524014666141202144601; McHugh JB, 2007, J CUTAN PATHOL, V34, P597, DOI 10.1111/j.1600-0560.2006.00678.x; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Piao SL, 2012, J CANCER RES CLIN, V138, P627, DOI 10.1007/s00432-011-1142-6; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Su J, 2015, ONCOTARGET; Sweeny L, 2012, EXP CELL RES, V318, P1788, DOI 10.1016/j.yexcr.2012.04.022; Walters DK, 2013, CELL CYCLE, V12, P3175, DOI 10.4161/cc.26193; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P157; Wu J, 2015, MOL CANCER THER, V14, P553, DOI 10.1158/1535-7163.MCT-14-0618; Zeng W, 2014, CURR MOL MED, V14, P163, DOI 10.2174/15665240113136660077; Zhao S, 2013, J DERMATOL SCI, V70, P182, DOI 10.1016/j.jdermsci.2013.02.005; Zhou SY, 2013, CANCER LETT, V337, P285, DOI 10.1016/j.canlet.2013.04.025; Zhou WH, 2013, CELL RES, V23, P599, DOI 10.1038/cr.2013.44	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183689	10.1371/journal.pone.0183689	http://dx.doi.org/10.1371/journal.pone.0183689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832687	gold, Green Submitted, Green Published			2022-12-26	WOS:000408355800082
J	Grewal, DS; Merlau, DJ; Giri, P; Munk, MR; Fawzi, AA; Jampol, LM; Tanna, AP				Grewal, Dilraj S.; Merlau, Daniel J.; Giri, Pushpanjali; Munk, Marion R.; Fawzi, Amani A.; Jampol, Lee M.; Tanna, Angelo P.			Peripapillary retinal splitting visualized on OCT in glaucoma and glaucoma suspect patients	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; VITREOMACULAR TRACTION SYNDROME; POSTERIOR VITREOUS DETACHMENT; MORNING GLORY SYNDROME; MACULAR SCHISIS; DISC PIT; INTRAOCULAR-PRESSURE; VITRECTOMY; MACULOPATHY	Purpose To identify the risk factors for development of peripapillary retinal splitting (schisis) in patients with glaucoma or suspicion of glaucoma Setting Glaucoma Clinic, Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL Methods In this institutional cross-sectional study, 495 patients (990 eyes) who had undergone spectral-domain optical coherence tomography (OCT Spectralis HRA-OCT, Heidelberg Engineering) optic nerve head (ONH) imaging and did not have identifiable optic nerve pits, pseudopits or coloboma were included. OCT scans were reviewed by two observers. Main outcome measures Presence of peripapillary retinal splitting identified on OCT raster scans. Results Eleven of 990 glaucoma and glaucoma suspect eyes (1.1%) of 7 patients (2 females, 5 males, mean age 64.5 +/- 9.2 years) had peripapillary retinal splitting. Two of these 11 eyes had extension of the splitting into the macula but none to the fovea. Of these 11 patients, 2 (28.6%) were glaucoma suspects, 3 (42.9%) had primary open-angle glaucoma, 1 (14.3%) had chronic angle-closure glaucoma and 1 (14.3%) had pigmentary glaucoma. 7/11 (63.6%) eyes had vitreous traction to the disc visualized on OCT and 6/11 eyes (54.5%) had beta-zone peripapillary atrophy. Conclusions We observed peripapillary retinal splitting in 1.1% of a series of 990 glaucoma and glaucoma-suspect eyes. Evidence of adherent vitreous with traction and peripapillary atrophy was found in a majority of the involved eyes. A comparison to an age and axial length matched cohort is required to determine if this is a condition that is associated with glaucoma.	[Grewal, Dilraj S.; Merlau, Daniel J.; Giri, Pushpanjali; Munk, Marion R.; Fawzi, Amani A.; Jampol, Lee M.; Tanna, Angelo P.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Grewal, Dilraj S.] Duke Univ, Med Ctr, Dept Ophthalmol, Duke Eye Ctr, Durham, NC 27710 USA; [Merlau, Daniel J.] Columbia Univ, New York, NY USA	Northwestern University; Feinberg School of Medicine; Duke University; Columbia University	Tanna, AP (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	atanna@northwestern.edu	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558; Tanna, Angelo/0000-0003-3089-6664; Grewal, Dilraj/0000-0002-2229-5343	Research to Prevent Blindness, NY; Ronald G. Michels Fellowship Foundation (Riderwood, MD); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER	Research to Prevent Blindness, NY(Research to Prevent Blindness (RPB)); Ronald G. Michels Fellowship Foundation (Riderwood, MD); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by an unrestricted grant from Research to Prevent Blindness, NY to the Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Heed Ophthalmic Foundation (San Francisco, CA) and Ronald G. Michels Fellowship Foundation (Riderwood, MD) (DSG). None of the authors have any financial or proprietary interest in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2012, CASE REP OPHTHALM, V3, P169, DOI 10.1159/000339292; Batta P, 2010, ARCH OPHTHALMOL-CHIC, V128, P692, DOI 10.1001/archophthalmol.2010.99; Besada Eulogio, 2003, Clin Exp Optom, V86, P390; Chang S, 2012, EYE, V26, P494, DOI 10.1038/eye.2011.354; COLL GE, 1995, GRAEF ARCH CLIN EXP, V233, P441, DOI 10.1007/BF00180949; Farjad H, 2010, OPTOMETRY VISION SCI; Fellman RL, 2012, ARCH OPHTHALMOL-CHIC, V130, P1220, DOI 10.1001/archophthalmol.2012.441; Freund KB, 2011, ARCH OPHTHALMOL-CHIC, V129, P1096, DOI 10.1001/archophthalmol.2011.208; FRIBERG TR, 1992, AM J OPHTHALMOL, V114, P767, DOI 10.1016/S0002-9394(14)74060-7; Gandorfer A, 2005, AM J OPHTHALMOL, V139, P638, DOI 10.1016/j.ajo.2004.11.035; Georgalas I, 2011, GRAEF ARCH CLIN EXP, V249, P1113, DOI 10.1007/s00417-011-1698-5; Haruta M, 2012, CLIN OPHTHALMOL, V6, P1361, DOI 10.2147/OPTH.S34962; Hasegawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130175; HIKICHI T, 1995, AM J OPHTHALMOL, V119, P55, DOI 10.1016/S0002-9394(14)73813-9; Hirakata A, 2005, JPN J OPHTHALMOL, V49, P264, DOI 10.1007/s10384-004-0185-5; Hirakata A, 2012, OPHTHALMOLOGY, V119, P810, DOI 10.1016/j.ophtha.2011.09.026; Hollander DA, 2005, ARCH OPHTHALMOL-CHIC, V123, P270, DOI 10.1001/archopht.123.2.270; Hubschman Jean-Pierre, 2010, Ophthalmic Surg Lasers Imaging, P1, DOI 10.3928/15428877-20100215-60; Hwang YH, 2013, SEMINARS OPHTHALMOLO; Hwang YH, 2014, BRIT J OPHTHALMOLOGY; Johnson Mark W, 2005, Trans Am Ophthalmol Soc, V103, P537; Johnson TM, 2004, ARCH OPHTHALMOL-CHIC, V122, P1793, DOI 10.1001/archopht.122.12.1793; Kahook MY, 2007, AM J OPHTHALMOL, V143, P697, DOI 10.1016/j.ajo.2006.10.054; Kusaka S, 2001, OPHTHALMOLOGICA, V215, P139, DOI 10.1159/000050847; LAMPERT PW, 1968, INVEST OPHTH VISUAL, V7, P199; Lee S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094070; Mavrikakis E, 2011, ACTA OPHTHALMOL, V89, P95, DOI 10.1111/j.1755-3768.2009.01553.x; Ornek N, 2013, BMJ CASE REPORTS, V2013; Ouyang YL, 2013, INVEST OPHTH VIS SCI, V54, P1144, DOI 10.1167/iovs.12-9903; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Pilon A, 2006, OPTOMETRY VISION SCI, V83, P415, DOI 10.1097/01.opx.0000218430.40132.68; Postel E A, 1998, Trans Am Ophthalmol Soc, V96, P73; Rutledge BK, 1996, OPHTHALMOLOGY, V103, P1047, DOI 10.1016/S0161-6420(96)30568-X; Shimada N, 2007, OPHTHALMOLOGY, V114, P2070, DOI 10.1016/j.ophtha.2007.01.016; Shimada Noriaki, 2009, International Ophthalmology, V29, P99, DOI 10.1007/s10792-007-9174-2; Silverman AL, 2015, OPHTHALMOLOGY; Spaide RF, 2003, RETINA-J RET VIT DIS, V23, P238, DOI 10.1097/00006982-200304000-00017; Takashina S, 2013, CLIN OPHTHALMOL, V7, P883, DOI 10.2147/OPTH.S42085; Xin DY, 2011, INVEST OPHTH VIS SCI, V52, P7180, DOI 10.1167/iovs.11-7716; Zhao M, 2011, GRAEF ARCH CLIN EXP, V249, P1255, DOI 10.1007/s00417-011-1668-y; Zumbro DS, 2007, AM J OPHTHALMOL, V144, P70, DOI 10.1016/j.ajo.2007.03.027	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182816	10.1371/journal.pone.0182816	http://dx.doi.org/10.1371/journal.pone.0182816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832670	gold, Green Submitted, Green Published			2022-12-26	WOS:000408355800034
J	Herklots, T; van Acht, L; Meguid, T; Franx, A; Jacod, B				Herklots, Tanneke; van Acht, Lieke; Meguid, Tarek; Franx, Arie; Jacod, Benoit			Severe maternal morbidity in Zanzibar's referral hospital: Measuring the impact of in-hospital care	PLOS ONE			English	Article							QUALITY-OF-CARE; TERTIARY HOSPITALS; PUBLIC HOSPITALS; NEAR-MISSES; HEALTH	Objective to analyse the impact of in-hospital care on severe maternal morbidity using WHO's near-miss approach in the low-resource, high mortality setting of Zanzibar's referral hospital. Setting Mnazi Mmoja Hospital, a tertiary care facility, in Zanzibar, Tanzania. Methods We identified all cases of morbidity and mortality in women admitted within 42 days after the end of pregnancy at Mnazi Mmoja Hospital in the period from April to October 2016. The severity of complications was classified using WHO's near-miss approach definitions: potentially life-threatening condition (PLTC), maternal near-miss (MNM) or maternal death (MD). Quality of in-hospital care was assessed using the mortality index (MI) defined as ratio between mortality and severe maternal outcome (SMO) where SMO = MD + MNM, cause-specific case facility rates and comparison with predicted mortality based on the Maternal Severity Index model. Main outcomes 5551 women were included. 569 (10.3%) had a potentially life-threatening condition and 65 (1.2%) a severe maternal outcome (SMO): 37 maternal near-miss cases and 28 maternal deaths. The mortality index was high at 0.43 and similar for women who developed a SMO within 12 hours of admission and women who developed a SMO after 12 hours. A standardized mortality ratio of 6.03 was found; six times higher than that expected in moderate maternal mortality settings given the same severity of cases. Obstetric haemorrhage was found to be the main cause of SMO. Ruptured uterus and admission to ICU had the highest case-fatality rates. Maternal death cases seemed to have received essential interventions less often. Conclusions WHO's near-miss approach can be used in this setting. The high mortality index observed shows that in-hospital care is not preventing progression of disease adequately once a severe complication occurs. Almost one in two women experiencing life-threatening complications will die. This is six times higher than in moderate mortality settings.	[Herklots, Tanneke; van Acht, Lieke; Franx, Arie] Univ Med Ctr Utrecht, Div Woman & Baby, Utrecht, Netherlands; [Meguid, Tarek] Mnazi Mmoja Hosp, Dept Obstet & Gynaecol, Stone Town, Zanzibar, Tanzania; [Meguid, Tarek] State Univ Zanzibar SUZA, Sch Hlth & Med Sci, Zanzibar, Tanzania; [Jacod, Benoit] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Herklots, T (corresponding author), Univ Med Ctr Utrecht, Div Woman & Baby, Utrecht, Netherlands.	tannekeherklots@gmail.com	Franx, Arie/AAA-1739-2021					Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; [Anonymous], 2014, MIDWIFERY, V30; [Anonymous], 2004, NUMB REV MAT DEATH C; Bashour H, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0733-7; Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Jabir M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-11; Kalisa R, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1119-1; Karolinski A, 2013, BJOG-INT J OBSTET GY, V120, P1685, DOI 10.1111/1471-0528.12395; Nakimuli A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0811-5; Nelissen EJT, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-141; Norhayati MN, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2895-2; Oladapo OT, 2016, BJOG-INT J OBSTET GY, V123, P928, DOI 10.1111/1471-0528.13450; Owolabi OO, 2016, INCIDENCE ABORTION R; Rulisa S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0619-8; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Shapovalova ND, 2015, LANCET GLOB HEALTH, V3, pE249, DOI 10.1016/S2214-109X(15)70104-X; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129; Tanimia H, 2016, AUST NZ J OBSTET GYN, V56, P148, DOI 10.1111/ajo.12430; Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x; Tuncalp O, 2013, INT J GYNECOL OBSTET, V123, P58, DOI 10.1016/j.ijgo.2013.06.003; van den Akker T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054805; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG	24	21	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0181470	10.1371/journal.pone.0181470	http://dx.doi.org/10.1371/journal.pone.0181470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832665	Green Published, gold, Green Submitted			2022-12-26	WOS:000408355800004
J	Rehnus, M; Palme, R				Rehnus, Maik; Palme, Rupert			How genetic data improve the interpretation of results of faecal glucocorticoid metabolite measurements in a free-living population	PLOS ONE			English	Article							HARES LEPUS-TIMIDUS; CORTISOL METABOLITES; DOMINANCE STATUS; PERSONALITY; STRESS; CHAMOIS; SEASON; SEX; IDENTIFICATION; CONSERVATION	Measurement of glucocorticoid metabolites (GCM) in faeces has become a widely used and effective tool for evaluating the amount of stress experienced by animals. However, the potential sampling bias resulting from an oversampling of individuals when collecting "anonymous" (unknown sex or individual) faeces has rarely been investigated. We used non-invasive genetic sampling (NIGS) to investigate potential interpretation errors of GCM measurements in a free-living population of mountain hares during the mating and post-reproductive periods. Genetic data improved the interpretation of results of faecal GCM measurements. In general GCM concentrations were influenced by season. However, genetic information revealed that it was sex-dependent. Within the mating period, females had higher GCM levels than males, but individual differences were more expressed in males. In the post-reproductive period, GCM concentrations were neither influenced by sex nor individual. We also identified potential pitfalls in the interpretation of anonymous faecal samples by individual differences in GCM concentrations and resampling rates. Our study showed that sex- and individual-dependent GCM levels led to a misinterpretation of GCM values when collecting "anonymous" faeces. To accurately evaluate the amount of stress experienced by free-living animals using faecal GCM measurements, we recommend documenting individuals and their sex of the sampled population. In stress-sensitive and elusive species, such documentation can be achieved by using NIGS and for diurnal animals with sexual and individual variation in appearance or marked individuals, it can be provided by a detailed field protocol.	[Rehnus, Maik] Snow & Landscape Res WSL, Swiss Fed Res Inst Forest, Zurcherstr 111, Birmensdorf, Switzerland; [Rehnus, Maik] WILDTIER SCHWEIZ, Winterthurerstr 92, Zurich, Switzerland; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci, Vet Pl 1, Vienna, Austria	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Veterinary Medicine Vienna	Rehnus, M (corresponding author), Snow & Landscape Res WSL, Swiss Fed Res Inst Forest, Zurcherstr 111, Birmensdorf, Switzerland.; Rehnus, M (corresponding author), WILDTIER SCHWEIZ, Winterthurerstr 92, Zurich, Switzerland.	maik.rehnus@wsl.ch	Palme, Rupert/A-3499-2008; Rehnus, Maik/F-7270-2011	Palme, Rupert/0000-0001-9466-3662; Rehnus, Maik/0000-0002-1973-4878	Margarethe and Rudolf Gsell Foundation; Migros; Bristol Foundation	Margarethe and Rudolf Gsell Foundation; Migros; Bristol Foundation	We thank the Margarethe and Rudolf Gsell Foundation, Migros and the Bristol Foundation for financially supporting the genetic analyses.	Alonso JC, 2010, BEHAV ECOL SOCIOBIOL, V64, P1589, DOI 10.1007/s00265-010-0972-6; Arlettaz R, 2015, ECOL APPL, V25, P1197, DOI 10.1890/14-1141.1; Bisi F, 2011, EUR J WILDLIFE RES, V57, P305, DOI 10.1007/s10344-010-0429-2; Boonstra R, 2013, FUNCT ECOL, V27, P11, DOI 10.1111/1365-2435.12008; Cavigelli SA, 2003, HORM BEHAV, V43, P166, DOI 10.1016/S0018-506X(02)00031-4; Cavigelli SA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0103; Clutton-Brock TH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0074; Corlatti L, 2014, NATURWISSENSCHAFTEN, V101, P577, DOI 10.1007/s00114-014-1195-x; Corlatti L, 2012, ANIM BEHAV, V84, P1061, DOI 10.1016/j.anbehav.2012.08.005; Dantzer B, 2016, J MAMMAL, V97, P1385, DOI 10.1093/jmammal/gyw095; Forsman A, 2016, ECOGRAPHY, V39, P630, DOI 10.1111/ecog.01357; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Goossens Benoit, 2009, V17, P167; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Goymann W, 2001, P ROY SOC B-BIOL SCI, V268, P2453, DOI 10.1098/rspb.2001.1828; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; GRAF RP, 1985, CAN J ZOOL, V63, P468, DOI 10.1139/z85-066; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hadinger U, 2015, METHODS ECOL EVOL, V6, P1349, DOI 10.1111/2041-210X.12422; Haller H., 2013, ATLAS SCHWEIZERISCHE; HEWSON R, 1990, J ZOOL, V220, P287, DOI 10.1111/j.1469-7998.1990.tb04309.x; HOLLEY AJF, 1986, MAMMAL REV, V16, P181, DOI 10.1111/j.1365-2907.1986.tb00040.x; Huber S, 2003, GEN COMP ENDOCR, V130, P48, DOI 10.1016/S0016-6480(02)00535-X; IUCN, 2016, PROT AR CAT GLAND IU; Jacob G, 2010, CONSERV GENET, V11, P33, DOI 10.1007/s10592-008-9794-8; Joly K, 2015, PLOS ONE, P10; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Lotz A., 2006, ALPINE HABITAT DIVER; Mesa-Cruz JB, 2016, J TROP ECOL, V32, P226, DOI 10.1017/S0266467416000213; Mooring MS, 2006, HORM BEHAV, V49, P369, DOI 10.1016/j.yhbeh.2005.08.008; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; Noer CL, 2016, APPL ANIM BEHAV SCI, V181, P191, DOI 10.1016/j.applanim.2016.05.003; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; R Development Core Team, 2016, R LANG ENV STAT COMP; Rehnus M., 2013, SCHNEEHASE ALPEN UBE; Rehnus M, 2016, EUR J WILDLIFE RES, V62, P737, DOI 10.1007/s10344-016-1053-6; Rehnus M, 2014, J APPL ECOL, V51, P6, DOI 10.1111/1365-2664.12174; Rehnus M, 2010, MAMMALIA, V74, P347, DOI 10.1515/MAMM.2010.032; Rehnus M, 2009, EUR J WILDLIFE RES, V55, P615, DOI 10.1007/s10344-009-0297-9; Saltzman W, 1998, HORM BEHAV, V33, P58, DOI 10.1006/hbeh.1998.1436; Sands J, 2004, ANIM BEHAV, V67, P387, DOI 10.1016/j.anbehav.2003.03.019; SAPOLSKY RM, 1990, BIOL PSYCHIAT, V28, P862, DOI 10.1016/0006-3223(90)90568-M; Schopper H, 2012, GEN COMP ENDOCR, V176, P18, DOI 10.1016/j.ygcen.2011.12.010; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Sloane MA, 2000, MOL ECOL, V9, P1233, DOI 10.1046/j.1365-294x.2000.00993.x; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Sun K, 1998, PLACENTA, V19, P353, DOI 10.1016/S0143-4004(98)90074-1; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Thulin C.-G., 2003, HDB SAUGETIERE EUROP, P155; Thulin CG, 2003, MAMMAL REV, V33, P29, DOI 10.1046/j.1365-2907.2003.00008.x; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Wallner B, 2001, MAMM BIOL, V66, P190; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wasserman MD, 2012, HORM BEHAV, V62, P553, DOI 10.1016/j.yhbeh.2012.09.005	57	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183718	10.1371/journal.pone.0183718	http://dx.doi.org/10.1371/journal.pone.0183718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832649	Green Published, gold, Green Submitted			2022-12-26	WOS:000408355800093
J	Jiang, X; Bao, Y; Liu, H; Kou, X; Zhang, Z; Sun, F; Qian, Z; Lin, Z; Li, X; Liu, X; Jiang, L; Yang, Y				Jiang, X.; Bao, Y.; Liu, H.; Kou, X.; Zhang, Z.; Sun, F.; Qian, Z.; Lin, Z.; Li, X.; Liu, X.; Jiang, L.; Yang, Y.			VPS34 stimulation of p62 phosphorylation for cancer progression	ONCOGENE			English	Article							TRANSCRIPTION FACTOR NRF2; INTERACTING PROTEIN P62; KAPPA-B ACTIVATION; BECLIN 1; SELECTIVE AUTOPHAGY; BREAST-CANCER; MEDIATED CLEAVAGE; P62/SQSTM1; APOPTOSIS; TUMORIGENESIS	Vps34, a class III PtdIns3 lipid kinase involved in the control of both autophagic and endocytic systems, has been studied extensively in numerous fundamental cellular processes. Accumulating evidence indicates that Vps34 may also contribute to the development and progression of human cancers. However, the mechanism of Vps34 in tumorigenesis remains elusive. Here, we report an unanticipated role of Vps34 in the activation of p62 for cancer development. We identified that Vps34 is a transcriptional activator of p62 through competition of Nrf2 (nuclear factor erythroid 2-related factor 2) for Keap1 binding. Vps34 augments the association of PKC-delta with p62 for its phosphorylation at Serine 349, which leads to positive feedback on the Nrf2-dependent transcription of oncogenes. Additionally, we found that the expression of Vps34 is correlated with the tumorigenic activity of human breast cancer cells. Normally inactive in breast cancer, caspase 8 can cleave Vps34 at residue D285, which directly abolished its lipid kinase activity and dramatically altered cell invasion potential, colony formation, as well as tumorigenesis in orthotopic engraftments in mice. The cleavage at D285 blocks expression of LC3-II, Nrf2 and subsequently, p62, in addition to blocking tumor growth, indicating that the intact structure of Vps34 is essential for its activity. Moreover, either knockout of PKC-delta or knockdown of p62 by small interfering RNA in MCF-7 cells abrogates Vps34-dependent tumor growth. Data presented here suggested that Vps34 stimulates tumor development mainly through PKC-delta-activation of p62.	[Jiang, X.; Bao, Y.; Liu, H.; Kou, X.; Zhang, Z.; Sun, F.; Qian, Z.; Yang, Y.] Fudan Univ, Sch Pharm, Dept Pharmacol & Biochem, 826 Zhangheng Rd, Shanghai 201203, Peoples R China; [Lin, Z.] Roche Innovat Ctr Shanghai, Chem Biol Roche Pharmaceut Res & Early Dev, Shanghai, Peoples R China; [Li, X.] Shanghai Eight People Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Liu, X.] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Jiang, L.] Oakland Univ, Dept Biol Sci, Rochester, MI USA	Fudan University; Georgetown University; Oakland University	Yang, Y (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol & Biochem, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.	yonghuayang@hotmail.com	Qian, Zhong Ming/E-8884-2016	Qian, Zhong Ming/0000-0002-6399-938X	National Natural Science Foundation of China [81572721, 81272391]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81572721 and 81272391 to YY).	Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Burdelski C, 2015, CLIN CANCER RES, V21, P3471, DOI 10.1158/1078-0432.CCR-14-0620; Cai-McRae X, 2015, ONCOGENE, V34, P2968, DOI 10.1038/onc.2014.244; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Hirsch DS, 2010, CANCER RES, V70, P5974, DOI 10.1158/0008-5472.CAN-09-2682; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jin MY, 2013, CELL, V152, P368, DOI 10.1016/j.cell.2013.01.004; Kang R, 2012, AUTOPHAGY, V8, P989, DOI 10.4161/auto.20258; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee E, 2016, ONCOTARGET, V7, P67919, DOI 10.18632/oncotarget.12084; Li H, 2011, CANCER RES, V71, P3625, DOI 10.1158/0008-5472.CAN-10-4475; Li LJ, 2013, CANCER CELL, V24, P738, DOI 10.1016/j.ccr.2013.10.025; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Paulus P, 2006, CANCER RES, V66, P4349, DOI 10.1158/0008-5472.CAN-05-3523; Sakakura K, 2015, CANCER SCI, V106, P1, DOI [10.1111/cas.12559, 10.1111/cas.12579]; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Shapiro G, 2015, CLIN CANCER RES, V21; Shi J, 2014, CELL DEATH DIFFER, V21, P1432, DOI 10.1038/cdd.2014.58; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	58	38	38	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 14	2017	36	50					6850	6862		10.1038/onc.2017.295	http://dx.doi.org/10.1038/onc.2017.295			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FQ0JM	28846113	Green Published, hybrid			2022-12-26	WOS:000418041800002
J	Jayakanthan, S; Braiterman, LT; Hasan, NM; Unger, VM; Lutsenko, S				Jayakanthan, Samuel; Braiterman, Lelita T.; Hasan, Nesrin M.; Unger, Vinzenz M.; Lutsenko, Svetlana			Human copper transporter ATP7B (Wilson disease protein) forms stable dimers in vitro and in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; calcium ATPase; copper transport; dimerization; membrane transport	POLARIZED HEPATIC CELLS; METAL-BINDING DOMAIN; FULGIDUS CU+-ATPASE; PARTICLE CRYO-EM; ELECTRON-MICROSCOPY; FUNCTIONAL-PROPERTIES; UCSF CHIMERA; TRAFFICKING; PHOSPHORYLATION; MECHANISM	ATP7B is a copper-transporting P-1B-type ATPase (Cu-ATPase) with an essential role in human physiology. Mutations in ATP7B cause the potentially fatal Wilson disease, and changes in ATP7B expression are observed in several cancers. Despite its physiologic importance, the biochemical information about ATP7B remains limited because of a complex multidomain organization of the protein. By analogy with the better characterized prokaryotic Cu-ATPases, ATP7B is assumed to be a single-chain monomer. We show that in eukaryotic cells, human ATP7B forms dimers that can be purified following solubilization. Deletion of the four N-terminal metal-binding domains, characteristic for human ATP7B, does not disrupt dimerization, i.e. the dimer interface is formed by the domains that are conserved among Cu-ATPases. Unlike the full-length ATP7B, which is targeted to the trans-Golgi network, 1-4MBD-7B is targeted primarily to vesicles. This result and the analysis of differentially tagged ATP7B variants indicate that the dimeric structure is retained during ATP7B trafficking between the intracellular compartments. Purified dimeric species of 1-4MBD-7B were characterized by a negative stain electron microscopy in the presence of ADP/MgCl2. Single-particle analysis yielded a low-resolution 3D model that provides the first insight into an overall architecture of a human Cu-ATPase, positions of the main domains, and a dimer interface.	[Jayakanthan, Samuel; Hasan, Nesrin M.; Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Hunterian 203,725 N Wolfe St, Baltimore, MD 21205 USA; [Braiterman, Lelita T.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Unger, Vinzenz M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Johns Hopkins University; Johns Hopkins University; Northwestern University	Lutsenko, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Hunterian 203,725 N Wolfe St, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu		Lutsenko, Svetlana/0000-0001-5275-2587	National Institutes of Health [P01GM067166, R01DK071865, 1R01GM115211-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115211, P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01GM067166 and R01DK071865 (to S. L.) and 1R01GM115211-01A1 (to V. M. U.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal S, 2010, PROTEINS, V78, P2450, DOI 10.1002/prot.22753; Andersson M, 2014, NAT STRUCT MOL BIOL, V21, P43, DOI 10.1038/nsmb.2721; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Bastaki M, 2002, MOL BIOL CELL, V13, P225, DOI 10.1091/mbc.01-07-0376; Braiterman LT, 2015, J BIOL CHEM, V290, P8803, DOI 10.1074/jbc.M114.627414; Braiterman LT, 2014, P NATL ACAD SCI USA, V111, pE1364, DOI 10.1073/pnas.1314161111; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Hasan NM, 2012, J BIOL CHEM, V287, P36041, DOI 10.1074/jbc.M112.370403; Hauer F, 2015, STRUCTURE, V23, P1769, DOI 10.1016/j.str.2015.06.029; Huster D, 2012, GASTROENTEROLOGY, V142, P947, DOI 10.1053/j.gastro.2011.12.048; Jayakanthan S, 2012, BIOSCIENCE REP, V32, P443, DOI 10.1042/BSR20120048; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; Liu YY, 2010, BIOCHEMISTRY-US, V49, P10006, DOI 10.1021/bi101423j; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Safaei R, 2013, METALLOMICS, V5, P964, DOI 10.1039/c3mt00131h; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidt TGM, 2013, PROTEIN EXPRES PURIF, V92, P54, DOI 10.1016/j.pep.2013.08.021; Schushan M, 2012, METALLOMICS, V4, P669, DOI 10.1039/c2mt20025b; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Squitti R, 2013, NEUROMOL MED, V15, P515, DOI 10.1007/s12017-013-8237-y; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025	40	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18760	18774		10.1074/jbc.M117.807263	http://dx.doi.org/10.1074/jbc.M117.807263			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28842499	Green Published, hybrid			2022-12-26	WOS:000415848000003
J	Johnson, ZI; Doolittle, AC; Snuggs, JW; Shapiro, IM; Le Maitre, CL; Risbud, MV				Johnson, Zariel I.; Doolittle, Alexandra C.; Snuggs, Joseph W.; Shapiro, Irving M.; Le Maitre, Christine L.; Risbud, Makarand V.			TNF-alpha promotes nuclear enrichment of the transcription factor TonEBP/NFAT5 to selectively control inflammatory but not osmoregulatory responses in nucleus pulposus cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; NF-KAPPA-B; INTERVERTEBRAL DISC DEGENERATION; NECROSIS-FACTOR-ALPHA; LOW-BACK-PAIN; CELLULAR-RESPONSE; WATER-CONTENT; EXPRESSION; MATRIX; REGULATOR	Intervertebral disc degeneration (IDD) causes chronic back pain and is linked to production of proinflammatory molecules by nucleus pulposus (NP) and other disc cells. Activation of tonicity-responsive enhancer-binding protein (TonEBP)/NFAT5 by non-osmotic stimuli, including proinflammatory molecules, occurs in cells involved in immune response. However, whether inflammatory stimuli activate TonEBP in NP cells and whether TonEBP controls inflammation during IDD is unknown. We show that TNF-alpha, but not IL-1 beta or LPS, promoted nuclear enrichment of TonEBP protein. However, TNF-alpha -mediated activation of TonEBP did not cause induction of osmoregulatory genes. RNA sequencing showed that 8.5% of TNF-alpha transcriptional responses were TonEBP-dependent and identified genes regulated by both TNF-alpha and TonEBP. These genes were over-enriched in pathways and diseases related to inflammatory response and inhibition of matrix metalloproteases. Based on RNA-sequencing results, we further investigated regulation of novel TonEBP targets CXCL1, CXCL2, and CXCL3. TonEBP acted synergistically with TNF-alpha and LPS to induce CXCL1-proximal promoter activity. Interestingly, this regulation required a highly conserved TNF-alpha B-binding site but not a predicted TonE, suggesting cross-talk between these two members of the Rel family. Finally, analysis of human NP tissue showed that TonEBP expression correlated with canonical osmoregulatory targets TauT/SLC6A6, SMIT/SLC5A3, and AR/AKR1B1, supporting in vitro findings that the inflammatory milieu during IDD does not interfere with TonEBP osmoregulation. In summary, whereas TonEBP participates in the proinflammatory response to TNF-alpha, therapeutic strategies targeting this transcription factor for treatment of disc disease must spare osmoprotective, prosurvival, and matrix homeostatic activities.	[Johnson, Zariel I.; Doolittle, Alexandra C.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Ste 511 Coll Bldg, Philadelphia, PA 19107 USA; [Snuggs, Joseph W.; Le Maitre, Christine L.] Sheffield Hallam Univ, Biomol Sci Res Ctr, Sheffield S1 1WB, S Yorkshire, England	Jefferson University; Sheffield Hallam University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Ste 511 Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu		Snuggs, Joseph/0000-0002-0200-4596	National Institutes of Health [AR055655, AR064733, T32AR052273]; Sheffield Hallam University Vice Chancellor Ph. D. Scholarship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR052273, R01AR064733, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sheffield Hallam University Vice Chancellor Ph. D. Scholarship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health Grants AR055655 and AR064733 (to M.V.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant T32AR052273.; Supported by a Sheffield Hallam University Vice Chancellor Ph. D. Scholarship.	ADAMS MA, 1983, SPINE, V8, P665, DOI 10.1097/00007632-198309000-00013; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Binch ALA, 2016, MATRIX BIOL, V52-54, P355, DOI 10.1016/j.matbio.2016.01.005; BOOS N, 1993, RADIOLOGY, V188, P351, DOI 10.1148/radiology.188.2.8327677; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Caron MMJ, 2013, BONE, V53, P94, DOI 10.1016/j.bone.2012.11.032; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Grava ALD, 2012, EUR SPINE J, V21, P537, DOI 10.1007/s00586-011-2027-8; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Gawri R, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4449; Hatanaka E, 2007, SHOCK, V27, P32, DOI 10.1097/01.shk.0000238061.69579.a5; Hiyama A, 2009, J BIOL CHEM, V284, P9824, DOI 10.1074/jbc.M807081200; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Jeong GR, 2016, J NEUROIMMUNOL, V295, P21, DOI 10.1016/j.jneuroim.2016.04.009; Johnson ZI, 2015, EUR CELLS MATER, V30, P104, DOI 10.22203/eCM.v030a08; Johnson ZI, 2016, J BIOL CHEM, V291, P26686, DOI 10.1074/jbc.M116.757732; Johnson ZI, 2014, MATRIX BIOL, V40, P10, DOI 10.1016/j.matbio.2014.08.014; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kepler CK, 2013, SPINE, V38, pE1291, DOI 10.1097/BRS.0b013e3182a42bc2; Kepler CK, 2013, SPINE, V38, P873, DOI 10.1097/BRS.0b013e318285ae08; Kim NH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.61; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Kojima R, 2010, J IMMUNOL, V184, P5253, DOI 10.4049/jimmunol.0901298; Kumaresan S, 2000, BIOMED SCI INSTRUM, V395, P141; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Lee H., 2014, J NANOMATER, V2014, P6; Livshits G, 2011, ANN RHEUM DIS, V70, P1740, DOI 10.1136/ard.2010.137836; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; NACHEMSON A, 1964, J BONE JOINT SURG AM, V46, P1077, DOI 10.2106/00004623-196446050-00012; Nazari J, 2015, MAGN RESON IMAGING, V33, P459, DOI 10.1016/j.mri.2015.01.006; PAAJANEN H, 1994, J ORTHOPAED RES, V12, P509, DOI 10.1002/jor.1100120407; Phillips KLE, 2015, OSTEOARTHR CARTILAGE, V23, P1165, DOI 10.1016/j.joca.2015.02.017; Phillips KLE, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4408; Purmessur D, 2013, BIOCHEM BIOPH RES CO, V433, P151, DOI 10.1016/j.bbrc.2013.02.034; Quero L, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4274; Ranjbar S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002620; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Roth I, 2010, MOL BIOL CELL, V21, P3459, DOI 10.1091/mbc.E10-02-0133; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9; Shen B, 2003, EUR SPINE J, V12, P66, DOI 10.1007/s00586-002-0454-2; Shen C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3443; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Tsai TT, 2006, J BIOL CHEM, V281, P25416, DOI 10.1074/jbc.M601969200; Ueno M, 2013, J LIPID RES, V54, P734, DOI 10.1194/jlr.M033365; Urban JPG, 2002, BIOCHEM SOC T, V30, P858, DOI 10.1042/bst0300858; URBAN JPG, 1985, BIORHEOLOGY, V22, P145; van der Windt AE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3031; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wang X, 2014, AM J PATHOL, V184, P2560, DOI 10.1016/j.ajpath.2014.06.006; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Yoon HJ, 2011, ARTHRITIS RHEUM-US, V63, P1843, DOI 10.1002/art.30229; Zhang D, 2015, MEDIAT INFLAMM, V2015	62	30	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17561	17575		10.1074/jbc.M117.790378	http://dx.doi.org/10.1074/jbc.M117.790378			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28842479	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000414009300035
J	Rahlwes, KC; Ha, SA; Motooka, D; Mayfield, JA; Baumoel, LR; Strickland, JN; Torres-Ocampo, AP; Nakamura, S; Morita, YS				Rahlwes, Kathryn C.; Ha, Stephanie A.; Motooka, Daisuke; Mayfield, Jacob A.; Baumoel, Lisa R.; Strickland, Justin N.; Torres-Ocampo, Ana P.; Nakamura, Shota; Morita, Yasu S.			The cell envelope-associated phospholipid-binding protein LmeA is required for mannan polymerization in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMEGMATIS ATCC 607; CORYNEBACTERIUM-GLUTAMICUM; OUTER-MEMBRANE; PHOSPHATIDYLINOSITOL MANNOSIDES; LIPOARABINOMANNAN BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; LIPID-COMPOSITION; CONSERVED GENE; IDENTIFICATION; TUBERCULOSIS	The integrity of the distinguishing, multilaminate cell envelope surrounding mycobacteria is critical to their survival and pathogenesis. The prevalence of phosphatidylinositol manno-sides in the cell envelope suggests an important role in the mycobacterial life cycle. Indeed, deletion of the pimE gene (Delta pimE) encoding the first committed step in phosphatidylinositol hexamannoside biosynthesis in Mycobacterium smegmatis results in the formation of smaller colonies than wild-type colonies on Middlebrook 7H10 agar. To further investigate potential contributors to cell-envelope mannan biosynthesis while taking advantage of this colony morphology defect, we isolated spontaneous suppressor mutants of Delta pimE that reverted to wild-type colony size. Of 22 suppressor mutants, 6 accumulated significantly shorter lipomannan or lipoarabinomannan. Genome sequencing of these mutants revealed mutations in genes involved in the lipomannan/lipoarabinomannan biosynthesis, such as those encoding the arabinosyltransferase EmbC and the mannosyltransferase MptA. Furthermore, we identified three mutants carrying a mutation in a previously uncharacterized gene, MSMEG_5785, that we designated lmeA. Complementation of these suppressor mutants with lmeA restored the original Delta pimE phenotypes and deletion of lmeA in wild-type M. smegmatis resulted in smaller lipomannan, as observed in the suppressor mutants. LmeA carries a predicted N-terminal signal peptide, and density gradient fractionation and detergent extractability experiments indicated that LmeA localizes to the cell envelope. Using a lipid ELISA, we found that LmeA binds to plasma membrane phospholipids, such as phosphatidylethanolamine and phosphatidylinositol. LmeA is widespread throughout the Corynebacteriales; therefore, we concluded that LmeA is an evolutionarily conserved cell-envelope protein critical for controlling the mannan chain length of lipomannan/lipoarabinomannan.	[Rahlwes, Kathryn C.; Ha, Stephanie A.; Baumoel, Lisa R.; Strickland, Justin N.; Torres-Ocampo, Ana P.; Morita, Yasu S.] Univ Massachusetts, Dept Microbiol, 639 N Pleasant St, Amherst, MA 01003 USA; [Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Microbial Dis Res Inst, Dept Infect Metagen, Osaka 5650871, Japan; [Mayfield, Jacob A.] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02445 USA	University of Massachusetts System; University of Massachusetts Amherst; Osaka University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Morita, YS (corresponding author), Univ Massachusetts, Dept Microbiol, 639 N Pleasant St, Amherst, MA 01003 USA.	ymorita@microbio.umass.edu	Nakamura, Shota/E-3033-2010	Nakamura, Shota/0000-0003-2058-5942; Rahlwes, Kathryn/0000-0002-8101-5604; Morita, Yasu/0000-0002-4514-9242; Torres-Ocampo, Ana P./0000-0003-1223-7120	American Lung Association [RG-414805]; Pittsfield AntiTuberculosis Association; UMass Amherst PREP Program	American Lung Association; Pittsfield AntiTuberculosis Association; UMass Amherst PREP Program	This work was supported by Biomedical Research Grant RG-414805 from the American Lung Association and a Research Grant from the Pittsfield AntiTuberculosis Association (to Y. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Summer research student supported by the UMass Amherst PREP Program.	Alva V, 2016, BBA-MOL CELL BIOL L, V1861, P913, DOI 10.1016/j.bbalip.2016.01.016; Bansal-Mutalik R, 2014, P NATL ACAD SCI USA, V111, P4958, DOI 10.1073/pnas.1403078111; Bansal-Mutalik R, 2011, P NATL ACAD SCI USA, V108, P15360, DOI 10.1073/pnas.1112572108; Cashmore TJ, 2017, J BIOL CHEM, V292, P4976, DOI 10.1074/jbc.M116.772202; Crellin PK, 2008, J BACTERIOL, V190, P3690, DOI 10.1128/JB.00200-08; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Fukuda T, 2013, MBIO, V4, DOI 10.1128/mBio.00472-12; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goude R, 2008, J BACTERIOL, V190, P4335, DOI 10.1128/JB.01825-07; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Hayashi JM, 2016, P NATL ACAD SCI USA, V113, P5400, DOI 10.1073/pnas.1525165113; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Ishikawa E, 2017, TRENDS IMMUNOL, V38, P66, DOI 10.1016/j.it.2016.10.009; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Jayaraman N., 2017, CHEMBIOCHEM, DOI [10.1002/cbic.201700247, DOI 10.1002/CBIC.201700247]; Joshi N. A., 2011, SICKLE SLIDING WINDO; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur D, 2006, P NATL ACAD SCI USA, V103, P13664, DOI 10.1073/pnas.0603049103; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; KHULLER GK, 1983, J APPL BACTERIOL, V54, P63, DOI 10.1111/j.1365-2672.1983.tb01301.x; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen M. H., 2007, CURR PROTOC MICROBIO, DOI [10.1002/mc10a02s69780471729259, DOI 10.1002/MC10A02S69780471729259]; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Lemassu A, 1996, MICROBIOL-UK, V142, P1513, DOI 10.1099/13500872-142-6-1513; LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351; Leversen NA, 2009, MICROBIOL-SGM, V155, P2375, DOI 10.1099/mic.0.025270-0; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Maes E, 2007, GLYCOCONJUGATE J, V24, P439, DOI 10.1007/s10719-007-9036-1; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Mkhikian H, 2016, ELIFE, V5, DOI 10.7554/eLife.14814; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2010, J BIOL CHEM, V285, P16643, DOI 10.1074/jbc.M110.119263; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; ORTALOMAGNE A, 1995, MICROBIOL-UK, V141, P1609, DOI 10.1099/13500872-141-7-1609; Perkowski EF, 2017, MBIO, V8, DOI 10.1128/mBio.00333-17; Rainczuk AK, 2012, J BIOL CHEM, V287, P42726, DOI 10.1074/jbc.M112.373415; Sena CBC, 2010, J BIOL CHEM, V285, P13326, DOI 10.1074/jbc.M109.077297; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; SUBRAMONIAM A, 1982, J GEN MICROBIOL, V128, P419; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van der Woude AD, 2013, J BACTERIOL, V195, P2050, DOI 10.1128/JB.02236-12; Vergne I, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00187; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005	55	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17407	17417		10.1074/jbc.M117.804377	http://dx.doi.org/10.1074/jbc.M117.804377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28855252	Green Published, hybrid			2022-12-26	WOS:000414009300022
J	Huang, HC; Singh, B; Morton, DP; Johnson, GP; Clements, B; Meyers, LA				Huang, Hsin-Chan; Singh, Bismark; Morton, David P.; Johnson, Gregory P.; Clements, Bruce; Meyers, Lauren Ancel			Equalizing access to pandemic influenza vaccines through optimal allocation to public health distribution points	PLOS ONE			English	Article							UNITED-STATES; EQUITY; VACCINATION; CHALLENGES; H1N1; CARE	Vaccines are arguably the most important means of pandemic influenza mitigation. However, as during the 2009 H1N1 pandemic, mass immunization with an effective vaccine may not begin until a pandemic is well underway. In the U.S., state-level public health agencies are responsible for quickly and fairly allocating vaccines as they become available to populations prioritized to receive vaccines. Allocation decisions can be ethically and logistically complex, given several vaccine types in limited and uncertain supply and given competing priority groups with distinct risk profiles and vaccine acceptabilities. We introduce a model for optimizing statewide allocation of multiple vaccine types to multiple priority groups, maximizing equal access. We assume a large fraction of available vaccines are distributed to healthcare providers based on their requests, and then optimize county-level allocation of the remaining doses to achieve equity. We have applied the model to the state of Texas, and incorporated it in a Web-based decision-support tool for the Texas Department of State Health Services (DSHS). Based on vaccine quantities delivered to registered healthcare providers in response to their requests during the 2009 H1N1 pandemic, we find that a relatively small cache of discretionary doses (DSHS reserved 6.8% in 2009) suffices to achieve equity across all counties in Texas.	[Huang, Hsin-Chan; Singh, Bismark] Univ Texas Austin, Operat Res & Ind Engn, Austin, TX 78712 USA; [Morton, David P.] Northwestern Univ, Ind Engn & Management Sci, Evanston, IL USA; [Johnson, Gregory P.] Univ Texas Austin, Texas Adv Comp Ctr, Austin, TX 78712 USA; [Clements, Bruce] Texas Dept State Hlth Serv, Hlth Emergency Preparedness & Response Sect, Austin, TX USA; [Meyers, Lauren Ancel] Univ Texas Austin, Integrat Biol, Austin, TX 78712 USA; [Meyers, Lauren Ancel] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Texas System; University of Texas Austin; Northwestern University; University of Texas System; University of Texas Austin; Texas Department of State Health Services; University of Texas System; University of Texas Austin; The Santa Fe Institute	Huang, HC (corresponding author), Univ Texas Austin, Operat Res & Ind Engn, Austin, TX 78712 USA.	neo.huang@utexas.edu	Singh, Bismark/AAW-8522-2021; Morton, David/K-2388-2014; Singh, Bismark/AAE-9864-2019; Singh, Bismark/AAK-3461-2021	Singh, Bismark/0000-0002-6943-657X; Singh, Bismark/0000-0002-6943-657X; Huang, Hsin-Chan/0000-0002-0994-4556; Morton, David/0000-0001-6001-9078; Meyers, Lauren/0000-0002-5828-8874	National Institutes of Health (Models of Infectious Disease Agent Study) [U01 GM087719]; Centers for Disease Control and Prevention (Public Health Emergency Preparedness)	National Institutes of Health (Models of Infectious Disease Agent Study); Centers for Disease Control and Prevention (Public Health Emergency Preparedness)	This study was supported by the National Institutes of Health (Models of Infectious Disease Agent Study grant U01 GM087719) and the Centers for Disease Control and Prevention (Public Health Emergency Preparedness). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAY LA, 1981, MED CARE, V19, P4, DOI 10.1097/00005650-198112001-00004; Araz OM, 2012, HEALTH CARE MANAG SC, V15, P175, DOI 10.1007/s10729-012-9199-6; Bayoumi AM, 2009, J PUBLIC HEALTH POL, V30, P176, DOI 10.1057/jphp.2009.9; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; CDC, 2010, 2009 H1N1 VACC DOS A; CDC, 2014, AV INFL A H7N9 VIR; Centers for Disease Control and Prevention (CDC), 2010, 2009 H1N1 OV PAND; Centers for Disease Control and Prevention (CDC), 2015, HIGHL PATH AV INFL A; Centers for Disease Control and Prevention (CDC), 2015, INFL FLU VACC AR MAD; Centers for Disease Control and Prevention (CDC), 2009, 2009 H1N1 MON INFL V; Centers for Disease Control and Prevention (CDC), 2009, 2009 H1N1 VACC REC 2; Culyer AJ, 2001, J MED ETHICS, V27, P275, DOI 10.1136/jme.27.4.275; Haaheim LR, 2009, VIRUSES-BASEL, V1, P1089, DOI 10.3390/v1031089; HHS (United States Department of Health and Human Services), 2005, HHS PAND INFL PLAN; Hopp W. J., 2008, FACTORY PHYS; HSC, 2005, NAT STRAT PAND INFL; Joseph A., 1984, ACCESSIBILITY UTILIZ; Keeling MJ, 2011, J R SOC INTERFACE, V8, P661, DOI 10.1098/rsif.2010.0474; Matrajt L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002964; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Mooney G, 2000, HEALTH CARE ANAL, V8, P203, DOI 10.1023/A:1009439917796; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Rambhia KJ, 2010, BIOSECUR BIOTERROR, V8, P321, DOI 10.1089/bsp.2010.0043; Rebmann T, 2012, EXPERT REV VACCINES, V11, P1009, DOI [10.1586/erv.12.63, 10.1586/ERV.12.63]; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Simchi-Levi D., 2008, DESIGNING MANAGING S, V(2nd; Stroud C, 2010, 2009 H1N1 INFLUENCA; Texas Department of State Health Services (DSHS), 2010, INT DASHB REP H1N1 V; Texas Department of State Health Services (DSHS), 2010, H1N1 VACC DOS COUNT; Texas Department of State Health Services (DSHS), 2010, H1N1 VACC DOS TEX LO; Texas Department of State Health Services (DSHS), 2014, HLTH SERV REG; Texas Department of State Health Services (DSHS), 2010, H1N1 VACC DOS TEX DS; Texas Department of State Health Services (DSHS), 2010, FIN ACT REP DSHS RES; Texas Department of State Health Services (DSHS) and The University of Texas at Austin, 2013, TEX PAND FLU TOOLK; U. S. Department of Health and Human Services (HHS), 2005, CONS ANT DRUG STOCKP; U. S. Department of Health and Human Services (HHS) and U. S. Department of Homeland Security (DHS), 2014, GUID ALL TARG PAND I; WHO, 2009, PAND INFL VACC MAN P; WHO, 2012, REP WHO PAND INFL A; Wu JT, 2007, P ROY SOC B-BIOL SCI, V274, P2811, DOI 10.1098/rspb.2007.0893	39	13	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182720	10.1371/journal.pone.0182720	http://dx.doi.org/10.1371/journal.pone.0182720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF1XX	28854244	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600015
J	Liu, SJ; Zheng, LY; Aweya, JJ; Zheng, Z; Zhong, MQ; Chen, JH; Wang, F; Zhang, YL				Liu, Shangjie; Zheng, Liyuan; Aweya, Jude Juventus; Zheng, Zhou; Zhong, Mingqi; Chen, Jiehui; Wang, Fan; Zhang, Yueling			Litopenaeus vannamei hemocyanin exhibits antitumor activity in S180 mouse model in vivo	PLOS ONE			English	Article							KEYHOLE-LIMPET HEMOCYANIN; MURINE BLADDER-CANCER; CYTOKINE PRODUCTION; TNF-ALPHA; IDENTIFICATION; IMMUNOTHERAPY; EVOLUTION; PROTEINS; IMMUNITY; GROWTH	Hemocyanin is a multifunctional glycoprotein, which also plays multiple roles in immune defense. While it has been demonstrated that hemocyanin from some mollusks can induce potent immune response and is therefore undergoing clinical trials to be used in anti-tumor immunotherapy, little is currently known about how hemocyanin from arthropods affect tumors. In this study we investigated the anti-tumor activity of hemocyanin from Litopenaeus vannamei on Sarcoma-180 (S180) tumor-bearing mice model. Eight days treatment with 4mg/kg bodyweight of hemocyanin significantly inhibited the growth of S180 up to 49% as compared to untreated. Similarly, histopathology analysis showed a significant decrease in tumor cell number and density in the tissues of treated mice. Moreover, there was a significant increase in immune organs index, lymphocyte proliferation, NK cell cytotoxic activity and serum TNF-alpha level, suggesting that hemocyanin could improve the immunity of the S180 tumor-bearing mice. Additionally, there was a significant increase in superoxide dismutase (SOD) activity and a decrease in the level of malondialdehyde (MDA) in serum and liver, which further suggest that hemocyanin improved the anti-oxidant ability of the S180 tumor-bearing mice. Collectively, our data demonstrated that L. vannamei hemocyanin had a significant antitumor activity in mice.	[Liu, Shangjie; Zheng, Liyuan; Aweya, Jude Juventus; Zheng, Zhou; Zhong, Mingqi; Chen, Jiehui; Wang, Fan; Zhang, Yueling] Shantou Univ, Dept Biol, Shantou, Peoples R China; [Liu, Shangjie; Zheng, Liyuan; Aweya, Jude Juventus; Zheng, Zhou; Zhong, Mingqi; Chen, Jiehui; Wang, Fan; Zhang, Yueling] Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou, Peoples R China; [Liu, Shangjie] Affiliated Jingzhou Cent Hosp, Tongji Med Coll, Dept Reprod Med, Jingzhou, Peoples R China	Shantou University; Shantou University	Wang, F; Zhang, YL (corresponding author), Shantou Univ, Dept Biol, Shantou, Peoples R China.; Wang, F; Zhang, YL (corresponding author), Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou, Peoples R China.	wangfan@stu.edu.cn; zhangyl@stu.edu.cn	Aweya, Jude Juventus/GUD-4163-2022; Aweya, Jude Juventus/D-7034-2013; Wang, Fan/AAD-8731-2020; Aweya, Jude J/J-6723-2017	Aweya, Jude Juventus/0000-0003-2554-9369; Aweya, Jude J/0000-0003-2554-9369	National Natural Science Foundation of China [31672689, 31372558]; National Key Growth Project of Guangdong Province College [2014GKXM043]; Key Innovation Project of Science and Technology of Guangdong Province College [2012CXZD0025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Growth Project of Guangdong Province College; Key Innovation Project of Science and Technology of Guangdong Province College	This work was sponsored by the National Natural Science Foundation of China (Nos. 31672689 & 31372558), The National Key Growth Project of Guangdong Province College (No. 2014GKXM043), and The Key Innovation Project of Science and Technology of Guangdong Province College (No. 2012CXZD0025).	Adachi K, 2005, PIGM CELL RES, V18, P214, DOI 10.1111/j.1600-0749.2005.00232.x; Aikemu A, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-157; Arancibia S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087240, 10.1371/journal.pone.0101786]; Baird S, 2007, BBA-PROTEINS PROTEOM, V1774, P1380, DOI 10.1016/j.bbapap.2007.08.019; Cao JF, 2016, BIOORG MED CHEM LETT, V26, P2098, DOI 10.1016/j.bmcl.2016.02.012; Coates CJ, 2017, CELL MOL LIFE SCI, V74, P293, DOI 10.1007/s00018-016-2326-7; Coates CJ, 2014, DEV COMP IMMUNOL, V45, P43, DOI 10.1016/j.dci.2014.01.021; Decker H, 1998, J BIOL CHEM, V273, P25889, DOI 10.1074/jbc.273.40.25889; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; del Campo M, 2011, REV MED CHILE, V139, P236, DOI /S0034-98872011000200015; Destoumieux-Garzon D, J BIOL CHEM, V276, P47070; Ebensperger LA, 2015, PHYSIOL BEHAV, V140, P61, DOI 10.1016/j.physbeh.2014.12.028; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Glazer L, 2013, J EXP BIOL, V216, P1898, DOI 10.1242/jeb.080945; Guo DY, 2009, EXP PARASITOL, V123, P277, DOI 10.1016/j.exppara.2009.07.013; Jaenicke E, 2004, MICRON, V35, P89, DOI 10.1016/j.micron.2003.10.027; Jaenicke E, 1999, J BIOL CHEM, V274, P34267, DOI 10.1074/jbc.274.48.34267; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; JURINCIC CD, 1988, J UROLOGY, V139, P723, DOI 10.1016/S0022-5347(17)42610-3; Kudryavtseva AV, 2016, ONCOTARGET, V7, P44879, DOI 10.18632/oncotarget.9821; Lamm DL, 2000, EUR UROL, V37, P41, DOI 10.1159/000052391; LAMM DL, 1993, J UROLOGY, V149, P648, DOI 10.1016/S0022-5347(17)36172-4; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; Moltedo B, 2006, J UROLOGY, V176, P2690, DOI 10.1016/j.juro.2006.07.136; Nesterova NV, 2011, ANTIVIR RES, V90, pA38, DOI 10.1016/j.antiviral.2011.03.052; OLSSON CA, 1974, J UROLOGY, V111, P173, DOI 10.1016/S0022-5347(17)59919-X; Pan QW, 2013, BIOL RES, V46, P87, DOI 10.4067/S0716-97602013000100013; Paul R., 1998, ZOOLOGY, V100, P319; Qiao J, 2011, FISH SHELLFISH IMMUN, V31, P736, DOI 10.1016/j.fsi.2011.07.005; Reyes D, 2013, BRIT J CANCER, V109, P1488, DOI 10.1038/bjc.2013.494; Ribeiro-Dias F, 2000, J IMMUNOL METHODS, V241, P121, DOI 10.1016/S0022-1759(00)00206-4; Riggs DR, 2005, AM J SURG, V189, P680, DOI 10.1016/j.amjsurg.2004.10.005; Saad EA, 2017, BIOCHEM BIOPH RES CO, V484, P579, DOI 10.1016/j.bbrc.2017.01.137; Sarker MMR, 2014, INDIAN J PHARMACOL, V46, P40, DOI 10.4103/0253-7613.125164; Sellos D, 1997, FEBS LETT, V407, P153, DOI 10.1016/S0014-5793(97)00350-5; SWERDLOW RD, 1994, J UROLOGY, V151, P1718, DOI 10.1016/S0022-5347(17)35352-1; Teijon C, 2003, TOXICOLOGY, V191, P245, DOI 10.1016/S0300-483X(03)00209-9; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Wen Y, 2016, FISH SHELLFISH IMMUN, V56, P450, DOI 10.1016/j.fsi.2016.08.002; Yan F, 2011, FISH SHELLFISH IMMUN, V30, P354, DOI 10.1016/j.fsi.2010.11.004; Yi JJ, 2017, FOOD FUNCT, V8, P151, DOI 10.1039/c6fo01235c; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; ZAGORODNYA SD, 2011, ANTIVIR RES, V90, pA66, DOI DOI 10.1016/J.ANTIVIRA1.2011.03.134; Zhang WD, 2003, IMMUNOLOGY, V108, P177, DOI 10.1046/j.1365-2567.2003.01489.x; Zhang XB, 2004, ANTIVIR RES, V61, P93, DOI 10.1016/j.antiviral.2003.08.019; Zhang YL, 2006, J PROTEOME RES, V5, P815, DOI 10.1021/pr0503984; Zhang YL, 2009, FISH SHELLFISH IMMUN, V27, P330, DOI 10.1016/j.fsi.2009.05.017; Zheng LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151801; Zhong TY, 2016, J IMMUNOL, V196, P4650, DOI 10.4049/jimmunol.1501156	50	18	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183783	10.1371/journal.pone.0183783	http://dx.doi.org/10.1371/journal.pone.0183783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854214	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600058
J	Osumi, H; Fujisaki, J; Suganuma, T; Horiuchi, Y; Omae, M; Yoshio, T; Ishiyama, A; Tsuchida, T; Miki, K				Osumi, Hiroki; Fujisaki, Junko; Suganuma, Takanori; Horiuchi, Yusuke; Omae, Masami; Yoshio, Toshiyuki; Ishiyama, Akiyoshi; Tsuchida, Tomohiro; Miki, Kazumasa			A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication	PLOS ONE			English	Article							SERUM PEPSINOGENS; H. PYLORI; TRIPLE THERAPY; INFECTION; DIAGNOSIS; ANTIBODY; GASTRIN; RADIOIMMUNOASSAY; ARTICLE; REGIMEN	Background Helicobacter pylori (H. pylori) eradication is usually assessed using the C-13-urea breath test (UBT), anti-H. pylori antibody and the H. pylori stool antigen test. However, a few reports have used pepsinogen (PG), in particular, the percentage change in the PG I/II ratio. Here, we evaluated the usefulness of the percentage changes in serum PG I/II ratios for determining the success of eradication therapy for H. pylori. Materials and methods In total, 650 patients received eradication therapy from October 2008 to March 2013 in our Cancer Institute Hospital. We evaluated the relationship between H. pylori eradication and percentage changes in serum PG I/II ratios before and 3 months after treatment with CLEIA (R) (FUJIREBIO Inc, Tokyo, Japan). The gold standard of H. pylori eradication was defined as negative by the UBT performed 3 months after completion of eradication treatment. Cut-off values for percentage changes in serum PG I/II ratios were set as +40, +25 and +10% when the serum PG I/II ratio before treatment was below 3.0, above 3.0 but below 5.0 and 5.0 or above, respectively. Results Serum PG I and PG II levels were measured in 562 patients with H. pylori infection before and after eradication therapy. Eradication of H. pylori was achieved in 433 patients studied (77.0%). The ratios of first, second, third-line and penicillin allergy eradication treatment were 73.8% (317/429), 88.3% (99/112), 75% (12/16) and 100% (5/5), respectively. An increasing percentage in the serum levels of the PG I/II ratios after treatment compared with the values before treatment clearly distinguished success from failure of eradication (108.2 +/- 57.2 vs. 6.8 +/- 30.7, p<0.05). Using the above cut-off values, the sensitivity, specificity and validity for determination of H. pylori were 93.1, 93.8 and 93.2%, respectively. Conclusion In conclusion, the percentage changes in serum PG I/II ratios are useful as evaluation criteria for assessing the success of eradication therapy for H. pylori.	[Osumi, Hiroki; Fujisaki, Junko; Horiuchi, Yusuke; Omae, Masami; Yoshio, Toshiyuki; Ishiyama, Akiyoshi; Tsuchida, Tomohiro; Miki, Kazumasa] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; [Suganuma, Takanori] Iida Municipal Hosp, Dept Gastroenterol, Nagano, Japan	Japanese Foundation for Cancer Research	Fujisaki, J (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan.	junko.fujisaki@jfcr.or.jp	Horiuchi, Yusuke/V-3881-2019; Yoshio, Toshiyuki/ABC-4723-2021	Horiuchi, Yusuke/0000-0001-8116-8152; Yoshio, Toshiyuki/0000-0002-6546-0329				Agreus L, 2012, SCAND J GASTROENTERO, V47, P136, DOI 10.3109/00365521.2011.645501; CHEN TS, 1994, AM J GASTROENTEROL, V89, P1511; Cutler A F, 1997, Gastroenterologist, V5, P202; DiMario F, 1996, GUT, V38, P793, DOI 10.1136/gut.38.5.793; Fujisawa T, 1999, Nihon Rinsho, V57, P101; Furuta T, 1997, AM J GASTROENTEROL, V92, P84; Furuta T, 2014, INTERNAL MED, V53, P571, DOI 10.2169/internalmedicine.53.1677; Furuta T, 2010, HEPATO-GASTROENTEROL, V57, P1314; Gatta L, 2011, CLIN GASTROENTEROL H, V9, P440, DOI 10.1016/j.cgh.2010.12.009; Gisbert JR, 2006, AM J GASTROENTEROL, V101, P1921, DOI 10.1111/j.1572-0241.2006.00668.x; Gisbert JP, 2004, ALIMENT PHARM THER, V20, P1001, DOI 10.1111/j.1365-2036.2004.02203.x; Gisbert JP, 2015, DIGEST LIVER DIS, V42, P287; HUNTER FM, 1993, DIGEST DIS SCI, V38, P2081, DOI 10.1007/BF01297088; ICHINOSE M, 1982, CLIN CHIM ACTA, V122, P61, DOI 10.1016/0009-8981(82)90095-X; ICHINOSE M, 1982, CLIN CHIM ACTA, V126, P183, DOI 10.1016/0009-8981(82)90034-1; Ito M., 2010, J JAPANESE SOC HELIC, V11, P91; Kato M, 2000, HELICOBACTER, V5, P109, DOI 10.1046/j.1523-5378.2000.00017.x; Kawai T, 2006, ALIMENT PHARM THERAP, V24, P23, DOI 10.1111/j.1365-2036.2006.00022.x; Laine L, 1997, GASTROINTEST ENDOSC, V45, P463, DOI 10.1016/S0016-5107(97)70174-3; Miki K, 2011, P JPN ACAD B-PHYS, V87, P405, DOI 10.2183/pjab.87.405; Murakami K, 2006, J GASTROEN HEPATOL, V21, P262, DOI 10.1111/j.1440-1746.2006.04183.x; Murakami K, 2013, J GASTROENTEROL, V48, P1128, DOI 10.1007/s00535-012-0731-8; Murata H, 1998, AM J GASTROENTEROL, V93, P2102, DOI 10.1111/j.1572-0241.1998.00601.x; Ohkusa T, 2004, ALIMENT PHARM THER, V20, P25, DOI 10.1111/j.1365-2036.2004.01970.x; Osumi H, 2015, J JAPANESE SOC HELIC, V17, P22; PerezParamo M, 1997, DIGEST DIS SCI, V42, P1734, DOI 10.1023/A:1018873717985; Sato M, 2012, J GASTROEN HEPATOL, V27, P23, DOI 10.1111/j.1440-1746.2012.07066.x; Shirai N, 2008, HEPATO-GASTROENTEROL, V55, P486; The Japanese Society for Helicobacter Research, 2009, J JAPANESE SOC HELIC, V10, P104; Tokieda M, 1995, Nihon Shokakibyo Gakkai Zasshi, V92, P1825; Vaira D, 2000, ALIMENT PHARM THER, V14, P13, DOI 10.1046/j.1365-2036.2000.00096.x	31	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183980	10.1371/journal.pone.0183980	http://dx.doi.org/10.1371/journal.pone.0183980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854276	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600074
J	Findik, BT; Randall, LL				Findik, Bahar T.; Randall, Linda L.			Determination of the intracellular concentration of the export chaperone SecB in Escherichia coli	PLOS ONE			English	Article							MALTOSE-BINDING-PROTEIN; TRANSLOCATION MACHINERY; DNA INTERACTIONS; MEMBRANE; SPECIFICITY; EXPRESSION; COMPONENTS; COMPLEXES; CHEMOTAXIS; SUFFICIENT	SecB, a small tetrameric chaperone in Escherichia coli, plays a crucial role during protein export via the general secretory pathway by binding precursor polypeptides in a nonnative conformation and passing them to SecA, the ATPase of the translocon. The dissociation constants for the interactions are known; however to relate studies in vitro to export in a living cell requires knowledge of the concentrations of the proteins in the cell. Presently in the literature there is no report of a rigorous determination of the intracellular concentration of SecB. The values available vary over 60 fold and the details of the techniques used are not given. Here we use quantitative immunoblotting to determine the level of SecB expressed from the chromosome in E. coli grown in two commonly used media. In rich medium SecB was present at 1.6 +/- 0.2 mu M and in minimal medium at 2.5 +/- 0.6 mu M. These values allow studies of SecB carried out in vitro to be applied to the situation in the cell as SecB interacts with its binding partners to move precursor polypeptides through the export pathway.	[Findik, Bahar T.; Randall, Linda L.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Randall, LL (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	craneje@missouri.edu	Findik, Bahar Tuba/ABB-3198-2021	Findik, Bahar Tuba/0000-0002-0030-4106	National Institutes of Health [GM29798]; Hugo Wurdack Trust at the University of Missouri	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hugo Wurdack Trust at the University of Missouri	This work was funded by National Institutes of Health Grant GM29798, L.L.R., https://www.nih.gov/, and Hugo Wurdack Trust at the University of Missouri, L.L.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; Cayley DS, 2000, BIOPHYS J, V78, P1748, DOI 10.1016/S0006-3495(00)76726-9; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; denBlaauwen T, 1997, FEBS LETT, V416, P35, DOI 10.1016/S0014-5793(97)01142-3; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; FEKKES P, 1995, BIOCHEMISTRY-US, V34, P10078, DOI 10.1021/bi00031a032; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; GANNON PM, 1989, J BACTERIOL, V171, P813, DOI 10.1128/jb.171.2.813-818.1989; Gouridis G, 2009, NATURE, V462, P363, DOI 10.1038/nature08559; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; KUMAMOTO CA, 1988, J BIOL CHEM, V263, P11554; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; KUSTERS R, 1989, J BIOL CHEM, V264, P20827; KUSUKAWA N, 1989, EMBO J, V8, P3517, DOI 10.1002/j.1460-2075.1989.tb08517.x; LARSEN PI, 1987, ARCH MICROBIOL, V147, P1, DOI 10.1007/BF00492896; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; LIU GP, 1989, P NATL ACAD SCI USA, V86, P9213, DOI 10.1073/pnas.86.23.9213; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; MATSUYAMA S, 1995, ADV CELL MOL BIOL M, V4, P61; Miller JH, 1974, EXPERIMENTS IN MOLEC; Patel CN, 2006, PROTEIN SCI, V15, P1379, DOI 10.1110/ps.062141006; POGLIANO KJ, 1994, J BACTERIOL, V176, P804, DOI 10.1128/jb.176.3.804-814.1994; POWERS EL, 1995, J BACTERIOL, V177, P1906, DOI 10.1128/jb.177.7.1906-1907.1995; Randall LL, 1998, PROTEIN SCI, V7, P2384, DOI 10.1002/pro.5560071115; Randall LL, 2005, J MOL BIOL, V348, P479, DOI 10.1016/j.jmb.2005.02.036; Randall LL, 1998, PROTEIN SCI, V7, P1195, DOI 10.1002/pro.5560070514; Randall LL, 2004, PROTEIN SCI, V13, P1124, DOI 10.1110/ps.03410104; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; RICHEY B, 1987, J BIOL CHEM, V262, P7157; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; SCHATZ PJ, 1991, EMBO J, V10, P1749, DOI 10.1002/j.1460-2075.1991.tb07699.x; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; Seoh HK, 1999, J BACTERIOL, V181, P1892, DOI 10.1128/JB.181.6.1892-1899.1999; Seoh HK, 1997, J BACTERIOL, V179, P1077, DOI 10.1128/jb.179.4.1077-1081.1997; Shimizu H, 1997, MOL MICROBIOL, V26, P1013, DOI 10.1046/j.1365-2958.1997.6392003.x; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; WATANABE M, 1989, P NATL ACAD SCI USA, V86, P2728, DOI 10.1073/pnas.86.8.2728; Woodbury RL, 2000, J BIOL CHEM, V275, P24191, DOI 10.1074/jbc.M002885200	44	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183231	10.1371/journal.pone.0183231	http://dx.doi.org/10.1371/journal.pone.0183231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850586	Green Submitted, Green Published, gold			2022-12-26	WOS:000408544200011
J	Lai, N; Kummitha, C; Hoppel, C				Lai, Nicola; Kummitha, China; Hoppel, Charles			Defects in skeletal muscle subsarcolemmal mitochondria in a non-obese model of type 2 diabetes mellitus	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; INSULIN-RESISTANCE; LIVER-MITOCHONDRIA; OXIDATIVE CAPACITY; COMPLEX-III; RAT; DEFICIENCY; DYSFUNCTION; TRANSPORT; OBESITY	Skeletal muscle resistance to insulin is related to accumulation of lipid-derived products, but it is not clear whether this accumulation is caused by skeletal muscle mitochondrial dysfunction. Diabetes and obesity are reported to have a selective effect on the function of subsarcolemmal and interfibrillar mitochondria in insulin-resistant skeletal muscle. The current study investigated the role of the subpopulations of mitochondria in the pathogenesis of insulin resistance in the absence of obesity. A non-obese spontaneous rat model of type 2 diabetes mellitus, (Goto-Kakizaki), was used to evaluate function and biochemical properties in both populations of skeletal muscle mitochondria. In subsarcolemmal mitochondria, minor defects are observed whereas in interfibrillar mitochondria function is preserved. Sub-sarcolemmal mitochondria defects characterized by a mild decline of oxidative phosphorylation efficiency are related to ATP synthase and structural alterations of inner mitochondria membrane but are considered unimportant because of the absence of defects upstream as shown with polarographic and spectrophometric assays. Fatty acid transport and oxidation is preserved in both population of mitochondria, whereas palmitoyl-CoA increased 25% in interfibrillar mitochondria of diabetic rats. Contrary to popular belief, these data provide compelling evidence that mitochondrial function is unaffected in insulin-resistant skeletal muscle from T2DM non-obese rats.	[Lai, Nicola; Kummitha, China] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23529 USA; [Lai, Nicola; Kummitha, China] Old Dominion Univ, Inst Biomed Engn, Norfolk, VA 23529 USA; [Lai, Nicola; Kummitha, China] Case Western Reserve Univ, Dept Biomed Engn, Sch Engn, Cleveland, OH 44106 USA; [Hoppel, Charles] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Hoppel, Charles] Case Western Reserve Univ, Sch Med, Ctr Mitochondrial Dis, Cleveland, OH USA; [Hoppel, Charles] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA	Old Dominion University; Old Dominion University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Lai, N (corresponding author), Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23529 USA.; Lai, N (corresponding author), Old Dominion Univ, Inst Biomed Engn, Norfolk, VA 23529 USA.; Lai, N (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Sch Engn, Cleveland, OH 44106 USA.	nlai@odu.edu	Lai, Nicola/AAR-8520-2021	Lai, Nicola/0000-0002-3436-289X	National Institute of Arthritis and Musculoskeletal and Skin Diseases(NIH-NIASM); National Institute of Diabetes and Digestive and Kidney (NIH-NIDDK) [K25AR057206, P30DK027651]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K25AR057206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088823] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(NIH-NIASM); National Institute of Diabetes and Digestive and Kidney (NIH-NIDDK); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NL was supported in part by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases(NIH-NIASM) and National Institute of Diabetes and Digestive and Kidney (NIH-NIDDK) under award number K25AR057206 and P30DK027651, respectively. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; CHAPPELL JB, 1964, BIOCHEM J, V90, P225, DOI 10.1042/bj0900225; Crescenzo R, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00512; Crescenzo R, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-79; Crescenzo R, 2014, NUTRITION, V30, P75, DOI 10.1016/j.nut.2013.05.022; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508; Goodpaster BH, 2013, DIABETES, V62, P1032, DOI 10.2337/db12-1612; GOTO Y, 1981, P JPN ACAD B-PHYS, V57, P381, DOI 10.2183/pjab.57.381; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Holloway GP, 2009, APPL PHYSIOL NUTR ME, V34, P440, DOI 10.1139/H09-028; Holloway GP, 2009, AM J PHYSIOL-ENDOC M, V296, pE738, DOI 10.1152/ajpendo.90896.2008; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; HOPPEL C, 1969, ARCH BIOCHEM BIOPHYS, V135, P173, DOI 10.1016/0003-9861(69)90528-1; HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Jorgensen W, 2012, AM J PHYSIOL-ENDOC M, V303, pE515, DOI 10.1152/ajpendo.00103.2012; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4; Larsen S, 2011, DIABETOLOGIA, V54, P1427, DOI 10.1007/s00125-011-2098-4; Lionetti L, 2007, INT J OBESITY, V31, P1596, DOI 10.1038/sj.ijo.0803636; Liu YC, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12890; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Macia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129579; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Murakami S, 2012, SCI WORLD J, DOI 10.1100/2012/680189; National Research Council, 2011, GUIDE FOR THE CARE A; O'Toole JF, 2010, BIOCHEM J, V427, P105, DOI 10.1042/BJ20091373; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Rosca MG, 2009, J MOL CELL CARDIOL, V46, P927, DOI 10.1016/j.yjmcc.2009.02.009; Shulman GI, 2004, PHYSIOLOGY, V19, P183, DOI 10.1152/physiol.00007.2004; Steiler TL, 2003, ENDOCRINOLOGY, V144, P5259, DOI 10.1210/en.2003-0447; Taube A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1004, DOI 10.1152/ajpendo.00241.2009; Turcotte LP, 2001, DIABETES, V50, P1389, DOI 10.2337/diabetes.50.6.1389; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wang X, 2014, DIABETES METAB SYNDR, V7, P381, DOI 10.2147/DMSO.S65818; Wessels B, 2015, AM J PHYSIOL-ENDOC M, V309, pE670, DOI 10.1152/ajpendo.00144.2015; WILLIAMS JN, 1964, ARCH BIOCHEM BIOPHYS, V107, P537, DOI 10.1016/0003-9861(64)90313-3; Yasuda K, 2002, CLIN EXP PHARMACOL P, V29, P1001, DOI 10.1046/j.1440-1681.2002.03757.x	50	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183978	10.1371/journal.pone.0183978	http://dx.doi.org/10.1371/journal.pone.0183978			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850625	gold, Green Published, Green Submitted			2022-12-26	WOS:000408544200050
J	Xiang, Y; Lai, FN; He, GF; Li, YP; Yang, LL; Shen, W; Huo, HQ; Zhu, J; Dai, HY; Zhang, YG				Xiang, Ya; Lai, Fangnong; He, Guifang; Li, Yapeng; Yang, Leilei; Shen, Wei; Huo, Heqiang; Zhu, Jun; Dai, Hongyi; Zhang, Yugang			Alleviation of Rosup-induced oxidative stress in porcine granulosa cells by anthocyanins from red-fleshed apples	PLOS ONE			English	Article							GLUTATHIONE-REDUCTASE; ANTIOXIDANT; APOPTOSIS; ZEARALENONE; PIGMENTS; NECROSIS; COLOR	Anthocyanins are the polyphenolic phytochemicals which have been shown to scavenge free radicals. In this study, we investigated the effects of anthocyanins extracted from red-fleshed apples (Malus sieversii) on reducing oxidative damage by Rosup in porcine granulosa cells (GCs) by measuring intracellular reactive oxygen species (ROS), content of glutathione (GSH), activities of superoxide dismutase (SOD1), catalase (CAT) and glutathione peroxidase (GPX1) and the gene expression of SOD1, CAT, GPX1. Apoptosis was determined with TdT-mediated dUTP-biotin nick end labeling (TUNEL) and apoptosis-related proteins were quantified with Western blotting. The results indicate that Rosup increases oxidative stress by inducing reactive oxygen species production in porcine GCs and the oxidative stress could be reduced by anthocyanins. The gene expression of SOD1, CAT, GPX1 and the activities of these enzymes were increased when GCs were treated with anthocyanins and Rosup for 6 hours. Anthocyanins inhibit Rosup-induced apoptosis by increasing expression of antiapoptotic protein Bcl-2 and suppressing the expression of proapoptotic protein Bax. Collectively, anthocyanins from red-fleshed apples reduce oxidative stress and inhibit apoptosis in porcine GCs in vitro. This approach indicates that antioxidants might be developed from red-fleshed apples.	[Xiang, Ya; Zhu, Jun; Dai, Hongyi; Zhang, Yugang] Qingdao Agr Univ, Coll Hort, Qingdao, Peoples R China; [Xiang, Ya; Dai, Hongyi; Zhang, Yugang] Qingdao Agr Univ, Qingdao Key Lab Genet Dev & Breeding Hort Plants, Qingdao, Peoples R China; [Lai, Fangnong; He, Guifang; Li, Yapeng; Yang, Leilei; Shen, Wei] Qingdao Agr Univ, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao, Peoples R China; [Yang, Leilei; Shen, Wei] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China; [Huo, Heqiang] Univ Florida, Midflorida Res & Educ Ctr, Apopka, FL USA	Qingdao Agricultural University; Qingdao Agricultural University; Qingdao Agricultural University; Qingdao Agricultural University; State University System of Florida; University of Florida	Zhang, YG (corresponding author), Qingdao Agr Univ, Coll Hort, Qingdao, Peoples R China.; Zhang, YG (corresponding author), Qingdao Agr Univ, Qingdao Key Lab Genet Dev & Breeding Hort Plants, Qingdao, Peoples R China.	ygzhang@qau.edu.cn	Yang, Lei-Lei/AAM-4080-2021	Yang, Lei-Lei/0000-0002-5082-2075; zhang, yu gang/0000-0002-2726-2153	National Natural Science Foundation of China [31372032]; China Agriculture Research System Foundation [CARS-27]; Shandong Provincial Improved Variety Engineering System Foundation; Taishan Scholar Constructive Foundation; "12th Five-Year" National Science and technology support program [2013BAD02601]; Qingdao Scientific Research Foundation [15-9-2-99-nsh, 15-10-2-2-nsh]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System Foundation; Shandong Provincial Improved Variety Engineering System Foundation; Taishan Scholar Constructive Foundation; "12th Five-Year" National Science and technology support program; Qingdao Scientific Research Foundation	This work was supported by the National Natural Science Foundation of China (Grant No. 31372032), China Agriculture Research System Foundation (Grant No. CARS-27), Shandong Provincial Improved Variety Engineering System Foundation, Taishan Scholar Constructive Foundation and Qingdao Scientific Research Foundation (Grant No. 15-9-2-99-nsh, 15-10-2-2-nsh), "12th Five-Year" National Science and technology support program (2013BAD02601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco L, 2016, PLANT J, V86, P62, DOI 10.1111/tpj.13145; Carlisi D, 2014, ONCOL REP, V32, P167, DOI 10.3892/or.2014.3212; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Chaudhary N, 2014, INT J HLTH SCI RES, V4, P216; Denis MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053725; Duda M, 2011, REPROD BIOL, V11, P117, DOI 10.1016/S1642-431X(12)60049-7; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Gonzalez-Talice J, 2013, SCI HORTIC-AMSTERDAM, V151, P83, DOI 10.1016/j.scienta.2012.12.007; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Huang WJ, 2016, BIOMED REP, V4, P519, DOI 10.3892/br.2016.630; Huang ZL, 2009, LWT-FOOD SCI TECHNOL, V42, P819, DOI 10.1016/j.lwt.2008.11.005; Igarashi K, 2000, BIOSCI BIOTECH BIOCH, V64, P1600, DOI 10.1271/bbb.64.1600; Jang H, 2013, WORLD J MENS HEALTH, V31, P239, DOI 10.5534/wjmh.2013.31.3.239; Jang H, 2012, REPROD FERT DEVELOP, V24, P649, DOI 10.1071/RD11174; Jhin C, 2014, INT J MOL SCI, V15, P14715, DOI 10.3390/ijms150814715; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Knollema S, 1996, J COMP NEUROL, V373, P157, DOI 10.1002/(SICI)1096-9861(19960916)373:2<157::AID-CNE1>3.0.CO;2-2; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Ma T, 2016, FOOD CHEM, V194, P296, DOI 10.1016/j.foodchem.2015.07.110; Marin DE, 2013, FOOD CHEM TOXICOL, V58, P408, DOI 10.1016/j.fct.2013.05.033; McMahon BK, 2012, J AM CHEM SOC, V134, P10725, DOI 10.1021/ja300887k; Nems A, 2015, FOOD CHEM, V172, P175, DOI 10.1016/j.foodchem.2014.09.033; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Park HB, 2010, J ORTHOP RES, V28, P1162, DOI 10.1002/jor.21097; Qin XC, 2015, INT J PHOTOENERGY, V2015, DOI 10.1155/2015/471364; Raghvendra VS, 2011, INT J PHARM SCI REV, V6, P28; Sakatani M, 2007, J REPROD DEVELOP, V53, P605, DOI 10.1262/jrd.18124; Sari P, 2012, FOOD CHEM, V132, P1908, DOI 10.1016/j.foodchem.2011.12.025; Seeram NP, 2002, J AGR FOOD CHEM, V50, P5308, DOI 10.1021/jf025671q; Sousa A, 2016, FOOD CHEM, V192, P142, DOI 10.1016/j.foodchem.2015.06.108; Streit E, 2012, TOXINS, V4, P788, DOI 10.3390/toxins4100788; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tedesco I, 2001, J NUTR BIOCHEM, V12, P505, DOI 10.1016/S0955-2863(01)00164-4; TSUDA T, 1994, J AGR FOOD CHEM, V42, P2407, DOI 10.1021/jf00047a009; Whitaker BD, 2008, REPROD FERT DEVELOP, V20, P694, DOI 10.1071/RD08037; [项亚 Xiang Ya], 2016, [植物生理学报, Plant Physiology Journal], V52, P1353; You J, 2010, THERIOGENOLOGY, V74, P777, DOI 10.1016/j.theriogenology.2010.04.002; ZHANG YC, 2016, INT J FUTUR GENER CO, V9, P1, DOI DOI 10.17660/EJHS.2016/81.5.3; Zheng J, 2011, FOOD CHEM, V126, P859, DOI 10.1016/j.foodchem.2010.11.052; Zhu L, 2012, J CELL PHYSIOL, V227, P1814, DOI 10.1002/jcp.22906; Zienolddiny S, 2000, CARCINOGENESIS, V21, P1521, DOI 10.1093/carcin/21.8.1521	43	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0184033	10.1371/journal.pone.0184033	http://dx.doi.org/10.1371/journal.pone.0184033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850606	Green Published, Green Submitted, gold			2022-12-26	WOS:000408544200053
J	Chouaid, C; Debieuvre, D; Durand-Zaleski, I; Fernandes, J; Scherpereel, A; Westeel, V; Blein, C; Gaudin, AF; Ozan, N; Leblanc, S; Vainchtock, A; Chauvin, P; Cotte, FE; Souquet, PJ				Chouaid, Christos; Debieuvre, Didier; Durand-Zaleski, Isabelle; Fernandes, Jerome; Scherpereel, Arnaud; Westeel, Virginie; Blein, Cecile; Gaudin, Anne-Francoise; Ozan, Nicolas; Leblanc, Soline; Vainchtock, Alexandre; Chauvin, Pierre; Cotte, Francois-Emery; Souquet, Pierre-Jean			Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study)	PLOS ONE			English	Article							COLORECTAL-CANCER; HEALTH-CARE; MORTALITY; DISPARITIES; STAGE; ACCESS; DEPRIVATION; MANAGEMENT; DIAGNOSIS; PATTERNS	The French healthcare system is a universal healthcare system with no financial barrier to access to health services and cancer drugs. The objective of the study is to investigate associations between, on the one hand, incidence and survival of patients diagnosed with lung cancer in France and, on the other, the socioeconomic deprivation and population density of their municipality of residence. A national, longitudinal analysis using data from the French National Hospital database crossed with the population density of the municipality and a social deprivation index based on census data aggregated at the municipality level. For lung cancer diagnosed at the metastatic stage, one-year and two-year survival was not associated with the population density of the municipality of residence. In contrast, mortality was higher for people living in very deprived, deprived and privileged areas compared to very privileged areas (hazard ratios at two years: 1.19 [1.13 - 1.25], 1.14 [1.08 - 1.20] and 1.10 [1.04 - 1.16] respectively). Similar associations are also observed in patients diagnosed with non-metastatic disease (hazard ratios at two years: 1.21 [1.13 - 1.30], 1.15 [1.08 - 1.23] and 1.10 [1.03 - 1.18] for people living in very deprived, deprived and privileged areas compared to very privileged areas). Despite a universal healthcare coverage, survival inequalities in patients with lung cancer can be observed in France with respect to certain socioeconomic indicators.	[Chouaid, Christos] Creteil Univ Hosp, Dept Chest Med, Creteil, France; [Debieuvre, Didier] Mulhouse Univ Hosp, Dept Chest Med, Mulhouse, France; [Durand-Zaleski, Isabelle] Hop Hotel Dieu, URCEco lle France, Paris, France; [Durand-Zaleski, Isabelle] Henri Mondor Hosp, Dept Publ Hlth, Creteil, France; [Fernandes, Jerome] Oc Sante, Montpellier, France; [Scherpereel, Arnaud] Lille Univ Hosp, Pulm & Thorac Oncol Dept, Lille, France; [Westeel, Virginie] Jean Minjoz Univ Hosp, Dept Chest Med, Besancon, France; [Blein, Cecile; Leblanc, Soline; Vainchtock, Alexandre] HEVA, Lyon, France; [Gaudin, Anne-Francoise; Ozan, Nicolas; Cotte, Francois-Emery] Lab Bristol Myers Squibb, Hlth Econ & Outcomes Res, Rueil Malmaison, France; [Chauvin, Pierre] Sorbonne Univ, UPMC Univ Paris 06, INSERM, IPLESP UMRS 1136,Dept Social Epidemiol, Paris, France; [Souquet, Pierre-Jean] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Chest Med, Pierre Benite, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite de Lille - ISITE; CHU Lille; Universite de Franche-Comte; CHU Besancon; Bristol-Myers Squibb; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Lyon	Cotte, FE (corresponding author), Lab Bristol Myers Squibb, Hlth Econ & Outcomes Res, Rueil Malmaison, France.	Francois-Emery.Cotte@bms.com	Chauvin, Pierre/S-2981-2019; Chauvin, Pierre/G-1095-2015; christos, chouaid/R-4477-2018	Chauvin, Pierre/0000-0002-9183-6406; Chauvin, Pierre/0000-0002-9183-6406; christos, chouaid/0000-0002-4290-5524	Bristol-Myers Squibb (BMS); BMS	Bristol-Myers Squibb (BMS)(Bristol-Myers Squibb); BMS(Bristol-Myers Squibb)	This study was funded by Bristol-Myers Squibb (BMS), a company which markets pharmaceuticals used in the treatment of lung cancer. AF Gaudin, N Ozan and FE Cotte are salaried employees of BMS. BMS contracted the data analysis for this study to HEVA, a contract research organisation. C Blein, S Leblanc and A Vainchtock are employees or shareholders of HEVA. BMS have funded editorial support in the form of preparation of slide sets or posters for presentations of data from the TERRITOIRE study on behalf of CC, IDZ and PJS, as well as editorial support for the preparation of this manuscript. The funders initiated, designed and supervised the study.	Atkins GT, 2017, ANN AM THORAC SOC, V14, P403, DOI 10.1513/AnnalsATS.201606-469OC; Bain NSC, 2000, FAM PRACT, V17, P475, DOI 10.1093/fampra/17.6.475; Berglund A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001048; Berglund A, 2010, THORAX, V65, P327, DOI 10.1136/thx.2009.125914; Booth CM, 2010, CANCER-AM CANCER SOC, V116, P4160, DOI 10.1002/cncr.25427; Coleman MP, 2001, CANCER, V91, P208, DOI 10.1002/1097-0142(20010101)91:1+<208::AID-CNCR6>3.0.CO;2-E; Dalton SO, 2015, ACTA ONCOL, V54, P797, DOI 10.3109/0284186X.2014.1001037; Debieuvre D, 2016, LUNG CANCER, V91, P1, DOI 10.1016/j.lungcan.2015.11.001; Dejardin O, 2014, HEALTH PLACE, V30, P36, DOI 10.1016/j.healthplace.2014.08.002; Doat S, 2016, REV EPIDEMIOL SANTE, V64, P145, DOI 10.1016/j.respe.2015.12.020; Erhunmwunsee L, 2012, CANCER-AM CANCER SOC, V118, P5117, DOI 10.1002/cncr.26185; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Forrest LF, 2015, THORAX, V70, P138, DOI 10.1136/thoraxjnl-2014-205517; Gisquet E., 2012, B EPID MIOLOGIQUE HE, V48, P547; Guignard R., 2015, Bulletin Epidemiologique Hebdomadaire, P281; International Agency for Research on Cancer World Health Organization, 2014, EUR CANC OBS EUCAN N; Johnson AM, 2014, LUNG CANCER, V83, P401, DOI 10.1016/j.lungcan.2014.01.008; Locher C, 2013, LUNG CANCER, V81, P32, DOI 10.1016/j.lungcan.2013.03.001; McMahon M, 2011, THORAX, V66, P453, DOI 10.1136/thoraxjnl-2011-200039; McPhail S, 2015, BRIT J CANCER, V112, pS108, DOI 10.1038/bjc.2015.49; Melvan JN, 2015, J AM COLL SURGEONS, V221, P550, DOI 10.1016/j.jamcollsurg.2015.03.056; Morere JF, 2015, EUR J CANCER PREV, V24, pS82, DOI 10.1097/CEJ.0000000000000143; Murage P, 2016, HEALTH PLACE, V42, P11, DOI 10.1016/j.healthplace.2016.08.014; O'Dowd EL, 2015, THORAX, V70, P161, DOI 10.1136/thoraxjnl-2014-205692; Pearce J, 2005, SOC SCI MED, V60, P2833, DOI 10.1016/j.socscimed.2004.11.014; Pozet A, 2008, LUNG CANCER, V59, P291, DOI 10.1016/j.lungcan.2007.08.039; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Riaz SP, 2011, J THORAC ONCOL, V6, P2005, DOI 10.1097/JTO.0b013e31822b02db; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Wagenaar KP, 2012, CANCER EPIDEMIOL, V36, P329, DOI 10.1016/j.canep.2012.03.003; World Health Organization, 2010, INT CLASSIFICATION D; Yang R, 2010, CANCER-AM CANCER SOC, V116, P2437, DOI 10.1002/cncr.24986	33	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182798	10.1371/journal.pone.0182798	http://dx.doi.org/10.1371/journal.pone.0182798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841679	Green Published, Green Submitted, gold			2022-12-26	WOS:000408370700010
J	Kucklich, M; Moller, M; Marcillo, A; Einspanier, A; Weiss, BM; Birkemeyer, C; Widdig, A				Kuecklich, Marlen; Moeller, Manfred; Marcillo, Andrea; Einspanier, Almuth; Weiss, Brigitte M.; Birkemeyer, Claudia; Widdig, Anja			Different methods for volatile sampling in mammals	PLOS ONE			English	Article							GAS CHROMATOGRAPHY/MASS SPECTROMETRY; CHEMICAL-COMPOSITION; THERMAL-DESORPTION; ORGANIC-COMPOUNDS; BODY ODOR; SCENT; IDENTIFICATION; SECRETIONS; COMMUNICATION; ECOLOGY	Previous studies showed that olfactory cues are important for mammalian communication. However, many specific compounds that convey information between conspecifics are still unknown. To understand mechanisms and functions of olfactory cues, olfactory signals such as volatile compounds emitted from individuals need to be assessed. Sampling of animals with and without scent glands was typically conducted using cotton swabs rubbed over the skin or fur and analysed by gas chromatography-mass spectrometry (GC-MS). However, this method has various drawbacks, including a high level of contaminations. Thus, we adapted two methods of volatile sampling from other research fields and compared them to sampling with cotton swabs. To do so we assessed the body odor of common marmosets (Callithrix jacchus) using cotton swabs, thermal desorption (TD) tubes and, alternatively, a mobile GC-MS device containing a thermal desorption trap. Overall, TD tubes comprised most compounds (N = 113), with half of those compounds being volatile (N = 52). The mobile GC-MS captured the fewest compounds (N = 35), of which all were volatile. Cotton swabs contained an intermediate number of compounds (N = 55), but very few volatiles (N = 10). Almost all compounds found with the mobile GC-MS were also captured with TD tubes (94%). Hence, we recommend TD tubes for state of the art sampling of body odor of mammals or other vertebrates, particularly for field studies, as they can be easily transported, stored and analysed with high performance instruments in the lab. Nevertheless, cotton swabs capture compounds which still may contribute to the body odor, e.g. after bacterial fermentation, while profiles from mobile GC-MS include only the most abundant volatiles of the body odor.	[Kuecklich, Marlen; Weiss, Brigitte M.; Widdig, Anja] Max Planck Inst Evolutionary Anthropol, Jr Res Grp Primate Kin Select, Dept Primatol, Leipzig, Germany; [Kuecklich, Marlen; Weiss, Brigitte M.; Widdig, Anja] Univ Leipzig, Behav Ecol Res Grp, Inst Biol, Leipzig, Germany; [Moeller, Manfred; Birkemeyer, Claudia] Rhein Westfal TH Aachen, Inst & Out Patient Clin Occupat Med, Aachen, Germany; [Marcillo, Andrea] Univ Leipzig, Res Grp Mass Spectrometry, Inst Analyt Chem, Leipzig, Germany; [Einspanier, Almuth] Univ Leipzig, Inst Physiol Chem, Fac Vet Med, Leipzig, Germany; [Widdig, Anja] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Max Planck Society; Leipzig University; RWTH Aachen University; Leipzig University; Leipzig University	Kucklich, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Jr Res Grp Primate Kin Select, Dept Primatol, Leipzig, Germany.; Kucklich, M (corresponding author), Univ Leipzig, Behav Ecol Res Grp, Inst Biol, Leipzig, Germany.	marlen_kuecklich@eva.mpg.de	; Birkemeyer, Claudia/L-8687-2015	Weiss, Brigitte/0000-0001-6316-5636; Kucklich, Marlen/0000-0001-7694-6474; Birkemeyer, Claudia/0000-0002-8538-8838	University of Leipzig; European Fund for Regional Structure Development, EFRE [100195810]; Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion, SENESCYT-Ecuador [861-2012]	University of Leipzig; European Fund for Regional Structure Development, EFRE; Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion, SENESCYT-Ecuador	This work was supported by the University of Leipzig including a graduate funding of the University of Leipzig to MK; the European Fund for Regional Structure Development, EFRE ("Europe funds Saxony", http://ec.europa.eu/ regional_policy/de/funding/erdf/, grant no. 100195810 to AW); and Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion, SENESCYT-Ecuador (http://www. senescyt.gob.ec/web/guest, grant no. 861-2012 to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen H., 2008, ANAL LINGUISTIC DATA; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Birkemeyer CS, 2016, CHEM SENSES, V41, P525, DOI 10.1093/chemse/bjw056; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; Burger BV, 1999, J CHEM ECOL, V25, P2099, DOI 10.1023/A:1021040923988; Charpentier MJE, 2012, FUNCT ECOL, V26, P769, DOI 10.1111/j.1365-2435.2012.01998.x; CONVERSE LJ, 1995, ANIM BEHAV, V49, P615; Costello BD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/014001; Curran AM, 2010, J FORENSIC SCI, V55, P50, DOI 10.1111/j.1556-4029.2009.01236.x; Curran AM, 2005, J CHEM ECOL, V31, P1607, DOI 10.1007/s10886-005-5801-4; De Preter V, 2009, J CHROMATOGR A, V1216, P1476, DOI 10.1016/j.chroma.2008.12.095; Dettmer K, 2002, ANAL BIOANAL CHEM, V373, P490, DOI 10.1007/s00216-002-1352-5; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Dormont L, 2013, J EXP BIOL, V216, P2783, DOI 10.1242/jeb.085936; Dormont L, 2013, J CHEM ECOL, V39, P569, DOI 10.1007/s10886-013-0286-z; Doving KB, 1998, J EXP BIOL, V201, P2913; Drea CM, 2013, AM J PRIMATOL, V75, P621, DOI 10.1002/ajp.22143; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Ezenwa VO, 2014, BIOESSAYS, V36, P847, DOI 10.1002/bies.201400016; FERKIN MH, 1995, ANIM BEHAV, V49, P37, DOI 10.1016/0003-3472(95)80151-0; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Gallego E, 2010, TALANTA, V81, P916, DOI 10.1016/j.talanta.2010.01.037; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Giron-Calva PS, 2014, J CHEM ECOL, V40, P1203, DOI 10.1007/s10886-014-0514-1; Heymann EW, 2006, AM J PRIMATOL, V68, P519, DOI 10.1002/ajp.20249; Hoover KC, 2010, AM J PHYS ANTHROPOL, P63, DOI 10.1002/ajpa.21441; Juan-Peiro L, 2012, J ANAL METHODS CHEM, V2012, DOI 10.1155/2012/728143; Leclaire S, 2014, BEHAV ECOL, V25, P996, DOI 10.1093/beheco/aru074; Leclaire S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1054; Lenochova P, 2009, CHEM SENSES, V34, P127, DOI 10.1093/chemse/bjn067; Marcillo A, J CHROMATOG IN PRESS; Marneweck C, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2376; McCormick AC, 2014, PLANT CELL ENVIRON, V37, P1836, DOI 10.1111/pce.12357; Mietsch M, 2015, LAB ANIM-UK, V49, P241, DOI 10.1177/0023677214565843; Nagashima H, 2015, J CHROMATOGR A, V1406, P279, DOI 10.1016/j.chroma.2015.06.011; Peron F, 2014, ANIM COGN, V17, P1007, DOI 10.1007/s10071-013-0717-9; R Core Team, 2013, R LANG ENV STAT COMP; Rabaud NE, 2002, J AGR FOOD CHEM, V50, P5139, DOI 10.1021/jf020204u; Royal Society of Chemistry, 2017, CHEMSPIDER SEARCH SH; Salthammer T., 2009, ORGANIC INDOOR AIR P; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Scordato ES, 2007, CHEM SENSES, V32, P493, DOI 10.1093/chemse/bjm018; Setchell JM, 2010, CHEM SENSES, V35, P205, DOI 10.1093/chemse/bjp105; Sigma-Aldrich Co, 1997, AMB XAD 2 POLYM ADS; Smith TE, 2001, CHEM SENSES, V26, P449, DOI 10.1093/chemse/26.5.449; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; Theis KR, 2013, P NATL ACAD SCI USA, V110, P19832, DOI 10.1073/pnas.1306477110; Theis KR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00615; Tholl D, 2006, PLANT J, V45, P540, DOI 10.1111/j.1365-313X.2005.02612.x; van Dam NM, 2010, J CHEM ECOL, V36, P1006, DOI 10.1007/s10886-010-9844-9; Woolfenden E, 1997, J AIR WASTE MANAGE, V47, P20, DOI 10.1080/10473289.1997.10464411; Wypych G., 2001, HDB SOLVENTS; Zhang SC, 2010, SENSOR ACTUAT B-CHEM, V146, P427, DOI 10.1016/j.snb.2009.11.028	56	20	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183440	10.1371/journal.pone.0183440	http://dx.doi.org/10.1371/journal.pone.0183440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841690	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700032
J	Lei, Y; Wang, SL; Ren, BS; Wang, J; Chen, J; Lu, J; Zhan, SH; Fu, YF; Huang, LH; Tan, JM				Lei, Yan; Wang, Shuiliang; Ren, Bingshuang; Wang, Jin; Chen, Jin; Lu, Jun; Zhan, Shihuai; Fu, Yunfeng; Huang, Lianghu; Tan, Jianming			CHOP favors endoplasmic reticulum stress-induced apoptosis in hepatocellular carcinoma cells via inhibition of autophagy	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; C/EBP-HOMOLOGOUS PROTEIN; DOUBLE-EDGED-SWORD; GENE-EXPRESSION; CANCER-CELLS; A549 CELLS; DEATH; MECHANISMS; PATHWAY; DISEASE	C/EBP-homologous protein (CHOP) is an important component of the endoplasmic reticulum (ER) stress response. We demonstrated the induction of ER stress in response to tunicamycin stimulation, as evidenced by increased expression of chaperone proteins Grp78, Grp94, and enhanced eukaryotic initiation factor 2 subunit 1 (eIF2 alpha) phosphorylation in hepatocellular carcinoma cells. Tunicamycin-induced ER stress resulted in apoptosis and autophagy simultaneously. While inhibition of autophagy mediated by 3-methyladenine pretreatment or direct knockdown of LC3B promoted cell apoptosis, activation of autophagy with rapamycin decreased tunicamycin-induced apoptosis in HCC cells. Furthermore, CHOP was shown to be significantly upregulated upon treatment with tunicamycin in HCC cells. Specific knockdown of CHOP not only enhanced tunicamycin-induced autophagy, but also significantly attenuated ER stress-induced apoptosis in HCC cells. Accordingly, simultaneous inhibition of autophagy in HCC cells with CHOP-knockdown could partially resensitize ER stress-induced apoptosis. Taken together, our data indicate that CHOP may favor ER stress-induced apoptosis in HCC cells via inhibition of autophagy in vitro.	[Lei, Yan; Wang, Shuiliang; Ren, Bingshuang; Wang, Jin; Chen, Jin; Lu, Jun; Zhan, Shihuai; Fu, Yunfeng; Huang, Lianghu; Tan, Jianming] Xiamen Univ, Fuzhou Gen Hosp, Dept Fujian Prov Key Lab Transplant Biol, Fuzhou, Fujian, Peoples R China	Xiamen University	Huang, LH; Tan, JM (corresponding author), Xiamen Univ, Fuzhou Gen Hosp, Dept Fujian Prov Key Lab Transplant Biol, Fuzhou, Fujian, Peoples R China.	huanglianghu@xmu.edu.cn; tanjm156@xmu.edu.cn	Lu, Jun/ADP-4733-2022; Wang, Shuiliang/R-4080-2019; Tan, Ming-Jen/A-3862-2011	Wang, Shuiliang/0000-0002-5054-9064; Tan, Ming-Jen/0000-0002-3583-1723; Chen, Jin/0000-0003-0794-3995	National Natural Science Foundation of China [81270431]; Natural Science Foundation of Fujian Province of China [2016J01577]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported in part by the National Natural Science Foundation of China (No. 81270431) (LH). This work was also supported in part by the Natural Science Foundation of Fujian Province of China (No.2016J01577) (SW).	B'chir W, 2014, CELL SIGNAL, V26, P1385, DOI 10.1016/j.cellsig.2014.03.009; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Chandrika BB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140025; Chikka MR, 2013, J BIOL CHEM, V288, P4405, DOI 10.1074/jbc.M112.432344; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hsu HC, 2016, EUR J NUTR, V55, P2245, DOI 10.1007/s00394-015-1034-7; Inagi R, 2014, NAT REV NEPHROL, V10, P369, DOI 10.1038/nrneph.2014.67; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li SY, 2015, CELL PHYSIOL BIOCHEM, V36, P2403, DOI 10.1159/000430202; Li XQ, 2010, AUTOPHAGY, V6, P1066, DOI 10.4161/auto.6.8.13366; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Rodriguez D, 2011, BBA-MOL CELL RES, V1813, P564, DOI 10.1016/j.bbamcr.2010.11.012; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubiolo JA, 2013, CELL SIGNAL; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Saha A, 2010, BIOL PHARM BULL, V33, P1291, DOI 10.1248/bpb.33.1291; Seong YA, 2014, CELL BIOCHEM BIOPHYS, V68, P369, DOI 10.1007/s12013-013-9717-2; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang H, 2015, INT J NANOMED, V10, P5505, DOI 10.2147/IJN.S83838; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Zhang JL, 2015, J SURG RES, V195, P588, DOI 10.1016/j.jss.2015.01.039; Zhang N, 2015, BIOCHEM BIOPH RES CO, V464, P1107, DOI 10.1016/j.bbrc.2015.07.086	29	52	56	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183680	10.1371/journal.pone.0183680	http://dx.doi.org/10.1371/journal.pone.0183680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841673	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700049
J	Yeh, KT; Lee, RP; Chen, IH; Yu, TC; Liu, KL; Peng, CH; Wang, JH; Chang, PY; Wu, WT				Yeh, Kuang-Ting; Lee, Ru-Ping; Chen, Ing-Ho; Yu, Tzai-Chiu; Liu, Kuan-Lin; Peng, Cheng-Huan; Wang, Jen-Hung; Chang, Pau-Yuan; Wu, Wen-Tien			Fresh frozen cortical strut allograft in two-level anterior cervical corpectomy and fusion	PLOS ONE			English	Article							FIBULAR ALLOGRAFT; PLATE FIXATION; RIGID PLATES; RECONSTRUCTION; COMPLICATIONS; MYELOPATHY; SPONDYLOSIS; AUTOGRAFT; KYPHOSIS; FAILURE	Anterior cervical corpectomy and fusion (ACCF) is one of the main surgical strategies for the management of multilevel cervical spondylotic myelopathy (MCSM). High complication rates of graft bone fracture, resorption, displacement, and fusion collapse or pseudarthrosis have been previously reported. The strategies to prevent the aforementioned complications include using fresh frozen cortical strut allograft (FFCSA) to keep most of the original bone quality and using additional anterior plate fixation to improve the fusion stability and union rate. In this study, we evaluated 4-year follow-ups for surgical outcomes and analyzed the risk factors of MCSM patients who received 2-level ACCF with FFCSA and titanium dynamic plate fixation. We retrospectively collected preoperative and postoperative radiographic and clinical data of patients from 2005 to 2009; the inclusion criteria were having been diagnosed as MCSM and having received 2-level ACCF with an FFCSA fibular shaft and an anterior dynamic plate. The cervical curvature lordosis improved and the neurogenic function recovered well postoperatively. Visual analog scale for neck pain and neck disability index scores both decreased after 12 and 48 months following surgery. The Japanese Orthopaedic Association score recovery rate at postoperative 4 years was 87.5%. Fusion rates achieved 100% at 12 months. The preoperative Nurick score seemed to be the only significant risk factor correlated with the functional recovery rate at 4 years after the surgery. In conclusion, based on a minimum 4-year follow-up of 2-level ACCF with FFCSA and dynamic titanium plates for patients with MCSM, the surgical results were satisfying and the complication rates were low.	[Yeh, Kuang-Ting; Chen, Ing-Ho; Yu, Tzai-Chiu; Liu, Kuan-Lin; Peng, Cheng-Huan; Wu, Wen-Tien] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Orthoped, Hualien, Taiwan; [Yeh, Kuang-Ting; Chen, Ing-Ho; Yu, Tzai-Chiu; Wu, Wen-Tien] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ru-Ping; Wu, Wen-Tien] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Wang, Jen-Hung] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med Res, Hualien, Taiwan; [Chang, Pau-Yuan] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Radiol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Wu, WT (corresponding author), Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Orthoped, Hualien, Taiwan.; Wu, WT (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Wu, WT (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	wentien2003@yahoo.com.tw	Yeh, Kuang-Ting/ABD-4398-2020					Aponte-Tinao LA, 2014, ORTHOP CLIN N AM, V45, P257, DOI 10.1016/j.ocl.2013.12.008; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102008; Daubs MD, 2005, SPINE, V30, P1402, DOI 10.1097/01.brs.0000166526.78058.3c; DiPaola CP, 2008, SPINE J, V8, P717, DOI 10.1016/j.spinee.2007.06.016; Douglas AF, 2007, NEUROSURGERY, V60, P137, DOI 10.1227/01.NEU.0000249224.59494.A0; FERNYHOUGH JC, 1991, SPINE, V16, pS561, DOI 10.1097/00007632-199110001-00022; Ghogawala Z, 2007, SPINE, V32, P429, DOI 10.1097/01.brs.0000255068.94058.8a; GROSSMAN W, 1992, SPINE, V17, P565, DOI 10.1097/00007632-199205000-00015; Hee HT, 2003, J SPINAL DISORD TECH, V16, P1, DOI 10.1097/00024720-200302000-00001; HERMAN JM, 1994, J NEUROSURG, V80, P963, DOI 10.3171/jns.1994.80.6.0963; Hirai T, 2011, SPINE, V36, P1940, DOI 10.1097/BRS.0b013e3181feeeb2; Kaminsky S B, 2004, Iowa Orthop J, V24, P95; MacDonald RL, 1997, J NEUROSURG, V86, P990, DOI 10.3171/jns.1997.86.6.0990; Nakase H, 2006, J SPINAL DISORD TECH, V19, P353, DOI 10.1097/01.bsd.0000210113.09521.aa; Nunley PD, 2009, SPINE J, V9, P121, DOI 10.1016/j.spinee.2007.11.009; Okawa A, 2011, SPINE, V36, pE582, DOI 10.1097/BRS.0b013e3181e0f06a; Pitzen TR, 2009, SPINE, V34, P641, DOI 10.1097/BRS.0b013e318198ce10; Resnick DK, 2007, NEUROSURGERY, V60, P112, DOI 10.1227/01.NEU.0000215350.95209.CA; Rhee JM, 2007, J AM ACAD ORTHOP SUR, V15, P640, DOI 10.5435/00124635-200711000-00002; Riew KD, 1999, SPINE, V24, P2404, DOI 10.1097/00007632-199911150-00019; Saunders RL, 1976, 4 LEVEL CERVICAL COR, P23; Schnee CL, 1997, SPINE, V22, P2222, DOI 10.1097/00007632-199710010-00005; Stulik J, 2007, EUR SPINE J, V16, P1689, DOI 10.1007/s00586-007-0451-6; Vaccaro AR, 1998, J SPINAL DISORD, V11, P410; Vitzthum HE, 2007, EUR SPINE J, V16, P2096, DOI 10.1007/s00586-007-0512-x; Witwer BP, 2007, NEUROSURGERY, V60, P130, DOI 10.1227/01.NEU.0000215351.32372.CE; Yan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112423; ZDEBLICK TA, 1989, J BONE JOINT SURG AM, V71A, P170, DOI 10.2106/00004623-198971020-00002	28	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183112	10.1371/journal.pone.0183112	http://dx.doi.org/10.1371/journal.pone.0183112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841652	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700018
J	Carlsson, J; Svennerstam, H; Moritz, T; Egertsdotter, U; Ganeteg, U				Carlsson, Johanna; Svennerstam, Henrik; Moritz, Thomas; Egertsdotter, Ulrika; Ganeteg, Ulrika			Nitrogen uptake and assimilation in proliferating embryogenic cultures of Norway spruce-Investigating the specific role of glutamine	PLOS ONE			English	Article							SCOTS PINE-SEEDLINGS; AMINO-ACID-UPTAKE; BOREAL FOREST PLANTS; SOMATIC EMBRYOGENESIS; INORGANIC NITROGEN; PICEA-ABIES; ORGANIC NITROGEN; ALANINE AMINOTRANSFERASE; ARABIDOPSIS-THALIANA; NITRATE UPTAKE	Somatic embryogenesis is an in vitro system employed for plant propagation and the study of embryo development. Nitrogen is essential for plant growth and development and, hence, the production of healthy embryos during somatic embryogenesis. Glutamine has been shown to increase plant biomass in many in vitro applications, including somatic embryogenesis. However, several aspects of nitrogen nutrition during somatic embryogenesis remain unclear. Therefore, we investigated the uptake and assimilation of nitrogen in Norway spruce pro-embryogenic masses to elucidate some of these aspects. In our study, addition of glutamine had a more positive effect on growth than inorganic nitrogen. The nitrogen uptake appeared to be regulated, with a strong preference for glutamine; 67% of the assimilated nitrogen in the free amino acid pool originated from glutamine-nitrogen. Glutamine addition also relieved the apparently limited metabolism (as evidenced by the low concentration of free amino acids) of pro-embryogenic masses grown on inorganic nitrogen only. The unusually high alanine concentration in the presence of glutamine, suggests that alanine biosynthesis was involved in alleviating these constraints. These findings inspire further studies of nitrogen nutrition during the somatic embryogenesis process; identifying the mechanism(s) that govern glutamine enhancement of pro-embryogenic masses growth is especially important in this regard.	[Carlsson, Johanna; Svennerstam, Henrik; Moritz, Thomas; Egertsdotter, Ulrika; Ganeteg, Ulrika] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden; [Carlsson, Johanna] Svenska Skogsplantor AB, Seed Prod, Lagan, Sweden; [Svennerstam, Henrik] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden; [Egertsdotter, Ulrika] Georgia Inst Technol, GW Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	Swedish University of Agricultural Sciences; Umea University; Umea University; University System of Georgia; Georgia Institute of Technology	Ganeteg, U (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden.	ulrika.ganeteg@slu.se		Egertsdotter, Ulrika/0000-0002-0696-4279; Moritz, Thomas/0000-0002-4258-3190	Svenska Skogsplantor AB; Swedish Governmental Agency for Innovation Systems (VINNOVA; UPSC Berzelii Center for Forest Biotechnology) [2012-01560]; Knut & Alice Wallenberg foundation [2011.02.12]; Nils and Dorthi Troedsson Foundation [859/15]	Svenska Skogsplantor AB; Swedish Governmental Agency for Innovation Systems (VINNOVA; UPSC Berzelii Center for Forest Biotechnology); Knut & Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Nils and Dorthi Troedsson Foundation	This study was conducted within the 2nd Research School of Forest Genetics, Biotechnology and Breeding (http://resschool.slu.se/), Umea Plant Science Centre (UPSC) and Swedish University of Agricultural Sciences (SLU) Sweden, in collaboration with Svenska Skogsplantor AB (http://www.skogsplantor.se/). The work was financed by Svenska Skogsplantor AB, the Swedish Governmental Agency for Innovation Systems (VINNOVA; UPSC Berzelii Center for Forest Biotechnology 2012-01560; www2.vinnova.se; including support to U.E, T.M. and U.G.), grants awarded to T.M. (Knut & Alice Wallenberg foundation; 2011.02.12; kaw.wallenberg.org) and H.S. (Nils and Dorthi Troedsson Foundation; 859/15; www.troedssonfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JD, 1997, PLANT CELL REP, V16, P411, DOI 10.1007/BF01146784; Bernard SM, 2009, NEW PHYTOL, V182, P608, DOI 10.1111/j.1469-8137.2009.02823.x; Bloom AJ, 1997, NITROGEN LIMITING FA; Bonga JM, 2010, PLANT CELL TISS ORG, V100, P241, DOI 10.1007/s11240-009-9647-2; BOZHKOV PV, 1993, J PLANT PHYSIOL, V142, P735, DOI 10.1016/S0176-1617(11)80911-9; BUCHMANN N, 1995, OECOLOGIA, V102, P361, DOI 10.1007/BF00329803; Canovas FM, 2007, J EXP BOT, V58, P2307, DOI 10.1093/jxb/erm051; Chalupa W, 1985, COMMUN I FOR CZECH R, V14, P57; de la Torre F, 2014, J EXP BOT, V65, P5527, DOI 10.1093/jxb/eru240; Dodeman VL, 1997, J EXP BOT, V48, P1493, DOI 10.1093/jexbot/48.313.1493; Filonova LH, 2000, J EXP BOT, V51, P249, DOI 10.1093/jexbot/51.343.249; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Ganeteg U, 2017, PLANT CELL ENVIRON, V40, P413, DOI 10.1111/pce.12881; George E, 2008, PLANT PROPAGATION TI, V1; Gessler A, 1998, NEW PHYTOL, V138, P275, DOI 10.1046/j.1469-8137.1998.00107.x; GEZELIUS K, 1993, TREE PHYSIOL, V13, P71, DOI 10.1093/treephys/13.1.71; GOOD AG, 1989, PLANT PHYSIOL, V90, P1305, DOI 10.1104/pp.90.4.1305; Grossnickle S. C., 1996, Tree Planters' Notes, V47, P48; Gruffman L, 2014, TREE PHYSIOL, V34, P205, DOI 10.1093/treephys/tpt121; Gruffman L, 2013, TREE PHYSIOL, V33, P590, DOI 10.1093/treephys/tpt041; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; HAKMAN I, 1985, PLANT SCI, V38, P53, DOI 10.1016/0168-9452(85)90079-2; Hamasaki Regina M., 2005, Braz. J. Plant Physiol., V17, P383, DOI 10.1590/S1677-04202005000400006; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; HRISTOFOROGLU K, 1995, PLANT CELL TISS ORG, V40, P277, DOI 10.1007/BF00048134; HUPPE HC, 1994, ANNU REV PLANT PHYS, V45, P577, DOI 10.1146/annurev.pp.45.060194.003045; Joy RW, 1997, J PLANT PHYSIOL, V151, P306, DOI 10.1016/S0176-1617(97)80257-X; KHLIFI S, 1995, PLANT CELL TISS ORG, V41, P23, DOI 10.1007/BF00124083; KIRBY EG, 1982, PHYSIOL PLANTARUM, V56, P114, DOI 10.1111/j.1399-3054.1982.tb04908.x; Krapp A, 2015, CURR OPIN PLANT BIOL, V25, P115, DOI 10.1016/j.pbi.2015.05.010; KROGSTRUP P, 1986, CAN J FOREST RES, V16, P664, DOI 10.1139/x86-116; Kronzucker HJ, 1996, PLANT PHYSIOL, V110, P773, DOI 10.1104/pp.110.3.773; Kronzucker HJ, 1997, NATURE, V385, P59, DOI 10.1038/385059a0; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Lea PJ, 1999, BOOK SOIL P, P1; Lee YH, 2007, PLANT J, V50, P305, DOI 10.1111/j.1365-313X.2007.03045.x; Lelu-Walter MA, 2013, TREE GENET GENOMES, V9, P883, DOI 10.1007/s11295-013-0620-1; Li HX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01318; Limami AM, 2008, J EXP BOT, V59, P2325, DOI 10.1093/jxb/ern102; Limami AM, 2014, PLANTA, V239, P531, DOI 10.1007/s00425-013-2015-9; Malagoli M, 2000, PLANT SOIL, V221, P1, DOI 10.1023/A:1004720002898; MARSCHNER H, 1991, TREES-STRUCT FUNCT, V5, P14, DOI 10.1007/BF00225330; Metcalfe RJ, 2011, CAN J FOREST RES, V41, P1626, DOI [10.1139/X11-090, 10.1139/x11-090]; Michaeli S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00419; Miller BD, 2007, TREE PHYSIOL, V27, P901, DOI 10.1093/treephys/27.6.901; Miyashita Y, 2007, PLANT J, V49, P1108, DOI 10.1111/j.1365-313X.2006.03023.x; Narsai R, 2011, NEW PHYTOL, V190, P472, DOI 10.1111/j.1469-8137.2010.03589.x; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Nehra NS, 2005, IN VITRO CELL DEV-PL, V41, P701, DOI 10.1079/IVP2005691; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Ogita S, 2001, IN VITRO CELL DEV-PL, V37, P268, DOI 10.1007/s11627-001-0048-4; Ohlund J, 2004, TREE PHYSIOL, V24, P1397; Ohlund J, 2001, TREE PHYSIOL, V21, P1319, DOI 10.1093/treephys/21.18.1319; Park YS, 2002, ANN FOR SCI, V59, P651, DOI 10.1051/forest:2002051; Paungfoo-Lonhienne C, 2012, PLANT SOIL, V359, P1, DOI 10.1007/s11104-012-1357-6; Perchlik M, 2014, J EXP BOT, V65, P5193, DOI 10.1093/jxb/eru278; Persson J, 2003, OECOLOGIA, V137, P252, DOI 10.1007/s00442-003-1334-0; Persson J, 2001, ECOL LETT, V4, P434, DOI 10.1046/j.1461-0248.2001.00260.x; Persson J, 2006, J EXP BOT, V57, P2651, DOI 10.1093/jxb/erl028; PINTO ACQ, 1993, IN VITRO CELL DEV-PL, V29P, P55, DOI 10.1007/BF02632252; Pullman GS, 2016, NEW FOREST, V47, P453, DOI 10.1007/s11056-016-9525-9; Pullman GS, 2014, NEW FOREST, V45, P353, DOI 10.1007/s11056-014-9407-y; Schmidt S, 1999, AUST J PLANT PHYSIOL, V26, P253, DOI 10.1071/PP98116; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; SIMOLA LK, 1990, PHYSIOL PLANTARUM, V80, P27; Svennerstam H, 2008, NEW PHYTOL, V180, P620, DOI 10.1111/j.1469-8137.2008.02589.x; Svennerstam H, 2011, NEW PHYTOL, V191, P459, DOI 10.1111/j.1469-8137.2011.03699.x; Vasudevan A, 2004, BIOL PLANTARUM, V48, P125, DOI 10.1023/B:BIOP.0000024288.82679.50; von Arnold S, 2002, PLANT CELL TISS ORG, V69, P233, DOI 10.1023/A:1015673200621; VONARNOLD S, 1981, CAN J BOT, V59, P870, DOI 10.1139/b81-121; WIJK CK, 1993, PLANT SOIL, V151, P91	71	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181785	10.1371/journal.pone.0181785	http://dx.doi.org/10.1371/journal.pone.0181785			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837647	Green Submitted, Green Published, gold			2022-12-26	WOS:000408365000012
J	Hsu, WT; Lai, CC; Wang, YH; Tseng, PH; Wang, K; Wang, CY; Chen, LK				Hsu, Wan-Tseng; Lai, Chih-Cheng; Wang, Ya-Hui; Tseng, Ping-Huei; Wang, Kun; Wang, Cheng-Yi; Chen, Likwang			Risk of pneumonia in patients with gastroesophageal reflux disease: A population-based cohort study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PROTON PUMP INHIBITORS; METAANALYSIS; OMEPRAZOLE; DRUGS	Purpose The prevalence of gastroesophagel reflux disease (GERD) has steadily increased. However, the association between GERD itself and the risk of pneumonia remains unclear. This study aimed to investigate the association between GERD and long-term risk of pneumonia and to identify the major risk factors for pneumonia in GERD patients. Methods Using the Taiwan National Health Insurance Research Database, we identified patients who were newly diagnosed with GERD and treated with proton pump inhibitors (PPIs) from January 1, 2004 through December 31, 2010. Two groups comprising 15,715 GERD cases and 15,715 non-GERD matched controls were generated using propensity score matching, thereby making the differences in basic demographics, concomitant medication use, and comorbidities between the two groups inconsiderable. Results Cumulative incidence of pneumonia was significantly higher in the patients with GERD than that in the non-GERD matched controls, with an adjusted HR of 1.48 (95% confidence interval [CI] = 1.31-1.67; P < 0.001) within 6-year follow-ups. Multivariate stratified analyses revealed similar results in many subgroups, with a highest risk in individuals younger than 40 years of age (HR = 2.17, 95% CI = 1.48-3.19). Crucially, patients with GERD using PPIs longer than 4 months were at a significantly increased risk of pneumonia than those who did not use PPIs or took PPIs less than 4 months. Conclusions GERD was significantly associated with long-term risk of pneumonia, especially in GERD with PPI use longer than 4 months or in the young population. Further prospective longitudinal studies should be conducted for validation and implementing clinical practice guidelines.	[Hsu, Wan-Tseng] Natl Taiwan Univ, Sch Pharm, Taipei, Taiwan; [Lai, Chih-Cheng] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Wang, Ya-Hui] Fu Jen Catholic Univ, Med Res Ctr, Cardinal Tien Hosp, Coll Med, New Taipei, Taiwan; [Wang, Ya-Hui; Wang, Kun; Wang, Cheng-Yi] Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan; [Tseng, Ping-Huei] Natl Taiwan Univ Hosp, Dept Internal Med, Coll Med, Taipei, Taiwan; [Wang, Kun; Wang, Cheng-Yi] Fu Jen Catholic Univ, Dept Internal Med, Cardinal Tien Hosp, New Taipei, Taiwan; [Chen, Likwang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Miaoli County, Taiwan	National Taiwan University; Chi Mei Hospital; Fu Jen Catholic University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; National Health Research Institutes - Taiwan	Wang, K (corresponding author), Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan.; Wang, K (corresponding author), Fu Jen Catholic Univ, Dept Internal Med, Cardinal Tien Hosp, New Taipei, Taiwan.	kunwang@mospital.com	Tseng, Ping-Huei/GZA-8772-2022	TSENG, PING-HUEI/0000-0002-7483-7538; Hsu, Wan-Tseng/0000-0001-6358-999X	National Health Research Institutes;  [CTH 106A-2603]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); 	This study was supported by grants CTH 106A-2603 (Dr. Kun Wang, Cardinal Tien Hospital, Taiwan) and National Health Research Institutes (Dr. Likwang Chen, intramural funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2017, STAT METHODS MED RES, V26, P201, DOI 10.1177/0962280214543508; AYBAY C, 1995, GEN PHARMACOL-VASC S, V26, P1413, DOI 10.1016/0306-3623(94)00301-3; Chao CT, 2014, J CANCER RES CLIN, V140, P613, DOI 10.1007/s00432-014-1600-z; El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269; Eom CS, 2011, CAN MED ASSOC J, V183, P310, DOI 10.1503/cmaj.092129; Filion KB, 2014, GUT, V63, P552, DOI 10.1136/gutjnl-2013-304738; Giuliano C, 2012, EXPERT REV CLIN PHAR, V5, P337, DOI [10.1586/ECP.12.20, 10.1586/ecp.12.20]; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Ho SW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001227; Ho SW, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006710; Johnstone J, 2010, ALIMENT PHARM THER, V31, P1165, DOI 10.1111/j.1365-2036.2010.04284.x; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lee Shou-Wu, 2015, J Clin Med Res, V7, P880, DOI 10.14740/jocmr2322w; Lee SW, 2015, J RES MED SCI, V20, P263; Morehead RS, 2009, EUR RESPIR REV, V18, P233, DOI 10.1183/09059180.00002509; Perng DW, 2007, CHEST, V132, P1548, DOI 10.1378/chest.07-1373; Sarkar M, 2008, ANN INTERN MED, V149, P391, DOI 10.7326/0003-4819-149-6-200809160-00005; Scaringi L, 1996, SCAND J IMMUNOL, V44, P204, DOI 10.1046/j.1365-3083.1996.d01-300.x; Shih CJ, 2014, INT J CARDIOL, V177, P292, DOI 10.1016/j.ijcard.2014.09.036; Vakil N, 2009, AM J GASTROENTEROL, V104, pS17, DOI 10.1038/ajg.2009.47; Yoshida N, 2000, ALIMENT PHARM THERAP, V14, P74, DOI 10.1046/j.1365-2036.2000.014s1074.x	21	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183808	10.1371/journal.pone.0183808	http://dx.doi.org/10.1371/journal.pone.0183808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837700	Green Submitted, Green Published, gold			2022-12-26	WOS:000408365000126
J	Kim, J; Kim, KH; Lee, BJ				Kim, Jihye; Kim, Keun Ho; Lee, Bum Ju			Association of peptic ulcer disease with obesity, nutritional components, and blood parameters in the Korean population	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; NATIONAL-HEALTH; DUODENAL-ULCER; GASTRIC-ULCER; UNITED-STATES; RISK-FACTORS; MEN; LIFE; AGE; ERADICATION	Objectives Peptic ulcer disease (PUD) is a common disorder, but whether an association exists between PUD and anthropometric indicators remains controversial. Furthermore, no studies on the association of PUD with anthropometric indices, blood parameters, and nutritional components have been reported. The aim of this study was to assess associations of anthropometrics, blood parameters, nutritional components, and lifestyle factors with PUD in the Korean population. Methods Data were collected from a nationally representative sample of the South Korean population using the Korea National Health and Nutrition Examination Survey. Logistic regression was used to examine associations of anthropometrics, blood parameters and nutritional components among patients with PUD. Results Age was the factor most strongly associated with PUD in women (p = < 0.0001, odds ratio (OR) = 0.770 [0.683-0.869]) and men (p = < 0.0001, OR = 0.715 [0.616-0.831]). In both crude and adjusted analyses, PUD was highly associated with weight (adjusted p = 0.0008, adjusted OR = 1.251 [95% CI: 1.098-1.426]), hip circumference (adjusted p = 0.005, adjusted OR = 1.198 [1.056-1.360]), and body mass index (adjusted p = 0.0001, adjusted OR = 1.303 [1.139-1.490]) in women and hip circumference (adjusted p = 0.0199, adjusted OR = 1.217 [1.031-1.435]) in men. PUD was significantly associated with intake of fiber (adjusted p = 0.0386, adjusted OR = 1.157 [1.008-1.328], vitamin B2 (adjusted p = 0.0477, adjusted OR = 1.155 [1.001-1.333]), sodium (adjusted p = 0.0154, adjusted OR = 1.191 [1.034-1.372]), calcium (adjusted p = 0.0079, adjusted OR = 1.243 [1.059-1.459]), and ash (adjusted p = 0.0468, adjusted OR = 1.152 [1.002-1.325] in women but not in men. None of the assessed blood parameters were associated with PUD in women, and only triglyceride level was associated with PUD in men (adjusted p = 0.0169, adjusted OR = 1.227 [1.037-1.451]). Discussion We found that obesity was associated with PUD in the Korean population; additionally, the association between nutritional components and PUD was greater in women than in men.	[Kim, Jihye; Kim, Keun Ho; Lee, Bum Ju] Korea Inst Oriental Med, KM Fundamental Res Div, Daejeon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Lee, BJ (corresponding author), Korea Inst Oriental Med, KM Fundamental Res Div, Daejeon, South Korea.	bjlee@kiom.re.kr		Kim, Jihye/0000-0003-3534-9627; Lee, Bum Ju/0000-0003-2682-5716	technology innovation program - Ministry of Trade, Industry & Energy, Republic of Korea [MOTIE 100060251, D16330]	technology innovation program - Ministry of Trade, Industry & Energy, Republic of Korea	This work was supported by a technology innovation program funded by the Ministry of Trade, Industry & Energy, Republic of Korea (MOTIE 100060251, D16330).	Aditi A, 2012, DIGEST DIS SCI, V57, P2504, DOI 10.1007/s10620-012-2203-7; Aldoori WH, 1997, AM J EPIDEMIOL, V145, P42, DOI 10.1093/oxfordjournals.aje.a009030; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Aro P, 2006, AM J EPIDEMIOL, V163, P1025, DOI 10.1093/aje/kwj129; Bae SJ, 2010, HLTH INSURANCE REV A; BLANCO CD, 1993, GASTROINTEST ENDOSC, V39, P50, DOI 10.1016/S0016-5107(93)70010-3; BLASER MJ, 1995, CANCER RES, V55, P562; Boylan MR, 2014, CLIN GASTROENTEROL H, V12, P1688, DOI 10.1016/j.cgh.2014.03.021; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Cheng Y, 2000, WESTERN J MED, V173, P101, DOI 10.1136/ewjm.173.2.101; Deding U, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0554-9; El-Serag HB, 2005, GUT, V54, P11, DOI 10.1136/gut.2004.040337; Everhart JE, 1998, AM J EPIDEMIOL, V147, P529; Jones MP, 2006, J PSYCHOSOM RES, V60, P407, DOI 10.1016/j.jpsychores.2005.08.009; Kalichman L, 2006, AM J HUM BIOL, V18, P350, DOI 10.1002/ajhb.20506; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Ko SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep36925; Korea Centers for Disease Control and Prevention, 2 4 KOR NAT HLTH NUT, P2001; Korea Centers for Disease Control and Prevention, 2010, 5 6 4 KOR NAT HLTH N; Kurata JH, 1997, J CLIN GASTROENTEROL, V24, P2, DOI 10.1097/00004836-199701000-00002; Kuri-Morales P, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-9; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165622; Lee BJ, 2015, IEEE J BIOMED HEALTH, V19, P1747, DOI 10.1109/JBHI.2014.2350014; Lee BJ, 2015, COMPUT BIOL MED, V57, P201, DOI 10.1016/j.compbiomed.2014.12.005; Lee BJ, 2014, IEEE J BIOMED HEALTH, V18, P555, DOI 10.1109/JBHI.2013.2264509; Lee BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084897; Levenstein S, 1998, BRIT MED J, V316, P538, DOI 10.1136/bmj.316.7130.538; Malfertheiner P, 2000, BEST PRACT RES CL GA, V14, P119, DOI 10.1053/bega.1999.0063; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Ministry of Health and Social Welfare National Health and Nutrition Survey, REP 1998 1 NAT HLTH; Miyake K, 2013, J NUTR SCI VITAMINOL, V59, P503, DOI 10.3177/jnsv.59.503; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; Park HS, 2007, DIABETES OBES METAB, V9, P50, DOI 10.1111/j.1463-1326.2005.00569.x; RAUWS EAJ, 1990, LANCET, V335, P1233, DOI 10.1016/0140-6736(90)91301-P; Raybould HE, 2012, J PHYSIOL-LONDON, V590, P441, DOI 10.1113/jphysiol.2011.222133; Rosmond R, 1996, OBES RES, V4, P245, DOI 10.1002/j.1550-8528.1996.tb00542.x; Ryan-Harshman M, 2004, CAN FAM PHYSICIAN, V50, P727; SCHOON IM, 1991, AGE AGEING, V20, P371, DOI 10.1093/ageing/20.5.371; SEGAWA K, 1995, AM J GASTROENTEROL, V90, P399; Sonnenberg A, 1996, AM J PUBLIC HEALTH, V86, P200, DOI 10.2105/AJPH.86.2.200; SONNENBERG A, 1988, GASTROENTEROLOGY, V95, P42, DOI 10.1016/0016-5085(88)90288-0; TAYLOR DN, 1991, EPIDEMIOL REV, V13, P42, DOI 10.1093/oxfordjournals.epirev.a036078; Torpy J. M., 2012, PEPTIC ULCER DIS J A, V307, P1329, DOI DOI 10.1001/JAMA.2012.184; Tsai WL, 2004, AM J EPIDEMIOL, V160, P557, DOI 10.1093/aje/kwh251; WEATHERALL R, 1988, EUR J CLIN NUTR, V42, P221; Wu AH, 2007, CANCER CAUSE CONTROL, V18, P713, DOI 10.1007/s10552-007-9014-8; Yun S, 2017, NUTR RES PRACT, V11, P147, DOI 10.4162/nrp.2017.11.2.147	48	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183777	10.1371/journal.pone.0183777	http://dx.doi.org/10.1371/journal.pone.0183777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837684	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000120
J	Ros-Santaella, JL; Pintus, E				Ros-Santaella, Jose Luis; Pintus, Eliana			Rooibos (Aspalathus linearis) extract enhances boar sperm velocity up to 96 hours of semen storage	PLOS ONE			English	Article							TEA CAMELLIA-SINENSIS; AFRICAN HERBAL TEAS; OXIDATIVE STRESS; SPERMATOZOA; QUERCETIN; MOTILITY; GREEN; SUPPLEMENTS; FERTILITY; CAPACITY	Rooibos (Aspalathus linearis) is a native shrub from South African fynbos and has become very popular in the last decades for its antioxidant and medicinal attributes. Several studies have shown its beneficial properties in numerous cell lines, but to date, the in vitro effects of rooibos extract on sperm cells are still unknown. In this study, boar semen was supplemented with four concentrations both of fermented and unfermented rooibos extracts during 96 h of liquid storage at 17 degrees C. The effects of rooibos extracts on sperm velocity, membrane integrity, and acrosomal status were evaluated at 2 h, 48 h, and 96 h of semen storage. Overall our results indicate that rooibos extract enhances sperm velocity, protects the acrosome structure, and tends to preserve the membrane integrity during semen storage. Although the unfermented rooibos showed higher total polyphenol content and total antioxidant capacity than the fermented one, the latter had better effects on sperm velocity leading to, for instance, an increase of 30% in the rectilinear velocity (VSL) at 48 h compared to the control group. Taking into account the different storage times, we established a suitable range of extracts concentrations to be used in boar semen. The rooibos extract ought to be considered as a powerful and natural source of antioxidants for the preservation of boar semen.	[Ros-Santaella, Jose Luis; Pintus, Eliana] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic	Czech University of Life Sciences Prague	Ros-Santaella, JL; Pintus, E (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic.	rossantaella@gmail.com; eliana.pintus27@gmail.com	Ros-Santaella, José Luis/F-9890-2019; Pintus, Eliana/AAF-8383-2021	Ros-Santaella, José Luis/0000-0002-4186-7730; Pintus, Eliana/0000-0002-8496-0820				Aitken RJ, 2012, J ANDROL, V33, P1096, DOI 10.2164/jandrol.112.016535; Awda BJ, 2009, BIOL REPROD, V81, P553, DOI 10.1095/biolreprod.109.076471; Awoniyi DO, 2011, AFR J BIOTECHNOL, V10, P17317, DOI 10.5897/AJB11.2210; Awoniyi DO, 2012, PHYTOTHER RES, V26, P1231, DOI 10.1002/ptr.3717; Birck A, 2010, THERIOGENOLOGY, V73, P1180, DOI 10.1016/j.theriogenology.2009.10.010; Bramati L, 2003, J AGR FOOD CHEM, V51, P7472, DOI 10.1021/jf0347721; Brouwers JF, 2005, THERIOGENOLOGY, V63, P458, DOI 10.1016/j.theriogenology.2004.09.046; Chan PJ, 1996, ARCH ANDROLOGY, V36, P25, DOI 10.3109/01485019608987881; CHENEY RALPH H., 1963, ECON BOT, V17, P186, DOI 10.1007/BF02859435; Comizzoli P, 2001, THERIOGENOLOGY, V56, P261, DOI 10.1016/S0093-691X(01)00561-1; DELAMIRANDE E, 1995, HUM REPROD, V10, P15, DOI 10.1093/humrep/10.suppl_1.15; Dludla PV, 2014, PHYTOMEDICINE, V21, P595, DOI 10.1016/j.phymed.2013.10.029; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Hernandez-Caravaca I, 2015, THERIOGENOLOGY, V83, P655, DOI 10.1016/j.theriogenology.2014.10.032; Hernandez-Caravaca I, 2012, ANIM REPROD SCI, V136, P14, DOI 10.1016/j.anireprosci.2012.10.007; Holt C, 1997, J ANDROL, V18, P312; Johinke D, 2014, ANIM REPROD SCI, V151, P208, DOI 10.1016/j.anireprosci.2014.10.017; Johnson LA, 2000, ANIM REPROD SCI, V62, P143, DOI 10.1016/S0378-4320(00)00157-3; Joubert E, 2008, J ETHNOPHARMACOL, V119, P376, DOI 10.1016/j.jep.2008.06.014; Joubert E, 2004, FOOD RES INT, V37, P133, DOI 10.1016/j.foodres.2003.09.011; Joubert E, 2011, S AFR J BOT, V77, P869, DOI 10.1016/j.sajb.2011.07.004; Koziorowska-Gilun M, 2011, REPROD DOMEST ANIM, V46, P527, DOI 10.1111/j.1439-0531.2010.01701.x; Magcwebeba TU, 2016, J PHARM PHARMACOL, V68, P1440, DOI 10.1111/jphp.12629; Malo C, 2010, CRYOBIOLOGY, V61, P142, DOI 10.1016/j.cryobiol.2010.06.009; Marnewick J, 2005, CANCER LETT, V224, P193, DOI 10.1016/j.canlet.2004.11.014; Matthijs A, 2000, J REPROD FERTIL, V120, P265, DOI 10.1530/reprod/120.2.265; McKay DL, 2007, PHYTOTHER RES, V21, P1, DOI 10.1002/ptr.1992; Monsees TK, 2017, S AFR J BOT, V110, P208, DOI 10.1016/j.sajb.2016.11.013; Moretti E, 2012, REPROD TOXICOL, V34, P651, DOI 10.1016/j.reprotox.2012.10.002; Nash LA, 2016, FOOD FUNCT, V7, P1166, DOI [10.1039/C5FO01222H, 10.1039/c5fo01222h]; Opuwari CS, 2015, ANDROLOGIA, V47, P52, DOI 10.1111/and.12221; Opuwari CS, 2014, ANDROLOGIA, V46, P867, DOI 10.1111/and.12158; Parrilla I, 2015, SCI REP, V5; PURSEL VG, 1972, J ANIM SCI, V34, P278; Schmidt H, 2004, REPRODUCTION, V128, P171, DOI 10.1530/rep.1.00153; Schroer SC, 2000, ZYGOTE, V8, P107, DOI 10.1017/S0967199400000885; Sikka SC, 2004, J ANDROL, V25, P5; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Tvrda E, 2016, REPROD DOMEST ANIM, V51, P524, DOI 10.1111/rda.12714; Yeste M, 2017, ANIM REPROD, V14, P69, DOI 10.21451/1984-3143-AR895; Yeste M, 2016, THERIOGENOLOGY, V85, P47, DOI 10.1016/j.theriogenology.2015.09.047	41	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183682	10.1371/journal.pone.0183682	http://dx.doi.org/10.1371/journal.pone.0183682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837611	gold, Green Submitted, Green Published			2022-12-26	WOS:000408365000101
J	Bhat, S; Hasenhuetl, PS; Kasture, A; El-Kasaby, A; Baumann, MH; Blough, BE; Sucic, S; Sandtner, W; Freissmuth, M				Bhat, Shreyas; Hasenhuetl, Peter S.; Kasture, Ameya; El-Kasaby, Ali; Baumann, Michael H.; Blough, Bruce E.; Sucic, Sonja; Sandtner, Walter; Freissmuth, Michael			Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOGENIC-AMINE TRANSPORTERS; DOPAMINE TRANSPORTER; PHARMACOLOGICAL CHAPERONES; CEREBRAL-CORTEX; BINDING; MUTATIONS; CYCLE; AMPHETAMINES; TERMINUS; IBOGAINE	Point mutations in SLC6 transporters cause misfolding, which can be remedied by pharmacochaperones. The serotonin transporter (SERT/SLC6A4) has a rich pharmacology including inhibitors, releasers (amphetamines, which promote the exchange mode), and more recently, discovered partial substrates. We hypothesized that partial substrates trapped the transporter in one or several states of the transport cycle. This conformational trapping may also be conducive to folding. We selected naphthylpropane-2-amines of the phenethylamine library (PAL) including the partial substrate PAL1045 and its congeners PAL287 and PAL1046. We analyzed their impact on the transport cycle of SERT by biochemical approaches and by electrophysiological recordings; substrate-induced peak currents and steady-state currents monitored the translocation of substrate and co-substrate Na+ across the lipid bilayer and the transport cycle, respectively. These experiments showed that PAL1045 and its congeners bound with different affinities (ranging from nM to mu M) to various conformational intermediates of SERT during the transport cycle. Consistent with the working hypothesis, PAL1045 was the most efficacious compound in restoring surface expression and transport activity to the folding-deficient mutant SERT-(601)PG(602)-AA. These experiments provide a proof-of-principle for a rational search for pharmacochaperones, which may be useful to restore function to clinically relevant folding-deficient transporter mutants.	[Bhat, Shreyas; Hasenhuetl, Peter S.; Kasture, Ameya; El-Kasaby, Ali; Sucic, Sonja; Sandtner, Walter; Freissmuth, Michael] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Bhat, Shreyas; Hasenhuetl, Peter S.; Kasture, Ameya; El-Kasaby, Ali; Sucic, Sonja; Sandtner, Walter; Freissmuth, Michael] Med Univ Vienna, Ctr Physiol & Pharmacol, Gaston H Glock Res Labs Exploratory Drug Dev, A-1090 Vienna, Austria; [Baumann, Michael H.] NIDA, Translat Pharmacol Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Blough, Bruce E.] Res Triangle Inst, Ctr Drug Discovery, Res Triangle Pk, NC 27709 USA	Medical University of Vienna; Medical University of Vienna; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Research Triangle Institute	Freissmuth, M (corresponding author), Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at	Hasenhuetl, Peter/AAG-6335-2019	Hasenhuetl, Peter/0000-0002-3121-9502; Freissmuth, Michael/0000-0001-9398-1765; Kasture, Ameya/0000-0002-2947-4803; Bhat, Shreyas/0000-0001-7019-9180; Baumann, Michael/0000-0001-7758-1470; Sucic, Sonja/0000-0001-5136-8022	National Institute on Drug Abuse [DA12970]; Austrian Science Fund/FWF Projects [P28090, P27518-B27]; doctoral program CCHD (Cell Communication in Health and Disease) [W1205]; Austrian Science Fund/FWF [W1205]; Medical University of Vienna;  [SFB35];  [F3510]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012970, ZIADA000522] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Austrian Science Fund/FWF Projects(Austrian Science Fund (FWF)); doctoral program CCHD (Cell Communication in Health and Disease); Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Medical University of Vienna; ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute on Drug Abuse Grant DA12970 (to B. E. B.). This work was also supported by the Austrian Science Fund/FWF Projects P28090 (to W. S.) and P27518-B27 (to S. S.) and Project Program Grant SFB35 (F3510 to M. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the doctoral program CCHD (Cell Communication in Health and Disease/W1205), which was jointly funded by Grant W1205 from the Austrian Science Fund/FWF and the Medical University of Vienna. This work is part of a dissertation submitted in partial fulfillment of the requirements of the Ph.D. degree.	Beerepoot P, 2016, J BIOL CHEM, V291, P22053, DOI 10.1074/jbc.M116.749119; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; DESCARRIES L, 1977, BRAIN RES, V133, P197, DOI 10.1016/0006-8993(77)90759-4; El-Kasaby A, 2014, J BIOL CHEM, V289, P28987, DOI 10.1074/jbc.M114.595090; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hasenhuetl PS, 2016, J BIOL CHEM, V291, P25864, DOI 10.1074/jbc.M116.753319; Hasenhuetl PS, 2015, MOL PHARMACOL, V88, P12, DOI 10.1124/mol.115.099036; Hohenegger M, 1996, MOL PHARMACOL, V49, P73; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Kasture A, 2016, J BIOL CHEM, V291, P20876, DOI 10.1074/jbc.M116.737551; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Kuum M, 2015, CELL CALCIUM, V58, P79, DOI 10.1016/j.ceca.2014.11.004; LIDOV HGW, 1980, NEUROSCIENCE, V5, P207, DOI 10.1016/0306-4522(80)90099-8; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; Rothman RB, 2012, J PHARMACOL EXP THER, V341, P251, DOI 10.1124/jpet.111.188946; Sandtner W, 2016, MOL PHARMACOL, V89, P165, DOI 10.1124/mol.115.101394; Sandtner W, 2014, BRIT J PHARMACOL, V171, P1007, DOI 10.1111/bph.12520; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Schmid D, 2015, BRIT J PHARMACOL, V172, P4775, DOI 10.1111/bph.12766; Schmitt KC, 2008, J NEUROCHEM, V107, P928, DOI 10.1111/j.1471-4159.2008.05667.x; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Schmitt KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025790; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sucic Sonja, 2016, J Neurol Neuromedicine, V1, P34; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154	34	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16773	16786		10.1074/jbc.M117.794081	http://dx.doi.org/10.1074/jbc.M117.794081			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842491	hybrid, Green Published			2022-12-26	WOS:000412414800035
J	Alonso Aller, E; Jiddawi, NS; Eklof, JS				Alonso Aller, Elisa; Jiddawi, Narriman S.; Eklof, Johan S.			Marine protected areas increase temporal stability of community structure, but not density or diversity, of tropical seagrass fish communities	PLOS ONE			English	Article							CORAL-REEF FISH; CLIMATE-CHANGE; CHWAKA BAY; RESERVES; PATTERNS; IMPACTS; BEDS; BIODIVERSITY; ASSEMBLAGES; LANDSCAPES	Marine protected areas (MPAs) have been shown to increase long-term temporal stability of fish communities and enhance ecosystem resilience to anthropogenic disturbance. Yet, the potential ability of MPAs to buffer effects of environmental variability at shorter time scales remains widely unknown. In the tropics, the yearly monsoon cycle is a major natural force affecting marine organisms in tropical regions, and its timing and severity are predicted to change over the coming century, with potentially severe effects on marine organisms, ecosystems and ecosystem services. Here, we assessed the ability of MPAs to buffer effects of monsoon seasonality on seagrass-associated fish communities, using a field survey in two MPAs (no-take zones) and two unprotected (open-access) sites around Zanzibar (Tanzania). We assessed the temporal stability of fish density and community structure within and outside MPAs during three monsoon seasons in 2014-2015, and investigated several possible mechanisms that could regulate temporal stability. Our results show that MPAs did not affect fish density and diversity, but that juvenile fish densities were temporally more stable within MPAs. Second, fish community structure was more stable within MPAs for juvenile and adult fish, but not for subadult fish or the total fish community. Third, the observed effects may be due to a combination of direct and indirect (seagrass-mediated) effects of seasonality and, potentially, fluctuating fishing pressure outside MPAs. In summary, these MPAs may not have the ability to enhance fish density and diversity and to buffer effects of monsoon seasonality on the whole fish community. However, they may increase the temporal stability of certain groups, such as juvenile fish. Consequently, our results question whether MPAs play a general role in the maintenance of biodiversity and ecosystem functioning under changing environmental conditions in tropical seagrass fish communities.	[Alonso Aller, Elisa; Eklof, Johan S.] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Jiddawi, Narriman S.] Dar Es Salaam Univ, Inst Marine Sci, Zanzibar, Tanzania	Stockholm University; University of Dar es Salaam	Alonso Aller, E (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden.	elisa.alonso-aller@su.se	Eklöf, Johan S/C-7722-2017; Alonso Aller, Elisa/J-4176-2014	Eklöf, Johan S/0000-0001-6936-0926; Alonso Aller, Elisa/0000-0002-3973-1703	Swedish Science Council Uforsk [SWE-2012-086]	Swedish Science Council Uforsk	This study was funded by grant number SWE-2012-086 from the Swedish Science Council Uforsk (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2015, MAR BIOL, V162, P1993, DOI 10.1007/s00227-015-2725-6; ADAMS SM, 1976, J EXP MAR BIOL ECOL, V22, P269, DOI 10.1016/0022-0981(76)90007-1; Alonso Aller E, 2014, MAR BIOL, V161, P2395, DOI 10.1007/s00227-014-2514-7; Anderson MJ, 2004, ECOL APPL, V14, P1921, DOI 10.1890/03-5379; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Barnett LAK, 2015, ECOL LETT, V18, P1301, DOI 10.1111/ele.12524; Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beck MW, 1997, OIKOS, V78, P265, DOI 10.2307/3546293; Bernhardt JR, 2013, ANNU REV MAR SCI, V5, P371, DOI 10.1146/annurev-marine-121211-172411; Campbell SJ, 2006, FISH RES, V79, P75, DOI 10.1016/j.fishres.2005.12.015; Campbell SJ, 2011, AQUAT BIOL, V13, P65, DOI 10.3354/ab00352; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; de la Moriniere EC, 2002, ESTUAR COAST SHELF S, V55, P309, DOI 10.1006/ecss.2001.0907; de la Torre-Castro M, 2004, OCEAN COAST MANAGE, V47, P361, DOI 10.1016/j.ocecoaman.2004.07.005; de la Torre-Castro M, 2014, MAR POLLUT BULL, V83, P398, DOI 10.1016/j.marpolbul.2014.03.034; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dorenbosch M, 2006, HYDROBIOLOGIA, V563, P45, DOI 10.1007/s10750-005-1428-2; Duarte CM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P271; Duffy JE, 2016, P NATL ACAD SCI USA, V113, P6230, DOI 10.1073/pnas.1524465113; Duffy JE, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P271; EcoAfrica, 2005, MNEMB ISL CHWAK BAY, P1; Eklof JS, 2009, MAR ECOL PROG SER, V384, P83, DOI 10.3354/meps08024; ERFTEMEIJER PLA, 1994, OECOLOGIA, V99, P45, DOI 10.1007/BF00317082; FRANCOUR P, 1994, OCEANOL ACTA, V17, P309; Fraschetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081838; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Grace J.B., 2006, STRUCT EQ MOD NAT; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Guidetti P, 2000, OCEANOL ACTA, V23, P759, DOI 10.1016/S0399-1784(00)01117-8; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Gullstrom M, 2006, ESTUAR COAST SHELF S, V67, P399, DOI 10.1016/j.ecss.2005.11.020; Gullstrom M, 2008, MAR ECOL PROG SER, V363, P241, DOI 10.3354/meps07427; Harmelin JG, 1995, MAR ECOL-P S Z N I, V16, P233, DOI 10.1111/j.1439-0485.1995.tb00408.x; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jiddawi NS, 2002, AMBIO, V31, P518, DOI 10.1639/0044-7447(2002)031[0518:MFIT]2.0.CO;2; Kloiber U., 2013, CHUMBE ISLAND CORAL, P1; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lee JY, 2014, CLIM DYNAM, V42, P101, DOI 10.1007/s00382-012-1564-0; Lefcheck L., 2015, METHODS ECOL EVOL, V573, P573, DOI DOI 10.1111/2041-210X.12512|; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lugendo BR, 2007, HYDROBIOLOGIA, V586, P1, DOI 10.1007/s10750-006-0398-3; Makame MO, 2013, VULNERABILITY ADAPTA, P1; Mangi SC, 2006, MAR POLLUT BULL, V52, P1646, DOI 10.1016/j.marpolbul.2006.06.006; Mariotti L, 2014, CLIMATIC CHANGE, V125, P53, DOI 10.1007/s10584-014-1097-0; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McClanahan TR, 2011, AQUAT CONSERV, V21, P186, DOI 10.1002/aqc.1172; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McClanahan TR, 2009, AQUAT CONSERV, V19, P758, DOI 10.1002/aqc.1020; MCCLANAHAN TR, 1988, MAR ECOL PROG SER, V44, P191, DOI 10.3354/meps044191; Mellin C, 2016, ECOL LETT, V19, P629, DOI 10.1111/ele.12598; Micheli F, 2008, ECOL MONOGR, V78, P225, DOI 10.1890/06-1605.1; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Nagelkerken I, 2002, MAR ECOL PROG SER, V245, P191, DOI 10.3354/meps245191; Nakamura Y, 2004, FISHERIES SCI, V70, P788, DOI 10.1111/j.1444-2906.2004.00872.x; Oksanen J, 2016, VEGAN COMMUNITY ECOL; Olds AD, 2014, GLOBAL CHANGE BIOL, V20, P3050, DOI 10.1111/gcb.12606; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; POLLARD DA, 1984, AQUAT BOT, V18, P3, DOI 10.1016/0304-3770(84)90079-2; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; Quiros TEAL, 2017, BIOL CONSERV, V209, P454, DOI 10.1016/j.biocon.2017.03.011; R Core Team, 2021, R LANGUAGE ENV STAT; Robbins BD, 2000, ECOLOGY, V81, P1193, DOI 10.2307/177201; Seytre C, 2009, ICES J MAR SCI, V66, P180, DOI 10.1093/icesjms/fsn196; Sunday JM, 2017, NAT CLIM CHANGE, V7, P81, DOI [10.1038/NCLIMATE3161, 10.1038/nclimate3161]; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; Tobisson E, 1998, AMBIO, V27, P677; Trenberth K, 2005, SCIENCE, V308, P1753, DOI 10.1126/science.1112551; Turner SJ, 1999, ESTUARIES, V22, P1016, DOI 10.2307/1353080; UNEP, 2001, E AFR ATL COAST RES; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	76	8	9	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183999	10.1371/journal.pone.0183999	http://dx.doi.org/10.1371/journal.pone.0183999			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854231	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600076
J	Lostao, L; Geyer, S; Albaladejo, R; Moreno-Lostao, A; Santos, JM; Regidor, E				Lostao, Lourdes; Geyer, Siegfried; Albaladejo, Romana; Moreno-Lostao, Almudena; Santos, Juana M.; Regidor, Enrique			Socioeconomic position and health services use in Germany and Spain during the Great Recession	PLOS ONE			English	Article							ECONOMIC-CRISIS; MEDICAL-CARE; COUNTRIES; REFORMS; INCOME	Objective The relationship of socioeconomic position with the use of health services may have changed with the emergence of the economic crisis. This study shows that relationship before and during the economic crisis, in Germany and in Spain. Methods Data from the 2006 and 2011 Socio-Economic Panel carried out in Germany, and from the 2006 and 2011 National Health Surveys carried out in Spain were used. The health services investigated were physician consultations and hospitalization. The measures of socioeconomic position used were education and household income. The magnitude of the relationship between socioeconomic position and the use of each health services was estimated by calculating the percentage ratio by binary regression. Results In Germany, in both periods, after adjusting for age, sex, type of health insurance and need for care, subjects belonging to the lower educational categories had a lower frequency of physician consultations, while those belonging to the lower income categories had a higher frequency of hospitalization. In the model comparing the two lower socioeconomic categories to the two higher categories, the percentage ratio for physician consultation by education was 0.97 (95% CI 0.96-0.98) in 2006 and 0.96 (95% CI 0.95-0.97) in 2011, and the percentage ratio for hospitalization by income was 1.14 (95% CI 1.05-1.25) in 2006 and 1.12 (95% CI 1.03-1.21) in 2011. In Spain, no significant socioeconomic differences were observed in either period in the frequency of use of these health services in the fully adjusted model. Conclusion The results suggest that the economic crisis did not alter accessibility to the health system in either country, given that the socioeconomic pattern in the use of these health services was similar before and during the crisis in both countries.	[Lostao, Lourdes] Univ Publ Navarra, Med Sociol, Dept Sociol, Pamplona, Spain; [Geyer, Siegfried] Hannover Med Sch, Med Sociol Unit, Hannover, Germany; [Albaladejo, Romana; Santos, Juana M.; Regidor, Enrique] Univ Complutense Madrid, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Moreno-Lostao, Almudena; Santos, Juana M.; Regidor, Enrique] Univ Navarra, Pamplona, Spain; [Santos, Juana M.; Regidor, Enrique] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Regidor, Enrique] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain	Universidad Publica de Navarra; Hannover Medical School; Complutense University of Madrid; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Clinico San Carlos	Lostao, L (corresponding author), Univ Publ Navarra, Med Sociol, Dept Sociol, Pamplona, Spain.	llostao@unavarra.es	Lostao, Lourdes/ABH-2196-2020; Moreno, Almudena/AAZ-1141-2020	Lostao, Lourdes/0000-0003-0891-0685; 	Ministerio de Economia y Competividad (ES) [CSO2013-40877-P]	Ministerio de Economia y Competividad (ES)	This work was supported by the Ministerio de Economia y Competividad (ES), www.mineco.gob.es, no. CSO2013-40877-P.	Cylus J, 2012, HEALTH SERV RES, V47, P2204, DOI 10.1111/j.1475-6773.2012.01428.x; Dubois H, IMPACTS CRISIS ACCES; Eurostat, DAT SOC COND HLTH CA; Geyer S, 2002, J EPIDEMIOL COMMUN H, V56, P109, DOI 10.1136/jech.56.2.109; Giovanella L, 2014, CAD SAUDE PUBLICA, V30, P2263, DOI 10.1590/0102-311X00021314; Gruber S, 2010, J PUBLIC HEALTH-HEID, V18, P351, DOI 10.1007/s10389-010-0321-2; Haisken-DeNew J.P., 2005, DTC DESKTOP COMPANIO; Hoebel J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155982; Instituto Nacional de Estad o A stica. Society, HLTH NAT HLTH SURV; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Kroll LE, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-271; Lostao L, 2011, HEALTH PLACE, V17, P830, DOI 10.1016/j.healthplace.2011.03.006; Lusardi A, 2015, SOC SCI QUART, V96, P202, DOI 10.1111/ssqu.12076; Mladovsky P., 2012, HLTH POLICY RESPONSE; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; OECD, 1982, OECD LIST SOC IND; OECD, 2013, HLTH GLANC 2013 OECD, DOI [10.1787/health_glance-2013-49-en, DOI 10.1787/HEALTH_GLANCE-2013-49-EN]; Organization for Economic Co-Operation and Development (OECD), OECD STAT HLTH CAR U; Quesnel-Vallee A, 2007, INT J EPIDEMIOL, V36, P1161, DOI 10.1093/ije/dym236; Regidor E, 2014, J EPIDEMIOL COMMUN H, V68, P280, DOI 10.1136/jech-2013-202944; Regidor E, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-183; Regidor Enrique, 2006, Gac Sanit, V20, P352, DOI 10.1157/13093202; Roos NP, 1997, MILBANK Q, V75, P89, DOI 10.1111/1468-0009.00045; Ruckert IM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-232; Stirbu I, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-288; Sutton M, 2002, ALLOCATION RESOURCES; The World Bank, DATA; Van der Heyden JHA, 2003, HEALTH POLICY, V65, P153, DOI 10.1016/S0168-8510(02)00213-0; van Doorslaer E, 2006, CAN MED ASSOC J, V174, P177, DOI 10.1503/cmaj.050584; Van Doorslaer E, 2004, 14 OECD; *WHO, EUR HLTH ALL DAT HFA; World Health Organization, EUR HLTH ALL DAT PUB	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183325	10.1371/journal.pone.0183325	http://dx.doi.org/10.1371/journal.pone.0183325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF1XX	28854226	Green Published, gold, Green Submitted			2022-12-26	WOS:000408693600037
J	Thongyuan, S; Kittayapong, P				Thongyuan, Suporn; Kittayapong, Pattamaporn			First evidence of dengue infection in domestic dogs living in different ecological settings in Thailand	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; AEDES-AEGYPTI; VIRUS-INFECTION; RT-PCR; MOSQUITO; BATS; IMMUNOGENICITY; ASSOCIATION; ANTIBODIES; SENTINELS	Background Dengue is a vector-borne disease transmitted by Aedes mosquitoes. It is considered an important public health problem in many countries worldwide. However, only a few studies have been conducted on primates and domestic animals that could potentially be a reservoir of dengue viruses. Since domestic dogs share both habitats and vectors with humans, this study aimed to investigate whether domestic dogs living in different ecological settings in dengue endemic areas in Thailand could be naturally infected with dengue viruses. Methodology/Principal findings Serum samples were collected from domestic dogs in three different ecological settings of Thailand: urban dengue endemic areas of Nakhon Sawan Province; rubber plantation areas of Rayong Province; and Koh Chang, an island tourist spot of Trat Province. These samples were screened for dengue viral genome by using semi-nested RT-PCR. Positive samples were then inoculated in mosquito and dog cell lines for virus isolation. Supernatant collected from cell culture was tested for the presence of dengue viral genome by semi-nested RTPCR, then double-strand DNA products were double-pass custom-sequenced. Partial nucleotide sequences were aligned with the sequences already recorded in GenBank, and a phylogenetic tree was constructed. In the urban setting, 632 domestic dog serum samples were screened for dengue virus genome by RT-PCR, and six samples (0.95%) tested positive for dengue virus. Four out of six dengue viruses from positive samples were successfully isolated. Dengue virus serotype 2 and serotype 3 were found to have circulated in domestic dog populations. One of 153 samples (0.65%) collected from the rubber plantation area showed a PCR-positive result, and dengue serotype 3 was successfully isolated. Partial gene phylogeny revealed that the isolated dengue viruses were closely related to those strains circulating in human populations. None of the 71 samples collected from the island tourist spot showed a positive result. Conclusions/Significance We concluded that domestic dogs can be infected with dengue virus strains circulating in dengue endemic areas. The role of domestic dogs in dengue transmission needs to be further investigated, i.e., whether they are potential reservoirs or incidental hosts of dengue viruses.	[Thongyuan, Suporn; Kittayapong, Pattamaporn] Mahidol Univ, Fac Sci, Ctr Excellence Vectors & Vector Borne Dis, Salaya, Nakhon Pathom, Thailand; [Thongyuan, Suporn; Kittayapong, Pattamaporn] Mahidol Univ, Dept Biol, Fac Sci, Bangkok, Thailand	Mahidol University; Mahidol University	Kittayapong, P (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Vectors & Vector Borne Dis, Salaya, Nakhon Pathom, Thailand.; Kittayapong, P (corresponding author), Mahidol Univ, Dept Biol, Fac Sci, Bangkok, Thailand.	pkittayapong@gmail.com	Thongyuan, Suporn/AAM-3268-2020; THONGYUAN, SUPORN/AAH-2640-2020	Thongyuan, Suporn/0000-0002-3472-7836	Mahidol University; International Development Research Centre, Ottawa, Canada through the FBLI Grant [106556]; International Development Research Centre (IDRC); Canadian International Development Agency (CIDA), Ottawa, Canada; Australian Agency for International Development (AUSAID) through the EcoEID Grant [105509-035]	Mahidol University; International Development Research Centre, Ottawa, Canada through the FBLI Grant; International Development Research Centre (IDRC); Canadian International Development Agency (CIDA), Ottawa, Canada; Australian Agency for International Development (AUSAID) through the EcoEID Grant	This research was supported by 1) Mahidol University Grant (PI - P. Kittayapong) for the work done in Nakhon Sawan Province, 2) the International Development Research Centre, Ottawa, Canada through the FBLI Grant to Mahidol University for the work done in Rayong Province (Grant No. 106556) (PI - P. Kittayapong), and 3) the International Development Research Centre (IDRC), the Canadian International Development Agency (CIDA), Ottawa, Canada, and the Australian Agency for International Development (AUSAID) through the EcoEID Grant to Mahidol University (Grant No. 105509-035) (PI - P. Kittayapong) for the work done in Koh Chang, Trat Province. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179; Aguilar-Setien A, 2008, EPIDEMIOL INFECT, V136, P1678, DOI 10.1017/S0950268808000460; Althouse BM, 2014, VIROLOGY, V452, P237, DOI 10.1016/j.virol.2014.01.015; [Anonymous], 1997, DENG HAEM FEV DIAGN, P2; Azhar E, 2010, INFECT DIS IMMUN, V2, P24; Barkham TM, 2006, T ROY SOC TROP MED H, V100, P142, DOI 10.1016/j.trstmh.2005.05.015; Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Calvignac-Spencer S, 2012, CLIN MICROBIOL INFEC, V18, P521, DOI 10.1111/j.1469-0691.2012.03816.x; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Conceicao TM, 2010, J VIROL METHODS, V163, P1, DOI 10.1016/j.jviromet.2009.10.001; De Paula Sérgio Oliveira, 2004, Braz J Infect Dis, V8, P390, DOI 10.1590/S1413-86702004000600002; De Paula SO, 2003, INTERVIROLOGY, V46, P227, DOI 10.1159/000072432; De Paula SO, 2002, T ROY SOC TROP MED H, V96, P266, DOI 10.1016/S0035-9203(02)90094-5; de Thoisy B, 2004, T ROY SOC TROP MED H, V98, P409, DOI 10.1016/j.trstmh.2003.12.003; de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280; Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Gubler DJ, 1988, CLIN MICROBIOL REV, V11, P258; Inoue S, 2003, J MED PRIMATOL, V32, P89, DOI 10.1034/j.1600-0684.2003.00015.x; Jarman RG, 2011, AM J TROP MED HYG, V84, P218, DOI 10.4269/ajtmh.2011.09-0798; Kek R, 2014, J MED ENTOMOL, V51, P880, DOI 10.1603/ME13213; Khaklang S, 2014, J VECTOR ECOL, V39, P448, DOI 10.1111/jvec.12122; Kile JC, 2005, JAVMA-J AM VET MED A, V226, P1349, DOI 10.2460/javma.2005.226.1349; Kurane I, 2007, COMP IMMUNOL MICROB, V30, P329, DOI 10.1016/j.cimid.2007.05.010; Lan DL, 2011, ARCH VIROL, V156, P893, DOI 10.1007/s00705-010-0913-8; Lanciotti RS, 1992, J CLIN MICROBIOL, V87, P873; Lavergne A, 2009, Med Trop (Mars), V69, P345; LEE E, 1992, J VIROL METHODS, V37, P275, DOI 10.1016/0166-0934(92)90029-D; Little E, 2011, ECOHEALTH, V8, P365, DOI 10.1007/s10393-011-0708-8; Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74; Machain-Williams C, 2013, J WILDLIFE DIS, V49, P684, DOI 10.7589/2012-12-318; Pinheiro VCS, 2005, MEM I OSWALDO CRUZ, V100, P833, DOI 10.1590/S0074-02762005000800003; Platt KB, 2000, J MED ENTOMOL, V37, P965, DOI 10.1603/0022-2585-37.6.965; Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2; Resnick MP, 2008, ZOONOSES PUBLIC HLTH, V55, P443, DOI 10.1111/j.1863-2378.2008.01116.x; Robertson ID, 2000, INT J PARASITOL, V30, P1369, DOI 10.1016/S0020-7519(00)00134-X; Roehrig J, 2007, GUIDELINES PLAQUE RE; RUDNICK ALBERT, 1965, J MED ENTOMOL, V2, P203, DOI 10.1093/jmedent/2.2.203; Sa-ngasang A, 2003, JPN J INFECT DIS, V56, P205; Samuel PP, 2006, INDIAN J MED RES, V123, P615; Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Shimoda H, 2013, J VIROL METHODS, V187, P85, DOI 10.1016/j.jviromet.2012.09.022; Shimoda H, 2010, EMERG INFECT DIS, V16, P1137, DOI 10.3201/eid1607.091757; Sirivichayakul C, 2016, J INFECT DIS, V213, P1562, DOI 10.1093/infdis/jiv762; Sotomayor-Bonilla J, 2014, AM J TROP MED HYG, V91, P129, DOI 10.4269/ajtmh.13-0524; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Watanaveeradej V, 2014, AM J TROP MED HYG, V91, P119, DOI 10.4269/ajtmh.13-0452; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310; Zhang H, 1998, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V12, P226	54	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0180013	10.1371/journal.pone.0180013	http://dx.doi.org/10.1371/journal.pone.0180013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854207	Green Published, gold, Green Submitted			2022-12-26	WOS:000408693600001
J	Kim, J; Heise, RL; Reynolds, AM; Pidaparti, RM				Kim, JongWon; Heise, Rebecca L.; Reynolds, Angela M.; Pidaparti, Ramana M.			Aging effects on airflow dynamics and lung function in human bronchioles	PLOS ONE			English	Article							PRESSURE-VOLUME CHARACTERISTICS; PARTICLE DEPOSITION; MECHANICAL VENTILATION; EMPHYSEMATOUS LUNGS; SENILE LUNG; AGE; MODELS; HEALTHY; MICE; RESISTANCE	Background and objective The mortality rate for patients requiring mechanical ventilation is about 35% and this rate increases to about 53% for the elderly. In general, with increasing age, the dynamic lung function and respiratory mechanics are compromised, and several experiments are being conducted to estimate these changes and understand the underlying mechanisms to better treat elderly patients. Materials and methods Human tracheobronchial (G1 similar to G9), bronchioles (G10 similar to G22) and alveolar sacs (G23) geometric models were developed based on reported anatomical dimensions for a 50 and an 80-year-old subject. The aged model was developed by altering the geometry and material properties of the model developed for the 50-year-old. Computational simulations using coupled fluid-solid analysis were performed for geometric models of bronchioles and alveolar sacs under mechanical ventilation to estimate the airflow and lung function characteristics. Findings The airway mechanical characteristics decreased with aging, specifically a 38% pressure drop was observed for the 80-year-old as compared to the 50-year-old. The shear stress on airway walls increased with aging and the highest shear stress was observed in the 80-year-old during inhalation. A 50% increase in peak strain was observed for the 80-year-old as compared to the 50-year-old during exhalation. The simulation results indicate that there is a 41% increase in lung compliance and a 35%-50% change in airway mechanical characteristics for the 80-year-old in comparison to the 50-year-old. Overall, the airway mechanical characteristics as well as lung function are compromised due to aging. Conclusion Our study demonstrates and quantifies the effects of aging on the airflow dynamics and lung capacity. These changes in the aging lung are important considerations for mechanical ventilation parameters in elderly patients. Realistic geometry and material properties need to be included in the computational models in future studies.	[Kim, JongWon; Pidaparti, Ramana M.] Univ Georgia, Coll Engn, Athens, GA 30602 USA; [Heise, Rebecca L.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA; [Heise, Rebecca L.; Reynolds, Angela M.] Virginia Commonwealth Univ, Med Ctr, VCU Johnson Ctr, Richmond, VA USA; [Reynolds, Angela M.] Virginia Commonwealth Univ, Dept Math & Appl Math, Richmond, VA USA	University System of Georgia; University of Georgia; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Pidaparti, RM (corresponding author), Univ Georgia, Coll Engn, Athens, GA 30602 USA.	rmparti@uga.edu			NIH - National Institute on Aging of the National Institutes of Health [R01AG041823]; NATIONAL INSTITUTE ON AGING [R01AG041823] Funding Source: NIH RePORTER	NIH - National Institute on Aging of the National Institutes of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH - National Institute on Aging of the National Institutes of Health under Award Number R01AG041823.	Albaiceta GM, 2011, CRIT CARE, V15, DOI 10.1186/cc10052; ANDREOTTI L, 1983, GERONTOLOGY, V29, P377, DOI 10.1159/000213148; [Anonymous], 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3_10; [Anonymous], MORPHOMETRY HUMAN LU; [Anonymous], 2015, MECH PROPERTIES AGIN, DOI DOI 10.1007/978-3-319-03970-1_5; BEREND N, 1980, J APPL PHYSIOL, V49, P558, DOI 10.1152/jappl.1980.49.4.558; Bozanich EM, 2005, J APPL PHYSIOL, V99, P108, DOI 10.1152/japplphysiol.01111.2004; Cakmak S, 2011, ENVIRON RES, V111, P1309, DOI 10.1016/j.envres.2011.09.016; Chan ED, 1998, CHEST, V114, P1704, DOI 10.1378/chest.114.6.1704; COHN JE, 1963, J CLIN INVEST, V42, P1406, DOI 10.1172/JCI104825; Elliott JE, 2016, AM J PHYSL LUNG CELL; Felippa CA, 2001, COMPUT METHOD APPL M, V190, P3247, DOI 10.1016/S0045-7825(00)00391-1; FRANK NR, 1957, J CLIN INVEST, V36, P1680, DOI 10.1172/JCI103569; Gattinoni L, 2012, CURR OPIN CRIT CARE, V18, P42, DOI 10.1097/MCC.0b013e32834f17d9; Gattinoni L, 2011, CHEST, V140, P11, DOI 10.1378/chest.11-0827; Gattinoni L, 2010, CRIT CARE MED, V38, pS539, DOI 10.1097/CCM.0b013e3181f1fcf7; Gefen A, 1999, J BIOMECH, V32, P891, DOI 10.1016/S0021-9290(99)00092-5; GIBSON GJ, 1976, J APPL PHYSIOL, V41, P20, DOI 10.1152/jappl.1976.41.1.20; Gonzalez-Lopez A, 2012, INTENS CARE MED, V38, P240, DOI 10.1007/s00134-011-2403-1; Grinnan DC, 2005, CRIT CARE, V9, P472, DOI 10.1186/cc3516; HAMMERSLEY JR, 1992, J APPL PHYSIOL, V72, P2402, DOI 10.1152/jappl.1992.72.6.2402; HEISTRACHER T, 1995, J AEROSOL SCI, V26, P497, DOI 10.1016/0021-8502(94)00113-D; Herbert JA, 2016, EXP GERONTOL, V81, P101, DOI 10.1016/j.exger.2016.05.005; HORSFIEL.K, 1971, J APPL PHYSIOL, V31, P207, DOI 10.1152/jappl.1971.31.2.207; Huang KW, 2007, J APPL PHYSIOL, V102, P200, DOI 10.1152/japplphysiol.00400.2006; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; KNUDSON RJ, 1977, J APPL PHYSIOL, V43, P1054, DOI 10.1152/jappl.1977.43.6.1054; Koch B, 2013, RESPIROLOGY, V18, P170, DOI 10.1111/j.1440-1843.2012.02268.x; Koombua K, 2008, MODELLING SIMULATION, V2008, P4; Lai-Fook SJ, 2000, J APPL PHYSIOL, V89, P163, DOI 10.1152/jappl.2000.89.1.163; MEAD J, 1960, J APPL PHYSIOL, V15, P736, DOI 10.1152/jappl.1960.15.4.736; MITTMAN C, 1965, J APPL PHYSIOL, V20, P1211, DOI 10.1152/jappl.1965.20.6.1211; Montaudon M, 2007, J ANAT, V211, P579, DOI 10.1111/j.1469-7580.2007.00811.x; NIEWOEHNER DE, 1974, J APPL PHYSIOL, V36, P412, DOI 10.1152/jappl.1974.36.4.412; Oakes JM, 2016, J BIOMECH, V49, P2213, DOI 10.1016/j.jbiomech.2015.11.026; Oakes JM, 2015, J BIOMECH, V48, P1147, DOI 10.1016/j.jbiomech.2015.01.004; Oakes JM, 2014, J APPL PHYSIOL, V116, P1561, DOI 10.1152/japplphysiol.01165.2013; Oakes JM, 2014, ANN BIOMED ENG, V42, P899, DOI 10.1007/s10439-013-0954-8; Oakes JM, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000870; Owen MR, 2001, SIAM J APPL MATH, V61, P1731; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P387, DOI 10.1016/0034-5687(70)90094-0; PERMUTT S, 1960, J APPL PHYSIOL, V15, P819, DOI 10.1152/jappl.1960.15.5.819; Pidaparti Ramana M., 2011, Molecular & Cellular Biomechanics, V8, P149; PIERCE JA, 1960, J CLIN INVEST, V39, P8, DOI 10.1172/JCI104030; Protti A, 2011, AM J RESP CRIT CARE, V183, P1354, DOI 10.1164/rccm.201010-1757OC; Russo J, 2008, MED ENG PHYS, V30, P581, DOI 10.1016/j.medengphy.2007.06.010; Singer BD, 2009, SOUTH MED J, V102, P1238, DOI 10.1097/SMJ.0b013e3181bfac4f; Sly PD, 2003, J APPL PHYSIOL, V94, P1460, DOI 10.1152/japplphysiol.00596.2002; Takubo Y, 1999, EXP GERONTOL, V34, P353, DOI 10.1016/S0531-5565(99)00017-0; Taylor D., 1996, HUMAN RESP TRACT MOD; Tehrani JN, 2015, PHYS MED BIOL, V60, P8833, DOI 10.1088/0031-9155/60/22/8833; TSUNODA S, 1974, RESP PHYSIOL, V22, P285, DOI 10.1016/0034-5687(74)90078-4; TURNER JM, 1968, J APPL PHYSIOL, V25, P664, DOI 10.1152/jappl.1968.25.6.664; VERBEKEN EK, 1992, CHEST, V101, P793, DOI 10.1378/chest.101.3.793; VERBEKEN EK, 1992, CHEST, V101, P800, DOI 10.1378/chest.101.3.800; Tramont CVVE, 2009, CLINICS, V64, P1065, DOI 10.1590/S1807-59322009001100006; WAHBA WM, 1983, ANESTH ANALG, V62, P764; Wunsch H, 2010, CRIT CARE MED, V38, P1947, DOI 10.1097/CCM.0b013e3181ef4460; Xia GH, 2010, ANN BIOMED ENG, V38, P1836, DOI 10.1007/s10439-010-9956-y; YEH HC, 1980, B MATH BIOL, V42, P461, DOI 10.1007/BF02460796; Zeleznik J, 2003, CLIN GERIATR MED, V19, P1, DOI 10.1016/S0749-0690(02)00063-0	61	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183654	10.1371/journal.pone.0183654	http://dx.doi.org/10.1371/journal.pone.0183654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846719	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600044
J	Juhel, AS; Barbu, CM; Franck, P; Roger-Estrade, J; Butier, A; Bazot, M; Valantin-Morison, M				Juhel, Amandine Suzanne; Barbu, Corentin Mario; Franck, Pierre; Roger-Estrade, Jean; Butier, Arnaud; Bazot, Mathieu; Valantin-Morison, Muriel			Characterization of the pollen beetle, Brassicogethes aeneus, dispersal from woodlands to winter oilseed rape fields	PLOS ONE			English	Article							INTEGRATED PEST-MANAGEMENT; BRASSICA-NAPUS L.; MELIGETHES-AENEUS; INSECT PESTS; CROPS; DAMAGE; PERSPECTIVES; PARASITOIDS; STRATEGIES	Many crop pests rely on resources out of crop fields; understanding how they colonize the fields is an important factor to develop integrated pest management. In particular, the time of crop colonization and damage severity might be determined by pest movements between fields and non-crop areas. Notably, the pollen beetle, Brassicogethes aeneus, previously named Meligethes aeneus, one of the most important pests of winter oilseed rape, overwinters in woodlands. As a result, its abundance increases in oilseed rape fields near wooded areas. Here, we assessed the spatio-temporal patterns of the dispersal from woodlands to oilseed rape fields in diversified landscapes of a same region. We observed on four dates the abundance of pollen beetles in 24 fields spread in the Eure department, France. We modeled the abundance as a result of the dispersal from the neighboring woodlands. We compared the modalities of dispersal corresponding to different hypotheses on the dispersal origin, kernel shape and sources of variability. Within oilseed rape the distance to the edges of woodlands is not the main determinant of pollen beetle abundance. On the contrary, the variability of the abundance between fields is largely explained by the dispersal from neighboring woodlands but there is considerable variability between dates, sites and, to a lesser extent, between fields. The two dispersal kernels received similar support from the data and lead to similar conclusions. The mean dispersal distance is 1.2 km but seems to increase from a few hundred meters the first week to more than two kilometers the fourth, allowing the pollen beetles to reach more distant OSR fields. These results suggest that early varieties away from woodlands and late varieties close to the woodlands may limit attacks at the time when oilseed rape is the most sensitive.	[Juhel, Amandine Suzanne; Barbu, Corentin Mario; Roger-Estrade, Jean; Butier, Arnaud; Bazot, Mathieu; Valantin-Morison, Muriel] Univ Paris Saclay, AgroParisTech, INRA, UMR Agron, Thiverval Grignon, France; [Franck, Pierre] INRA, Plantes & Syst Culture Hort UR1115, Avignon, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Juhel, AS (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, UMR Agron, Thiverval Grignon, France.	juhelamandine1@gmail.com		Roger-Estrade, Jean/0000-0003-1443-0303; Franck, Pierre/0000-0002-1904-8325	Predictive Ecological Engineering for landscape ecosystem services and sustainability [ANR-12-AGRO-0006]; Sustainable Management of Crop Health	Predictive Ecological Engineering for landscape ecosystem services and sustainability; Sustainable Management of Crop Health	Funding provided by Predictive Ecological Engineering for landscape ecosystem services and sustainability (ANR-12-AGRO-0006), PF MVM; and Sustainable Management of Crop Health (http://www.smach.inra.fr/).	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Audisio P., 1993, COLEOPTERA NITIDULID; Barbu CM, 2017, YET ANOTHER METROPOL; Barbu C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000777; Bivand R, 2013, INTERFACE GEOMETRY E; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Buchi R, 2002, AGR ECOSYST ENVIRON, V90, P255, DOI 10.1016/S0167-8809(01)00213-4; Cook SM, 2007, ARTHROPOD-PLANT INTE, V1, P57, DOI 10.1007/s11829-007-9004-5; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cook Samantha M., 2004, IOBC-WPRS Bulletin, V27, P199; Ferguson AW, 2003, AGR ECOSYST ENVIRON, V95, P509, DOI 10.1016/S0167-8809(02)00200-1; Ferguson AW, 2014, PEST MANAG SCI; Frearson DJT, 2005, ENTOMOL EXP APPL, V116, P21, DOI 10.1111/j.1570-7458.2005.00299.x; FREE JB, 1978, J AGR SCI, V90, P417, DOI 10.1017/S0021859600055520; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Geweke J, 1991, BAYESIAN STAT, V4; Hansen LM, 2004, CROP PROT, V23, P43, DOI 10.1016/S0261-2194(03)00167-4; Hansen LM, 2003, PEST MANAG SCI, V59, P1057, DOI 10.1002/ps.737; Heimbach U, 2013, PEST MANAG SCI, V69, P209, DOI 10.1002/ps.3351; Herve MR, 2014, ARTHROPOD-PLANT INTE, V8, P383, DOI 10.1007/s11829-014-9321-4; Hokkanen Heikki M.T., 2004, IOBC-WPRS Bulletin, V27, P293; Husberg GB, 2001, BIOCONTROL, V46, P261, DOI 10.1023/A:1011479616787; Junk J, 2016, METEOROL Z, V25, P357, DOI 10.1127/metz/2015/0665; Mauchline AL, 2017, PEST MANAG SCI, V73, P1076, DOI 10.1002/ps.4550; McCollin D, 2000, J ENVIRON MANAGE, V60, P77, DOI 10.1006/jema.2000.0363; Nathan R, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P187; Nilsson Christer, 2004, IOBC-WPRS Bulletin, V27, P215; Raftery AE., 1992, BAYESIAN STAT, V4, P763; Richardson D. M., 2008, Bulletin OEPP, V38, P68, DOI 10.1111/j.1365-2338.2008.01183.x; Rusch A, 2012, LANDSCAPE URBAN PLAN, V105, P62, DOI 10.1016/j.landurbplan.2011.11.021; Rusch A, 2013, AGR ECOSYST ENVIRON, V166, P118, DOI 10.1016/j.agee.2011.05.004; Rusch A, 2012, AGR FOREST ENTOMOL, V14, P37, DOI 10.1111/j.1461-9563.2011.00547.x; Schneider G, 2015, J APPL ECOL, V52, P1283, DOI 10.1111/1365-2664.12471; Skellern MP, 2017, AGR ECOSYST ENVIRON, V241, P150, DOI 10.1016/j.agee.2017.03.008; STECHMANN DH, 1976, ANZ SCHADLINGSKD PFL, V49, P183, DOI 10.1007/BF01984584; TAIMR LUBOMIR, 1967, ACTA ENTOMOL BOHEMOSLOV, V64, P325; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Valantin-Morison M, 2007, CROP PROT, V26, P1108, DOI 10.1016/j.cropro.2006.10.005; Veromann E., 2006, Agronomy Research, V4, P447; Williams IH, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P1, DOI 10.1007/978-90-481-3983-5; Williams IH, 2007, AGR FOREST ENTOMOL, V9, P279, DOI 10.1111/j.1461-9563.2007.00343.x; Zaller JG, 2008, BASIC APPL ECOL, V9, P682, DOI 10.1016/j.baae.2007.10.004; Zaller JG, 2008, AGR ECOSYST ENVIRON, V123, P233, DOI 10.1016/j.agee.2007.07.002	43	10	10	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183878	10.1371/journal.pone.0183878	http://dx.doi.org/10.1371/journal.pone.0183878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841712	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700067
J	Tapia, F; Jordan, I; Genzel, Y; Reichl, U				Tapia, Felipe; Jordan, Ingo; Genzel, Yvonne; Reichl, Udo			Efficient and stable production of Modified Vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems	PLOS ONE			English	Article							SERUM-FREE MEDIA; INFLUENZA-VIRUS; MALARIA VACCINES; CULTURES; MVA; IMMUNOGENICITY; BIOREACTORS; BACULOVIRUS; PROTECTION; VECTORS	One important aim in cell culture-based viral vaccine and vector production is the implementation of continuous processes. Such a development has the potential to reduce costs of vaccine manufacturing as volumetric productivity is increased and the manufacturing footprint is reduced. In this work, continuous production of Modified Vaccinia Ankara (MVA) virus was investigated. First, a semi-continuous two-stage cultivation system consisting of two shaker flasks in series was established as a small-scale approach. Cultures of the avian AGE1.CR.pIX cell line were expanded in the first shaker, and MVA virus was propagated and harvested in the second shaker over a period of 8-15 days. A total of nine small-scale cultivations were performed to investigate the impact of process parameters on virus yields. Harvest volumes of 0.7-1 L with maximum TCID50 titers of up to 1.0x10(9) virions/mL were obtained. Genetic analysis of control experiments using a recombinant MVA virus containing green-fluorescent-protein suggested that the virus was stable over at least 16 d of cultivation. In addition, a decrease or fluctuation of infectious units that may indicate an excessive accumulation of defective interfering particles was not observed. The process was automated in a two-stage continuous system comprising two connected 1 L stirred tank bioreactors. Stable MVA virus titers, and a total production volume of 7.1 L with an average TCID50 titer of 9x10(7) virions/mL was achieved. Because titers were at the lower range of the shake flask cultivations potential for further process optimization at large scale will be discussed. Overall, MVA virus was efficiently produced in continuous and semi-continuous cultivations making two-stage stirred tank bioreactor systems a promising platform for industrial production of MVA-derived recombinant vaccines and viral vectors.	[Tapia, Felipe] Int Max Planck Res Sch Adv Methods Proc & Syst En, Magdeburg, Germany; [Tapia, Felipe; Genzel, Yvonne; Reichl, Udo] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany; [Jordan, Ingo] ProBioGen AG, Berlin, Germany; [Reichl, Udo] Otto von Guericke Univ, Bioproc Engn, Magdeburg, Germany; [Jordan, Ingo] CureVac AG, Tubingen, Germany	Max Planck Society; Otto von Guericke University; CureVac N.V.	Tapia, F (corresponding author), Int Max Planck Res Sch Adv Methods Proc & Syst En, Magdeburg, Germany.; Tapia, F (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany.	tapia@mpi-magdeburg.mpg.de		Jordan, Ingo/0000-0003-2711-7252; Tapia Delgado, Felipe/0000-0002-8470-2047	Max Planck Society	Max Planck Society(Max Planck Society)	This work was supported by the Max Planck Society to FT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATT BC, 1990, BIOTECHNOL PROGR, V6, P458, DOI 10.1021/bp00006a600; deGooijer CD, 1996, ENZYME MICROB TECH, V18, P202, DOI 10.1016/0141-0229(95)00090-9; Dunachie S, 2015, VACCINE, V33, P5321, DOI 10.1016/j.vaccine.2015.07.087; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Frensing T, 2015, BIOTECHNOL J, V10, P681, DOI 10.1002/biot.201400429; Frensing T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072288; Genzel Y, 2006, VACCINE, V24, P6074, DOI 10.1016/j.vaccine.2006.05.023; GORI GB, 1965, APPL MICROBIOL, V13, P909, DOI 10.1128/AEM.13.6.909-917.1965; Green CA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5745; Henry O, 2008, BIOTECHNOL PROGR, V24, P921, DOI [10.1002/btpr.17, 10.1021/bp.17]; Ortiz JMJ, 2014, VACCINE, V32, P4625, DOI 10.1016/j.vaccine.2014.06.075; Jordan I, 2009, VACCINE, V27, P748, DOI 10.1016/j.vaccine.2008.11.066; Jordan I, 2013, VIRUSES-BASEL, V5, P321, DOI 10.3390/v5010321; Jordan I, 2011, BIOLOGICALS, V39, P50, DOI 10.1016/j.biologicals.2010.11.005; Konstantinov KB, 2015, J PHARM SCI-US, V104, P813, DOI 10.1002/jps.24268; Kreijtz JHCM, 2015, J INFECT DIS, V211, P791, DOI 10.1093/infdis/jiu528; Kremer Melanie, 2012, Methods Mol Biol, V890, P59, DOI 10.1007/978-1-61779-876-4_4; Leung-Theung-Long S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143552; Lohr V, 2009, VACCINE, V27, P4975, DOI 10.1016/j.vaccine.2009.05.083; Lohr V., 2014, THESIS; Marin-Lopez A, 2016, METHODS MOL BIOL, V1349, P137, DOI 10.1007/978-1-4939-3008-1_9; Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218; MOSS B, 1981, P NATL ACAD SCI-BIOL, V78, P1614, DOI 10.1073/pnas.78.3.1614; MOYER RW, 1980, VIROLOGY, V102, P119, DOI 10.1016/0042-6822(80)90075-6; Sebastian S, 2016, EXPERT REV VACCINES, V15, P91, DOI 10.1586/14760584.2016.1106319; Tapia F, 2016, APPL MICROBIOL BIOT, V100, P2121, DOI 10.1007/s00253-015-7267-9; vanLier FLJ, 1996, ENZYME MICROB TECH, V18, P460, DOI 10.1016/0141-0229(95)00129-8; VANLIER FLJ, 1990, APPL MICROBIOL BIOT, V33, P43, DOI 10.1007/BF00170567; Verheust C, 2012, VACCINE, V30, P2623, DOI 10.1016/j.vaccine.2012.02.016; Vijayan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133595; Volz A, 2016, VACCINE, V34, P1915, DOI 10.1016/j.vaccine.2016.02.042; Walther J, 2015, J BIOTECHNOL, V213, P3, DOI 10.1016/j.jbiotec.2015.05.010; Weber C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003684; WESTGATE PJ, 1990, BIOTECHNOL BIOENG, V35, P437, DOI 10.1002/bit.260350502; Zitzmann-Roth EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122653	35	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182553	10.1371/journal.pone.0182553	http://dx.doi.org/10.1371/journal.pone.0182553			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837572	gold, Green Published			2022-12-26	WOS:000408365000020
J	Tung, CH; Lu, MC; Lai, NS; Wu, SF				Tung, Chien-Hsueh; Lu, Ming-Chi; Lai, Ning-Sheng; Wu, Shu-Fen			Tumor necrosis factor-alpha blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis	PLOS ONE			English	Article							CARTILAGE PANNUS JUNCTION; TNF-ALPHA; CD40 LIGAND; T-CELLS; PEPTIDE ANTIBODY; DISEASE-ACTIVITY; SERUM-LEVELS; THERAPY; METHOTREXATE; INFLIXIMAB	Contexts CD154 (commonly referred to as CD40-ligand) is a critical T cell factor that participates in the pathogenesis of autoimmune and is over-expressed in rheumatoid arthritis (RA). TNF-alpha blockade treatment had dramatic efficacy in RA. Objective To investigate whether TNF-alpha blockade treatment can inhibit CD154 expression in RA. Methods Blood samples were collected from 33 patients with rheumatoid arthritis before and 3 months after TNF-alpha blockade treatment. Clinical serological data determined by standard assays and T cell CD154 expression levels determined by flow cytometry were statistically analyzed for these two time points. Results The percentage of CD154 expression on gated CD4+ T cells of PBMCs from RA patients after 3 months TNF-alpha blockade treatment was significantly lower than before treatment (2.94 +/- 3.21% vs. 7.21 +/- 5.64%; p = 0.0001). The disease activity and anti-CCP antibody levels were also significantly reduced after TNF-alpha blockade treatment. The CD154 expression levels were positively correlated with disease activity index DAS28, and CRP. The post-stimulated CD154 expression percentage of purified CD4+ T cells between baseline and after TNF-alpha blockade treatment was not significantly different (p = 0.221). Baseline CD154 levels were positively correlated with treatment-induced changes in DAS28 (p = 0.014; r2 = 0.187). Conclusions TNF-alpha blockade treatment significantly decreased the CD154 expression on CD4+ T cells, disease activity and anti-CCP antibody simultaneously in RA patients. However TNF-alpha blockade did not impair T cell capacity to express CD154 after stimulation. These results suggest that decreased CD154 expression after TNF-alpha blockade may be due to decreased RA disease activity but not direct inhibition of CD154 responsiveness of T cells.	[Tung, Chien-Hsueh; Lu, Ming-Chi; Lai, Ning-Sheng] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Tung, Chien-Hsueh; Lu, Ming-Chi; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Tung, Chien-Hsueh; Wu, Shu-Fen] Natl Chung Cheng Univ, Inst Mol Biol, Dept Life Sci, Min Hsiung, Chia Yi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; National Chung Cheng University	Wu, SF (corresponding author), Natl Chung Cheng Univ, Inst Mol Biol, Dept Life Sci, Min Hsiung, Chia Yi, Taiwan.	biosfw@ccu.edu.tw						Alessandri C, 2004, ANN RHEUM DIS, V63, P1218, DOI 10.1136/ard.2003.014647; Aspalter RM, 2003, J LEUKOCYTE BIOL, V74, P572, DOI 10.1189/jlb.0303112; Berner B, 2000, ANN RHEUM DIS, V59, P190, DOI 10.1136/ard.59.3.190; Brunner M, 2008, GENES IMMUN, V9, P640, DOI 10.1038/gene.2008.67; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Charles P, 1999, J IMMUNOL, V163, P1521; Chatzidakis I, 2010, CURR DIR AUTOIMMUN, V11, P105, DOI 10.1159/000289200; CHU CQ, 1991, ARTHRITIS RHEUM, V34, P1125, DOI 10.1002/art.1780340908; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Cuchacovich M, 2008, CLIN EXP RHEUMATOL, V26, P1067; Danese S, 2006, J IMMUNOL, V176, P2617, DOI 10.4049/jimmunol.176.4.2617; Gonzalez-Alvaro I, 2003, CLIN EXP RHEUMATOL, V21, P639; Goules A, 2006, J AUTOIMMUN, V26, P165, DOI 10.1016/j.jaut.2006.02.002; Ichikawa T, 2010, RHEUMATOL INT, V30, P725, DOI 10.1007/s00296-009-1356-y; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Kroot EJJA, 2000, ARTHRITIS RHEUM, V43, P1831, DOI 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6; Lin Q, 2010, RHEUMATOL INT, V30, P317, DOI 10.1007/s00296-009-0958-8; Lin ZM, 2014, INFLAMMATION, V37, P2056, DOI 10.1007/s10753-014-9938-6; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Liu MF, 2001, AUTOIMMUNITY, V34, P107, DOI 10.3109/08916930109001958; Liu S, 2014, IMMUNOL CELL BIOL, V92, P752, DOI 10.1038/icb.2014.45; Lourenco EV, 2011, AUTOIMMUNITY, V44, P33, DOI 10.3109/08916931003782155; Lowe RM, 2014, GENES IMMUN, V15, P137, DOI 10.1038/gene.2014.3; Lu MC, 2010, ARTHRITIS RHEUM-US, V62, P1213, DOI 10.1002/art.27386; Lun SWM, 2007, INT IMMUNOPHARMACOL, V7, P1668, DOI 10.1016/j.intimp.2007.08.021; MacDonald KPA, 1997, J CLIN INVEST, V100, P2404, DOI 10.1172/JCI119781; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Petrovic-Rackov L, 2006, CLIN RHEUMATOL, V25, P448, DOI 10.1007/s10067-005-0106-0; Reparon-Schuijt CC, 2001, ARTHRITIS RHEUM, V44, P41, DOI 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; SCHUBERT LA, 1995, J BIOL CHEM, V270, P29624; SHIOZAWA S, 1983, ARTHRITIS RHEUM-US, V26, P472, DOI 10.1002/art.1780260404; Szalay B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104298; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vastesaeger N, 2016, RHEUMATOLOGY, V55, P1466, DOI 10.1093/rheumatology/kew179; Wagner C, 2013, J RHEUMATOL, V40, P590, DOI 10.3899/jrheum.120889	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183726	10.1371/journal.pone.0183726	http://dx.doi.org/10.1371/journal.pone.0183726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837666	gold, Green Submitted, Green Published			2022-12-26	WOS:000408365000105
J	Shao, XQ; Kang, H; Loveless, T; Lee, GR; Seok, C; Weis, WI; Choi, HJ; Hardin, J				Shao, Xiangqiang; Kang, Hyunook; Loveless, Timothy; Lee, Gyu Rie; Seok, Chaok; Weis, William I.; Choi, Hee-Jung; Hardin, Jeff			Cell-cell adhesion in metazoans relies on evolutionarily conserved features of the alpha-catenin center dot beta-catenin-binding interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; ACTIN-BINDING; E-CADHERIN; F-ACTIN; TYROSINE PHOSPHORYLATION; IN-VITRO; SUBCELLULAR-LOCALIZATION; STRUCTURE REFINEMENT; SIGNALING FUNCTIONS; ADHERENS JUNCTIONS	Stable tissue integrity during embryonic development relies on the function of the cadherin center dot catenin complex (CCC). The Caenorhabditis elegans CCC is a useful paradigm for analyzing in vivo requirements for specific interactions among the core components of the CCC, and it provides a unique opportunity to examine evolutionarily conserved mechanisms that govern the interaction between alpha- and beta-catenin. HMP-1, unlike its mammalian homolog alpha-catenin, is constitutively monomeric, and its binding affinity for HMP-2/beta-catenin is higher than that of alpha-catenin for beta-catenin. A crystal structure shows that the HMP-1 center dot HMP-2 complex forms a five-helical bundle structure distinct from the structure of the mammalian alpha-catenin beta-catenin complex. Deletion analysis based on the crystal structure shows that the first helix of HMP-1 is necessary for binding HMP-2 avidly in vitro and for efficient recruitment of HMP-1 to adherens junctions in embryos. HMP-2 Ser-47 and Tyr-69 flank its binding interface with HMP-1, and we show that phosphomimetic mutations at these two sites decrease binding affinity of HMP-1 to HMP-2 by 40-100-fold in vitro. In vivo experiments using HMP-2 S47E and Y69E mutants showed that they are unable to rescue hmp-2(zu364) mutants, suggesting that phosphorylation of HMP-2 on Ser-47 and Tyr-69 could be important for regulating CCC formation in C. elegans. Our data provide novel insights into how cadherin-dependent cell-cell adhesion is modulated in metazoans by conserved elements as well as features unique to specific organisms.	[Shao, Xiangqiang; Hardin, Jeff] Univ Wisconsin, Program Genet, Madison, WI 53706 USA; [Shao, Xiangqiang; Loveless, Timothy; Hardin, Jeff] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Loveless, Timothy; Hardin, Jeff] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Kang, Hyunook; Choi, Hee-Jung] Seoul Natl Univ, Dept Biol Sci, Seoul 08826, South Korea; [Lee, Gyu Rie; Seok, Chaok] Seoul Natl Univ, Dept Chem, Seoul 08826, South Korea; [Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Seoul National University (SNU); Seoul National University (SNU); Stanford University; Stanford University	Choi, HJ (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea.; Hardin, J (corresponding author), Univ Wisconsin, Dept Integrat Biol, Madison, WI 53706 USA.	choihj@snu.ac.kr; jdhardin@wisc.edu	; Weis, William/G-1437-2011	Shao, Xiangqiang/0000-0002-8789-2333; Lee, Gyu Rie/0000-0002-9119-5303; Weis, William/0000-0002-5583-6150; Choi, Hee Jung/0000-0002-1468-4074	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS from the National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114462, P41GM103393, U01GM094663, R01GM058038] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS from the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Members of the Hardin laboratory thank Bethany Lucas for helpful discussions. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by Department of Energy Office of Biological and Environmental Research and by NIGMS Grant P41GM103393 from the National Institutes of Health.	Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; ABERLE H, 1994, J CELL SCI, V107, P3655; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; BRENNER S, 1974, GENETICS, V77, P71; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Callaci S, 2015, BIOCHEM J, V472, P339, DOI 10.1042/BJ20150410; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Choi HJ, 2015, DEV CELL, V33, P82, DOI 10.1016/j.devcel.2015.02.005; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; David MD, 2008, J CELL SCI, V121, P2718, DOI 10.1242/jcs.029660; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Dickinson DJ, 2011, SCIENCE, V331, P1336, DOI 10.1126/science.1199633; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Du C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033830; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; HERRENKNECHT K, 1991, P NATL ACAD SCI USA, V88, P9156, DOI 10.1073/pnas.88.20.9156; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Huber O, 1997, J CELL SCI, V110, P1759; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Jaggi M, 2008, MOL CANCER THER, V7, P2703, DOI 10.1158/1535-7163.MCT-08-0119; Kang H, 2017, J BIOL CHEM, V292, P7077, DOI 10.1074/jbc.M116.769778; Kang H, 2016, ACTA CRYSTALLOGR F, V72, P234, DOI 10.1107/S2053230X16001862; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Lee GR, 2016, PROTEINS, V84, P293, DOI 10.1002/prot.24858; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Maiden SL, 2013, J BIOL CHEM, V288, P5694, DOI 10.1074/jbc.M112.438093; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; McEwen AE, 2014, MOL BIOL CELL, V25, P2365, DOI 10.1091/mbc.E14-01-0690; Miller PW, 2013, CURR TOP MEMBR, V72, P267, DOI 10.1016/B978-0-12-417027-8.00008-8; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Muller T, 1999, J BIOL CHEM, V274, P10173, DOI 10.1074/jbc.274.15.10173; Natarajan L, 2001, GENETICS, V159, P159; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Park H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113811; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Phillips BT, 2009, DEV CELL, V17, P27, DOI 10.1016/j.devcel.2009.07.002; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Taddei ML, 2002, CANCER RES, V62, P6489; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Tamada M, 2012, DEV CELL, V22, P309, DOI 10.1016/j.devcel.2011.12.025; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; Tominaga J, 2008, GENES CELLS, V13, P67, DOI 10.1111/j.1365-2443.2007.01149.x; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	68	6	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16477	16490		10.1074/jbc.M117.795567	http://dx.doi.org/10.1074/jbc.M117.795567			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842483	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000412414800006
J	Austin, AN; Hansen, JP; Donadi, S; Eklof, JS				Austin, Asa N.; Hansen, Joakim P.; Donadi, Serena; Eklof, Johan S.			Relationships between aquatic vegetation and water turbidity: A field survey across seasons and spatial scales	PLOS ONE			English	Article							SUSPENDED SEDIMENT TRANSPORT; DISSOLVED ORGANIC-MATTER; AIC MODEL SELECTION; BALTIC SEA; DEPTH DISTRIBUTION; COASTAL LAGOONS; SHALLOW LAKES; SECCHI DEPTH; FRESH-WATER; SEAGRASS	Field surveys often show that high water turbidity limits cover of aquatic vegetation, while many small-scale experiments show that vegetation can reduce turbidity by decreasing water flow, stabilizing sediments, and competing with phytoplankton for nutrients. Here we bridged these two views by exploring the direction and strength of causal relationships between aquatic vegetation and turbidity across seasons (spring and late summer) and spatial scales (local and regional), using causal modeling based on data from a field survey along the central Swedish Baltic Sea coast. The two best-fitting regional-scale models both suggested that in spring, high cover of vegetation reduces water turbidity. In summer, the relationships differed between the two models; in the first model high vegetation cover reduced turbidity; while in the second model reduction of summer turbidity by high vegetation cover in spring had a positive effect on summer vegetation which suggests a positive feedback of vegetation on itself. Nitrogen load had a positive effect on turbidity in both seasons, which was comparable in strength to the effect of vegetation on turbidity. To assess whether the effect of vegetation was primarily caused by sediment stabilization or a reduction of phytoplankton, we also tested models where turbidity was replaced by phytoplankton fluorescence or sediment-driven turbidity. The best-fitting regional-scale models suggested that high sediment-driven turbidity in spring reduces vegetation cover in summer, which in turn has a negative effect on sediment-driven turbidity in summer, indicating a potential positive feedback of sediment-driven turbidity on itself. Using data at the local scale, few relationships were significant, likely due to the influence of unmeasured variables and/or spatial heterogeneity. In summary, causal modeling based on data from a large-scale field survey suggested that aquatic vegetation can reduce turbidity at regional scales, and that high vegetation cover vs. high sediment-driven turbidity may represent two self-enhancing, alternative states of shallow bay ecosystems.	[Austin, Asa N.; Donadi, Serena; Eklof, Johan S.] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Hansen, Joakim P.] Stockholm Univ, Balt Sea Ctr, Stockholm, Sweden; [Donadi, Serena] Swedish Univ Agr Sci, Dept Aquat Resources, Drottningholm, Sweden	Stockholm University; Stockholm University; Swedish University of Agricultural Sciences	Austin, AN (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden.	asa.austin@su.se	Eklöf, Johan S/C-7722-2017; Donadi, Serena/I-5092-2019	Eklöf, Johan S/0000-0001-6936-0926; Donadi, Serena/0000-0002-8920-9630	Formas [2013-1074]; BalticSea (project "Levande Kust"); Stockholm University Baltic Sea Centre	Formas(Swedish Research Council Formas); BalticSea (project "Levande Kust"); Stockholm University Baltic Sea Centre	Funded by Formas (grant 2013-1074), BalticSea 2020 (project "Levande Kust"), Stockholm University Baltic Sea Centre (Asko Grant to ANA).	Adams MP, 2016, LIMNOL OCEANOGR, V61, P1937, DOI 10.1002/lno.10319; Alsterberg C, 2013, P NATL ACAD SCI USA, V110, P8603, DOI 10.1073/pnas.1303797110; [Anonymous], 2021, LANG ENV STAT COMP; Arheimer B, 2012, HYDROL RES, V43, P315, DOI 10.2166/nh.2012.010; Baastrup-Spohr L, 2013, FRESHWATER BIOL, V58, P1682, DOI 10.1111/fwb.12159; Benoy GA, 1999, LIMNOL OCEANOGR, V44, P1081, DOI 10.4319/lo.1999.44.4.1081; Berglund J, 2003, ESTUAR COAST SHELF S, V56, P1167, DOI 10.1016/S0272-7714(02)00326-8; Bergstrom U, 2017, P R SOC LONDON B; Blindow I, 2002, AQUAT BOT, V72, P315, DOI 10.1016/S0304-3770(01)00208-X; Blomqvist S, 2004, LIMNOL OCEANOGR, V49, P2236, DOI 10.4319/lo.2004.49.6.2236; BREUKELAAR AW, 1994, FRESHWATER BIOL, V32, P113, DOI 10.1111/j.1365-2427.1994.tb00871.x; BRICAUD A, 1981, LIMNOL OCEANOGR, V26, P43; Bullock HE, 1994, STRUCT EQU MODELING, V1, P253, DOI 10.1080/10705519409539977; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cabaco S, 2008, ESTUAR COAST SHELF S, V79, P354, DOI 10.1016/j.ecss.2008.04.021; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; CHAMBERS PA, 1985, CAN J FISH AQUAT SCI, V42, P701, DOI 10.1139/f85-090; Chen SN, 2007, ESTUAR COAST, V30, P296, DOI 10.1007/BF02700172; Dahlgren S, 2004, HYDROBIOLOGIA, V514, P249, DOI 10.1023/B:hydr.0000018223.26997.b0; DENNISON WC, 1987, AQUAT BOT, V27, P15, DOI 10.1016/0304-3770(87)90083-0; DUARTE CM, 1991, AQUAT BOT, V40, P363, DOI 10.1016/0304-3770(91)90081-F; GOPAL B, 1990, ECOLOGY MANAGEMENT A, P79; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Grace JB., 2015, STRUCTURAL EQUATION; Gustafsson BG, 2012, AMBIO, V41, P534, DOI 10.1007/s13280-012-0318-x; Hansen JP, 2014, HYDROBIOLOGIA, V738, P171, DOI 10.1007/s10750-014-1928-z; Hansen JP, 2013, EFFECTS SHORE LEVEL; Harvey ET, 2015, AMBIO, V44, pS392, DOI 10.1007/s13280-015-0658-4; HILTON J, 1982, J APPL ECOL, V19, P143, DOI 10.2307/2402998; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; IVERSON RL, 1986, ESTUAR COAST SHELF S, V22, P577, DOI 10.1016/0272-7714(86)90015-6; JUPP BP, 1977, J ECOL, V65, P175, DOI 10.2307/2259072; Kari E, 2017, INT J REMOTE SENS, V38, P1983, DOI 10.1080/01431161.2016.1230289; KAUTSKY L, 1988, OIKOS, V53, P126, DOI 10.2307/3565672; Kilham SS, 1996, LIMNOL OCEANOGR, V41, P1052, DOI 10.4319/lo.1996.41.5.1052; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Koroleff F., 1983, METHODS SEAWATER ANA, P125; Kratzer S, 2009, HYDROBIOLOGIA, V629, P169, DOI 10.1007/s10750-009-9769-x; Krause-Jensen D, 2011, MAR ECOL PROG SER, V425, P91, DOI 10.3354/meps09026; Krause-Jensen D, 2009, ECOL INDIC, V9, P1284, DOI 10.1016/j.ecolind.2009.02.010; KUFEL L, 1994, HYDROBIOLOGIA, V275, P277, DOI 10.1007/BF00026718; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Lou J, 1997, ESTUAR COAST SHELF S, V45, P1; Maxwell PS, 2017, BIOL REV, V92, P1521, DOI 10.1111/brv.12294; MEIJER M L, 1989, Hydrobiological Bulletin, V23, P49, DOI 10.1007/BF02286426; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Moore KA, 2004, J COASTAL RES, P162, DOI 10.2112/SI45-162.1; Munsterhjelm Riggert, 1997, Acta Botanica Fennica, V157, P1; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nepf HM, 1999, LIMNOL OCEANOGR, V44, P1072, DOI 10.4319/lo.1999.44.4.1072; Olesen B, 1996, MAR ECOL PROG SER, V134, P187, DOI 10.3354/meps134187; Orth RJ, 2012, MAR ECOL PROG SER, V448, P177, DOI 10.3354/meps09522; Perrow MR, 1997, HYDROBIOLOGIA, V342, P355, DOI 10.1023/A:1017092802529; Redfield A. C., 1934, P176; Rosqvist K., 2010, DISTRIBUTION ROLE MA; Rosqvist K, 2010, AQUAT BOT, V93, P39, DOI 10.1016/j.aquabot.2010.03.002; Sand-Jensen K, 2008, J ECOL, V96, P260, DOI 10.1111/j.1365-2745.2007.01339.x; Sandel B, 2009, OIKOS, V118, P1284, DOI 10.1111/j.1600-0706.2009.17421.x; SANDJENSEN K, 1991, AQUAT BOT, V41, P137, DOI 10.1016/0304-3770(91)90042-4; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Shipley B., 2000, CAUSE CORRELATIONS B; Shipley B, 2013, ECOLOGY, V94, P560, DOI 10.1890/12-0976.1; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Snickars M, 2009, ESTUAR COAST SHELF S, V81, P247, DOI 10.1016/j.ecss.2008.10.021; Snickars M, 2010, MAR ECOL PROG SER, V398, P235, DOI 10.3354/meps08313; Team QD, 2016, QGIS GEOGR INF SYST; Tokoro T, 2014, GLOBAL CHANGE BIOL, V20, P1873, DOI 10.1111/gcb.12543; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; van de Koppel J, 2012, J EXP BIOL, V215, P962, DOI 10.1242/jeb.060467; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; WIUMANDERSEN S, 1982, OIKOS, V39, P187, DOI 10.2307/3544484	77	18	18	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0181419	10.1371/journal.pone.0181419	http://dx.doi.org/10.1371/journal.pone.0181419			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854185	Green Published, gold, Green Submitted			2022-12-26	WOS:000408693600007
J	Han, XT; Guo, XX; Lee, PY; Morgan, IG; He, MG				Han, Xiaotong; Guo, Xinxing; Lee, Pei Ying; Morgan, Ian G.; He, Mingguang			Six-year changes in refraction and related ocular biometric factors in an adult Chinese population	PLOS ONE			English	Article							BLUE MOUNTAINS EYE; BEAVER DAM EYE; RISK-FACTORS; OLDER POPULATION; LENS PARADOX; PREVALENCE; ERRORS; SINGAPORE; CATARACT; MYOPIA	Purpose To investigate longitudinal changes in refraction and biometry in Chinese adults. Design Population-based prospective cohort study. Methods 1817 subjects aged >= 35 years were randomly recruited from Yuexiu district, Guangzhou, China in 2008. Of which 1595 (87.8%) were reexamined in 2010 and 1427 (78.5%) were reexamined in 2014. Non-cycloplegic automated refraction and visual acuity test were performed at baseline and the 6-year follow-up examination for all participants. In addition, 50% of the participants were randomly selected for axial length (AL), anterior chamber depth (ACD) and lens thickness (LT) measurements using non-contact partial coherence laser interferometry. Lens power (LP) was calculated with the Bennett's equation. Results A total of 1300 participants were included in current analysis (2008 mean [SD] age, 51.4 [10.6] years; 54.5% women). Mean change in spherical equivalence (SE) was +0.24 (95% confidence interval [CI], +0.19 to +0.30), +0.51 (95% CI, +0.46 to +0.57), +0.26 (95% CI, +0.15 to +0.38) and -0.05 (95% CI, -0.21 to +0.10) diopters (D) for individuals in the age groups of 35 to 44, 45 to 54, 55 to 64 and 65+ years at baseline, respectively. Corneal power, AL and LT increased while ACD and LP decreased during the follow-up. Baseline SE and changes in biometric factors could explain 97.2% of the variance in longitudinal SE change while LP solely could explain 65.2%. Six-year mean change in cylinder power was -0.16 (95% CI, -0.19 to -0.13) D, the axis of astigmatism changed from "with-the-rule" to "against-the-rule" in 16.4% of the participants and to "oblique" in 0.9%. Conclusions This study confirms a hyperopic shift in the elderly before 65 years old and a myopic shift thereafter. Longitudinal refraction change could be well explained by corresponding biometry changes, especially LP. There is also a shift to "against-the-rule" astigmatism for the adult population.	[Han, Xiaotong; Guo, Xinxing; Morgan, Ian G.; He, Mingguang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Han, Xiaotong; Lee, Pei Ying; He, Mingguang] Univ Melbourne, Dept Surg, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Morgan, Ian G.] Australian Natl Univ, Coll Med Biol & Environm, ARC Ctr Excellence Vis Sci & Visual Sci Grp, Res Sch Biol, Canberra, ACT, Australia	Sun Yat Sen University; Centre for Eye Research Australia; University of Melbourne; Australian National University	He, MG (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.; He, MG (corresponding author), Univ Melbourne, Dept Surg, Ctr Eye Res Australia, Melbourne, Vic, Australia.	mingguang_he@yahoo.com	Guo, Xinxing/AAT-1652-2020; He, Mingguang/AAY-5239-2020; Morgan, Ian G/D-1190-2009	He, Mingguang/0000-0002-6912-2810; Morgan, Ian G/0000-0002-4548-3574; Han, Xiaotong/0000-0001-6836-3447	World Health Organization, Geneva, Switzerland (under National Institutes of Health, Bethesda, MD) [N01-EY-2103]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology at the Zhongshan Ophthalmic Center; University of Melbourne at Research Accelerator Program; CERA Foundation	World Health Organization, Geneva, Switzerland (under National Institutes of Health, Bethesda, MD); Fundamental Research Funds of the State Key Laboratory of Ophthalmology at the Zhongshan Ophthalmic Center; University of Melbourne at Research Accelerator Program; CERA Foundation	This study was supported by the World Health Organization, Geneva, Switzerland (under National Institutes of Health, Bethesda, MD, contract No. N01-EY-2103) and the by Fundamental Research Funds of the State Key Laboratory of Ophthalmology at the Zhongshan Ophthalmic Center. Prof. He receives support from the University of Melbourne at Research Accelerator Program and the CERA Foundation. The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian State Government. The sponsor or funding organization had no role in the design or conduct of this research.	Attebo K, 1999, OPHTHALMOLOGY, V106, P1066, DOI 10.1016/S0161-6420(99)90251-8; BENNETT AG, 1988, OPHTHAL PHYSL OPT, V8, P53, DOI 10.1016/0275-5408(88)90089-0; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Dubbelman M, 2001, VISION RES, V41, P1867, DOI 10.1016/S0042-6989(01)00057-8; Fotedar R, 2008, OPHTHALMOLOGY, V115, P1273, DOI 10.1016/j.ophtha.2007.11.003; Gudmundsdottir E, 2005, OPHTHALMOLOGY, V112, P672, DOI 10.1016/j.ophtha.2004.11.039; Guzowski M, 2003, OPHTHALMOLOGY, V110, P1364, DOI 10.1016/S0161-6420(03)00465-2; Hashemi H, 2004, OPHTHAL EPIDEMIOL, V11, P213, DOI 10.1080/09286580490514513; Hashemi H, 2016, CLIN EXPT OPHTHALMOL; Hashemi H, 2012, CLIN EXP OPHTHALMOL, V40, P247, DOI 10.1111/j.1442-9071.2011.02635.x; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; He MG, 2014, JAMA OPHTHALMOL, V132, P978, DOI 10.1001/jamaophthalmol.2014.1011; He MG, 2014, OPHTHALMOLOGY, V121, P417, DOI 10.1016/j.ophtha.2013.06.051; Holden B.A., 2016, OPHTHALMOLOGY; Hrynchak PK, 2013, OPTOMETRY VISION SCI, V90, P1331, DOI 10.1097/OPX.0000000000000069; Hyman L, 2007, OPHTHAL EPIDEMIOL, V14, P192, DOI 10.1080/09286580701535517; Lee KE, 2002, INVEST OPHTH VIS SCI, V43, P2566; Lee KE, 1999, INVEST OPHTH VIS SCI, V40, P1645; Moffat BA, 2002, OPTOMETRY VISION SCI, V79, P148, DOI 10.1097/00006324-200203000-00008; Nemeth G, 2013, EUR J OPHTHALMOL, V23, P779, DOI 10.5301/ejo.5000294; Pablo Gluzmann DP, 2013, STATA J, V15, P325; Pan CW, 2013, AM J OPHTHALMOL, V156, P1021, DOI 10.1016/j.ajo.2013.06.005; Panchapakesan J, 2003, OPHTHALMIC EPIDEMIOL, V10, P241, DOI 10.1076/opep.10.4.241.15911; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Tan CSH, 2011, EYE, V25, P1294, DOI 10.1038/eye.2011.144; Varma R, 2016, AM J OPHTHALMOLOGY; Williams KM, 2015, OPHTHALMOLOGY, V122, P1489, DOI 10.1016/j.ophtha.2015.03.018; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Wu SY, 2005, INVEST OPHTH VIS SCI, V46, P4032, DOI 10.1167/iovs.05-0332	29	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183364	10.1371/journal.pone.0183364	http://dx.doi.org/10.1371/journal.pone.0183364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854269	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600042
J	Hilmarsson, HS; Hytonen, T; Isobe, S; Goransson, M; Toivainen, T; Hallsson, JH				Hilmarsson, Hrannar Smari; Hytonen, Timo; Isobe, Sachiko; Goransson, Magnus; Toivainen, Tuomas; Hallsson, Jon Hallsteinn			Population genetic analysis of a global collection of Fragaria vesca using microsatellite markers	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; CULTIVATED STRAWBERRY; DIVERSITY ANALYSIS; LINKAGE MAP; X ANANASSA; GENOME; DOMESTICATION; ARABIDOPSIS; INFERENCE; MODEL	The woodland strawberry, Fragaria vesca, holds great promise as a model organism. It not only represents the important Rosaceae family that includes economically important species such as apples, pears, peaches and roses, but it also complements the well-known model organism Arabidopsis thaliana in key areas such as perennial life cycle and the development of fleshy fruit. Analysis of wild populations of A. thaliana has shed light on several important developmental pathways controlling, for example, flowering time and plant growth, suggesting that a similar approach using F. vesca might add to our understanding on the development of rosaceous species and perennials in general. As a first step, 298 F. vesca plants were analyzed using microsatellite markers with the primary aim of analyzing population structure and distribution of genetic diversity. Of the 68 markers tested, 56 were polymorphic, with an average of 4.46 alleles per locus. Our analysis partly confirms previous classification of F. vesca subspecies in North America and suggests two groups within the subsp. bracteata. In addition, F. vesca subsp. vesca forms a single global population with evidence that the Icelandic group is a separate cluster from the main Eurasian population.	[Hilmarsson, Hrannar Smari; Goransson, Magnus; Hallsson, Jon Hallsteinn] Agr Univ Iceland, Fac Agr & Environm Sci, Reykjavik, Iceland; [Hytonen, Timo; Toivainen, Tuomas] Univ Helsinki, Viikki Plant Sci Ctr, Dept Agr Sci, Helsinki, Finland; [Hytonen, Timo] Univ Helsinki, Viikki Plant Sci Ctr, Dept Biosci, Helsinki, Finland; [Isobe, Sachiko] KDRI, Chiba, Japan; [Goransson, Magnus] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway	University of Helsinki; University of Helsinki; Norwegian University of Life Sciences	Hallsson, JH (corresponding author), Agr Univ Iceland, Fac Agr & Environm Sci, Reykjavik, Iceland.	jonhal@lbhi.is	Hallsson, Jon Hallsteinn/AAF-6986-2020; Hytönen, Timo/M-2388-2015; Göransson, Magnus/A-8629-2008	Hytönen, Timo/0000-0002-5231-4031; Goransson, Magnus/0000-0002-0081-2207; Hallsson, Jon/0000-0002-9127-2137				Aguilar-Melendez A, 2009, AM J BOT, V96, P1190, DOI 10.3732/ajb.0800155; ARULSEKAR S, 1981, J HERED, V72, P117, DOI 10.1093/oxfordjournals.jhered.a109438; Bauer A., 1994, Progress in temperate fruit breeding. Proceedings of the Eucarpia Fruit Breeding Section Meeting, Wadenswil/Einsiedeln, Switzerland, 30 August to 3 September, 1993., P189; Blamey M, 1992, MYNDSKREYTT FLORA IS; Bocher T, 1966, GRONLANDS FLORA; BRINGHURST RS, 1966, AM J BOT, V53, P1000, DOI 10.2307/2440678; Bringhurst RS, 1978, GENETICS, V50, P510; Brunings AM, 2010, EUPHYTICA, V173, P63, DOI 10.1007/s10681-009-0112-4; Cabrera A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-562; Chambers A, 2013, MOL BREEDING, V31, P615, DOI 10.1007/s11032-012-9819-3; Chambers AH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-217; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; DARROW G. M., 1966, The Strawberry.; Davis TM, 2006, J AM SOC HORTIC SCI, V131, P506, DOI 10.21273/JASHS.131.4.506; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; Durham S., 2013, AGR RES, V61, P13; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Eidesen PB, 2013, NEW PHYTOL, V200, P898, DOI 10.1111/nph.12412; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Marti AFI, 2015, GENET RESOUR CROP EV, V62, P205, DOI 10.1007/s10722-014-0146-x; Folta KM, 2013, INT J FRUIT SCI, V13, P162, DOI 10.1080/15538362.2012.698150; Govan CL, 2008, MOL BREEDING, V22, P649, DOI 10.1007/s11032-008-9206-2; Gross BL, 2014, AM J BOT, V101, P1770, DOI 10.3732/ajb.1400297; Hadonou AM, 2004, GENOME, V47, P429, DOI 10.1139/G03-142; Hancock J.F., 1999, STRAWBERRIES, P25; Horvath A, 2011, ANN APPL BIOL, V159, P358, DOI 10.1111/j.1744-7348.2011.00503.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hulten E, 1971, ATLAS O E VER VA E X; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iqbal MJ, 2001, THEOR APPL GENET, V103, P547, DOI 10.1007/PL00002908; Isobe SN, 2013, DNA RES, V20, P79, DOI 10.1093/dnares/dss035; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; Kilian B, 2007, MOL BIOL EVOL, V24, P2657, DOI 10.1093/molbev/msm192; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Lewers KS, 2005, J AM SOC HORTIC SCI, V130, P102, DOI 10.21273/JASHS.130.1.102; Liston A, 2014, AM J BOT; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Longhi S, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.1; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Maxted N, 2009, REPORT NO 39; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Nakaya A, 2012, ANN BOT-LONDON, V110, P1303, DOI 10.1093/aob/mcs109; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; Oosumi T, 2006, PLANTA, V223, P1219, DOI 10.1007/s00425-005-0170-3; Ortiz R, 2001, THEOR APPL GENET, V103, P792, DOI 10.1007/s001220100649; Papa R, 2003, THEOR APPL GENET, V106, P239, DOI 10.1007/s00122-002-1085-z; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Rivarola M, 2011, PLANT GENOME-US, V4, P12, DOI 10.3835/plantgenome2010.08.0018; Rohloff J, 2012, PHYTOCHEMISTRY, V77, P99, DOI 10.1016/j.phytochem.2012.01.024; Rousseau-Gueutin M, 2011, PLANT BREEDING, V130, P248, DOI 10.1111/j.1439-0523.2010.01785.x; Rousseau-Gueutin M, 2009, MOL PHYLOGENET EVOL, V51, P515, DOI 10.1016/j.ympev.2008.12.024; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sargent DJ, 2012, THEOR APPL GENET, V124, P1229, DOI 10.1007/s00122-011-1782-6; Sargent DJ, 2003, MOL ECOL NOTES, V3, P550, DOI 10.1046/j.1471-8286.2003.00507.x; Sato S, 2005, DNA RES, V12, P301, DOI 10.1093/dnares/dsi018; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Slovin JP, 2007, FRAGARIA VESCA USEFU; Stanley L, 2015, BOTANY, V93, P573, DOI 10.1139/cjb-2015-0031; Staudt G., 1999, SYSTEMATICS GEOGRAPH, V81; Staudt Gunter, 2003, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V125, P53, DOI 10.1127/0006-8152/2003/0125-0053; Stefan Stefansson, FLORA ISLANDS; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; USDA, 2015, PLANTS PROF FRAG VES; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wachsmuth B., 2014, ANNOTATED LIST ALPIN; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Warschefsky E, 2014, AM J BOT, V101, P1791, DOI 10.3732/ajb.1400116; Weebadde CK, 2008, PLANT BREEDING, V127, P94, DOI 10.1111/j.1439-0523.2007.01430.x; Weigel D, 2012, PLANT PHYSIOL, V158, P2, DOI 10.1104/pp.111.189845; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891	78	18	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183384	10.1371/journal.pone.0183384	http://dx.doi.org/10.1371/journal.pone.0183384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854285	Green Published, gold			2022-12-26	WOS:000408693600043
J	Maden, M; Ertugrul, IF; Orhan, EO; Erik, CE; Yetis, CC; Tuncer, Y; Kahriman, M				Maden, Murat; Ertugrul, Ihsan Furkan; Orhan, Ekim Onur; Erik, Cevat Emre; Yetis, Ceylan Cagil; Tuncer, Yasin; Kahriman, Mesud			Enhancing antibacterial effect of sodium hypochlorite by low electric current-assisted sonic agitation	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS BIOFILM; POLYMERASE-CHAIN-REACTION; ULTRASONIC IRRIGATION; ROOT; BACTERIA; SYSTEM; DISINFECTION; TIME	Background This research focused on the effects of low electric current (mu E)-assisted sonic agitation of sodium hypochlorite on Enterococcus faecalis infected human root dentin. Methods Extracted human canine roots were instrumented, sterilized, and experimentally contaminated with E. faecalis. After incubation for 21 days, the presence of the biofilm was confirmed by scanning electron microscopy (n = 3). Roots were randomly divided into seven groups according to decontamination procedures: G1: no treatment; G2: sterile saline; G3: 5.25% sodium hypochlorite; G4: passive ultrasonic irrigation; G5: EndoActivator (Dentsply Tulsa Dental Specialties, Tulsa, OK) agitation (EA); G6: mu E agitation; and G7: mu E-assisted sonic agitation. Fixed mu E amperage and intensities were applied in G6 and G7. Following microbial sampling, bacterial colonies were counted using the direct plating method. Results Biofilm was not eradicated in any sample. The mu E-assisted sonic agitation of sodium hypochlorite revealed the lowest cfu values (p<0.05), whereas there were no significant differences among the passive ultrasonic irrigation, EndoActivator and mu E agitation alone (p>0.05). Conclusions Based on available evidence, the following conclusions were drawn: The mu E-assisted sonic agitation increased the antibiofilm efficiency of sodium hypochlorite than passive ultrasonic irrigation and EndoActivator. The mu E-assisted sonic agitation on 5.25% sodium hypochlorite is not capable to eradicate biofilms at 10mA energy level in 60s.	[Maden, Murat; Erik, Cevat Emre] Suleyman Demirel Univ, Fac Dent, Dept Endodont, Isparta, Turkey; [Ertugrul, Ihsan Furkan] Pamukkale Univ, Dept Endodont Dent, Fac Dent, Denizli, Turkey; [Orhan, Ekim Onur] Eskisehir Osmangazi Univ, Dept Endodont, Fac Dent, Eskisehir, Turkey; [Yetis, Ceylan Cagil] Suleyman Demirel Univ, Fac Dent, Dept Pediat Dent, Isparta, Turkey; [Tuncer, Yasin] Suleyman Demirel Univ, Dept Food Engn, Fac Engn & Architect, Isparta, Turkey; [Kahriman, Mesud] Suleyman Demirel Univ, Dept Elect & Commun, Fac Engn & Architect, Isparta, Turkey	Suleyman Demirel University; Pamukkale University; Eskisehir Osmangazi University; Suleyman Demirel University; Suleyman Demirel University; Suleyman Demirel University	Orhan, EO (corresponding author), Eskisehir Osmangazi Univ, Dept Endodont, Fac Dent, Eskisehir, Turkey.	eonurdentus@hotmail.com	ORHAN, Ekim Onur/Q-6015-2019; Tuncer, Yasin/G-3101-2013; Ertugrul, İhsan Furkan/Y-7841-2018; Erik, Emre/W-3109-2019	ORHAN, Ekim Onur/0000-0002-8755-2558; Ertugrul, İhsan Furkan/0000-0001-7583-6679; Erik, Emre/0000-0003-2706-1914; kahriman, mesud/0000-0003-0731-0936	Division of Scientific Research, Suleyman Demirel University [3691-D1-13]	Division of Scientific Research, Suleyman Demirel University	This project labelled 3691-D1-13 has been supported by the Division of Scientific Research, Suleyman Demirel University.	Basrani B., 2015, ENDODONTIC IRRIGATIO; BAYER ME, 1990, J GEN MICROBIOL, V136, P867, DOI 10.1099/00221287-136-5-867; BECKING AG, 1991, ORAL SURG ORAL MED O, V71, P346, DOI 10.1016/0030-4220(91)90313-2; Brito PRR, 2009, J ENDODONT, V35, P1422, DOI 10.1016/j.joen.2009.07.001; Cachovan G, 2013, J ENDODONT, V39, P1171, DOI 10.1016/j.joen.2013.06.008; Case PD, 2012, J ENDODONT, V38, P523, DOI 10.1016/j.joen.2011.12.020; Chivatxaranukul P, 2008, INT ENDOD J, V41, P873, DOI 10.1111/j.1365-2591.2008.01445.x; DAVIS CP, 1989, ANTIMICROB AGENTS CH, V33, P442, DOI 10.1128/AAC.33.4.442; de Almeida AP, 2014, J ENDODONT, V40, P1953, DOI 10.1016/j.joen.2014.08.025; Ertugrul IF, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0152-1; Ertugrul Ihsan Furkan, 2014, Eur J Dent, V8, P464, DOI 10.4103/1305-7456.143622; Estrela C, 2009, J APPL ORAL SCI, V17, P87, DOI 10.1590/S1678-77572009000200003; Estrela Carlos, 2002, Braz. Dent. J., V13, P113, DOI 10.1590/S0103-64402002000200007; German Institute for Standardization, 2005, EFF CURR HUM BEING 1; Ghinzelli GC, 2014, PHOTODIAGN PHOTODYN, V11, P472, DOI 10.1016/j.pdpdt.2014.07.004; Grundling GL, 2011, J ENDODONT, V37, P1128, DOI 10.1016/j.joen.2011.05.006; Gu LS, 2009, J ENDODONT, V35, P791, DOI 10.1016/j.joen.2009.03.010; Guerreiro-Tanomaru Juliane Maria, 2015, Braz. Dent. J., V26, P342, DOI 10.1590/0103-6440201300022; Haapasalo M, 2014, BRIT DENT J, V216, P299, DOI 10.1038/sj.bdj.2014.204; HAAPASALO M, 1987, J DENT RES, V66, P1375, DOI 10.1177/00220345870660081801; Huque J, 1998, INT ENDOD J, V31, P242; Joyce E, 2003, ULTRASON SONOCHEM, V10, P315, DOI 10.1016/S1350-4177(03)00101-9; KAKEHASHI S, 1965, ORAL SURG ORAL MED O, V20, P340, DOI 10.1016/0030-4220(65)90166-0; Love RM, 2001, INT ENDOD J, V34, P399, DOI 10.1046/j.1365-2591.2001.00437.x; MARTIN H, 1984, INT DENT J, V34, P198; Mathew Joan, 2014, J Conserv Dent, V17, P444, DOI 10.4103/0972-0707.139833; MOORER WR, 1982, INT ENDOD J, V15, P187, DOI 10.1111/j.1365-2591.1982.tb01277.x; Mozo S, 2012, MED ORAL PATOL ORAL, V17, pE512, DOI 10.4317/medoral.17621; Munley PJ, 2007, J ENDODONT, V33, P578, DOI 10.1016/j.joen.2007.01.009; Nekoofar MH, 2006, INT ENDOD J, V39, P595, DOI 10.1111/j.1365-2591.2006.01131.x; Parmar D, 2011, INT ENDOD J, V44, P644, DOI 10.1111/j.1365-2591.2011.01867.x; Pasqualini D, 2010, J ENDODONT, V36, P1358, DOI 10.1016/j.joen.2010.03.035; Pladisai P, 2016, J ENDODONT, V42, P460, DOI 10.1016/j.joen.2015.12.016; Sedgley C, 2006, J ENDODONT, V32, P173, DOI 10.1016/j.joen.2005.10.037; Shenoy Amarnath, 2013, Indian J Dent Res, V24, P537, DOI 10.4103/0970-9290.123361; Siqueira JF, 2004, ORAL SURG ORAL MED O, V97, P85, DOI 10.1016/S1079-2104(03)00353-6; Siqueira JF, 2011, J ENDODONT, V37, P1499, DOI 10.1016/j.joen.2011.08.012; Takemura N, 2004, EUR J ORAL SCI, V112, P523, DOI 10.1111/j.1600-0722.2004.00165.x; Valle A, 2007, J APPL MICROBIOL, V103, P1376, DOI 10.1111/j.1365-2672.2007.03374.x; Weller R N, 1980, J Endod, V6, P740	40	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183895	10.1371/journal.pone.0183895	http://dx.doi.org/10.1371/journal.pone.0183895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854274	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600066
J	Mino, CI; de Souza, ED; Moralez-Silva, E; Valdes, TA; Rodrigues, VLCC; Del Lama, SN				Mino, Carolina Isabel; de Souza, Elaine Dantas; Moralez-Silva, Emmanuel; Valdes, Talita Alvarenga; Cortico Correa Rodrigues, Vera Lucia; Del Lama, Silvia Nassif			Use of noninvasive 'bug-eggs' to enable comparative inferences on genetic mating system with and without parental information: A study in a cattle egret colony	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; CONSPECIFIC BROOD PARASITISM; TERN STERNA-HIRUNDO; PANSTRONGYLUS-MEGISTUS HEMIPTERA; INTRASPECIFIC NEST PARASITISM; BASE-LINE CORTICOSTERONE; BUBULCUS-IBIS; NATURAL-POPULATIONS; MICROSATELLITE LOCI; AVES CICONIIFORMES	Colonial waterbirds such as herons, egrets and spoonbills exhibit ecological characteristics that could have promoted the evolution of conspecific brood parasitism and extra-pair copulation. However, an adequate characterization of the genetic mating systems of this avian group has been hindered by the lack of samples of elusive candidate parents which precluded conducting conventional parentage allocation tests. Here, we investigate the genetic mating system of the invasive cattle egret using hematophagous insects contained in fake eggs to collect blood from incubating adults in a wild breeding colony. We tested a protocol with a previously unused Neotropical Triatominae, Panstrongylus megistus, obtained blood samples from males and females in 31 nests built on trees, drew blood from 89 nestlings at those nests, and genotyped all samples at 14 microsatellite loci, including six new species-specific loci. We comparatively addressed the performance of parentage allocation versus kinship classification of nestlings to infer the genetic mating system of cattle egrets. In line with previous behavioral observations, we found evidence in support of a non-monogamous genetic mating system, including extra-pair paternity (EPP) and conspecific brood parasitism (CBP). Parentage allocation tests detected a higher percentage of nests with alternative reproductive tactics (EPP: 61.7%; CBP: 64.5%) than the kinship classification method (EPP: 50.0%; CBP: 43.3%). Overall, these results indicate that rates of alternative reproductive tactics inferred in the absence of parental genetic information could be underestimated and should be interpreted with caution. This study highlights the importance of incorporating samples from candidate parents to adequately determine the genetic mating system of a species. We expand knowledge on the reproductive tactics of colonial waterbirds, contributing novel data on the genetic mating system of the cattle egret, valuable for the design of management strategies for this invasive bird.	[Mino, Carolina Isabel] Univ Nacl Misiones UNaM, IBS, CONICET, Puerto Iguazu, Misiones, Argentina; [de Souza, Elaine Dantas; Moralez-Silva, Emmanuel; Valdes, Talita Alvarenga; Del Lama, Silvia Nassif] Univ Fed Sao Carlos, Dept Genet & Evolucao, Sao Carlos, SP, Brazil; [Cortico Correa Rodrigues, Vera Lucia] Superintendencia Controle Endemias, Mogi Guacu, SP, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal de Sao Carlos	Mino, CI (corresponding author), Univ Nacl Misiones UNaM, IBS, CONICET, Puerto Iguazu, Misiones, Argentina.	carolinamino@conicet.gov.ar	Miño, Carolina Isabel/K-7120-2019	Mino, Carolina Isabel/0000-0002-9098-583X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2004/15205-8, 2010/50406-5, 2016/01673-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [563299/2010-0]; Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior CAPES [870195/1997-2]; CAPES [2637/2010]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Brazilian fostering agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (#2004/15205-8, #2010/50406-5, #2016/01673-7: www.fapesp.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (#563299/2010-0; www.cnpq.br) through research grants awarded to SNDL, the Brazilian fostering agency Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior CAPES (www.capes.gov.br), through a master's scholarship to EDS and CNPq through a doctoral scholarship to EMS (#870195/1997-2). At the time of data collection for this manuscript, CIM was supported by CAPES through a post-doctoral fellowship under the scheme 'Programa de Apoio a Projetos Institucionais com a Participagao de Recem-Doutores' (PRODOC #2637/2010). CIM is currently a research fellow supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina; www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JM, 2008, J AVIAN BIOL, V39, P588, DOI 10.1111/j.0908-8857.2008.04265.x; Bachir AS, 2011, J ARID ENVIRON, V75, P1232, DOI 10.1016/j.jaridenv.2011.04.021; Barbosa SE, 2003, J MED ENTOMOL, V40, P411, DOI 10.1603/0022-2585-40.4.411; Bauch C, 2016, MOL ECOL, V25, P5785, DOI 10.1111/mec.13874; Bauch C, 2013, J ORNITHOL, V154, P581, DOI 10.1007/s10336-013-0931-x; Bauch C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2540; Bauch C, 2010, J COMP PHYSIOL B, V180, P835, DOI 10.1007/s00360-010-0453-2; Bazin E, 2014, BIOL INVASIONS, V16, P875, DOI 10.1007/s10530-013-0544-6; Becker PH, 2006, J ORNITHOL, V147, P115, DOI 10.1007/s10336-005-0027-3; BELTON W, 1974, BIRD BANDING, V45, P59, DOI 10.2307/4512002; Blackburn TM, 2009, OXFORD AVIAN BIOL, P77; BLAKER D, 1969, Ostrich, V40, P75, DOI 10.1080/00306525.1969.9634335; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; BURGER J, 1978, CONDOR, V80, P15, DOI 10.2307/1367786; Campanini EB, 2012, CONSERV GENET RESOUR, V4, P707, DOI 10.1007/s12686-012-9627-4; Carney KM, 1999, WATERBIRDS, V22, P68, DOI 10.2307/1521995; Cezilly Frank, 2008, P429; Choi Yu-Seong, 2013, [Korean Journal of Ornithology, 한국조류학회지], V20, P125; Clark RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090616; Congrains C, 2016, J AVIAN BIOL, V47, P846, DOI 10.1111/jav.00972; Nunes MFC, 2010, REV BRAS ORNITOL, V18, P315; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Ferrie GM, 2013, ZOO BIOL, V32, P556, DOI 10.1002/zoo.21090; FUJIOKA M, 1985, ANIM BEHAV, V33, P1228, DOI 10.1016/S0003-3472(85)80183-4; FUJIOKA M, 1986, IBIS, V128, P419, DOI 10.1111/j.1474-919X.1986.tb02692.x; FUJIOKA M, 1981, AUK, V98, P134; Fulmer AG, 2016, J ORNITHOL, V157, P219, DOI 10.1007/s10336-015-1270-x; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Herbinger CM, 2006, MOL ECOL, V15, P2261, DOI 10.1111/j.1365-294X.2006.02923.x; Janowski Susann, 2014, Open Ornithology Journal, V7, P11; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Krebs EA, 2004, BEHAVIOUR, V141, P479, DOI 10.1163/156853904323066757; LANCASTER D A, 1970, Living Bird, V9, P167; Lemons PR, 2015, MOL ECOL RESOUR, V15, P107, DOI 10.1111/1755-0998.12287; Lopes IF, 2013, GENETICA, V141, P195, DOI 10.1007/s10709-013-9718-5; Lyon BE, 2008, ANNU REV ECOL EVOL S, V39, P343, DOI 10.1146/annurev.ecolsys.39.110707.173354; McGuire HL, 2002, MOL ECOL NOTES, V2, P170, DOI 10.1046/j.1471-8286.2002.00191.x; MCKILLIGAN NG, 1990, AUK, V107, P334, DOI 10.2307/4087617; Meese RJ, 2012, CALIF FISH GAME, V98, P47; Minias P, 2016, BEHAV ECOL SOCIOBIOL, V70, P369, DOI 10.1007/s00265-015-2056-0; Mino CI, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-196; Mino Carolina Isabel, 2009, Oecologia Brasiliensis, V13, P141; Mino CI, 2009, J EXP ZOOL PART A, V311A, P453, DOI 10.1002/jez.543; Souza ASMDE, 2013, J EXP ZOOL PART A, V319A, P277, DOI 10.1002/jez.1792; Moralez-Silva Emmanuel, 2014, NeoBiota, V21, P49; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petry MV, 2005, ACTA ZOOL-STOCKHOLM, V86, P217, DOI 10.1111/j.1463-6395.2005.00200.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reid JM, 2015, EVOLUTION, V69, P59, DOI 10.1111/evo.12557; Riechert J, 2014, OECOLOGIA, V176, P715, DOI 10.1007/s00442-014-3040-5; Riechert J, 2014, PHYSIOL BIOCHEM ZOOL, V87, P420, DOI 10.1086/675682; Riechert J, 2013, J COMP PHYSIOL A, V199, P799, DOI 10.1007/s00359-013-0840-8; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sambrook J., 2001, MOL CLONING LAB MANU; Stadler A, 2011, PARASITOL RES MG, V1, P243, DOI 10.1007/978-3-642-19382-8_11; Stadele V, 2016, ECOL EVOL, V6, P6107, DOI 10.1002/ece3.2346; Sumasgutner P., 2014, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V116, P247; Telfair PC, 2004, WATERBIRDS, V27, P69, DOI 10.1675/1524-4695(2004)027[0069:LBSOTC]2.0.CO;2; TELFAIR RC, 1983, KLEBERG STUDIES NATU, P144; Turjeman SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep27976; Van de Casteele T, 2001, MOL ECOL, V10, P1539, DOI 10.1046/j.1365-294X.2001.01288.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Villela MM, 2010, REV SOC BRAS MED TRO, V43, P125, DOI 10.1590/S0037-86822010000200004; Voigt CC, 2004, GEN COMP ENDOCR, V135, P100, DOI 10.1016/j.ygcen.2003.08.005; VONHELVERSEN O, 1986, EXPERIENTIA, V42, P809, DOI 10.1007/BF01941531; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang J, 2007, HEREDITY, V99, P205, DOI 10.1038/sj.hdy.6800984; Wang JL, 2006, THEOR POPUL BIOL, V70, P300, DOI 10.1016/j.tpb.2005.11.003; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Yom-Tov Y, 2001, IBIS, V143, P133, DOI 10.1111/j.1474-919X.2001.tb04177.x; YOMTOV Y, 1980, BIOL REV, V55, P93, DOI 10.1111/j.1469-185X.1980.tb00689.x	76	4	4	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183153	10.1371/journal.pone.0183153	http://dx.doi.org/10.1371/journal.pone.0183153			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854191	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600032
J	Palatnik, A; Ye, S; Kendziorski, C; Iden, M; Zigman, JS; Hessner, MJ; Rader, JS				Palatnik, Anna; Ye, Shuyun; Kendziorski, Christina; Iden, Marissa; Zigman, Jessica S.; Hessner, Martin J.; Rader, Janet S.			Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer	PLOS ONE			English	Article							IMMUNOGLOBULIN-G; CELLS; EXPRESSION; CARCINOGENESIS; DISEASE; BLOOD	Objective Tumor cells that escape local tissue control can convert inflammatory cells from tumor suppressors to tumor promoters. Moreover, soluble immune-modulating factors secreted from the tumor environment can be difficult to identify in patient serum due to their low abundance. We used an alternative strategy to infer a metastatic signature induced by sera of cervical cancer patients. Methods Sera from patients with local and metastatic cervical cancer were used to induce a disease-specific transcriptional signature in cultured, healthy peripheral blood mononuclear cells (PBMCs). An empirical Bayesian method, EBarrays, was used to identify differentially expressed (DE) genes with a target false discovery rate of <5%. Ingenuity Pathway Analysis (IPA) software was used to detect the top molecular and cellular functions associated with the DE genes. IPA and in silco analysis was used to pinpoint candidate upstream regulators, including cancer-related microRNAs (miRNAs). Results We identified enriched pathways in the metastatic cervical group related to immune surveillance functions, such as downregulation of engulfment, accumulation, and phagocytosis of hematopoietic cells. The predicted top upstream genes were IL-10 and immunoglobulins. In silco analysis identified miRNAs predicted to drive the transcriptional signature. Two of the 4 miRNAs (miR-23a-3p and miR-944) were validated in a cohort of women with local and metastatic cervical cancer. Conclusions This study supports the use of a cell-based assay that uses PBMC "reporters" to predict biologically relevant factors in patient serum. Further, disease-specific transcriptional signatures induced by patient sera have the potential to differentiate patients with local versus metastatic disease.	[Palatnik, Anna; Iden, Marissa; Zigman, Jessica S.; Rader, Janet S.] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Ye, Shuyun; Kendziorski, Christina] UW Madison, Dept Biostat & Med Informat, Madison, WI USA; [Hessner, Martin J.] Med Coll Wisconsin, Childrens Hosp Wisconsin, Max McGee Natl Res Ctr Juvenile Diabet, Dept Pediat,Childrens Res Inst, Milwaukee, WI 53226 USA	Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison; Children's Hospital of Wisconsin; Medical College of Wisconsin	Palatnik, A (corresponding author), Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA.	apalatnik@mcw.edu		palatnik, anna/0000-0001-6568-0201				Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Cabrera SM, 2016, DIABETOLOGIA, V59, P414, DOI 10.1007/s00125-015-3843-x; Chen D, 2014, HUM MOL GENET, V23, P6047, DOI 10.1093/hmg/ddu304; Chopra V, 1998, CANCER INVEST, V16, P152, DOI 10.3109/07357909809050029; Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047; Gening TP, 2014, B EXP BIOL MED+, V157, P776, DOI 10.1007/s10517-014-2665-z; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grasedieck S, 2012, LEUKEMIA, V26, P2414, DOI 10.1038/leu.2012.106; Grigsby PW, 2004, J CLIN ONCOL, V22, P2167, DOI 10.1200/JCO.2004.09.035; Gurram B, 2016, CLIN EXP IMMUNOL, V184, P36, DOI 10.1111/cei.12753; Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kobayashi A, 2008, MUCOSAL IMMUNOL, V1, P412, DOI 10.1038/mi.2008.33; Lan HY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/125094; Levy H, 2012, GENES IMMUN, V13, P593, DOI 10.1038/gene.2012.41; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liao QY, 2015, ONCOTARGET, V6, P40081, DOI 10.18632/oncotarget.5542; Mohme M, 2016, NAT REV CLIN ONCOL; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Ortiz-Quintero B, 2016, CELL PROLIFERAT, V49, P281, DOI 10.1111/cpr.12262; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Tanikawa T, 2012, CANCER RES, V72, P420, DOI 10.1158/0008-5472.CAN-10-4627; Viswanathan V, 2014, J MOL MED, V92, P1129, DOI 10.1007/s00109-014-1208-4; Wang JP, 2014, ONCOTARGET, V5, P9727, DOI 10.18632/oncotarget.2359; Wang Y, 2016, CANCER DISCOV, V6, P1022, DOI 10.1158/2159-8290.CD-15-1412; Xie H, 2015, INT J CANCER, V136, pE230, DOI 10.1002/ijc.29160; Zhang QW, 2005, J CLIN INVEST, V115, P2855, DOI 10.1172/JCI25429	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0181242	10.1371/journal.pone.0181242	http://dx.doi.org/10.1371/journal.pone.0181242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854209	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600005
J	Sobolciak, P; Ali, A; Hassan, MK; Helal, MI; Tanvir, A; Popelka, A; Al-Maadeed, MA; Krupa, I; Mahmoud, KA				Sobolciak, Patrik; Ali, Adnan; Hassan, Mohammad K.; Helal, Mohamed I.; Tanvir, Aisha; Popelka, Anton; Al-Maadeed, Mariam A.; Krupa, Igor; Mahmoud, Khaled A.			2D Ti3C2Tx (MXene)-reinforced polyvinyl alcohol (PVA) nanofibers with enhanced mechanical and electrical properties	PLOS ONE			English	Article							2-DIMENSIONAL TITANIUM CARBIDE; HIGH VOLUMETRIC CAPACITANCE; POLY(VINYL ALCOHOL); HYBRID MEMBRANES; THIN-FILMS; NANOCOMPOSITES; COMPOSITE; FABRICATION; NANOCELLULOSE; CONDUCTIVITY	Novel 2D Ti3C2Tx (MXene)-reinforced polyvinyl alcohol (PVA) nanofibers have been successfully fabricated by an electrospinning technique. The high aspect ratio, hydrophilic surfaces, and metallic conductivity of delaminated MXene nanosheet render it promising nanofiller for high performance nanocomposites. Cellulose nanocrystals (CNC) were used to improve the mechanical properties of the nanofibers. The obtained electrospun nanofibers had diameter from 174 to 194 nm depending on ratio between PVA, CNC and MXene. Dynamic mechanical analysis demonstrated an increase in the elastic modulus from 392 MPa for neat PVA fibers to 855 MPa for fibers containing CNC and MXene at 25 degrees C. Moreover, PVA nanofibers containing 0.14 wt. % Ti3C2Tx exhibited dc conductivity of 0.8 mS/cm conductivity which is superior compared to similar composites prepared using methods other than electrospinning. Improved mechanical and electrical characteristics of the Ti3C2Tx/CNC/PVA composites make them viable materials for high performance energy applications.	[Sobolciak, Patrik; Hassan, Mohammad K.; Tanvir, Aisha; Popelka, Anton; Al-Maadeed, Mariam A.] Qatar Univ, Ctr Adv Mat, Doha, Qatar; [Ali, Adnan; Helal, Mohamed I.; Mahmoud, Khaled A.] HBKU, QEERI, Doha, Qatar; [Al-Maadeed, Mariam A.] Qatar Univ, Mat Sci & Technol Program, Doha, Qatar; [Krupa, Igor] Qatar Univ, QAPCO Polymer Chair, Ctr Adv Mat, Doha, Qatar; [Mahmoud, Khaled A.] Port Said Univ, Dept Phys & Math Engn, Fac Engn, Port Said, Egypt	Qatar University; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Environment & Energy Research Institute; Qatar University; Qatar University; Egyptian Knowledge Bank (EKB); Port Said University	Mahmoud, KA (corresponding author), HBKU, QEERI, Doha, Qatar.; Mahmoud, KA (corresponding author), Port Said Univ, Dept Phys & Math Engn, Fac Engn, Port Said, Egypt.	kmahmoud@hbku.edu.qa	Hassan, Mohammad/GZA-7507-2022; Ali, Adnan/AAF-1297-2020; Helal, Mohamed I./S-7100-2016	Hassan, Mohammad/0000-0002-1712-0004; Helal, Mohamed I./0000-0002-0419-432X; Tanvir, Aisha/0000-0003-4788-6921; Hassan, Mohamed/0000-0002-5316-2463; Ali, Adnan/0000-0003-3976-326X; Mahmoud, Khaled/0000-0003-1246-4067; Al-maadeed, Somaya/0000-0002-0241-2899	NPRP grants from the Qatar National Research Fund (A Member of Qatar Foundation) [7-1724-3-438, 9-254-2-120]	NPRP grants from the Qatar National Research Fund (A Member of Qatar Foundation)	This work was made possible by NPRP grants # 7-1724-3-438, and 9-254-2-120 from the Qatar National Research Fund (A Member of Qatar Foundation).	Ali A, 2014, APPL PHYS A-MATER, V114, P323, DOI 10.1007/s00339-013-8136-y; Anasori B, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.98; Barsoum MW, 2000, PROG SOLID STATE CH, V28, P201, DOI 10.1016/S0079-6786(00)00006-6; Bettaieb F, 2015, IND CROP PROD, V72, P175, DOI 10.1016/j.indcrop.2014.12.038; Bolto B, 2009, PROG POLYM SCI, V34, P969, DOI 10.1016/j.progpolymsci.2009.05.003; Chang CY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2198480; Chang TE, 2006, POLYMER, V47, P7740, DOI 10.1016/j.polymer.2006.09.013; Cho MJ, 2011, J IND ENG CHEM, V17, P36, DOI 10.1016/j.jiec.2010.10.006; Choi KH, 2013, J KOREAN PHYS SOC, V62, P269, DOI 10.3938/jkps.62.269; Come J, 2012, J ELECTROCHEM SOC, V159, pA1368, DOI 10.1149/2.003208jes; DeValve C, 2013, CARBON, V63, P71, DOI 10.1016/j.carbon.2013.06.041; Ghidiu M, 2014, NATURE, V516, P78, DOI 10.1038/nature13970; Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104; Gohil JM, 2006, J POLYM RES, V13, P161, DOI 10.1007/s10965-005-9023-9; Habibi Y, 2014, CHEM SOC REV, V43, P1519, DOI 10.1039/c3cs60204d; Halim J, 2014, CHEM MATER, V26, P2374, DOI 10.1021/cm500641a; Hassan MK, 2016, ARAB J CHEM, V9, P305, DOI 10.1016/j.arabjc.2015.07.016; Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7; Jonscher AK, 1999, J PHYS D APPL PHYS, V32, pR57, DOI 10.1088/0022-3727/32/14/201; Kaboorani A, 2012, EUR POLYM J, V48, P1829, DOI 10.1016/j.eurpolymj.2012.08.008; Khazaka R, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/6/065501; Kim CH, 2012, CARBON, V50, P2472, DOI 10.1016/j.carbon.2012.01.069; Kim DS, 2004, J MEMBRANE SCI, V240, P37, DOI 10.1016/j.memsci.2004.04.010; Leung ACW, 2011, SMALL, V7, P302, DOI 10.1002/smll.201001715; Li W, 2014, CARBOHYD POLYM, V113, P403, DOI 10.1016/j.carbpol.2014.07.031; Liau LCK, 2017, J LUMIN, V181, P217, DOI 10.1016/j.jlumin.2016.08.067; Ling Z, 2014, P NATL ACAD SCI USA, V111, P16676, DOI 10.1073/pnas.1414215111; Lukatskaya MR, 2013, SCIENCE, V341, P1502, DOI 10.1126/science.1241488; Luzi F, 2014, IND CROP PROD, V56, P175, DOI 10.1016/j.indcrop.2014.03.006; Mandal A, 2014, J IND ENG CHEM, V20, P462, DOI 10.1016/j.jiec.2013.05.003; Naguib M, 2014, ADV MATER, V26, P992, DOI 10.1002/adma.201304138; Obrzut J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195211; Paralikar S., 2006, THESIS; Park Hongkwan, 2012, Journal of Pharmaceutical Investigation, V42, P89, DOI 10.1007/s40005-012-0014-7; Peng FB, 2007, J MEMBRANE SCI, V297, P236, DOI 10.1016/j.memsci.2007.03.048; Ramalingam KJ, 2014, SYNTHETIC MET, V191, P113, DOI 10.1016/j.synthmet.2014.03.004; REHWALD W, 1987, Z PHYS B CON MAT, V68, P143, DOI 10.1007/BF01304219; Sairam M, 2006, J MEMBRANE SCI, V283, P65, DOI 10.1016/j.memsci.2006.06.013; Schildknecht CE, 1973, J POLYM SCI POL LETT; Sheng N, 2004, POLYMER, V45, P487, DOI 10.1016/j.polymer.2003.10.100; Tang Q, 2013, PROG MATER SCI, V58, P1244, DOI 10.1016/j.pmatsci.2013.04.003; Thakur VK, 2014, RSC ADV, V4, P18240, DOI 10.1039/c4ra01894j; Thakur VK, 2014, RSC ADV, V4, P6677, DOI 10.1039/c3ra46592f; Thakur VK, 2012, J MATER CHEM, V22, P5951, DOI 10.1039/c2jm15665b; Yang EL, 2008, MATER LETT, V62, P3555, DOI 10.1016/j.matlet.2008.03.049; Zhang XD, 2013, ANGEW CHEM INT EDIT, V52, P4361, DOI 10.1002/anie.201300285; Zhang XT, 2011, J MATER CHEM, V21, P6494, DOI 10.1039/c1jm10239g; Zhao MQ, 2015, ADV MATER, V27, P339, DOI 10.1002/adma.201404140	48	68	71	18	277	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183705	10.1371/journal.pone.0183705	http://dx.doi.org/10.1371/journal.pone.0183705			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854241	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600055
J	Verma, K; Jyotsana, N; Buenting, I; Luther, S; Pfanne, A; Thum, T; Ganser, A; Heuser, M; Weissinger, EM; Hambach, L				Verma, Kriti; Jyotsana, Nidhi; Buenting, Ivonne; Luther, Susanne; Pfanne, Angelika; Thum, Thomas; Ganser, Arnold; Heuser, Michael; Weissinger, Eva M.; Hambach, Lothar			miR-625-3p is upregulated in CD8+T cells during early immune reconstitution after allogeneic stem cell transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; MINOR HISTOCOMPATIBILITY ANTIGENS; CD8(+) T-CELLS; PROLIFERATION; EXPRESSION; MICRORNA; RECEPTOR; DIFFERENTIATION; LYMPHOCYTES; RESPONSES	Alloreactive CD8+ T-cells mediate the curative graft-versus-leukaemia effect, the anti-viral immunity and graft-versus-host-disease (GvHD) after allogeneic stem cell transplantation (SCT). Thus, immune reconstitution with CD8+ T-cells is critical for the outcome of patients after allogeneic SCT. Certain miRNAs such as miR-146a or miR-155 play an important role in the regulation of post-transplant immunity in mice. While some miRNAs e.g. miR-423 or miR-155 are regulated in plasma or full blood during acute GvHD also in man, the relevance and expression profile of miRNAs in T-cells after allogeneic SCT is unknown. miR-625-3p has recently been described to be overexpressed in colorectal malignancies where it promotes migration, invasion and apoptosis resistance. Since similar regulative functions in cancer and T-cells have been described for an increasing number of miRNAs, we assumed a role for the cancer-related miR-625-3p also in T-cells. Here, we studied miR-625-3p expression selectively in CD8+ T-cells both in vitro and during immune reconstitution after allogeneic SCT in man. T-cell receptor stimulation lead to miR-625-3p upregulation in human CD8+ T-cells in vitro. Maintenance of elevated miR-625-3p expression levels was dependent on ongoing T-cell proliferation and was abrogated by withdrawal of interleukin 2 or the mTOR inhibitor rapamycin. Finally, miR-625-3p expression was analyzed in human CD8+ T-cells purified from 137 peripheral blood samples longitudinally collected from 74 patients after allogeneic SCT. miR-625-3p expression was upregulated on day 25 and on day 45, i.e. during the early phase of CD8+ T-cell reconstitution after allogeneic SCT and subsequently declined with completion of CD8+ T-cell reconstitution until day 150. In conclusion, this study has shown for the first time that miR-625-3p is regulated in CD8+ T-cells during proliferation in vitro and during early immune reconstitution after allogeneic SCT in vivo. These results warrant further studies to identify the targets and function of miR-625-3p in CD8+ T-cells and to analyze its predictive value for an effective immune reconstitution.	[Verma, Kriti; Jyotsana, Nidhi; Buenting, Ivonne; Luther, Susanne; Ganser, Arnold; Heuser, Michael; Weissinger, Eva M.; Hambach, Lothar] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Verma, Kriti] Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Pfanne, Angelika; Thum, Thomas] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, Hannover, Germany; [Thum, Thomas] Hannover Med Sch, REBIRTH Excellence Cluster, Hannover, Germany; [Thum, Thomas] Imperial Coll London, Natl Heart & Lung Inst, London, England	Hannover Medical School; Hannover Medical School; Hannover Medical School; Imperial College London	Hambach, L (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	hambach.lothar@mh-hannover.de	Heuser, Michael/S-2363-2017	Heuser, Michael/0000-0001-5318-9044; Verma, Kriti/0000-0002-7368-8171; Jyotsana, Nidhi/0000-0003-2090-2856	German Federal Ministry of Education and Research [01EO1302]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (reference number: 01EO1302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Atarod S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00420; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; BISELLI R, 1992, SCAND J IMMUNOL, V35, P439, DOI 10.1111/j.1365-3083.1992.tb02879.x; Bleakley M, 2011, IMMUNOL CELL BIOL, V89, P396, DOI 10.1038/icb.2010.124; Bondanza A, 2011, BLOOD, V117, P6469, DOI 10.1182/blood-2010-11-320366; Borchers S, 2011, TRANSPL INFECT DIS, V13, P222, DOI 10.1111/j.1399-3062.2011.00626.x; Breslin EM, 2005, BRIT J PHARMACOL, V144, P791, DOI 10.1038/sj.bjp.0706061; CHILSON OP, 1989, EUR J IMMUNOL, V19, P389, DOI 10.1002/eji.1830190225; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Fallen PR, 2003, BONE MARROW TRANSPL, V32, P1001, DOI 10.1038/sj.bmt.1704235; Ferguson I, 2014, J IMMUNOL S, V192; Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Grigoryev YA, 2011, J IMMUNOL, V187, P2233, DOI 10.4049/jimmunol.1101233; Hambach L, 2005, CURR OPIN IMMUNOL, V17, P202, DOI 10.1016/j.coi.2005.01.010; Ikezoe T, 2007, LEUKEMIA RES, V31, P673, DOI 10.1016/j.leukres.2006.08.001; KANELLOPOULOS JM, 1985, EUR J IMMUNOL, V15, P479, DOI 10.1002/eji.1830150512; Kawase T, 2008, BLOOD, V111, P3286, DOI 10.1182/blood-2007-10-118950; Khan AA, 2013, BLOOD, V121, P4473, DOI 10.1182/blood-2012-06-435412; Labbaye C, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-13; Liang Y, 2015, J LEUKOCYTE BIOL, V97, P487, DOI 10.1189/jlb.1RU0814-369R; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Podgorny PJ, 2014, BIOL BLOOD MARROW TR, V20, P450, DOI 10.1016/j.bbmt.2014.01.002; Ranganathan P, 2012, BLOOD, V119, P4786, DOI 10.1182/blood-2011-10-387522; Rasmussen MH, 2013, MOL ONCOL, V7, P637, DOI 10.1016/j.molonc.2013.02.016; Rasmussen MH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12436; Riddell SR, 2003, BLOOD REV, V17, P153, DOI 10.1016/S0268-960X(03)00007-9; Rusca N, 2012, MOL CELL BIOL, V32, P4432, DOI 10.1128/MCB.00824-12; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Spiegel JC, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002080; Stickel N, 2014, BLOOD, V124, P2586, DOI 10.1182/blood-2014-04-569046; Storek J, 2008, SEMIN IMMUNOPATHOL, V30, P425, DOI 10.1007/s00281-008-0132-5; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Williams KA, 2007, SEMIN IMMUNOL, V19, P318, DOI 10.1016/j.smim.2007.10.004; Wu YX, 2015, BLOOD, V126, P1314, DOI 10.1182/blood-2015-02-627356; Xiao B, 2013, BLOOD, V122, P3365, DOI 10.1182/blood-2013-06-510586; Zhao XH, 2013, NANO, V8, DOI 10.1142/S1793292013500318	42	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183828	10.1371/journal.pone.0183828	http://dx.doi.org/10.1371/journal.pone.0183828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854245	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600059
J	Yang, XF; Torres, M; Kirkpatrick, S; Curran, WJ; Liu, T				Yang, Xiaofeng; Torres, Mylin; Kirkpatrick, Stephanie; Curran, Walter J.; Liu, Tian			Ultrasound 2D strain measurement for arm lymphedema using deformable registration: A feasibility study	PLOS ONE			English	Article							NONRIGID IMAGE REGISTRATION; B-MODE ECHOCARDIOGRAMS; POST-BREAST CANCER; ELASTIC PROPERTIES; DISPLACEMENT ESTIMATION; 3D ECHOCARDIOGRAPHY; FREEHAND ULTRASOUND; MEDICAL ULTRASOUND; BIOLOGICAL TISSUES; LARGE DEFORMATIONS	Purpose Lymphedema, a swelling of the extremity, is a debilitating morbidity of cancer treatment. Current clinical evaluation of lymphedema is often based on medical history and physical examinations, which is subjective. In this paper, the authors report an objective, quantitative 2D strain imaging approach using a hybrid deformable registration to measure soft-tissue stiffness and assess the severity of lymphedema. Methods The authors have developed a new 2D strain imaging method using registration of pre-and post-compression ultrasound B-mode images, which combines the statistical intensity-and structure-based similarity measures using normalized mutual information (NMI) metric and normalized sum-of-squared-differences (NSSD), with an affine-based global and B-spline-based local transformation model. This 2D strain method was tested through a series of experiments using elastography phantom under various pressures. Clinical feasibility was tested with four participants: two patients with arm lymphedema following breast-cancer radiotherapy and two healthy volunteers. Results The phantom experiments have shown that the proposed registration-based strain method significantly increased the signal-to-noise and contrast-to-noise ratio under various pressures as compared with the commonly used cross-correlation-based elastography method. In the pilot study, the strain images were successfully generated for all participants. The averaged strain values of the lymphedema affected arms were much higher than those of the normal arms. Conclusions The authors have developed a deformable registration-based 2D strain method for the evaluation of arm lymphedema. The initial findings are encouraging and a large clinical study is warranted to further evaluate this 2D ultrasound strain imaging technology.	[Yang, Xiaofeng; Liu, Tian] Emory Univ, Radiat Oncol, Atlanta, GA 30322 USA; Emory Univ, Winship Canc Inst, Atlanta, GA USA	Emory University; Emory University	Yang, XF; Liu, T (corresponding author), Emory Univ, Radiat Oncol, Atlanta, GA 30322 USA.	Xiaofeng.Yang@emory.edu; tliu34@emory.edu	Yang, Xiaofeng/G-9479-2012; Yang, Xiaofeng/AAN-9258-2020	Yang, Xiaofeng/0000-0001-9023-5855	DOD PCRP [W81XWH-13-1-0269]; Dunwoody Golf Club Prostate Cancer Research Award; Winship Cancer Institute of Emory University; Susan Komen for the Cure foundation; Department of Defense (DoD) Prostate Cancer Research Program (PCRP) Award [W81XWH-13-1-0269]	DOD PCRP; Dunwoody Golf Club Prostate Cancer Research Award; Winship Cancer Institute of Emory University; Susan Komen for the Cure foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense (DoD) Prostate Cancer Research Program (PCRP) Award	This research was supported in part by DOD PCRP Award W81XWH-13-1-0269, Dunwoody Golf Club Prostate Cancer Research Award, a philanthropic award provided by the Winship Cancer Institute of Emory University, and Susan Komen for the Cure foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported in part by the Department of Defense (DoD) Prostate Cancer Research Program (PCRP) Award W81XWH-13-1-0269 and Dunwoody Golf Club Prostate Cancer Research Award, a philanthropic award provided by the Winship Cancer Institute of Emory University.	Almeida NM, 2012, PROC SPIE, V8320, DOI 10.1117/12.911401; Arbuck SG, 1998, ANN ONCOL, V9, P12; Bar V, 2010, INT J RADIAT ONCOL, V76, P85, DOI 10.1016/j.ijrobp.2009.01.024; Basarab A, 2007, IM PROC 2007 ICIP 20; Basarab A, 2008, MED IMAGE ANAL, V12, P259, DOI 10.1016/j.media.2007.10.007; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Chandrashekara R, 2004, IEEE T MED IMAGING, V23, P1245, DOI 10.1109/TMI.2004.834607; Chaturvedi P, 1998, IEEE T ULTRASON FERR, V45, P1022, DOI 10.1109/58.710585; Chen H, 2007, ULTRASOUND MED BIOL, V33, P48, DOI 10.1016/j.ultrasmedbio.2006.07.022; Chen LJ, 2009, MED IMAGE ANAL, V13, P286, DOI 10.1016/j.media.2008.10.007; De Craene M, 2012, MED IMAGE ANAL, V16, P427, DOI 10.1016/j.media.2011.10.006; Deprez JF, 2008, ULTRASON, P544, DOI 10.1109/ULTSYM.2008.0132; Doyley MM, 2012, PHYS MED BIOL, V57, pR35, DOI 10.1088/0031-9155/57/3/R35; Doyley MM, 2001, ULTRASOUND MED BIOL, V27, P1347, DOI 10.1016/S0301-5629(01)00429-X; Elen A, 2008, IEEE T MED IMAGING, V27, P1580, DOI 10.1109/TMI.2008.2004420; Forsey D. R., 1988, Computer Graphics, V22, P205, DOI 10.1145/378456.378512; Fu MR, 2009, AM J NURS, V109, P48, DOI 10.1097/01.NAJ.0000357172.94131.58; Fu MR, 2009, AM J NURS, V109, P34, DOI 10.1097/01.NAJ.0000358492.91678.78; Gergich NLS, 2008, CANCER-AM CANCER SOC, V112, P2809, DOI 10.1002/cncr.23494; Greenleaf JF, 2003, ANNU REV BIOMED ENG, V5, P57, DOI 10.1146/annurev.bioeng.5.040202.121623; Hall TJ, 2003, ULTRASOUND MED BIOL, V29, P427, DOI 10.1016/S0301-5629(02)00733-0; Hayes S, 2010, CANCER, V116, P259, DOI 10.1002/cncr.24733; Hayes SC, 2008, J CLIN ONCOL, V26, P3536, DOI 10.1200/JCO.2007.14.4899; Hennessy R, 2011, P SOC PHOTO-OPT INS, V7892; Hiltawsky KM, 2001, ULTRASOUND MED BIOL, V27, P1461, DOI 10.1016/S0301-5629(01)00434-3; Insana MF, 1999, LECT NOTES COMPUT SC, V1613, P1; Jiang J, 2007, PHYS MED BIOL, V52, P3773, DOI 10.1088/0031-9155/52/13/008; Konofagou EE, 2001, ULTRASOUND MED BIOL, V27, P1387, DOI 10.1016/S0301-5629(01)00433-1; Ledesma-Carbayo MJ, 2005, IEEE T MED IMAGING, V24, P1113, DOI 10.1109/TMI.2005.852050; Lee S, 1997, IEEE T VIS COMPUT GR, V3, P228, DOI 10.1109/2945.620490; Liang Y, 2010, PHYS MED BIOL, V55, P6377, DOI 10.1088/0031-9155/55/21/003; Lindop JE, 2006, ULTRASOUND MED BIOL, V32, P529, DOI 10.1016/j.ultrasmedbio.2005.11.018; Lindop JE, 2008, IEEE T ULTRASON FERR, V55, P94, DOI 10.1109/TUFFC.2008.620; Lopata RGP, 2009, ULTRASOUND MED BIOL, V35, P796, DOI 10.1016/j.ultrasmedbio.2008.11.002; Maurice RL, 1999, IEEE T MED IMAGING, V18, P593, DOI 10.1109/42.790459; ODONNELL M, 1994, IEEE T ULTRASON FERR, V41, P314, DOI 10.1109/58.285465; Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Parker KJ, 2011, PHYS MED BIOL, V56, pR1, DOI 10.1088/0031-9155/56/1/R01; Pellot-Barakat C, 2004, IEEE T MED IMAGING, V23, P153, DOI 10.1109/TMI.2003.822825; Pesavento A, 1999, IEEE T ULTRASON FERR, V46, P1057, DOI 10.1109/58.796111; Piella G, 2013, MED IMAGE ANAL, V17, P348, DOI 10.1016/j.media.2013.01.002; Rappaport D, 2006, ULTRASOUND MED BIOL, V32, P1181, DOI 10.1016/j.ultrasmedbio.2006.05.005; Richards MS, 2013, ULTRASOUND MED BIOL, V39, P515, DOI 10.1016/j.ultrasmedbio.2012.09.023; Righetti R, 2004, ULTRASOUND MED BIOL, V30, P215, DOI 10.1016/j.ultrasmedbio.2003.10.022; Righetti R, 2007, PHYS MED BIOL, V52, P6525, DOI 10.1088/0031-9155/52/21/013; Rivaz H, 2011, IEEE T MED IMAGING, V30, P928, DOI 10.1109/TMI.2010.2091966; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sagen A, 2009, ACTA ONCOL, V48, P1102, DOI 10.3109/02841860903061683; Skovoroda AR, 1999, IEEE T ULTRASON FERR, V46, P523, DOI 10.1109/58.764839; Studholme C, 1997, MED PHYS, V24, P25, DOI 10.1118/1.598130; Suhling M, 2005, IEEE T IMAGE PROCESS, V14, P525, DOI 10.1109/TIP.2004.838709; Treece G, 2011, INTERFACE FOCUS, V1, P540, DOI 10.1098/rsfs.2011.0011; Varghese T, 1998, ULTRASOUND MED BIOL, V24, P915, DOI 10.1016/S0301-5629(98)00047-7; Varghese T, 1996, ULTRASOUND MED BIOL, V22, P1043, DOI 10.1016/S0301-5629(96)00128-7; Viola F, 2003, IEEE T ULTRASON FERR, V50, P392, DOI 10.1109/TUFFC.2003.1197962; Wells PNT, 2011, J R SOC INTERFACE, V8, P1521, DOI 10.1098/rsif.2011.0054; Wells Peter N. T., 2011, Journal of Medical Engineering & Technology, V35, P289, DOI 10.3109/03091902.2011.595531; Yang XF, 2014, INT J RADIAT ONCOL, V90, P1225, DOI 10.1016/j.ijrobp.2014.08.350; Yang XF, 2014, PROC SPIE, V9040, DOI 10.1117/12.2043865; Yeung F, 1998, ULTRASOUND MED BIOL, V24, P427, DOI 10.1016/S0301-5629(97)00281-0; Zhu YN, 2002, ULTRASONIC IMAGING, V24, P161, DOI 10.1177/016173460202400303; Zhu YN, 1999, ULTRASONIC IMAGING, V21, P127, DOI 10.1177/016173469902100204	63	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0181250	10.1371/journal.pone.0181250	http://dx.doi.org/10.1371/journal.pone.0181250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854199	gold, Green Submitted, Green Published			2022-12-26	WOS:000408693600006
J	Zhou, R; Lin, X; Li, DY; Wang, XF; Greenbaum, J; Chen, YC; Zeng, CP; Lu, JM; Ao, ZX; Peng, LP; Bai, XC; Shen, J; Deng, HW				Zhou, Rou; Lin, Xu; Li, Ding-You; Wang, Xia-Fang; Greenbaum, Jonathan; Chen, Yuan-Cheng; Zeng, Chun-Ping; Lu, Jun-Min; Ao, Zeng-Xing; Peng, Lin-Ping; Bai, Xiao Chun; Shen, Jie; Deng, Hong-Wen			Identification of novel genetic loci for osteoporosis and/or rheumatoid arthritis using cFDR approach	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HISTOCOMPATIBILITY COMPLEX; ASSOCIATION; SUSCEPTIBILITY; POLYMORPHISMS; METAANALYSIS; EPIDEMIOLOGY; EXPRESSION; MODULATOR	There are co-morbidity between osteoporosis (OP) and rheumatoid arthritis (RA). Some genetic risk factors have been identified for these two phenotypes respectively in previous research; however, they accounted for only a small portion of the underlying total genetic variances. Here, we sought to identify additional common genetic loci associated with OP and/or RA. The conditional false discovery rate (cFDR) approach allows detection of additional genetic factors (those respective ones as well as common pleiotropic ones) for the two associated phenotypes. We collected and analyzed summary statistics provided by large, multi-center GWAS studies of FNK (femoral neck) BMD (a major risk factor for osteoporosis) (n = 53,236) and RA (n = 80,799). The conditional quantile-quantile (Q-Q) plots can assess the enrichment of SNPs related to FNK BMD and RA, respectively. Furthermore, we identified shared loci between FNK BMD and RA using conjunction cFDR (ccFDR). We found strong enrichment of p-values in FNK BMD when conditional Q-Q was done on RA and vice versa. We identified 30 novel OP-RA associated pleiotropic loci that have not been reported in previous OP or RA GWAS, 18 of which located in the MHC (major histocompatibility complex) region previously reported to play an important role in immune system and bone health. We identified some specific novel polygenic factors for OP and RA respectively, and identified 30 novel OP-RA associated pleiotropic loci. These discovery findings may offer novel pathobiological insights, and suggest new targets and pathways for drug development in OP and RA patients.	[Zhou, Rou; Lin, Xu; Wang, Xia-Fang; Chen, Yuan-Cheng; Zeng, Chun-Ping; Lu, Jun-Min; Ao, Zeng-Xing; Peng, Lin-Ping; Bai, Xiao Chun; Shen, Jie; Deng, Hong-Wen] Southern Med Univ, Dept Endocrinol & Metab, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Li, Ding-You] Univ Missouri, Sch Med, Dept Gastroenterol, Childrens Mercy Kansas City, Kansas City, MO 64108 USA; [Greenbaum, Jonathan; Deng, Hong-Wen] Tulane Univ, Ctr Bioinformat & Genom, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA	Southern Medical University - China; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Tulane University	Deng, HW (corresponding author), Southern Med Univ, Dept Endocrinol & Metab, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China.; Deng, HW (corresponding author), Tulane Univ, Ctr Bioinformat & Genom, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA.	hdeng2@tulane.edu			NIH [P50AR055081, R01AR057049, R01AR059781, D43TW009107, P20 GM109036, R01MH107354, R01MH104680, R01GM109068]; FOGARTY INTERNATIONAL CENTER [D43TW009107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the NIH (Grant Number: P50AR055081, R01AR057049, R01AR059781, D43TW009107, P20 GM109036, R01MH107354, R01MH104680, R01GM109068). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; AlFadhli S, 2013, IMMUNOL LETT, V150, P130, DOI 10.1016/j.imlet.2013.01.002; Andreassen OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003455; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Bauler TJ, 2011, DIS MODEL MECH, V4, P228, DOI 10.1242/dmm.006130; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Boyce BF, 2006, CURR OPIN RHEUMATOL, V18, P427, DOI 10.1097/01.bor.0000231913.32364.32; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Chen L, 2015, 2ND INTERNATIONAL CONFERENCE ON INFORMATION AND COMMUNICATION TECHNOLOGY FOR EDUCATION (ICTE 2015), P1; Chen YH, 2016, ARCH MED RES, V47, P134, DOI 10.1016/j.arcmed.2016.05.001; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Ferron M, 2011, CELL METAB, V14, P466, DOI 10.1016/j.cmet.2011.08.013; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Goertz B, 2003, CLIN EXP RHEUMATOL, V21, P333; Greenbaum J, 2017, BONE, V99, P62, DOI 10.1016/j.bone.2017.03.052; Haugeberg G, 2000, ARTHRITIS RHEUM, V43, P522, DOI 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y; Haugeberg G, 2000, ARTHRITIS RHEUM-US, V43, P2776, DOI 10.1002/1529-0131(200012)43:12<2776::AID-ANR18>3.0.CO;2-N; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; Jiao JT, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0234-y; Kim K, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204749; Kochi Y, 2004, ARTHRITIS RHEUM, V50, P63, DOI 10.1002/art.11366; Li N, 2014, MENOPAUSE, V21, P515, DOI 10.1097/GME.0b013e3182a34981; Liu YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003160; Liu ZH, 1997, OSTEOPOROSIS INT, V7, P84, DOI 10.1007/BF03194349; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; Morel J, 2004, ANN RHEUM DIS, V63, P1581, DOI 10.1136/ard.2003.012294; Mosaad YM, 2014, HUM IMMUNOL, V75, P452, DOI 10.1016/j.humimm.2014.02.009; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; PECK WA, 1993, AM J MED, V94, P646; Pei YF, 2014, HUM GENET, V133, P265, DOI 10.1007/s00439-013-1366-4; Peng C, 2017, BONE, V103, P70, DOI 10.1016/j.bone.2017.06.016; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin L, 2016, PLOS ONE, V11; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Roshandel D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028031; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Stanford SM, 2013, ARTHRITIS RHEUM-US, V65, P1171, DOI 10.1002/art.37872; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Szekanecz Z, 1998, CA BONE, V1, P45; Tsao HW, 2013, P NATL ACAD SCI USA, V110, P15776, DOI 10.1073/pnas.1304343110; Vacher J, 2013, ANN NY ACAD SCI, V1280, P52, DOI 10.1111/nyas.12014; Vignal C, 2009, ARTHRITIS RHEUM-US, V60, P53, DOI 10.1002/art.24138; Yoshida S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104587; Zeng C.P., 2016, J DIABETES; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878; Zheng WY, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0715-1; Zhou Y, 2015, FASEB J, V29, P1635, DOI 10.1096/fj.14-260844; Zhu H, 2016, PLOS ONE, V11	55	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183842	10.1371/journal.pone.0183842	http://dx.doi.org/10.1371/journal.pone.0183842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854271	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600061
J	Haj, S; Chodick, G; Refaeli, R; Goren, S; Shalev, V; Muhsen, K				Haj, Saeda; Chodick, Gabriel; Refaeli, Rotem; Goren, Sophy; Shalev, Varda; Muhsen, Khitam			Associations of Helicobacter pylori infection and peptic disease with diabetic mellitus: Results from a large population-based study	PLOS ONE			English	Article							HUMAN GASTRIC-MUCOSA; SOCIOECONOMIC POSITION; CELLULAR-LOCALIZATION; RISK-FACTORS; METAANALYSIS; PEPSINOGENS; GHRELIN; STOMACH; LEPTIN; IMMUNOFLUORESCENCE	Background Evidence is conflicting regarding the association between Helicobacter pylori infection and diabetes mellitus. The study objective was to examine associations of H. pylori infection, gastric ulcers and duodenal ulcers, with diabetes mellitus. Methods This cross-sectional study was undertaken using coded data from the computerized database of Maccabi Health Services in Israel, on 147,936 individuals aged 25-95 years who underwent the urea breath test during 2002-2012. Multiple logistic regression models were conducted, while adjusting for known risk factors for diabetes mellitus. Results A H. pylori positive test was recorded for 76,992 (52.0%) individuals and diabetes for 12,207 (8.3%). The prevalence of diabetes was similar in individuals with and without H. pylori infection, but this association was modified (P for heterogeneity 0.049) by body mass index (BMI): adjusted odds ratio (aOR) 1.16 (95% confidence intervals (CI) 1.04-1.29) in persons with BMI<25 kg/m(2) versus aOR 1.03 (95% CI 0.98-1.08) in persons with BMI >= 25 kg/m(2). Diabetes mellitus prevalence was higher in persons with gastric (aOR 1.20 (95% CI 1.06-1.34)) and duodenal ulcers (aOR 1.20 (95% CI 1.12-1.28)) compared to persons without these diagnoses. Conclusions In this large population-based study, we demonstrated significant positive associations, albeit of small magnitude, of H. pylori infection and peptic disease with diabetes. The long-term gastric inflammation and associated-damage to the gastric mucosa might play a role in such associations.	[Haj, Saeda; Chodick, Gabriel; Refaeli, Rotem; Goren, Sophy; Shalev, Varda; Muhsen, Khitam] Tel Aviv Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel; [Chodick, Gabriel; Shalev, Varda] Maccabi Hlth Serv, Med Div, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Muhsen, K (corresponding author), Tel Aviv Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel.	kmuhsen@post.tau.ac.il		Muhsen, Khitam/0000-0003-1086-7559; /0000-0002-5189-8995				Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Bahadoran Z, 2015, ENDOCRINOL METAB, V30, P280; Bajaj Sarita, 2014, Indian J Endocrinol Metab, V18, P694, DOI 10.4103/2230-8210.139235; Baudron CR, 2013, HELICOBACTER, V18, P44, DOI 10.1111/hel.12077; Bener A, 2007, TURK J GASTROENTEROL, V18, P225; Chen Y, 2012, J INFECT DIS, V205, P1195, DOI 10.1093/infdis/jis106; Chuang CH, 2009, HELICOBACTER, V14, P54, DOI 10.1111/j.1523-5378.2009.00653.x; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Demir M, 2008, DIGEST DIS SCI, V53, P2646, DOI 10.1007/s10620-007-0185-7; Devrajani BR, 2010, INT J DIABETES DEV C, V30, P22, DOI 10.4103/0973-3930.60008; Dore MP, 2000, NUTRITION, V16, P407, DOI 10.1016/S0899-9007(00)00267-7; Espelt A, 2011, CURR DIABETES REV, V7, P148, DOI 10.2174/157339911795843131; Francois F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-37; Gillum RF, 2004, J NATL MED ASSOC, V96, P1470; Goll R, 2007, HELICOBACTER, V12, P185, DOI 10.1111/j.1523-5378.2007.00495.x; Graham DY, 2006, CLIN GASTROENTEROL H, V4, P306, DOI 10.1016/j.cgh.2005.11.003; Han X, 2016, DIABETES-METAB RES, V32, P95, DOI 10.1002/dmrr.2677; HARRIS MI, 1995, CLIN INVEST MED, V18, P231; Heymann AD, 2006, DIABETES RES CLIN PR, V71, P290, DOI 10.1016/j.diabres.2005.07.002; Hsieh MC, 2013, EUR J CLIN INVEST, V43, P949, DOI 10.1111/eci.12124; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Israel Centeral Bureau of Statistics, 2013, CHAR CLASS GEAGR UN; Israel Minsitry of Health, 2014, NAT PROGR QUAL IND C; Israel Minsitry of Health, 2012, ISR NAT HLTH INT SUR; Jeon CY, 2012, DIABETES CARE, V35, P520, DOI 10.2337/dc11-1043; Ko GTC, 2001, ENDOCR RES, V27, P171, DOI 10.1081/ERC-100107178; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lutsey PL, 2009, DIABETIC MED, V26, P149, DOI 10.1111/j.1464-5491.2008.02632.x; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; MEDALIE JH, 1975, ARCH INTERN MED, V135, P811, DOI 10.1001/archinte.135.6.811; Miki K, 2007, J DIGEST DIS, V8, P8, DOI 10.1111/j.1443-9573.2007.00278.x; Muhsen K, 2012, EPIDEMIOL INFECT, V140, P1207, DOI 10.1017/S0950268811002081; Muhsen K, 2012, J TROP PEDIATRICS, V58, P208, DOI 10.1093/tropej/fmr068; Powers AC, 2013, HARRISONS PRINCIPLES; Robinson K, 2008, GUT, V57, P1375, DOI 10.1136/gut.2007.137539; Roper J, 2008, J CLIN ENDOCR METAB, V93, P2350, DOI 10.1210/jc.2007-2057; SAMLOFF IM, 1973, GASTROENTEROLOGY, V65, P36; SAMLOFF IM, 1971, GASTROENTEROLOGY, V61, P185; Steyn NP, 2004, PUBLIC HEALTH NUTR, V7, P147, DOI 10.1079/PHN2003586; Tamura T, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1371-2; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wang F, 2013, SCAND J INFECT DIS, V45, P930, DOI 10.3109/00365548.2013.844351; Weitzman D, 2014, HYPERTENSION, V64, P501, DOI 10.1161/HYPERTENSIONAHA.114.03718; Xia HHX, 2001, AM J GASTROENTEROL, V96, P1039, DOI 10.1111/j.1572-0241.2001.03604.x; Zhou XY, 2013, DIABETES RES CLIN PR, V99, P200, DOI 10.1016/j.diabres.2012.11.012	49	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183687	10.1371/journal.pone.0183687	http://dx.doi.org/10.1371/journal.pone.0183687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850590	Green Published, gold, Green Submitted			2022-12-26	WOS:000408544200024
J	McKnight, DT; Ligon, DB				McKnight, Donald T.; Ligon, Day B.			Correcting for unequal catchability in sex ratio and population size estimates	PLOS ONE			English	Article							RECAPTURE METHODS	Wildlife populations often exhibit unequal catchability between subgroups such as males and females. This heterogeneity of capture probabilities can bias both population size and sex ratio estimates. Several authors have suggested that this problem can be overcome by treating males and females as separate populations and calculating a population estimate for each of them. However, this suggestion has received little testing, and many researchers do not implement it. Therefore, we used two simulations to test the utility of this method. One simulated a closed population, while the other simulated an open population and used the robust design to calculate population sizes. We tested both simulations with multiple levels of heterogeneity, and we used a third simulation to test several methods for detecting heterogeneity of capture probabilities. We found that treating males and females as separate populations produced more accurate population and sex ratio estimates. The benefits of this method were particularly pronounced for sex ratio estimates. When males and females were included as a single population, the sex ratio estimates became inaccurate when even slight heterogeneity was present, but when males and females were treated separately, the estimates were accurate even when large biases were present. Nevertheless, treating males and females separately reduced precision, and this method may not be appropriate when capture and recapture rates are low. None of the methods for detecting heterogeneity were robust, and we do not recommend that researchers rely on them. Rather, we suggest separating populations by sex, age, or other subgroups whenever sample sizes permit.	[McKnight, Donald T.; Ligon, Day B.] Missouri State Univ, Dept Biol, Springfield, MO 65897 USA; [McKnight, Donald T.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia	Missouri State University; James Cook University	McKnight, DT (corresponding author), Missouri State Univ, Dept Biol, Springfield, MO 65897 USA.; McKnight, DT (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	donald.mcknight@my.jcu.edu.au	McKnight, Donald Thomas/AAL-1621-2020	McKnight, Donald Thomas/0000-0001-8543-098X				[Anonymous], 1982, ESTIMATION ANIMAL AB; Baillargeon S., 2007, J STAT SOFTW, V19, P1, DOI [DOI 10.18637/JSS.V019.I05, 10.18637/jss.v019.i05]; BEGON M., 1979, INVESTIGATING ANIMAL; CAROTHERS AD, 1973, J ANIM ECOL, V42, P125, DOI 10.2307/3408; Caughley G., 1977, ANAL VERTEBRATE POPU; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHAPMAN DG, 1952, BIOMETRICS, V8, P286, DOI 10.2307/3001864; DARROCH JN, 1993, J AM STAT ASSOC, V88, P1137, DOI 10.2307/2290811; Dorn NJ, 2005, J N AM BENTHOL SOC, V24, P346, DOI 10.1899/04-037.1; DOWNING RL, 1977, J WILDLIFE MANAGE, V41, P709, DOI 10.2307/3799993; Dwyer TJ, 1988, US FISH WILDLIFE SER, V4, P1; Gibbons J.W., 1990, P171; Hothor T, 2015, CRAN 2015; KING C M, 1975, Mammal Review, V5, P1, DOI 10.1111/j.1365-2907.1975.tb00180.x; Koper N, 1998, CAN J ZOOL, V76, P458, DOI 10.1139/cjz-76-3-458; Krebs C.J., 1999, ECOLOGICAL METHODOLO; MCCULLOUGH DR, 1988, J WILDLIFE MANAGE, V52, P534, DOI 10.2307/3801606; Ogutu JO, 2006, J ZOOL, V269, P161, DOI 10.1111/j.1469-7998.2006.00058.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pickett EJ, 2012, WILDLIFE RES, V39, P350, DOI 10.1071/WR11193; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pollock KH, 2000, J AM STAT ASSOC, V95, P293; R Development Core Team, 2014, R LANG ENV STAT COMP; REAM C, 1966, AM MIDL NAT, V75, P325, DOI 10.2307/2423395; Rivest LP, 2007, BIOMETRICS, V63, P999, DOI 10.1111/j.1541-0420.2007.00779.x; Schwarz CJ, 1999, STAT SCI, V14, P427; SEBER GAF, 1965, BIOMETRIKA, V52, P249; SEBER GAF, 1992, INT STAT REV, V60, P129, DOI 10.2307/1403646; SEBER GAF, 1986, BIOMETRICS, V42, P267, DOI 10.2307/2531049; Solmundsson J, 2003, FISH RES, V61, P57, DOI 10.1016/S0165-7836(02)00212-6; Southerwood TRE, 2000, ECOLOGICAL METHODS, P3; Stanford KM, 2004, COPEIA, P465; Szymanski J, 2004, AM MIDL NAT, V152, P304, DOI 10.1674/0003-0031(2004)152[0304:PSOTEM]2.0.CO;2; TABASHNIK BE, 1980, OECOLOGIA, V47, P175, DOI 10.1007/BF00346817; TOPPING CJ, 1992, J APPL ECOL, V29, P485, DOI 10.2307/2404516; WHITE E G, 1975, Researches on Population Ecology (Tokyo), V16, P153, DOI 10.1007/BF02511058; Ziegler PE, 2002, MAR FRESHWATER RES, V53, P1143, DOI 10.1071/MF01243	38	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0184101	10.1371/journal.pone.0184101	http://dx.doi.org/10.1371/journal.pone.0184101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850601	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000408544200056
J	Boemer, F; Detilleux, J; Cello, C; Amory, H; Marcillaud-Pitel, C; Richard, E; van Galen, G; van Loon, G; Lefere, L; Votion, DM				Boemer, Francois; Detilleux, Johann; Cello, Christophe; Amory, Helene; Marcillaud-Pitel, Christel; Richard, Eric; van Galen, Gaby; van Loon, Gunther; Lefere, Laurence; Votion, Dominique-Marie			Acylcarnitines profile best predicts survival in horses with atypical myopathy	PLOS ONE			English	Article							JAMAICAN VOMITING SICKNESS; ACYL-COA DEHYDROGENASE; EUROPEAN OUTBREAKS; HYPOGLYCIN; ACID; METABOLITE; IDENTIFICATION; INACTIVATION; MECHANISM; HISTORY	Equine atypical myopathy (AM) is caused by hypoglycin A intoxication and is characterized by a high fatality rate. Predictive estimation of survival in AM horses is necessary to prevent unnecessary suffering of animals that are unlikely to survive and to focus supportive therapy on horses with a possible favourable prognosis of survival. We hypothesized that outcome may be predicted early in the course of disease based on the assumption that the acylcarnitine profile reflects the derangement of muscle energetics. We developed a statistical model to prognosticate the risk of death of diseased animals and found that estimation of outcome may be drawn from three acylcarnitines (C2, C10:2 and C18 -carnitines) with a high sensitivity and specificity. The calculation of the prognosis of survival makes it possible to distinguish the horses that will survive from those that will die despite severe signs of acute rhabdomyolysis in both groups.	[Boemer, Francois; Cello, Christophe] Univ Liege, CHU Sart Tilman, Biochem Genet Lab, Liege, Belgium; [Detilleux, Johann] Univ Liege, Fac Vet Med, Dept Anim Prod Biostat Econ & Anim Select, FARAH, Liege, Belgium; [Amory, Helene; van Galen, Gaby; Votion, Dominique-Marie] Univ Liege, Fac Vet Med, Equine Pole, FARAH, Liege, Belgium; [Marcillaud-Pitel, Christel] RESPE, Caen, France; [Richard, Eric] UNICAEN, Normandie Univ, Labeo Frank Duncombe, Caen, France; [van Loon, Gunther; Lefere, Laurence] Univ Ghent, Large Anim Internal Med, Ghent, Belgium; [van Galen, Gaby] Univ Copenhagen, Dept Large Anim Sci, Copenhagen, Denmark	University of Liege; University of Liege; University of Liege; Universite de Caen Normandie; Ghent University; University of Copenhagen	Votion, DM (corresponding author), Univ Liege, Fac Vet Med, Equine Pole, FARAH, Liege, Belgium.	dominique.votion@ulg.ac.be	Richard, Eric A./T-9257-2017; van Loon, Gunther/B-8526-2009; van Galen, Gaby/J-4405-2013	Richard, Eric A./0000-0002-5890-8658; van Loon, Gunther/0000-0001-5191-5241; van Galen, Gaby/0000-0002-0689-7141; Votion, Dominique-Marie/0000-0003-2899-8207; BOEMER, Francois/0000-0003-4470-9524	"Institut francais du cheval et de I'equitation (ifce)" of France; "Les Fonds Speciaux pour la Recherche (FSR)" of Liege University (Belgium)	"Institut francais du cheval et de I'equitation (ifce)" of France; "Les Fonds Speciaux pour la Recherche (FSR)" of Liege University (Belgium)	The study was supported by the "Institut francais du cheval et de I'equitation (ifce)" of France and by "Les Fonds Speciaux pour la Recherche (FSR)" of Liege University (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baise E., 2015, EQUINE VET J; Barceloux DG, 2009, DM-DIS MON, V55, P318, DOI [10.1016/j.disamonth.2009.03.006, 10.1016/j.disamonth.2009.03.005, 10.1016/j.disamonth.2009.03.010, 10.1016/j.disamonth.2009.03.007, 10.1016/j.disamonth.2009.03.011, 10.1016/j.disamonth.2009.03.002, 10.1016/j.disamonth.2009.03.004, 10.1016/j.disamonth.2009.03.003, 10.1016/j.disamonth.2009.03.008]; Bochnia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136785; Boemer F, 2015, J CHROMATOGR B, V997, P75, DOI 10.1016/j.jchromb.2015.06.004; Carlier J, 2015, J CHROMATOGR B, V978, P70, DOI 10.1016/j.jchromb.2014.11.029; Chace DH, 2003, PEDIATR RES, V53, P823, DOI 10.1203/01.PDR.0000059220.39578.3D; Delguste C, 2002, ANN MED VET, V146, P235; Detilleux J, 1999, PREV VET MED, V41, P75, DOI 10.1016/S0167-5877(99)00054-9; ENTMAN M, 1967, MOL PHARMACOL, V3, P333; Filee R, 2014, JIMD REP, V13, P119, DOI 10.1007/8904_2013_265; Gonzalez-Medina S, 2017, EQUINE VET J; Grunes DE, 2012, CASE REPORTS TRANSPL; Hoffer SE, 2016, J EQUINE VET SCI, V47, P77, DOI 10.1016/j.jevs.2016.08.010; IKEDA Y, 1990, BIOCHIM BIOPHYS ACTA, V1038, P216, DOI 10.1016/0167-4838(90)90208-W; LAI MT, 1993, J AM CHEM SOC, V115, P1619, DOI 10.1021/ja00058a001; McKenzie RK, 2016, NEW ZEAL VET J, V64, P182, DOI 10.1080/00480169.2015.1123123; OSMUNDSEN H, 1975, FEBS LETT, V55, P38, DOI 10.1016/0014-5793(75)80951-3; Sander J, 2016, J VET DIAGN INVEST, V28, P98, DOI 10.1177/1040638715624736; SHIH VE, 1978, CLIN CHIM ACTA, V88, P539, DOI 10.1016/0009-8981(78)90289-9; TANAKA K, 1971, P NATL ACAD SCI USA, V68, P20, DOI 10.1073/pnas.68.1.20; TANAKA K, 1976, NEW ENGL J MED, V295, P461, DOI 10.1056/NEJM197608262950901; TANAKA K, 1972, J BIOL CHEM, V247, P7465; van Galen G, 2013, EQUINE VET EDUC, V25, P264, DOI 10.1111/j.2042-3292.2012.00439.x; van Galen G, 2013, J VET INTERN MED, V27, P186, DOI 10.1111/jvim.12003; van Galen G, 2012, EQUINE VET J, V44, P621, DOI 10.1111/j.2042-3306.2012.00555.x; van Galen G, 2012, EQUINE VET J, V44, P614, DOI 10.1111/j.2042-3306.2012.00556.x; Verheyen T, 2012, J VET INTERN MED, V26, P1019, DOI 10.1111/j.1939-1676.2012.00945.x; VONHOLT C, 1966, BIOCHIM BIOPHYS ACTA, V125, P1, DOI 10.1016/0005-2760(66)90138-X; Votion DM, 2014, EQUINE VET J, V46, P146, DOI 10.1111/evj.12117; Votion DM, 2007, J VET INTERN MED, V21, P1380, DOI 10.1892/07-053.1; Votion DM, 2009, VET J, V180, P77, DOI 10.1016/j.tvjl.2008.01.016; Westermann CM, 2008, NEUROMUSCULAR DISORD, V18, P355, DOI 10.1016/j.nmd.2008.02.007; Westermann CM, 2016, J VET INTERN MED, V30, P880, DOI 10.1111/jvim.13927	33	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182761	10.1371/journal.pone.0182761	http://dx.doi.org/10.1371/journal.pone.0182761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846683	gold, Green Published, Green Submitted			2022-12-26	WOS:000408438600013
J	Irizarry, KJL; Downs, E; Bryden, R; Clark, J; Griggs, L; Kopulos, R; Boettger, CM; Carr, TJ; Keeler, CL; Collisson, E; Drechsler, Y				Irizarry, Kristopher J. L.; Downs, Eileen; Bryden, Randall; Clark, Jory; Griggs, Lisa; Kopulos, Renee; Boettger, Cynthia M.; Carr, Thomas J., Jr.; Keeler, Calvin L.; Collisson, Ellen; Drechsler, Yvonne			RNA sequencing demonstrates large-scale temporal dysregulation of gene expression in stimulated macrophages derived from MHC-defined chicken haplotypes	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TOLL-LIKE RECEPTOR; PRO-INFLAMMATORY CYTOKINE; AVIAN INFLUENZA-VIRUS; CD8(+) T-LYMPHOCYTES; INTERFERON-GAMMA; SALMONELLA-ENTERITIDIS; MYCOBACTERIUM-BOVIS; DISEASE RESISTANCE; HOST-RESISTANCE	Discovering genetic biomarkers associated with disease resistance and enhanced immunity is critical to developing advanced strategies for controlling viral and bacterial infections in different species. Macrophages, important cells of innate immunity, are directly involved in cellular interactions with pathogens, the release of cytokines activating other immune cells and antigen presentation to cells of the adaptive immune response. IFN gamma. is a potent activator of macrophages and increased production has been associated with disease resistance in several species. This study characterizes the molecular basis for dramatically different nitric oxide production and immune function between the B2 and the B19 haplotype chicken macrophages. A large-scale RNA sequencing approach was employed to sequence the RNA of purified macrophages from each haplotype group (B2 vs. B19) during differentiation and after stimulation. Our results demonstrate that a large number of genes exhibit divergent expression between B2 and B19 haplotype cells both prior and after stimulation. These differences in gene expression appear to be regulated by complex epigenetic mechanisms that need further investigation.	[Irizarry, Kristopher J. L.; Bryden, Randall; Clark, Jory; Griggs, Lisa; Collisson, Ellen; Drechsler, Yvonne] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA; [Irizarry, Kristopher J. L.] Western Univ Hlth Sci, Grad Coll Biomed Sci, Appl Genom Ctr, Pomona, CA 91766 USA; [Downs, Eileen] Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA; [Boettger, Cynthia M.; Carr, Thomas J., Jr.; Keeler, Calvin L.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Kopulos, Renee] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL USA	Western University of Health Sciences; Western University of Health Sciences; Michigan State University; University of Delaware; Northern Illinois University	Irizarry, KJL; Drechsler, Y (corresponding author), Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA.; Irizarry, KJL (corresponding author), Western Univ Hlth Sci, Grad Coll Biomed Sci, Appl Genom Ctr, Pomona, CA 91766 USA.	kirizarry@westernu.edu; ydrechsler@westernu.edu			United States Department of Agriculture [2008-35204-04806]	United States Department of Agriculture(United States Department of Agriculture (USDA))	Funded by United States Department of Agriculture 2008-35204-04806 http://www.reeis.usda.gov/web/crisprojectpages/0214956-impact-of-immune-resporses-of-chickensas-with-defined-b-haplotypes-on-resistance-to-respiratory-coronavirus-infection.html and Merial Veterinary-Scholars Program http://www.merialscholars.com/ Pages/home.aspx.	Banat GR, 2013, DEV COMP IMMUNOL, V39, P430, DOI 10.1016/j.dci.2012.10.006; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Bharti D, 2014, IMMUNOGENETICS, V66, P675, DOI 10.1007/s00251-014-0806-1; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Castillo-Velazquez U, 2013, VET IMMUNOL IMMUNOP, V154, P8, DOI 10.1016/j.vetimm.2013.04.010; Chan G, 2008, J IMMUNOL, V181, P698, DOI 10.4049/jimmunol.181.1.698; Collisson E, 2017, DEV COMP IMMUNOL, V67, P249, DOI 10.1016/j.dci.2016.09.013; Crippen TL, 2003, DEV COMP IMMUNOL, V27, P603, DOI 10.1016/S0145-305X(03)00035-1; Nguyen CT, 2014, J INFECT DIS, V210, P1745, DOI 10.1093/infdis/jiu352; Dalpke AH, 2003, EUR J IMMUNOL, V33, P1776, DOI 10.1002/eji.200323621; DARMANI H, 1994, INT J EXP PATHOL, V75, P363; Dawes ME, 2014, POULTRY SCI, V93, P830, DOI 10.3382/ps.2013-03511; Drechsler Y, 2013, J ZOO WILDLIFE MED, V44, P251, DOI 10.1638/2011-0229R1.1; Drechsler Y, 2009, VIROLOGY, V386, P380, DOI 10.1016/j.virol.2009.01.027; Ferro PJ, 2004, EPIDEMIOL INFECT, V132, P1029, DOI 10.1017/S0950268804002687; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hasko G, 2007, PHARMACOL THERAPEUT, V113, P264, DOI 10.1016/j.pharmthera.2006.08.003; He HQ, 2006, MOL IMMUNOL, V43, P783, DOI 10.1016/j.molimm.2005.07.002; HEINZELMANN EW, 1981, POULTRY SCI, V60, P2171, DOI 10.3382/ps.0602171; HONG CC, 1971, APPL MICROBIOL, V22, P818, DOI 10.1128/AEM.22.5.818-820.1971; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Hunt HD, 2010, AVIAN DIS, V54, P572, DOI 10.1637/8888-042409-ResNote.1; KASPERS B, 1994, VET IMMUNOL IMMUNOP, V44, P71, DOI 10.1016/0165-2427(94)90170-8; Kaufman J, 1996, CURR TOP MICROBIOL, V212, P129; Kim DK, 2008, POULTRY SCI, V87, P433, DOI 10.3382/ps.2007-00383; LAMONT SJ, 1989, J DAIRY SCI, V72, P1328, DOI 10.3168/jds.S0022-0302(89)79240-7; Lowenthal JW, 1997, J INTERF CYTOK RES, V17, P551, DOI 10.1089/jir.1997.17.551; Malek M, 2003, GENET SEL EVOL, V35, pS99, DOI 10.1051/gse:2003019; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mita Y, 2001, IMMUNOL LETT, V78, P97, DOI 10.1016/S0165-2478(01)00241-3; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Qureshi T, 1996, VET IMMUNOL IMMUNOP, V50, P55, DOI 10.1016/0165-2427(95)05492-8; Raza S, 2014, J LEUKOCYTE BIOL, V96, P167, DOI 10.1189/jlb.6HI0313-169R; SCHAT KA, 1994, POULTRY SCI, V73, P502, DOI 10.3382/ps.0730502; Schroder K, 2007, J IMMUNOL, V179, P3495, DOI 10.4049/jimmunol.179.6.3495; Schroder K, 2007, J LEUKOCYTE BIOL, V81, P1577, DOI 10.1189/jlb.0107036; Shi KQ, 2012, J VIRAL HEPATITIS, V19, pE66, DOI 10.1111/j.1365-2893.2011.01540.x; Si ZH, 2006, P NATL ACAD SCI USA, V103, P7454, DOI 10.1073/pnas.0600771103; Singh S, 2010, VIROLOGY, V405, P62, DOI 10.1016/j.virol.2010.05.002; Swaggerty CL, 2008, VET IMMUNOL IMMUNOP, V126, P35, DOI 10.1016/j.vetimm.2008.06.005; Sweet MJ, 2003, ARCH IMMUNOL THER EX, V51, P169; van Erp K, 2006, PHYSIOL GENOMICS, V25, P75, DOI 10.1152/physiolgenomics.00188.2005; van Hateren A, 2013, J BIOL CHEM, V288, P32797, DOI 10.1074/jbc.M113.474031; YOO BH, 1992, BRIT POULTRY SCI, V33, P613, DOI 10.1080/00071669208417500	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0179391	10.1371/journal.pone.0179391	http://dx.doi.org/10.1371/journal.pone.0179391			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846708	gold, Green Submitted, Green Published			2022-12-26	WOS:000408438600001
J	Kormann, MSD; Dewerth, A; Eichner, F; Baskaran, P; Hector, A; Regamey, N; Hartl, D; Handgretinger, R; Antony, JS				Kormann, Michael S. D.; Dewerth, Alexander; Eichner, Felizitas; Baskaran, Praveen; Hector, Andreas; Regamey, Nicolas; Hartl, Dominik; Handgretinger, Rupert; Antony, Justin S.			Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity	PLOS ONE			English	Article							GENE-EXPRESSION; PSEUDOMONAS-AERUGINOSA; RNA-SEQ; DISORDERS; CHILDREN; CFTR	Cystic Fibrosis (CF) is the most common monogenic disease among people of Western European descent and caused by mutations in the CFTR gene. However, the disease severity is immensely variable even among patients with similar CFTR mutations due to the possible effect of 'modifier genes'. To identify genetic modifiers, we applied RNA-seq based transcriptomic analyses in CF patients with a mild and severe lung phenotype. Global gene expression and enrichment analyses revealed that genes of the type I interferon response and ribosomal stalk proteins are potential modifiers of CF related lung dysfunction. The results provide a new set of CF modifier genes with possible implications as new therapeutic targets for the treatment of CF.	[Kormann, Michael S. D.; Dewerth, Alexander; Eichner, Felizitas; Antony, Justin S.] Univ Tubingen, Dept Pediat Pediat Infectiol & Immunol Translat G, Tubingen, Germany; [Baskaran, Praveen] Univ Tubingen, Ctr Quantitat Biol, Tubingen, Germany; [Hector, Andreas; Hartl, Dominik] Univ Tubingen, Univ Childrens Clin, Dept Paediat Paediat Infectiol & Immunol 1, Tubingen, Germany; [Regamey, Nicolas] Univ Bern, Div Paediat Resp Med, Bern, Switzerland; [Regamey, Nicolas] Univ Bern, Dept Clin Res, Bern, Switzerland; [Regamey, Nicolas] Childrens Hopsital Lucerne, Paediat Pulmonol, Luzern, Switzerland; [Handgretinger, Rupert] Univ Tubingen, Univ Childrens Clin, Dept Paediat Hematol & Oncol 1, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Bern; University of Bern; Eberhard Karls University of Tubingen	Antony, JS (corresponding author), Univ Tubingen, Dept Pediat Pediat Infectiol & Immunol Translat G, Tubingen, Germany.	justin.s.antony@gmail.com	ANTONY, JUSTIN S/F-3994-2010	Hector, Andreas/0000-0002-5745-4746; Regamey, Nicolas/0000-0001-6849-6469	Europe Research Council Starting Grant [637752]; HMZ Private Foundation; Open Access Publishing Fund from University of Ribingen	Europe Research Council Starting Grant; HMZ Private Foundation; Open Access Publishing Fund from University of Ribingen	JSA was supported by Europe Research Council Starting Grant (to M.S.D.K., No. 637752). AD was supported by HMZ Private Foundation (to M.S.D.K.). The authors acknowledge the support of the Open Access Publishing Fund from University of Ribingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Balloy V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140979; Blanchard AC, 2017, J CYST FIBROS, V16, P395, DOI 10.1016/j.jcf.2017.01.007; Cai ZW, 2011, ACTA PHARMACOL SIN, V32, P693, DOI 10.1038/aps.2011.71; Chen FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135720; Clarke LA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-38; Corvol H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9382; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Frickmann H, 2012, EUR J MICROBIOL IMMU, V2, P161, DOI 10.1556/EuJMI.2.2012.3.1; Furlan LL, 2016, HUM GENET, V135, P881, DOI 10.1007/s00439-016-1684-4; Gallati S, 2014, APPL CLIN GENET, V7, P133, DOI 10.2147/TACG.S18675; Genin E, 2008, HUM GENET, V124, P357, DOI 10.1007/s00439-008-0560-2; Gu YY, 2009, NATURE, V458, P1039, DOI 10.1038/nature07811; Hamilton BA, 2012, PLOS GENET, V8, P326, DOI 10.1371/journal.pgen.1002644; HAMOSH A, 1993, NEW ENGL J MED, V329, P1308; Hector A, 2013, AM J RESP CELL MOL, V48, P71, DOI 10.1165/rcmb.2012-0061OC; Jundi K, 2015, BIOMOLECULES, V5, P1386, DOI 10.3390/biom5031386; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mekus F, 2000, Twin Res, V3, P277, DOI 10.1375/twin.3.4.277; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Parker D, 2012, AM J RESP CELL MOL, V46, P6, DOI 10.1165/rcmb.2011-0080OC; Parker D, 2011, MBIO, V2, DOI 10.1128/mBio.00016-11; Parker D, 2011, TRENDS IMMUNOL, V32, P582, DOI 10.1016/j.it.2011.09.003; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shah VS, 2016, SCIENCE, V351, P503, DOI 10.1126/science.aad5589; Smeekens SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2343; Trouve P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173822; Valdivieso AG, 2016, CELL PHYSIOL BIOCHEM, V38, P49, DOI 10.1159/000438608; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Veit G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002462; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Virella-Lowell I, 2004, MOL THER, V10, P562, DOI 10.1016/j.ymthe.2004.06.215; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Wright JM, 2006, AM J RESP CELL MOL, V35, P327, DOI 10.1165/rcmb.2005-0359OC; Zabner J, 2005, AM J PHYSIOL-LUNG C, V289, pL545, DOI 10.1152/ajplung.00065.2005; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	44	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183526	10.1371/journal.pone.0183526	http://dx.doi.org/10.1371/journal.pone.0183526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846703	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600032
J	Markaki, I; Klironomos, S; Kostulas, K; Sjostrand, C				Markaki, Ioanna; Klironomos, Stefanos; Kostulas, Konstantinos; Sjostrand, Christina			Elevated plasma homocysteine upon ischemic stroke is associated with increased long-term mortality in women	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; DISEASE; DEATH; RISK	Background Ischemic stroke is a leading cause of death worldwide, despite preventive and therapeutic advances during the last twenty years. Blood-borne biomarkers have been studied in association to short-and long-term outcome, in order to investigate possible modifiable predictors of disability and death. Increased homocysteine has been associated with increased vascular risk and unfavorable outcome, but homocysteine lowering treatment has not consistently been successful in risk reduction. The aim of this study was to investigate homocysteine levels upon acute ischemic stroke in association to long-term mortality. Methods Of 622 patients included in our hospital-based registry, 331 survived the first month after admission, and had a diagnosis of ischemic stroke and available homocysteine values. All-cause and vascular mortality were investigated based on the national patient-and cause of death-registries. Survival analysis and Cox proportional hazard models were used to investigate time to death and predictors of outcome. Results Of 331 patients, 148 (45%) had low homocysteine (<13 micromol/L) and 183 (55%) had high homocysteine (>= 13 micromol/L). During 10 years of follow-up (median 5.5 years), 47 patients (32%) with low homocysteine and 94 (51%) with high homocysteine died (p<0.0001). Estimated median survival was not reached for the low homocysteine group, and was 80 months in the high homocysteine group (p with log-rank test 0.002). High homocysteine was not independently associated with increased risk for death after adjustment for age, sex, comorbidities, and eGFR (HR 1.29, 95% CI 0.86-1.93; p = 0.2). Subgroup analysis by sex showed that high homocysteine was an independent predictor of mortality in women after adjustment for age and vascular comorbidities (HR 1.85; 95% CI 1.03-3.31; p = 0.04), but not in men (HR 0.87; 95% CI 0.52-1.43; p = 0.6). Conclusion Increased plasma homocysteine (>= 13 micromol/L) upon acute ischemic stroke was not independently associated with mortality in our study. In the subgroup of women, high homocysteine was associated with increased five-year risk of death. Our study's retrospective design and the exploratory nature of subgroup analysis, prevent robust conclusions based on that observation. Future studies on homocysteine levels before as well as upon stroke will shed further light on a possible causal association.	[Markaki, Ioanna; Klironomos, Stefanos; Kostulas, Konstantinos; Sjostrand, Christina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet	Markaki, I (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	ioanna.markaki@ki.se		Klironomos, Stefanos/0000-0002-3279-7902; Markaki, Ioanna/0000-0003-3328-5746	Stockholm County Council (ALF project) [20150335, 20160454]	Stockholm County Council (ALF project)(Stockholm County Council)	This study was supported by grants (20150335, 20160454) provided by the Stockholm County Council (ALF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnadottir M, 1996, SCAND J CLIN LAB INV, V56, P41, DOI 10.3109/00365519609088586; Barron E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127550; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Forti P, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.460; Ham AC, 2014, DRUG AGING, V31, P611, DOI 10.1007/s40266-014-0192-2; Hankey GJ, 2012, LANCET NEUROL, V11, P512, DOI 10.1016/S1474-4422(12)70091-1; Ji Y, 2013, NEUROLOGY, V81, P1298, DOI 10.1212/WNL.0b013e3182a823cc; Koton S, 2010, NEUROEPIDEMIOLOGY, V34, P90, DOI 10.1159/000264826; Lewerin C, 2007, J INTERN MED, V261, P65, DOI 10.1111/j.1365-2796.2006.01732.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mueller C, 2008, SWISS MED WKLY, V138, P225, DOI 2008/15/smw-12180; Sahebkar A, 2016, CURR MED CHEM, V23, P4490, DOI 10.2174/0929867323666161007155310; Shi ZH, 2015, STROKE, V46, P2419, DOI 10.1161/STROKEAHA.115.009136; Swart KMA, 2012, EUR J CLIN NUTR, V66, P188, DOI 10.1038/ejcn.2011.186; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Zhong C, 2016, MOL NEUROBIOL	17	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183571	10.1371/journal.pone.0183571	http://dx.doi.org/10.1371/journal.pone.0183571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846725	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600037
J	Han, SY; Liu, H; Yan, M; Qi, FY; Wang, YQ; Sun, ZQ; Huang, BY; Dong, WZ; Tang, FS; Zhang, XY; He, GH				Han, Suoyi; Liu, Hua; Yan, Mei; Qi, Feiyan; Wang, Yaqi; Sun, Ziqi; Huang, Bingyan; Dong, Wenzhao; Tang, Fengshou; Zhang, Xinyou; He, Guohao			Differential gene expression in leaf tissues between mutant and wild-type genotypes response to late leaf spot in peanut (Arachis hypogaea L.)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; RNA-SEQ; PHOTOSYNTHETIC CONSEQUENCES; CERCOSPORIDIUM-PERSONATUM; CORE COLLECTION; RESISTANCE; SENESCENCE; ARABIDOPSIS; RUST; PROTEINS	Late leaf spot (LLS) is a major foliar disease in peanut (A. hypogaea L.) worldwide, causing significant losses of potential yield in the absence of fungicide applications. Mutants are important materials to study the function of disease-related genes. In this study, the mutant line M14 was derived from cultivar Yuanza 9102 treated with EMS. Yuanza 9102 was selected from an interspecific cross of cultivar Baisha 1016 with A. diogoi, and is resistant to several fungal diseases. By contrast, the M14 was highly susceptible to late leaf spot. RNA-Seq analysis in the leaf tissues of the M14 and its wild type Yuanza 9102 under pathogen challenge showed 2219 differentially expressed genes including1317 up-regulated genes and 902 down-regulated genes. Of these genes, 1541, 1988, 1344, 643 and 533 unigenes were obtained and annotated by public protein databases of SwissPort, TrEMBL, gene ontology (GO), KEGG and clusters of orthologous groups (COG), respectively. Differentially expressed genes (DEGs) showed that expression of inducible pathogenesis-related (PR) proteins was significantly up-regulated; in the meantime DEGs related to photosynthesis were down-regulated in the susceptible M14 in comparison to the resistant WT. Moreover, the up-regulated WRKY transcription factors and down-regulated plant hormones related to plant growth were detected in the M14. The results suggest that down-regulated chloroplast genes, up-regulated WRKY transcription factors, and depressed plant hormones related to plant growth in the M14 might coordinately render the susceptibility though there was a significant high level of PRs. Those negative effectors might be triggered in the susceptible plant by fungal infection and resulted in reduction of photosynthesis and phytohormones and led to symptom formation.	[Han, Suoyi; Liu, Hua; Yan, Mei; Qi, Feiyan] Henan Acad Agr Sci, Ind Crops Res Inst, Zhengzhou, Henan, Peoples R China; [Han, Suoyi; He, Guohao] Tuskegee Univ, Coll Agr Environm & Nutr Sci, Dept Agr & Environm Sci, Tuskegee, AL 36088 USA; [Wang, Yaqi; Sun, Ziqi; Huang, Bingyan] Henan Prov Key Lab Oil Crops Improvement, Zhengzhou, Henan, Peoples R China; [Dong, Wenzhao; Tang, Fengshou; Zhang, Xinyou] Minist Agr, Key Lab Oil Crops Huanghuaihai Plains, Zhengzhou, Henan, Peoples R China	Henan Academy of Agricultural Sciences; Tuskegee University; Ministry of Agriculture & Rural Affairs	He, GH (corresponding author), Tuskegee Univ, Coll Agr Environm & Nutr Sci, Dept Agr & Environm Sci, Tuskegee, AL 36088 USA.; Zhang, XY (corresponding author), Minist Agr, Key Lab Oil Crops Huanghuaihai Plains, Zhengzhou, Henan, Peoples R China.	haasz@126.com; hguohao@mytu.tuskegee.edu			National High-Tech R&D Program of China (863 program) [2013AA102602-6]; China Agriculture Research System [CARS-13]; Science Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences [2013YQ08]	National High-Tech R&D Program of China (863 program); China Agriculture Research System; Science Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences	This work was funded by grants to XYZ, National High-Tech R&D Program of China (863 program), 2013AA102602-6, http://program.most.gov.cn/; XYZ, China Agriculture Research System, CARS-13, http://119.253.58.231/; SYH, Science Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences, 2013YQ08, http://www.hriagri.org.cn/kygl/index.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, NATURE P; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bassanezi RB, 2002, J PHYTOPATHOL, V150, P37, DOI 10.1046/j.1439-0434.2002.00714.x; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Cho WK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136736; El-Kereamy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017973; Erickson JE, 2004, NEW PHYTOL, V161, P577, DOI 10.1046/j.1469-8137.2003.00968.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gremillion SK, 2011, PLANT DIS, V95, P263, DOI 10.1094/PDIS-06-10-0454; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; HOLBROOK CC, 1995, CROP SCI, V35, P1700, DOI 10.2135/cropsci1995.0011183X003500060032x; JOGLOY S, 1987, Peanut Science, V14, P86, DOI 10.3146/i0095-3679-14-2-9; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; Kim MJ, 2005, PLANT MOL BIOL, V59, P981, DOI 10.1007/s11103-005-2619-y; KNAUFT D A, 1986, Peanut Science, V13, P82, DOI 10.3146/i0095-3679-13-2-11; KNAUFT D A, 1988, Peanut Science, V15, P9, DOI 10.3146/i0095-3679-15-1-3; Kong LF, 2014, MOL PLANT, V7, P691, DOI 10.1093/mp/sst158; KORNEGAY J L, 1980, Peanut Science, V7, P4, DOI 10.3146/i0095-3679-7-1-2; Kumar D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117559; de Sa MEL, 2012, GENET MOL BIOL, V35, P272, DOI 10.1590/S1415-47572012000200008; Luo M, 2005, PHYTOPATHOLOGY, V95, P381, DOI 10.1094/PHYTO-95-0381; Mahdavi F, 2012, APPL BIOCHEM BIOTECH, V166, P1008, DOI 10.1007/s12010-011-9489-3; Mallikarjuna N, 2012, EUR J PLANT PATHOL, V132, P17, DOI 10.1007/s10658-011-9859-2; Martin LBB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00066; MAUCH F, 1991, PLANT MOL BIOL, V16, P1089, DOI 10.1007/BF00016083; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; MILLER I L, 1990, Peanut Science, V17, P52, DOI 10.3146/i0095-3679-17-2-2; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEVILL DJ, 1982, OLEAGINEUX, V37, P355; PENSUK V, 2003, SONGKLANAKARIN J SCI, V25, P289; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; Prusty R, 2004, P NATL ACAD SCI USA, V101, P4153, DOI 10.1073/pnas.0400659101; Radhajeyalakshmi R., 2003, Acta Phytopathologica et Entomologica Hungarica, V38, P251, DOI 10.1556/APhyt.38.2003.3-4.5; Reddy DS Bhatnagar-Mathur, 2013, PLOS ONE, V8; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; Shoba D, 2012, EUPHYTICA, V188, P265, DOI 10.1007/s10681-012-0718-9; Singh BK, 2013, PLOS ONE, V8; Singh MP, 2011, CROP SCI, V51, P2741, DOI 10.2135/cropsci2011.03.0144; Singh MP, 2011, AGRON J, V105, P1307; SUBRAHMANYAM P, 1989, ECON BOT, V43, P444, DOI 10.1007/BF02935917; Sudini H, 2015, AUSTRALAS PLANT PATH, V44, P557, DOI 10.1007/s13313-015-0368-1; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	49	8	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183428	10.1371/journal.pone.0183428	http://dx.doi.org/10.1371/journal.pone.0183428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841668	Green Submitted, gold, Green Published			2022-12-26	WOS:000408370700030
J	Solomon, RB; Conover, K; Shizgal, P				Solomon, Rebecca Brana; Conover, Kent; Shizgal, Peter			Valuation of opportunity costs by rats working for rewarding electrical brain stimulation	PLOS ONE			English	Article							LATERAL HYPOTHALAMIC-STIMULATION; SUBJECTIVE MAGNITUDE; OPERANT PERFORMANCE; TIME-LEFT; STRENGTH; COMPETITION; FREQUENCY; SUMMATION; DURATION; SUCROSE	Pursuit of one goal typically precludes simultaneous pursuit of another. Thus, each exclusive activity entails an "opportunity cost:" the forgone benefits from the next-best activity eschewed. The present experiment estimates, in laboratory rats, the function that maps objective opportunity costs into subjective ones. In an operant chamber, rewarding electrical brain stimulation was delivered when the cumulative time a lever had been depressed reached a criterion duration. The value of the activities forgone during this duration is the opportunity cost of the electrical reward. We determined which of four functions best describes how objective opportunity costs, expressed as the required duration of lever depression, are translated into their subjective equivalents. The simplest account is the identity function, which equates subjective and objective opportunity costs. A variant of this function called the "sigmoidal-slope function," converges on the identity function at longer durations but deviates from it at shorter durations. The sigmoidal-slope function has the form of a hockey stick. The flat "blade" denotes a range over which opportunity costs are subjectively equivalent; these durations are too short to allow substitution of more beneficial activities. The blade extends into an upward-curving portion over which costs become discriminable and finally into the straight "handle," over which objective and subjective costs match. The two remaining functions are based on hyperbolic and exponential temporal discounting, respectively. The results are best described by the sigmoidal-slope function. That this is so suggests that different principles of intertemporal choice are involved in the evaluation of time spent working for a reward or waiting for its delivery. The subjective opportunitycost function plays a key role in the evaluation and selection of goals. An accurate description of its form and parameters is essential to successful modeling and prediction of instrumental performance and reward-related decision making.	[Solomon, Rebecca Brana; Conover, Kent; Shizgal, Peter] Concordia Univ, Ctr Studies Behav Neurobiol, Grp Rech Neurobiol Comportementale, Dept Psychol, Montreal, PQ, Canada	Concordia University - Canada	Shizgal, P (corresponding author), Concordia Univ, Ctr Studies Behav Neurobiol, Grp Rech Neurobiol Comportementale, Dept Psychol, Montreal, PQ, Canada.	peter.shizgal@concordia.ca	Shizgal, Peter/H-9823-2013; Shizgal, Peter/V-5602-2019	Shizgal, Peter/0000-0003-4265-0792	Bourse de Doctorat de Recherche scholarship from the Fonds Quebecois de Recherche sur la Nature et les Technologies to Rebecca Solomon; Bourse de Doctorat de Recherche scholarship from the Natural Sciences and Engineering Research Council of Canada [RGPIN-308-06 RGPIN-308-11]; Concordia University Research Chairs program; Fonds de recherche du Que-bec-Sante; Concordia University	Bourse de Doctorat de Recherche scholarship from the Fonds Quebecois de Recherche sur la Nature et les Technologies to Rebecca Solomon; Bourse de Doctorat de Recherche scholarship from the Natural Sciences and Engineering Research Council of Canada; Concordia University Research Chairs program; Fonds de recherche du Que-bec-Sante(Fonds de la Recherche en Sante du Quebec); Concordia University	This study was supported by a Bourse de Doctorat de Recherche scholarship from the Fonds Quebecois de Recherche sur la Nature et les Technologies to Rebecca Solomon, grants from the Natural Sciences and Engineering Research Council of Canada (Peter Shizgal, p.i., RGPIN-308-06 & RGPIN-308-11), and support to Peter Shizgal from the Concordia University Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Steve Cabilio developed and maintained the experimental-control and data acquisition software used in this study. The experimental-control and data acquisition hardware was designed, built, and maintained by David Munro. The experiments were carried out in the facilities of the "Groupe de Recherche en Neurobiologie Comportementale" / Center for Studies in Behavioural Neurobiology, which was supported by grants from the "Fonds de recherche du Que-bec-Sante" and Concordia University. The authors thank Peter Dayan and Sarah Nolan-Poupart for much appreciated, helpful comments on the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arvanitogiannis A, 2008, BEHAV NEUROSCI, V122, P1126, DOI 10.1037/a0012679; Breton YA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00284; Breton YA, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00125; Breton YA, 2009, BEHAV BRAIN RES, V202, P77, DOI 10.1016/j.bbr.2009.03.019; Cerutti DT, 2004, J EXP PSYCHOL-ANIM B, V30, P45, DOI 10.1037/0097-7403.30.1.45; Conover KL, 2005, GAME ECON BEHAV, V52, P283, DOI 10.1016/j.geb.2004.08.003; CONOVER KL, 1994, BEHAV NEUROSCI, V108, P549; CONOVER KL, 1994, BEHAV NEUROSCI, V108, P559; CONOVER KL, 1994, BEHAV NEUROSCI, V108, P537, DOI 10.1037/0735-7044.108.3.537; Efron B., 1993, INTRO BOOTSTRAP, V57; Fouriezos G, 1997, BEHAV BRAIN RES, V87, P111, DOI 10.1016/S0166-4328(97)02280-8; Frank Robert H., 2010, MICROECONOMICS BEHAV; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; GALLISTEL CR, 1991, BEHAV NEUROSCI, V105, P913, DOI 10.1037/0735-7044.105.6.913; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; GIBBON J, 1981, J EXP PSYCHOL ANIM B, V7, P87, DOI 10.1037/0097-7403.7.2.87; HAMILTON AL, 1985, PHYSIOL BEHAV, V35, P897, DOI 10.1016/0031-9384(85)90257-4; Hartmann MN, 2013, BEHAV PROCESS, V100, P192, DOI 10.1016/j.beproc.2013.09.014; Hernandez G, 2012, J NEUROSCI, V32, P11032, DOI 10.1523/JNEUROSCI.1051-12.2012; Hernandez G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015081; HERRNSTE.RJ, 1974, J EXP ANAL BEHAV, V21, P159, DOI 10.1901/jeab.1974.21-159; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Kagel John H., 1995, EC CHOICE THEORY EXP; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kalenscher T, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00082; Klein-Flugge MC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004116; Krugman P. R., 2009, ECONOMICS; LEON M, 1992, BEHAV BRAIN RES, V52, P183, DOI 10.1016/S0166-4328(05)80229-3; MARK TA, 1993, BEHAV NEUROSCI, V107, P389, DOI 10.1037/0735-7044.107.2.389; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; MAZUR JE, 1987, BEHAV PROCESS, V15, P143, DOI 10.1016/0376-6357(87)90003-9; MAZUR JE, 1986, J EXP ANAL BEHAV, V46, P67, DOI 10.1901/jeab.1986.46-67; McDowell JJ, 2005, J EXP ANAL BEHAV, V84, P111, DOI 10.1901/jeab.2005.59-04; MCFARLAND DJ, 1975, PHILOS T ROY SOC B, V270, P265, DOI 10.1098/rstb.1975.0009; Namboodiri V.M.K., 2014, TIMING TIME PERCEPT, V1, P1; Namboodiri VMK, 2014, FRONT BEHAV NEUROSCI, P8; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Niyogi RK, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003894; Niyogi RK, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0969; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; ROBBINS L, 1935, ESSAY NATURE SIGNIFI; Samuelson PA, 1938, ECONOMICA-NEW SER, V5, P61, DOI 10.2307/2548836; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Shizgal P, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00020; SIMMONS JM, 1994, BEHAV NEUROSCI, V108, P151, DOI 10.1037/0735-7044.108.1.151; Solomon RB, 2015, BEHAV BRAIN RES, V292, P327, DOI 10.1016/j.bbr.2015.06.008; Solomon RB, 2006, SUBJECTIVE ESTIMATES; Solomon RB, 2007, SOC NEUR ABSTR, V37, P742; Solomon RB, 2014, THESIS; Sonnenschein B, 2003, BEHAV NEUROSCI, V117, P978, DOI 10.1037/0735-7044.117.5.978; Staddon JER, 1999, J EXP ANAL BEHAV, V71, P215, DOI 10.1901/jeab.1999.71-215; Stephens D., 2007, FORAGING BEHAV ECOLO; Stephens D.W., 1986, pi; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Trujillo-Pisanty I, 2014, PSYCHOPHARMACOLOGY, V231, P1351, DOI 10.1007/s00213-013-3328-x; Trujillo-Pisanty I, 2011, J NEUROSCI, V31, P5426, DOI 10.1523/JNEUROSCI.0079-11.2011; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wikenheiser AM, 2013, P NATL ACAD SCI USA, V110, P8308, DOI 10.1073/pnas.1220738110	63	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182120	10.1371/journal.pone.0182120	http://dx.doi.org/10.1371/journal.pone.0182120			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841663	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000408370700005
J	Whatcott, CJ; Ng, S; Barrett, MT; Hostetter, G; Von Hoff, DD; Han, HY				Whatcott, Clifford J.; Ng, Serina; Barrett, Michael T.; Hostetter, Galen; Von Hoff, Daniel D.; Han, Haiyong			Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; TGF-BETA; GEMCITABINE; DESMOPLASIA; ACTIVATION; EXPRESSION; MIGRATION; MOLECULE; FIBROSIS; COLLAGEN	ROCK, or Rho-associated coiled coil-containing protein kinase, is a member of the AGC kinase family and has been shown to play a role in cell migration, ECM synthesis, stressfiber assembly, and cell contraction. Increased ROCK expression has been reported in multiple pathological conditions, including cancer. Here, we report increased expression of ROCK 1 in pancreatic tumor epithelial cells as well as in cancer associated fibroblasts (CAF). In our analysis, 62% of tumor samples exhibited >= 2+ in staining intensity by IHC analysis, versus 40% of adjacent normal tissue samples (P<0.0001). Thus, we hypothesized that ROCKs may play a significant role in pancreatic cancer progression, and may serve as a suitable target for treatment. We report a low frequency (4/34) amplification of the ROCK1 gene locus at chromosome 18q11.1 in pancreatic ductal adenocarcinoma (PDAC) patient tissue samples by aCGH analysis. Inhibition of ROCK kinase activity by a small molecule inhibitor (fasudil) resulted in moderate (IC(50)s of 6-71 mu M) inhibition of PDAC cell proliferation, migration, and activation of co-cultured stellate cells. In the KPC mouse model for pancreatic cancer, fasudil decreased tumor collagen deposition. This translated to an enhanced overall survival of the mice and an increase in gemcitabine uptake. Though fasudil may target both the tumor epithelial cells and the CAFs, our findings are consistent with the hypothesis that inhibition of tumor stroma enhances drug penetration and efficacy in PDAC. Overall, our data suggests that ROCK1 may serve as a potential therapeutic target to enhance current treatment regimens for pancreatic cancer.	[Whatcott, Clifford J.; Ng, Serina; Von Hoff, Daniel D.; Han, Haiyong] Translat Genom Res Inst, Div Mol Med, Phoenix, AZ 85004 USA; [Barrett, Michael T.] Mayo Clin, Ctr Canc, Scottsdale, AZ USA; [Hostetter, Galen] Van Andel Res Inst, Lab Analyt Pathol, Grand Rapids, MI USA	Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix; Van Andel Institute	Han, HY (corresponding author), Translat Genom Res Inst, Div Mol Med, Phoenix, AZ 85004 USA.	hhan@tgen.org			NIH/NCI [R01 (CM 69281), U01 (CA128454)]; National Foundation for Cancer Research; Stand Up To Cancer-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant [SU2C-AACR-DT-20-16]; NATIONAL CANCER INSTITUTE [R01CA169281] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Foundation for Cancer Research; Stand Up To Cancer-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a R01 (CM 69281) grant and a U01 (CA128454) grant from the NIH/NCI, a grant from the National Foundation for Cancer Research, and a Stand Up To Cancer-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant (Grant Number: SU2C-AACR-DT-20-16). Stand Up To Cancer is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian K, 2009, CANCER RES, V69, P9169, DOI 10.1158/0008-5472.CAN-09-1705; Agbunag C, 2004, CANCER RES, V64, P5659, DOI 10.1158/0008-5472.CAN-04-0807; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bapiro TE, 2011, CANCER CHEMOTH PHARM, V68, P1243, DOI 10.1007/s00280-011-1613-0; Bouzin C, 2007, DRUG RESIST UPDATE, V10, P109, DOI 10.1016/j.drup.2007.03.001; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Diep CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032783; Diep CH, 2011, CLIN CANCER RES, V17, P2744, DOI 10.1158/1078-0432.CCR-10-2214; Gabet AS, 2011, CELL DEATH DIFFER, V18, P678, DOI 10.1038/cdd.2010.140; Garton AJ, 2008, METHOD ENZYMOL, V439, P491, DOI 10.1016/S0076-6879(07)00433-8; Grzesiak JJ, 2007, PANCREAS, V35, P293, DOI 10.1097/mpa.0b013e31811f4526; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haudek SB, 2009, CARDIOVASC RES, V83, P511, DOI 10.1093/cvr/cvp135; Herpin A, 2007, FEBS J, V274, P2977, DOI 10.1111/j.1742-4658.2007.05840.x; Herrlich P, 2000, ANN NY ACAD SCI, V910, P106; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hirooka Yoshitaka, 2005, Am J Cardiovasc Drugs, V5, P31, DOI 10.2165/00129784-200505010-00005; Hong SP, 2009, INT J CANCER, V125, P2323, DOI 10.1002/ijc.24573; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Kaneko K, 2002, PANCREAS, V24, P251, DOI 10.1097/00006676-200204000-00007; Kolar C, 1997, PANCREAS, V15, P265, DOI 10.1097/00006676-199710000-00008; Lane J, 2008, INT J ONCOL, V33, P585, DOI 10.3892/ijo_00000044; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Liu XZ, 2011, J ORTHOP RES, V29, P1259, DOI 10.1002/jor.21403; Lochhead PA, 2010, ONCOGENE, V29, P2591, DOI 10.1038/onc.2010.3; Magzoub M, 2008, FASEB J, V22, P276, DOI 10.1096/fj.07-9150com; Masamune A, 2003, BRIT J PHARMACOL, V140, P1292, DOI 10.1038/sj.bjp.0705551; Masamune A, 2009, CLIN GASTROENTEROL H, V7, pS48, DOI 10.1016/j.cgh.2009.07.038; Naber HPH, 2008, CURR CANCER DRUG TAR, V8, P466, DOI 10.2174/156800908785699342; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Papadimitriou E, 2011, CELL PHYSIOL BIOCHEM, V28, P229, DOI 10.1159/000331734; Pham NA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-8; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Rath N, 2017, EMBO MOL MED, V9, P198, DOI 10.15252/emmm.201606743; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Ruiz C, 2011, P NATL ACAD SCI USA, V108, P12054, DOI 10.1073/pnas.1104009108; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smith PC, 2006, J PERIODONTAL RES, V41, P418, DOI 10.1111/j.1600-0765.2006.00886.x; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Yen TNF, 2002, SURGERY, V131, P129, DOI 10.1067/msy.2002.119192	51	50	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183871	10.1371/journal.pone.0183871	http://dx.doi.org/10.1371/journal.pone.0183871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841710	Green Submitted, Green Published, gold			2022-12-26	WOS:000408370700066
J	Apostolidis, L; Schwarz, D; Xia, A; Weiler, M; Heckel, A; Godel, T; Heiland, S; Schlemmer, HP; Jager, D; Bendszus, M; Baumer, P				Apostolidis, Leonidas; Schwarz, Daniel; Xia, Annie; Weiler, Markus; Heckel, Andreas; Godel, Tim; Heiland, Sabine; Schlemmer, Heinz-Peter; Jaeger, Dirk; Bendszus, Martin; Baeumer, Philipp			Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathy	PLOS ONE			English	Article							INDUCED PERIPHERAL NEUROPATHY; ADVANCED COLORECTAL-CANCER; INDUCED NEUROTOXICITY; NERVOUS-SYSTEM; CISPLATIN; CHEMOTHERAPY; FLUOROURACIL; LEUCOVORIN; TRIAL; RAT	Purpose To investigate in vivo morphological and functional correlates of oxaliplatin-induced peripheral neuropathy (OXA-PNP) by magnetic resonance neurography (MRN). Methods Twenty patients (7 female, 13 male, 58.9 +/- 10.0 years) with mild to moderate OXA-PNP and 20 matched controls (8 female, 12 male, 55.7 +/- 15.6 years) were prospectively enrolled. All patients underwent a detailed neurophysiological examination prior to neuroimaging. A standardized imaging protocol at 3.0 Tesla included the lumbosacral plexus and both sciatic nerves and their branches using T2-weighted fat-saturated sequences and diffusion tensor imaging. Quantitative assessment included volumetry of the dorsal root ganglia (DRG), sciatic nerve normalized T2 (nT2) signal and caliber, and fractional anisotropy (FA), mean diffusivity (MD), axial (AD) and radial diffusivity (RD). Additional qualitative evaluation of sciatic, peroneal, and tibial nerves evaluated the presence, degree, and distribution of nerve lesions. Results DRG hypertrophy in OXA-PNP patients (207.3 +/- 47.7mm(3) vs. 153.0 +/- 47.1mm(3) in controls, p = 0.001) was found as significant morphological correlate of the sensory neuronopathy. In contrast, peripheral nerves only exhibited minor morphological alterations qualitatively. Quantitatively, sciatic nerve caliber (27.3 +/- 6.7mm(2) vs. 27.4 +/- 7.4mm(2), p = 0.80) and nT2 signal were not significantly changed in patients (1.32 +/- 0.22 vs. 1.22 +/- 0.26, p = 0.16). AD, RD, and MD showed a non-significant decrease in patients, while FA was unchanged. Conclusion OXA-PNP manifests with morphological and functional correlates that can be detected in vivo by MRN. We report hypertrophy of the DRG that stands in contrast to experimental and postmortem studies. DRG volume should be further investigated as a biomarker in other sensory peripheral neuropathies and ganglionopathies.	[Apostolidis, Leonidas; Jaeger, Dirk] Natl Ctr Tumor Dis, Dept Med Oncol, Heidelberg, Germany; [Schwarz, Daniel; Xia, Annie; Heckel, Andreas; Godel, Tim; Heiland, Sabine; Bendszus, Martin; Baeumer, Philipp] Heidelberg Univ Hosp, Dept Neuroradiol, Heidelberg, Germany; [Weiler, Markus] Heidelberg Univ Hosp, Dept Neurol, Heidelberg, Germany; [Schlemmer, Heinz-Peter; Baeumer, Philipp] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Baumer, P (corresponding author), Heidelberg Univ Hosp, Dept Neuroradiol, Heidelberg, Germany.; Baumer, P (corresponding author), German Canc Res Ctr, Dept Radiol, Heidelberg, Germany.	p.baeumer@dkfz-heidelberg.de	Apostolidis, Leonidas/AAV-9989-2021	Apostolidis, Leonidas/0000-0002-6358-8206; Schwarz, Daniel/0000-0002-9017-8245				Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Alberti P, 2014, ANN ONCOL, V25, P257, DOI 10.1093/annonc/mdt409; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Argyriou AA, 2008, CANCER TREAT REV, V34, P368, DOI 10.1016/j.ctrv.2008.01.003; Argyriou AA, 2012, CRIT REV ONCOL HEMAT, V82, P51, DOI 10.1016/j.critrevonc.2011.04.012; Avan A, 2015, ONCOLOGIST, V20, P411, DOI 10.1634/theoncologist.2014-0044; Baumer P, 2016, NEUROLOGY, V87, P1884, DOI 10.1212/WNL.0000000000003287; Baumer P, 2011, RADIOLOGY, V260, P199, DOI 10.1148/radiol.11102357; Baumer P, 2014, RADIOLOGY; Birnbaum J, 2014, MEDICINE, V93, P121, DOI 10.1097/MD.0000000000000024; Burakgazi AZ, 2011, NEUROLOGY, V77, P980, DOI 10.1212/WNL.0b013e31822cfc59; CAVALETTI G, 1991, INT J TISSUE REACT, V13, P151; CAVALETTI G, 1992, ACTA NEUROPATHOL, V84, P364; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Coriat R, 2014, J CLIN INVEST, V124, P262, DOI 10.1172/JCI68730; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Dyck PJ, 2010, MUSCLE NERVE, V42, P157, DOI 10.1002/mus.21661; Godel T, 2016, NEUROIMAGE, V141, P81, DOI 10.1016/j.neuroimage.2016.07.030; Golfinopoulos V, 2007, LANCET ONCOL, V8, P898, DOI 10.1016/S1470-2045(07)70281-4; GREGG RW, 1992, J CLIN ONCOL, V10, P795, DOI 10.1200/JCO.1992.10.5.795; Grothey Axel, 2005, Clin Colorectal Cancer, V5 Suppl 1, pS38, DOI 10.3816/CCC.2005.s.006; Heckel A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130833; Holmes J, 1998, TOXICOL SCI, V46, P342, DOI 10.1093/toxsci/46.2.342; JACOBS JM, 1978, ENVIRON HEALTH PERSP, V26, P107, DOI 10.2307/3428830; Jamieson SMF, 2005, CANCER CHEMOTH PHARM, V56, P391, DOI 10.1007/s00280-004-0953-4; Jimenez-Andrade JM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-10; Krarup-Hansen A, 1999, NEUROPATH APPL NEURO, V25, P29; LEVI FA, 1994, JNCI-J NATL CANCER I, V86, P1608, DOI 10.1093/jnci/86.21.1608; Park SB, 2011, ONCOLOGIST, V16, P708, DOI 10.1634/theoncologist.2010-0248; Park SB, 2009, BRAIN, V132, P2712, DOI 10.1093/brain/awp219; Pham M, 2015, ANN NEUROL, V78, P939, DOI 10.1002/ana.24524; Pietrangeli A, 2006, EUR NEUROL, V56, P13, DOI 10.1159/000094376; Postma TJ, 2005, EUR J CANCER, V41, P1135, DOI 10.1016/j.ejca.2005.02.012; Postma TJ, 1998, ANN ONCOL, V9, P739, DOI 10.1023/A:1008344507482; Shen J, 2006, AM J NEURORADIOL, V27, P2098; Silverstein MP, 2015, INT J SPINE SURG, V9, DOI 10.14444/2003; Velasco R, 2014, J NEUROL NEUROSUR PS, V85, P392, DOI 10.1136/jnnp-2013-305334	38	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183845	10.1371/journal.pone.0183845	http://dx.doi.org/10.1371/journal.pone.0183845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837658	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000130
J	Dobler, L; de Carvalho, BR; Alves, WD; Neves, BC; Freire, DMG; Almeida, RV				Dobler, Leticia; de Carvalho, Bruna Rocha; Alves, Wilber de Sousa; Neves, Bianca Cruz; Guimaraes Freire, Denise Maria; Almeida, Rodrigo Volcan			Enhanced rhamnolipid production by Pseudomonas aeruginosa overexpressing estA in a simple medium	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOSURFACTANT; MEMBRANE; DISPLAY; CARBON	A modified Pseudomonas aeruginosa strain capable of overexpressing the estA gene, an encoding gene for a membrane-bound esterase, was constructed and its rhamnolipid RML) production was studied. Fermentations using wild-type WT) and modified P. aeruginosa strains were conducted until exhaustion of glycerol in Medium Salt Production, using two different C/N ratios. At a C/N of 83.2, the modified strain produced up to 3.9 times more RMLs than the WT, yielding a maximum concentration of 14.62 g/L RML when measured by HPLC and 22 g/L by the orcinol assay. Cell-free supernatant from the modified strain reduced surface tension to 29.4 mN/m and had a CMC of 240 mg/L and CMD of 56.05. This is the first report on the construction of an estA-based recombinant strain for RML production.	[Dobler, Leticia; de Carvalho, Bruna Rocha; Alves, Wilber de Sousa; Neves, Bianca Cruz; Almeida, Rodrigo Volcan] Univ Fed Rio de Janeiro, Chem Inst, LaMMP Lab Microbiol Mol & Prot, Rio De Janeiro, Brazil; [Guimaraes Freire, Denise Maria] Univ Fed Rio de Janeiro, Chem Inst, LaBiM Lab Biotecnol Microbiana, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Dobler, L; Almeida, RV (corresponding author), Univ Fed Rio de Janeiro, Chem Inst, LaMMP Lab Microbiol Mol & Prot, Rio De Janeiro, Brazil.; Freire, DMG (corresponding author), Univ Fed Rio de Janeiro, Chem Inst, LaBiM Lab Biotecnol Microbiana, Rio De Janeiro, Brazil.	ledobler@ufrj.br; freire@iq.ifrj.br; volcan@iq.ufrj.br	Almeida, Rodrigo V/I-4362-2013; Almeida, Rodrigo/GZH-0682-2022; Almeida, Rodrigo/AAE-3019-2019; Dobler, Leticia/F-2086-2016; Neves, Bianca C/D-8929-2015; Freire, Denise Maria Guimaraes/D-8699-2014	Almeida, Rodrigo V/0000-0002-0164-6044; Almeida, Rodrigo/0000-0002-0164-6044; Dobler, Leticia/0000-0002-1582-4198; Neves, Bianca C/0000-0002-6985-8828; Freire, Denise Maria Guimaraes/0000-0002-8298-5936	Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work is supported by Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis (www:anp.gov.br) - LD, Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (www.capes.gov.br) - LD, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpg.br) - BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Professor Herbert Schweizer from Colorado State University for providing the pUCP26 vector, ANP (Agencia Nacional de Petroleo) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for their financial support, the engineer Antonio Carlos de Oliveira Machado for his help with the CMC calculus, and Fabio Diniz Vale for his help with the TS/CMC measurements. All authors are disclose to any conflict of interest.	Abdel-Mawgoud AM, 2010, APPL MICROBIOL BIOT, V86, P1323, DOI 10.1007/s00253-010-2498-2; Becker S, 2005, FEBS LETT, V579, P1177, DOI 10.1016/j.febslet.2004.12.087; Becker S, 2008, ANGEW CHEM INT EDIT, V47, P5085, DOI 10.1002/anie.200705236; Benincasa M, 2002, J FOOD ENG, V54, P283, DOI 10.1016/S0260-8774(01)00214-X; Binder U, 2010, J MOL BIOL, V400, P783, DOI 10.1016/j.jmb.2010.05.049; Cha M, 2008, BIORESOURCE TECHNOL, V99, P2192, DOI 10.1016/j.biortech.2007.05.035; Chandrasekaran E V., 1980, METHODS CARBOHYDRATE, P372; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Colak A. K., 2013, Environmental and Experimental Biology, V11, P125; Dobler L, 2016, NEW BIOTECHNOL, V33, P123, DOI 10.1016/j.nbt.2015.09.005; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Giani C, 1997, US, Patent No. [US5641659 A, US5641659]; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Kahraman H, 2012, APPL BIOCHEM MICRO+, V48, P188, DOI 10.1134/S000368381202007X; KOCH AK, 1991, J BACTERIOL, V173, P4212, DOI 10.1128/jb.173.13.4212-4219.1991; Lourith N., 2009, International Journal of Cosmetic Science, V31, P255, DOI 10.1111/j.1468-2494.2009.00493.x; Matsufuji M, 1997, BIOTECHNOL LETT, V19, P1213, DOI 10.1023/A:1018489905076; Mendes AN., 2015, J BIOMATERIALS NANOB, V6, P64, DOI DOI 10.4236/JBNB.2015.61007; Muller MM, 2011, APPL MICROBIOL BIOT, V89, P585, DOI 10.1007/s00253-010-2901-z; Muller MM, 2010, APPL MICROBIOL BIOT, V87, P167, DOI 10.1007/s00253-010-2513-7; OCHSNER UA, 1994, J BIOL CHEM, V269, P19787; Prim N, 2003, J MOL CATAL B-ENZYM, V22, P339, DOI 10.1016/S1381-1177(03)00048-1; Rhamnolipid IM., 2015, J SERB CHEM, V80, P279; Santos AS, 2002, APPL BIOCHEM BIOTECH, V98, P1025, DOI 10.1385/ABAB:98-100:1-9:1025; Sekhon Randhawa Kamaljeet K, 2014, Front Microbiol, V5, P454, DOI 10.3389/fmicb.2014.00454; Tavares LFD, 2013, APPL MICROBIOL BIOT, V97, P1909, DOI 10.1007/s00253-012-4454-9; Tielen P, 2010, MICROBIOL-SGM, V156, P2239, DOI 10.1099/mic.0.037036-0; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Wilhelm S, 1999, J BACTERIOL, V181, P6977, DOI 10.1128/JB.181.22.6977-6986.1999; Wilhelm S, 2007, J BACTERIOL, V189, P6695, DOI 10.1128/JB.00023-07; Wittgens A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-80	33	19	20	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183857	10.1371/journal.pone.0183857	http://dx.doi.org/10.1371/journal.pone.0183857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837648	Green Submitted, gold, Green Published			2022-12-26	WOS:000408365000132
J	McPheeters, MT; Wang, YT; Werdich, AA; Jenkins, MW; Laurita, KR				McPheeters, Matthew T.; Wang, Yves T.; Werdich, Andreas A.; Jenkins, Michael W.; Laurita, Kenneth R.			An infrared optical pacing system for screening cardiac electrophysiology in human cardiomyocytes	PLOS ONE			English	Article							CELL-DERIVED CARDIOMYOCYTES; QT INTERVAL PROLONGATION; VENTRICULAR-FIBRILLATION; NEONATAL CARDIOMYOCYTES; MULTIELECTRODE ARRAY; ATRIAL-FIBRILLATION; PREMATURE STIMULUS; INDUCED ARRHYTHMIA; ACTION-POTENTIALS; IN-VITRO	Human cardiac myocytes derived from pluripotent stem cells (hCM) have invigorated interest in genetic disease mechanisms and cardiac safety testing; however, the technology to fully assess electrophysiological function in an assay that is amenable to high throughput screening has lagged. We describe a fully contactless system using optical pacing with an infrared (IR) laser and multi-site high fidelity fluorescence imaging to assess multiple electrophysiological parameters from hCM monolayers in a standard 96-well plate. Simultaneous multi-site action potentials (FluoVolt) or Ca2+ transients (Fluo4-AM) were measured, from which high resolution maps of conduction velocity and action potential duration (APD) were obtained in a single well. Energy thresholds for optical pacing were determined for cell plating density, laser spot size, pulse width, and wavelength and found to be within ranges reported previously for reliable pacing. Action potentials measured using FluoVolt and a microelectrode exhibited the same morphology and rate of depolarization. Importantly, we show that this can be achieved accurately with minimal damage to hCM due to optical pacing or fluorescence excitation. Finally, using this assay we demonstrate that hCM exhibit reproducible changes in repolarization and impulse conduction velocity for Flecainide and Quinidine, two well described reference compounds. In conclusion, we demonstrate a high fidelity electrophysiological screening assay that incorporates optical pacing with IR light to control beating rate of hCM monolayers.	[McPheeters, Matthew T.; Wang, Yves T.; Jenkins, Michael W.] Case Western Reserve Univ, Pediat, Cleveland, OH 44106 USA; [McPheeters, Matthew T.; Wang, Yves T.; Jenkins, Michael W.; Laurita, Kenneth R.] Case Western Reserve Univ, Biomed Engn, Cleveland, OH 44106 USA; [Werdich, Andreas A.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA USA; [Laurita, Kenneth R.] Case Western Reserve Univ, Heart & Vasc Res Ctr, MetroHlth Campus, Cleveland, OH 44106 USA; Case Western Reserve Univ, Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Case Western Reserve University; MetroHealth System; Case Western Reserve University	Laurita, KR (corresponding author), Case Western Reserve Univ, Biomed Engn, Cleveland, OH 44106 USA.; Laurita, KR (corresponding author), Case Western Reserve Univ, Heart & Vasc Res Ctr, MetroHlth Campus, Cleveland, OH 44106 USA.	Kenneth.Laurita@case.edu		Jenkins, Michael/0000-0002-8908-5383; Wang, Yves/0000-0003-2095-3506; Werdich, Andreas/0000-0002-1222-1180	National Institutes of Health [HL123012, HL118807, HL126747, T32EB007509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL123012, R43HL118807, R01HL126747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB007509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This material is based upon work supported by National Institutes of Health (https://www.nih.gov/) grants HL123012, HL118807 (KRL), HL126747 (MWJ), and T32EB007509. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ES, 2012, J NEUROPHYSIOL, V107, P3227, DOI 10.1152/jn.00424.2011; Aliot E, 2011, EUROPACE, V13, P161, DOI 10.1093/europace/euq382; Asakura K, 2015, J PHARMACOL TOX MET, V75, P17, DOI 10.1016/j.vascn.2015.04.002; Askar SFA, 2011, CARDIOVASC RES, V90, P295, DOI 10.1093/cvr/cvr011; Bedut S, 2016, AM J PHYSIOL-HEART C, V311, pH44, DOI 10.1152/ajpheart.00793.2015; BOYETT MR, 1978, J PHYSIOL-LONDON, V285, P359, DOI 10.1113/jphysiol.1978.sp012576; Cao JM, 1999, CIRC RES, V84, P1318, DOI 10.1161/01.RES.84.11.1318; Cayce JM, 2014, CELL CALCIUM, V55, P183, DOI 10.1016/j.ceca.2014.01.004; Chang MG, 2006, CIRCULATION, V113, P1832, DOI 10.1161/CIRCULATIONAHA.105.593038; Chuck ET, 2001, J CARD FAIL, V7, P1; Coumel P, 2003, J CARDIOVASC PHARM, V41, P771, DOI 10.1097/00005344-200305000-00015; Dempsey GT, 2016, J PHARMACOL TOX MET, V81, P240, DOI 10.1016/j.vascn.2016.05.003; Dittami GM, 2011, J PHYSIOL-LONDON, V589, P1295, DOI 10.1113/jphysiol.2010.198804; Duke AR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02600; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; Ford SM, 2017, CONGENIT HEART DIS, V12, P322, DOI 10.1111/chd.12443; Gibson JK, 2014, J PHARMACOL TOX MET, V70, P255, DOI 10.1016/j.vascn.2014.09.005; Gotoh M, 1997, CIRCULATION, V95, P2141, DOI 10.1161/01.CIR.95.8.2141; Harris K, 2013, TOXICOL SCI, V134, P412, DOI 10.1093/toxsci/kft113; Hoffmann Peter, 2006, Journal of Pharmacological and Toxicological Methods, V53, P87, DOI 10.1016/j.vascn.2005.07.003; HOLMES B, 1985, DRUGS, V29, P1, DOI 10.2165/00003495-198529010-00001; Hou LQ, 2010, CIRC RES, V107, P1503, DOI 10.1161/CIRCRESAHA.110.232470; Jahnke HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068971; Jenkins MW, 2010, NAT PHOTONICS, V4, P623, DOI 10.1038/NPHOTON.2010.166; Jenkins MW, 2013, BIOMED OPT EXPRESS, V4, P1626, DOI 10.1364/BOE.4.001626; JURKIEWICZ NK, 1993, CIRC RES, V72, P75, DOI 10.1161/01.RES.72.1.75; Katritsis D, 1995, EUR HEART J, V16, P1930, DOI 10.1093/oxfordjournals.eurheartj.a060850; Kattman SJ, 2011, J CARDIOVASC TRANSL, V4, P66, DOI 10.1007/s12265-010-9235-1; KIDWELL GA, 1993, J CARDIOVASC PHARM, V21, P621, DOI 10.1097/00005344-199304000-00017; Kitaguchi T, 2016, J PHARMACOL TOX MET, V78, P93, DOI 10.1016/j.vascn.2015.12.002; Klimas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11542; KNISLEY SB, 1994, BIOPHYS J, V66, P719, DOI 10.1016/S0006-3495(94)80846-X; KRISHNAN SC, 1993, CIRCULATION, V87, P562, DOI 10.1161/01.CIR.87.2.562; Laurita KR, 1996, CIRC RES, V79, P493, DOI 10.1161/01.RES.79.3.493; Lee P, 2012, CIRC RES, V110, P1556, DOI 10.1161/CIRCRESAHA.111.262535; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Liu Q, 2014, BIOPHYS J, V106, P1570, DOI 10.1016/j.bpj.2014.03.008; Lothet EH, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011010; Lumbreras V, 2014, J NEUROPHYSIOL, V112, P1246, DOI 10.1152/jn.00253.2014; Martin CA, 2011, PFLUG ARCH EUR J PHY, V462, P495, DOI 10.1007/s00424-011-0989-3; Matiukas A, 2007, HEART RHYTHM, V4, P1441, DOI 10.1016/j.hrthm.2007.07.012; Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109; Navarrete EG, 2013, CIRCULATION, V128, pS3, DOI 10.1161/CIRCULATIONAHA.112.000570; NEUNLIST M, 1995, BIOPHYS J, V68, P2310, DOI 10.1016/S0006-3495(95)80413-3; Nikolski VP, 2002, AM J PHYSIOL-HEART C, V282, pH565, DOI 10.1152/ajpheart.00544.2001; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Peters MF, 2012, ASSAY DRUG DEV TECHN, V10, P525, DOI 10.1089/adt.2011.442; Pollard CE, 2010, BRIT J PHARMACOL, V159, P12, DOI 10.1111/j.1476-5381.2009.00207.x; RODEN DM, 1986, NEW ENGL J MED, V315, P36, DOI 10.1056/NEJM198607033150106; RUDY Y, 1987, CIRC RES, V61, P815, DOI 10.1161/01.RES.61.6.815; SANCHEZCHAPULA J, 1983, CIRC RES, V52, P557, DOI 10.1161/01.RES.52.5.557; Sattayaprasert P, 2016, J MOL CELL CARDIOL, V98, P138, DOI 10.1016/j.yjmcc.2016.05.014; SAUMAREZ RC, 1992, CIRCULATION, V86, P467, DOI 10.1161/01.CIR.86.2.467; Shapiro MG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1742; Shintani SA, 2015, BIOCHEM BIOPH RES CO, V457, P165, DOI 10.1016/j.bbrc.2014.12.077; Teudt IU, 2011, IEEE T BIO-MED ENG, V58, P1648, DOI 10.1109/TBME.2011.2108297; Thompson Alexander C, 2014, Curr Mol Imaging, V3, P162; Valentin JP, 2010, BRIT J PHARMACOL, V159, P25, DOI 10.1111/j.1476-5381.2009.00530.x; WALTON MK, 1983, BIOPHYS J, V44, P9, DOI 10.1016/S0006-3495(83)84273-8; Wang YT, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.060505; Wang YT, 2014, BIOMED OPT EXPRESS, V5, P1000, DOI 10.1364/BOE.5.001000; Wells J, 2005, OPT LETT, V30, P504, DOI 10.1364/OL.30.000504; Wells JD, 2007, LASER SURG MED, V39, P513, DOI 10.1002/lsm.20522; Werdich AA, 2012, PROG BIOPHYS MOL BIO, V110, P154, DOI 10.1016/j.pbiomolbio.2012.07.006	65	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183761	10.1371/journal.pone.0183761	http://dx.doi.org/10.1371/journal.pone.0183761			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837652	Green Submitted, Green Published, gold			2022-12-26	WOS:000408365000114
J	Saar, M; Gilad, T; Kilon-Kallner, T; Rosenfeld, A; Subach, A; Scharf, I				Saar, Maya; Gilad, Tomer; Kilon-Kallner, Tal; Rosenfeld, Adar; Subach, Aziz; Scharf, Inon			The interplay between maze complexity, colony size, learning and memory in ants while solving a maze: A test at the colony level	PLOS ONE			English	Article							GIGANTIOPS-DESTRUCTOR; FORAGING STRATEGIES; LASIUS-NIGER; BEHAVIOR; ENVIRONMENT; CUES; ORIENTATION; EVOLUTION; INSECTS; COSTS	Central-place foragers need to explore their immediate habitat in order to reach food. We let colonies of the individually foraging desert ant Cataglyphis niger search for a food reward in a maze. We did so for three tests per day over two successive days and an additional test after a time interval of 4-20 days (seven tests in total). We examined whether the colonies reached the food reward faster, consumed more food and changed the number of workers searching over time, within and between days. Colonies' food-discovery time shortened within and between days, indicating that some workers learnt and became more efficient in moving through the maze. Such workers, however, also forgot and deteriorated in their food-discovery time, leveling off back to initial performance after about two weeks. We used mazes of increasing complexity levels, differing in the potential number of wrong turns. The number of workers searching increased with colony size. Food-discovery time also increased with colony size in complex mazes but not in simple ones, perhaps due to the more frequent interactions among workers in large colonies having to move through narrow routes. Finally, the motivation to solve the maze was probably not only the food reward, because food consumption did not change over time.	[Saar, Maya; Gilad, Tomer; Kilon-Kallner, Tal; Rosenfeld, Adar; Subach, Aziz; Scharf, Inon] Tel Aviv Univ, Sch Zool, Fac Life Sci, Tel Aviv, Israel	Tel Aviv University	Scharf, I (corresponding author), Tel Aviv Univ, Sch Zool, Fac Life Sci, Tel Aviv, Israel.	scharfi@post.tau.ac.il	Scharf, Inon/AAF-2343-2020; Saar, Maya/AAJ-6973-2021	Scharf, Inon/0000-0002-8506-7161; Saar, Maya/0000-0002-2734-1871	US-Israel Binational Science Foundation [2013086]; Israel Science Foundation [442/16]	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This work was supported by US-Israel Binational Science Foundation (grant no. 2013086) and Israel Science Foundation (grant no. 442/16).	ALLOWAY TM, 1972, ANNU REV ENTOMOL, V17, P43, DOI 10.1146/annurev.en.17.010172.000355; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; Bernays Elizabeth A., 1993, P1; Beugnon G, 2016, J COMP PHYSIOL A, V202, P287, DOI 10.1007/s00359-016-1075-2; Brown S, 2009, LEARN MEMORY, V16, P210, DOI 10.1101/lm.1241909; Burns JG, 2011, P ROY SOC B-BIOL SCI, V278, P923, DOI 10.1098/rspb.2010.2488; Cunningham JP, 2004, J EXP BIOL, V207, P87, DOI 10.1242/jeb.00733; Czaczkes TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2723; Czaczkes TJ, 2013, J EXP BIOL, V216, P188, DOI 10.1242/jeb.076570; Dornhaus A, 2008, BEHAV ECOL SOCIOBIOL, V63, P43, DOI 10.1007/s00265-008-0634-0; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Dukas Reuven, 1998, P89; Dukas Reuven, 1998, P129; Dunlap AS, 2012, BEHAV PROCESS, V89, P86, DOI 10.1016/j.beproc.2011.10.005; Freas CA, 2017, J COMP PHYSIOL A, V203, P353, DOI 10.1007/s00359-017-1174-8; GIRALDEAU LA, 1982, ANIM BEHAV, V30, P1036, DOI 10.1016/S0003-3472(82)80193-0; Gonzalo A, 2009, ANIM COGN, V12, P745, DOI 10.1007/s10071-009-0232-1; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; Gruter C, 2015, ANIM BEHAV, V104, P189, DOI 10.1016/j.anbehav.2015.03.017; HOFFMANN G, 1983, BEHAV ECOL SOCIOBIOL, V13, P81, DOI 10.1007/BF00293798; Hollis KL, 2011, COMP COGN BEHAV REV, V6, P24, DOI 10.3819/ccbr.2011.6004; Hollis KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017958; Hunt ER, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0945; JAFFE K, 1990, INSECT SOC, V37, P101, DOI 10.1007/BF02224024; Karson MA, 2003, J COMP PSYCHOL, V117, P149, DOI 10.1037/0735-7036.117.2.149; Kelber A, 1996, J EXP BIOL, V199, P1127; Korb J, 2004, NATURWISSENSCHAFTEN, V91, P291, DOI 10.1007/s00114-004-0529-5; Kraemer PJ, 1997, PSYCHON B REV, V4, P480, DOI 10.3758/BF03214337; Krakauer DC, 1995, J THEOR BIOL, V177, P417, DOI 10.1006/jtbi.1995.0258; Kramer BH, 2014, BEHAV ECOL SOCIOBIOL, V68, P41, DOI 10.1007/s00265-013-1620-8; Kuszewska K, 2016, ANIM COGN, V19, P1037, DOI 10.1007/s10071-016-1000-7; Langridge EA, 2004, BEHAV ECOL SOCIOBIOL, V56, P523, DOI 10.1007/s00265-004-0824-3; Macquart D, 2008, ANIM BEHAV, V75, P1693, DOI 10.1016/j.anbehav.2007.10.023; MCGUIRE TR, 1984, BEHAV GENET, V14, P479, DOI 10.1007/BF01065445; Pamminger T, 2011, BEHAV ECOL, V22, P255, DOI 10.1093/beheco/arq191; Papaj D.R., 1993, INSECT LEARNING ECOL; Reid CR, 2011, J EXP BIOL, V214, P50, DOI 10.1242/jeb.048173; Sakiyama T, 2013, INSECT SOC, V60, P155, DOI 10.1007/s00040-012-0279-x; Scharf I, 2016, ANIM BEHAV, V119, P37, DOI 10.1016/j.anbehav.2016.06.019; Scharf I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033314; Schatz B, 1999, NATURE, V399, P769, DOI 10.1038/21625; SCHMIDHEMPEL P, 1984, INSECT SOC, V31, P345, DOI 10.1007/BF02223652; Shettleworth S. J., 2009, COGNITION EVOLUTION; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; STRATTON LO, 1973, J COMP PHYSIOL PSYCH, V83, P7, DOI 10.1037/h0034261; Tapia DH, 2015, ANIM BEHAV, V106, P1, DOI 10.1016/j.anbehav.2015.04.027; Thomas ML, 2003, NATURWISSENSCHAFTEN, V90, P88, DOI 10.1007/s00114-002-0396-x; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; van Baaren J, 1998, BEHAV ECOL SOCIOBIOL, V42, P9, DOI 10.1007/s002650050406; WEIER JA, 1995, BEHAV ECOL SOCIOBIOL, V36, P291, DOI 10.1007/BF00167790; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; Zhang SW, 1996, NEUROBIOL LEARN MEM, V66, P267, DOI 10.1006/nlme.1996.0069	52	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183753	10.1371/journal.pone.0183753	http://dx.doi.org/10.1371/journal.pone.0183753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837675	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000111
J	Azpiazu, D; Gonzalez-Parra, E; Ortiz, A; Egido, J; Villa-Bellosta, R				Azpiazu, Daniel; Gonzalez-Parra, Emilio; Ortiz, Alberto; Egido, Jesus; Villa-Bellosta, Ricardo			Impact of post-dialysis calcium level on ex vivo rat aortic wall calcification	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; VASCULAR CALCIFICATION; TISSUE CALCIFICATION; PARATHYROID-HORMONE; MORTALITY RISK; HEMODIALYSIS; ACETAZOLAMIDE; ASSOCIATION; PHOSPHORUS; DEPOSITION	Objectives Vascular calcification is a frequent complication in chronic haemodialysis patients and is associated with adverse outcomes. Serum calcium and phosphate levels and imbalances in calcification regulators are thought to contribute to the process. In this regard, the dialysate calcium concentration is a modifiable tool for modulating the risk of vascular calcification. We explored pre-and post-dialysis phosphate and calcium concentrations in stable chronic haemodialysis patients treated by dialysis with the KDIGO-suggested 1.5 mmol/L calcium dialysate to investigate the effects on ex vivo calcification of rat aortic rings. Approach and results At the end of haemodialysis, mean serum calcium levels were increased in 88% of paired pre-/post-dialysis samples, while mean serum phosphate and parathyroid hormone levels were decreased. Rat aortic ring cultures grown at the same calcium and phosphate concentrations revealed that pre-and post-dialysis resulted in a similar degree of calcification. By contrast, haemodialysis with unchanged serum calcium resulted in a 5-fold reduction in calcium deposition. Conclusion Dialysis with the widely prescribed 1.5 mmol/L calcium dose results in persistent high serum calcification potential in a sizable proportion of patients, driven by increased post-dialysis calcium concentration. This could potentially be mitigated by individualising dialysate calcium dosage based on pre-dialysis serum calcium levels.	[Azpiazu, Daniel; Gonzalez-Parra, Emilio; Ortiz, Alberto; Egido, Jesus; Villa-Bellosta, Ricardo] FJD, FIIS, Madrid, Spain		Villa-Bellosta, R (corresponding author), FJD, FIIS, Madrid, Spain.	ricardo.villa@fjd.es	ortiz, alberto/Y-7582-2018	ortiz, alberto/0000-0002-9805-9523; Villa-Bellosta, Ricardo/0000-0002-1680-552X	Spanish Ministerio de Economia y Competitividad (MINECO) [SAF-2014-60699-JIN]; Foundation SENEFRO (Spanish Nephrology Society)	Spanish Ministerio de Economia y Competitividad (MINECO); Foundation SENEFRO (Spanish Nephrology Society)	This study was supported by grant SAF-2014-60699-JIN from the Spanish Ministerio de Economia y Competitividad (MINECO) to RVB and grant from Foundation SENEFRO (Spanish Nephrology Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile C, 2015, CLIN KIDNEY J, V8, P393, DOI 10.1093/ckj/sfv038; Basile C, 2012, AM J KIDNEY DIS, V59, P92, DOI 10.1053/j.ajkd.2011.08.033; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; de Solis AJ, 2009, J NEPHROL, V22, P647; Finer G, 2014, AM J MED GENET A, V164, P1545, DOI 10.1002/ajmg.a.36476; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gonzalez-Parra E, 2014, BLOOD PURIFICAT, V38, P224, DOI 10.1159/000366126; Gotch FA, 2010, KIDNEY INT, V78, P343, DOI 10.1038/ki.2010.157; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Leibrock CB, 2016, J MOL MED, V94, P95, DOI 10.1007/s00109-015-1331-x; Locatelli F, 2015, CLIN KIDNEY J, V8, P580, DOI 10.1093/ckj/sfv057; Mendoza FJ, 2008, KIDNEY INT, V73, P407, DOI 10.1038/sj.ki.5002646; O'Neill WC, 2007, KIDNEY INT, V72, P792, DOI 10.1038/sj.ki.5002412; Ok E, 2016, J AM SOC NEPHROL, V27, P2475, DOI 10.1681/ASN.2015030268; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Villa-Bellosta R, 2015, CURR CARDIOL REV, V11, P341, DOI 10.2174/1573403X11666150805120505; Villa-Bellosta R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159858; Villa-Bellosta R, 2015, METHODS MOL BIOL, V1339, P119, DOI 10.1007/978-1-4939-2929-0_8; Villa-Bellosta R, 2013, CIRC J, V77, P2145, DOI 10.1253/circj.CJ-13-0016; Villa-Bellosta R, 2011, AM J PHYSIOL-CELL PH, V300, pC210, DOI 10.1152/ajpcell.00229.2010	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183730	10.1371/journal.pone.0183730	http://dx.doi.org/10.1371/journal.pone.0183730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832652	Green Published, Green Submitted, gold			2022-12-26	WOS:000408355800097
J	Ruan, H; Zhan, YY; Hou, J; Xu, B; Chen, B; Tian, Y; Wu, D; Zhao, Y; Zhang, Y; Chen, X; Mi, P; Zhang, L; Zhang, S; Wang, X; Cao, H; Zhang, W; Wang, H; Li, H; Su, Y; Zhang, XK; Hu, T				Ruan, H.; Zhan, Y. Y.; Hou, J.; Xu, B.; Chen, B.; Tian, Y.; Wu, D.; Zhao, Y.; Zhang, Y.; Chen, X.; Mi, P.; Zhang, L.; Zhang, S.; Wang, X.; Cao, H.; Zhang, W.; Wang, H.; Li, H.; Su, Y.; Zhang, X. K.; Hu, T.			Berberine binds RXR alpha to suppress beta-catenin signaling in colon cancer cells	ONCOGENE			English	Article							RETINOID-X-RECEPTOR; ADENOMATOUS-POLYPOSIS-COLI; COLORECTAL-CANCER; NUCLEAR RECEPTORS; DOWN-REGULATION; C-CBL; WNT; IDENTIFICATION; GROWTH; INHIBITION	Berberine, an isoquinoline alkaloid, is a traditional oriental medicine used to treat diarrhea and gastroenteritis. Recently, we reported that it could inhibit the growth of intestinal polyp in animals and in patients with the familial adenomatous polyposis by downregulating beta-catenin signaling. However, the intracellular target mediating the effects of berberine remains elusive. Here, we provide evidence that berberine inhibits beta-catenin function via directly binding to a unique region comprising residues Gln275, Arg316 and Arg371 in nuclear receptor retinoid X receptor alpha (RXR alpha), where berberine concomitantly binding to and synergistically activating RXR alpha with 9-cis-retinoic acid (9-cis-RA), a natural ligand binding to the classical ligand-binding pocket of RXR alpha. Berberine binding promotes RXR alpha interaction with nuclear beta-catenin, leading to c-Cbl mediated degradation of beta-catenin, and consequently inhibits the proliferation of colon cancer cells. Furthermore, berberine suppresses the growth of human colon carcinoma xenograft in nude mice in an RXR alpha-dependent manner. Together, our study not only identifies RXRa as a direct protein target for berberine but also dissects their binding mode and validates that berberine indeed suppresses beta-catenin signaling and cell growth in colon cancer via binding RXR alpha, which provide new strategies for the design of new RXR alpha-based antitumor agents and drug combinations.	[Ruan, H.; Zhan, Y. Y.; Hou, J.; Xu, B.; Chen, B.; Tian, Y.; Wu, D.; Zhao, Y.; Zhang, Y.; Chen, X.; Mi, P.; Cao, H.; Zhang, W.; Hu, T.] Xiamen Univ, Canc Res Ctr, Med Coll, 315 Chengyi Bldg,Xiangan Campus, Xiamen 361102, Fujian, Peoples R China; [Zhang, L.] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Zhang, S.; Wang, X.; Wang, H.; Li, H.] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Su, Y.; Zhang, X. K.] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China; [Zhang, X. K.] Sanford Burnham Med Res Inst, Canc Ctr, La Jolla, CA USA	Xiamen University; Xiamen University; Tsinghua University; Xiamen University; Sanford Burnham Prebys Medical Discovery Institute	Zhan, YY; Hu, T (corresponding author), Xiamen Univ, Canc Res Ctr, Med Coll, 315 Chengyi Bldg,Xiangan Campus, Xiamen 361102, Fujian, Peoples R China.; Zhang, XK (corresponding author), Sanford Burnham Med Res Inst, Canc Ctr, La Jolla, CA USA.	yyzhan@xmu.edu.cn; xkzhang@xmu.edu.cn; thu@xmu.edu.cn	; Li, Haitao/B-2668-2012	Yujie, Zhao/0000-0002-7028-2408; Li, Haitao/0000-0001-6741-293X	National Natural Science Foundation of China [U1405228, 81472568, 81572589]; Natural Science Foundation of Fujian [2014J07010, 2017J06020, 2015R1036-1, 2017R1036-4, 2016R1034-1, 2016R1034-4]; Fundamental Research Funds for the Central Universities [20720150058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian(Natural Science Foundation of Fujian Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grants from the National Natural Science Foundation of China (U1405228, 81472568 and 81572589), the Natural Science Foundation of Fujian grant (2014J07010, 2017J06020, 2015R1036-1, 2017R1036-4, 2016R1034-1 and 2016R1034-4) and the Fundamental Research Funds for the Central Universities (20720150058).	Albring KF, 2013, BIOFACTORS, V39, P652, DOI 10.1002/biof.1133; Beildeck ME, 2010, EXP CELL RES, V316, P1763, DOI 10.1016/j.yexcr.2010.02.001; Casimiro MC, 2014, EXPERT OPIN INV DRUG, V23, P295, DOI 10.1517/13543784.2014.867017; Cesario RM, 2006, CANCER LETT, V240, P225, DOI 10.1016/j.canlet.2005.09.010; Chai YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090850; Chen LQ, 2014, CHEM BIOL, V21, P596, DOI 10.1016/j.chembiol.2014.02.017; Chitalia V, 2013, J BIOL CHEM, V288, P23505, DOI 10.1074/jbc.M113.473801; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Dawson MI, 2002, CURR MED CHEM, V9, P623, DOI 10.2174/0929867023370789; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Delfosse V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9089; Dillard AC, 2008, NUTR CANCER, V60, P97, DOI 10.1080/01635580701586754; Duvic M, 2001, J CLIN ONCOL, V19, P2456, DOI 10.1200/JCO.2001.19.9.2456; Egan JB, 2010, CANCER RES, V70, P1496, DOI 10.1158/0008-5472.CAN-09-3264; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Guldenschuh L, 2001, DIS COLON RECTUM, V44, P1090, DOI 10.1007/BF02234627; Gwyn K, 2002, AM J GASTROENTEROL, V97, P13, DOI 10.1111/j.1572-0241.2002.05435.x; Han AJ, 2008, CANCER BIOL THER, V7, P454, DOI 10.4161/cbt.7.3.5455; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Jacobs ET, 2010, CARCINOGENESIS, V31, P1412, DOI 10.1093/carcin/bgq127; Janakiram NB, 2013, CANCER PREV RES, V6, P1251, DOI 10.1158/1940-6207.CAPR-13-0249; Kersten S, 1998, J MOL BIOL, V284, P21, DOI 10.1006/jmbi.1998.2168; Kolluri SK, 2005, P NATL ACAD SCI USA, V102, P2525, DOI 10.1073/pnas.0409721102; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Mak PA, 2002, J LIPID RES, V43, P2037, DOI 10.1194/jlr.C200014-JLR200; Meade EA, 1999, J BIOL CHEM, V274, P8328, DOI 10.1074/jbc.274.12.8328; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Park JJ, 2012, BIOCHEM BIOPH RES CO, V426, P461, DOI 10.1016/j.bbrc.2012.08.091; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Perez E, 2012, BBA-MOL CELL BIOL L, V1821, P57, DOI 10.1016/j.bbalip.2011.04.003; Rayasam GV, 2010, PHYTOTHER RES, V24, P1260, DOI 10.1002/ptr.3165; Saha SK, 2014, EUR J PHARMACOL, V744, P132, DOI 10.1016/j.ejphar.2014.09.048; Sekiya T, 2002, CANCER RES, V62, P3322; Seo HS, 2015, MOL MED REP, V12, P800, DOI 10.3892/mmr.2015.3480; Shivanna S, 2015, J BIOL CHEM, V290, P12537, DOI 10.1074/jbc.M114.616623; Tang H, 2014, CANCER BIOMARK, V14, P313, DOI 10.3233/CBM-140409; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Volate SR, 2009, MOL CARCINOGEN, V48, P920, DOI 10.1002/mc.20542; Wang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056666; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wang W, 2011, CELL RES, V21, P730, DOI 10.1038/cr.2011.30; Wu K, 2012, INT J ONCOL, V41, P292, DOI 10.3892/ijo.2012.1423; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Yamazaki K, 2007, GUT, V56, P1557, DOI 10.1136/gut.2007.129858; Yu ML, 2014, MOL MED REP, V9, P249, DOI 10.3892/mmr.2013.1762; Zhang HT, 2011, J MOL BIOL, V407, P13, DOI 10.1016/j.jmb.2011.01.032; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; Zhang JF, 2013, J CELL MOL MED, V17, P1484, DOI 10.1111/jcmm.12119; Zhang XK, 2015, ACTA PHARMACOL SIN, V36, P102, DOI 10.1038/aps.2014.109; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493; Zhou H, 2010, CANCER CELL, V17, P560, DOI 10.1016/j.ccr.2010.04.023; Zuo F, 2006, DRUG METAB DISPOS, V34, P2064, DOI 10.1124/dmd.106.011361	55	83	90	3	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 14	2017	36	50					6906	6918		10.1038/onc.2017.296	http://dx.doi.org/10.1038/onc.2017.296			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FQ0JM	28846104	Green Published, hybrid			2022-12-26	WOS:000418041800007
J	Lyons, JD; Klingensmith, NJ; Otani, S; Mittal, R; Liang, Z; Ford, ML; Coopersmith, CM				Lyons, John D.; Klingensmith, Nathan J.; Otani, Shunsuke; Mittal, Rohit; Liang, Zhe; Ford, Mandy L.; Coopersmith, Craig M.			Sepsis reveals compartment-specific responses in intestinal proliferation and apoptosis in transgenic mice whose enterocytes re-enter the cell cycle	FASEB JOURNAL			English	Article						gut; critical illness; stress; cyclin; barrier	PSEUDOMONAS-AERUGINOSA PNEUMONIA; CRITICAL ILLNESS; T-ANTIGEN; EPITHELIAL APOPTOSIS; BARRIER DYSFUNCTION; IMPROVES SURVIVAL; MURINE MODEL; GUT; MECHANISMS; MORTALITY	Cellproductionanddeathare tightly regulatedinthe rapidly renewing gut epithelium, with proliferation confined to crypts and apoptosis occurring in villi and crypts. This study sought to determine how stress alters these compartmentalized processes. Wild-type mice made septic via cecal ligation and puncture had decreased crypt proliferation and increased crypt and villus apoptosis. Fabpi-TAg mice expressing large T-antigen solely in villi had ectopic enterocyte proliferation with increased villus apoptosis in unmanipulated animals. Septic fabpi-TAg mice had an unexpected increase in villus proliferation compared with unmanipulated littermates, whereas crypt proliferation was decreased. Cell cycle regulators cyclin D1 and cyclin D2 were decreased in jejunal tissue in septic transgenic mice. In contrast, villus and crypt apoptosis were increased in septic fabpi-TAg mice. To examine the relationship between apoptosis and proliferation in a compartment-specific manner, fabpi-TAg mice were crossed with fabpl-Bcl-2 mice, resulting in expression of both genes in the villus but Bcl-2 alone in the crypt. Septic bitransgenic animals had decreased crypt apoptosis but had a paradoxical increase in villus apoptosis comparedwith septic fabpi-TAg mice, associated with decreased proliferation in both compartments. Thus, sepsis unmasks compartment-specific proliferative and apoptotic regulation that is not present under homeostatic conditions.	[Lyons, John D.; Klingensmith, Nathan J.; Otani, Shunsuke; Mittal, Rohit; Liang, Zhe; Ford, Mandy L.; Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Lyons, John D.; Klingensmith, Nathan J.; Otani, Shunsuke; Mittal, Rohit; Liang, Zhe; Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Crit Care Ctr, Atlanta, GA 30322 USA; [Ford, Mandy L.] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Otani, Shunsuke] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan	Emory University; Emory University; Emory University; Chiba University	Coopersmith, CM (corresponding author), Emory Univ, 101 Woodruff Circle,Suite WMB 5105, Atlanta, GA 30322 USA.	cmcoop3@emory.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences Grants [GM072808, GM095442, GM104323, GM109779, GM113228, GM117895]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, T32GM095442, R01GM113228, R01GM109779, F32GM117895, R01GM104323] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences Grants; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants GM072808, GM095442, GM104323, GM109779, GM113228, and GM117895. The authors declare no conflicts of interest.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Alverdy JC, 2017, CRIT CARE MED, V45, P337, DOI [10.1097/CCM.0000000000002172, 10.1097/ccm.0000000000002172]; Ban KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076790; Blachier F, 2017, AM J PATHOL, V187, P476, DOI 10.1016/j.ajpath.2016.11.015; Butin-Israeli V, 2010, J VIROL, V84, P3431, DOI 10.1128/JVI.01735-09; Chandrasekaran C, 1996, J BIOL CHEM, V271, P28414, DOI 10.1074/jbc.271.45.28414; Clark JA, 2008, SHOCK, V30, P36, DOI 10.1097/SHK.0b013e31815D0820; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Coopersmith CM, 2003, CRIT CARE MED, V31, P1630, DOI 10.1097/01.CCM.0000055385.29232.11; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Coopersmith CM, 1999, AM J PHYSIOL-GASTR L, V276, pG677, DOI 10.1152/ajpgi.1999.276.3.G677; Coopersmith CM, 1997, ONCOGENE, V15, P131, DOI 10.1038/sj.onc.1201176; Darzynkiewicz Z, 2015, ONCOTARGET, V6, P11735, DOI 10.18632/oncotarget.4149; Dominguez JA, 2011, SHOCK, V36, P381, DOI 10.1097/SHK.0b013e31822793c4; Drayman N, 2016, ONCOTARGET, V7, P52643, DOI 10.18632/oncotarget.10769; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Fay KT, 2017, BBA-MOL BASIS DIS, V1863, P2574, DOI 10.1016/j.bbadis.2017.03.005; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Gerbe F, 2012, CELL MOL LIFE SCI, V69, P2907, DOI 10.1007/s00018-012-0984-7; HALL PA, 1994, J CELL SCI, V107, P3569; HAUFT SM, 1992, J CELL BIOL, V117, P825, DOI 10.1083/jcb.117.4.825; Hayakawa M, 2011, DIGEST DIS SCI, V56, P2361, DOI 10.1007/s10620-011-1649-3; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; Klingensmith NJ, 2017, SHOCK, V47, P184, DOI 10.1097/SHK.0000000000000709; Klingensmith NJ, 2016, CRIT CARE CLIN, V32, P203, DOI 10.1016/j.ccc.2015.11.004; Li QR, 2009, J PATHOL, V218, P210, DOI 10.1002/path.2525; Lyons JD, 2017, PEDIATR CRIT CARE ME, V18, pS46, DOI 10.1097/PCC.0000000000001046; McDonald D, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00199-16; Meng M, 2017, CURR OPIN CRIT CARE, V23, P143, DOI 10.1097/MCC.0000000000000386; Mittal R, 2014, TRENDS MOL MED, V20, P214, DOI 10.1016/j.molmed.2013.08.004; Mollereau B, 2013, CELL DEATH DIFFER, V20, P181, DOI 10.1038/cdd.2012.82; Neal MD, 2013, J IMMUNOL, V190, P3541, DOI 10.4049/jimmunol.1202264; Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Perrone EE, 2012, SHOCK, V38, P68, DOI 10.1097/SHK.0b013e318259abdb; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Robles MTS, 2009, SEMIN CANCER BIOL, V19, P229, DOI 10.1016/j.semcancer.2009.02.002; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Tsai SC, 2000, J BIOL CHEM, V275, P3239, DOI 10.1074/jbc.275.5.3239; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Yoseph BP, 2016, SHOCK, V46, P52, DOI 10.1097/SHK.0000000000000565	50	3	4	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5507	5519		10.1096/fj.201700015RR	http://dx.doi.org/10.1096/fj.201700015RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842422	Green Published			2022-12-26	WOS:000416588300032
J	Li, C; Park, S; Zhang, XW; Eisenberg, LM; Zhao, H; Darzynkiewicz, Z; Xu, DZ				Li, Cen; Park, Soyoung; Zhang, Xiaowen; Eisenberg, Leonard M.; Zhao, Hong; Darzynkiewicz, Zbigniew; Xu, Dazhong			Nuclear Gene 33/Mig6 regulates the DNA damage response through an ATM serine/threonine kinase-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ABL; TYROSINE KINASE; EGF RECEPTOR; ENDOGENOUS INHIBITOR; APOPTOTIC RESPONSE; LATE TRANSDUCER; KAPPA-B; ACTIVATION; BINDING; PROTEIN	Gene 33 (Mig6, ERRFI1) is an adaptor protein with multiple cellular functions. We recently linked Gene 33 to the DNA damage response (DDR) induced by hexavalent chromium (Cr(VI)), but the molecular mechanism remains unknown. Here we show that ectopic expression of Gene 33 triggers DDR in an ATM serine/threonine kinase (ATM)-dependent fashion and through pathways dependent or not dependent on ABL proto-oncogene 1 non-receptor tyrosine kinase (c-Abl). We observed the clear presence of Gene 33 in the nucleus and chromatin fractions of the cell. We also found that the nuclear localization of Gene 33 is regulated by its 14-3-3-binding domain and that the chromatin localization of Gene 33 is partially dependent on its ErbB-binding domain. Our data further indicated that Gene 33 may regulate the targeting of c-Abl to chromatin. Moreover, we observed a clear association of Gene 33 with histone H2AX and that ectopic expression of Gene 33 promotes the interaction between ATM and histone H2AX without triggering DNA damage. In summary, our results reveal nuclear functions of Gene 33 that regulate DDR. The nuclear localization of Gene 33 also provides a spatial explanation of the previously reported regulation of apoptosis by Gene 33 via the c-Abl/p73 pathway. On the basis of these findings and our previous studies, we propose that Gene 33 is a proximal regulator of DDR that promotes DNA repair.	[Li, Cen; Park, Soyoung; Zhang, Xiaowen; Zhao, Hong; Darzynkiewicz, Zbigniew; Xu, Dazhong] New York Med Coll, Sch Med, Dept Pathol, 15 Dana Rd, Valhalla, NY 10595 USA; [Eisenberg, Leonard M.] New York Med Coll, Sch Med, Dept Physiol, Valhalla, NY 10595 USA; [Zhao, Hong; Darzynkiewicz, Zbigniew] New York Med Coll, Sch Med, Brander Canc Res Inst, Valhalla, NY 10595 USA	New York Medical College; New York Medical College; New York Medical College	Xu, DZ (corresponding author), New York Med Coll, Sch Med, Dept Pathol, 15 Dana Rd, Valhalla, NY 10595 USA.	Dazhong_xu@nymc.edu			National Institutes of Health [R21ES023862]; startup fund from New York Medical College; New York Medical College Castle-Krob Research Endowment Fund under the College's Intramural Research Support Program; Robert A. Welke Cancer Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES023862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); startup fund from New York Medical College; New York Medical College Castle-Krob Research Endowment Fund under the College's Intramural Research Support Program; Robert A. Welke Cancer Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grant R21ES023862 (to D. X.), a startup fund from New York Medical College (to D. X.), funds from the New York Medical College Castle-Krob Research Endowment Fund under the College's Intramural Research Support Program (to D. X.), and the Robert A. Welke Cancer Research Foundation (to Z. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agami R, 1999, NATURE, V399, P809; Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590; Anastasi S, 2003, ONCOGENE, V22, P4221, DOI 10.1038/sj.onc.1206516; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Breccia M, 2010, LEUKEMIA RES, V34, P129, DOI 10.1016/j.leukres.2009.08.031; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Cai J, 2009, HYPERTENSION, V53, P539, DOI 10.1161/HYPERTENSIONAHA.108.120816; Chen YC, 2014, DIABETOLOGIA, V57, P2066, DOI 10.1007/s00125-014-3311-z; Chen YC, 2013, MOL ENDOCRINOL, V27, P162, DOI 10.1210/me.2012-1174; Chou RH, 2014, DEV CELL, V30, P224, DOI 10.1016/j.devcel.2014.06.008; Chung JH, 2005, CANCER RES, V65, P4108, DOI 10.1158/0008-5472.CAN-05-0124; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Fiorini M, 2002, ONCOGENE, V21, P6530, DOI 10.1038/sj.onc.1205823; Gong JG, 1999, NATURE, V399, P806; Gu JJ, 2001, CANCER RES, V61, P6703; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hopkins S, 2012, DEV CELL, V23, P547, DOI 10.1016/j.devcel.2012.08.001; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Liu N, 2012, EMBO J, V31, P2365, DOI 10.1038/emboj.2012.88; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pante G, 2005, J CELL BIOL, V171, P337, DOI 10.1083/jcb.200502013; Park S, 2016, ONCOTARGET, V7, P8916, DOI 10.18632/oncotarget.6866; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; REDDEL RR, 1988, CANCER RES, V48, P1904; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takeda K, 2013, GENES CELLS, V18, P369, DOI 10.1111/gtc.12043; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tsunoda T, 2002, CANCER RES, V62, P5668; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; van Laar T, 2001, MOL CARCINOGEN, V31, P63, DOI 10.1002/mc.1040; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Xie BS, 2013, BIOL CELL, V105, P488, DOI 10.1111/boc.201200052; Xu DZ, 2006, MOL CELL BIOL, V26, P5043, DOI 10.1128/MCB.02387-05; Xu DZ, 2005, J BIOL CHEM, V280, P2924, DOI 10.1074/jbc.M408907200; Xu J, 2005, BREAST CANCER RES TR, V91, P207, DOI 10.1007/s10549-005-1040-1; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790	56	6	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16746	16759		10.1074/jbc.M117.803338	http://dx.doi.org/10.1074/jbc.M117.803338			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842482	hybrid, Green Published			2022-12-26	WOS:000412414800033
J	Sun, AJR; Panchal, SK; Friis, T; Sekar, S; Crawford, R; Brown, L; Xiao, Y; Prasadam, I				Sun, Antonia RuJia; Panchal, Sunil K.; Friis, Thor; Sekar, Sunderajhan; Crawford, Ross; Brown, Lindsay; Xiao, Yin; Prasadam, Indira			Obesity-associated metabolic syndrome spontaneously induces infiltration of pro-inflammatory macrophage in synovium and promotes osteoarthritis	PLOS ONE			English	Article							DIET-INDUCED-OBESITY; ARTICULAR-CARTILAGE CHONDROCYTES; SUBCHONDRAL BONE OSTEOBLASTS; ADIPOSE-TISSUE INFLAMMATION; HIGH-FAT DIET; DIABETES-MELLITUS; CRUCIAL ROLE; INSULIN; CELLS; ACTIVATION	Objectives Epidemiological and experimental studies have established obesity to be an important risk factor for osteoarthritis (OA), however, the mechanisms underlying this link remains largely unknown. Here, we studied local inflammatory responses in metabolic-OA. Methods Wistar rats were fed with control diet (CD) and high-carbohydrate, high-fat diet (HCHF) for period of 8 and 16 weeks. After euthanasia, the knees were examined to assess the articular cartilage changes and inflammation in synovial membrane. Further IHC was conducted to determine the macrophage-polarization status of the synovium. In addition, CD and HCHF synovial fluid was co-cultured with bone marrow-derived macrophages to assess the effect of synovial fluid inflammation on macrophage polarisation. Results Our study showed that, obesity induced by a high-carbohydrate, high-fat (HCHF) diet is associated with spontaneous and local inflammation of the synovial membranes in rats even before the cartilage degradation. This was followed by increased synovitis and increased macrophage infiltration into the synovium and a predominant elevation of pro-inflammatory M1 macrophages. In addition, bone marrow derived macrophages, cultured with synovial fluid collected from the knees of obese rats exhibited a pro-inflammatory M1 macrophage phenotype. Conclusion Our study demonstrate a strong association between obesity and a dynamic immune response locally within synovial tissues. Furthermore, we have also identified synovial resident macrophages to play a vital role in the inflammation caused by the HCHF diet. Therefore, future therapeutic strategies targeted at the synovial macrophage phenotype may be the key to break the link between obesity and OA.	[Sun, Antonia RuJia; Friis, Thor; Sekar, Sunderajhan; Xiao, Yin; Prasadam, Indira] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Chem Phys Mech Engn, Brisbane, Qld, Australia; [Panchal, Sunil K.; Brown, Lindsay] Univ Southern Queensland, Inst Agr & Environm, Toowoomba, Qld, Australia; [Panchal, Sunil K.; Brown, Lindsay] Univ Southern Queensland, Sch Hlth & Wellbeing, Toowoomba, Qld, Australia; [Crawford, Ross] Prince Charles Hosp, Orthoped Dept, Brisbane, Qld, Australia	Queensland University of Technology (QUT); University of Southern Queensland; University of Southern Queensland; Prince Charles Hospital	Prasadam, I (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Chem Phys Mech Engn, Brisbane, Qld, Australia.	i.prasadam@qut.edu.au	Sun, Antonia/AAL-3556-2021; Sekar, Sunderajhan/U-5651-2017; Xiao, Yin/AAM-4033-2020	Sekar, Sunderajhan/0000-0003-1566-9316; Xiao, Yin/0000-0003-1785-3491; Prasadam, Indira/0000-0001-5057-2427; Panchal, Sunil K/0000-0001-5464-3376; Sun, Antonia RuJia/0000-0003-0108-9046	The Prince Charles Hospital Research Foundation [MS2014-12]; Prince Charles Hospital Foundation [RF-01]; Arthritis Australia Research Fellowship	The Prince Charles Hospital Research Foundation; Prince Charles Hospital Foundation; Arthritis Australia Research Fellowship	This work was supported by the program grant from The Prince Charles Hospital Research Foundation (MS2014-12), Prince Charles Hospital Foundation Research Fellowship (RF-01) and Arthritis Australia Research Fellowship fd. Indira Prasadam. The funders had no rolein study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Amos N, 2006, RHEUMATOLOGY, V45, P1201, DOI 10.1093/rheumatology/kel078; Balakrishnan L, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-1; Batsis JA, 2015, SCAND J RHEUMATOL, V44, P495, DOI 10.3109/03009742.2015.1021376; Bay-Jensen AC, 2013, MENOPAUSE, V20, P578, DOI 10.1097/GME.0b013e3182745993; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Bliddal H, 2014, OBES REV, V15, P578, DOI 10.1111/obr.12173; Blom AB, 2007, ARTHRITIS RHEUM, V56, P147, DOI 10.1002/art.22337; Boyan BD, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-3; Chang J, 2013, EUR J IMMUNOL, V43, P967, DOI 10.1002/eji.201242772; Collins KH, 2015, OSTEOARTHR CARTILAGE, V23, P1989, DOI 10.1016/j.joca.2015.03.014; Collins KH, 2015, OSTEOARTHR CARTILAGE, V23, P957, DOI 10.1016/j.joca.2015.01.015; Collins KH, 2016, J ORTHOP RES, V34, P1010, DOI 10.1002/jor.23103; Dali-Youcef N, 2013, ANN MED, V45, P242, DOI 10.3109/07853890.2012.705015; Danks L, 2002, ANN RHEUM DIS, V61, P916, DOI 10.1136/ard.61.10.916; de Boer TN, 2012, OSTEOARTHR CARTILAGE, V20, P846, DOI 10.1016/j.joca.2012.05.002; de Munter W, 2016, OSTEOARTHR CARTILAGE, V24, P844, DOI 10.1016/j.joca.2015.11.016; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; El Karib AO, 2016, ARCH PHYSIOL BIOCHEM, V122, P148, DOI 10.3109/13813455.2016.1159698; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Griffin TM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3068; Hamada D, 2016, ARTHRITIS RHEUMATOL, V68, P1392, DOI 10.1002/art.39561; Hoff P, 2013, INT ORTHOP, V37, P145, DOI 10.1007/s00264-012-1724-1; HOLNESS CL, 1993, BLOOD, V81, P1607; Hooshmand Shirin, 2015, J Immunoassay Immunochem, V36, P284, DOI 10.1080/15321819.2014.947431; Iannone F, 2010, CURR DRUG TARGETS, V11, P586, DOI 10.2174/138945010791011857; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Kawanishi N, 2012, BRAIN BEHAV IMMUN, V26, P931, DOI 10.1016/j.bbi.2012.04.006; KAY J, 1991, ARTHRITIS RHEUM, V34, P687, DOI 10.1002/art.1780340609; Khodabandehloo H, 2016, TRANSL RES, V167, P228, DOI 10.1016/j.trsl.2015.08.011; Krasnokutsky S, 2011, ARTHRITIS RHEUM-US, V63, P2983, DOI 10.1002/art.30471; Laiguillon MC, 2015, OSTEOARTHR CARTILAGE, V23, P1513, DOI 10.1016/j.joca.2015.04.026; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Lu H, 2013, EXP THER MED, V6, P684, DOI 10.3892/etm.2013.1223; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maes M, 2007, NEUROENDOCRINOL LETT, V28, P463; Marques C, 2016, ADIPOCYTE, V5, P11, DOI 10.1080/21623945.2015.1061723; Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188; Mia S, 2014, SCAND J IMMUNOL, V79, P305, DOI 10.1111/sji.12162; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Muschter D, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0684-4; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Oliviero F, 2012, CLIN CHIM ACTA, V413, P303, DOI 10.1016/j.cca.2011.10.019; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; PETZELBAUER P, 1993, J INVEST DERMATOL, V101, P256, DOI 10.1111/1523-1747.ep12365183; Poonpet T, 2014, WORLD J ORTHOP, V5, P319, DOI 10.5312/wjo.v5.i3.319; Prasadam I, 2014, RHEUMATOLOGY, V53, P2280, DOI 10.1093/rheumatology/keu262; Prasadam I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4333; Prasadam I, 2012, J RHEUMATOL, V39, P621, DOI 10.3899/jrheum.110777; Prasadam I, 2010, ARTHRITIS RHEUM-US, V62, P1349, DOI 10.1002/art.27397; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; Rayahin JE, 2015, ACS BIOMATER SCI ENG, V1, P481, DOI 10.1021/acsbiomaterials.5b00181; Robinson WH, 2016, NAT REV RHEUMATOL, V12, P580, DOI 10.1038/nrrheum.2016.136; Scanzello CR, 2008, CURR OPIN RHEUMATOL, V20, P565, DOI 10.1097/BOR.0b013e32830aba34; Schelbergen RF, 2014, OSTEOARTHR CARTILAGE, V22, P1158, DOI 10.1016/j.joca.2014.05.022; Seifer DR, 2008, OSTEOARTHR CARTILAGE, V16, P1532, DOI 10.1016/j.joca.2008.04.013; Sekar S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46457; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stannus O, 2010, OSTEOARTHR CARTILAGE, V18, P1441, DOI 10.1016/j.joca.2010.08.016; Sun AR, 2016, CURRENT RHEUMATOLOGY, V18, p1 ; Thijssen E, 2014, RHEUMATOLOGY; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Tsuchida AI, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4107; Utomo L, 2016, OSTEOARTHR CARTILAGE, V24, P2162, DOI 10.1016/j.joca.2016.07.018; Vaamonde- Garcia C, 2017, J BIOL CHEM; Van Landuyt KB, 2010, ARTHRITIS RES THER, V12, P1; van Lent PLEM, 2012, ARTHRITIS RHEUM-US, V64, P1466, DOI 10.1002/art.34315; Wu CL, 2015, ANN RHEUM DIS, V74, P2076, DOI 10.1136/annrheumdis-2014-205601; Wu CL, 2017, ARTHRITIS RHEUMATOLO; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang ZH, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00533; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135; Zimmermann T, 2001, ARTHRITIS RES, V3, P72, DOI 10.1186/ar142	80	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183693	10.1371/journal.pone.0183693	http://dx.doi.org/10.1371/journal.pone.0183693			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859108	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000408740500031
J	Lantz, SM; Karubian, J				Lantz, Samantha M.; Karubian, Jordan			Environmental disturbance increases social connectivity in a passerine bird	PLOS ONE			English	Article							NETWORK STRUCTURE; SEXUAL SELECTION; FIRE; CONSERVATION; INFORMATION; RESOURCES; PREDATION; DYNAMICS; BEHAVIOR; PLUMAGE	Individual level response to natural and anthropogenic disturbance represents an increasingly important, but as yet little understood, component of animal behavior. Disturbance events often alter habitat, which in turn can modify behaviors of individuals in affected areas, including changes in habitat use and associated changes in social structure. To better understand these relationships, we investigated aspects of habitat selection and social connectivity of a small passerine bird, the red-backed fairywren (Malurus melanocephalus), before vs. after naturally occurring fire disturbance in Northern Territory, Australia. We utilized a social network framework to evaluate changes in social dynamics pre-vs. post-fire. Our study covered the non-breeding season in two consecutive years in which fires occurred, and individuals whose habitat was affected and those that were not affected by fire. Individuals in habitat affected by fires had stronger social ties (i.e. higher weighted degree) after fires, while those that were in areas that were not affected by fire actually had lower weighted degree. We suggest that this change in social connections may be linked to habitat. Before fires, fairywrens used habitat that had similar grass cover to available habitat plots randomly generated within our study site. Fire caused a reduction in grass cover, and fairywrens responded by selecting habitat with higher grass cover relative to random plots. This study demonstrates how changes in habitat and/or resource availability caused by disturbance can lead to substantive changes in the social environment that individuals experience.	[Lantz, Samantha M.; Karubian, Jordan] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA	Tulane University	Lantz, SM (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	samlantz@gmail.com			NSF IRES [1131641, 1460048]; Department of Ecology & Evolutionary Biology at Tulane University	NSF IRES(National Science Foundation (NSF)NSF - Office of the Director (OD)); Department of Ecology & Evolutionary Biology at Tulane University	The research was supported by NSF IRES awards #1131641 and 1460048, and a dissertation semester fellowship from the Department of Ecology & Evolutionary Biology at Tulane University.	Andersson Malte, 1994; Ansmann IC, 2012, ANIM BEHAV, V84, P575, DOI 10.1016/j.anbehav.2012.06.009; Aplin LM, 2015, NATURE, V518, P538, DOI 10.1038/nature13998; Baldassarre D. T., 2013, P ROYAL SOC B, V280, P1, DOI DOI 10.1098/RSPB.2013.2175; Bejder L, 1998, ANIM BEHAV, V56, P719, DOI 10.1006/anbe.1998.0802; Butts Carter T., 2016, SNA TOOLS SOCIAL NET; Candolin U, 2013, EVOL BIOL, V40, P589, DOI 10.1007/s11692-013-9234-7; Chan K, 2003, ECOL RES, V18, P73, DOI 10.1046/j.1440-1703.2003.00534.x; Chaverri G, 2010, ADV STUDY BEHAV; Chilvers BL, 2001, TRAWLING BOTTLENOSE, P1901; CRAWFORD DN, 1979, EMU, V79, P150, DOI 10.1071/MU9790150; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Edenbrow M, 2011, ANIM BEHAV, V81, P551, DOI 10.1016/j.anbehav.2010.11.026; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Farine DR, 2015, J EVOLUTION BIOL, V28, P547, DOI 10.1111/jeb.12587; Farine DR, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150367; Farine DR, 2015, J ANIM ECOL, V84, P1144, DOI 10.1111/1365-2656.12418; Farine DR, 2014, ANIM BEHAV, V89, P141, DOI 10.1016/j.anbehav.2014.01.001; Farine DR, 2013, METHODS ECOL EVOL, V4, P1187, DOI 10.1111/2041-210X.12121; Fenner AL, 2011, J ANIM ECOL, V80, P835, DOI 10.1111/j.1365-2656.2011.01825.x; Firth JA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2350; Foster EA, 2012, ANIM BEHAV, V83, P731, DOI 10.1016/j.anbehav.2011.12.021; Gill A. M., 1999, 1 DEP ENV HER; Goodale E, 2010, TRENDS ECOL EVOL, V25, P354, DOI 10.1016/j.tree.2010.01.002; Haddad N. M., 2015, HABITAT FRAGMENTATIO, P1; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Jones HAC, 2010, APPL ANIM BEHAV SCI, V127, P139, DOI 10.1016/j.applanim.2010.09.004; Karubian J, 2002, EVOLUTION, V56, P1673; Kelley JL, 2011, PREDATION RISK SHAPE, P6; Klute DS, 1997, J FIELD ORNITHOL, V68, P253; Krause J, 2010, PHILOS T R SOC B, V365, P4099, DOI 10.1098/rstb.2010.0216; Lantz SM, 2016, AUK, V133, P338, DOI 10.1642/AUK-15-185.1; Lattanzio MS, 2014, J ANIM ECOL, V83, P1490, DOI 10.1111/1365-2656.12252; Leu ST, 2016, ANIM BEHAV, V111, P23, DOI 10.1016/j.anbehav.2015.10.001; Mokross K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2599; Murphy SA, 2010, WILDLIFE RES, V37, P145, DOI 10.1071/WR09007; Nakamura Mao, 2010, Journal of the Yamashina Institute for Ornithology, V42, P47; Orpwood JE, 2008, ANIM BEHAV, V76, P143, DOI 10.1016/j.anbehav.2008.01.016; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Pinter-Wollman N, 2009, P ROY SOC B-BIOL SCI, V276, P1009, DOI 10.1098/rspb.2008.1538; Pinter-Wollman N, 2014, BEHAV ECOL, V25, P242, DOI 10.1093/beheco/art047; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; Radford IJ, 2012, AUSTRAL ECOL, V37, P733, DOI 10.1111/j.1442-9993.2012.02413.x; Rose A, 2014, TULANE UNDERGRAD RES; Rowley I., 1997, FAIRY WRENS GRASSWRE; Stanley CR, 2013, ANIM BEHAV, V85, P771, DOI 10.1016/j.anbehav.2013.01.020; STEWARTOATEN A, 1986, ECOLOGY, V67, P929, DOI 10.2307/1939815; Sundaresan SR, 2007, OECOLOGIA, V151, P140, DOI 10.1007/s00442-006-0553-6; Team RC, 2016, R LANG ENV STAT COMP; Thibault JC, 2006, INT J WILDLAND FIRE, V15, P81, DOI 10.1071/WF04037; Valentine LE, 2007, BURNING SEASON INFLU, P7; Valentine LE, 2012, AUSTRAL ECOL, V37, P23, DOI 10.1111/j.1442-9993.2011.02244.x; Webster MM, 2013, AM NAT, V181, P235, DOI 10.1086/668825; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Wong MYL, 2012, BIOL CONSERV, V155, P77, DOI 10.1016/j.biocon.2012.05.018	59	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183144	10.1371/journal.pone.0183144	http://dx.doi.org/10.1371/journal.pone.0183144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854197	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600031
J	Lee, JY; Shin, DW; Oh, JW; Kim, W; Joo, SK; Jeon, MJ; Kim, SM; Yun, M; Yun, JM; Son, KY; Park, JH; Cho, B; Lee, SM				Lee, Jae Yeon; Shin, Dong Wook; Oh, Jeong Won; Kim, Won; Joo, Sae Kyung; Jeon, Myung Jae; Kim, Sun Min; Yun, Moon; Yun, Jae Moon; Son, Ki Young; Park, Jin Ho; Cho, Belong; Lee, Seung Mi			Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women	PLOS ONE			English	Article							QUALITY-OF-LIFE; METABOLIC SYNDROME; ARTERIAL STIFFNESS; NATURAL-HISTORY; STEATOHEPATITIS; ADIPONECTIN; PREVALENCE; ADULTS	Objective Non-alcoholic fatty liver disease (NAFLD) has become a common and important chronic liver disease worldwide. Previous studies have indicated that NAFLD has an adverse effect on the quality of life, but information is lacking about the impact of NAFLD on female sexual dysfunction. The aim of this study was to determine the association between NAFLD and female sexual dysfunction in premenopausal women. Methods This retrospective study consisted of premenopausal women who were sexually active and visited the outpatient clinic for a routine health check-up between January 2010 and December 2011. Based on the examination of the liver ultrasound scan, the study population was divided into 2 groups: cases with NAFLD and normal controls (cases without NAFLD). The female sexual function was compared between the two groups of cases. For the assessment of sexual function, a female sexual function index (FSFI) questionnaire was used. Results Four hundred seventy women were included, and the prevalence of NAFLD and female sexual dysfunction were 67/470 (14.3%) and 238/470 (50.6%), respectively. Cases with NAFLD had a lower total FSFI score and higher rate of female sexual dysfunction than the normal control [median score of total FSFI (interquartile range): 24.7 (21.9-27.8) in NAFLD vs. 26.7 (23.7-29.8) in normal control, p<0.005; the female sexual dysfunction: 64.2% in NAFLD vs. 48.4% in normal control, p<0.05]. This difference in female sexual dysfunction between the two groups remained significant after adjustment. Conclusion NAFLD is associated with female sexual dysfunction in premenopausal women.	[Lee, Jae Yeon; Oh, Jeong Won; Jeon, Myung Jae; Kim, Sun Min; Lee, Seung Mi] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Jae Yeon; Kim, Sun Min] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Obstet & Gynecol, Seoul, South Korea; [Shin, Dong Wook; Yun, Jae Moon; Son, Ki Young; Park, Jin Ho; Cho, Belong] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Shin, Dong Wook; Kim, Sun Min; Yun, Jae Moon; Son, Ki Young; Park, Jin Ho; Cho, Belong; Lee, Seung Mi] Seoul Natl Univ Hosp, Hlth Promot Ctr, Seoul, South Korea; [Shin, Dong Wook] Samsung Med Ctr, Dept Family Med, Seoul, South Korea; [Kim, Won; Joo, Sae Kyung] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital	Lee, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.; Lee, SM (corresponding author), Seoul Natl Univ Hosp, Hlth Promot Ctr, Seoul, South Korea.	smleemd@hanmail.net	Kim, Won/H-6940-2019; Cho, Belong/GLU-3443-2022; Jeon, Myung Jae/O-2486-2019	Kim, Won/0000-0002-2926-1007; Cho, Belong/0000-0001-9558-689X; Jeon, Myung Jae/0000-0001-5582-1488; Son, Ki Young/0000-0003-1262-100X	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center [03-2014-4]	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center	This work was supported by a clinical research grant-in-aid from the Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center (03-2014-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BACH N, 1989, HEPATOLOGY, V9, P698, DOI 10.1002/hep.1840090507; Basson R, 2000, J UROLOGY, V163, P888, DOI 10.1016/S0022-5347(05)67828-7; Basson R, 2010, J SEX MED, V7, P314, DOI 10.1111/j.1743-6109.2009.01617.x; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Berman JR, 1999, UROLOGY, V54, P385, DOI 10.1016/S0090-4295(99)00230-7; Caldwell S, 2010, DIGEST DIS, V28, P162, DOI 10.1159/000282081; Cho HC, 2015, PREVALENCE FACTORS A; Choi Joohee, 2015, Obstet Gynecol Sci, V58, P302, DOI 10.5468/ogs.2015.58.4.302; Choi SY, 2009, AM J GASTROENTEROL, V104, P1953, DOI 10.1038/ajg.2009.238; Dan AA, 2007, ALIMENT PHARM THER, V26, P815, DOI 10.1111/j.1365-2036.2007.03426.x; David K, 2009, HEPATOLOGY, V49, P1904, DOI 10.1002/hep.22868; Esposito K, 2005, INT J IMPOT RES, V17, P224, DOI 10.1038/sj.ijir.3901310; Esposito K, 2005, DIABETES CARE, V28, P756, DOI 10.2337/diacare.28.3.756; Fang FS, 2014, INTERNAL MED, V53, P189, DOI 10.2169/internalmedicine.53.0690; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kim BJ, 2012, CARDIOLOGY, V123, P54, DOI 10.1159/000341248; Kim HY, 2002, KOREAN J ANDROL, V20, P50; Kim YH, 2011, J SEX MED, V8, P1123, DOI 10.1111/j.1743-6109.2010.02174.x; Kowalczyk R, 2015, GINEKOL POL, V86, P100; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Mahmud A, 2005, AM J HYPERTENS, V18, P1543, DOI 10.1016/j.amjhyper.2005.06.014; Nappi RE, 2015, CLIMACTERIC, P1; Oksuz E, 2006, J UROLOGY, V175, P654, DOI 10.1016/S0022-5347(05)00149-7; Ouedraogo R, 2006, DIABETES, V55, P1840, DOI 10.2337/db05-1174; Papagianni M, 2015, WORLD J HEPATOL, V7, P638, DOI 10.4254/wjh.v7.i4.638; Ponholzer A, 2008, INT J IMPOT RES, V20, P100, DOI 10.1038/sj.ijir.3901605; Pontiroli AE, 2013, J SEX MED, V10, P1044, DOI 10.1111/jsm.12065; Ramesh S, 2005, J HEPATOL, V42, pS2, DOI 10.1016/j.jhep.2004.11.022; Seo NK, 2015, J GASTROEN HEPATOL, V30, P1211, DOI 10.1111/jgh.12935; Song SH, 2008, J SEX MED, V5, P1694, DOI 10.1111/j.1743-6109.2008.00840.x; Sookoian S, 2010, ATHEROSCLEROSIS, V209, P585, DOI 10.1016/j.atherosclerosis.2009.10.011; Targher G, 2006, CLIN ENDOCRINOL, V64, P679, DOI 10.1111/j.1365-2265.2006.02527.x; TAYLOR KJW, 1986, RADIOLOGY, V160, P65, DOI 10.1148/radiology.160.1.3520657; Thuy S, 2008, J NUTR, V138, P1452, DOI 10.1093/jn/138.8.1452; Tsochatzis E, 2006, AM J GASTROENTEROL, V101, P2629, DOI 10.1111/j.1572-0241.2006.00848.x; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vignozzi L, 2014, MOL CELL ENDOCRINOL, V384, P143, DOI 10.1016/j.mce.2014.01.014; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Vlachopoulos C, 2010, AM J HYPERTENS, V23, P1183, DOI 10.1038/ajh.2010.144; Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206	41	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182708	10.1371/journal.pone.0182708	http://dx.doi.org/10.1371/journal.pone.0182708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854246	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600014
J	Moreno-Torres, KI; Pomeroy, LW; Moritz, M; Saville, W; Wolfe, B; Garabed, R				Moreno-Torres, Karla I.; Pomeroy, Laura W.; Moritz, Mark; Saville, William; Wolfe, Barbara; Garabed, Rebecca			Host species heterogeneity in the epidemiology of Nesopora caninum	PLOS ONE			English	Article							NEOSPORA-CANINUM; BEEF-CATTLE; ECONOMIC-IMPACT; RISK-FACTORS; DAIRY; TRANSMISSION; SEROPREVALENCE; INFECTION; VALIDATION; ABORTION	Pathogen transmission across species drives disease emergence; however, mechanisms by which multi-host pathogens cross species boundaries are not well identified. This knowledge gap prevents integrated and targeted control in an epidemiologically continuous ecosystem. Our goal is to describe the impact of host species heterogeneity on the epidemiology of Neospora caninum circulating between livestock and wildlife in southeastern Ohio. We collected biological samples from Pere David's deer (Elaphurus davidianus) located at an outdoor wildlife conservation center; from cattle raised at farms adjacent to the center; and from wild white-tailed deer that roamed across farm and center boundaries. We designed nested infectious disease models of competing hypotheses about transmission and used collected data to fit the models, thereby estimating important immunological and transmission quantities which describe the species-specific contribution to the persistence of this pathogen in the community. We applied these data and models to suggest appropriate species-specific disease control methods. Results show that immunity in cattle and Pere David's deer wanes over time, while in white-tailed deer immunity appears to be lifelong. Transmission quantities for cattle were estimated at values below the threshold for an outbreak (R-t < 1), meaning that chains of transmission are not maintained within this population and infections must occur due to reintroduction from an outside source. Pere David's deer and white-tailed deer both could maintain continuous chains of transmission within their group (R-t > 1). Therefore, we propose that control of contact with outside sources will be useful for disease control in cattle; boosting immunity with vaccines might be an avenue to prevent infection in cattle and Pere David's deer. White-tailed deer are a potential maintenance host for infection and require further study to determine optimal control methods. Community-level investigations like this allow us to better evaluate heterogeneities in transmission processes that ultimately guide targeted control.	[Moreno-Torres, Karla I.; Pomeroy, Laura W.; Saville, William; Garabed, Rebecca] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Moritz, Mark] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Wolfe, Barbara] Morris Anim Fdn, Denver, CO USA; [Garabed, Rebecca] Ohio State Univ, Publ Hlth Preparedness Infect Dis Program, Columbus, OH 43210 USA; [Moreno-Torres, Karla I.] USDA, Ctr Epidemiol & Anim Hlth, Monitoring & Modeling, Anim & Plant Hlth Inspect Serv, Ft Collins, CO 80526 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; United States Department of Agriculture (USDA)	Moreno-Torres, KI (corresponding author), Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA.; Moreno-Torres, KI (corresponding author), USDA, Ctr Epidemiol & Anim Hlth, Monitoring & Modeling, Anim & Plant Hlth Inspect Serv, Ft Collins, CO 80526 USA.	irazema.moreno@gmail.com	Moritz, Mark/X-4052-2019	Moritz, Mark/0000-0003-0644-0069; Moreno Torres, Karla/0000-0001-9755-0938	National Science Foundation Ecology and Evolution of Infectious Diseases program [DEB-1015908]; OSU CARES [2012 Seed]; Columbus Zoo Aquarium [GRT00030170]	National Science Foundation Ecology and Evolution of Infectious Diseases program; OSU CARES; Columbus Zoo Aquarium	LWP was funded by the National Science Foundation Ecology and Evolution of Infectious Diseases program under DEB-1015908. This research was supported by OSU CARES (Grant/Award Number: '2012 Seed') and Columbus Zoo & Aquarium (Grant/Award Number: GRT00030170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Almeria S, 2009, VET PARASITOL, V163, P323, DOI 10.1016/j.vetpar.2009.04.026; Almeria Sonia, 2013, ISRN Parasitol, V2013, P947347, DOI 10.5402/2013/947347; ANDERSON R M, 1991; Armengol R, 2007, J PARASITOL, V93, P1029, DOI 10.1645/GE-1242R.1; Bapodra P, 2015, VET REC OPEN, V2; Bartels CJM, 2006, VET PARASITOL, V137, P17, DOI 10.1016/j.vetpar.2005.12.016; BARTLETT MS, 1960, J R STAT SOC SER A-G, V123, P37, DOI 10.2307/2343186; Baszler TV, 1999, J CLIN MICROBIOL, V37, P4059, DOI 10.1128/JCM.37.12.4059-4064.1999; Baszler TV, 1996, J CLIN MICROBIOL, V34, P1423, DOI 10.1128/JCM.34.6.1423-1428.1996; Baszler TV, 2001, J CLIN MICROBIOL, V39, P3851, DOI 10.1128/JCM.39.11.3851-3857.2001; Cain AT, 2001, A GUIDE TO AGE DETER; Davison HC, 1999, INT J PARASITOL, V29, P1683, DOI 10.1016/S0020-7519(99)00129-0; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dubey JP, 2011, VET PARASITOL, V180, P90, DOI 10.1016/j.vetpar.2011.05.031; Eiras C, 2011, PREV VET MED, V98, P128, DOI 10.1016/j.prevetmed.2010.10.014; England RB, 1984, A GUIDE TO AGE DETER; French NP, 1999, INT J PARASITOL, V29, P1691, DOI 10.1016/S0020-7519(99)00131-9; Ghanem ME, 2009, CAN VET J, V50, P389; Giraudoux P, 2008, PARASITE, V15, P469, DOI 10.1051/parasite/2008153469; Gondim LFP, 2006, TRENDS PARASITOL, V22, P247, DOI 10.1016/j.pt.2006.03.008; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Haddad JPA, 2005, CAN VET J, V46, P230; Hamilton R, 1985, P ANN C SE ASS FISH; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Hinrichs KC, 2003, SEROPREVALENCE OF AN; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Lembo T, 2007, P ROY SOC B-BIOL SCI, V274, P2123, DOI 10.1098/rspb.2007.0664; Lewis FI, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-9; Monney T, 2011, ANIMALS-BASEL, V1, P306, DOI 10.3390/ani1030306; Monney T, 2014, EXP PARASITOL, V140, P52, DOI 10.1016/j.exppara.2014.02.015; Moore DP, 2014, VET PARASITOL, V203, P259, DOI 10.1016/j.vetpar.2014.04.011; Moreno Torres K., 2016, THE WILDLIFE LIVESTO; Moreno-Torres K, 2016, ECOL EVOL, V6, P2216, DOI 10.1002/ece3.2050; Muench H, 1959, CATALYTIC MODELS IN; Munir M, 2014, TRANSBOUND EMERG DIS, V61, P411, DOI 10.1111/tbed.12052; Nash JC, 2016, OPTIMR A REPLACEMENT; Pomeroy LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136642; R. Core Team, 2015, R A LANGUAGE AND ENV; Reichel MP, 2013, INT J PARASITOL, V43, P133, DOI 10.1016/j.ijpara.2012.10.022; RICHARDSON C, 1990, VET REC, V126, P279; Rinaldi L, 2005, VET PARASITOL, V128, P219, DOI 10.1016/j.vetpar.2004.12.011; Sanderson MW, 2000, VET PARASITOL, V90, P15, DOI 10.1016/S0304-4017(00)00234-X; Santolaria P, 2011, VET PARASITOL, V178, P70, DOI 10.1016/j.vetpar.2010.12.018; Streicker DG, 2013, ECOL LETT, V16, P975, DOI 10.1111/ele.12122; Trees AJ, 1999, INT J PARASITOL, V29, P1195, DOI 10.1016/S0020-7519(99)00093-4; Weston JF, 2012, PREV VET MED, V103, P136, DOI 10.1016/j.prevetmed.2011.08.010; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026	49	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183900	10.1371/journal.pone.0183900	http://dx.doi.org/10.1371/journal.pone.0183900			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850580	Green Published, gold, Green Submitted			2022-12-26	WOS:000408544200039
J	Park, C; Kang, MY; Kim, D; Park, J; Eom, H; Kim, EA				Park, Chulyong; Kang, Mo-Yeol; Kim, Dohyung; Park, Jaechan; Eom, Huisu; Kim, Eun-A			Prevalence of abortion and adverse pregnancy outcomes among working women in Korea: A cross-sectional study	PLOS ONE			English	Article							ETHYLENE-GLYCOL ETHERS; FEMALE FLIGHT ATTENDANTS; PLASTICS INDUSTRY; HAIRDRESSERS; INFERTILITY; NURSES; RISK	Objectives To investigate incidence and distribution of major adverse reproductive health problems related to various kinds of industries in Korea and to compare risks for major reproductive outcomes to assess maternal health in working and non-working women. Methods We requested claim data from the Korean National Health Insurance. We defined reference groups as (1) non-working women and (2) workers in the education field. Women working in each industry were compared with reference groups regarding rates of miscarriage, threatened abortion, preterm labor, and intrauterine growth restriction. Logistic regression was used for multivariate analysis, and age and income adjustment was performed. Results The percentages of all adverse obstetric outcomes were higher in working women than in non-working women. Working women had higher and statistically significant adjusted odds ratios (ORs) for miscarriage in 18 of the 21 industries. The age and income-adjusted OR for miscarriage for all working women was 1.26 (95% confidence interval, 1.23-1.28). Business facilities management and business support services, manufacturing, human health and social work activities, wholesale and retail trade, and professional, scientific, and technical activities were major industries with higher adjusted ORs for adverse obstetric outcomes. Conclusions We confirmed that compared to non-working women, working women have a higher risk for adverse pregnancy outcomes. Thus, adverse pregnancy outcomes such as threatened abortion, preterm labor, and intrauterine growth restriction may be associated with working status. This exploratory study identified several industries where in-depth studies are required in future to improve occupational safety in women of reproductive age.	[Park, Chulyong; Kim, Dohyung; Park, Jaechan; Eom, Huisu; Kim, Eun-A] Korea Occupat Safety & Hlth Agcy, Occupat Safety & Hlth Res Inst, Ulsan, South Korea; [Park, Chulyong] Sungkyunkwan Univ, Dept Occupat & Environm Med, Sch Med, Seoul, South Korea; [Kang, Mo-Yeol] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Seoul National University (SNU)	Kim, EA (corresponding author), Korea Occupat Safety & Hlth Agcy, Occupat Safety & Hlth Res Inst, Ulsan, South Korea.	toxneuro@gmail.com	Eun-A, KIM/AAK-4245-2020; Park, Chulyong/AAN-1464-2020	Eun-A, KIM/0000-0002-8582-234X; Park, Chulyong/0000-0001-8584-5376				AHLBORG G, 1987, AM J IND MED, V12, P507, DOI 10.1002/ajim.4700120505; Aspholm R, 1999, J OCCUP ENVIRON MED, V41, P486, DOI 10.1097/00043764-199906000-00015; Axmon A, 2006, SCAND J WORK ENV HEA, V32, P51, DOI 10.5271/sjweh.976; Bonde JP, 2013, SCAND J WORK ENV HEA, V39, P325, DOI 10.5271/sjweh.3337; Burdorf A, 2006, OCCUP MED-OXFORD, V56, P516, DOI 10.1093/occmed/kql113; Chen PC, 2002, EPIDEMIOLOGY, V13, P191, DOI 10.1097/00001648-200203000-00014; Cone JE, 1998, J OCCUP ENVIRON MED, V40, P210, DOI 10.1097/00043764-199803000-00002; Correa A, 1996, AM J EPIDEMIOL, V143, P707; Elliott RC, 1999, AM J IND MED, V36, P557, DOI 10.1002/(SICI)1097-0274(199911)36:5<557::AID-AJIM8>3.0.CO;2-Q; Figa-Talamanca I, 2000, EPIDEMIOL REV, V22, P249, DOI 10.1093/oxfordjournals.epirev.a018037; Gan HF, 2003, J OCCUP HEALTH, V45, P400, DOI 10.1539/joh.45.400; Halliday-Bell JA, 2010, OCCUP MED-OXFORD, V60, P310, DOI 10.1093/occmed/kqq018; Halliday-Bell JA, 2009, OCCUP MED-OXFORD, V59, P180, DOI 10.1093/occmed/kqp017; Hougaard KS, 2006, HUM REPROD, V21, P3122, DOI 10.1093/humrep/del160; Hougaard KS, 2009, REPROD TOXICOL, V27, P186, DOI 10.1016/j.reprotox.2009.01.003; Hsieh GY, 2005, OCCUP ENVIRON MED, V62, P510, DOI 10.1136/oem.2004.016014; Jin LZ, 2004, J OCCUP ENVIRON MED, V46, P1144, DOI 10.1097/01.jom.0000145168.21614.21; Jones RK, 2011, OBSTET GYNECOL, V117, P1358, DOI 10.1097/AOG.0b013e31821c405e; Jorgensen KT, 2013, SCAND J WORK ENV HEA, V39, P302, DOI 10.5271/sjweh.3330; Kim D, 2016, INT ARCH OCC ENV HEA, V89, P739, DOI 10.1007/s00420-016-1112-z; Kim I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123679; Kumar S, 2011, REPROD SCI, V18, P915, DOI 10.1177/1933719111413298; Lauria L, 2006, AVIAT SPACE ENVIR MD, V77, P533; Lawson CC, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.030; LEMASTERS GK, 1989, J OCCUP ENVIRON MED, V31, P115; LEMASTERS GK, 1989, J CLIN EPIDEMIOL, V42, P975, DOI 10.1016/0895-4356(89)90162-5; LINDBOHM M-L, 1985, Public Health Reviews, V13, P55; PASTIDES H, 1988, J OCCUP ENVIRON MED, V30, P543; Ratner PA, 2010, BMC NURS, V9, DOI 10.1186/1472-6955-9-15; Ronda E, 2010, INT ARCH OCC ENV HEA, V83, P945, DOI 10.1007/s00420-010-0517-3; Rylander L, 2002, OCCUP ENVIRON MED, V59, P517, DOI 10.1136/oem.59.8.517; SAURELCUBIZOLLES MJ, 1994, INT ARCH OCC ENV HEA, V66, P235, DOI 10.1007/BF00454361; Silva ID, 2009, J OCCUP ENVIRON MED, V51, P1298, DOI 10.1097/JOM.0b013e3181b9ae2f; Tang Ning, 2003, Int J Occup Med Environ Health, V16, P359; Wennborg H, 2002, SCAND J WORK ENV HEA, V28, P5, DOI 10.5271/sjweh.640; Whelan EA, 2007, EPIDEMIOLOGY, V18, P350, DOI 10.1097/01.ede.0000259988.77314.a4; Yang HJ, 2014, BIRTH-ISS PERINAT C, V41, P262, DOI 10.1111/birt.12118	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0182341	10.1371/journal.pone.0182341	http://dx.doi.org/10.1371/journal.pone.0182341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850585	gold, Green Published, Green Submitted			2022-12-26	WOS:000408544200002
J	Gal, B; Vesely, M; Collakova, J; Nekulova, M; Juzova, V; Chmelik, R; Vesely, P				Gal, Bretislav; Vesely, Miroslav; Collakova, Jana; Nekulova, Marta; Juzova, Veronika; Chmelik, Radim; Vesely, Pavel			Distinctive behaviour of live biopsy-derived carcinoma cells unveiled using coherence-controlled holographic microscopy	PLOS ONE			English	Article							CANCER; P63; LINES; HEAD	Head and neck squamous cell carcinoma is one of the most aggressive tumours and is typically diagnosed too late. Late diagnosis requires an urgent decision on an effective therapy. An individualized test of chemosensitivity should quickly indicate the suitability of chemotherapy and radiotherapy. No ex vivo chemosensitivity assessment developed thus far has become a part of general clinical practice. Therefore, we attempted to explore the new technique of coherence-controlled holographic microscopy to investigate the motility and growth of live cells from a head and neck squamous cell carcinoma biopsy. We expected to reveal behavioural patterns characteristic for malignant cells that can be used to imrove future predictive evaluation of chemotherapy. We managed to cultivate primary SACR2 carcinoma cells from head and neck squamous cell carcinoma biopsy verified through histopathology. The cells grew as a cohesive sheet of suspected carcinoma origin, and western blots showed positivity for the tumour marker p63 confirming cancerous origin. Unlike the roundish colonies of the established FaDu carcinoma cell line, the SACR2 cells formed irregularly shaped colonies, eliciting the impression of the collective invasion of carcinoma cells. Time-lapse recordings of the cohesive sheet activity revealed the rapid migration and high plasticity of these epithelial-like cells. Individual cells frequently abandoned the swiftly migrating crowd by moving aside and crawling faster. The increasing mass of fast migrating epithelial-like cells before and after mitosis confirmed the continuation of the cell cycle. In immunofluorescence, analogously shaped cells expressed the p63 tumour marker, considered proof of their origin from a carcinoma. These behavioural traits indicate the feasible identification of carcinoma cells in culture according to the proposed concept of the carcinoma cell dynamic phenotype. If further developed, this approach could later serve in a new functional online analysis of reactions of carcinoma cells to therapy. Such efforts conform to current trends in precision medicine.	[Gal, Bretislav; Vesely, Miroslav] St Annes Univ Hosp FNUSA, Dept Otorhinolaryngol & Head & Neck Surg, Brno, Czech Republic; [Collakova, Jana; Juzova, Veronika; Chmelik, Radim; Vesely, Pavel] Brno Univ Technol, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Collakova, Jana; Chmelik, Radim] Brno Univ Technol, Fac Mech Engn, Inst Phys Engn IPE, Brno, Czech Republic; [Nekulova, Marta] Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol RECAMO, Brno, Czech Republic	St Anne's University Hospital Brno (FNUSA-ICRC); Brno University of Technology; Brno University of Technology; Masaryk Memorial Cancer Institute	Gal, B (corresponding author), St Annes Univ Hosp FNUSA, Dept Otorhinolaryngol & Head & Neck Surg, Brno, Czech Republic.	b.gal@fnusa.cz	Vesely, Pavel/D-9921-2012; Nekulova, Marta/D-2334-2013; Gal, Bretislav/AAK-5738-2021; Chmelik, Radim/D-7616-2012	Vesely, Pavel/0000-0003-3420-395X; Gal, Bretislav/0000-0003-3351-4449; Chmelik, Radim/0000-0001-5410-4794	Ministry of Education, Youth and Sports of the Czech Republic projects CEITEC, 2020 [LQ1601]; Nanofabrication and Nanocharacterization Core Facility, CEITEC [LM2011020]; CZECH-BIOIMAGING: National Infrastructure for Biological and Medical Imaging [LM2015062]; Project MEYS - NPS I [LO1413]; League against Cancer Prague; Brno University of Technology, Application of Advanced Optical Methods [FSI-S-14-2494]; Czech Science Foundation [15-14612S]; St. Anne's University Hospital (FNUSA); Brno University of Technology [FSI-S-14-2494]; Nanofabrication and Nanocharacterization Core Facility, CEITEC under the activity "Projects of major infrastructures for research, development and innovations" [LM2011020];  [MEYS-NPS I-LO1413]	Ministry of Education, Youth and Sports of the Czech Republic projects CEITEC, 2020; Nanofabrication and Nanocharacterization Core Facility, CEITEC; CZECH-BIOIMAGING: National Infrastructure for Biological and Medical Imaging; Project MEYS - NPS I; League against Cancer Prague; Brno University of Technology, Application of Advanced Optical Methods; Czech Science Foundation(Grant Agency of the Czech Republic); St. Anne's University Hospital (FNUSA); Brno University of Technology; Nanofabrication and Nanocharacterization Core Facility, CEITEC under the activity "Projects of major infrastructures for research, development and innovations"; 	Funded by The Ministry of Education, Youth and Sports of the Czech Republic projects CEITEC, 2020, ID number LQ1601; http://www.msmt.cz/, RC; Nanofabrication and Nanocharacterization Core Facility, CEITEC, ID number LM2011020;https://www.ceitec.eu/, RC; CZECH-BIOIMAGING: National Infrastructure for Biological and Medical Imaging, ID number LM2015062;http://www.czech-bioimaging.cz/ RC, MV; Project MEYS - NPS I, ID number LO1413; http://www.msmt.cz/, MN; The League against Cancer Prague grant, https://www.lpr.cz/index.php/english, PV; Brno University of Technology, Application of Advanced Optical Methods, ID number FSI-S-14-2494; https://www.vutbr.cz/en/ RC; Czech Science Foundation grant, ID number 15-14612S; https://www.vutbr.cz/en/, RC; St. Annes University Hospital (FNUSA) institutional grant;, http://www.fnusa.cz/, BG.r This research was financially supported by the Ministry of Education, Youth and Sports of the Czech Republic under the projects CEITEC 2020 (LQ1601), Nanofabrication and Nanocharacterization Core Facility, CEITEC open access project, ID number LM2011020, under the activity "Projects of major infrastructures for research, development and innovations," and CZECH-BIOIMAGING: National Infrastructure for Biological and Medical Imaging (LM2015062) and Brno University of Technology in grant FSI-S-14-2494 (Application of Advanced Optical Methods), Czech Science Foundation (15-14612S). M. Nekulova was supported by the project MEYS-NPS I-LO1413. The League against Cancer Prague, and the St. Anne's University Hospital (FNUSA) also supported this work.	Balvan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145016; Balvan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121674; BARER R, 1957, J OPT SOC AM, V47, P545, DOI 10.1364/JOSA.47.000545; Brozova M, 2007, BREAST CANCER RES TR, V103, P247, DOI 10.1007/s10549-006-9358-x; Burstein HJ, 2011, J CLIN ONCOL, V29, P3328, DOI 10.1200/JCO.2011.36.0354; Chmelik R, 2011, patent, Patent No. 302491; Chmelik R, 2014, PROG OPTICS, V59, P267, DOI 10.1016/B978-0-444-63379-8.00005-2; Collakova J, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.11.111213; Dang TT, 2016, ONCOTARGET, DOI 10.18632/oncotarget.8696; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dotsch V, 2010, COLD SPRING HARBOR P, V2; DUNN GA, 1993, SYM SOC EXP BIOL, V47, P91; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Gandalovicova A, 2017, TRENDS CANCER, V3, P391, DOI 10.1016/j.trecan.2017.04.008; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Kalia M, 2013, METABOLISM, V62, pS11, DOI 10.1016/j.metabol.2012.08.016; Kalluri R, 2010, J CLIN INVEST, V120, P1786, DOI 10.1172/JCI39104C1; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Khan NR, 2012, ASIAN PAC J CANCER P, V13, P975, DOI 10.7314/APJCP.2012.13.3.975; Krizova A, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.11.111214; Li H, 2014, MOL CANCER RES, V12, P571, DOI 10.1158/1541-7786.MCR-13-0396; Liebertz DJ, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-5; Lippert TH, 2011, INT J MED SCI, V8, P245, DOI 10.7150/ijms.8.245; Nylander K, 2000, INT J CANCER, V87, P368, DOI 10.1002/1097-0215(20000801)87:3<368::AID-IJC9>3.3.CO;2-A; Palm D, 2005, SEMIN CANCER BIOL, V15, P396, DOI 10.1016/j.semcancer.2005.06.008; PARTIN AW, 1989, P NATL ACAD SCI USA, V86, P1254, DOI 10.1073/pnas.86.4.1254; Popescu G, 2008, AJP CELL PHYSL, V295; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Re M, 2014, EUR ARCH OTO-RHINO-L, V271, P1641, DOI 10.1007/s00405-013-2833-1; Sinha Anju, 2015, J Oral Biol Craniofac Res, V5, P165, DOI 10.1016/j.jobcr.2015.07.001; Slaby T, 2013, OPT EXPRESS, V21, P14747, DOI 10.1364/OE.21.014747; Su YR, 2016, CANCER MED-US, V5, P558, DOI 10.1002/cam4.616; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; VESELY P, 1985, SCANNING, V7, P141, DOI 10.1002/sca.4950070307; Watanabe E, 2013, OPT LETT, V38, P1319, DOI 10.1364/OL.38.001319; Zhao M, 2011, CLIN CANC RES; Zhao TT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1209-x	38	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183399	10.1371/journal.pone.0183399	http://dx.doi.org/10.1371/journal.pone.0183399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846747	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600028
J	Llontop, C; Garcia-Quero, C; Castro, A; Dalmau, R; Casitas, R; Galera, R; Iglesias, A; Martinez-Ceron, E; Soriano, JB; Garcia-Rio, F				Llontop, Claudia; Garcia-Quero, Cristina; Castro, Almudena; Dalmau, Regina; Casitas, Raquel; Galera, Raul; Iglesias, Alberto; Martinez-Ceron, Elisabet; Soriano, Joan B.; Garcia-Rio, Francisco			Small airway dysfunction in smokers with stable ischemic heart disease	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; IMPULSE OSCILLOMETRY; FORCED OSCILLATION; FLOW LIMITATION; COPD; PREVALENCE; SPIROMETRY; EMPHYSEMA; STANDARDIZATION	Background A higher prevalence of airflow limitation (AL) has been described in patients with ischemic heart disease (IHD). Although small airway dysfunction (SAD) is an early feature of AL, there is little information about its occurrence in IHD patients. Our objective was to describe the prevalence of SAD in IHD patients, while comparing patient-related outcomes and future health risk among IHD patients with AL, SAD and normal lung function. Methods In 118 consecutive smoking patients with stable IHD, comorbidities, utilization of healthcare resources, current treatment, blood biochemistry and health status were recorded. SAD was evaluated by impulse oscillometry, and pre- and post-bronchodilator spirometry was performed. Results The prevalence of AL and SAD were 20.3 (95% CI, 13.1-27.6%) and 26.3% (95% CI, 18.3-34.2%), respectively. Compared to the normal lung function group, patients with SAD and without AL had lower spirometric values, poorer quality of life and higher levels of C-reactive protein (CRP), as well as increased cardiovascular risk and more vascular age. In patients with normal spirometry, the presence of SAD was independently associated with pack-years, HDL-cholesterol and CRP levels. Conclusion In patients with IHD, the presence of SAD is common and that it is associated with reduced health status and increased future cardiac risk.	[Llontop, Claudia] Hop La Pitie Salpetriere, Serv Pneumol & Reanimat Med, Paris, France; [Garcia-Quero, Cristina; Casitas, Raquel; Galera, Raul; Iglesias, Alberto; Martinez-Ceron, Elisabet; Garcia-Rio, Francisco] Hosp Univ La Paz, IdiPAZ, Serv Neumol, Madrid, Spain; [Castro, Almudena; Dalmau, Regina] Hosp Univ La Paz, IdiPAZ, Serv Cardiol, Madrid, Spain; [Casitas, Raquel; Galera, Raul; Martinez-Ceron, Elisabet; Garcia-Rio, Francisco] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Soriano, Joan B.] Hosp Univ Princesa IISP, Inst Invest, Madrid, Spain; [Soriano, Joan B.; Garcia-Rio, Francisco] Univ Autonoma Madrid, Fac Med, Madrid, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital Universitario La Paz; Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital de La Princesa; Autonomous University of Madrid	Garcia-Rio, F (corresponding author), Hosp Univ La Paz, IdiPAZ, Serv Neumol, Madrid, Spain.; Garcia-Rio, F (corresponding author), CIBER Enfermedades Resp CIBERES, Madrid, Spain.; Garcia-Rio, F (corresponding author), Univ Autonoma Madrid, Fac Med, Madrid, Spain.	fgr01m@gmail.com	Garcia-Rio, Francisco/AAC-9981-2020; Soriano, Joan B/O-1215-2017	Dalmau, Regina/0000-0003-0112-4382; Garcia-Rio, Francisco/0000-0002-7227-2238; Soriano, Joan B/0000-0001-9740-2994	Consejeria de Educacion, Comunidad de Madrid, Spain [S2010/BMD-2542]	Consejeria de Educacion, Comunidad de Madrid, Spain	This work was supported by the Consejeria de Educacion, Comunidad de Madrid, Spain [grant number S2010/BMD-2542].	Berend N, 2016, RESPIROLOGY, V21, P237, DOI 10.1111/resp.12644; Bhatt SP, 2016, AM J RESP CRIT CARE, V194, P178, DOI 10.1164/rccm.201511-2219OC; Burkart KM, 2014, EUR RESPIR J, V43, P1003, DOI 10.1183/09031936.00147612; Crim C, 2011, RESP MED, V105, P1069, DOI 10.1016/j.rmed.2011.01.010; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Franssen FME, 2016, AM J RESP CRIT CARE, V194, P568, DOI 10.1164/rccm.201512-2480OC; Friedman SM, 2011, AM J RESP CRIT CARE, V184, P582, DOI 10.1164/rccm.201011-1909OC; Garcia-Rio F, 2013, ARCH BRONCONEUMOL, V49, P388, DOI 10.1016/j.arbres.2013.04.001; Gimeno D, 2011, EUR J EPIDEMIOL, V26, P135, DOI 10.1007/s10654-010-9526-5; Goldman MD, 2005, RESP PHYSIOL NEUROBI, V148, P179, DOI 10.1016/j.resp.2005.05.026; HALES CA, 1974, NEW ENGL J MED, V290, P761, DOI 10.1056/NEJM197404042901402; Hogg JC, 2013, CHEST, V143, P1436, DOI 10.1378/chest.12-1766; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Martinez FJ, 2008, COPD, V5, P85, DOI 10.1080/15412550801940721; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mitzner W, 2011, NEW ENGL J MED, V365, P1637, DOI 10.1056/NEJMe1110635; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Onishi K, 2014, INT J CHRONIC OBSTR, V9, P563, DOI 10.2147/COPD.S59962; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Oostveen E, 2013, EUR RESPIR J, V42, P1513, DOI 10.1183/09031936.00126212; PATAKAS D, 1983, THORAX, V38, P108, DOI 10.1136/thx.38.2.108; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Puhan MA, 2009, LANCET, V374, P704, DOI 10.1016/S0140-6736(09)61301-5; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rodriguez-Roisin R, 2017, AM J RESP CRIT CARE, V195, P17, DOI 10.1164/rccm.201607-1376PP; Schermer T, 2010, RESPIROLOGY, V15, P975, DOI 10.1111/j.1440-1843.2010.01809.x; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; Soriano JB, 2010, CHEST, V137, P333, DOI 10.1378/chest.09-1264; Sorkness RL, 2013, AM J RESP CELL MOL, V49, P808, DOI 10.1165/rcmb.2013-0096OC; Spyratos DG, 2011, HEART LUNG, V40, P97, DOI 10.1016/j.hrtlng.2010.05.055; Timmins SC, 2012, CHEST, V142, P312, DOI 10.1378/chest.11-2169; VANNOORD JA, 1989, EUR RESPIR J, V2, P846; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wada H, 2010, RESPIROLOGY, V15, P1252, DOI 10.1111/j.1440-1843.2010.01854.x; Walter RE, 2008, CHEST, V133, P19, DOI 10.1378/chest.07-0058; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971; Xia P, 1999, J BIOL CHEM, V274, P33143, DOI 10.1074/jbc.274.46.33143; Young RP, 2016, AM J RESP CELL MOL, V54, P161, DOI 10.1165/rcmb.2015-0250PS	41	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182858	10.1371/journal.pone.0182858	http://dx.doi.org/10.1371/journal.pone.0182858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846677	gold, Green Published, Green Submitted			2022-12-26	WOS:000408438600017
J	Wang, HK; Qu, YY; Dai, B; Zhu, Y; Shi, GH; Zhu, YP; Shen, YJ; Zhang, HL; Ye, DW				Wang, HongKai; Qu, YuanYuan; Dai, Bo; Zhu, Yao; Shi, GuoHai; Zhu, YiPing; Shen, YiJun; Zhang, HaiLiang; Ye, DingWei			PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway	PLOS ONE			English	Article							BAF180; EXPRESSION; CHEMOKINES; INDUCTION	PBRM1 is a novel tumor suppressor gene that can inhibit cancer cell proliferation and predict the outcome of renal cell carcinoma (RCC), but its biological role needs further elucidation. We examined expression of the PBRM1 gene in RCC cell lines and the effect of PBRM1 on cell proliferation and cell cycle in RCC ACHN cells. Microarray processing and analysis was used to explore novel pathways involved in tumorigenesis related to PBRM1 knockdown. PBRM1 was expressed at high levels in RCC ACHN cells and lentivirus-mediated PBRM1 knockdown in these cells caused an increase in the proportion of cells in S phase of the cell cycle and promoted in vitro proliferation and migration. In vivo experiments showed that downregulation of PBRM1 promoted tumorigenesis in nude mice. In pathway gene chip analysis, the chemokine/chemokine receptor interaction pathway showed the greatest difference in gene expression upon PBRM1 knockdown. Protein levels of IL6ST and CCL2 were increased, whereas levels of interleukin (IL)-8, IL-6, and CXCL2 were decreased, in knockdown cells. Re-expression of IL-8 in PBRM1 knockdown ACHN cells could significantly decrease cell proliferation/migration and induced cell arrest in the G2/M phase. These findings indicate that PBRM1 alters cell cycle progression and inhibits proliferation and migration of ACHN cells through the chemokine/chemokine receptor pathway.	[Wang, HongKai; Qu, YuanYuan; Dai, Bo; Zhu, Yao; Shi, GuoHai; Zhu, YiPing; Shen, YiJun; Zhang, HaiLiang; Ye, DingWei] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai, Peoples R China; [Wang, HongKai; Qu, YuanYuan; Dai, Bo; Zhu, Yao; Shi, GuoHai; Zhu, YiPing; Shen, YiJun; Zhang, HaiLiang; Ye, DingWei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Fudan University; Fudan University	Zhang, HL; Ye, DW (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai, Peoples R China.; Zhang, HL; Ye, DW (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	zhanghl918@163.com; dwyeli@163.com	Zhang, Hailiang/AAF-4937-2020; Shen, Yi/GRS-3602-2022		National Natural Science Foundation of China [81202004, 81472377]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (no. 81202004 and no. 81472377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee PM, 2014, CELL REP, V6, P973, DOI 10.1016/j.celrep.2014.02.012; Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107; Capitanio U, 2016, LANCET, V387, P894, DOI 10.1016/S0140-6736(15)00046-X; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Chowdhury B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153718; Cowey CL, 2009, CURR ONCOL REP, V11, P94, DOI 10.1007/s11912-009-0015-5; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; da Costa WH, 2014, BJU INT, V113, pE157, DOI 10.1111/bju.12426; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Jeong SM, 2010, J BIOL CHEM, V285, P2340, DOI 10.1074/jbc.M109.026997; Johrer K, 2005, CLIN CANCER RES, V11, P2459, DOI 10.1158/1078-0432.CCR-04-0405; Kakarougkas A, 2014, MOL CELL, V55, P723, DOI 10.1016/j.molcel.2014.06.028; KASAMA T, 1994, J IMMUNOL, V152, P3559; Khanjani S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/504952; Klatte T, 2008, J UROLOGY, V179, P61, DOI 10.1016/j.juro.2007.08.148; Li ZH, 2015, EURASIP J ADV SIG PR, DOI 10.1186/s13634-015-0222-1; Masliah-Planchon J, 2015, ANNU REV PATHOL-MECH, V10, P145, DOI 10.1146/annurev-pathol-012414-040445; Melik-Parsadaniantz S, 2008, J NEUROIMMUNOL, V198, P62, DOI 10.1016/j.jneuroim.2008.04.022; Mestas J, 2005, J IMMUNOL, V175, P5351, DOI 10.4049/jimmunol.175.8.5351; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Parihar Jaspreet S, 2014, Rev Urol, V16, P118; Pawlowski R, 2013, INT J CANCER, V132, pE11, DOI 10.1002/ijc.27822; Payne AS, 2002, J INVEST DERMATOL, V118, P915, DOI 10.1046/j.1523-1747.2002.01725.x; Shuch B, 2015, EUR UROL, V67, P85, DOI 10.1016/j.eururo.2014.04.029; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Wente MN, 2006, CANCER LETT, V241, P221, DOI 10.1016/j.canlet.2005.10.041; Wurster AL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-9; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276	34	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0180862	10.1371/journal.pone.0180862	http://dx.doi.org/10.1371/journal.pone.0180862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846693	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600004
J	Rehman, A; Hu, SH; Tnimov, Z; Whitten, AE; King, GJ; Jarrott, RJ; Norwood, SJ; Alexandrov, K; Collins, BM; Christie, MP; Martin, JL				Rehman, Asma; Hu, Shu-Hong; Tnimov, Zakir; Whitten, Andrew E.; King, Gordon J.; Jarrott, Russell J.; Norwood, Suzanne J.; Alexandrov, Kirill; Collins, Brett M.; Christie, Michelle P.; Martin, Jennifer L.			The nature of the Syntaxin4 C-terminus affects Munc18c-supported SNARE assembly	PLOS ONE			English	Article							N-PEPTIDE; MEMBRANE-FUSION; CLOSED-CONFORMATION; MUNC18-1 BINDING; COMPLEX; MODES; TRAFFICKING; ACTIVATION; EXOCYTOSIS; LACKING	Vesicular transport of cellular cargo requires targeted membrane fusion and formation of a SNARE protein complex that draws the two apposing fusing membranes together. Insulin-regulated delivery and fusion of glucose transporter-4 storage vesicles at the cell surface is dependent on two key proteins: the SNARE integral membrane protein Syntaxin4 (Sx4) and the soluble regulatory protein Munc18c. Many reported in vitro studies of Munc18c:Sx4 interactions and of SNARE complex formation have used soluble Sx4 constructs lacking the native transmembrane domain. As a consequence, the importance of the Sx4 C-terminal anchor remains poorly understood. Here we show that soluble C-terminally truncated Sx4 dissociates more rapidly from Munc18c than Sx4 where the C-terminal transmembrane domain is replaced with a T4-lysozyme fusion. We also show that Munc18c appears to inhibit SNARE complex formation when soluble C-terminally truncated Sx4 is used but does not inhibit SNARE complex formation when Sx4 is C-terminally anchored (by a C-terminal His-tag bound to resin, by a C-terminal T4L fusion or by the native C-terminal transmembrane domain in detergent micelles). We conclude that the C- terminus of Sx4 is critical for its interaction with Munc18c, and that the reported inhibitory role of Munc18c may be an artifact of experimental design. These results support the notion that a primary role of Munc18c is to support SNARE complex formation and membrane fusion.	[Rehman, Asma; Hu, Shu-Hong; Whitten, Andrew E.; King, Gordon J.; Jarrott, Russell J.; Christie, Michelle P.; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia; [Tnimov, Zakir; Norwood, Suzanne J.; Alexandrov, Kirill; Collins, Brett M.] Univ Queensland, Inst Mol Biosci, Div Cell Biol & Mol Med, Brisbane, Qld, Australia; [Rehman, Asma] Inst Biophys, Dulbecco Telethon Inst, Genoa, Italy; [Hu, Shu-Hong; Jarrott, Russell J.; Martin, Jennifer L.] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Tnimov, Zakir] MRC Lab Mol Biol, Cambridge, England; [Whitten, Andrew E.] Australian Nucl Sci & Technol Org, Lucas Heights, NSW, Australia; [Christie, Michelle P.] St Vincents Inst Med Res, Fitzroy, Vic, Australia	University of Queensland; University of Queensland; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Griffith University; MRC Laboratory Molecular Biology; Australian Nuclear Science & Technology Organisation; St. Vincent's Institute of Medical Research	Christie, MP; Martin, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia.; Martin, JL (corresponding author), Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia.; Christie, MP (corresponding author), St Vincents Inst Med Res, Fitzroy, Vic, Australia.	mchristie@svi.edu.au; jlm@griffith.edu.au	Tnimov, Zakir/L-3052-2019; Alexandrov, Kirill/A-5830-2013; Rehman, Asma/X-4632-2018; Collins, Brett/J-1563-2014; Martin, Jennifer L./A-6039-2010	Tnimov, Zakir/0000-0003-2466-2220; Alexandrov, Kirill/0000-0002-0957-6511; Rehman, Asma/0000-0002-0653-9053; Collins, Brett/0000-0002-6070-3774; Christie, Michelle/0000-0002-7001-3400; Martin, Jennifer L./0000-0002-9225-8863; Whitten, Andrew/0000-0001-8856-3120; Jarrott, Russell/0000-0003-4326-1203	Australian National Health and Medical Research Council (NHMRC) [535921, 1066069]; NHMRC Peter Doherty Fellowship [569864]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council (NHMRC) program grant 535921 and project grant 1066069. At the time of this work, AEW was supported by an NHMRC Peter Doherty Fellowship (569864); KA was an ARC Future Fellow (FT0991611); BMC was an ARC Future Fellow (FT100100027) and is now an NHMRC Career Development Fellow (APP1061574); and JLM was an ARC Australian Laureate Fellow (FL0992138) and honorary NHMRC Fellow (APP455829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran V, 2009, BIOCHEM J, V419, P655, DOI 10.1042/BJ20082293; Archbold JK, 2014, CURR OPIN STRUC BIOL, V29, P44, DOI 10.1016/j.sbi.2014.09.003; Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Burkhardt P, 2011, P NATL ACAD SCI USA, V108, P15264, DOI 10.1073/pnas.1106189108; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christie MP, 2012, P NATL ACAD SCI USA, V109, P9816, DOI 10.1073/pnas.1116975109; Colbert KN, 2013, P NATL ACAD SCI USA, V110, P12637, DOI 10.1073/pnas.1303753110; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Diao JJ, 2010, ACS CHEM NEUROSCI, V1, P168, DOI 10.1021/cn900034p; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Liang BY, 2013, P NATL ACAD SCI USA, V110, P19384, DOI 10.1073/pnas.1314699110; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Malintan NT, 2009, J BIOL CHEM, V284, P21637, DOI 10.1074/jbc.M109.013508; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Peng RW, 2010, BIOCHEM J, V431, P353, DOI 10.1042/BJ20100145; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Rehman A, 2014, IUCRJ, V1, P505, DOI 10.1107/S2052252514020727; Rehman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083499; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rodkey TL, 2008, MOL BIOL CELL, V19, P5422, DOI 10.1091/mbc.E08-05-0538; Schollmeier Y, 2011, J BIOL CHEM, V286, P30582, DOI 10.1074/jbc.M111.269886; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Sudhof TC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005637; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010	46	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183366	10.1371/journal.pone.0183366	http://dx.doi.org/10.1371/journal.pone.0183366			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841669	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700027
J	Wang, HS; Williams, D; Griffin, J; Saito, T; Saido, TC; Fraser, PE; Rogaeva, E; Schmitt-Ulms, G				Wang, Hansen; Williams, Declan; Griffin, Jennifer; Saito, Takashi; Saido, Takaomi C.; Fraser, Paul E.; Rogaeva, Ekaterina; Schmitt-Ulms, Gerold			Time-course global proteome analyses reveal an inverse correlation between A beta burden and immunoglobulin M levels in the APP(NL-F) mouse model of Alzheimer disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; QUANTITATIVE PROTEOMICS; PEPTIDE IDENTIFICATION; NATURAL ANTIBODIES; PLASMA; PHOSPHORYLCHOLINE; IMPAIRMENT; CLEARANCE; DEFICITS	Alzheimer disease (AD) stands out amongst highly prevalent diseases because there is no effective treatment nor can the disease be reliably diagnosed at an early stage. A hallmark of AD is the accumulation of aggregation-prone amyloid beta peptides (A beta), the main constituent of amyloid plaques. To identify A beta-dependent changes to the global proteome we used the recently introduced APP(NL-F) mouse model of AD, which faithfully recapitulates the A beta pathology of the disease, and a workflow that interrogated the brain proteome of these mice by quantitative mass spectrometry at three different ages. The elevated A beta burden in these mice was observed to cause almost no changes to steady-state protein levels of the most abundant >2,500 brain proteins, including 12 proteins encoded by well-confirmed AD risk loci. The notable exception was a striking reduction in immunoglobulin heavy mu chain (IGHM) protein levels in homozygote APP(NL-F/NL-F) mice, relative to APP(NL-F/wt) littermates. Follow-up experiments revealed that IGHM levels generally increase with age in this model. Although discovered with brain samples, the relative IGHM depletion in APP(NL-F/NL-F) mice was validated to manifest systemically in the blood, and did not extend to other blood proteins, including immunoglobulin G. Results presented are consistent with a cause-effect relationship between the excessive accumulation of A beta and the selective depletion of IGHM levels, which may be of relevance for understanding the etiology of the disease and ongoing efforts to devise blood-based AD diagnostics.	[Wang, Hansen; Williams, Declan; Griffin, Jennifer; Fraser, Paul E.; Rogaeva, Ekaterina; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Saito, Takashi; Saido, Takaomi C.] RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama, Japan; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Rogaeva, Ekaterina] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; RIKEN; University of Toronto; University of Toronto; University of Toronto	Schmitt-Ulms, G (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.; Schmitt-Ulms, G (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	g.schmittulms@utoronto.ca	Saido, Takaomi C/N-5472-2015; Sado, Takaomi/AAN-2759-2021; Saito, Takashi/G-2563-2015; Wang, Hansen/H-7703-2014	Saido, Takaomi C/0000-0003-1970-6903; Sado, Takaomi/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251; Wang, Hansen/0000-0003-4414-3372	Canadian Institute for Health Research (CIHR); Canadian Foundation for Innovation; National Institutes of Health	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work on this project was supported by an operating grant from the Canadian Institute for Health Research (CIHR) to GS, an infrastructure grant from the Canadian Foundation for Innovation to GS, PF and ER, as well as support from the National Institutes of Health to ER. The authors are most grateful to the Irwin family for their continued support and acknowledge a generous gift by the Rosiak family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm C, 2015, MOL CELL NEUROSCI, V66, P3, DOI 10.1016/j.mcn.2015.02.016; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Chin J, 2011, METHODS MOL BIOL, V670, P169, DOI 10.1007/978-1-60761-744-0_13; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dayon Loic, 2012, Methods Mol Biol, V893, P115, DOI 10.1007/978-1-61779-885-6_9; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Eriksson UK, 2010, J ALZHEIMERS DIS, V21, P577, DOI 10.3233/JAD-2010-091705; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GASKIN F, 1993, J EXP MED, V177, P1181, DOI 10.1084/jem.177.4.1181; Ghani M, 2017, NEURODEGENERATIVE DI; Giedraitis V, 2007, NEUROSCI LETT, V427, P127, DOI 10.1016/j.neulet.2007.09.023; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gunawardana CG, 2015, MOL CELL PROTEOMICS, V14, P3000, DOI 10.1074/mcp.M115.050724; Gustaw-Rothenberg KA, 2010, EXP GERONTOL, V45, P47, DOI 10.1016/j.exger.2009.10.003; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; INOUE T, 1986, J CLIN IMMUNOL, V6, P130, DOI 10.1007/BF00918745; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kawarabayashi T, 2008, CURR OPIN PSYCHIATR, V21, P260, DOI 10.1097/YCO.0b013e3282fc989f; Li QY, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-22; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Marcello A, 2011, NEUROBIOL AGING, V32, P1379, DOI 10.1016/j.neurobiolaging.2009.08.011; Marcello A, 2009, J NEURAL TRANSM, V116, P913, DOI 10.1007/s00702-009-0224-y; Mehrabian M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114594; Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200; Pihlgren M, 2013, BLOOD, V121, P85, DOI 10.1182/blood-2012-02-413831; Prince M, 2015, GLOBAL IMPACT DEMENT; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Silajdzic E, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0260-1; Song F, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-5; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Udan MLD, 2008, J NEUROCHEM, V104, P524, DOI 10.1111/j.1471-4159.2007.05001.x; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Yung S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139365; Zhang W, 2012, J NEUROL SCI, V315, P67, DOI 10.1016/j.jns.2011.11.032	43	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182844	10.1371/journal.pone.0182844	http://dx.doi.org/10.1371/journal.pone.0182844			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832675	gold, Green Submitted, Green Published			2022-12-26	WOS:000408355800036
J	Allam, H; Johnson, BP; Zhang, M; Lu, ZP; Cannon, MJ; Abbott, KL				Allam, Heba; Johnson, Blake P.; Zhang, Mao; Lu, Zhongpeng; Cannon, Martin J.; Abbott, Karen L.			The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOMIC ANALYSIS; MICROARRAY DATA; IDENTIFICATION; GLYCOSYLATION; PATHWAY; SITES; TOOL	Glycosylation changes associated with cellular transformation can facilitate the growth and progression of tumors. Previously we discovered that the gene Mgat3 encoding the glycosyltransferase GnT-III is elevated in epithelial ovarian carcinomas (EOCs) and leads to the production of abnormal truncated N-linked glycan structures instead of the typical bisected forms. In this study, we are interested in discovering how these abnormal glycans impact the growth and progression of ovarian cancer. We have discovered using stable shRNA gene suppression that GnT-III expression controls the expansion of side-population cells, also known as cancer stem cells. More specifically, we found that GnT-III expression regulates the levels and activation of the heavily glycosylated Notch receptor involved in normal and malignant development. Suppression of GnT-III in EOC cell lines and primary tumor-derived cells resulted in an inhibition of Notch signaling that was more potent than pharmacologic blockage of Notch activation via gamma-secretase inhibition. The inhibition resulted from the redirection of the Notch receptor to the lysosome, a novel mechanism. These findings demonstrate a new role for bisecting glycosylation in the control of Notch transport and demonstrate the therapeutic potential of inhibiting GnT-III as a treatment for controlling EOC growth and recurrence.	[Allam, Heba] Menofiya Univ, Med Microbiol & Immunol Dept, Cairo 11795, Egypt; [Johnson, Blake P.] Ouachita Baptist Univ, Dept Biol, Arkadelphia, AR 71998 USA; [Zhang, Mao; Lu, Zhongpeng; Abbott, Karen L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Cannon, Martin J.] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA	Egyptian Knowledge Bank (EKB); Menofia University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Abbott, KL (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	kabbott@uams.edu	Allam, Heba/AAC-9226-2019	Allam, Heba/0000-0003-3053-8066	NCI, National Institutes of Health [UO1CA168870]; NATIONAL CANCER INSTITUTE [U01CA168870] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant UO1CA168870 (to K. L. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott KL, 2008, PROTEOMICS, V8, P3210, DOI 10.1002/pmic.200800157; Allam H, 2015, J PROTEOME RES, V14, P434, DOI 10.1021/pr501174p; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Iida A, 1998, GENE CHROMOSOME CANC, V21, P108, DOI 10.1002/(SICI)1098-2264(199802)21:2<108::AID-GCC5>3.0.CO;2-4; Kakuda S, 2017, DEV CELL, V40, P193, DOI 10.1016/j.devcel.2016.12.013; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Nagahata Takemitsu, 2002, Breast Cancer, V9, P208, DOI 10.1007/BF02967591; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; NYE JS, 1994, DEVELOPMENT, V120, P2421; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Rose SL, 2010, GYNECOL ONCOL, V117, P130, DOI 10.1016/j.ygyno.2009.12.003; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Wang LJ, 2012, MOL CELL BIOCHEM, V363, P257, DOI 10.1007/s11010-011-1178-6; Wu XT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10533; YOSHIMURA M, 1995, INT J CANCER, V60, P443, DOI 10.1002/ijc.2910600404; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	28	26	27	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16351	16359		10.1074/jbc.M117.783936	http://dx.doi.org/10.1074/jbc.M117.783936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28842505	Green Published, hybrid			2022-12-26	WOS:000412109400032
J	Andersen, M; Sajid, Z; Pedersen, RK; Gudmand-Hoeyer, J; Ellervik, C; Skov, V; Kjaer, L; Pallisgaard, N; Kruse, TA; Thomassen, M; Troelsen, J; Hasselbalch, HC; Ottesen, JT				Andersen, Morten; Sajid, Zamra; Pedersen, Rasmus K.; Gudmand-Hoeyer, Johanne; Ellervik, Christina; Skov, Vibe; Kjaer, Lasse; Pallisgaard, Niels; Kruse, Torben A.; Thomassen, Mads; Troelsen, Jesper; Hasselbalch, Hans Carl; Ottesen, Johnny T.			Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development	PLOS ONE			English	Article							CHRONIC MYELOPROLIFERATIVE NEOPLASMS; C-REACTIVE PROTEIN; ACUTE MYELOID-LEUKEMIA; TYROSINE KINASE JAK2; NF-KAPPA-B; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; CLONAL EVOLUTION; CIRCULATING YKL-40; SOMATIC MUTATIONS	The chronic Philadelphia-negative myeloproliferative neoplasms (MPNs) are acquired stem cell neoplasms which ultimately may transform to acute myelogenous leukemia. Most recently, chronic inflammation has been described as an important factor for the development and progression of MPNs in the biological continuum from early cancer stage to the advanced myelofibrosis stage, the MPNs being described as "A Human Inflammation Model for Cancer Development". This novel concept has been built upon clinical, experimental, genomic, immunological and not least epidemiological studies. Only a few studies have described the development of MPNs by mathematical models, and none have addressed the role of inflammation for clonal evolution and disease progression. Herein, we aim at using mathematical modelling to substantiate the concept of chronic inflammation as an important trigger and driver of MPNs. The basics of the model describe the proliferation from stem cells to mature cells including mutations of healthy stem cells to become malignant stem cells. We include a simple inflammatory coupling coping with cell death and affecting the basic model beneath. First, we describe the system without feedbacks or regulatory interactions. Next, we introduce inflammatory feedback into the system. Finally, we include other feedbacks and regulatory interactions forming the inflammatory-MPN model. Using mathematical modeling, we add further proof to the concept that chronic inflammation may be both a trigger of clonal evolution and an important driving force for MPN disease progression. Our findings support intervention at the earliest stage of cancer development to target the malignant clone and dampen concomitant inflammation.	[Andersen, Morten; Sajid, Zamra; Pedersen, Rasmus K.; Gudmand-Hoeyer, Johanne; Troelsen, Jesper; Ottesen, Johnny T.] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Ellervik, Christina] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Skov, Vibe; Kjaer, Lasse; Hasselbalch, Hans Carl] Univ Copenhagen, Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark; [Pallisgaard, Niels] Univ Copenhagen, Zealand Univ Hosp, Dept Pathol, Roskilde, Denmark; [Kruse, Torben A.; Thomassen, Mads] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark	Roskilde University; Harvard University; Boston Children's Hospital; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Hasselbalch, HC (corresponding author), Univ Copenhagen, Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark.	hans.hasselbalch@gmail.com	Ellervik, Christina/H-2977-2019; Troelsen, Jesper Thorvald T/B-6264-2013	Ellervik, Christina/0000-0002-3088-4375; Troelsen, Jesper Thorvald T/0000-0002-4177-3267; Gudmand-Hoeyer, Johanne/0000-0002-4972-0653; Pedersen, Rasmus Kristoffer/0000-0001-5946-8220; Andersen, Morten/0000-0001-7582-0685; Pallisgaard, Niels/0000-0002-0749-0810; Hasselbalch, Hans/0000-0003-3936-8032				Andersen CL, 2014, LEUKEMIA RES, V38, P816, DOI 10.1016/j.leukres.2014.04.002; Attolini CSO, 2010, P NATL ACAD SCI USA, V107, P17604, DOI 10.1073/pnas.1009117107; Bak M, 2017, JAMA OPHTHALMOL, V135, P835, DOI 10.1001/jamaophthalmol.2017.2011; Baker M, 2013, MATH MED BIOL, V30, P311, DOI 10.1093/imammb/dqs026; Barbui T, 2013, LEUKEMIA, V27, P2084, DOI 10.1038/leu.2013.207; Barbui T, 2011, HAEMATOL-HEMATOL J, V96, P315, DOI 10.3324/haematol.2010.031070; Barosi G, 2014, CURR HEMATOL MALIG R, V9, P331, DOI 10.1007/s11899-014-0227-0; Barosi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035631; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bjorkholm M, 2011, J CLIN ONCOL, V29, P2410, DOI 10.1200/JCO.2011.34.7542; Bjorn ME, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/648090; Bjorn ME, 2014, EUR J HAEMATOL, V93, P224, DOI 10.1111/ejh.12332; Brevetti G, 2010, CIRCULATION, V122, P1862, DOI 10.1161/CIRCULATIONAHA.109.918417; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Cazzola M, 2014, BLOOD, V123, P3714, DOI 10.1182/blood-2014-03-530865; Christensen AS, 2014, LEUKEMIA RES, V38, P490, DOI 10.1016/j.leukres.2014.01.014; Ciaffoni F, 2015, BLOOD CELL MOL DIS, V54, P234, DOI 10.1016/j.bcmd.2014.12.005; Cokic VP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/453020; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Cross NCP, 2011, HEMATOL-AM SOC HEMAT, P208, DOI 10.1182/asheducation-2011.1.208; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; de Pillis LG, 2005, CANCER RES, V65, P7950, DOI 10.1158/0008-5472.CAN-05-0564; De Pillis LG, 2003, MATH COMPUT MODEL, V37, P1221, DOI 10.1016/S0895-7177(03)00133-X; Desterke C, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/415024; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Dunster JL, 2014, B MATH BIOL, V76, P1953, DOI 10.1007/s11538-014-9987-x; Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Enblom A, 2015, EUR J INTERN MED, V26, P344, DOI 10.1016/j.ejim.2015.03.009; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P3, DOI 10.1016/j.mrfmmm.2010.03.007; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P108, DOI 10.1016/j.mrfmmm.2010.01.017; Frederiksen H, 2015, LANCET HAEMATOL, V2, pE289, DOI 10.1016/S2352-3026(15)00092-7; Frederiksen H, 2011, BLOOD, V118, P6515, DOI 10.1182/blood-2011-04-348755; Gentry SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071128; Geyer HL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/284706; GOLDIE JH, 1983, CANCER TREAT REP, V67, P923; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Haeno H, 2009, P NATL ACAD SCI USA, V106, P16616, DOI 10.1073/pnas.0908107106; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hasselbalch HC, 2014, EXPERT REV HEMATOL, V7, P203, DOI 10.1586/17474086.2013.876356; Hasselbalch HC, 2014, LEUKEMIA RES, V38, P263, DOI 10.1016/j.leukres.2013.07.002; Hasselbalch HC, 2013, CYTOKINE GROWTH F R, V24, P133, DOI 10.1016/j.cytogfr.2013.01.004; Hasselbalch HC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/102476; Hasselbalch HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112786; Hasselbalch HC, 2014, LEUKEMIA RES, V38, P1230, DOI 10.1016/j.leukres.2014.07.006; Hasselbalch HC, 2013, LEUKEMIA RES, V37, P214, DOI 10.1016/j.leukres.2012.10.020; Hasselbalch HC, 2012, BLOOD, V119, P3219, DOI 10.1182/blood-2011-11-394775; Hasselbalch HC, 2011, EXPERT REV HEMATOL, V4, P637, DOI 10.1586/EHM.11.63; Hasselbalch HC, 2015, LEUK RES, V015; Heischman AG, 2011, BLOOD, V118, P6392; Herald MC, 2010, B MATH BIOL, V72, P765, DOI 10.1007/s11538-009-9468-9; Hermouet S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/964613; Hermouet S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/145293; Hermouet S, 2011, HAEMATOL-HEMATOL J, V96, P1575, DOI 10.3324/haematol.2011.055392; Jackson AL, 1998, GENETICS, V148, P1483; JACQUEZ JA, 1993, SIAM REV, V35, P43, DOI 10.1137/1035003; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Jutzi JS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/101987; Jutzi JS, 2013, J EXP MED, V210, P1003, DOI 10.1084/jem.20120521; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kaufmann KB, 2012, J EXP MED, V209, P35, DOI 10.1084/jem.20110540; Kiladjian JJ, 2016, LEUKEMIA, V30, P776, DOI 10.1038/leu.2015.326; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kiraly O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004901; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kleppe M, 2015, CANCER DISCOV, V5, P316, DOI 10.1158/2159-8290.CD-14-0736; Koschmieder S, 2016, LEUKEMIA, V30, P1018, DOI 10.1038/leu.2016.12; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kristinsson SY, 2010, HAEMATOL-HEMATOL J, V95, P1216, DOI 10.3324/haematol.2009.020412; Larsen TS, 2007, EUR J HAEMATOL, V79, P508, DOI 10.1111/j.1600-0609.2007.00960.x; Leblanc R, 2016, BLOOD, V128, P24, DOI 10.1182/blood-2016-01-636399; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lo WC, 2013, J THEOR BIOL, V317, P20, DOI 10.1016/j.jtbi.2012.09.025; Lu M, 2015, BLOOD, V126, P972, DOI 10.1182/blood-2014-12-618595; Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167; Mantovani A, 2010, ANN MED, V42, P161, DOI 10.3109/07853890903405753; Marchioli R, 2005, J CLIN ONCOL, V23, P2224, DOI 10.1200/JCO.2005.07.062; MARTYRE MC, 1994, BRIT J HAEMATOL, V88, P9, DOI 10.1111/j.1365-2141.1994.tb04970.x; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Michor F, 2008, J CLIN ONCOL, V26, P2854, DOI 10.1200/JCO.2007.15.2421; Michor F, 2006, P NATL ACAD SCI USA, V103, P14931, DOI 10.1073/pnas.0607006103; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Nielsen C, 2014, HAEMATOLOGICA, V99, P1448, DOI 10.3324/haematol.2014.107631; Nielsen C, 2011, HAEMATOL-HEMATOL J, V96, P450, DOI 10.3324/haematol.2010.033191; Nielsen KHM, 2014, MATH MED BIOL, V31, P205, DOI 10.1093/imammb/dqt006; Nikas JB, 2013, SCI REP-UK, V3, DOI 10.1038/srep03254; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Panteli KE, 2005, BRIT J HAEMATOL, V130, P709, DOI 10.1111/j.1365-2141.2005.05674.x; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Pettersson H, 2015, EUR J HAEMATOL, V94, P152, DOI 10.1111/ejh.12410; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pittet MJ, 2011, EUR J IMMUNOL, V41, P2519, DOI 10.1002/eji.201141727; Pourcelot E, 2014, EXP HEMATOL, V42, P360, DOI 10.1016/j.exphem.2014.01.006; Rank C, 2015, LIB SERVICES BIRTH 5, P1; Ridker PM, 1998, CIRCULATION, V97, P425; Riley CH, 2016, EUR J HAEMATOL, V97, P83, DOI 10.1111/ejh.12687; Riley CH, 2015, EUR J HAEMATOL, V94, P227, DOI 10.1111/ejh.12420; Riley CH, 2011, BLOOD, V118, P2170, DOI 10.1182/blood-2011-03-340992; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Roelz R, 2010, EXP HEMATOL, V38, P792, DOI 10.1016/j.exphem.2010.05.005; Salehi M., 2012, INT J SCI RES PUBLIC, V2, P1; Silver RT, 2013, EXPERT REV HEMATOL, V6, P49, DOI [10.1586/ehm.12.69, 10.1586/EHM.12.69]; Skov V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161570; Skov V, 2013, LEUKEMIA LYMPHOMA, V54, P2269, DOI 10.3109/10428194.2013.764417; Skov V, 2012, LEUKEMIA RES, V36, P1387, DOI 10.1016/j.leukres.2012.07.009; Skov V, 2012, EXP HEMATOL, V40, P771, DOI 10.1016/j.exphem.2012.05.011; Skov V, 2011, EUR J HAEMATOL, V87, P54, DOI 10.1111/j.1600-0609.2011.01618.x; Sorensen AL, 2016, EUR J HAEMATOL, V97, P63, DOI 10.1111/ejh.12684; Sorensen AL, 2016, LEUKEMIA RES, V41, P27, DOI 10.1016/j.leukres.2015.11.017; Stiehl T, 2012, MATH MODEL NAT PHENO, V7, P166, DOI 10.1051/mmnp/20127199; Stiehl T, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0154-1; Stiehl T, 2015, CANCER RES, V75, P940, DOI 10.1158/0008-5472.CAN-14-2508; Stiehl T, 2011, MATH COMPUT MODEL, V53, P1505, DOI 10.1016/j.mcm.2010.03.057; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Tapper W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7691; Tefferi A, 2000, NEW ENGL J MED, V342, P1255, DOI 10.1056/NEJM200004273421706; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Titmarsh GJ, 2014, CANCER EPIDEMIOL, V38, P56, DOI 10.1016/j.canep.2013.10.009; Vaidya R, 2012, AM J HEMATOL, V87, P1003, DOI 10.1002/ajh.23295; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Walenda T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003599; Wehrle J, 2013, HAEMATOLOGICA, V98, P1073, DOI 10.3324/haematol.2012.071183; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; Zhang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074974	128	27	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183620	10.1371/journal.pone.0183620	http://dx.doi.org/10.1371/journal.pone.0183620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859112	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500025
J	Danner, N; Keller, A; Hartel, S; Steffan-Dewenter, I				Danner, Nadja; Keller, Alexander; Haertel, Stephan; Steffan-Dewenter, Ingolf			Honey bee foraging ecology: Season but not landscape diversity shapes the amount and diversity of collected pollen	PLOS ONE			English	Article							COLONY DEVELOPMENT; APIS-MELLIFERA; DIET	The availability of pollen in agricultural landscapes is essential for the successful growth and reproduction of honey bee colonies (Apis mellifera L.). The quantity and diversity of collected pollen can influence the growth and health of honey bee colonies, but little is known about the influence of landscape structure on pollen diet. In a field experiment, we rotated 16 honey bee colonies across 16 agricultural landscapes, used traps to collect samples of collected pollen and observed intra-colonial dance communication to gain information about foraging distances. DNA metabarcoding was applied to analyze mixed pollen samples. Neither the amount of collected pollen nor pollen diversity was related to landscape diversity. However, we found a strong seasonal variation in the amount and diversity of collected pollen in all sites independent of landscape diversity. The observed increase in foraging distances with decreasing landscape diversity suggests that honey bees compensated for lower landscape diversity by increasing their pollen foraging range in order to maintain pollen amount and diversity. Our results underscore the importance of a diverse pollen diet for honey bee colonies. Agri-environmental schemes aiming to support pollinators should focus on possible spatial and temporal gaps in pollen availability and diversity in agricultural landscapes.	[Danner, Nadja; Keller, Alexander; Haertel, Stephan; Steffan-Dewenter, Ingolf] Univ Wurzburg, Bioctr, Wurzburg, Germany	University of Wurzburg	Danner, N (corresponding author), Univ Wurzburg, Bioctr, Wurzburg, Germany.	nadjadanner@web.de	Keller, Alexander/D-1221-2009	Keller, Alexander/0000-0001-5716-3634	European Commission under the Framework Programme 7 [289706]	European Commission under the Framework Programme 7	This research was funded by the European Commission under the Framework Programme 7, Grant agreement 289706 (AMIGA: Assessing and Monitoring the Impacts of Genetically modiefied plants on Agro-ecosystems).	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alves RD, 2014, PALYNOLOGY, V38, P90, DOI 10.1080/01916122.2013.846280; Anderson D, 2004, MODEL SELECTION MULT, V2nd; Ankenbrand MJ, 2015, MOL BIOL EVOL, V32, P3030, DOI 10.1093/molbev/msv174; Avni D, 2014, J INSECT PHYSIOL, V69, P65, DOI 10.1016/j.jinsphys.2014.07.001; Avni D, 2009, ISR J PLANT SCI, V57, P263, DOI 10.1560/IJPS.57.3.263; Barton K., 2012, MUMIN MULTIMODEL INF; Bates DM, 2015, LME4 LINEAR MIXED EF, P4; Baum KA, 2004, ENVIRON ENTOMOL, V33, P727, DOI 10.1603/0046-225X-33.3.727; Benjamini Y, 2001, ANN STAT, V29, P1165; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Couvillon MJ, 2012, INSECT SOC, V59, P297, DOI 10.1007/s00040-012-0224-z; Danner N, 2016, ECOL APPL, V26, P1920, DOI 10.1890/15-1840.1; Danner N, 2014, BASIC APPL ECOL, V15, P677, DOI 10.1016/j.baae.2014.08.010; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Frisch K. v., 1967, DANCE LANGUAGE ORIEN; Garbuzov M, 2015, AGR ECOSYST ENVIRON, V203, P62, DOI 10.1016/j.agee.2014.12.009; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hendriksma HP, 2016, BEHAV ECOL SOCIOBIOL, V70, P509, DOI 10.1007/s00265-016-2067-5; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Keller I, 2005, BEE WORLD, V86, P27, DOI 10.1080/0005772X.2005.11099650; Koppler K, 2007, APIDOLOGIE, V38, P341, DOI 10.1051/apido:2007020; MACGARIGAL K, 1994, FRAGSTATS SPATIAL PA; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nagendra H, 2002, APPL GEOGR, V22, P175, DOI 10.1016/S0143-6228(02)00002-4; Nurnberger F, 2017, PEERJ, V5, DOI 10.7717/peerj.3441; Odoux JF, 2012, APIDOLOGIE, V43, P561, DOI 10.1007/s13592-012-0125-1; Pernal SF, 2001, BEHAV ECOL SOCIOBIOL, V51, P53, DOI 10.1007/s002650100412; Piroux M, 2014, APPL ECOL ENV RES, V12, P423, DOI 10.15666/aeer/1202_423439; Requier F, 2015, ECOL APPL, V25, P881, DOI 10.1890/14-1011.1; Sickel W, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0051-y; Smart M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152685; Smart MD, 2016, AGR ECOSYST ENVIRON, V230, P139, DOI 10.1016/j.agee.2016.05.030; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Team RDC. R, 2015, LANG ENV STAT COMP; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Winston M., 1987, The biology of the honey bee.; Woodcock BA, 2013, AGR ECOSYST ENVIRON, V171, P1, DOI 10.1016/j.agee.2013.03.005	41	70	71	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183716	10.1371/journal.pone.0183716	http://dx.doi.org/10.1371/journal.pone.0183716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854210	gold, Green Published			2022-12-26	WOS:000408693600056
J	Portes, SAR; Carvalho-Costa, FA; Rocha, MS; Fumian, TM; Maranhao, AG; de Assis, RM; Xavier, MDTP; Rocha, MS; Miagostovich, MP; Leite, JPG; Volotao, ED				Rodrigues Portes, Silvana Augusta; Carvalho-Costa, Filipe Anibal; Rocha, Monica Simoes; Fumian, Tulio Machado; Maranhao, Adriana Goncalves; de Assis, Rosane Maria; Trindade Pinheiro Xavier, Maria da Penha; Rocha, Myrna Santos; Miagostovich, Marize Pereira; Gagliardi Leite, Jose Paulo; Volotao, Eduardo de Mello			Enteric viruses in HIV-1 seropositive and HIV-1 seronegative children with diarrheal diseases in Brazil	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ROTAVIRUS STRAINS; HUMAN ADENOVIRUS; HUMAN BOCAVIRUS; PCR; PREVALENCE; INFECTION; IDENTIFICATION; CALICIVIRUS; SEQUENCES	Diarrheal diseases (DD) have distinct etiological profiles in immune-deficient and immune-competent patients. This study compares detection rates, genotype distribution and viral loads of different enteric viral agents in HIV-1 seropositive (n = 200) and HIV-1 seronegative (n = 125) children hospitalized with DD in Rio de Janeiro, Brazil. Except for group A rotavirus (RVA), which were detected through enzyme immunoassay, the other enteric viruses (noro-virus [NoV], astrovirus [HAstV], adenovirus [HAdV] and bocavirus [HBoV]) were detected through PCR or RT-PCR. A quantitative PCR was performed for RVA, NoV, HAstV, HAdV and HBoV. Infections with NoV (19% vs. 9.6%; p<0.001), HBoV (14% vs. 7.2%; p = 0.042) and HAdV (30.5% vs. 14.4%; p<0.001) were significantly more frequent among HIV-1 seropositive children. RVA was significantly less frequent among HIV-1 seropositive patients (6.5% vs. 20%; p<0.001). Similarly, frequency of infection with HAstV was lower among HIV-1 seropositive children (5.5% vs. 12.8%; p = 0.018). Among HIV-1 seropositive children 33 (16.5%) had co-infections, including three enteric viruses, such as NoV, HBoV and HAdV (n = 2) and NoV, HAstV and HAdV (n = 2). The frequency of infection with more than one virus was 17 (13.6%) in the HIV-1 negative group, triple infection (NoV + HAstV + HBoV) being observed in only one patient. The median viral load of HAstV in feces was significantly higher among HIV-1 positive children compared to HIV-1 negative children. Concerning children infected with RVA, NoV, HBoV and HAdV, no statistically significant differences were observed in the medians of viral loads in feces, comparing HIV-1 seropositive and HIV-1 seronegative children. Similar detection rates were observed for RVA, HAstV and HAdV, whilst NoV and HBoV were significantly more prevalent among children with CD4(+) T lymphocyte count below 200 cells/mm(3). Enteric viruses should be considered an important cause of DD in HIV-1 seropositive children, along with pathogens more classically associated with intestinal infections in immunocompromised hosts.	[Rodrigues Portes, Silvana Augusta; Carvalho-Costa, Filipe Anibal; Rocha, Monica Simoes; Fumian, Tulio Machado; Maranhao, Adriana Goncalves; de Assis, Rosane Maria; Trindade Pinheiro Xavier, Maria da Penha; Miagostovich, Marize Pereira; Gagliardi Leite, Jose Paulo; Volotao, Eduardo de Mello] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, RJ, Brazil; [Carvalho-Costa, Filipe Anibal] Escritorio Reg Fiocruz Piaui, Teresina, Piaui, Brazil; [Rocha, Myrna Santos] Hosp Municipal Jesus, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Portes, SAR (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, RJ, Brazil.	sil@ioc.fiocruz.br	Fumian, Tulio/AAC-4724-2021; LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020	Xavier, Maria/0000-0001-9657-1980	Oswaldo Cruz Institute/Fiocruz; National Council for Scientific and Technological Development (PAPES) [VI/Fiocruz-CNPq-407566]; PAEF/Fiocruz [IOC008-FIO-15-71]; Coordination for Improvement of Higher Level Personnel (CAPES); Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro [FAPERJ-E-26/202.968/2015]	Oswaldo Cruz Institute/Fiocruz; National Council for Scientific and Technological Development (PAPES)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PAEF/Fiocruz; Coordination for Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro	This study was sponsored by Oswaldo Cruz Institute/Fiocruz, National Council for Scientific and Technological Development (PAPES VI/Fiocruz-CNPq-407566), PAEF/Fiocruz (IOC008-FIO-15-71), Coordination for Improvement of Higher Level Personnel (CAPES) and Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ-E-26/202.968/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Arvelo W, 2010, INT J INFECT DIS, V14, pE1002, DOI 10.1016/j.ijid.2010.06.014; Rossit ARB, 2009, REV INST MED TROP SP, V51, P59, DOI 10.1590/S0036-46652009000200001; Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bosch A, 2014, CLIN MICROBIOL REV, V27, P1048, DOI 10.1128/CMR.00013-14; Campe H, 2008, J CLIN VIROL, V43, P340, DOI 10.1016/j.jcv.2008.07.014; Clark B, 2004, CURR OPIN INFECT DIS, V17, P461, DOI 10.1097/00001432-200410000-00011; Dai YC, 2010, ARCH VIROL, V155, P977, DOI 10.1007/s00705-010-0664-6; DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994; Drexler JF, 2011, EMERG INFECT DIS, V17, P1544, DOI 10.3201/eid1708.101556; Fischer TK, 2000, J CLIN MICROBIOL, V38, P264; Fumian TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145391; Garbino J, 2008, AIDS, V22, P701, DOI 10.1097/QAD.0b013e3282f470ac; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Ghebremedhin B, 2014, EUR J MICROBIOL IMMU, V4, P26, DOI 10.1556/EuJMI.4.2014.1.2; Giordano MO, 1999, AIDS RES HUM RETROV, V15, P1427, DOI 10.1089/088922299309937; Goncalves ACM, 2009, AM J TROP MED HYG, V81, P463, DOI 10.4269/ajtmh.2009.81.463; Gonzalez GG, 1998, J MED VIROL, V55, P288, DOI 10.1002/(SICI)1096-9071(199808)55:4&lt;288::AID-JMV6&gt;3.0.CO;2-X; GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1338, DOI 10.1128/JCM.32.5.1338-1340.1994; GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103; Groome MJ, 2012, VACCINE, V30, pA173, DOI 10.1016/j.vaccine.2011.08.004; Hernroth BE, 2002, APPL ENVIRON MICROB, V68, P4523, DOI 10.1128/AEM.68.9.4523-4533.2002; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kantola K, 2010, J CLIN MICROBIOL, V48, P4044, DOI 10.1128/JCM.00686-10; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; La Rosa G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/142912; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Liste MB, 2000, J CLIN MICROBIOL, V38, P2873, DOI 10.1128/JCM.38.8.2873-2877.2000; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mans J, 2014, J MED VIROL, V86, P75, DOI 10.1002/jmv.23784; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Morillo SG, 2010, T ROY SOC TROP MED H, V104, P165, DOI 10.1016/j.trstmh.2009.07.023; Moyo S, 2014, INFECT GENET EVOL, V26, P340, DOI 10.1016/j.meegid.2014.06.013; Moyo SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097562; Moyo SJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0666-1; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Nunes MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086448; Page NA, 2017, EPIDEMIOL INFECT, V10, P1; Pollok RCG, 2001, NOVART FDN SYMP, V238, P276; Rodriguez-Guillen L, 2005, J CLIN VIROL, V33, P104, DOI 10.1016/j.jcv.2004.09.031; Santos N, 2010, J CLIN VIROL, V48, P127, DOI 10.1016/j.jcv.2010.03.014; Silva RC, 2010, BRAZ J INFECT DIS, V14, P549, DOI 10.1590/S1413-86702010000600012; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Thomas P D, 1999, HIV Med, V1, P19, DOI 10.1046/j.1468-1293.1999.00004.x; Tse H, 2012, J VIROL, V86, P9531, DOI 10.1128/JVI.01312-12; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Vu DL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9020033; World Health Organization, 2010, GLOB ROT INF SURV B, V4; World Health Organization (WHO), 2009, MAN ROT DET CHAR MET; Yan ZQ, 1998, AM J SURG PATHOL, V22, P1101, DOI 10.1097/00000478-199809000-00009; Zeng SQ, 2008, J VIROL METHODS, V153, P238, DOI 10.1016/j.jviromet.2008.08.004	59	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183196	10.1371/journal.pone.0183196	http://dx.doi.org/10.1371/journal.pone.0183196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854225	Green Published, gold, Green Submitted			2022-12-26	WOS:000408693600033
J	Shekarabi, M; Hajikhani, B; Chirani, AS; Fazeli, M; Goudarzi, M				Shekarabi, Marjan; Hajikhani, Bahareh; Chirani, Alireza Salimi; Fazeli, Maryam; Goudarzi, Mehdi			Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: A three year study in Tehran, Iran	PLOS ONE			English	Article							HERSHEY-MEDICAL-CENTER; MULTIPLEX PCR; UNITED-STATES; HIGH-LEVEL; INTERMEDIATE; EMERGENCE; PATIENT; SUSCEPTIBILITY; IDENTIFICATION; PREVALENCE	Introduction Emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant S. aureus (VRSA) strains has led to great concern in global public health in both developing and developed countries. This study investigated distribution and molecular characterization of VRSA strains in Tehran's hospitals using a combination of molecular typing methods. Materials and methods A total of 1789 S. aureus isolates obtained between 2014 and 2017 and were characterized using antibiogram, SCCmec typing, spa typing, and multilocus-sequence typing. Resistance to vancomycin was determined by E-test method. After confirmation of the isolated VRSA strain, genetic analysis was performed by evaluating vanA and vanB genes presence. The presence of resistance (ermA, ermB, ermC, mupA, msrA, msrB, tetM, ant (4')-Ia, aac (6')Ie/aph (2'), aph (3')-IIIa) and toxin (etb, eta, pvl, tst) encoding genes was investigated by the polymerase chain reaction (PCR) technique. Results Of all S. aureus tested isolates, four isolates were confirmed as VRSA isolates and two isolates confirmed as VISA isolates. ST5-SCCmec II/t002 and ST239-SCCmec III/t037 strains had MIC values of 512 mu g/ml, ST239-SCCmec III/t037 and ST8-SCCmecIV/t008 strains had MIC values of 64 mu g/ml and ST22-SCCmec IV/t790 and ST239-SCCmec III/t030 strains had MIC values >= 8 mu g/ml. pvl-encoding gene was confirmed in ST8-SCCmecIV/t008 and ST22-SCCmec IV/t790 strains. The isolates differed in the carriage of resistance and toxin encoding genes. Conclusions The study revealed the existence of VRSA strains in capital of Iran, Tehran. To our knowledge, this is the first report of ST239-SCCmec III/t037 as VRSA strain. These findings support the need for future surveillance studies on VRSA strains to keep the emergence and transmission of these isolates to a minimum.	[Shekarabi, Marjan; Hajikhani, Bahareh; Chirani, Alireza Salimi; Goudarzi, Mehdi] Shahid Beheshti Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran; [Shekarabi, Marjan] Shahid Beheshti Univ, Fac Biol Sci, Dept Microbiol, Tehran, Iran; [Fazeli, Maryam] Pasteur Inst Iran, WHO Collaborating Ctr Reference & Res Rabies, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; World Health Organization	Goudarzi, M (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran.	gudarzim@yahoo.com	Hajikhani, Bahareh/AAX-3410-2021; Hajikhani, Bahareh/HHS-5611-2022; Goudarzi, Mehdi/I-5998-2019; Salimi Chirani, Alireza/E-9218-2019	Hajikhani, Bahareh/0000-0001-7966-6267; Goudarzi, Mehdi/0000-0001-6720-9341; Salimi Chirani, Alireza/0000-0001-7365-2681	Shahid Beheshti University of Medical Sciences [11417]	Shahid Beheshti University of Medical Sciences	This study was supported financially by the grant (No 11417) from Research Deputy of Shahid Beheshti University of Medical Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligholi M, 2008, MED PRIN PRACT, V17, P432, DOI 10.1159/000141513; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P16, DOI 10.1111/j.1469-0691.2006.01344.x; Askari E, 2015, J MED BACTERIOL, V1, P53; Azimian A, 2012, J CLIN MICROBIOL, V50, P3581, DOI 10.1128/JCM.01727-12; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; Bozdogan B, 2004, ANTIMICROB AGENTS CH, V48, P4762, DOI 10.1128/AAC.48.12.4762-4765.2004; Bush K, 2004, CLIN INFECT DIS, V38, P1056, DOI 10.1086/382366; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; CLSI, 2014, APPROVED GUIDELINE, pM100; Control CfD Prevention, 2002, MMWR-MORBID MORTAL W, V51, P902; Control CfD Prevention, 2004, MMWR-MORBID MORTAL W, V53, P322; Dezfulian A, 2012, IRAN J BASIC MED SCI, V15, P783; Fridkin SK, 2001, CLIN INFECT DIS, V32, P108, DOI 10.1086/317542; Gardete S, 2014, J CLIN INVEST, V124, P2836, DOI 10.1172/JCI68834; Goudarzi M, 2017, MICROB PATHOGENESIS, V105, P1, DOI 10.1016/j.micpath.2017.02.004; Goudarzi M, 2017, MICROB PATHOGENESIS, V104, P328, DOI 10.1016/j.micpath.2017.01.055; Goudarzi M, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.35685; Goudarzi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155529; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hasan R, 2016, TZU CHI MED J, V28, P49, DOI 10.1016/j.tcmj.2016.03.002; Havaei SA, 2012, ISRN MICROBIOL, V2012; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Howden BP, 2010, J BACTERIOL, V192, P5848, DOI 10.1128/JB.00951-10; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kim MN, 2000, J CLIN MICROBIOL, V38, P3879, DOI 10.1128/JCM.38.10.3879-3881.2000; Kosowska-Shick K, 2008, ANTIMICROB AGENTS CH, V52, P4510, DOI 10.1128/AAC.01073-08; Lina G, 1999, ANTIMICROB AGENTS CH, V43, P1062, DOI 10.1128/AAC.43.5.1062; Martineau F, 2000, ANTIMICROB AGENTS CH, V44, P231, DOI 10.1128/AAC.44.2.231-238.2000; McDougal LK, 2010, ANTIMICROB AGENTS CH, V54, P3804, DOI 10.1128/AAC.00351-10; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nezhad RR, 2017, JUNDISHAPUR J MICROB, V10, DOI 10.5812/jjm.41666; Oliveira GA, 2001, INFECT CONT HOSP EP, V22, P443, DOI 10.1086/501932; Ploy MC, 1998, LANCET, V351, P1212, DOI 10.1016/S0140-6736(05)79166-2; Ranjbary AG, 2016, REV MED MICROBIOL, V27, P36, DOI 10.1097/MRM.0000000000000061; Saadat Sareh, 2014, Oman Med J, V29, P335, DOI 10.5001/omj.2014.90; Saderi H., 2005, Archives of Iranian Medicine, V8, P100; Saha B, 2008, J MED MICROBIOL, V57, P72, DOI 10.1099/jmm.0.47144-0; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Thati Venubabu, 2011, Indian J Med Res, V134, P704, DOI 10.4103/0971-5916.91001; Tiwari HK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-156; Udo EE, 2001, J MED MICROBIOL, V50, P909, DOI 10.1099/0022-1317-50-10-909; Walsh TR, 2002, ANNU REV MICROBIOL, V56, P657, DOI 10.1146/annurev.micro.56.012302.160806; Zhu WM, 2008, ANTIMICROB AGENTS CH, V52, P452, DOI 10.1128/AAC.00908-07; Zhu XH, 2015, INT J INFECT DIS, V33, P185, DOI 10.1016/j.ijid.2014.12.038	44	47	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183607	10.1371/journal.pone.0183607	http://dx.doi.org/10.1371/journal.pone.0183607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854219	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600049
J	Thanapprapasr, K; Nartthanarung, A; Thanapprapasr, D; Jinawath, A				Thanapprapasr, Kamolrat; Nartthanarung, Adisak; Thanapprapasr, Duangmani; Jinawath, Artit			pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma	PLOS ONE			English	Article							FOCAL ADHESION KINASE; HIGH-GRADE OSTEOSARCOMA; STUDY-GROUP PROTOCOLS; NEOADJUVANT CHEMOTHERAPY; POOR-PROGNOSIS; HEPATOCELLULAR-CARCINOMA; EXTREMITY OSTEOSARCOMA; SINGLE INSTITUTION; LUNG METASTASIS; CANCER	Focal adhesion kinase (FAK) is important for tumor cell survival and metastasis in various cancers. However, its expression and prognostic value in patients with metastatic osteosarcoma remain unknown. We investigated the expression of FAK and its phosphorylated form (pFAK-Y397) in osteosarcoma tissues from 53 patients by immunohistochemistry and evaluated their correlations with clinicopathologic characteristics and outcomes. The prognostic values were assessed using Kaplan-Meier survival and Cox regression analyses. Total FAK and pFAK-Y397 were overexpressed in 48 (90.6%) and 33 (62.3%) cases, respectively. pFAK-Y397 overexpression was correlated with poor histologic response after neoadjuvant chemotherapy in patients with osteosarcoma regardless of the presence of metastasis or not. Kaplan-Meier curve showed that patients with metastatic osteosarcoma with pFAKY397 overexpression had significantly worse overall survival (OS) than those with non-overexpression (P = 0.044). Multivariate Cox regression analysis confirmed pFAK-Y397 overexpression as an independent prognostic predictor for OS and post metastases OS (PMOS) (P = 0.017, P = 0.006, respectively). Age at diagnosis was also an independent indicator for PMOS (P = 0.003). However, total FAK expression was not correlated with any clinicopathologic characteristics or OS in patients with metastatic osteosarcoma. In conclusion, our findings identified FAK as a common aberrant protein overexpression in various subtypes of osteosarcoma. pFAK-Y397 overexpression can be used as a prognostic biomarker predicting poor OS for patients with metastatic osteosarcoma, and the expression of pFAK-Y397 differentiated good and poor responders to neoadjuvant chemotherapy.	[Thanapprapasr, Kamolrat] Natl Sci & Technol Dev Agcy, Natl Met & Mat Technol Ctr, Biomed Engn Res Unit, Pathum Thani, Thailand; [Nartthanarung, Adisak] Mahidol Univ, Ramathibodi Hosp, Fac Med, Musculoskeletal Oncol Unit,Dept Orthopaed, Bangkok, Thailand; [Thanapprapasr, Duangmani] Bangkok Hosp, Wattanosoth Canc Hosp, Med Ctr, Surg Oncol Unit, Bangkok, Thailand; [Jinawath, Artit] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok, Thailand	National Science & Technology Development Agency - Thailand; National Metal & Materials Technology Center (MTEC); Mahidol University; Mahidol University	Thanapprapasr, K (corresponding author), Natl Sci & Technol Dev Agcy, Natl Met & Mat Technol Ctr, Biomed Engn Res Unit, Pathum Thani, Thailand.; Jinawath, A (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok, Thailand.	kamolrat.thanapprapasr@nstda.or.th; artitjp@yahoo.com		jinawath, artit/0000-0003-3506-6694	National Metal and Materials Technology Center (MTEC); National Science and Technology Development Agency (NSTDA), Thailand [P1450113]	National Metal and Materials Technology Center (MTEC); National Science and Technology Development Agency (NSTDA), Thailand	This research work was supported by the National Metal and Materials Technology Center (MTEC), National Science and Technology Development Agency (NSTDA), Thailand (Grant No. P1450113). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasri A, 2014, ANTICANCER RES, V34, P3969; Aust S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-67; Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bacci G, 2003, ANN ONCOL, V14, P1126, DOI 10.1093/annonc/mdg286; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Chang HP, 2015, BIOCHEM BIOPH RES CO, V464, P45, DOI 10.1016/j.bbrc.2015.05.092; Ding LS, 2010, TRANSL RES, V156, P45, DOI 10.1016/j.trsl.2010.05.001; Durnali AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152621; Fujii T, 2004, J HEPATOL, V41, P104, DOI 10.1016/j.jhep.2004.03.029; Gabriel B, 2006, CLIN CANCER RES, V12, P2476, DOI 10.1158/1078-0432.CCR-05-1867; Golubovskaya VM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-769; Gvozdenovic A, 2013, J BONE MINER RES, V28, P838, DOI 10.1002/jbmr.1817; Haddox CL, 2014, SARCOMA, V2014, DOI DOI 10.1155/2014/402509; Han XJ, 2013, EXP MOL PATHOL, V95, P270, DOI 10.1016/j.yexmp.2013.07.008; Harting MT, 2010, J CANCER RES CLIN, V136, P561, DOI 10.1007/s00432-009-0690-5; Iwata S, 2014, ANN SURG ONCOL, V21, P263, DOI 10.1245/s10434-013-3210-4; Janeway KA, 2012, CANCER-AM CANCER SOC, V118, P4597, DOI 10.1002/cncr.27414; Ji HF, 2013, J CANCER RES CLIN, V139, P429, DOI 10.1007/s00432-012-1342-8; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kim MS, 2009, ANN ONCOL, V20, P955, DOI 10.1093/annonc/mdn723; Kim MS, 2008, ANN SURG ONCOL, V15, P906, DOI 10.1245/s10434-007-9779-8; Lai IR, 2010, AM J PATHOL, V177, P1629, DOI 10.2353/ajpath.2010.100172; Le Guellec S, 2013, HUM PATHOL, V44, P2149, DOI 10.1016/j.humpath.2013.03.020; Liang SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127236; Mialou V, 2005, CANCER-AM CANCER SOC, V104, P1100, DOI 10.1002/cncr.21263; Miwa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071362; Murata T, 2008, INT J ONCOL, V32, P791; OWENS LV, 1995, CANCER RES, V55, P2752; Picci P, 2010, ANN ONCOL, V21, P1366, DOI 10.1093/annonc/mdp502; Ren K, 2015, ONCOTARGET, V6, P31085, DOI 10.18632/oncotarget.5044; Ren ZW, 2016, TUMOR BIOL, V37, P5089, DOI 10.1007/s13277-015-4352-8; Salah S, 2015, MOL CLIN ONCOL, V3, P157, DOI 10.3892/mco.2014.426; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Stone RL, 2014, CANCER BIOL THER, V15, P919, DOI 10.4161/cbt.28882; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Thanapprapasr D, 2015, MOL CANCER THER, V14, P1466, DOI 10.1158/1535-7163.MCT-14-1077; Thanapprapasr D, 2012, CURR PHARM DESIGN, V18, P2713, DOI 10.2174/138161212800626201; Wang JL, 2014, TUMOR BIOL, V35, P1551, DOI 10.1007/s13277-013-1214-0; Whelan JS, 2012, ANN ONCOL, V23, P1607, DOI 10.1093/annonc/mdr491; Yoon H, 2015, J HISTOCHEM CYTOCHEM, V63, P114, DOI 10.1369/0022155414561498; Yuan Z, 2010, J CANCER RES CLIN, V136, P1489, DOI 10.1007/s00432-010-0806-y; Zhang M, 2015, INT J CLIN EXP PATHO, V8, P14965; Zhou J, 2013, GYNECOL ONCOL, V128, P344, DOI 10.1016/j.ygyno.2012.07.128	44	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e182989	10.1371/journal.pone.0182989	http://dx.doi.org/10.1371/journal.pone.0182989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846700	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600020
J	Werbowy, O; Werbowy, S; Kaczorowski, T				Werbowy, Olesia; Werbowy, Slawomir; Kaczorowski, Tadeusz			Plasmid stability analysis based on a new theoretical model employing stochastic simulations	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEMS; RECOMBINANT ESCHERICHIA-COLI; COPY NUMBER PLASMIDS; BACTERIAL PLASMIDS; MULTICOPY PLASMIDS; GENETIC ELEMENTS; METABOLIC BURDEN; CARRIES GENES; RNA DECAY; MAINTENANCE	Here, we present a simple theoretical model to study plasmid stability, based on one input parameter which is the copy number of plasmids present in a host cell. The Monte Carlo approach was used to analyze random fluctuations affecting plasmid replication and segregation leading to gradual reduction in the plasmid population within the host cell. This model was employed to investigate maintenance of pEC156 derivatives, a high-copy number ColE1-type Escherichia coli plasmid that carries an EcoVIII restriction-modification system. Plasmid stability was examined in selected Escherichia coli strains (MG1655, wild-type; MG1655 pcnB, and hyper-recombinogenic JC8679 sbcA). We have compared the experimental data concerning plasmid maintenance with the simulations and found that the theoretical stability patterns exhibited an excellent agreement with those empirically tested. In our simulations, we have investigated the influence of replication fails (a parameter) and uneven partition as a consequence of multimer resolution fails (delta parameter), and the post-segregation killing factor (beta parameter). All of these factors act at the same time and affect plasmid inheritance at different levels. In case of pEC156-derivatives we concluded that multimerization is a major determinant of plasmid stability. Our data indicate that even small changes in the fidelity of segregation can have serious effects on plasmid stability. Use of the proposed mathematical model can provide a valuable description of plasmid maintenance, as well as enable prediction of the probability of the plasmid loss.	[Werbowy, Olesia; Kaczorowski, Tadeusz] Univ Gdansk, Dept Microbiol, Fac Biol, Lab Extremophiles Biol, Wita Stwosza 59, Gdansk, Poland; [Werbowy, Slawomir] Univ Gdansk, Fac Math Phys & Informat, Inst Expt Phys, Ul Wita Stwosza 57, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Kaczorowski, T (corresponding author), Univ Gdansk, Dept Microbiol, Fac Biol, Lab Extremophiles Biol, Wita Stwosza 59, Gdansk, Poland.	tadeusz.kaczorowski@biol.ug.edu.pl	Kaczorowski, Tadeusz/AAX-2027-2020	Werbowy, Slawomir/0000-0002-5255-9880; Werbowy, Olesia/0000-0002-0194-0673	National Science Center, Poland [N302 654240]	National Science Center, Poland(National Science Centre, Poland)	This work was supported by grant N302 654240 from the National Science Center, Poland.; We want to thank Dr. George Szatmari for critical reading of the manuscript and for providing us with helpful comments and suggestions. This work was supported by grant N302 654240 from the National Science Center, Poland.	Actis Luis A., 1999, Frontiers in Bioscience, V4, pD43, DOI 10.2741/Actis; AUSTIN SJ, 1984, J BACTERIOL, V158, P742, DOI 10.1128/JB.158.2.742-745.1984; BEDBROOK JR, 1976, CELL, V9, P707, DOI 10.1016/0092-8674(76)90134-3; BENTLEY WE, 1993, BIOTECHNOL BIOENG, V42, P222, DOI 10.1002/bit.260420210; BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; Broach JR, 1991, GENOME DYNAMICS PROT, P297; Camps Manel, 2010, Recent Pat DNA Gene Seq, V4, P58; COOPER NS, 1987, J GEN MICROBIOL, V133, P1871; Dahlberg C, 2003, GENETICS, V165, P1641; De Gelder L, 2004, GENETICS, V168, P1131, DOI 10.1534/genetics.104.033431; De Gelder L, 2007, MICROBIOL-SGM, V153, P452, DOI 10.1099/mic.0.2006/001784-0; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; GILLEN JR, 1981, J BACTERIOL, V145, P521, DOI 10.1128/JB.145.1.521-532.1981; Harrison Ellie, 2016, Mob Genet Elements, V6, pe1179074, DOI 10.1080/2159256X.2016.1179074; HE L, 1993, MOL MICROBIOL, V9, P1131, DOI 10.1111/j.1365-2958.1993.tb01243.x; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Hulter N, 2017, CURR OPIN MICROBIOL, V38, P74, DOI 10.1016/j.mib.2017.05.001; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Joanny G, 2007, NUCLEIC ACIDS RES, V35, P2494, DOI 10.1093/nar/gkm120; KULAKAUSKAS S, 1995, J BACTERIOL, V177, P3451, DOI 10.1128/jb.177.12.3451-3454.1995; KUSANO K, 1995, P NATL ACAD SCI USA, V92, P11095, DOI 10.1073/pnas.92.24.11095; LAMOTTE D, 1994, BIOTECHNOL LETT, V16, P1113, DOI 10.1007/BF01020835; Lau BTC, 2013, PLASMID, V70, P353, DOI 10.1016/j.plasmid.2013.07.007; Leclercq Sebastien, 2012, Mob Genet Elements, V2, P115; LEDERBERG J, 1952, PHYSIOL REV, V32, P403, DOI 10.1152/physrev.1952.32.4.403; LEONARD AC, 1988, J BACTERIOL, V170, P1380, DOI 10.1128/jb.170.3.1380-1383.1988; LEVIN BR, 1993, CURR OPIN GENET DEV, V3, P849, DOI 10.1016/0959-437X(93)90004-9; LIU JD, 1989, J BACTERIOL, V171, P1254, DOI 10.1128/jb.171.3.1254-1261.1989; Lobato-Marquez D, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00066; MASUKATA H, 1990, CELL, V62, P331, DOI 10.1016/0092-8674(90)90370-T; Miller R, 2014, NAT COMMUN, V5, P5208; Million-Weaver S, 2014, PLASMID, V75, P27, DOI 10.1016/j.plasmid.2014.07.002; Mruk I, 2003, APPL ENVIRON MICROB, V69, P2638, DOI 10.1128/AEM.69.5.2638-2650.2003; Mruk I, 2001, PLASMID, V46, P128, DOI 10.1006/plas.2001.1534; Mruk I, 2007, APPL ENVIRON MICROB, V73, P4286, DOI 10.1128/AEM.00119-07; Mruk I, 2014, NUCLEIC ACIDS RES, V42, P70, DOI 10.1093/nar/gkt711; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; Nordstrom K, 2003, PLASMID, V50, P95, DOI 10.1016/S0147-619X(03)00056-8; NORDSTROM K, 1984, MOL GEN GENET, V197, P1, DOI 10.1007/BF00327915; NORDSTROM K, 1989, ANNU REV GENET, V23, P37, DOI 10.1146/annurev.genet.23.1.37; OHARA EB, 1995, P NATL ACAD SCI USA, V92, P1807, DOI 10.1073/pnas.92.6.1807; ORSKOV I, 1973, ACTA PATH MICRO IM B, VB 81, P59; Patnaik PR, 2000, BIOCHEM ENG J, V5, P101, DOI 10.1016/S1369-703X(99)00058-3; Paulsson J, 1998, J MOL BIOL, V279, P73, DOI 10.1006/jmbi.1998.1751; Plotka M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169846; Pogliano J, 2001, P NATL ACAD SCI USA, V98, P4486, DOI 10.1073/pnas.081075798; Ponciano JM, 2007, GENETICS, V176, P957, DOI 10.1534/genetics.106.061937; Regnier P, 2009, PROG MOL BIOL TRANSL, V85, P137, DOI 10.1016/S0079-6603(08)00804-0; Reyes-Lamothe R, 2014, NUCLEIC ACIDS RES, V42, P1042, DOI 10.1093/nar/gkt918; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmidt T, 1999, ANAL BIOCHEM, V274, P235, DOI 10.1006/abio.1999.4291; Sengupta M, 2011, INFECT IMMUN, V79, P2502, DOI 10.1128/IAI.00127-11; Silva F, 2012, BIOTECHNOL ADV, V30, P691, DOI 10.1016/j.biotechadv.2011.12.005; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; SUMMERS DK, 1991, TRENDS BIOTECHNOL, V9, P273, DOI 10.1016/0167-7799(91)90089-Z; SUMMERS DK, 1984, CELL, V36, P1097, DOI 10.1016/0092-8674(84)90060-6; SUMMERS DK, 1993, MOL MICROBIOL, V8, P1031, DOI 10.1111/j.1365-2958.1993.tb01648.x; Toussaint A, 2002, PLASMID, V47, P26, DOI 10.1006/plas.2001.1552; Vazquez M, 2005, J MOL BIOL, V346, P493, DOI 10.1016/j.jmb.2004.11.055; Venkatesan MM, 2001, INFECT IMMUN, V69, P3271, DOI 10.1128/IAI.69.5.3271-3285.2001; Wang Y, 2017, PLASMID, V91, P2, DOI 10.1016/j.plasmid.2017.02.005; Wang Y, 2016, BIOPHYS J, V111, P467, DOI 10.1016/j.bpj.2016.06.033; Werbowy O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148355; Werbowy O, 2015, PLASMID, V77, P39, DOI 10.1016/j.plasmid.2014.12.002; WILLIAMS DR, 1992, J GEN MICROBIOL, V138, P1; Wrobel B, 1998, GENE, V212, P57, DOI 10.1016/S0378-1119(98)00127-9; XU FF, 1993, P NATL ACAD SCI USA, V90, P6756, DOI 10.1073/pnas.90.14.6756; Yao SY, 2007, J BACTERIOL, V189, P1946, DOI 10.1128/JB.01451-06; Zielenkiewicz U, 2001, ACTA BIOCHIM POL, V48, P1003; Zillig W, 1996, FEMS MICROBIOL REV, V18, P225, DOI 10.1111/j.1574-6976.1996.tb00239.x	73	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183512	10.1371/journal.pone.0183512	http://dx.doi.org/10.1371/journal.pone.0183512			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846713	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600030
J	Zhang, AL; Wang, DY; Li, JY; Gao, F; Fan, XC				Zhang, Ailian; Wang, Danyang; Li, Jinyao; Gao, Feng; Fan, Xucheng			The effect of aqueous extract of Xinjiang Artemisia rupestris L. (an influenza virus vaccine adjuvant) on enhancing immune responses and reducing antigen dose required for immunity	PLOS ONE			English	Article							CHINESE HERBAL MEDICINE; IN-VIVO; CTL RESPONSE; POLYSACCHARIDES; INFECTION; IMMUNIZATION; ADULTS; CELLS; MACROPHAGES; MATURATION	Potent adjuvant can improve the effectiveness of vaccines and reduce the antigen doses required for initiating the protective immunity. In this study, we identified that aqueous extract of Artemisia rupestris L. (AEAR) could be employed as an efficient adjuvant for influenza virus vaccine (V) to enhance immune responses and reduce the antigen doses required for initiating immunity, without compromising the immune response. ICR mice were subcutaneously co-administrated with V combined with different concentrations of AEAR demonstrated that 300 mu g AEAR could significantly improve hemagglutination inhibition (HI) and increase IgG antibody titers in serum (P < 0.05) and the population of CD4(+)CD44(+) and CD8(+)CD44(+) (P < 0.05). Next, 300 mu g AEAR combined with different doses of V in vivo markedly increased HI and specific IgG antibody level(P < 0.05). It also significantly increased the amount of CD4(+) and CD8(+) T cells, CD4(+)CD44(+) and CD8(+)CD44(+) T cells (P < 0.05), improved lymphocyte proliferation, the secretion of CD4(+) IL-4, CD4(+) IFN-gamma and CD8(+)IFN-gamma (P < 0.05), and the killing efficacy of cytotoxic T lymphocyte (CTL) (P < 0.05). Furthermore, the combination increased the expression of major histocompatibility complex-II (MHC-II) and co-stimulatory molecules including CD40, CD80, and CD86 on dendritic cells (DCs), and downregulated the expression of CD25(+) Foxp3(+)Treg cells (P < 0.05). No significant difference was observed between high-dose V and low-dose AEAR-V (10-fold lower) vaccination group (P > 0.05), indicating a 10-fold reduction of antigen required for V vaccine administration. In conclusion, this study demonstrated that AEAR, as an adjuvant for influenza vaccine, could stimulate potent humoral and cellular immune responses and reduce the antigen dose required for effective vaccination, which were mediated by promoting DCs activation and repressing Treg expression.	[Zhang, Ailian; Wang, Danyang; Li, Jinyao] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Peoples R China; [Gao, Feng; Fan, Xucheng] Urumqi Ctr Dis Control & Prevent, Urumqi, Peoples R China	Xinjiang University	Zhang, AL (corresponding author), Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Peoples R China.	xjzal@163.com			National Natural Science Foundation of China [31360224, 31660259]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31360224,31660259). The funders had no role in study design, data collection and analysis, decision to publish, preparation or of the manuscript.	Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Belska NV, 2010, INT IMMUNOPHARMACOL, V10, P933, DOI 10.1016/j.intimp.2010.05.005; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Chen H, 2016, J MED FOOD, V19, P253, DOI 10.1089/jmf.2015.3513; Ciabattini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019346; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Feng HB, 2015, INT J BIOL MACROMOL, V78, P405, DOI 10.1016/j.ijbiomac.2015.04.044; Feng HB, 2015, IMMUNOL INVEST, V44, P288, DOI 10.3109/08820139.2015.1009546; Gritzapis AD, 2006, CANCER RES, V66, P5452, DOI 10.1158/0008-5472.CAN-05-4018; Hasegawa H, 2015, CURR TOP MICROBIOL, V386, P371, DOI 10.1007/82_2014_402; Honda-Okubo Y, 2012, VACCINE, V30, P5373, DOI 10.1016/j.vaccine.2012.06.021; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Hung YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159333; Jager E, 2000, P NATL ACAD SCI USA, V97, P12198, DOI 10.1073/pnas.220413497; Jiang MH, 2010, EXPERT OPIN THER TAR, V14, P1367, DOI 10.1517/14728222.2010.531010; Jin ML, 2014, INT J BIOL MACROMOL, V64, P257, DOI 10.1016/j.ijbiomac.2013.12.002; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Lai CY, 2010, VACCINE, V28, P4945, DOI 10.1016/j.vaccine.2010.05.037; Li JY, 2015, J ETHNOPHARMACOL, V171, P184, DOI 10.1016/j.jep.2015.05.050; Liu G, 2011, PLOS ONE, V6, P9408; Loubet P, 2016, EXPERT REV VACCINES, V15, P1507, DOI 10.1080/14760584.2016.1188696; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Oleszycka E, 2014, CURR OPIN IMMUNOL, V28, P1, DOI 10.1016/j.coi.2013.12.007; Principi N, 2012, HUM VACC IMMUNOTHER, V8, P59, DOI 10.4161/hv.8.1.18011; Raghavan S, 2010, INFECT IMMUN, V78, P4251, DOI 10.1128/IAI.00536-10; Rechtsteiner G, 2005, J IMMUNOL, V174, P2476, DOI 10.4049/jimmunol.174.5.2476; Rupp R, 2015, VACCINE, V33, P6351, DOI 10.1016/j.vaccine.2015.09.008; Shim BS, 2013, J MICROBIOL, V51, P130, DOI 10.1007/s12275-013-2399-z; Tan S, 2011, J INFECTION, V62, P388, DOI 10.1016/j.jinf.2011.03.002; Tsai TF, 2011, YAKUGAKU ZASSHI, V131, P1733, DOI 10.1248/yakushi.131.1733; Ulrich JT, 2000, J IMMUNOL, V164, P5492, DOI 10.4049/jimmunol.164.10.5492; Walker WT, 2010, EXPERT REV VACCINES, V9, P1385, DOI [10.1586/erv.10.141, 10.1586/ERV.10.141]; Wang M, 2016, INT J BIOL MACROMOL, V6, p809 ; Xu ZT, 2011, AM J CHINESE MED, V39, P15, DOI 10.1142/S0192415X11008610; Yoo DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033678; Yoshida A, 2009, ANTICANCER RES, V29, P4867; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Zaragoza B, 2016, NAT MED, V22, P16, DOI 10.1038/nm.4019; Zhang AL, 2017, VACCINE, V35, P1037, DOI 10.1016/j.vaccine.2017.01.002; Zhu FJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00066	41	11	16	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183720	10.1371/journal.pone.0183720	http://dx.doi.org/10.1371/journal.pone.0183720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841693	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700052
J	Challacombe, JF; Pillai, S; Kuske, CR				Challacombe, Jean F.; Pillai, Segaran; Kuske, Cheryl R.			Shared features of cryptic plasmids from environmental and pathogenic Francisella species	PLOS ONE			English	Article							SP NOV.; BACTERIAL CONJUGATION; HELICOBACTER-PYLORI; COMB. NOV; REPLICATION; GENOME; DNA; SYSTEMS; TULARENSIS; SEQUENCES	The Francisella genus includes several recognized species, additional potential species, and other representatives that inhabit a range of incredibly diverse ecological niches, but are not closely related to the named species. Francisella species have been obtained from a wide variety of clinical and environmental sources; documented species include highly virulent human and animal pathogens, fish pathogens, opportunistic human pathogens, tick endosymbionts, and free-living isolates inhabiting brackish water. While more than 120 Francisella genomes have been sequenced to date, only a few contain plasmids, and most of these appear to be cryptic, with unknown benefit to the host cell. We have identified several putative cryptic plasmids in the sequenced genomes of three Francisella novicida and F. novicida-like strains (TX07-6608, AZ06-7470, DPG_3A-IS) and two new Francisella species (F. frigiditurris CA97-1460 and F. opportunistica MA06-7296). These plasmids were compared to each other and to previously identified plasmids from other Francisella species. Some of the plasmids encoded functions potentially involved in replication, conjugal transfer and partitioning, environmental survival (transcriptional regulation, signaling, metabolism), and hypothetical proteins with no assignable functions. Genomic and phylogenetic comparisons of these new plasmids to the other known Francisella plasmids revealed some similarities that add to our understanding of the evolutionary relationships among the diverse Francisella species.	[Challacombe, Jean F.; Kuske, Cheryl R.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Pillai, Segaran] US FDA, Off Lab Sci & Safety, Silver Spring, MD USA	United States Department of Energy (DOE); Los Alamos National Laboratory; US Food & Drug Administration (FDA)	Challacombe, JF (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	jchalla@lanl.gov						Actis L. A., 1999, FRONT BIOSCI-LANDMRK, V4, P43; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Barkay T, 2005, ASM NEWS, V71, P412; Barns SM, 2005, APPL ENVIRON MICROB, V71, P5494, DOI 10.1128/AEM.71.9.5494-5500.2005; Barns SM, 2005, LAUR062332 DHS; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Birdsell Dawn N, 2009, BMC Res Notes, V2, P223, DOI 10.1186/1756-0500-2-223; Brett ME, 2014, CLIN INFECT DIS, V59, P826, DOI 10.1093/cid/ciu430; Brevik OJ, 2011, J APPL MICROBIOL, V111, P1044, DOI 10.1111/j.1365-2672.2011.05133.x; Brown CJ, 2013, APPL ENVIRON MICROB, V79, P7684, DOI 10.1128/AEM.02252-13; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Byrd DR, 1997, MOL MICROBIOL, V25, P1011, DOI 10.1046/j.1365-2958.1997.5241885.x; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; Challacombe J--F, 2016, APPL ENVIRON MICROB, V83; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Colquhoun DJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-47; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gordon D, 2013, BIOINFORMATICS, V29, P2936, DOI 10.1093/bioinformatics/btt515; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; Han CS, 2006, 2006 INT C BIOINF CO; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Hofler C, 2004, INT J MED MICROBIOL, V294, P141, DOI 10.1016/j.ijmm.2004.06.021; HOLLIS DG, 1989, J CLIN MICROBIOL, V27, P1601, DOI 10.1128/JCM.27.7.1601-1608.1989; hrman C, 2015, GENOME ANNOUNC, V3; Huber B, 2010, INT J SYST EVOL MICR, V60, P1887, DOI 10.1099/ijs.0.015941-0; Johansson A, 2004, APMIS, V112, P898, DOI 10.1111/j.1600-0463.2004.apm11211-1212.x; Johnson SL, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01046-15; Johnson SL, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00147-15; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Khan SA, 2005, PLASMID, V53, P126, DOI 10.1016/j.plasmid.2004.12.008; KUES U, 1989, MICROBIOL REV, V53, P491; Kugeler KJ, 2008, J CLIN MICROBIOL, V46, P2428, DOI 10.1128/JCM.00698-08; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurenbach B, 2006, MICROBIOL-SGM, V152, P637, DOI 10.1099/mic.0.28468-0; Kuske CR, 2006, J FORENSIC SCI, V51, P548, DOI 10.1111/j.1556-4029.2006.00131.x; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; Larson MA, 2016, INT J SYST EVOL MICR, V66, P1200, DOI 10.1099/ijsem.0.000855; Le Pihive E, 2009, PLASMID, V62, P147, DOI 10.1016/j.plasmid.2009.07.001; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; ORTEGA S, 1986, NUCLEIC ACIDS RES, V14, P4865, DOI 10.1093/nar/14.12.4865; Ottem KF, 2008, J FISH DIS, V31, P525, DOI 10.1111/j.1365-2761.2008.00930.x; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Pavlov VM, 1996, FEMS IMMUNOL MED MIC, V13, P253, DOI 10.1111/j.1574-695X.1996.tb00247.x; Petersen JM, 2009, LETT APPL MICROBIOL, V48, P663, DOI 10.1111/j.1472-765X.2009.02589.x; Pomerantsev AP, 2001, PLASMID, V46, P210, DOI 10.1006/plas.2001.1548; Qu PH, 2016, INT J SYST EVOL MICR, V66, P4832, DOI 10.1099/ijsem.0.001437; Qu PH, 2013, INT J SYST EVOL MICR, V63, P3628, DOI 10.1099/ijs.0.049916-0; Rajewska M, 2012, FEMS MICROBIOL REV, V36, P408, DOI 10.1111/j.1574-6976.2011.00300.x; Respicio-Kingry LB, 2013, J CLIN MICROBIOL, V51, P3456, DOI 10.1128/JCM.01105-13; Rydzewski K, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-169; Schroder G, 2002, J BACTERIOL, V184, P2767, DOI 10.1128/JB.184.10.2767-2779.2002; SCOTT JR, 1984, MICROBIOL REV, V48, P1; Siddaramappa S, 2014, GENOME, V57, P137, DOI 10.1139/gen-2013-0231; Siddaramappa S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-422; Siddaramappa S, 2011, APPL ENVIRON MICROB, V77, P5110, DOI 10.1128/AEM.00337-11; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	74	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183554	10.1371/journal.pone.0183554	http://dx.doi.org/10.1371/journal.pone.0183554			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837612	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000080
J	Chaston, JJ; Stewart, AG; Christie, M				Chaston, Jessica J.; Stewart, Alastair Gordon; Christie, Mary			Structural characterisation of TNRC6A nuclear localisation signal in complex with importinalpha	PLOS ONE			English	Article							CRYSTALLOGRAPHIC ANALYSIS; TERMINAL DOMAIN; GW182; ARGONAUTE; PROTEINS; IMPORT; RECOGNITION; BINDING; DEADENYLASE; SEQUENCES	The GW182/TNRC6 family of proteins are central scaffolds that link microRNA-associated Argonaute proteins to the cytoplasmic decay machinery for targeted mRNA degradation processes. Although nuclear roles for the GW182/TNRC6 proteins are unknown, recent reports have demonstrated nucleocytoplasmic shuttling activity that utilises the importin-alpha and importin-beta transport receptors for nuclear translocation. Here we describe the structure of mouse importin-alpha in complex with the TNRC6A nuclear localisation signal peptide. We further show that the interactions observed between TNRC6A and importin-alpha are conserved between mouse and human complexes. Our results highlight the ability of monopartite cNLS sequences to maximise contacts at the importin-alpha major binding site, as well as regions outside the main binding cavities.	[Chaston, Jessica J.; Stewart, Alastair Gordon; Christie, Mary] Victor Chang Cardiac Res Inst, Mol Struct & Computat Biol Div, Sydney, NSW, Australia; [Chaston, Jessica J.; Stewart, Alastair Gordon; Christie, Mary] Univ New South Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Christie, M (corresponding author), Victor Chang Cardiac Res Inst, Mol Struct & Computat Biol Div, Sydney, NSW, Australia.; Christie, M (corresponding author), Univ New South Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia.	m.christie@victorchang.edu.au	Stewart, Alastair G/A-7182-2012	Stewart, Alastair/0000-0002-2070-6030; Christie, Mary/0000-0002-0955-665X	Australian Research Council [DE160100608]; National Health and Medical Research Council [APP1090408]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	MC is the recipient of an Australian Research Council Discovery Early Career Research Award (DE160100608). AGS is the recipient of a National Health and Medical Research Council Peter Doherty Fellowship (APP1090408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Ameyar-Zazoua M, 2012, NAT STRUCT MOL BIOL, V19, P998, DOI 10.1038/nsmb.2373; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Bernardes NE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128687; Braun JE, 2013, ADV EXP MED BIOL, V768, P147, DOI 10.1007/978-1-4614-5107-5_9; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chang CW, 2013, TRAFFIC, V14, P1144, DOI 10.1111/tra.12098; Chang CW, 2012, PLANT CELL, V24, P5074, DOI 10.1105/tpc.112.104422; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; Christie M, 2013, MOL CELL, V51, P360, DOI 10.1016/j.molcel.2013.07.011; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; de Barros AC, 2016, J MOL BIOL, V428, P2120, DOI 10.1016/j.jmb.2016.01.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Huntzinger E, 2010, EMBO J, V29, P4146, DOI 10.1038/emboj.2010.274; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; Kalantari R, 2016, NUCLEIC ACIDS RES, V44, P524, DOI 10.1093/nar/gkv1305; Kim MS, 2010, J PATHOL, V221, P139, DOI 10.1002/path.2683; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kozlov G, 2010, J BIOL CHEM, V285, P13599, DOI 10.1074/jbc.M109.089540; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lazzaretti D, 2009, RNA, V15, P1059, DOI 10.1261/rna.1606309; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Matsui M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12855; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishi K, 2015, NUCLEIC ACIDS RES, V43, P9856, DOI 10.1093/nar/gkv1026; Nishi K, 2013, RNA, V19, P17, DOI 10.1261/rna.034769.112; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Rona G, 2013, ACTA CRYSTALLOGR D, V69, P2495, DOI 10.1107/S0907444913023354; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Sankhala RS, 2016, J BIOL CHEM, V291, P11420, DOI 10.1074/jbc.M116.724393; Schraivogel D, 2015, NUCLEIC ACIDS RES, V43, P7447, DOI 10.1093/nar/gkv705; Schraivogel D, 2014, TRENDS BIOCHEM SCI, V39, P420, DOI 10.1016/j.tibs.2014.07.004; Suzawa M, 2017, J MOL BIOL; Takeda AAS, 2011, J MOL BIOL, V412, P226, DOI 10.1016/j.jmb.2011.07.038; Takimoto K, 2009, RNA, V15, P1078, DOI 10.1261/rna.1363109; Teh T, 1999, ACTA CRYSTALLOGR D, V55, P561, DOI 10.1107/S0907444998012943; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Trowitzsch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7011; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	71	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183587	10.1371/journal.pone.0183587	http://dx.doi.org/10.1371/journal.pone.0183587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837617	gold, Green Submitted, Green Published			2022-12-26	WOS:000408365000083
J	Kiouptsi, K; Grill, A; Mann, A; Dohrmann, M; Lillich, M; Jackel, S; Malinarich, F; Formes, H; Manukyan, D; Subramaniam, S; Khandagale, A; Karwot, C; Thal, SC; Bosmann, M; Scharrer, I; Jurk, K; Reinhardt, C				Kiouptsi, Klytaimnistra; Grill, Alexandra; Mann, Amrit; Doehrmann, Mareike; Lillich, Maren; Jaeckel, Sven; Malinarich, Frano; Formes, Henning; Manukyan, Davit; Subramaniam, Saravanan; Khandagale, Avinash; Karwot, Cornelia; Thal, Serge C.; Bosmann, Markus; Scharrer, Inge; Jurk, Kerstin; Reinhardt, Christoph			Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels	PLOS ONE			English	Article							VONWILLEBRAND-FACTOR VWF; RECOMBINANT FACTOR-VIII; ENDOTHELIAL-CELLS; DOMINANT MODIFIER; MOUSE MODEL; A MICE; ADAMTS13; CLEAVAGE; HEMOSTASIS; ACTIVATION	Von Willebrand factor (VWF) is the carrier protein of the anti-haemophilic Factor VIII (FVIII) in plasma. It has been reported that the infusion of FVIII concentrate in haemophilia A patients results in lowered VWF plasma levels. However, the impact of F8-deficiency on VWF plasma levels in F8(-/y) mice is unresolved. In order to avoid confounding variables, we back-crossed F8-deficient mice onto a pure C57BL/6J background and analysed VWF plasma concentrations relative to C57BL/6J WT (F8(+/y)) littermate controls. F8(-/y) mice showed strongly elevated VWF plasma concentrations and signs of hepatic inflammation, as indicated by increased TNF-alpha, CD45, and TLR4 transcripts and by elevated macrophage counts in the liver. Furthermore, immunohistochemistry showed that expression of VWF antigen was significantly enhanced in the hepatic endothelium of F8-/y mice, most likely resulting from increased macrophage recruitment. There were no signs of liver damage, as judged by glutamate-pyruvate-transaminase (GPT) and glutamate-oxalacetate-transaminase (GOT) in the plasma and no signs of systemic inflammation, as white blood cell subsets were unchanged. As expected, impaired haemostasis was reflected by joint bleeding, prolonged in vitro clotting time and decreased platelet-dependent thrombin generation. Our results point towards a novel role of FVIII, synthesized by the liver endothelium, in the control of hepatic low-grade inflammation and VWF plasma levels.	[Kiouptsi, Klytaimnistra; Grill, Alexandra; Mann, Amrit; Doehrmann, Mareike; Lillich, Maren; Jaeckel, Sven; Malinarich, Frano; Formes, Henning; Subramaniam, Saravanan; Khandagale, Avinash; Karwot, Cornelia; Bosmann, Markus; Scharrer, Inge; Jurk, Kerstin; Reinhardt, Christoph] Univ Med Ctr Mainz, CTH, Mainz, Germany; [Jaeckel, Sven; Reinhardt, Christoph] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Mainz, Germany; [Manukyan, Davit] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany; [Thal, Serge C.] Univ Med Ctr Mainz, Dept Anesthesiol, Mainz, Germany	Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Reinhardt, C (corresponding author), Univ Med Ctr Mainz, CTH, Mainz, Germany.; Reinhardt, C (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Mainz, Germany.	Christoph.Reinhardt@unimedizin-mainz.de	Jurk, Kerstin/AAT-7768-2020; Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Bosmann, Markus/0000-0003-2773-1033; Subramaniam, Saravanan/0000-0002-0194-5044	CTH Junior Group Translational Research in Thrombosis and Hemostasis (Bundesministerium fur Bildung and Forschung) [01EO1003, 01EO1503]; Boehringer Ingelheim Foundation	CTH Junior Group Translational Research in Thrombosis and Hemostasis (Bundesministerium fur Bildung and Forschung); Boehringer Ingelheim Foundation(Boehringer Ingelheim)	The project was funded by the CTH Junior Group Translational Research in Thrombosis and Hemostasis (Bundesministerium fur Bildung and Forschung 01EO1003 and 01EO1503), and a project grant from the Boehringer Ingelheim Foundation to CR. SJ, AG, and CR are members of Young Deutsches Zentrum fur Herz-Kreislauf-Forschung (DZHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHOU WF, 1989, J CLIN INVEST, V84, P56, DOI 10.1172/JCI114169; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Cao WJ, 2008, P NATL ACAD SCI USA, V105, P7416, DOI 10.1073/pnas.0801735105; Cao WJ, 2012, J BIOL CHEM, V287, P32459, DOI 10.1074/jbc.M112.390690; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; FURIE B, 1992, NEW ENGL J MED, V326, P800; Groth MP, 2014, LAB ANIM-UK, V48, P225, DOI 10.1177/0023677214524381; Kawecki C, 2017, J THROMB HAEMOST, V15, P1285, DOI 10.1111/jth.13696; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Landskroner KA, 2005, HAEMOPHILIA, V11, P346, DOI 10.1111/j.1365-2516.2005.01104.x; Lau AG, 2014, HAEMOPHILIA, V20, P716, DOI 10.1111/hae.12399; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Macauley MS, 2014, J BIOL CHEM, V289, P35149, DOI 10.1074/jbc.M114.606517; Mohlke KL, 1999, CELL, V96, P111, DOI 10.1016/S0092-8674(00)80964-2; MORFINI M, 1993, THROMB HAEMOSTASIS, V70, P270; Oldenburg J, 2001, THROMB HAEMOSTASIS, V85, P577; Ovlisen K, 2008, J THROMB HAEMOST, V6, P969, DOI 10.1111/j.1538-7836.2008.02954.x; Pendu R, 2006, BLOOD, V108, P3746, DOI 10.1182/blood-2006-03-010322; Roosendaal G, 1999, HISTOPATHOLOGY, V34, P144; Shi QZ, 2010, BLOOD, V116, P3049, DOI 10.1182/blood-2010-03-272419; Skipwith CG, 2010, J BIOL CHEM, V285, P28596, DOI 10.1074/jbc.M110.131227; STEL HV, 1983, NATURE, V303, P530, DOI 10.1038/303530a0; Teyssandier M, 2012, HAEMATOL-HEMATOL J, V97, P1115, DOI 10.3324/haematol.2012.065235; van Bladel ER, 2014, HAEMOPHILIA, V20, P92, DOI 10.1111/hae.12266; Vischer UM, 1998, THROMB HAEMOSTASIS, V80, P1002	27	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183590	10.1371/journal.pone.0183590	http://dx.doi.org/10.1371/journal.pone.0183590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837614	Green Submitted, gold, Green Published			2022-12-26	WOS:000408365000084
J	Liu, YD; Li, Q; Zhou, ZH; Yeah, YW; Chang, CC; Lee, CY; Tsui, PH				Liu, Yi-Da; Li, Qiang; Zhou, Zhuhuang; Yeah, Yao-Wen; Chang, Chien-Cheng; Lee, Chia-Yen; Tsui, Po-Hsiang			Adaptive ultrasound temperature imaging for monitoring radiofrequency ablation	PLOS ONE			English	Article							THERMAL ABLATION; ECHO-SHIFTS; ATTENUATION; DEPENDENCE; TISSUE	Radiofrequency ablation (RFA) has been widely used as an alternative treatment modality for liver tumors. Monitoring the temperature distribution in the tissue during RFA is required to assess the thermal dosage. Ultrasound temperature imaging based on the detection of echo time shifts has received the most attention in the past decade. The coefficient k, connecting the temperature change and the echo time shift, is a medium-dependent parameter used to describe the confounding effects of changes in the speed of sound and thermal expansion as temperature increases. The current algorithm of temperature estimate based on echo time shift detection typically uses a constant k, resulting in estimation errors when ablation temperatures are higher than 50 degrees C. This study proposes an adaptive-k algorithm that enables the automatic adjustment of the coefficient k during ultrasound temperature monitoring of RFA. To verify the proposed algorithm, RFA experiments on in vitro porcine liver samples (total n = 15) were performed using ablation powers of 10, 15, and 20 W. During RFA, a clinical ultrasound system equipped with a 7.5-MHz linear transducer was used to collect backscattered signals for ultrasound temperature imaging using the constant-and adaptive-k algorithms. Concurrently, an infrared imaging system and thermocouples were used to measure surface temperature distribution of the sample and internal ablation temperatures for comparisons with ultrasound estimates. Experimental results demonstrated that the proposed adaptive-k method improved the performance in visualizing the temperature distribution. In particular, the estimation errors were also reduced even when the temperature of the tissue is higher than 50 degrees C. The proposed adaptive-k ultrasound temperature imaging strategy has potential to serve as a thermal dosage evaluation tool for monitoring high-temperature RFA.	[Liu, Yi-Da; Li, Qiang] Tianjin Univ, Sch Elect Informat Engn, Tianjin, Peoples R China; [Zhou, Zhuhuang] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Zhou, Zhuhuang] Beijing Univ Technol, Fac Informat Technol, Beijing, Peoples R China; [Yeah, Yao-Wen; Chang, Chien-Cheng] Natl Taiwan Univ, Inst Appl Mech, Taipei, Taiwan; [Lee, Chia-Yen] Natl United Univ, Dept Elect Engn, Miaoli, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Inst Radiol Res, Med Imaging Res Ctr, Taoyuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan	Tianjin University; Beijing University of Technology; Beijing University of Technology; National Taiwan University; National United University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chang, CC (corresponding author), Natl Taiwan Univ, Inst Appl Mech, Taipei, Taiwan.; Tsui, PH (corresponding author), Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.; Tsui, PH (corresponding author), Chang Gung Univ, Inst Radiol Res, Med Imaging Res Ctr, Taoyuan, Taiwan.; Tsui, PH (corresponding author), Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan.; Tsui, PH (corresponding author), Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan.	mechang@iam.ntu.edu.tw; tsuiph@mail.cgu.edu.tw	Tsui, Po-Hsiang/AHE-7426-2022; Zhou, Zhuhuang/M-3301-2019; Li, Qiang/ABF-4555-2021	Zhou, Zhuhuang/0000-0003-0570-8473; Tsui, Po-Hsiang/0000-0002-5604-1800	Ministry of Science and Technology (Taiwan) [MOST 103-2221-E-182-001-MY3]; Chang Gung Memorial Hospital (Linkou, Taiwan) [CIRPD1E0023, CMRPD1G0401, CMRPD1F0311]; National Natural Science Foundation of China [61471263]; Natural Science Foundation of Tianjin, China [16JCZDJC31100]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, TaiwanMinistry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital (Linkou, Taiwan)(Chang Gung Memorial Hospital); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin)	This work was supported by the Ministry of Science and Technology (Taiwan) under Grant No. MOST 103-2221-E-182-001-MY3 and the Chang Gung Memorial Hospital (Linkou, Taiwan) under Grant Nos. CIRPD1E0023, CMRPD1G0401, and CMRPD1F0311. This work was also supported by the National Natural Science Foundation of China (No. 61471263) and the Natural Science Foundation of Tianjin, China under Grant 16JCZDJC31100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2008, ULTRASOUND MED BIOL, V34, P1449, DOI 10.1016/j.ultrasmedbio.2008.02.004; Arthur RM, 2005, INT J HYPERTHER, V21, P589, DOI 10.1080/02656730500159103; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chiou SY, 2007, J ULTRAS MED, V26, P487, DOI 10.7863/jum.2007.26.4.487; Curley SA, 1999, ANN SURG, V230, P1, DOI 10.1097/00000658-199907000-00001; Damianou CA, 1997, J ACOUST SOC AM, V102, P628, DOI 10.1121/1.419737; Daniels MJ, 2007, PHYS MED BIOL, V52, P4827, DOI 10.1088/0031-9155/52/16/008; Daniels MJ, 2010, PHYS MED BIOL, V55, P4735, DOI 10.1088/0031-9155/55/16/008; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Foiret J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134938; Fuhrmann TA, 2016, J THER ULTRASOUND, V4, P1, DOI 10.1186/s40349-016-0071-x; Geng X, 2014, JPN J APPL PHYS, V53, P205; Goldberg S N, 2001, Eur J Ultrasound, V13, P129, DOI 10.1016/S0929-8266(01)00126-4; Iseki Y, 2016, THERM MED, V32, p17 ; Jiao LR, 1999, AM J SURG, V177, P303, DOI 10.1016/S0002-9610(99)00043-4; Lencioni R, 2007, TECH VASC INTERV RAD, V10, P38, DOI 10.1053/j.tvir.2007.08.006; Lewis MA, 2015, INT J HYPERTHER, V31, P163, DOI 10.3109/02656736.2015.1009180; Liu DL, 2010, IEEE T BIO-MED ENG, V57, P12, DOI 10.1109/TBME.2009.2035103; MaassMoreno R, 1996, J ACOUST SOC AM, V100, P2514, DOI 10.1121/1.417359; MaassMoreno R, 1996, J ACOUST SOC AM, V100, P2522, DOI 10.1121/1.417360; Machi J, 2002, SURG LAPARO ENDO PER, V12, P160, DOI 10.1097/00129689-200206000-00004; Miller NR, 2002, ULTRASOUND MED BIOL, V28, P1319, DOI 10.1016/S0301-5629(02)00608-7; Pernot M, 2004, IEEE T ULTRASON FERR, V51, P606, DOI 10.1109/TUFFC.2004.1320832; Seip R, 1996, IEEE T ULTRASON FERR, V43, P1063, DOI 10.1109/58.542050; Seo CH, 2011, INTERFACE FOCUS, V1, P649, DOI 10.1098/rsfs.2011.0010; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simon C, 1998, IEEE T ULTRASON FERR, V45, P1088, DOI 10.1109/58.710592; Sokka SD, 2003, PHYS MED BIOL, V48, P223, DOI 10.1088/0031-9155/48/2/306; STRAUBE WL, 1994, ULTRASOUND MED BIOL, V20, P915, DOI 10.1016/0301-5629(94)90051-5; Subramanian S, 2014, ULTRASOUND MED BIOL, V40, P102, DOI 10.1016/j.ultrasmedbio.2013.09.007; Trobaugh JW, 2008, ULTRASOUND MED BIOL, V34, P289, DOI 10.1016/j.ultrasmedbio.2007.07.015; Tsui PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162488; Tsui PH, 2012, ULTRASONICS, V52, P925, DOI 10.1016/j.ultras.2012.03.001; Tyreus PD, 2004, PHYS MED BIOL, V49, P533, DOI 10.1088/0031-9155/49/4/005; Varghese T, 2002, ULTRASOUND MED BIOL, V28, P321, DOI 10.1016/S0301-5629(01)00519-1; Varghese T, 2002, ULTRASOUND MED BIOL, V28, P1467, DOI 10.1016/S0301-5629(02)00656-7; Wang CY, 2013, MED PHYS, V40, DOI 10.1118/1.4808115	37	14	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182457	10.1371/journal.pone.0182457	http://dx.doi.org/10.1371/journal.pone.0182457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837584	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000018
J	Lopez-de-Andres, A; Hernandez-Barrera, V; Martinez-Huedo, MA; Villanueva-Martinez, M; Jimenez-Trujillo, I; Jimenez-Garcia, R				Lopez-de-Andres, Ana; Hernandez-Barrera, Valentin; Martinez-Huedo, Maria A.; Villanueva-Martinez, Manuel; Jimenez-Trujillo, Isabel; Jimenez-Garcia, Rodrigo			Type 2 diabetes and in-hospital complications after revision of total hip and knee arthroplasty	PLOS ONE			English	Article							TOTAL JOINT ARTHROPLASTY; UNITED-STATES; ASEPTIC REVISION; GLYCEMIC CONTROL; MORBID-OBESITY; RISK-FACTORS; REPLACEMENT; OUTCOMES; INFECTION; MELLITUS	Purpose To assess the effect of type 2 diabetes (T2DM) on hospital outcomes such as in hospital postoperative complications (IHPC), length of hospital stay (LOHS) and in-hospital mortality (IHM) after the revision of total hip arthroplasty (RHA) and total knee arthroplasty (RKA) and to identify factors associated with IHPC among T2DM patients undergoing these procedures. Methods We performed a retrospective study using the Spanish National Hospital Discharge Database, 2005-2014. We included patients who were >= 40 years old that had undergone RHA and RKA. For each T2DM patient, we selected a year-, gender-, age- and Charlson Comorbidity Index-matched non-diabetic patient. Results We identified 44,055 and 39,938 patients who underwent RHA (12.72% with T2DM) and RKA (15.01% with T2DM). We matched 4,700 and 5,394 couples with RHA and RKA, respectively. Any IHPC was more frequent among patients with T2DM than among non-2DM patients (19% vs. 15.64% in the RHA cohort and 12.94% vs. 11.09% in the RKA cohort, respectively). For patients who underwent RHA, postoperative infection (4.51% vs. 2.94%, p<0.001), acute post-hemorrhagic anemia (9.53% vs. 7.70%, p<0.001), mean LOHS and IHM were significantly higher in patients with T2DM. Among RKA patients, the incidence of acute posthemorrhagic anemia (7.21% vs. 5.62%; p = 0.001) and urinary tract infection (1.13% vs. 0.72%; p = 0.029) was significantly higher in patients with diabetes. Older age, obesity, infection due to internal joint prosthesis, myocardial infarction, congestive heart failure, mild liver disease and renal disease and emergency room admission were significantly associated with a higher risk of IHPC in T2DM patients. IHPC decreased over time only in T2DM patients who underwent RHA (OR 0.94, 95% CI 0.89-0.98). Conclusions Patients with T2DM who underwent RHA and RKA procedures had more IHPC after controlling for the effects of possible confounders. LOHS and IHM were also higher among RHA patients with diabetes. Older age, comorbidity, obesity and emergency room admission were strong predictors of IHPC in diabetic patients.	[Lopez-de-Andres, Ana; Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel; Jimenez-Garcia, Rodrigo] Univ Rey Juan Carlos, Med & Surg Psychol Prevent Med & Publ Hlth Med Mi, Comunidad Madrid, Mostoles, Spain; [Martinez-Huedo, Maria A.] Hosp Univ La Paz, Prevent Med Dept, Madrid, Spain; [Villanueva-Martinez, Manuel] Hosp Beata Maria, Unit Revis Hip & Knee Arthroplasty, Unidad Recambios Protes, Madrid, Spain	Universidad Rey Juan Carlos; Hospital Universitario La Paz	Jimenez-Garcia, R (corresponding author), Univ Rey Juan Carlos, Med & Surg Psychol Prevent Med & Publ Hlth Med Mi, Comunidad Madrid, Mostoles, Spain.	rodrigo.jimenez@urjc.es	Lopez-de-Andres, Ana/D-4498-2019; Jimenez-Trujillo, Isabel/AAP-7746-2021; Jimenez-Garcia, Rodrigo/D-4953-2019; Lopez-de-Andres, Ana/AAD-8703-2019	Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Trujillo, Isabel/0000-0002-9394-6799; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Lopez-de-Andres, Ana/0000-0001-5551-5181; Hernandez-Barrera, Valentin/0000-0001-5790-1959	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund) - European Union through Fondo Europeo de Desarrollo Regional (FEDER) [PI13/00118, PI16/00564]; Grupo de Excelencia Investigadora URJC-Banco Santander [30VCPIGI03]	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund) - European Union through Fondo Europeo de Desarrollo Regional (FEDER); Grupo de Excelencia Investigadora URJC-Banco Santander	This study is part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, grant no. PI13/00118 & grant no. PI16/00564, Institute de Salud Carlos III) co-financed by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa") and by the Grupo de Excelencia Investigadora URJC-Banco Santander No30VCPIGI03: Investigacion traslacional en el proceso de salud - enfermedad (ITPSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antwi-Bafour Samuel, 2016, J Med Case Rep, V10, P110, DOI 10.1186/s13256-016-0889-4; Basilico FC, 2008, ARTHRITIS RHEUM, V58, P1915, DOI 10.1002/art.23607; Bolognesi MP, 2008, J ARTHROPLASTY, V23, P92, DOI 10.1016/j.arth.2008.05.012; Chun Young-Soo, 2014, Hip Pelvis, V26, P136, DOI 10.5371/hp.2014.26.3.136; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Dieterich JD, 2014, J ARTHROPLASTY, V29, P2163, DOI 10.1016/j.arth.2014.07.004; Dronge AS, 2006, ARCH SURG-CHICAGO, V141, P375, DOI 10.1001/archsurg.141.4.375; Ekinci EI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168471; Fu AZ, 2014, J DIABETES COMPLICAT, V28, P805, DOI 10.1016/j.jdiacomp.2014.06.009; George J, 2017, CLIN ORTHOP RELAT RE; Hamilton DF, 2015, BONE JOINT J, V97B, P723, DOI 10.1302/0301-620X.97B6.35185; Houdek MT, 2015, J BONE JOINT SURG AM, V97A, P326, DOI 10.2106/JBJS.N.00515; Jain Ravi Kant, 2015, Eur J Orthop Surg Traumatol, V25, P251, DOI 10.1007/s00590-014-1475-3; Jamsen E, 2013, ANN RHEUM DIS, V72, P1975, DOI 10.1136/annrheumdis-2012-202064; Jiang Jason, 2016, CMAJ Open, V4, pE646, DOI 10.9778/cmajo.20160128; Kamath AF, 2015, J ARTHROPLASTY, V30, P1492, DOI 10.1016/j.arth.2015.03.035; Khokhar B, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009952; King KB, 2013, CLIN ORTHOP RELAT R, V471, P3049, DOI 10.1007/s11999-013-3026-3; Koenig K, 2012, J ARTHROPLASTY, V27, P1402, DOI 10.1016/j.arth.2011.11.013; Kowalik TD, 2016, J AM ACAD ORTHOP SUR, V24, P393, DOI 10.5435/JAAOS-D-15-00596; Kunutsor SK, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150866, 10.1371/journal.pone.0151537]; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Labek G, 2011, J BONE JOINT SURG BR, V93B, P293, DOI 10.1302/0301-620X.93B3.25467; Lakomkin N, 2016, J ARTHROPLASTY; Liodakis E, 2015, J ARTHROPLASTY, V30, P1868, DOI 10.1016/j.arth.2015.05.029; Lohmander LS, 2006, ACTA ORTHOP, V77, P733, DOI 10.1080/17453670610012917; Lubbeke A, 2008, ARTHRIT RHEUM-ARTHR, V59, P738, DOI 10.1002/art.23562; Marchant MH, 2009, J BONE JOINT SURG AM, V91A, P1621, DOI 10.2106/JBJS.H.00116; Martinez- Huedo MA, 2008, EUR J ORTHOP SURG TR, V23, P53, DOI DOI 10.1007/S00590-011-0915-6; Ministerio de Sanidad, SERV SOC IG REG ALT; Namba RS, 2013, J ARTHROPLASTY, V28, P122, DOI 10.1016/j.arth.2013.04.050; Parvizi J, 2013, BONE JOINT J, V95B, P1450, DOI 10.1302/0301-620X.95B11.33135; Pedersen AB, 2010, J BONE JOINT SURG BR, V92B, P929, DOI 10.1302/0301-620X.92B7.24461; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ribera A, 2008, REV ESP CARDIOL, V61, P843, DOI 10.1016/S1885-5857(08)60232-7; Sams JD, 2012, J ARTHROPLASTY, V27, P758, DOI 10.1016/j.arth.2011.09.007; Sams JD, 2010, J ARTHROPLASTY, V25, P826, DOI 10.1016/j.arth.2010.01.097; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmolders J, 2015, INT ORTHOP, V39, P1771, DOI 10.1007/s00264-015-2810-y; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Villanueva-Martinez M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-37; Viola J, 2015, J ARTHROPLASTY, V30, P846, DOI 10.1016/j.arth.2014.12.026; Watts CD, 2015, CLIN ORTHOP RELAT R, V473, P2621, DOI 10.1007/s11999-015-4283-0; Wild Sarah, 2016, J Diabetes Sci Technol, V10, P1073, DOI 10.1177/1932296816645120; Yang Z, 2014, BONE JOINT J, V96B, P1637, DOI 10.1302/0301-620X.96B12.34378; Zmistowski B, 2013, J ARTHROPLASTY, V28, P1486, DOI 10.1016/j.arth.2013.02.021	46	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183796	10.1371/journal.pone.0183796	http://dx.doi.org/10.1371/journal.pone.0183796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837689	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000123
J	Serrano-Gomez, SJ; Sanabria-Salas, MAC; Garay, J; Baddoo, MC; Hernandez-Suarez, G; Mejia, JC; Garcia, O; Miele, L; Fejerman, L; Zabaleta, J				Serrano-Gomez, Silvia J.; Carolina Sanabria-Salas, Maria A.; Garay, Jone; Baddoo, Melody C.; Hernandez-Suarez, Gustavo; Carlos Mejia, Juan; Garcia, Oscar; Miele, Lucio; Fejerman, Laura; Zabaleta, Jovanny			Ancestry as a potential modifier of gene expression in breast tumors from Colombian women	PLOS ONE			English	Article							CANCER INTRINSIC SUBTYPES; GRB7; HER2; IMMUNOHISTOCHEMISTRY; CHEMOTHERAPY; CLASSIFICATION; IDENTIFICATION; POLYMORPHISMS; ASSOCIATION; MANAGEMENT	Background Hispanic/Latino populations are a genetically admixed and heterogeneous group, with variable fractions of European, Indigenous American and African ancestries. The molecular profile of breast cancer has been widely described in non-Hispanic Whites but equivalent knowledge is lacking in Hispanic/Latinas. We have previously reported that the most prevalent breast cancer intrinsic subtype in Colombian women was Luminal B as defined by St. Gallen 2013 criteria. In this study we explored ancestry-associated differences in molecular profiles of Luminal B tumors among these highly admixed women. Methods We performed whole-transcriptome RNA-seq analysis in 42 Luminal tumors (21 Luminal A and 21 Luminal B) from Colombian women. Genetic ancestry was estimated from a panel of 80 ancestry-informative markers (AIM). We categorized patients according to Luminal subtype and to the proportion of European and Indigenous American ancestry and performed differential expression analysis comparing Luminal B against Luminal A tumors according to the assigned ancestry groups. Results We found 5 genes potentially modulated by genetic ancestry: ERBB2 (log2FC = 2.367, padj<0.01), GRB7 (log2FC = 2.327, padj<0.01), GSDMB (log2FC = 1.723, padj<0.01, MIEN1 (log2FC = 2.195, padj<0.01 and ONECUT2 (log2FC = 2.204, padj<0.01). In the replication set we found a statistical significant association between ERBB2 expression with Indigenous American ancestry (p = 0.02, B = 3.11). This association was not biased by the distribution of HER2+ tumors among the groups analyzed. Conclusions Our results suggest that genetic ancestry in Hispanic/Latina women might modify ERBB2 gene expression in Luminal tumors. Further analyses are needed to confirm these findings and explore their prognostic value.	[Serrano-Gomez, Silvia J.; Carolina Sanabria-Salas, Maria A.; Hernandez-Suarez, Gustavo] Inst Nacl Cancerol, Grp Invest Biol Canc, Bogota, Colombia; [Serrano-Gomez, Silvia J.] Pontificia Univ Javeriana, Programa Doctorado Ciencias Biol, Bogota, Colombia; [Garay, Jone; Zabaleta, Jovanny] LSUHSC, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Baddoo, Melody C.] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Carlos Mejia, Juan] Inst Nacl Cancerol, Grp Patol, Bogota, Colombia; [Garcia, Oscar] Inst Nacl Cancerol, Grp Seno & Tejidos Blandos, Bogota, Colombia; [Miele, Lucio] LSUHSC, Dept Genet, New Orleans, LA USA; [Fejerman, Laura] Univ Calif San Francisco, Dept Med, Inst Human Genet, San Francisco, CA USA; [Zabaleta, Jovanny] LSUHSC, Dept Pediat, New Orleans, LA 70112 USA	Pontificia Universidad Javeriana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of California System; University of California San Francisco; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zabaleta, J (corresponding author), LSUHSC, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA.; Zabaleta, J (corresponding author), LSUHSC, Dept Pediat, New Orleans, LA 70112 USA.	jzabal@lsuhsc.edu		Fejerman, Laura/0000-0003-3179-1151; SANABRIA SALAS, MARIA CAROLINA/0000-0002-7946-2026; Miele, Lucio/0000-0002-5853-7287	National Institute of General Medical Sciences (NIGMS) [P20GM103501, P30GM114732, U54GM104940-01]; National Institute on Minority Health and Health Disparities (NIMHD) [P20MD004817, U54MD008176-01]; NATIONAL CANCER INSTITUTE [P20CA202922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114732] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Colombian National Cancer Institute (C41030610-110 to MCSS). National Cancer Institute (CA 160607 to L.F.). J.Z. has been partially supported by grants from the National Institute of General Medical Sciences (NIGMS, P20GM103501 subproject # 2, P30GM114732, U54GM104940-01) and the National Institute on Minority Health and Health Disparities (NIMHD, P20MD004817, U54MD008176-01).	Ades F, 2014, J CLIN ONCOL, V32, P2794, DOI 10.1200/JCO.2013.54.1870; Aronesty E., 2011, EA UTILS COMMAND LIN; Artigalas O, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0373-9; Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Bertucci F, 2004, ONCOGENE, V23, P2564, DOI 10.1038/sj.onc.1207361; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Carey LA, 2006, J AM MED ASS, V295; Chavez-MacGregor M, 2014, CANCER EPIDEM BIOMAR, V23, P316, DOI 10.1158/1055-9965.EPI-13-0929; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Creighton CJ, 2012, BIOL-TARGETS THER, V6, P289, DOI 10.2147/BTT.S29923; Creighton CJ, 2009, BREAST CANCER RES TR, V114, P287, DOI 10.1007/s10549-008-0017-2; D'Arcy M, 2015, BREAST CANCER RES TR, V152, P437, DOI 10.1007/s10549-015-3474-4; de Ronde JJ, 2010, BREAST CANCER RES TR, V119, P119, DOI 10.1007/s10549-009-0499-6; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Fejerman L, 2013, CANCER RES, V73, P7243, DOI 10.1158/0008-5472.CAN-13-2014; Field LA, 2012, CANCER-AM CANCER SOC, V118, P1334, DOI 10.1002/cncr.26405; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Grunda Jessica M, 2012, BMC Res Notes, V5, P248, DOI 10.1186/1756-0500-5-248; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang X, 2015, CANC MED; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kpetemey M, 2016, ONCOTARGET, V7, P54913, DOI 10.18632/oncotarget.10798; Kpetemey M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0428-8; Kristensen VN, 2005, J STEROID BIOCHEM, V95, P105, DOI 10.1016/j.jsbmb.2005.04.028; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li ZH, 2016, ONCOTARGET, V7, P65024, DOI 10.18632/oncotarget.11344; Lips EH, 2013, BREAST CANCER RES TR, V140, P63, DOI 10.1007/s10549-013-2620-0; Long JR, 2006, CANCER EPIDEM BIOMAR, V15, P2115, DOI 10.1158/1055-9965.EPI-06-0464; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lusa L, 2007, JNCI-J NATL CANCER I, V99, P1715, DOI 10.1093/jnci/djm216; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Nadler Y, 2010, ANN ONCOL, V21, P466, DOI 10.1093/annonc/mdp346; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2015, BREAST, V24, pS26, DOI 10.1016/j.breast.2015.07.008; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Pritchard JK, 2000, GENETICS, V155, P945; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Romero A, 2011, AM J PATHOL, V178, P1453, DOI 10.1016/j.ajpath.2010.12.042; Rugo HS, 2008, ANN ONCOL, V19, P16, DOI 10.1093/annonc/mdm282; Serrano-Gomez SJ, 2016, CARCINOGENESIS; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sparano JA, 2009, CLIN CANCER RES, V15, P7693, DOI 10.1158/1078-0432.CCR-09-1450; Staaf J, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju386; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Stern Mariana C, 2016, Curr Epidemiol Rep, V3, P181, DOI 10.1007/s40471-016-0083-7; Stewart PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082460; Tao YM, 2014, P NATL ACAD SCI USA, V111, pE4429, DOI 10.1073/pnas.1407139111; Tishchenko I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158259; Vinatzer U, 2005, CLIN CANCER RES, V11, P8348, DOI 10.1158/1078-0432.CCR-05-0841; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wu Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1844; Yersal O, 2014, WORLD J CLIN ONCOL, V5, P412, DOI 10.5306/wjco.v5.i3.412; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972	66	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183179	10.1371/journal.pone.0183179	http://dx.doi.org/10.1371/journal.pone.0183179			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832682	Green Published, Green Submitted, gold			2022-12-26	WOS:000408355800050
J	Tsuboko-Ishii, S; Burton, RS				Tsuboko-Ishii, Satomi; Burton, Ronald S.			Sex-specific rejection in mate-guarding pair formation in the intertidal copepod, Tigriopus californicus	PLOS ONE			English	Article							MATING SYSTEM; RATIOS; SWITCH; MODEL; FIELD; TIME	Securing a potential mate is one of the most important processes in sexual reproduction of animals. Intertidal copepods of the genus Tigriopus show mate-guarding behavior where a male captures a female and continues to clasp her for up to two weeks prior to copulation. Although these copepods form a mate-guarding pair between a male and a female with high accuracy, interactions between the sexes in pair formation have not been well described and the mechanism allowing successful male-female pair formation is not yet understood. In this study, we performed experiments with Tigriopus californicus to analyze the behavior of both a capturer (male) and a captured individual (female or male) in formation of a guarding pair. While capturer males were attracted by both females and males, capture of virgin males was terminated in a significantly shorter time than that of virgin females. However, when presented freshly killed females or males, regardless of the sex of the body, capturer males continued to clasp the body for a comparable time as in an attempt on a living female. Our results suggest that a sex-specific rejection signal actively sent by captured males prevents male-male pair formation. Experiments also suggest that mated females reject an attempt of pair formation. To our knowledge, this is the first study to suggest involvement of active rejection by a captured individual in facilitation of reproductively successful malefemale guarding pair formation in the genus Tigriopus.	[Tsuboko-Ishii, Satomi; Burton, Ronald S.] Univ Calif San Diego, Scripps Inst Oceanog, Marine Biol Res Div, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Tsuboko-Ishii, S (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Marine Biol Res Div, La Jolla, CA 92093 USA.	tsuboko.medaka@gmail.com	Burton, R/F-7694-2010; Tsuboko-Ishii, Satomi/J-2713-2019	Burton, R/0000-0002-6995-5329; Tsuboko-Ishii, Satomi/0000-0003-4374-6200	Sumitomo Foundation, Japan [150932]	Sumitomo Foundation, Japan	This work is supported by Grant for Basic Science Research Projects from the Sumitomo Foundation, Japan (to STI and RB, 150932, http:// www.sumitomo.or.jp/e/index.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by Grant for Basic Science Research Projects from the Sumitomo Foundation, Japan. We thank Ms. Kiana Michelle Woodward for assistance with maintenance of the animals.	Alexander HJ, 2015, J EVOLUTION BIOL, V28, P2196, DOI 10.1111/jeb.12743; Alexander HJ, 2014, J EVOLUTION BIOL, V27, P1921, DOI 10.1111/jeb.12449; Andrew DR, 2012, J COMP NEUROL, V520, P3446, DOI 10.1002/cne.23099; Ar-Rushdi AH, 1958, 10 INT C GEN MCGILL; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; BURTON RS, 1985, MAR BIOL, V86, P247, DOI 10.1007/BF00397511; Buss David M, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P23; Coxworth JE, 2015, P NATL ACAD SCI USA, V112, P11806, DOI 10.1073/pnas.1599993112; Edward DA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a017707; Egami N., 1951, Annotationes Zoologicae Japonenses, V24, P131; Egloff DA, 1966, TIGRIOPUS CALIFORNIC; Fraser J. H., 1936, Journal of the Marine Biological Association Plymouth, V20, P523; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; GRAFEN A, 1983, J THEOR BIOL, V102, P549, DOI 10.1016/0022-5193(83)90390-9; HAGIWARA A, 1995, FISHERIES SCI, V61, P618, DOI 10.2331/fishsci.61.618; Hockham LR, 1997, J INSECT BEHAV, V10, P247, DOI 10.1007/BF02765557; Ito T., 1988, ANN REPORT SETO MARI, V2, P28; Jormalainen V, 1998, Q REV BIOL, V73, P275, DOI 10.1086/420306; Kelly LS, 1998, PHILOS T R SOC B, V353, P737, DOI 10.1098/rstb.1998.0239; LAZZARETTO I, 1990, CRUSTACEANA, V59, P171, DOI 10.1163/156854090X00642; LAZZARETTO I, 1994, HYDROBIOLOGIA, V293, P229; Obara Y, 2011, NATURWISSENSCHAFTEN, V98, P989, DOI 10.1007/s00114-011-0847-3; PARKER GA, 1974, BEHAVIOUR, V48, P157, DOI 10.1163/156853974X00327; Peterson DL, 2013, J BIOGEOGR, V40, P1664, DOI 10.1111/jbi.12107; Raisuddin S, 2007, AQUAT TOXICOL, V83, P161, DOI 10.1016/j.aquatox.2007.04.005; Rondeau A, 2001, BIOL BULL-US, V201, P204, DOI 10.2307/1543335; Setchell JM, 2005, ANIM BEHAV, V70, P1105, DOI 10.1016/j.anbehav.2005.02.021; VACQUIER VD, 1965, SCIENCE, V150, P1619, DOI 10.1126/science.150.3703.1619; Vittor BA, 1971, TIGRIOPUS CALIFORNIC; Voordouw MJ, 2002, BIOL J LINN SOC, V76, P511, DOI 10.1046/j.1095-8312.2002.00087.x; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Yokoi S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005009	33	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183758	10.1371/journal.pone.0183758	http://dx.doi.org/10.1371/journal.pone.0183758			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832683	Green Published, gold			2022-12-26	WOS:000408355800098
J	Hlushchuk, R; Styp-Rekowska, B; Dzambazi, J; Wnuk, M; Huynh-Do, U; Makanya, A; Djonov, V				Hlushchuk, Ruslan; Styp-Rekowska, Beata; Dzambazi, Jehona; Wnuk, Monika; Huynh-Do, Uyen; Makanya, Andrew; Djonov, Valentin			Endoglin inhibition leads to intussusceptive angiogenesis via activation of factors related to COUP-TFII signaling pathway	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROSTATE-CANCER; CROSS-TALK; NOTCH; RECOVERY; CELLS; PTK787/ZK222584; RECRUITMENT; EXPRESSION; PROMOTER	Angiogenesis is a highly coordinated, extremely complex process orchestrated by multiple signaling molecules and blood flow conditions. While sprouting mode of angiogenesis is very well investigated, the molecular mechanisms underlying intussusception, the second mode of angiogenesis, remain largely unclear. In the current study two molecules involved in vascular growth and differentiation, namely endoglin (ENG/CD105) and chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) were examined to unravel their specific roles in angiogenesis. Down-respectively up-regulation of both molecules tightly correlates with intussusceptive microvascular growth. Upon ENG inhibition in chicken embryo model, formation of irregular capillary meshwork accompanied by increased expression of COUP-TFII could be observed. This dynamic expression pattern of ENG and COUP-TFII during vascular development and remodeling correlated with formation of pillars and progression of intussusceptive angiogenesis. Similar findings could be observed in mammalian model of acute rat Thy1.1 glomerulonephritis, which was induced by intravenous injection of anti-Thy1 antibody and has shown upregulation of COUP-TFII in initial phase of intussusception, while ENG expression was not disturbed compared to the controls but decreased over the time of pillar formation. In this study, we have shown that ENG inhibition and at the same time up-regulation of COUP-TFII expression promotes intussusceptive angiogenesis.	[Hlushchuk, Ruslan; Styp-Rekowska, Beata; Dzambazi, Jehona; Wnuk, Monika; Makanya, Andrew; Djonov, Valentin] Univ Bern, Inst Anat, Bern, Switzerland; [Huynh-Do, Uyen] Inselspital Bern, Dept Hypertens & Nephrol, Bern, Switzerland; [Makanya, Andrew] Univ Nairobi, Dept Vet Anat & Physiol, Nairobi, Kenya	University of Bern; University of Bern; University Hospital of Bern; University of Nairobi	Djonov, V (corresponding author), Univ Bern, Inst Anat, Bern, Switzerland.	valentin.djonov@ana.unibe.ch	Makanya, Andrew N/F-4180-2012; Hlushchuk, Ruslan/AAE-7872-2022	Makanya, Andrew N/0000-0002-9983-785X; Hlushchuk, Ruslan/0000-0002-6722-8996; Djonov, Valentin/0000-0002-5062-1169	Swiss National Foundation [31003A_135740]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	The present study was financially supported by the Swiss National Foundation (Grant Nr: 31003A_135740 to VD and RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Burri PH, 2002, MOL ASPECTS MED, V23, pS1; Calonge MJ, 2004, J BIOL CHEM, V279, P23759, DOI 10.1074/jbc.M402178200; Ceausu RA, 2013, IN VIVO, V27, P61; Chang ACY, 2011, DEV CELL, V21, P288, DOI 10.1016/j.devcel.2011.06.022; Choi EJ, 2012, CEREBROVASC DIS, V33, P540, DOI 10.1159/000337762; Dill MT, 2012, GASTROENTEROLOGY, V142, P967, DOI 10.1053/j.gastro.2011.12.052; Dimova DVI, 2017, PHYSL PATHOLOGIC ANG; Dimova I, 2013, ANGIOGENESIS, V16, P921, DOI 10.1007/s10456-013-9366-5; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3; Djonov V, 2000, CIRC RES, V86, P286, DOI 10.1161/01.RES.86.3.286; Sanchez-Nino MD, 2012, J PATHOL, V228, P266, DOI 10.1002/path.4101; Fonsatti Ester, 2004, J Transl Med, V2, P18, DOI 10.1186/1479-5876-2-18; Fu YX, 2009, J BIOL CHEM, V284, P19452, DOI 10.1074/jbc.M109.011833; Ghayur A, 2013, KIDNEY RES CLIN PRAC, V32, P3, DOI 10.1016/j.krcp.2013.01.003; HARRIS SE, 1994, PROSTATE, V24, P204, DOI 10.1002/pros.2990240406; Hlushchuk R, 2008, AM J PATHOL, V173, P1173, DOI 10.2353/ajpath.2008.071131; Hlushchuk R, 2011, INT J DEV BIOL, V55, P563, DOI 10.1387/ijdb.103231rh; Jonker L, 2002, MECH DEVELOP, V110, P193, DOI 10.1016/S0925-4773(01)00562-7; Korten S, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0362-0; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; Mancini ML, 2009, DEV DYNAM, V238, P2479, DOI 10.1002/dvdy.22066; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Pardali E, 2012, INT J BIOL SCI, V8, P195, DOI [10.7150/ijbs.8.195, 10.7150/ijbs.3805]; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Qin J, 2013, NATURE, V493, P236, DOI 10.1038/nature11674; Qin J, 2010, P NATL ACAD SCI USA, V107, P3687, DOI 10.1073/pnas.0914619107; Qiu Y, 1996, J STEROID BIOCHEM, V56, P81, DOI 10.1016/0960-0760(95)00225-1; Ray BN, 2010, CARCINOGENESIS, V31, P435, DOI 10.1093/carcin/bgp327; Seront E, 2012, ANN ONCOL, V23, P2663, DOI 10.1093/annonc/mds057; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Venkatesh DA, 2008, CIRC RES, V103, P423, DOI 10.1161/CIRCRESAHA.108.177808; Wnuk M, 2012, KIDNEY INT, V81, P1212, DOI 10.1038/ki.2012.17; Wnuk M, 2011, AM J PATHOL, V178, P1899, DOI 10.1016/j.ajpath.2010.12.049; Yang S, 2008, CANCER RES, V68, P198, DOI 10.1158/0008-5472.CAN-07-5074; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511	40	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0182813	10.1371/journal.pone.0182813	http://dx.doi.org/10.1371/journal.pone.0182813			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859090	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500006
J	Hung, KLJ; Ascher, JS; Holway, DA				Hung, Keng-Lou James; Ascher, John S.; Holway, David A.			Urbanization-induced habitat fragmentation erodes multiple components of temporal diversity in a Southern California native bee assemblage	PLOS ONE			English	Article							POLLINATION; TURNOVER; BIODIVERSITY; HYMENOPTERA; SHIFTS; PLANTS; BETA; COMMUNITIES; VARIABILITY; PHENOLOGY	Despite a large number of ecological studies that document diversity loss resulting from anthropogenic disturbance, surprisingly few consider how disturbance affects temporal patterns of diversity that result from seasonal turnover of species. Temporal dynamics can play an important role in the structure and function of biological assemblages. Here, we investigate the temporal diversity patterns of bee faunas in Southern California coastal sage scrub ecosystems that have been extensively fragmented by urbanization. Using a two-year dataset of 235 bee species (n = 12,036 specimens), we compared 1-ha plots in scrub fragments and scrub reserves with respect to three components of temporal diversity: overall plot-level diversity pooled over time (temporal gamma diversity), diversity at discrete points in time (temporal alpha diversity), and seasonal turnover in assemblage composition (temporal beta diversity). Compared to reserves, fragments harbored bee assemblages with lower species richness and assemblage evenness both when summed across temporal samples (i.e., lower temporal gamma diversity) and at single points in time (i.e., lower temporal alpha diversity). Bee assemblages in fragments also exhibited reduced seasonal turnover (i.e., lower temporal beta diversity). While fragments and reserves did not differ in overall bee abundance, bee abundance in fragments peaked later in the season compared to that in reserves. Our results argue for an increased awareness of temporal diversity patterns, as information about the distinct components of temporal diversity is essential both for characterizing the assemblage dynamics of seasonal organisms and for identifying potential impacts of anthropogenic disturbance on ecosystem function through its effects on assemblage dynamics.	[Hung, Keng-Lou James; Holway, David A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ascher, John S.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Hung, Keng-Lou James] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	University of California System; University of California San Diego; National University of Singapore; University System of Ohio; Ohio State University	Hung, KLJ (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.; Hung, KLJ (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA.	kenglou.hung@gmail.com	Hung, Keng-Lou James/H-6043-2019	Hung, Keng-Lou James/0000-0002-1557-3958	University of California, San Diego: Academic Senate Bridge Fund [BIO088B]; National Science Foundation: Doctoral Dissertation Improvement Grant [DEB-1501566]; National Geographic Society: Young Explorer Grant [9014-11]; University of California Natural Reserve System: Mildred E. Mathias Graduate Student Research Grant; University of California, San Diego: The Jeanne Marie Messier Memorial Endowed Fund; Sigma Xi Society [G20111015158245]	University of California, San Diego: Academic Senate Bridge Fund; National Science Foundation: Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); National Geographic Society: Young Explorer Grant(National Geographic Society); University of California Natural Reserve System: Mildred E. Mathias Graduate Student Research Grant; University of California, San Diego: The Jeanne Marie Messier Memorial Endowed Fund; Sigma Xi Society	This work was supported by the University of California, San Diego: Academic Senate Bridge Fund Grant BIO088B to DH; The National Science Foundation: Doctoral Dissertation Improvement Grant DEB-1501566 to KH and DH; The National Geographic Society: Young Explorer Grant 9014-11 to KH; The University of California Natural Reserve System: Mildred E. Mathias Graduate Student Research Grant 2013 to KH; The University of California, San Diego: The Jeanne Marie Messier Memorial Endowed Fund 2011 to KH and the Sigma Xi Society: Grant in Aid of Research G20111015158245 to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Balvanera P, 2005, ECOL APPL, V15, P360, DOI 10.1890/03-5192; Benadi G, 2014, J ANIM ECOL, V83, P639, DOI 10.1111/1365-2656.12158; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Burkle LA, 2012, ECOLOGY, V93, P2329, DOI 10.1890/12-0367.1; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; Cane JH, 2001, CONSERV ECOL, V5; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Crooks KR, 2004, BIOL CONSERV, V115, P451, DOI 10.1016/S0006-3207(03)00162-9; Dornelas M, 2012, P ROYAL SOC B, V280, P1; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Fortel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104679; Fox J., 2018, R COMPANION APPL REG, VThird; Fraterrigo JM, 2008, ECOL LETT, V11, P756, DOI 10.1111/j.1461-0248.2008.01191.x; Gezon ZJ, 2015, METHODS ECOL EVOL, V6, P1044, DOI 10.1111/2041-210X.12375; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hung KLJ, 2015, J INSECT CONSERV, V19, P175, DOI 10.1007/s10841-015-9763-8; Hurd P. D. Jr., 1979, Catalog of Hymenoptera in America north of Mexico. Volume 2. Apocrita (Aculeata)., P1741; Kehinde T, 2014, AGR FOREST ENTOMOL, V16, P95, DOI 10.1111/afe.12038; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Korhonen JJ, 2010, ECOLOGY, V91, P508, DOI 10.1890/09-0392.1; Laakkonen J, 2001, J ANIM ECOL, V70, P776, DOI 10.1046/j.0021-8790.2001.00542.x; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Magurran AE, 2010, PHILOS T R SOC B, V365, P3611, DOI 10.1098/rstb.2010.0285; Marini L, 2014, ECOGRAPHY, V37, P544, DOI 10.1111/j.1600-0587.2013.00369.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Michener C. D., 2000, The bees of the world; MICHENER CD, 1979, ANN MO BOT GARD, V66, P277, DOI 10.2307/2398833; Moldenke A.R., 1974, BEES CALIFORNIA CATA; Pilosof S, 2013, J ANIM ECOL, V82, P987, DOI 10.1111/1365-2656.12090; R Core Team, 2016, R FDN STAT COMP; Rafferty NE, 2015, OIKOS, V124, P14, DOI 10.1111/oik.01523; Rafferty NE, 2012, ECOLOGY, V93, P803, DOI 10.1890/11-0967.1; Rightmyer MG, 2014, ZOOTAXA, V3872, P48, DOI 10.11646/zootaxa.3872.1.4; Robbirt KM, 2014, CURR BIOL, V24, P2845, DOI 10.1016/j.cub.2014.10.033; Rollin O, 2015, BIODIVERS CONSERV, V24, P1195, DOI 10.1007/s10531-014-0852-x; Schuepp C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052109; Simanonok MP, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00323.1; Stegen JC, 2013, GLOBAL ECOL BIOGEOGR, V22, P202, DOI 10.1111/j.1466-8238.2012.00780.x; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Uchida K, 2015, J APPL ECOL, V52, P1033, DOI 10.1111/1365-2664.12443; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Westrich P., 1996, The conservation of bees., P1; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Williams NM, 2001, CONSERV ECOL, V5; Wilsey BJ, 2011, PERSPECT PLANT ECOL, V13, P265, DOI 10.1016/j.ppees.2011.07.002; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Wray JC, 2015, LANDSCAPE ECOL, V30, P261, DOI 10.1007/s10980-014-0121-0; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	61	24	25	9	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184136	10.1371/journal.pone.0184136	http://dx.doi.org/10.1371/journal.pone.0184136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854229	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600088
J	Makela, A; Witte, U; Archambault, P				Makela, Anni; Witte, Ursula; Archambault, Philippe			Benthic macroinfaunal community structure, resource utilisation and trophic relationships in two Canadian Arctic Archipelago polynyas	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; NORTHEAST WATER POLYNYA; MARGINAL ICE-ZONE; STABLE-ISOTOPE RATIOS; BEAUFORT SEA SHELF; BERING-SEA; BARENTS SEA; DEEP-SEA; DELTA-N-15 ANALYSIS; ORGANIC-MATTER	Climate change driven alterations to patterns of Arctic marine primary production, with increasing phytoplankton-and decreasing ice algal production, have the potential to change the resource utilisation and trophic structure of the benthic communities relying on the algae for food. To predict the benthic responses to dietary changes, we studied the macroinfaunal community compositions, and used the faunal delta(13) C and delta(15) N signatures to investigate their main food sources and trophic positions in North Water (NOW) and Lancaster Sound (LS) polynyas in the Canadian Arctic Archipelago. Macroinfaunal density (10 952 ind. m(-2)) and biomass (3190 mg C m(-2)) recorded in NOW were higher than previously found in the Arctic at depths >500m, and significantly higher than in LS (8355 ind. m-2 and 2110 mg C m(-2)). This was attributed to higher particulate organic matter fluxes to seafloor in NOW. Polychaetes were significant taxa at both sites in terms of density and biomass, and in addition crustacean density in NOW and bivalve density in LS were high. Facultative filter and surface deposit feeders were highly prevalent at both sites, suggesting feeding plasticity is a successful strategy for accessing different food sources. The macrofaunal delta(13) C signatures reflected the signatures of pelagic particulate organic matter at the sites, and an isotope mixing model confirmed phytoplankton as the main food source for most taxa and feeding guilds. The food web length in LS was longer than in NOW (3.2 vs. 2.8 trophic levels). This was attributed to a larger reliance on reworked organic matter by the benthic community in LS, whereas the high export fluxes at the highly productive NOW resulted in higher rates of selective consumption of fresh algal matter. Despite studies suggesting that loss of ice algae from consumer diets in the Arctic might have a negative impact on the benthos, this study suggests that Arctic macrobenthic communities thrive using phytoplankton as their main food source and should thus be able to cope or even benefit from predicted changes to patterns of primary production.	[Makela, Anni; Witte, Ursula] Univ Aberdeen, Sch Biol Sci, Oceanlab, Newburgh, Aberdeen, Scotland; [Archambault, Philippe] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ, Canada; [Archambault, Philippe] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Archambault, Philippe] Univ Laval, Dept Biol, Quebec City, PQ, Canada	University of Aberdeen; University of Quebec; Stanford University; Laval University	Makela, A (corresponding author), Univ Aberdeen, Sch Biol Sci, Oceanlab, Newburgh, Aberdeen, Scotland.	anni.makela10@gmail.com		Makela, Anni/0000-0001-6115-7747	Natural Environment Research Council [NE/J023094]; University of Aberdeen "The North" theme; Natural Environment Research Council [NE/J023094/1] Funding Source: researchfish; NERC [NE/J023094/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Aberdeen "The North" theme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by Natural Environment Research Council grant NE/J023094, http://www.nerc.ac.uk (UW); University of Aberdeen The North theme (AM); ArcticNet, http://www.arcticnet.ulaval.ca/ (PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE WG, 1995, J GEOPHYS RES-OCEANS, V100, P4411, DOI 10.1029/94JC01982; Ardyna M, 2011, MAR ECOL PROG SER, V442, P37, DOI 10.3354/meps09378; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Barber DG, 2015, PROG OCEANOGR, V139, P122, DOI 10.1016/j.pocean.2015.09.003; Belanger S, 2013, BIOGEOSCIENCES, V9, P13987; Bell LE, 2016, MAR ECOL PROG SER, V550, P1, DOI 10.3354/meps11725; Bergmann M, 2009, DEEP-SEA RES PT I, V56, P408, DOI 10.1016/j.dsr.2008.10.004; Bicknell AWJ, 2011, RAPID COMMUN MASS SP, V25, P1794, DOI 10.1002/rcm.5049; Bluhm BA, 2005, POLAR BIOL, V28, P218, DOI 10.1007/s00300-004-0675-4; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; BORSTAD GA, 1984, ARCTIC, V37, P224; Bosley KL, 1999, CAN J FISH AQUAT SCI, V56, P2181, DOI 10.1139/cjfas-56-11-2181; Brandt A, 1999, POLAR BIOL, V22, P75, DOI 10.1007/s003000050392; BRANDT A, 1995, MAR ECOL PROG SER, V121, P39, DOI 10.3354/meps121039; CADEE GC, 1984, LETHAIA, V17, P289, DOI 10.1111/j.1502-3931.1984.tb00674.x; CAREY AG, 1987, MAR ECOL PROG SER, V40, P247, DOI 10.3354/meps040247; Carroll ML, 2012, POLAR BIOL, V35, P1259, DOI 10.1007/s00300-012-1171-x; Challenges H., 2012, POLAR BIOL, V35, P447; Clough LM, 2005, CAN J FISH AQUAT SCI, V62, P1756, DOI 10.1139/F05-102; Clough LM, 1997, DEEP-SEA RES PT II, V44, P1683, DOI 10.1016/S0967-0645(97)00052-0; Cochrane SKJ, 2009, J SEA RES, V61, P222, DOI 10.1016/j.seares.2009.01.003; Conlan K, 2008, J MARINE SYST, V74, P864, DOI 10.1016/j.jmarsys.2007.10.002; Cooper LW, 2013, DEEP-SEA RES PT II, V94, P31, DOI 10.1016/j.dsr2.2013.03.009; Coyle KO, 2007, DEEP-SEA RES PT II, V54, P2885, DOI 10.1016/j.dsr2.2007.08.025; Degen R, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.24008; Deming JW, 2002, DEEP-SEA RES PT II, V49, P4887, DOI 10.1016/S0967-0645(02)00168-6; Demopoulos AWJ, 2007, OECOLOGIA, V153, P675, DOI 10.1007/s00442-007-0751-x; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Deubel H., 2003, P MARINE SCI, P237; DEUBEL H, 2000, BER POLARFORSCH, V370, P1; Divine LM, 2015, MAR ECOL PROG SER, V531, P15, DOI 10.3354/meps11340; Drazen JC, 2008, MAR ECOL PROG SER, V372, P157, DOI 10.3354/meps07707; Duerksen SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114070; Dunton KH, 2012, ESTUAR COAST, V35, P416, DOI 10.1007/s12237-012-9475-1; DUNTON KH, 1987, MAR BIOL, V93, P615, DOI 10.1007/BF00392799; Edwards MS, 2002, COPEIA, P1106; Falk-Petersen S, 1998, POLAR BIOL, V20, P41, DOI 10.1007/s003000050274; Fanelli E, 2010, J EXP MAR BIOL ECOL, V395, P93, DOI 10.1016/j.jembe.2010.08.020; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Feder HM, 2011, POLAR BIOL, V34, P521, DOI 10.1007/s00300-010-0906-9; Gaillard B, 2015, MAR ECOL PROG SER, V536, P175, DOI 10.3354/meps11424; Galeron J, 2000, MAR ECOL PROG SER, V197, P121, DOI 10.3354/meps197121; Gontikaki E, 2011, DEEP-SEA RES PT I, V58, P160, DOI 10.1016/j.dsr.2010.11.011; Gonzalez-Bergonzoni I, 2015, METHODS ECOL EVOL, V6, P307, DOI 10.1111/2041-210X.12313; Gradinger R, 2009, DEEP-SEA RES PT II, V56, P1201, DOI 10.1016/j.dsr2.2008.10.016; Grant J, 2002, DEEP-SEA RES PT II, V49, P5259, DOI 10.1016/S0967-0645(02)00189-3; Grebmeier J.M., 1991, Journal of Marine Systems, V2, P495, DOI 10.1016/0924-7963(91)90049-Z; Grebmeier JM, 2007, ELSEV OCEANOGR SERIE, V74, P363, DOI 10.1016/S0422-9894(06)74011-9; GREBMEIER JM, 1989, MAR ECOL PROG SER, V51, P253, DOI 10.3354/meps051253; GREBMEIER JM, 1988, MAR ECOL PROG SER, V48, P57, DOI 10.3354/meps048057; Harada N, 2016, GLOBAL PLANET CHANGE, V136, P1, DOI 10.1016/j.gloplacha.2015.11.005; Heide-Jorgensen MP, 2013, AMBIO, V42, P596, DOI 10.1007/s13280-012-0357-3; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; Hobson KA, 2002, DEEP-SEA RES PT II, V49, P5131, DOI 10.1016/S0967-0645(02)00182-0; Hobson KA, 1995, MAR ECOL PROG SER, V128, P1, DOI 10.3354/meps128001; Hudson IR, 2004, MAR ECOL PROG SER, V281, P109, DOI 10.3354/meps281109; Iken K, 2005, POLAR BIOL, V28, P238, DOI 10.1007/s00300-004-0669-2; Iken K, 2001, PROG OCEANOGR, V50, P383, DOI 10.1016/S0079-6611(01)00062-3; Iken K, 2010, DEEP-SEA RES PT II, V57, P71, DOI 10.1016/j.dsr2.2009.08.007; Kaehler S, 2001, MAR ECOL PROG SER, V219, P299, DOI 10.3354/meps219299; Kaufman MR, 2008, OECOLOGIA, V158, P11, DOI 10.1007/s00442-008-1122-y; Kazanidis G, 2016, MAR BIOL RES, V12, P932, DOI 10.1080/17451000.2016.1216569; Kedra M, 2012, ESTUAR COAST SHELF S, V114, P183, DOI 10.1016/j.ecss.2012.08.015; Kenchington E, 2011, IDENTIFICATION MEGA; Klein B, 2002, DEEP-SEA RES PT II, V49, P4983, DOI 10.1016/S0967-0645(02)00174-1; Kroncke I, 1998, POLAR BIOL, V19, P383, DOI 10.1007/s003000050263; KRONCKE I, 1994, POLAR BIOL, V14, P519, DOI 10.1007/BF00238221; Kroncke I, 2000, MAR ECOL PROG SER, V199, P31, DOI 10.3354/meps199031; Lalande C., 2003, COMPOSITION STRUCTUR; Lalande C, 2009, CONT SHELF RES, V29, P2157, DOI 10.1016/j.csr.2009.08.009; Lau DCP, 2012, LIMNOL OCEANOGR-METH, V10, P75, DOI 10.4319/lom.2012.10.75; Layman CA, 2013, MAR BIOL RES, V9, P831; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Leu E, 2015, PROG OCEANOGR, V139, P151, DOI 10.1016/j.pocean.2015.07.012; Leu E, 2011, PROG OCEANOGR, V90, P18, DOI 10.1016/j.pocean.2011.02.004; Leu E, 2006, CAN J FISH AQUAT SCI, V63, P2760, DOI 10.1139/F06-159; Link H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074077; Link H, 2011, POLAR BIOL, V34, P2025, DOI 10.1007/s00300-011-1046-6; Lovvorn JR, 2016, MAR ECOL PROG SER, V548, P11, DOI 10.3354/meps11651; Lovvorn JR, 2005, MAR ECOL PROG SER, V291, P135, DOI 10.3354/meps291135; MacDonald IR, 2010, DEEP-SEA RES PT II, V57, P136, DOI 10.1016/j.dsr2.2009.08.012; Macdonald TA, 2012, MAR ECOL PROG SER, V445, P129, DOI 10.3354/meps09478; Mateo MA, 2008, OECOLOGIA, V157, P105, DOI 10.1007/s00442-008-1052-8; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; McMahon KW, 2006, MAR ECOL PROG SER, V310, P1, DOI 10.3354/meps310001; Michel C, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000408; Michel C, 2006, PROG OCEANOGR, V71, P379, DOI 10.1016/j.pocean.2006.09.006; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Mincks SL, 2008, DEEP-SEA RES PT II, V55, P2502, DOI 10.1016/j.dsr2.2008.06.009; NAIDU AS, 1993, CONT SHELF RES, V13, P669, DOI 10.1016/0278-4343(93)90099-J; North CA, 2014, ECOL APPL, V24, P1525, DOI 10.1890/13-0486.1; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Pabi S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004578; Parnell A. C., 2013, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PAUL AZ, 1974, MAR BIOL, V27, P251, DOI 10.1007/BF00391950; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Piepenburg D, 1997, J MARINE SYST, V10, P467, DOI 10.1016/S0924-7963(96)00050-4; PIEPENBURG D, 1995, MAR ECOL PROG SER, V118, P199, DOI 10.3354/meps118199; Piepenburg Dieter, 2011, Marine Biodiversity, V41, P51, DOI 10.1007/s12526-010-0059-7; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Renaud PE, 2007, J EXP MAR BIOL ECOL, V349, P248, DOI 10.1016/j.jembe.2007.05.021; Renaud PE, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00031; Renaud PE, 2011, MAR BIOL RES, V7, P13, DOI 10.1080/17451001003671597; Riaux-Gobin C, 1993, HDB METHODS AQUATIC, P369, DOI DOI 10.1201/9780203752746-43; Roy V, 2015, DEEP-SEA RES PT I, V102, P55, DOI 10.1016/j.dsr.2015.04.009; Roy V, 2015, ARCTIC, V68, P180, DOI 10.14430/arctic4486; Roy V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100900; Sakshaug E, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P57; Sarakinos HC, 2002, CAN J ZOOL, V80, P381, DOI 10.1139/z02-007; Schonberg SV, 2014, DEEP-SEA RES PT II, V102, P144, DOI 10.1016/j.dsr2.2013.11.004; Slagstad D, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00085; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Soltwedel T, 1998, POLAR BIOL, V19, P52; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; STEWART PL, 1985, ARCTIC, V38, P281; STIRLING I, 1980, ARCTIC, V33, P303; Stoker S. W, 1978, BENTHIC INVERTEBRATE; Sun MY, 2009, J EXP MAR BIOL ECOL, V376, P110, DOI 10.1016/j.jembe.2009.06.018; Sweetman AK, 2008, DEEP-SEA RES PT I, V55, P1503, DOI 10.1016/j.dsr.2008.06.004; Tamelander T, 2006, MAR ECOL PROG SER, V310, P33, DOI 10.3354/meps310033; Tamelander T, 2008, DEEP-SEA RES PT II, V55, P2330, DOI 10.1016/j.dsr2.2008.05.019; THOMSON DH, 1982, ARCTIC, V35, P61; Tremblay JE, 2002, DEEP-SEA RES PT II, V49, P4927, DOI 10.1016/S0967-0645(02)00171-6; Tremblay JE, 2006, PROG OCEANOGR, V71, P402, DOI 10.1016/j.pocean.2006.10.006; Tu KL, 2015, MAR ECOL PROG SER, V528, P19, DOI 10.3354/meps11216; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; WASSMANN P, 1991, POLAR RES, V10, P209, DOI 10.1111/j.1751-8369.1991.tb00647.x; Wassmann P, 2006, PROG OCEANOGR, V71, P232, DOI 10.1016/j.pocean.2006.10.003; WELCH HE, 1992, ARCTIC, V45, P343; Wlodarska Maria, 1996, Oceanologia, V38, P251; Wlodarska-Kowalczuk M, 2004, DEEP-SEA RES PT I, V51, P1903, DOI 10.1016/j.dsr.2004.07.013; WoRMS Editorial Board, 2016, WORLD REGISTER MARIN; Wurzberg L, 2011, DEEP-SEA RES PT II, V58, P153, DOI 10.1016/j.dsr2.2010.10.014; Xu J, 2011, AQUAT ECOL, V45, P483, DOI 10.1007/s10452-011-9369-5; Yokoyama H, 2005, MAR ECOL PROG SER, V296, P115, DOI 10.3354/meps296115	137	7	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183034	10.1371/journal.pone.0183034	http://dx.doi.org/10.1371/journal.pone.0183034			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850574	Green Submitted, Green Published, gold			2022-12-26	WOS:000408544200009
J	Belykh, E; Kalinin, AA; Patel, AA; Miller, EJ; Bohl, MA; Stepanov, IA; Bardonova, LA; Kerimbaev, T; Asantsev, AO; Giers, MB; Preul, MC; Byvaltsev, VA				Belykh, Evgenii; Kalinin, Andrey A.; Patel, Arpan A.; Miller, Eric J.; Bohl, Michael A.; Stepanov, Ivan A.; Bardonova, Liudmila A.; Kerimbaev, Talgat; Asantsev, Anton O.; Giers, Morgan B.; Preul, Mark C.; Byvaltsev, Vadim A.			Apparent diffusion coefficient maps in the assessment of surgical patients with lumbar spine degeneration	PLOS ONE			English	Article							INTERVERTEBRAL DISC DEGENERATION; NERVE ROOT ENTRAPMENT; MODIC CHANGES; WEIGHTED MRI; HERNIATION; DISEASE; SYMPTOMS; SYSTEM	Purpose To assess the utility of apparent diffusion coefficient (ADC) maps for the assessment of patients with advanced degenerative lumbar spine disease and describe characteristic features of ADC maps in various degenerative lumbar spinal conditions. Methods T1-weighted, T2-weighted and diffusion weighted (DWI) MR images of 100 consecutive patients admitted to the spinal surgery service were assessed. ADC maps were generated from DWI images using Osyrix software. The ADC values and characteristic ADC maps were assessed in the regions of interest over the different pathological entities of the lumbar spine. Results The study included 452 lumbar vertebral segments available for analysis of ADCs. Characteristic ADC map features were identified for protrusion, extrusion and sequester types of lumbar disk herniations, spondylolisthesis, reactive Modic endplate changes, Pfirrmann grades of IVD degeneration, and compromised spinal nerves. Compromised nerve roots had significantly higher mean ADC values than adjacent (p < 0.001), contralateral (p < 0.001) or adjacent contralateral (p < 0.001) nerve roots. Compared to the normal bone marrow, Modic I changes showed higher ADC values (p = 0.01) and Modic 2 changes showed lower ADC values (p = 0.02) respectively. ADC values correlated with the Pfirrmann grading, however differed from herniated and non-herniated disks of the matched Pfirrmann 3 and 4 grades. Conclusion Quantitative and qualitative evaluation of ADC mapping may provide additional useful information regarding the fluid dynamics of the degenerated spine and may complement standard MRI imaging protocol for the comprehensive assessment of surgical patients with lumbar spine pathology. ADC maps were advantageous in differentiating reactive bone marrow changes, and more precise assessment of the disk degeneration state. ADC mapping of compressed nerve roots showed promise but requires further investigation on a larger cohort of patients.	[Belykh, Evgenii; Kalinin, Andrey A.; Stepanov, Ivan A.; Bardonova, Liudmila A.; Asantsev, Anton O.; Byvaltsev, Vadim A.] Irkutsk Sci Ctr Surg & Traumatol, Lab Neurosurg, Irkutsk, Russia; [Belykh, Evgenii; Kalinin, Andrey A.; Stepanov, Ivan A.; Bardonova, Liudmila A.; Asantsev, Anton O.; Byvaltsev, Vadim A.] Irkutsk State Med Univ, Dept Neurosurg, Irkutsk, Russia; [Belykh, Evgenii; Patel, Arpan A.; Miller, Eric J.; Bohl, Michael A.; Giers, Morgan B.; Preul, Mark C.] St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Kerimbaev, Talgat] JSC Natl Sci Ctr Neurosurg, Dept Spinal Surg & Pathol Peripheral Nervous Syst, Astana, Kazakhstan	Irkutsk Science Centre of the Russian Academy of Sciences; Irkutsk Scientific Center of Surgery & Traumatology; Irkutsk State Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Belykh, E (corresponding author), Irkutsk Sci Ctr Surg & Traumatol, Lab Neurosurg, Irkutsk, Russia.; Belykh, E (corresponding author), Irkutsk State Med Univ, Dept Neurosurg, Irkutsk, Russia.; Belykh, E (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA.	belykhevgenii@gmail.com	Kerimbayev, Talgat/Y-2409-2018; Belykh, Evgenii/O-8279-2017; Kerimbayev, Talgat/N-7615-2019; Giers, Morgan/AAT-1536-2021; Byvaltsev, Vadim A./GPX-8832-2022; Byvaltsev, Vadim/D-1962-2018; Kalinin, Andrei A./R-7408-2016	Belykh, Evgenii/0000-0003-2060-5739; Byvaltsev, Vadim/0000-0003-4349-7101; Kalinin, Andrei A./0000-0002-6059-4344; Stepanov, Ivan/0000-0001-9039-9147; Giers, Morgan B/0000-0002-2247-1167	Russian Science Foundation [15-15-30037]; Newsome Chair in Neurosurgery Research	Russian Science Foundation(Russian Science Foundation (RSF)); Newsome Chair in Neurosurgery Research	This work was supported by Russian Science Foundation, Project 15-15-30037, WWW rsct.ru/en. Dr. Preul acknowledges support from a Newsome Chair in Neurosurgery Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors are thankful to the staff of the radiology department at the Irkutsk Railway Clinical Hospital. Dr. Preul acknowledges support from a Newsome Chair in Neurosurgery Research.	Beattie PF, 2000, SPINE, V25, P819, DOI 10.1097/00007632-200004010-00010; Belykh E, 2015, WORLD NEUROSURG, V84, P871, DOI 10.1016/j.wneu.2015.08.011; Chuanting L, 2014, ACTA RADIOL, V55, P969; Dudli S, 2016, EUR SPINE J, V25, P3723, DOI 10.1007/s00586-016-4459-7; Eguchi Y, 2016, BONE JOINT J, V98B, P387, DOI 10.1302/0301-620X.98B3.36036; Eguchi Y, 2011, SPINE, V36, pE198, DOI 10.1097/BRS.0b013e3181d5ff05; Eguchi Y, 2010, EUR SPINE J, V19, P1874, DOI 10.1007/s00586-010-1520-9; Fardon DF, 2014, SPINE, V39, pE1448, DOI 10.1097/BRS.0b013e3182a8866d; Feng ZY, 2016, SPINE, V41, pE987, DOI 10.1097/BRS.0000000000001526; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Huang YC, 2014, NAT REV RHEUMATOL, V10, P561, DOI 10.1038/nrrheum.2014.91; Kottlors M, 2010, J NEUROSURG-SPINE, V12, P314, DOI 10.3171/2009.9.SPINE09114; Koyama H, 2013, CLIN IMAG, V37, P925, DOI 10.1016/j.clinimag.2013.05.001; Messiou C, 2012, BRIT J RADIOL, V85, pE1198, DOI 10.1259/bjr/52759767; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; Niinimaki J, 2009, MAGN RESON IMAGING, V27, P641, DOI 10.1016/j.mri.2008.10.005; Patel KB, 2014, AM J NEURORADIOL, V35, P1647, DOI 10.3174/ajnr.A3948; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Reinhold M, 2015, EUR SPINE J, V24, P319, DOI 10.1007/s00586-014-3602-6; Rim Dae Cheol, 2016, Korean J Spine, V13, P1, DOI 10.14245/kjs.2016.13.1.1; Sakai T, 2014, J MED INVESTIG, V61, P197, DOI 10.2152/jmi.61.197; Sartoretti-Schefer S, 2013, CLIN IMAG, V37, P176, DOI 10.1016/j.clinimag.2012.02.022; Sucu HK, 2006, EUR SPINE J, V15, P570, DOI 10.1007/s00586-005-0971-x; Takashima H, 2013, SPINE, V38, pE998, DOI 10.1097/BRS.0b013e31829862d3; Yu HJ, 2015, EUR SPINE J, V24, P2442, DOI 10.1007/s00586-014-3721-0; Zhang W, 2014, EUR SPINE J, V23, P1830, DOI 10.1007/s00586-014-3285-z; Zhang ZP, 2012, MAGN RESON IMAGING, V30, P181, DOI 10.1016/j.mri.2011.09.021; Zhang ZW, 2009, SPINE, V34, pE245, DOI 10.1097/BRS.0b013e318197162e	29	6	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183697	10.1371/journal.pone.0183697	http://dx.doi.org/10.1371/journal.pone.0183697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846710	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600046
J	Plein, M; Morris, WK; Moir, ML; Vesk, PA				Plein, Michaela; Morris, William K.; Moir, Melinda L.; Vesk, Peter A.			Identifying species at coextinction risk when detection is imperfect: Model evaluation and case study	PLOS ONE			English	Article							PLANT; SPECIALIZATION; BIODIVERSITY; EXTINCTION; NETWORKS; CONSERVATION; POLLINATORS; COMMUNITIES; TURNOVER; ECOLOGY	Losing a species from a community can cause further extinctions, a process also known as coextinction. The risk of being extirpated with an interaction partner is commonly inferred from a species' host-breadth, derived from observing interactions between species. But observational data suffers from imperfect detection, making coextinction estimates highly unreliable. To address this issue and to account for data uncertainty, we fit a hierarchical N-mixture model to individual-level interaction data from a mutualistic network. We predict (1) with how many interaction partners each species interacts (to indicate their coextinction risk) and (2) how completely the community was sampled. We fit the model to simulated interactions to investigate how variation in sampling effort, interaction probability, and animal abundances influence model accuracy and apply it to an empirical dataset of flowering plants and their insect visitors. The model performed well in predicting the number of interaction partners for scenarios with high abundances, but indicated high parameter uncertainty for networks with many rare species. Yet, model predictions were generally closer to the true value than the observations. Our mutualistic plant-insect community most closely resembled the scenario of high interaction rates with low abundances. Median estimates of interaction partners were frequently much higher than the empirical data indicate, but uncertainty was high. Our analysis suggested that we only detected 14-59% of the flower-visiting insect species, indicating that our study design, which is common for pollinator studies, was inadequate to detect many species. Imperfect detection strongly affects the inferences from observed interaction networks and hence, host specificity, specialisation estimates and network metrics from observational data may be highly misleading for assessing a species' coextinction risks. Our study shows how models can help to estimate coextinction risk, but also indicates the need for better data (i.e., intensified sampling and individual-level observations) to reduce uncertainty.	[Plein, Michaela] Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld 4072, Australia; [Plein, Michaela; Morris, William K.; Vesk, Peter A.] Univ Melbourne, Sch BioSci, Parkville, Vic 3010, Australia; [Moir, Melinda L.] Univ Western Australia, Sch Biol Sci, Crawley, WA 6009, Australia	University of Queensland; University of Melbourne; University of Western Australia	Plein, M (corresponding author), Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld 4072, Australia.; Plein, M (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic 3010, Australia.	m.plein@uq.edu.au	Vesk, Peter/AAG-9970-2020	Vesk, Peter/0000-0003-2008-7062; Moir, Melinda/0000-0002-6765-5162; Plein, Michaela/0000-0002-7912-2486	Centre of Excellence for Environmental Decisions, Australian Research Council Australian Postgraduate Award	Centre of Excellence for Environmental Decisions, Australian Research Council Australian Postgraduate Award(Australian Research Council)	This work was supported by Centre of Excellence for Environmental Decisions, Australian Research Council Australian Postgraduate Award.	Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Barrett S, 2015, AUSTRAL ECOL, V40, P423, DOI 10.1111/aec.12199; Bartomeus I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069200; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Beckett SJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.140536; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; CaraDonna PJ, 2017, ECOL LETT, V20, P385, DOI 10.1111/ele.12740; Chacoff NP, 2012, J ANIM ECOL, V81, P190, DOI 10.1111/j.1365-2656.2011.01883.x; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Dorado J, 2011, ECOLOGY, V92, P19, DOI 10.1890/10-0794.1; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Evans R, 2003, GIANT ANDERSONIA AND; Fonseca CR, 2009, CONSERV BIOL, V23, P1507, DOI 10.1111/j.1523-1739.2009.01327.x; Fontaine C, 2009, P R SOC B, V276, P3027, DOI 10.1098/rspb.2009.0635; Frund J, 2016, OIKOS, V125, P502, DOI 10.1111/oik.02256; Gelman Andrew, 2006, DATA ANALYSIS USING; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Hastings A, 1999, AM NAT, V153, P295, DOI 10.1086/303172; Hegland SJ, 2010, BIOL CONSERV, V143, P2092, DOI 10.1016/j.biocon.2010.05.018; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Kaiser-Bunbury CN, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv076; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Moir ML, 2013, NATIONAL CLIMATE CHA; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nipperess DA, 2012, BIODIVERS CONSERV, V21, P323, DOI 10.1007/s10531-011-0185-y; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Phillimore R, 2001, THE INTERIM RECOVERY; Plein M, 2013, ECOLOGY, V94, P1296, DOI 10.1890/12-1213.1; Plummer M., 2015, RJAGS BAYESIAN GRAPH; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; R Development Core Team, 2008, A LANGUAGE AND ENVIR; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; Schleuning M, 2015, ECOGRAPHY, V38, P380, DOI 10.1111/ecog.00983; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422; Strona G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2723; Thacker JI, 2006, ORYX, V40, P233, DOI 10.1017/S0030605306000123; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; V. Optimal Foraging and Predator-Prey Dynamics, 1996, THEORETICAL POPULATI, V49, P265; Vamosi JC, 2014, ECOL EVOL, V4, P2303, DOI 10.1002/ece3.1051; Vazquez DP, 2015, ECOL LETT, V18, P385, DOI 10.1111/ele.12411; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, OIKOS, V108, P421, DOI 10.1111/j.0030-1299.2005.13619.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vesk PA, 2010, METHODS ECOL EVOL, V1, P292, DOI 10.1111/j.2041-210X.2010.00026.x; Vieira MC, 2015, ECOL LETT, V18, P144, DOI 10.1111/ele.12394; Walker JG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0095; Wells K, 2013, METHODS ECOL EVOL, V4, P1, DOI 10.1111/j.2041-210x.2012.00249.x	59	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183351	10.1371/journal.pone.0183351	http://dx.doi.org/10.1371/journal.pone.0183351			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846734	Green Published, gold			2022-12-26	WOS:000408438600027
J	Sevilhano, T; de Carvalho, RF; Oliveira, NAD; Oliveira, JE; Maltarollo, VG; Trossini, G; Garcez, R; Bartolini, P				Sevilhano, Thais; de Carvalho, Roberto Feitosa; de Jesus Oliveira, Nelio Alessandro; Oliveira, Joao Ezequiel; Maltarollo, Vinicius Goncalves; Trossini, Gustavo; Garcez, Riviane; Bartolini, Paolo			Molecular cloning and characterization of pirarucu (Arapaima gigas) follicle-stimulating hormone and luteinizing hormone beta-subunit cDNAs	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ACTIVE RECOMBINANT FSH; GLYCOPROTEIN HORMONE; ALPHA-SUBUNIT; LH-BETA; GONADOTROPIN SUBUNITS; RECEPTOR-BINDING; SEAT-BELT; SEQUENCE; FOLLITROPIN	The common gonadotrophic hormone alpha-subunit (GTH alpha) has been previously isolated by our research group from A. gigas pituitaries; in the present work the cDNA sequences encoding FSH beta and LH beta subunits have also been isolated from the same species of fish. The FSH beta-subunit consists of 126 amino acids with a putative 18 amino acid signal peptide and a 108 amino acid mature peptide, while the LH beta-subunit consists of 141 amino acids with a putative 24 amino acid amino acid signal peptide and a 117 amino acid mature peptide. The highest identity, based on the amino acid sequences, was found with the order of Anguilliformes (61%) for FSH beta and of Cypriniformes (76%) for LH beta, followed by Siluriformes, 53% for FSH beta and 75% for LH beta. Interestingly, the identity with the corresponding human amino acid sequences was still remarkable: 45.1% for FSH beta and 51.4% for LH beta. Three dimensional models of ag-FSH and ag-LH, generated by using the crystal structures of h-FSH and h-LH as the respective templates and carried out via comparative modeling and molecular dynamics simulations, suggested the presence of the so-called "seat-belt", favored by a disulfide bond formed between the 3rd and 12th cysteine in both beta-subunits. The sequences found will be used for the biotechnological synthesis of A. gigas gonadotrophic hormones (ag-FSH and ag-LH). In a first approach, to ascertain that the cloned transcripts allow the expression of the heterodimeric hormones, ag-FSH has been synthesized in human embryonic kidney 293 (HEK293) cells, preliminarily purified and characterized.	[Sevilhano, Thais; de Carvalho, Roberto Feitosa; de Jesus Oliveira, Nelio Alessandro; Oliveira, Joao Ezequiel; Bartolini, Paolo] IPEN CNEN SP, Dept Biotechnol, Cidade Univ, Sao Paulo, SP, Brazil; [Maltarollo, Vinicius Goncalves; Trossini, Gustavo] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Pharm, Sao Paulo, Brazil; [Garcez, Riviane] Univ Sao Paulo, Genet Ichthyol Lab, Biosci Inst, Sao Paulo, Brazil	Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Bartolini, P (corresponding author), IPEN CNEN SP, Dept Biotechnol, Cidade Univ, Sao Paulo, SP, Brazil.	pbartoli@ipen.br	Maltarollo, Vinicius Gonçalves/AAV-6849-2021; Trossini, Gustavo/A-5789-2013; Trossini, Gustavo/AAQ-2537-2020	Maltarollo, Vinicius Gonçalves/0000-0001-9675-5907; Trossini, Gustavo/0000-0003-3634-2531; Trossini, Gustavo/0000-0003-3634-2531; Oliveira, Joao Ezequiel/0000-0002-6937-1120	Sao Paulo State Research Financing Agency (FAPESP) [2012/10779-2]; National Research Council (CNPq - Brasilia) [2015-5/142319]	Sao Paulo State Research Financing Agency (FAPESP); National Research Council (CNPq - Brasilia)	This work was supported by the Sao Paulo State Research Financing Agency (FAPESP), Project N 2012/10779-2 and National Research Council (CNPq - Brasilia), Project N 2015-5/142319. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Sao Paulo State Research Financing Agency (FAPESP), Project N 2012/10779-2 and National Research Council (CNPq Brasilia), Project N 2015-5/142319.	Aizen J, 2007, BIOL REPROD, V76, P692, DOI 10.1095/biolreprod.106.055822; Aizen J, 2014, GEN COMP ENDOCR, V207, P28, DOI 10.1016/j.ygcen.2014.05.028; Aizen J, 2012, MOL CELL ENDOCRINOL, V364, P89, DOI 10.1016/j.mce.2012.08.013; Almeida BE, 2014, ANAL METHODS-UK, V6, P6688, DOI 10.1039/c4ay01104j; Baldwin RL, 2008, ANNU REV BIOPHYS, V37, P1, DOI 10.1146/annurev.biophys.37.032807.125948; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Boime I, 1999, RECENT PROG HORM RES, V54, P271; Borella M, 2009, FISH PHYSIOL BIOCHEM, V35, P3, DOI 10.1007/s10695-008-9254-x; Bousfield GR, 2007, MOL CELL ENDOCRINOL, V260, P40, DOI 10.1016/j.mce.2006.02.017; Butnev VY, 1998, BIOL REPROD, V58, P458, DOI 10.1095/biolreprod58.2.458; CAMPBELL RK, 1991, P NATL ACAD SCI USA, V88, P760, DOI 10.1073/pnas.88.3.760; Cao H, 2009, MOL CELL ENDOCRINOL, V303, P34, DOI 10.1016/j.mce.2009.01.015; Carvalho CM, 2009, J CHROMATOGR A, V1216, P1431, DOI 10.1016/j.chroma.2008.12.096; Castello L, 2011, REV FISH BIOL FISHER, V21, P623, DOI 10.1007/s11160-010-9197-z; Cerda J, 2008, GEN COMP ENDOCR, V156, P470, DOI 10.1016/j.ygcen.2008.02.006; Chatterjee A, 2005, GEN COMP ENDOCR, V143, P278, DOI 10.1016/j.ygcen.2005.04.004; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Choi E, 2005, FISHERIES SCI, V71, P1193, DOI 10.1111/j.1444-2906.2005.01083.x; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Chu-Koo F, 2009, FISH PHYSIOL BIOCHEM, V35, P125, DOI 10.1007/s10695-008-9211-8; COMBARNOUS Y, 1992, ENDOCR REV, V13, P670, DOI 10.1210/edrv-13-4-670; Degani G, 2003, COMP BIOCHEM PHYS B, V136, P283, DOI 10.1016/S1096-4959(03)00207-0; DIAS JA, 1994, J BIOL CHEM, V269, P25289; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan H, 2004, PROTEIN SCI, V13, P211, DOI 10.1110/ps.03381404; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Faria MT, 2013, FISH PHYSIOL BIOCHEM, V39, P683, DOI 10.1007/s10695-012-9730-1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Grossmann M, 1997, J BIOL CHEM, V272, P15532, DOI 10.1074/jbc.272.24.15532; Guzman JM, 2013, GEN COMP ENDOCR, V193, P37, DOI 10.1016/j.ygcen.2013.07.007; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han YS, 2002, FISH PHYSIOL BIOCHEM, V26, P111, DOI 10.1023/A:1025478031158; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang H, 2009, GEN COMP ENDOCR, V162, P192, DOI 10.1016/j.ygcen.2009.02.012; Hurvitz A, 2005, GEN COMP ENDOCR, V140, P61, DOI 10.1016/j.ygcen.2004.09.019; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Kamei H, 2003, GEN COMP ENDOCR, V134, P244, DOI 10.1016/S0016-6480(03)00259-4; Kasuto H, 2005, GEN COMP ENDOCR, V140, P222, DOI 10.1016/j.ygcen.2004.10.016; Kawauchi H, 2006, GEN COMP ENDOCR, V148, P3, DOI 10.1016/j.ygcen.2005.10.011; Kazeto Y, 2008, BIOL REPROD, V79, P938, DOI 10.1095/biolreprod.108.070052; Kim DJ, 2005, GEN COMP ENDOCR, V141, P282, DOI 10.1016/j.ygcen.2005.01.001; Kobayashi M, 2003, FISH PHYSIOL BIOCHEM, V28, P469, DOI 10.1023/B:FISH.0000030631.25673.a7; Kobayashi M, 1997, GEN COMP ENDOCR, V105, P372, DOI 10.1006/gcen.1996.6840; Lapthorn AJ, 1994, NATURE; LEHLE L, 1978, EUR J BIOCHEM, V83, P563, DOI 10.1111/j.1432-1033.1978.tb12124.x; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Li MD, 1998, J ENDOCRINOL, V156, P529, DOI 10.1677/joe.0.1560529; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loureiro RF, 2006, J CHROMATOGR A, V1136, P10, DOI 10.1016/j.chroma.2006.09.037; Lovell S.C., 2003, PROTEINS STRUCT FUNC, V50, P437, DOI [10.1002/prot.10286, DOI 10.1002/PROT.10286]; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martins W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/654170; Mittelholzer C, 2009, COMP BIOCHEM PHYS B, V153, P288, DOI 10.1016/j.cbpb.2009.03.011; Morgan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053785; Mylonas CC, 2010, GEN COMP ENDOCR, V165, P516, DOI 10.1016/j.ygcen.2009.03.007; Ohta K, 2008, J EXP ZOOL PART A, V309A, P534, DOI 10.1002/jez.485; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Querat B, 2000, BIOL REPROD, V63, P222, DOI 10.1095/biolreprod63.1.222; Querat B, 2001, GEN COMP ENDOCR, V124, P308, DOI 10.1006/gcen.2001.7715; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sant'Ana CD, 2008, BIOCHIMIE, V90, P500, DOI 10.1016/j.biochi.2007.10.005; Schulz RW, 2010, GEN COMP ENDOCR, V65, P490; Senthilkumaran B, 2011, FRONT BIOSCI-LANDMRK, V16, P1898, DOI 10.2741/3829; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; So WK, 2005, BIOL REPROD, V72, P1382, DOI 10.1095/biolreprod.104.038216; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STEELMAN SL, 1953, ENDOCRINOLOGY, V53, P604, DOI 10.1210/endo-53-6-604; Storring PL, 2001, J ENDOCRINOL, V171, P119, DOI 10.1677/joe.0.1710119; SUZUKI K, 1988, GEN COMP ENDOCR, V71, P292, DOI 10.1016/0016-6480(88)90257-2; Swanson P, 2003, FISH PHYSIOL BIOCHEM, V28, P53, DOI 10.1023/B:FISH.0000030476.73360.07; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ulloa-Aguirre A, 2007, ENDOCRINE, V32, P251, DOI 10.1007/s12020-008-9041-6; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; WAKO H, 1995, BBA-PROTEIN STRUCT M, V1247, P104, DOI 10.1016/0167-4838(94)00216-4; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weltzien FA, 2003, GEN COMP ENDOCR, V131, P87, DOI 10.1016/S0016-6480(02)00606-8; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Xing YN, 2004, J BIOL CHEM, V279, P35449, DOI 10.1074/jbc.M403054200; Yoshiura Y, 1997, GEN COMP ENDOCR, V105, P379, DOI 10.1006/gcen.1996.6839; Yu XB, 2010, FISH PHYSIOL BIOCHEM, V36, P273, DOI 10.1007/s10695-008-9244-z; Zaqueo KD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/595186; Zmora N, 2007, J ENDOCRINOL, V194, P407, DOI 10.1677/JOE-07-0171	87	6	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183545	10.1371/journal.pone.0183545	http://dx.doi.org/10.1371/journal.pone.0183545			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846736	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600034
J	Pati, S; Schellevis, FG				Pati, Sandipana; Schellevis, F. G.			Prevalence and pattern of co morbidity among type2 diabetics attending urban primary healthcare centers at Bhubaneswar (India)	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; MELLITUS; MULTIMORBIDITY; COMORBIDITY; IMPACT; EPIDEMIOLOGY; HYPERTENSION; POPULATION; DEPRESSION; DISEASE	Objective India has the second largest diabetic population in the world. The chronic nature of the disease and high prevalence of co-existing chronic medical conditions or "co morbidities" makes diabetes management complex for the patient and for health care providers. Hence a strong need was felt to explore the problem of co morbidity among diabetics and its dimensions in primary health care practices. Method This cross sectional survey was carried out on 912 type 2 diabetes patients attending different urban primary health care facilities at Bhubaneswar. Data regarding existence of co morbidity and demographical details were elicited by a predesigned, pretested questionnaire "Diabetes Co morbidity Evaluation Tool in Primary Care (DCET-PC)". Statistical analyses were done using STATA. Results Overall 84% had one ormore than one comorbid condition. The most frequent co morbid conditions were hypertension [62%], acid peptic disease [28%], chronic back ache [22%] and osteoarthritis [21%]. The median number of co morbid conditions among both males and females is 2[IQR = 2]. The range of the number of co morbid conditions was wider among males [0 - 14] than females [0 - 6]. The number of co morbidities was highest in the age group > = 60 across both sexes. Most of the male patients below 40 years of age had either single [53%] or three co morbidities [11%] whereas among female patients of the same age group single [40%] or two co morbidities [22%] were more predominantly present. Age was found to be a strong independent predictor for diabetes co morbidity. The odds of having co morbidity among people above poverty line and schedule caste were found to be [OR = 3.50; 95% CI 1.85 - 6.62] and [OR = 2.46; CI 95% 1.16 - 5.25] respectively. Odds were increased for retired status [OR = 1.21; 95% CI 1.01 - 3.91] and obesity [OR = 3.96; 95% CI 1.01 - 15.76]. Conclusion The results show a high prevalence of co morbidities in patients with type 2 diabetes attending urban primary health care facilities. Hypertension, acid peptic disease, chronic back ache and arthritis being the most common, strategies need to be designed taking into account the multiple demands of co morbidities.	[Pati, Sandipana] Govt Odisha, Dept Hlth & Family Welf, Bhubaneswar, Orissa, India; [Schellevis, F. G.] NIVEL Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Schellevis, F. G.] Vrije Univ Amsterdam, Dept Gen Practice & Elderly Care Med, Amsterdam Publ Hlth Res Inst, Med Ctr, Amsterdam, Netherlands	Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam	Pati, S (corresponding author), Govt Odisha, Dept Hlth & Family Welf, Bhubaneswar, Orissa, India.	sandipana.pati@gmail.com						Agrawal S, 2012, PUBLIC HEALTH NUTR, V15, P1065, DOI 10.1017/S1368980011002813; Alaba O, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-63; Amaducci L, 1997, INT J EPIDEMIOL, V26, P995; Ashton CM, 2003, AM J MANAG CARE, V9, P145; Bai P V, 1999, J Assoc Physicians India, V47, P1060; Banjare P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097832; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bhojani U, 2013, CONSTRAINTS FACED UR, P6; Bhojani U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106522; Bratzke LC, 2015, INT J NURS STUD, V52, P744, DOI 10.1016/j.ijnurstu.2014.10.010; Bytzer P, 2001, ARCH INTERN MED, V161, P1989, DOI 10.1001/archinte.161.16.1989; Cheraghi-Sohi S, 2013, SAGE OPEN MED, V1, DOI 10.1177/2050312113503955; Druss Benjamin G., 2001, COMP NATL EC BURDEN, V20, P233; Du Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-166; Ganguly S, 2013, J ADOLESCENT HEALTH, V52, P546, DOI 10.1016/j.jadohealth.2012.09.012; Gross R, 1996, Public Health Rev, V24, P167; Guruprasad K G, 2012, Indian J Psychol Med, V34, P30, DOI 10.4103/0253-7176.96153; Huber CA, 2014, DIABET METAB SYND OB, V7, P455, DOI 10.2147/DMSO.S69520; Jacob B, 2015, ACAD MED J INDIA, V3, P8; Jacob R, 2014, AM J HEALTH BEHAV, V38, P297, DOI 10.5993/AJHB.38.2.15; Joshi SR, 2012, DIABETES TECHNOL THE, V14, P8, DOI 10.1089/dia.2011.0243; Joshi Shashank R, 2008, J Assoc Physicians India, V56, P443; Kerr EA, 2007, J GEN INTERN MED, V22, P1635, DOI 10.1007/s11606-007-0313-2; Khanam MA, 2011, J HEALTH POPUL NUTR, V29, P406, DOI 10.3329/jhpn.v29i4.8458; Krein SL, 2005, DIABETES CARE, V28, P65, DOI 10.2337/diacare.28.1.65; Lin PJ, 2015, AM J MANAG CARE, V21, pE23; Liu ZL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-62; Lkhagva D, 2012, J DIABETES COMPLICAT, V26, P129, DOI 10.1016/j.jdiacomp.2011.12.004; Luijks H, 2012, MULTIMORBIDITY, V10, P19; Patel M, 2011, ELECT PHYS, P3; Pati S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6582487; Pati S, 2015, ANN FAM MED, V13, P446, DOI 10.1370/afm.1843; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Poongothai S, 2010, DIABETES TECHNOL THE, V12, P989, DOI 10.1089/dia.2010.0081; Promberger R, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-132; Ramachandran A, 1999, J Assoc Physicians India, V47, P1152; Rema M, 2000, BRIT J OPHTHALMOL, V84, P1058, DOI 10.1136/bjo.84.9.1058; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schoenberg NE, 2009, J HEALTH CARE POOR U, V20, P134, DOI 10.1353/hpu.0.0115; Siddiqui S, 2014, POSTGRADUATE MED J; Singh RB, 1998, INT J CARDIOL, V66, P65, DOI 10.1016/S0167-5273(98)00141-7; Struijs JN, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-84; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Unwin N, 2012, IDF DIAB ATL 2012 UP; Vijayakumar G, 2009, J Assoc Physicians India, V57, P563; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yadav Dhananjay, 2014, Osong Public Health Res Perspect, V5, P169, DOI 10.1016/j.phrp.2014.04.009; Yadav N, ASS SOZIODEMOGRAPHIC	48	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0181661	10.1371/journal.pone.0181661	http://dx.doi.org/10.1371/journal.pone.0181661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841665	gold, Green Published, Green Submitted			2022-12-26	WOS:000408370700003
J	Pepin, KM; Davis, AJ; Cunningham, FL; VerCauteren, KC; Eckery, DC				Pepin, Kim M.; Davis, Amy J.; Cunningham, Fred L.; VerCauteren, Kurt C.; Eckery, Doug C.			Potential effects of incorporating fertility control into typical culling regimes in wild pig populations	PLOS ONE			English	Article							PREDATOR-PREY THEORY; BOAR SUS-SCROFA; FERAL PIGS; SOUTHERN TEXAS; NATIONAL-PARK; BRUSHTAIL POSSUMS; DYNAMICS; REPRODUCTION; ERADICATION; HELICOPTER	Effective management of widespread invasive species such as wild pigs (Sus scrofa) is limited by resources available to devote to the effort. Better insight of the effectiveness of different management strategies on population dynamics is important for guiding decisions of resource allocation over space and time. Using a dynamic population model, we quantified effects of culling intensities and time between culling events on population dynamics of wild pigs in the USA using empirical culling patterns and data-based demographic parameters. In simulated populations closed to immigration, substantial population declines (50-100%) occurred within 4 years when 20-60% of the population was culled annually, but when immigration from surrounding areas occurred, there was a maximum of 50% reduction, even with the maximum culling intensity of 60%. Incorporating hypothetical levels of fertility control with realistic culling intensities was most effective in reducing populations when they were closed to immigration and when intrinsic population growth rate was too high (> = 1.78) to be controlled by culling alone. However, substantial benefits from fertility control used in conjunction with culling may only occur over a narrow range of net population growth rates (i.e., where net is the result of intrinsic growth rates and culling) that varies depending on intrinsic population growth rate. The management implications are that the decision to use fertility control in conjunction with culling should rely on concurrent consideration of achievable culling intensity, underlying demographic parameters, and costs of culling and fertility control. The addition of fertility control reduced abundance substantially more than culling alone, however the effects of fertility control were weaker than in populations without immigration. Because these populations were not being reduced substantially by culling alone, fertility control could be an especially helpful enhancement to culling for reducing abundance to target levels in areas where immigration can't be prevented.	[Pepin, Kim M.; Davis, Amy J.; VerCauteren, Kurt C.; Eckery, Doug C.] USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80524 USA; [Cunningham, Fred L.] USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr, Mississippi State, MS 80720 USA	United States Department of Agriculture (USDA); Mississippi State University; United States Department of Agriculture (USDA)	Pepin, KM (corresponding author), USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80524 USA.	kim.m.pepin@aphis.usda.gov	Davis, Amy/ABE-2065-2021					[Anonymous], HCSU004 U HAW HIL; [Anonymous], 1996, MANAGING VERTEBRATE; Artois M, 1997, REPROD FERT DEVELOP, V9, P17, DOI 10.1071/R96090; BABER DW, 1986, J MAMMAL, V67, P512, DOI 10.2307/1381283; Baber DW, 1977, SOCIAL ORG BEHAV FER; Barlow ND, 2000, J APPL ECOL, V37, P897, DOI 10.1046/j.1365-2664.2000.00591.x; Barlow ND, 1997, WILDLIFE RES, P24; Barlow ND, 1994, J APPL ECOL, V31; BARRETT RH, 1978, HILGARDIA, V46, P283, DOI 10.3733/hilg.v46n09p283; Barrett RH, 1971, ECOLOGY FERAL HOG TE; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Belden Robert C., 1990, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V44, P231; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; Burton JL, 2013, US ARMY CORPS ENG ER, P1; Campbell TA, 2009, FOREST ECOL MANAG, V257, P2319, DOI 10.1016/j.foreco.2009.03.036; CAUGHLEY G, 1992, WILDLIFE RES, V19, P623, DOI 10.1071/WR9920623; CHOQUENOT D, 1993, WILDLIFE RES, V20, P15, DOI 10.1071/WR9930015; Choquenot D, 1999, WILDLIFE RES, V26, P251, DOI 10.1071/WR98006; Courchamp F, 2000, J APPL ECOL, V37, P903, DOI 10.1046/j.1365-2664.2000.00545.x; Cowled BD, 2006, J WILDLIFE MANAGE, V70, P1690, DOI 10.2193/0022-541X(2006)70[1690:MTDAGE]2.0.CO;2; Crouch LC, 1983, MOVEMENTS HABITAT UT; Cruz F, 2005, BIOL CONSERV, V121, P473, DOI 10.1016/j.biocon.2004.05.018; Delgado-Acevedo J, 2013, INT J PEST MANAGE, V59, P122, DOI 10.1080/09670874.2013.776723; Dexter N, 1996, WILDLIFE RES, V23, P435, DOI 10.1071/WR9960435; Dexter N, 2015, ECOL EVOL, V5, P2036, DOI 10.1002/ece3.1489; Diong CH, 1982, KIPAHULA VALLEY; Ditchkoff SS, 2012, J WILDLIFE MANAGE, V76, P1235, DOI 10.1002/jwmg.356; Duncan RW, 1974, REPROD BIOL EUROPEAN; Gabor TM, 1999, J ZOOL, V247, P311, DOI 10.1111/j.1469-7998.1999.tb00994.x; Garcelon DK, 2005, P 6 CAL ISL S 2003 D; Gee RW, 2002, AUST VET J, V80, P96, DOI 10.1111/j.1751-0813.2002.tb12850.x; Gentle M, 2013, WILDLIFE RES, V40, P459, DOI 10.1071/WR13100; Gese EM, 2015, BIOL CONSERV, V192, P11, DOI 10.1016/j.biocon.2015.09.003; Gonyou HW, 2001, SOCIAL BEHAV FARM AN; Gunduz A, 2007, WILD ENVIRON MED, V18, P117, DOI 10.1580/06-WEME-CR-033R1.1; Hanson LB, 2009, WILDLIFE RES, V36, P185, DOI 10.1071/WR08077; Hanson LB, 2006, DEMOGRAPHY FERAL PIG; HENRY VG, 1968, J WILDLIFE MANAGE, V32, P406, DOI 10.2307/3798986; Henry VG, 1978, P ANN C SE ASS FISH, V32, P406; HONE J, 1990, AUST WILDLIFE RES, V17, P123, DOI 10.1071/WR9900123; HONE J, 1992, J APPL ECOL, V29, P695, DOI 10.2307/2404478; Hone J, 2002, BIOL CONSERV, V105, P231, DOI 10.1016/S0006-3207(01)00185-9; Hughes TW, 1985, HOME RANGE HABITAT U; ILSE LM, 1995, J MAMMAL, V76, P993, DOI 10.2307/1382593; Ji WH, 2000, J APPL ECOL, V37, P926, DOI 10.1046/j.1365-2664.2000.00546.x; Johnson K.G., 1982, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V36, P552; Kaminski G, 2005, CAN J ZOOL, V83, P474, DOI 10.1139/Z05-019; KATAHIRA LK, 1993, WILDLIFE SOC B, V21, P269; Kay SL, 2017, MOV ECOL, V5, DOI 10.1186/s40462-017-0105-1; Keuling O, 2010, EUR J WILDLIFE RES, V56, P159, DOI 10.1007/s10344-009-0296-x; Klinger R., 2011, Occasional Papers of the IUCN Species Survival Commission, V42, P78; Lombardo CA, 2000, P 5 CAL ISL S APR WA; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; Mayer JJ, 2009, ENERGY DO; Mccann BE, 2008, J WILDLIFE MANAGE, V72, P1287, DOI 10.2193/2007-164; McLeod SR, 2014, ECOL MODEL, V273, P1, DOI 10.1016/j.ecolmodel.2013.10.016; McMahon CR, 2010, METHODS ECOL EVOL, V1, P53, DOI 10.1111/j.2041-210X.2009.00002.x; Mellish JM, 2014, SOUTHEAST NAT, V13, P367, DOI 10.1656/058.013.0217; Merrill JA, 2006, J WILDLIFE MANAGE, V70, P268, DOI 10.2193/0022-541X(2006)70[268:MAODPB]2.0.CO;2; Miller LA, 2013, J ZOO WILDLIFE MED, V44, pS84, DOI 10.1638/1042-7260-44.4S.S84; Morrison SA, 2007, FRONT ECOL ENVIRON, V5, P271, DOI 10.1890/1540-9295(2007)5[271:FTDAEE]2.0.CO;2; Otto SP, 2007, BIOL GUIDE MATH MODE; Parkes JP, 2010, BIOL CONSERV, V143, P634, DOI 10.1016/j.biocon.2009.11.028; Peine JD, 1990, WILD HOG MANAGEMENT; Ramsey D, 2005, J APPL ECOL, V42, P348, DOI 10.1111/j.1365-2664.2005.01006.x; Rushton SP, 2006, J WILDLIFE MANAGE, V70, P1102, DOI 10.2193/0022-541X(2006)70[1102:EOCFPA]2.0.CO;2; Salinas RA, 2015, NAT RESOUR MODEL, V28, P18, DOI 10.1111/nrm.12055; SAUNDERS G, 1988, AUST WILDLIFE RES, V15, P73, DOI 10.1071/WR9880073; Sims R, W70001135 PWD RP; Smith TN, 2014, WILDLIFE SOC B, V38, P175, DOI 10.1002/wsb.376; Snow NP, 2017, J APPL ECOL IN PRESS; Sparklin BD, 2009, J WILDLIFE MANAGE, V73, P497, DOI 10.2193/2007-585; Steen D., 2006, P 22 VET PEST C, P361; Taylor RB, 1998, J MAMMAL, V79, P1325, DOI 10.2307/1383024; Timmons J., 2012, FERAL HOG POPULATION; West Ben C., 2009, P1; Williams BL, 2011, J WILDLIFE MANAGE, V75, P432, DOI 10.1002/jwmg.64; Wood GW, 1977, RES MANAGEMENT WILD, P23; Yoak AJ, 2016, ECOL MODEL, V341, P53, DOI 10.1016/j.ecolmodel.2016.09.018	79	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183441	10.1371/journal.pone.0183441	http://dx.doi.org/10.1371/journal.pone.0183441			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837610	Green Submitted, Green Published, gold			2022-12-26	WOS:000408365000067
J	Huang, MR; Chen, RA; Ren, GC				Huang, Miaorong; Chen, Ruiai; Ren, Guangcai			Secretory expression and purification of Bacillus licheniformis keratinase in insect cells	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA KERATINASE; KERATINOLYTIC SERINE PROTEINASE; FUNCTIONAL EXPRESSION; SUBTILIS; CLONING; OPTIMIZATION; GENES	The keratinase (kerA) gene from Bacillus licheniformis PWD-1 was expressed and purified in insect cells. First, the sequence encoding Ker-His-Flag was designed based on the amino acid sequence of the protein and peptide and codon optimization in order to ensure the high expression in insect cells. In the next step, the synthetic DNA was inserted into the pUC57 vector and then sub-cloned in the pFastBac (TM)-1 donor vector by BamHI/ HindIII restriction sites. The constructed vector was transformed to E. coli wDH10Bac (TM) cell to generate recombinant bacmid carrying Ker-His-Flag. Recombinant viruses were produced by infecting insect Spodoptera frugiperda (Sf9) cells with bacmid DNA and used for proteins production. Target proteins were purified from the cell supernatants by Ni2+-NTA affinity chromatography and evaluated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDSPAGE) and western blot. The purified product contained two peptides with molecular weights of 38 kDa and 30 kDa and had an optimal pH and temperature at 8.0 and 45 degrees C for keratinolytic activity, respectively. The final product had a specific activity of about 635 U/mg. In summary, we have demonstrated that the open reading frame containing recombinant Ker-His-Flag was expressed and secreted by leader peptide of mellittin from Apis mellitera in insect cells and affinity purification through 8His-Flag tag. It presents an alternative technology for producing keratinases. To our knowledge, it was the first report on the expression of functional keratinase from Bacillus licheniformis in insect cells system.	[Huang, Miaorong; Chen, Ruiai; Ren, Guangcai] Minist Agr, Key Lab Biotechnol & Drug Mfg Anim Epidem Prevent, Zhaoqing, Peoples R China; [Chen, Ruiai] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China	Ministry of Agriculture & Rural Affairs; South China Agricultural University	Huang, MR (corresponding author), Minist Agr, Key Lab Biotechnol & Drug Mfg Anim Epidem Prevent, Zhaoqing, Peoples R China.	747526035@qq.com			Guangdong Wens Dahuanong biotechnology Co., Ltd [03-3A201309-1]	Guangdong Wens Dahuanong biotechnology Co., Ltd	Our work was financially supported by Guangdong Wens Dahuanong biotechnology Co., Ltd (No. 03-3A201309-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D., 1995, FOCUS, V17, P53; BOCKLE B, 1995, APPL ENVIRON MICROB, V61, P3705; Bressollier P, 1999, APPL ENVIRON MICROB, V65, P2570; Cai CG, 2008, J ZHEJIANG UNIV-SC B, V9, P713, DOI 10.1631/jzus.B0820128; Cao ZJ, 2012, ENVIRON SCI POLLUT R, V19, P2690, DOI 10.1007/s11356-012-0763-x; Fang Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep27953; Fang Z, 2016, MICROB BIOTECHNOL, V9, P35, DOI 10.1111/1751-7915.12300; Fang Z, 2014, PROCESS BIOCHEM, V49, P647, DOI 10.1016/j.procbio.2014.01.009; Gopinath SC, 2015, BIOMED RES INT; Guler-Gane G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155340; Hassan MA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/175012; Hemmerich J, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0604-6; Hola-Jamriska L, 2000, PROTEIN EXPRES PURIF, V19, P384, DOI 10.1006/prep.2000.1261; Hu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058393; Huang MR, 2013, TRANSGENIC RES, V22, P779, DOI 10.1007/s11248-012-9681-4; Jaouadi NZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076722; Kim Jeong-Dong, 2005, Mycobiology, V33, P121, DOI 10.4489/MYCO.2005.33.2.121; Kim Jeong-Dong, 2007, Mycobiology, V35, P219, DOI 10.4489/MYCO.2007.35.4.219; Kornillowicz-Kowalska T, 2011, WASTE MANAGE, V31, P1689, DOI 10.1016/j.wasman.2011.03.024; Krammer F, 2010, MOL BIOTECHNOL, V45, P226, DOI 10.1007/s12033-010-9268-3; Lateef A, 2015, BIOTECHNOL BIOTEC EQ, V29, P54, DOI 10.1080/13102818.2014.986360; Lin HH, 2009, J AGR FOOD CHEM, V57, P7779, DOI 10.1021/jf901903p; Lin HH, 2009, J AGR FOOD CHEM, V57, P5321, DOI 10.1021/jf900417t; Lin HH, 2009, J AGR FOOD CHEM, V57, P3506, DOI 10.1021/jf803752j; LIN XA, 1992, APPL ENVIRON MICROB, V58, P3271, DOI 10.1128/AEM.58.10.3271-3275.1992; Lo WH, 2012, J BIOSCI BIOENG, V114, P640, DOI 10.1016/j.jbiosc.2012.07.014; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Majorek KA, 2014, PROTEIN SCI, V23, P1359, DOI 10.1002/pro.2520; Prateek AB, 2010, TALANTA, V81, P1477; Qiu GF, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/746289; Radha S, 2007, J APPL MICROBIOL, V103, P1301, DOI 10.1111/j.1365-2672.2007.03372.x; Sharma R, 2010, BIOTECHNOL LETT, V32, P1863, DOI 10.1007/s10529-010-0361-2; Sletta H, 2007, APPL ENVIRON MICROB, V73, P906, DOI 10.1128/AEM.01804-06; Stepanyuk GA, 2008, PROTEIN EXPRES PURIF, V61, P142, DOI 10.1016/j.pep.2008.05.013; Zhao DX, 2016, BIOINORG CHEM APPL, V2016, DOI 10.1155/2016/8206854	35	5	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183764	10.1371/journal.pone.0183764	http://dx.doi.org/10.1371/journal.pone.0183764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832667	Green Submitted, gold, Green Published			2022-12-26	WOS:000408355800099
J	Lexomboon, D; Karlsson, P; Adolfsson, J; Ekbom, A; Naimi-Akbar, A; Bahmanyar, S; Montgomery, S; Sandborgh-Englund, G				Lexomboon, Duangjai; Karlsson, Par; Adolfsson, Jan; Ekbom, Anders; Naimi-Akbar, Aron; Bahmanyar, Shahram; Montgomery, Scott; Sandborgh-Englund, Gunilla			Consumption and direct costs of dental care for patients with head and neck cancer: A 16-year cohort study	PLOS ONE			English	Article							EPIDEMIOLOGY; RADIATION; RISK	Patients with head and neck (H&N) cancer are commonly treated with surgery and/or radiotherapy, which can increase the risk of oral infection, dental caries, and periodontal disease. The present study investigated dental care consumption and costs in patient with H&N cancer before and after the cancer diagnosis. Data from Swedish regional and national registers were used to follow up dental care utilization and dental procedure costs. The analysis included 2,754 patients who had been diagnosed with H&N cancer (exposed cohort) in Stockholm County, Sweden, during 2000-2012 and 13,036 matched persons without cancer (unexposed cohort). The exposed cohort was sub-grouped into irradiated and non-irradiated patients for analysis. The exposed cohort underwent a moderately higher number of dental procedures per year than the unexposed cohort in both the year of the cancer diagnosis and the year after cancer diagnosis; in addition, these numbers were higher in the irradiated than in the non-irradiated subgroup of the exposed cohort. Dental care consumption and costs in the exposed cohort declined over time but remained at a slightly higher level than in the unexposed cohort over the long term (more than two years). Examinations and preventive procedures accounted for most of the higher consumption in the short term (2 years) and at the longer term follow-up. Swedish national insurance subsidized costs for dental treatment, which were highest in the irradiated subgroup and lowest in the unexposed cohort. Direct costs to the patient, however, were similar among the groups. Swedish national health insurance protects patients with H&N cancer from high dental expenditures. Further studies on the cost-effectiveness of preventive dental care for patients are needed.	[Lexomboon, Duangjai; Sandborgh-Englund, Gunilla] Acad Ctr Geriatr Dent, Stockholm, Sweden; [Lexomboon, Duangjai] Karlstad Univ, Dept Hlth Sci, Karlstad, Sweden; [Karlsson, Par; Bahmanyar, Shahram] Karolinska Inst, Dept Med, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Adolfsson, Jan] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Ekbom, Anders; Montgomery, Scott] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Naimi-Akbar, Aron; Sandborgh-Englund, Gunilla] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Montgomery, Scott] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden; [Montgomery, Scott] UCL, Dept Epidemiol & Publ Hlth, London, England	Karlstad University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Orebro University; University of London; University College London	Lexomboon, D (corresponding author), Acad Ctr Geriatr Dent, Stockholm, Sweden.; Lexomboon, D (corresponding author), Karlstad Univ, Dept Hlth Sci, Karlstad, Sweden.	duangjai.lexomboon@kau.se	Montgomery, Scott/AAN-2546-2020	Montgomery, Scott/0000-0001-6328-5494; Bahmanyar, Shahram/0000-0002-9205-6540; Sandborgh Englund, Gunilla/0000-0002-7260-4706; Karlsson, Par/0000-0002-7177-1713; Adolfsson, Jan/0000-0003-2992-1869	Stockholm County council (SOF) [0F18101423]; Stockholm County Council (SOF)	Stockholm County council (SOF)(Stockholm County Council); Stockholm County Council (SOF)(Stockholm County Council)	This work was supported by Grant no 0F18101423 from the Stockholm County council (SOF) to GSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from Stockholm County Council (SOF).	Anell Anders, 2012, Health Syst Transit, V14, P1; Carson Susan J, 2016, Evid Based Dent, V17, P73, DOI 10.1038/sj.ebd.6401182; Cognetti DM, 2008, CANCER-AM CANCER SOC, V113, P1911, DOI 10.1002/cncr.23654; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Frydrych AM, 2016, AUST DENT J; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Heegaard K, 2011, J PUBLIC HEALTH DENT, V71, P318, DOI 10.1111/j.1752-7325.2011.00276.x; Hjern A, 2001, COMMUNITY DENT ORAL, V29, P167, DOI 10.1034/j.1600-0528.2001.290302.x; Jawad H, 2015, BRIT DENT J, V218, P65, DOI 10.1038/sj.bdj.2015.28; Jawad H, 2015, BRIT DENT J, V218, P69, DOI 10.1038/sj.bdj.2015.29; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1039, DOI 10.1007/s00520-010-0827-8; Joshi VK, 2010, ORAL ONCOL, V46, P475, DOI 10.1016/j.oraloncology.2010.03.010; Khan Z, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/394696; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Maasland DHE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-187; Meurman JH, 2010, ORAL ONCOL, V46, P464, DOI 10.1016/j.oraloncology.2010.02.025; Molarius A, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-134; Montero PH, 2015, SURG ONCOL CLIN N AM, V24, P491, DOI 10.1016/j.soc.2015.03.006; Pezzuto F, 2015, ONCOLOGY-BASEL, V89, P125, DOI 10.1159/000381717; Rettig EM, 2015, SURG ONCOL CLIN N AM, V24, P379, DOI 10.1016/j.soc.2015.03.001; Roosaar A, 2008, INT J CANCER, V123, P168, DOI 10.1002/ijc.23469; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P991, DOI 10.1080/00016480510043440; Swedish Association of Local Authorities and Regions (SALAR), 2015, STAT HLS OCH REG UTV; Swedish National Board of Health and Welfare, 2015, CAUS DEATH REG; Swedish Social Insurance Agency, DEMT CAR; The Dental and Pharmaceutical Benefits Agency (TLV), HDB TILL TLVFS 2010, V2010, P2; The Swedish National Board of Health and Welfare, DENT HLTH REG; The Swedish Social Insurance Administration (Fo E rsa E kringskassan), NAT DENT CAR SUBS; Vissink A, 2015, ORAL DIS, V21, pE1, DOI 10.1111/odi.12222; Zhou JC, 2013, INT J CANCER, V132, P1911, DOI 10.1002/ijc.27839	30	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182877	10.1371/journal.pone.0182877	http://dx.doi.org/10.1371/journal.pone.0182877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832673	Green Published, Green Submitted, gold			2022-12-26	WOS:000408355800038
J	Huang, Q; Voloudakis, G; Ren, YM; Yoon, Y; Zhang, E; Kajiwara, Y; Shao, ZP; Xuan, Z; Lebedev, D; Georgakopoulos, A; Robakis, NK				Huang, Qian; Voloudakis, Georgios; Ren, Yimin; Yoon, Yonejung; Zhang, Emily; Kajiwara, Yuji; Shao, Zhiping; Xuan, Zhao; Lebedev, Denis; Georgakopoulos, Anastasios; Robakis, Nikolaos K.			Presenilin1/gamma-secretase protects neurons from glucose deprivation-induced death by regulating miR-212 and PEA15	FASEB JOURNAL			English	Article						CREB; microRNA; NMDAR	POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; METABOLISM; EXPRESSION; APOPTOSIS; LIGAND; DEGENERATION; INHIBITORS; IMPAIRMENT	Reduced cerebral glucose utilization is found in aged individuals and often is an early sign of neuro-degeneration. Here, we show that under glucose deprivation (GD) conditions, decreased expression of presenilin 1(PS1) results in decreased neuronal survival, whereas increased PS1 increases neuronal survival. Inhibition of g-secretase also decreases neuronal survival under GD conditions, which suggests the PS1/gamma-secretase system protects neurons from GD-induced death. We also show that neuronal levels of the survival protein, phosphoprotein enriched in astrocytes at similar to 15 kDa (PEA15), and its mRNA are regulated by PS1/gamma-secretase. Furthermore, down-regulation of PEA15 decreases neuronal survival under reduced glucose conditions, whereas exogenous PEA15 increases neuronal survival even in the absence of PS1, which indicates that PEA15 promotes neuronal survival under GD conditions. The absence or reduction of PS1, as well asg-secretase inhibitors, increases neuronal miR-212, which targets PEA15 mRNA. PS1/gamma-secretase activates the transcription factor, cAMP response element-binding protein, regulating miR-212, which targets PEA15 mRNA. Taken together, our data show that under conditions of reduced glucose, the PS1/gamma-secretase system decreases neuronal losses by suppressing miR-212 and increasing its target survival factor, PEA15. These observations have implications for mechanisms of neuronal death under conditions of reduced glucose and may provide targets for intervention in neurodegenerative disorders.	[Huang, Qian; Voloudakis, Georgios; Ren, Yimin; Yoon, Yonejung; Zhang, Emily; Kajiwara, Yuji; Shao, Zhiping; Xuan, Zhao; Lebedev, Denis; Georgakopoulos, Anastasios; Robakis, Nikolaos K.] Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, One Gustave Levy Pl, New York, NY 10029 USA; [Huang, Qian; Voloudakis, Georgios; Ren, Yimin; Yoon, Yonejung; Zhang, Emily; Kajiwara, Yuji; Shao, Zhiping; Xuan, Zhao; Lebedev, Denis; Georgakopoulos, Anastasios; Robakis, Nikolaos K.] Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Neurosci, One Gustave Levy Pl, New York, NY 10029 USA; [Voloudakis, Georgios] Univ Crete, Sch Med, Iraklion, Crete, Greece	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Crete	Robakis, NK (corresponding author), Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, One Gustave Levy Pl, New York, NY 10029 USA.; Robakis, NK (corresponding author), Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Neurosci, One Gustave Levy Pl, New York, NY 10029 USA.	nikos.robakis@mssm.edu	Voloudakis, Georgios/B-8858-2019; Robakis, Nikolaos/AAA-1838-2021	Voloudakis, Georgios/0000-0002-5729-632X; Yoon, YoneJung/0000-0002-1608-2122; kajiwara, yuji/0000-0002-9307-8215; Xuan, Zhao/0000-0002-8254-2887; Georgakopoulos, Anastasios/0000-0001-8241-6306	U.S. National Institutes of Health (NIH) National Institute on Aging [AG17926, AG08200, AG05138]; NIH National Institute of Neurological Disorders and Stroke [NS047229]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG017926, P50AG005138, R01AG008200, RF1AG008200, R01AG017926] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health (NIH) National Institute on Aging Grants AG17926, AG08200, and AG05138; and NIH National Institute of Neurological Disorders and Stroke Grant NS047229. The authors declare no conflicts of interest.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Auffret A, 2010, J ALZHEIMERS DIS, V19, P1021, DOI 10.3233/JAD-2010-1302; Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Barthet G, 2013, NEUROBIOL AGING, V34, P499, DOI 10.1016/j.neurobiolaging.2012.02.024; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; BlumDegen D, 1995, J NEURAL TRANSM-SUPP, P139; Bruban J, 2015, FASEB J, V29, P3702, DOI 10.1096/fj.15-270645; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Costantini LC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S16; Dai C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015008; de la Torre JC, 2000, ANN NY ACAD SCI, V924, P136; DELEON MJ, 1993, AM J NEURORADIOL, V14, P897; Eckert A, 2008, ONCOGENE, V27, P1155, DOI 10.1038/sj.onc.1210732; Estelles A, 1999, DEV BIOL, V216, P16, DOI 10.1006/dbio.1999.9510; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Giannakopoulos P, 1997, AM J PATHOL, V150, P429; Goussakov I, 2010, J NEUROSCI, V30, P12128, DOI 10.1523/JNEUROSCI.2474-10.2010; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hernandez-Rapp J, 2017, PROG NEURO-PSYCHOPH, V73, P79, DOI 10.1016/j.pnpbp.2016.04.011; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; KENNEDY AM, 1995, ALZ DIS ASSOC DIS, V9, P17, DOI 10.1097/00002093-199505000-00005; KENNEDY AM, 1995, NEUROSCI LETT, V186, P17, DOI 10.1016/0304-3940(95)11270-7; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mattson MP, 2000, J NEUROSCI, V20, P1358; Mergenthaler P, 2012, P NATL ACAD SCI USA, V109, P1518, DOI 10.1073/pnas.1108225109; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ramos JW, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-134; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Scholl M, 2011, J ALZHEIMERS DIS, V24, P495, DOI 10.3233/JAD-2011-101563; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Smith GS, 2012, ARCH NEUROL-CHICAGO, V69, P1141, DOI 10.1001/archneurol.2012.590; Smith PY, 2015, HUM MOL GENET, V24, P6721, DOI 10.1093/hmg/ddv377; Song JH, 2006, J NEUROSCI, V26, P3299, DOI 10.1523/JNEUROSCI.5572-05.2006; Sonntag KC, 2010, BRAIN RES, V1338, P48, DOI 10.1016/j.brainres.2010.03.106; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Suh SW, 2003, J NEUROSCI, V23, P10681; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visser PJ, 1999, J NEUROL, V246, P477, DOI 10.1007/s004150050387; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Xu JD, 2009, J BIOL CHEM, V284, P27220, DOI 10.1074/jbc.M109.048728; Xuan Z, 2013, J BIOL CHEM, V288, P30495, DOI 10.1074/jbc.M113.499004; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	60	7	7	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					243	+		10.1096/fj.201700447RR	http://dx.doi.org/10.1096/fj.201700447RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855274	Green Published			2022-12-26	WOS:000419172700023
J	Ma, XY; Zhang, HB; Xue, X; Shah, YM				Ma, Xiaoya; Zhang, Huabing; Xue, Xiang; Shah, Yatrik M.			Hypoxia-inducible factor 2 alpha (HIF-2 alpha) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						colon cancer; Hippo pathway; hypoxia; hypoxia-inducible factor (HIF); yes-associated protein (YAP)	CELL-PROLIFERATION; HIPPO PATHWAY; SIGNALING PATHWAY; FACTOR-I; TAZ; INDUCTION; HIF-1-ALPHA; ACTIVATION; COLITIS; COMPLEX	Colorectal cancer (CRC) is the third-leading cause of cancer mortality in the United States and other industrialized countries. A hypoxic microenvironment is a hallmark for solid tumors. The hypoxia-induced signal transduction is transcriptionally mediated by hypoxia-inducible factor (HIF). Three major HIF isoforms, HIF-1, HIF-2, and HIF-3, are present in the intestine. Our previous work demonstrates that HIF-2 is essential for CRC growth and progression. However, the mechanisms mediating cell proliferation after hypoxia or HIF-2 activation in CRC are unclear. Data mining of RNA-Seq experiments with mouse models of intestinal HIF-2 or Yes-associated protein 1 (YAP1) overexpression indicates a significant overlap of genes in these conditions. YAP1 is a transcriptional co-activator in the Hippo signaling pathway, and YAP1-induced transcriptional responses are essential in cancer cell proliferation. Here, we report that HIF-2 robustly increases YAP1 expression and activity in CRC-derived cell lines and in mouse models. The potentiation of YAP1 activity by HIF-2 was not via canonical signaling mechanisms such as Src (non-receptor tyrosine kinase), PI3K, ERK, or MAPK pathways. Moreover, we detected no direct interaction of HIF-2 with YAP1. Of note, YAP1 activation was critical for cancer cell growth under hypoxia. Our findings indicate that HIF-2 increases cancer cell growth by up-regulating YAP1 activity, suggesting that this pathway might be targeted in potential anti-cancer approaches for treating CRC patients.	[Ma, Xiaoya; Zhang, Huabing; Xue, Xiang; Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shah, YM (corresponding author), 1137 Catherine St MSII R7703, Ann Arbor, MI 48109 USA.	shahy@umich.edu	Xue, Xiang/P-9071-2014	Xue, Xiang/0000-0003-4704-1814	National Institutes of Health [CA148828, DK095201]; NATIONAL CANCER INSTITUTE [R01CA148828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA148828 and DK095201 (to Y. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Cai J, 2015, GENE DEV, V29, P1493, DOI 10.1101/gad.264515.115; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chen LF, 2012, PROTEIN CELL, V3, P305, DOI 10.1007/s13238-012-2913-9; Dai XY, 2016, ONCOTARGET, V7, P6933, DOI 10.18632/oncotarget.6903; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Feng JT, 2016, ONCOTARGETS THER, V9, P5371, DOI 10.2147/OTT.S109979; Feng Y, 2013, AM J PATHOL, V183, P493, DOI 10.1016/j.ajpath.2013.04.013; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Green SL, 2001, MOL CELL BIOL, V21, P1196, DOI 10.1128/MCB.21.4.1196-1206.2001; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Imada S, 2016, MOL CELL BIOL, V36, P2811, DOI 10.1128/MCB.00311-16; Imajo M, 2015, NAT CELL BIOL, V17, P7, DOI 10.1038/ncb3084; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kim HB, 2017, GASTROENTEROLOGY, V152, P616, DOI 10.1053/j.gastro.2016.11.005; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Liao T, 2017, ONCOTARGET, V8, P11719, DOI 10.18632/oncotarget.14319; Ma XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179889; Ma XY, 2013, INT J SPORT NUTR EXE, V23, P513, DOI 10.1123/ijsnem.23.5.513; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Panciera T, 2016, CELL STEM CELL, V19, P725, DOI 10.1016/j.stem.2016.08.009; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Shah YM, 2008, GASTROENTEROLOGY, V134, P2036, DOI 10.1053/j.gastro.2008.03.009; Sostres Carlos, 2014, World J Gastrointest Pharmacol Ther, V5, P40, DOI 10.4292/wjgpt.v5.i1.40; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; WANG GL, 1993, J BIOL CHEM, V268, P21513; Xiang LS, 2015, ONCOTARGET, V6, P11768, DOI 10.18632/oncotarget.4190; Xie LW, 2014, MOL CELL BIOL, V34, P3013, DOI 10.1128/MCB.00324-14; Xue X, 2016, CELL METAB, V24, P447, DOI 10.1016/j.cmet.2016.07.015; Xue X, 2014, AM J PHYSIOL-GASTR L, V307, pG187, DOI 10.1152/ajpgi.00112.2014; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Xue X, 2013, CARCINOGENESIS, V34, P163, DOI 10.1093/carcin/bgs313; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang HB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5418; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhu CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep35489	61	35	37	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17046	17056		10.1074/jbc.M117.805655	http://dx.doi.org/10.1074/jbc.M117.805655			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28848049	Green Published, hybrid			2022-12-26	WOS:000413140600024
J	McQueen, AE; Kanamaluru, D; Yan, K; Gray, NE; Wu, L; Li, ML; Chang, A; Hasan, A; Stifler, D; Koliwad, SK; Wang, JC				McQueen, Allison E.; Kanamaluru, Deepthi; Yan, Kimberly; Gray, Nora E.; Wu, Leslie; Li, Mei-Lan; Chang, Anthony; Hasan, Adeeba; Stifler, Daniel; Koliwad, Suneil K.; Wang, Jen-Chywan			The C-terminal fibrinogen-like domain of angiopoietin-like 4 stimulates adipose tissue lipolysis and promotes energy expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVES GLUCOSE-TOLERANCE; BEIGE FAT DEVELOPMENT; INSULIN-RESISTANCE; BROWN FAT; LIPOPROTEIN-LIPASE; PROTEIN-KINASE; ANGPTL4; ADIPOCYTES; MICE; GENE	Angptl4 (Angiopoietin-like 4) is a circulating protein secreted by white and brown adipose tissues and the liver. Structurally, Angptl4 contains an N-terminal coiled-coil domain (CCD) connected to a C-terminal fibrinogen-like domain (FLD) via a cleavable linker, and both full-length Angptl4 and its individual domains circulate in the bloodstream. Angptl4 inhibits extracellular lipoprotein lipase (LPL) activity and stimulates the lipolysis of triacylglycerol stored by adipocytes in the white adipose tissue (WAT). The former activity is furnished by the CCD, but the Angptl4 domain responsible for stimulating adipocyte lipolysis is unknown. We show here that the purified FLD of Angptl4 is sufficient to stimulate lipolysis in mouse primary adipocytes and that increasing circulating FLD levels in mice through adenovirus-mediated overexpression (Ad-FLD) not only induces WAT lipolysis in vivo but also reduces diet-induced obesity without affecting LPL activity. Intriguingly, reduced adiposity in Ad-FLD mice was associated with increased oxygen consumption, fat utilization, and the expression of thermogenic genes (Ucp1 and Ppargc1a) in subcutaneous WAT. Moreover, Ad-FLD mice exhibited increased glucose tolerance. Chronically enhancing WAT lipolysis could produce ectopic steatosis because of an overflow of lipids from the WAT to peripheral tissues; however, this did not occur when Ad-FLD mice were fed a high-fat diet. Rather, these mice had reductions in both circulating triacylglycerol levels and the mRNA levels of lipogenic genes in the liver and skeletal muscle. We conclude that separating the FLD from the CCD-mediated LPL-inhibitory activity of full-length Angptl4 reveals lipolytic and thermo-genic properties with therapeutic relevance to obesity and diabetes.	[McQueen, Allison E.; Gray, Nora E.; Wang, Jen-Chywan] Univ Calif Berkeley, Metab Biol Grad Program, Berkeley, CA 94720 USA; [McQueen, Allison E.; Kanamaluru, Deepthi; Yan, Kimberly; Gray, Nora E.; Wu, Leslie; Li, Mei-Lan; Chang, Anthony; Hasan, Adeeba; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 315 Morgan Hall, Berkeley, CA 94720 USA; [Stifler, Daniel; Koliwad, Suneil K.] Univ Calif San Francisco, Diabet Ctr, Med Sci S1230A,513 Parnassus Ave, San Francisco, CA 94143 USA; [Koliwad, Suneil K.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wang, JC (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 315 Morgan Hall, Berkeley, CA 94720 USA.; Koliwad, SK (corresponding author), Univ Calif San Francisco, Diabet Ctr, Med Sci S1230A,513 Parnassus Ave, San Francisco, CA 94143 USA.	skoliwad@diabetes.ucsf.edu; walwang@berkeley.edu	Wang, Jen-Chywan/AAX-4445-2020	Wang, Jen-Chywan/0000-0001-6030-6886	National Institutes of Health [R01DK084591]; American Heart Association [15GRNT22920008]; NIDDK, National Institutes of Health [P30 DK098722-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083591, P30DK098722, R44DK084591, P30DK063720, R01DK103175, R43DK084591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01DK084591 (to J.-C.W.) and American Heart Association Grant 15GRNT22920008 (to J.-C.W.). The UCSF Nutrition and Obesity Research Center Mouse Metabolism Core is supported by NIDDK, National Institutes of Health Grant P30 DK098722-01A1. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arner P, 2014, TRENDS ENDOCRIN MET, V25, P255, DOI 10.1016/j.tem.2014.03.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Catoire M, 2014, P NATL ACAD SCI USA, V111, pE1043, DOI 10.1073/pnas.1400889111; Dempersmier J, 2015, MOL CELL, V57, P235, DOI 10.1016/j.molcel.2014.12.005; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Dickson LM, 2016, AM J PHYSIOL-REG I, V311, pR79, DOI 10.1152/ajpregu.00114.2016; Dijk W, 2015, ELIFE, V4, DOI 10.7554/eLife.08428; Dijk W, 2014, TRENDS ENDOCRIN MET, V25, P146, DOI 10.1016/j.tem.2013.12.005; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Gray NE, 2012, J BIOL CHEM, V287, P8444, DOI 10.1074/jbc.M111.294124; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Inagaki T, 2016, NAT REV MOL CELL BIO, V17, P480, DOI 10.1038/nrm.2016.62; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kim HK, 2010, DIABETES, V59, P2772, DOI 10.2337/db10-0145; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Koliwad SK, 2012, ADIPOCYTE, V1, P182, DOI 10.4161/adip.20787; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kuo TY, 2014, J LIPID RES, V55, P919, DOI 10.1194/jlr.M047860; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024; Perdiguero EG, 2016, J PATHOL, V240, P461, DOI 10.1002/path.4805; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Santulli G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00004; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Wang Y, 2016, MOL MED REP, V14, P3293, DOI 10.3892/mmr.2016.5637; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325; Zhu PC, 2012, BIOSCIENCE REP, V32, P211, DOI 10.1042/BSR20110102; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	46	33	33	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16122	16134		10.1074/jbc.M117.803973	http://dx.doi.org/10.1074/jbc.M117.803973			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28842503	Green Published, hybrid			2022-12-26	WOS:000412109400012
J	Huang, TC; Lee, PT; Wu, MH; Huang, CC; Ko, CY; Lee, YC; Lin, DY; Cheng, YW; Lee, KH				Huang, Tsui-Chin; Lee, Pin-Tse; Wu, Ming-Heng; Huang, Chi-Chen; Ko, Chiung-Yuan; Lee, Yi-Chao; Lin, Ding-Yen; Cheng, Ya-Wen; Lee, Kuen-Haur			Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells	PLOS ONE			English	Article							BREAST-CANCER; GROWTH-FACTOR; UP-REGULATION; COLON-CANCER; WNT-5A; MUTATION; PROLIFERATION; MECHANISMS; PROGNOSIS; CATENIN	The canonical Wnt/beta-catenin pathway is constitutively activated in more than 90% of colorectal cancer (CRC) cases in which beta-catenin contributes to CRC cell growth and survival. In contrast to the Wnt/beta-catenin pathway, the non-canonical Wnt pathway can antagonize functions of the canonical Wnt/beta-catenin pathway. Wnt5a is a key factor in the non-canonical Wnt pathway, and it plays diverse roles in different types of cancers. It was shown that reintroducing Wnt5a into CRC cells resulted in inhibited cell proliferation and impaired cell motility. However, contradictory results were reported describing increased Wnt5a expression being associated with a poor prognosis of CRC patients. Recently, it was shown that the diverse roles of Wnt5a are due to two distinct roles of Wnt5a isoforms. However, the exact roles and functions of the Wnt5a isoforms in CRC remain largely unclear. The present study for the first time showed the ambiguous role of Wnt5a in CRC was due to the encoding of distinct roles of the various Wnt5a mRNA isoforms. A relatively high expression level of the Wnt5a-short (S) isoform transcript and a low expression level of the Wnt5a-long (L) isoform transcript were detected in CRC cell lines and specimens. In addition, high expression levels of the Wnt5a-S mRNA isoform and low expression levels of the Wnt5a-L mRNA isoform were significantly positively correlated with tumor depth of CRC patients. Furthermore, knockdown of the endogenous expression of the Wnt5a-S mRNA isoform in HCT116 cells drastically inhibited their growth ability by inducing apoptosis through induction of FASLG expression and reduction of TNFRSF11B expression. Moreover, reactivation of methylation inactivation of the Wnt5a-L mRNA isoform by treatment with 5-azacytidine (5-Aza) enhanced the siWnt5a-S isoform's ability to induce apoptosis. Finally, we showed that the simultaneous reactivation of Wnt5a-L mRNA isoform and knockdown of Wnt5a-S mRNA isoform expression enhanced siWnt5a-S isoform-induced apoptosis and siWnt5a-L isoform-regulated suppression of beta-catenin expression in vitro. High expression levels of the Wnt5a-S mRNA isoform and low expression levels of the Wnt5a-L mRNA isoform were significantly positively correlated with high mRNA levels of beta-catenin detection in vivo. Altogether, our study showed that, for the first time, different Wnt5a mRNA isoforms play distinct roles in CRC and can be used as novel prognostic markers for CRC in the future.	[Huang, Tsui-Chin; Lin, Ding-Yen; Cheng, Ya-Wen; Lee, Kuen-Haur] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan; [Lee, Pin-Tse] NIDA, Cellular Pathobiol Sect, Intramural Res Program, Rockville, MD USA; [Wu, Ming-Heng] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Translat Med, Taipei, Taiwan; [Huang, Chi-Chen; Ko, Chiung-Yuan; Lee, Yi-Chao] Taipei Med Univ, Grad Inst Neural Regenerat Med, Coll Med Sci & Technol, Taipei, Taiwan; [Lin, Ding-Yen] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan, Taiwan; [Cheng, Ya-Wen; Lee, Kuen-Haur] Taipei Med Univ, Ctr Canc, Taipei Med Univ Hosp, Taipei, Taiwan	Taipei Medical University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Taipei Medical University; Taipei Medical University; National Cheng Kung University; Taipei Medical University; Taipei Medical University Hospital	Cheng, YW; Lee, KH (corresponding author), Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan.; Cheng, YW; Lee, KH (corresponding author), Taipei Med Univ, Ctr Canc, Taipei Med Univ Hosp, Taipei, Taiwan.	ywc@tmu.edu.tw; khlee@tmu.edu.tw		Lee, Kuen-Haur/0000-0002-6354-3315				Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Albuquerque C, 2010, GENE CHROMOSOME CANC, V49, P746, DOI 10.1002/gcc.20786; Bakker ERM, 2013, CARCINOGENESIS, V34, P2629, DOI 10.1093/carcin/bgt215; Bauer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080526; Blanc E, 2005, ONCOGENE, V24, P1277, DOI 10.1038/sj.onc.1208255; Chen TH, 2013, COLORECTAL DIS, V15, P1367, DOI 10.1111/codi.12318; Cheng RF, 2014, J CELL PHYSIOL, V229, P1908, DOI 10.1002/jcp.24566; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Hassan AB, 2005, GUT, V54, P1209, DOI 10.1136/gut.2005.070946; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; IOZZO RV, 1995, CANCER RES, V55, P3495; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Katula KS, 2012, DNA CELL BIOL, V31, P1585, DOI 10.1089/dna.2012.1698; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Kumawat K, 2016, CELL MOL LIFE SCI, V73, P567, DOI 10.1007/s00018-015-2076-y; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; Lee KH, 2011, J BIOL CHEM, V286, P39247, DOI 10.1074/jbc.M111.264598; LEJEUNE S, 1995, CLIN CANCER RES, V1, P215; Leris ACA, 2005, ANTICANCER RES, V25, P731; Mehta Sunali, 2010, Ther Adv Med Oncol, V2, P125, DOI 10.1177/1758834009360519; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Saitoh T, 2002, INT J MOL MED, V9, P515; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Xu XM, 2012, EUR J CLIN INVEST, V42, P751, DOI 10.1111/j.1365-2362.2011.02641.x; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644	29	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0181034	10.1371/journal.pone.0181034	http://dx.doi.org/10.1371/journal.pone.0181034			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859077	gold, Green Submitted, Green Published			2022-12-26	WOS:000408740500001
J	Schreiner, F; Ackermann, M; Michalik, M; Hucklenbruch-Rother, E; Bilkei-Gorzo, A; Racz, I; Bindila, L; Lutz, B; Dotsch, J; Zimmer, A; Woelfle, J				Schreiner, Felix; Ackermann, Merle; Michalik, Michael; Hucklenbruch-Rother, Eva; Bilkei-Gorzo, Andras; Racz, Ildiko; Bindila, Laura; Lutz, Beat; Doetsch, Joerg; Zimmer, Andreas; Woelfle, Joachim			Developmental programming of somatic growth, behavior and endocannabinoid metabolism by variation of early postnatal nutrition in a cross-fostering mouse model	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; CATCH-UP GROWTH; TUMOR-NECROSIS-FACTOR; ADIPOSE-TISSUE; INSULIN-RESISTANCE; CB1 RECEPTOR; CARDIOVASCULAR-DISEASE; LIPID-METABOLISM; GENE-EXPRESSION; SOCIAL-BEHAVIOR	Background Nutrient deprivation during early development has been associated with the predisposition to metabolic disorders in adulthood. Considering its interaction with metabolism, appetite and behavior, the endocannabinoid (eCB) system represents a promising target of developmental programming. Methods By cross-fostering and variation of litter size, early postnatal nutrition of CB6F1-hybrid mice was controlled during the lactation period (3, 6, or 10 pups/mother). After weaning and redistribution at P21, all pups received standard chow ad libitum. Gene expression analyses (liver, visceral fat, hypothalamus) were performed at P50, eCB concentrations were determined in liver and visceral fat. Locomotor activity and social behavior were analyzed by means of computer-assisted videotracking. Results Body growth was permanently altered, with differences for length, weight, body mass index and fat mass persisting beyond P100 (all 3>6>10, p<0.01). This was paralleled by differences in hepatic IGF-I expression (p<0.01). Distinct gene expression patterns for key enzymes of the eCB system were observed in fat (eCB-synthesis: 3>6>10 (DAGL alpha p<0.05; NAPE-PLD p = 0.05)) and liver (eCB-degradation: 3>6>10 (FAAH p<0.05; MGL p<0.01)). Concentrations of endocannabinoids AEA and 2-AG in liver and visceral fat were largely comparable, except for a borderline significance for higher AEA (liver, p = 0.049) in formerly overfed mice and, vice versa, tendencies (p<0.1) towards lower AEA (fat) and 2-AG (liver) in formerly underfed animals. In the arcuate nucleus, formerly underfed mice tended to express more eCB-receptor transcripts (CB1R p<0.05; CB2R p = 0.08) than their overfed fellows. Open-field social behavior testing revealed significant group differences, with formerly underfed mice turning out to be the most sociable animals (p<0.01). Locomotor activity did not differ. Conclusion Our data indicate a developmental plasticity of somatic growth, behavior and parameters of the eCB system, with long-lasting impact of early postnatal nutrition. Developmental programming of the eCB system in metabolically active tissues, as shown here for liver and fat, may play a role in the formation of the adult cardiometabolic risk profile following perinatal malnutrition in humans.	[Schreiner, Felix; Ackermann, Merle; Michalik, Michael; Woelfle, Joachim] Univ Bonn, Childrens Hosp, Pediat Endocrinol Div, Bonn, Germany; [Hucklenbruch-Rother, Eva; Doetsch, Joerg] Univ Cologne, Fac Med, Dept Pediat & Adolescent Med, Cologne, Germany; [Bilkei-Gorzo, Andras; Racz, Ildiko; Zimmer, Andreas] Univ Hosp Bonn, Dept Mol Psychiat, Bonn, Germany; [Bindila, Laura; Lutz, Beat] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, Mainz, Germany	University of Bonn; University of Cologne; University of Bonn; Johannes Gutenberg University of Mainz	Schreiner, F (corresponding author), Univ Bonn, Childrens Hosp, Pediat Endocrinol Div, Bonn, Germany.	felix.schreiner@ukb.uni-bonn.de	Lutz, Beat/AAG-4538-2022; Lutz, Beat/AFK-6229-2022; Bilkei-Gorzo, Andras/F-8114-2010; Racz, I./C-3074-2009; Zimmer, Andreas/B-8357-2009; Woellfe, joachim F/E-9406-2014	Racz, I./0000-0002-1549-3616; , Joachim/0000-0002-9132-6174				Al-Massadi O, 2010, J NEUROENDOCRINOL, V22, P1127, DOI 10.1111/j.1365-2826.2010.02065.x; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Brunton PJ, 2015, J NEUROENDOCRINOL, V27, P468, DOI 10.1111/jne.12265; Cable JC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-129; Cooper ME, 2014, BRIT J CLIN PHARMACO, V77, P21, DOI 10.1111/bcp.12102; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; de Angelis L, 1979, Psychopharmacology (Berl), V64, P127; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Dimitsantos E, 2007, PHYSIOL BEHAV, V92, P708, DOI 10.1016/j.physbeh.2007.05.066; El-Talatini MR, 2010, FERTIL STERIL, V93, P1989, DOI 10.1016/j.fertnstert.2008.12.033; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Engeli S, 2014, OBESITY, V22, pE70, DOI 10.1002/oby.20728; Fairless AH, 2012, BEHAV BRAIN RES, V228, P299, DOI 10.1016/j.bbr.2011.12.001; FOLTIN RW, 1987, DRUG ALCOHOL DEPEN, V20, P87, DOI 10.1016/0376-8716(87)90079-2; Gohlke BC, 2010, J CLIN ENDOCR METAB, V95, P5375, DOI 10.1210/jc.2010-0271; Gonzalez S, 2000, BIOCHEM BIOPH RES CO, V270, P260, DOI 10.1006/bbrc.2000.2406; Haller J, 2004, EUR J NEUROSCI, V19, P1906, DOI 10.1111/j.1460-9568.2004.03293.x; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Jenniches I, 2016, BIOL PSYCHIAT, V79, P858, DOI 10.1016/j.biopsych.2015.03.033; Jourdan T, 2012, HEPATOLOGY, V55, P790, DOI 10.1002/hep.24733; Kappeler L, 2009, ENDOCRINOLOGY, V150, P314, DOI 10.1210/en.2008-0981; Kelishadi R, 2015, PAEDIATR INT CHILD H, V35, P110, DOI 10.1179/2046905514Y.0000000136; Kempf K, 2007, HORM METAB RES, V39, P596, DOI 10.1055/s-2007-984459; Kim J, 2011, NUTRITION, V27, P624, DOI 10.1016/j.nut.2010.11.003; Kitsios K, 2012, J ENDOCRINOL METAB, V2, P120, DOI 10.4021/jem111w; Leger J, 1998, J CLIN ENDOCR METAB, V83, P3512, DOI 10.1210/jc.83.10.3512; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lofgren P, 2007, J CLIN ENDOCR METAB, V92, P1555, DOI 10.1210/jc.2006-2240; Lomazzo E, 2015, NEUROPSYCHOPHARMACOL, V40, P488, DOI 10.1038/npp.2014.198; Maccari S, 2014, J NEUROENDOCRINOL, V26, P707, DOI 10.1111/jne.12175; Mallat A, 2008, AM J PHYSIOL-GASTR L, V294, pG9, DOI 10.1152/ajpgi.00467.2007; Manduca A, 2015, EUR NEUROPSYCHOPHARM, V25, P1362, DOI 10.1016/j.euroneuro.2015.04.005; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Migliarini B, 2008, MOL CELL ENDOCRINOL, V286, pS12, DOI 10.1016/j.mce.2008.01.021; Miles HL, 2005, REV ENDOCR METAB DIS, V6, P261, DOI 10.1007/s11154-005-6184-0; Mukhopadhyay B, 2010, J BIOL CHEM, V285, P19002, DOI 10.1074/jbc.M109.068460; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pagano C, 2007, J CLIN ENDOCR METAB, V92, P4810, DOI 10.1210/jc.2007-0768; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Patchev AV, 2014, ACTA PHYSIOL, V210, P46, DOI 10.1111/apha.12140; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; Silvestri C, 2012, EXPERT OPIN INV DRUG, V21, P1309, DOI 10.1517/13543784.2012.704019; Stevens A, 2014, PHARMACOGENOMICS J, V14, P376, DOI 10.1038/tpj.2014.4; Swaroop JJ, 2012, INDIAN J MED RES, V135, P127, DOI 10.4103/0971-5916.93435; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Williams CM, 1999, PSYCHOPHARMACOLOGY, V143, P315, DOI 10.1007/s002130050953; Woods KA, 2002, PEDIATR RES, V51, P76, DOI 10.1203/00006450-200201000-00014	50	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0182754	10.1371/journal.pone.0182754	http://dx.doi.org/10.1371/journal.pone.0182754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859076	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500005
J	Mills, S; White, M; Wrieden, W; Brown, H; Stead, M; Adams, J				Mills, Susanna; White, Martin; Wrieden, Wendy; Brown, Heather; Stead, Martine; Adams, Jean			Home food preparation practices, experiences and perceptions: A qualitative interview study with photo-elicitation	PLOS ONE			English	Article							GLOBAL BURDEN; RISK-FACTORS; COOKING; HEALTH; HABITS; CHOICE; MEALS; INVOLVEMENT; SPILLOVER; BARRIERS	Food-related choices have an important impact on health. Food preparation methods may be linked to diet and health benefits. However, the factors influencing people's food choices, and how they are shaped by food preparation experiences, are still not fully understood. We aimed to study home food preparation practices, experiences and perceptions amongst adults in North East England. A matrix was used to purposively sample participants with diverse socio-demographic characteristics. Participants developed photographic food diaries that were used as prompts during semi-structured interviews. Data were analysed using the Framework Method. Interviews were conducted with 18 adults (five men and 13 women), aged approximately 20 to 80 years, to reach data saturation. Participants' practices varied widely, from reliance on pre-prepared foods, to preparing complex meals entirely from basic ingredients. Key themes emerged regarding the cook (identity), the task (process of cooking), and the context (situational drivers). Resources, in terms of time, money and facilities, were also underpinning influences on food preparation. Participants' practices were determined by both personal motivations to cook, and the influence of others, and generally reflected compromises between varied competing demands and challenges in life. Most people appeared to be overall content with their food preparation behaviour, though ideally aspired to cook more frequently, using basic ingredients. This often seemed to be driven by social desirability. Home food preparation is complex, with heterogeneous practices, experiences and perceptions both between individuals and within the same individual over time, according to shifting priorities and circumstances. Generalisability of these findings may be limited by the regional participant sample; however the results support and build upon previous research. Focussing interventions on life transition points at which priorities and circumstances change, with careful targeting to stimulate personal motivation and social norms, may prove effective in encouraging home food preparation.	[Mills, Susanna; White, Martin; Brown, Heather] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [White, Martin; Adams, Jean] Univ Cambridge, Ctr Diet & Act Res CEDAR, MRC, Epidemiol Unit,Sch Clin Med, Cambridge, England; [Wrieden, Wendy] Newcastle Univ, Sch Med, Inst Hlth & Soc, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Stead, Martine] Univ Stirling, Inst Social Mkt, Stirling, Scotland	Newcastle University - UK; University of Cambridge; Newcastle University - UK; University of Stirling	Mills, S (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.	susanna.mills@newcastle.ac.uk	Brown, Heather/GYU-1759-2022	Brown, Heather/0000-0002-0067-991X; Stead, Martine/0000-0002-3066-4604; White, Martin/0000-0002-1861-6757	National Institute for Health Research [DRF-2014-07-020]; Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; UKCRC Public Health Research Centre of Excellence [MR/K02325X/1]; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust, under the UKCRC; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1, MR/K02325X/1] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust, under the UKCRC(Wellcome Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This report is independent research arising from a Doctoral Research Fellowship Grant DRF-2014-07-020 for the lead author (SM), supported by the National Institute for Health Research. JA and MW received funding from the Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. HB and SM are members of Fuse, also a UKCRC Public Health Research Centre of Excellence. Grant reference number is MR/K02325X/1. Funding for CEDAR and for Fuse from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research and the Wellcome Trust, under the auspices of the UKCRC, is gratefully acknowledged. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the Department of Health, the funders or UKCRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2015, INT J BEHAV NUTR PHY, V12, P1, DOI DOI 10.1186/S12966-015-0261-X; Britten N., 1995, BMJ-BRIT MED J, V311, P251; Chu YL, 2014, J NUTR EDUC BEHAV, V46, P304, DOI 10.1016/j.jneb.2013.10.003; Clark-Ibanez M, 2004, AM BEHAV SCI, V47, P1507, DOI 10.1177/0002764204266236; Condrasky M., 2010, J EXT, V48, P1; Curry SJ, 2001, PSYCHOL ADDICT BEHAV, V15, P126, DOI 10.1037/0893-164X.15.2.126; de Onis M, 2004, JAMA-J AM MED ASSOC, V291, P2600, DOI 10.1001/jama.291.21.2600; Demark-Wahnefried W, 2005, J CLIN ONCOL, V23, P5814, DOI 10.1200/JCO.2005.01.230; Department for Communities and Local Government, 2015, ENGL IND DEPR 2015; Devine CM, 2006, SOC SCI MED, V63, P2591, DOI 10.1016/j.socscimed.2006.06.029; Devine CM, 2003, SOC SCI MED, V56, P617, DOI 10.1016/S0277-9536(02)00058-8; Engler-Stringer R, 2010, CAN J DIET PRACT RES, V71, P141, DOI 10.3148/71.3.2010.141; Engler-Stringer R, 2010, HEALTH EDUC BEHAV, V37, P211, DOI 10.1177/1090198109339453; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gatley A, 2014, APPETITE, V75, P71, DOI 10.1016/j.appet.2013.12.014; Greatist, 2014, 13 CO MAK HLTH MEALS; Gustafsson K, 2002, J ADV NURS, V39, P164, DOI 10.1046/j.1365-2648.2002.02256.x; Harper D., 2002, VISUAL STUD, V17, P13; Hughes G, 2004, APPETITE, V43, P269, DOI 10.1016/j.appet.2004.06.002; Jabs J, 2007, J NUTR EDUC BEHAV, V39, P18, DOI 10.1016/j.jneb.2006.08.011; Jenkins Jamie, 2013, WOMEN LABOUR MARKET; Jones SA, 2014, J ACAD NUTR DIET, V114, P1552, DOI 10.1016/j.jand.2014.05.003; Kemmer D, 1998, SOCIOL REV, V46, P48, DOI 10.1111/1467-954X.00089; Kusenbach M, 2003, ETHNOGRAPHY, V4, P455, DOI DOI 10.1177/146613810343007; Lavelle F, 2016, APPETITE, V107, P383, DOI 10.1016/j.appet.2016.08.115; Leech RM, 2014, APPETITE, V75, P64, DOI 10.1016/j.appet.2013.12.021; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McBride CM, 2003, HEALTH EDUC RES, V18, P156, DOI 10.1093/her/18.2.156; Michaud P., 2007, Topics in Clinical Nutrition, V22, P336; Mills S, 2017, APPETITE, V111, P116, DOI 10.1016/j.appet.2016.12.022; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; NatCen Social Research, 2015, MRC HUM NUTR RES; O'Connell R, 2013, INT J SOC RES METHOD, V16, P31, DOI 10.1080/13645579.2011.647517; Ogden J, 2008, HEALTH-LONDON, V12, P419, DOI 10.1177/1363459308094417; Oliffe JL, 2008, RES NURS HEALTH, V31, P529, DOI 10.1002/nur.20269; Pettinger C, 2006, PUBLIC HEALTH NUTR, V9, P1020, DOI 10.1017/PHN2006945; Power Elaine M., 2003, J STUDY FOOD SOC, V6, P9, DOI DOI 10.2752/152897903786769670; Reicks M, 2014, J NUTR EDUC BEHAV, V46, P259, DOI 10.1016/j.jneb.2014.02.001; Richards H, 2000, FAM PRACT, V17, P71, DOI 10.1093/fampra/17.1.71; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Sellaeg K, 2008, APPETITE, V51, P120, DOI 10.1016/j.appet.2008.01.003; SHORT F, 2003, J HEIA, V0010; Slater J, 2012, HEALTH PROMOT INT, V27, P405, DOI 10.1093/heapro/dar037; Soliah L, 2003, J FAM CONSUM SCI, V95, P68; Soliah L., 2006, COLL STUD J, V40, P729; statista, 2015, MON HLTH SDGS, P2016; Sweetman P, 2009, SOCIOL REV, V57, P491, DOI 10.1111/j.1467-954X.2009.01851.x; Szabo M, 2013, SOCIOLOGY, V47, P623, DOI 10.1177/0038038512448562; Thompson C, 2016, CRIT PUBLIC HEALTH, V26, P322, DOI 10.1080/09581596.2015.1089353; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torp JA, 2013, J OCCUP SCI, V20, P146, DOI 10.1080/14427591.2012.734426; Van Someren M.W., 1994, THINK ALOUD METHOD P; Wang MC, 2014, ECOL FOOD NUTR, V53, P658, DOI 10.1080/03670244.2014.911178; WHO, 2016, REP COMM END CHILDH; Wolfson JA, 2016, APPETITE, V97, P146, DOI 10.1016/j.appet.2015.11.030	58	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182842	10.1371/journal.pone.0182842	http://dx.doi.org/10.1371/journal.pone.0182842			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF1XX	28854196	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600019
J	Qi, L; Zhang, WJ; Cheng, ZQ; Tang, N; Ding, YQ				Qi, Lu; Zhang, Wenjuan; Cheng, Zhiqiang; Tang, Na; Ding, Yanqing			Study on molecular mechanism of ANOS1 promoting development of colorectal cancer	PLOS ONE			English	Article							KAPLAN-MEIER METHOD; PROGRESSION; EXPRESSION	Our main aim was to elucidate the molecular mechanism responsible for the development and metastasis of colorectal cancer. Furthermore, we also identified the key genes participating in this molecular mechanism and stimulating the progression of colorectal cancer. In our experiment, the ANOS1 gene showed up-regulated expression levels continuously, whereas the methylation level showed downregulated levels when the colorectal cancer progressed through the four clinical stages of development and metastasis. We obtained this information by analyzing the expression profile data and methylation data of ANOS1 gene in colorectal cancer. This phenomenon indicates that ANOS1 gene shows continuous activation during the progression of colorectal cancer. According to the results of survival analysis, the expression of ANOS1 gene is closely related to the overall survival rate of patients (p = 0.003); moreover, the expression of ANOS1 gene is also strongly associated with the disease-specific survival rate (p = 0.001). When the expression of ANOS1 gene is high, the survival rate is low in patients. When the expression of ANOS1 gene is low, the survival rate of patients is high. To elucidate the possible molecular mechanism of ANOS1, we performed GSEA enrichment analysis based on the expression value of ANOS1 gene. We found that gene with an up-regulated expression was mainly involved in Wnt signaling pathway; these up-regulated genes were present in the group of high ANOS1 expression. Although several genes were involved in Wnt signaling pathway, CTHRC1 gene was of higher occurrence frequency. By co-expression analysis, we found that both expression value and expression extent of CTHRC1 were associated with ANOS1. All these results indicate that ANOS1 possibly promotes the activation of Wnt signaling pathway with its co-expression partner CTHRC1. Thus, ANOS1 and CTHRC1 genes promote the development and metastasis of colorectal cancer.	[Qi, Lu; Zhang, Wenjuan; Ding, Yanqing] Southern Med Univ, Dept Pathol, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Cheng, Zhiqiang; Tang, Na] Shenzhen Peoples Hosp, Dept Pathol, Shenzhen, Peoples R China; [Ding, Yanqing] Southern Med Univ, Dept Pathol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Jinan University; Southern Medical University - China	Ding, YQ (corresponding author), Southern Med Univ, Dept Pathol, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China.; Ding, YQ (corresponding author), Southern Med Univ, Dept Pathol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	dyq@fimmu.com			National Key Basic Research Program of China (973 Program) [2015CB554002]; Project of the National Natural Science Foundation of China - NSFC-Guangdong Joint Fund [U1201226]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Project of the National Natural Science Foundation of China - NSFC-Guangdong Joint Fund	This work was supported by the National Key Basic Research Program of China (973 Program, 2015CB554002), Project of the National Natural Science Foundation of China supported by NSFC-Guangdong Joint Fund (U1201226).	Damian D, 2004, NAT GENET, V36, P663, DOI 10.1038/ng0704-663a; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Jager KJ, 2008, KIDNEY INT, V74, P560, DOI 10.1038/ki.2008.217; Kanda M, 2016, INT J CANCER, V138, P721, DOI 10.1002/ijc.29803; Kim HC, 2014, ONCOTARGET, V5, P519, DOI 10.18632/oncotarget.1714; Liu JN, 2015, J ORAL PATHOL MED, V44, P109, DOI 10.1111/jop.12206; Stel VS, 2011, NEPHRON CLIN PRACT, V119, pC83, DOI 10.1159/000324758; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tan F, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0473-3; Yang XM, 2015, INT J CLIN EXP PATHO, V8, P12793; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956	12	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182964	10.1371/journal.pone.0182964	http://dx.doi.org/10.1371/journal.pone.0182964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854193	gold, Green Submitted, Green Published			2022-12-26	WOS:000408693600024
J	Alidori, S; Thorek, DLJ; Beattie, BJ; Ulmert, D; Almeida, BA; Monette, S; Scheinberg, DA; McDevitt, MR				Alidori, Simone; Thorek, Daniel L. J.; Beattie, Bradley J.; Ulmert, David; Almeida, Bryan Aristega; Monette, Sebastien; Scheinberg, David A.; McDevitt, Michael R.			Carbon nanotubes exhibit fibrillar pharmacology in primates	PLOS ONE			English	Article							PHARMACOKINETICS; EXCRETION; TOXICITY; SIRNA; PET; DNA	Nanomedicine rests at the nexus of medicine, bioengineering, and biology with great potential for improving health through innovation and development of new drugs and devices. Carbon nanotubes are an example of a fibrillar nanomaterial poised to translate into medical practice. The leading candidate material in this class is ammonium-functionalized carbon nanotubes (fCNT) that exhibits unexpected pharmacological behavior in vivo with important biotechnology applications. Here, we provide a multi-organ evaluation of the distribution, uptake and processing of fCNT in nonhuman primates using quantitative whole body positron emission tomography (PET), compartmental modeling of pharmacokinetic data, serum biomarkers and ex vivo pathology investigation. Kidney and liver are the two major organ systems that accumulate and excrete [Y-86] fCNT in nonhuman primates and accumulation is cell specific as described by compartmental modeling analyses of the quantitative PET data. A serial two-compartment model explains renal processing of tracer-labeled fCNT; hepatic data fits a parallel two-compartment model. These modeling data also reveal significant elimination of the injected activity (>99.8%) from the primate within 3 days (t(1/2) = 11.9 hours). These favorable results in nonhuman primates provide important insight to the fate of fCNT in vivo and pave the way to further engineering design considerations for sophisticated nanomedicines to aid late stage development and clinical use in man.	[Alidori, Simone; Ulmert, David; Almeida, Bryan Aristega; McDevitt, Michael R.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Thorek, Daniel L. J.] Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD USA; [Thorek, Daniel L. J.] Johns Hopkins Sch Med, Dept Radiol Sci, Baltimore, MD USA; [Beattie, Bradley J.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Monette, Sebastien] Rockefeller Univ, Mem Sloan Kettering Canc Ctr, Weill Cornell Med, Triinst Lab Comparat Pathol, 1230 York Ave, New York, NY 10021 USA; [Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Scheinberg, David A.] Weill Cornell Med, Dept Pharmacol, New York, NY USA; [Scheinberg, David A.] Weill Cornell Med, Dept Med, New York, NY USA; [McDevitt, Michael R.] Weill Cornell Med, Dept Radiol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	McDevitt, MR (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.; McDevitt, MR (corresponding author), Weill Cornell Med, Dept Radiol, New York, NY 10065 USA.	m-mcdevitt@ski.mskcc.org		Aristega Almeida, Bryan/0000-0001-9347-3998	Office of Science (BER), U.S. Department of Energy [DE-SC0002456]; NIH MSTP Grant [GM07739, R21 CM 28406, R01 CM 66078, R01 CA55349, R25T CA046945, R24 CA83084, P30 CA008748, P01 CA33049, F31 CA167863]; Memorial Sloan Kettering Center for Molecular Imaging and Nanotechnology (CM INT); Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE [F31CA167863, P01CA033049, R01CA055349, P30CA008748, R21CA128406, R24CA083084, R01CA166078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); NIH MSTP Grant; Memorial Sloan Kettering Center for Molecular Imaging and Nanotechnology (CM INT); Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Office of Science (BER), U.S. Department of Energy (Award DE-SC0002456), NIH MSTP Grant GM07739, R21 CM 28406, R01 CM 66078, R01 CA55349, R25T CA046945, R24 CA83084, P30 CA008748, P01 CA33049, F31 CA167863, the Memorial Sloan Kettering Center for Molecular Imaging and Nanotechnology (CM INT), Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, and The Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center.; The authors acknowledge the expert assistance of Mr. Muc Du and Mr. Simon Marim of the Cornel Bioimaging Core Facility, Dr. Heather Martin of the MSKCC veterinary staff, Ms. Desiree Powell of the MSKCC LCP, Ms. Amy Carol McDevitt for graphic illustration, Mr. Yevgeniy Romin of the MSK Molecular Cytology Core Facility, and Dr. Tong Wang of the CUNY Advanced Science Research Center. This work was supported by the Office of Science (BER), U. S. Department of Energy (Award DE-SC0002456), NIH MSTP Grant GM07739, R21 CA128406, R01 CA166078, R01 CA55349, R25T CA046945, R24 CA83084, P30 CA008748, P01 CA33049, F31 CA167863, the Memorial Sloan Kettering Center for Molecular Imaging and Nanotechnology (CMINT), Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, and The Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center.	Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108; Alidori S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12343; Alidori S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac9647; Alidori S, 2013, J PHYS CHEM C, V117, P5982, DOI 10.1021/jp312416d; Bartholomeusz G, 2009, NANO RES, V2, P279, DOI 10.1007/s12274-009-9026-7; Beattie BJ, 2003, MED PHYS, V30, P2410, DOI 10.1118/1.1595599; Chamanza R, 2010, TOXICOL PATHOL, V38, P642, DOI 10.1177/0192623310368981; Elgrabli D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124490; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Kostarelos K, 2008, NAT BIOTECHNOL, V26, P774, DOI 10.1038/nbt0708-774; Kostarelos K, 2010, NAT MATER, V9, P793, DOI 10.1038/nmat2871; Lacerda L, 2008, SMALL, V4, P1130, DOI 10.1002/smll.200800323; Lacerda L, 2008, NANOMEDICINE-UK, V3, P149, DOI 10.2217/17435889.3.2.149; Lacerda L, 2008, ADV MATER, V20, P225, DOI 10.1002/adma.200702334; McDevitt MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000907; McDevitt Michael R., 2014, Critical Reviews in Oncogenesis, V19, P261; Mulvey JJ, 2014, INT J NANOMED, V9, P4245, DOI 10.2147/IJN.S66050; Mulvey JJ, 2013, NAT NANOTECHNOL, V8, P763, DOI 10.1038/nnano.2013.190; Park HK, 2016, LAB ANIM RES, V32, P79; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Ruggiero A, 2010, P NATL ACAD SCI USA, V107, P12369, DOI 10.1073/pnas.0913667107; Sato J, 2012, J TOXICOL PATHOL, V25, P63, DOI 10.1293/tox.25.63; Scheinberg DA, 2010, NAT REV CLIN ONCOL, V7, P266, DOI 10.1038/nrclinonc.2010.38; Schluep T, 2009, P NATL ACAD SCI USA, V106, P11394, DOI 10.1073/pnas.0905487106; Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064892	27	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183902	10.1371/journal.pone.0183902	http://dx.doi.org/10.1371/journal.pone.0183902			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846728	gold, Green Published, Green Submitted			2022-12-26	WOS:000408438600056
J	Cardea, E; Nordhjem, B; Marcusson-Clavertz, D; Holmqvist, K				Cardea, Etzel; Nordhjem, Barbara; Marcusson-Clavertz, David; Holmqvist, Kenneth			The "hypnotic state" and eye movements: Less there than meets the eye?	PLOS ONE			English	Article							HYPNOSIS; SUSCEPTIBILITY; HYPOTHESIS	Responsiveness to hypnotic procedures has been related to unusual eye behaviors for centuries. Kallio and collaborators claimed recently that they had found a reliable index for "the hypnotic state" through eye-tracking methods. Whether or not hypnotic responding involves a special state of consciousness has been part of a contentious debate in the field, so the potential validity of their claim would constitute a landmark. However, their conclusion was based on 1 highly hypnotizable individual compared with 14 controls who were not measured on hypnotizability. We sought to replicate their results with a sample screened for High (n = 16) or Low (n = 13) hypnotizability. We used a factorial 2 (high vs. low hypnotizability) x 2 (hypnosis vs. resting conditions) counterbalanced order design with these eye-tracking tasks: Fixation, Saccade, Optokinetic nystagmus (OKN), Smooth pursuit, and Antisaccade (the first three tasks has been used in Kallio et al.'s experiment). Highs reported being more deeply in hypnosis than Lows but only in the hypnotic condition, as expected. There were no significant main or interaction effects for the Fixation, OKN, or Smooth pursuit tasks. For the Saccade task both Highs and Lows had smaller saccades during hypnosis, and in the Antisaccade task both groups had slower Antisaccades during hypnosis. Although a couple of results suggest that a hypnotic condition may produce reduced eye motility, the lack of significant interactions (e.g., showing only Highs expressing a particular eye behavior during hypnosis) does not support the claim that eye behaviors (at least as measured with the techniques used) are an indicator of a "hypnotic state." Our results do not preclude the possibility that in a more spontaneous or different setting the experience of being hypnotized might relate to specific eye behaviors.	[Cardea, Etzel; Marcusson-Clavertz, David] Lund Univ, Dept Psychol, Ctr Res Consciousness & Anomalous Psychol CERCAP, Lund, Sweden; [Nordhjem, Barbara] Univ Groningen, Univ Med Ctr Groningen, Sch Behav & Cognit Neurosci, Lab Expt Ophthalmol, Groningen, Netherlands; [Marcusson-Clavertz, David] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Holmqvist, Kenneth] Lund Univ, Humanities Lab, Eye Tracking Grp, Lund, Sweden; [Holmqvist, Kenneth] UPSET, NWU Vaal, Vanderbijlpark, South Africa	Lund University; University of Groningen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Lund University	Cardea, E (corresponding author), Lund Univ, Dept Psychol, Ctr Res Consciousness & Anomalous Psychol CERCAP, Lund, Sweden.	etzel.cardena@psy.lu.se		Cardena, Etzel/0000-0001-6775-8017; Nordhjem, Barbara/0000-0001-7725-4437	Bial [227-10]; European Union's Horizon 2020 Research and Innovation Programme [641805]	Bial(Bial Group); European Union's Horizon 2020 Research and Innovation Programme	The first author's contribution was partly supported by Bial grant # 227-10. The authors also gratefully acknowledge the Lund University Humanities Lab. The second author (BN) received funding from the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement no. 641805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The first author's contribution was partly supported by Bial grant # 227-10. The authors also gratefully acknowledge the Lund University Humanities Lab. The second author (BN) received funding from the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement No 641805. We thank Sakari Kallio, Ph. D., for sending us his three eye tracking programs, on which we modeled our corresponding ones. The ms. also includes our responses to his review (as per PLOS ONE policy). We are also grateful to two anonymous reviewers who provided very useful suggestions to improve the paper.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Braffman W, 1999, J PERS SOC PSYCHOL, V77, P578, DOI 10.1037/0022-3514.77.3.578; Cardena E., 2016, PSYCHOL CONSCIOUS, V3, P61, DOI [10.1037/cns0000080, DOI 10.1037/CNS0000080]; Cardena E, 2013, CORTEX, V49, P375, DOI 10.1016/j.cortex.2012.04.001; Carlson EB, ASSESSMENT; Charcot JM, 1972, DEMONIAQUES ART; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Council Jr, 1999, DISSOCIAT TRAUM MEM, P119; Crawford HJ, 2000, NEUROIMAGE, P11; Deuter CE, 2013, PSYCHOPHYSIOLOGY, V50, P1056, DOI 10.1111/psyp.12083; Di Gruttola F, 2014, EXP BRAIN RES, V232, P3763, DOI 10.1007/s00221-014-4073-z; DUNWOODY RC, 1974, AM J CLIN HYPN, V16, P270; Eckstein MK, 2016, DEV COGN NEUROSCI; Ellenberger H., 1970, DISCOV UNCONSCIOUS; EVANS FJ, 1966, INT J CLIN EXP HYP, V14, P333, DOI 10.1080/00207146608412976; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Irwin HJ, 1999, PERCEPT MOTOR SKILL, V89, P1230; Kallio S, 2016, INT J CLIN EXP HYP, V64, P261, DOI 10.1080/00207144.2016.1171088; Kallio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026374; Kihlstrom J.F., 2008, OXFORD HDB HYPNOSIS, P21, DOI [https://doi.org/10.1093/oxfordhb/9780198570097.013.0002, DOI 10.1093/OXFORDHB/9780198570097.013.0002]; KIRSCH I, 1995, AM PSYCHOL, V50, P846, DOI 10.1037/0003-066X.50.10.846; KIRSCH I, 1990, INT J CLIN EXP HYP, V38, P112, DOI 10.1080/00207149008414506; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; LAURENCE JR, 1986, INT J CLIN EXP HYP, V34, P215, DOI 10.1080/00207148608406987; Levy Deborah L, 2004, World Psychiatry, V3, P32; Lichtenberg P, 2008, INT J CLIN EXP HYP, V56, P243, DOI 10.1080/00207140802039474; LINDSAY S, 1993, INT J CLIN EXP HYP, V41, P92, DOI 10.1080/00207149308414540; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; McGeown WJ, 2009, CONSCIOUS COGN, V18, P848, DOI 10.1016/j.concog.2009.09.001; O'Driscoll GA, 2008, BRAIN COGNITION, V68, P359, DOI 10.1016/j.bandc.2008.08.023; REGISTER PA, 1986, INT J CLIN EXP HYP, V34, P84, DOI 10.1080/00207148608406974; Sargant W, 1973, MIND POSSESSED PHYSL; Sargant W., 1957, BATTLE FOR THE MIND; SHEEHAN DV, 1979, INT J CLIN EXP HYP, V27, P103, DOI 10.1080/00207147908407550; Shor R. E., 1962, HARVARD GROUP SCALE; Smilek D, 2010, PSYCHOL SCI, V21, P786, DOI 10.1177/0956797610368063; Spiegel H., 1978, TRANCE TREATMENT CLI; TEBECIS AK, 1975, BIOL PSYCHOL, V3, P31, DOI 10.1016/0301-0511(75)90004-6; Weitzenhoffer A., 1969, AM J CLIN HYPN, p11 221; WEITZENHOFFER A M, 1971, American Journal of Clinical Hypnosis, V14, P102; WEITZENHOFFER AM, 1969, PERCEPT MOTOR SKILL, V28, P671, DOI 10.2466/pms.1969.28.2.671; Weitzenhoffer AM, 1962, STANFORD HYPNOTIC SU, V27; Woody Erik Z., 1994, P52; Yeates LB, 2013, THESIS	44	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182546	10.1371/journal.pone.0182546	http://dx.doi.org/10.1371/journal.pone.0182546			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846696	Green Published, Green Submitted, gold			2022-12-26	WOS:000408438600012
J	Oliveira, AF; Fernandes, FF; Mariano, VS; Almeida, F; Ruas, LP; Oliveira, LL; Oliver, C; Jamur, MC; Roque-Barreira, MC				Oliveira, Aline Ferreira; Fernandes, Fabricio Freitas; Mariano, Vania Sammartino; Almeida, Fausto; Ruas, Luciana Pereira; Oliveira, Leandro Licursi; Oliver, Constance; Jamur, Maria Celia; Roque-Barreira, Maria Cristina			Paracoccin distribution supports its role in Paracoccidioides brasiliensis growth and dimorphic transformation	PLOS ONE			English	Article							CANDIDA-ALBICANS; CELL-WALL; YEAST FORM; SACCHAROMYCES-CEREVISIAE; CHITIN SYNTHESIS; BINDING LECTIN; SPITZENKORPER; EXPRESSION; GENE; IDENTIFICATION	Paracoccidioides brasiliensis yeast was reported to express paracoccin, a GlcNAc-binding protein that displays N-acetyl-beta-D-glucosaminidase (NAGase) activity. Highly specific antiparacoccin antibodies have been previously used to examine the localization of paracoccin in yeast and inhibit its growth in vitro. In the present study, anti-paracoccin antibodies were used to characterize, by scanning confocal microscopy, the distribution of paracoccin in P. brasiliensis hyphae, transition forms from hyphae to yeast, and mature yeast. In the mycelial phase, paracoccin was detected mainly in the hyphae tips, where it demonstrated a punctate distribution, and was associated with the cell wall. During the first 48 hours after a temperature shift from 26 degrees C to 37 degrees C, paracoccin expression in the differentiating hyphae was mainly detected in the budding regions, i.e. lateral protrusions, and inside the new daughter cells. There was an increased number of chlamydoconidia that expressed a high concentration of paracoccin on their surfaces and/or in their interiors 72-96 hours after the temperature shift. After 120 hours, yeast cells were the predominant form and their cytoplasm stained extensively for paracoccin, whereas Wheat Germ Agglutinin (WGA) staining was predominant on their exterior walls. After 10 days at 37 degrees C, the interior of both mother and daughter yeast cells, as well as the budding regions, stained intensely for paracoccin. The comparison of mRNA-expression in the different fungal forms showed that PCN transcripts, although detected in all evaluated morphological forms, were higher in hypha and yeast-tohypha transition forms. In conclusion, the pattern of paracoccin distribution in all P. brasiliensis morphotypes supports prevalent beliefs that it plays important roles in fungal growth and dimorphic transformation.	[Oliveira, Aline Ferreira; Fernandes, Fabricio Freitas; Mariano, Vania Sammartino; Almeida, Fausto; Ruas, Luciana Pereira; Oliver, Constance; Jamur, Maria Celia; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Ribeirao Preto, SP, Brazil; [Oliveira, Leandro Licursi] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Vicosa	Roque-Barreira, MC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Ribeirao Preto, SP, Brazil.	mcrbarre@fmrp.usp.br	Mariano, Vânia Sammartino/AAV-1851-2020; de Oliveira Pereira, Aline Ferreira/AAT-5134-2020; de Oliveira, Leandro Licursi/D-3616-2009; Ruas, Luciana/A-4259-2013; Almeida, Fausto/N-6540-2013; Roque Barreira, Maria Cristina/A-4552-2008	Mariano, Vânia Sammartino/0000-0002-5399-5676; de Oliveira, Leandro Licursi/0000-0003-4353-7011; Ruas, Luciana/0000-0002-1028-7872; Almeida, Fausto/0000-0002-3782-3698; Roque Barreira, Maria Cristina/0000-0001-7425-0908	FAPESP [2007/58879-7, 2009/51197-3, 2013/10741-8, 2006/60642-2]; CNPq; FAEPA	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAEPA	This work was supported by FAPESP, grant numbers 2007/58879-7, 2009/51197-3, 2013/10741-8 and 2006/60642-2. Additional financial help was provided by CNPq and FAEPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by FAPESP, grant numbers 2007/58879-7, 2009/51197-3, 2013/10741-8 and 2006/60642-2. Additional financial help was provided by CNPq and FAEPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Sandra Thomaz and Patricia Vendruscolo for technical support.	Almeida F, 2016, CURR GENOMICS, V17, P112, DOI 10.2174/1389202917666151116212705; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505; CABIB E, 1982, ANNU REV BIOCHEM, V51, P763, DOI 10.1146/annurev.bi.51.070182.003555; CARBONELL LM, 1970, J BACTERIOL, V101, P636, DOI 10.1128/JB.101.2.636-642.1970; CARBONELL LM, 1967, J BACTERIOL, V94, P213, DOI 10.1002/path.1700940130; CARBONELL LM, 1965, J BACTERIOL, V90, P504, DOI 10.1128/JB.90.2.504-510.1965; CARBONELL LM, 1969, J BACTERIOL, V100, P1076, DOI 10.1128/JB.100.2.1076-1082.1969; Chen DL, 2007, MOL MICROBIOL, V65, P761, DOI 10.1111/j.1365-2958.2007.05824.x; Coltri KC, 2006, MICROBES INFECT, V8, P704, DOI 10.1016/j.micinf.2005.09.008; Court H, 2007, MOL BIOL CELL, V18, P265, DOI 10.1091/mbc.E06-05-0411; da Silva SP, 1999, MOL MICROBIOL, V31, P1039, DOI 10.1046/j.1365-2958.1999.01236.x; Dasilva AMM, 1994, MYCOSES, V37; Almeida FBD, 2014, YEAST, V31, P1, DOI 10.1002/yea.2983; Almeida FBD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029216; Almeida FBD, 2010, YEAST, V27, P67, DOI 10.1002/yea.1731; Dunkler A, 2005, FUNGAL GENET BIOL, V42, P935, DOI 10.1016/j.fgb.2005.08.001; Fernandes FF, 2017, MBIO, V8, DOI [10.1128/mBio.00537-17, 10.1128/mbio.00537-17]; Franco M, 1987, Rev Soc Bras Med Trop, V20, P129, DOI 10.1590/S0037-86821987000200012; FRANCO M, 1989, REV I MED TROP, V31, P151, DOI 10.1590/S0036-46651989000300004; Ganiko L, 2007, MICROBES INFECT, V9, P695, DOI 10.1016/j.micinf.2007.02.012; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; GROVE SN, 1970, J BACTERIOL, V104, P989, DOI 10.1128/JB.104.2.989-1009.1970; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Hernandez O, 2011, YEAST, V28, P771, DOI 10.1002/yea.1902; KANETSUNA F, 1972, J BACTERIOL, V110, P208, DOI 10.1128/JB.110.1.208-218.1972; KANETSUNA F, 1969, J BACTERIOL, V97, P1036, DOI 10.1128/JB.97.3.1036-1041.1969; MCEWEN JG, 1987, AM J TROP MED HYG, V36, P603, DOI 10.4269/ajtmh.1987.36.603; Miyaji Makoto, 2003, Nihon Ishinkin Gakkai Zasshi, V44, P133, DOI 10.3314/jjmm.44.133; Munro CA, 1998, MICROBIOL-SGM, V144, P391, DOI 10.1099/00221287-144-2-391; Nunes LR, 2005, EUKARYOT CELL, V4, P2115, DOI 10.1128/EC.4.12.2115-2128.2005; Alegre ACP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002788; PATINO MM, 1984, SABOURAUDIA, V22, P509; Puccia R, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00257; Rezende TCV, 2011, J PROTEOMICS, V75, P572, DOI 10.1016/j.jprot.2011.08.020; SALAZAR ME, 1988, INFECT IMMUN, V56, P711, DOI 10.1128/IAI.56.3.711-713.1988; San-Blas G, 2008, MYCOPATHOLOGIA, V165, P183, DOI 10.1007/s11046-007-9040-9; SANTANNA OA, 1982, J IMMUNOGENET, V9, P191; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tanaka R, 2001, MYCOSES, V44, P9, DOI 10.1046/j.1439-0507.2001.00612.x; Tavares AH, 2015, FUNGAL GENET BIOL, V81, P98, DOI 10.1016/j.fgb.2014.01.008; VALDIVIESO MH, 1991, J CELL BIOL, V114, P101, DOI 10.1083/jcb.114.1.101	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0184010	10.1371/journal.pone.0184010	http://dx.doi.org/10.1371/journal.pone.0184010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846733	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600064
J	Haldar, K; Bafadhel, M; Lau, K; Berg, A; Kwambana, B; Kebadze, T; Ramsheh, MY; Barker, B; Haldar, P; Johnston, S; Ketley, JM; Brightling, CE; Barer, MR				Haldar, Koirobi; Bafadhel, Mona; Lau, Kelvin; Berg, Adam; Kwambana, Brenda; Kebadze, Tatiana; Ramsheh, Mohammadali Yavari; Barker, Bethan; Haldar, Pranabashis; Johnston, Sebastian; Ketley, Julian M.; Brightling, Christopher E.; Barer, Michael R.			Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY MICROBIOME; BRONCHIECTASIS; DYNAMICS	Background While a subgroup of patients with exacerbations of chronic obstructive pulmonary disease (COPD) clearly benefit from antibiotics, their identification remains challenging. We hypothesised that selective assessment of the balance between the two dominant bacterial groups (Gammaproteobacteria (G) and Firmicutes (F)) in COPD sputum samples might reveal a subgroup with a bacterial community structure change at exacerbation that was restored to baseline on recovery and potentially reflects effective antibiotic treatment. Methods Phylogenetically specific 16S rRNA genes were determined by quantitative real time PCR to derive a G: F ratio in serial sputum samples from 66 extensively-phenotyped COPD exacerbation episodes. Results Cluster analysis based on Euclidean distance measures, generated across the 4 visit times (stable and exacerbation day: 0,14 and 42) for the 66 exacerbation episodes, revealed three subgroups designated HG, HF, and GF reflecting predominance or equivalence of the two target bacterial groups. While the other subgroups showed no change at exacerbation, the HG cluster (n = 20) was characterized by G:F ratios that increased significantly at exacerbation and returned to baseline on recovery (p<0.00001); ratios in the HG group also correlated positively with inflammatory markers and negatively with FEV1. At exacerbation G:F showed a significant receiver-operator-characteristic curve to identify the HG subgroup (AUC 0.90, p<0.0001). Conclusions The G:F ratio at exacerbation can be determined on a timescale compatible with decisions regarding clinical management. We propose that the G:F ratio has potential for use as a biomarker enabling selective use of antibiotics in COPD exacerbations and hence warrants further clinical evaluation.	[Haldar, Koirobi; Bafadhel, Mona; Lau, Kelvin; Berg, Adam; Kwambana, Brenda; Ramsheh, Mohammadali Yavari; Barker, Bethan; Haldar, Pranabashis; Brightling, Christopher E.; Barer, Michael R.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Bafadhel, Mona; Barker, Bethan; Haldar, Pranabashis; Brightling, Christopher E.; Barer, Michael R.] Univ Leicester, Glenfield Hosp, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England; [Lau, Kelvin; Berg, Adam; Ketley, Julian M.] Univ Leicester, Dept Genet, Leicester, Leics, England; [Kebadze, Tatiana; Johnston, Sebastian] Imperial Coll, Natl Heart & Lung Inst, Airway Dis Infect Sect, London, England; [Brightling, Christopher E.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Barer, Michael R.] Univ Hosp Leicester NHS Trust, Dept Clin Microbiol, Leicester, Leics, England; [Bafadhel, Mona] Univ Oxford, Nuffield Dept Clin Med, Resp Med Unit, Oxford, England; [Lau, Kelvin] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Kwambana, Brenda] MRC Unit, Vaccinol Theme, Fajara, Gambia	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leicester; Imperial College London; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University of Oxford; University of Auckland; University of London; London School of Hygiene & Tropical Medicine	Barer, MR (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.; Barer, MR (corresponding author), Univ Leicester, Glenfield Hosp, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England.; Barer, MR (corresponding author), Univ Hosp Leicester NHS Trust, Dept Clin Microbiol, Leicester, Leics, England.	mrb19@le.ac.uk	Lau, Kelvin/ABA-6687-2021; Kwambana, Brenda/U-5786-2017; Bafadhel, Mona/ABB-1170-2021; Johnston, Sebastian Lennox/I-2423-2012; haldar, kairabi/HDO-4827-2022	Lau, Kelvin/0000-0003-0977-1357; Kwambana, Brenda/0000-0002-1202-8540; Johnston, Sebastian Lennox/0000-0003-3009-9200; Bafadhel, Mona/0000-0002-9993-2478; brightling, chris/0000-0002-9345-4903; Barer, Michael/0000-0002-0377-3100; Haldar, Pranabashis/0000-0002-1572-5421	Medical Research Council (UK); Wellcome Trust Senior Fellowship (CEB); National Institute for Health Research (NIHR Senior Investigator Award CEB); National Institute for Health Research (NIHR Post-Doctoral Fellowship award MB); Leicester Respiratory Biomedical Research Unit; National Institute for Health Research (NIHR); Biotechnology and Biological Sciences Research Council [BB/J016667/1] Funding Source: researchfish; Medical Research Council [G0601369, G0801980] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10018, PDF-2013-06-052] Funding Source: researchfish; Asthma UK [CH11SJ] Funding Source: researchfish; BBSRC [BB/J016667/1] Funding Source: UKRI; MRC [G0801980, G0601369] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Senior Fellowship (CEB); National Institute for Health Research (NIHR Senior Investigator Award CEB); National Institute for Health Research (NIHR Post-Doctoral Fellowship award MB); Leicester Respiratory Biomedical Research Unit; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was part funded by Medical Research Council (UK), a Wellcome Trust Senior Fellowship (CEB) and a National Institute for Health Research (NIHR Senior Investigator Award CEB; NIHR Post-Doctoral Fellowship award MB) and the Leicester Respiratory Biomedical Research Unit. This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Barker BL, 2014, CHEST; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Dickson RP, 2014, LANCET, V384, P691, DOI 10.1016/S0140-6736(14)61136-3; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Dorak M.T., 2006, REAL TIME PCR, P89; Haldar K, 2011, THORAX, V66, pA10, DOI 10.1136/thoraxjnl-2011-201054b.16; Health Protection Agency, 2009, INV BRONCH LAV SPUT, P3; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; NICE, 2010, CHRON OBSTR PULM DIS; Rogers Geraint B, 2014, Ann Am Thorac Soc, V11, P496, DOI 10.1513/AnnalsATS.201310-335OC; Sethi Sanjay, 2009, Proc Am Thorac Soc, V6, P532, DOI 10.1513/pats.200905-025DS; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Z, 2016, EUR RESPIR J, V47, P1082, DOI 10.1183/13993003.01406-2015; Wilson CB, 1997, AM J RESP CRIT CARE, V156, P536, DOI 10.1164/ajrccm.156.2.9607083; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127	23	20	21	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182833	10.1371/journal.pone.0182833	http://dx.doi.org/10.1371/journal.pone.0182833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841671	Green Published, gold			2022-12-26	WOS:000408370700011
J	Kojima, T; Kanzaki, S; Oishi, N; Ogawa, K				Kojima, Takashi; Kanzaki, Sho; Oishi, Naoki; Ogawa, Kaoru			Clinical characteristics of patients with tinnitus evaluated with the Tinnitus Sample Case History Questionnaire in Japan: A case series	PLOS ONE			English	Article							PURE-TONE THRESHOLDS; PREVALENCE; ANXIETY; CARE	Background The Tinnitus Sample Case History Questionnaire was determined as a standardized questionnaire for obtaining patient case histories and for characterizing patients into subgroups at the Tinnitus Research Initiative in 2006. In this study, we developed a Japanese version of this questionnaire for evaluating the clinical characteristics of patients with tinnitus. The Japanese version of the questionnaire will be available for evaluating treatments for tinnitus and for comparing data on tinnitus in research centers. Aims/Objectives To evaluate the clinical characteristics of patients with tinnitus in Japan using a newly developed Japanese version of Tinnitus Sample Case History Questionnaire. Study design This was a prospective study based on patient records. Setting University hospitals, general hospitals, and clinics. Subjects and methods We collected patient data using a Japanese translated version of the Tinnitus Sample Case History Questionnaire. In total, 584 patients who visited our institutions in Japan between August 2012 and March 2014 were included (280 males and 304 females; age 13 - 92 years; mean age, 60.8). We examined patients after dividing them into two groups according to the presence or absence of hyperacusis. The collected results were compared with those from the Tinnitus Research Initiative database. Results Compared with the TRI database, there were significantly more elderly female patients and fewer patients with trauma-associated tinnitus. There was a statistically lower ratio of patients with hyperacusis. We found that patients with tinnitus in addition to hyperacusis had greater tinnitus severity and exhibited higher rates of various complications. Conclusion The Japanese version of the Tinnitus Sample Case History Questionnaire developed in this study can be a useful tool for evaluating patients with tinnitus in Japan. The results of this multicenter study reflect the characteristics of patients with tinnitus who require medical care in Japan. Our data provides a preliminary basis for an international comparison of tinnitus epidemiology.	[Kojima, Takashi; Kanzaki, Sho; Oishi, Naoki; Ogawa, Kaoru] Keio Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Shinjuku Ku, Tokyo, Japan; [Kojima, Takashi] Machida Municipal Hosp, Dept Otorhinolaryngol, Machida, Tokyo, Japan	Keio University	Kanzaki, S (corresponding author), Keio Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Shinjuku Ku, Tokyo, Japan.	skan@keio.jp	Oishi, Naoki/ABG-7065-2020; Kanzaki, Sho/AAU-6136-2020	Oishi, Naoki/0000-0001-8204-9518; Kojima, Takashi/0000-0002-7492-165X	Japan Agency for Medical Research and Development grant [16dk0310065s0801]	Japan Agency for Medical Research and Development grant(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Japan Agency for Medical Research and Development grant (16dk0310065s0801) (http://www.amed.go.jp/en/program/).	Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Bruggemann P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00341; Cima RFF, 2012, LANCET, V379, P1951, DOI 10.1016/S0140-6736(12)60469-3; Dreisbach LE, 2007, INT J AUDIOL, V46, P419, DOI 10.1080/14992020701355074; Fujii K, 2011, J EPIDEMIOL, V21, P299, DOI 10.2188/jea.JE20100124; Gallus S, 2015, NEUROEPIDEMIOLOGY, V45, P12, DOI 10.1159/000431376; Guichard E, 2016, HEADACHE, V56, P987, DOI 10.1111/head.12845; HAZELL JWP, 1990, J OTOLARYNGOL, V19, P1; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; Katzenell U, 2001, OTOL NEUROTOL, V22, P321, DOI 10.1097/00129492-200105000-00009; Kim HJ, 2014, LARYNGOSCOPE, V124, P2155, DOI 10.1002/lary.24722; Kim HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127578; Kreuzer PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045599; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Lee SY, 2014, J AFFECT DISORDERS, V155, P130, DOI 10.1016/j.jad.2013.10.037; Levine RA, 2007, PROG BRAIN RES, V166, P195, DOI 10.1016/S0079-6123(07)66017-8; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Oishi N, 2011, INT J AUDIOL, V50, P491, DOI 10.3109/14992027.2011.560904; Oiticica J, 2015, BRAZ J OTORHINOLAR, V81, P167, DOI 10.1016/j.bjorl.2014.12.004; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Savage J, 2014, BMJ CLIN EVIDENCE, V2014; Schecklmann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086944; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; She WD, 2009, MED SCI MONITOR, V15, pPI35; Tunkel DE, 2014, OTOLARYNG HEAD NECK, V151, pS1, DOI 10.1177/0194599814545325; Vielsmeier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038887; Zeman F, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-7; Zeman F, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-128; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0180609	10.1371/journal.pone.0180609	http://dx.doi.org/10.1371/journal.pone.0180609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841656	Green Submitted, Green Published, gold			2022-12-26	WOS:000408370700001
J	Ranhem, C; Larsson, GL; Hedman, H; Lindquist, D; Karlsson, MG; Hellstrom, AC; Ostensson, E; Sorbe, B; Hellman, K; Andersson, S				Ranhem, Cecilia; larsson, Gabriella Lillsunde; Hedman, Hakan; Lindquist, David; Karlsson, Mats G.; Hellstrom, Ann-Cathrin; Ostensson, Ellinor; Sorbe, Bengt; Hellman, Kristina; Andersson, Sonia			Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS STATUS; PATIENT SURVIVAL; CERVICAL-CANCER; TUMOR-MARKERS; BIOMARKER; IMPACT	Background Primary vaginal carcinoma (PVC) is a rare malignancy. Established prognostic factors include tumour stage and age at diagnosis. The leucine-rich repeats and immunoglobuline-like domains (LRIG)-1 protein functions as a tumour suppressor, but less is known about the functions of LRIG2 and LRIG3. The present study aimed to evaluate the expression of LRIG proteins and analyse their possible associations with clinical characteristics and survival in a cohort of PVC patients. Methods We used immunohistochemistry to investigate LRIG1, LRIG2, and LRIG3 expression in tumour samples from a consecutive cohort of 70 PVC patients. The association between LRIG protein expression and clinical characteristics and cancer-specific survival was investigated using univariate and multivariate analyses. Results The majority of PVC patients (72%) had > 50% LRIG1-and LRIG2-positive cells, and no or low LRIG3-positive cells. HPV status was significantly correlated with LRIG1 expression (p = 0.0047). Having high LRIG1 expression was significantly correlated with superior cancer-specific survival in univariate and multivariate analyses. LRIG2 and LRIG3 expression did not significantly correlate with clinical characteristics or survival. Conclusion LRIG1 expression might be of interest as a prognostic marker in PVC patients, whereas the role of LRIG2 and LRIG3 expression remains to be clarified.	[Ranhem, Cecilia; Hellstrom, Ann-Cathrin; Ostensson, Ellinor; Andersson, Sonia] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Ranhem, Cecilia] Reg Vastmanland Uppsala Univ, Clin Res Ctr, Hosp Vastmanland Vasteras, Vasteras, Sweden; [larsson, Gabriella Lillsunde] Orebro Univ, Sch Hlth & Med Sci, Orebro, Sweden; [larsson, Gabriella Lillsunde] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden; [Hedman, Hakan; Lindquist, David] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Karlsson, Mats G.] Orebro Univ, Fac Med & Hlth, Dept Lab Med, Orebro, Sweden; [Ostensson, Ellinor] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sorbe, Bengt] Orebro Univ Hosp, Dept Oncol, Orebro, Sweden; [Hellman, Kristina] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet; Vasteras Central Hospital; Orebro University; Orebro University; Umea University; Orebro University; Karolinska Institutet; Orebro University; Karolinska Institutet	Andersson, S (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	sonia.andersson@ki.se	Lindquist, David/AAM-3662-2020; Hedman, Håkan/F-9495-2012; Karlsson, Mats G/AAV-7542-2021; Hellman, Kristina/Q-2154-2015	Lindquist, David/0000-0002-7507-937X; Karlsson, Mats G/0000-0001-6881-237X; Andersson, Sonia/0000-0003-2120-7222	Swedish Cancer Foundation [070623, CAN 2007/1044, 11 0544, CAN 2011/471]; Karolinska Institutet Cancer Strategic Grants [5888/05-722]; Swedish Research Council [521-2008-2899]; Stockholm County Council [20130097]; Region Orebro County [OLL-526041]; Lion's Cancer Research Foundation; University of Umea; Gustaf V Jubilee Fund [154022]; Region Vastmanland - Uppsala University Centre for Clinical Research Hospital of Vastmanland Vasteras	Swedish Cancer Foundation; Karolinska Institutet Cancer Strategic Grants; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Region Orebro County; Lion's Cancer Research Foundation; University of Umea; Gustaf V Jubilee Fund; Region Vastmanland - Uppsala University Centre for Clinical Research Hospital of Vastmanland Vasteras	The Swedish Cancer Foundation (070623, CAN 2007/1044, 11 0544, CAN 2011/471) URL: www.cancerfonden.se, SA; Karolinska Institutet Cancer Strategic Grants (5888/05-722) URL: www.ki.se, SA; The Swedish Research Council (521-2008-2899), URL: www.vr.se, SA; Stockholm County Council (20130097) URL: www.skl.se, SA; Region Orebro County (OLL-526041) URL: http://www.fou.nu/is/oll/ansokan/526041, GLL, MK; Lion's Cancer Research Foundation, University of Umea, URL: http://www.cancerforskningsfond-umea.lions.se, DL; The Gustaf V Jubilee Fund (154022) URL: www.rahfo.se, SA; Region Vastmanland - Uppsala University Centre for Clinical Research Hospital of Vastmanland Vasteras, URL: https://www.researchweb.org/is/ltv/ansokan/564291, CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso I, 2012, GYNECOL ONCOL, V125, P194, DOI 10.1016/j.ygyno.2011.12.449; An YZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002081; Beller U, 2006, INT J GYNECOL OBSTET, V95, pS29, DOI 10.1016/S0020-7292(06)60029-5; Brunner AH, 2011, INT J GYNECOL CANCER, V21, P923, DOI 10.1097/IGC.0b013e31821bc615; Chang JH, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e17; Fuste V, 2010, HISTOPATHOLOGY, V57, P907, DOI 10.1111/j.1365-2559.2010.03727.x; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Gunderson CC, 2013, J LOW GENIT TRACT DI, V17, P409, DOI 10.1097/LGT.0b013e3182800ee2; Guo DS, 2006, ACTA NEUROPATHOL, V111, P238, DOI 10.1007/s00401-006-0032-5; Habermann JK, 2004, CANCER GENET CYTOGEN, V148, P7, DOI 10.1016/S0165-4608(03)00245-0; Hacker NF, 2015, INT J GYNECOL OBSTET, V131, pS84, DOI 10.1016/j.ijgo.2015.06.003; Hedman H, 2010, ACTA ONCOL, V49, P812, DOI 10.3109/0284186X.2010.492789; Hellman K, 2004, INT J GYNECOL CANCER, V14, P491, DOI 10.1111/j.1048-891x.2004.014310.x; Hellman K, 2014, BRIT J CANCER, V110, P1561, DOI 10.1038/bjc.2014.32; Hellman K, 2013, INT J GYNECOL CANCER, V23, P41, DOI 10.1097/IGC.0b013e31827670c4; Holmlund C, 2004, GENE, V332, P35, DOI 10.1016/j.gene.2004.02.002; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Kvarnbrink S, 2015, ACTA ONCOL, V54, P1113, DOI 10.3109/0284186X.2015.1021427; Lando M, 2015, EPIGENETICS-US, V10, P970, DOI 10.1080/15592294.2015.1085140; Larsson GL, 2013, GYNECOL ONCOL, V129, P406, DOI 10.1016/j.ygyno.2013.02.004; Lindquist D, 2014, BRIT J CANCER, V110, P1793, DOI 10.1038/bjc.2014.87; Lindquist D, 2014, ACTA ONCOL, V53, P1135, DOI 10.3109/0284186X.2014.953258; Lindstrom AK, 2008, INT J GYNECOL CANCER, V18, P312, DOI 10.1111/j.1525-1438.2007.01021.x; Lindstrom AK, 2011, GYNECOL ONCOL, V122, P372, DOI 10.1016/j.ygyno.2011.04.049; Lindstrom AK, 2014, EUR J HISTOCHEM, V58, P83, DOI 10.4081/ejh.2014.2227; Muller S, 2013, INT J ONCOL, V42, P247, DOI 10.3892/ijo.2012.1702; Nilsson J, 2003, CELL TISSUE RES, V312, P65, DOI 10.1007/s00441-003-0697-1; Orton A, 2016, GYNECOL ONCOL, V141, P501, DOI 10.1016/j.ygyno.2016.03.011; Rafidi H, 2013, J BIOL CHEM, V288, P21593, DOI 10.1074/jbc.M113.486050; Rajagopalan MS, 2014, GYNECOL ONCOL, V135, P495, DOI 10.1016/j.ygyno.2014.09.018; Simion C, 2014, ENDOCR-RELAT CANCER, V21, pR431, DOI 10.1530/ERC-14-0179; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Wu XP, 2012, ACTA ONCOL, V51, P69, DOI 10.3109/0284186X.2011.562239; Yi W, 2011, EXP CELL RES, V317, P504, DOI 10.1016/j.yexcr.2010.11.005	35	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183816	10.1371/journal.pone.0183816	http://dx.doi.org/10.1371/journal.pone.0183816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841699	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700059
J	Shen, XQ; Wang, TT; Cao, XS; Cai, L				Shen, Xiaoqin; Wang, Tiantian; Cao, Xiaoshan; Cai, Li			The geometric model of the human mitral valve	PLOS ONE			English	Article								The mitral valve, which lies between the left atrium and the left ventricle, plays an important role in controlling the uniflux of blood from the left atrium to the left ventricle as one of the four human heart valves. A precise description of the shape of human mitral valve has vital significance in studying its physiological structure and periodic movement. Unsatisfyingly, there is almost no unified mathematical description of the same shape of human mitral valve in literature. In this paper, we present a geometric model for human mitral valve, as an elastic shell with a special shape. Parametric equations for the shape of human mitral valve are provided, including the anterior and the posterior parts, which can be thought as portions of two interfacing semi-elliptic cylindrical shells. The minor axis of one ellipse is equal to the major axis of the other. All the parameters are determined from the statistical data. Comparison of fitting results with existing examples validates the accuracy of our geometric model. Based on the fitting shape, one can further simulate the physiological function of the mitral valve using a suitable dynamic physical equation.	[Shen, Xiaoqin; Wang, Tiantian; Cao, Xiaoshan] Xian Univ Technol, Sch Sci, Xian 710054, Shaanxi, Peoples R China; [Cao, Xiaoshan] Chinese Acad Sci, State Key Lab Transducer Technol, Shanghai 200050, Peoples R China; [Cai, Li] Northwestern Polytech Univ, NPU UoG Int Cooperat Lab Computat & Applicat Card, Xian 710072, Shaanxi, Peoples R China	Xi'an University of Technology; Chinese Academy of Sciences; Northwestern Polytechnical University	Shen, XQ (corresponding author), Xian Univ Technol, Sch Sci, Xian 710054, Shaanxi, Peoples R China.	xqshen@xaut.edu.cn	Li, Cai/Y-7599-2018	, Xiaoshan/0000-0003-2711-3921	National Natural Science Foundation of China [11571275, 11572244, 11471261]; Program of Industry in Shaanxi Province [2015GY021, 2015JQ1001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Industry in Shaanxi Province	This paper is supported by National Natural Science Foundation of China (11571275, 11572244, 11471261) and Program of Industry in Shaanxi Province (2015GY021, 2015JQ1001).	Ajit P, 2010, THESIS; CHIECHI MA, 1956, J THORAC SURG, V32, P378; Dagum P, 2001, J THORAC CARDIOV SUR, V122, P665, DOI 10.1067/mtc.2001.116313; Dominik J, 2010, HEART VALVE SURG ILU; Gao H, 2016, INT J NUMERICAL METH; Howe R, 2011, THESIS; Kunzelman K S, 1994, J Heart Valve Dis, V3, P491; Kunzelman K S, 1993, J Heart Valve Dis, V2, P326; Liu MX, 2016, IEEE T MED IMAGING, V35, P1463, DOI 10.1109/TMI.2016.2515021; Liu MX, 2015, HUM BRAIN MAPP, V36, P1847, DOI 10.1002/hbm.22741; Ma XS, 2013, COMPUT FLUIDS, V71, P417, DOI 10.1016/j.compfluid.2012.10.025; RANGANATHAN N, 1970, CIRCULATION, V41, P459, DOI 10.1161/01.CIR.41.3.459; RUSTED IE, 1952, CIRCULATION, V6, P825, DOI 10.1161/01.CIR.6.6.825; Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122; Schneider RJ, 2011, LECT NOTES COMPUT SC, V6893, P520, DOI 10.1007/978-3-642-23626-6_64; Schneider RJ, 2011, LECT NOTES COMPUT SC, V6666, P215, DOI 10.1007/978-3-642-21028-0_27; Stevanella M, 2009, BIOMECHANICAL ENG T, V131, P1011; Timek TA, 2003, ANN THORAC SURG, V76, P1944, DOI 10.1016/S0003-4975(03)01078-6; Weinberg EJ, 2007, J BIOMECH, V40, P705, DOI 10.1016/j.jbiomech.2006.01.003; [钟琪 Zhong Qi], 2014, [医用生物力学, Journal of Medical Biomechanics], V29, P53	20	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183362	10.1371/journal.pone.0183362	http://dx.doi.org/10.1371/journal.pone.0183362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841703	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700026
J	Gesing, J; Scheuermann, K; Wagner, IV; Loffler, D; Friebe, D; Kiess, W; Schuster, V; Korner, A				Gesing, Julia; Scheuermann, Kathrin; Wagner, Isabel Viola; Loeffler, Dennis; Friebe, Daniela; Kiess, Wieland; Schuster, Volker; Koerner, Antje			NAMPT serum levels are selectively elevated in acute infectious disease and in acute relapse of chronic inflammatory diseases in children	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; VISFATIN; ADIPOCYTOKINE; ARTHRITIS; PROTEIN	Nicotinamide phosphoribosyl transferase (NAMPT) is an inflammatory adipocytokine shown to interact in immune modulation in chronic inflammatory diseases, acute respiratory distress syndrome, sepsis, cancer and obesity in adulthood. It is, however, not clear whether this association reflects a chronic elevation or acute inflammatory response. We analyzed NAMPT concentrations in distinct states of inflammation in 102 children and found consistently significantly increased NAMPT levels in subjects with acute infections. NAMPT concentrations in children with stable chronic inflammatory diseases were not significantly different, whereas in patients with acute relapse of chronic disease NAMPT was significantly higher than in children in remission or healthy controls. In states of low-grade inflammation (children with atopic disease or obesity) we did not detect alterations in NAMPT serum levels. NAMPT correlated positively with inflammatory markers such as CRP. The most predictive factor for NAMPT serum concentrations was leucocyte count and therein the neutrophil count. Furthermore, systemic circulating NAMPT levels were closely associated with NAMPT release from corresponding cultured PBMCs. In conclusion, NAMPT is selectively increased in states of acute but not chronic inflammation in children. The close relationship between systemic circulating NAMPT with leucocyte counts and release indicate that leucocytes most probably are the source of inflammation related NAMPT levels.	[Gesing, Julia; Scheuermann, Kathrin; Friebe, Daniela; Kiess, Wieland; Schuster, Volker; Koerner, Antje] Univ Leipzig, Hosp Children & Adolescents, Leipzig, Saxony, Germany; [Scheuermann, Kathrin; Kiess, Wieland; Koerner, Antje] Leipzig Univ Med Ctr IFB Adipos Dis, Leipzig, Saxony, Germany; [Wagner, Isabel Viola] Univ Hosp Cologne, Hosp Children & Adolescents, Cologne, North Rhine Wes, Germany; [Loeffler, Dennis] Fraunhofer Inst Cell Therapy & Immunol Leipzig, Leipzig, Saxony, Germany	Leipzig University; University of Cologne	Korner, A (corresponding author), Univ Leipzig, Hosp Children & Adolescents, Leipzig, Saxony, Germany.; Korner, A (corresponding author), Leipzig Univ Med Ctr IFB Adipos Dis, Leipzig, Saxony, Germany.	antje.koerner@medizin.uni-leipzig.de	Körner, Antje/B-3988-2015; Frielitz, Fabian/ABH-2518-2020	Körner, Antje/0000-0001-6001-0356; 	German Research Foundation [CRC1052/1 C05]; LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig) - European Union; uropean Regional Development Fund (ERFD); Federal Ministry of Education and Research (BMBF), Germany, Integrated Research and Treatment Centre (IFB) Adiposity Diseases FKZ [01EO1001]; German Research Foundation (DFG) [CRC1052/1 C05]	German Research Foundation(German Research Foundation (DFG)); LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig) - European Union; uropean Regional Development Fund (ERFD); Federal Ministry of Education and Research (BMBF), Germany, Integrated Research and Treatment Centre (IFB) Adiposity Diseases FKZ; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation for the Clinical Research Center "Obesity Mechanisms" CRC1052/1 C05 and by the LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), funded by the European Union, by the European Regional Development Fund (ERFD) by means of the Free State of Saxony within the framework of the excellence initiative, and by the Federal Ministry of Education and Research (BMBF), Germany, Integrated Research and Treatment Centre (IFB) Adiposity Diseases FKZ: 01EO1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the pediatric endocrinology and immunology teams and colleagues for their assistance in the collection of blood samples. This work was supported by the German Research Foundation (DFG) for the Clinical Research Center "Obesity Mechanisms" CRC1052/1 C05 and by the LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), funded by the European Union, by the European Regional Development Fund (ERFD) by means of the Free State of Saxony within the framework of the excellence initiative, and by the Federal Ministry of Education and Research (BMBF), Germany, Integrated Research and Treatment Centre (IFB) Adiposity Diseases FKZ: 01EO1001.	Brentano F, 2007, ARTHRITIS RHEUM, V56, P2829, DOI 10.1002/art.22833; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Camp SM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13135; Cekmez F, 2011, EUR CYTOKINE NETW, V22, P113, DOI 10.1684/ecn.2011.0283; Damanaki A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/912821; Dogan S, 2016, J CLIN LAB ANAL, V30, P552, DOI 10.1002/jcla.21901; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Funk RS, 2016, CTS-CLIN TRANSL SCI, V9, P149, DOI 10.1111/cts.12399; Gao ZY, 2015, GENET MOL RES, V14, P5287, DOI 10.4238/2015.May.18.21; Garten A, 2011, HANDB EXP PHARMACOL, V203, P147, DOI 10.1007/978-3-642-17214-4_7; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Haider DG, 2006, J PEDIATR GASTR NUTR, V43, P548, DOI 10.1097/01.mpg.0000235749.50820.b3; Hollensted M, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0253-3; Hu W, 2013, PEPTIDES, V43, P8, DOI 10.1016/j.peptides.2013.02.017; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Korner A, 2007, J CLIN ENDOCR METAB, V92, P4783, DOI 10.1210/jc.2007-1304; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lee KA, 2011, CHEST, V140, P382, DOI 10.1378/chest.10-3100; Martos-Moreno GA, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-9; Meier FMP, 2012, J BIOL CHEM, V287, P28378, DOI 10.1074/jbc.M111.312884; Montecucco F, 2013, CURR TOP MED CHEM, V13, P2930, DOI 10.2174/15680266113136660208; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; NOKHBEHSAIM M, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/437123; Oh H, 2015, OSTEOARTHR CARTILAGE, V23, P2288, DOI 10.1016/j.joca.2015.07.009; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sawicka-Gutaj N, 2016, ENDOCRINE, V53, P497, DOI 10.1007/s12020-015-0855-8; Schuster S, 2015, BIOCHEM BIOPH RES CO, V458, P334, DOI 10.1016/j.bbrc.2015.01.111; Tabassum R, 2012, DIABETES, V61, P626, DOI 10.2337/db11-1501; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Valentini L, 2009, NUTRITION, V25, P172, DOI 10.1016/j.nut.2008.07.020; Zhang LQ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.132	35	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183027	10.1371/journal.pone.0183027	http://dx.doi.org/10.1371/journal.pone.0183027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837586	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000042
J	Olusanya, BO; Slusher, TM; Imosemi, DO; Emokpae, AA				Olusanya, Bolajoko O.; Slusher, Tina M.; Imosemi, Donald O.; Emokpae, Abieyuwa A.			Maternal detection of neonatal jaundice during birth hospitalization using a novel twocolor icterometer	PLOS ONE			English	Article							NEWBORN; HYPERBILIRUBINEMIA; COUNTRIES; DISCHARGE; KERNICTERUS; READMISSION; BILIRUBIN; VIETNAM; INFANTS; MOTHERS	Background Mothers are frequently the first to observe the onset of jaundice in their newborn infants before the decision to seek treatment. However, simple-to-use tools that could facilitate early detection of jaundice and assist mothers to seek professional care, especially after hospital discharge, are rare. This study therefore, set out to evaluate the performance of a -two-color icterometer (Bilistrip T) as a possible screening tool for detecting significant jaundice by mothers or care-givers in the first week of life. Methods Prior to discharge, mothers in a maternity hospital were trained to use the Bilistrip T on the blanched skin of their baby's nose to ascertain absence (Light Yellow) or presence (Dark Yellow) of significant jaundice. Their babies had transcutaneous bilirubin (TcB) measurements independently, along with total serum bilirubin (TSB) if indicated. The reliability of Bilistrip T as a screening test for significant jaundice was determined at different TcB and TSB thresholds. The predictive performance of Bilistrip T was also evaluated with multivariable logistic regression. Results Some 2492 mother-infant pairs were enrolled over 15 months, of which 347 (13.9%) chose Dark Yellow. The mean TcB for Dark Yellow (10mg/ dL) was significantly higher (p < 0.001) than for Light Yellow (6.1mg/ dL). Bilistrip T showed increasing sensitivity (47.0% -92.6%) and negative predictive value (NPV) (91.4% -99.9%) for selected TcB thresholds (>= 10mg/ dL, >= 12mg/ dL, >= 15mg/ dL, and >= 17mg/ dL). Among neonates with TSB measurements (n = 124), Bilistrip T was associated also with increasing sensitivity (86.8% -100%) and NPV (62.5% -100%). The sensitivity and NPV for detecting neonates requiring phototherapy were 95.8% respectively. Only one of the 24 neonates who required phototherapy was missed by the Bilistrip (TM) Conclusions Bilistrip T is a potential decision-making tool for empowering mothers to detect neonates with clinically significant jaundice that may require close monitoring or treatment, and neonates not requiring treatment for jaundice in the first week of life.	[Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, Lagos, Nigeria; [Slusher, Tina M.] Univ Minnesota, Dept Pediat, Div Global Hlth, Minneapolis, MN 55455 USA; [Slusher, Tina M.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Imosemi, Donald O.] Lagos Isl Matern Hosp, Lagos, Nigeria; [Emokpae, Abieyuwa A.] Massey St Childrens Hosp, Lagos, Nigeria	University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center	Olusanya, BO (corresponding author), Ctr Hlth Start Initiat, Lagos, Nigeria.	bolajoko.olusanya@uclmail.net	Olusanya, Bolajoko O./F-4504-2012	Olusanya, Bolajoko O./0000-0002-3826-0583	Advanced Instruments Norwood, MA	Advanced Instruments Norwood, MA	Draeger Medical Telford, PA loaned the JM103 (R) transcutaneous bilirubinometer; Advanced Instruments Norwood, MA provided BR2 kits at a subsidized cost for our Advanced Bilirubin Stat-Analyzer. Bilimetrix and sponsors had no role in conceptualizing, analyzing, interpreting, writing, or the decision to submit this paper for publication. The authors have indicated they have no other financial relationships relevant to this article to disclose.	American Academy of Pediatrics Subcommittee on Hyperbilirrubinemia, 2004, PEDIATRICS, V114, P297, DOI DOI 10.1542/PEDS.114.1.297; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Boo N Y, 2011, Med J Malaysia, V66, P239; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Burke BL, 2009, PEDIATRICS, V123, P524, DOI 10.1542/peds.2007-2915; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; CHAIBVA NTR, 1974, S AFR MED J, V48, P1533; Ezeaka CV, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-192; GOSSET IH, 1960, LANCET, V1, P87; Goulet L, 2007, BIRTH-ISS PERINAT C, V34, P131, DOI 10.1111/j.1523-536X.2007.00159.x; GUPTA P C, 1991, Indian Pediatrics, V28, P473; HAMEL BCJ, 1982, TROP DOCT, V12, P213, DOI 10.1177/004947558201200429; Hannon PR, 2001, ARCH PEDIAT ADOL MED, V155, P1357, DOI 10.1001/archpedi.155.12.1357; Hansen TWR, 2011, DEV MED CHILD NEUROL, V53, P24, DOI 10.1111/j.1469-8749.2011.04059.x; Herbert HK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001183; Lain SJ, 2015, PEDIATRICS, V135, P314, DOI 10.1542/peds.2014-2388; Le LT, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-264; Luu MN, 2014, J PAEDIATR CHILD H, V50, P674, DOI 10.1111/jpc.12611; Madlon-Kay DJ, 2002, J FAM PRACTICE, V51, P445; MadlonKay DJ, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.3.e3; Maisels MJ, 2016, ACTA PAEDIATR, V105, pE567, DOI 10.1111/apa.13599; Moawad EMI, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004804; NICE. UK National Institute for Health and Clinical Excellence, 2010, CLIN GUID NEON JAUND; Obuchowski N A, 1998, Stat Methods Med Res, V7, P371, DOI 10.1191/096228098678080061; Olusanya BO, 2016, NIGER J CLIN PRACT, V19, P1, DOI 10.4103/1119-3077.173703; Olusanya BO, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0907; Olusanya BO, 2015, WORLD J PEDIATR, V11, P293, DOI 10.1007/s12519-015-0037-z; Olusanya BO, 2014, ARCH DIS CHILD, V99, P1117, DOI 10.1136/archdischild-2013-305506; SCHUMACHER RE, 1985, PEDIATRICS, V76, P10; Slusher TM, 2015, NEW ENGL J MED, V373, P1115, DOI 10.1056/NEJMoa1501074; Xue GC, 2016, ACTA PAEDIATR, V105, pE561, DOI 10.1111/apa.13542; Zhang L, 2015, MED SCI MONITOR, V21, P1668	33	13	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183882	10.1371/journal.pone.0183882	http://dx.doi.org/10.1371/journal.pone.0183882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837635	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000133
J	Van Goor, A; Stromberg, ZR; Mellata, M				Van Goor, Angelica; Stromberg, Zachary R.; Mellata, Melha			A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli	PLOS ONE			English	Article							IMMUNE-RESPONSES; COMPARATIVE GENOMICS; TRAT PROTEIN; DNA-SEQUENCE; VIRULENCE; RESISTANCE; SERUM; CHICKEN; CELLS; IL-18	Chickens are a major source of protein worldwide, yet infectious diseases continue to threaten the poultry industry. Avian pathogenic Escherichia coli (APEC), a subgroup of extraintestinal pathogenic E. coli (ExPEC), causes colibacillosis in chickens resulting in economic loss because of treatment, condemnation of products, and death. In this study, we evaluated a recombinant antigens (rAg) vaccine combining common ExPEC surface proteins EtsC, OmpA, OmpT, and TraT for broad protective potential against APEC infections in chickens. The specific objectives were to evaluate antibody (serum) and cytokines (lymphoid organs) responses to vaccination; in vitro bactericidal ability of serum and splenocytes against multiple APEC serotypes; and in vivo protection against APEC challenge in chickens. Groups of four-day old chickens (N = 10) were vaccinated twice (two-week interval) subcutaneously with rAgs alone or in combination and CpG adjuvant or PBS (control). IgY antibody in the serum and mRNA expression of IL-1 beta, IL-6, IL-18, IFN-gamma, IL-4, IFN-beta, and IL-8 in bursa, spleen, and thymus were measured using ELISA and RT-qPCR, respectively. Serum and splenocytes were tested for their bactericidal ability in vitro against multiple APEC isolates. Vaccinated and non-vaccinated chickens were challenged with 10(8) CFU of APEC-O2 via air sac at 31 days post first vaccination. Vaccine protection was determined by the decrease of bacterial loads in blood and organs (lung, heart, spleen, and liver), as well as gross colibacillosis lesion scores in air sac, heart, and liver. Vaccination significantly (P < 0.05) elicited IgY against specific antigens, induced immune related mRNA expression in the spleen and bursa, reduced in vitro growth of multiple APEC serotypes, and decreased bacterial loads in the heart and spleen, and gross lesion scores of the air sac, heart and liver in chickens. The vaccine reported may be used to provide broad protection against APEC strains, increasing animal welfare and food production.	[Van Goor, Angelica; Stromberg, Zachary R.; Mellata, Melha] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA	Iowa State University	Mellata, M (corresponding author), Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA.	mmellata@iastate.edu	Mellata, Melha/AAP-5491-2020; Stromberg, Zachary/ABF-4365-2021; Stromberg, Zachary R/H-8711-2018	Stromberg, Zachary/0000-0002-1137-1128; Stromberg, Zachary R/0000-0002-1137-1128; Mellata, Melha/0000-0002-4967-7173; Van Goor, Angelica/0000-0002-0385-7187	U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI [2011-67005-25080]; Iowa State University	U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI; Iowa State University	This research was supported by a grant from the U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI grant 2011-67005-25080 (https://nifa.usda.gov/) to MM and Iowa State University (http://www.iastate.edu/) start-up funding to MM. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1977, P NATL ACAD SCI USA, V74, P5104, DOI 10.1073/pnas.74.11.5104; Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Ariaans MP, 2008, VET IMMUNOL IMMUNOP, V123, P240, DOI 10.1016/j.vetimm.2008.02.003; Barbieri NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072322; BINNS MM, 1979, NATURE, V279, P778, DOI 10.1038/279778a0; Brown PK, 1996, P NATL ACAD SCI USA, V93, P11149, DOI 10.1073/pnas.93.20.11149; CROFT S, 1991, J IMMUNOL, V146, P793; Degen WGJ, 2005, VACCINE, V23, P4212, DOI 10.1016/j.vaccine.2005.04.003; FAO, 2009, FEED WORLD 2050 HIGH; Gobel TW, 2003, J IMMUNOL, V171, P1809, DOI 10.4049/jimmunol.171.4.1809; Guabiraba R, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv118; Guan QF, 2015, APPL MICROBIOL BIOT, V99, P5451, DOI 10.1007/s00253-014-6339-6; HARRISON JL, 1990, RES MICROBIOL, V141, P1009, DOI 10.1016/0923-2508(90)90142-D; Hejair HMA, 2017, RES VET SCI, V115, P109, DOI 10.1016/j.rvsc.2017.01.026; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Jorgensen SL, 2017, STAND GENOMIC SCI, V12, DOI 10.1186/s40793-017-0245-3; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markland SM, 2015, ZOONOSES PUBLIC HLTH, V62, P491, DOI 10.1111/zph.12194; Maturana Victor Goncalves, 2011, Open Microbiol J, V5, P55, DOI 10.2174/1874285801105010055; Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003; Mellata M, 2016, VACCINE, V34, P656, DOI 10.1016/j.vaccine.2015.12.014; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Mitchell NM, 2015, APPL ENVIRON MICROB, V81, P1177, DOI 10.1128/AEM.03524-14; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Nakano H, 2003, INT IMMUNOL, V15, P611, DOI 10.1093/intimm/dxg062; Nie QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041645; Okamura M, 2004, COMP IMMUNOL MICROB, V27, P255, DOI 10.1016/j.cimid.2003.12.001; Olsen RH, 2012, VET MICROBIOL, V158, P384, DOI 10.1016/j.vetmic.2012.03.008; Pfaff-McDonough SJ, 2000, AVIAN DIS, V44, P23, DOI 10.2307/1592504; Pollock KGJ, 2003, IMMUNOLOGY, V108, P137, DOI 10.1046/j.1365-2567.2003.01581.x; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; PRAMOONJAGO P, 1992, J IMMUNOL, V148, P827; RUSSELLJONES GJ, 1993, VACCINE, V11, P1310, DOI 10.1016/0264-410X(93)90100-C; Sadeyen JR, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-19; Sandford Erin E, 2012, Results Immunol, V2, P44, DOI 10.1016/j.rinim.2012.02.003; Sandford EE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-469; Schouler C, 2012, J CLIN MICROBIOL, V50, P1673, DOI 10.1128/JCM.05057-11; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Stacy AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086565; Stromberg ZR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180599; Sun H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1209-2; Teng CH, 2006, INFECT IMMUN, V74, P5609, DOI 10.1128/IAI.00321-06; Wan L, 2014, PAK J PHARM SCI, V27, P617; Wang Y, 2010, AVIAN PATHOL, V39, P297, DOI 10.1080/03079457.2010.495742; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991; Wieser A, 2012, INT J MED MICROBIOL, V302, P10, DOI 10.1016/j.ijmm.2011.09.012; Wieser A, 2010, INFECT IMMUN, V78, P3432, DOI 10.1128/IAI.00174-10; Wijetunge DS, 2015, GENOME ANNOUNC, V3; Xie Y, 2008, BIOCHEM BIOPH RES CO, V365, P201, DOI 10.1016/j.bbrc.2007.10.174	52	12	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183929	10.1371/journal.pone.0183929	http://dx.doi.org/10.1371/journal.pone.0183929			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837660	Green Submitted, gold, Green Published			2022-12-26	WOS:000408365000136
J	Hsu, FF; Chiang, MT; Li, FA; Yeh, CT; Lee, WH; Chau, LY				Hsu, F-F; Chiang, M-T; Li, F-A; Yeh, C-T; Lee, W-H; Chau, L-Y			Acetylation is essential for nuclear heme oxygenase-1-enhanced tumor growth and invasiveness	ONCOGENE			English	Article							SIGNAL PEPTIDE PEPTIDASE; CHRONIC MYELOID-LEUKEMIA; PROSTATE-CANCER CELLS; CONFERS RESISTANCE; HDAC INHIBITORS; LUNG-CANCER; PROLIFERATION; INVASION; JUND; TRANSCRIPTION	Overexpression of heme oxygenase-1 (HO-1), an endoplasmic reticulum-anchored enzyme, is observed in many cancers. HO-1 nuclear translocation has been shown to correlate with progression of several cancers. We recently reported that HO-1 is susceptible to intramembrane proteolysis and translocates to the nucleus to promote cancer growth and invasiveness without depending on its enzymatic activity. In the present study, we show that the HO-1 lacking C-terminal transmembrane segment (t-HO-1) was susceptible to acetylation by p300 and CREB-binding protein (CBP) histone acetyltransferase in the nucleus. Mass spectrometry analysis of HO-1 isolated from human embryonic kidney cells 293T (HEK293T) cells overexpressing CBP and t-HO-1 revealed two acetylation sites located at K243 and K256. Mutation of both lysine residues to arginine (R) abolished t-HO-1-enhanced tumor cell growth, migration and invasion. However, mutation of the lysine residues to glutamine (Q), a mimic of acetylated lysine, had no significant effect on t-HO-1-mediated tumorigenicity. Mechanistic studies demonstrated that transcriptional factor JunD interacted with wild-type (WT) t-HO-1 and mutant carrying K243/256Q but not K243/256 R mutation. Moreover, JunD-induced AP-1 transcriptional activity was significantly enhanced by coexpression with WT and acetylation-mimic but not acetylation-defective t-HO-1. Consistent with the in vitro observations, the implication of K243/256 acetylation in t-HO-1-enhanced tumorigenicity was also demonstrated in xenograft models. Immunohistochemistry performed with a specific antibody against acetyl-HO-1 showed the positive acetyl-HO-1 nuclear staining in human lung cancer tissues but not in the corresponding non-tumor tissues, supporting its clinical significance. Collectively, our findings highlight the importance of nuclear HO-1 post-translational modification in the induction of cancer progression.	[Hsu, F-F; Chiang, M-T; Li, F-A; Chau, L-Y] Acad Sinica, Inst Biomed Sci, 128,Sec 2,Acad Rd, Taipei 115, Taiwan; [Yeh, C-T; Lee, W-H] Taipei Med Univ, Shuang Ho Hosp, Canc Ctr, Taipei, Taiwan	Academia Sinica - Taiwan; Taipei Medical University; Shuang Ho Hospital	Chau, LY (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sec 2,Acad Rd, Taipei 115, Taiwan.	lyc@ibms.sinica.edu.tw	Chau, Lee-Young/N-7659-2018; Li, Fu-An/M-8506-2019	Chau, Lee-Young/0000-0002-6316-2328; Li, Fu-An/0000-0002-0580-7765	Ministry of Science and Technology Taiwan [MOST 103-2320-B-001-013-MY3]; IBMS proteomics core	Ministry of Science and Technology Taiwan(Ministry of Science and Technology, Taiwan); IBMS proteomics core	This work was supported by the Ministry of Science and Technology Taiwan (MOST 103-2320-B-001-013-MY3). We thank IBMS proteomics core for the LC-MS analysis.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Biswas C, 2014, J BIOL CHEM, V289, P26882, DOI 10.1074/jbc.M114.567685; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Chau LY, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0128-0; Collinson EJ, 2011, J BIOL CHEM, V286, P2205, DOI 10.1074/jbc.M110.187062; Das C, 2005, IUBMB LIFE, V57, P137, DOI 10.1080/15216540500090629; Degese MS, 2012, LUNG CANCER, V77, P168, DOI 10.1016/j.lungcan.2012.02.016; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; Gandini NA, 2012, EXP MOL PATHOL, V93, P237, DOI 10.1016/j.yexmp.2012.05.001; Hanna Colton, 2016, J Vis Exp, DOI 10.3791/54944; Hernandez JM, 2008, ONCOGENE, V27, P4757, DOI 10.1038/onc.2008.120; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hsu FF, 2015, ONCOGENE, V34, P2360, DOI 10.1038/onc.2014.166; Hwang HW, 2009, J BIOL CHEM, V284, P22672, DOI 10.1074/jbc.M109.028001; Kajanne R, 2009, INT J ONCOL, V35, P1175, DOI 10.3892/ijo_00000434; Kaypee S, 2016, PHARMACOL THERAPEUT, V162, P98, DOI 10.1016/j.pharmthera.2016.01.011; Li MY, 2008, EUR RESPIR J, V32, P911, DOI 10.1183/09031936.00064508; Lin KT, 2012, CLIN CANCER RES, V18, P4691, DOI 10.1158/1078-0432.CCR-12-0633; Lin PH, 2013, ONCOGENE, V32, P2325, DOI 10.1038/onc.2012.244; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Liu XF, 2016, CELL REP, V14, P1169, DOI 10.1016/j.celrep.2015.12.104; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; Millena AC, 2016, J BIOL CHEM, V291, P17964, DOI 10.1074/jbc.M116.714899; Miyake M, 2011, ONCOL REP, V25, P653, DOI 10.3892/or.2010.1125; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okazaki S, 1998, BIOCHEM BIOPH RES CO, V250, P347, DOI 10.1006/bbrc.1998.9331; Otterbein LE, 2011, P NATL ACAD SCI USA, V108, P14491, DOI 10.1073/pnas.1102295108; Pulukuri SMK, 2007, J BIOL CHEM, V282, P35594, DOI 10.1074/jbc.M705867200; Sacca P, 2007, BRIT J CANCER, V97, P1683, DOI 10.1038/sj.bjc.6604081; Sunamura Makoto, 2003, Angiogenesis, V6, P15, DOI 10.1023/A:1025803600840; Tibullo D, 2016, ONCOTARGET, V7, P28868, DOI 10.18632/oncotarget.7563; Tibullo D, 2013, CURR PHARM DESIGN, V19, P2765, DOI 10.2174/1381612811319150012; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Wang D, 2008, BIOTECH HISTOCHEM, V83, P179, DOI 10.1080/10520290802451085; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Wegiel B, 2013, CANCER RES, V73, P7009, DOI 10.1158/0008-5472.CAN-13-1075; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xu L, 2015, ONCOL REP, V33, P1057, DOI 10.3892/or.2014.3680; Zerbini LF, 2011, CELL CYCLE, V10, P2583, DOI 10.4161/cc.10.15.16057; Zhang Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2350-x	44	22	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 7	2017	36	49					6805	6814		10.1038/onc.2017.294	http://dx.doi.org/10.1038/onc.2017.294			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FP0IK	28846111				2022-12-26	WOS:000417282500006
J	Grabinska, KA; Edani, BH; Park, EJ; Kraehling, JR; Sessa, WC				Grabinska, Kariona A.; Edani, Ban H.; Park, Eon Joo; Kraehling, Jan R.; Sessa, William C.			A conserved C-terminal RXG motif in the NgBR subunit of cis-prenyltransferase is critical for prenyltransferase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE; UNDECAPRENYL-PYROPHOSPHATE SYNTHASE; NOGO-B RECEPTOR; DOLICHYL-PHOSPHATE BIOSYNTHESIS; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; RUBBER BIOSYNTHESIS; KEY ENZYME; IDENTIFICATION; GLYCOSYLATION	cis-Prenyltransferases (cis-PTs) constitute a large family of enzymes conserved during evolution and present in all domains of life. In eukaryotes and archaea, cis-PT is the first enzyme committed to the synthesis of dolichyl phosphate, an obligate lipid carrier in protein glycosylation reactions. The homodimeric bacterial enzyme, undecaprenyl diphosphate synthase, generates 11 isoprene units and has been structurally and mechanistically characterized in great detail. Recently, we discovered that unlike undecaprenyl diphosphate synthase, mammalian cis-PT is a heteromer consisting of NgBR (Nus1) and hCIT (dehydrodolichol diphosphate synthase) subunits, and this composition has been confirmed in plants and fungal cis-PTs. Here, we establish the first purification system for heteromeric cis-PT and show that both NgBR and hCIT subunits function in catalysis and substrate binding. Finally, we identified a critical RXG sequence in the C-terminal tail of NgBR that is conserved and essential for enzyme activity across phyla. In summary, our findings show that eukaryotic cis-PT is composed of the NgBR and hCIT subunits. The strong conservation of the RXG motif among NgBR orthologs indicates that this subunit is critical for the synthesis of polyprenol diphosphates and cellular function.	Yale Univ, Sch Med, Dept Pharmacol & Vasc Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Therapeut Program, New Haven, CT 06520 USA	Yale University; Yale University	Sessa, WC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, Vasc Biol & Therapeut Program, Amistad Res Bldg,10 Amistad St, New Haven, CT 06520 USA.	william.sessa@yale.edu	Sessa, William C/B-6844-2011	Sessa, William C/0000-0001-5759-1938; Grabinska, Kariona A./0000-0002-1232-2555	National Institutes of Health [R01 HL64793, R01 HL61371, HL133018]; Leducq Fondation (MIRVAD network); American Heart Association Scientist Development Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133018, R01HL064793, R01HL061371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Fondation (MIRVAD network); American Heart Association Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL64793, R01 HL61371, and HL133018; a grant from the Leducq Fondation (MIRVAD network; to W. C. S.); and an American Heart Association Scientist Development Grant (to E. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADAIR WL, 1987, ARCH BIOCHEM BIOPHYS, V259, P589; ADAIR WL, 1984, J BIOL CHEM, V259, P4441; Akhtar TA, 2013, PLANT J, V73, P640, DOI 10.1111/tpj.12063; Apfel CM, 1999, J BACTERIOL, V181, P483, DOI 10.1128/JB.181.2.483-492.1999; Brasher MI, 2015, PLANT J, V82, P903, DOI 10.1111/tpj.12859; Chan YT, 2017, ACS OMEGA, V2, P930, DOI 10.1021/acsomega.6b00562; Chang SY, 2003, J BIOL CHEM, V278, P29298, DOI 10.1074/jbc.M302687200; Cunillera N, 2000, FEBS LETT, V477, P170, DOI 10.1016/S0014-5793(00)01798-1; DENNIS MS, 1989, J BIOL CHEM, V264, P18618; Dowhan W, 2017, J BIOL CHEM, V292, P10755, DOI 10.1074/jbc.X117.794891; Endo S, 2003, BBA-GENE STRUCT EXPR, V1625, P291, DOI 10.1016/S0167-4781(02)00628-0; Epping J, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.48; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; Grabinska K, 2005, ACTA BIOCHIM POL, V52, P221; Grabinska KA, 2016, J BIOL CHEM, V291, P18582, DOI 10.1074/jbc.R116.739490; Grabinska KA, 2010, GLYCOBIOLOGY, V20, P824, DOI 10.1093/glycob/cwq036; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Hartley MD, 2012, ARCH BIOCHEM BIOPHYS, V517, P83, DOI 10.1016/j.abb.2011.10.018; Kera K, 2012, FEBS J, V279, P3813, DOI 10.1111/j.1742-4658.2012.08742.x; Ko TP, 2001, J BIOL CHEM, V276, P47474, DOI 10.1074/jbc.M106747200; KOYAMA T, 1988, J BIOCHEM-TOKYO, V103, P867, DOI 10.1093/oxfordjournals.jbchem.a122363; Kurisaki A, 1996, BIOSCI BIOTECH BIOCH, V60, P1109, DOI 10.1271/bbb.60.1109; Kwon M, 2016, METHOD ENZYMOL, V576, P121, DOI 10.1016/bs.mie.2016.02.026; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Milani D, 2016, CONGENIT ANOM, V56, P187, DOI 10.1111/cga.12164; Ogawa T, 2016, FEBS J, V283, P2369, DOI 10.1111/febs.13749; Oh SK, 2000, J BIOL CHEM, V275, P18482, DOI 10.1074/jbc.M002000200; Park EJ, 2016, EMBO REP, V17, P167, DOI 10.15252/embr.201540789; Park EJ, 2014, CELL METAB, V20, P448, DOI 10.1016/j.cmet.2014.06.016; Qu Y, 2015, J BIOL CHEM, V290, P1898, DOI 10.1074/jbc.M114.616920; Sabry S, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0468-1; Sato M, 1999, MOL CELL BIOL, V19, P471; Shridas P, 2003, BIOCHEM BIOPH RES CO, V312, P1349, DOI 10.1016/j.bbrc.2003.11.065; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Surmacz L, 2014, BBA-MOL CELL BIOL L, V1841, P240, DOI 10.1016/j.bbalip.2013.11.011; Szafranski P, 2015, EUR J HUM GENET, V23, P173, DOI 10.1038/ejhg.2014.75; Szkopinska A, 1997, J LIPID RES, V38, P962; Takahashi S, 2006, CHEM REC, V6, P194, DOI 10.1002/tcr.20083; Teng KH, 2012, BIOORG CHEM, V43, P51, DOI 10.1016/j.bioorg.2011.09.004; Venturini G, 2015, GENET MED, V17, P285, DOI 10.1038/gim.2014.132; Wang W, 2008, J MOL BIOL, V381, P129, DOI 10.1016/j.jmb.2008.05.060; Weiss MC, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.116, 10.1038/NMICROBIOL.2016.116]; Yamashita S., 2016, HEVEA BRASILIENSIS E, V5; Zelinger L, 2011, AM J HUM GENET, V88, P207, DOI 10.1016/j.ajhg.2011.01.002; Zhang HR, 2008, PLANT CELL, V20, P1879, DOI 10.1105/tpc.108.061150; Zuchner S, 2011, AM J HUM GENET, V88, P201, DOI 10.1016/j.ajhg.2011.01.001	47	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17351	17361		10.1074/jbc.M117.806034	http://dx.doi.org/10.1074/jbc.M117.806034			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28842490	Green Published, hybrid			2022-12-26	WOS:000414009300017
J	Punia, R; Raina, K; Agarwal, R; Singh, RP				Punia, Reenu; Raina, Komal; Agarwal, Rajesh; Singh, Rana P.			Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells	PLOS ONE			English	Article							CANCER CELLS; IN-VITRO; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; CYCLE ARREST; COMBINATION; EXPRESSION; APOPTOSIS; GROWTH; VIVO	Background Anthracyclines are efficient and potent agents to treat broad range of cancers but cytotoxicity induced by them limits their use in therapeutics. Use of plant-derived agents help to prevent or delay the process of cancer progression and their combination increases the anticancer potential of mainstream compound. However, multidrug resistance is major cause of treatment failure in cancer patients. Purpose In this study, combination treatments of fisetin or acacetin with doxorubicin were explored for their potential synergistic effect on non-small-cell lung carcinoma (NSCLC) cells. Study design During this study, NSCLC model cell lines A549 and H1299 were used to determine the combinatorial effect of phytochemicals namly acacetin and fisetin with doxorubicin. Methods The effects of individual compounds and their combination on cell viability, clonogenic potential and cell cycle progression were studied. Efflux of doxorubicin was measured by spectrofluorophotometer, whereas accumulation inside the cells was analyzed by flow cytometry and confocal microscopy. Expression of MDR1 was checked by semi-quantitative PCR. Results The results showed that the cell viability of A549 and H1299 cells were significantly decreased in time-and dose-dependent manner, although A549 cells showed more sensitivity toward doxorubicin than H1299 cells. Mostly, combination of doxorubicin showed good synergy with acacetin in both the cell lines whereas, fisetin exerted synergistic effect only at 72 h of treatment in H1299 cells. Acacetin with doxorubicin caused G2/M arrest by downregulating CDK-cyclin complex in A549 cells. Acacetin-doxorubicin combination decreased the clonogenic potential of A549 and H1299 cells upto 82% and 59%, respectively, as compared to control. Acacetin also decreased efflux of doxorubicin by 59% after 30 mins of exposure to A549 cells and further increased accumulation of doxorubicin inside the cells upto 55% in 2 h. The modulatory effect of acacetin-doxorubicin combination on doxorubicin influx and efflux was mediated through downregulation of MDR1 treansporter in NSCLC cells. Conclusion These findings suggested that acacetin augments the cytotoxicity of doxorubicin at lower concentrations in lung cancer cells. Their combination leads to more retention of doxorubicin in the cells by modulating drug trasporter and thus enhances its therapeutic potential.	[Punia, Reenu; Singh, Rana P.] Cent Univ Gujarat, Sch Life Sci, Gandhinagar, Gujarat, India; [Punia, Reenu; Singh, Rana P.] Jawaharlal Nehru Univ, Sch Life Sci, Canc Biol Lab, New Delhi, India; [Raina, Komal; Agarwal, Rajesh] Univ Colorado Denver, Sch Pharm, Dept Pharmaceut Sci, Aurora, CO USA; [Raina, Komal; Agarwal, Rajesh] Univ Colorado, Ctr Canc, Aurora, CO USA	Central University of Gujarat; Jawaharlal Nehru University, New Delhi; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Singh, RP (corresponding author), Cent Univ Gujarat, Sch Life Sci, Gandhinagar, Gujarat, India.; Singh, RP (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Canc Biol Lab, New Delhi, India.	ranaps@hotmail.com		Singh, Rana Pratap/0000-0003-4261-7044; Raina, Komal/0000-0003-0371-1070	Central University of Gujarat, India; DST-PURSE, India; UPE-II, India; UGCRN, India; JNU, India; NCI Cancer Center Support Grant [P30CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Central University of Gujarat, India; DST-PURSE, India; UPE-II, India; UGCRN, India; JNU, India; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funding support by Central University of Gujarat, India; DST-PURSE, UPE-II and UGC-RN, JNU, India are gratefully acknowledged. FAGS analysis core facility of University of Colorado Cancer Center through funding from NCI Cancer Center Support Grant (P30CA046934) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bai XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149370; Bhat TA, 2013, CANCER PREV RES, V6, P1128, DOI 10.1158/1940-6207.CAPR-13-0209; Bhat TA, 2012, CARCINOGENESIS, V33, P385, DOI 10.1093/carcin/bgr282; Bidet M, 2012, MOL CANCER RES, V10, P1496, DOI 10.1158/1541-7786.MCR-11-0578; Hemaiswarya S, 2013, PHYTOMEDICINE, V20, P151, DOI 10.1016/j.phymed.2012.10.009; Hershman DL, 2009, ONCOLOGY-NY, V23, P227; Hu J, 2015, ONCOTARGET, V6, P44643, DOI 10.18632/oncotarget.5989; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Kim HR, INT J MOL MED; Kim KY, 2015, MOL MED REP, V12, P1898, DOI 10.3892/mmr.2015.3633; Klimaszewska-Wisniewska A, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0288-3; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; Mateen S, 2010, MOL CARCINOGEN, V49, P247, DOI 10.1002/mc.20595; Meng GM, 2015, INT J ONCOL, V46, P1007, DOI 10.3892/ijo.2015.2814; Mi J, 2008, MOL THER, V16, P66, DOI 10.1038/sj.mt.6300320; Mittal A, 2014, PHYTOMEDICINE, V21, P340, DOI 10.1016/j.phymed.2013.09.002; Pal HC, 2016, MINI-REV MED CHEM, V16, P953, DOI 10.2174/1389557516666160211120157; Sadava D, 2013, CANCER LETT, V339, P102, DOI 10.1016/j.canlet.2013.07.017; Shanker M, 2010, LUNG CANCER-TARGETS, V1, P23; Shin H, 2012, ONCOL REP, V27, P1111, DOI 10.3892/or.2011.1585; Singh N, 2013, NUTR CANCER, V65, P36, DOI 10.1080/01635581.2013.785007; Stewart DJ, 2010, CRIT REV ONCOL HEMAT, V75, P173, DOI 10.1016/j.critrevonc.2009.11.006; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; TAYLOR CW, 1991, BRIT J CANCER, V63, P923, DOI 10.1038/bjc.1991.202; Vatsyayan R, 2009, INT J ONCOL, V34, P1505, DOI 10.3892/ijo_00000279; Vinod BS, 2013, ANTIOXID REDOX SIGN, V18, P1307, DOI 10.1089/ars.2012.4573; Vundru SS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-280; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Xu GD, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-174; Zhou Z, 2016, SCI PROGRAM, V2016, P1, DOI DOI 10.1016/J.T0XLET.2016.07.710	31	42	42	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0182870	10.1371/journal.pone.0182870	http://dx.doi.org/10.1371/journal.pone.0182870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859099	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500007
J	Kato, S; Osaki, T; Kamiya, S; Zhang, XS; Blaser, MJ				Kato, Seiichi; Osaki, Takako; Kamiya, Shigeru; Zhang, Xue-Song; Blaser, Martin J.			Helicobacter pylori sabA gene is associated with iron deficiency anemia in childhood and adolescence	PLOS ONE			English	Article							JAPANESE CHILDREN; INFECTION; EXPRESSION; CYTOTOXIN; GASTRITIS; FUR; IDENTIFICATION; PATHOGENESIS; MULTICENTER; ACTIVATION	Background Gastric Helicobacter pylori colonization leads to iron deficiency anemia (IDA), especially in children and adolescents. However the pathogenesis is poorly understood. Objective We sought to identify specific H. pylori genes involved in IDA development, by comparing bacterial genome-wide expression profiling in patients affected or not. Methods H. pylori were isolated from four children with IDA and four from matched controls without IDA. Based on these isolates, cDNA microarrays under iron-replete or depleted conditions were systematically performed to compare gene expression profiles at the whole genome level. Real-time reverse-transcription (RT-) PCR and protein assays were performed for further assessing the profile differentiation of the identified H. pylori IDA-associated genes. Results We identified 29 and 11 genes with significantly higher or lower expression in the IDA isolates compared to non-IDA isolates, respectively. Especially notable were higher expression of sabA gene encoding sialic acid-binding adhesin in the IDA isolates, which was confirmed by real-time RT-PCR study. Moreover, iron-depletion in vitro led to up-regulation of fecA1 and frpB1 genes and down-regulation of pfr, as predicted. Known iron-regulated genes such as fur, pfr, fecA, and feoB did not significantly differ between both groups. The IDA isolates had significantly higher expression of vacuolating cytotoxin gene vacA than non-IDA isolates, consistent with the results of VacA protein assays. There were no significant differences in bacterial growth value between IDA and non-IDA isolates. Conclusions It is likely that H. pylori carrying high expression of sabA causes IDA, especially in children and adolescents who have increased daily iron demand. In addition, it is possible that several host-interactive genes, including vacA, may play a synergistic role for sabA in IDA development.	[Kato, Seiichi] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi, Japan; [Kato, Seiichi; Osaki, Takako; Kamiya, Shigeru] Kyorin Univ, Sch Med, Dept Infect Dis, Mitaka, Tokyo, Japan; [Zhang, Xue-Song; Blaser, Martin J.] NYU, Sch Med, Dept Med, New York, NY USA; [Zhang, Xue-Song; Blaser, Martin J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Kato, Seiichi] Kato Childrens Clin, Natori, Miyagi, Japan	Tohoku University; Kyorin University; New York University; New York University	Kato, S (corresponding author), Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi, Japan.; Kato, S (corresponding author), Kyorin Univ, Sch Med, Dept Infect Dis, Mitaka, Tokyo, Japan.; Kato, S (corresponding author), Kato Childrens Clin, Natori, Miyagi, Japan.	skato@kato-kidsclinic.jp		Zhang, Xue-Song/0000-0001-5080-0098; Blaser, Martin/0000-0003-2447-2443	Japan Society for the Promotion of Science [JP19590709, JP21590492]; National Institutes of Health [R01GM63270]; Knapp Family Fund; Grants-in-Aid for Scientific Research [15K08471] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knapp Family Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work of SeK is supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/j-grantsinaid/index.html) to SeK (Grant No. JP19590709). The work of TO and ShK is supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/j.grantsinaid/index.html) to TO (Grant No. JP21590492). The work of XSZ and MJB is supported by the National Institutes of Health (R01GM63270) (https://grants.nih.gov/grants/oer.htm) and the Knapp Family Fund (https://www.theknappfamilyfoundation.org/) to MJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Annibale B, 2003, GUT, V52, P496, DOI 10.1136/gut.52.4.496; Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Barabino A, 2002, HELICOBACTER, V7, P71, DOI 10.1046/j.1083-4389.2002.00073.x; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Choe YH, 2001, J PEDIATR-US, V139, P100, DOI 10.1067/mpd.2001.114700; Choe YH, 2001, HELICOBACTER, V6, P55, DOI 10.1046/j.1523-5378.2001.00007.x; de Klerk N, 2016, INFECT IMMUN, V84, P1526, DOI 10.1128/IAI.00163-16; Delany I, 2001, J BACTERIOL, V183, P4932, DOI 10.1128/JB.183.16.4932-4937.2001; Dhaenens L, 1997, INFECT IMMUN, V65, P514, DOI 10.1128/IAI.65.2.514-518.1997; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Ernst FD, 2005, MICROBIOL-SGM, V151, P533, DOI 10.1099/mic.0.27404-0; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Jeon BH, 2004, HELICOBACTER, V9, P330, DOI 10.1111/j.1083-4389.2004.00239.x; Kao CY, 2012, HELICOBACTER, V17, P411, DOI 10.1111/j.1523-5378.2012.00974.x; Kato S, 2006, DIGEST DIS SCI, V51, P99, DOI 10.1007/s10620-006-3091-5; Kato S, 2004, J GASTROENTEROL, V39, P734, DOI 10.1007/s00535-004-1381-2; Kato S, 2004, HELICOBACTER, V9, P100, DOI 10.1111/j.1083-4389.2004.00205.x; Kato S, 2002, AM J GASTROENTEROL, V97, P1668, DOI 10.1111/j.1572-0241.2002.05825.x; Kato S, 1998, HELICOBACTER, V3, P278, DOI 10.1046/j.1523-5378.1998.08030.x-i1; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lombard M, 1997, GUT, V40, P435, DOI 10.1136/gut.40.4.435; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Merrell DS, 2003, INFECT IMMUN, V71, P6510, DOI 10.1128/IAI.71.11.6510-6525.2003; Naz A, 2015, INFECT GENET EVOL, V32, P280, DOI 10.1016/j.meegid.2015.03.027; Park SA, 2006, PROTEOMICS, V6, P1319, DOI 10.1002/pmic.200500293; Rathinavelu S, 2005, HELICOBACTER, V10, P424, DOI 10.1111/j.1523-5378.2005.00350.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Unemo M, 2005, J BIOL CHEM, V280, P15390, DOI 10.1074/jbc.M412725200; van Vliet AHM, 2002, HELICOBACTER, V7, P237, DOI 10.1046/j.1523-5378.2002.00088.x; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; WORST DJ, 1995, INFECT IMMUN, V63, P4161, DOI 10.1128/IAI.63.10.4161-4165.1995; Yamaguchi H, 1998, FEMS MICROBIOL LETT, V168, P277; Yamaoka Y, 2008, J INFECT DEV COUNTR, V2, P174, DOI 10.3855/jidc.259; Yokota S, 2008, CLIN INFECT DIS, V46, pE31, DOI 10.1086/526784; Yuan JP, 2004, WORLD J GASTROENTERO, V10, P1528	37	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184046	10.1371/journal.pone.0184046	http://dx.doi.org/10.1371/journal.pone.0184046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854239	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600081
J	Shrestha, G; Skovgard, H; Reddy, GVP; Steenberg, T; Enkegaard, A				Shrestha, Govinda; Skovgard, Henrik; Reddy, Gadi V. P.; Steenberg, Tove; Enkegaard, Annie			Role of the aphid species and their feeding locations in parasitization behavior of Aphelinus abdominalis, a parasitoid of the lettuce aphid Nasonovia ribisnigri	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; HEMIPTERA APHIDIDAE; HYMENOPTERA-APHELINIDAE; INSECTICIDE RESISTANCE; OVIPOSITION DECISIONS; COLEMANI HYMENOPTERA; ACYRTHOSIPHON-PISUM; BEAUVERIA-BASSIANA; BINODOXYS-COMMUNIS; NATURAL ENEMIES	Aphid species feeding on lettuce occupy distinct feeding sites: the lettuce aphid Nasonovia ribisnigri prefers to feed on heart leaves, whereas the potato aphid Macrosiphum euphorbiae feeds only on outer leaves. The aphid parasitoid Aphelinus abdominalis, known to be able to regulate M. euphorbiae on many crops, has recently been indicated as a promising biocontrol candidate also for use against N. ribisnigri, a major pest of lettuce. This study therefore examined A. abdominalis parasitization preference between N. ribisnigri and M. euphorbiae and its ability to parasitize aphids feeding on different parts of lettuce plants. In addition, life history traits of A. abdominalis on these aphid species were investigated. In nochoice laboratory experiments on leaf discs and 24 h exposure, A. abdominalis successfully parasitized 54% and 60% of the offered N. ribisnigri and M. euphorbiae, respectively, with no significant difference. In the corresponding choice experiment, however, A. abdominalis had a tendency for a significantly higher preference for M. euphorbiae (38%) compared to N. ribisnigri (30%). Growth chamber experiments on whole plants demonstrated that A. abdominalis was able to parasitize aphids, regardless of their feeding locations on lettuce plants. However, aphid feeding behavior had a significant effect on the parasitization rate. A. abdominalis parasitized significantly higher percentages of M. euphorbiae or N. ribisnigri when aphids were exposed separately to parasitoids on whole lettuce plants as compared with N. ribisnigri exposed only on heart leaf. A significant preference of A. abdominalis for M. euphorbiae compared to N. ribisnigri was also observed in the growth chamber choice experiment. A high percentage of adult emergence (> 84%) and female-biased sex ratio (> 83%) were found irrespective of the aphid species.	[Shrestha, Govinda; Reddy, Gadi V. P.] Montana State Univ, Western Triangle Ag Res Ctr, Conrad, MT 59425 USA; [Shrestha, Govinda; Skovgard, Henrik; Steenberg, Tove; Enkegaard, Annie] Aarhus Univ, Res Ctr Flakkebjerg, Dept Agroecol Sci & Technol, Forsogsvej 1, Slagelse, Denmark	Montana State University System; Montana State University Bozeman; Aarhus University	Shrestha, G (corresponding author), Montana State Univ, Western Triangle Ag Res Ctr, Conrad, MT 59425 USA.; Shrestha, G (corresponding author), Aarhus Univ, Res Ctr Flakkebjerg, Dept Agroecol Sci & Technol, Forsogsvej 1, Slagelse, Denmark.	govinda.shrestha@montana.edu	Reddy, Gadi V.P./J-5270-2015	Reddy, Gadi V.P./0000-0001-6377-0721	Aarhus University Denmark; National Institute of Food and Agriculture, U.S. Department of Agriculture [W3185]; Working Group Biological Control of Pest Management Systems of Plants [231844]	Aarhus University Denmark; National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Working Group Biological Control of Pest Management Systems of Plants	This study was financially supported by Aarhus University Denmark and the National Institute of Food and Agriculture, U.S. Department of Agriculture, Multistate Project W3185, The Working Group Biological Control of Pest Management Systems of Plants under Accession #231844.	[Anonymous], 2012, LANG ENV STAT COMP; [Anonymous], 1925, J ECON ENTOMOL; Asman K, 2007, BIOL AGRIC HORTIC, V25, P153, DOI 10.1080/01448765.2007.9755043; Asplen MK, 2014, ECOL ENTOMOL, V39, P736, DOI 10.1111/een.12153; Barber MD, 1999, B ENTOMOL RES, V89, P17, DOI 10.1017/S0007485399000036; Battaglia D, 2000, ENTOMOL EXP APPL, V94, P219, DOI 10.1023/A:1003968700811; Blackman R.L., 2000, J ECON ENTOMOL, V2; Boivin G, 2012, CAN J PLANT SCI, V92, P1, DOI [10.4141/cjps2011-045, 10.4141/CJPS2011-045]; Bruck E, 2009, CROP PROT, V28, P838, DOI 10.1016/j.cropro.2009.06.015; Bueno V, 2002, APH 2002 8 INT S EC, P17; CHARNOV EL, 1985, ENVIRON ENTOMOL, V14, P383, DOI 10.1093/ee/14.4.383; Chau A, 2001, BIOL CONTROL, V20, P30, DOI 10.1006/bcon.2000.0881; Colinet H, 2005, ECOL ENTOMOL, V30, P473, DOI 10.1111/j.0307-6946.2005.00716.x; De Conti BF, 2011, B INSECTOL, V64, P63; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Desneux N, 2009, ANN ENTOMOL SOC AM, V102, P925, DOI 10.1603/008.102.0603; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Desneux N, 2009, J INSECT PHYSIOL, V55, P321, DOI 10.1016/j.jinsphys.2008.12.009; Dewar AM, 2007, APHIDS AS CROP PESTS, P391, DOI 10.1079/9780851998190.0391; Diaz BM, 2009, BIOCONTROL, V54, P825, DOI 10.1007/s10526-009-9218-9; Diaz BM, 2005, ENVIRON ENTOMOL, V34, P527, DOI 10.1603/0046-225X-34.3.527; Fagan LL, 2010, B ENTOMOL RES, V100, P217, DOI 10.1017/S0007485309990174; FLETCHER JP, 1994, P ROY SOC B-BIOL SCI, V258, P163, DOI 10.1098/rspb.1994.0157; Fournier V, 2000, ENVIRON ENTOMOL, V29, P568, DOI 10.1603/0046-225X-29.3.568; GARDNER SM, 1985, ECOL ENTOMOL, V10, P171, DOI 10.1111/j.1365-2311.1985.tb00546.x; GERLING D, 1990, J INSECT BEHAV, V3, P501, DOI 10.1007/BF01052014; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Hagvar E.B., 1991, Biocontrol News and Information, V12, P13; Heimpel GE, 2000, BIOL CONTROL, V19, P77, DOI 10.1006/bcon.2000.0849; Honek A, 1998, J AGR ENTOMOL, V15, P209; Hopper JV, 2011, BIOL CONTROL, V58, P271, DOI 10.1016/j.biocontrol.2011.03.017; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jarosik V, 2003, B ENTOMOL RES, V93, P255, DOI 10.1079/BER2003229; Jarosik V, 1996, OCHR ROSTL, V32, P82; Kift NB, 2004, AGR FOREST ENTOMOL, V6, P295, DOI 10.1111/j.1461-9555.2004.00226.x; Koureas M, 2012, TOXICOL LETT, V210, P155, DOI 10.1016/j.toxlet.2011.10.007; Libbrecht R, 2007, J INSECT BEHAV, V20, P25, DOI 10.1007/s10905-006-9055-y; Liu YB, 2004, J ECON ENTOMOL, V97, P883, DOI 10.1603/0022-0493(2004)097[0883:DAPDON]2.0.CO;2; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; MACKENZIE J R, 1988, Journal of the Entomological Society of British Columbia, V85, P10; MINKENBERG OPJM, 1992, OIKOS, V65, P134, DOI 10.2307/3544896; MUELLER TF, 1992, J APPL ENTOMOL, V114, P143, DOI 10.1111/j.1439-0418.1992.tb01109.x; Ode PJ, 2005, ENTOMOL EXP APPL, V115, P303, DOI 10.1111/j.1570-7458.2005.00261.x; Parker WE, 2002, CROP PROT, V21, P235, DOI 10.1016/S0261-2194(01)00090-4; Perdikis DC, 2004, EUR J ENTOMOL, V101, P333, DOI 10.14411/eje.2004.044; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; QUENTIN U, 1995, J APPL ENTOMOL, V119, P227, DOI 10.1111/j.1439-0418.1995.tb01275.x; Reinink K., 1993, IOBC-WPRS Bulletin, V16, P56; Rohne O, 2002, J APPL ENTOMOL, V126, P572, DOI 10.1046/j.1439-0418.2002.00608.x; Rufingier C, 1997, J ECON ENTOMOL, V90, P1445, DOI 10.1093/jee/90.6.1445; SANCES FV, 1993, J ECON ENTOMOL, V86, P1781, DOI 10.1093/jee/86.6.1781; Shrestha G, 2014, ENVIRON ENTOMOL, V43, P1535, DOI 10.1603/EN14068; Shrestha G, 2017, ANN ENTOMOL SOC AM, V110, P121, DOI 10.1093/aesa/saw066; Shrestha G, 2015, BIOCONTROL, V60, P463, DOI 10.1007/s10526-015-9661-8; Shrestha G, 2015, BIOL CONTROL, V85, P37, DOI 10.1016/j.biocontrol.2015.03.005; Shrestha G, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.9401; Smith HA, 2008, J ECON ENTOMOL, V101, P1526, DOI 10.1603/0022-0493(2008)101[1526:ROSLAO]2.0.CO;2; STADLER B, 1991, ENTOMOL EXP APPL, V58, P221, DOI 10.1111/j.1570-7458.1991.tb01471.x; Syngenta, TECHNICAL REPORT; Tepa-Yotto GT, 2013, APPL ENTOMOL ZOOL, V48, P447, DOI 10.1007/s13355-013-0203-5; van Lenteren JC, 2012, BIOCONTROL, V57, P1, DOI 10.1007/s10526-011-9395-1; WAHAB WA, 1985, Z ANGEW ENTOMOL, V100, P290; Wyckhuys KAG, 2008, B ENTOMOL RES, V98, P361, DOI 10.1017/S000748530800566X	63	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184080	10.1371/journal.pone.0184080	http://dx.doi.org/10.1371/journal.pone.0184080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854232	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600083
J	Giuliodori, AM; Brandi, A; Kotla, S; Perrozzi, F; Gunnella, R; Ottaviano, L; Spurio, R; Fabbretti, A				Giuliodori, Anna Maria; Brandi, Anna; Kotla, Shivaram; Perrozzi, Francesco; Gunnella, Roberto; Ottaviano, Luca; Spurio, Roberto; Fabbretti, Attilio			Development of a graphene oxide-based assay for the sequence-specific detection of double-stranded DNA molecules	PLOS ONE			English	Article							ESCHERICHIA-COLI; NUCLEIC-ACID; SHOCK; CSPA; BIOMOLECULES; TRANSLATION; ADAPTATION; ADSORPTION; EXPRESSION; REDUCTION	Graphene oxide (GO) is a promising material for the development of cost-effective detection systems. In this work, we have devised a simple and rapid GO-based method for the sequence-specific identification of DNA molecules generated by PCR amplification. The csp genes of Escherichia coli, which share a high degree of sequence identity, were selected as paradigm DNA templates. All tested csp genes were amplified with unlabelled primers, which can be rapidly removed at the end of the PCR taking advantage of the preferential binding to GO of single-stranded versus duplex DNA molecules. The amplified DNAs (targets) were heat-denatured and hybridized to a fluorescently-labelled single strand oligonucleotide (probe), which recognizes a region of the target DNAs displaying sequence variability. This interaction is extremely specific, taking place with high efficiency only when target and probe show perfect or near perfect matching. Upon GO addition, the unbound fraction of the probe was captured and its fluorescence quenched by the GO's molecular properties. On the other hand, the probe-target complexes remained in solution and emitted a fluorescent signal whose intensity was related to their degree of complementarity.	[Giuliodori, Anna Maria; Brandi, Anna; Spurio, Roberto; Fabbretti, Attilio] Univ Camerino, Sch Biosci & Vet Med, Camerino, MC, Italy; [Kotla, Shivaram; Gunnella, Roberto] Univ Camerino, Sez Fis, Scuola Sci & Tecnol, Camerino, MC, Italy; [Perrozzi, Francesco; Ottaviano, Luca] Univ Aquila, DSFC, Laquila, Italy; [Ottaviano, Luca] Ist CRN SPIN UOS, Laquila, Italy	University of Camerino; University of Camerino; University of L'Aquila	Giuliodori, AM (corresponding author), Univ Camerino, Sch Biosci & Vet Med, Camerino, MC, Italy.	annamaria.giuliodori@unicam.it	Ha, Dat Thinh/D-4995-2015; Fabbretti, Attilio/L-2524-2013	Ha, Dat Thinh/0000-0003-4260-4876; Fabbretti, Attilio/0000-0003-3928-2781; Giuliodori, Anna Maria/0000-0002-6567-1118; Spurio, Roberto/0000-0002-7611-4341	FAR (Fondo di Ateneo per la Ricerca) of the University of Camerino	FAR (Fondo di Ateneo per la Ricerca) of the University of Camerino	This work was supported by the FAR (Fondo di Ateneo per la Ricerca) grants of the University of Camerinoto A.M.G., R.S.and A.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the FAR (Fondo di Ateneo per la Ricerca) grants of the University of Camerino to A.M.G., R.S. and A.F.	Bichenkova EV, 2011, BBA-GENE REGUL MECH, V1809, P1, DOI 10.1016/j.bbagrm.2010.11.002; Bitounis D, 2013, ADV MATER, V25, P2258, DOI 10.1002/adma.201203700; Brandi A, 1996, MOL MICROBIOL, V19, P231, DOI 10.1046/j.1365-2958.1996.362897.x; Chung C, 2013, ACCOUNTS CHEM RES, V46, P2211, DOI 10.1021/ar300159f; Di Pietro F, 2013, MICROBIOLOGYOPEN, V2, P293, DOI 10.1002/mbo3.68; Giangrossi M, 2002, MOL MICROBIOL, V44, P205, DOI 10.1046/j.1365-2958.2002.02868.x; Giangrossi M, 2007, MOL MICROBIOL, V64, P807, DOI 10.1111/j.1365-2958.2007.05699.x; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639; Hwang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136954; Jung I, 2008, J PHYS CHEM C, V112, P8499, DOI 10.1021/jp802173m; Kuznetsov AA, 2016, ACTA NATURAE, V8, P87, DOI 10.32607/20758251-2016-8-2-87-91; Law JWF, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00770; Lee J, 2014, BIOSENS BIOELECTRON, V62, P140, DOI 10.1016/j.bios.2014.06.028; Liu JW, 2012, PHYS CHEM CHEM PHYS, V14, P10485, DOI 10.1039/c2cp41186e; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; Mothershed EA, 2006, CLIN CHIM ACTA, V363, P206, DOI 10.1016/j.cccn.2005.05.050; Nemes-Incze P, 2008, CARBON, V46, P1435, DOI 10.1016/j.carbon.2008.06.022; Park JS, 2014, LANGMUIR, V30, P12587, DOI 10.1021/la503401d; Perrozzi F, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/1/013002; Perrozzi F, 2013, J PHYS CHEM C, V117, P620, DOI 10.1021/jp3069738; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sibley CD, 2012, INFECT GENET EVOL, V12, P505, DOI 10.1016/j.meegid.2012.01.011; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Swathi RS, 2009, J CHEM SCI, V121, P777, DOI 10.1007/s12039-009-0092-x; TIBANYENDA N, 1984, EUR J BIOCHEM, V139, P19, DOI 10.1111/j.1432-1033.1984.tb07970.x; Varghese N, 2009, CHEMPHYSCHEM, V10, P206, DOI 10.1002/cphc.200800459; Wang JS, 2013, NANOSCALE, V5, P3589, DOI 10.1039/c3nr00084b; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x	29	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183952	10.1371/journal.pone.0183952	http://dx.doi.org/10.1371/journal.pone.0183952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850626	Green Published, Green Submitted, gold			2022-12-26	WOS:000408544200047
J	Lemola, S; Oser, N; Urfer-Maurer, N; Brand, S; Holsboer-Trachsler, E; Bechtel, N; Grob, A; Weber, P; Datta, AN				Lemola, Sakari; Oser, Nadine; Urfer-Maurer, Natalie; Brand, Serge; Holsboer-Trachsler, Edith; Bechtel, Nina; Grob, Alexander; Weber, Peter; Datta, Alexandre N.			Effects of gestational age on brain volume and cognitive functions in generally healthy very preterm born children during school-age: A voxel-based morphometry study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; CORTICAL DEVELOPMENT; ADOLESCENTS BORN; EARLY ADULTHOOD; INFANTS; HIPPOCAMPAL; GROWTH; MEMORY; METAANALYSIS; IMPAIRMENT	Objective To determine whether the relationship of gestational age (GA) with brain volumes and cognitive functions is linear or whether it follows a threshold model in preterm and term born children during school-age. Study design We studied 106 children (M = 10 years 1 month, SD = 16 months; 40 females) enrolled in primary school: 57 were healthy very preterm children (10 children born 24-27 completed weeks' gestation (extremely preterm), 14 children born 28-29 completed weeks' gestation, 19 children born 30-31 completed weeks' gestation (very preterm), and 14 born 32 completed weeks' gestation (moderately preterm)) all born appropriate for GA (AGA) and 49 term-born children. Neuroimaging involved voxel-based morphometry with the statistical parametric mapping software. Cognitive functions were assessed with the WISC-IV. General Linear Models and multiple regressions were conducted controlling age, sex, and maternal education. Results Compared to groups of children born 30 completed weeks' gestation and later, children born <28 completed weeks' gestation had less gray matter volume (GMV) and white matter volume (WMV) and poorer cognitive functions including decreased full scale IQ, and processing speed. Differences in GMV partially mediated the relationship between GA and full scale IQ in preterm born children. Conclusions In preterm children who are born AGA and without major complications GA is associated with brain volume and cognitive functions. In particular, decreased brain volume becomes evident in the extremely preterm group (born <28 completed weeks' gestation). In preterm children born 30 completed weeks' gestation and later the relationship of GA with brain volume and cognitive functions may be less strong as previously thought.	[Lemola, Sakari] Univ Warwick, Dept Psychol, Coventry, W Midlands, England; [Oser, Nadine; Bechtel, Nina; Weber, Peter; Datta, Alexandre N.] Univ Basel, Childrens Hosp Basel, Div Neuropediat & Dev Med, Basel, Switzerland; [Urfer-Maurer, Natalie; Grob, Alexander] Univ Basel, Dept Psychol, Basel, Switzerland; [Brand, Serge; Holsboer-Trachsler, Edith] Univ Basel, Ctr Affect Stress & Sleep Disorders ZASS, Psychiat Clin UPK, Basel, Switzerland; [Brand, Serge] Univ Basel, Div Sport & Psychosocial Hlth, Fac Med, Dept Sport Exercise & Hlth, Basel, Switzerland; [Brand, Serge] Kermanshah Univ Med Sci, Sleep Disorders Res Ctr, Kermanshah, Iran	University of Warwick; University of Basel; University of Basel; University of Basel; University of Basel; University of Geneva; Kermanshah University of Medical Sciences	Lemola, S (corresponding author), Univ Warwick, Dept Psychol, Coventry, W Midlands, England.	s.lemola@warwick.ac.uk	Lemola, Sakari/A-2659-2008; Grob, Alexander/AAU-5842-2021; Brand, Serge/H-7159-2019	Lemola, Sakari/0000-0002-1314-6194; Brand, Serge/0000-0003-2175-2765	Swiss National Science Foundation [143962, 159362]; University of Basel [DPE2083]; Gottfried and Julia Bangerter-Rhyner-Stiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel; Gottfried and Julia Bangerter-Rhyner-Stiftung	The present study was funded by the Swiss National Science Foundation (projects: Sleep, cognitive, and socio-emotional development in preterm children during middle and late childhood, grant number: 143962; Socio-emotional development and mental health of preterm children: The role of HPA-axis function, sleep, neuroplasticity, and physical exercise during the transition to adolescence, grant number: 159362), the Research Fund of the University of Basel (project: Early origins of self-regulation and sleep, grant number: DPE2083), and the Gottfried and Julia Bangerter-Rhyner-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Brumbaugh JE, 2016, PEDIATR RES, V80, P197, DOI 10.1038/pr.2016.82; Davis EP, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00001; Gimenez M, 2004, NEUROIMAGE, V23, P869, DOI 10.1016/j.neuroimage.2004.07.029; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Guellec I, 2015, J PEDIATR-US, V167, P975, DOI 10.1016/j.jpeds.2015.08.025; Isaacs EB, 2000, PEDIATR RES, V47, P713, DOI 10.1203/00006450-200006000-00006; Kapellou O, 2006, PLOS MED, V3, P1382, DOI 10.1371/journal.pmed.0030265; Kerr-Wilson CO, 2012, J PUBLIC HEALTH-UK, V34, P209, DOI 10.1093/pubmed/fdr024; Lidzba K, 2006, NEUROPSYCHOLOGIA, V44, P1088, DOI 10.1016/j.neuropsychologia.2005.10.022; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; Meng C, 2016, BRAIN STRUCT FUNCT, V221, P2109, DOI 10.1007/s00429-015-1032-9; Monson BB, 2016, JAMA PEDIATR, V170, P772, DOI 10.1001/jamapediatrics.2016.0781; Munakata S, 2013, BRAIN DEV-JPN, V35, P10, DOI 10.1016/j.braindev.2011.12.011; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Northam GB, 2011, ANN NEUROL, V69, P702, DOI 10.1002/ana.22263; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Nosarti C, 2016, DEV MED CHILD NEUROL, V58, P35, DOI 10.1111/dmcn.13042; Nosarti C, 2014, NEUROIMAGE-CLIN, V6, P180, DOI 10.1016/j.nicl.2014.08.005; Nosarti C, 2013, EARLY HUM DEV, V89, P221, DOI 10.1016/j.earlhumdev.2013.02.002; Petermann F., 2011, WECHSLER INTELLIGENC; Rogers CE, 2014, J PEDIATR-US, V165, P928, DOI 10.1016/j.jpeds.2014.06.063; Ruegger C, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-17; Soria-Pastor S, 2008, INT J DEV NEUROSCI, V26, P647, DOI 10.1016/j.ijdevneu.2008.08.001; Soria-Pastor S, 2009, PEDIATRICS, V124, pE1161, DOI 10.1542/peds.2009-0244; Voigt M, 2007, GEBURTSH FRAUENHEILK, V67, P256, DOI 10.1055/s-2007-965047; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Wolke D, 2015, J PEDIATR-US, V166, P1410, DOI 10.1016/j.jpeds.2015.02.065; Zubiaurre-Elorza L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042148; Zubiaurre-Elorza L, 2011, PEDIATR RES, V69, P554, DOI 10.1203/PDR.0b013e3182182366	34	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183519	10.1371/journal.pone.0183519	http://dx.doi.org/10.1371/journal.pone.0183519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850616	gold, Green Published, Green Submitted			2022-12-26	WOS:000408544200017
J	Lujic, S; Simpson, JM; Zwar, N; Hosseinzadeh, H; Jorm, L				Lujic, Sanja; Simpson, Judy M.; Zwar, Nicholas; Hosseinzadeh, Hassan; Jorm, Louisa			Multimorbidity in Australia: Comparing estimates derived using administrative data sources and survey data	PLOS ONE			English	Article							CO-MORBIDITY; RXRISK-V; HEALTH; PREVALENCE; CHARLSON; VALIDITY; INDEX; CLASSIFICATION; INFORMATION; MEDICATIONS	Background Estimating multimorbidity (presence of two or more chronic conditions) using administrative data is becoming increasingly common. We investigated (1) the concordance of identification of chronic conditions and multimorbidity using self- report survey and administrative datasets; (2) characteristics of people with multimorbidity ascertained using different data sources; and (3) whether the same individuals are classified as multimorbid using different data sources. Methods Baseline survey data for 90,352 participants of the 45 and Up Study D a cohort study of residents of New South Wales, Australia, aged 45 years and over D were linked to prior twoyear pharmaceutical claims and hospital admission records. Concordance of eight selfreport chronic conditions (reference) with claims and hospital data were examined using sensitivity (Sn), positive predictive value (PPV), and kappa (k). The characteristics of people classified as multimorbid were compared using logistic regression modelling. Results Agreement was found to be highest for diabetes in both hospital and claims data (k=0.79, 0.78; Sn = 79%, 72%; PPV = 86%, 90%). The prevalence of multimorbidity was highest using self-report data (37.4%), followed by claims data (36.1%) and hospital data (19.3%). Combining all three datasets identified a total of 46 683 (52%) people with multimorbidity, with half of these identified using a single dataset only, and up to 20% identified on all three datasets. Characteristics of persons with and without multimorbidity were generally similar. However, the age gradient was more pronounced and people speaking a language other than English at home were more likely to be identified as multimorbid by administrative data. Conclusions Different individuals, with different combinations of conditions, are identified as multimorbid when different data sources are used. As such, caution should be applied when ascertaining morbidity from a single data source as the agreement between self-report and administrative data is generally poor. Future multimorbidity research exploring specific disease combinations and clusters of diseases that commonly co-occur, rather than a simple disease count, is likely to provide more useful insights into the complex care needs of individuals with multiple chronic conditions.	[Lujic, Sanja; Jorm, Louisa] Univ New South Wales, Ctr Big Data Res Hlth, Sydney, NSW, Australia; [Simpson, Judy M.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Zwar, Nicholas; Hosseinzadeh, Hassan] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney	Lujic, S (corresponding author), Univ New South Wales, Ctr Big Data Res Hlth, Sydney, NSW, Australia.	s.lujic@unsw.edu.au	Jorm, Louisa/AAN-6874-2020; Hosseinzadeh, Hassan/AAZ-9650-2021	Jorm, Louisa/0000-0003-0390-661X; Hosseinzadeh, Hassan/0000-0002-8638-5372; Zwar, Nicholas/0000-0001-6462-9121; Lujic, Sanja/0000-0002-9555-0261	National Health and Medical Research Council Partnership Project Grant [1036858]; Australian Commission on Safety and Quality in Health Care; Agency for Clinical Innovation and the NSW Bureau of Health Information	National Health and Medical Research Council Partnership Project Grant; Australian Commission on Safety and Quality in Health Care; Agency for Clinical Innovation and the NSW Bureau of Health Information	This work was supported by a National Health and Medical Research Council Partnership Project Grant (#1036858) and by partner agencies the Australian Commission on Safety and Quality in Health Care, the Agency for Clinical Innovation and the NSW Bureau of Health Information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assareh H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147087; Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 1 RE; Australian Bureau of Statistics, 2007, NAT HLTH SURV SUMM R; Australian Institute of Health and Welfare, NAT HLTH PRIOR AR 20; Australian Institute of Health and Welfare, 2014, AUSTR HLTH SER, V14; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Bayliss Elizabeth A, 2005, Health Qual Life Outcomes, V3, P51; Brett T, 2013, ANN FAM MED, V11, P535, DOI 10.1370/afm.1570; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Byles JE, 2005, J CLIN EPIDEMIOL, V58, P997, DOI 10.1016/j.jclinepi.2005.02.025; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chini F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-688; Chong WF, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-105; Comino EJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-481; Crimmins EM, 2004, ANNU REV PUBL HEALTH, V25, P79, DOI 10.1146/annurev.publhealth.25.102802.124401; Tran DT, 2012, AUST NZ J PUBL HEAL, V36, P310, DOI 10.1111/j.1753-6405.2012.00893.x; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Halfon P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-453; Harrison C, 2016, AUST NZ J PUBL HEAL, V40, P239, DOI 10.1111/1753-6405.12509; Harrison C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004694; Held FP, 2015, J GERONTOL A; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Huber CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1030; Inacio MCS, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0835-4; Islam MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083783; Jowsey T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059379; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Lamers LM, 2004, HEALTH POLICY, V68, P113, DOI 10.1016/j.healthpol.2003.09.001; Leal JR, 2010, CLIN MICROBIOL INFEC, V16, P715, DOI 10.1111/j.1469-0691.2009.02867.x; Lix L, 2006, DEFINING VALIDATING; Lix LM, 2008, CHRONIC DIS CAN, V29, P31; Lu CY, 2011, J CLIN EPIDEMIOL, V64, P223, DOI 10.1016/j.jclinepi.2010.02.015; Lujic S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005768; Marengoni A, 2016, EUR J INTERN MED, V31, P29, DOI 10.1016/j.ejim.2016.02.014; Mcrae I, 2013, AUST J PRIM HEALTH, V19, P144, DOI 10.1071/PY12035; Mellish Leigh, 2015, BMC Res Notes, V8, P634, DOI 10.1186/s13104-015-1616-8; Muggah E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-16; National Centre for Classification in Health, 2006, INT STAT CLASS DIS H; Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x; O'Shea M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-23; Olesen JB, 2011, BMJ, V342; Orueta JF, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-365; Pache B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1515-x; Preen DB, 2006, J CLIN EPIDEMIOL, V59, P940, DOI 10.1016/j.jclinepi.2005.12.013; Preen DB, 2004, J CLIN EPIDEMIOL, V57, P1295, DOI 10.1016/j.jclinepi.2004.03.016; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Quinones AR, 2011, J GERONTOL B-PSYCHOL, V66, P739, DOI 10.1093/geronb/gbr106; Rector TS, 2004, HEALTH SERV RES, V39, P1839, DOI 10.1111/j.1475-6773.2004.00321.x; SAS Institute, 2010, SAS VERS 9 3 SOFTW; Schneider F, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13533; Sloan KL, 2003, MED CARE, V41, P761, DOI 10.1097/00005650-200306000-00009; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van den Bussche H, 2013, J CLIN EPIDEMIOL, V66, P209, DOI 10.1016/j.jclinepi.2012.07.019; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; Vitry A, 2009, AUST NZ J PUBL HEAL, V33, P126, DOI 10.1111/j.1753-6405.2009.00357.x; Vivas D, 2011, HEALTH POLICY, V103, P9, DOI 10.1016/j.healthpol.2011.08.014; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; World Health Organization, 2014, GLOB HLTH EST DEATHS, DOI 10.1371/journal.pgen.1004412.20	64	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183817	10.1371/journal.pone.0183817	http://dx.doi.org/10.1371/journal.pone.0183817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE9SU	28850593	Green Published, Green Submitted, gold			2022-12-26	WOS:000408544200029
J	Barradas-Bautista, D; Fernandez-Recio, J				Barradas-Bautista, Didier; Fernandez-Recio, Juan			Docking-based modeling of protein-protein interfaces for extensive structural and functional characterization of missense mutations	PLOS ONE			English	Article							SCALE MAP; NETWORKS; DATABASE; REFINEMENT; PRINCIPLES; SITES	Next-generation sequencing (NGS) technologies are providing genomic information for an increasing number of healthy individuals and patient populations. In the context of the large amount of generated genomic data that is being generated, understanding the effect of disease-related mutations at molecular level can contribute to close the gap between genotype and phenotype and thus improve prevention, diagnosis or treatment of a pathological condition. In order to fully characterize the effect of a pathological mutation and have useful information for prediction purposes, it is important first to identify whether the mutation is located at a protein-binding interface, and second to understand the effect on the binding affinity of the affected interaction/s. Computational methods, such as protein docking are currently used to complement experimental efforts and could help to build the human structural inter-actome. Here we have extended the original pyDockNIP method to predict the location of disease-associated nsSNPs at protein-protein interfaces, when there is no available structure for the protein-protein complex. We have applied this approach to the pathological interaction networks of six diseases with low structural data on PPIs. This approach can almost double the number of nsSNPs that can be characterized and identify edgetic effects in many nsSNPs that were previously unknown. This can help to annotate and interpret genomic data from large-scale population studies, and to achieve a better understanding of disease at molecular level.	[Barradas-Bautista, Didier; Fernandez-Recio, Juan] BSC, Life Sci Dept, Barcelona, Spain; [Fernandez-Recio, Juan] CSIC, Inst Biol Mol Barcelona, Struct Biol Unit, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Fernandez-Recio, J (corresponding author), BSC, Life Sci Dept, Barcelona, Spain.; Fernandez-Recio, J (corresponding author), CSIC, Inst Biol Mol Barcelona, Struct Biol Unit, Barcelona, Spain.	juanf@bsc.es	Barradas-Bautista, Didier/D-3269-2018	Barradas-Bautista, Didier/0000-0002-6464-6607; Fernandez-Recio, Juan/0000-0002-3986-7686	Spanish Ministry of Economy and Competitiveness [BI02013-48213-R, BI02016-79930-R]; Interreg POCTEFA [EFA086/15]; CONACyT from the Mexican Government	Spanish Ministry of Economy and Competitiveness(Spanish Government); Interreg POCTEFA; CONACyT from the Mexican Government	This work was funded by grants number BI02013-48213-R and BI02016-79930-R from the Spanish Ministry of Economy and Competitiveness, and grant number EFA086/15 from Interreg POCTEFA. D. Barradas-Bautista was supported by a CONACyT predoctoral fellowship from the Mexican Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cheng TMK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002738; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; David A, 2015, J MOL BIOL, V427, P2886, DOI 10.1016/j.jmb.2015.07.004; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; Fraser JS, 2013, MOL CELL, V49, P222, DOI 10.1016/j.molcel.2013.01.003; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Grosdidier S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-447; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guney E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10331; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; Kanehisa M., NOVARTIS FOUNDATION, P91; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kiel C, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.20145092; Kiel C, 2012, STRUCTURE, V20, P1806, DOI 10.1016/j.str.2012.10.002; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Mashiach E, 2010, PROTEINS, V78, P1503, DOI 10.1002/prot.22668; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mosca R, 2015, NAT METHODS, V12, P167, DOI 10.1038/nmeth.3289; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Mosca R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000490; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Scott AF, BIOIN FORMATICS DATA, P77; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wu XG, 2014, J THEOR BIOL, V362, P44, DOI 10.1016/j.jtbi.2014.05.031; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001; Zhang CS, 2011, J COMPUT CHEM, V32, P2598, DOI 10.1002/jcc.21839; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	44	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183643	10.1371/journal.pone.0183643	http://dx.doi.org/10.1371/journal.pone.0183643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841721	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700046
J	Shokry, E; Pereira, J; Marques, JG; da Cunha, PHJ; Noronha, ADF; da Silva, JA; Fioravanti, MCS; de Oliveira, AE; Antoniosi, NR				Shokry, Engy; Pereira, Juliao; Marques Junior, Jair Gonzalez; Jorge da Cunha, Paulo Henrique; Feitosa Noronha Filho, Antonio Dionisio; da Silva, Jessica Alves; Soares Fioravanti, Maria Clorinda; de Oliveira, Anselmo Elcana; Antoniosi Filho, Nelson Roberto			Earwax metabolomics: An innovative pilot metabolic profiling study for assessing metabolic changes in ewes during periparturition period	PLOS ONE			English	Article							LATE PREGNANCY; BLOOD; PARAMETERS; LACTATION; HORMONES; UREA; BIOMARKERS; COLOSTRUM; EXPOSURE; CERUMEN	Important metabolic changes occur during transition period of late pregnancy and early lactation to meet increasing energy demands of the growing fetus and for milk production. The aim of this investigation is to present an innovative and non-invasive tool using ewe earwax sample analysis to assess the metabolic profile in ewes during late pregnancy and early lactation. In this work, earwax samples were collected from 28 healthy Brazilian Santa Ines ewes divided into 3 sub-groups: 9 non-pregnant ewes, 6 pregnant ewes in the last 30 days of gestation, and 13 lactating ewes <= 30 days postpartum. Then, a range of metabolites including volatile organic compounds (VOC), amino acids (AA), and minerals were profiled and quantified in the samples by applying headspace gas chromatography/mass spectrometry, high performance liquid chromatography/tandem mass spectrometry, and inductively coupled plasma-optical emission spectrometry, respectively. As evident in our results, significant changes were observed in the metabolite profile of earwax between the studied groups where a remarkable elevation was detected in the levels of non-esterified fatty acids, alcohols, ketones, and hydroxy urea in the VOC profile of samples obtained from pregnant and lactating ewes. Meanwhile, a significant decrease was detected in the levels of 9 minerals and 14 AA including essential AA (leucine, phenyl alanine, lysine, isoleucine, threonine, valine), conditionally essential AA (arginine, glycine, tyrosine, proline, serine), and a nonessential AA (alanine). Multivariate analysis using robust principal component analysis and hierarchical cluster analysis was successfully applied to discriminate the three study groups using the variations of metabolites in the two stress states (pregnancy and lactation) from the healthy non-stress condition. The innovative developed method was successful in evaluating pre- and post-parturient metabolic changes using earwax and can in the future be applied to recognize markers for diagnosis, prevention, and intervention of pregnancy complications in ewes.	[Shokry, Engy; Pereira, Juliao; Marques Junior, Jair Gonzalez; Antoniosi Filho, Nelson Roberto] Univ Fed Goias, Lab Metodos Extracao & Separacao LAMES, IQ, Campus Samambaia, Goiania, Go, Brazil; [Jorge da Cunha, Paulo Henrique; Feitosa Noronha Filho, Antonio Dionisio; da Silva, Jessica Alves; Soares Fioravanti, Maria Clorinda] Univ Fed Goias, Escola Vet & Zootecnia, Campus Samambaia, Goiania, Go, Brazil; [de Oliveira, Anselmo Elcana] Univ Fed Goias, IQ, Campus Samambaia, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Shokry, E (corresponding author), Univ Fed Goias, Lab Metodos Extracao & Separacao LAMES, IQ, Campus Samambaia, Goiania, Go, Brazil.	angeliqa26582@yahoo.com	Filho, Nelson Roberto Antoniosi/R-8297-2019; Jorge da Cunha, Paulo Henrique/E-7107-2019; Shokry, Engy/P-8269-2014; de Oliveira, A. E./I-2736-2015	Filho, Nelson Roberto Antoniosi/0000-0002-3067-0385; Jorge da Cunha, Paulo Henrique/0000-0002-1478-3670; Shokry, Engy/0000-0002-5932-9332; de Oliveira, A. E./0000-0001-7468-8221; Soares Fioravanti, Maria Clorinda/0000-0002-4993-5523	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [1516965]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [312280]	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We wish to acknowledge Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the research fund (grant number 1516965) provided within the postdoc program (PNPD) for the first author, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the research productivity grant (grant number 312280) to Nelson Antoniosi and FUNAPE for management of financial resources.; We wish to acknowledge Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the research fund (grant number 1516965) provided within the postdoc program (PNPD) for the first author, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the research productivity grant (grant number 312280) to Nelson Antoniosi and FUNAPE for management of financial resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvord L S, 1997, J Am Acad Audiol, V8, P383; [Anonymous], GUID BIOAN METH VAL; Antunovic Z, 2011, BULG J AGRIC SCI, V17, P687; Antunovic Z, 2011, ARCH TIERZUCHT, V54, P535, DOI 10.5194/aab-54-535-2011; Araz O.B., 2013, J ANIM SCI, V2, P11; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Azab ME, 1999, SMALL RUMINANT RES, V34, P77, DOI 10.1016/S0921-4488(99)00049-8; Balaraman S, 2014, ALCOHOL CLIN EXP RES, V38, P1390, DOI 10.1111/acer.12378; Banchero GE, 2006, REPROD NUTR DEV, V46, P447, DOI 10.1051/rnd:2006024; Bell C., 1975, OBSTET GYNECOL SURV, V30, P359; BORTZ JT, 1990, J AM ACAD DERMATOL, V23, P845, DOI 10.1016/0190-9622(90)70301-W; BRANDAURABAN A, 1972, J INVEST DERMATOL, V58, P14, DOI 10.1111/1523-1747.ep13077196; Burkhart CN, 2000, AM J OTOL, V21, P157, DOI 10.1016/S0196-0709(00)80002-2; Castagnino DD, 2015, REV BRAS ZOOTECN, V44, P92, DOI 10.1590/S1806-92902015000300003; Chilliard Y, 2000, P NUTR SOC, V59, P127, DOI 10.1017/S002966510000015X; Dakka A. A., 1992, Assiut Veterinary Medical Journal, V28, P242; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Durak MH, 2006, TURK J VET ANIM SCI, V30, P497; El-Sherif MMA, 2001, SMALL RUMINANT RES, V40, P269, DOI 10.1016/S0921-4488(01)00174-2; Enjalbert F, 2001, J DAIRY SCI, V84, P583, DOI 10.3168/jds.S0022-0302(01)74511-0; Eski F, 2015, TURK J VET ANIM SCI, V39, P401, DOI 10.3906/vet-1412-25; FAICHNEY G J, 1981, Proceedings of the Nutrition Society of Australia Annual Conference, V6, P48; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Firat A., 1996, Turk Veterinerlik ve Hayvancilik Dergisi, V20, P387; Gurgoze SY, 2009, KAFKAS UNIV VET FAK, V15, P957; Harmeyer J, 2006, RES VET SCI, V81, P254, DOI 10.1016/j.rvsc.2005.10.010; Kamel FM, 1988, THESIS; Kataoka H, 2013, BIOANALYSIS, V5, P1443, DOI [10.4155/BIO.13.85, 10.4155/bio.13.85]; Khatun A, 2011, ASIAN J ANIM VET ADV, V6, P175, DOI 10.3923/ajava.2011.175.181; Loor J. J., 2010, Energy and protein metabolism and nutrition. 3rd EAAP International Symposium on Energy and Protein Metabolism and Nutrition, Parma, Italy, 6-10 September, 2010, P59; Maeda Y., 2012, Journal of Veterinary Medicine and Animal Health, V4, P124; Oliveira Roseane Pinto Martins de, 2014, Ciênc. anim. bras., V15, P81, DOI 10.5216/cab.v15i1.15720; Mesquita FS, 2012, ANIM REPROD, V9, P713; Murtagh R, 2013, WIEN TIERARZTL MONAT, V100, P247; ODoherty JV, 1997, ANIM SCI, V64, P87, DOI 10.1017/S1357729800015587; Otten JJ, 2006, 309100917 NAT AC SCI; Ozpinar A, 2003, ANN NUTR METAB, V47, P139, DOI 10.1159/000070036; Piccione G, 2009, ANIM SCI PAP REP, V27, P321; Regnault TRH, 2005, PLACENTA, V26, pS52, DOI 10.1016/j.placenta.2005.01.003; Rios C, 2006, ARCH MED VET, V38, P19, DOI 10.4067/S0301-732X2006000100003; Robinson JJ, 1999, ANIM SCI, V68, P315, DOI 10.1017/S1357729800050323; Rodriguez MN, 1996, CAN J ANIM SCI, V76, P469, DOI 10.4141/cjas96-070; SANSOM BF, 1982, BRIT VET J, V138, P393, DOI 10.1016/S0007-1935(17)30984-3; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Schlumbohm C, 2004, J DAIRY SCI, V87, P350, DOI 10.3168/jds.S0022-0302(04)73174-4; Shagun Agrawal, 2007, Indian Journal of Small Ruminants, V13, P192; Shetaewi M. M., 1994, Assiut Veterinary Medical Journal, V30, P64; Shokry E, 2017, TOXICON, V137, P54, DOI 10.1016/j.toxicon.2017.07.014; Shokry E, 2017, FORENSIC TOXICOL, V35, P389, DOI 10.1007/s11419-017-0370-0; Shokry E, 2017, FORENSIC TOXICOL, V35, P348, DOI 10.1007/s11419-017-0363-z; Shokry E, 2017, J PROTEOMICS, V159, P92, DOI 10.1016/j.jprot.2017.03.005; Soliman E. B., 2014, Egyptian Journal of Sheep and Goat Sciences, V9, P33; Tanritanir P, 2009, J ANIM VET ADV, V8, P530; Trumble SJ, 2013, P NATL ACAD SCI USA, V110, P16922, DOI 10.1073/pnas.1311418110; Waziri MA, 2010, VET ARHIV, V80, P215; Yassin A, 1966, J Laryngol Otol, V80, P933, DOI 10.1017/S0022215100066196	56	9	9	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183538	10.1371/journal.pone.0183538	http://dx.doi.org/10.1371/journal.pone.0183538			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841695	Green Published, Green Submitted, gold			2022-12-26	WOS:000408370700040
J	Husser, D; Ueberham, L; Hindricks, G; Buttner, P; Ingram, C; Weeke, P; Shoemaker, MB; Adams, V; Arya, A; Sommer, P; Darbar, D; Roden, DM; Bollmann, A				Husser, Daniela; Ueberham, Laura; Hindricks, Gerhard; Buettner, Petra; Ingram, Christie; Weeke, Peter; Shoemaker, M. Benjamin; Adams, Volker; Arya, Arash; Sommer, Philipp; Darbar, Dawood; Roden, Dan M.; Bollmann, Andreas			Rare variants in genes encoding the cardiac sodium channel and associated compounds and their impact on outcome of catheter ablation of atrial fibrillation	PLOS ONE			English	Article							LONG-QT SYNDROME; PULMONARY VEIN ISOLATION; BRUGADA-SYNDROME; MUTATIONS; RECURRENCE; SCN5A; SUSCEPTIBILITY; POLYMORPHISM; PREVALENCE; DISEASE	Aim Rare variants of genes encoding the cardiac sodium channel and associated compounds have been linked with atrial fibrillation (AF). Nevertheless, current expert consensus does not support genetic testing in AF, which is in part based on the fact that "there is no therapeutic impact derived from AF genetic test results". However, there are no studies available supporting this recommendation. Consequently, this study analyzed the impact of rare variants affecting the cardiac sodium channel on rhythm outcome of AF catheter ablation. Methods and results In 137 consecutive patients with lone AF enrolled in the Leipzig Heart Center AF ablation registry, screening for mutations in SCN5A, SCN1B - 4B, CAV3, GPD1L, SNTA1 and MOG1 was performed. We identified 3 rare non-synonymous variants in SCN5A, 5 in SCN1B, 1 in SCN4B, 1 in CAV3, 6 in GPD1L, 3 in SNTA1 and 3 in MOG1 (16%). Variant carriers were otherwise comparable with non-variant carriers. Analysis of AF recurrence rates after radiofrequency AF catheter ablation by serial 7-day Holter ECG monitoring between 3 and 12 months revealed no difference between groups, i.e. 45% in variant carriers vs. 49% in non-variant carriers. Conclusions Rare variants in genes encoding the cardiac sodium channel and associated compounds are frequently found in lone AF but were not found to impact the outcome of AF catheter ablation. This finding supports current recommendations not to screen for rare variants for the ablation outcome in AF. Nevertheless, it may at least be helpful for understanding AF mechanisms and larger studies are needed to further explore the possible association between genotype and response to AF therapies.	[Husser, Daniela; Ueberham, Laura; Hindricks, Gerhard; Buettner, Petra; Adams, Volker; Arya, Arash; Sommer, Philipp; Bollmann, Andreas] Univ Leipzig, Ctr Heart, Dept Electrophysiol, Leipzig, Germany; [Ingram, Christie; Weeke, Peter; Shoemaker, M. Benjamin; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Weeke, Peter] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Darbar, Dawood] Univ Illinois, Div Cardiol, Chicago, IL USA	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Vanderbilt University; University of Copenhagen; Herlev & Gentofte Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Husser, D (corresponding author), Univ Leipzig, Ctr Heart, Dept Electrophysiol, Leipzig, Germany.	Dani11@gmx.net	Büttner, Petra/ADR-1721-2022; Roden, Dan/ABD-5412-2021; Sommer, Philipp/AAV-3133-2020	Buttner, Petra/0000-0003-0799-4725	Volkswagen Foundation Germany [84901]; German Cardiac Society; National Institutes of Health (NIH) [1K23HL127704]; American Heart Association (AHA) [11CRP7420009]; NIH [U19HL65962, UL1RR024975, R01HL092217]; AHA [EIA094116N]; Office Of The Director [1157751] Funding Source: National Science Foundation	Volkswagen Foundation Germany(Volkswagen); German Cardiac Society; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	DH was supported by the Volkswagen Foundation Germany (84901), LU was supported by the German Cardiac Society (Otto Hess Stipend). MBS was supported by grants from the National Institutes of Health (NIH) (1K23HL127704) and American Heart Association (AHA) (11CRP7420009). DR was supported by grants from the NIH (U19HL65962 and UL1RR024975). DD was supported by grants from the NIH (R01HL092217) and AHA (EIA094116N).	Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Bezzina C, 1999, CIRC RES, V85, P1206; Chakrabarti S, 2013, CIRC-ARRHYTHMIA ELEC, V6, P392, DOI 10.1161/CIRCEP.111.000206; Cheng JD, 2013, J MOL CELL CARDIOL, V61, P102, DOI 10.1016/j.yjmcc.2013.03.013; Cheng JD, 2009, CIRC-ARRHYTHMIA ELEC, V2, P667, DOI 10.1161/CIRCEP.109.891440; Conte G, 2014, EUROPACE, V16, P528, DOI 10.1093/europace/eut309; Darbar D, 2008, CIRCULATION, V117, P1927, DOI 10.1161/CIRCULATIONAHA.107.757955; Effinor PT, 2008, HEART RHYTHM, V5, P99, DOI [10.1016/j.hrthm.2007.09.015, 10.1016/j.hrthm.2008.01.014]; Eitel C, 2010, HEART RHYTHM, V7, P157, DOI 10.1016/j.hrthm.2009.10.003; Hu RM, 2013, AM J PHYSIOL-HEART C, V304, pH994, DOI 10.1152/ajpheart.00705.2012; Hu YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057593, 10.1371/journal.pone.0056362, 10.1371/journal.pone.0073264, 10.1371/journal.pone.0056440]; Husser D, 2010, J AM COLL CARDIOL, V55, P747, DOI 10.1016/j.jacc.2009.11.041; Johnson JN, 2008, HEART RHYTHM, V5, P704, DOI 10.1016/j.hrthm.2008.02.007; Kattygnarath D, 2011, CIRC-CARDIOVASC GENE, V4, P261, DOI 10.1161/CIRCGENETICS.110.959130; Kusano KF, 2008, J AM COLL CARDIOL, V51, P1169, DOI 10.1016/j.jacc.2007.10.060; Leong IUS, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0176-z; London B, 2007, CIRCULATION, V116, P2260, DOI 10.1161/CIRCULATIONAHA.107.703330; Olesen MS, 2012, HEART RHYTHM, V9, P770, DOI 10.1016/j.hrthm.2011.12.005; Olesen MS, 2011, CAN J CARDIOL, V27, DOI 10.1016/j.cjca.2011.01.003; Priori SG, 2013, EUROPACE, V15, P1389, DOI 10.1093/europace/eut272; Sairaku A, 2013, INT J CARDIOL, V168, P5273, DOI 10.1016/j.ijcard.2013.08.016; Shirai N, 2002, CARDIOVASC RES, V53, P348, DOI 10.1016/S0008-6363(01)00494-1; Shoemaker MB, 2015, CIRC-ARRHYTHMIA ELEC, V8, P296, DOI 10.1161/CIRCEP.114.001909; Shoemaker MB, 2013, HEART RHYTHM, V10, P394, DOI 10.1016/j.hrthm.2012.11.012; Ueberham L, 2013, CIRC-ARRHYTHMIA ELEC, V6, P732, DOI 10.1161/CIRCEP.113.000253; Vaidyanathan R, 2013, J BIOL CHEM, V288, P17472, DOI 10.1074/jbc.M112.435370; Van Norstrand DW, 2007, CIRCULATION, V116, P2253, DOI 10.1161/CIRCULATIONAHA.107.704627; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Wang QS, 2015, J RENIN-ANGIO-ALDO S, V16, P888, DOI 10.1177/1470320315594315; Watanabe H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P268, DOI 10.1161/CIRCEP.108.779181; Wilde AAM, 2011, CIRC RES, V108, P884, DOI 10.1161/CIRCRESAHA.110.238469; Wu G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099623; Wu GR, 2008, CIRC-ARRHYTHMIA ELEC, V1, P193, DOI 10.1161/CIRCEP.108.769224; Wutzler A, 2013, INT J CARDIOL, V168, P3647, DOI 10.1016/j.ijcard.2013.05.010	34	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183690	10.1371/journal.pone.0183690	http://dx.doi.org/10.1371/journal.pone.0183690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837624	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000103
J	Spivey, TJ; Lindberg, MS; Meixell, BW; Smith, KR; Puryear, WB; Davis, KR; Runstadler, JA; Stallknecht, DE; Ramey, AM				Spivey, Timothy J.; Lindberg, Mark S.; Meixell, Brandt W.; Smith, Kyle R.; Puryear, Wendy B.; Davis, Kimberly R.; Runstadler, Jonathan A.; Stallknecht, David E.; Ramey, Andrew M.			Maintenance of influenza A viruses and antibody response in mallards (Anas platyrhynchos) sampled during the non-reeding season in Alaska	PLOS ONE			English	Article							AVIAN INFLUENZA; NORTHERN EUROPE; ANNUAL CYCLE; WILD BIRDS; DUCKS; WATERFOWL; SURVEILLANCE; INFECTION; PARAMYXOVIRUSES; TRANSMISSION	Prevalence of influenza A virus (IAV) infections in northern-breeding waterfowl has previously been reported to reach an annual peak during late summer or autumn; however, little is known about IAV infection dynamics in waterfowl populations persisting at high-latitude regions such as Alaska, during winter. We captured mallards (Anas platyrhynchos) throughout the non-breeding season (August-April) of 2012-2015 in Fairbanks and Anchorage, the two largest cities in Alaska, to assess patterns of IAV infection and antibody production using molecular methods and a standard serologic assay. In addition, we used virus isolation, genetic sequencing, and a virus microneutralization assay to characterize viral subtypes and to evaluate the immune response of mallards captured on multiple occasions through time. We captured 923 mallards during three successive sampling years: Fairbanks in 2012/13 and 2013/14, and Anchorage in 2014/15. Prevalence varied by age, season, and year/site with high and relatively stable estimates throughout the non-breeding season. Infected birds were detected in all locations/seasons except early-winter in Fairbanks during 2013/14. IAVs with 17 combinations of hemagglutinin (H1-5, H7-9, H11, H12) and neuraminidase (N1-6, N8, N9) subtypes were isolated. Antibodies to IAVs were detected throughout autumn and winter for all sampling locations and years, however, seroprevalence was higher among adults and varied among years. Mallards exhibited individual heterogeneity with regard to immune response, providing instances of both seroconversion and seroreversion to detected viral subtypes. The probability that an individual transitioned from one serostatus to another varied by age, with juvenile mallards having higher rates of seroconversion and seroreversion than adults. Our study provides evidence that a diversity	[Spivey, Timothy J.; Lindberg, Mark S.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Spivey, Timothy J.; Meixell, Brandt W.; Ramey, Andrew M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Lindberg, Mark S.] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Smith, Kyle R.] Alaska Dept Fish & Game, 333 Raspberry Rd, Anchorage, AK 99518 USA; [Puryear, Wendy B.; Davis, Kimberly R.; Runstadler, Jonathan A.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Puryear, Wendy B.; Davis, Kimberly R.; Runstadler, Jonathan A.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Stallknecht, David E.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Athens, GA USA; [Puryear, Wendy B.; Davis, Kimberly R.; Runstadler, Jonathan A.] Tufts Univ, Sch Vet Med, Dept Infect Dis & Global Hlth, 200 Westboro Rd, North Grafton, MA 01536 USA	University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; Alaska Department of Fish & Game; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University System of Georgia; University of Georgia; Tufts University	Spivey, TJ (corresponding author), Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA.; Spivey, TJ (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	tspivey@alaska.edu			U.S. Geological Survey Wildlife Program of the Ecosystems Mission area; National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services [HHSN272201400006C, HHSN272201400008C]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007020] Funding Source: NIH RePORTER	U.S. Geological Survey Wildlife Program of the Ecosystems Mission area; National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was received by BWM and AMR from the U.S. Geological Survey Wildlife Program of the Ecosystems Mission area. Additional funding was provided in part by the National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services, under contracts HHSN272201400006C received by DES and HHSN272201400008C received by JAR. The funding agencies were not involved in the design, implementation, or publishing of this study, and the research presented herein represents the opinions of the authors but not necessarily the opinions of the funding agencies. There was no additional external funding received for this study.	[Anonymous], 2021, LANG ENV STAT COMP; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Brown JD, 2009, CLIN VACCINE IMMUNOL, V16, P824, DOI 10.1128/CVI.00084-09; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carney S.M., 1992, SPECIES AGE SEX IDEN; Ely CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057614; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; Hanson BA, 2003, AVIAN DIS, V47, P867, DOI 10.1637/0005-2086-47.s3.867; Henaux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031471; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Hill NJ, 2016, ECOL LETT, V19, P915, DOI 10.1111/ele.12629; Hill SC, 2016, P R SOC B, V283, P1; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; HOCHBAUM H. A., 1942, Transactions 7th N. Amer. Wildlife Conf., P299; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Latorre-Margalef N, BIO REV UNPUB; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Meixell BW, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1666-3; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; National Audubon Society, 2015, CHRISTM BIRD COUNT H; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Ramey AM, 2015, J WILDLIFE DIS, V51, P938, DOI 10.7589/2015-03-057; Reeves AB, 2011, INFECT GENET EVOL, V11, P2004, DOI 10.1016/j.meegid.2011.09.011; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; Samuel MD, 2015, ECOL APPL, V25, P1851, DOI 10.1890/14-1820.1; Shriner SA, 2016, J VIROL METHODS, V228, P130, DOI 10.1016/j.jviromet.2015.11.021; SLEMONS RD, 1974, AVIAN DIS, V18, P119, DOI 10.2307/1589250; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2009, AVIAN DIS, V53, P276, DOI 10.1637/8520-111708-Reg.1; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; Tolf C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061201; Verhagen JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038256; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1976, J GEN VIROL, V32, P217, DOI 10.1099/0022-1317-32-2-217; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058308; Winker K, 2007, EMERG INFECT DIS, V13, P547, DOI 10.3201/eid1304.061072	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183505	10.1371/journal.pone.0183505	http://dx.doi.org/10.1371/journal.pone.0183505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837606	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000074
J	Bond, R; Ly, NN; Cyert, MS				Bond, Rachel; Ly, Nina; Cyert, Martha S.			The unique C terminus of the calcineurin isoform CNA beta 1 confers non-canonical regulation of enzyme activity by Ca2+ and calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPHILIN-CYCLOSPORINE-A; PHOSPHATASE-ACTIVITY; AUTOINHIBITORY DOMAIN; SACCHAROMYCES-CEREVISIAE; MYOCARDIAL-INFARCTION; TRANSCRIPTION FACTOR; PROTEIN PHOSPHATASE; VARIANT CNA-BETA-1; GENE-EXPRESSION; NFAT ACTIVATION	Calcineurin, the conserved Ca2+/calmodulin-regulated phosphatase and target of immunosuppressants, plays important roles in the circulatory, nervous, and immune systems. Calcineurin activity strictly depends on Ca2+ and Ca2+-bound calmodulin (Ca2+/CaM) to relieve autoinhibition of the catalytic subunit (CNA) by its C terminus. The C terminus contains two regulatory domains, the autoinhibitory domain (AID) and calmodulin-binding domain (CBD), which block the catalytic center and a conserved substrate-binding groove, respectively. However, this mechanism cannot apply to CNA beta 1, an atypical CNA isoform generated by alternative 3'-end processing, whose divergent C terminus shares the CBD common to all isoforms, but lacks the AID. We present the first biochemical characterization of CNA beta 1, which is ubiquitously expressed and conserved in vertebrates. We identify a distinct C-terminal autoinhibitory four-residue sequence in CNA beta 1, (462)LAVP(465), which competitively inhibits substrate dephosphorylation. In vitro and cell-based assays revealed that the CNA beta 1-containing holoenzyme, CN beta 1, is autoinhibited at a single site by either of two inhibitory regions, CBD and LAVP, which block substrate access to the substrate-binding groove. We found that the autoinhibitory segment (AIS), located within the CBD, is progressively removed by Ca2+ and Ca2+/CaM, whereas LAVP remains engaged. This regulatory strategy conferred higher basal and Ca2+-dependent activity to CN beta 1, decreasing its dependence on CaM, but also limited maximal enzyme activity through persistence of LAVP-mediated autoinhibiton during Ca2+/CaM stimulation. These regulatory properties may underlie observed differences between the biological activities of CN beta 1 and canonical CN beta 2. Our insights lay the groundwork for further studies of CN beta 1, whose physiological substrates are currently unknown.	[Bond, Rachel; Ly, Nina; Cyert, Martha S.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Cyert, MS (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	mcyert@stanford.edu		Cyert, Martha/0000-0003-3825-7437	National Institutes of Health NIGMS Grant [1R01GM119336]; National Institutes of Health [2T32GM007276, 5T32GM008412]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119336, T32GM007276] Funding Source: NIH RePORTER	National Institutes of Health NIGMS Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Grant 1R01GM119336. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant 2T32GM007276.; Supported by National Institutes of Health Grant 5T32GM008412.	Becker D. M., 2001, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb1307s27, DOI 10.1002/0471142727]; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Davey NE, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0120-z; DAVIS TN, 1986, CELL, V47, P423, DOI 10.1016/0092-8674(86)90599-4; DONELLADEANA A, 1994, EUR J BIOCHEM, V219, P109, DOI 10.1111/j.1432-1033.1994.tb19920.x; ETZKORN FA, 1994, BIOCHEMISTRY-US, V33, P2380, DOI 10.1021/bi00175a005; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Felkin LE, 2011, CIRCULATION, V123, P2838, DOI 10.1161/CIRCULATIONAHA.110.012211; Goldman A, 2014, MOL CELL, V55, P422, DOI 10.1016/j.molcel.2014.05.012; Gomez-Salinero JM, 2016, CELL CHEM BIOL, V23, P1372, DOI 10.1016/j.chembiol.2016.09.010; Grigoriu S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001492; GUERINI D, 1989, P NATL ACAD SCI USA, V86, P9183, DOI 10.1073/pnas.86.23.9183; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; HUBBARD MJ, 1987, J BIOL CHEM, V262, P15062; HUBBARD MJ, 1989, BIOCHEMISTRY-US, V28, P1868, DOI 10.1021/bi00430a066; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Lara-Pezzi E, 2007, J CELL BIOL, V179, P1205, DOI 10.1083/jcb.200704179; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Li SJ, 2016, CELL RES, V26, P336, DOI 10.1038/cr.2016.14; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lopez-Olaneta MM, 2014, CARDIOVASC RES, V102, P396, DOI 10.1093/cvr/cvu068; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; MARTIN BL, 1986, J BIOL CHEM, V261, P4545; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; Perrino BA, 1999, ARCH BIOCHEM BIOPHYS, V372, P159, DOI 10.1006/abbi.1999.1485; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rumi-Masante J, 2012, J MOL BIOL, V415, P307, DOI 10.1016/j.jmb.2011.11.008; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sagoo JK, 1996, BIOCHEM J, V320, P879, DOI 10.1042/bj3200879; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Sheftic SR, 2016, SCI REP-UK, V6, DOI 10.1038/srep38920; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; SWANSON SKH, 1992, P NATL ACAD SCI USA, V89, P3741, DOI 10.1073/pnas.89.9.3741; Yang SA, 2000, BIOCHEMISTRY-US, V39, P16147, DOI 10.1021/bi001321q	49	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16709	16721		10.1074/jbc.M117.795146	http://dx.doi.org/10.1074/jbc.M117.795146			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842480	Green Published, hybrid			2022-12-26	WOS:000412414800030
J	Zhao, PS; Wang, LR; Zhao, X; Chen, GX; Ma, XF				Zhao, Pengshan; Wang, Lirong; Zhao, Xin; Chen, Guoxiong; Ma, Xiao-Fei			A comparative transcriptomic analysis reveals the core genetic components of salt and osmotic stress responses in Braya humilis	PLOS ONE			English	Article							FUNCTIONAL GENOMICS; CANDIDATE GENES; PROVIDES TOOLS; ARABIDOPSIS; EXPRESSION; IDENTIFICATION; ADAPTATION; EVOLUTION; SELECTION; PATTERNS	Braya humilis is a member of the Euclidieae tribe within the family Brassicaceae. This species exhibits a broad range of adaptations to different climatic zones and latitudes as it has a distribution that ranges from northern Asia to the arctic-alpine regions of northern North America. In China, B. humilis is mainly found on the Qinghai-Tibetan Plateau (QTP) and in adjacent arid regions. In this study, we sequenced a sample from an arid region adjacent to the QTP using the Illumina platform generating a total of 46,485 highly accurate unigenes, of which 78.41% were annotated by BLASTing versus public protein databases. The B. humilis transcriptome is characterized by a high level of sequence conservation compared with its close relative, Arabidopsis thaliana. We also used reciprocal blast to identify shared orthologous genes between B. humilis and four other sequenced Brassicaceae species (i.e. A. thaliana, A. lyrata, Capsella rubella, and Thellungiella parvula). To enable precise characterization of orthologous genes, the early-diverging basal angiosperm Amborella trichopoda was also included. A total of 6,689 orthologous genes were identified before stricter criteria for the determination of e-values, amino acid hit lengths, and identity values was applied to further reduce this list. This led to a final list of 381 core orthologous genes for B. humilis; 39 out of these genes are involved in salt and osmotic stress responses and estimations of non-synonymous/synonymous substitution ratios for this species and A. thaliana orthologs show that these genes are under purifying selection in B. humilis. Expression of six genes was detected in B. humilis seedlings under salt and osmotic stress treatments. Comparable expression patterns to their counterparts in Arabidopsis suggest that these orthologous genes are both sequence and functional conservation. The results of this study demonstrate that the environmental adaptations of B. humilis are mainly the results of preexisting genetic components. Future work will be required to characterize the expression patterns of these orthologous genes in natural populations and will provide further insights into the adaptive mechanisms underlying the wide range of B. humilis adaptations.	[Zhao, Pengshan; Zhao, Xin; Chen, Guoxiong; Ma, Xiao-Fei] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Key Lab Stress Physiol & Ecol Cold & Arid Reg, Lanzhou, Gansu, Peoples R China; [Zhao, Pengshan; Zhao, Xin; Chen, Guoxiong; Ma, Xiao-Fei] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Shapotou Desert Res & Expt Stn, Lanzhou, Gansu, Peoples R China; [Wang, Lirong] Gansu Agr Univ, Coll Forestry, Lanzhou, Gansu, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Gansu Agricultural University	Zhao, PS; Ma, XF (corresponding author), Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Key Lab Stress Physiol & Ecol Cold & Arid Reg, Lanzhou, Gansu, Peoples R China.; Zhao, PS; Ma, XF (corresponding author), Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Shapotou Desert Res & Expt Stn, Lanzhou, Gansu, Peoples R China.	zhaopengshan@lzb.ac.cn; maxiaofei@lzb.ac.cn	Ma, Xiaofei/ABB-5302-2022	Ma, Xiaofei/0000-0001-9456-0065	National Natural Science Foundation of China [41201048]; Innovation Research Group Fund of Gansu Province, China [1308RJIA002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Research Group Fund of Gansu Province, China	This work was supported by grants from the National Natural Science Foundation of China (No. 41201048), and by the Innovation Research Group Fund (1308RJIA002) of Gansu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; AlShehbaz IA, 1997, NOVON, V7, P93, DOI 10.2307/3392176; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Chamala S, 2013, SCIENCE, V342, P1516, DOI 10.1126/science.1241130; Chen LY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10098; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dorn KM, 2015, DNA RES, V22, P121, DOI 10.1093/dnares/dsu045; Dorn KM, 2013, PLANT J, V75, P1028, DOI 10.1111/tpj.12267; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Golicz AA, 2015, J EXP BOT, V66, P1489, DOI 10.1093/jxb/eru510; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Liu TM, 2014, PLANT MOL BIOL, V86, P85, DOI 10.1007/s11103-014-0214-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oh DH, 2014, PLANT PHYSIOL, V164, P2123, DOI 10.1104/pp.113.233551; Oh DH, 2010, PLANT PHYSIOL, V154, P1040, DOI 10.1104/pp.110.163923; Provart NJ, 2003, PLANT PHYSIOL, V132, P893, DOI 10.1104/pp.103.021261; R Core Team, 2018, R LANG ENV STAT COMP; Schilling RK, 2017, TRENDS PLANT SCI, V22, P154, DOI 10.1016/j.tplants.2016.11.012; Slotte T, 2013, NAT GENET, V45, P831, DOI 10.1038/ng.2669; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Wang LR, 2016, ACTA SOC BOT POL, V85, DOI 10.5586/asbp.3487; Warwick SI, 2004, CAN J BOT, V82, P376, DOI 10.1139/B04-012; Warwick SI, 2007, ANN MO BOT GARD, V94, P56, DOI 10.3417/0026-6493(2007)94[56:PRITTA]2.0.CO;2; Yang RL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00046; Yi X, 2013, NUCLEIC ACIDS RES, V41, pW98, DOI 10.1093/nar/gkt281; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066370; Zhang ML, 2014, PHYTOTAXA, V167, P89, DOI 10.11646/phytotaxa.167.1.5; Zhao PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-872; Zhou TY, 2001, FLORA CHINA, V8	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183778	10.1371/journal.pone.0183778	http://dx.doi.org/10.1371/journal.pone.0183778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859098	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500033
J	Lin, L; Wang, Y; Liu, TX				Lin, Le; Wang, Ying; Liu, Tianxue			Perception of recovery of households affected by 2008 Wenchuan earthquake: A structural equation model	PLOS ONE			English	Article							HOUSING RECOVERY; DISASTER RECOVERY; YAOAN EARTHQUAKE; CIVIL-SOCIETY; COMMUNITY; KOBE; RESILIENCE; SURVIVORS; HEALTH; POLICY	Much of the literature on recovery focuses on the economy, the physical environment and infrastructure at a macro level, which may ignore the personal experiences of affected individuals during recovery. This paper combines internal factors at a micro level and external factors at a macro level to model for understanding perception of recovery (PoR). This study focuses on areas devastated by the 2008 Wenchuan earthquake in China. With respect to three recovery-related aspects (house recovery condition (HRC), family recovery power (FRP) and reconstruction investment (RI)), structural equation modeling (SEM) was applied. It was found that the three aspects (FRP, HRC and RI) effectively explain how earthquake affected households perceive recovery. Internal factors associated with FRP contributed the most to favourable PoR, followed by external factors associated with HRC. Findings identified that for PoR the importance of active recovery within households outweighed an advantageous house recovery condition. At the same time, households trapped in unfavourable external conditions would invest more in housing recovery, which result in wealth accumulation and improved quality of life leading to a high level of PoR. In addition, schooling in households showed a negative effect on improving PoR. This research contributes to current debates around post-disaster permanent housing policy. It is implied that a one-size-fits-all policy in disaster recovery may not be effective and more specific assistance should be provided to those people in need.	[Lin, Le; Wang, Ying; Liu, Tianxue] Beijing Normal Univ, Minist Educ, Key Lab Environm Change & Nat Disaster, Beijing, Peoples R China; [Lin, Le; Wang, Ying; Liu, Tianxue] Beijing Normal Univ, Acad Disaster Reduct & Emergency Management, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University	Wang, Y (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Environm Change & Nat Disaster, Beijing, Peoples R China.; Wang, Y (corresponding author), Beijing Normal Univ, Acad Disaster Reduct & Emergency Management, Beijing, Peoples R China.	wy@bnu.edu.cn			National Natural Science Foundation of China [41271544]; National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by National Natural Science Foundation of China (No. 41271544), which is available from http://npd.nsfc.gov.cn/fundingProjectSearchAction.action. Ying Wang received the funding. National Natural Science Foundation of China provided funding for data collection and publication fees in this research.	Aldrich DP, 2012, DISASTERS, V36, P398, DOI 10.1111/j.1467-7717.2011.01263.x; Aldrich DP, 2011, NAT HAZARDS, V56, P595, DOI 10.1007/s11069-010-9577-7; Andrew SA, 2013, J HOUS BUILT ENVIRON, V28, P17, DOI 10.1007/s10901-012-9266-9; Argyrous G., 2011, STAT RES GUIDE SPSS; Arshad S, 2013, RURAL HOUSING RECONS; BOLIN R, 1976, MASS EMERGENCIES, V1, P267; Bolin RC, 1983, INT J MASS EMERG DIS, V1, P125; Bollen KA, 1989, STRUCTURAL EQUATIONS; Burton CG, 2015, ANN ASSOC AM GEOGR, V105, P67, DOI 10.1080/00045608.2014.960039; Chang SE, 2010, DISASTERS, V34, P303, DOI 10.1111/j.1467-7717.2009.01130.x; Cheng YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096644; Cox RS, 2011, AM J COMMUN PSYCHOL, V48, P395, DOI 10.1007/s10464-011-9427-0; Cui P, 2009, LANDSLIDES, V6, P209, DOI 10.1007/s10346-009-0160-9; Dong H, 2009, SOCIAL INVESTIGATION; Erikson K.T., 1976, EVERYTHING ITS PATH; Expert group from National Disaster Reduction Commission and Ministry of Science and Technology, 2008, COMPR AN ASS WENCH E; Finch C, 2010, POPUL ENVIRON, V31, P179, DOI 10.1007/s11111-009-0099-8; Fothergill, 2012, HEADS WATER GENDER C; Gioli G, 2014, REG ENVIRON CHANGE, V14, P1151, DOI 10.1007/s10113-013-0550-3; Grace J.B., 2006, STRUCT EQ MOD NAT; Hirayama Y, 2000, HOUSING STUD, V15, P111, DOI 10.1080/02673030082504; HU LT, 1992, PSYCHOL BULL, V112, P351, DOI 10.1037//0033-2909.112.2.351; Huang YN, 2014, SOC INDIC RES, V117, P421, DOI 10.1007/s11205-013-0354-3; Hunter LM, 2005, POPUL ENVIRON, V26, P273, DOI 10.1007/s11111-005-3343-x; Iuchi K., 2011, REDEFINING PLACE LIV; Jha AK, 2010, SAFER HOMES, STRONGER COMMUNITIES: A HANDBOOK FOR RECONSTRUCTING AFTER NATURAL DISASTERS, P1, DOI 10.1596/978-0-8213-8045-1; Kelloway, 1998, USING LISREL STRUCTU; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Khunwishit S., 2012, J HOMEL SECUR EMERG, V9, P1; Liang Y, 2014, SOC INDIC RES, V119, P943, DOI 10.1007/s11205-013-0525-2; Nakagawa Y., 2004, INT J MASS EMERGENCI, V22, P5; Nigg JM, 1995, 219 U DEL DIS RES CT; Oyerinde GT, 2015, REG ENVIRON CHANGE, V15, P1627, DOI 10.1007/s10113-014-0716-7; Peacock W.G., 2007, HDB DISASTER RES, P258, DOI DOI 10.1007/978-0-387-32353-4_15; Peacock WG, 2014, J AM PLANN ASSOC, V80, P356, DOI 10.1080/01944363.2014.980440; Quarantelli, 1995, DISASTER PREVENTION, V4, P43, DOI DOI 10.1108/09653569510088069; Quarantelli EL, 1999, 286 U DEL DIS RES CT; Rathfon D, 2013, DISASTERS, V37, P333, DOI 10.1111/j.1467-7717.2012.01305.x; Roco L, 2015, REG ENVIRON CHANGE, V15, P867, DOI 10.1007/s10113-014-0669-x; Schumacker R.E., 2004, BEGINNERS GUIDE STRU, V2nd ed.; Schumann RL, 2015, MEANING PLACE RECOVE; Shaw R, 2004, DISASTERS, V28, P16, DOI 10.1111/j.0361-3666.2004.00241.x; State Council of PRC, 2008, COMPR PLAN REC REC W; State Council of PRC, 2008, REG REC REC WENCH EA; Statistical Bureau of Sichuan, 2008, SICH STAT YB 2008; Stephens C, 2008, SOC SCI MED, V66, P1174, DOI 10.1016/j.socscimed.2007.11.026; Stratta P, 2015, PERS INDIV DIFFER, V77, P55, DOI 10.1016/j.paid.2014.12.035; Struyk RJ, 2006, HOUSING STUD, V21, P97, DOI 10.1080/02673030500391197; Tafti MT, 2015, INT DEV PLANN REV, V37, P165, DOI 10.3828/idpr.2015.14; Tamura K, 2000, J SOC SAF SCI, V2, P25; Tamura K., 2001, I SOCIAL SAFETY SCI, V3, P33; UN-United Nations, 2015, SEND FRAM DIS RISK R; Wang Y, 2015, NAT HAZARDS, V75, P1853, DOI 10.1007/s11069-014-1400-4; Wang Y, 2014, DISASTERS, V38, P774, DOI 10.1111/disa.12083; Wang Y, 2012, NAT HAZARDS, V64, P37, DOI 10.1007/s11069-012-0224-3; Wen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043081; Woolcock M, 1998, THEOR SOC, V27, P151, DOI 10.1023/A:1006884930135; Xu JP, 2012, PSYCHIAT CLIN NEUROS, V66, P210, DOI 10.1111/j.1440-1819.2012.02331.x; Yin YP, 2009, LANDSLIDES, V6, P139, DOI 10.1007/s10346-009-0148-5; Zifa W, 2008, EARTHQ ENG ENG VIB, V7, P225, DOI 10.1007/s11803-008-0856-1	60	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183631	10.1371/journal.pone.0183631	http://dx.doi.org/10.1371/journal.pone.0183631			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF1XX	28854217	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600051
J	InanlooRahatloo, K; Liang, G; Vo, D; Ebert, A; Nguyen, I; Nguyen, PK				InanlooRahatloo, Kolsoum; Liang, Grace; Vo, Davis; Ebert, Antje; Nguyen, Ivy; Nguyen, Patricia K.			Sex-based differences in myocardial gene expression in recently deceased organ donors with no prior cardiovascular disease	PLOS ONE			English	Article							GENDER-RELATED DIFFERENCES; KAPPA-B; HEART; HYPERTROPHY; 17-BETA-ESTRADIOL; ATHEROSCLEROSIS; MECHANISMS; VCAM-1; MICE	Sex differences in the development of the normal heart and the prevalence of cardiomyopathies have been reported. The molecular basis of these differences remains unclear. Sex differences in the human heart might be related to patterns of gene expression. Recent studies have shown that sex specific differences in gene expression in tissues including the brain, kidney, skeletal muscle, and liver. Similar data is limited for the heart. Herein we address this issue by analyzing donor and post-mortem adult human heart samples originating from 46 control individuals to study whole-genome gene expression in the human left ventricle. Using data from the genotype tissue expression (GTEx) project, we compared the transcriptome expression profiles of male and female hearts. We found that genes located on sex chromosomes were the most abundant ones among the sexually dimorphic genes. The majority of differentially expressed autosomal genes were those involved in the regulation of inflammation, which has been found to be an important contributor to left ventricular remodeling. Specifically, genes on autosomal chromosomes encoding chemokines with inflammatory functions (e.g. CCL4, CX3CL1, TNFAIP3) and a gene that regulates adhesion of immune cells to the endothelium (e.g., VCAM1) were identified with sex-specific expression levels. This study underlines the relevance of sex as an important modifier of cardiac gene expression. These results have important implications in the understanding of the differences in the physiology of the male and female heart transcriptome and how they may lead to different sex specific difference in human cardiac health and its control.	[InanlooRahatloo, Kolsoum; Liang, Grace; Vo, Davis; Ebert, Antje; Nguyen, Ivy; Nguyen, Patricia K.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [InanlooRahatloo, Kolsoum; Nguyen, Patricia K.] Stanford Univ, Dept Med, Div Cardiol, Sch Med, Stanford, CA 94305 USA; [InanlooRahatloo, Kolsoum] Univ Social Welf & Rehabil Sci, Dept Genet, Genet Res Ctr, Tehran, Iran; [Nguyen, Patricia K.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Nguyen, Patricia K.] Stanford Univ, Dept Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA; [Nguyen, Patricia K.] Vet Affairs Palo Alto, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Nguyen, PK (corresponding author), Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.; Nguyen, PK (corresponding author), Stanford Univ, Dept Med, Div Cardiol, Sch Med, Stanford, CA 94305 USA.; Nguyen, PK (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Nguyen, PK (corresponding author), Stanford Univ, Dept Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA.; Nguyen, PK (corresponding author), Vet Affairs Palo Alto, Palo Alto, CA 94304 USA.	pknguyen@stanford.edu	Inanloorahatloo, kolsoum/D-7701-2017	Inanloorahatloo, kolsoum/0000-0002-5316-8259; Nguyen, Ivy/0000-0001-5612-8159	American Heart Association [10SDG4280129]; Stanford University School of Medicine; U.S. Department of Veterans Affairs [HSRD 10-032]	American Heart Association(American Heart Association); Stanford University School of Medicine; U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the American Heart Association (10SDG4280129) to Dr. Patricia Nguyen; Stanford University School of Medicine to Ivy Nguyen; and U.S. Department of Veterans Affairs (HSRD 10-032) to Dr. Patricia Nguyen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Apostolakis S, 2013, ACTA PHARMACOL SIN, V34, P1251, DOI 10.1038/aps.2013.92; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Boheler KR, 2003, P NATL ACAD SCI USA, V100, P2754, DOI 10.1073/pnas.0436564100; Bowden RA, 2002, CIRC RES, V90, P562, DOI 10.1161/01.RES.0000013835.53611.97; Chang TT, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0439-9; Chen C.Y, 2016, BIORXIV, DOI [10.1101/082289, DOI 10.1101/082289]; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Czubryt MP, 2006, CAN J PHYSIOL PHARM, V84, P93, DOI 10.1139/Y05-151; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dubey RK, 1998, HYPERTENSION, V31, P522, DOI 10.1161/01.HYP.31.1.522; Fernandez-Ruiz I, 2016, NAT REV CARDIOL, V13, P503, DOI [10.1038/nrcardio.2016.127, 10.1038/nrcardio.2016.58]; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hewagama A, 2009, GENES IMMUN, V10, P509, DOI 10.1038/gene.2009.12; Isensee J, 2008, J MOL MED, V86, P61, DOI 10.1007/s00109-007-0240-z; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Ley K, 2001, J CLIN INVEST, V107, P1209, DOI 10.1172/JCI13005; Liao XD, 2015, J CLIN INVEST, V125, P3461, DOI 10.1172/JCI79964; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Mahmoodzadeh S, 2012, CARDIOVASC RES, V96, P411, DOI 10.1093/cvr/cvs281; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mathur P, 2015, CARDIOVASC DRUG THER, V29, P319, DOI 10.1007/s10557-015-6596-3; Merz CNB, 1996, AM HEART J, V131, P704; Meyer S, 2014, EUR J HEART FAIL, V16, P238, DOI 10.1002/ejhf.15; Miklos DB, 2005, BLOOD, V105, P2973, DOI 10.1182/blood-2004-09-3660; Miller Virginia M, 2011, Sex Reprod Menopause, V9, P21; Nemska S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161273; Ostadal B, 2007, RESP PHYSIOL NEUROBI, V158, P224, DOI 10.1016/j.resp.2007.03.005; Petrov G, 2010, CIRCULATION, V122, pS23, DOI 10.1161/CIRCULATIONAHA.109.927764; Regitz-Zagrosek V, 2010, CIRC J, V74, P1265, DOI 10.1253/circj.CJ-10-0196; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sharma N, 2012, ARTERIOSCL THROM VAS, V32, P2836, DOI 10.1161/ATVBAHA.112.300471; Skelton RJP, 2014, STEM CELL RES, V13, P172, DOI 10.1016/j.scr.2014.04.016; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Vassalle C, 2012, GYNECOL ENDOCRINOL, V28, P746, DOI 10.3109/09513590.2011.652720; Yoshida T, 2014, J BIOL CHEM, V289, P26107, DOI 10.1074/jbc.M114.582809; Zhou L, 2007, EUR J PHARMACOL, V567, P186, DOI 10.1016/j.ejphar.2007.03.047	42	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183874	10.1371/journal.pone.0183874	http://dx.doi.org/10.1371/journal.pone.0183874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850583	Green Published, gold, Green Submitted			2022-12-26	WOS:000408544200036
J	Naito, T; Fujiwara, M; Miki, T; Araki, R; Fujiwara, A; Shiode, Y; Morizane, Y; Nagayama, M; Shiraga, F				Naito, Tomoko; Fujiwara, Miyuki; Miki, Takako; Araki, Ryoichi; Fujiwara, Atsushi; Shiode, Yusuke; Morizane, Yuki; Nagayama, Mikio; Shiraga, Fumio			Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure < 15 mmHg	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; FILTRATION SURGERY; MITOMYCIN-C; FOLLOW-UP; EYES; PREVALENCE; POPULATION; EFFICACY; TARGETS; TAJIMI	We examined the effectiveness of trabeculectomy in decreasing the slope of mean deviation (MD) in Japanese patients with progressive normal-tension glaucoma (NTG) at low intraocular pressure (IOP) levels. The charts of patients who had undergone initial trabeculectomy with adjunctive mitomycin C for progressive NTG with medically controlled IOP < 15 mmHg in 2010-2013 were retrospectively reviewed. Seventeen eyes of 13 NTG patients who had undergone at least 5 times of visual field (VF) examinations in both of preoperatively and postoperatively with postoperative follow-up of >= 2 years were enrolled. Preoperative and postoperative MD slopes were compared to evaluate the effectiveness of trabeculectomy in slowing progression of VF. Mean IOP (8.1 +/- 2.9 mmHg) and number of IOP-lowering medications (0.8 +/- 1.5) were significantly lower postoperatively than preoperatively (13.9 +/- 0.9 mmHg; P < 0.001 and 3.0 +/- 0.4; P < 0.0001). In total, 91.7% of eyes with single-digit IOP postoperatively showed improvement in MD slope, whereas only 20.0% of eyes with IOP >= 10 mmHg postoperatively showed the improvement. Three eyes (17.6%) showed a decrease in visual acuity (VA) of >= 0.1 unit; this group had a lower mean postoperative IOP (6.0 +/- 1.0 vs. 8.6 +/- 3.0 mmHg; P = 0.1717) and a higher mean IOP reduction rate (56.2 vs. 38.5%; P = 0.8296) than eyes with a VA decrease of < 0.1 unit or no change. Thus, in this analysis of Japanese NTG patients with medically controlled IOP < 15 mmHg, achieving an IOP < 10 mmHg with trabeculectomy was beneficial for reducing the VF progression rate in progressive NTG at low IOP levels. However, an IOP < 7 mmHg by surgery would be required careful attention to VA decline.	[Naito, Tomoko; Fujiwara, Miyuki; Miki, Takako; Araki, Ryoichi; Fujiwara, Atsushi; Shiode, Yusuke; Morizane, Yuki; Shiraga, Fumio] Okayama Univ, Med Sch Hosp, Dept Ophthalmol, Okayama, Japan; [Nagayama, Mikio] Nagayama Eye Clin, Okayama, Japan	Okayama University	Naito, T (corresponding author), Okayama Univ, Med Sch Hosp, Dept Ophthalmol, Okayama, Japan.	tomokoum@gmail.com						Aoyama A, 2010, JPN J OPHTHALMOL, V54, P117, DOI 10.1007/s10384-009-0779-z; Armstrong James J, 2017, J Glaucoma, V26, P511, DOI 10.1097/IJG.0000000000000643; Bhandari A, 1997, OPHTHALMOLOGY, V104, P1131, DOI 10.1016/S0161-6420(97)30172-9; Collaborative Normal-Tension Glaucoma Study Group, 1998, AM J OPHTHALMOL, V126, P487; Collaborative Normal-Tension Glaucoma Study Group, 1998, AM J OPHTHALMOL, V126, P498; Daugeliene L, 1998, JPN J OPHTHALMOL, V42, P286, DOI 10.1016/S0021-5155(98)00013-6; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Hagiwara Y, 2000, GRAEF ARCH CLIN EXP, V238, P232; Hirooka K, 2009, J GLAUCOMA, V18, P689, DOI 10.1097/IJG.0b013e31819c49f4; Iverson SM, 2016, J GLAUCOMA, V25, P408, DOI 10.1097/IJG.0000000000000240; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Japan Glaucoma Society, 2002, GUID GLAUC; Jongsareejit B, 2005, JPN J OPHTHALMOL, V49, P223, DOI 10.1007/s10384-004-0181-9; Kiuchi T, 2006, OPHTHALMOLOGY, V113, P2150, DOI 10.1016/j.ophtha.2006.06.014; Komori S, 2014, GRAEF ARCH CLIN EXP, V252, P1963, DOI 10.1007/s00417-014-2767-3; Konstas AGP, 2006, OPHTHALMOLOGY, V113, P761, DOI 10.1016/j.ophtha.2006.01.029; Koseki N, 1997, OPHTHALMOLOGY, V104, P197, DOI 10.1016/S0161-6420(97)30334-0; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Medeiros FA, 2002, J OCUL PHARMACOL TH, V18, P489, DOI 10.1089/108076802321021036; Membrey WL, 2001, BRIT J OPHTHALMOL, V85, P696, DOI 10.1136/bjo.85.6.696; Miglior S, 2007, AM J OPHTHALMOL, V144, P266, DOI 10.1016/j.ajo.2007.04.040; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Reiko Ishii, 1990, SINSHO GANKA JAPANES, V44, P1445; Sawada A, 2014, INVEST OPHTH VIS SCI, V55, P446, DOI 10.1167/iovs.13-13030; Sawada A, 2012, GRAEF ARCH CLIN EXP, V250, P1361, DOI 10.1007/s00417-012-1942-7; Schultz SK, 2016, J GLAUCOMA, V25, P217, DOI 10.1097/IJG.0000000000000145; Shigeeda T, 2002, OPHTHALMOLOGY, V109, P766, DOI 10.1016/S0161-6420(01)01009-0; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Weizer JS, 2010, OPHTHAL SURG LAS IM, V41, P532, DOI 10.3928/15428877-20100726-06; Yamada M, 2010, OPHTHAL EPIDEMIOL, V17, P50, DOI 10.3109/09286580903450346; Yamamoto T, 2005, OPHTHALMOLOGY, V112, P1661, DOI 10.1016/j.ophtha.2005.05.012; Yoshiaki Kitazawa, 2001, NIPPON GANKA GAKKAI, V105, P828	33	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0184096	10.1371/journal.pone.0184096	http://dx.doi.org/10.1371/journal.pone.0184096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850613	Green Published, gold, Green Submitted			2022-12-26	WOS:000408544200055
J	Gong, X; Hung, KH; Ting, YW; Hsu, TW; Malikova, L; Tran, HT; Huang, CL; Liu, SH; Chiang, TY				Gong, Xun; Hung, Kuo-Hsiang; Ting, Yu-Wei; Hsu, Tsai-Wen; Malikova, Lenka; Huyen Trang Tran; Huang, Chao-Li; Liu, Shih-Hui; Chiang, Tzen-Yuh			Frequent gene flow blurred taxonomic boundaries of sections in Lilium L. (Liliaceae)	PLOS ONE			English	Article							TRANSCRIBED SPACER REGION; MOLECULAR PHYLOGENY; EUROPEAN LILIES; DNA; CHLOROPLAST; EVOLUTION; GENOME; DIVERGENCE; SEQUENCES; INTROGRESSION	Gene flow between species may last a long time in plants. Reticulation inevitably causes difficulties in phylogenetic reconstruction. In this study, we looked into the genetic divergence and phylogeny of 20 Lilium species based on multilocus analyses of 8 genes of chloroplast DNA (cpDNA), the internally transcribed nuclear ribosomal DNA (nrITS) spacer and 20 loci extracted from the expressed sequence tag (EST) libraries of L. longiflorum Thunb. and L. formosanum Wallace. The phylogeny based on the combined data of the maternally inherited cpDNA and nrITS was largely consistent with the taxonomy of Lilium sections. This phylogeny was deemed the hypothetical species tree and uncovered three groups, i.e., Cluster A consisting of 4 taxa from the sections Pseudolirium and Liriotypus, Cluster B consisting of the 4 taxa from the sections Leucolirion, Archelirion and Daurolirion, and Cluster C comprising 10 taxa mostly from the sections Martagon and Sinomartagon. In contrast, systematic inconsistency occurred across the EST loci, with up to 19 genes (95%) displaying tree topologies deviating from the hypothetical species tree. The phylogenetic incongruence was likely attributable to the frequent genetic exchanges between species/sections, as indicated by the high levels of genetic recombination and the IMa analyses with the EST loci. Nevertheless, multilocus analysis could provide complementary information among the loci on the species split and the extent of gene flow between the species. In conclusion, this study not only detected frequent gene flow among Lilium sections that resulted in phylogenetic incongruence but also reconstructed a hypothetical species tree that gave insights into the nature of the complex relationships among Lilium species.	[Gong, Xun] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Hung, Kuo-Hsiang] Natl Pingtung Univ Sci & Technol, Grad Inst Bioresources, Pingtung, Taiwan; [Ting, Yu-Wei; Malikova, Lenka; Huyen Trang Tran; Chiang, Tzen-Yuh] Natl Cheng Kung Univ, Dept Life Sci, Tainan, Taiwan; [Hsu, Tsai-Wen] Endem Species Res Inst, Nantou, Taiwan; [Malikova, Lenka] Inst Bot CAS, Trebon, Czech Republic; [Huyen Trang Tran] Vinh Univ, Inst Nat Sci Educ, Vinh, Nghe An, Vietnam; [Huang, Chao-Li] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan, Taiwan; [Liu, Shih-Hui] St Louis Univ, Dept Biol, St Louis, MO 63107 USA; [Liu, Shih-Hui] Missouri Bot Garden, St Louis, MO 63110 USA; [Chiang, Tzen-Yuh] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan, Taiwan	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; National Pingtung University Science & Technology; National Cheng Kung University; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Vinh University; National Cheng Kung University; Saint Louis University; Missouri Botanical Gardens; National Cheng Kung University	Chiang, TY (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan, Taiwan.; Huang, CL (corresponding author), Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan, Taiwan.; Liu, SH (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63107 USA.; Liu, SH (corresponding author), Missouri Bot Garden, St Louis, MO 63110 USA.; Chiang, TY (corresponding author), Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan, Taiwan.	clhuang65535@gmail.com; liushihhui@gmail.com; tychiang@mail.ncku.edu.tw	Liu, Shih-Hui/HHC-0223-2022	Liu, Shih-Hui/0000-0002-5429-6869; Huang, Chao-Li/0000-0002-1059-432X	Ministry of Science and Technology [104-2621-B-006-002]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Ministry of Science and Technology: 104-2621-B-006-002, https://www.most.gov.tw/en/.public. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriola PE, 1996, AM J BOT, V83, P1153, DOI 10.2307/2446198; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Bao L. Y., 2004, FOR PROD SPECIALITY, V69, P54; BARANOVA M V, 1988, Botanicheskii Zhurnal (St. Petersburg), V73, P1319; BYRNE M, 1994, HEREDITY, V73, P18, DOI 10.1038/hdy.1994.94; Comas I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S7; Comber HF, 1949, R HORT SOC LILY YB, V13, P86; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Endlicher S., 1840, GENERA PLANTARUM SEC; Ennos RA, 2005, TRENDS ECOL EVOL, V20, P164, DOI 10.1016/j.tree.2005.01.012; Gao YD, 2013, MOL PHYLOGENET EVOL, V68, P443, DOI 10.1016/j.ympev.2013.04.026; Gao YD, 2012, PLANT SYST EVOL, V298, P69, DOI 10.1007/s00606-011-0524-1; Gauthier O, 2007, SYST BOT, V32, P8, DOI 10.1600/036364407780360238; Gojobori T, 2016, ECOLOGICAL GENETICS, V1, P8; Hayashi K, 2005, ACTA HORTIC, P43, DOI 10.17660/ActaHortic.2005.673.3; Hayashi Kazuhiko, 2000, Plant Species Biology, V15, P73, DOI 10.1046/j.1442-1984.2000.00025.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; HUDSON RR, 1985, GENETICS, V111, P147; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ikinci Nursel, 2006, Willdenowia, V36, P647, DOI 10.3372/wi.36.36201; Jefferson-Brown MJ, 1995, GARDENERS GUIDE GROW; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Ji YH, 2006, ANN BOT-LONDON, V98, P245, DOI 10.1093/aob/mcl095; Kane NC, 2009, EVOLUTION, V63, P2061, DOI 10.1111/j.1558-5646.2009.00703.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lee CS, 2011, J PLANT BIOL, V54, P159, DOI 10.1007/s12374-011-9152-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu-Irving P, 2013, BOT J LINN SOC, V171, P103, DOI 10.1111/j.1095-8339.2012.01305.x; MacRae EA., 1998, LILIES GUIDE GROWERS; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Minder AM, 2008, MOL ECOL, V17, P1552, DOI 10.1111/j.1365-294X.2008.03709.x; MOENS PB, 1970, J CELL SCI, V7, P55; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Muratovic E, 2010, ADV SCI LETT, V3, P180, DOI 10.1166/asl.2010.1116; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Naciri Y, 2015, TAXON, V64, P3, DOI 10.12705/641.24; Nishikawa T, 1999, J MOL EVOL, V49, P238, DOI 10.1007/PL00006546; Nishikawa T, 2001, BREEDING SCI, V51, P39, DOI 10.1270/jsbbs.51.39; Nishikawa T., 2008, MOL PHYLOGENY GENUS; Patterson TB, 2002, EVOLUTION, V56, P233, DOI 10.1111/j.0014-3820.2002.tb01334.x; Peruzzi L, 2009, ANN BOT-LONDON, V103, P459, DOI 10.1093/aob/mcn230; Peterson A, 2004, PLANT SYST EVOL, V245, P145, DOI 10.1007/s00606-003-0114-y; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas A, 2003, EVOL DEV, V5, P346, DOI 10.1046/j.1525-142X.2003.03042.x; Rong LP, 2011, GENET RESOUR CROP EV, V58, P115, DOI 10.1007/s10722-010-9584-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Soltis ED, 2000, PLANT MOL BIOL, V42, P45, DOI 10.1023/A:1006371803911; Sullivan J, 1996, SYST BIOL, V45, P375, DOI 10.2307/2413571; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Tuyl JM, 2011, ACTA HORTIC, V900, P223; Wang WK, 2011, PLANT MOL BIOL REP, V29, P88, DOI 10.1007/s11105-010-0214-0; Wang WK, 2010, NEW PHYTOL, V188, P488, DOI 10.1111/j.1469-8137.2010.03383.x; Wendel JF, 1998, MOL SYSTEMATICS PLAN, P26; Wilson E.H.., 1925, LILIES E ASIA; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; Woodcock H, 1950, LILIES WORLD THEIR C; Wu X. W., 2006, PLANT GENET RES, V7, P327; Xu B, 2012, MOL PHYLOGENET EVOL, V62, P346, DOI 10.1016/j.ympev.2011.10.007; ZIMMER EA, 1980, P NATL ACAD SCI-BIOL, V77, P2158, DOI 10.1073/pnas.77.4.2158	72	8	8	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183209	10.1371/journal.pone.0183209	http://dx.doi.org/10.1371/journal.pone.0183209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841664	Green Published, Green Submitted, gold			2022-12-26	WOS:000408370700020
J	Hurnakova, J; Hulejova, H; Zavada, J; Hanova, P; Komarc, M; Mann, H; Klein, M; Sleglova, O; Olejarova, M; Forejtova, S; Ruzickova, O; Vencovsky, J; Pavelka, K; Senolt, L				Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Hanova, Petra; Komarc, Martin; Mann, Herman; Klein, Martin; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav			Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; ACUTE-PHASE REACTANTS; LEUKOCYTE PROTEIN; ACTIVITY INDEX; SYNOVITIS; ULTRASONOGRAPHY; ASSOCIATION; PREDICTOR; PLASMA; JOINTS	Background Calprotectin may be a sensitive biomarker of rheumatoid arthritis (RA) disease activity. Objectives In the current study, we investigated whether calprotectin is a better biomarker than CRP for predicting clinical activity and ultrasound parameters in patients with RA. Methods A total of 160 patients with RA underwent clinical (swollen joint count-SJC, tender joint count-TJC, Disease Activity Score-DAS28, Clinical Disease Activity Index-CDAI, and simplified Disease Activity Index-SDAI) and ultrasound (German US7) examination. Clinical and laboratory measures were correlated with ultrasound findings using Spearman's correlation coefficient. Differences in serum calprotectin levels in patients with variable disease activity according to the DAS28-ESR and CDAI scores were assessed using ANOVA. Multivariate regression analysis was used to determine the predictive values of calprotectin, CRP and SJC for CDAI and PD US synovitis scores. Results Serum calprotectin was significantly associated with DAS28-ESR (r = 0.321, p<0.001), DAS28-CRP (r = 0.346, p<0.001), SDAI (r = 0.305, p<0.001), CDAI (r = 0.279, p<0.001) scores and CRP levels (r = 0.556, p<0.001). Moreover, calprotectin was significantly correlated with GS (r = 0.379, p<0.001) and PD synovitis scores (r = 0.419, p<0.001). The multi-variate regression analysis showed that calprotectin is a better predictor of the CDAI score and PD US synovitis than CRP. Conclusions The results of this study support an additional role of calprotectin in assessing inflammatory activity in patients with RA.	[Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Hanova, Petra; Mann, Herman; Klein, Martin; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav] Inst Rheumatol, Prague, Czech Republic; [Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Hanova, Petra; Mann, Herman; Klein, Martin; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav] Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic; [Klein, Martin] Charles Univ Prague, Fac Phys Educ & Sport, Dept Methodol, Prague, Czech Republic	Institute of Rheumatology; Charles University Prague; Charles University Prague	Senolt, L (corresponding author), Inst Rheumatol, Prague, Czech Republic.; Senolt, L (corresponding author), Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic.	senolt@revma.cz	Komarc, Martin/A-7308-2017; Hulejová, Hana/H-1909-2019; Pavelka, Karel/E-6578-2017; Vencovsky, Jiri/G-6094-2017; Závada, Jakub/N-3159-2017; Komarc, Martin/O-2575-2019; Mann, Herman Felix/G-5871-2014; Hanova, Petra/O-6675-2017; Forejtova, Sarka/N-7448-2017; Senolt, Ladislav/O-6097-2017; Klein, Martin/N-6958-2017; Ruzickova, Olga/O-4214-2017; Olejarova, Marta/O-8800-2017; Sleglova, Olga/N-3022-2017; Hurnakova, Jana/P-1932-2017	Komarc, Martin/0000-0003-4106-5217; Hulejová, Hana/0000-0002-2335-6996; Pavelka, Karel/0000-0003-1952-8422; Vencovsky, Jiri/0000-0002-0851-0713; Závada, Jakub/0000-0002-9802-6545; Komarc, Martin/0000-0003-4106-5217; Mann, Herman Felix/0000-0002-4243-235X; Hanova, Petra/0000-0003-4473-9766; Forejtova, Sarka/0000-0002-7510-7895; Senolt, Ladislav/0000-0001-5500-7312; Klein, Martin/0000-0002-1027-0923; Ruzickova, Olga/0000-0003-4284-1003; Olejarova, Marta/0000-0002-0586-361X; Sleglova, Olga/0000-0003-1764-5852; Hurnakova, Jana/0000-0002-1139-539X	project of the Ministry of Health of the Czech Republic for conceptual research development by organization [023728]; Specific Academy Research Projects (SW) [260 373]	project of the Ministry of Health of the Czech Republic for conceptual research development by organization; Specific Academy Research Projects (SW)	This work was supported by a project of the Ministry of Health of the Czech Republic for conceptual research development by organization [023728] and Specific Academy Research Projects (SW) [260 373]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Andersson AK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2370; Backhaus M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1194, DOI 10.1002/art.24646; BERNTZEN HB, 1991, SCAND J RHEUMATOL, V20, P74, DOI 10.3109/03009749109165280; BRUN JG, 1994, J RHEUMATOL, V21, P733; BRUN JG, 1992, J RHEUMATOL, V19, P859; Cerezo LA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3426; Choi IY, 2015, ANN RHEUM DIS, V74, P499, DOI 10.1136/annrheumdis-2013-203923; Colebatch AN, 2013, ANN RHEUM DIS, V72, P804, DOI 10.1136/annrheumdis-2012-203158; DALE I, 1983, J IMMUNOL METHODS, V65, P245, DOI 10.1016/0022-1759(83)90321-6; DALE I, 1983, EUR J BIOCHEM, V134, P1, DOI 10.1111/j.1432-1033.1983.tb07522.x; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Garcia-Arias M, 2013, MOL DIAGN THER, V17, P49, DOI 10.1007/s40291-013-0016-9; Hammer HB, 2007, ANN RHEUM DIS, V66, P1093, DOI 10.1136/ard.2006.064741; Hammer HB, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3503; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Hurnakova J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165498; Hurnakova J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0764-5; Inciarte-Mundo J, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1032-z; Inciarte-Mundo J, 2016, ARTHRIT CARE RES, V68, P899, DOI 10.1002/acr.22795; Inciarte-Mundo J, 2015, RHEUMATOLOGY, V54, P2239, DOI 10.1093/rheumatology/kev251; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Nair SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152362; Naredo E, 2005, ANN RHEUM DIS, V64, P375, DOI 10.1136/ard.2004.023929; Nordal HH, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1201-0; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rammes A, 1997, J BIOL CHEM, V272, P9496; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Szkudlarek M, 2003, ARTHRITIS RHEUM, V48, P955, DOI 10.1002/art.10877; WILKINSON MM, 1988, J CELL SCI, V91, P221	35	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183420	10.1371/journal.pone.0183420	http://dx.doi.org/10.1371/journal.pone.0183420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832684	Green Submitted, gold, Green Published			2022-12-26	WOS:000408355800058
J	Komatsu, H; Cook, C; Wang, CH; Medrano, L; Lin, H; Kandeel, F; Tai, YC; Mullen, Y				Komatsu, Hirotake; Cook, Colin; Wang, Chia-Hao; Medrano, Leonard; Lin, Henry; Kandeel, Fouad; Tai, Yu-Chong; Mullen, Yoko			Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival	PLOS ONE			English	Article							INSULIN-SECRETION; BETA-CELLS; TRANSPLANTATION; RAT; GLUCOSE; MASS; AUTOTRANSPLANTATION; CONSUMPTION; METABOLISM; STRATEGIES	Background Type 1 diabetes is an autoimmune disease that destroys insulin-producing beta cells in the pancreas. Pancreatic islet transplantation could be an effective treatment option for type 1 diabetes once several issues are resolved, including donor shortage, prevention of islet necrosis and loss in pre-and post-transplantation, and optimization of immunosuppression. This study seeks to determine the cause of necrotic loss of isolated islets to improve transplant efficiency. Methodology The oxygen tension inside isolated human islets of different sizes was simulated under varying oxygen environments using a computational in silico model. In vitro human islet viability was also assessed after culturing in different oxygen conditions. Correlation between simulation data and experimentally measured islet viability was examined. Using these in vitro viability data of human islets, the effect of islet diameter and oxygen tension of the culture environment on islet viability was also analyzed using a logistic regression model. Principal findings Computational simulation clearly revealed the oxygen gradient inside the islet structure. We found that oxygen tension in the islet core was greatly lower (hypoxic) than that on the islet surface due to the oxygen consumption by the cells. The hypoxic core was expanded in the larger islets or in lower oxygen cultures. These findings were consistent with results from in vitro islet viability assays that measured central necrosis in the islet core, indicating that hypoxia is one of the major causes of central necrosis. The logistic regression analysis revealed a negative effect of large islet and low oxygen culture on islet survival. Conclusions/Significance Hypoxic core conditions, induced by the oxygen gradient inside islets, contribute to the development of central necrosis of human isolated islets. Supplying sufficient oxygen during culture could be an effective and reasonable method to maintain isolated islets viable.	[Komatsu, Hirotake; Wang, Chia-Hao; Medrano, Leonard; Lin, Henry; Kandeel, Fouad; Mullen, Yoko] City Hope Natl Med Ctr, Dept Diabet & Metab Res, Div Dev & Translat Diabet & Endocrinol Res, Beckman Res Inst, Duarte, CA 91010 USA; [Cook, Colin; Tai, Yu-Chong] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA	City of Hope; Beckman Research Institute of City of Hope; California Institute of Technology	Komatsu, H (corresponding author), City Hope Natl Med Ctr, Dept Diabet & Metab Res, Div Dev & Translat Diabet & Endocrinol Res, Beckman Res Inst, Duarte, CA 91010 USA.	hkomatsu@coh.org	KOMATSU, HIROTAKE/R-7234-2019	KOMATSU, HIROTAKE/0000-0003-0876-4809	Nora Eccles Treadwell Foundation [30.6990.973667]	Nora Eccles Treadwell Foundation	This work was supported by a grant from the Nora Eccles Treadwell Foundation (30.6990.973667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIELI R, 1988, COMP BIOCHEM PHYS A, V91, P221, DOI 10.1016/0300-9629(88)90408-2; Avgoustiniatos ES, 1997, ANN NY ACAD SCI, V831, P145; Barkai Uriel, 2016, World J Transplant, V6, P69, DOI 10.5500/wjt.v6.i1.69; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Buchwald P, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-5; Carlsson PO, 1998, DIABETES, V47, P1027, DOI 10.2337/diabetes.47.7.1027; Carlsson PO, 2001, DIABETES, V50, P489, DOI 10.2337/diabetes.50.3.489; Chavko M, 2008, EUR J APPL PHYSIOL, V102, P525, DOI 10.1007/s00421-007-0611-8; Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116; Citro A, 2013, CURR DIABETES REP, V13, P733, DOI 10.1007/s11892-013-0401-0; CLARK JM, 1988, EXP LUNG RES, V14, P897, DOI 10.3109/01902148809064182; Farhat B, 2013, ISLETS, V5, P87, DOI 10.4161/isl.24780; Farney AC, 2016, PANCREAS, V45, P8, DOI 10.1097/MPA.0000000000000391; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Fullerton B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012161; JANSSON L, 1983, DIABETOLOGIA, V25, P45; Johnson MB, 2016, LANCET DIABETES ENDO, V4, P862, DOI 10.1016/S2213-8587(16)30095-X; Komatsu H, 2016, CELL TRANSPLANT, V25, P1777, DOI 10.3727/096368915X689721; Komatsu H, 2016, BIOCHEM BIOPH RES CO, V470, P534, DOI 10.1016/j.bbrc.2016.01.110; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; LI W, 2014, J DIABETES RES, V2014, DOI DOI 10.1155/2014/192093; Lilly MA, 2016, AM J STEM CELLS, V5, P87; LONGO EA, 1991, J BIOL CHEM, V266, P9314; Ma ZH, 2014, BIOCHEM BIOPH RES CO, V443, P223, DOI 10.1016/j.bbrc.2013.11.088; Miao G, 2006, AM J TRANSPLANT, V6, P2636, DOI 10.1111/j.1600-6143.2006.01541.x; Migliorini A, 2014, MOL METAB, V3, P268, DOI 10.1016/j.molmet.2014.01.010; Montazeri L, 2016, BIOMATERIALS, V89, P157, DOI 10.1016/j.biomaterials.2016.02.043; Mueller-Klieser W, 2000, CRIT REV ONCOL HEMAT, V36, P123, DOI 10.1016/S1040-8428(00)00082-2; Olsson R, 2011, DIABETES, V60, P2350, DOI 10.2337/db09-0490; Omori K, 2015, MINERVA ENDOCRINOL, V40, P85; Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; RICORDI C, 1991, PANCREAS, V6, P242, DOI 10.1097/00006676-199103000-00018; Rodriguez-Brotons A, 2016, TISSUE ENG PT A, V22, P1327, DOI 10.1089/ten.tea.2016.0064; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; Sakai T, 2011, PANCREAS, V40, P403, DOI 10.1097/MPA.0b013e318204e815; Sakata N, 2014, DIABETES-METAB RES, V30, P1, DOI 10.1002/dmrr.2463; Shapiro A M James, 2012, Rev Diabet Stud, V9, P385, DOI 10.1900/RDS.2012.9.385; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sterkers A, 2013, AM J TRANSPLANT, V13, P891, DOI 10.1111/ajt.12136; Striegel DA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004423; Suszynski T., 2016, J DIABETES RES, V2016; Suszynski Thomas M, 2014, J Diabetes Sci Technol, V8, P575, DOI 10.1177/1932296814525827; Suszynski TM, 2014, TRANSPLANTATION, V97, P1286, DOI 10.1097/01.TP.0000441873.35383.1e; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Umpierrez G, 2016, NAT REV ENDOCRINOL, V12, P222, DOI 10.1038/nrendo.2016.15; Visperas A, 2016, J IMMUNOL, V197, P3762, DOI 10.4049/jimmunol.1601118	48	69	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183780	10.1371/journal.pone.0183780	http://dx.doi.org/10.1371/journal.pone.0183780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832685	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000408355800100
J	Cooper, PE; McClenaghan, C; Chen, XY; Stary-Weinzinger, A; Nichols, CG				Cooper, Paige E.; McClenaghan, Conor; Chen, Xingyu; Stary-Weinzinger, Anna; Nichols, Colin G.			Conserved functional consequences of disease-associated mutations in the slide helix of Kir6.1 and Kir6.2 subunits of the ATP-sensitive potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANTU SYNDROME; K+ CHANNELS; BETA-CELL; SULFONYLUREA BLOCK; MODULATION; MECHANISM; INSULIN; PROTEIN; KCNJ8; GAIN	Cantu syndrome (CS) is a condition characterized by a range of anatomical defects, including cardiomegaly, hyperflexibility of the joints, hypertrichosis, and craniofacial dysmorphology. CS is associated with multiple missense mutations in the genes encoding the regulatory sulfonylurea receptor 2 (SUR2) sub-units of the ATP-sensitive K+ (K-ATP) channel as well as two mutations (V65M and C176S) in the Kir6.1 (KCNJ8) subunit. Previous analysis of leucine and alanine substitutions at the Val-65- equivalent site (Val-64) in Kir6.2 indicated no major effects on channel function. In this study, we characterized the effects of both valine-to-methionine and valine-to-leucine substitutions at this position in both Kir6.1 and Kir6.2 using ion flux and patch clamp techniques. We report that methionine substitution, but not leucine substitution, results in increased open state stability and hence significantly reduced ATP sensitivity and a marked increase of channel activity in the intact cell irrespective of the identity of the coassembled SUR subunit. Sulfonylurea inhibitors, such as glibenclamide, are potential therapies for CS. However, as a consequence of the increased open state stability, both Kir6.1(V65M) and Kir6.2(V64M) mutations essentially abolish high-affinity sensitivity to the KATP blocker glibenclamide in both intact cells and excised patches. This raises the possibility that, at least for some CS mutations, sulfonylurea therapy may not prove to be successful and highlights the need for detailed pharmacogenomic analyses of CS mutations.	[Cooper, Paige E.; McClenaghan, Conor; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA; [Cooper, Paige E.; McClenaghan, Conor; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Chen, Xingyu; Stary-Weinzinger, Anna] Univ Vienna, Dept Pharmacol & Toxicol, Althanstr 14, A-1090 Vienna, Austria	Washington University (WUSTL); Washington University (WUSTL); University of Vienna	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	cnichols@wustl.edu	Stary-Weinzinger, Anna/A-3629-2014	Stary-Weinzinger, Anna/0000-0002-9202-0484; McClenaghan, Conor/0000-0002-0859-3854	National Institutes of Health [HL45742, HL007275]; Austrian Science Fund [W1232]; E-Rare Joint Transnational CantuTreat Program [I-2101-B26]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL140024, R01HL045742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); E-Rare Joint Transnational CantuTreat Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL45742 (to C. G. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Grant HL007275.; Supported by Austrian Science Fund Grant W1232.; Supported by E-Rare Joint Transnational CantuTreat Program Grant I-2101-B26.	Afifi HH, 2016, PEDIATR DERMATOL, V33, pE109, DOI 10.1111/pde.12821; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Brownstein CA, 2013, EUR J MED GENET, V56, P678, DOI 10.1016/j.ejmg.2013.09.009; Cooper PE, 2015, J GEN PHYSIOL, V146, P527, DOI 10.1085/jgp.201511495; Cooper PE, 2014, HUM MUTAT, V35, P809, DOI 10.1002/humu.22555; Enkvetchakul D, 2003, J GEN PHYSIOL, V122, P471, DOI 10.1085/jgp.200308878; Enkvetchakul D, 2001, BIOPHYS J, V80, P719, DOI 10.1016/S0006-3495(01)76051-1; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Gribble FM, 1999, DIABETOLOGIA, V42, P845, DOI 10.1007/s001250051236; Guerrero CRL, 2016, NEUROLOGY, V87, P270, DOI 10.1212/WNL.0000000000002861; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harakalova M, 2012, NAT GENET, V44, P793, DOI 10.1038/ng.2324; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Lee SJ, 2016, J GEN PHYSIOL, V148, P227, DOI 10.1085/jgp.201611616; Levin MD, 2016, P NATL ACAD SCI USA, V113, P6773, DOI 10.1073/pnas.1606465113; Li AL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000365; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; Loussouarn G, 2001, P NATL ACAD SCI USA, V98, P4227, DOI 10.1073/pnas.061452698; Mannikko R, 2010, HUM MOL GENET, V19, P963, DOI 10.1093/hmg/ddp554; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.24149; Masia R, 2005, J MOL CELL CARDIOL, V39, P491, DOI 10.1016/j.yjmcc.2005.03.009; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nichols CG, 2013, CIRC RES, V112, P1059, DOI 10.1161/CIRCRESAHA.112.300514; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2013, DIABETES, V62, P3909, DOI 10.2337/db13-0531; Reimann F, 2003, J PHYSIOL-LONDON, V547, P159, DOI 10.1113/jphysiol.2002.031625; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; van Bon BWM, 2012, AM J HUM GENET, V90, P1094, DOI 10.1016/j.ajhg.2012.04.014; Wambach JA, 2010, PEDIATR DIABETES, V11, P286, DOI 10.1111/j.1399-5448.2009.00557.x; Winkler M, 2009, J BIOL CHEM, V284, P6752, DOI 10.1074/jbc.M805435200; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507	34	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17387	17398		10.1074/jbc.M117.804971	http://dx.doi.org/10.1074/jbc.M117.804971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28842488	Green Published, hybrid			2022-12-26	WOS:000414009300020
J	Fernando, ME; Crowther, RG; Lazzarini, PA; Yogakanthi, S; Sangla, KS; Buttner, P; Jones, R; Golledge, J				Fernando, Malindu E.; Crowther, Robert G.; Lazzarini, Peter A.; Yogakanthi, Saiumaeswar; Sangla, Kunwarjit S.; Buttner, Petra; Jones, Rhondda; Golledge, Jonathan			Plantar pressures are elevated in people with longstanding diabetes-related foot ulcers during follow-up	PLOS ONE			English	Article							CUSTOM-MADE FOOTWEAR; OFFLOADING INTERVENTIONS; HIGH-RISK; PREVENTION; MANAGEMENT; ASSOCIATION; ULCERATION; NEUROPATHY; PROTOCOLS; HISTORY	Objective High plantar pressures are implicated in the development of diabetes-related foot ulcers. Whether plantar pressures remain high in patients with chronic diabetes-related foot ulcers over time is uncertain. The primary aim of this study was to compare plantar pressures at baseline and three and six months later in participants with chronic diabetes-related foot ulcers (cases) to participants without foot ulcers (controls). Methods Standardised protocols were used to measure mean peak plantar pressure and pressure-time integral at 10 plantar foot sites (the hallux, toes, metatarsals 1 to 5, mid-foot, medial heel and lateral heel) during barefoot walking. Measurements were performed at three study visits: baseline, three and six months. Linear mixed effects random-intercept models were utilised to assess whether plantar pressures differed between cases and controls after adjusting for age, sex, body mass index, neuropathy status and follow-up time. Standardised mean differences (Cohen's d) were used to measure effect size. Results Twenty-one cases and 69 controls started the study and 16 cases and 63 controls completed the study. Cases had a higher mean peak plantar pressure at several foot sites including the toes (p = 0.005, Cohen's d = 0.36) and mid-foot (p = 0.01, d = 0.36) and a higher pressure-time integral at the hallux (p<0.001, d = 0.42), metatarsal 1 (p = 0.02, d = 0.33) and mid-foot (p = 0.04, d = 0.64) compared to controls throughout follow-up. A reduction in pressure-time integral at multiple plantar sites over time was detected in all participants (p<0.05, respectively). Conclusions Plantar pressures assessed during gait are higher in diabetes patients with chronic foot ulcers than controls at several plantar sites throughout prolonged follow-up. Long term offloading is needed in diabetes patients with diabetes-related foot ulcers to facilitate ulcer healing.	[Fernando, Malindu E.; Golledge, Jonathan] James Cook Univ, Vasc Biol Unit, Queensland Res Ctr Peripheral Vasc Dis, Coll Med & Dent, Townsville, Qld, Australia; [Fernando, Malindu E.; Lazzarini, Peter A.] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia; [Fernando, Malindu E.; Crowther, Robert G.] James Cook Univ, Movement Anal Lab, Sports & Exercise Sci, Townsville, Qld, Australia; [Fernando, Malindu E.] Kirwan Community Hlth Campus, Podiatry Serv, Townsville, Qld, Australia; [Crowther, Robert G.] Univ South Australia, Sch Hlth Sci, Adelaide, SA, Australia; [Lazzarini, Peter A.] Metro North Hosp, Allied Hlth Res Collaborat, Brisbane, Qld, Australia; [Lazzarini, Peter A.] Queensland Hlth, Hlth Serv, Brisbane, Qld, Australia; [Yogakanthi, Saiumaeswar] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Sangla, Kunwarjit S.] Townsville Hosp, Dept Endocrinol & Diabet, Townsville, Qld, Australia; [Buttner, Petra] James Cook Univ, Ctr Chron Dis Prevent, Cairns, Qld, Australia; [Jones, Rhondda] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia	James Cook University; Queensland University of Technology (QUT); James Cook University; University of South Australia; Queensland Health; Monash University; James Cook University; James Cook University	Fernando, ME (corresponding author), James Cook Univ, Vasc Biol Unit, Queensland Res Ctr Peripheral Vasc Dis, Coll Med & Dent, Townsville, Qld, Australia.; Fernando, ME (corresponding author), Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia.; Fernando, ME (corresponding author), James Cook Univ, Movement Anal Lab, Sports & Exercise Sci, Townsville, Qld, Australia.; Fernando, ME (corresponding author), Kirwan Community Hlth Campus, Podiatry Serv, Townsville, Qld, Australia.	malindu.fernando@my.jcu.edu.au	golledge, jonathan/I-2371-2013	golledge, jonathan/0000-0002-5779-8848; Lazzarini, Peter/0000-0002-8235-7964	Department of Health, Queensland Government; Graduate Research School, James Cook University; National Health and Medical Research Council; National Health and Medical Research Council, Australia [1019921]; Queensland Government; James Cook University; College of Medicine, James Cook University	Department of Health, Queensland Government; Graduate Research School, James Cook University; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government; James Cook University; College of Medicine, James Cook University	Funding from the Department of Health, Queensland Government under the Health Practitioner Research Grant Scheme (2013-2014), funding from the Graduate Research School, James Cook University and funding from the National Health and Medical Research Council supported this work.JG holds a Practitioner Fellowships from the National Health and Medical Research Council, Australia (1019921). JG holds a Senior Clinical Research Fellowship from the Queensland Government. MF is currently supported by an Australian Postgraduate Award Scholarship at James Cook University and a scholarship from College of Medicine, James Cook University.	Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS72, DOI 10.2337/dc16-S012; Armstrong D G, 1998, J Foot Ankle Surg, V37, P303; Barn R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117443; Boulton AJM, 2004, AM J SURG, V187, p17S, DOI 10.1016/S0002-9610(03)00297-6; BOULTON AJM, 1987, DIABETES RES CLIN EX, V5, P73; Boulton AJM, 2004, DIABETOLOGIA, V47, P1343, DOI 10.1007/s00125-004-1463-y; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Bus SA, 2008, DIABETES-METAB RES, V24, pS162, DOI 10.1002/dmrr.850; Bus SA, 2016, DIABETES-METAB RES, V32, P25, DOI 10.1002/dmrr.2697; Bus SA, 2005, CLIN BIOMECH, V20, P892, DOI 10.1016/j.clinbiomech.2005.05.004; Bus SA, 2013, DIABETES CARE, V36, P4109, DOI 10.2337/dc13-0996; Bus SA, 2011, DIABETES CARE, V34, P1595, DOI 10.2337/dc10-2206; Cavanagh PR, 2010, J VASC SURG, V52, p37S, DOI 10.1016/j.jvs.2010.06.007; Chow I, 2008, PHARMACOECONOMICS, V26, P1019, DOI 10.2165/0019053-200826120-00005; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dinh Thanh L, 2005, Int J Low Extrem Wounds, V4, P154, DOI 10.1177/1534734605280130; Driver VR, 2010, J VASC SURG, V52, p17S, DOI 10.1016/j.jvs.2010.06.003; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; England JD, 2005, ARCH PHYS MED REHAB, V86, P167, DOI 10.1016/j.apmr.2004.09.011; Fernando M, 2013, CLIN BIOMECH; Fernando M, 2016, J FOOT ANKLE RES, V9, DOI 10.1186/s13047-016-0135-8; Fernando ME, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0131-9; Fernando ME, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010764.pub2; Fernando ME, 2016, CLIN BIOMECH, V37, P98, DOI 10.1016/j.clinbiomech.2016.06.006; Fernando ME, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0057-7; Fernando ME, 2014, PLOS ONE, P9; Frykberg RG, 1998, DIABETES CARE, V21, P1714, DOI 10.2337/diacare.21.10.1714; Frykberg RG, 2015, ADV WOUND CARE, V4, P560, DOI 10.1089/wound.2015.0635; Garrow AP, 2001, J AM PODIAT MED ASSN, V91, P74, DOI 10.7547/87507315-91-2-74; Gurney JK, 2008, GAIT POSTURE, V27, P706, DOI 10.1016/j.gaitpost.2007.07.002; Hopkins W., 2002, SCALE MAGNITUDES EFF, DOI DOI 10.1590/1677-5449.180095; Jan YK, 2013, PHYSIOL MEAS, V34, P53, DOI 10.1088/0967-3334/34/1/53; Jeffcoate WJ, 2016, LANCET DIABETES ENDO, V4, P781, DOI 10.1016/S2213-8587(16)30012-2; Jeffcoate WJ, 2004, DIABETES-METAB RES, V20, pS78, DOI 10.1002/dmrr.476; Kanade RV, 2006, DIABETOLOGIA, P49; Lavery L A, 1996, J Foot Ankle Surg, V35, P528; Lazzarini PA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010811; Lazzarini PA, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-24; Ledoux WR, 2013, J DIABETES COMPLICAT, V27, P621, DOI 10.1016/j.jdiacomp.2013.07.004; Lung CW, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00054; Maluf KS, 2003, CLIN BIOMECH, V18, P567, DOI 10.1016/S0268-0033(03)00118-9; McPoil TG, 1999, J AM PODIAT MED ASSN, V89, P495, DOI 10.7547/87507315-89-10-495; Melai T, 2011, GAIT POSTURE, V34, P379, DOI 10.1016/j.gaitpost.2011.06.005; Perkins BA, 2010, DIABETES CARE, V33, P1549, DOI 10.2337/dc09-1835; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Pinheiro J, TEAM ARC NLME LINEAR; Qiu X, 2013, DIABETES TECHNOL THE, V15, P1025, DOI 10.1089/dia.2013.0085; Quinton TR, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0072-y; Rafehi H, 2011, INT WOUND J, V8, P12, DOI 10.1111/j.1742-481X.2010.00745.x; VEVES A, 1992, DIABETOLOGIA, V35, P660, DOI 10.1007/BF00400259; Veves A, 1992, DIABETOLOGIA, P35; Waaijman R, 2013, DIABETES CARE, V36, P1613, DOI 10.2337/dc12-1330; Wu SC, 2008, DIABETES CARE, V31, P2118, DOI 10.2337/dc08-0771; Zammit GV, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-11	54	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0181916	10.1371/journal.pone.0181916	http://dx.doi.org/10.1371/journal.pone.0181916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859075	Green Published, Green Accepted, gold			2022-12-26	WOS:000408740500002
J	Henaux, V; Calavas, D				Henaux, Viviane; Calavas, Didier			Evaluation of the cost-effectiveness of bovine brucellosis surveillance in a disease-free country using stochastic scenario tree modelling	PLOS ONE			English	Article							DAIRY-CATTLE; RISK; IMPORTATION; PREVALENCE; ABORTION; ANIMALS; VACCINE; SYSTEM	Surveillance systems of exotic infectious diseases aim to ensure transparency about the country-specific animal disease situation (i.e. demonstrate disease freedom) and to identify any introductions. In a context of decreasing resources, evaluation of surveillance efficiency is essential to help stakeholders make relevant decisions about prioritization of measures and funding allocation. This study evaluated the efficiency (sensitivity related to cost) of the French bovine brucellosis surveillance system using stochastic scenario tree models. Cattle herds were categorized into three risk groups based on the annual number of purchases, given that trading is considered as the main route of brucellosis introduction in cattle herds. The sensitivity in detecting the disease and the costs of the current surveillance system, which includes clinical (abortion) surveillance, programmed serological testing and introduction controls, were compared to those of 19 alternative surveillance scenarios. Surveillance costs included veterinary fees and laboratory analyses. The sensitivity over a year of the current surveillance system was predicted to be 91 +/- 7% at a design prevalence of 0.01% for a total cost of 14.9 +/- 1.8 million (sic). Several alternative surveillance scenarios, based on clinical surveillance and random or risk-based serological screening in a sample (20%) of the population, were predicted to be at least as sensitive but for a lower cost. Such changes would reduce whole surveillance costs by 20 to 61% annually, and the costs for farmers only would be decreased from about 12.0 million (sic) presently to 5.3-9.0 million (sic) (i.e. 25-56% decrease). Besides, fostering the evolution of the surveillance system in one of these directions would be in agreement with the European regulations and farmers perceptions on brucellosis risk and surveillance.	[Henaux, Viviane; Calavas, Didier] Univ Lyon, Agence Natl Secur Sanit Alimentat Envirom & Trava, Unite Epidemiol, Lyon, France		Henaux, V (corresponding author), Univ Lyon, Agence Natl Secur Sanit Alimentat Envirom & Trava, Unite Epidemiol, Lyon, France.	viviane.henaux@anses.fr		HENAUX, VIVIANE/0000-0002-8630-3066				Abernethy DA, 2006, VET REC, V158, P717, DOI 10.1136/vr.158.21.717; Acha PN, 2001, ZOONOSES COMMUNICABL, V1, P3; Alvarez J, 2011, RES VET SCI, V90, P208, DOI 10.1016/j.rvsc.2010.05.028; AMOSSON SH, 1984, PREV VET MED, V3, P53, DOI 10.1016/0167-5877(84)90024-2; [Anonymous], 2014, R LANG ENV STAT COMP; Borba MR, 2013, PREV VET MED, V110, P169, DOI 10.1016/j.prevetmed.2012.11.013; Bronner A, 2015, PREV VET MED, V120, P62, DOI 10.1016/j.prevetmed.2015.02.019; Bronner A, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-93; Bronner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063246; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Dalrymple M, 1993, Rev Sci Tech, V12, P1175; Aparicio ED, 2013, REV SCI TECH OIE, V32, P43; England T, 2004, PREV VET MED, V63, P63, DOI 10.1016/j.prevetmed.2004.01.009; FAO (Food and Agriculture Organization of the United Nations), 2014, 17 FAO; FENSTERBANK R, 1987, ANN RECH VET, V18, P421; FORAR AL, 1995, THERIOGENOLOGY, V43, P989, DOI 10.1016/0093-691X(95)00063-E; Gache K, 2016, JOURNEES NATL GROUPE, P18; Gall D, 2004, REV SCI TECH OIE, V23, P989; Grosbois V, 2015, PREV VET MED, V120, P70, DOI 10.1016/j.prevetmed.2014.12.014; Hadorn DC, 2009, VET RES, V40, DOI 10.1051/vetres/2009040; Hadorn DC, 2008, VET RES, V39, DOI 10.1051/vetres:2008033; Hasler B, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-225; Henaux V., 2015, B EPID SANTE ANIM AL, V69, P28; Hendrikx P, 2011, INT C AN HLTH SURV I; Hendrikx P., 2012, B EPID SANTE ANIM AL, V48, P2; Hoinville LJ, 2013, PREV VET MED, V112, P1, DOI 10.1016/j.prevetmed.2013.06.006; Jones RD, 2004, PREV VET MED, V63, P51, DOI 10.1016/j.prevetmed.2004.01.008; Knight-Jones TJD, 2010, VET RES, V41, DOI 10.1051/vetres/2010023; Mailles A, 2012, EURO SURVEILLANCE B, V17; Makita K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-60; Martin RAJ, 2007, PREV VET MED, V79, P71, DOI 10.1016/j.prevetmed.2006.09.008; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mick E, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087257, 10.1371/journal.pone.0094168]; Morley R S, 1993, Rev Sci Tech, V12, P1055; Nielsen K, 1990, ANIMAL BRUCELLOSIS, P131; Nusinovici S, 2012, THERIOGENOLOGY, V78, P1140, DOI 10.1016/j.theriogenology.2012.05.010; Olsen SC, 2011, CLIN VACCINE IMMUNOL, V18, P2075, DOI 10.1128/CVI.05383-11; Perrin JB, 2015, B EPID SANTE ANIM AL, V71, P12; Poester FP, 2006, VACCINE, V24, P5327, DOI 10.1016/j.vaccine.2006.04.020; Rautureau S., 2013, B EPIDEMIOL SANTE AN, V59, P11; Rubin DB, 2004, MULTIPLE IMPUTATION; Stringer LA, 2008, PREV VET MED, V84, P72, DOI 10.1016/j.prevetmed.2007.11.005; Tabynov K, 2014, VACCINE, V32, P5889, DOI 10.1016/j.vaccine.2014.08.073; Touratier A., 2012, Bulletin des G.T.V., P99; Yamamoto T, 2008, PREV VET MED, V86, P57, DOI 10.1016/j.prevetmed.2008.03.004	45	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183037	10.1371/journal.pone.0183037	http://dx.doi.org/10.1371/journal.pone.0183037			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859107	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500008
J	Feitoza, L; Costa, L; Guerra, M				Feitoza, Lidiane; Costa, Lucas; Guerra, Marcelo			Condensation patterns of prophase/prometaphase chromosome are correlated with H4K5 histone acetylation and genomic DNA contents in plants	PLOS ONE			English	Article							CELL-CYCLE; ELEUTHERINE-BULBOSA; REPETITIVE DNA; FLOW-CYTOMETRY; TOMATO GENOME; VULGARIS L.; HETEROCHROMATIN; REPLICATION; EUCHROMATIN; NUCLEI	Mitotic prophase chromosome condensation plays an essential role in nuclear division being therefore regulated by highly conserved mechanisms. However, degrees of chromatin condensation in prophase-prometaphase cells may vary along the chromosomes resulting in specific condensation patterns. We examined different condensation patterns (CPs) of prophase and prometaphase chromosomes and investigated their relationship with genome size and distribution of histone H4 acetylated at lysine 5 (H4K5ac) in 17 plant species. Our results showed that most species with small genomes (2C < 5 pg) (Arachis pusilla, Bixa orellana, Costus spiralis, Eleutherine bulbosa, Indigofera campestris, Phaseolus lunatus, P. vulgaris, Poncirus trifoliata, and Solanum lycopersicum) displayed prophase chromosomes with late condensing terminal regions that were highly enriched in H4K5ac, and early condensing regions with apparently non-acetylated proximal chromatin. The species with large genomes (Allium cepa, Callisia repens, Araucaria angustifolia and Nothoscordum pulchellum) displayed uniformly condensed and acetylated prophase/prometaphase chromosomes. Three species with small genomes (Eleocharis geniculata, Rhynchospora pubera, and R. tenuis) displayed CP and H4K5ac labeling patterns similar to species with large genomes, whereas a forth species (Emilia sonchifolia) exhibited a gradual chromosome labeling, being more acetylated in the terminal regions and less acetylated in the proximal ones. The nucleolus organizer chromatin was the only chromosomal region that in prometaphase or metaphase could be hyperacetylated, hypoacetylated or non-acetylated, depending on the species. Our data indicate that the CP of a plant chromosome complement is influenced but not exclusively determined by nuclear and chromosomal DNA contents, whereas the CP of individual chromosomes is clearly correlated with H4K5ac distribution.	[Feitoza, Lidiane; Costa, Lucas; Guerra, Marcelo] Univ Fed Pernambuco, Dept Bot, Lab Plant Cytogenet & Evolut, Recife, PE, Brazil	Universidade Federal de Pernambuco	Guerra, M (corresponding author), Univ Fed Pernambuco, Dept Bot, Lab Plant Cytogenet & Evolut, Recife, PE, Brazil.	msfguerra@hotmail.com			CNPq (Brazil); FACEPE (Brazil)	CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FACEPE (Brazil)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	M.G. was supported by a grant from CNPq (Brazil) and L.F. received support from FACEPE (Brazil).	Baez M, 2016, CYTOGENET GENOME RES, V148, P88; BARLOW PW, 1977, ANN SCI NAT BOT BIOL, V18, P193; Silva AEBE, 2010, BIOTECH HISTOCHEM, V85, P115, DOI [10.3109/10520290903149596, 10.1080/10520290903149596]; Silva AEBE, 2010, CHROMOSOME RES, V18, P503, DOI 10.1007/s10577-010-9130-2; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Bonifacio EM, 2012, THEOR APPL GENET, V124, P1513, DOI 10.1007/s00122-012-1806-x; Brasileiro-Vidal AC, 2007, GENETICA, V129, P273, DOI 10.1007/s10709-006-0007-4; Brasileiro-Vidal AC, 2009, MICRON, V40, P851, DOI 10.1016/j.micron.2009.06.004; Castiglione MR, 1996, BIOL ZENT BL, V114, P57; Dantas LG, 2010, GENET MOL BIOL, V33, P94, DOI 10.1590/S1415-47572009005000103; de Almeida Pedro Marcos, 2006, Cytologia (Tokyo), V71, P391, DOI 10.1508/cytologia.71.391; Delay C., 1949, RECHERCHES STRUCTURE; Dhar MK, 2009, CYTOGENET GENOME RES, V125, P235, DOI 10.1159/000230007; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; DROUIN R, 1991, CYTOGENET CELL GENET, V57, P91, DOI 10.1159/000133121; EICHHORN ANDRE, 1934, CYTOLOGIA, V5, P253, DOI 10.1508/cytologia.5.253; Feitoza L, 2011, CYTOGENET GENOME RES, V135, P160, DOI 10.1159/000331231; Feitoza L, 2011, GENETICA, V139, P305, DOI 10.1007/s10709-011-9550-8; Felix LP, 2010, BOT J LINN SOC, V163, P234, DOI 10.1111/j.1095-8339.2010.01059.x; FISKESJO G, 1974, HEREDITAS, V78, P153; Fonseca A, 2014, CYTOGENET GENOME RES, V143, P168, DOI 10.1159/000360572; Forni-Martins ER, 1999, CARYOLOGIA, V52, P97, DOI 10.1080/00087114.1998.10589160; Fransz PF, 2002, CURR OPIN PLANT BIOL, V5, P560, DOI 10.1016/S1369-5266(02)00298-4; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; FUKUI K, 1988, JPN J GENET, V63, P359, DOI 10.1266/jjg.63.359; Fukui K, 2005, CYTOGENET GENOME RES, V109, P83, DOI 10.1159/000082386; Guerra M, 2000, B SOC ARGENT BOT, V35, P283; GUERRA MD, 1988, CHROMOSOMA, V97, P80, DOI 10.1007/BF00331797; GUERRA MD, 1987, CYTOLOGIA, V52, P213, DOI 10.1508/cytologia.52.213; Hanson L, 2001, ANN BOT-LONDON, V88, P851, DOI 10.1006/anbo.2001.1528; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Houben A, 1997, CHROMOSOME RES, V5, P233, DOI 10.1023/B:CHRO.0000032297.10876.86; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Houben A, 1996, CHROMOSOME RES, V4, P191, DOI 10.1007/BF02254958; Idei S, 1996, CHROMOSOMA, V105, P293, DOI 10.1007/BF02524647; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Jasencakova Z, 2001, CHROMOSOMA, V110, P83, DOI 10.1007/s004120100132; Jeppesen P, 1997, BIOESSAYS, V19, P67, DOI 10.1002/bies.950190111; Johnson CA, 1998, NUCLEIC ACIDS RES, V26, P994, DOI 10.1093/nar/26.4.994; Kschonsak M, 2015, BIOESSAYS, V37, P755, DOI 10.1002/bies.201500020; KUROIWA T, 1971, EXP CELL RES, V69, P97, DOI 10.1016/0014-4827(71)90315-6; Lafontaine FG, 1974, CELL NUCLEUS, V1, P149; Lavia GI, 2000, CARYOLOGIA, V53, P277, DOI 10.1080/00087114.2000.10589206; Loureiro J, 2007, ANN BOT-LONDON, V100, P875, DOI 10.1093/aob/mcm152; Meng YC, 2016, NUCLEIC ACIDS RES, V44, P4934, DOI 10.1093/nar/gkw195; Miranda M, 2007, AUST J BOT, V55, P165, DOI 10.1071/BT06087; Moscone EA, 1999, GENOME, V42, P1224, DOI 10.1139/gen-42-6-1224; Ribeiro T, 2017, CHROMOSOMA, V126, P325, DOI 10.1007/s00412-016-0616-3; Shearer LA, 2014, G3-GENES GENOM GENET, V4, P1395, DOI 10.1534/g3.114.011197; Sumner AT., 2003, CHROMOSOMES ORG FUNC; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Vyskot B, 1999, GENOME, V42, P343, DOI 10.1139/gen-42-2-343; Wako T, 2002, PLANT MOL BIOL, V49, P645, DOI 10.1023/A:1015554124675; Wang Y, 2006, GENETICS, V172, P2529, DOI 10.1534/genetics.106.055772	54	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183341	10.1371/journal.pone.0183341	http://dx.doi.org/10.1371/journal.pone.0183341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854212	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600038
J	Goold, C; Newberry, RC				Goold, Conor; Newberry, Ruth C.			Aggressiveness as a latent personality trait of domestic dogs: Testing local independence and measurement invariance	PLOS ONE			English	Article							ITEM RESPONSE THEORY; BEHAVIORAL SYNDROMES; CANIS-FAMILIARIS; SHELTER DOGS; TEMPERAMENT; IDENTIFICATION; QUESTIONNAIRE; REPEATABILITY; PERFORMANCE; VALIDATION	Studies of animal personality attempt to uncover underlying or "latent" personality traits that explain broad patterns of behaviour, often by applying latent variable statistical models (e.g., factor analysis) to multivariate data sets. Two integral, but infrequently confirmed, assumptions of latent variable models in animal personality are: i) behavioural variables are independent (i.e., uncorrelated) conditional on the latent personality traits they reflect (local independence), and ii) personality traits are associated with behavioural variables in the same way across individuals or groups of individuals (measurement invariance). We tested these assumptions using observations of aggression in four age classes (4-10 months, 10 months-3 years, 3-6 years, over 6 years) of male and female shelter dogs (N = 4,743) in 11 different contexts. A structural equation model supported the hypothesis of two positively correlated personality traits underlying aggression across contexts: aggressiveness towards people and aggressiveness towards dogs (comparative fit index: 0.96; TuckerLewis index: 0.95; root mean square error of approximation: 0.03). Aggression across contexts was moderately repeatable (towards people: intraclass correlation coefficient (ICC) = 0.479; towards dogs: ICC = 0.303). However, certain contexts related to aggressiveness towards people (but not dogs) shared significant residual relationships unaccounted for by latent levels of aggressiveness. Furthermore, aggressiveness towards people and dogs in different contexts interacted with sex and age. Thus, sex and age differences in displays of aggression were not simple functions of underlying aggressiveness. Our results illustrate that the robustness of traits in latent variable models must be critically assessed before making conclusions about the effects of, or factors influencing, animal personality. Our findings are of concern because inaccurate "aggressive personality" trait attributions can be costly to dogs, recipients of aggression and society in general.	[Goold, Conor; Newberry, Ruth C.] Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, As, Akershus, Norway	Norwegian University of Life Sciences	Goold, C (corresponding author), Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, As, Akershus, Norway.	conor.goold@nmbu.no	Newberry, Ruth C/L-5054-2013	Newberry, Ruth C/0000-0002-5238-6959; Goold, Conor/0000-0002-9198-0889				Adolf J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00883; Araya-Ajoy YG, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2645; Arden R, 2016, INTELLIGENCE, V55, P79, DOI 10.1016/j.intell.2016.01.008; Asp HE, 2015, APPL ANIM BEHAV SCI, V169, P69, DOI 10.1016/j.applanim.2015.04.010; Barnard S, 2017, SCI REP, V7, P1; Beaujean AA, 2014, LATENT VARIABLE MODE, DOI DOI 10.4324/9781315869780; Bennett SL, 2012, APPL ANIM BEHAV SCI, V141, P139, DOI 10.1016/j.applanim.2012.08.005; Biro PA, 2015, ANIM BEHAV, V105, P223, DOI 10.1016/j.anbehav.2015.04.008; BOLLEN K, 1991, PSYCHOL BULL, V110, P305, DOI 10.1037/0033-2909.110.2.305; Bollen KA, 2002, ANNU REV PSYCHOL, V53, P605, DOI 10.1146/annurev.psych.53.100901.135239; Borsboom D., 2005, MEASURING MIND CONCE; Borsboom D, 2010, THE CONCEPT OF VALID, P135; Borsboom D, 2006, PSYCHOMETRIKA, V71, P425, DOI 10.1007/s11336-006-1447-6; Budaev DS, 1998, INT J COMP PSYCHOL; Budaev S., 2011, FISH COGNITION BEHAV, P135, DOI DOI 10.1002/9781444342536.CH7; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; Carter AJ, 2012, ANIM BEHAV, V84, P603, DOI 10.1016/j.anbehav.2012.06.015; Casey RA, 2014, APPL ANIM BEHAV SCI, V152, P52, DOI 10.1016/j.applanim.2013.12.003; Chen JJ, 2000, DRUG INF J, V34, P569, DOI 10.1177/009286150003400225; Cole DA, 2007, PSYCHOL METHODS, V12, P381, DOI 10.1037/1082-989X.12.4.381; Cramer AOJ, 2012, EUR J PERSONALITY, V26, P414, DOI 10.1002/per.1866; Dingemanse NJ, 2010, ANIM BEHAV, V79, P439, DOI 10.1016/j.anbehav.2009.11.024; Dochtermann NA, 2013, BEHAV ECOL; Dochtermann NA, 2007, P R SOC B, V274, P2343, DOI 10.1098/rspb.2007.0622; DRASGOW F, 1987, J APPL PSYCHOL, V72, P19, DOI 10.1037/0021-9010.72.1.19; Duckworth RA, 2015, ANN NY ACAD SCI, V1360, P54, DOI 10.1111/nyas.12797; Edelen MO, 2007, QUAL LIFE RES, V16, P5, DOI 10.1007/s11136-007-9198-0; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; GODDARD ME, 1982, THEOR APPL GENET, V62, P97, DOI 10.1007/BF00293339; Goodloe L P, 1998, J Appl Anim Welf Sci, V1, P303, DOI 10.1207/s15327604jaws0104_1; Hamaker EL, 2007, J RES PERS, V41, P295, DOI 10.1016/j.jrp.2006.04.003; Haverbeke A, 2015, J VET BEHAV, V10, P5, DOI 10.1016/j.jveb.2014.07.004; Hermida R., 2015, COMPUT METHODS SOC S, V3, P5; Honaker J., 2015, AMELIA PROGRAM MISSI; Hsu YY, 2010, APPL ANIM BEHAV SCI, V123, P108, DOI 10.1016/j.applanim.2010.01.013; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Jansen BRJ, 1997, DEV REV, V17, P321, DOI 10.1006/drev.1997.0437; Jones A.C., 2008, THESIS; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Jorgensen Terrence D., 2016, SEMTOOLS USEFUL TOOL; Kamata A, 2001, J EDUC MEAS, V38, P79, DOI 10.1111/j.1745-3984.2001.tb01117.x; Koski SE, 2011, PRIMATOL MONOGR, P115, DOI 10.1007/978-4-431-53892-9_5; Kruschke JK, 2014, JAGS STAN, V2nd, DOI DOI 10.1016/B978-0-12-405888-0.09996-7; Kruschke JK, 2010, WIRES COGN SCI, V1, P658, DOI 10.1002/wcs.72; Markus K. A., 2013, MULTIVARIATE APPL SE, V341; Martin JS, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22670; Maul A, 2016, MEASUREMENT, V79, P311, DOI 10.1016/j.measurement.2015.11.001; Mellenbergh G.J., 1989, INT J EDUC RES, V13, P127, DOI [10.1016/0883-0355(89)90002-5, DOI 10.1016/0883-0355(89)90002-5]; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Mohan-Gibbons Heather, 2012, Animals (Basel), V2, P331, DOI 10.3390/ani2030331; Molenaar P.C.M., 2004, MEAS-INTERDISCIP RES, V2, P201, DOI [10.1207/s15366359mea0204_1, DOI 10.1207/S15366359MEA0204_1]; Mornement KM, 2015, APPL ANIM BEHAV SCI, V167, P35, DOI 10.1016/j.applanim.2015.03.013; MUTHEN B, 1981, PSYCHOMETRIKA, V46, P407, DOI 10.1007/BF02293798; MUTHEN B, 1984, PSYCHOMETRIKA, V49, P115, DOI 10.1007/BF02294210; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Olson KR, 2015, VET J, V206, P197, DOI 10.1016/j.tvjl.2015.07.019; Orritt R, 2015, VET REC, V176, P640, DOI 10.1136/vr.h3215; Owczarczak-Garstecka SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163620; Patronek GJ, 2016, J VET BEHAV, V15, P66, DOI 10.1016/j.jveb.2016.08.001; Persson ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep33439; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Posluns JA, APPL ANIM BEHAV SCI; Preacher K. J., 2003, UNDERSTANDING STAT, V2, P13, DOI DOI 10.1207/S15328031US0201_02; R Development Core Team, 2016, R LANG ENV STAT COMP; Rayment DJ, 2015, APPL ANIM BEHAV SCI, V163, P1, DOI 10.1016/j.applanim.2014.11.020; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Riemer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101237; Rosseel Y., 2016, LAVAAN LATENT VARIAB; Schmittmann VD, 2013, NEW IDEAS PSYCHOL, V31, P43, DOI 10.1016/j.newideapsych.2011.02.007; Scott J.P., 2012, GENETICS SOCIAL BEHA; Sherman CK, 1996, APPL ANIM BEHAV SCI, V47, P91, DOI 10.1016/0168-1591(95)01013-0; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Simpson RJ, 2012, JAVMA-J AM VET MED A, V241, P1163, DOI 10.2460/javma.241.9.1163; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stamps JA, 2012, ANIM BEHAV, V83, P1325, DOI 10.1016/j.anbehav.2012.02.017; Stan Development Team, 2016, STAN MOD LANG US GUI; Sundman AS, 2016, GENES BRAIN BEHAV, V15, P750, DOI 10.1111/gbb.12317; Svartberg K, 2006, APPL ANIM BEHAV SCI, V96, P293, DOI 10.1016/j.applanim.2005.06.014; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Taylor KD, 2006, J VET BEHAV, V1, P94, DOI 10.1016/j.jveb.2006.09.002; van den Berg SM, 2010, APPL ANIM BEHAV SCI, V124, P136, DOI 10.1016/j.applanim.2010.02.005; Van den Noortgate W, 2005, J EDUC BEHAV STAT, V30, P443, DOI 10.3102/10769986030004443; Vehtari A., 2016, LOO EFFICIENT LEAVE; Voith V, 2013, AM J SOCIOLOGICAL RE, V3, P17, DOI DOI 10.5923/J.SOCIOLOGY.20130302.02; Westneat DF, 2015, BIOL REV, V90, P729, DOI 10.1111/brv.12131; Wicherts J. M., 2010, EDUC MEAS-ISSUES PRA, V29, P39, DOI [DOI 10.1111/J.1745-3992.2010.00182.X, 10.1111/j.1745-3992.2010.00182.x]; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; YEN WM, 1993, J EDUC MEAS, V30, P187, DOI 10.1111/j.1745-3984.1993.tb00423.x	93	5	5	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183595	10.1371/journal.pone.0183595	http://dx.doi.org/10.1371/journal.pone.0183595			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF1XX	28854267	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000408693600048
J	Michel, A; Nicolas, JM; Rose, S; Jackson, M; Colman, P; Brione, W; Sciberras, D; Muglia, P; Scheller, DK; Citron, M; Downey, P				Michel, Anne; Nicolas, Jean-Marie; Rose, Sarah; Jackson, Michael; Colman, Peter; Brione, Willy; Sciberras, David; Muglia, Pierandrea; Scheller, Dieter K.; Citron, Martin; Downey, Patrick			Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets	PLOS ONE			English	Article							ADENOSINE A(2A) RECEPTORS; PARKINSONS-DISEASE; ANIMAL-MODELS; TYROSINE PHOSPHORYLATION; BEHAVIORAL SENSITIZATION; GLUTAMATE RECEPTORS; COMMON MARMOSET; MOTOR FUNCTION; ANTAGONIST; NMDA	Objective Investigate a combination of two clinically tested drugs, the NR2B antagonist Radiprodil and the A(2A) antagonist Tozadenant in the MPTP-treated marmoset model of Parkinson's Disease (PD). Background In PD, there remains a need for the development of non-dopaminergic drugs to effectively treat the motor symptoms without the induction of L-Dopa-induced motor complications. Methods Clinically relevant doses of Radiprodil and Tozadenant were given both alone and in combination without the addition of L-Dopa, and the antiparkinsonian efficacy of the treatments was assessed in a primate model of PD. Results When compared to the drugs tested alone, the drug combination led to a significant increase of motor activity and an improvement of motor disability in MPTP-treated marmosets. In addition, the motor restoration brought about by the combination was almost completely devoid of dyskinesia. Interestingly, treated primates were not overstimulated, but were able to move normally when motivated by the exploration of novel objects. Conclusion We have demonstrated in a primate model that, the "Radiprodil/Tozadenant" combination significantly improves motor activity, extending previous results obtained in unilaterally lesioned 6-OHDA-rats. The strength of the preclinical data accumulated so far suggests that the use of such an A(2A) and NR2B antagonist combination could bring significant motor improvement to PD patients, without inducing the motor complications induced by L-Dopa therapy. Although encouraging, these preclinical data need to be confirmed in the clinic.	[Michel, Anne; Nicolas, Jean-Marie; Brione, Willy; Sciberras, David; Muglia, Pierandrea; Scheller, Dieter K.; Citron, Martin; Downey, Patrick] UCB BioPharma, Braine Lalleud, Belgium; [Rose, Sarah; Jackson, Michael] Kings Coll London, Inst Pharmaceut Sci, London, England; [Colman, Peter] UCB BioPharma, Slough, Berks, England	University of London; King's College London	Michel, A (corresponding author), UCB BioPharma, Braine Lalleud, Belgium.	Anne.michel@ucb.com	Muglia, Pierandrea/ABD-9235-2020	Muglia, Pierandrea/0000-0002-3973-8606; ROSE, SARAH/0000-0003-4723-7665; Michel, Anne/0000-0002-7271-7903	UCB BioPharma	UCB BioPharma	UCB BioPharma provided support in the form of salaries for authors (A.M., J-M.N., P.C., W. B., D.S., P.M., D.K.S., M.C., P.D.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Addy C, 2009, J CLIN PHARMACOL, V49, P856, DOI 10.1177/0091270009336735; Ando K, 2014, PHARMACOL BIOCHEM BE, V127, P62, DOI 10.1016/j.pbb.2014.10.009; Ba MW, 2015, DRUG DES DEV THER, V9, P199, DOI 10.2147/DDDT.S75495; Bibbiani F, 2003, EXP NEUROL, V184, P285, DOI 10.1016/S0014-4886(03)00250-4; BRONSTEIN PM, 1974, ANIM LEARN BEHAV, V2, P92, DOI 10.3758/BF03199129; CAREY RJ, 1991, BRAIN RES, V568, P205, DOI 10.1016/0006-8993(91)91399-L; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121; Duty S, 2012, CNS DRUGS, V26, P1017, DOI 10.1007/s40263-012-0016-z; Fernandez HH, 2010, PARKINSONISM RELAT D, V16, P16, DOI 10.1016/j.parkreldis.2009.06.008; Fuxe K., 2003, Neurology, V61, pS19; Grondin R, 1999, NEUROLOGY, V52, P1673, DOI 10.1212/WNL.52.8.1673; Hallett PJ, 2004, PHARMACOL THERAPEUT, V102, P155, DOI 10.1016/j.pharmthera.2004.04.001; Hauser RA, 2007, MOVEMENT DISORD, V22, P2409, DOI 10.1002/mds.21743; Hauser RA, 2014, LANCET NEUROL, V13, P767, DOI 10.1016/S1474-4422(14)70148-6; Hodgson RA, 2009, J PHARMACOL EXP THER, V330, P294, DOI 10.1124/jpet.108.149617; Jackson MJ, 2012, MPTP TREATED PRIMATE, P371; Kanda T, 1998, NEUROREPORT, V9, P2857, DOI 10.1097/00001756-199808240-00032; Kanda T, 1998, ANN NEUROL, V43, P507, DOI 10.1002/ana.410430415; Kong M, 2015, BEHAV BRAIN RES, V282, P46, DOI 10.1016/j.bbr.2014.12.059; Loschmann PA, 2004, EXP NEUROL, V187, P86, DOI 10.1016/j.expneurol.2004.01.018; Mancel V., 2016, XENOBIOTICA, V1, P14, DOI [10.1080/00498254.2016.1221164, DOI 10.1080/00498254.2016.1221164]; Michel A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135949; Michel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114086; Nash JE, 2000, EXP NEUROL, V165, P136, DOI 10.1006/exnr.2000.7444; Nash JE, 2000, J NEUROSCI, V20, P7782; News CT, 2010, RAD TRIAL FAILS SHOW; Nutt JG, 2008, MOVEMENT DISORD, V23, P1860, DOI 10.1002/mds.22169; Oertel Wolfgang H, 2017, F1000Res, V6, P260, DOI 10.12688/f1000research.10100.1; Pearce RKB, 1995, MOVEMENT DISORD, V10, P731, DOI 10.1002/mds.870100606; Pinna A, 2002, EUR J PHARMACOL, V446, P75, DOI 10.1016/S0014-2999(02)01818-6; Pinna A, 2001, SYNAPSE, V39, P233, DOI 10.1002/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K; Ramaswami M, 2014, NEURON, V82, P1216, DOI 10.1016/j.neuron.2014.04.035; Sarantis K, 2015, J NEUROCHEM, V135, P714, DOI 10.1111/jnc.13291; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; Shook BC, 2010, J MED CHEM, V53, P8104, DOI 10.1021/jm100971t; Tirelli E, 2005, BEHAV BRAIN RES, V165, P18, DOI 10.1016/j.bbr.2005.06.029	37	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182887	10.1371/journal.pone.0182887	http://dx.doi.org/10.1371/journal.pone.0182887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854243	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600022
J	Di Bono, MG; Begliomini, C; Budisavljevic, S; Sartori, L; Miotto, D; Motta, R; Castiello, U				Di Bono, Maria Grazia; Begliomini, Chiara; Budisavljevic, Sanja; Sartori, Luisa; Miotto, Diego; Motta, Raffaella; Castiello, Umberto			Decoding social intentions in human prehensile actions: Insights from a combined kinematics-fMRI study	PLOS ONE			English	Article							CORTICAL CONTROL; NEURAL BASIS; MIRROR; BRAIN; MOTOR; SELF; COGNITION; SYSTEMS; REPRESENTATIONS; NEUROSCIENCE	Consistent evidence suggests that the way we reach and grasp an object is modulated not only by object properties (e.g., size, shape, texture, fragility and weight), but also by the types of intention driving the action, among which the intention to interact with another agent (i.e., social intention). Action observation studies ascribe the neural substrate of this 'intentional' component to the putative mirror neuron (pMNS) and the mentalizing (MS) systems. How social intentions are translated into executed actions, however, has yet to be addressed. We conducted a kinematic and a functional Magnetic Resonance Imaging (fMRI) study considering a reach-to-grasp movement performed towards the same object positioned at the same location but with different intentions: passing it to another person (social condition) or putting it on a concave base (individual condition). Kinematics showed that individual and social intentions are characterized by different profiles, with a slower movement at the level of both the reaching (i.e., arm movement) and the grasping (i.e., hand aperture) components. fMRI results showed that: (i)distinct voxel pattern activity for the social and the individual condition are present within the pMNS and the MS during action execution; (ii) decoding accuracies of regions belonging to the pMNS and the MS are correlated, suggesting that these two systems could interact for the generation of appropriate motor commands. Results are discussed in terms of motor simulation and inferential processes as part of a hierarchical generative model for action intention understanding and generation of appropriate motor commands.	[Di Bono, Maria Grazia; Begliomini, Chiara; Budisavljevic, Sanja; Sartori, Luisa; Castiello, Umberto] Univ Padua, Dept Gen Psychol, Neurosci Movement NeMo Lab, Padua, Italy; [Miotto, Diego; Motta, Raffaella] Univ Padua, Dept Med, Padua, Italy; [Castiello, Umberto] Accademia Lincei, Ctr Interdisciplinare Beniamino Segre, Rome, Italy	University of Padua; University of Padua	Di Bono, MG (corresponding author), Univ Padua, Dept Gen Psychol, Neurosci Movement NeMo Lab, Padua, Italy.	mgdibono@gmail.com	Budisavljevic, Sanja/AAC-9119-2020; BEGLIOMINI, CHIARA/D-1516-2014	Castiello, Umberto/0000-0003-0629-1286; BEGLIOMINI, CHIARA/0000-0001-7433-0414; Budisavljevic, Sanja/0000-0002-5019-9121; MOTTA, RAFFAELLA/0000-0002-1886-9826	MIUR [287713]; FP7: REWIRE project; Progetto Strategico, Universitaa di Padova [2010XPMFVV4]; SIR grant (Scientific Independence of Young Researchers) [RBSI141QKX]	MIUR(Ministry of Education, Universities and Research (MIUR)); FP7: REWIRE project; Progetto Strategico, Universitaa di Padova; SIR grant (Scientific Independence of Young Researchers)	This work was supported by a grant from the MIUR (N. 287713), the FP7: REWIRE project, by Progetto Strategico, Universitaa di Padova (N. 2010XPMFVV4) to UC and by SIR grant (Scientific Independence of Young Researchers - N. RBSI141QKX) to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the MIUR (N. 287713), the FP7: REWIRE project, by Progetto Strategico, Universitaa di Padova (N. 2010XPMFW4) to UC and by SIR grant (Scientific Independence of Young Researchers N. RBSI141QKX) to LS.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Ansuini C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00815; Avikainen S, 2002, NEUROIMAGE, V15, P640, DOI 10.1006/nimg.2001.1029; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2008, COGNITION, V106, P894, DOI 10.1016/j.cognition.2007.05.004; Becchio C, 2012, NEUROIMAGE, V61, P240, DOI 10.1016/j.neuroimage.2012.03.013; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; Brewer JA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00647; Buccino G, 2007, NEUROIMAGE, V36, pT119, DOI 10.1016/j.neuroimage.2007.03.036; Budisavljevic S, 2017, CEREB CORTEX, V27, P1532, DOI 10.1093/cercor/bhv348; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Canessa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042347; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 2008, NEUROSCIENTIST, V14, P157, DOI 10.1177/1073858407312080; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Chang SW, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00064; Ciaramidaro A, 2014, SOC COGN AFFECT NEUR, V9, P909, DOI 10.1093/scan/nst062; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Di Bono MG, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.412; Fabbri S, 2014, NEUROIMAGE, V94, P138, DOI 10.1016/j.neuroimage.2014.03.017; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gallagher S, 2001, J CONSCIOUSNESS STUD, V8, P83; Gallagher S, 2008, CONSCIOUS COGN, V17, P535, DOI 10.1016/j.concog.2008.03.003; Gallivan JP, 2011, J NEUROSCI, V31, P9599, DOI 10.1523/JNEUROSCI.0080-11.2011; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Hagberg GE, 2001, NEUROIMAGE, V14, P1193, DOI 10.1006/nimg.2001.0880; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jacob P, 2005, TRENDS COGN SCI, V9, P21, DOI 10.1016/j.tics.2004.11.003; Jimura K, 2012, NEUROPSYCHOLOGIA, V50, P544, DOI 10.1016/j.neuropsychologia.2011.11.007; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Knoblich G., 2002, ADV CONSCIOU RES, V42, P115, DOI [10.1075/aicr.42.10kno, DOI 10.1075/AICR.42.10KNO, DOI 10.1075/AICR.42.10KN0]; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lombardo MV, 2010, J COGNITIVE NEUROSCI, V22, P1623, DOI 10.1162/jocn.2009.21287; Newman-Norlund RD, 2007, SOC NEUROSCI-UK, V2, P48, DOI 10.1080/17470910701224623; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poldrack RA, 2009, SOC COGN AFFECT NEUR, V4, P208, DOI 10.1093/scan/nsp011; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schilbach L, 2010, J COGNITIVE NEUROSCI, V22, P2702, DOI 10.1162/jocn.2009.21401; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Thioux M, 2008, CURR BIOL, V18, pR431, DOI 10.1016/j.cub.2008.03.018; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vesia M, 2012, EXP BRAIN RES, V221, P1, DOI 10.1007/s00221-012-3158-9; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zaki J, 2009, P NATL ACAD SCI USA, V106, P11382, DOI 10.1073/pnas.0902666106; Zorzi M, 2011, NEUROIMAGE, V56, P674, DOI 10.1016/j.neuroimage.2010.06.035	61	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0184008	10.1371/journal.pone.0184008	http://dx.doi.org/10.1371/journal.pone.0184008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846741	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600063
J	Stafylis, C; Klausner, JD				Stafylis, Chrysovalantis; Klausner, Jeffrey D.			Evaluation of two 4th generation point-of-care assays for the detection of Human Immunodeficiency Virus infection	PLOS ONE			English	Article							ACUTE HIV-INFECTION; P24 ANTIGEN; ANTIBODY; IMMUNOASSAY	Background Fourth generation assays detect simultaneously antibodies for HIV and the p24 antigen, identifying HIV infection earlier than previous generation tests. Previous studies have shown that the Alere Determine HIV-1/2 Combo has lower than anticipated performance in detecting antibodies for HIV and the p24 antigen. Furthermore, there are currently very few studies evaluating the performance of Standard Diagnostics BIOLINE HIV Ag/Ab Combo. Objective To evaluate the performance of the Alere Determine HIV-1/2 Combo and the Standard Diagnostics BIOLINE HIV Ag/Ab Combo in a panel of frozen serum samples. Study design The testing panel included 133 previously frozen serum specimens from the UCLA Clinical Microbiology & Immunoserology laboratory. Reference testing included testing for HIV antibodies by a 3rd generation enzyme immunoassay followed by HIV RNA detection. Antibody negative and RNA positive sera were also tested by a laboratory 4th generation HIV Ab/Ag enzyme immunoassay. Results Reference testing yielded 97 positives for HIV infection and 36 negative samples. Sensitivity of the Alere test was 95% (88-98%), while the SD Bioline sensitivity was 91% (83-96%). Both assays showed 100% (90-100%) specificity. No indeterminate or invalid results were recorded. Among 13 samples with acute infection (HIV RNA positive, HIV antibody negative), 12 were found positive by the first assay and 8 by the second. The antigen component of the Alere assay detected 10 acute samples, while the SD Bioline assay detected only one. Conclusions Both rapid assays showed very good overall performance in detecting HIV infection in frozen serum samples, but further improvements are required to improve the performance in acute infection.	[Stafylis, Chrysovalantis; Klausner, Jeffrey D.] UCLA, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Stafylis, C (corresponding author), UCLA, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA.	cstafylis@mednet.ucla.edu	Stafylis, Chrysovalantis/S-3569-2019	Stafylis, Chrysovalantis/0000-0002-1486-1130				[Anonymous], 2013, SD BIOLINE HIV AG AB; [Anonymous], DETERMINE HIV 1 2 AG, V1, P1; Brauer M, 2013, J VIROL METHODS, V189, P180, DOI 10.1016/j.jviromet.2013.01.017; Chetty V, 2012, J CLIN VIROL, V54, P180, DOI 10.1016/j.jcv.2012.02.021; Cragin L, 2012, HIV CLIN TRIALS, V13, P11, DOI [10.1310/hct1301-11, 10.1310/hct1301-011]; Faraoni S, 2013, J CLIN VIROL, V57, P84, DOI 10.1016/j.jcv.2013.01.007; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fitzgerald N, 2017, SEX TRANSM INFECT, V93, P100, DOI 10.1136/sextrans-2015-052491; Fransen K, 2016, J CLIN VIROLOGY; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Pandori MW, 2009, J CLIN MICROBIOL, V47, P2639, DOI 10.1128/JCM.00119-09; Qiu XX, 2017, J CLIN VIROL, V92, P62, DOI 10.1016/j.jcv.2017.05.005; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Smallwood M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149592; World Health Organization (WHO), 2013, WHO PREQ DIAGN PROGR	15	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183944	10.1371/journal.pone.0183944	http://dx.doi.org/10.1371/journal.pone.0183944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846743	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600059
J	Rickard, JP; Ryan, G; Hall, E; de Graaf, SP; Hermes, R				Rickard, Jessica Paige; Ryan, Gabrielle; Hall, Evelyn; de Graaf, Simon Paul; Hermes, Robert			Using transrectal ultrasound to examine the effect of exogenous progesterone on early embryonic loss in sheep	PLOS ONE			English	Article							EARLY-PREGNANCY DIAGNOSIS; ESTROUS-CYCLE; SURVIVAL; EWES; MORTALITY; CONCEPTUS; ULTRASONOGRAPHY; SUPPLEMENTATION; FERTILIZATION; IMPLANTATION	The financial impact of early embryonic loss in Australia may be as high as $137 million AUD/year. Embryos may be lost due to environmental conditions, or maternal factors such as nutrition or progesterone (P4) profiles. However, studies on the supplementation of P4 during early pregnancy have returned contradictory results, partly as a reliable method of detecting embryos in the early stages of gestation (<day 20) has yet be established. As such, Merino ewes (n = 62) were either not supplemented (control) or were given exogenous P4 at the time of insemination (day 0) or 3 days later (day 3). Transrectal ultrasound (TRUS) was performed on day 10, 12, 14, 17, 19 and 29 following laparoscopic artificial insemination. Transcutaneous ultrasound (TCUS) was performed on day 54 to confirm pregnancy and peripheral blood was collected for hormone analysis on day 19 to compare the accuracy of all three pregnancy diagnosis methods. Data were then analysed in developmental periods. The percentage of ewes detected as pregnant by TRUS during pre-, peri- and post implantation was 66% (41/62; day 12 and 14), 61% (38/62; day 17 and 19) and 58% (36/62; day 29), respectively. TCUS during established gestation recorded a pregnancy rate of 60% (37/62). The sensitivity of TRUS to correctly diagnose ewes as pregnant during pre-, peri- and post implantation was 68% (25/37), 89% (33/37) and 100% (36/36), respectively, while the sensitivity to correctly identify multiples was 49% (16/33), 60% (21/35) and 97% (34/35), respectively (P<0.05). The majority of embryonic loss occurred between pre- and peri-implantation (0.9 +/- 0.15 per ewe; P<0.001). No further loss was recorded after this point. Ewes that were given P4 at day 0 had significantly higher embryonic loss (77%) compared to the control (52%) and day 3-ewes (56%; P<0.05). These results show TRUS is a viable tool for investigating early embryonic loss and that the variability noted in previous P4 supplementation studies may be due to variation in time and length of treatment.	[Rickard, Jessica Paige; Ryan, Gabrielle; Hall, Evelyn; de Graaf, Simon Paul; Hermes, Robert] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia; [Hermes, Robert] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany	University of Sydney; Leibniz Institut fur Zoo und Wildtierforschung	Rickard, JP (corresponding author), Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia.	jessica.rickard@sydney.edu.au	de Graaf, Simon P/B-8295-2013; Ryan, Greg/B-7618-2016	de Graaf, Simon P/0000-0002-0870-4219; Rickard, Jessica/0000-0002-4137-2818	University of Sydney; New South Wales, Department of Primary Industries (NSW DPI) [R5089 20601 1122904]; New South Wales Department of Primary Industries (NSW DPI)	University of Sydney(University of Sydney); New South Wales, Department of Primary Industries (NSW DPI); New South Wales Department of Primary Industries (NSW DPI)	Dr Rickard received research compact funding from the University of Sydney and the New South Wales, Department of Primary Industries (NSW DPI), account code: R5089 20601 1122904. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by research compact funding from The University of Sydney and the New South Wales Department of Primary Industries (NSW DPI). Zoetis Australia (Rhodes, Australia) are thanked for the donation of EaziBreed CIDRs and Vetoquinol Australia (Brisbane, Australia) for the donation of Ovagest sponges and eCG (Pregancol). The authors would also like to thank Mr Brian Sharrock (Hamilton Genetics) for donating his time during inseminations and Dr Gordon Refshauge, Mr Cameron Sharpe, Miss Taylor Pini, Miss Naomi Bernecic, Miss Jessie Maddison, Dr Angela Crean, Miss Nicola Culey, Miss Bethan Arthur, Miss Kiri Farmer and Mr Max Lloyd for their on-farm assistance.	ABARES, 2016, AGR COMM STAT; Abecia JA, 2015, ZYGOTE, V23, P116, DOI 10.1017/S096719941300035X; Abecia JA, 1999, THERIOGENOLOGY, V52, P1203, DOI 10.1016/S0093-691X(99)00212-5; Ashworth C.J., 1984, P 10 INT C ANIMAL RE, P74; ASHWORTH CJ, 1989, J REPROD FERTIL, V87, P23, DOI 10.1530/jrf.0.0870023; ASHWORTH CJ, 1989, BIOL REPROD, V40, P425, DOI 10.1095/biolreprod40.2.425; Bari F, 2003, THERIOGENOLOGY, V59, P1265, DOI 10.1016/S0093-691X(02)01162-7; BEDFORD CA, 1972, J ENDOCRINOL, V55, P105, DOI 10.1677/joe.0.0550105; BINDON BM, 1971, AUST J BIOL SCI, V24, P149, DOI 10.1071/BI9710149; BINDON BM, 1971, AUST J BIOL SCI, V24, P131, DOI 10.1071/BI9710131; Bolet G., 1986, Embryonic mortality in farm animals., P12; BOSHIER DP, 1969, J REPROD FERTIL, V19, P51, DOI 10.1530/jrf.0.0190051; BRYDEN MM, 1972, J MORPHOL, V138, P169, DOI 10.1002/jmor.1051380204; Carr A. L., 2001, Sheep and Goat Research Journal, V17, P27; CHANG MC, 1965, ANAT REC, V152, P303, DOI 10.1002/ar.1091520310; DAY BN, 1968, J REPROD FERTIL, V17, P227, DOI 10.1530/jrf.0.0170227; Diskin MG, 2008, REPROD DOMEST ANIM, V43, P260, DOI 10.1111/j.1439-0531.2008.01171.x; DISKIN MG, 1989, J ANIM SCI, V67, P1559; Dixon AB, 2007, J ANIM SCI, V85, P1274, DOI 10.2527/jas.2006-129; DUTT RH, 1963, J ANIM SCI, V22, P713, DOI 10.2527/jas1963.223713x; EDEY TN, 1967, J REPROD FERTIL, V13, P437, DOI 10.1530/jrf.0.0130437; EDEY TN, 1966, J AGR SCI-CAMBRIDGE, V67, P287, DOI 10.1017/S0021859600017299; Evans G., 1987, SALAMONS ARTIFICIAL; GARCIA A, 1993, THERIOGENOLOGY, V39, P847, DOI 10.1016/0093-691X(93)90423-3; GARRETT JE, 1988, J REPROD FERTIL, V84, P437, DOI 10.1530/jrf.0.0840437; Grazul-Bilska AT, 2011, REPRODUCTION, V141, P529, DOI 10.1530/REP-10-0505; Green WW, 1945, TECH B MINN AGR EXP, P169; GUILLOMOT M, 1981, PLACENTA, V2, P169, DOI 10.1016/S0143-4004(81)80021-5; Holler TL, 2014, J ANIM SCI, V92, P3108, DOI 10.2527/jas.2013-7489; HOLST PJ, 1986, AUST J AGR RES, V37, P647, DOI 10.1071/AR9860647; KLEEMANN DO, 1991, REPROD FERT DEVELOP, V3, P71, DOI 10.1071/RD9910071; KLEEMANN DO, 1994, J REPROD FERTIL, V102, P411, DOI 10.1530/jrf.0.1020411; LAWSON RAS, 1983, J REPROD FERTIL, V67, P473, DOI 10.1530/jrf.0.0670473; Lonergan P, 2007, REPROD FERT DEVELOP, V19, P861, DOI 10.1071/RD07089; MILLER BG, 1977, AUST J BIOL SCI, V30, P279, DOI 10.1071/BI9770279; MLA, 2017, HOOKS IND SHEEP LAMB; Moufort JD, 1990, COMPENDIUM CONTINUIN, V12, P1182; O'Connell AR, 2016, THERIOGENOLOGY, V86, P1285, DOI 10.1016/j.theriogenology.2016.04.069; O'Connell AR, 2013, THERIOGENOLOGY, V80, P269, DOI 10.1016/j.theriogenology.2013.04.006; OTTOBRE JS, 1980, BIOL REPROD, V23, P1046, DOI 10.1095/biolreprod23.5.1046; PARR RA, 1992, REPROD FERT DEVELOP, V4, P297, DOI 10.1071/RD9920297; PARR RA, 1982, J AGR SCI, V98, P39, DOI 10.1017/S0021859600041083; QUINLIVAN TD, 1966, J REPROD FERTIL, V11, P379, DOI 10.1530/jrf.0.0110379; RESTALL BJ, 1976, AUST J EXP AGR, V16, P329, DOI 10.1071/EA9760329; RHIND SM, 1989, ANIM PROD, V48, P149, DOI 10.1017/S0003356100003883; ROBERTSON HA, 1971, J ENDOCRINOL, V49, P407, DOI 10.1677/joe.0.0490407; Romano JE, 2008, SMALL RUMINANT RES, V77, P51, DOI 10.1016/j.smallrumres.2008.02.004; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Scenna FN, 2005, PROSTAG OTH LIPID M, V78, P38, DOI 10.1016/j.prostaglandins.2005.02.003; SCHRICK FN, 1993, THERIOGENOLOGY, V40, P295, DOI 10.1016/0093-691X(93)90267-9; Shorten PR, 2013, J ANIM SCI, V91, P4641, DOI 10.2527/jas.2013-6415; Sirard MA, 2006, THERIOGENOLOGY, V65, P126, DOI 10.1016/j.theriogenology.2005.09.020; Soede NM, 2012, REPROD DOMEST ANIM, V47, P835, DOI 10.1111/j.1439-0531.2011.01977.x; Spencer TE, 2004, REPRODUCTION, V128, P657, DOI 10.1530/rep.1.00398; VINCENT DL, 1986, ENDOCRINOLOGY, V119, P527, DOI 10.1210/endo-119-2-527; VINCENT DL, 1986, PROSTAG OTH LIPID M, V31, P715, DOI 10.1016/0090-6980(86)90176-0; Vinoles C, 2012, REPROD FERT DEVELOP, V24, P1040, DOI 10.1071/RD11281; WILMUT I, 1985, THERIOGENOLOGY, V23, P107, DOI 10.1016/0093-691X(85)90076-7; WILMUT I, 1986, J REPROD FERTIL, V76, P851, DOI 10.1530/jrf.0.0760851; Wilsher S, 2012, EQUINE VET J, V44, P432, DOI 10.1111/j.2042-3306.2011.00473.x; WOODY CO, 1967, J ANIM SCI, V26, P139, DOI 10.2527/jas1967.261139x	61	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183659	10.1371/journal.pone.0183659	http://dx.doi.org/10.1371/journal.pone.0183659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841708	Green Published, Green Submitted, gold			2022-12-26	WOS:000408370700048
J	Adeniyi, OV; Ajayi, AI; Selanto-Chairman, N; Ter Goon, D; Boon, G; Fuentes, YO; Hofmeyr, GJ; Avramovic, G; Carty, C; Lambert, J				Adeniyi, Oladele Vincent; Ajayi, Anthony Idowu; Selanto-Chairman, Nonkosi; Ter Goon, Daniel; Boon, Gerry; Fuentes, Yusimi Ordaz; Hofmeyr, George Justus; Avramovic, Gordana; Carty, Craig; Lambert, John		East London Prospective Cohort	Demographic, clinical and behavioural determinants of HIV serostatus nondisclosure to sex partners among HIV-infected pregnant women in the Eastern Cape, South Africa	PLOS ONE			English	Article							TRANSMISSION RISK; DISCLOSURE; PEOPLE; HIV/AIDS; PREDICTORS; ABSENT	Objectives Drawing from a baseline sample of a cohort study, the study examines the extent and correlates of serostatus non-disclosure to sex partners and family members, and reasons for non-disclosure among HIV-infected pregnant women in the Eastern Cape Province, South Africa. Methods This longitudinal cohort study recruited 1709 pregnant women living with HIV who attended three of the largest maternity centres in the Eastern Cape, South Africa, for delivery between September 2015 and May 2016. Relevant items on demographics, serostatus awareness, disclosure to sex partners and family members, and lifestyle behaviours were obtained using structured interviews. Age-stratified binary logistic regression models were used to determine the significant correlates of non-disclosure among the participants. Results A higher rate of HIV serostatus non-disclosure to sex partners (25.6%) in comparison to family members (20%) was reported by the participants. Younger age, not living with partners and alcohol use were significantly associated with non-disclosure of HIV serostatus to sex partners. Non-disclosure of HIV serostatus to sex partners was significantly (p<0.05) associated with poor adherence to the highly active anti-retroviral therapy (HAART), failure to keep clinic appointments and high viral load at the delivery of the baby. Perceived fear of intimate partner violence, fear of rejection, guilt of not disclosing at the onset of the relationship, sex partner's non-disclosure of HIV serostatus, and guilt of unfaithfulness were some of the reasons for non-disclosure of HIV serostatus to sex partners. Conclusions Non-disclosure of HIV serostatus is a public health concern with serious implications for both mother-to-child transmission, as well as horizontal transmission, in our setting. Strategic efforts toward ending the epidemic of HIV and AIDS in South Africa should address the sociocultural and behavioural determinants of non-disclosure.	[Adeniyi, Oladele Vincent] Walter Sisulu Univ, Cecilia Makiwane Hosp, Dept Family Med & Rural Hlth, East London Hosp Complex, East London, South Africa; [Ajayi, Anthony Idowu] Univ Ft Hare, Dept Sociol, East London, South Africa; [Selanto-Chairman, Nonkosi] Buffalo City Metro Dept Hlth, East London, South Africa; [Ter Goon, Daniel] Univ Ft Hare, Fac Hlth Sci, East London, South Africa; [Boon, Gerry] Walter Sisulu Univ, Frere Hosp, Dept Paediat, East London Hosp Complex, East London, South Africa; [Fuentes, Yusimi Ordaz] Cecilia Makiwane Hosp, Dept Family Med, East London Hosp Complex, East London, South Africa; [Hofmeyr, George Justus] Walter Sisulu Univ, Frere Hosp, Effect Care Res Unit, East London Hosp Complex, East London, South Africa; [Avramovic, Gordana] Univ Coll Dublin, Mater Misericordiae Univ Hosp, Catherine McAuley Educ & Res Ctr, Dublin, Ireland; [Carty, Craig] Relevance Network, Johannesburg, South Africa; [Lambert, John] Univ Coll Dublin, Mater Misericordiae Univ Hosp, Catherine McAuley Educ & Res Ctr, Dublin, Ireland	Walter Sisulu University; University of Fort Hare; University of Fort Hare; Walter Sisulu University; Walter Sisulu University; Mater Misericordiae University Hospital; University College Dublin; Mater Misericordiae University Hospital; University College Dublin	Adeniyi, OV (corresponding author), Walter Sisulu Univ, Cecilia Makiwane Hosp, Dept Family Med & Rural Hlth, East London Hosp Complex, East London, South Africa.	vincoladele@gmail.com	Goon, Daniel Ter/C-2912-2019; Ajayi, Anthony Idowu/N-4272-2016	Goon, Daniel Ter/0000-0001-9070-7875; Ajayi, Anthony Idowu/0000-0002-6004-3972; Avramovic, Gordana/0000-0001-9610-6472; ADENIYI, OLADELE VINCENT/0000-0003-0216-6701; lambert, john/0000-0001-5404-2415	Positive Action Grant from ViiV Healthcare Limited; Discovery Foundation; Association of African Universities	Positive Action Grant from ViiV Healthcare Limited; Discovery Foundation; Association of African Universities	Development and implementation of electronic database was supported by the Positive Action Grant from ViiV Healthcare Limited to CC, JL & OVA. OVA received research grants from Discovery Foundation and Association of African Universities. Funders have no involvement in the process of the study or content thereof.	Adeniyi VO, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0414-8; Ahn JV, 2016, AIDS BEHAV, V20, P174, DOI 10.1007/s10461-015-1089-8; Amoran OE, 2012, NIGER J CLIN PRACT, V15, P385, DOI 10.4103/1119-3077.104507; Anglewicz P, 2011, AIDS CARE, V23, P998, DOI 10.1080/09540121.2010.542130; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Arnold EM, 2008, AIDS CARE, V20, P80, DOI 10.1080/09540120701449138; Bachanas P, 2013, AIDS PATIENT CARE ST, V27, P425, DOI 10.1089/apc.2012.0388; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Biadgilign S, 2009, SAHARA J J SOCIAL AS, V6; Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Conserve DF, 2014, AIDS BEHAV, V18, P1037, DOI 10.1007/s10461-013-0685-8; Denis P, 2006, BABA MEN FATHERHOOD, P237; Gadisa T, 2016, AIDS BEHAV, P1; Holt R, 1998, AIDS CARE, V10, P49, DOI 10.1080/09540129850124578; Jasseron C, 2013, AIDS BEHAV, V17, P488, DOI 10.1007/s10461-011-0084-y; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Kiula ES, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-433; Madhavan S, 2008, J S AFR STUD, V34, P647, DOI 10.1080/03057070802259902; Makin JD, 2008, AIDS PATIENT CARE ST, V22, P907, DOI 10.1089/apc.2007.0194; NDoHS, 2015, NAT CONS GUID PREV M; Norman A, 2007, AM J PUBLIC HEALTH, V97, P1775, DOI 10.2105/AJPH.2005.082511; O'Connell AA, 2015, AIDS BEHAV, V19, P283, DOI 10.1007/s10461-014-0848-2; Onovo AA, 2015, BMC PUBLIC HEALTH, V15, P1; Padi T, 2014, S AFR REV SOCIOL, V45, P44, DOI 10.1080/21528586.2014.917879; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Przybyla SM, 2013, AIDS CARE, V25, P566, DOI 10.1080/09540121.2012.722601; Qiao S, 2016, AIDS CARE, P1; Rujumba J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17429; Seid M, 2012, AFRICAN J REPROD HLT, V16; Sendo EG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-765; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Stutterheim SE, 2011, AIDS CARE, V23, P195, DOI 10.1080/09540121.2010.498873; Titilope Adeyemo A, 2011, Niger Med J, V52, P55; Trinh TT, 2014, PARTNER DISCLOSURE E; Tsai AC, 2013, ANN BEHAV MED, V46, P285, DOI 10.1007/s12160-013-9514-6; UNAIDS, 2016, PREP S AFR GEN; Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y; Yonah G, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-5; Zuma K, 2016, AJAR-AFR J AIDS RES, V15, P67, DOI 10.2989/16085906.2016.1153491	39	23	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181730	10.1371/journal.pone.0181730	http://dx.doi.org/10.1371/journal.pone.0181730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837563	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000010
J	Flechsenhar, AF; Gamer, M				Flechsenhar, Aleya Felicia; Gamer, Matthias			Top-down influence on gaze patterns in the presence of social features	PLOS ONE			English	Article							HIGH-LEVEL POP; VISUAL-ATTENTION; FACES; EYES; SELECTION; CONTINGENT; PERCEPTION; RESPONSES; FIXATION; OBJECTS	Visual saliency maps reflecting locations that stand out from the background in terms of their low-level physical features have proven to be very useful for empirical research on attentional exploration and reliably predict gaze behavior. In the present study we tested these predictions for socially relevant stimuli occurring in naturalistic scenes using eye tracking. We hypothesized that social features (i.e. human faces or bodies) would be processed preferentially over non-social features (i.e. objects, animals) regardless of their low-level saliency. To challenge this notion, we included three tasks that deliberately addressed non-ocial attributes. In agreement with our hypothesis, social information, especially heads, was preferentially attended compared to highly salient image regions across all tasks. Social information was never required to solve a task but was regarded nevertheless. More so, after completing the task requirements, viewing behavior reverted back to that of free-viewing with heavy prioritization of social features. Additionally, initial eye movements reflecting potentially automatic shifts of attention, were predominantly directed towards heads irrespective of top-down task demands. On these grounds, we suggest that social stimuli may provide exclusive access to the priority map, enabling social attention to override reflexive and controlled attentional processes. Furthermore, our results challenge the generalizability of saliency-based attention models.	[Flechsenhar, Aleya Felicia; Gamer, Matthias] Julius Maximilian Univ Wuerzburg, Dept Psychol, Wurzburg, Germany	University of Wurzburg	Flechsenhar, AF (corresponding author), Julius Maximilian Univ Wuerzburg, Dept Psychol, Wurzburg, Germany.	aleya.flechsenhar@uni-wuerzburg.de	Gamer, Matthias/E-7967-2010	Gamer, Matthias/0000-0002-9676-9038; Flechsenhar, Aleya/0000-0003-1287-4832	European Research Council (ERC-StG) [336305]	European Research Council (ERC-StG)(European Research Council (ERC))	The present research was supported by a grant of the European Research Council (ERC-2013-StG #336305) awarded to M.G. The funding agency was not involved in decisions concerning the study design, the data collection, the analysis and interpretation of data, the writing of the report, and the submission of the article for publication.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bindemann M, 2007, J VISION, V7, DOI 10.1167/7.10.15; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; Birmingham E, 2009, VISION RES, V49, P2992, DOI 10.1016/j.visres.2009.09.014; Borji A, 2013, IEEE T PATTERN ANAL, V35, P185, DOI 10.1109/TPAMI.2012.89; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Cerf M, 2008, PROCEEDINGS OF THE EYE TRACKING RESEARCH AND APPLICATIONS SYMPOSIUM (ETRA 2008), P143, DOI 10.1145/1344471.1344508; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; DeAngelus M, 2009, VIS COGN, V17, P790, DOI 10.1080/13506280902793843; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Elazary L, 2008, J VISION, V8, DOI 10.1167/8.3.3; End A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00418; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Fletcher-Watson S, 2008, PERCEPTION, V37, P571, DOI 10.1068/p5705; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; Foulsham T, 2011, ATTEN PERCEPT PSYCHO, V73, P266, DOI 10.3758/s13414-010-0014-5; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Gamer M, 2013, CURR BIOL, V23, pR917, DOI 10.1016/j.cub.2013.09.008; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jednorog K, BEHAV RES METHODS; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Judd T., 2012, MITCSAILTR2012001; Kennedy DP, 2011, NEUROPSYCHOLOGIA, V49, P589, DOI 10.1016/j.neuropsychologia.2011.02.026; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Koval MJ, 2005, EXP BRAIN RES, V167, P475, DOI 10.1007/s00221-005-0206-8; Kuhn G, 2016, COGNITION, V146, P136, DOI 10.1016/j.cognition.2015.08.005; Lawrence M., 2016, EASY ANAL VISUALIZAT; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Loschky LC, 2002, J EXP PSYCHOL-APPL, V8, P99, DOI 10.1037/1076-898X.8.2.99; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Nuthmann A, 2015, ANN NY ACAD SCI, V1339, P82, DOI 10.1111/nyas.12705; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Ricciardelli P, 2002, NEUROREPORT, V13, P2259, DOI 10.1097/00001756-200212030-00018; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Scheller E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041792; Sharma P, 2015, J IMAGING SCI TECHN, V59, DOI 10.2352/AmagingSci.Technol.2015.59.5.050501; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; van Diepen PMJ, 2003, VIS COGN, V10, P79, DOI 10.1080/13506280143000023; VanRullen R, 2006, VISION RES, V46, P3017, DOI 10.1016/j.visres.2005.07.009; Vuilleumier P, 2001, NEUROPSYCHOLOGIA, V39, P1144, DOI 10.1016/S0028-3932(01)00048-3; Vuilleumier P, 2000, NEUROPSYCHOLOGIA, V38, P693, DOI 10.1016/S0028-3932(99)00107-4; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	52	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183799	10.1371/journal.pone.0183799	http://dx.doi.org/10.1371/journal.pone.0183799			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837673	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000124
J	Liang, JY; Kulasiri, D; Samarasinghe, S				Liang, Jingyi; Kulasiri, Don; Samarasinghe, Sandhya			Computational investigation of Amyloid-beta-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer's disease	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-II; GLUTAMATE UPTAKE; SYNAPTIC PLASTICITY; CALCIUM HYPOTHESIS; RECEPTOR TRAFFICKING; SENSITIVITY-ANALYSIS; CULTURED ASTROCYTES; SOLUBLE OLIGOMERS; MEMORY FORMATION	In Alzheimer's disease (AD), dysregulation of intracellular Ca2+ signalling has been observed as an early event prior to the presence of clinical symptoms and is believed to be a crucial factor contributing to AD pathogenesis. Amyloid-beta oligomers (A beta Os) disturb the N-methyl-D-aspartate receptor (NMDAR)-mediated postsynaptic Ca2+ signalling in response to presynaptic stimulation by increasing the availability of extracellular glutamate as well as directly disturbing the NMDARs. The abnormal Ca2+ response can further lead to impairments in long-term potentiation (LTP), an important process in memory formation. In this study, we develop a mathematical model of a CA1 pyramidal dendritic spine and conduct computational experiments. We use this model to mimic alterations by A beta Os under AD conditions to investigate how they are involved in the Ca2+ dysregulation in the dendritic spine. The alterations in glutamate availability, as well as NMDAR availability and activity, are studied both individually and globally. The simulation results suggest that alterations in glutamate availability mostly affect the synaptic response and have limited effects on the extra-synaptic receptors. Moreover, overactivation of extrasynaptic NMDARs in AD is unlikely to be induced by presynaptic stimulation, but by upregulation of the resting level of glutamate, possibly resulting from these alterations. Furthermore, internalisation of synaptic NR2A-NMDAR shows greater damage to the postsynaptic Ca2+ response in comparison with the internalisation of NR2B-NMDARs; thus, the suggested neuroprotective role of the latter is very limited during synaptic transmission in AD. We integrate a CaMKII state transition model with the Ca2+ model to further study the effects of alterations of NMDARs in the CaMKII state transition, an important downstream event in the early phase of LTP. The model reveals that cooperation between NR2A- and NR2B-NMDAR is required for LTP induction. Under AD conditions, internalisation of membrane NMDARs is suggested to be the cause of the loss of synapse numbers by disrupting CaMKII-NMDAR formation.	[Liang, Jingyi; Kulasiri, Don; Samarasinghe, Sandhya] Lincoln Univ, Ctr Adv Computat Solut C FACS, Christchurch, New Zealand	Lincoln University - New Zealand	Kulasiri, D (corresponding author), Lincoln Univ, Ctr Adv Computat Solut C FACS, Christchurch, New Zealand.	Don.Kulasiri@lincoln.ac.nz	Kulasiri, Don/C-8789-2018; samarasinghe, sandhya/O-9809-2018	Kulasiri, Don/0000-0001-8744-1578; samarasinghe, sandhya/0000-0003-2943-4331				Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; ARIAS C, 1995, J NEUROSCI RES, V41, P561, DOI 10.1002/jnr.490410416; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; Bobich JA, 2004, J ALZHEIMERS DIS, V6, P243; Bordji K, 2010, J NEUROSCI, V30, P15927, DOI 10.1523/JNEUROSCI.3021-10.2010; Butterfield DA, 2003, CNS DRUGS, V17, P641, DOI 10.2165/00023210-200317090-00004; Chen QS, 2002, NEUROBIOL LEARN MEM, V77, P354, DOI 10.1006/nlme.2001.4034; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Chin JH, 2007, J NEUROSCI, V27, P9262, DOI 10.1523/JNEUROSCI.1843-07.2007; Chua JJE, 2010, J CELL SCI, V123, P819, DOI 10.1242/jcs.052696; CHUANG DM, 1992, MOL PHARMACOL, V42, P210; Chung S. -H., 2007, BIOL MEMBRANE ION CH, p507?543; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Danysz W, 2012, BRIT J PHARMACOL, V167, P324, DOI 10.1111/j.1476-5381.2012.02057.x; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Fernandez-Tome P, 2004, NEUROBIOL DIS, V15, P580, DOI 10.1016/j.nbd.2003.12.006; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Goto Y, 2006, BIOCHEM BIOPH RES CO, V351, P259, DOI 10.1016/j.bbrc.2006.10.030; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS ME, 1995, NEUROREPORT, V6, P1875, DOI 10.1097/00001756-199510020-00013; Harris ME, 1996, J NEUROCHEM, V67, P277; He Y, 2015, J THEOR BIOL, V365, P403, DOI 10.1016/j.jtbi.2014.11.001; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kabogo D, 2010, NEUROBIOL AGING, V31, P1164, DOI 10.1016/j.neurobiolaging.2008.08.009; Kelliher M, 1999, NEUROSCIENCE, V92, P499, DOI 10.1016/S0306-4522(99)00042-1; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Koffie RM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-63; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kulasiri D, 2017, J THEOR BIOL, V419, P116, DOI 10.1016/j.jtbi.2017.02.003; Kumar A, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00007; Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Liang JY, 2015, BIOSYSTEMS, V134, P1, DOI 10.1016/j.biosystems.2015.05.003; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Matos M, 2008, NEUROSCIENCE, V156, P898, DOI 10.1016/j.neuroscience.2008.08.022; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Moussawi K, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00094; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Noda M, 1999, NEUROSCIENCE, V92, P1465, DOI 10.1016/S0306-4522(99)00036-6; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Ondrejcak T, 2010, NEUROMOL MED, V12, P13, DOI 10.1007/s12017-009-8091-0; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; ParpuraGill A, 1997, BRAIN RES, V754, P65, DOI 10.1016/S0006-8993(97)00043-7; Petralia RS, 2012, SCI WORLD J, DOI 10.1100/2012/267120; Prince M., 2016, WORLD ALZHEIMER REPO; Regehr WG, 1990, NATURE, P345; Rusakov DA, 2001, BIOPHYS J, V81, P1947, DOI 10.1016/S0006-3495(01)75846-8; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Santucci DM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000208; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Stys PK, 2012, J PHYSIOL-LONDON, V590, P1357, DOI 10.1113/jphysiol.2011.225276; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; VanDongen AMJ, 2009, FRONT NEUROSCI; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	91	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182743	10.1371/journal.pone.0182743	http://dx.doi.org/10.1371/journal.pone.0182743			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837653	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000024
J	Liland, NS; Biancarosa, I; Araujo, P; Biemans, D; Bruckner, CG; Waagbo, R; Torstensen, BE; Lock, EJ				Liland, Nina S.; Biancarosa, Irene; Araujo, Pedro; Biemans, Daan; Bruckner, Christian G.; Waagbo, Rune; Torstensen, Bente E.; Lock, Erik-Jan			Modulation of nutrient composition of black soldier fly (Hermetia illucens) larvae by feeding seaweed-enriched media	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN; CONVERSION; NITROGEN; FOODS; MEAL	Black soldier fly (Hermetia illucens) larvae are a promising source of protein and lipid for animal feeds. The nutritional composition of the BSF larvae depend partly on the composition of the feeding medium. The BSF lipid profile in part mimics the feeding media lipid profile, and micronutrients, like minerals and vitamins, can readily accumulate in black soldier fly larvae. However, investigative studies on bioconversion and accumulation of nutrients from media to black soldier fly larvae are scarce. Here we show that inclusion of the brown algae Ascophyllum nodosum in the substrate for black soldier fly larvae can introduce valuable nutrients, commonly associated with the marine environment, into the larvae. The omega-3 fatty acid eicosapentaenoic acid (20:5n-3), iodine and vitamin E concentrations increased in the larvae when more seaweed was included in the diet. When the feeding media consisted of more than 50% seaweed, the larvae experienced poorer growth, lower nutrient retention and lower lipid levels, compared to a pure plant based feeding medium. Our results confirm the plasticity of the nutritional make-up of black soldier fly larvae, allowing it to accumulate both lipid-and water-soluble compounds. A broader understanding of the effect of the composition of the feeding media on the larvae composition can help to tailor black soldier fly larvae into a nutrient profile more suited for specific feed or food purposes.	[Liland, Nina S.; Biancarosa, Irene; Araujo, Pedro; Waagbo, Rune; Torstensen, Bente E.; Lock, Erik-Jan] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Biemans, Daan] Protix Biosyst BV, Ind Str 3, Dongen, Netherlands; [Bruckner, Christian G.] Norwegian Inst Bioecon Res NIBIO, Torggarden, Norway; [Torstensen, Bente E.] NOFIMA, Kjerreidviken 16, Fyllingsdalen, Norway	Norwegian Institute of Bioeconomy Research; Nofima	Lock, EJ (corresponding author), Natl Inst Nutr & Seafood Res, Bergen, Norway.	erik-jan.lock@nifes.no	Waagbø, Rune/M-4567-2019; Liland, Nina Sylvia/AAC-8701-2020; Lock, Erik-Jan/AAM-9766-2020	Waagbo, Rune/0000-0001-6075-3221; Araujo, Pedro/0000-0002-1962-6084; Lock, Erik-Jan/0000-0002-8157-5249; Liland, Nina Sylvia/0000-0002-1310-0620	Norwegian Research Council (NRC) [238997]; RAFFPINN [220634]	Norwegian Research Council (NRC)(Research Council of Norway); RAFFPINN	This study was funded by the Norwegian Research Council (NRC) project Aquafly, grant number 238997 and RAFFPINN, grant number 220634. The funder provided support in the form of salaries for authors (NLI, IBI, PAR, CBR, RWA, BTO, ELO) and the costs of analyses, but did not have any additional role in the study design, data collection and type of analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Protix Biosystems BV has facilitated the experiment, however did not contribute financially or intellectually to this trial.	Ackman R.G., 1980, ADV FISH SCI TECHNOL, P87; Araujo P, 2005, ACCREDIT QUAL ASSUR, V10, P185, DOI 10.1007/s00769-005-0907-5; Araujo P, 2008, ISR J AQUACULT-BAMID, V60, P134; Biancarosa I, 2017, J APPL PHYCOL, V29, P1001, DOI 10.1007/s10811-016-0984-3; Cherian G, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0029-9; Cickova H, 2015, WASTE MANAGE, V35, P68, DOI 10.1016/j.wasman.2014.09.026; COLLETT JI, 1976, J INSECT PHYSIOL, V22, P1395, DOI 10.1016/0022-1910(76)90163-3; Dayrit FM, 2015, J AM OIL CHEM SOC, V92, P1, DOI 10.1007/s11746-014-2562-7; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; Dominguez H, 2013, WOODHEAD PUBL FOOD S, V256, P1, DOI 10.1533/9780857098689; Espe M, 2014, BRIT J NUTR, V112, P1274, DOI 10.1017/S0007114514002062; FAO, 2014, STATE WORLD FISHERIE; Finke MD, 2013, ZOO BIOL, V32, P27, DOI 10.1002/zoo.21012; Guiry MD, 2016, ALGAEBASE WORLD WIDE; Hamre K, 2010, FOOD CHEM, V119, P270, DOI 10.1016/j.foodchem.2009.06.024; HARKINS RW, 1968, J AMER MED ASSOC, V203, P272, DOI 10.1001/jama.203.4.272; Henry M, 2015, ANIM FEED SCI TECH, V203, P1, DOI 10.1016/j.anifeedsci.2015.03.001; Jiao GL, 2011, MAR DRUGS, V9, P196, DOI 10.3390/md9020196; Julshamn K, 2001, J AOAC INT, V84, P1976; Konings EJM, 1996, J AOAC INT, V79, P902; Kraan S, 2013, WOODHEAD PUBL FOOD S, V256, P205, DOI 10.1533/9780857098689.1.205; Kroeckel S, 2012, AQUACULTURE, V364, P345, DOI 10.1016/j.aquaculture.2012.08.041; LIE O, 1991, J CHROMATOGR-BIOMED, V565, P119, DOI 10.1016/0378-4347(91)80376-N; Liu Y., 2015, J ANIM SCI BIOTECHNO, V6; Lourenco SO, 2004, EUR J PHYCOL, V39, P17, DOI 10.1080/0967026032000157156; Maehre HK, 2014, J SCI FOOD AGR, V94, P3281, DOI 10.1002/jsfa.6681; Makkar HPS, 2016, ANIM FEED SCI TECH, V212, P1, DOI 10.1016/j.anifeedsci.2015.09.018; Marono S, 2015, ITAL J ANIM SCI, V14, DOI 10.4081/ijas.2015.3889; NEWTON GL, 1977, J ANIM SCI, V44, P395, DOI 10.2527/jas1977.443395x; Njaa L.R., 1982, Fiskeridirektoratets Skrifter Serie Ernaering, V2, P25; NRC, 2011, COMM NUTR REQ FISH S, P363; Oonincx DGAB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144601; R Development Core Team, 2011, R FDN STAT COMP; RONNESTAD I, 1993, MAR BIOL, V116, P349, DOI 10.1007/BF00350051; Ronnestad Ivar, 1993, Reviews in Fisheries Science, V1, P239; Ruperez P, 2002, FOOD CHEM, V79, P23, DOI 10.1016/S0308-8146(02)00171-1; Salmo salar L, 2004, AQUACULT NUTR, V10, P175; SaloVaananen PP, 1996, FOOD CHEM, V57, P27, DOI 10.1016/0308-8146(96)00157-4; Sissener N, 2016, EFFEKTER ENDRET FETT, P99; Skjermo J, 2012, VALUE CREATED PRODUC, P83; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P309, DOI 10.1111/j.1749-7345.2007.00101.x; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P59, DOI 10.1111/j.1749-7345.2006.00073.x; Tschirner M, 2015, J INSECTS FOOD FEED, V1, P249, DOI 10.3920/JIFF2014.0008; Urich K., 1994, COMPARATIVE ANIMAL B, P403; Veldkamp T, 2012, REPORT 639, P62; Vlahakis C, 2000, J AM OIL CHEM SOC, V77, P49, DOI 10.1007/s11746-000-0008-6; Wang XS, 2008, FOOD CHEM, V107, P11, DOI 10.1016/j.foodchem.2007.06.064	47	195	200	29	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183188	10.1371/journal.pone.0183188	http://dx.doi.org/10.1371/journal.pone.0183188			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837591	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000051
J	Ross, SL; Sherman, M; McElroy, PL; Lofgren, JA; Moody, G; Baeuerle, PA; Coxon, A; Arvedson, T				Ross, Sandra L.; Sherman, Marika; McElroy, Patricia L.; Lofgren, Julie A.; Moody, Gordon; Baeuerle, Patrick A.; Coxon, Angela; Arvedson, Tara			Bispecific T cell engager (BiTE (R)) antibody constructs can mediate bystander tumor cell killing	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; INTERFERON-GAMMA; UP-REGULATION; CANCER; ACTIVATION; LINES; FAS; INDUCTION; LEUKEMIA; PATHWAY	For targets that are homogenously expressed, such as CD19 on cells of the B lymphocyte lineage, immunotherapies can be highly effective. Targeting CD19 with blinatumomab, a CD19/CD3 bispecific antibody construct (BiTE (R)), or with chimeric antigen receptor T cells (CAR-T) has shown great promise for treating certain CD19-positive hematological malignancies. In contrast, solid tumors with heterogeneous expression of the tumor-associated antigen (TAA) may present a challenge for targeted therapies. To prevent escape of TAA-negative cancer cells, immunotherapies with a local bystander effect would be beneficial. As a model to investigate BiTE (R)-mediated bystander killing in the solid tumor setting, we used epidermal growth factor receptor (EGFR) as a target. We measured lysis of EGFR-negative populations in vitro and in vivo when co-cultured with EGFR-positive cells, human T cells and an EGFR/CD3 BiTE (R) antibody construct. Bystander EGFR-negative cells were efficiently lysed by BiTE (R)-activated T cells only when proximal to EGFR-positive cells. Our mechanistic analysis suggests that cytokines released by BiTE (R)-activated T-cells induced upregulation of ICAM-1 and FAS on EGFR-negative bystander cells, contributing to T cell-induced bystander cell lysis.	[Ross, Sandra L.; Sherman, Marika; McElroy, Patricia L.; Lofgren, Julie A.; Moody, Gordon; Coxon, Angela; Arvedson, Tara] Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA; [Baeuerle, Patrick A.] Amgen Inc, Dept Amgen Res Munich, Munich, Germany; [Sherman, Marika] Kite Pharma Inc, Dept Translat Sci, Santa Monica, CA USA; [Moody, Gordon] Medimmune, Dept Oncol, Gaithersburg, MD USA; [Baeuerle, Patrick A.] MPM Capital, Cambridge, MA USA	Amgen; Amgen; Amgen Research Munich GmbH; AstraZeneca; Medimmune	Arvedson, T (corresponding author), Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA.	taraa@amgen.com			Amgen Inc.	Amgen Inc.(Amgen)	The authors received no specific funding for this work. Amgen Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKIYAMA S, 1988, JPN J SURG, V18, P438, DOI 10.1007/BF02471470; Azuma A, 1992, CANC RES; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Bander NH, 2013, METHODS MOL BIOL, V1045, P29, DOI 10.1007/978-1-62703-541-5_2; Zhang B, 2008, J CLIN INVEST, V118, P1398, DOI 10.1172/JCI33522; Bornstein GG, 2015, AAPS J, V17, P525, DOI 10.1208/s12248-015-9738-4; Brandl C, 2007, CANCER IMMUNOL IMMUN, V56, P1551, DOI 10.1007/s00262-007-0298-z; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; CHONG ASF, 1994, CANCER IMMUNOL IMMUN, V39, P127, DOI 10.1007/s002620050103; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; de Vries JF, 2007, HAEMATOLOGICA, V92, P1671, DOI 10.3324/haematol.11308; Dreier T, 2002, INT J CANCER, V100, P690, DOI 10.1002/ijc.10557; Dustin ML, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002873; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Frankel SR, 2013, CURR OPIN CHEM BIOL, V17, P385, DOI 10.1016/j.cbpa.2013.03.029; Friedrich M, 2014, MOL CANCER THER, V13, P1549, DOI 10.1158/1535-7163.MCT-13-0956; Friedrich M, 2012, MOL CANCER THER, V11, P2664, DOI 10.1158/1535-7163.MCT-12-0042; Gaglia JL, 2000, J IMMUNOL, V165, P6091, DOI 10.4049/jimmunol.165.11.6091; Goebeler ME, 2016, J CLIN ONCOL, V34, P1104, DOI 10.1200/JCO.2014.59.1586; Haas C, 2009, IMMUNOBIOLOGY, V214, P441, DOI 10.1016/j.imbio.2008.11.014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassin D, 2011, IMMUNOLOGY, V133, P190, DOI 10.1111/j.1365-2567.2011.03426.x; HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9; Hipp S, 2017, LEUKEMIA; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; Huehls AM, 2015, IMMUNOL CELL BIOL, V93, P290, DOI 10.1038/icb.2014.93; Jenkinson SR, 2005, J IMMUNOL, V174, P3401, DOI 10.4049/jimmunol.174.6.3401; Klinger M, 2016, IMMUNOL REV, V270, P193, DOI 10.1111/imr.12393; Klinger M, 2012, BLOOD, V119, P6226, DOI 10.1182/blood-2012-01-400515; Kojima H, 1997, J IMMUNOL, V159, P2728; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li D, 2009, J BIOL CHEM, V284, P21001, DOI 10.1074/jbc.M109.002865; Li Y, 2000, BIOCHEM BIOPH RES CO, V268, P398, DOI 10.1006/bbrc.2000.2129; LOLLO BA, 1993, J BIOL CHEM, V268, P21693; Lutterbuese R, 2010, P NATL ACAD SCI USA, V107, P12605, DOI 10.1073/pnas.1000976107; Mack M, 1997, J IMMUNOL, V158, P3965; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Melis M, 1996, EUR RESPIR J, V9, P1831, DOI 10.1183/09031936.96.09091831; Mori S, 1997, CANCER IMMUNOL IMMUN, V44, P282, DOI 10.1007/s002620050384; Offner S, 2006, MOL IMMUNOL, V43, P763, DOI 10.1016/j.molimm.2005.03.007; Osada T, 2010, BRIT J CANCER, V102, P124, DOI 10.1038/sj.bjc.6605364; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Peter ME, 2015, CELL DEATH DIFFER, V22, P549, DOI 10.1038/cdd.2015.3; Ramsey P, 1993, CANC RES; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; Shin EC, 2001, INT J CANCER, V93, P262, DOI 10.1002/ijc.1310; SINGH S, 1992, J EXP MED, V175, P139, DOI 10.1084/jem.175.1.139; Smyth MJ, 1998, J VIROL, V72, P5948, DOI 10.1128/JVI.72.7.5948-5954.1998; van der Zouwen B, 2014, BIOL BLOOD MARROW TR, V20, P760, DOI 10.1016/j.bbmt.2014.03.002; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Waring P, 1999, IMMUNOL CELL BIOL, V77, P312, DOI 10.1046/j.1440-1711.1999.00837.x; Xu XL, 1998, CANCER RES, V58, P2832	54	42	52	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183390	10.1371/journal.pone.0183390	http://dx.doi.org/10.1371/journal.pone.0183390			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837681	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000062
J	Kuot, A; Hewitt, AW; Snibson, GR; Souzeau, E; Mills, R; Craig, JE; Burdon, KP; Sharma, S				Kuot, Abraham; Hewitt, Alex W.; Snibson, Grant R.; Souzeau, Emmanuelle; Mills, Richard; Craig, Jamie E.; Burdon, Kathryn P.; Sharma, Shiwani			TGC repeat expansion in the TCF4 gene increases the risk of Fuchs' endothelial corneal dystrophy in Australian cases	PLOS ONE			English	Article							CTG18.1 TRINUCLEOTIDE REPEAT; MYOTONIC-DYSTROPHY; MISSENSE MUTATIONS; SPINOCEREBELLAR ATAXIA; NUCLEAR FOCI; RNA TOXICITY; ASSOCIATION; DISEASE; PROTEINS; POLYMORPHISMS	Fuchs' endothelial corneal dystrophy (FECD) is a progressive, vision impairing disease. Common single nucleotide polymorphisms (SNPs) and a trinucleotide repeat polymorphism, thymine-guanine-cytosine (TGC), in the TCF4 gene have been associated with the risk of FECD in some populations. We previously reported association of SNPs in TCF4 with FECD risk in the Australian population. The aim of this study was to determine whether TGC repeat polymorphism in TCF4 is associated with FECD in the Australian population. In 189 unrelated Australian cases with advanced late-onset FECD and 183 matched controls, the TGC repeat polymorphism located in intron 3 of TCF4 was genotyped using a short tandem repeat (STR) assay. The repeat length was verified by direct sequencing in selected homozygous carriers. We found significant association between the expanded TGC repeat (>= 40 repeats) in TCF4 and advanced FECD (P = 2.58 x 10(-22); OR = 15.66 (95% CI: 7.79-31.49)). Genotypic analysis showed that 51% of cases (97) compared to 5% of controls (9) were heterozygous or homozygous for the expanded repeat allele. Furthermore, the repeat expansion showed stronger association than the most significantly associated SNP, rs613872, in TCF4, with the disease in the Australian cohort. This and haplotype analysis of both the polymorphisms suggest that considering both the polymorphisms together rather than either of the two alone would better predict susceptibility to FECD in the Australian population. This is the first study to report association of the TGC trinucleotide repeat expansion in TCF4 with advanced FECD in the Australian population.	[Kuot, Abraham; Souzeau, Emmanuelle; Mills, Richard; Craig, Jamie E.; Burdon, Kathryn P.; Sharma, Shiwani] Flinders Univ S Australia, Coll Med & Publ Hlth, Dept Ophthalmol, Adelaide, SA, Australia; [Hewitt, Alex W.; Snibson, Grant R.] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Hewitt, Alex W.; Burdon, Kathryn P.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia	Flinders University South Australia; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Tasmania; Menzies Institute for Medical Research	Sharma, S (corresponding author), Flinders Univ S Australia, Coll Med & Publ Hlth, Dept Ophthalmol, Adelaide, SA, Australia.	shiwani.sharma@flinders.edu.au	Kuot, Abraham/W-7246-2019; Burdon, Kathryn/A-5026-2009; Souzeau, Emmanuelle/AAB-5608-2022; Burdon, Kathryn/AAD-2334-2022	Burdon, Kathryn/0000-0001-8217-1249; Souzeau, Emmanuelle/0000-0002-2015-6577; Burdon, Kathryn/0000-0001-8217-1249; Sharma, Shiwani/0000-0002-0828-025X; Craig, Jamie/0000-0001-9955-9696; Hewitt, Alex/0000-0002-5123-5999; Mills, Richard/0000-0002-7386-2571	National Health and Medical Research Council (NHMRC), Australia [1023911]; Ophthalmic Research Institute of Australia; Flinders Medical Centre Foundation, South Australia, Australia; NHMRC	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; Flinders Medical Centre Foundation, South Australia, Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by grants from the National Health and Medical Research Council (NHMRC), Australia, grant #1023911, Ophthalmic Research Institute of Australia, and the Flinders Medical Centre Foundation, South Australia, Australia. JEC and KPB are recipients of NHMRC practitioner and research fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1993, SURV OPHTHALMOL, V38, P149, DOI 10.1016/0039-6257(93)90099-S; Afshari NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14898; Awadalla MS, 2014, JAMA OPHTHALMOL, V132, P970, DOI 10.1001/jamaophthalmol.2014.946; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Breschel TS, 1997, HUM MOL GENET, V6, P1855, DOI 10.1093/hmg/6.11.1855; Brusco A, 2004, ARCH NEUROL-CHICAGO, V61, P727, DOI 10.1001/archneur.61.5.727; Burdon KP, 2011, INVEST OPHTH VIS SCI, V52, P8514, DOI 10.1167/iovs.11-8261; Coffey N, AUSTR CORNEAL GRAFT; Dimasi DP, 2012, AM J OPHTHALMOL, V154, P833, DOI 10.1016/j.ajo.2012.04.023; Du JT, 2015, J BIOL CHEM, V290, P5979, DOI 10.1074/jbc.M114.621607; Echeverria GV, 2012, BRAIN RES, V1462, P100, DOI 10.1016/j.brainres.2012.02.030; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Goodwin M, 2015, CELL REP, V12, P1159, DOI 10.1016/j.celrep.2015.07.029; Hamill CE, 2013, SEMIN OPHTHALMOL, V28, P281, DOI 10.3109/08820538.2013.825283; Kabosova A, 2007, INVEST OPHTH VIS SCI, V48, P4989, DOI 10.1167/iovs.07-0654; Kannabiran C, 2009, J GENET, V88, P487, DOI 10.1007/s12041-009-0067-1; KENNEY MC, 1984, EXP EYE RES, V39, P267, DOI 10.1016/0014-4835(84)90015-0; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Konieczny P, 2014, NUCLEIC ACIDS RES, V42, P10873, DOI 10.1093/nar/gku767; Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Kuot A, 2012, EUR J HUM GENET, V20, P632, DOI 10.1038/ejhg.2011.248; Li YJ, 2015, MOL THER, V23, P1055, DOI 10.1038/mt.2015.41; Li YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018044; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Mehta JS, 2008, INVEST OPHTH VIS SCI, V49, P184, DOI 10.1167/iovs.07-0847; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mok JW, 2009, EYE, V23, P895, DOI 10.1038/eye.2008.116; Mootha VV, 2015, INVEST OPHTH VIS SCI, V56, P2003, DOI 10.1167/iovs.14-16222; Mootha VV, 2014, INVEST OPHTH VIS SCI, V55, P33, DOI 10.1167/iovs.13-12611; Nakano M, 2015, INVEST OPHTH VIS SCI, V56, P4865, DOI 10.1167/iovs.15-17082; Nanda GG, 2014, INVEST OPHTH VIS SCI, V55, P7674, DOI 10.1167/iovs.14-15297; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; O'Rourke JR, 2009, J BIOL CHEM, V284, P7419, DOI 10.1074/jbc.R800025200; Oodak M, 2015, BIOMED RES INT, V2015; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Price MO, 2010, OPHTHALMOLOGY, V117, P438, DOI 10.1016/j.ophtha.2009.07.036; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riazuddin SA, 2013, AM J HUM GENET, V93, P758, DOI 10.1016/j.ajhg.2013.08.010; Riazuddin SA, 2012, AM J HUM GENET, V90, P533, DOI 10.1016/j.ajhg.2012.01.013; Riazuddin SA, 2011, INVEST OPHTH VIS SCI, V52, P2825, DOI 10.1167/iovs.10-6497; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; SANTO RM, 1995, OPHTHALMOLOGY, V102, P557, DOI 10.1016/S0161-6420(95)30982-7; Santos R, 2010, ANTIOXID REDOX SIGN, V13, P651, DOI 10.1089/ars.2009.3015; Thalamuthu A, 2011, INVEST OPHTH VIS SCI, V52, P5573, DOI 10.1167/iovs.11-7568; Vasanth S, 2015, INVEST OPHTH VIS SCI, V56, P4531, DOI 10.1167/iovs.14-16122; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Wieben ED, 2017, INVEST OPHTH VIS SCI, V58, P343, DOI 10.1167/iovs.16-20900; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083; Xing C, 2014, INVEST OPHTH VIS SCI, V55, P7073, DOI 10.1167/iovs.14-15390; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	54	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183719	10.1371/journal.pone.0183719	http://dx.doi.org/10.1371/journal.pone.0183719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832669	Green Accepted, Green Published, gold			2022-12-26	WOS:000408355800094
J	Zhao, PY; Zhang, F; Liu, DL; Imani, J; Langen, G; Kogel, KH				Zhao, Puyan; Zhang, Fei; Liu, Dilin; Imani, Jafargholi; Langen, Gregor; Kogel, Karl-Heinz			Matrix metalloproteinases operate redundantly in Arabidopsis immunity against necrotrophic and biotrophic fungal pathogens	PLOS ONE			English	Article							SOYBEAN LEAF METALLOPROTEINASE; INNATE IMMUNITY; CELL-DEATH; LOCALIZATION; THALIANA; FAMILY; SENESCENCE; GENE; METALLOENDOPROTEINASE; INFLAMMATION	Matrix metalloproteinases (MMPs) are evolutionarily conserved and multifunctional effector molecules playing pivotal roles in development and homeostasis. In this study we explored the involvement of the five Arabidopsis thaliana At-MMPs in plant defence against microbial pathogens. Expression of At2-MMP was most responsive to inoculation with fungi and a bacterial pathogen followed by At3-MMP and At5-MMP, while At1-MMP and At4-MMP were non-responsive to these biotic stresses. Loss-of-function mutants for all tested At-MMPs displayed increased susceptibility to the necrotrophic fungus Botrytis cinerea and double mutant at2,3-mmp and triple mutant at2,3,5-mmp plants developed even stronger symptoms. Consistent with this, transgenic Arabidopsis plants that expressed At2-MMP constitutively under the Cauliflower mosaic virus 35S promoter showed enhanced resistance to the necrotrophic pathogen. Similarly, resistance to the biotrophic Arabidopsis powdery mildew fungus Golovinomyces orontii was also compromised particularly in the at2,3-mmp / at2,3,5-mmp multiplex mutants, and increased in At2-MMP overexpressor plants. The degree of disease resistance of at-mmp mutants and At2-MMP overexpressor plants also correlated positively with the degree of MAMP-triggered callose deposition in response to the bacterial flagellin peptide flg22, suggesting that matrix metalloproteinases contribute to pattern-triggered immunity (PTI) in interactions of Arabidopsis with necrotrophic and biotrophic pathogens.	[Zhao, Puyan; Zhang, Fei; Liu, Dilin; Imani, Jafargholi; Langen, Gregor; Kogel, Karl-Heinz] Justus Liebig Univ Giessen, Inst Phytopathol, Giessen, Germany; [Zhao, Puyan] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China; [Zhang, Fei] Guangdong Acad Agr Sci, Rice Res Inst, Guangzhou, Guangdong, Peoples R China; [Langen, Gregor] Univ Cologne, Bot Inst, Zulpicher Str 47b, Cologne, Germany	Justus Liebig University Giessen; South China Agricultural University; Guangdong Academy of Agricultural Sciences; University of Cologne	Langen, G; Kogel, KH (corresponding author), Justus Liebig Univ Giessen, Inst Phytopathol, Giessen, Germany.; Langen, G (corresponding author), Univ Cologne, Bot Inst, Zulpicher Str 47b, Cologne, Germany.	glangen1@uni-koeln.de; karl-heinz.kogel@agrar.uni-giessen.de	Langen, Gregor/B-1407-2014; Kogel, KH/K-1626-2019	Langen, Gregor/0000-0002-8321-1756; Kogel, KH/0000-0003-1226-003X	German Research Foundation [DFG FOR666]; CSC (China Scholarship Council); Cluster of Excellence on Plant Sciences (CEPLAS) [EXC 1028]	German Research Foundation(German Research Foundation (DFG)); CSC (China Scholarship Council)(China Scholarship Council); Cluster of Excellence on Plant Sciences (CEPLAS)	This work was supported in part by the German Research Foundation grant DFG FOR666 to KHK, the CSC (China Scholarship Council) scholarship granted to PZ and FZ and by the Cluster of Excellence on Plant Sciences (CEPLAS, EXC 1028) to GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank M. Claar, E. Stein (Justus Liebig University Giessen) and L. Leson (University of Cologne) for their excellent technical assistance. This work was supported in part by the German Research Foundation grant DFG FOR666 to KHK, the CSC (China Scholarship Council) scholarship granted to PZ and FZ and by the Cluster of Excellence on Plant Sciences (CEPLAS, EXC 1028) to GL.	Altincicek B, 2008, DEV COMP IMMUNOL, V32, P400, DOI 10.1016/j.dci.2007.08.001; Altincicek B, 2009, BIOL CHEM, V390, P1303, DOI 10.1515/BC.2009.128; Brown I, 1998, PLANT J, V15, P333, DOI 10.1046/j.1365-313X.1998.00215.x; Chen H, 2006, BIOINFORMATICS, V22, P376, DOI 10.1093/bioinformatics/bti822; Cho CW, 2009, BIOL PLANTARUM, V53, P461, DOI 10.1007/s10535-009-0086-z; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Combier JP, 2007, PLANT PHYSIOL, V144, P703, DOI 10.1104/pp.106.092585; Delorme VGR, 2000, PLANT PHYSIOL, V123, P917, DOI 10.1104/pp.123.3.917; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Flinn BS, 2008, FUNCT PLANT BIOL, V35, P1183, DOI 10.1071/FP08182; Golldack D, 2002, J BIOL CHEM, V277, P5541, DOI 10.1074/jbc.M106197200; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; GRAHAM JS, 1991, PLANT PHYSIOL, V97, P786, DOI 10.1104/pp.97.2.786; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Kang S, 2010, PLANT PATHOLOGY J, V26, P402, DOI 10.5423/PPJ.2010.26.4.402; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Li DY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0536-z; Liu YQ, 2001, PLANT PHYSIOL, V127, P1788, DOI 10.1104/pp.010593; Lohaus G, 2001, PHYSIOL PLANTARUM, V111, P457, DOI 10.1034/j.1399-3054.2001.1110405.x; LOW MG, 1987, BIOCHEM J, V244, P1; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Maidment JM, 1999, J BIOL CHEM, V274, P34706, DOI 10.1074/jbc.274.49.34706; Mandal MK, 2010, PLANTA, V232, P899, DOI 10.1007/s00425-010-1221-y; Marino G, 2014, BIOCHEM J, V457, P335, DOI 10.1042/BJ20130196; Marino G, 2012, PHYSIOL PLANTARUM, V145, P196, DOI 10.1111/j.1399-3054.2011.01544.x; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; MCGEEHAN G, 1992, PLANT PHYSIOL, V99, P1179, DOI 10.1104/pp.99.3.1179; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Pak JH, 1997, FEBS LETT, V404, P283, DOI 10.1016/S0014-5793(97)00141-5; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pham GH, 2004, PLANT SURFACE MICROBIOLOGY, P593; Schiermeyer A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-83; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stein E, 2008, PLANT CELL PHYSIOL, V49, P1747, DOI 10.1093/pcp/pcn147; Svetek J, 1999, J BIOL CHEM, V274, P14724, DOI 10.1074/jbc.274.21.14724; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zimmermann D, 2016, PLANT PHYSIOL, V171, P1456, DOI 10.1104/pp.16.00513; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	42	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183577	10.1371/journal.pone.0183577	http://dx.doi.org/10.1371/journal.pone.0183577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832648	Green Published, gold, Green Submitted			2022-12-26	WOS:000408355800067
J	Chen, X; Cheng, HF; Zhou, JW; Chan, CY; Lau, KF; Tsui, SKW; Au, SWN				Chen, Xin; Cheng, Hiu-fu; Zhou, Junwei; Chan, Chiu-yeung; Lau, Kwok-fai; Tsui, Stephen Kwok-wing; Au, Shannon Wing-ngor			Structural basis of the PE-PPE protein interaction in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; protein complex; protein secretion; protein structure; tuberculosis	PE/PPE MULTIGENE FAMILY; VII SECRETION SYSTEM; VIRULENCE; COMPLEX; ESX-1; CLUSTERS; INSIGHTS; PHENIX; EXPORT; ESPB	Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, has developed multiple strategies to adapt to the human host. The five type VII secretion systems, ESX-1-5, direct the export of many virulence-promoting protein effectors across the complex mycobacterial cell wall. One class of ESX substrates is the PE-PPE family of proteins, which is unique to mycobacteria and essential for infection, antigenic variation, and host-pathogen interactions. The genome of Mtb encodes 168 PE-PPE proteins. Many of them are thought to be secreted through ESX-5 secretion system and to function in pairs. However, understanding of the specific pairing of PE-PPE proteins and their structure-function relationship is limited by the challenging purification of many PE-PPE proteins, and our knowledge of the PE-PPE interactions therefore has been restricted to the PE25-PPE41 pair and its complex with the ESX-5 secretion system chaperone EspG5. Here, we report the crystal structure of a new PE-PPE pair, PE8-PPE15, in complex with EspG5. Our structure revealed that the EspG5-binding sites on PPE15 are relatively conserved among Mtb PPE proteins, suggesting that EspG5-PPE15 represents a more typical model for EspG5-PPE interactions than EspG5-PPE41. A structural comparison with the PE25-PPE41 complex disclosed conformational changes in the four-helix bundle structure and a unique binding mode in the PE8-PPE15 pair. Moreover, homology-modeling and mutagenesis studies further delineated the molecular determinants of the specific PE-PPE interactions. These findings help develop an atomic algorithm of ESX-5 substrate recognition and PE-PPE pairing.	[Chen, Xin; Cheng, Hiu-fu; Zhou, Junwei; Lau, Kwok-fai; Au, Shannon Wing-ngor] Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Chan, Chiu-yeung] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Tsui, Stephen Kwok-wing] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Au, SWN (corresponding author), Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China.	shannon-au@cuhk.edu.hk	Tsui, Stephen Kwok-Wing/E-4385-2015	Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Lau, Kwok-Fai/0000-0002-0193-1152	University Grants Council of Hong Kong Special Administrative Region One-Off Special Equipment Grant [SEG UCHK08]	University Grants Council of Hong Kong Special Administrative Region One-Off Special Equipment Grant	We thank the University Grants Council of Hong Kong Special Administrative Region One-Off Special Equipment Grant SEG UCHK08 for the equipment used in this work. We also thank the staff of Beamline 13B1 at National Synchrotron Radiation Research Center in Taiwan.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2011, J IMMUNOL, V187, P4744, DOI 10.4049/jimmunol.1101457; Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bottai D, 2009, MOL MICROBIOL, V73, P325, DOI 10.1111/j.1365-2958.2009.06784.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Daleke MH, 2012, J BIOL CHEM, V287, P31939, DOI 10.1074/jbc.M112.397596; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Ejeta E., 2013, SCI TECHNOL ARTS RES, V2, P97, DOI DOI 10.4314/STAR.V2I2.98895; Ekiert DC, 2014, P NATL ACAD SCI USA, V111, P14758, DOI 10.1073/pnas.1409345111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Fu Li M, 2009, Int J Microbiol, V2009, P879621, DOI 10.1155/2009/879621; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Karboul A, 2008, J BACTERIOL, V190, P7838, DOI 10.1128/JB.00827-08; Kaufmann S. H, 2016, CAN WE IMPROVE EXIST; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kholod N, 2001, BIOTECHNIQUES, V31, P322, DOI 10.2144/01312st03; Khubaib M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00719; Kohli S, 2012, NUCLEIC ACIDS RES, V40, P7113, DOI 10.1093/nar/gks465; Korotkova N, 2015, J STRUCT BIOL, V191, P236, DOI 10.1016/j.jsb.2015.06.003; Korotkova N, 2014, MOL MICROBIOL, V94, P367, DOI 10.1111/mmi.12770; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shah S, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00049; Shah S, 2015, INFECT IMMUN, V83, P4349, DOI 10.1128/IAI.00827-15; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Solomonson M, 2015, STRUCTURE, V23, P571, DOI 10.1016/j.str.2015.01.002; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; WHO, 2016, GLOB TUB REP	44	24	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16880	16890		10.1074/jbc.M117.802645	http://dx.doi.org/10.1074/jbc.M117.802645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842489	Green Published, hybrid			2022-12-26	WOS:000413140600010
J	Takano, T; Motozono, C; Imai, T; Sonoda, KH; Nakanishi, Y; Yamasaki, S				Takano, Tomotsugu; Motozono, Chihiro; Imai, Takashi; Sonoda, Koh-Hei; Nakanishi, Yoichi; Yamasaki, Sho			Dectin-1 intracellular domain determines species-specific ligand spectrum by modulating receptor sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; lectin; polysaccharide; receptor; signal transduction; glucan	C-TYPE LECTIN; BETA-GLUCAN RECOGNITION; KAPPA-B-ALPHA; PATTERN-RECOGNITION; CANDIDA-ALBICANS; SITE; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; MINCLE	C-type lectin receptors (CLRs) comprise a large family of immunoreceptors that recognize polysaccharide ligands exposed on pathogen surfaces and are conserved among mammals. However, interspecies differences in their ligand spectrums are not fully understood. Dectin-1 is a well-characterized CLR that recognizes -glucan. We report here that seaweed-derived fucan activates cells expressing human Dectin-1 but not mouse Dectin-1. Low-valency -glucan components within fucan appeared to be responsible for this activation, as the ligand activity was eliminated by -glucanase treatment. The low-valency -glucan laminarin also acted as an agonist for human Dectin-1 but not for mouse Dectin-1, whereas the high-valency -glucan curdlan activated both human and mouse Dectin-1. Reciprocal mutagenesis analysis revealed that the ligand-binding domain of human Dectin-1 does not determine its unique sensitivity to low-valency -glucan. Rather, we found that its intracellular domain renders human Dectin-1 reactive to low-valency -glucan ligand. Substitution with two amino acids, Glu(2) and Pro(5), located in the human Dectin-1 intracellular domain was sufficient to confer sensitivity to low-valency -glucan in mouse Dectin-1. Conversely, the introduction of mouse-specific amino acids, Lys(2) and Ser(5), to human Dectin-1 reduced the reactivity to low-valency -glucan. Indeed, low-valency ligands induced a set of proinflammatory genes in human but not mouse dendritic cells. These results suggest that the intracellular domain, not ligand-binding domain, of Dectin-1 determines the species-specific ligand profile.	[Takano, Tomotsugu; Imai, Takashi; Yamasaki, Sho] Kyushu Univ, Grad Sch Med Sci, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 8128582, Japan; [Takano, Tomotsugu; Nakanishi, Yoichi] Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, Fukuoka 8128582, Japan; [Motozono, Chihiro; Sonoda, Koh-Hei] Kyushu Univ, Grad Sch Med Sci, Dept Ocular Pathol & Imaging Sci, Fukuoka 8128582, Japan; [Takano, Tomotsugu; Motozono, Chihiro; Imai, Takashi; Yamasaki, Sho] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 5650871, Japan; [Takano, Tomotsugu; Motozono, Chihiro; Imai, Takashi; Yamasaki, Sho] Osaka Univ, Dept Mol Immunol, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba 2608673, Japan	Kyushu University; Kyushu University; Kyushu University; Osaka University; Osaka University; Chiba University	Yamasaki, S (corresponding author), Kyushu Univ, Grad Sch Med Sci, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 8128582, Japan.; Motozono, C (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Ocular Pathol & Imaging Sci, Fukuoka 8128582, Japan.; Motozono, C; Yamasaki, S (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 5650871, Japan.; Motozono, C; Yamasaki, S (corresponding author), Osaka Univ, Dept Mol Immunol, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan.; Yamasaki, S (corresponding author), Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba 2608673, Japan.	motozono@biken.osaka-u.ac.jp; yamasaki@biken.osaka-u.ac.jp			Advanced Research and Development Programs for Medical Innovation (AMED-CREST) [26110009, 17K15730]; Research on Development of New Drugs Grants from Japan Agency for Medical Research and Development (AMED) [16ak0101010h0005, 17933742]; Takeda Science Foundation	Advanced Research and Development Programs for Medical Innovation (AMED-CREST); Research on Development of New Drugs Grants from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-Aid 26110009 for Scientific Research on Innovative Areas, Young Scientists (B) Grant 17K15730, Advanced Research and Development Programs for Medical Innovation (AMED-CREST), and Research on Development of New Drugs Grants (16ak0101010h0005 and 17933742) from the Japan Agency for Medical Research and Development (AMED), and Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi Y, 2004, INFECT IMMUN, V72, P4159, DOI 10.1128/IAI.72.7.4159-4171.2004; Arase H, 2004, REV MED VIROL, V14, P83, DOI 10.1002/rmv.422; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Hattori Y, 2014, J BIOL CHEM, V289, P15405, DOI 10.1074/jbc.M114.566489; Iborra S, 2015, IMMUNOBIOLOGY, V220, P175, DOI 10.1016/j.imbio.2014.09.013; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Kiyotake R, 2015, J BIOL CHEM, V290, P25322, DOI 10.1074/jbc.M115.645234; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Mori D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169562; Muller R, 2000, P NATL ACAD SCI USA, V97, P8451, DOI 10.1073/pnas.97.15.8451; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sahasrabudhe NM, 2016, MOL NUTR FOOD RES, V60, P458, DOI 10.1002/mnfr.201500582; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Shah S, 2017, J LEUKOCYTE BIOL, V101, P421, DOI 10.1189/jlb.2AB0516-228R; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xiao Y, 2016, NAT MED, V22, P906, DOI 10.1038/nm.4141; Yokota K, 2001, GENE, V272, P51, DOI 10.1016/S0378-1119(01)00528-5; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005	31	15	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16933	16941		10.1074/jbc.M117.800847	http://dx.doi.org/10.1074/jbc.M117.800847			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28848046	Green Published, hybrid			2022-12-26	WOS:000413140600014
J	Navaratnarajah, P; Gershenson, A; Ross, EM				Navaratnarajah, Punya; Gershenson, Anne; Ross, Elliott M.			The binding of activated G alpha(q) to phospholipase C-beta exhibits anomalous affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; MUSCARINIC RECEPTOR; ALPHA-SUBUNIT; RHO GTPASES; PROTEIN; G(Q); DOMAIN; MEMBRANE; C-BETA-1; SITE	Upon activation by the G(q) family of G alpha subunits, G beta gamma subunits, and some Rho family GTPases, phospholipase C-beta (PLC-beta) isoforms hydrolyze phosphatidylinositol 4,5-bisphosphate to the second messengers inositol 1,4,5-trisphosphate and diacylglycerol. PLC-beta isoforms also function as GTPase-activating proteins, potentiating G(q) deactivation. To elucidate the mechanism of this mutual regulation, we measured the thermodynamics and kinetics of PLC-beta 3 binding to G alpha(q). FRET and fluorescence correlation spectroscopy, two physically distinct methods, both yielded K-d values of about 200 nM for PLC-beta 3-G alpha(q) binding. This K-d is 50-100 times greater than the EC50 for G alpha(q)-mediated PLC-beta 3 activation and for the G alpha(q) GTPase-activating protein activity of PLC-beta. The measured K-d was not altered either by the presence of phospholipid vesicles, phosphatidylinositol 4,5-bisphosphate and Ca2+, or by the identity of the fluorescent labels. FRET-based kinetic measurements were also consistent with a K-d of 200 nM. We determined that PLC-beta 3 hysteresis, whereby PLC-beta 3 remains active for some time following either G alpha(q)-PLC-beta 3 dissociation or PLC-beta 3-potentiated G alpha(q) deactivation, is not sufficient to explain the observed discrepancy between EC50 and K-d. These results indicate that the mechanism by which G alpha(q) and PLC-beta 3 mutually regulate each other is far more complex than a simple, two-state allosteric model and instead is probably kinetically determined.	[Navaratnarajah, Punya; Ross, Elliott M.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Navaratnarajah, Punya; Ross, Elliott M.] Univ Texas Southwestern Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Gershenson, Anne] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Massachusetts System; University of Massachusetts Amherst	Ross, EM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Elliott.Ross@UTSouthwestern.edu		Ross, Elliott M./0000-0002-0252-8197; Gershenson, Anne/0000-0003-3124-9610	National Institutes of Health [R01GM030355, R21DC015744, R01GM060418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030355, R01GM060418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC015744] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01GM030355 and R21DC015744 (to E. M. R.) and R01GM060418 (to A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASSEL D, 1977, J CYCLIC NUCL PROT, V3, P393; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Charpentier TH, 2014, J BIOL CHEM, V289, P29545, DOI 10.1074/jbc.M114.586784; Cheng JJ, 2013, BIOPHYS J, V104, P185, DOI 10.1016/j.bpj.2012.11.015; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; Chidiac P., 1999, J BIOL; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; Gendron PO, 2008, J FLUORESC, V18, P1093, DOI 10.1007/s10895-008-0357-7; Harden TK, 2011, CHEM REV, V111, P6120, DOI 10.1021/cr200209p; Hepler JR, 1996, J BIOL CHEM, V271, P496, DOI 10.1074/jbc.271.1.496; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Ilkaeva O, 2002, J BIOL CHEM, V277, P4294, DOI 10.1074/jbc.M109612200; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kadamur G, 2016, J BIOL CHEM, V291, P11394, DOI 10.1074/jbc.M116.723940; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kozasa T., 1995, J BIOL CHEM; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; LEE CW, 1994, J BIOL CHEM, V269, P25335; Lyon AM, 2014, STRUCTURE, V22, P1844, DOI 10.1016/j.str.2014.10.008; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Lyon AM, 2011, NAT STRUCT MOL BIOL, V18, P999, DOI 10.1038/nsmb.2095; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Padrick SB, 2011, METHODS, V54, P39, DOI 10.1016/j.ymeth.2011.01.002; Paulssen RH, 1996, J BIOL CHEM, V271, P26622, DOI 10.1074/jbc.271.43.26622; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Segel IH., 1975, ENZYME KINETICS, P227; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Turcotte M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000148; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Widengren J., 1996, Bioimaging, V4, P149, DOI 10.1002/1361-6374(199609)4:3<149::AID-BIO5>3.3.CO;2-4	48	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16788	16801		10.1074/jbc.M117.809673	http://dx.doi.org/10.1074/jbc.M117.809673			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842497	Green Published, hybrid			2022-12-26	WOS:000412414800036
J	Woo, S; Yang, SH; Chen, HJ; Tseng, YF; Hwang, SJ; De Palmas, S; Denis, V; Imahara, Y; Iwase, F; Yum, S; Tang, SL				Woo, Seonock; Yang, Shan-Hua; Chen, Hsing-Ju; Tseng, Yu-Fang; Hwang, Sung-Jin; De Palmas, Stephane; Denis, Vianney; Imahara, Yukimitsu; Iwase, Fumihito; Yum, Seungshic; Tang, Sen-Lin			Geographical variations in bacterial communities associated with soft coral Scleronephthya gracillimum	PLOS ONE			English	Article							LOPHELIA-PERTUSA; SOUTHERN TAIWAN; SEA; DIVERSITY; OCTOCORALLIA; MICROBIOMES; SPECIFICITY; ALCYONACEA; GRADIENTS; DYNAMICS	Environmental impacts can alter relationships between a coral and its symbiotic microbial community. Furthermore, changes in the microbial community associated with increased seawater temperatures can cause opportunistic infections, coral disease and death. Interactions between soft corals and their associated microbes are not well understood. The species Scleronephthya gracillimum is distributed in tropical to temperate zones in coral assemblages along the Kuroshio Current region. In this study we collected S. gracillimum from various sites at different latitudes, and compared composition of their bacterial communities using Next Generation Sequencing. Coral samples from six geographically distinct areas (two sites each in Taiwan, Japan, and Korea) had considerable variation in their associated bacterial communities and diversity. Endozoicimonaceae was the dominant group in corals from Korea and Japan, whereas Mycoplasma was dominant in corals from Taiwan corals. Interestingly, the latter corals had lower relative abundance of Endozoicimonaceae, but greater diversity. These biogeographic differences in bacterial composition may have been due to varying environmental conditions among study locations, or because of host responses to prevailing environmental conditions. This study provided a baseline for future studies of soft coral microbiomes, and assessment of functions of host metabolites and soft coral holobionts.	[Woo, Seonock; Yum, Seungshic] Korea Inst Ocean Sci & Technol, Geoje, South Korea; [Woo, Seonock; Yum, Seungshic] Univ Sci & Technol, Fac Marine Environm Sci, Geoje, South Korea; [Yang, Shan-Hua; Chen, Hsing-Ju; Tseng, Yu-Fang; Tang, Sen-Lin] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Hwang, Sung-Jin] Woosuk Univ, Dept Ecobiol Sci, Jincheon, South Korea; [De Palmas, Stephane] Acad Sinica, Biodivers Program, Taiwan Int Grad Program, Taipei, Taiwan; [De Palmas, Stephane] Natl Taiwan Normal Univ, Taipei, Taiwan; [De Palmas, Stephane] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Denis, Vianney] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan; [Imahara, Yukimitsu] Biol Inst Kuroshio, Wakayama Lab, Wakayama, Wakayama, Japan; [Iwase, Fumihito] Shikoku Marine Life Lab, Otsuki Town, Kochi, Japan	Korea Institute of Ocean Science & Technology (KIOST); Academia Sinica - Taiwan; Woosuk University; Academia Sinica - Taiwan; National Taiwan Normal University; National Taiwan Normal University; National Taiwan University	Tang, SL (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.	sltang@gate.sinica.edu.tw	, de PALMAS Stéphane/AAS-8982-2021; Denis, Vianney/E-6868-2013	, de PALMAS Stéphane/0000-0002-2567-1789; Denis, Vianney/0000-0002-0914-5586	Korean Institute of Ocean Science and Technology [PE99541, NRF-2017R1A2B201254]; Korean Coral Resources Bank (KCRB) - Ministry of Land, Transport and Maritime Affairs, Korea and Biodiversity Research Center, Academia Sinica; Seto Marine Biological Laboratory, Kyoto University, and Biological Institute on Kuroshio; Ministry Of Science and Technology (Taiwan) [104-2611-M-002 -020 -MY2]	Korean Institute of Ocean Science and Technology; Korean Coral Resources Bank (KCRB) - Ministry of Land, Transport and Maritime Affairs, Korea and Biodiversity Research Center, Academia Sinica; Seto Marine Biological Laboratory, Kyoto University, and Biological Institute on Kuroshio; Ministry Of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by Korean Institute of Ocean Science and Technology (PE99541, NRF-2017R1A2B201254), Korean Coral Resources Bank (KCRB) funded by the Ministry of Land, Transport and Maritime Affairs, Korea and Biodiversity Research Center, Academia Sinica, and the Seto Marine Biological Laboratory, Kyoto University, and Biological Institute on Kuroshio. VD is supported by a grant from the Ministry Of Science and Technology (Taiwan, no. 104-2611-M-002 -020 -MY2).	Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; Anzai Y, 1997, INT J SYST BACTERIOL, V47, P249, DOI 10.1099/00207713-47-2-249; Apprill A, 2012, APPL ENVIRON MICROB, V78, P7467, DOI 10.1128/AEM.01232-12; Bayer T, 2013, MAR ECOL PROG SER, V479, P75, DOI 10.3354/meps10197; Belkin IM, 2009, J MARINE SYST, V78, P317, DOI 10.1016/j.jmarsys.2008.10.016; Benayahu Y, 2004, ZOOL STUD, V43, P548; Bivand R., 2016, MAPTOOLS TOOLS READI; Bourne DG, 2016, ANNU REV MICROBIOL, V70, P317, DOI 10.1146/annurev-micro-102215-095440; Bourne DG, 2013, ISME J, V7, P1452, DOI 10.1038/ismej.2012.172; Buddemeir RW, 2004, CORAL REEFS GLOBAL C; Chen CP, 2011, ISME J, V5, P728, DOI 10.1038/ismej.2010.151; Chu T. Y., 1974, ACTA OCEANOGR TAIWAN, V4, P1; Clarke K.R., 2006, PRIMER V6 USER MANUA; Correa H, 2013, MICROB ECOL, V66, P972, DOI 10.1007/s00248-013-0267-3; Ding JY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00251; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Friedman CS, 2000, INT J SYST EVOL MICR, V50, P847, DOI 10.1099/00207713-50-2-847; Fujiwara Shuichi, 2000, P131; Gray MA, 2011, FEMS MICROBIOL ECOL, V76, P109, DOI 10.1111/j.1574-6941.2010.01033.x; Guppy R, 2006, MAR ECOL PROG SER, V328, P133, DOI 10.3354/meps328133; Hong MJ, 2009, APPL ENVIRON MICROB, V75, P7797, DOI 10.1128/AEM.01418-09; Hsin YC, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004485; Hu J, 2000, J OCEANOGR, V56, P607, DOI DOI 10.1023/A:1011117531252; Hwang Sung Jin, 2009, Galaxea - Tokyo, V11, P155; Hwang Sung-Jin, 2013, Animal Systematics Evolution and Diversity, V29, P160, DOI 10.5635/ASED.2013.29.2.160; Imahara Y, 2014, OCTOCORALS SAGAMI BA, P15; Kellogg CA, 2009, APPL ENVIRON MICROB, V75, P2294, DOI 10.1128/AEM.02357-08; Kelly LW, 2014, P NATL ACAD SCI USA, V111, P10227, DOI 10.1073/pnas.1403319111; Kim KR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021211; Kim Min-Sun, 2014, Animal Systematics Evolution and Diversity, V30, DOI 10.5635/ASED.2014.30.2.095; Klaus JS, 2007, ENVIRON MICROBIOL, V9, P1291, DOI 10.1111/j.1462-2920.2007.01249.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; La Riviere M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057385; Larsen B, 2010, INFECT DIS OBSTET GY, V2010, P1, DOI DOI 10.1155/2010/521921; Lawler SN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00458; Lee HJ, 1999, ESTUAR COAST SHELF S, V49, P775, DOI 10.1006/ecss.1999.0524; Lee OO, 2012, APPL ENVIRON MICROB, V78, P7173, DOI 10.1128/AEM.01111-12; Liu PJ, 2012, MAR POLLUT BULL, V64, P1129, DOI 10.1016/j.marpolbul.2012.03.031; Lu HJ, 2014, FISH RES, V155, P103, DOI 10.1016/j.fishres.2014.02.032; McCauley EP, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw147; McCulloch MT, 2000, CHEM GEOL, V169, P107, DOI 10.1016/S0009-2541(00)00260-6; Mendoza M, 2013, DIS AQUAT ORGAN, V106, P31, DOI 10.3354/dao02636; NAMIAS J, 1970, J GEOPHYS RES, V75, P565, DOI 10.1029/JC075i003p00565; Neave MJ, 2017, ISME J, V11, P186, DOI 10.1038/ismej.2016.95; Neave MJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00802-14; Neulinger SC, 2009, APPL ENVIRON MICROB, V75, P1437, DOI 10.1128/AEM.01781-08; Pantos O, 2015, ISME J, V9, P1916, DOI 10.1038/ismej.2015.3; Park WS, 2000, PROG OCEANOGR, V47, P191, DOI 10.1016/S0079-6611(00)00036-7; Penn K, 2006, APPL ENVIRON MICROB, V72, P1680, DOI 10.1128/AEM.72.2.1680-1683.2006; Pitcher DG, 2005, VET J, V170, P300, DOI 10.1016/j.tvjl.2004.08.011; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; R Core Team, 2013, R LANG ENV STAT COMP; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rohwer F, 2004, CORAL HEALTH AND DISEASE, P265; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SEO YW, 1995, TETRAHEDRON, V51, P2497, DOI 10.1016/0040-4020(95)00014-Y; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; 강도형, 2005, Ocean and Polar Research, V27, P25; Suh SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131633; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Vezzulli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067745; Williams AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144902; Wu CR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033942; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Yang S, 2013, MAR BIOTECHNOL, V15, P540, DOI 10.1007/s10126-013-9503-6; Yang SH, 2016, LIMNOL OCEANOGR, V61, P1078, DOI 10.1002/lno.10277; Yasin Z, 2011, GEOPH INF TEACH WORK	69	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183663	10.1371/journal.pone.0183663	http://dx.doi.org/10.1371/journal.pone.0183663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859111	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500029
J	Sanosyan, A; de Maudave, AF; Bollore, K; Zimmermann, V; Foulongne, V; Van de Perre, P; Tuaillon, E				Sanosyan, Armen; de Maudave, Alexis Fayd'herbe; Bollore, Karine; Zimmermann, Valerie; Foulongne, Vincent; Van de Perre, Philippe; Tuaillon, Edouard			The impact of targeting repetitive BamHI-W sequences on the sensitivity and precision of EBV DNA quantification	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; STEM-CELL TRANSPLANTATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PREEMPTIVE RITUXIMAB; INFECTIOUS-MONONUCLEOSIS; INTERNATIONAL STANDARD; WHOLE-BLOOD; PCR; LOAD; DIAGNOSIS	Background Viral load monitoring and early Epstein-Barr virus (EBV) DNA detection are essential in routine laboratory testing, especially in preemptive management of Post-transplant Lymphoproliferative Disorder. Targeting the repetitive BamHI-W sequence was shown to increase the sensitivity of EBV DNA quantification, but the variability of BamHI-W reiterations was suggested to be a source of quantification bias. We aimed to assess the extent of variability associated with BamHI-W PCR and its impact on the sensitivity of EBV DNA quantification using the 1st WHO international standard, EBV strains and clinical samples. Methods Repetitive BamHI-W- and LMP2 single-sequences were amplified by in-house qPCRs and BXLF-1 sequence by a commercial assay (EBV R-gene T, BioMerieux). Linearity and limits of detection of in-house methods were assessed. The impact of repeated versus single target sequences on EBV DNA quantification precision was tested on B95.8 and Raji cell lines, possessing 11 and 7 copies of the BamHI-W sequence, respectively, and on clinical samples. Results BamHI-W qPCR demonstrated a lower limit of detection compared to LMP2 qPCR (2.33 log(10) versus 3.08 log(10) IU/mL; P = 0.0002). BamHI-W qPCR underestimated the EBV DNA load on Raji strain which contained fewer BamHI-W copies than the WHO standard derived from the B95.8 EBV strain (mean bias: - 0.21 log(10); 95% CI, -0.54 to 0.12). Comparison of BamHI-W qPCR versus LMP2 and BXLF-1 qPCR showed an acceptable variability between EBV DNA levels in clinical samples with the mean bias being within 0.5 log10 IU/mL EBV DNA, whereas a better quantitative concordance was observed between LMP2 and BXLF-1 assays. Conclusions Targeting BamHI-W resulted to a higher sensitivity compared to LMP2 but the variable reiterations of BamHI-W segment are associated with higher quantification variability. BamHI-Wcan be considered for clinical and therapeutic monitoring to detect an early EBV DNA and a dynamic change in viral load.	[Sanosyan, Armen; Foulongne, Vincent; Van de Perre, Philippe; Tuaillon, Edouard] CHU Montpellier, Montpellier, France; [Sanosyan, Armen; de Maudave, Alexis Fayd'herbe; Bollore, Karine; Foulongne, Vincent; Van de Perre, Philippe; Tuaillon, Edouard] Univ Montpellier, Pathogenesis & Control Chron Infect, INSERM, EFS, Montpellier, France; [Zimmermann, Valerie] Univ Montpellier, Inst Genet Mol Montpellier, CNRS, UMR 5535, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Sanosyan, A (corresponding author), CHU Montpellier, Montpellier, France.; Sanosyan, A (corresponding author), Univ Montpellier, Pathogenesis & Control Chron Infect, INSERM, EFS, Montpellier, France.	armen.sanosyan@yahoo.com	Van de Perre, Philippe/B-9692-2008	Van de Perre, Philippe/0000-0002-3912-0427; Fayd'herbe de Maudave, Alexis/0000-0002-0903-1108; Tuaillon, Edouard/0000-0001-5866-9530	Erasmus Mundus for A. Sanosyan's PhD scholarship	Erasmus Mundus for A. Sanosyan's PhD scholarship	This work was supported by Erasmus Mundus for A. Sanosyans PhD scholarship.	Abeynayake J, 2014, J CLIN MICROBIOL, V52, P3802, DOI 10.1128/JCM.01676-14; ALLAN GJ, 1989, VIROLOGY, V173, P489, DOI 10.1016/0042-6822(89)90561-8; Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Edvinsson B, 2006, CLIN MICROBIOL INFEC, V12, P131, DOI 10.1111/j.1469-0691.2005.01332.x; Fafi-Kremer S, 2008, J MOL DIAGN, V10, P78, DOI 10.2353/jmoldx.2008.070054; Fryer JF, 2016, BIOL J INT ASS BIOL; Gartner B, 2010, J CLIN VIROL, V48, P82, DOI 10.1016/j.jcv.2010.03.016; Gulley ML, 2010, CLIN MICROBIOL REV, V23, P350, DOI 10.1128/CMR.00006-09; Hadinoto V, 2008, BLOOD, V111, P1420, DOI 10.1182/blood-2007-06-093278; Hofmann N, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001788; Ishii H, 2007, J MED VIROL, V79, P562, DOI 10.1002/jmv.20853; JONES MD, 1983, NUCLEIC ACIDS RES, V11, P3919, DOI 10.1093/nar/11.12.3919; Kamdar KY, 2011, CURR OPIN ORGAN TRAN, V16, P274, DOI 10.1097/MOT.0b013e3283465715; Kanakry JA, 2016, BLOOD, V127, P2007, DOI 10.1182/blood-2015-09-672030; Kieff E, 2001, FIELDS VIROLOGY; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Le Q-T, 2005, AM ASS CANC RES, V11, P5700; Mukohyama J, 2016, ONCOTARGET; Patriarca F, 2013, TRANSPL INFECT DIS, V15, P259, DOI 10.1111/tid.12061; Peng RS, 2005, J VIROL, V79, P4492, DOI 10.1128/JVI.79.7.4492-4505.2005; Ryan JL, 2004, J MOL DIAGN, V6, P378, DOI 10.1016/S1525-1578(10)60535-1; Ryan JL, 2009, LAB INVEST, V89, P80, DOI 10.1038/labinvest.2008.103; Semenova T, 2016, J CLIN MICROBIOL, V54, P1746, DOI 10.1128/JCM.03336-15; Styczynski J, 2016, HAEMATOLOGICA, V101, P803, DOI 10.3324/haematol.2016.144428; SZEKELY L, 1993, P NATL ACAD SCI USA, V90, P5455, DOI 10.1073/pnas.90.12.5455; Tierney RJ, 2011, J VIROL, V85, P12362, DOI 10.1128/JVI.06059-11; Tsai DE, 2008, AM J TRANSPLANT, V8, P1016, DOI 10.1111/j.1600-6143.2008.02183.x; van der Velden WJFM, 2013, BONE MARROW TRANSPL, V48, P1465, DOI 10.1038/bmt.2013.84; Vouloumanou EK, 2012, CURR OPIN HEMATOL, V19, P14, DOI 10.1097/MOH.0b013e32834daa08; World Health Organization, INT REF MAT; Worth A, 2011, BRIT J HAEMATOL, V155, P377, DOI 10.1111/j.1365-2141.2011.08855.x	31	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183856	10.1371/journal.pone.0183856	http://dx.doi.org/10.1371/journal.pone.0183856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850597	Green Submitted, gold, Green Published			2022-12-26	WOS:000408544200034
J	Steca, P; Monzani, D; Greco, A; Franzelli, C; Magrin, ME; Miglioretti, M; Sarini, M; Scrignaro, M; Vecchio, L; Fattirolli, F; D'Addario, M				Steca, Patrizia; Monzani, Dario; Greco, Andrea; Franzelli, Cristina; Magrin, Maria Elena; Miglioretti, Massimo; Sarini, Marcello; Scrignaro, Marta; Vecchio, Luca; Fattirolli, Francesco; D'Addario, Marco			Stability and change of lifestyle profiles in cardiovascular patients after their first acute coronary event	PLOS ONE			English	Article							CARDIAC REHABILITATION; MYOCARDIAL-INFARCTION; RISK-FACTORS; SECONDARY PREVENTION; PHYSICAL-ACTIVITY; DEPRESSION SCALE; HOSPITAL ANXIETY; PATIENTS BELIEFS; HEART-DISEASE; ASSOCIATION	Background Acute coronary syndrome (ACS) is a major cause of morbidity and mortality. Lifestyle and health behavior changes play an important role in the primary and secondary prevention of ACS recurrence. Changes in unhealthy lifestyles after an acute coronary event have been analyzed by considering separate behaviors individually, even though research on the healthy population has demonstrated that unhealthy behaviors tend to co-occur. Purpose The aim of this study was to identify lifestyle profiles of ACS patients and to explore their pathways of change for one year after their first coronary event by adopting a typological approach. Methods Two hundred and twenty-three patients (84% male; mean age = 57.14) completed self-report measures of health-related behaviors at the beginning of cardiac rehabilitation, and six months and twelve months after. At each wave depression, anxiety and heart rate were also evaluated. Cluster analysis was performed to identify lifestyle profiles and to analyze their change over time. Differences in psychological factors and heart rate among clusters were assessed. Results Patients' diet, physical activity, and smoking behavior greatly improved six months after their first coronary event. No further improvements were detected after one year. At each wave specific lifestyle profiles were identified, ranging from more maladaptive to healthier clusters. Patients with multiple unhealthy behaviors experience greater difficulties in maintaining a healthier lifestyle over time. Moreover, the results demonstrated the association between lifestyle profiles at twelve months after the acute coronary event and depression measured six months earlier. Finally, the most maladaptive lifestyle profile had many members with elevated heart rate at twelve months after the cardiac rehabilitation. Conclusions Current findings may have a strong practical impact in the development and implementation of personalized secondary prevention programs targeting lifestyles of ACS patients.	[Steca, Patrizia; Monzani, Dario; Greco, Andrea; Magrin, Maria Elena; Miglioretti, Massimo; Sarini, Marcello; Scrignaro, Marta; Vecchio, Luca; D'Addario, Marco] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Franzelli, Cristina] Ist Clin Perfezionamento Hosp, Cardiac Rehabil Ctr, Milan, Italy; [Fattirolli, Francesco] Univ Florence, Dept Med & Surg Crit Care, Cardiac Rehabil Unit, Florence, Italy; [Fattirolli, Francesco] Azienda Osped Univ Careggi, Florence, Italy	University of Milano-Bicocca; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Monzani, D (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	dario.monzani@unimib.it	Vecchio, Luca/C-1670-2013; Greco, Andrea/I-7266-2016; Monzani, Dario/AAR-2609-2021; D'Addario, Marco/AAY-6426-2021; Monzani, Dario/AAP-4501-2020	Vecchio, Luca/0000-0001-6784-2817; Greco, Andrea/0000-0002-8086-2801; D'ADDARIO, MARCO/0000-0002-7659-885X	Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca" [RBFR08YVUL]	Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca"	This work was supported by the Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca" [grant number RBFR08YVUL]; Principal Investigator: PS, http://futuroinricerca.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abood D, 1994, HEALTH VALUES, V18, P51; Beckie TM, 2010, J CARDIOPULM REHABIL, V30, P147, DOI 10.1097/HCR.0b013e3181d0c2ce; Bergman L., 2002, SLEIPNER A STATISTIC; Bergman L. R., 2003, STUDYING INDIVIDUAL; Bergman LR, 2012, INT J BEHAV DEV, V36, P237, DOI 10.1177/0165025412440947; Berlin I, 2006, ADDICTION, V101, P1814, DOI 10.1111/j.1360-0443.2006.01616.x; Burke V, 1997, PREV MED, V26, P724, DOI 10.1006/pmed.1997.0198; Cooper AF, 2007, HEART, V93, P53, DOI 10.1136/hrt.2005.081299; Cooper AF, 2005, CLIN REHABIL, V19, P87, DOI 10.1191/0269215505cr818oa; Costantini M, 1999, SUPPORT CARE CANCER, V7, P121, DOI 10.1007/s005200050241; Cuenca-Garcia M, 2013, J NUTR EDUC BEHAV, V45, P549, DOI 10.1016/j.jneb.2013.02.006; de Vries H, 2008, PREV MED, V46, P203, DOI 10.1016/j.ypmed.2007.08.005; Doyle B, 2012, J CLIN NURS, V21, P32, DOI 10.1111/j.1365-2702.2010.03636.x; Facila L, 2012, WORLD J CARDIOL, V4, P15, DOI 10.4330/wjc.v4.i1.15; Farley Robyn L, 2003, Eur J Cardiovasc Nurs, V2, P205; Fine LJ, 2004, AM J PREV MED, V27, P18, DOI 10.1016/j.amepre.2004.04.017; Garcia-Lopez M, 2014, EUR J PREV CARDIOL, V21, P521, DOI 10.1177/2047487312467871; GLASSMAN AH, 1990, JAMA-J AM MED ASSOC, V264, P1546, DOI 10.1001/jama.264.12.1546; Grace SL, 2002, GEN HOSP PSYCHIAT, V24, P127, DOI 10.1016/S0163-8343(02)00179-2; Hayes SN, 2009, WOMENS HEALTH, V5, P709, DOI 10.2217/WHE.09.56; Hu MX, 2016, PREV MED, V94, P12; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Lampropoulos K, 2016, KARDIOL POL, V74, P1154, DOI 10.5603/KP.a2016.0059; Mahoney JL, 2001, INT J BEHAV DEV, V25, P509, DOI 10.1080/01650250042000456; Mayou RA, 2000, PSYCHOSOM MED, V62, P212, DOI 10.1097/00006842-200003000-00011; Morris LJ, 2016, PREV MED, V84, P1, DOI 10.1016/j.ypmed.2015.12.009; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Niaura R, 2001, PSYCHOL ADDICT BEHAV, V15, P13, DOI 10.1037/0893-164X.15.1.13; Palaniappan U, 2001, J NUTR, V131, P1952, DOI 10.1093/jn/131.7.1952; Panagiotakos DB, 2015, MATURITAS, V80, P205, DOI 10.1016/j.maturitas.2014.11.011; Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P1, DOI 10.1097/HJR.0b013e3283313592; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Prochaska JJ, 2011, AM J LIFESTYLE MED, V5, P208, DOI 10.1177/1559827610391883; Schlecht NF, 1999, AM J EPIDEMIOL, V150, P1129, DOI 10.1093/oxfordjournals.aje.a009938; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; SIMOES EJ, 1995, AM J PUBLIC HEALTH, V85, P240, DOI 10.2105/AJPH.85.2.240; Slattery ML, 2002, MED SCI SPORT EXER, V34, P913, DOI 10.1097/00005768-200206000-00002; Sofi F, 2011, ACTA CARDIOL, V66, P791, DOI 10.1080/AC.66.6.2136965; Steca P, 2015, APPL PSYCHOL HEALTH; Topolski T. D., 2006, CTR DIS CONTROL PREV, V3, P1; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Vervueren PL, 2012, ARCH CARDIOVASC DIS, V105, P478, DOI 10.1016/j.acvd.2012.05.008; Vickers KS, 2006, AM J HEALTH BEHAV, V30, P353, DOI 10.5993/AJHB.30.4.2; WHO, 2011, GLOBAL STATUS REPORT; WOODWARD M, 1994, PREV MED, V23, P354, DOI 10.1006/pmed.1994.1049; Yehle KS, 2012, J CARDIOPULM REHABIL, V32, P203, DOI 10.1097/HCR.0b013e31825b4e6a; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann-Viehoff F, 2010, EUR J CARDIOV PREV R, V17, P509, DOI 10.1097/HJR.0b013e328337b57b	49	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183905	10.1371/journal.pone.0183905	http://dx.doi.org/10.1371/journal.pone.0183905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE9SU	28850579	Green Published, gold, Green Submitted			2022-12-26	WOS:000408544200040
J	Belongie, KJ; Ferrannini, E; Johnson, K; Andrade-Gordon, P; Hansen, MK; Petrie, JR				Belongie, Kirstine J.; Ferrannini, Ele; Johnson, Kjell; Andrade-Gordon, Patricia; Hansen, Michael K.; Petrie, John R.			Identification of novel biomarkers to monitor beta-cell function and enable early detection of type 2 diabetes risk	PLOS ONE			English	Article							FACTOR-ALPHA RECEPTOR-2; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; MESENCHYMAL TRANSITION; MESSENGER-RNA; SENSITIVITY; EXPRESSION; PROX1; DIFFERENTIATION	A decline in beta-cell function is a prerequisite for the development of type 2 diabetes, yet the level of beta-cell function in individuals at risk of the condition is rarely measured. This is due, in part, to the fact that current methods for assessing beta-cell function are inaccurate, prone to error, labor-intensive, or affected by glucose-lowering therapy. The aim of the current study was to identify novel circulating biomarkers to monitor beta-cell function and to identify individuals at high risk of developing beta-cell dysfunction. In a nested case-control study from the Relationship between Insulin Sensitivity and Cardiovascular disease (RISC) cohort (n = 1157), proteomics and miRNA profiling were performed on fasting plasma samples from 43 individuals who progressed to impaired glucose tolerance (IGT) and 43 controls who maintained normal glucose tolerance (NGT) over three years. Groups were matched at baseline for age, gender, body mass index (BMI), insulin sensitivity (euglycemic clamp) and beta-cell glucose sensitivity (mathematical modeling). Proteomic profiling was performed using the SomaLogic platform (Colorado, USA); miRNA expression was performed using a modified RT-PCR protocol (Regulus Therapeutics, California, USA). Results showed differentially expressed proteins and miRNAs including some with known links to type 2 diabetes, such as adiponectin, but also novel biomarkers and pathways. In cross sectional analysis at year 3, the top differentially expressed biomarkers in people with IGT/reduced beta-cell glucose sensitivity were adiponectin, alpha1-antitrypsin (known to regulate adiponectin levels), endocan, miR-181a, miR-342, and miR-323. At baseline, adiponectin, cathepsin D and NCAM.L1 (proteins expressed by pancreatic beta-cells) were significantly lower in those that progressed to IGT. Many of the novel prognostic biomarker candidates were within the epithelial-mesenchymal transition (EMT) pathway: for example, Noggin, DLL4 and miR-181a. Further validation studies are required in additional clinical cohorts and in patients with type 2 diabetes, but these results identify novel pathways and biomarkers that may have utility in monitoring beta-cell function and/or predicting future decline, allowing more targeted efforts to prevent and intercept type 2 diabetes.	[Belongie, Kirstine J.; Andrade-Gordon, Patricia; Hansen, Michael K.] Janssen Res & Dev, Cardiovasc & Metab Dis Res, Spring House, PA USA; [Ferrannini, Ele] CNR, Inst Clin Physiol, Pisa, Italy; [Johnson, Kjell] Arbor Analyt, Ann Arbor, MI USA; [Petrie, John R.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	Johnson & Johnson; Janssen Pharmaceuticals; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Glasgow	Petrie, JR (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	john.petrie@glasgow.ac.uk		Petrie, John/0000-0002-4894-9819	Janssen Pharmaceuticals; EU [QLG1-CT-2001-01252]; AstraZeneca (Sweden); Novo Nordisk (Europe); Janssen Research Development; Arbor Analytics	Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); EU(European Commission); AstraZeneca (Sweden)(AstraZeneca); Novo Nordisk (Europe); Janssen Research Development; Arbor Analytics	This work was funded by an unrestricted grant from Janssen Pharmaceuticals. The Relationship between Insulin Sensitivity and Cardiovascular disease (RISC) study was partly supported by EU Framework V Program Grant QLG1-CT-2001-01252 with additional funding from AstraZeneca (Sweden). RISC is run by the European Group for the study of Insulin Resistance (EGIR) which at the time of this manuscript submission was supported by Novo Nordisk (Europe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Janssen Research & Development (KJB, PAG, MKH) and Arbor Analytics (KJ) provided support in the form of salaries for authors (as per initials) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of each author is articulated in the 'author contributions' section.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Baldi S, 2013, DIABETES CARE, V36, P4125, DOI 10.2337/dc13-0682; Balta S, 2015, ATHEROSCLEROSIS, V243, P339, DOI 10.1016/j.atherosclerosis.2015.09.030; Caperuto LC, 2008, ENDOCRINOLOGY, V149, P6326, DOI 10.1210/en.2008-0655; Carter S, 2014, ATHEROSCLEROSIS, V237, P645, DOI 10.1016/j.atherosclerosis.2014.09.022; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Cinti F, 2016, J CLIN ENDOCR METAB, V101, P1044, DOI 10.1210/jc.2015-2860; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Costa A, 2003, METABOLISM, V52, P1068, DOI 10.1016/S0026-0495(03)00108-2; Curran AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161350; Efrat S, 2016, DIABETES OBES METAB, V18, P97, DOI 10.1111/dom.12724; Ferrannini E, 2007, DIABETOLOGIA, V50, P2342, DOI 10.1007/s00125-007-0806-x; Ferrannini E, 2011, DIABETOLOGIA, V54, P1507, DOI 10.1007/s00125-011-2112-x; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Green A, 2004, IMPLICATIONS LONG TE, P74; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta A, 2005, J PEDIATR ENDOCR MET, V18, P75; Hamet P, 2016, J HYPERTENS, V34, pE58, DOI 10.1097/01.hjh.0000500001.33810.04; Herder C, 2016, EUR J ENDOCRINOL, V175, P367, DOI 10.1530/EJE-16-0528; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Hills SA, 2004, DIABETOLOGIA, V47, P566, DOI 10.1007/s00125-004-1335-5; Janke J, 2006, HORM METAB RES, V38, P28, DOI 10.1055/s-2006-924973; Jiang YN, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000194; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Klein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055064; Kothari AN, 2014, CLIN TRANSLATIONAL M, V3, P1, DOI DOI 10.1186/2001-1326-3-1; Kraus M, 2015, MOL CELL ENDOCRINOL, V414, P177, DOI 10.1016/j.mce.2015.07.026; Krause C, 2011, INT J BIOCHEM CELL B, V43, P478, DOI 10.1016/j.biocel.2011.01.007; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Latreille M, 2015, J MOL MED, V93, P1159, DOI 10.1007/s00109-015-1296-9; Lecompte S, 2013, DIABETES, V62, P1738, DOI 10.2337/db12-0864; Liao XY, 2013, J CELL SCI, V126, P3848, DOI 10.1242/jcs.123570; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Maahs DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013051; Malm HA, 2016, MOL CELL ENDOCRINOL, V424, P23, DOI 10.1016/j.mce.2016.01.010; Manco M, 2010, DIABETES CARE, V33, P2090, DOI 10.2337/dc09-2261; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; Mari A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1159, DOI 10.1152/ajpendo.00093.2002; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; Mari A, 2008, DIABETES OBES METAB, V10, P77, DOI 10.1111/j.1463-1326.2008.00946.x; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Mather KJ, 2008, DIABETES, V57, P980, DOI 10.2337/db07-1419; Mezza T, 2016, J CLIN ENDOCR METAB, V101, P470, DOI 10.1210/jc.2015-2802; Mock K, 2015, ONCOTARGET, V6, P14399, DOI 10.18632/oncotarget.3882; Moly PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153591; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nielsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087308; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Nowak C, 2016, DIABETES, V65, P276, DOI 10.2337/db15-0881; Ohgushi M, 2007, METABOLISM, V56, P571, DOI 10.1016/j.metabol.2006.12.007; Page KA, 2013, CURR DIABETES REP, V13, P252, DOI 10.1007/s11892-013-0363-2; Parray HA, 2015, INT J MOL SCI, V16, P14441, DOI 10.3390/ijms160714441; Paul L, 2016, DIABETES, V65, P687, DOI 10.2337/db15-0713; Polidori D, 2014, DIABETOLOGIA, V57, P891, DOI 10.1007/s00125-014-3196-x; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Rodrigues KF, 2015, DIABETES-METAB RES, V31, P479, DOI 10.1002/dmrr.2639; Sandstrom CS, 2008, DIABETIC MED, V25, P1370, DOI 10.1111/j.1464-5491.2008.02584.x; Shang J, 2015, MOL ENDOCRINOL, V29, P1243, DOI 10.1210/me.2014-1335; Shang XL, 2009, MED HYPOTHESES, V72, P427, DOI 10.1016/j.mehy.2008.10.027; Sharma M, 2011, INT J ENDOCRINOLOGY, V2011; STANTON LW, 1991, MOL ENDOCRINOL, V5, P860, DOI 10.1210/mend-5-6-860; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Thamer C, 2006, HORM METAB RES, V38, P178, DOI 10.1055/s-2006-925204; van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272; Wang Y, 2006, PROTEOMICS, V6, P3862, DOI 10.1002/pmic.200500840; Wei W, 2016, J CELL SCI, V129, P39, DOI 10.1242/jcs.174235; Wellner M, 2003, HORM METAB RES, V35, P217; Westergren HU, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0353-1; Wu ZH, 2016, TUMOR BIOL, V37, P7939, DOI 10.1007/s13277-015-4665-7; Yeh SH, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0246-6; Zeng LQ, 2015, MOL MED REP, V11, P67, DOI 10.3892/mmr.2014.2723; Zheng YL, 2010, J NEUROL SCI, V299, P101, DOI 10.1016/j.jns.2010.08.067; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8	76	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182932	10.1371/journal.pone.0182932	http://dx.doi.org/10.1371/journal.pone.0182932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846711	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000408438600019
J	Blotnick, E; Sol, A; Muhlrad, A				Blotnick, Edna; Sol, Asaf; Muhlrad, Andras			Histones bundle F-actin filaments and affect actin structure	PLOS ONE			English	Article							CYSTIC-FIBROSIS SPUTUM; EXTRACELLULAR HISTONES; ANTIMICROBIAL ACTIVITY; NUCLEAR ACTIN; CROSS-LINKING; HOST-DEFENSE; I COMPLEX; BINDING; PROTEINS; COFILIN	Histones are small polycationic proteins complexed with DNA located in the cell nucleus. Upon apoptosis they are secreted from the cells and react with extracellular polyanionic compounds. Actin which is a polyanionic protein, is also secreted from necrotic cells and interacts with histones. We showed that both histone mixture (histone type III) and the recombinant H2A histone bundles F-actin, increases the viscosity of the F-actin containing solution and polymerizes G-actin. The histone-actin bundles are relatively insensitive to increase of ionic strength, unlike other polycation, histatin, lysozyme, spermine and LL-37 induced F-actin bundles. The histone-actin bundles dissociate completely only in the presence of 300-400 mM NaCl. DNA, which competes with F-actin for histones, disassembles histone induced actin bundles. DNase1, which depolymerizes F- to G-actin, actively unbundles the H2A histone induced but slightly affects the histone mixture induced actin bundles. Cofilin decreases the amount of F-actin sedimented by low speed centrifugation, increases light scattering and viscosity of F-actin-histone mixture containing solutions and forms star like superstructures by copolymerizing G-actin with H2A histone. The results indicate that histones are tightly attached to F-actin by strong electrostatic and hydrophobic forces. Since both histones and F-actin are present in the sputum of patients with cystic fibrosis, therefore, the formation of the stable histone-actin bundles can contribute to the pathology of this disease by increasing the viscosity of the sputum. The actin-histone interaction in the nucleus might affect gene expression.	[Blotnick, Edna] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Med Neurobiol, Jerusalem, Israel; [Sol, Asaf; Muhlrad, Andras] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Jerusalem, Israel; [Sol, Asaf] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tufts University	Muhlrad, A (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Jerusalem, Israel.	andras.muhlrad@mail.huji.ac.il		Sol, Asaf/0000-0002-8731-2490	Hebrew University of Jerusalem	Hebrew University of Jerusalem	This work was supported by Hebrew University of Jerusalem Science Fund (AM).	Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 2016, CYTOSKELETON, V73, P477, DOI 10.1002/cm.21282; Beall B, 2001, BIOCHEMISTRY-US, V40, P14252, DOI 10.1021/bi011806u; Bobkov AA, 2002, J MOL BIOL, V323, P739, DOI 10.1016/S0022-2836(02)01008-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROGAN TD, 1975, THORAX, V30, P72, DOI 10.1136/thx.30.1.72; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Doyle A, 2011, J STRUCT BIOL, V176, P370, DOI 10.1016/j.jsb.2011.09.004; Furukawa R, 1997, INT REV CYTOL, V175, P29, DOI 10.1016/S0074-7696(08)62125-7; GINSBURG I, 1993, INFLAMMATION, V17, P295, DOI 10.1007/BF00918992; Goebel HH, 1997, NEUROMUSCULAR DISORD, V7, P13, DOI 10.1016/S0960-8966(96)00404-X; Grintsevich EE, 2016, NAT CELL BIOL, V18, P876, DOI 10.1038/ncb3390; Gurel PS, 2014, CURR BIOL, V24, P156, DOI 10.1016/j.cub.2013.12.018; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Jay X., 2005, AM J PHYSIOL-LUNG C, V289, pL599; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kanai Y, 2003, MICROBIOL IMMUNOL, V47, P553, DOI 10.1111/j.1348-0421.2003.tb03417.x; Kawasaki H., 2008, Infectious Disorders - Drug Targets, V8, P195; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lee DY, 2009, J INVEST DERMATOL, V129, P2489, DOI 10.1038/jid.2009.106; MAGRI E, 1978, BIOCHEM BIOPH RES CO, V82, P1207, DOI 10.1016/0006-291X(78)90315-7; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; MANNHERZ HG, 1975, FEBS LETT, V60, P34, DOI 10.1016/0014-5793(75)80412-1; Minamide LS, 2010, J BIOL CHEM, V285, P5450, DOI 10.1074/jbc.M109.063768; Muhlrad A, 2011, BIOPHYS CHEM, V155, P45, DOI 10.1016/j.bpc.2011.02.008; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; Richards RC, 2001, BIOCHEM BIOPH RES CO, V284, P549, DOI 10.1006/bbrc.2001.5020; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Sanders LK, 2007, P NATL ACAD SCI USA, V104, P15994, DOI 10.1073/pnas.0705898104; SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X; Schmoller KM, 2011, J STRUCT BIOL, V173, P350, DOI 10.1016/j.jsb.2010.09.003; Serebryannyy LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28460; Silvan U, 2016, J STRUCT BIOL, V195, P159, DOI 10.1016/j.jsb.2016.05.008; Sol A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01248; Sol A, 2015, RSC ADV, V5, P9361, DOI 10.1039/c4ra13007c; Sol A, 2014, J BIOL CHEM, V289, P22926, DOI 10.1074/jbc.M114.579672; Sol A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050078; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tang JX, 1997, EUR J BIOCHEM, V247, P432, DOI 10.1111/j.1432-1033.1997.00432.x; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; Varju I, 2015, THROMB HAEMOSTASIS, V113, P1289, DOI 10.1160/TH14-08-0669; VASCONCELLOS CA, 1994, SCIENCE, V263, P969, DOI 10.1126/science.8310295; Virtanen JA, 2017, CURR OPIN CELL BIOL, V46, P33, DOI 10.1016/j.ceb.2016.12.004; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; WELSH MJ, 1995, SCI AM, V273, P52, DOI 10.1038/scientificamerican1295-52; Williamson WD, 2012, FRONT BIOSCI-LANDMRK, V17, P984, DOI 10.2741/3969; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Xu ZH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/205054; Yarmola EG, 2001, J BIOL CHEM, V276, P22351, DOI 10.1074/jbc.M101457200	53	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183760	10.1371/journal.pone.0183760	http://dx.doi.org/10.1371/journal.pone.0183760			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846729	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600049
J	Fornaro, L; Vivaldi, C; Lin, D; Xue, H; Falcone, A; Wang, YZ; Crea, F; Bootman, MD				Fornaro, Lorenzo; Vivaldi, Caterina; Lin, Dong; Xue, Hui; Falcone, Alfredo; Wang, Yuzhuo; Crea, Francesco; Bootman, Martin D.			Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation	PLOS ONE			English	Article							CA2+ CHANNELS; CELL-GROWTH; CANCER; GLIOBLASTOMA; XENOGRAFTS; INHIBITION; TOOLS; PROLIFERATION; MIBEFRADIL; APOPTOSIS	Background T-type calcium channels (TTCCs) mediate calcium influx across the cell membrane. TTCCs regulate numerous physiological processes including cardiac pacemaking and neuronal activity. In addition, they have been implicated in the proliferation, migration and differentiation of tumour tissues. Although the signalling events downstream of TTCC-mediated calcium influx are not fully elucidated, it is clear that variations in the expression of TTCCs promote tumour formation and hinder response to treatment. Methods We examined the expression of TTCC genes (all three subtypes; CACNA-1G, CACNA-1H and CACNA-1I) and their prognostic value in three major solid tumours (i.e. gastric, lung and ovarian cancers) via a publicly accessible database. Results In gastric cancer, expression of all the CACNA genes was associated with overall survival (OS) among stage I-IV patients (all p<0.05). By combining the three potential biomarkers, a TTCC signature was developed, which retained a significant association with OS both in stage IV and stage I-III patients. In lung and ovarian cancer, association with OS was also significant when all tumour stages were considered, but was partly lost or inconclusive after splitting cases into localized and metastatic subsets. Conclusions Alterations in CACNA gene expression are linked to tumour prognosis. Gastric cancer represents the most promising setting for further evaluation.	[Fornaro, Lorenzo; Vivaldi, Caterina; Falcone, Alfredo] Azienda Osped Univ Pisana, Unit Med Oncol 2, Pisa, Italy; [Lin, Dong; Xue, Hui; Wang, Yuzhuo] BC Canc Res Ctr, Expt Therapeut, Vancouver, BC, Canada; [Crea, Francesco; Bootman, Martin D.] Open Univ, Sch Life Hlth & Chem Sci, Walton Hall, Milton Keynes, Bucks, England	University of Pisa; Azienda Ospedaliero Universitaria Pisana; British Columbia Cancer Agency; Open University - UK	Fornaro, L (corresponding author), Azienda Osped Univ Pisana, Unit Med Oncol 2, Pisa, Italy.; Crea, F; Bootman, MD (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, Walton Hall, Milton Keynes, Bucks, England.	lorenzo.fornaro@gmail.com; francesco.crea@open.ac.uk; martin.bootman@open.ac.uk	Bootman, Martin/AAB-3330-2019; Vivaldi, Caterina/AAD-8742-2019	Bootman, Martin/0000-0002-6447-3451; Vivaldi, Caterina/0000-0001-9307-2326; Falcone, Alfredo/0000-0001-5840-2529; Crea, Francesco/0000-0002-4903-2973; Wang, Yuzhuo/0000-0002-9749-8591; Fornaro, Lorenzo/0000-0002-0187-5904				Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertolesi GE, 2002, MOL PHARMACOL, V62, P210, DOI 10.1124/mol.62.2.210; Buchanan PJ, 2016, EUR BIOPHYS J BIOPHY, V45, P621, DOI 10.1007/s00249-016-1144-z; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Dziegielewska B, 2014, MOL CANCER RES, V12, P348, DOI 10.1158/1541-7786.MCR-13-0485; Dziegielewska B, 2014, PFLUG ARCH EUR J PHY, V466, P801, DOI 10.1007/s00424-014-1444-z; Fogar P, 1997, ANTICANCER RES, V17, P1227; Gray LS, 2013, EXPERT REV ANTICANC, V13, P589, DOI [10.1586/ERA.13.34, 10.1586/era.13.34]; Heo JH, 2008, BIOORG MED CHEM LETT, V18, P3899, DOI 10.1016/j.bmcl.2008.06.034; Huang WF, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0171-4; Iftinca M C, 2011, J Med Life, V4, P126; Kiryushko D, 2006, MOL BIOL CELL, V17, P2278, DOI 10.1091/mbc.E05-10-0987; Leanza L, 2016, BBA-MOL CELL RES, V1863, P1385, DOI 10.1016/j.bbamcr.2015.11.032; Lester-Coll NH, 2016, NEURO-ONCOLOGY, V18, P51; Li W, 2011, CANCER INVEST, V29, P339, DOI 10.3109/07357907.2011.568565; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Lordick F, 2014, CANCER TREAT REV, V40, P692, DOI 10.1016/j.ctrv.2014.03.002; Lu FM, 2008, CELL CALCIUM, V43, P49, DOI 10.1016/j.ceca.2007.03.006; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Panner A, 2006, CELL CALCIUM, V40, P253, DOI 10.1016/j.ceca.2006.04.029; Press JZ, 2008, GYNECOL ONCOL, V110, P256, DOI 10.1016/j.ygyno.2008.03.011; Santoni G, 2012, BRIT J PHARMACOL, V166, P1244, DOI 10.1111/j.1476-5381.2012.01908.x; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Taylor JT, 2008, CANCER LETT, V267, P116, DOI 10.1016/j.canlet.2008.03.032; Valerie NCK, 2013, BIOCHEM PHARMACOL, V85, P888, DOI 10.1016/j.bcp.2012.12.017; Wu C, 2016, INT J ONCOL, P2236, DOI [1016/j.ceca.2007.03.006, DOI 1016/j.ceca.2007.03.006]; Zhang Y, 2014, PFLUG ARCH EUR J PHY, V466, P811, DOI 10.1007/s00424-013-1427-5; Zhang Y, 2012, BRIT J PHARMACOL, V166, P1247, DOI 10.1111/j.1476-5381.2012.01852.x; Zhuang QD, 2017, CAN RESPIR J, V2017, DOI 10.1155/2017/3685261	34	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182818	10.1371/journal.pone.0182818	http://dx.doi.org/10.1371/journal.pone.0182818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846697	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000408438600016
J	Mayrinck, D; Brito, PM; Meunier, FJ; Alvarado-Ortega, J; Otero, O				Mayrinck, Diogo; Brito, Paulo M.; Meunier, Francois J.; Alvarado-Ortega, Jesus; Otero, Olga			Sorbinicharax verraesi: An unexpected case of a benthic fish outside Acanthomorpha in the Upper Cretaceous of the Tethyan Sea	PLOS ONE			English	Article							PHYLOGENETIC SIGNIFICANCE; BONE	Sorbinicharax verraesi is a marine teleostean fish from the Upper Cretaceous of Nardo (Italy). It was first attributed to the otophysan order Characiformes, which represents potential evidence for the controversial marine origin of the clade. Through a review of all the available material, we demonstrate that this species is not an otophysan since it lacks key structures that would allow for its inclusion in this group. Sorbinicharax has a body shape that recalls ground fishes classically assigned to Acanthomorpha. However, no unambiguous feature allows us to relate it to this clade. In fact, the presence of cellular bony tissue supports its exclusion from Eurypterygii. Since no feature permits the definitive attribution of Sorbinicharax to any teleost group, it remains as Teleostei incertae sedis. We infer that the morphology of Sorbinicharax indicates a benthic ecology. It displays: an anteriorly wide body with enlarged ribs; large pectoral fins, while anal and dorsal fins are reduced; a large head measuring 1/4 of the total body length; and a mouth opening dorsally in a high position. Such morphology was so far undescribed in Nardo. It is surprisingly displayed by a non-eurypterygian teleost fish which means by a fish which does not belong to the clades that diversify since the upper Cretaceous and include the extant families that show ground ecomorphologies.	[Mayrinck, Diogo] Univ Estado Rio de Janeiro, Dept Ensino Ciencias & Biol, Rio De Janeiro, Brazil; [Brito, Paulo M.] Univ Estado Rio de Janeiro, Dept Zool, Rio De Janeiro, Brazil; [Meunier, Francois J.] UPMC, CNRS, IRD,UMR 7208, BOREA,Dept Milieux & Peuplements Aquat,Museum Nat, CP026, Paris, France; [Alvarado-Ortega, Jesus] Univ Nacl Autonoma Mexico, Dept Palaeontol, Mexico City, DF, Mexico; [Otero, Olga] Lab Paleontol Poitiers, UMR 7262, Bat B35 TSA51106, Poitiers, France	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers	Mayrinck, D (corresponding author), Univ Estado Rio de Janeiro, Dept Ensino Ciencias & Biol, Rio De Janeiro, Brazil.	mdiogobio@yahoo.com.br	Otero, Olga/T-5467-2018	Otero, Olga/0000-0002-8129-2054; Alvarado-Ortega, Jesus/0000-0001-8458-7205; Mayrinck, Diogo/0000-0002-6899-1432				[Anonymous], 2003, B MUS CIV STOR NAT V, V27, P29; BARTRAM A, 1977, J NAT HIST, V11, P361, DOI 10.1080/00222937700770271; Bellwood DR, 1996, CORAL REEFS, V15, P11, DOI 10.1007/BF01626074; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Berkovitz BKB, 2017, TEETH OF NON- MAMMALIAN VERTEBRATES, P43, DOI 10.1016/B978-0-12-802850-6.00004-7; Cowman PF, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00394; Davesne D, 2016, FRONT ECOL EVOL, V4; Fink Sara V., 1996, P209, DOI 10.1016/B978-012670950-6/50012-6; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; FINK SV, 1984, COPEIA, P1033; Friedman M, 2012, PALAEONTOLOGY, V55, P707, DOI 10.1111/j.1475-4983.2012.01165.x; GAYET M, 1986, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V8, P393; Gayet M., 1985, COMUNICACOES SERVICO, V71, P91; Gayet M, 1981, COMUN SERV GEOL PORT, V67, P173; Goatley CHR, 2009, CORAL REEFS, V28, P449, DOI 10.1007/s00338-009-0477-9; Goatley CHR, 2010, PALEOBIOLOGY, V36, P415, DOI 10.1666/09035.1; JOHNSON GD, 1992, COPEIA, P8; JOHNSON GD, 1993, B MAR SCI, V52, P554; Kolliker A, 1859, P R SOC LONDON, V9, P656; Lobato FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102094; Mayrinck D, 2015, J SYST PALAEONTOL, V13, P397, DOI 10.1080/14772019.2014.893260; Mayrinck D, 2015, CRETACEOUS RES, V56, P66, DOI 10.1016/j.cretres.2015.03.002; MOSS ML, 1965, ACTA ANAT, V60, P262; Muller J., 1846, PHYSIKALISCH MATHEMA, V1846, P117; Murray AM, 2009, PALAEONTOLOGY, V52, P429, DOI 10.1111/j.1475-4983.2009.00851.x; Otero O, 2008, GEOL SOC SPEC PUBL, V295, P155, DOI 10.1144/SP295.10; Otero Olga, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V202, P313; PARENTI LR, 1986, ZOOL J LINN SOC-LOND, V87, P37, DOI 10.1111/j.1096-3642.1986.tb01329.x; PATTERSON C, 1993, B MAR SCI, V52, P29; ROBERTS CD, 1993, B MAR SCI, V52, P60; Schluter M, 2008, CRETACEOUS RES, V29, P100, DOI 10.1016/j.cretres.2007.04.005; Stiassny Melanie L.J., 1996, P405, DOI 10.1016/B978-012670950-6/50016-3; Taverne Louis, 2003, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V27, P29; Taverne Louis, 2003, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V27, P3; Tyler James C., 2000, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V24, P11; WAINWRIGHT PC, 1991, AM ZOOL, V31, P680; Wainwright Peter C., 2002, P33, DOI 10.1016/B978-012615185-5/50004-9; Wiley E.O., 2010, P123	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183879	10.1371/journal.pone.0183879	http://dx.doi.org/10.1371/journal.pone.0183879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846739	gold, Green Published, Green Submitted			2022-12-26	WOS:000408438600054
J	Sauwen, N; Acou, M; Bharath, HN; Sima, DM; Veraart, J; Maes, F; Himmelreich, U; Achten, E; Van Huffel, S				Sauwen, Nicolas; Acou, Marjan; Bharath, Halandur N.; Sima, Diana M.; Veraart, Jelle; Maes, Frederik; Himmelreich, Uwe; Achten, Eric; Van Huffel, Sabine			The successive projection algorithm as an initialization method for brain tumor segmentation using non-negative matrix factorization	PLOS ONE			English	Article							SVD BASED INITIALIZATION	Non-negative matrix factorization (NMF) has become a widely used tool for additive parts-based analysis in a wide range of applications. As NMF is a non-convex problem, the quality of the solution will depend on the initialization of the factor matrices. In this study, the successive projection algorithm (SPA) is proposed as an initialization method for NMF. SPA builds on convex geometry and allocates endmembers based on successive orthogonal subspace projections of the input data. SPA is a fast and reproducible method, and it aligns well with the assumptions made in near-separable NMF analyses. SPA was applied to multi-parametric magnetic resonance imaging (MRI) datasets for brain tumor segmentation using different NMF algorithms. Comparison with common initialization methods shows that SPA achieves similar segmentation quality and it is competitive in terms of convergence rate. Whereas SPA was previously applied as a direct endmember extraction tool, we have shown improved segmentation results when using SPA as an initialization method, as it allows further enhancement of the sources during the NMF iterative procedure.	[Sauwen, Nicolas; Bharath, Halandur N.; Sima, Diana M.; Van Huffel, Sabine] Katholieke Univ Leuven, Dept Elect Engn ESAT, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium; [Sauwen, Nicolas; Bharath, Halandur N.; Sima, Diana M.; Van Huffel, Sabine] IMEC, Leuven, Belgium; [Acou, Marjan; Achten, Eric] Ghent Univ Hosp, Dept Radiol, Ghent, Belgium; [Sima, Diana M.] Icometrix, R&D Dept, Leuven, Belgium; [Veraart, Jelle] Univ Antwerp, IMinds Vis Lab, Dept Phys, Antwerp, Belgium; [Maes, Frederik] Katholieke Univ Leuven, Dept Elect Engn ESAT, PSI Ctr Proc Speech & Images, Leuven, Belgium; [Himmelreich, Uwe] Katholieke Univ Leuven, Dept Imaging & Pathol, Biomed MRI MoSAIC, Leuven, Belgium	KU Leuven; IMEC; Ghent University; Ghent University Hospital; IMEC; University of Antwerp; KU Leuven; KU Leuven	Van Huffel, S (corresponding author), Katholieke Univ Leuven, Dept Elect Engn ESAT, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium.; Van Huffel, S (corresponding author), IMEC, Leuven, Belgium.	sabine.vanhuffel@kuleuven.be	Maes, Frederik/I-7572-2013	Maes, Frederik/0000-0003-0027-1479; Himmelreich, Uwe/0000-0002-2060-8895; Sima, Diana M/0000-0002-0118-2905; Veraart, Jelle/0000-0003-0781-0420	Research Foundation Flanders (FWO) [G.0869.12N, IWT IM 135005]; Henri Benedictus Fellowship of the Belgian American Educational Foundation; Interuniversity Attraction Poles Program [P7/11]; Belgian Science Policy Office; government agency for Innovation by Science and Technology (IWT) [IM 135005]; European Research Council under the European Union's Seventh Framework Programme [339804, 316679]; European Research Council under the European Union's Seventh Framework Programme (FP7); ERC Advanced Grant: BIOTENSORS [339804]; EU MC ITN TRANSACT [316679]	Research Foundation Flanders (FWO)(FWO); Henri Benedictus Fellowship of the Belgian American Educational Foundation; Interuniversity Attraction Poles Program(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); government agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); European Research Council under the European Union's Seventh Framework Programme (FP7); ERC Advanced Grant: BIOTENSORS; EU MC ITN TRANSACT	d NS, DMS and MA received funding from the Research Foundation Flanders (FWO), grant number G.0869.12N. JV received funding from the Henri Benedictus Fellowship of the Belgian American Educational Foundation; Interuniversity Attraction Poles Program (P7/11) initiated by the Belgian Science Policy Office. SVH received funding from the government agency for Innovation by Science and Technology (IWT), grant number IM 135005. SVH and HNB received funding from the European Research Council under the European Union's Seventh Framework Programme, grant number 339804. SVH and DMS received funding from the European Research Council under the European Union's Seventh Framework Programme, grant number 316679. Icometrix provided support in the form of salary for author DMS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work has been funded by the following projects: Research Foundation Flanders (FWO), grant number G.0869.12N; IWT IM 135005; Henri Benedictus Fellowship of the Belgian American Educational Foundation; Interuniversity Attraction Poles Program (P7/11) initiated by the Belgian Science Policy Office. European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013), ERC Advanced Grant: BIOTENSORS (no 339804) and the EU MC ITN TRANSACT 2012 (no 316679).	Araujo MCU, 2001, CHEMOMETR INTELL LAB, V57, P65, DOI 10.1016/S0169-7439(01)00119-8; Arora S, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P145; Bauer S, 2013, PHYS MED BIOL, V58, pR97, DOI 10.1088/0031-9155/58/13/R97; Boutsidis C, 2008, PATTERN RECOGN, V41, P1350, DOI 10.1016/j.patcog.2007.09.010; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Casalino G, 2014, INFORM SCIENCES, V257, P369, DOI 10.1016/j.ins.2013.05.038; Ding C, 2010, IEEE T PATTERN ANAL, V32, P45, DOI 10.1109/TPAMI.2008.277; Gillis N, 2014, SIAM J IMAGING SCI, V7, P1420, DOI 10.1137/130946782; Gillis N, 2014, IEEE T PATTERN ANAL, V36, P698, DOI 10.1109/TPAMI.2013.226; Gillis N, 2012, NEURAL COMPUT, V24, P1085, DOI 10.1162/NECO_a_00256; Heinrich Kevin E, 2008, Comput Intell Neurosci, P276535, DOI 10.1155/2008/276535; Langville A. N., 2006, P 12 ACM SIGKDD INT, P23; Laudadio T, 2013, P ESMRMB 2013 TOUL O, P474; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li YQ, 2013, NMR BIOMED, V26, P307, DOI 10.1002/nbm.2850; Lin CJ, 2007, NEURAL COMPUT, V19, P2756, DOI 10.1162/neco.2007.19.10.2756; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Mizutani T., 2015, ARXIV150608387; Niegowski M, 2014, IEEE ENG MED BIO, P4212, DOI 10.1109/EMBC.2014.6944553; Nocedal J, 2006, SPRINGER SER OPER RE, P135; Nock R, 2006, IEEE T PATTERN ANAL, V28, P1223, DOI 10.1109/TPAMI.2006.168; Ortega-Martorell S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-38; Poot DHJ, 2010, IEEE T MED IMAGING, V29, P819, DOI 10.1109/TMI.2009.2037915; Poullet J-B, 2008, THESIS; Poullet JB, 2007, J MAGN RESON, V186, P293, DOI 10.1016/j.jmr.2007.03.015; Qiao HL, 2015, PATTERN RECOGN LETT, V63, P71, DOI 10.1016/j.patrec.2015.05.019; Rezaei M., 2011, Journal of Applied Sciences, V11, P354, DOI 10.3923/jas.2011.354.359; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Sauwen N, 2015, NMR BIOMED, V28, P1599, DOI 10.1002/nbm.3413; Sava ARC, 2011, NMR BIOMED, V24, P824, DOI 10.1002/nbm.1628; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Wang YX, 2013, IEEE T KNOWL DATA EN, V25, P1336, DOI 10.1109/TKDE.2012.51; Wild S, 2004, PATTERN RECOGN, V37, P2217, DOI 10.1016/j.patcog.2004.02.013; Yu SH, 2012, SPECTROCHIM ACTA A, V86, P315, DOI 10.1016/j.saa.2011.10.042; Zhang J, 2008, SENSORS-BASEL, V8, P1321, DOI 10.3390/s8021321; Zhao LH, 2008, 2008 7TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-23, P6826, DOI 10.1109/WCICA.2008.4593968; Zheng ZL, 2007, ENG APPL ARTIF INTEL, V20, P101, DOI 10.1016/j.engappai.2006.03.001	38	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0180268	10.1371/journal.pone.0180268	http://dx.doi.org/10.1371/journal.pone.0180268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846686	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600002
J	Fatehi, F; Salort-Campana, E; Le Troter, A; Lareau-Trudel, E; Bydder, M; Foure, A; Guye, M; Bendahan, D; Attarian, S				Fatehi, Farzad; Salort-Campana, Emmanuelle; Le Troter, Arnaud; Lareau-Trudel, Emilie; Bydder, Mark; Foure, Alexandre; Guye, Maxime; Bendahan, David; Attarian, Shahram			Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; DISEASE PROGRESSION; NEUROMUSCULAR DISORDERS; DNA REARRANGEMENTS; PREVALENCE; INVOLVEMENT; POPULATION; BOYS; FSHD; AGE	Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common hereditary muscular disorders. Currently FSHD has no known effective treatment and detailed data on the natural history are lacking. Determination of the efficacy of a given therapeutic approach might be difficult in FSHD given the slow and highly variable disease progression. Magnetic resonance imaging (MRI) has been widely used to qualitatively and quantitatively evaluate in vivo the muscle alterations in various neuromuscular disorders. The main aim of the present study was to investigate longitudinally the time-dependent changes occurring in thigh muscles of FSHD patients using quantitative MRI and to assess the potential relationships with the clinical findings. Thirty-five FSHD1 patients (17 females) were enrolled. Clinical assessment tools including manual muscle testing using medical research council score (MRC), and motor function measure (MFM) were recorded each year for a period ranging from 1 to 2 years. For the MRI measurements, we used a new quantitative index, i.e., the mean pixel intensity (MPI) calculated from the pixel-intensity distribution in T1 weighted images. The corresponding MPI scores were calculated for each thigh, for each compartment and for both thighs totally (MPItotal). The total mean pixel intensity (MPItotal) refers to the sum of each pixel signal intensity divided by the corresponding number of pixels. An increased MPItotal indicates both a raised fat infiltration together with a reduced muscle volume thereby illustrating disease progression. Clinical scores did not change significantly over time whereas MPItotal increased significantly from an initial averaged value of 39.6 to 41.1 with a corresponding rate of 0.62/year. While clinical scores and MPItotal measured at the start of the study were significantly related, no correlation was found between the rate of MPItotal and MRC sum score changes, MFMtotal and MFM subscores. The relative rate of MPItotal change was 2.3% (0.5-4.3)/year and was significantly higher than the corresponding rates measured for MRCS 0% (0-1.7)/year and MFMtotal 0% (0-2.0)/year (p = 0.000). On the basis of these results, we suggested that muscle MRI and more particularly the MPItotal index could be used as a reliable biomarker and outcome measure of disease progression. In slowly progressive myopathies such as FSHD, the MPItotal index might reveal subclinical changes, which could not be evidenced using clinical scales over a short period of time.	[Fatehi, Farzad; Salort-Campana, Emmanuelle; Lareau-Trudel, Emilie; Attarian, Shahram] Univ Aix Marseille, Ctr Reference Malad Neuromusculaires, Marseille, France; [Fatehi, Farzad; Salort-Campana, Emmanuelle; Lareau-Trudel, Emilie; Attarian, Shahram] Univ Aix Marseille, SLA, Ctr Hosp Univ Timone, Marseille, France; [Fatehi, Farzad; Le Troter, Arnaud; Lareau-Trudel, Emilie; Bydder, Mark; Foure, Alexandre; Guye, Maxime; Bendahan, David] Aix Marseille Univ, Ctr Resonance Magnet Biol & Med, CNRS, UMR 7339, Marseille, France; [Salort-Campana, Emmanuelle; Attarian, Shahram] Aix Marseille Univ, INSERM, GMGF, Marseille, France; [Salort-Campana, Emmanuelle; Attarian, Shahram] FILNEMUS, Marseille, France; [Fatehi, Farzad] Univ Tehran Med Sci, Shariati Hosp, Iranian Ctr Neurol Res, Tehran, Iran; [Lareau-Trudel, Emilie] Univ Sherbrooke, Div Neurol, Dept Med, Sherbrooke, PQ, Canada	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Tehran University of Medical Sciences; University of Sherbrooke	Salort-Campana, E (corresponding author), Univ Aix Marseille, Ctr Reference Malad Neuromusculaires, Marseille, France.; Salort-Campana, E (corresponding author), Univ Aix Marseille, SLA, Ctr Hosp Univ Timone, Marseille, France.; Salort-Campana, E (corresponding author), Aix Marseille Univ, INSERM, GMGF, Marseille, France.; Salort-Campana, E (corresponding author), FILNEMUS, Marseille, France.	emmanuelle.salort-campana@ap-hm.fr	Attarian, Shahram/AAE-6214-2021; Fouré, Alexandre/AAI-9587-2020; Fatehi, Farzad/AAM-7430-2020; Bendahan, David/AAU-1420-2020	Fouré, Alexandre/0000-0002-9678-8773; Fatehi, Farzad/0000-0002-6774-7825; le troter, arnaud/0000-0002-7897-9672				Arpan I, 2014, NEUROLOGY, V83, P974, DOI 10.1212/WNL.0000000000000775; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Berard C, 2005, NEUROMUSCULAR DISORD, V15, P463, DOI 10.1016/j.nmd.2005.03.004; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonati U, 2015, NEUROMUSCULAR DISORD, V25, P679, DOI 10.1016/j.nmd.2015.05.006; Dahlqvist JR, 2014, NEUROLOGY, V83, P1178, DOI 10.1212/WNL.0000000000000828; Deenen JCW, 2014, NEUROLOGY, V83, P1056, DOI 10.1212/WNL.0000000000000797; Fatehi F, 2016, REV NEUROL-FRANCE, V172, P566, DOI 10.1016/j.neurol.2016.08.002; Fischer D, 2016, CURR OPIN NEUROL, V29, P614, DOI 10.1097/WCO.0000000000000364; Fischmann A, 2012, J NEUROL, V259, P1648, DOI 10.1007/s00415-011-6393-2; Gerevini S, 2016, EUR RADIOL, V26, P693, DOI 10.1007/s00330-015-3890-1; Guizard N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133352; Janssen B, 2016, NEUROLOGY, V86, P1700, DOI 10.1212/WNL.0000000000002640; Janssen BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085416; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kan HE, 2009, NEUROMUSCULAR DISORD, V19, P357, DOI 10.1016/j.nmd.2009.02.009; Lareau-Trudel E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132717; Le Troter A, 2016, MAGN RESON MATER PHY, V29, P245, DOI 10.1007/s10334-016-0535-6; Leung DG, 2015, MUSCLE NERVE, V52, P512, DOI 10.1002/mus.24569; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Morrow JM, 2016, LANCET NEUROL, V15, P65, DOI 10.1016/S1474-4422(15)00242-2; Morrow JM, 2014, EUR RADIOL, V24, P1610, DOI 10.1007/s00330-014-3145-6; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Olsen DB, 2006, J NEUROL, V253, P1437, DOI 10.1007/s00415-006-0230-z; Regula JU, 2016, CLIN NEURORADIOL, V26, P445, DOI 10.1007/s00062-015-0386-y; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Statland J, 2014, NEUROL CLIN, V32, P721, DOI 10.1016/j.ncl.2014.04.003; Statland JM, 2013, NEUROMUSCULAR DISORD, V23, P306, DOI 10.1016/j.nmd.2013.01.008; Tasca G, 2016, ANN NEUROL; Tasca G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100292; Tawil R, 1997, NEUROLOGY, V48, P38, DOI 10.1212/wnl.48.1.38; Theadom A, 2014, NEUROEPIDEMIOLOGY, V43, P259, DOI 10.1159/000369343; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WIJMENGA C, 1993, NEUROMUSCULAR DISORD, V3, P487, DOI 10.1016/0960-8966(93)90102-P; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Willcocks RJ, 2014, NEUROMUSCULAR DISORD, V24, P393, DOI 10.1016/j.nmd.2013.12.012; Willis TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070993; Wokke BH, 2013, J MAGN RESON IMAGING, V38, P619, DOI 10.1002/jmri.23998	41	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183825	10.1371/journal.pone.0183825	http://dx.doi.org/10.1371/journal.pone.0183825			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841698	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700060
J	Weckbach, LT; Maurer, U; Schramm, R; Huber, BC; Lackermair, K; Weiss, M; Meiser, B; Hagl, C; Massberg, S; Eifert, S; Grabmaier, U				Weckbach, Ludwig T.; Maurer, Ulrich; Schramm, Rene; Huber, Bruno C.; Lackermair, Korbinian; Weiss, Max; Meiser, Bruno; Hagl, Christian; Massberg, Steffen; Eifert, Sandra; Grabmaier, Ulrich			Lower frequency routine surveillance endomyocardial biopsies after heart transplantation	PLOS ONE			English	Article							INTERNATIONAL SOCIETY; MYCOPHENOLATE-MOFETIL; REJECTION; RECIPIENTS; REGISTRY	In heart transplantation (HTx) patients, routine surveillance endomyocardial biopsies (rsEMB) are recommended for the detection of early cardiac allograft rejection. However, there is no consensus on the optimal frequency of rsEMB. Frequent rsEMB have shown a low diagnostic yield in the new era of potent immunosuppressive regimen. Efficacy and safety of lower frequency rsEMB have not been investigated so far. In this retrospective, single centre, observational study we evaluated 282 patients transplanted between 2004 and 2014. 218 of these patients were investigated by rsEMB and symptom-triggered EMB (stEMB). We evaluated EMB results, complications, risk factors for rejection, survival 1 and 5 years as well as incidence of cardiac allograft vasculopathy (CAV) 3 years after HTx. A mean of 7.1 +/- 2.5 rsEMB were conducted per patient within the first year after HTx identifying 7 patients with asymptomatic and 9 patients with symptomatic acute rejection requiring glucocorticoide pulse therapy. Despite this relatively low frequency of rsEMB, only 6 unscheduled stEMB were required in the first year after HTx leading to 2 additional treatments. In 6 deaths among all 282 patients (2.1%), acute rejection could not be ruled out as a potential underlying cause. Overall survival at 1 year was 78.7% and 5-year survival was 74%. Incidence of CAV was 17% at 3-year follow-up. Morbidity and mortality of lower frequency rsEMB are comparable with data from the International Society for Heart and Lung Transplantation (ISHLT) registry. Consensus is needed on the optimal frequency of EMB.	[Weckbach, Ludwig T.; Huber, Bruno C.; Lackermair, Korbinian; Massberg, Steffen] Ludwig Maximilians Univ Munchen, Dept Med 1, Campus Grosshadern, Munich, Germany; [Maurer, Ulrich; Schramm, Rene; Hagl, Christian; Eifert, Sandra; Grabmaier, Ulrich] Ludwig Maximilians Univ Munchen, Dept Cardiac Surg, Munich, Germany; [Schramm, Rene; Meiser, Bruno; Eifert, Sandra; Grabmaier, Ulrich] Ludwig Maximilians Univ Munchen, Transplantat Ctr, Munich, Germany; [Weiss, Max] Ludwig Maximilians Univ Munchen, Inst Pathol, Munich, Germany; [Massberg, Steffen; Grabmaier, Ulrich] DZHK German Ctr Cardiovasc Res, Partner Site Munich, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; German Centre for Cardiovascular Research	Grabmaier, U (corresponding author), Ludwig Maximilians Univ Munchen, Dept Cardiac Surg, Munich, Germany.; Grabmaier, U (corresponding author), Ludwig Maximilians Univ Munchen, Transplantat Ctr, Munich, Germany.; Grabmaier, U (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Munich, Munich, Germany.	ulrich.grabmaier@med.uni-muenchen.de	Massberg, Steffen/AAN-6054-2021	Weckbach, Ludwig T/0000-0002-0981-2246; Huber, Bruno/0000-0002-1032-7686				[Anonymous], CURR OPIN CARDIOL; Chimenti C, 2013, CIRCULATION, V128, P1531, DOI 10.1161/CIRCULATIONAHA.13.001414; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; Delgado JF, 2006, EXPERT OPIN PHARMACO, V7, P1139, DOI 10.1517/14656566.7.9.1139; Drury JH, 1997, ECHOCARDIOGR-J CARD, V14, P469, DOI 10.1111/j.1540-8175.1997.tb00754.x; Fiorelli AI, 2012, TRANSPL P, V44, P2479, DOI 10.1016/j.transproceed.2012.07.024; Gradek WQ, 2001, J HEART LUNG TRANSPL, V20, P497, DOI 10.1016/S1053-2498(01)00236-4; Hamour IM, 2008, TRANSPLANTATION, V85, P969, DOI 10.1097/TP.0b013e318168d571; JARCHO J, 1994, J HEART LUNG TRANSPL, V13, P583; Kobashigawa J, 1998, TRANSPLANTATION, V66, P507, DOI 10.1097/00007890-199808270-00016; Kobashigawa JA, 2006, AM J TRANSPLANT, V6, P1377, DOI 10.1111/j.1600-6143.2006.01290.x; Lund LH, 2014, J HEART LUNG TRANSPL, V33, P996, DOI 10.1016/j.healun.2014.08.003; Shah KB, 2015, TRANSPLANTATION, V99, pE75, DOI 10.1097/TP.0000000000000615; Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Williams MJA, 1996, AM J CARDIOL, V77, P1339, DOI 10.1016/S0002-9149(96)00202-0	16	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182880	10.1371/journal.pone.0182880	http://dx.doi.org/10.1371/journal.pone.0182880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841655	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700013
J	Chiba, R; Akiya, M; Hashimura, M; Oguri, Y; Inukai, M; Hara, A; Saegusa, M				Chiba, Risako; Akiya, Masashi; Hashimura, Miki; Oguri, Yasuko; Inukai, Madoka; Hara, Atsuko; Saegusa, Makoto			ALK signaling cascade confers multiple advantages to glioblastoma cells through neovascularization and cell proliferation	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ANAPLASTIC LYMPHOMA KINASE; CANCER STEM-CELLS; VEGF EXPRESSION; NERVOUS-SYSTEM; UP-REGULATION; HYPOXIA; GENE; NEUROBLASTOMA; TUMORS	Anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase, is essentially and transiently expressed in the developing nervous system. Here we examined the functional role of the ALK gene in glioblastomas (GBMs). In clinical samples of GBMs, high ALK expression without gene rearrangements or mutations was frequently observed in perivascular lesions, in contrast to the relatively low expression in the perinecrotic areas, which was positively correlated with N-myc and phosphorylated (p) Stat3 scores and Ki-67 labeling indices. ALK immunoreactivity was also found to be associated with neovascular features including vascular co-option and vascular mimicry. In astrocytoma cell lines, cells stably overexpressing full-length ALK showed an increase in expression of pStat3 and pAkt proteins, as well as hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor- A (VEGF-A) mRNAs, in contrast to cells with knockdown of endogenous ALK which showed decreased expression of these molecules. Transfection of the constitutively active form of Stat3 induced an increase in HIF-1 alpha promoter activity, and the overexpression of HIF-1 alpha in turn resulted in enhancement of VEGF-A promoter activity. In addition, cells with overexpression or knockdown of ALK also showed a tendency toward increased and decreased proliferation, respectively, through changes in expression of pAkt and pStat3. Finally, ALK promoter was significantly activated by transfection of Sox4 and N-myc, which are known to contribute to neuronal properties. These findings therefore suggest that Nmyc/Sox4-mediated ALK signaling cascades containing Stat3, Akt, HIF-1 alpha, and VEGF-A confer multiple advantages to tumor growth through alterations in neovascularization and cell proliferation in GBMs.	[Chiba, Risako; Akiya, Masashi; Hashimura, Miki; Oguri, Yasuko; Inukai, Madoka; Hara, Atsuko; Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, Sagamihara, Kanagawa, Japan	Kitasato University	Saegusa, M (corresponding author), Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, Sagamihara, Kanagawa, Japan.	msaegusa@med.kitasato-u.ac.jp						AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; BEN-NERIAH Y, 1988, NATURE, V333, P672, DOI 10.1038/333672a0; BERNARDS A, 1990, EMBO J, V9, P2279, DOI 10.1002/j.1460-2075.1990.tb07399.x; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Dejean E, 2011, LEUKEMIA, V25, P1882, DOI 10.1038/leu.2011.168; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hara A, 2016, CANCER MED-US, V5, P3412, DOI 10.1002/cam4.937; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; Hasan MK, 2013, SCI REP-UK, V3, DOI 10.1038/srep03450; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Inoue H, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0609-8; Inukai M, 2015, HUM PATHOL, V46, P1496, DOI 10.1016/j.humpath.2015.06.008; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Kwon MJ, 2012, PATHOL RES PRAC, V57, P682; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Louis, 2016, WHO CLASSIFICATION G; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MARU Y, 1990, ONCOGENE RES, V5, P199; Marzec M, 2011, ONCOGENE, V30, P1372, DOI 10.1038/onc.2010.505; McDonnell SRP, 2012, ONCOGENE, V31, P3733, DOI 10.1038/onc.2011.542; Medford ARL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-27; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Parliament MB, 2000, BRIT J CANCER, V82, P635; Reiff T, 2011, DEVELOPMENT, V13, P685; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Saegusa M, 2012, LAB INVEST, V92, P511, DOI 10.1038/labinvest.2011.196; Soda Y, 2001, P NAT ACAD SCI, V108, P4274; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Williamson SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13322; Yoshida T, 2013, LAB INVEST, V93, P1184, DOI 10.1038/labinvest.2013.111; Zhang L, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1141087; Zhang L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1690	43	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183516	10.1371/journal.pone.0183516	http://dx.doi.org/10.1371/journal.pone.0183516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837676	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000076
J	Portbury, SD; Hare, DJ; Finkelstein, DI; Adlard, PA				Portbury, Stuart D.; Hare, Dominic J.; Finkelstein, David I.; Adlard, Paul A.			Trehalose improves traumatic brain injury-induced cognitive impairment	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CONTROLLED CORTICAL IMPACT; CELLULAR STRESS RESPONSES; FOOTBALL-LEAGUE PLAYER; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HEAD-INJURY; RAT MODEL; SUBVENTRICULAR ZONE; MEMORY FORMATION	Traumatic brain Injury (TBI) is a significant cause of death and long-term disability for which there are currently no effective pharmacological treatment options. In this study then, we utilized a mouse model of TBI to assess the therapeutic potential of the stable disaccharide trehalose, which is known to protect against oxidative stress, increase levels of chaperone molecules and enhance autophagy. Furthermore, trehalose has demonstrated neuroprotective properties in numerous animal models and has been proposed as a potential treatment for neurodegeneration. As TBI (and associated neurodegenerative disorders) is complicated by a sudden and dramatic change in brain metal concentrations, including iron (Fe) and zinc (Zn), the collective accumulation and translocation of which has been hypothesized to contribute to the pathogenesis of TBI, then we also sought to determine whether trehalose modulated the metal dyshomeostasis associated with TBI. In this study three-monthold C57Bl/6 wildtype mice received a controlled cortical impact TBI, and were subsequently treated for one month with trehalose. During this time animals were assessed on multiple behavioral tasks prior to tissue collection. Results showed an overall significant improvement in the Morris water maze, Y-maze and open field behavioral tests in trehalose-treated mice when compared to controls. These functional benefits occurred in the absence of any change in lesion volume or any significant modulation of biometals, as assessed by laser ablation inductively coupled plasma mass spectrometry. Western blot analysis, however, revealed an upregulation of synaptophysin, doublecortin and brain derived neurotrophic factor protein in trehalose treated mice in the contralateral cortex. These results indicate that trehalose may be efficacious in improving functional outcomes following TBI by a previously undescribed mechanism of action that has relevance to multiple disorders of the central nervous system.	[Portbury, Stuart D.; Hare, Dominic J.; Finkelstein, David I.; Adlard, Paul A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Hare, Dominic J.] Univ Technol Sydney, Elemental Bioimaging, Sydney, NSW, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Technology Sydney	Adlard, PA (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.	paul.adlard@florey.edu.au	Finkelstein, David/B-9617-2009; Hare, Dominic/H-2481-2011; Hare, Dominic/AAM-7725-2020	Finkelstein, David/0000-0002-8167-4917; Hare, Dominic/0000-0002-5922-7643; 	Australian Research Council Future Fellowship [FT120100030]; Australian Research Council; Agilent Technologies [LP140100095]	Australian Research Council Future Fellowship(Australian Research Council); Australian Research Council(Australian Research Council); Agilent Technologies	P.A.A. is supported by an Australian Research Council Future Fellowship (FT120100030). D.J.H. is supported by an Australian Research Council Linkage Project with Agilent Technologies (LP140100095).	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Alonso M, 2005, LEARN MEMORY, V12, P504, DOI 10.1101/lm.27305; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Ayton S, 2015, NEUROTHERAPEUTICS, V12, P109, DOI 10.1007/s13311-014-0312-z; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Beranger F, 2008, BIOCHEM BIOPH RES CO, V374, P44, DOI 10.1016/j.bbrc.2008.06.094; Calabrese EJ, 2016, PHARMACOL RES, V110, P242, DOI 10.1016/j.phrs.2015.12.021; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Carri MT, 2003, BRAIN RES BULL, V61, P365, DOI 10.1016/S0361-9230(03)00179-5; Castillo K, 2013, AUTOPHAGY, V9, P1308, DOI 10.4161/auto.25188; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Cope EC, 2010, CURR OPIN CLIN NUTR, V13, P685, DOI 10.1097/MCO.0b013e32833df61a; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; Doering P, 2007, NEUROSCIENCE, V150, P93, DOI 10.1016/j.neuroscience.2007.09.066; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Du J, 2013, J PHARM PHARMACOL, V65, P1753, DOI 10.1111/jphp.12108; Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Holler CJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0114-3; Ikeda S, 2013, EXCLI J, V12, P641; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Klevay LM, 2013, MED HYPOTHESES, V81, P995, DOI 10.1016/j.mehy.2013.09.011; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Liu MY, 2013, FOOD CHEM, V136, P485, DOI 10.1016/j.foodchem.2012.09.031; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu LY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470676; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Portbury SD, 2017, METALLOMICS, V9, P402, DOI 10.1039/c6mt00260a; Portbury SD, 2016, METALLOMICS, V8, P193, DOI 10.1039/c5mt00234f; Portbury SD, 2015, J ALZHEIMERS DIS, V46, P297, DOI 10.3233/JAD-143048; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Tanji K, 2015, BIOCHEM BIOPH RES CO, V465, P746, DOI 10.1016/j.bbrc.2015.08.076; Tokuyama W, 2000, NAT NEUROSCI, V3, P1134, DOI 10.1038/80655; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	88	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183683	10.1371/journal.pone.0183683	http://dx.doi.org/10.1371/journal.pone.0183683			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837626	gold, Green Published			2022-12-26	WOS:000408365000102
J	Rode, S; Ohm, H; Zipfel, J; Rumpf, S				Rode, Sandra; Ohm, Henrike; Zipfel, Jaqueline; Rumpf, Sebastian			The spliceosome-associated protein Mfap1 binds to VCP in Drosophila	PLOS ONE			English	Article							MECHANISMS; DENDRITES; NEURONS; SYSTEM	Posttranscriptional regulation of gene expression contributes to many developmental transitions. Previously, we found that the AAA chaperone Valosin-Containing Protein (VCP) regulates ecdysone-dependent dendrite pruning of Drosophila class IV dendritic arborization (c4da) neurons via an effect on RNA metabolism. In a search for RNA binding proteins associated with VCP, we identified the spliceosome-associated protein Mfap1, a component of the tri-snRNP complex. Mfap1 is a nucleolar protein in neurons and its levels are regulated by VCP. Mfap1 binds to VCP and TDP-43, a disease-associated RNA-binding protein. via distinct regions in its N- and C-terminal halfs. Similar to vcp mutations, Mfap1 overexpression causes c4da neuron dendrite pruning defects and mislocalization of TDP-43 in these cells, but genetic analyses show that Mfap1 is not a crucial VCP target during dendrite pruning. Finally, rescue experiments with a lethal mfap1 mutant show that the VCP binding region is not essential for Mfap1 function, but may act to increase its stability or activity.	[Rode, Sandra; Ohm, Henrike; Zipfel, Jaqueline; Rumpf, Sebastian] Univ Munster, Inst Neurobiol, Badestr 9, Munster, Germany	University of Munster	Rumpf, S (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, Munster, Germany.	sebastian.rumpf@uni-muenster.de	Rumpf, Sebastian/AHC-9393-2022		DFG Cluster of Excellence "Cells in Motion" [EXC1003]	DFG Cluster of Excellence "Cells in Motion"(German Research Foundation (DFG))	This study was supported by the DFG Cluster of Excellence "Cells in Motion" (EXC1003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DS, 2008, J BIOL CHEM, V283, P31256, DOI 10.1074/jbc.M803512200; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bischof J, 2013, DEVELOPMENT, V140, P2434, DOI 10.1242/dev.088757; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Han C, 2014, NEURON, V81, P544, DOI 10.1016/j.neuron.2013.11.021; Herzmann S, 2017, EMBO J, V36, P1981, DOI 10.15252/embj.201695890; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kanamori T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7515; Kirilly D, 2009, NAT NEUROSCI, V12, P1497, DOI 10.1038/nn.2415; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018068; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; Loncle N, 2012, J NEUROSCI, V32, P17086, DOI 10.1523/JNEUROSCI.1391-12.2012; Ma L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002827; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; REIMER G, 1987, ARTHRITIS RHEUM, V30, P793, DOI 10.1002/art.1780300709; Rumpf S, 2014, P NATL ACAD SCI USA, V111, P7331, DOI 10.1073/pnas.1406898111; Rumpf S, 2011, DEVELOPMENT, V138, P1153, DOI 10.1242/dev.062703; Schuldiner O, 2015, CELL MOL LIFE SCI, V72, P101, DOI 10.1007/s00018-014-1729-6; Ulrich AKC, 2016, STRUCTURE, V24, P1972, DOI 10.1016/j.str.2016.09.007; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Zhang X, 2014, G3-GENES GENOM GENET, V4, P2409, DOI 10.1534/g3.114.013979	25	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183733	10.1371/journal.pone.0183733	http://dx.doi.org/10.1371/journal.pone.0183733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837687	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000107
J	Rzeznik, M; Triba, MN; Levy, P; Jungo, S; Botosoa, E; Duchemann, B; Le Moyec, L; Bernaudin, JF; Savarin, P; Guez, D				Rzeznik, Matthias; Triba, Mohamed Nawfal; Levy, Pierre; Jungo, Sebastien; Botosoa, Eliot; Duchemann, Boris; Le Moyec, Laurence; Bernaudin, Jean-Francois; Savarin, Philippe; Guez, Dominique			Identification of a discriminative metabolomic fingerprint of potential clinical relevance in saliva of patients with periodontitis using H-1 nuclear magnetic resonance (NMR) spectroscopy	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; METABONOMIC ANALYSIS; CASE DEFINITIONS; OXYGEN-TENSION; DISEASE; BACTERIA; PLAQUE; INFLAMMATION; LACTOBACILLI; POPULATION	Periodontitis is characterized by the loss of the supporting tissues of the teeth in an inflammatory-infectious context. The diagnosis relies on clinical and X-ray examination. Unfortunately, clinical signs of tissue destruction occur late in the disease progression. Therefore, it is mandatory to identify reliable biomarkers to facilitate a better and earlier management of this disease. To this end, saliva represents a promising fluid for identification of biomarkers as metabolomic fingerprints. The present study used high-resolution H-1-nuclear magnetic resonance (NMR) spectroscopy coupled with multivariate statistical analysis to identify the metabolic signature of active periodontitis. The metabolome of stimulated saliva of 26 patients with generalized periodontitis (18 chronic and 8 aggressive) was compared to that of 25 healthy controls. Principal Components Analysis (PCA), performed with clinical variables, indicated that the patient population was homogeneous, demonstrating a strong correlation between the clinical and the radiological variables used to assess the loss of periodontal tissues and criteria of active disease. Orthogonal Projection to Latent Structure (OPLS) analysis showed that patients with periodontitis can be discriminated from controls on the basis of metabolite concentrations in saliva with satisfactory explained variance (R2X = 0.81 and R2Y = 0.61) and predictability (Q2Y = 0.49, CV-AUROC = 0.94). Interestingly, this discrimination was irrespective of the type of generalized periodontitis, i.e. chronic or aggressive. Among the main discriminating metabolites were short chain fatty acids as butyrate, observed in higher concentrations, and lactate, gamma-amino-butyrate, methanol, and threonine observed in lower concentrations in periodontitis. The association of lactate, GABA, and butyrate to generate an aggregated variable reached the best positive predictive value for diagnosis of periodontitis. In conclusion, this pilot study showed that 1H-NMR spectroscopy analysis of saliva could differentiate patients with periodontitis from controls. Therefore, this simple, robust, non-invasive method, may offer a significant help for early diagnosis and follow-up of periodontitis.	[Rzeznik, Matthias; Triba, Mohamed Nawfal; Botosoa, Eliot; Duchemann, Boris; Savarin, Philippe] Paris 13 Univ, Sorbonne Paris Cite, CSPBAT, CNRS,UMR 7244, Bobigny, France; [Rzeznik, Matthias; Jungo, Sebastien; Guez, Dominique] Paris Descartes Univ, Bretonneau Hosp, APHP, Dept Periodontol, Paris, France; [Levy, Pierre] Tenon Hosp, APHP, Dept Publ Hlth, Paris, France; [Levy, Pierre] Sorbonne Univ, INSERM UPMC, UMR S1136, EPAR Team, Paris, France; [Duchemann, Boris; Bernaudin, Jean-Francois] Avicenne Hosp, APHP, Dept Pneumol, Bobigny, France; [Le Moyec, Laurence] Univ Paris Saclay, UBIAE, Univ Evry, Evry, France; [Bernaudin, Jean-Francois] Sorbonne Univ, UPMC Paris 6, Paris, France; [Bernaudin, Jean-Francois] Paris 13 Univ, Sorbonne Paris Cite, EA2363, Bobigny, France; [Botosoa, Eliot] Artois Univ, EA 7394, Inst Charles Violette, Lens, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Avicenne - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Savarin, P (corresponding author), Paris 13 Univ, Sorbonne Paris Cite, CSPBAT, CNRS,UMR 7244, Bobigny, France.; Guez, D (corresponding author), Paris Descartes Univ, Bretonneau Hosp, APHP, Dept Periodontol, Paris, France.	philippe.savarin@univ-paris13.fr; dominique.guez@parisdescartes.fr		Savarin, Philippe/0000-0003-1451-2376; BOTOSOA, Eliot Patrick/0000-0002-1885-3824; Jungo, Sebastien/0000-0001-7747-7286; Levy, Pierre/0000-0002-2485-3628; BERNAUDIN, Jean-Francois/0000-0002-4893-0106; Duchemann, Boris/0000-0003-0872-2983	Institut Francais de Recherche Odontologique (IFRO)	Institut Francais de Recherche Odontologique (IFRO)	The study has been partly supported by a grant from Institut Francais de Recherche Odontologique (IFRO, 2013). There was no additional external funding received for this study.	Acquier AB, 2016, REDOX REPORT, P1; Aimetti M, 2012, METABOLOMICS, V8, P465, DOI 10.1007/s11306-011-0331-2; AINAMO J, 1975, INT DENT J, V25, P229; Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; Amathieu R, 2016, WORLD J GASTROENTERO, V22, P417, DOI 10.3748/wjg.v22.i1.417; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Barnes VM, 2014, PLOS ONE, V9; Bertram HC, 2009, ANAL CHEM, V81, P9188, DOI 10.1021/ac9020598; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; Bourgeois D, 2007, J PERIODONTAL RES, V42, P219, DOI 10.1111/j.1600-0765.2006.00936.x; Chang MC, 2013, J PERIODONTAL RES, V48, P66, DOI 10.1111/j.1600-0765.2012.01504.x; CHAVES ES, 1993, J CLIN PERIODONTOL, V20, P139, DOI 10.1111/j.1600-051X.1993.tb00328.x; Costalonga M, 2014, IMMUNOL LETT, V162, P22, DOI 10.1016/j.imlet.2014.08.017; Cuevas-Cordoba B, 2014, OMICS, V18, P87, DOI 10.1089/omi.2013.0064; de Laurentiis G, 2008, EUR RESPIR J, V32, P1175, DOI 10.1183/09031936.00072408; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Duchemann B, 2016, SARCOIDOSIS VASC DIF, V33, P10; EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861; Eke P. I., 2015, J PERIODONTOL, V86, P611, DOI DOI 10.1902/J0P.2015.140520; Eke PI, 2016, PERIODONTOL 2000, V72, P76, DOI 10.1111/prd.12145; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Estreicher A, 1996, ARCH ORAL BIOL, V41, P733, DOI 10.1016/S0003-9969(96)00076-3; Fayol-Messaoudi D, 2005, APPL ENVIRON MICROB, V71, P6008, DOI 10.1128/AEM.71.10.6008-6013.2005; Giannobile William V, 2012, J Am Dent Assoc, V143, p6S; Grant MM, 2010, J CLIN PERIODONTOL, V37, P1039, DOI 10.1111/j.1600-051X.2010.01622.x; Grootveld M, 2005, BIOCHEM BIOPH RES CO, V329, P1, DOI 10.1016/j.bbrc.2005.01.112; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; Gupta Abhaya, 2015, J Oral Biol Craniofac Res, V5, P46, DOI 10.1016/j.jobcr.2015.01.001; Hajishengallis G, 2014, MOL ORAL MICROBIOL, V29, P248, DOI 10.1111/omi.12065; Hanioka T, 2000, J PERIODONTOL, V71, P550, DOI 10.1902/jop.2000.71.4.550; He XS, 2010, MICROB ECOL, V60, P655, DOI 10.1007/s00248-010-9708-4; HUGOSON A, 1982, COMMUNITY DENT ORAL, V10, P187, DOI 10.1111/j.1600-0528.1982.tb00377.x; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Jiao Y, 2014, J DENT RES, V93, P539, DOI 10.1177/0022034514528212; Kageyama S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174782; Kambouchner M, 2014, HISTOPATHOLOGY, V65, P549, DOI 10.1111/his.12415; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koll-Klais P, 2005, ORAL MICROBIOL IMMUN, V20, P354, DOI 10.1111/j.1399-302X.2005.00239.x; Kruk J, 2017, APPL MAGN RESON, V48, P1, DOI 10.1007/s00723-016-0846-9; Kuboniwa M, 2016, J DENT RES, V95, P1381, DOI 10.1177/0022034516661142; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; LANG NP, 1990, J CLIN PERIODONTOL, V17, P714, DOI 10.1111/j.1600-051X.1990.tb01059.x; LANG NP, 1986, J CLIN PERIODONTOL, V13, P590, DOI 10.1111/j.1600-051X.1986.tb00852.x; Lazar V, 2016, CURR PHARM DESIGN, V22, P230, DOI 10.2174/138161282202151221124307; LISTGARTEN MA, 1988, J CLIN PERIODONTOL, V15, P485, DOI 10.1111/j.1600-051X.1988.tb01019.x; Almerich-Silla JM, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/653537; Martin-Cabezas R, 2016, AM HEART J, V180, P98, DOI 10.1016/j.ahj.2016.07.018; Mombelli A, 2003, ORAL DIS, V9, P6, DOI 10.1034/j.1601-0825.9.s1.2.x; Munshi SU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064298; Nam H, 2007, J MICROBIOL, V45, P515; Nibali L, 2015, VIRULENCE, V6, P223, DOI 10.4161/21505594.2014.986407; Niederman R, 1997, CRIT REV ORAL BIOL M, V8, P269, DOI 10.1177/10454411970080030301; Nishihara T, 2000, PERIODONTOL, V36, P14, DOI DOI 10.1111/J.1600-0757.2004.03671.X; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Pessi T, 2000, CLIN EXP ALLERGY, V30, P1804, DOI 10.1046/j.1365-2222.2000.00948.x; Pessione E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00086; Qiqiang L, 2012, J PERIODONTAL RES, V47, P740, DOI 10.1111/j.1600-0765.2012.01489.x; Range H, 2012, J CLIN PERIODONTOL, V39, P799, DOI 10.1111/j.1600-051X.2012.01913.x; Rosa N, 2012, ARCH ORAL BIOL, V57, P853, DOI 10.1016/j.archoralbio.2011.12.010; Santone C, 2014, J PHARMACEUT BIOMED, V88, P441, DOI 10.1016/j.jpba.2013.09.021; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Scannapieco FA, 2016, PERIODONTOL 2000, V72, P153, DOI 10.1111/prd.12129; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Silwood CJL, 2002, J DENT RES, V81, P422, DOI 10.1177/154405910208100613; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sousa V, 2016, CLIN ORAL IMPLAN RES, V27, P787, DOI 10.1111/clr.12684; Trindade F, 2015, PROTEOM CLIN APPL, V9, P917, DOI 10.1002/prca.201400191; Trindade F, 2014, PROTEOM CLIN APPL, V8, P748, DOI 10.1002/prca.201400028; Tsai C.-Y., 2016, J MICROBIOLOGY IMMUN; Uematsu H, 2003, ARCH ORAL BIOL, V48, P423, DOI 10.1016/S0003-9969(03)00031-1; Wallner-Liebniann S, 2016, J PROTEOME RES, V15, P1787, DOI 10.1021/acs.jproteome.5b01060; YAMADANOSAKA A, 1991, ARCH ORAL BIOL, V36, P697, DOI 10.1016/0003-9969(91)90025-P; YANG RG, 1992, APPL ENVIRON MICROB, V58, P3355, DOI 10.1128/AEM.58.10.3355-3359.1992	76	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182767	10.1371/journal.pone.0182767	http://dx.doi.org/10.1371/journal.pone.0182767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837579	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000025
J	Shang, HM; Zhou, HZ; Li, R; Duan, MY; Wu, HX; Lou, YJ				Shang, Hong-Mei; Zhou, Hai-Zhu; Li, Ran; Duan, Meng-Ying; Wu, Hong-Xin; Lou, Yu-Jie			Extraction optimization and influences of drying methods on antioxidant activities of polysaccharide from cup plant (Silphium perfoliatum L.)	PLOS ONE			English	Article							MICROWAVE-ASSISTED EXTRACTION; STRUCTURAL-CHARACTERIZATION; PHYSICOCHEMICAL PROPERTIES; CHEMICAL-COMPOSITION; FRACTIONS; FRUIT	Response surface methodology (RSM) was used to investigate the extraction condition of polysaccharide from cup plant (Silphium perfoliatum L.) (named CPP). Water to raw material ratio (10-30 mL/g), extraction time (40-80 min) and extraction temperature (60-100 degrees C) were set as the 3 independent variables, and their effects on the extraction yield of CPP were measured. In addition, the effects of drying methods including hot air drying (HD), vacuum drying (VD) and freeze drying (FD) on the antioxidant activities of CPP were evaluated. The results showed that the optimal condition to extract CPP was: water to raw material ratio (15 mL/g), extraction time (61 min), and extraction temperature (97 degrees C), a maximum CPP yield of 6.49% was obtained under this condition. CPP drying with FD method showed stronger reducing power (0.943 at 6 mg/mL) and radical scavenging capacities against DPPH radical (75.71% at 1.2 mg/mL) and ABTS radical (98.06 at 1.6 mg/mL) than CPP drying with HD and VD methods. Therefore, freeze drying served as a good method for keeping the antioxidant activities of polysaccharide from cup plant. The polysaccharide from cup plant has potential to use as a natural antioxidant.	[Shang, Hong-Mei; Zhou, Hai-Zhu; Li, Ran; Duan, Meng-Ying; Lou, Yu-Jie] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Shang, Hong-Mei; Zhou, Hai-Zhu; Lou, Yu-Jie] Jilin Agr Univ, Key Lab Anim Nutr & Feed Sci Jilin Prov, Changchun, Jilin, Peoples R China; [Wu, Hong-Xin] CAAS, Grassland Res Inst, Neimenggu, Hohhot, Peoples R China	Jilin Agricultural University; Jilin Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Lou, YJ (corresponding author), Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China.; Lou, YJ (corresponding author), Jilin Agr Univ, Key Lab Anim Nutr & Feed Sci Jilin Prov, Changchun, Jilin, Peoples R China.	lyjjlau@163.com	Shang, Hongmei/HDL-7105-2022	Shang, Hongmei/0000-0002-0961-491X	China Postdoctoral Science Foundation; National Natural Science Foundation of China [31601972]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project funded by China Postdoctoral Science Foundation and the National Natural Science Foundation of China (No. 31601972). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, PHARM BIOL, V6, P494; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen C, 2015, CARBOHYD POLYM, V130, P122, DOI 10.1016/j.carbpol.2015.05.003; Chen HX, 2008, FOOD CHEM, V106, P559, DOI 10.1016/j.foodchem.2007.06.040; Chen RZ, 2015, IND CROP PROD, V77, P434, DOI 10.1016/j.indcrop.2015.08.006; DODGSON KS, 1962, BIOCHEM J, V84, P106, DOI 10.1042/bj0840106; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fan LP, 2012, CARBOHYD POLYM, V87, P1849, DOI 10.1016/j.carbpol.2011.10.018; Jing YQ, 2016, INT J BIOL MACROMOL, V91, P188, DOI 10.1016/j.ijbiomac.2016.05.069; Jing YS, 2015, J AGR FOOD CHEM, V63, P3464, DOI 10.1021/jf505915t; Kang MC, 2014, CARBOHYD POLYM, V99, P365, DOI 10.1016/j.carbpol.2013.07.091; Kong LS, 2015, CARBOHYD POLYM, V125, P1, DOI 10.1016/j.carbpol.2015.02.042; Kumar CS, 2016, INT J BIOL MACROMOL, V92, P682, DOI 10.1016/j.ijbiomac.2016.07.062; Li XY, 2016, PROCESS BIOCHEM, V51, P1100, DOI 10.1016/j.procbio.2016.05.006; Liu ZG, 2013, INT J BIOL MACROMOL, V61, P127, DOI 10.1016/j.ijbiomac.2013.06.042; Ma LS, 2013, FOOD RES INT, V50, P633, DOI 10.1016/j.foodres.2011.05.005; Pan SK, 2014, CARBOHYD POLYM, V111, P606, DOI 10.1016/j.carbpol.2014.05.022; Radoslaw K., 2009, FOOD CHEM, V112, P820; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rostami H, 2016, CARBOHYD POLYM, V143, P100, DOI 10.1016/j.carbpol.2016.01.075; Wang JQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5692852; Wang W, 2016, INT J BIOL MACROMOL, V82, P979, DOI 10.1016/j.ijbiomac.2015.10.051; Wu CY, 2014, INT J BIOL MACROMOL, V64, P458, DOI 10.1016/j.ijbiomac.2013.12.025; Wu LC, 2006, FOOD CHEM, V95, P319, DOI 10.1016/j.foodchem.2005.01.002; Wu Z, 2015, INT J BIOL MACROMOL, V76, P218, DOI 10.1016/j.ijbiomac.2015.02.043; Xiong SL, 2011, CARBOHYD POLYM, V86, P1273, DOI 10.1016/j.carbpol.2011.06.025; Xu FF, 2016, CARBOHYD POLYM, V151, P364, DOI 10.1016/j.carbpol.2016.05.091; Xu YQ, 2016, FOOD CHEM, V194, P650, DOI 10.1016/j.foodchem.2015.08.061; Yang SF, PLOS ONE; Ying Z, 2011, FOOD CHEM, V127, P1273, DOI 10.1016/j.foodchem.2011.01.083; Zhao QS, 2015, CARBOHYD POLYM, V127, P176, DOI 10.1016/j.carbpol.2015.03.041; Zheng Q, 2016, INT J BIOL MACROMOL, V91, P856, DOI 10.1016/j.ijbiomac.2016.06.042	33	29	29	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183001	10.1371/journal.pone.0183001	http://dx.doi.org/10.1371/journal.pone.0183001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837625	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000041
J	Park, JL; Lee, YS; Song, MJ; Hong, SH; Ahn, JH; Seo, EH; Shin, SP; Lee, SJ; Johnson, BH; Stampfer, MR; Kim, HP; Kim, SY; Lee, YS				Park, J-L; Lee, Y-S; Song, M-J; Hong, S-H; Ahn, J-H; Seo, E-H; Shin, S-P; Lee, S-J; Johnson, B. H.; Stampfer, M. R.; Kim, H-P; Kim, S-Y; Lee, Y. S.			Epigenetic regulation of RNA polymerase III transcription in early breast tumorigenesis	ONCOGENE			English	Article							MAMMARY EPITHELIAL-CELLS; DNA METHYLATION; NONCODING RNA; C-MYC; GENOMIC BINDING; P53 FUNCTION; POL II; CANCER; ACTIVATION; CHROMATIN	RNA polymerase III (Pol III) transcribes medium-sized non-coding RNAs (collectively termed Pol III genes). Emerging diverse roles of Pol III genes suggest that individual Pol III genes are exquisitely regulated by transcription and epigenetic factors. Here we report global Pol III expression/methylation profiles and molecular mechanisms of Pol III regulation that have not been as extensively studied, using nc886 as a representative Pol III gene. In a human mammary epithelial cell system that recapitulates early breast tumorigenesis, the fraction of actively transcribed Pol III genes increases reaching a plateau during immortalization. Hyper-methylation of Pol III genes inhibits Pol III binding to DNA via inducing repressed chromatin and is a determinant for the Pol III repertoire. When Pol III genes are hypo-methylated, MYC amplifies their transcription, regardless of its recognition DNA motif. Thus, Pol III expression during tumorigenesis is delineated by methylation and magnified by MYC.	[Park, J-L; Seo, E-H; Kim, S-Y] KRIBB, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Park, J-L; Seo, E-H; Kim, S-Y] Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea; [Lee, Y-S; Hong, S-H] Natl Canc Ctr, Res Inst, Rare Canc Branch, Goyang Si, South Korea; [Song, M-J; Kim, H-P] Yonsei Univ, Dept Environm Med Biol, Coll Med, Seoul, South Korea; [Ahn, J-H] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea; [Ahn, J-H] Kyung Hee Univ, Dept Oriental Pharm, Seoul, South Korea; [Shin, S-P; Lee, S-J] Natl Canc Ctr, Res Inst, Immunotherapeut Branch, Goyang Si, South Korea; [Johnson, B. H.; Lee, Y. S.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Stampfer, M. R.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA USA; [Kim, H-P] Yonsei Univ, Inst Trop Med, Coll Med, Seoul, South Korea; [Kim, H-P] Yonsei Univ, Brain Korea Plus Project Med Sci 21, Coll Med, Seoul, South Korea; [Lee, Y. S.] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, 323 Ilsan Ro, Goyang 10408, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; Kyung Hee University; Kyung Hee University; National Cancer Center - Korea (NCC); University of Texas System; University of Texas Medical Branch Galveston; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC)	Kim, HP; Kim, SY; Lee, YS (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, 323 Ilsan Ro, Goyang 10408, South Korea.	kimhp@yuhs.ac; kimsy@kribb.re.kr; yslee@ncc.re.kr		Shin, Seung-Phil/0000-0003-4290-3067; Kim, Hyoung-Pyo/0000-0003-1441-8822	American Cancer Society [RSG-12-187-01-RMC]; Ministry of Science, ICT and Future Planning [NRF-2012M3A9D1054670, NRF-2014M3C9A3068554]; KRIBB Research Initiative; National Research Foundation of Korea [2016R1A2B4014183, 2017M3C9A5029978]; National Cancer Center (Korea) [1610090]; US Department of Energy [DE-AC02-05CH11231]	American Cancer Society(American Cancer Society); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); KRIBB Research Initiative; National Research Foundation of Korea(National Research Foundation of Korea); National Cancer Center (Korea); US Department of Energy(United States Department of Energy (DOE))	This work was supported by a Research Scholar Grant, RSG-12-187-01-RMC from the American Cancer Society to YSL; grants NRF-2012M3A9D1054670 and NRF-2014M3C9A3068554 funded by the Ministry of Science, ICT and Future Planning and KRIBB Research Initiative to S-YK; a grant 2016R1A2B4014183 and 2017M3C9A5029978 funded by National Research Foundation of Korea to H-PK; National Cancer Center (Korea) intramural project # 1610090 to Y-SL; and US Department of Energy under Contract No. DE-AC02-05CH11231 to MRS.	Alla RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085648; Banati F, 2008, FEBS LETT, V582, P705, DOI 10.1016/j.febslet.2008.01.042; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; BESSER D, 1990, FEBS LETT, V269, P358, DOI 10.1016/0014-5793(90)81193-R; Bhargava P, 2013, BBA-GENE REGUL MECH, V1829, P1015, DOI 10.1016/j.bbagrm.2013.05.005; Canella D, 2012, GENOME RES, V22, P666, DOI 10.1101/gr.130286.111; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; Cao JZ, 2013, CANCER RES, V73, P3326, DOI 10.1158/0008-5472.CAN-12-3055; Carriere L, 2012, NUCLEIC ACIDS RES, V40, P270, DOI 10.1093/nar/gkr737; Chen W, 1997, J PATHOL, V183, P345, DOI 10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8; Chen W, 1997, EUR J CANCER, V33, P288, DOI 10.1016/S0959-8049(96)00453-4; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Felton-Edkins ZA, 2002, J BIOL CHEM, V277, P48182, DOI 10.1074/jbc.M201333200; Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375; Fu Yu, 2015, Genomics & Informatics, V13, P94, DOI 10.5808/GI.2015.13.4.94; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Garbe JC, 2014, CELL CYCLE, V13, P3423, DOI 10.4161/15384101.2014.954456; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hines WC, 2016, BREAST CANCER RES TR, V155, P37, DOI 10.1007/s10549-015-3649-z; Hu SS, 2012, INT J BIOCHEM CELL B, V44, P1847, DOI 10.1016/j.biocel.2012.07.013; JUTTERMANN R, 1991, J VIROL, V65, P1735; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Kenneth NS, 2007, P NATL ACAD SCI USA, V104, P14917, DOI 10.1073/pnas.0702909104; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; LaBarge MA, 2013, JOVE-J VIS EXP, DOI 10.3791/50011; Lee EK, 2016, ONCOTARGET, V7, P75000, DOI 10.18632/oncotarget.11852; Lee HS, 2014, ONCOTARGET, V5, P3472, DOI 10.18632/oncotarget.1927; Lee JK, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00013; Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111; Lee KS, 2014, ONCOTARGET, V5, P3944, DOI 10.18632/oncotarget.2047; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; LIU WM, 1993, NUCLEIC ACIDS RES, V21, P1351, DOI 10.1093/nar/21.6.1351; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Moqtaderi Z, 2010, NAT STRUCT MOL BIOL, V17, P635, DOI 10.1038/nsmb.1794; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Park JL, 2017, EPIGENOMICS-UK, V9, P171, DOI 10.2217/epi-2016-0108; Park K, 2012, J LEUKOCYTE BIOL, V91, P245, DOI 10.1189/jlb.0111020; Romanelli V, 2014, EPIGENETICS-US, V9, P783, DOI 10.4161/epi.28323; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Selvakumar T, 2012, J BIOL CHEM, V287, P7039, DOI 10.1074/jbc.M111.285601; Silver MJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0660-y; Stampfer MR, 2003, ONCOGENE, V22, P5238, DOI 10.1038/sj.onc.1206667; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Stampfer MR, 2013, CELL MOL BIOL BREAST, P323, DOI [10.1007/978-1-62703-634-4_15, DOI 10.1007/978-1-62703-634-4_15]; Treppendahl MB, 2012, BLOOD, V119, P206, DOI 10.1182/blood-2011-06-362541; Varshney D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7569; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Xie HH, 2010, P NATL ACAD SCI USA, V107, P6952, DOI 10.1073/pnas.0913836107	60	16	16	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 7	2017	36	49					6793	6804		10.1038/onc.2017.285	http://dx.doi.org/10.1038/onc.2017.285			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FP0IK	28846112	Green Published			2022-12-26	WOS:000417282500005
J	Feng, D; Chen, Z; Yang, K; Miao, SS; Xu, BL; Kang, YS; Xie, HB; Zhao, CT				Feng, Dong; Chen, Zhe; Yang, Kuang; Miao, Shanshan; Xu, Bolin; Kang, Yunsi; Xie, Haibo; Zhao, Chengtian			The cytoplasmic tail of rhodopsin triggers rapid rod degeneration in kinesin-2 mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; HETEROTRIMERIC KINESIN-2; VERTEBRATE PHOTORECEPTOR; OUTER SEGMENTS; RETINITIS-PIGMENTOSA; IFT-PARTICLE; DOUBLE CONE; CELL-DEATH; ZEBRAFISH; CILIARY	Photoreceptor degeneration can lead to blindness and represents the most common form of neural degenerative disease worldwide. Although many genes involved in photoreceptor degeneration have been identified, the underlying mechanisms remain to be elucidated. Here we examined photoreceptor development in zebrafish kif3a and kif3b mutants, which affect two subunits of the kinesin-2 complex. In both mutants, rods degenerated quickly, whereas cones underwent a slow degeneration process. Notably, the photoreceptor defects were considerably more severe in kif3a mutants than in kif3b mutants. In the cone photoreceptors of kif3a mutants, opsin proteins accumulated in the apical region and formed abnormal membrane structures. In contrast, rhodopsins were enriched in the rod cell body membrane and represented the primary reason for rapid rod degeneration in these mutants. Moreover, removal of the cytoplasmic tail of rhodopsin to reduce its function, but not decreasing rhodopsin expression levels, prevented rod degeneration in both kif3a and kif3b mutants. Of note, overexpression of full-length rhodopsin or its cytoplasmic tail domain, but not of rhodopsin lacking the cytoplasmic tail, exacerbated rod degeneration in kif3a mutants, implying an important role of the cytoplasmic tail in rod degeneration. Finally, we showed that the cytoplasmic tail of rhodopsin might trigger rod degeneration through activating the downstream calcium signaling pathway, as drug treatment with inhibitors of intracellular calcium release prevented rod degeneration in kif3a mutants. Our results demonstrate a previously unknown function of the rhodopsin cytoplasmic domain during opsin-triggered photoreceptor degeneration and may open up new avenues for managing this disease.	[Feng, Dong; Chen, Zhe; Yang, Kuang; Miao, Shanshan; Xu, Bolin; Kang, Yunsi; Xie, Haibo; Zhao, Chengtian] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao 266003, Peoples R China; [Zhao, Chengtian] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266003, Peoples R China; [Zhao, Chengtian] Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao 266003, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology; Ocean University of China	Zhao, CT (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao 266003, Peoples R China.; Zhao, CT (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266003, Peoples R China.; Zhao, CT (corresponding author), Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao 266003, Peoples R China.	chengtian_zhao@ouc.edu.cn			National Natural Science Foundation of China [31372274, 31422051, 81301718]; Shandong Provincial Natural Science Foundation [JQ201506]; Fundamental Research Funds for the Central Universities [201562029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31372274, 31422051, and 81301718; Shandong Provincial Natural Science Foundation Grant JQ201506; and Fundamental Research Funds for the Central Universities Grant 201562029. The authors declare that they have no conflicts of interest with the contents of this article.	Alfinito PD, 2002, P NATL ACAD SCI USA, V99, P5655, DOI 10.1073/pnas.072557799; APFELSTEDTSYLLA E, 1993, BRIT J OPHTHALMOL, V77, P495, DOI 10.1136/bjo.77.8.495; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; [陈哲 Chen Zhe], 2015, [中国实验动物学报, Acta Laboratorium Animalis Scientia Sinica], V23, P453; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Craft JM, 2015, J CELL BIOL, V208, P223, DOI 10.1083/jcb.201409036; Fadool JM, 2003, DEV BIOL, V258, P277, DOI 10.1016/S0012-1606(03)00125-8; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; Ile KE, 2010, TRAFFIC, V11, P1151, DOI 10.1111/j.1600-0854.2010.01085.x; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Insinna C, 2009, DEV DYNAM, V238, P2211, DOI 10.1002/dvdy.21956; Jiang L, 2015, FASEB J, V29, P4866, DOI 10.1096/fj.15-275677; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Kang YY, 2016, FEBS J, V283, P816, DOI 10.1111/febs.13561; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Kisselev OG, 2004, J BIOL CHEM, V279, P51203, DOI 10.1074/jbc.M407341200; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397; LARISON KD, 1990, DEVELOPMENT, V109, P567; Leventea E, 2016, METHOD CELL BIOL, V133, P179, DOI 10.1016/bs.mcb.2016.04.016; Lopes VS, 2010, MOL BIOL CELL, V21, P4076, DOI 10.1091/mbc.E10-08-0715; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pooranachandran N, 2016, GENETICS, V203, P771, DOI 10.1534/genetics.115.180943; Pujic Z, 2004, SEMIN CELL DEV BIOL, V15, P105, DOI 10.1016/j.semcdb.2003.09.008; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Song Z, 2016, J GENET GENOMICS, V43, P107, DOI 10.1016/j.jgg.2016.02.001; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Trivedi D, 2012, J NEUROSCI, V32, P10587, DOI 10.1523/JNEUROSCI.0015-12.2012; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Yin J, 2012, INVEST OPHTH VIS SCI, V53, P4943, DOI 10.1167/iovs.12-9511; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, INVEST OPHTH VISUAL, V8, P222; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004; Zhao CT, 2012, P NATL ACAD SCI USA, V109, P2388, DOI 10.1073/pnas.1116035109; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165	48	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17375	17386		10.1074/jbc.M117.784017	http://dx.doi.org/10.1074/jbc.M117.784017			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28855254	Green Published, hybrid			2022-12-26	WOS:000414009300019
J	Kumar, R; Grosbart, M; Nurse, P; Bahng, S; Wyman, CL; Marians, KJ				Kumar, Rupesh; Grosbart, Malgorzata; Nurse, Pearl; Bahng, Soon; Wyman, Claire L.; Marians, Kenneth J.			The bacterial condensin MukB compacts DNA by sequestering supercoils and stabilizing topologically isolated loops	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromosomes; DNA; DNA structure; DNA topology; nucleic acid enzymology; DNA enzymes; nucleic acids; nucleic acid enzymes	ESCHERICHIA-COLI CHROMOSOME; SEPARATE CELL HALVES; STRUCTURAL MAINTENANCE; CRYSTAL-STRUCTURE; TOPOISOMERASE-IV; HINGE DOMAIN; COMPLEX; PROTEIN; ATP; ORGANIZATION	MukB is a structural maintenance of chromosome-like protein required for DNA condensation. The complete condensin is a large tripartite complex of MukB, the kleisin, MukF, and an accessory protein, MukE. As found previously, MukB DNA condensation is a stepwise process. We have defined these steps topologically. They proceed first via the formation of negative supercoils that are sequestered by the protein followed by hinge-hinge interactions between MukB dimers that stabilize topologically isolated loops in the DNA. MukB itself is sufficient to mediate both of these topological alterations; neither ATP nor MukEF is required. We show that the MukB hinge region binds DNA and that this region of the protein is involved in sequestration of supercoils. Cells carrying mutations in the MukB hinge that reduce DNA condensation in vitro exhibit nucleoid decondensation in vivo.	[Kumar, Rupesh; Nurse, Pearl; Bahng, Soon; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA; [Grosbart, Malgorzata; Wyman, Claire L.] Erasmus Univ, Med Ctr, Dept Mol Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Wyman, Claire L.] Erasmus Univ, Med Ctr, Dept Radiat Oncol, POB 2040, NL-3000 CA Rotterdam, Netherlands	Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu	Kumar, Rupesh/A-2077-2019	Kumar, Rupesh/0000-0001-5661-8828	National Institutes of Health Cancer Center Core Support Grant from NCI [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Core Support Grant from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank James Berger and Chris Lima for discussion. The Memorial Sloan Kettering Cancer Center was recipient of National Institutes of Health Cancer Center Core Support Grant P30CA008748 from NCI.	Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Bahng S, 2016, J BIOL CHEM, V291, P23999, DOI 10.1074/jbc.M116.749994; Chen N, 2008, J BACTERIOL, V190, P3731, DOI 10.1128/JB.01863-07; Cui YB, 2008, NAT STRUCT MOL BIOL, V15, P411, DOI 10.1038/nsmb.1410; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Eng T, 2015, MOL BIOL CELL, V26, P4224, DOI 10.1091/mbc.E15-06-0331; Farcas AM, 2011, MOL CELL, V44, P97, DOI 10.1016/j.molcel.2011.07.034; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hayama R, 2013, J BIOL CHEM, V288, P7653, DOI 10.1074/jbc.M112.418087; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; Kanno T, 2015, CELL REP, V12, P1471, DOI 10.1016/j.celrep.2015.07.048; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10200; Ku B, 2010, PROTEINS, V78, P1483, DOI 10.1002/prot.22664; Kumar R, 2017, J BIOL CHEM, V292, P16921, DOI 10.1074/jbc.M117.803346; LEHMAN IR, 1974, SCIENCE, V186, P790; Li YY, 2010, J MOL BIOL, V395, P11, DOI 10.1016/j.jmb.2009.10.040; LIU LF, 1976, J MOL BIOL, V106, P439, DOI 10.1016/0022-2836(76)90095-4; Matoba K, 2005, BIOCHEM BIOPH RES CO, V333, P694, DOI 10.1016/j.bbrc.2005.05.163; Michieletto D, 2015, P NATL ACAD SCI USA, V112, pE5471, DOI 10.1073/pnas.1506907112; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Murphy LD, 1997, J STRUCT BIOL, V119, P321, DOI 10.1006/jsbi.1997.3883; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Niki H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29469; Nolivos S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10466; Ohsumi K, 2001, MOL MICROBIOL, V40, P835, DOI 10.1046/j.1365-2958.2001.02447.x; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Ristic D, 2011, METHODS MOL BIOL, V783, P213, DOI 10.1007/978-1-61779-282-3_12; Rybenkov VV, 2014, J MOL MICROB BIOTECH, V24, P371, DOI 10.1159/000369099; Sanchez H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0457-8; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; SHUMAN S, 1990, J BIOL CHEM, V265, P17826; Soh YM, 2015, MOL CELL, V57, P290, DOI 10.1016/j.molcel.2014.11.023; Stigler J, 2016, CELL REP, V15, P988, DOI 10.1016/j.celrep.2016.04.003; Sun MX, 2013, NUCLEIC ACIDS RES, V41, P6149, DOI 10.1093/nar/gkt303; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Wilhelm L, 2015, ELIFE, V4, DOI 10.7554/eLife.06659; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873; Yazdi NH, 2012, MOL MICROBIOL, V86, P1318, DOI 10.1111/mmi.12071; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111; Yi Jiang, 2015, ICIC Express Letters, V9, P81; Youngren B, 2014, GENE DEV, V28, P71, DOI 10.1101/gad.231050.113	52	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16904	16920		10.1074/jbc.M117.803312	http://dx.doi.org/10.1074/jbc.M117.803312			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842486	hybrid, Green Published			2022-12-26	WOS:000413140600012
J	Crotty, SM; Angelini, C; Bertness, MD				Crotty, Sinead M.; Angelini, Christine; Bertness, Mark D.			Multiple stressors and the potential for synergistic loss of New England salt marshes	PLOS ONE			English	Article							CLIMATE-CHANGE; CORAL-REEFS; ECOSYSTEM; FUTURE; BIODIVERSITY; RESILIENCE; IMPACTS; DEGRADATION; CORDGRASS; COLLAPSE	Climate change and other anthropogenic stressors are converging on coastal ecosystems worldwide. Understanding how these stressors interact to affect ecosystem structure and function has immediate implications for coastal planning, however few studies quantify stressor interactions. We examined past and potential future interactions between two leading stressors on New England salt marshes: sea-level rise and marsh crab (Sesarma reticulatum) grazing driven low marsh die-off. Geospatial analyses reveal that crab-driven die-off has led to an order of magnitude more marsh loss than sea-level rise between 2005 and 2013. However, field transplant experimental results suggest that sea-level rise will facilitate crab expansion into higher elevation marsh platforms by inundating and gradually softening now-tough high marsh peat, exposing large areas to crab-driven die-off. Taking interactive effects of marsh softening and concomitant overgrazing into account, we estimate that even modest levels of sea-level rise will lead to levels of salt marsh habitat loss that are 3x greater than the additive effects of sea-level rise and crab-driven die-off would predict. These findings highlight the importance of multiple stressor studies in enhancing mechanistic understanding of ecosystem vulnerabilities to future stress scenarios and encourage managers to focus on ameliorating local stressors to break detrimental synergisms, reduce future ecosystem loss, and enhance ecosystem resilience to global change.	[Crotty, Sinead M.; Angelini, Christine] Univ Florida, Dept Environm Engn Sci, Engn Sch Sustainable Infrastruct & Environm, Gainesville, FL 32611 USA; [Crotty, Sinead M.; Bertness, Mark D.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	State University System of Florida; University of Florida; Brown University	Crotty, SM (corresponding author), Univ Florida, Dept Environm Engn Sci, Engn Sch Sustainable Infrastruct & Environm, Gainesville, FL 32611 USA.; Crotty, SM (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	scrotty@ufl.edu			Brown University Undergraduate Teaching and Research Award	Brown University Undergraduate Teaching and Research Award	This work was funded by a Brown University Undergraduate Teaching and Research Award to Sinead M. Crotty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti J, 2008, ECOLOGY, V89, P155, DOI 10.1890/07-0045.1; Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bertness MD, 2014, ECOL LETT, V17, P830, DOI 10.1111/ele.12287; Bertness MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092916; Bertness MD, 2009, ECOLOGY, V90, P2108, DOI 10.1890/08-1396.1; BERTNESS MD, 1984, ECOLOGY, V65, P1794, DOI 10.2307/1937776; BERTNESS MD, 1988, ECOLOGY, V69, P703, DOI 10.2307/1941018; Boyd J, 2015, RHODE ISLAND SEA LEV; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Clarke A, 2003, ENVIRON CONSERV, V30, P1, DOI 10.1017/S0376892903000018; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Cote IM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2592; Coverdale TC, 2013, FRONT ECOL ENVIRON, V11, P69, DOI 10.1890/120130; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Donnelly JP, 2001, P NATL ACAD SCI USA, V98, P14218, DOI 10.1073/pnas.251209298; Edenhofer O., 2014, CONTRIBUTION WORKING; FitzGerald DM, 2008, ANNU REV EARTH PL SC, V36, P601, DOI 10.1146/annurev.earth.35.031306.140139; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harley CDG, 2004, CAL COOP OCEAN FISH, V45, P98; He Q, 2017, ECOL LETT, V20, P194, DOI 10.1111/ele.12721; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Lauzon-Guay JS, 2009, J SHELLFISH RES, V28, P581, DOI 10.2983/035.028.0322; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; McClanahan TR, 2002, ENVIRON CONSERV, V29, P460, DOI 10.1017/S0376892902000334; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Raposa KB, ESTUARIES COAST, V40, P640; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Silliman BR, 2013, ANNU REV ECOL EVOL S, V44, P503, DOI 10.1146/annurev-ecolsys-110512-135753; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Sorte CJB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145191; Strain EMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120837; Strain EMA, 2014, GLOBAL CHANGE BIOL, V20, P3300, DOI 10.1111/gcb.12619; Szura K, 2017, J EXP MAR BIOL ECOL, V486, P282, DOI 10.1016/j.jembe.2016.10.029; Valle M, 2014, BIOL CONSERV, V170, P74, DOI 10.1016/j.biocon.2013.12.017; WARREN RS, 1993, ECOLOGY, V74, P96, DOI 10.2307/1939504; Watson EB, 2017, ESTUAR COAST, V40, P617, DOI [10.1007/s12237-016-0166-1, 10.1007/s12237-016-0069-1]; Witman JD, 2003, ECOL MONOGR, V73, P441, DOI 10.1890/01-4073; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zhang KQ, 2004, CLIMATIC CHANGE, V64, P41, DOI 10.1023/B:CLIM.0000024690.32682.48	52	16	16	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183058	10.1371/journal.pone.0183058	http://dx.doi.org/10.1371/journal.pone.0183058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859097	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500009
J	Lee, MK; Lin, SP; HuangFu, WC; Yang, DS; Liu, IH				Lee, Ming-Kang; Lin, Shau-Ping; HuangFu, Wei-Chun; Yang, Dee-Shiuh; Liu, I-Hsuan			Endothelial-derived extracellular matrix ameliorate the stemness deprivation during ex vivo expansion of mouse bone marrow-derived mesenchymal stem cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; STROMAL CELLS; IN-VITRO; OSTEOGENIC DIFFERENTIATION; OSTEOBLASTIC DIFFERENTIATION; INTERFERON-GAMMA; PROGENITOR CELLS; ADIPOSE-TISSUE; ADULT; PROLIFERATION	Mesenchymal stem cells (MSCs) hold great potential in cell therapies by virtue of the regenerative effects and immunomodulatory properties, but the scarce nature of MSCs makes ex vivo expansion indispensable prior to transplantation purposes. However, potential loss of stemness ensuing culture expansion has hindered the advancements in MSCs-based treatments. In principle, stemness could be preserved by reconstructing the stem cell niche. To test whether the endothelial cells (ECs) participate in the constitution of the stem cell niche for mesenchymal stem cells (MSCs), ECs derivatives including extracellular matrix (ECM) and conditioned medium (CM) prepared from aortic endothelial cells (AECs) and Mile Sven 1 endothelial cell line (MS1) were investigated for the potential to maintain MSCs stemness. MSCs expanded on endothelial ECMs, especially on MS1-ECM, possessed a more juvenile morphology and showed delayed proliferation, when compared with untreated MSCs and MSCs on MSC-ECM and in CMs. Once induced, MS1-ECM group showed better tri-lineage differentiations indicating that MS1-ECM could better preserve MSC stemness. MSCs on MS1-ECM showed stronger immune-modulatory potential and had significantly higher H3K27me3 with lower Kdm6b expression. Taken together, MS1-ECM shapes an inhibitory chromatin signature and retains MSCs stemness. Our work provided supportive evidence that MSCs can reside in a perivascular niche, and a feasible novel approach for MSCs expansion.	[Lee, Ming-Kang; Yang, Dee-Shiuh; Liu, I-Hsuan] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Lin, Shau-Ping] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Lin, Shau-Ping; Liu, I-Hsuan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan; [Lin, Shau-Ping] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan; [HuangFu, Wei-Chun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Canc Biol & Drug Discovery, Taipei, Taiwan; [Liu, I-Hsuan] Natl Taiwan Univ, Sch Vet Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Taipei Medical University; National Taiwan University	Liu, IH (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Liu, IH (corresponding author), Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan.; Liu, IH (corresponding author), Natl Taiwan Univ, Sch Vet Med, Taipei, Taiwan.	ihliu@ntu.edu.tw	Liu, I-Hsuan/D-9043-2017	Liu, I-Hsuan/0000-0002-4524-3263; Lin, Shau-Ping/0000-0003-3423-991X	Ministry of Science and Technology [103-2313-B-002-037, 105-2628-B-002-005-MY4]; National Health Research Institutes, Taiwan [NHRI-EX104-10116EC]; Taipei Medical University [105TMU-CIT-01-1]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Taipei Medical University	This work was financially supported by Ministry of Science and Technology (103-2313-B-002-037 and 105-2628-B-002-005-MY4), National Health Research Institutes (NHRI-EX104-10116EC), Taiwan, to I-Hsuan Liu as well as Taipei Medical University (105TMU-CIT-01-1) to Wei-Chun HuangFu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Chen XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136991; Cheng CC, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-21; Cheng CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036085; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001; Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fischer ER, 2012, SCANNING ELECT MICRO; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Guerrero J, 2013, ACTA BIOMATER, V9, P8200, DOI 10.1016/j.actbio.2013.05.025; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kim J, 2013, BIOMATERIALS, V34, P7257, DOI 10.1016/j.biomaterials.2013.06.029; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Meyer MB, 2016, J BIOL CHEM, V291, P17829, DOI 10.1074/jbc.M116.736538; Munneke JM, 2015, TRANSPLANTATION; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012; Narbona-Carceles J, 2014, INJURY, V45, pS42, DOI 10.1016/S0020-1383(14)70009-9; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Rizk M, 2016, BIOL BLOOD MARROW TR, V22, P1416, DOI 10.1016/j.bbmt.2016.04.010; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Saleh F A, 2011, Eur Cell Mater, V22, P242; Saleh FA, 2011, STEM CELLS DEV, V20, P391, DOI 10.1089/scd.2010.0168; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sun Y, 2011, FASEB J, V25, P1474, DOI 10.1096/fj.10-161497; Thebaud NB, 2012, J TISSUE ENG REGEN M, V6, pe51, DOI 10.1002/term.1539; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; von Bahr L, 2012, BIOL BLOOD MARROW TR, V18, P557, DOI 10.1016/j.bbmt.2011.07.023; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388; Xiao GY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23120; Ye L, 2012, CELL STEM CELL, V11, P50, DOI 10.1016/j.stem.2012.04.009; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128; Zeitouni S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003396; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	76	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184111	10.1371/journal.pone.0184111	http://dx.doi.org/10.1371/journal.pone.0184111			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854282	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600085
J	Stinnesbeck, W; Becker, J; Hering, F; Frey, E; Gonzalez, AG; Fohlmeister, J; Stinnesbeck, S; Frank, N; Mata, AT; Benavente, ME; Olguin, JA; Nunez, EA; Zell, P; Deininger, M				Stinnesbeck, Wolfgang; Becker, Julia; Hering, Fabio; Frey, Eberhard; Gonzalez Gonzalez, Arturo; Fohlmeister, Jens; Stinnesbeck, Sarah; Frank, Norbert; Terrazas Mata, Alejandro; Elena Benavente, Martha; Aviles Olguin, Jeronimo; Aceves Nunez, Eugenio; Zell, Patrick; Deininger, Michael			The earliest settlers of Mesoamerica date back to the late Pleistocene	PLOS ONE			English	Article							CAPIVARA-NATIONAL-PARK; SEA-LEVEL RISE; LAST DEGLACIATION; YUCATAN PENINSULA; STABLE-ISOTOPES; YOUNGER DRYAS; NEW-WORLD; CLIMATE; RECORD; DISPERSAL	Preceramic human skeletal remains preserved in submerged caves near Tulum in the Mexican state of Quintana Roo, Mexico, reveal conflicting results regarding C-14 dating. Here we use U-series techniques for dating a stalagmite overgrowing the pelvis of a human skeleton discovered in the submerged Chan Hol cave. The oldest closed system U/Th age comes from around 21 mm above the pelvis defining the terminus ante quem for the pelvis to 11311 +/- 370 y BP. However, the skeleton might be considerable older, probably as old as 13 ky BP as indicated by the speleothem stable isotope data. The Chan Hol individual confirms a late Pleistocene settling of Mesoamerica and represents one of the oldest human osteological remains in America.	[Stinnesbeck, Wolfgang; Hering, Fabio] Heidelberg Univ, Inst Geowissensch, Neuenheimer Feld 234, Heidelberg, Germany; [Becker, Julia] Karlsruher Inst Technol, Inst Meteorol & Klimaforsch, H v Helmholtz Pl 1, Leopoldshafen, Germany; [Frey, Eberhard; Stinnesbeck, Sarah] Staatliches Museum Nat Kunde Karlsruhe, Geowissensch Abt, Erbprinzstr 13, Karlsuhe, Germany; [Gonzalez Gonzalez, Arturo] Museo Desierto, Nuevo Ctr Metropolitano Saltillo, Carlos Abedrop Davila 3745, Saltillo, Coahuila, Mexico; [Fohlmeister, Jens] Univ Potsdam, Inst Erd & Umweltwissensch, Karl Liebknecht Str 24, Potsdam, Germany; [Frank, Norbert] Heidelberg Univ, Inst Umweltphys, Neuenheimer Feld 229, Heidelberg, Germany; [Terrazas Mata, Alejandro; Elena Benavente, Martha] Univ Nacl Autonoma Mexico, Inst Invest Antropol, Area Prehist & Evoluc, Mexico City, DF, Mexico; [Aviles Olguin, Jeronimo; Aceves Nunez, Eugenio] Inst Prehist Amer, Carretera Fed 307, Solidaridad, Quintana Roo, Mexico; [Zell, Patrick] Hess Landesmuseum Darmstadt, Friedenspl 1, Darmstadt, Germany; [Deininger, Michael] Univ Coll Dublin, UCD Sch Earth Sci, Dublin 4, Ireland	Ruprecht Karls University Heidelberg; University of Potsdam; Ruprecht Karls University Heidelberg; Universidad Nacional Autonoma de Mexico; University College Dublin	Stinnesbeck, W (corresponding author), Heidelberg Univ, Inst Geowissensch, Neuenheimer Feld 234, Heidelberg, Germany.	wolfgang.stinnesbeck@geow.uni-heidelberg.de	Frank, Norbert/D-6486-2016	Frank, Norbert/0000-0002-0416-9546	Internationales Buro of the German Bundesministerium fur Bildung und Forschung (BMBF) [01DN119]; Deutsche Forschungsgemeinschaft (DFG) [STI 128/28-1]; Irish Research Council (IRC) by a Government of Ireland [GOIPD/2015/789]; BMBF; DFG; IRC	Internationales Buro of the German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Irish Research Council (IRC) by a Government of Ireland; BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); IRC	All the funding or sources of support received during this specific study have been presented. This financial support was granted to us by the Internationales Buro of the German Bundesministerium fur Bildung und Forschung (BMBF project 01DN119) and the Deutsche Forschungsgemeinschaft (DFG project STI 128/28-1). MD acknowledges support by the Irish Research Council (IRC) by a Government of Ireland Postdoctoral Fellowship (GOIPD/2015/789). BMBF and DFG financed our field work in Mexico and provided funds for laboratory work. Author Michael Deininger received a salary from the IRC during part of this study. Other than that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; Asmerom Y, 2007, GEOLOGY, V35, P1, DOI 10.1130/G22865A.1; Asmerom Y, 2010, NAT GEOSCI, V3, P114, DOI 10.1038/NGEO754; Beddows P. A., 2004, THESIS; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; Blanchon P, 2009, NATURE, V458, P881, DOI 10.1038/nature07933; Brenner M., 2002, ANCIENT MESOAM, V13, P141, DOI [DOI 10.1017/S0956536102131063, 10.1017/S0956536102131063]; Bueno L, 2013, QUATERN INT, V301, P74, DOI 10.1016/j.quaint.2013.03.042; Carlson A.E., 2013, ENCY Q SCI, V3, P126, DOI DOI 10.1016/B978-0-444-53643-3.00029-7; Chatters JC, 2014, SCIENCE, V344, P750, DOI 10.1126/science.1252619; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Collins SV, 2015, QUATERNARY SCI REV, V124, P68, DOI 10.1016/j.quascirev.2015.06.024; Curtis JH, 1996, QUATERNARY RES, V46, P37, DOI 10.1006/qres.1996.0042; DANSGAARD W, 1964, TELLUS, V16, P436; Dilla T, 2015, PATIENT PREFER ADHER, V10, DOI 10.2147/PPA.S93760; Douglas PMJ, 2015, P NATL ACAD SCI USA, V112, P5607, DOI 10.1073/pnas.1419133112; Douville E, 2010, CHEM GEOL, V272, P1, DOI 10.1016/j.chemgeo.2010.01.007; Erlandson JM, 2015, J ISL COAST ARCHAEOL, V10, P392, DOI 10.1080/15564894.2014.1001923; Erlandson JM, 2011, SCIENCE, V331, P1181, DOI 10.1126/science.1201477; Escobar J, 2012, QUATERNARY SCI REV, V37, P92, DOI 10.1016/j.quascirev.2012.01.020; Feehan J., 2001, BOOK BURREN, P14; Felis T, 2015, INTEGRATED ANAL INTE, P69; Ferring CR, 2001, ARCHAEOLOGY PALEOECO, P1; Fiedel SJ, 2000, J ARCHAEOL RES, V8, P39, DOI 10.1023/A:1009400309773; Fontugne M, 2013, RADIOCARBON, V55, P1191, DOI 10.1017/S0033822200048104; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gonzalez A.H., 2008, CURR RES PLEISTOCENE, V25, P1; Gonzalez Gonzalez AH, 2013, PALEOAMERICAN ODYSSE, P399; Grant KM, 2012, NATURE, V491, P744, DOI 10.1038/nature11593; Halligan JJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600375; Haug G. H., 2001, Science, V293, P1304, DOI 10.1126/science.1059725; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Heintzman PD, 2016, P NATL ACAD SCI USA, V113, P8057, DOI 10.1073/pnas.1601077113; Hodell DA, 2008, QUATERNARY SCI REV, V27, P1152, DOI 10.1016/j.quascirev.2008.02.008; Hoffecker JF, 2016, EVOL ANTHROPOL, V25, P64, DOI 10.1002/evan.21478; IntCal04, 2004, CAL ISS RAD, V46, P3; Jackson D, 2014, PALEOAMERICA, V1, P213; Jenkins DL, 2013, PALEOAMERICAN ODYSSE, P485; Joyce DJ, 2013, PALEOAMERICAN ODYSSE, P467; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; Lafuente B., 2015, HIGHLIGHTS MINERALOG, P1, DOI DOI 10.1515/9783110417104-003; Lefticariu M, 2006, SEDIMENT GEOL, V183, P51, DOI 10.1016/j.sedgeo.2005.09.008; Lessa A, 2002, AM J PHYS ANTHROPOL, V118, P99, DOI 10.1002/ajpa.10084; Leyden B.W., 1993, GEOPHYSICAL MONOGRAP, P165, DOI 10.1029/GM078p0165; Leyden BW, 1995, QUATERNARY SCI REV, V14, P833, DOI 10.1016/0277-3791(95)00065-8; Marin LE, 1990, THESIS; Millard AR, 1996, GEOCHIM COSMOCHIM AC, V60, P2139, DOI 10.1016/0016-7037(96)00050-6; MOORE YH, 1992, GROUND WATER, V30, P343, DOI 10.1111/j.1745-6584.1992.tb02002.x; Moseley GE, 2015, HOLOCENE, V25, P1511, DOI 10.1177/0959683615585832; Neves WA, 2013, PALEOAMERICAN ODYSSE, P397; Pedersen MW, 2016, NATURE, V537, P45, DOI 10.1038/nature19085; Pike AWG, 2003, REV MINERAL GEOCHEM, V52, P607, DOI 10.2113/0520607; Prufer K, 2015, SCIENCE, V347, DOI 10.1126/science.1260617; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen S. O., 2006, J GEOPHYS RES ATMOS, V111, P1; Reed Elizabeth, 2009, Journal of Taphonomy, V7, P265; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Sambridge M, 2012, QUAT GEOCHRONOL, V9, P42, DOI 10.1016/j.quageo.2012.02.010; Sanchez G, 2014, P NATL ACAD SCI USA, V111, P10972, DOI 10.1073/pnas.1404546111; Smart PL, 2006, GEOL SOC AM SPEC PAP, V404, P105, DOI 10.1130/2006.2404(10); Stanford DJ, 2012, ACROSS ATLANTIC ICE: THE ORIGIN OF AMERICA'S CLOVIS CULTURE, P1; Stuiver M, 1995, QUATERNARY RES, V44, P341, DOI 10.1006/qres.1995.1079; Taylor RE, 2009, RADIOCARBON, V51, P173, DOI 10.1017/S0033822200033774; Wagner JDM, 2010, NAT GEOSCI, V3, P110, DOI 10.1038/NGEO707; Ward W.C., 1985, GEOLOGY HYDROGEOLOGY, P23, DOI DOI 10.1016/J.PROENG.2015.08.363; Waters MR, 2014, PALEOAMERICAN ODYSSE, P541; Weide A.E., 1985, GEOLOGY HYDROGEOLOGY, P1; Yang Y, 2010, SCI CHINA EARTH SCI, V53, P633, DOI 10.1007/s11430-010-0025-z	70	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183345	10.1371/journal.pone.0183345	http://dx.doi.org/10.1371/journal.pone.0183345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854194	Green Published, gold, Green Submitted			2022-12-26	WOS:000408693600041
J	Abrao, FO; Duarte, ER; Pessoa, MS; dos Santos, VL; de Freitas, LF; Barros, KD; Hughes, AFD; Silva, TD; Rodriguez, NM				Abrao, Flavia Oliveira; Duarte, Eduardo Robson; Pessoa, Moises Sena; dos Santos, Vera Lucia; de Freitas Junior, Luiz Fernando; Barros, Katharina de Oliveira; da Silva Hughes, Alice Ferreira; Silva, Thiago Dias; Rodriguez, Norberto Mario			Notable fibrolytic enzyme production by Aspergillus spp. isolates from the gastrointestinal tract of beef cattle fed in lignified pastures	PLOS ONE			English	Article							FUNGI; CELLULASE; PERFORMANCE; DIGESTION	Fungi have the ability to degrade vegetal cell wall carbohydrates, and their presence in the digestive tract of ruminants can minimize the effects of lignified forage on ruminal fermentation. Here, we evaluated enzyme production by Aspergillus spp. isolates from the digestive tracts of cattle grazed in tropical pastures during the dry season. Filamentous fungi were isolated from rumen and feces by culture in cellulose-based medium. Ninety fungal strains were isolated and identified by rDNA sequence analysis, microculture, or both. Aspergillus terreus was the most frequently isolated species, followed by Aspergillus fumigatus. The isolates were characterized with respect to their cellulolytic, xylanolytic, and lignolytic activity through qualitative evaluation in culture medium containing a specific corresponding carbon source. Carboxymethyl cellulase (CMCase) activity was quantified by the reducing sugar method. In the avicel and xilan degradation test, the enzyme activity (EA) at 48 h was significantly higher other periods (P < 0.05). Intra- and inter-specific differences in EA were verified, and high levels of phenoloxidases, which are crucial for lignin degradation, were observed in 28.9% of the isolates. Aspergillus terreus showed significantly higher EA for avicelase (3.96 +/- 1.77) and xylanase (3.13 +/- .091) than the other Aspergillus species at 48 h of incubation. Isolates AT13 and AF69 showed the highest CMCase specific activity (54.84 and 33.03 U mg(-1) protein, respectively). Selected Aspergillus spp. isolates produced remarkable levels of enzymes involved in vegetal cell wall degradation, suggesting their potential as antimicrobial additives or probiotics in ruminant diets.	[Abrao, Flavia Oliveira; Silva, Thiago Dias] Inst Fed Goiano, Ceres, Brazil; [Duarte, Eduardo Robson] Univ Fed Minas Gerais, Inst Ciencias Agr, Montes Claros, Brazil; [Pessoa, Moises Sena] Univ Fed Goias, Goiania, Go, Brazil; [dos Santos, Vera Lucia; de Freitas Junior, Luiz Fernando; Barros, Katharina de Oliveira; da Silva Hughes, Alice Ferreira] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Rodriguez, Norberto Mario] Univ Fed Minas Gerais, Escola Vet, Belo Horizonte, MG, Brazil	Instituto Federal Goiano; Universidade Federal de Minas Gerais; Universidade Federal de Goias; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Duarte, ER (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Agr, Montes Claros, Brazil.	duarvet@pq.cnpq.br	santos, Vera Lúcia dos/J-2507-2018	Abrao Pessoa, Flavia Oliveira/0000-0002-9768-7405; Ferreira-Silva, Alice/0000-0002-1927-3194	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [308204/2015-8]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerias (FAPEMIG); Institute Federal Goiano; Pro-reitoria de Pesquisa and Pos-Graduacao da Universidade Federal de Minas Gerais	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerias (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Institute Federal Goiano; Pro-reitoria de Pesquisa and Pos-Graduacao da Universidade Federal de Minas Gerais	This work was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 308204/2015-8), Fundacao de Amparo a Pesquisa do Estado de Minas Gerias (FAPEMIG), Institute Federal Goiano, and Pro-reitoria de Pesquisa and Pos-Graduacao da Universidade Federal de Minas Gerais.	Abo-State M. A. M., 2010, American-Eurasian Journal of Agricultural and Environmental Science, V8, P402; Abrao F. O., 2015, Revista Brasileira de Medicina Veterinaria, V37, P7; Abrao FO, 2014, CURR MICROBIOL, V69, P649, DOI 10.1007/s00284-014-0633-5; Adesogan AT, 2014, J ANIM SCI, V92, P1317, DOI 10.2527/jas.2013-7273; Aguiar CM, 2011, ACTA SCI-TECHNOL, V33, P385; Ahmed SA, 2016, BIOCATAL AGRIC BIOTE, V7, P134, DOI 10.1016/j.bcab.2016.05.015; Batista-Garcia RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105893; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Facchini FDA, 2011, BIOPROC BIOSYST ENG, V34, P347, DOI 10.1007/s00449-010-0477-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARDER JH, 1986, ANAL BIOCHEM, V153, P75, DOI 10.1016/0003-2697(86)90063-1; CASTELLANI A., 1939, JOUR TROP MED AND HYG, V42, P225; Colonia B. S. O., 2014, African Journal of Biotechnology, V13, P4694; Conceicao DM, 2004, ARQ I BIOL-SAO PAULO, V71, P99; Dashtban Mehdi, 2010, Int J Biochem Mol Biol, V1, P36; Davidson RW, 1938, J AGRIC RES, V57, P0683; Flipphi M, 2009, FUNGAL GENET BIOL, V46, pS19, DOI 10.1016/j.fgb.2008.07.018; Gao JM, 2008, BIORESOURCE TECHNOL, V99, P7623, DOI 10.1016/j.biortech.2008.02.005; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gibson LJ, 2012, J R SOC INTERFACE, V9, P2749, DOI 10.1098/rsif.2012.0341; Gomes J. E. G., 2014, African Journal of Microbiology Research, V8, P551; Jahromi MF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/397934; Jahromi MF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/196264; Kamra DN, 2005, CURR SCI INDIA, V89, P124; Khan MMH, 2007, J ENVIRON SCI HEAL B, V42, P381, DOI 10.1080/03601230701312647; Kung L, 2000, J DAIRY SCI, V83, P115, DOI 10.3168/jds.S0022-0302(00)74862-4; Lacaz CS, 2012, REV BRAS ZOOTECN, V41, P2336; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; MACIEL CDCS, 2010, EXACTA, V8, P299; Mahmood RT, 2013, APPL BIOCHEM BIOTECH, V170, P895, DOI 10.1007/s12010-013-0227-x; Almeida PNM, 2014, REV CAATINGA, V27, P202; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moore KJ, 2001, J RANGE MANAGE, V54, P420, DOI 10.2307/4003113; Oyeleke SB, 2008, AFR J BIOTECHNOL, V7, P1530; Paul SS, 2004, REPROD NUTR DEV, V44, P313, DOI 10.1051/rnd:2004036; Ray RR, 2015, B ENV PHARM LIFE SCI, V4; Rodriguez IG, 2007, VITAE, V14, P1; Rosa LH, 2009, POLAR BIOL, V32, P161, DOI 10.1007/s00300-008-0515-z; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Salgado JM, 2013, BIOM CONVER BIOREF, V1, P1; Sharma N.K., 2012, ISRN AGRON, V2012, DOI [10.5402/2012/359673, DOI 10.5402/2012/359673]; Silva MG, 2011, SCI PLENA, V7, P1; Sun H, 2017, ANIM SCI J, V88, P602, DOI 10.1111/asj.12646; Suto M, 2001, J BIOSCI BIOENG, V92, P305, DOI 10.1263/jbb.92.305; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Wang XW, 2017, ANTON LEEUW INT J G, V110, P87, DOI 10.1007/s10482-016-0779-1; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yang WZ, 2000, J DAIRY SCI, V83, P2512, DOI 10.3168/jds.S0022-0302(00)75143-5	49	15	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183628	10.1371/journal.pone.0183628	http://dx.doi.org/10.1371/journal.pone.0183628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850605	gold, Green Submitted, Green Published			2022-12-26	WOS:000408544200022
J	Fiori, E; Oddi, D; Ventura, R; Colamartino, M; Valzania, A; D'Amato, FR; Bruinenberg, V; van der Zee, E; Puglisi-Allegra, S; Pascucci, T				Fiori, Elena; Oddi, Diego; Ventura, Rossella; Colamartino, Marco; Valzania, Alessandro; D'Amato, Francesca Romana; Bruinenberg, Vibeke; van der Zee, Eddy; Puglisi-Allegra, Stefano; Pascucci, Tiziana			Early-onset behavioral and neurochemical deficits in the genetic mouse model of phenylketonuria	PLOS ONE			English	Article							GLUTAMATERGIC SYNAPTIC-TRANSMISSION; COGNITIVE DEFICITS; PREFRONTAL CORTEX; SEROTONIN; PKU; METABOLITES; DISORDERS; AFFERENTS; OUTCOMES	Phenylketonuria (PKU) is one of the most common human inborn errors of metabolism, caused by phenylalanine hydroxylase deficiency, leading to high phenylalanine and low tyrosine levels in blood and brain causing profound cognitive disability, if untreated. Since 1960, population is screened for hyperphenylalaninemia shortly after birth and submitted to early treatment in order to prevent the major manifestations of the disease. However, the dietetic regimen (phenylalanine free diet) is difficult to maintain, and despite the recommendation to a strict and lifelong compliance, up to 60% of adolescents partially or totally abandons the treatment. The development and the study of new treatments continue to be sought, taking advantage of preclinical models, the most used of which is the PAH(enu2) (BTBR ENU2), the genetic murine model of PKU. To date, adult behavioral and neurochemical alterations have been mainly investigated in ENU2 mice, whereas there are no clear indications about the onset of these deficiencies. Here we investigated and report, for the first time, a comprehensive behavioral and neurochemical assay of the developing ENU2 mice. Overall, our findings demonstrate that ENU2 mice are significantly smaller than WT until pnd 24, present a significant delay in the acquisition of tested developmental reflexes, impaired communicative, motor and social skills, and have early reduced biogenic amine levels in several brain areas. Our results extend the understanding of behavioral and cerebral abnormalities in PKU mice, providing instruments to an early preclinical evaluation of the effects of new treatments.	[Fiori, Elena; Ventura, Rossella; Colamartino, Marco; Valzania, Alessandro; Puglisi-Allegra, Stefano; Pascucci, Tiziana] Sapienza Univ, Dept Psychol, Rome, Italy; [Fiori, Elena; Ventura, Rossella; Colamartino, Marco; Valzania, Alessandro; Puglisi-Allegra, Stefano; Pascucci, Tiziana] Sapienza Univ, Ctr Daniel Bovet, Rome, Italy; [Fiori, Elena; Oddi, Diego; D'Amato, Francesca Romana] CNR, Cell Biol & Neurobiol Inst, Rome, Italy; [Fiori, Elena] European Brain Res Inst, Rome, Italy; [Fiori, Elena; Oddi, Diego; Ventura, Rossella; Colamartino, Marco; Valzania, Alessandro; D'Amato, Francesca Romana; Puglisi-Allegra, Stefano; Pascucci, Tiziana] Fdn Santa Lucia, IRCCS, Rome, Italy; [Bruinenberg, Vibeke; van der Zee, Eddy] Univ Groningen, Mol Neurobiol, GELIFES, Groningen, Netherlands	Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; University of Groningen	Pascucci, T (corresponding author), Sapienza Univ, Dept Psychol, Rome, Italy.; Pascucci, T (corresponding author), Sapienza Univ, Ctr Daniel Bovet, Rome, Italy.; Pascucci, T (corresponding author), Fdn Santa Lucia, IRCCS, Rome, Italy.	tiziana.pascucci@uniroma1.it	van der Zee, Eddy/AAZ-2120-2020; Puglisi-Allegra, Stefano/ABI-7468-2020; Pascucci, Tiziana/AAB-9706-2019; Ventura, Rossella/AAA-8816-2019	Puglisi-Allegra, Stefano/0000-0002-9433-2000; Ventura, Rossella/0000-0002-7601-8683; Fiori, Elena/0000-0003-2990-9624; D'Amato, Francesca/0000-0002-4577-4574; Pascucci, Tiziana/0000-0003-1520-7373	Comitato Telethon Fondazione ONLUS [GGP09254]; Sapienza University of Rome	Comitato Telethon Fondazione ONLUS(Fondazione Telethon); Sapienza University of Rome	This work was supported by the Comitato Telethon Fondazione ONLUS (Grant GGP09254; http://www.telethon.it/ricerca-progetti/progetti-finanziati/dettagli/manipulation-of-serotonin-transmission-on-behavioural-and-neurochemical-deficits) and Sapienza University of Rome (Scientific Research grants 2010, 2011 and 2015; http://www.uniroma1.it/ricerca/finanziamenti/finanziamenti-di-ateneo/archivio-finanziamenti).; This work was supported by the Comitato Telethon Fondazione ONLUS (Grant GGP09254) and Sapienza University of Rome (Scientific Research grants 2010, 2011 and 2015).	Andolina D, 2011, INT J NEUROPSYCHOPH, V14, P479, DOI 10.1017/S1461145710001288; BENNETTCLARKE CA, 1995, BRAIN RES, V702, P255, DOI 10.1016/0006-8993(95)00867-5; BENNETTCLARKE CA, 1994, J NEUROSCI, V14, P7594; Bignami G, 1996, ENVIRON HEALTH PERSP, V104, P285, DOI 10.2307/3432648; Blau N, 2015, EXPERT OPIN PHARMACO, V16, P791, DOI 10.1517/14656566.2015.1013030; Bruinenberg VM, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00233; Burlina AB, 2000, J INHERIT METAB DIS, V23, P313, DOI 10.1023/A:1005694122277; BUTLER IJ, 1981, J PEDIATR-US, V98, P729, DOI 10.1016/S0022-3476(81)80832-3; Cabib S, 2003, BEHAV GENET, V33, P301, DOI 10.1023/A:1023498508987; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Curtius H C, 1981, Adv Exp Med Biol, V133, P277; D'Amato FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018637; de Groot MJ, 2010, MOL GENET METAB, V99, pS86, DOI 10.1016/j.ymgme.2009.10.016; DeRoche K, 2008, DEV NEUROPSYCHOL, V33, P474, DOI 10.1080/87565640802101482; Diamond A, 1997, MONOGR SOC RES CHILD, V62, P1; Dokoupil K, 2012, CLIN NUTR, V31, P16, DOI 10.1016/j.clnu.2011.09.001; Douglas TD, 2013, MOL GENET METAB, V109, P243, DOI 10.1016/j.ymgme.2013.04.017; Embury JE, 2005, PEDIATR RES, V58, P283, DOI 10.1203/01.PDR.0000170000.78670.44; Glushakov AV, 2005, BRAIN, V128, P300, DOI 10.1093/brain/awh354; Heyser CJ, 2004, CURR PROTOC NEUROSCI, V8, P1; Joseph B, 2003, J NEUROCHEM, V86, P615, DOI 10.1046/j.1471-4159.2003.01887.x; LOU HC, 1985, EUR J PEDIATR, V144, P17, DOI 10.1007/BF00491918; Martynyuk AE, 2010, MOL GENET METAB, V99, pS100, DOI 10.1016/j.ymgme.2009.10.181; Martynyuk AE, 2005, MOL GENET METAB, V86, pS34, DOI 10.1016/j.ymgme.2005.06.014; MCDONALD JD, 1990, P NATL ACAD SCI USA, V87, P1965, DOI 10.1073/pnas.87.5.1965; McDonald JD, 2000, CONTEMP TOP LAB ANIM, V39, P54; MCKEAN CM, 1972, BRAIN RES, V47, P469, DOI 10.1016/0006-8993(72)90653-1; Mitchell JJ, 2001, GENET MED, V13, P697; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Ney DM, 2016, AM J CLIN NUTR, V104, P334, DOI 10.3945/ajcn.116.135293; Ognibene E, 2007, BEHAV BRAIN RES, V177, P142, DOI 10.1016/j.bbr.2006.10.027; Pascucci T, 2002, NEUROREPORT, V13, P2561, DOI 10.1097/00001756-200212200-00036; Pascucci T, 2008, BRAIN RES, V1217, P232, DOI 10.1016/j.brainres.2008.04.006; Pascucci T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084697; Pascucci T, 2012, J INHERIT METAB DIS, V35, P1001, DOI 10.1007/s10545-012-9473-2; Pascucci T, 2009, INT J NEUROPSYCHOPH, V12, P1067, DOI 10.1017/S1461145709990381; Persico AM, 2001, J NEUROSCI, V21, P6862, DOI 10.1523/JNEUROSCI.21-17-06862.2001; Puglisi-Allegra S, 2000, NEUROREPORT, V11, P1361, DOI 10.1097/00001756-200004270-00042; Rebuffat A, 2010, HUM GENE THER, V21, P463, DOI 10.1089/hum.2009.127; Rossi L, 2014, J CONTROL RELEASE, V194, P37, DOI 10.1016/j.jconrel.2014.08.012; Scattoni ML, 2010, BEHAV BRAIN RES, V208, P250, DOI 10.1016/j.bbr.2009.12.002; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; Smith CB, 2000, P NATL ACAD SCI USA, V97, P11014, DOI 10.1073/pnas.97.20.11014; Stemerdink BA, 2000, J INHERIT METAB DIS, V23, P548, DOI 10.1023/A:1005669610722; van Spronsen FJ, 2017, LANCET DIABETES ENDO, V5, P743, DOI 10.1016/S2213-8587(16)30320-5; van Vliet D, 2016, AM J CLIN NUTR, V104, P1292, DOI 10.3945/ajcn.116.135996; Waisbren SE, 2007, MOL GENET METAB, V92, P63, DOI 10.1016/j.ymgme.2007.05.006; Yano S, 2016, PLOS ONE, V11, P60; Zagreda L, 1999, J NEUROSCI, V19, P6175, DOI 10.1523/JNEUROSCI.19-14-06175.1999	51	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183430	10.1371/journal.pone.0183430	http://dx.doi.org/10.1371/journal.pone.0183430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850618	gold, Green Published, Green Submitted			2022-12-26	WOS:000408544200013
J	Berggren, O; Hagberg, N; Alexsson, A; Weber, G; Ronnblom, L; Eloranta, ML				Berggren, Olof; Hagberg, Niklas; Alexsson, Andrei; Weber, Gert; Ronnblom, Lars; Eloranta, Maija-Leena			Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotype	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERFERON; ACTIVATION; EXPRESSION; AUTOIMMUNITY; SECRETION; ENHANCE; CD27	Background Hyperactive B cells and a continuous interferon (IFN)-alpha production by plasmacytoid dendritic cells (pDCs) play a key role in systemic lupus erythematosus (SLE). We asked whether the interaction between B cells and pDCs stimulated with RNA-containing immune complexes affects peripheral B cell subsets. Methods B cells and pDCs were isolated from blood of healthy individuals and stimulated with immune complexes consisting of SLE-IgG and U1snRNP (RNA-IC). Expression of cell surface molecules as well as IL-6 and IL-10 production were determined by flow cytometry and immunoassays. Gene expression profiles were determined by a NanoString nCounter expression array. Results We found a remarkable increase of double negative CD27-IgD-B cells, from 7% within fresh CD19+B cells to 37% in the RNA-IC-stimulated co-cultures of B cells and pDCs, comparable to the frequency of double negative B cells in SLE patients. Gene expression analysis of the double negative CD27-IgD -and the CD27 + IgD-memory B cells revealed that twenty-one genes were differentially expressed between the two B cell subsets (>= 2-fold, p< 0.001). The, IL21R, IL4R, CCL4, CCL3, CD83 and the IKAROS Family Zinc Finger 2 (IKZ2) showed higher expression in the double negative CD27-IgD-B cells. Conclusion The interactions between B cells and pDCs together with RNA-containing IC led to an expansion of B cells with similar phenotype as seen in SLE, suggesting that the pDC-B cell crosstalk contributes to the autoimmune feed-forward loop in SLE.	[Berggren, Olof; Hagberg, Niklas; Alexsson, Andrei; Ronnblom, Lars; Eloranta, Maija-Leena] Uppsala Univ, Dept Med Sci, Sci Life Lab, Rheumatol, Uppsala, Sweden; [Weber, Gert] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Dept Mol Struct Biol, Greifswald, Germany	Uppsala University; Ernst Moritz Arndt Universitat Greifswald	Eloranta, ML (corresponding author), Uppsala Univ, Dept Med Sci, Sci Life Lab, Rheumatol, Uppsala, Sweden.	maija-leena.eloranta@medsci.uu.se	Weber, Gert/I-1800-2013; Eloranta, Maija-Leena/A-8775-2016	Weber, Gert/0000-0003-3624-1060; Eloranta, Maija-Leena/0000-0002-8454-1351	Swedish Rheumatism Association [R-569291, R-653711]; King Gustaf V's 80-years Foundation [FAI-2015-0140]; Agnes och Mac Rudbergs Stiftelse; Swedish Research Council [521-2013-2830]	Swedish Rheumatism Association; King Gustaf V's 80-years Foundation; Agnes och Mac Rudbergs Stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by The Swedish Rheumatism Association (https://www.reumatikerforbundet.org), R-569291 (MLE), R-653711 (LR); King Gustaf V's 80-years Foundation, FAI-2015-0140 (MLE) (LR); Agnes och Mac Rudbergs Stiftelse (OB); and The Swedish Research Council 521-2013-2830 (LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour A, 2016, J ALLERGY CLIN IMMUN; Anolik JH, 2013, LUPUS, V22, P342, DOI 10.1177/0961203312471576; Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; Berggren O, 2012, ARTHRITIS RHEUM-US, V64, P3409, DOI 10.1002/art.34599; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Cederblad B, 1998, J AUTOIMMUN, V11, P465, DOI 10.1006/jaut.1998.0215; CEDERBLAD B, 1991, SCAND J IMMUNOL, V34, P549, DOI 10.1111/j.1365-3083.1991.tb01578.x; Dorner T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3433; Dorner T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2780; Eloranta ML, 2016, J MOL MED, V94, P1103, DOI 10.1007/s00109-016-1421-4; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Gao N, 2014, ARTHRITIS RHEUMATOL, V66, P2849, DOI 10.1002/art.38742; Georg P, 2012, AUTOIMMUNITY, V45, P579, DOI 10.3109/08916934.2012.719955; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Iwata S, 2016, LUPUS, V25, P850, DOI 10.1177/0961203316643172; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Krzyzak L, 2016, J IMMUNOL, V196, P3581, DOI 10.4049/jimmunol.1502163; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu BS, 2014, EUR J IMMUNOL, V44, P2121, DOI 10.1002/eji.201344341; Mauri C, 2010, NAT REV RHEUMATOL, V6, P636, DOI 10.1038/nrrheum.2010.140; Menon M, 2016, IMMUNITY, V44, P683, DOI 10.1016/j.immuni.2016.02.012; Nakou M, 2013, CLIN EXP RHEUMATOL, V31, P172; Richardson C, 2013, J IMMUNOL, V191, P4926, DOI 10.4049/jimmunol.1202263; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Sanz I, 2014, SEMIN IMMUNOPATHOL, V36, P365, DOI 10.1007/s00281-014-0430-z; Sawaf M, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5767106; Silva R, 2011, BLOOD, V117, P5870, DOI 10.1182/blood-2010-09-310318; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tsokos GC, 2016, NAT REV RHEUMATOL, V12, P716, DOI 10.1038/nrrheum.2016.186; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624	34	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183946	10.1371/journal.pone.0183946	http://dx.doi.org/10.1371/journal.pone.0183946			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846748	Green Published, Green Submitted, gold			2022-12-26	WOS:000408438600061
J	Kaushik, J; Tandon, S; Gupta, V; Nayyar, J; Singla, SK; Tandon, C				Kaushik, Jyoti; Tandon, Simran; Gupta, Varun; Nayyar, Jasamrit; Singla, Surinder Kumar; Tandon, Chanderdeep			Response surface methodology based extraction of Tribulus terrestris leads to an upsurge of antilithiatic potential by inhibition of calcium oxalate crystallization processes	PLOS ONE			English	Article							DIHYDRATE CRYSTALS; CELLS; MONOHYDRATE; OPTIMIZATION; PROTEIN	Tribulus terrestris has significant antilithiatic efficacy established via both in vitro as well as in vivo studies and is used in numerous anti-urolithiatic herbal formulations viz. Cystone, Uri-flow, Uritone and Neeri. However, to fully utilize its antilithiatic potential, the influence of different extraction parameters on antilithiatic ability of T. terrestris aqueous extract needs elucidation. Thus, the current study was undertaken using statistically optimized extraction conditions for aqueous extract preparation. Response surface methodology was employed to observe the influence of three variables i.e. temperature (degrees C), time (h) and solid: liquid ratio (S: L) on the extraction yield (%) and protein content (mg/g) of T. terrestris aqueous extract. RSM results revealed that the high S: L ratio, low temperature and reduced incubation time were optimal conditions for aqueous extraction. Under such extraction conditions the protein content reached the value of 26.6 +/- 1.22 mg/g and the obtained extraction yield was 27.32 +/- 1.62%. The assessment of antilithiatic activity of 4 selected extracts (AE1-4), revealed enhanced nucleation and aggregation inhibition of calcium oxalate crystals with AE1 and AE2, which in addition significantly altered the size and morphology of calcium oxalate monohydrate (COM) crystals compared to AE3 and AE4. In vitro cell culture based studies on renal epithelial cells (MDCK, NRK-52E and PK 15) proved that the AE1 showed higher cytoprotective potency by increasing cell viability as compared to the oxalate treated group. The free radical scavenging activity of aqueous extract lowered the reactive oxygen specie's induced damage and potentially reduced the signals of programmed cell death due to oxalate injury. In addition, modulation of the COM crystal morphology was enhanced by AE1 as compared to AE2. The FTIR and GC-MS analysis of AE1, showed the presence of biomolecules which could aid in the attenuation of lithiatic process. In the light of these results the utility of the RSM approach to fully optimize the antilithiatic potential of T. terrestris cannot be undermined.	[Kaushik, Jyoti; Tandon, Chanderdeep] Amity Univ, Amity Inst Biotechnol, Noida, India; [Tandon, Simran] Amity Univ, Amity Inst Mol Med & Stem Cell Res, Noida, India; [Gupta, Varun] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India; [Nayyar, Jasamrit] SD Coll, Dept Chem, Chandigarh, India; [Singla, Surinder Kumar] Panjab Univ, Dept Biochem, Chandigarh, India	Amity University Noida; Amity University Noida; Jaypee University of Information Technology; Goswami Ganesh Dutta S. D. College; Panjab University	Tandon, C (corresponding author), Amity Univ, Amity Inst Biotechnol, Noida, India.	ctandon@amity.edu	Tandon, Chanderdeep/AAF-1124-2020; TANDON, simran/AAF-1158-2020; Kaur, Jasamrit/AAI-1966-2020; Kumar, Varun/AAC-9780-2020	Tandon, Chanderdeep/0000-0003-3720-0455; Kaur, Jasamrit/0000-0002-6068-1245; Tandon, Simran/0000-0002-6937-0216	Department of Biotechnology (DBT) [BT/PR7290/PBD/17/853/2013]; Ministry of Science and Technology, Govt. of India	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Ministry of Science and Technology, Govt. of India	This work was funded by Department of Biotechnology (DBT), Project No. BT/PR7290/PBD/17/853/2013, Ministry of Science and Technology, Govt. of India.; This work was financially supported by the Department of Biotechnology (DBT), Project No. BT/PR7290/PBD/17/853/2013, Ministry of Science and Technology, Govt. of India and carried out at Amity University, Noida, India.	Aggarwal A, 2014, INDIAN J EXP BIOL, V52, P103; Aggarwal A, 2012, PROTEIN PEPTIDE LETT, V19, P812, DOI 10.2174/092986612801619552; Aparna V, 2012, CHEM BIOL DRUG DES, V80, P434, DOI 10.1111/j.1747-0285.2012.01418.x; Barros ME, 2003, UROL RES, V30, P374, DOI 10.1007/s00240-002-0285-y; Bashir S, 2009, J ETHNOPHARMACOL, V122, P106, DOI 10.1016/j.jep.2008.12.004; Basvaraj DR, 2007, EUR ASS UROL, V5, P126; Bele A.A., 2011, IRJP, V2, P56; Box G.E.P., 2005, STAT EXPT; BOX GEP, 1951, J R STAT SOC B, V13, P1, DOI 10.1111/j.2517-6161.1951.tb00067.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Citalingam K, 2015, MOLECULES, V20, P3406, DOI 10.3390/molecules20023406; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Conrad J, 2004, FITOTERAPIA, V75, P117, DOI 10.1016/j.fitote.2003.09.001; Indu S., 2014, EUR J BIOT BIOS, V2, P38; Jambrak AR, 2011, J FOOD PROCESSING TE, V2, P2, DOI [10.4172/2157-7110.1000102e, DOI 10.4172/2157-7110.1000102E]; Joshi VS, 2005, J CRYST GROWTH, V275, pE1403, DOI 10.1016/j.jcrysgro.2004.11.240; Khan S., 2000, EFFECTS EXTRACT HERN, P621; Khan Saeed R, 2004, Clin Exp Nephrol, V8, P75; Khan SR, 2014, TRANSL ANDROL UROL, V3, P256, DOI 10.3978/j.issn.2223-4683.2014.06.04; Kim JH, 2014, PHARMACOGN MAG, V10, P606, DOI 10.4103/0973-1296.139798; Koganti B, 2008, EVALUATION SESBANIA, P300; Kumari V, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0460-4; Lieske JC, 1996, CALCIFIED TISSUE INT, V58, P195, DOI 10.1007/BF02526887; Lieske JC, 1998, KIDNEY INT, V54, P796, DOI 10.1046/j.1523-1755.1998.00058.x; Liyana-Pathirana CM, 2005, J AGR FOOD CHEM, V53, P2433, DOI 10.1021/jf049320i; Mitra N., 2012, International Journal of Modern Botany, V2, P35, DOI 10.5923/j.ijmb.20120203.01; Mittal A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162600; Nessa F, 2015, EUROPEAN J MED PLANT, V9, P1; Pachana K, 2010, SCIENCEASIA, V36, P165, DOI 10.2306/scienceasia1513-1874.2010.36.165; Prasad K., 2007, PHCOG REV, V1, P175; Price R., 1985, PHYSL PLANT PATHOL, V27, P255, DOI DOI 10.1016/0048-4059(85)90073-6; Raja M., 2011, Der Pharmacia Sinica, V2, P136; Schepers MSJ, 2003, KIDNEY INT, V64, P493, DOI 10.1046/j.1523-1755.2003.00107.x; Sharma D, 2016, EGYPT J BASIC APPL S, P1; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Sun XY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.359; Usman H., 2007, RES J BIOSCI, V2, P244; Wang TT, 2010, BJU INT, V106, P1768, DOI 10.1111/j.1464-410X.2010.09258.x; WHO, 2002, ANC REM NEW DIS; Wiessner JH, 2001, KIDNEY INT, V59, P637, DOI 10.1046/j.1523-1755.2001.059002637.x; World Health Organisation (WHO), 2002, MON SEL MED PLANTS; Wu TS, 1999, PHYTOCHEMISTRY, V50, P1411, DOI 10.1016/S0031-9422(97)01086-8; Zhang CY, 2012, MAR DRUGS, V10, P119, DOI 10.3390/md10010119	43	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183218	10.1371/journal.pone.0183218	http://dx.doi.org/10.1371/journal.pone.0183218			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846699	gold, Green Submitted, Green Published			2022-12-26	WOS:000408438600023
J	Stefic, K; Chaillon, A; Bouvin-Pley, M; Moreau, A; Braibant, M; Bastides, F; Gras, G; Bernard, L; Barin, F				Stefic, Karl; Chaillon, Antoine; Bouvin-Pley, Melanie; Moreau, Alain; Braibant, Martine; Bastides, Frederic; Gras, Guillaume; Bernard, Louis; Barin, Francis			Probing the compartmentalization of HIV-1 in the central nervous system through its neutralization properties	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CEREBROSPINAL-FLUID; ENV COMPARTMENTALIZATION; GENE FLOW; INFECTION; BRAIN; EVOLUTION; GLYCOPROTEINS; ANTIBODIES; ENVELOPES	Compartmentalization of HIV-1 has been observed in the cerebrospinal fluid (CSF) of patients at different clinical stages. Considering the low permeability of the blood-brain barrier, we wondered if a reduced selective pressure by neutralizing antibodies (NAb) in the central nervous system (CNS) could favor the evolution of NAb-sensitive viruses in this compartment. Single genome amplification (SGA) was used to sequence full-length HIV-1 envelope variants (453 sequences) from paired CSF and blood plasma samples in 9 subjects infected by HIV variants of various clades and suffering from diverse neurologic disorders. Dynamics of viral evolution were evaluated with a bayesian coalescent approach for individuals with longitudinal samples. Pseudotyped viruses expressing envelope glycoproteins variants representative of the quasi-species present in each compartment were generated, and their sensitivity to autologous neutralization, broadly neutralizing antibodies (bNAbs) and entry inhibitors was assessed. Significant compartmentalization of HIV populations between blood and CSF were detected in 5 out of 9 subjects. Some of the previously described genetic determinants for compartmentalization in the CNS were observed regardless of the HIV-1 clade. There was no difference of sensitivity to autologous neutralization between blood-and CSF-variants, even for subjects with compartmentalization, suggesting that selective pressure by autologous NAb is not the main driver of HIV evolution in the CNS. However, we observed major differences of sensitivity to sCD4 or to at least one bNAb targeting either the N160-V1V2 site, the N332-V3 site or the CD4bs, between bloodand CSF-variants in all cases. In particular, HIV-1 variants present in the CSF were more resistant to bNAbs than their blood counterpart in some cases. Considering the possible migration from CSF to blood, the CNS could be a reservoir of bNAb resistant viruses, an observation that should be considered for immunotherapeutic approaches.	[Stefic, Karl; Bouvin-Pley, Melanie; Moreau, Alain; Braibant, Martine; Barin, Francis] Univ Tours, Inserm U966, Tours, France; [Stefic, Karl; Barin, Francis] CHU Bretonneau, Lab Bacteriol Virol, Tours, France; [Chaillon, Antoine] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Bastides, Frederic; Gras, Guillaume; Bernard, Louis] CHU Bretonneau, Med Interne & Malad Infect, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; University of California System; University of California San Diego; CHU Tours	Barin, F (corresponding author), Univ Tours, Inserm U966, Tours, France.; Barin, F (corresponding author), CHU Bretonneau, Lab Bacteriol Virol, Tours, France.	francis.barin@univ-tours.fr	chaillon, antoine/GNH-1623-2022; Stefic, Karl/C-5052-2019; Chaillon, Antoine/GNH-6121-2022	Stefic, Karl/0000-0002-9686-9194; 	Inserm; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, France	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, France	This work was supported by Inserm and Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrildt KT, 2015, J VIROL, V89, P11294, DOI 10.1128/JVI.00946-15; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Bednar MM, 2015, CURR HIV-AIDS REP, V12, P262, DOI 10.1007/s11904-015-0265-9; Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Bouvin-Pley M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003477; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Caskey M, 2017, NAT MED; Chaillon A, 2014, J INFECT DIS, V209, P1642, DOI 10.1093/infdis/jit678; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dahm T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8562805; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dunfee RL, 2006, P NATL ACAD SCI USA, V103, P15160, DOI 10.1073/pnas.0605513103; Evering TH, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0065-0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harrington PR, 2009, AIDS, V23, P907, DOI 10.1097/QAD.0b013e3283299129; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, GENETICS, V132, P583; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lamers SL, 2010, J NEUROVIROL, V16, P230, DOI 10.3109/13550281003735709; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Ohagen A, 2003, J VIROL, V77, P12336, DOI 10.1128/JVI.77.22.12336-12345.2003; Oliveira MF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006112; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Pilcher CD, 2001, AIDS, V15, P837, DOI 10.1097/00002030-200105040-00004; Pillai SK, 2006, BRAIN, V129, P1872, DOI 10.1093/brain/awl136; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; POWER C, 1994, J VIROL, V68, P4643, DOI 10.1128/JVI.68.7.4643-4649.1994; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Ritola K, 2005, J VIROL, V79, P10830, DOI 10.1128/JVI.79.16.10830-10834.2005; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salemi M, 2016, CURR HIV RES, V14, P110, DOI 10.2174/1570162X13666151029102413; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schnell G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000395; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; SLATKIN M, 1989, GENETICS, V123, P603; Soulie C, 2015, J ANTIMICROB CHEMOTH, V70, P566, DOI 10.1093/jac/dku419; Spudich SS, 2016, CURR OPIN HIV AIDS, V11, P226, DOI 10.1097/COH.0000000000000243; Stam AJ, 2013, AIDS REV, V15, P152; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Sturdevant CB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004720; Sturdevant CB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003094; Tambussi G, 2000, CLIN INFECT DIS, V30, P962, DOI 10.1086/313810; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Zarate S, 2007, J VIROL, V81, P6643, DOI 10.1128/JVI.02268-06; Zayyad Z, 2015, CURR HIV-AIDS REP, V12, P16, DOI 10.1007/s11904-014-0255-3; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	64	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0181680	10.1371/journal.pone.0181680	http://dx.doi.org/10.1371/journal.pone.0181680			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841647	gold, Green Published, Green Submitted			2022-12-26	WOS:000408370700004
J	Altet, N; Latorre, I; Jimenez-Fuentes, MA; Maldonado, J; Molina, I; Gonzalez-Diaz, Y; Mila, C; Garcia-Garcia, E; Muriel, B; Villar-Hernandez, R; Laabei, M; Gomez, AC; Godoy, P; de Souza-Galvao, ML; Solano, S; Jimenez-Ruiz, CA; Dominguez, J				Altet, Neus; Latorre, Irene; Aangeles Jimenez-Fuentes, Maria; Maldonado, Jose; Molina, Israel; Gonzalez-Diaz, Yoel; Mila, Celia; Garcia-Garcia, Esther; Muriel, Beatriz; Villar-Hernandez, Raquel; Laabei, Maisem; Gomez, Andromeda-Celeste; Godoy, Pere; Luiza de Souza-Galvao, Maria; Solano, Segismundo; Jimenez-Ruiz, Carlos A.; Dominguez, Jose		PII Smoking SEPAR Working Grp	Assessment of the influence of direct tobacco smoke on infection and active TB management	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; TUBERCULOSIS INFECTION; CIGARETTE-SMOKING; INCREASES RISK; CELL RESPONSE; DIAGNOSIS; ASSOCIATION; CONVERSION; EXPOSURE; ALVEOLAR	Background Smoking is a risk factor for tuberculosis (TB) infection and disease progression. Tobacco smoking increases susceptibility to TB in a variety of ways, one of which is due to a reduction of the IFN-gamma response. Consequently, an impaired immune response could affect performance of IFN-gamma Release Assays (IGRAs). Objective In the present study, we assess the impact of direct tobacco smoking on radiological manifestations, sputum conversion and immune response to Mycobacterium tuberculosis, analyzing IFN-gamma secretion by IGRAs. Methods A total of 525 participants were studied: (i) 175 active pulmonary TB patients and (ii) 350 individuals coming from contact tracing studies, 41 of whom were secondary TB cases. Clinical, radiological and microbiological data were collected. T-SPOT. TB and QFN-G-IT were processed according manufacturer's instructions. Results In smoking patients with active TB, QFN-G-IT (34.4%) and T-SPOT. TB (19.5%) had high frequencies of negative results. In addition, by means of an unconditional logistic regression, smoking was a main factor associated with IGRAs' false-negative results (aOR: 3.35; 95% CI: 1.47-7.61; p<0.05). Smoking patients with active TB presented a high probability of having cavitary lesions (aOR: 1.88; 95% CI: 1.02-3.46; p<0.05). Mean culture negativization (months) +/- standard deviation (SD) was higher in smokers than in non-smokers (2.47 +/- 1.3 versus 1.69 +/- 1.4). Latent TB infection (LTBI) was favored in smoking contacts, being a risk factor associated with infection (aOR: 11.57; 95% CI: 5.97-22.41; p<0.00005). The IFN-gamma response was significantly higher in non-smokers than in smokers. Smoking quantity and IFN-gamma response analyzed by IGRAs were dose-dependent related. Conclusions Smoking had a negative effect on radiological manifestations, delaying time of sputum conversion. Our data establish a link between tobacco smoking and TB due to a weakened IFN-gamma response caused by direct tobacco smoke.	[Altet, Neus; Aangeles Jimenez-Fuentes, Maria; Mila, Celia; Luiza de Souza-Galvao, Maria] Hosp Univ Vall dHebron, Unitat TB Vall dHebron Drassanes, Barcelona, Spain; [Altet, Neus; Maldonado, Jose; Molina, Israel; Gonzalez-Diaz, Yoel] Unitat Clinica Tractament Directament Observat TB, Serv Clin, Barcelona, Spain; [Latorre, Irene; Garcia-Garcia, Esther; Muriel, Beatriz; Villar-Hernandez, Raquel; Laabei, Maisem; Gomez, Andromeda-Celeste; Dominguez, Jose] Univ Autonoma Barcelona, Inst Invest Germans Trias & Pujol, CIBER Enfermedades Resp, Badalona, Spain; [Gomez, Andromeda-Celeste] Inst Biotecnol & Biomed, Barcelona, Spain; [Godoy, Pere] Univ Lleida, Dept Salut, Generalitat Cataluna, CIBER Epidemiol & Salud Publ,IRB Lleida, Lleida, Spain; [Solano, Segismundo] Hosp Univ Gregorio Maranon, Madrid, Spain; [Jimenez-Ruiz, Carlos A.] Unidad Tabaquismo Comunidad Autonoma Madrid, Madrid, Spain	Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat de Lleida; General University Gregorio Maranon Hospital	Dominguez, J (corresponding author), Univ Autonoma Barcelona, Inst Invest Germans Trias & Pujol, CIBER Enfermedades Resp, Badalona, Spain.	jadominguez@igtp.cat	Villar Hernández, Raquel/AFN-3894-2022; Gómez, Andromeda/AAI-8082-2020; Villar-Hernández, Raquel/AGD-6666-2022; Laabei, Maisem/AAH-6383-2021; Latorre, Irene/H-8814-2017	Villar Hernández, Raquel/0000-0002-2249-0579; Gómez, Andromeda/0000-0002-0075-6903; Villar-Hernández, Raquel/0000-0002-2249-0579; Laabei, Maisem/0000-0002-8425-3704; Latorre, Irene/0000-0001-8159-2455; Godoy, Pere/0000-0002-2896-7286; Dominguez, Jose/0000-0001-7888-0309; Garcia, Esther/0000-0003-3997-493X; Molina Romero, Israel/0000-0001-6642-7515	Miguel Servet program of the Instituto de Salud Carlos III (Spain); ERS/SEPAR fellowship (LTRF); Instituto de Salud Carlos III [PI 13/01546, PI 16/01912]; ISCIII Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR; Barcelona, Spain)	Miguel Servet program of the Instituto de Salud Carlos III (Spain); ERS/SEPAR fellowship (LTRF); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ISCIII Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR; Barcelona, Spain)	JD is funded by the Miguel Servet program of the Instituto de Salud Carlos III (Spain). ML was supported by a joint ERS/SEPAR fellowship (LTRF 2015). The research was partially supported by a grant from the Instituto de Salud Carlos III (PI 13/01546 and PI 16/01912), integrated in the Plan Nacional de I+D+I and cofunded by the ISCIII Subdireccion General de Evaluacion and the Fondo Europeo de Desarrollo Regional (FEDER); and a grant from the Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR; Barcelona, Spain) (Smoking Integrated Research Programme Call) to NA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-379; Abal AT, 2005, RESP MED, V99, P415, DOI 10.1016/j.rmed.2004.08.016; Aichelburg MC, 2014, INT J TUBERC LUNG D, V18, P709, DOI 10.5588/ijtld.13.0813; Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; Altet N, 2015, ANN AM THORAC SOC, V12, P680, DOI 10.1513/AnnalsATS.201408-394OC; Altet-Gomez MN, 2005, INT J TUBERC LUNG D, V9, P430; [Anonymous], 2015, WHO REP GLOB TOB EP; Awaisu A, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-2; Chan ED, 2010, AM J RESP CRIT CARE, V182, P990, DOI 10.1164/rccm.201006-0861ED; Chen CM, 2015, PLOS ONE, V10; de Boer RN, 2014, TUBERCULOSIS, V94, P87, DOI 10.1016/j.tube.2013.10.005; DEMARTINO M, 2014, BMC INFECT DIS S1, V14; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Domingo-Salvany A., 2000, ATEN PRIM, V25, P350, DOI [10.1016/s0212-6567(00)78518-0, DOI 10.1016/S0212-6567(00)78518-0]; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Fiore MC, 2008, RESP CARE, V53, P1217; Huang CC, 2014, INT J TUBERC LUNG D, V18, P1285, DOI 10.5588/ijtld.14.0309; Kherad O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-217; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Latorre I, 2009, DIAGN MICR INFEC DIS, V65, P236, DOI 10.1016/j.diagmicrobio.2009.07.015; Leung CC, 2003, INT J TUBERC LUNG D, V7, P980; Leung CC, 2015, EUR RESPIR J, V45, P738, DOI 10.1183/09031936.00114214; Lindsay RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093137; Mahishale Vinay, 2015, Chonnam Med J, V51, P86, DOI 10.4068/cmj.2015.51.2.86; Manejo diagnostico y tratamiento del tabaquismo en la practica clinica diaria, 2015, MAN SEPAR PROC; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Metanat M., 2010, Iranian Journal of Clinical Infectious Diseases, V5, P14; O'Leary SM, 2014, AM J RESP CRIT CARE, V190, P1430, DOI 10.1164/rccm.201407-1385OC; Organization WH, 2016, GLOBAL TUBERCULOSIS; Ruiz-Manzano J, 2008, ARCH BRONCONEUMOL, V44, P551, DOI 10.1016/S1579-2129(08)60102-0; Semple PL, 2013, AM J RESP CRIT CARE, V187, P1249, DOI 10.1164/rccm.201210-1934OC; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Shaler CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059185; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Smit RNV, 2010, EUR RESPIR J, V35, P27, DOI 10.1183/09031936.00072909; van Zyl-Smit RN, 2014, THORAX, V69, P363, DOI 10.1136/thoraxjnl-2013-204229; Visser ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029588; World Health Organization, 2006, BMI CLASSIFICATION; World Health Organization, 2014, GUID TUB PAT QUIT SM; World Health Organization International Union Against Tuberculosis and Lung Diseases, 2015, WHOHTMTB2007390; Yen YF, 2014, INT J TUBERC LUNG D, V18, P492, DOI 10.5588/ijtld.13.0694; Zellweger JP, 2015, AM J RESP CRIT CARE, V191, P1176, DOI 10.1164/rccm.201502-0232OC	45	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182998	10.1371/journal.pone.0182998	http://dx.doi.org/10.1371/journal.pone.0182998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837570	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000040
J	Au, ED; Fernandez-Godino, R; Kaczynksi, TJ; Sousa, ME; Farkas, MH				Au, Elizabeth D.; Fernandez-Godino, Rosario; Kaczynksi, Tadeusz J.; Sousa, Maria E.; Farkas, Michael H.			Characterization of lincRNA expression in the human retinal pigment epithelium and differentiated induced pluripotent stem cells	PLOS ONE			English	Article							LONG NONCODING RNA; MOLECULAR SIGNATURE; GENE; RPE; MUTATIONS; TRANSCRIPTOME; ANNOTATION; EVOLUTION; PROGRESS; GENCODE	Long intervening non-coding RNAs (lincRNAs) are increasingly being implicated as important factors in many aspects of cellular development, function, and disease, but remain poorly understood. In this study, we examine the human retinal pigment epithelium (RPE) lincRNA transcriptome using RNA-Seq data generated from human fetal RPE (fRPE), RPE derived from human induced pluripotent stem cells (iPS-RPE), and undifferentiated iPS (iPS). In addition, we determine the suitability of iPS-RPE, from a transcriptome standpoint, as a model for use in future studies of lincRNA structure and function. A comparison of gene and isoform expression across the whole transcriptome shows only minimal differences between all sample types, though fRPE and iPS-RPE show higher concordance than either shows with iPS. Notably, RPE signature genes show the highest degree of fRPE to iPSRPE concordance, indicating that iPS-RPE cells provide a suitable model for use in future studies. An analysis of lincRNAs demonstrates high concordance between fRPE and iPS-RPE, but low concordance between either RPE and iPS. While most lincRNAs are expressed at low levels (RPKM < 10), there is a high degree of concordance among replicates within each sample type, suggesting the expression is consistent, even at levels subject to high variability. Finally, we identified and annotated 180 putative novel genes in the fRPE samples, a majority of which are also expressed in the iPS-RPE. Overall, this study represents the first characterization of lincRNA expression in the human RPE, and provides a model for studying the role lincRNAs play in RPE development, function, and disease.	[Au, Elizabeth D.; Kaczynksi, Tadeusz J.; Sousa, Maria E.; Farkas, Michael H.] SUNY Buffalo, Dept Ophthalmol, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14226 USA; [Fernandez-Godino, Rosario] Harvard Med Sch, Ocular Genom Inst, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA USA; [Kaczynksi, Tadeusz J.; Sousa, Maria E.; Farkas, Michael H.] Vet Adm Western New York Healthcare Syst, Res Serv, Buffalo, NY 14215 USA; [Farkas, Michael H.] SUNY Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14226 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Farkas, MH (corresponding author), SUNY Buffalo, Dept Ophthalmol, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14226 USA.; Farkas, MH (corresponding author), Vet Adm Western New York Healthcare Syst, Res Serv, Buffalo, NY 14215 USA.; Farkas, MH (corresponding author), SUNY Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14226 USA.	mhfarkas@buffalo.edu			Departments of Ophthalmology at the State University of New York at Buffalo; Massachusetts Eye and Ear Infirmary; Research to Prevent Blindness	Departments of Ophthalmology at the State University of New York at Buffalo; Massachusetts Eye and Ear Infirmary; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by the Departments of Ophthalmology at the State University of New York at Buffalo and Massachusetts Eye and Ear Infirmary to MHF. This work was also supported, in part, by an Unrestricted Grant to the Department of Ophthalmology, University at Buffalo, from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bennis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141597; Caldwell GM, 1999, GENOMICS, V58, P98, DOI 10.1006/geno.1999.5808; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chiang J, 2015, EXPERT REV MOL DIAGN, V15, P1269, DOI 10.1586/14737159.2015.1081057; Daiger SP, 2013, NA CA2, V5; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Deniz E, 2017, FUNCT INTEGR GENOMIC, V17, P135, DOI 10.1007/s10142-016-0524-x; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Farkas MH, 2014, AM J PATHOL, V184, P2641, DOI 10.1016/j.ajpath.2014.06.026; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gamm DM, 2010, REGEN MED, V5, P315, DOI 10.2217/RME.10.28; Graziotto JJ, 2011, INVEST OPHTH VIS SCI, V52, P190, DOI 10.1167/iovs.10-5194; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Huang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027288; Iguchi T, 2015, ANTICANCER RES, V35, P1385; Kalloniatis Michael, 2004, Clin Exp Optom, V87, P65; Klassen H, 2016, EXPERT OPIN BIOL TH, V16, P7, DOI 10.1517/14712598.2016.1093110; Le Y-Z, 2015, ASS RES VISION OPHTH, V56, P4274; Levin LA, 2017, OPHTHALMOLOGY; Li F, 2016, INT J MOL SCI, P17; Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muniz A, 2014, INVEST OPHTH VIS SCI, V55, P198, DOI 10.1167/iovs.13-11740; Mustafi D, 2013, HUM MOL GENET, V22, P2992, DOI 10.1093/hmg/ddt156; Nashun B, 2015, EMBO J; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Nguyen HV, 2015, J CLIN MED, V4, P567, DOI 10.3390/jcm4040567; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Pan Q, 2005, TRENDS GENET, V21, P73, DOI 10.1016/j.tig.2004.12.004; Peng SM, 2013, STEM CELL TRANSL MED, V2, P534, DOI 10.5966/sctm.2012-0134; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Pereira B, 2015, O RNA SEQ READS COUN; Pierce EA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017285; Rakoczy EP, 2015, ESSENT OPHTHALMOL, P61, DOI 10.1007/978-3-662-45188-5_5; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Samuel W, 2017, MOL VIS, V23, P60; Schulz HL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-50; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Singh R, 2013, HUM MOL GENET, V22, P593, DOI 10.1093/hmg/dds469; St Laurent G, 2015, TRENDS GENET, V31, P239, DOI 10.1016/j.tig.2015.03.007; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tian LF, 2015, GENOMICS, V105, P253, DOI 10.1016/j.ygeno.2015.01.008; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Westenskow PD, 2014, ADV EXP MED BIOL, V801, P323, DOI 10.1007/978-1-4614-3209-8_41; Wiley LA, 2015, PROG RETIN EYE RES, V44, P15, DOI 10.1016/j.preteyeres.2014.10.002; Wright LS, 2014, EXP EYE RES, V123, P161, DOI 10.1016/j.exer.2013.12.001; ZHONG H, 2015, SCI REP UK, V5	61	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183939	10.1371/journal.pone.0183939	http://dx.doi.org/10.1371/journal.pone.0183939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837677	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000137
J	Kim, KH; Kim, DH; Jeong, HJ; Ryu, JS; Kim, YJ; Oh, JY; Kim, MK; Wee, WR				Kim, Kyeong Hwan; Kim, Dong Hyun; Jeong, Hyun Jeong; Ryu, Jin Suk; Kim, Yu Jeong; Oh, Joo Youn; Kim, Mee Kum; Wee, Won Ryang			Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjogren's syndrome	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; HMGB1; PROTEIN; PROMOTES; IL-22; TH17	Purpose Extracellular high mobility group box 1 (HMGB1) acts as a damage associated molecular pattern molecule through the Toll-like receptor to promote autoreactive B cell activation, which may be involved in the pathogenesis of Sjogren's syndrome. The aim of this study was to investigate the effect of subconjunctival administration of anti-HMGB1 on dry eye in a mouse model of Sjogren's syndrome. Methods Ten weeks-old NOD.B10.H2b mice were subconjunctivally injected with 0.02 to 2 mu g of anti-HMGB1 antibodies or PBS twice a week for two consecutive weeks. Tear volume and corneal staining scores were measured and compared between before-and after-treatment. Goblet cell density was counted in PAS stained forniceal conjunctiva and inflammatory foci score (>50 cells/focus) was measured in extraorbital glands. Flow cytometry was performed to evaluate the changes in BrdU(+) cells, IL-17-, IL-10-, or IFN gamma-secreting cells, functional B cells, and IL-22 secreting innate lymphoid cells (ILC3s) in cervical lymph nodes. The level of IL-22 in intraorbital glands was measured by ELISA. Results Injection of 2 mu g or 0.02 mu g anti-HMGB1 attenuated corneal epithelial erosions and increased tear secretion (p< 0.05). Goblet cell density was increased in 0.2 mu g and 2 mu g anti-HMGB1-treated-mice with marginal significance. The inflammatory foci score, and the number of BrdU(+) cells, IL-17-, IL-10-, IFN gamma-secreting cells, and functional B cells did not significantly change following anti-HMGB1 treatment. Surprisingly, the percentage of ILC3s was significantly increased in the draining lymph nodes (p< 0.05), and the expression of IL-22 was significantly increased in the intraorbital glands (p<0.05) after administration of 2 mu g anti-HMGB1. Conclusion This study shows that subconjunctival administration of anti-HMGB1 attenuates clinical manifestations of dry eye. The improvement of dry eye may involve an increase of ILC3s, rather than modulation of B or plasma cells, as shown using a mouse model of Sjogren's syndrome.	[Kim, Kyeong Hwan; Kim, Dong Hyun; Jeong, Hyun Jeong; Ryu, Jin Suk; Kim, Yu Jeong; Oh, Joo Youn; Kim, Mee Kum; Wee, Won Ryang] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul Artificial Eye Ctr, Lab Ocular Regenerat Med & Immunol, Seoul, South Korea; [Kim, Kyeong Hwan] Haeundae Paik Hosp, Dept Ophthalmol, Busan, South Korea; [Kim, Kyeong Hwan] Inje Univ, Coll Med, Dept Ophthalmol, Busan, South Korea; [Kim, Dong Hyun] Gachon Univ, Gil Med Ctr, Dept Ophthalmol, Incheon, South Korea; [Kim, Yu Jeong; Oh, Joo Youn; Kim, Mee Kum; Wee, Won Ryang] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Inje University; Gachon University; Seoul National University (SNU)	Kim, MK (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Seoul Artificial Eye Ctr, Lab Ocular Regenerat Med & Immunol, Seoul, South Korea.; Kim, MK (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	kmk9@snu.ac.kr	Kim, Kyeong Hwan/C-5036-2012	Kim, Kyeong Hwan/0000-0002-7359-663X	Seoul National University Hospital Research Fund [03-2012-0340, 04-2013-0510]	Seoul National University Hospital Research Fund	This work was supported by a grant from the Seoul National University Hospital Research Fund (Project No. 03-2012-0340 and Project No. 04-2013-0510; http://bri.snuh.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi A, 2015, CURR OPIN RHEUMATOL, V27, P468, DOI 10.1097/BOR.0000000000000195; Annunziato F, 2015, J ALLERGY CLIN IMMUN, V135, P626, DOI 10.1016/j.jaci.2014.11.001; Avalos AM, 2010, AUTOIMMUNITY, V43, P103, DOI 10.3109/08916930903384591; Bertheloot D, 2016, CELL MOL IMMUNOL; Chen YT, 2009, MOL VIS, V15, P563; Delaleu N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3313; Doyle ME, 2007, AM J PATHOL, V171, P1224, DOI 10.2353/ajpath.2007.070388; Duan LH, 2011, LAB INVEST, V91, P43, DOI 10.1038/labinvest.2010.141; Dupire G, 2012, SCAND J RHEUMATOL, V41, P120, DOI 10.3109/03009742.2011.633099; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Ek M, 2006, ARTHRITIS RHEUM, V54, P2289, DOI 10.1002/art.21969; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; He Z, 2012, SCAND J IMMUNOL, V76, P483, DOI 10.1111/j.1365-3083.2012.02759.x; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Lavoie TN, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/549107; Lee Y, 2013, J IMMUNOL, V190, P5296, DOI 10.4049/jimmunol.1201452; Liu A, 2012, COMP MATH MATH PHYS, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0035379; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Nguyen C, 2006, MOL IMMUNOL, V43, P1332, DOI 10.1016/j.molimm.2005.09.003; Nikoopour E, 2015, CYTOKINE, V74, P35, DOI 10.1016/j.cyto.2014.09.007; Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T; Sanati G, 2015, EXPERT REV CLIN IMMU, V11, P885, DOI 10.1586/1744666X.2015.1050382; Scardina Giuseppe Alessandro, 2007, Med Oral Patol Oral Cir Bucal, V12, pE565; Sedda S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/235460; Straino S, 2008, J INVEST DERMATOL, V128, P1545, DOI 10.1038/sj.jid.5701212; Su ZJ, 2011, 2011 24TH INTERNATIONAL VACUUM NANOELECTRONICS CONFERENCE (IVNC), P41; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276; von Burg N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00416; Wild CA, 2012, INT IMMUNOL, V24, P485, DOI 10.1093/intimm/dxs051; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Zhang F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/257930	36	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183678	10.1371/journal.pone.0183678	http://dx.doi.org/10.1371/journal.pone.0183678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837629	gold, Green Submitted, Green Published			2022-12-26	WOS:000408365000099
J	Letsinger, J; Rommel, C; Hirschi, R; Nirula, R; Hawryluk, GWJ				Letsinger, Joshua; Rommel, Casey; Hirschi, Ryan; Nirula, Raminder; Hawryluk, Gregory W. J.			The aggressiveness of neurotrauma practitioners and the influence of the IMPACT prognostic calculator	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; EXTERNAL VALIDATION; OUTCOME PREDICTION; HEAD-INJURY; INTERNATIONAL MISSION; CLINICAL-TRIALS; MODELS; MODERATE; CRASH; MORTALITY	Published guidelines have helped to standardize the care of patients with traumatic brain injury; however, there remains substantial variation in the decision to pursue or withhold aggressive care. The International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) prognostic calculator offers the opportunity to study and decrease variability in physician aggressiveness. The authors wish to understand how IMPACT's prognostic calculations currently influence patient care and to better understand physician aggressiveness. The authors conducted an anonymous international, multidisciplinary survey of practitioners who provide care to patients with traumatic brain injury. Questions were designed to determine current use rates of the IMPACT prognostic calculator and thresholds of age and risk for death or poor outcome that might cause practitioners to consider withholding aggressive care. Correlations between physician aggressiveness, putative predictors of aggressiveness, and demographics were examined. One hundred fifty-four responses were received, half of which were from physicians who were familiar with the IMPACT calculator. The most frequent use of the calculator was to improve communication with patients and their families. On average, respondents indicated that in patients older than 76 years or those with a >85% chance of death or poor outcome it might be reasonable to pursue non-aggressive care. These thresholds were robust and were not influenced by provider or institutional characteristics. This study demonstrates the need to educate physicians about the IMPACT prognostic calculator. The consensus values for age and prognosis identified in our study may be explored in future studies aimed at reducing variability in physician aggressiveness and should not serve as a basis for withdrawing care.	[Letsinger, Joshua; Hawryluk, Gregory W. J.] Univ Utah, Dept Surg, Clin Neurosci Ctr, Salt Lake City, UT 84112 USA; [Rommel, Casey] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA; [Hirschi, Ryan] Univ Utah, Sch Med, Salt Lake City, UT USA; [Nirula, Raminder] Univ Utah, Dept Surg, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Hawryluk, GWJ (corresponding author), Univ Utah, Dept Surg, Clin Neurosci Ctr, Salt Lake City, UT 84112 USA.	gregory.hawryluk@hsc.utah.edu	Rommel, Casey/N-9261-2019	Rommel, Casey/0000-0001-7757-9573; Hawryluk, Gregory/0000-0002-5604-7057	National Institutes of Health, United States National Library of Medicine [T15LM007124]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007744] Funding Source: NIH RePORTER	National Institutes of Health, United States National Library of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CR is funded as a pre-doctoral trainee via the National Institutes of Health, United States National Library of Medicine, Grant Number T15LM007124. CR has received the University of Utah, Richard A. Fay and Carol M. Fay Endowed Graduate Fellowship for the Department of Biomedical Informatics in Honor of Homer R. Warner, M.D., Ph.D. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no other specific funding for this work.	Alvis-Miranda Hernando, 2013, Bull Emerg Trauma, V1, P60; Baltazar GA, 2015, AM SURGEON, V81, pE61; Bazzazi A, 2014, ULUS TRAVMA ACIL CER, V20, P236, DOI 10.5505/tjtes.2014.57089; Brandner S, 2015, J NEUROSURG ANESTH, V27, P26, DOI 10.1097/ANA.0000000000000083; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Butler E, 1923, Cal State J Med, V21, P295; Carney N, 2016, NEUROSURGERY; Carter EL, 2016, BRIT J NEUROSURG, V30, P227, DOI 10.3109/02688697.2016.1139048; Castano-Leon AM, 2016, J NEUROTRAUM, V33, P1598, DOI 10.1089/neu.2015.4182; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Gao L, 2015, FRONT BIOSCI-LANDMRK, V20, P763, DOI 10.2741/4335; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V128, P761, DOI 10.1016/B978-0-444-63521-1.00047-9; Iorio-Morin C, 2016, CLIN NEUROL NEUROSUR, V142, P48, DOI 10.1016/j.clineuro.2016.01.021; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kirschen MP, 2015, SEMIN PEDIATR NEUROL, V22, P187, DOI 10.1016/j.spen.2015.05.004; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Liedes H, 2016, STUD HEALTH TECHNOL, V224, P175, DOI 10.3233/978-1-61499-653-8-175; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lu J, 2013, J NEUROTRAUM, V30, P1925, DOI 10.1089/neu.2013.2891; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Mikola A, 2015, IEEE ENG MED BIO, P1532, DOI 10.1109/EMBC.2015.7318663; Moore NA, 2013, BRIT J NEUROSURG, V27, P340, DOI 10.3109/02688697.2012.754402; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Olivecrona M, 2012, ACTA NEUROCHIR, V154, P1567, DOI 10.1007/s00701-012-1351-z; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Pourahmad S, 2016, METHOD INFORM MED, V55, P440, DOI 10.3414/ME15-01-0080; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Ramesh VG, 2013, J NEUROSURG, V119, P1351, DOI 10.3171/2013.4.JNS13875; Rizoli S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0098-x; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Sobuwa S, 2014, SAMJ S AFR MED J, V104, P492, DOI [10.7196/SAMJ.7720, 10.7196/samj.7720]; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762	59	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183552	10.1371/journal.pone.0183552	http://dx.doi.org/10.1371/journal.pone.0183552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832674	gold, Green Published, Green Submitted			2022-12-26	WOS:000408355800063
J	Weiss, E; Hanzelmann, D; Fehlhaber, B; Klos, A; von Loewenich, FD; Liese, J; Peschel, A; Kretschmer, D				Weiss, Elisabeth; Hanzelmann, Dennis; Fehlhaber, Beate; Klos, Andreas; von Loewenich, Friederike D.; Liese, Jan; Peschel, Andreas; Kretschmer, Dorothee			Formyl-peptide receptor 2 governs leukocyte influx in local Staphylococcus aureus infections	FASEB JOURNAL			English	Article						mFpr2; PSMs; innate immunity; neutrophil; Hoxb8	N-FORMYLPEPTIDE RECEPTOR; COMMUNITY-ASSOCIATED MRSA; VIRULENCE DETERMINANTS; LISTERIA-MONOCYTOGENES; NEUTROPHIL CHEMOTAXIS; BACTERIAL; PROTEIN; FPR2; IDENTIFICATION; MACROPHAGES	Leukocytes express formyl-peptide receptors (FPRs), which sensemicrobe-associated molecular pattern (MAMP) molecules, leading to leukocyte chemotaxis and activation. Werecently demonstrated that phenol-soluble modulin (PSM) peptides from highly pathogenic Staphylococcus aureus are efficient ligands for the human FPR2. HowPSMdetection by FPR2 impacts on the course of S. aureus infections has remained unknown. We characterized the specificity of mouse FPR2 (mFpr2) using a receptor-transfected cell line, homeobox b8 (Hoxb8), and primary neutrophils isolated from wild-type (WT) or mFpr2(-/-) mice. The influx of leukocytes into the peritoneum of WT and mFpr2(-/-) mice was analyzed. We demonstrate that mFpr2 is specifically activated by PSMs in mice, and they represent the first secreted pathogen-derived ligands for the mFpr2. Intraperitoneal infection with S. aureus led to lower numbers of immigrated leukocytes in mFpr2(-/-) compared with WT mice at 3 h after infection, and this difference was not observed when mice were infected with an S. aureus PSM mutant. Our data support the hypothesis that themFpr2 is the functional homolog of the human FPR2 and that amouse infectionmodel represents a suitablemodel for analyzing the role ofPSMs during infection. PSMrecognition bymFpr2 shapes leukocyte influx in local infections, the typical infections caused by S. aureus.	[Weiss, Elisabeth; Hanzelmann, Dennis; Peschel, Andreas; Kretschmer, Dorothee] Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen IMI, Infect Biol, Morgenstelle 28, D-72076 Tubingen, Germany; [Liese, Jan] Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen IMI, Med Microbiol & Hyg, Tubingen, Germany; [Fehlhaber, Beate; Klos, Andreas] Med Sch Hannover, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany; [von Loewenich, Friederike D.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Med Microbiol & Hyg, Mainz, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Hannover Medical School; Johannes Gutenberg University of Mainz	Kretschmer, D (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen IMI, Infect Biol, Morgenstelle 28, D-72076 Tubingen, Germany.	dorothee.kretschmer@uni-tuebingen.de	Loewenich, Friederike/AAL-1587-2020	Peschel, Andreas/0000-0002-3209-8626	German Research Council [SFB685, SFB766, TRR156, PE805/5-1, TRR34, KL 603/10-1]; University of Tubingen Medical Faculty Fortune Program	German Research Council(German Research Foundation (DFG)); University of Tubingen Medical Faculty Fortune Program	The authors thank Cordula Gekeler (University of Tubingen) for technical support, Philip Murphy for providing vectors for mFpr1 and mFpr2 cloning, and Ji Ming Wang (both from the U.S. National Institutes of Health) for providing C57BL/6 mFpr2<SUP>-/-</SUP> mice. This work was supported by grants from the German Research Council (SFB685, SFB766, TRR156, and PE805/5-1 to A.P.; TRR34 to A.P. and D.K.; and KL 603/10-1 to A.K.) and the University of Tubingen Medical Faculty Fortune Program (to D.K.). The authors declare no conflicts of interest.	Belkaid Y, 2016, NAT REV IMMUNOL, V16, P353, DOI 10.1038/nri.2016.48; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Bloes DA, 2015, NAT REV MICROBIOL, V13, P95, DOI 10.1038/nrmicro3390; Bloes DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039910; Bufe B, 2015, J BIOL CHEM, V290, P7369, DOI 10.1074/jbc.M114.626747; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Correia-de-Sa P, 2013, TOXICON, V61, P16, DOI 10.1016/j.toxicon.2012.10.014; Dahlgren C, 2016, BIOCHEM PHARMACOL, V114, P22, DOI 10.1016/j.bcp.2016.04.014; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; GAO JL, 1993, J BIOL CHEM, V268, P25395; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; Hanzelmann D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12304; Hartt JK, 1999, J EXP MED, V190, P741, DOI 10.1084/jem.190.5.741; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HJ, 2012, J HUM GENET, V57, P247, DOI 10.1038/jhg.2012.12; Kretschmer D, 2015, J LEUKOCYTE BIOL, V97, P689, DOI 10.1189/jlb.2A0514-275R; Kretschmer D, 2012, J INNATE IMMUN, V4, P201, DOI 10.1159/000332142; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Kruger A, 2015, EMBO REP, V16, P1656, DOI 10.15252/embr.201540861; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; Muto Y, 2015, J MOL EVOL, V80, P130, DOI 10.1007/s00239-015-9666-z; Onnheim K, 2008, IMMUNOLOGY, V125, P591, DOI 10.1111/j.1365-2567.2008.02873.x; OSEAS RS, 1980, J LAB CLIN MED, V96, P213; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Prat C, 2006, J IMMUNOL, V177, P8017, DOI 10.4049/jimmunol.177.11.8017; Prat C, 2009, J IMMUNOL, V183, P6569, DOI 10.4049/jimmunol.0801523; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; Rzodkiewicz P, 2010, INFLAMM RES, V59, P187, DOI 10.1007/s00011-009-0124-5; Sharma Ashimav Deb, 2012, Indian J Dermatol, V57, P233, DOI 10.4103/0019-5154.96211; Skovbakke SL, 2016, BIOCHEM PHARMACOL, V119, P56, DOI 10.1016/j.bcp.2016.09.004; SNYDERMAN R, 1980, SCIENCE, V209, P493, DOI 10.1126/science.6248959; Sordi R, 2013, INT IMMUNOPHARMACOL, V17, P283, DOI 10.1016/j.intimp.2013.06.010; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Stempel H, 2016, J BIOL CHEM, V291, P9762, DOI 10.1074/jbc.M116.714493; Swamydas Muthulekha, 2015, Curr Protoc Immunol, V110, DOI 10.1002/0471142735.im0320s110; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Tiffany HL, 2001, J BIOL CHEM, V276, P23645, DOI 10.1074/jbc.M101031200; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Xie XH, 2012, J HUAZHONG U SCI-MED, V32, P317, DOI 10.1007/s11596-012-0055-1; Yang EM, 2010, ANN ALLERG ASTHMA IM, V105, P96, DOI 10.1016/j.anai.2010.05.003; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang Y, 2003, GENES IMMUN, V4, P22, DOI 10.1038/sj.gene.6363900	53	17	18	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					26	36		10.1096/fj.201700441R	http://dx.doi.org/10.1096/fj.201700441R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855276	Green Published			2022-12-26	WOS:000419172700005
J	Lai, CJ; Cheng, HC; Lin, CY; Huang, SH; Chen, TH; Chung, CJ; Chang, CH; Wang, HD; Chuu, CP				Lai, Chih-Jen; Cheng, Hsu-Chen; Lin, Ching-Yu; Huang, Shih-Han; Chen, Ting-Huan; Chung, Chi-Jung; Chang, Chung-Ho; Wang, Horng-Dar; Chuu, Chih-Pin			Activation of liver X receptor suppresses angiogenesis via induction of ApoD	FASEB JOURNAL			English	Article						T0901317; HUVEC; Akt	ENDOTHELIAL GROWTH-FACTOR; CELL-PROLIFERATION; LIPID-METABOLISM; INHIBITION; EXPRESSION; PATHWAY; LXRS; CHOLESTEROL; MODULATION; AGONIST	LiverXreceptors (LXRs) are important sensors andregulators for cholesterol, fattyacid, andglucose. LXRs play essential roles in the development and progression of cardiovascular diseases. We examined the effects of T0901317, a potent LXR agonist, on angiogenesis of human umbilical vein endothelial cells (HUVECs). Treatment with T0901317 inhibited the tube formation and migration of HUVECs and reduced the in vivo angiogenesis, as determined by chorioallantoic membrane assay. T0901317 stimulated gene and protein expression of LXR target gene apolipoprotein D (ApoD). Overexpression of ApoD suppressed the tube formation of HUVECs. ApoD interacted with scavenger receptor class B member 1 (SR-B1), while knockdown of SR-B1 blocked suppressive effects of T0901317 on HUVEC migration. T0901317 treatment or overexpression of ApoD lessened expression of proteins regulating angiogenesis, including phospho-eNOS S1177, phospho-Akt T308, phospho-Akt S473, eNOS, mammalian target of rapamycin, VEGF-A, VEGF-C, IL-8, RhoB, matrixmetalloproteinase (MMP)-8, -9, and monocyte chemoattractant protein 1. Our study suggested that activation of LXR interferes with angiogenesis through induction of LXR target gene ApoD, which in turn suppresses PI3K-Akt-eNOS signaling, an essential pathway regulating angiogenesis. ApoD may be a potential therapeutic target for tumor angiogenesis.	[Lai, Chih-Jen; Lin, Ching-Yu; Huang, Shih-Han; Chen, Ting-Huan; Chang, Chung-Ho; Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Miaoli 35053, Taiwan; [Lai, Chih-Jen; Chen, Ting-Huan; Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan; [Cheng, Hsu-Chen] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Chuu, Chih-Pin] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung, Taiwan; [Huang, Shih-Han] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Chung, Chi-Jung] China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan; [Chuu, Chih-Pin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chuu, Chih-Pin] China Med Univ, Grad Program Aging, Taichung, Taiwan; [Chang, Chung-Ho] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Chung Hsing University; National Chung Hsing University; National Central University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Changhua Christian Hospital	Chuu, CP (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Miaoli 35053, Taiwan.; Wang, HD (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	hdwang@life.nthu.edu.tw; cpchuu@nhri.org.tw	Chuu, Chih-Pin/N-6697-2019; Lin, Ching Yu/AAN-9581-2020	Lin, Ching Yu/0000-0001-9041-5653; Wang, Horng-Dar/0000-0001-9570-3611; Cheng, Hsu-Chen/0000-0002-6586-6425	National Health Research Institutes [CS-105-PP-14]; Ministry of Science and Technology (MOST) [105-2314-B-400-020, 105-2628-B-400-005-MY3, 105-2923-B-400-001-MY3, 105-2633-B-400-001, 02-2311-B-007-008-MY3]; Live Cell Imaging Core Facility of the National Health Research Institutes	National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Live Cell Imaging Core Facility of the National Health Research Institutes	The authors thank the reviewers and the editor for useful suggestions and advice. This work was supported, in part, by the National Health Research Institutes (Grants CS-105-PP-14) and the Ministry of Science and Technology (MOST; 105-2314-B-400-020, 105-2628-B-400-005-MY3, 105-2923-B-400-001-MY3, and 105-2633-B-400-001; to C.P.C. C.Y.L. is supported by MOST 105-2811-B-400-031, and H.D.W. is supported by MOST 102-2311-B-007-008-MY3. The authors acknowledge support from the Live Cell Imaging Core Facility of the National Health Research Institutes.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Birbrair A, 2014, AM J PHYSIOL-CELL PH, V307, pC25, DOI 10.1152/ajpcell.00084.2014; Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Bouloumie A, 1999, CARDIOVASC RES, V41, P773, DOI 10.1016/S0008-6363(98)00228-4; Braesch-Andersen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115180; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Efanov AM, 2004, DIABETES, V53, pS75, DOI 10.2337/diabetes.53.suppl_3.S75; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Hong CC, 2015, MOL IMMUNOL, V66, P340, DOI 10.1016/j.molimm.2015.03.254; Howe GA, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-1; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Karkkainen MJ, 2000, ONCOGENE, V19, P5598, DOI 10.1038/sj.onc.1203855; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Kroll J, 1998, BIOCHEM BIOPH RES CO, V252, P743, DOI 10.1006/bbrc.1998.9719; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lu CW, 2017, CANCER LETT, V388, P130, DOI 10.1016/j.canlet.2016.11.033; Maffucci T, 2005, CANCER RES, V65, P8339, DOI 10.1158/0008-5472.CAN-05-0121; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Noghero A, 2012, ARTERIOSCL THROM VAS, V32, P2280, DOI 10.1161/ATVBAHA.112.250621; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Park HJ, 2006, STEM CELL REV, V2, P93, DOI 10.1007/s12015-006-0015-x; Santhekadur PK, 2012, J BIOL CHEM, V287, P3425, DOI 10.1074/jbc.M111.298976; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Verhamme P, 2006, ACTA CLIN BELG, V61, P213, DOI 10.1179/acb.2006.036; Wu BJ, 2015, INT J CARDIOL, V199, P204, DOI 10.1016/j.ijcard.2015.07.014	33	13	13	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5568	5576		10.1096/fj.201700374R	http://dx.doi.org/10.1096/fj.201700374R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842423				2022-12-26	WOS:000416588300037
J	Srivastava, S; Savanur, MA; Sinha, D; Birje, A; Vigneshwaran, R; Saha, PP; D'Silva, P				Srivastava, Shubhi; Savanur, Mohammad Azharuddin; Sinha, Devanjan; Birje, Abhijit; Vigneshwaran, R.; Saha, Prasenjit Prasad; D'Silva, Patrick			Regulation of mitochondrial protein import by the nucleotide exchange factors GrpEL1 and GrpEL2 in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70 kilodalton heat shock protein (Hsp70); cell culture; mitochondria; mitochondrial transport; protein import; protein translocation; yeast; nucleotide exchange factor; mitochondrial Hsp70	HSP70 CHAPERONES; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; MATRIX HSP70; TRANSLOCATION; EXISTENCE; MECHANISM; INTERACTS; HOMOLOG; MTHSP70	Mitochondria are organelles indispensable for maintenance of cellular energy homeostasis. Most mitochondrial proteins are nuclearly encoded and are imported into the matrix compartment where they are properly folded. This process is facilitated by the mitochondrial heat shock protein 70 (mtHsp70), a chaperone contributing to mitochondrial protein quality control. The affinity of mtHsp70 for its protein clients and its chaperone function are regulated by binding of ATP/ADP to mtHsp70's nucleotide-binding domain. Nucleotide exchange factors (NEFs) play a crucial role in exchanging ADP for ATP at mtHsp70's nucleotide-binding domain, thereby modulating mtHsp70's chaperone activity. A single NEF, Mge1, regulates mtHsp70's chaperone activity in lower eukaryotes, but the mammalian orthologs are unknown. Here, we report that two putative NEF orthologs, GrpE-like 1 (GrpEL1) and GrpEL2, modulate mtHsp70's function in human cells. We found that both GrpEL1 and GrpEL2 associate with mtHsp70 as a hetero-oligomeric subcomplex and regulate mtHsp70 function. The formation of this subcomplex was critical for conferring stability to the NEFs, helped fine-tune mitochondrial protein quality control, and regulated crucial mtHsp70 functions, such as import of preproteins and biogenesis of Fe-S clusters. Our results also suggested that GrpEL2 has evolved as a possible stress resistance protein in higher vertebrates to maintain chaperone activity under stress conditions. In conclusion, our findings support the idea that GrpEL1 has a role as a stress modulator in mammalian cells and highlight that multiple NEFs are involved in controlling protein quality in mammalian mitochondria.	[Srivastava, Shubhi; Savanur, Mohammad Azharuddin; Sinha, Devanjan; Birje, Abhijit; Vigneshwaran, R.; Saha, Prasenjit Prasad; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, CV Raman Ave, Bangalore 560012, Karnataka, India; [Sinha, Devanjan] Banaras Hindu Univ, Inst Sci, Dept Zool, Varanasi 221005, Uttar Pradesh, India; [Saha, Prasenjit Prasad] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA	Indian Institute of Science (IISC) - Bangalore; Banaras Hindu University (BHU); Cleveland Clinic Foundation	D'Silva, P (corresponding author), Indian Inst Sci, Dept Biochem, CV Raman Ave, Bangalore 560012, Karnataka, India.	patrick@iisc.ac.in	Sinha, Devanjan/A-3953-2017; Saha, Prasenjit/ABC-6481-2020; D'Silva, Patrick/L-6653-2019; Srivastava, Shubhi/C-7048-2018	Sinha, Devanjan/0000-0001-5060-2075; Srivastava, Shubhi/0000-0001-9922-1943; Saha, Prasenjit/0000-0003-4679-2368	Department of Science and Technology (DST) [DST/SJF/LS-01/2011-2012]; Lady Tata Memorial Trust Young Researcher Award; Department of Biochemistry-Indian Institute of Science (DBT-IISc) Partnership Program Grant [DBT/BF/PR/INS/2011-12/IISc]; DST-Fund for Improvement of Science and Technology Infrastructure (FIST) Program [SR/FST/LSII-023/2009]; University Grants Commission (UGC)-Centre of Advanced Study (CAS) Special Assistance Programme (SAP)-II program Grant UGC [LT. F. 5-2/2012.SAP-II]; DST-Innovation in Science Pursuit for Inspired Research (INSPIRE) fellowship; Council of Scientific and Industrial Research fellowship; UGC-D. S. Kothari postdoctoral fellowship	Department of Science and Technology (DST)(Department of Science & Technology (India)); Lady Tata Memorial Trust Young Researcher Award; Department of Biochemistry-Indian Institute of Science (DBT-IISc) Partnership Program Grant; DST-Fund for Improvement of Science and Technology Infrastructure (FIST) Program; University Grants Commission (UGC)-Centre of Advanced Study (CAS) Special Assistance Programme (SAP)-II program Grant UGC; DST-Innovation in Science Pursuit for Inspired Research (INSPIRE) fellowship; Council of Scientific and Industrial Research fellowship(Council of Scientific & Industrial Research (CSIR) - India); UGC-D. S. Kothari postdoctoral fellowship	This work was supported by Department of Science and Technology (DST) Swarnajayanti Fellowship DST/SJF/LS-01/2011-2012, a Lady Tata Memorial Trust Young Researcher Award, Department of Biochemistry-Indian Institute of Science (DBT-IISc) Partnership Program Grant DBT/BF/PR/INS/2011-12/IISc, DST-Fund for Improvement of Science and Technology Infrastructure (FIST) Program Grant SR/FST/LSII-023/2009, and University Grants Commission (UGC)-Centre of Advanced Study (CAS) Special Assistance Programme (SAP)-II program Grant UGC LT. F. 5-2/2012.SAP-II) (to P. D.); a DST-Innovation in Science Pursuit for Inspired Research (INSPIRE) fellowship (to S. S.); a Council of Scientific and Industrial Research fellowship (to P. P. S. and A. B.); and a UGC-D. S. Kothari postdoctoral fellowship (to A. M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Amick J, 2014, PROTEIN SCI, V23, P833, DOI 10.1002/pro.2466; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Copley SD, 2014, BIOCHEM SOC T, V42, P1684, DOI 10.1042/BST20140245; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Fernandez-Cabezudo MJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86873; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hatle KM, 2013, MOL CELL BIOL, V33, P2302, DOI 10.1128/MCB.00189-13; Hoogenraad NJ, 2001, IUBMB LIFE, V51, P345; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; LALORAYA S, 1995, MOL CELL BIOL, V15, P7098; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Marada A, 2013, MOL BIOL CELL, V24, P692, DOI 10.1091/mbc.E12-10-0719; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Moro F, 2002, J BIOL CHEM, V277, P6874, DOI 10.1074/jbc.M107935200; Naylor DJ, 1998, J BIOL CHEM, V273, P21169, DOI 10.1074/jbc.273.33.21169; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; Richter-Dennerlein R, 2014, CELL METAB, V20, P158, DOI 10.1016/j.cmet.2014.04.016; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Schusdziarra C, 2013, HUM MOL GENET, V22, P1348, DOI 10.1093/hmg/dds541; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; SEPTINUS M, 1983, HISTOCHEMISTRY, V79, P443, DOI 10.1007/BF00491779; SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697; Sinha D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.72; Sinha D, 2014, MOL CELL BIOL, V34, P1757, DOI 10.1128/MCB.01527-13; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Srivastava S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.355; VOOS W, 1994, MOL CELL BIOL, V14, P6627, DOI 10.1128/MCB.14.10.6627; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x	52	20	21	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18075	18090		10.1074/jbc.M117.788463	http://dx.doi.org/10.1074/jbc.M117.788463			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28848044	Green Published, hybrid			2022-12-26	WOS:000414458200008
J	Song, K; Fu, JX; Song, JH; Herzog, BH; Bergstrom, K; Kondo, Y; McDaniel, JM; McGee, S; Silasi-Mansat, R; Lupu, F; Chen, H; Bagavant, H; Xia, LJ				Song, Kai; Fu, Jianxin; Song, Jianhua; Herzog, Brett H.; Bergstrom, Kirk; Kondo, Yuji; McDaniel, J. Michael; McGee, Samuel; Silasi-Mansat, Robert; Lupu, Florea; Chen, Hong; Bagavant, Harini; Xia, Lijun			Loss of mucin-type O-glycans impairs the integrity of the glomerular filtration barrier in the mouse kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR SIALOPROTEIN; EPITHELIAL-CELL; MDCK CELLS; PODOCYTE; PODOCALYXIN; MICE; PODOPLANIN; POLARIZATION; SIALYLATION; EXPRESSION	The kidney's filtration activity is essential for removing toxins and waste products from the body. The vascular endothelial cells of the glomerulus are fenestrated, flattened, and surrounded by podocytes, specialized cells that support glomerular endothelial cells. Mucin-type core 1-derived O-glycans (O-glycans) are highly expressed on both glomerular capillary endothelial cells and their supporting podocytes, but their biological role is unclear. Biosynthesis of core 1-derived O-glycans is catalyzed by the glycosyltransferase core 1 beta 1,3-galactosyltransferase (C1galt1). Here we report that neonatal or adult mice with inducible deletion of C1galt1 (iC1galt1(-/-)) exhibit spontaneous proteinuria and rapidly progressing glomerulosclerosis. Ultrastructural analysis of the glomerular filtration barrier components revealed that loss of O-glycans results in altered podocyte foot processes. Further analysis indicated that O-glycan is essential for the normal signaling function of podocalyxin, a podocyte foot process-associated glycoprotein. Our results reveal a new function of O-glycosylation in the integrity of the glomerular filtration barrier.	[Song, Kai; Fu, Jianxin; Song, Jianhua; Herzog, Brett H.; Bergstrom, Kirk; Kondo, Yuji; McDaniel, J. Michael; McGee, Samuel; Silasi-Mansat, Robert; Lupu, Florea; Xia, Lijun] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Song, Kai; Chen, Hong] Harvard Med Sch, Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Bagavant, Harini] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Xia, Lijun] Soochow Univ, Key Lab Thrombosis & Hemostasis, Collaborat Innovat Ctr Hematol, Jiangsu Inst Hematol,Minist Hlth,Affiliated Hosp, Suzhou 215006, Jiangsu, Peoples R China; [Xia, Lijun] Univ Oklahoma, Hlth Sci Ctr, Dept Mol Biol & Biochem, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; Harvard University; Boston Children's Hospital; Harvard Medical School; Oklahoma Medical Research Foundation; Soochow University - China; University of Oklahoma System; University of Oklahoma Health Sciences Center	Xia, LJ (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	lijun-xia@omrf.org	Lupu, Florea/AAV-3257-2021; Lupu, Florea/C-3162-2009; Bagavant, Harini/V-7735-2019; Bergstrom, Kirk/AAZ-8856-2021	Lupu, Florea/0000-0003-1249-9278; Lupu, Florea/0000-0003-1249-9278; Silasi, Robert/0000-0001-9590-6160; Fu, Jianxin/0000-0002-3067-8539	National Institutes of Health [GM114731, HL128390, HD083418, DK085691, HL093242, HL118676]; National Natural Science Foundation of China [81520108005, 81470825, 81370617]; Jiangsu Province Key Medical Center Grant [ZX201102]; Scientist Development Grants from the American Heart Association [11SDG7410022, 17SDG33630161]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD083418] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093242, R01HL128390, R01HL118676, R01HL133216, R01HL137229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Key Medical Center Grant; Scientist Development Grants from the American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM114731, HL128390, HD083418, DK085691, HL093242, and HL118676; National Natural Science Foundation of China Grants 81520108005, 81470825, and 81370617; Jiangsu Province Key Medical Center Grant ZX201102; and Scientist Development Grants from the American Heart Association 11SDG7410022 (to J. F.) and 17SDG33630161 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander WS, 2006, P NATL ACAD SCI USA, V103, P16442, DOI 10.1073/pnas.0607872103; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Chang BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7380; Chau YY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002404; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; Hara M, 2005, J AM SOC NEPHROL, V16, P408, DOI 10.1681/ASN.2004070564; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; KERJASCHKI D, 1985, AM J PATHOL, V118, P343; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kojima K, 2004, J AM SOC NEPHROL, V15, P2079, DOI 10.1097/01.ASN.0000133531.43177.21; Liu ZH, 2014, CONTRIB NEPHROL, V183, P1; Macauley MS, 2014, J BIOL CHEM, V289, P35149, DOI 10.1074/jbc.M114.606517; Matsui K, 1999, NEPHROL DIAL TRANSPL, V14, P9, DOI 10.1093/ndt/14.suppl_1.9; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Pan YF, 2014, BLOOD, V124, P3656, DOI 10.1182/blood-2014-04-572107; PICARELLA DE, 1992, P NATL ACAD SCI USA, V89, P10036, DOI 10.1073/pnas.89.21.10036; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Tian X, 2014, J CLIN INVEST, V124, P1098, DOI 10.1172/JCI69778; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; VARKI A, 1999, ESSENTIALS GLYCOBIOL, P1, DOI [10.1101/9781621824213, DOI 10.1101/9781621824213]; Wang JR, 2010, GENESIS, V48, P446, DOI 10.1002/dvg.20635; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yang ZF, 2016, DEV BIOL, V418, P66, DOI 10.1016/j.ydbio.2016.08.009; Yu CY, 2007, MOL BIOL CELL, V18, P1710, DOI 10.1091/mbc.E06-07-0629	33	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16491	16497		10.1074/jbc.M117.798512	http://dx.doi.org/10.1074/jbc.M117.798512			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842487	hybrid, Green Published			2022-12-26	WOS:000412414800007
J	Sifaoui, I; Lopez-Arencibia, A; Martin-Navarro, CM; Reyes-Batlle, M; Wagner, C; Chiboub, O; Mejri, M; Valladares, B; Abderrabba, M; Pinero, JE; Lorenzo-Morales, J				Sifaoui, Ines; Lopez-Arencibia, Atteneri; Martin-Navarro, Carmen Ma; Reyes-Batlle, Maria; Wagner, Carolina; Chiboub, Olfa; Mejri, Mondher; Valladares, Basilio; Abderrabba, Manef; Pinero, Jose E.; Lorenzo-Morales, Jacob			Programmed cell death in Acanthamoeba castellanii Neff induced by several molecules present in olive leaf extracts	PLOS ONE			English	Article							STRAINS; DISEASE; STAGE; ACID	Therapy against Acanthamoeba infections such as Granulomatous Amoebic Encephalitis (GAE) and Acanthamoeba Keratitis (AK), remains as an issue to be solved due to the existence of a cyst stage which is highly resistant to most chemical and physical agents. Recently, the activity of Olive Leaf Extracts (OLE) was demonstrated against Acanthamoeba species. However, the molecules involved in this activity were not identified and/or evaluated. Therefore, the aim of this study was to evaluate the activity of the main molecules which are present in OLE and secondly to study their mechanism of action in Acanthamoeba. Among the tested molecules, the observed activities ranged from an IC50 of 6.59 in the case of apigenine to an IC50 > 100 mu g/ml for other molecules. After that, elucidation of the mechanism of action of these molecules was evaluated by the detection of changes in the phosphatidylserine (PS) exposure, the permeability of the plasma membrane, the mitochondrial membrane potential and the ATP levels in the treated cells. Vanillic, syringic and ursolic acids induced the higher permeabilization of the plasma membrane. Nevertheless, the mitochondrial membrane was altered by all tested molecules which were also able to decrease the ATP levels to less than 50% in IC90 treated cells after 24 h. Therefore, all the molecules tested in this study could be considered as a future therapeutic alternative against Acanthamoeba spp. Further studies are needed in order to establish the true potential of these molecules against these emerging opportunistic pathogenic protozoa.	[Sifaoui, Ines; Chiboub, Olfa; Mejri, Mondher; Abderrabba, Manef] Univ Carthage, IPEST, Lab Mat Mol & & Applicat, Tunis, Tunisia; [Sifaoui, Ines; Lopez-Arencibia, Atteneri; Martin-Navarro, Carmen Ma; Reyes-Batlle, Maria; Wagner, Carolina; Chiboub, Olfa; Valladares, Basilio; Pinero, Jose E.; Lorenzo-Morales, Jacob] Univ La Laguna, Univ Inst Trop Dis & Publ Hlth, Avda Francisco Sanchez S-N,Campus Anchieta, Tenerife, Canary Islands, Spain; [Wagner, Carolina] Univ Cent Venezuela, Fac Med, Escuela Bioanal, Catedra Parasitol, Caracas, Venezuela	Universite de Carthage; Universidad de la Laguna; University of Central Venezuela	Sifaoui, I (corresponding author), Univ Carthage, IPEST, Lab Mat Mol & & Applicat, Tunis, Tunisia.; Sifaoui, I (corresponding author), Univ La Laguna, Univ Inst Trop Dis & Publ Hlth, Avda Francisco Sanchez S-N,Campus Anchieta, Tenerife, Canary Islands, Spain.	ines.sifaoui@hotmail.com	Reyes-Batlle, María/S-5726-2017; Piñero, Jose/S-9958-2019; Abderrabba, Manef/AAD-6206-2021; chiboub, olfa/AAZ-1282-2020; Lorenzo-Morales, Jacob/H-4458-2019; Abderabah, Mohamed Abdelamanaf Ben/R-8262-2019; López-Arencibia, Atteneri/F-1665-2019; sifaoui, ines/HCG-8488-2022; SIFAOUI, INES/AAU-5424-2020	Reyes-Batlle, María/0000-0002-2290-5746; Piñero, Jose/0000-0001-6233-8224; Abderabah, Mohamed Abdelamanaf Ben/0000-0002-1129-0539; López-Arencibia, Atteneri/0000-0002-0675-8221; SIFAOUI, INES/0000-0002-5649-8333; chiboub, olfa/0000-0002-0338-3831	RICET of the programme of Redes Tematicas de Investigacion Cooperativa, FIS [RD06/0021/0005]; Spanish Ministry of Health, Madrid, Spain; Instituto de Salud Carlos III [FIS PI10/01298, PI13/00490]; Agustin de Betancourt Programme; Ayudas Proyectos Puente de la Universidad de La Laguna	RICET of the programme of Redes Tematicas de Investigacion Cooperativa, FIS; Spanish Ministry of Health, Madrid, Spain(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Agustin de Betancourt Programme; Ayudas Proyectos Puente de la Universidad de La Laguna	This work was supported by the grants RICET (project no. RD06/0021/0005 of the programme of Redes Tematicas de Investigacion Cooperativa, FIS), Spanish Ministry of Health, Madrid, Spain, and the Project FIS PI10/01298 "Protozoosis emergentes por amebas de vida libre: aislamiento y caracterizacion molecular, identificacion de cepas transportadoras de otros agentes patogenos y busqueda de quimioterapias efectivas and PI13/00490 "Protozoosis Emergentes por Amebas de Vida Libre: Aislamiento, Caracterizacion, Nuevas AproximacionesTerapeuticas y Traslacion Clinica de los Resultados" from the Instituto de Salud Carlos III. IS and ALA were funded by the Agustin de Betancourt Programme. JLM was funded by Ayudas Proyectos Puente de la Universidad de La Laguna 2017.; This work was supported by the grants RICET (project no. RD06/0021/0005 of the programme of Redes Tematicas de Investigacio An Cooperativa, FIS), Spanish Ministry of Health, Madrid, Spain and the Project FIS PI10/01298 "Protozoosis emergentes por amebas de vida libre: aislamiento y caracterizacion molecular, identificacion de cepas transportadoras de otros agentes patogenos y busqueda de quimioterapias efectivas and PI13/00490 "Protozoosis Emergentes por Amebas de Vida Libre: Aislamiento, Caracterizacion, Nuevas Aproximaciones Terapeuticas y Traslacion Clinica de los Resultados" from the Instituto de Salud Carlos III. IS and ALA were funded by the Agustoin de Betancourt Programme. JLM was funded by Ayudas Proyectos Puente de la Universidad de La Laguna 2017.	Charisiadis P, 2011, J NAT PROD, V74, P2462, DOI 10.1021/np200329a; Derda M, 2013, ACTA POL PHARM, V70, P1027; Goulas V, 2009, MOL NUTR FOOD RES, V53, P600, DOI 10.1002/mnfr.200800204; Jemai H, 2009, J AGR FOOD CHEM, V57, P8798, DOI 10.1021/jf901280r; Joshi DC, 2011, JOVE-J VIS EXP, DOI 10.3791/2704; Kaczanowski S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-44; Kim KH, 2006, FOOD CHEM, V95, P466, DOI 10.1016/j.foodchem.2005.01.032; Kim KH, 2011, ARCH PHARM RES, V34, P1363, DOI 10.1007/s12272-011-0817-5; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; Lee-Huang S, 2003, BIOCHEM BIOPH RES CO, V307, P1029, DOI 10.1016/S0006-291X(03)01292-0; Lopez-Arencibia A, 2015, ANTIMICROB AGENTS CH, V59, P2867, DOI 10.1128/AAC.00226-15; Lorenzo-Morales J, 2013, TRENDS PARASITOL, V29, P181, DOI 10.1016/j.pt.2013.01.006; Lorenzo-Morales J, 2010, ANTIMICROB AGENTS CH, V54, P5151, DOI 10.1128/AAC.00329-10; Mangoni ML, 2005, J BIOL CHEM, V280, P984, DOI 10.1074/jbc.M410795200; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Martin-Navarro CM, 2008, J MED MICROBIOL, V57, P1399, DOI 10.1099/jmm.0.2008/003459-0; Martin-Navarro CM, 2015, ANTIMICROB AGENTS CH, V59, P2817, DOI 10.1128/AAC.00066-15; McBride J, 2005, J CLIN MICROBIOL, V43, P629, DOI 10.1128/JCM.43.2.629-634.2005; Saija A, 2000, TRENDS FOOD SCI TECH, V11, P357, DOI 10.1016/S0924-2244(00)00068-6; Sanchez-Tena S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059392; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6; Sifaoui I, 2014, EXP PARASITOL, V145, pS111, DOI 10.1016/j.exppara.2014.02.018; Sifaoui I, 2014, PHYTOMEDICINE, V21, P1689, DOI 10.1016/j.phymed.2014.08.004; Sifaoui I, 2013, PARASITOL RES, V112, P2825, DOI 10.1007/s00436-013-3453-9; Somova LI, 2003, J ETHNOPHARMACOL, V84, P299, DOI 10.1016/S0378-8741(02)00332-X; Sudjana AN, 2009, INT J ANTIMICROB AG, V33, P461, DOI 10.1016/j.ijantimicag.2008.10.026	27	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183795	10.1371/journal.pone.0183795	http://dx.doi.org/10.1371/journal.pone.0183795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859105	gold, Green Submitted, Green Published			2022-12-26	WOS:000408740500035
J	Ebina, K; Hirao, M; Takagi, K; Ueno, S; Morimoto, T; Matsuoka, H; Kitaguchi, K; Iwahashi, T; Hashimoto, J; Yoshikawa, H				Ebina, Kosuke; Hirao, Makoto; Takagi, Keishi; Ueno, Sachi; Morimoto, Tokimitsu; Matsuoka, Hozo; Kitaguchi, Kazuma; Iwahashi, Toru; Hashimoto, Jun; Yoshikawa, Hideki			Comparison of the effects of forefoot joint-preserving arthroplasty and resection-replacement arthroplasty on walking plantar pressure distribution and patient-based outcomes in patients with rheumatoid arthritis	PLOS ONE			English	Article							FOOT; ANKLE; DEFORMITIES; POSITION; SURGERY	Purpose The purpose of this retrospective study is to clarify the difference in plantar pressure distribution during walking and related patient-based outcomes between forefoot joint-preserving arthroplasty and resection-replacement arthroplasty in patients with rheumatoid arthritis (RA). Methods Four groups of patients were recruited. Group1 included 22 feet of 11 healthy controls (age 48.6 years), Group2 included 36 feet of 28 RA patients with deformed non-operated feet (age 64.8 years, Disease activity score assessing 28 joints with CRP [DAS28-CRP] 2.3), Group3 included 27 feet of 20 RA patients with metatarsal head resection-replacement arthroplasty (age 60.7 years, post-operative duration 5.6 years, DAS28-CRP 2.4), and Group4 included 34 feet of 29 RA patients with metatarsophalangeal (MTP) joint-preserving arthroplasty (age 64.6 years, post-operative duration 3.2 years, DAS28-CRP 2.3). Patients were cross-sectionally examined by F-SCAN II to evaluate walking plantar pressure, and the self-administered foot evaluation questionnaire (SAFE-Q). Twenty joint-preserving arthroplasty feet were longitudinally examined at both pre- and post-operation. Results In the 1st MTP joint, Group4 showed higher pressure distribution (13.7%) than Group2 (8.0%) and Group3 (6.7%) (P<0.001). In the 2nd-3rd MTP joint, Group4 showed lower pressure distribution (9.0%) than Group2 (14.5%) (P<0.001) and Group3 (11.5%) (P<0.05). On longitudinal analysis, Group4 showed increased 1st MTP joint pressure (8.5% vs. 14.7%; P<0.001) and decreased 2nd-3rd MTP joint pressure (15.2% vs. 10.7%; P<0.01) distribution. In the SAFE-Q subscale scores, Group4 showed higher scores than Group3 in pain and pain-related scores (84.1 vs. 71.7; P<0.01) and in shoe-related scores (62.5 vs. 43.1; P< 0.01). Conclusions Joint-preserving arthroplasty resulted in higher 1st MTP joint and lower 2nd-3rd MTP joint pressures than resection-replacement arthroplasty, which were associated with better patient-based outcomes.	[Ebina, Kosuke; Hirao, Makoto; Matsuoka, Hozo; Kitaguchi, Kazuma; Iwahashi, Toru; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan; [Takagi, Keishi; Ueno, Sachi] Osaka Univ, Grad Sch Med, Dept Rehabil, Suita, Osaka, Japan; [Morimoto, Tokimitsu] Suita Municipal Hosp, Dept Orthopaed Surg, Osaka, Japan; [Hashimoto, Jun] Osaka Minami Med Ctr, Natl Hosp Org, Dept Rheumatol, Kawachi Nagano, Osaka, Japan	Osaka University; Osaka University	Ebina, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan.	k-ebina@umin.ac.jp	Ebina, Kosuke/AAH-6171-2019	Ebina, Kosuke/0000-0002-2426-1024				Collins NS, 2016, OSTEOARTHRITIS CARTI; Coughlin MJ, 2000, J BONE JOINT SURG AM, V82A, P322, DOI 10.2106/00004623-200003000-00004; Ebina K, 2016, MOD RHEUMATOL, P1; Farrow SJ, 2005, ARTHRIT RHEUM-ARTHR, V53, P593, DOI 10.1002/art.21327; Hanyu T, 1997, CLIN ORTHOP RELAT R, P131; Hiraiwa M., 2016, MOD RHEUMATOL, P1, DOI 10.1088/0960-1317/25/5/055013; Hirao M, 2017, MOD RHEUMATOL, P1; Jaakkola JI, 2004, FOOT ANKLE INT, V25, P866, DOI 10.1177/107110070402501205; Jeng C, 2008, FOOT ANKLE INT, V29, P959, DOI 10.3113/FAI.2008.0959; Kristen KH, 2002, FOOT ANKLE INT, V23, P221, DOI 10.1177/107110070202300306; Kumar C Senthil, 2007, Foot Ankle Clin, V12, P405; Mann RA, 1996, RHEUM DIS CLIN N AM, V22, P457, DOI 10.1016/S0889-857X(05)70282-9; MICHELSON J, 1994, FOOT ANKLE INT, V15, P608, DOI 10.1177/107110079401501106; Niki H, 2015, MOD RHEUMATOL, V25, P683, DOI 10.3109/14397595.2015.1008672; Niki H, 2013, J ORTHOP SCI, V18, P298, DOI 10.1007/s00776-012-0337-2; Rolfson O, 2016, ACTA ORTHOP, V87, P3, DOI 10.1080/17453674.2016.1181815; Roukis TS, 2010, J FOOT ANKLE SURG, V49, P390, DOI 10.1053/j.jfas.2010.02.023; Roy K J, 1988, Clin Podiatr Med Surg, V5, P491; Schaff P S, 1993, Clin Podiatr Med Surg, V10, P403; Shi Kenrin, 2007, Mod Rheumatol, V17, P110, DOI 10.1007/s10165-006-0551-x; Shirzad K, 2011, J AM ACAD ORTHOP SUR, V19, P505, DOI 10.5435/00124635-201108000-00006; Silvester RN, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-24; STOKES IAF, 1979, CLIN ORTHOP RELAT R, P64; Tuna H, 2005, RHEUMATOL INT, V26, P42, DOI 10.1007/s00296-004-0504-7; van der Leeden M, 2006, RHEUMATOLOGY, V45, P465, DOI 10.1093/rheumatology/kei186; Vidmar G, 2009, INT J REHABIL RES, V32, P36, DOI 10.1097/MRR.0b013e328307bdc2; Weijers RE, 2003, FOOT ANKLE INT, V24, P349, DOI 10.1177/107110070302400408; Woodburn J, 1997, BRIT J RHEUMATOL, V36, P932; Woodburn J, 1996, ANN RHEUM DIS, V55, P806, DOI 10.1136/ard.55.11.806	29	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183805	10.1371/journal.pone.0183805	http://dx.doi.org/10.1371/journal.pone.0183805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850582	Green Published, Green Submitted, gold			2022-12-26	WOS:000408544200027
J	Turner, JS; Benet, ZL; Grigorova, I				Turner, Jackson S.; Benet, Zachary L.; Grigorova, Irina			Transiently antigen primed B cells can generate multiple subsets of memory cells	PLOS ONE			English	Article							GERMINAL-CENTERS; CLONAL SELECTION; PLASMA-CELLS; ANTIBODIES; AFFINITY	Memory B cells are long-lived cells that generate a more vigorous response upon recognition of antigen (Ag) and T cell help than naive B cells and ensure maintenance of durable humoral immunity. Functionally distinct subsets of murine memory B cells have been identified based on isotype switching of BCRs and surface expression of the co-stimulatory molecule CD80 and co-inhibitory molecule PD-L2. Memory B cells in a subpopulation with low surface expression of CD80 and PD-L2 are predominantly non-isotype switched and can be efficiently recruited into germinal centers (GCs) in secondary responses. In contrast, a CD80 and PD-L2 positive subset arises predominantly from GCs and can quickly differentiate into antibody-secreting plasma cells (PCs). Here we demonstrate that single transient acquisition of Ag by B cells may be sufficient for their long-term participation in GC responses and for development of various memory B cell subsets including CD80 and PD-L2 positive effector-like memory cells that rapidly differentiate into class-switched PCs during recall responses.	[Turner, Jackson S.; Benet, Zachary L.; Grigorova, Irina] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Grigorova, I (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	igrigor@umich.edu	Grigorova, Irina/AAR-8795-2020	Grigorova, Irina/0000-0002-4963-7403	National Institutes of Health [R01 AI106806]; Herman and Dorothy Miller Award for Innovative Immunology Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herman and Dorothy Miller Award for Innovative Immunology Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01 AI106806 to I.G. and by the Herman and Dorothy Miller Award for Innovative Immunology Research to J.S.T. and Z.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; LAVOIE TB, 1992, J IMMUNOL, V148, P503; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Turner JS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15072; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	20	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183877	10.1371/journal.pone.0183877	http://dx.doi.org/10.1371/journal.pone.0183877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850584	gold, Green Published, Green Submitted			2022-12-26	WOS:000408544200037
J	Barrantes, S; Egea, AJS; Rojas, HAG; Marti, MJ; Compta, Y; Valldeoriola, F; Mezquita, ES; Tolosa, E; Valls-Sole, J				Barrantes, Sergi; Sanchez Egea, Antonio J.; Gonzalez Rojas, Hernan A.; Marti, Maria J.; Compta, Yaroslau; Valldeoriola, Francesc; Simo Mezquita, Ester; Tolosa, Eduard; Valls-Sole, Josep			Differential diagnosis between Parkinson's disease and essential tremor using the smartphone's accelerometer	PLOS ONE			English	Article							PHYSIOLOGICAL TREMOR	Background The differential diagnosis between patients with essential tremor (ET) and those with Parkinson's disease (PD) whose main manifestation is tremor may be difficult unless using complex neuroimaging techniques such as I-123-FP-CIT SPECT. We considered that using smartphone's accelerometer to stablish a diagnostic test based on time-frequency differences between PD an ET could support the clinical diagnosis. Methods The study was carried out in 17 patients with PD, 16 patients with ET, 12 healthy volunteers and 7 patients with tremor of undecided diagnosis (TUD), who were re-evaluated one year after the first visit to reach the definite diagnosis. The smartphone was placed over the hand dorsum to record epochs of 30 s at rest and 30 s during arm stretching. We generated frequency power spectra and calculated receiver operating characteristics curves (ROC) curves of total spectral power, to establish a threshold to separate subjects with and without tremor. In patients with PD and ET, we found that the ROC curve of relative energy was the feature discriminating better between the two groups. This threshold was then used to classify the TUD patients. Results We could correctly classify 49 out of 52 subjects in the category with/without tremor (97.96% sensitivity and 83.3% specificity) and 27 out of 32 patients in the category PD/ET (84.38% discrimination accuracy). Among TUD patients, 2 of 2 PD and 2 of 4 ET were correctly classified, and one patient having PD plus ET was classified as PD. Conclusions Based on the analysis of smartphone accelerometer recordings, we found several kinematic features in the analysis of tremor that distinguished first between healthy subjects and patients and, ultimately, between PD and ET patients. The proposed method can give immediate results for the clinician to gain valuable information for the diagnosis of tremor. This can be useful in environments where more sophisticated diagnostic techniques are unavailable.	[Barrantes, Sergi; Marti, Maria J.; Compta, Yaroslau; Valldeoriola, Francesc; Tolosa, Eduard; Valls-Sole, Josep] UB, Sch Med, Barcelona, Catalonia, Spain; [Sanchez Egea, Antonio J.; Gonzalez Rojas, Hernan A.] Politech Univ Catalonia UPC, Mech Engn Dept EPSEVG, Barcelona, Spain; [Marti, Maria J.; Compta, Yaroslau; Valldeoriola, Francesc] CIBERNED Barcelona, Hosp Clin IDIBAPS, Dept Neurol, Parkinsons Dis & Movement disorder Unit, Catalonia, Spain; [Simo Mezquita, Ester] Politech Univ Catalonia UPC, Math Dept EPSEVG, Barcelona, Spain; [Valls-Sole, Josep] Hosp Clin Barcelona, Dept Neurol, EMG & Motor Control Unit, Barcelona, Spain	University of Barcelona; Universitat Politecnica de Catalunya; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Politecnica de Catalunya; University of Barcelona; Hospital Clinic de Barcelona	Valls-Sole, J (corresponding author), UB, Sch Med, Barcelona, Catalonia, Spain.; Valls-Sole, J (corresponding author), Hosp Clin Barcelona, Dept Neurol, EMG & Motor Control Unit, Barcelona, Spain.	jvalls@clinic.cat	Egea, Antonio J. Sánchez/S-4790-2016; Compta, Yaroslau/U-8298-2017	Egea, Antonio J. Sánchez/0000-0001-8085-6869; Compta, Yaroslau/0000-0001-6443-0104; Valls-Sole, Josep/0000-0001-6779-0156; Simo, Ester/0000-0003-4587-7028; Gonzalez Rojas, Hernan Alberto/0000-0001-8911-0115				Antonini A, 2008, MOVEMENT DISORD, V23, P2202, DOI 10.1002/mds.22278; Bain P, 2000, NEUROLOGY, V54, pS7; Brittain JS, 2015, J NEUROSCI, V35, P795, DOI 10.1523/JNEUROSCI.3768-14.2015; Daneault JF, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00357; Fahn S, 1993, MOVEMENT DISORD, V2, P271; GE Healthcare Inc, 2017, OMNIPAQUE IOH INJ; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Helmich RC, 2013, CURR NEUROL NEUROSCI, P13; Hossen A, 2013, BIO-MED MATER ENG, V23, P513, DOI 10.3233/BME-130773; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Marti MJ, 2013, NAT REV NEUROL, V9, P190, DOI 10.1038/nrneurol.2013.47; Joundi RA, 2011, PARKINSONISM RELAT D, V17, P288, DOI 10.1016/j.parkreldis.2011.01.001; Kostikis N, 2015, IEEE J BIOMED HEALTH, V19, P1835, DOI 10.1109/JBHI.2015.2471093; Kostikis N, 2014, IEEE ENG MED BIO, P906, DOI 10.1109/EMBC.2014.6943738; Muthuraman M, 2011, MOVEMENT DISORD, V26, P1548, DOI 10.1002/mds.23672; Raethjen J, 2000, CLIN NEUROPHYSIOL, V111, P1825, DOI 10.1016/S1388-2457(00)00384-9; Raethjen J, 2004, CLIN NEUROPHYSIOL, V115, P2151, DOI 10.1016/j.clinph.2004.04.006; Senova S, 2015, STEREOT FUNCT NEUROS, V93, P94, DOI 10.1159/000369354; Thanawattano C, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0098-1; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Trenado C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112782; Wile DJ, 2014, J NEUROSCI METH, V230, P1, DOI 10.1016/j.jneumeth.2014.04.021; Woods AM, 2014, PERVASIVE MOB COMPUT, V13, P1, DOI 10.1016/j.pmcj.2013.10.002; Zeuner KE, 2012, CURR OPIN NEUROL, V25, P475, DOI 10.1097/WCO.0b013e3283550c7e	24	44	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183843	10.1371/journal.pone.0183843	http://dx.doi.org/10.1371/journal.pone.0183843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841694	Green Published, Green Submitted, gold			2022-12-26	WOS:000408370700062
J	Xu, Y; Jiang, Y; Shi, T; Cai, HF; Lan, XY; Zhao, X; Plath, M; Chen, H				Xu, Yao; Jiang, Yu; Shi, Tao; Cai, Hanfang; Lan, Xianyong; Zhao, Xin; Plath, Martin; Chen, Hong			Whole-genome sequencing reveals mutational landscape underlying phenotypic differences between two widespread Chinese cattle breeds	PLOS ONE			English	Article							COPY NUMBER VARIATIONS; STRUCTURAL VARIATION; GENETIC ARCHITECTURE; WIDE ASSOCIATION; CARCASS MERIT; GROWTH TRAITS; SHORT-READ; POLYMORPHISMS; EXPRESSION; EVOLUTION	Whole-genome sequencing provides a powerful tool to obtain more genetic variability that could produce a range of benefits for cattle breeding industry. Nanyang (Bos indicus) and Qinchuan (Bos taurus) are two important Chinese indigenous cattle breeds with distinct phenotypes. To identify the genetic characteristics responsible for variation in phenotypes between the two breeds, in the present study, we for the first time sequenced the genomes of four Nanyang and four Qinchuan cattle with 10 to 12 fold on average of 97.86% and 98.98% coverage of genomes, respectively. Comparison with the Bos_taurus_UMD_3.1 reference assembly yielded 9,010,096 SNPs for Nanyang, and 6,965,062 for Qinchuan cattle, 51% and 29% of which were novel SNPs, respectively. A total of 154,934 and 115,032 small indels (1 to 3 bp) were found in the Nanyang and Qinchuan genomes, respectively. The SNP and indel distribution revealed that Nanyang showed a genetically high diversity as compared to Qinchuan cattle. Furthermore, a total of 2,907 putative cases of copy number variation (CNV) were identified by aligning Nanyang to Qinchuan genome, 783 of which (27%) encompassed the coding regions of 495 functional genes. The gene ontology (GO) analysis revealed that many CNV genes were enriched in the immune system and environment adaptability. Among several CNV genes related to lipid transport and fat metabolism, Lepin receptor gene (LEPR) overlapping with CNV_1815 showed remarkably higher copy number in Qinchuan than Nanyang (log(2) (ratio) = -2.34988; P value = 1.53E-102). Further qPCR and association analysis investigated that the copy number of the LEPR gene presented positive correlations with transcriptional expression and phenotypic traits, suggesting the LEPR CNV may contribute to the higher fat deposition in muscles of Qinchuan cattle. Our findings provide evidence that the distinct phenotypes of Nanyang and Qinchuan breeds may be due to the different genetic variations including SNPs, indels and CNV.	[Xu, Yao; Jiang, Yu; Shi, Tao; Cai, Hanfang; Lan, Xianyong; Zhao, Xin; Plath, Martin; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Xu, Yao] Wuhan Univ Sci & Technol, Inst Biol & Med, Coll Life Sci & Hlth, Wuhan, Hubei, Peoples R China	Northwest A&F University - China; Wuhan University of Science & Technology	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	chenhong1212@263.net	Zhao, Xin/M-4312-2015; Jiang, Yu/O-5114-2015	Zhao, Xin/0000-0002-1078-7332; Jiang, Yu/0000-0003-4821-3585	National Natural Science Foundation of China [30972080, 31272408, 31600617]; Program of the National Beef Cattle Industrial Technology System [CARS-38]; National 863 Program of China [2013AA102505]; Natural Science Foundation of Jiangsu Province [BK2011206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of the National Beef Cattle Industrial Technology System; National 863 Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Natural Science Foundation of China (Grant No. 30972080, 31272408, 31600617), the Program of the National Beef Cattle Industrial Technology System (CARS-38), the National 863 Program of China (Grant No. 2013AA102505), and the Natural Science Foundation of Jiangsu Province (BK2011206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (Grant No. 30972080, 31272408, 31600617), the Program of the National Beef Cattle Industrial Technology System (CARS-38), the National 863 Program of China (Grant No. 2013AA102505), and the Natural Science Foundation of Jiangsu Province (BK2011206).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Bickhart DM, 2016, DNA RES, V23, P253, DOI 10.1093/dnares/dsw013; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Blattler A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0469-0; Boerner V, 2015, J ANIM SCI, V93, P513, DOI 10.2527/jas.2014-8357; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen WK, 2009, GENOME RES, V19, P500, DOI 10.1101/gr.083741.108; Crispell J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3569-x; Cucco DC, 2009, GENET MOL RES, V8, P291, DOI 10.4238/vol8-4gmr650; Du QZ, 2016, NEW PHYTOL, V209, P1067, DOI 10.1111/nph.13695; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Geisler SB, 2007, GENOMICS, V89, P521, DOI 10.1016/j.ygeno.2006.12.004; Hill WG, 2000, LIVEST PROD SCI, V63, P99, DOI 10.1016/S0301-6226(99)00115-3; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Islam KK, 2009, ANIM GENET, V40, P766, DOI 10.1111/j.1365-2052.2009.01912.x; Jeon JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-426; Keel BN, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00207; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Larkin DM, 2012, P NATL ACAD SCI USA, V109, P7693, DOI 10.1073/pnas.1114546109; Lee KT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-519; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu GE, 2008, DEV BIOLOGICALS, V132, P231, DOI 10.1159/000317165; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu YJ, 2004, PHYSIOL GENOMICS, V17, P101, DOI 10.1152/physiolgenomics.00213.2003; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Matsuhashi T, 2011, J ANIM SCI, V89, P12, DOI 10.2527/jas.2010-3121; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Medeiros de Oliveira Silva R, 2017, PLOS ONE, V12; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Nkrumah JD, 2005, J ANIM SCI, V83, P20; Ohshima Kazuhiko, 2013, Int J Evol Biol, V2013, P424726, DOI 10.1155/2013/424726; Pannier L, 2010, MEAT SCI, V85, P515, DOI 10.1016/j.meatsci.2010.02.025; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Singleton AB, 2011, LANCET NEUROL, V10, P942, DOI 10.1016/S1474-4422(11)70196-X; Stafuzza N.B., 2017, PLOS ONE, V12; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Uddin M, 2015, GENET MED, V17, P747, DOI 10.1038/gim.2014.178; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Xu LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23161; Xu Y, 2014, GENE, V535, P106, DOI 10.1016/j.gene.2013.11.057; Xu Y, 2013, MAMM GENOME, V24, P508, DOI 10.1007/s00335-013-9483-x; Yang J, 2016, MOL BIOL EVOL, V33, P2576, DOI 10.1093/molbev/msw129; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	60	17	17	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183921	10.1371/journal.pone.0183921	http://dx.doi.org/10.1371/journal.pone.0183921			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841720	Green Published, Green Submitted, gold			2022-12-26	WOS:000408370700068
J	Beaver, LM; Truong, L; Barton, CL; Chase, TT; Gonnerman, GD; Wong, CP; Tanguay, RL; Ho, E				Beaver, Laura M.; Truong, Lisa; Barton, Carrie L.; Chase, Tyler T.; Gonnerman, Greg D.; Wong, Carmen P.; Tanguay, Robert L.; Ho, Emily			Combinatorial effects of zinc deficiency and arsenic exposure on zebrafish (Danio rerio) development	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; IN-VIVO; INTELLECTUAL FUNCTION; EMBRYONIC-DEVELOPMENT; GLUCOSE-HOMEOSTASIS; DRINKING-WATER; RAT; EXPRESSION; PREGNANCY	Zinc deficiency and chronic low level exposures to inorganic arsenic in drinking water are both significant public health concerns that affect millions of people including pregnant women. These two conditions can co-exist in the human population but little is known about their interaction, and in particular, whether zinc deficiency sensitizes individuals to arsenic exposure and toxicity, especially during critical windows of development. To address this, we utilized the Danio rerio (zebrafish) model to test the hypothesis that parental zinc deficiency sensitizes the developing embryo to low-concentration arsenic toxicity, leading to altered developmental outcomes. Adult zebrafish were fed defined zinc deficient and zinc adequate diets and were spawned resulting in zinc adequate and zinc deficient embryos. The embryos were treated with environmentally relevant concentrations of 0, 50, and 500 ppb arsenic. Arsenic exposure significantly reduced the amount of zinc in the developing embryo by similar to 7%. The combination of zinc deficiency and low-level arsenic exposures did not sensitize the developing embryo to increased developmental malformations or mortality. The combination did cause a 40% decline in physical activity of the embryos, and this decline was significantly greater than what was observed with zinc deficiency or arsenic exposure alone. Significant changes in RNA expression of genes that regulate zinc homeostasis, response to oxidative stress and insulin production (including zip1, znt7, nrf2, ogg1, pax4, and insa) were found in zinc deficient, or zinc deficiency and arsenic exposed embryos. Overall, the data suggests that the combination of zinc deficiency and arsenic exposure has harmful effects on the developing embryo and may increase the risk for developing chronic diseases like diabetes.	[Beaver, Laura M.; Chase, Tyler T.; Wong, Carmen P.; Ho, Emily] Oregon State Univ, Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Beaver, Laura M.; Wong, Carmen P.; Tanguay, Robert L.; Ho, Emily] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Truong, Lisa; Barton, Carrie L.; Gonnerman, Greg D.; Tanguay, Robert L.] Oregon State Univ, Dept Environm & Mol Toxicol, Sinnhuber Aquat Res Lab, Corvallis, OR 97331 USA; [Truong, Lisa; Barton, Carrie L.; Gonnerman, Greg D.; Tanguay, Robert L.; Ho, Emily] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA; [Tanguay, Robert L.; Ho, Emily] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Ho, Emily] Oregon State Univ, Moore Family Ctr Whole Grain Foods Nutr & Prevent, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University; Oregon State University; Oregon State University	Ho, E (corresponding author), Oregon State Univ, Biol & Populat Hlth Sci, Corvallis, OR 97331 USA.; Ho, E (corresponding author), Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.; Ho, E (corresponding author), Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA.; Ho, E (corresponding author), Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA.; Ho, E (corresponding author), Oregon State Univ, Moore Family Ctr Whole Grain Foods Nutr & Prevent, Corvallis, OR 97331 USA.	Emily.Ho@oregonstate.edu		Truong, Lisa/0000-0003-1751-4617	National Institute of Environmental Health Sciences [R21-ES023937, R01-ES021100-03S1, P30 ES000210]; Oregon Agricultural Experimental Station	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Oregon Agricultural Experimental Station	Work conducted in the authors' laboratory is supported by and National Institute of Environmental Health Sciences grants R21-ES023937, R01-ES021100-03S1, P30 ES000210 as well as Oregon Agricultural Experimental Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul KSM, 2015, ENVIRON TOXICOL PHAR, V40, P828, DOI 10.1016/j.etap.2015.09.016; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; [Anonymous], 2014, LANG ENV STAT COMP; Bailey Kathryn, 2014, Reviews on Environmental Health, V29, P9, DOI 10.1515/reveh-2014-0006; Basaki M, 2012, BIOL TRACE ELEM RES, V148, P161, DOI 10.1007/s12011-012-9360-6; Beaver LM, 2017, J NUTR BIOCHEM, V43, P78, DOI 10.1016/j.jnutbio.2017.02.006; Bugel Sean M, 2014, Curr Environ Health Rep, V1, P341; Caulfield LE, 1998, AM J CLIN NUTR, V68, p499S, DOI 10.1093/ajcn/68.2.499S; Caulfield LE, COMP QUANTIFICATION; Chen J, 2016, TOXICOL SCI, V153, P124, DOI 10.1093/toxsci/kfw110; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Cooper KL, 2013, TOXICOL APPL PHARM, V269, P81, DOI 10.1016/j.taap.2013.03.008; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Eide DJ, 2011, METALLOMICS, V3, P1124, DOI 10.1039/c1mt00064k; Ettinger AS, 2009, ENVIRON HEALTH PERSP, V117, P1059, DOI 10.1289/ehp0800533; Farzan SF, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0194-0; Franklin RB, 2003, J INORG BIOCHEM, V96, P435, DOI 10.1016/S0162-0134(03)00249-6; Fung EB, 2015, NUTRIENTS, V7, P4296, DOI 10.3390/nu7064296; Gao HL, 2009, NEUROTOX RES, V16, P416, DOI 10.1007/s12640-009-9072-7; Garg Hemant K., 1993, Indian Journal of Physiology and Pharmacology, V37, P276; Hess SY, 2009, FOOD NUTR BULL, V30, pS60, DOI 10.1177/15648265090301S105; Ho E, 2003, J NUTR, V133, P2543, DOI 10.1093/jn/133.8.2543; Ho E, 2012, COMP BIOCHEM PHYS C, V155, P26, DOI 10.1016/j.cbpc.2011.05.002; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huestis J, 2016, J INORG BIOCHEM, V163, P45, DOI 10.1016/j.jinorgbio.2016.08.003; JANKOWSKI MA, 1995, TERATOLOGY, V51, P85, DOI 10.1002/tera.1420510207; Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649; Jou MY, 2012, PEDIATR RES, V71, P228, DOI 10.1038/pr.2011.44; Jou MY, 2010, J NUTR, V140, P1621, DOI 10.3945/jn.109.119677; Jurowski K, 2014, J BIOL INORG CHEM, V19, P1069, DOI 10.1007/s00775-014-1139-0; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kile ML, 2016, EPIDEMIOLOGY, V27, P173, DOI 10.1097/EDE.0000000000000416; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimmel RA, 2015, SCI REP-UK, V5, DOI 10.1038/srep14241; Kimmel RA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-75; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Kloubert V, 2015, FOOD FUNCT, V6, P3195, DOI [10.1039/C5FO00630A, 10.1039/c5fo00630a]; Kurita H, 2013, J NUTR BIOCHEM, V24, P256, DOI 10.1016/j.jnutbio.2012.05.013; Kwok RK, 2006, J HEALTH POPUL NUTR, V24, P190; Li B, 2014, J CELL MOL MED, V18, P895, DOI 10.1111/jcmm.12239; Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235; LIU HJ, 1992, BIOL TRACE ELEM RES, V34, P55, DOI 10.1007/BF02783898; Lopez V, 2008, BIOL TRACE ELEM RES, V122, P238, DOI 10.1007/s12011-007-8079-2; Mandrell D, 2012, JALA-J LAB AUTOM, V17, P66, DOI 10.1177/2211068211432197; MEADOWS N, 1983, ARCH DIS CHILD, V58, P807, DOI 10.1136/adc.58.10.807; Milton AG, 2004, BIOMETALS, V17, P707, DOI 10.1007/s10534-004-1210-3; Morello-Frosch R, 2016, ENVIRON SCI TECHNOL, V50, P12464, DOI 10.1021/acs.est.6b03492; Myers SL, 2010, J EPIDEMIOL COMMUN H, V64, P325, DOI 10.1136/jech.2008.084392; Myers SA, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/173712; Naujokas MF, 2013, ENVIRON HEALTH PERSP, V121, P295, DOI 10.1289/ehp.1205875; Navas-Acien A, 2006, ENVIRON HEALTH PERSP, V114, P641, DOI 10.1289/ehp.8551; Olivares CI, 2016, CHEMOSPHERE, V148, P361, DOI 10.1016/j.chemosphere.2016.01.050; OTEIZA PI, 1990, BIOL TRACE ELEM RES, V24, P13, DOI 10.1007/BF02789137; Padmavathi IJN, 2009, EXP PHYSIOL, V94, P761, DOI 10.1113/expphysiol.2008.045856; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Pan WC, 2013, AM J EPIDEMIOL, V178, P1563, DOI 10.1093/aje/kwt195; Papasani MR, 2006, PHYSIOL GENOMICS, V27, P79, DOI 10.1152/physiolgenomics.00012.2006; Parvez F, 2011, ENVIRON HEALTH PERSP, V119, P1665, DOI 10.1289/ehp.1103548; PETERS JM, 1991, P SOC EXP BIOL MED, V198, P561; Pineda J, 2013, J TRACE ELEM MED BIO, V27, P236, DOI 10.1016/j.jtemb.2012.12.006; Prakash A, 2015, FUND CLIN PHARMACOL, V29, P131, DOI 10.1111/fcp.12110; Quansah R, 2015, ENVIRON HEALTH PERSP, V123, P412, DOI 10.1289/ehp.1307894; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Rodrigues EG, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0127-y; Romualdo GR, 2016, FOOD CHEM TOXICOL, V96, P280, DOI 10.1016/j.fct.2016.08.020; Sen J, 2008, ARH HIG RADA TOKSIKO, V59, P271, DOI 10.2478/10004-1254-59-2008-1871; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Song Y, 2009, J NUTR, V139, P1626, DOI 10.3945/jn.109.106369; Stephens WZ, 2016, ISME J, V10, P644, DOI 10.1038/ismej.2015.140; Timme-Laragy AR, 2012, J BIOL CHEM, V287, P4609, DOI 10.1074/jbc.M111.260125; Truong L, 2011, METHODS MOL BIOL, V691, P271, DOI 10.1007/978-1-60761-849-2_16; Tyler Christina R, 2014, Curr Environ Health Rep, V1, P132; United States Institute of Medicine, 2001, PAN MICR DRI DIET RE; URIUHARE JY, 1989, DIABETES, V38, P1282, DOI 10.2337/diabetes.38.10.1282; VAHTER M, 1994, APPL ORGANOMET CHEM, V8, P175, DOI 10.1002/aoc.590080304; Verbanac D, 1997, BIOL TRACE ELEM RES, V57, P91, DOI 10.1007/BF02803873; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Wasserman GA, 2007, ENVIRON HEALTH PERSP, V115, P285, DOI 10.1289/ehp.9501; Welch AH, 2000, GROUND WATER, V38, P589, DOI 10.1111/j.1745-6584.2000.tb00251.x; Xu H, 2016, TOXICOL SCI, V149, P31, DOI 10.1093/toxsci/kfv211; Zhou XX, 2011, J BIOL CHEM, V286, P22855, DOI 10.1074/jbc.M111.232926	82	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183831	10.1371/journal.pone.0183831	http://dx.doi.org/10.1371/journal.pone.0183831			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837703	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000129
J	Kittikraisak, W; Suntarattiwong, P; Ditsungnoen, D; Pallas, SE; Abimbola, TO; Klungthong, C; Fernandez, S; Srisarang, S; Chotpitayasunondh, T; Dawood, FS; Olsen, SJ; Lindblade, KA				Kittikraisak, Wanitchaya; Suntarattiwong, Piyarat; Ditsungnoen, Darunee; Pallas, Sarah E.; Abimbola, Taiwo O.; Klungthong, Chonticha; Fernandez, Stefan; Srisarang, Suchada; Chotpitayasunondh, Tawee; Dawood, Fatimah S.; Olsen, Sonja J.; Lindblade, Kim A.			Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children <= 60 months of age	PLOS ONE			English	Article							QUALITY-OF-LIFE; ECONOMIC-IMPACT; SOUTHERN; VIRUSES; HEALTH	Background Vaccination is the best measure to prevent influenza. We conducted a cost-effectiveness evaluation of trivalent inactivated seasonal influenza vaccination, compared to no vaccination, in children <= 60 months of age participating in a prospective cohort study in Bangkok, Thailand. Methods A static decision tree model was constructed to simulate the population of children in the cohort. Proportions of children with laboratory-confirmed influenza were derived from children followed weekly. The societal perspective and one-year analytic horizon were used for each influenza season; the model was repeated for three influenza seasons (2012-2014). Direct and indirect costs associated with influenza illness were collected and summed. Cost of the trivalent inactivated seasonal influenza vaccine (IIV3) including promotion, administration, and supervision cost was added for children who were vaccinated. Quality-adjusted life years (QALY), derived from literature, were used to quantify health outcomes. The incremental cost-effectiveness ratio (ICER) was calculated as the difference in the expected total costs between the vaccinated and unvaccinated groups divided by the difference in QALYs for both groups. Results Compared to no vaccination, IIV3 vaccination among children <= 60 months in our cohort was not cost-effective in the introductory year (2012 season; 24,450 USD/QALY gained), highly cost-effective in the 2013 season (554 USD/QALY gained), and cost-effective in the 2014 season (16,200 USD/QALY gained). Conclusion The cost-effectiveness of IIV3 vaccination among children participating in the cohort study varied by influenza season, with vaccine cost and proportion of high-risk children demonstrating the greatest influence in sensitivity analyses. Vaccinating children against influenza can be economically favorable depending on the maturity of the program, influenza vaccine performance, and target population.	[Kittikraisak, Wanitchaya; Ditsungnoen, Darunee; Lindblade, Kim A.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Influenza Program, Nonthaburi, Thailand; [Suntarattiwong, Piyarat; Srisarang, Suchada; Chotpitayasunondh, Tawee] Minist Publ Hlth, Queen Sirikit Natl Inst Child Hlth, Infect Dis Unit, Bangkok, Thailand; [Pallas, Sarah E.; Abimbola, Taiwo O.] US Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA USA; [Klungthong, Chonticha; Fernandez, Stefan] Armed Forces Res Inst Med Sci, Lab Virol, Bangkok, Thailand; [Dawood, Fatimah S.; Olsen, Sonja J.; Lindblade, Kim A.] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Centers for Disease Control & Prevention - USA	Kittikraisak, W (corresponding author), US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Influenza Program, Nonthaburi, Thailand.	glr9@cdc.gov		Pallas, Sarah/0000-0002-9719-6278; Lindblade, Kim/0000-0002-5593-0470	U.S. Centers for Disease Control and Prevention [5U01GH000152]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was funded by U.S. Centers for Disease Control and Prevention through cooperative agreement 5U01GH000152.	Canaway AG, 2014, INT J OBESITY, V38, P1146, DOI 10.1038/ijo.2013.219; Chit A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133606; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; Cohen GM, 2000, PEDIATRICS, V106, P973, DOI 10.1542/peds.106.5.973; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Duncan Ian G, 2012, Cost Eff Resour Alloc, V10, P10; Esposito S, 2006, VACCINE, V24, P629, DOI 10.1016/j.vaccine.2005.08.054; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Garcia A, 2016, HUM VACC IMMUNOTHER, V12, P2269, DOI 10.1080/21645515.2016.1182275; Haddix AC, 2003, PREVENTION EFFECTIVE; Hall JL, 2005, J PEDIATR-US, V147, P807, DOI 10.1016/j.jpeds.2005.06.031; Hannoun C, 2013, EXPERT REV VACCINES, V12, P1085, DOI 10.1586/14760584.2013.824709; Hibbert CL, 2007, VACCINE, V25, P8010, DOI 10.1016/j.vaccine.2007.09.018; Hirve S, 2015, SEASONAL INFLUENZA V; Johannesson M, 1996, HEALTH POLICY, V36, P231, DOI 10.1016/0168-8510(96)00815-9; Kittikraisak W, 2016, PEDIATR INFECT DIS J, V35, pE318, DOI 10.1097/INF.0000000000001280; Kittikraisak W, 2015, INFLUENZA OTHER RESP, V9, P85, DOI 10.1111/irv.12302; Lee BY, 2015, MED CARE, V53, P218, DOI 10.1097/MLR.0000000000000302; Luce BR, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e24; Marchetti M, 2007, HUM VACCINES, V3, P14, DOI 10.4161/hv.3.1.3657; Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1; Meeyai A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001829; Meier G, 2015, J MED ECON, V18, P746, DOI 10.3111/13696998.2015.1044456; Owusu JT, 2015, VACCINE, V33, P742, DOI 10.1016/j.vaccine.2014.10.029; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; Ropero-Alvarez AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-361; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Suntarattiwong P, 2016, INFLUENZA INCIDENCE; Tarride JE, 2012, CLINICOECONOMIC OUTC, V4, P287, DOI 10.2147/CEOR.S33444; Van Bellinghen LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098437; World Bank, 2016, GDP PER CAP; World Health Organization, COST EFFECTIVENESS A; World Health Organization, 2012, M STRAT ADV GROUP EX	33	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183391	10.1371/journal.pone.0183391	http://dx.doi.org/10.1371/journal.pone.0183391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837594	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000063
J	Thomas, AJ; Pulsipher, A; Davis, BM; Alt, JA				Thomas, Andrew J.; Pulsipher, Abigail; Davis, Brock M.; Alt, Jeremiah A.			LL-37 causes cell death of human nasal epithelial cells, which is inhibited with a synthetic glycosaminoglycan	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; NF-KAPPA-B; CHRONIC RHINOSINUSITIS; INFLAMMATORY CASPASES; CATHELICIDIN LL-37; DISEASE SEVERITY; EXPRESSION; PHOSPHATIDYLSERINE; APOPTOSIS; IL-8	LL-37 is an immune peptide that regulates innate and adaptive immune responses in the upper airways. Elevated levels of LL-37 have been linked to cell death and inflammatory diseases, such as chronic rhinosinusitis (CRS). Glycosaminoglycans (GAGs) are polysaccharides that are found on respiratory epithelial cells and serve important roles in mucosal surface repair. Recent findings suggest that a synthetic glycosaminoglycan (GM-0111) can protect against LL-37-induced sinonasal mucosal inflammation and cell death in a murine model of acute RS. Herein, we elucidated the mechanisms by which LL-37 causes sinonasal inflammation and how GM-0111 can prevent these mechanisms. When challenged with LL-37, human nasal epithelial cells (HNEpCs) and mouse macrophages (J774.2) demonstrated increased release of adenosine triphosphate (ATP) and interleukin (IL)-6 and -8, as well as cell death and lysis. These cellular responses were all blocked dose-dependently by pre-treatment with GM-0111. We identified that LL-37-induced cell death is associated with caspase-1 and -8 activation, but not activation of caspase-3/7. These responses were again blocked by GM-0111. Our data suggest that LL-37 causes cellular death of HNEpCs and macrophages through the pro-inflammatory necrotic and/or pyroptotic pathways rather than apoptosis, and that a GM-0111 is capable of inhibiting these pro-inflammatory cellular events.	[Thomas, Andrew J.; Pulsipher, Abigail; Davis, Brock M.; Alt, Jeremiah A.] Univ Utah, Sch Med, Dept Surg,Rhinol Sinus & Skull Base Surg Program, Div Head & Neck Surg, Salt Lake City, UT 84132 USA; [Pulsipher, Abigail; Alt, Jeremiah A.] GlycoMira Therapeut, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah	Alt, JA (corresponding author), Univ Utah, Sch Med, Dept Surg,Rhinol Sinus & Skull Base Surg Program, Div Head & Neck Surg, Salt Lake City, UT 84132 USA.; Alt, JA (corresponding author), GlycoMira Therapeut, Salt Lake City, UT 84108 USA.	jeremiah.alt@hsc.utah.edu		Thomas, Andrew/0000-0002-5890-1325; Alt, Jeremiah/0000-0003-0560-5028	University of Utah Program in Personalized Health and the National Center for Advancing Translational Sciences [KL2TR001065]; National Institute on Allergy and Infectious Diseases (NIAID) [R43 AI126987-01]; University of Utah Program in Personalized Health and the National Center for Advancing Translational Sciences [KL2TR001065]; National Institute on Allergy and Infectious Diseases (NIAID) [R43 AI126987-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI126987] Funding Source: NIH RePORTER	University of Utah Program in Personalized Health and the National Center for Advancing Translational Sciences; National Institute on Allergy and Infectious Diseases (NIAID); University of Utah Program in Personalized Health and the National Center for Advancing Translational Sciences; National Institute on Allergy and Infectious Diseases (NIAID); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant numbers KL2TR001065 (JAA) and R43 AI126987-01 (AP, JAA) from the University of Utah Program in Personalized Health and the National Center for Advancing Translational Sciences and National Institute on Allergy and Infectious Diseases (NIAID), respectively. The funders had no role in study design, data collection and analysis, and decision to publish or preparation of the manuscript. J.A.A. is a consultant for Spirox (Menlo Park, CA; USA) and Medtronic, Inc. (Jacksonville, FL; USA), which are not affiliated with this investigation. AP and JAA declare financial interest and/or other relationships with GlycoMira Therapeutics, Inc. (Salt Lake City, UT; USA). GlycoMira Therapeutics, Inc. provided support in the form of salary for AP and reagents/supplies, but did not have additional roles in study design, data collection and analysis, and decision to publish or preparation of the manuscript.	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Alagarasu K, 2017, PEPTIDES, V92, P23, DOI 10.1016/j.peptides.2017.04.002; Alt JA, 2014, LARYNGOSCOPE; Alt JA, 2015, INT FORUM ALLERGY RH, V5, P1141, DOI 10.1002/alr.21634; Alt JA, 2013, INT FORUM ALLERGY RH, V3, P941, DOI 10.1002/alr.21217; Alt JA, 2013, LARYNGOSCOPE, V123, P2364, DOI 10.1002/lary.24040; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; BECKER S, 1991, J IMMUNOL, V147, P4307; Bhattacharyya N, 2007, CURR ALLERGY ASTHM R, V7, P216, DOI 10.1007/s11882-007-0075-2; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Chen PH, 2004, AM J RHINOL, V18, P381, DOI 10.1177/194589240401800608; Edfeldt K, 2006, ARTERIOSCL THROM VAS, V26, P1551, DOI 10.1161/01.ATV.0000223901.08459.57; Elenius V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172350; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gerdin B, 1997, J INTERN MED, V242, P49, DOI 10.1046/j.1365-2796.1997.00173.x; Ghaffar O, 1998, OTOLARYNG HEAD NECK, V118, P504, DOI 10.1016/S0194-5998(98)70209-8; Henriquez KM, 2015, J MED VIROL, V87, P330, DOI 10.1002/jmv.24042; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kennedy JL, 2013, AM J RHINOL ALLERGY, V27, P367, DOI 10.2500/ajra.2013.27.3906; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; Krysko O, 2004, APOPTOSIS, V9, P495, DOI 10.1023/B:APPT.0000031452.75162.75; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; Lau YE, 2006, AM J RESP CELL MOL, V34, P399, DOI 10.1165/rcmb.2005-0170OC; Lecoeur H, 2001, CYTOMETRY, V44, P65, DOI 10.1002/1097-0320(20010501)44:1<65::AID-CYTO1083>3.0.CO;2-Q; Lee Stella, 2011, Curr Infect Dis Rep, V13, P159, DOI 10.1007/s11908-011-0166-z; Lee WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077854; Litvack JR, 2009, AM J RHINOL ALLERGY, V23, P139, DOI 10.2500/ajra.2009.23.3286; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Mader JS, 2009, MOL CANCER RES, V7, P689, DOI 10.1158/1541-7786.MCR-08-0274; Manuele C, 2016, INT J PEDIATR OTORHI, V85, P22, DOI 10.1016/j.ijporl.2016.03.015; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Min YG, 1999, AM J RHINOL, V13, P339, DOI 10.2500/105065899781367546; Min YG, 2000, J KOREAN MED SCI, V15, P255, DOI 10.3346/jkms.2000.15.3.255; Monie TP, 2015, IMMUNOL REV, V265, P181, DOI 10.1111/imr.12284; Negrini D, 2008, INTENS CARE MED, V34, P610, DOI 10.1007/s00134-007-0962-y; Nell MJ, 2004, FEMS IMMUNOL MED MIC, V42, P225, DOI 10.1016/j.femsim.2004.05.013; Ohkubo Kimihiro, 1998, Rhinology (Utrecht), V36, P156; Ooi EH, 2007, AM J RHINOL, V21, P395, DOI 10.2500/ajr.2007.21.3048; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS3, DOI 10.1002/alr.21694; Peters AT, 2010, J ALLERGY CLIN IMMUN, V125, P397, DOI 10.1016/j.jaci.2009.10.072; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Pulsipher A, 2016, INT FORUM ALLERGY RH; Rhyoo C, 1999, J ALLERGY CLIN IMMUN, V103, P395, DOI 10.1016/S0091-6749(99)70462-8; Riechelmann H, 2005, CLIN EXP ALLERGY, V35, P1186, DOI 10.1111/j.1365-2222.2005.02316.x; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Sejima T, 2012, ALLERGOL INT, V61, P115, DOI 10.2332/allergolint.10-OA-0290; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Smith TL, 2010, OTOLARYNG HEAD NECK, V142, P55, DOI 10.1016/j.otohns.2009.10.009; Soler ZM, 2011, LARYNGOSCOPE, V121, P2672, DOI 10.1002/lary.21847; Souza CO, 2012, BBA-GEN SUBJECTS, V1820, P1867, DOI 10.1016/j.bbagen.2012.08.013; Suzuki H, 1996, J ALLERGY CLIN IMMUN, V98, P659, DOI 10.1016/S0091-6749(96)70100-8; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tan BK, 2013, AM J RESP CRIT CARE, V188, P1275, DOI 10.1164/rccm.201308-1500ED; Thienhaus ML, 2011, RHINOLOGY, V49, P554, DOI [10.4193/Rhino11.072, 10.4193/Rhino10.072]; Torres-Juarez F, 2015, INFECT IMMUN, V83, P4495, DOI 10.1128/IAI.00936-15; Turino GM, 2003, AM J RESP CRIT CARE, V167, P1169, DOI 10.1164/rccm.200205-449PP; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang Q, 2013, INT IMMUNOL, V25, P363, DOI 10.1093/intimm/dxs161; Waring P, 1999, CELL DEATH DIFFER, V6, P624, DOI 10.1038/sj.cdd.4400540; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Xie Dan, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P337; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020500; Zhang YK, 2014, BIOCHEM BIOPH RES CO, V443, P103, DOI 10.1016/j.bbrc.2013.11.074	74	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183542	10.1371/journal.pone.0183542	http://dx.doi.org/10.1371/journal.pone.0183542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837619	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000077
J	Danobeitia, JS; Ziemelis, M; Ma, XB; Zitur, LJ; Zens, T; Chlebeck, PJ; Van Amersfoort, ES; Fernandez, LA				Danobeitia, Juan S.; Ziemelis, Martynas; Ma, Xiaobo; Zitur, Laura J.; Zens, Tiffany; Chlebeck, Peter J.; Van Amersfoort, Edwin S.; Fernandez, Luis A.			Complement inhibition attenuates acute kidney injury after ischemia-reperfusion and limits progression to renal fibrosis in mice	PLOS ONE			English	Article							C1 INHIBITOR; IMMUNE-RESPONSE; C5A; ACTIVATION; PATHWAY; ANAPHYLATOXINS; MECHANISMS; INNATE; C3A; INFLAMMATION	The complement system is an essential component of innate immunity and plays a major role in the pathogenesis of ischemia-reperfusion injury (IRI). In this study, we investigated the impact of human C1-inhibitor (C1INH) on the early inflammatory response to IRI and the subsequent progression to fibrosis in mice. We evaluated structural damage, renal function, acute inflammatory response, progression to fibrosis and overall survival at 90-days post-injury. Animals receiving C1INH prior to reperfusion had a significant improvement in survival rate along with superior renal function when compared to vehicle (PBS) treated counterparts. Pre-treatment with C1INH also prevented acute IL-6, CXCL1 and MCP-1 upregulation, C5a release, C3b deposition and infiltration by neutrophils and macrophages into renal tissue. This anti-inflammatory effect correlated with a significant reduction in the expression of markers of fibrosis alpha smooth muscle actin, desmin and picrosirius red at 30 and 90 days post-IRI and reduced renal levels of TGF-beta 1 when compared to untreated controls. Our findings indicate that intravenous delivery of C1INH prior to ischemic injury protects kidneys from inflammatory injury and subsequent progression to fibrosis. We conclude that early complement blockade in the context of IRI constitutes an effective strategy in the prevention of fibrosis after ischemic acute kidney injury.	[Danobeitia, Juan S.; Ziemelis, Martynas; Ma, Xiaobo; Zitur, Laura J.; Zens, Tiffany; Chlebeck, Peter J.; Fernandez, Luis A.] Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA; [Van Amersfoort, Edwin S.] Pharming Technol BV, Leiden, Netherlands	University of Wisconsin System; University of Wisconsin Madison	Fernandez, LA (corresponding author), Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA.	luisf@surgery.wisc.edu	van Amersfoort, Edwin S/J-9944-2018; Danobeitia, Juan/AAC-5327-2020	Danobeitia, Juan/0000-0003-1641-3822; ZITUR, LAURA/0000-0002-1238-2726	NIH [T32AI125231]; Department of Surgery at the University of Wisconsin Madison; Pharming Technologies BV; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI125231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery at the University of Wisconsin Madison; Pharming Technologies BV; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a T32 training grant from the NIH (T32AI125231) and internal funds of the Department of Surgery at the University of Wisconsin Madison. ESVA is employed by Pharming Technologies BV. Pharming Technologies BV provided support in the form of salary for author ESVA and kindly provided the experimental drug used in this study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section."	Bao LH, 2011, KIDNEY INT, V80, P524, DOI 10.1038/ki.2011.158; Barnett ANR, 2013, CLIN TRANSPLANT, V27, pE216, DOI 10.1111/ctr.12102; Begieneman MPV, 2012, J BURN CARE RES, V33, P544, DOI 10.1097/BCR.0b013e31823bc2fc; Bergamaschini L, 2001, CLIN EXP IMMUNOL, V126, P412, DOI 10.1046/j.1365-2249.2001.01695.x; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343; Castellano G, 2010, AM J PATHOL, V176, P1648, DOI 10.2353/ajpath.2010.090276; Curci C, 2014, NEPHROL DIAL TRANSPL, V29, P799, DOI 10.1093/ndt/gft516; Danobeitia JS, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-16; Danobeitia JS, 2012, J SURG RES, V176, P639, DOI 10.1016/j.jss.2011.10.042; Davis AE, 2010, THROMB HAEMOSTASIS, V104, P886, DOI 10.1160/TH10-01-0073; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; de Vries B, 2004, AM J PATHOL, V165, P1677, DOI 10.1016/S0002-9440(10)63424-4; de Vries B, 2003, J IMMUNOL, V170, P3883, DOI 10.4049/jimmunol.170.7.3883; De Vries B, 2003, TRANSPLANTATION, V75, P375, DOI 10.1097/01.TP.0000044455.05584.2A; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Farrar CA, 2016, IMMUNOBIOLOGY, V221, P1068, DOI 10.1016/j.imbio.2016.05.004; Fu JR, 2006, BIOCHEM BIOPH RES CO, V349, P504, DOI 10.1016/j.bbrc.2006.08.065; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Guerrot D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S15; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; Jansen PM, 1998, J IMMUNOL, V160, P475; Jiang HX, 2001, J EXP MED, V194, P1609, DOI 10.1084/jem.194.11.1609; Jordan JE, 2001, CIRCULATION, V104, P1413, DOI 10.1161/hc3601.095578; Kaplan AP, 2014, ADV IMMUNOL, V121, P41, DOI 10.1016/B978-0-12-800100-4.00002-7; Kielar ML, 2005, J AM SOC NEPHROL, V16, P3315, DOI 10.1681/asn.2003090757; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Liu D, 2007, J IMMUNOL, V179, P3966, DOI 10.4049/jimmunol.179.6.3966; Lu FX, 2008, AM J PHYSIOL-GASTR L, V295, pG1042, DOI 10.1152/ajpgi.90460.2008; Lu FX, 2013, CARDIOVASC PATHOL, V22, P75, DOI 10.1016/j.carpath.2012.05.003; NURNBERGER W, 1994, INTENS CARE MED, V20, P242, DOI 10.1007/BF01704710; Patel NSA, 2005, J PHARMACOL EXP THER, V312, P1170, DOI 10.1124/jpet.104.078659; Peng Q, 2012, J AM SOC NEPHROL, V23, P1474, DOI 10.1681/ASN.2011111072; Peng Qi, 2009, Inflammation & Allergy Drug Targets, V8, P236; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Stahl GL, 2003, AM J PATHOL, V162, P449, DOI 10.1016/S0002-9440(10)63839-4; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; Veszeli N, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0374-y; Wang PHM, 2006, INT IMMUNOPHARMACOL, V6, P1960, DOI 10.1016/j.intimp.2006.07.031; Zhao HL, 2014, AM J PHYSIOL-RENAL, V306, pF801, DOI 10.1152/ajprenal.00469.2013; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621; Zhou WD, 2012, IMMUNOBIOLOGY, V217, P225, DOI 10.1016/j.imbio.2011.07.016	53	30	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183701	10.1371/journal.pone.0183701	http://dx.doi.org/10.1371/journal.pone.0183701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832655	Green Submitted, Green Published, gold			2022-12-26	WOS:000408355800087
J	De Weggheleire, A; An, S; De Baetselier, I; Soeung, P; Keath, H; So, V; Ros, S; Teav, S; Smekens, B; Buyze, J; Florence, E; van Griensven, J; Thai, S; Francque, S; Lynen, L				De Weggheleire, Anja; An, Sokkab; De Baetselier, Irith; Soeung, Pisith; Keath, Huy; So, Veasna; Ros, Sreyphors; Teav, Syna; Smekens, Bart; Buyze, Jozefien; Florence, Eric; van Griensven, Johan; Thai, Sopheak; Francque, Sven; Lynen, Lutgarde			A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening	PLOS ONE			English	Article							VIRUS-INFECTION; SPONTANEOUS CLEARANCE; INJECTION PRACTICES; VIRAL-HEPATITIS; NATURAL-HISTORY; BLOOD-DONORS; EPIDEMIOLOGY; COINFECTION; VIREMIA	The epidemiology of hepatitis C in Cambodia is not well-known. We evaluated the prevalence of hepatitis C virus (HCV) and risk factors in the HIV cohort of Sihanouk Hospital Center of Hope in Phnom Penh to strengthen the evidence for suitable HCV testing strategies among people living with HIV (PLWH) in Cambodia. All consenting adult PLWH without a history of HCV treatment were tested for HCV between November 2014 and May 2016 according to the CDC algorithm (HCV antibody II electro-chemiluminescence immunoassay, followed by COBAS (R) AmpliPrep/COBAS (R) TaqMan (R) HCV PCR and INNO-LIA (R) HCV Score immunoblot end-testing). Genotyping was performed using the line probe assay Versant HCV genotype 2.0 (R). The study enrolled a total of 3045 patients (43% males, median age: 42.5 years, <1% high-risk). HCV antibodies were detected in 230 (7.6%; 95% confidence interval [CI] 6.6-8.5). Upon further testing, HCV antibodies were confirmed in 157 (5.2%; 95% CI 4.4-6.0) and active HCV in 106 (3.5%; 95% CI 2.8-4.2). Viremic prevalence peaked among men aged 50-55 years (7.3%) and women aged >55 years (11.2%). Genotype 1b (45%) and 6 (41%) were predominant. Coinfected patients had a higher aspartate-to-platelet ratio index, lower platelets, a lower HBsAg positivity rate and more frequent diabetes. Based on logistic regression, blood transfusion antecedents (adjusted odds ratio 2.9; 95% CI 1.7-4.9), unsafe medical injections (2.0; 1.3-3.2), and partner (3.4; 1.5-7.6) or household member (2.4; 1.3-3.2) with liver disease were independently associated with HCV in women. However, having a tattoo/scarification (1.9; 1.1-3.4) and household member (3.1; 1.3-7.3) with liver disease were associated with HCV in men. Thus, our study found intermediate endemicity of active hepatitis C in a large Cambodian HIV cohort and provides initial arguments for targeted HCV screening (>50 years, partner/household member with liver disease, diabetes, increased aspartate-to-platelet ratio index) as efficient way forward.	[De Weggheleire, Anja; De Baetselier, Irith; Smekens, Bart; Buyze, Jozefien; Florence, Eric; van Griensven, Johan; Lynen, Lutgarde] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium; [An, Sokkab; Soeung, Pisith; Keath, Huy; So, Veasna; Ros, Sreyphors; Teav, Syna; Thai, Sopheak] Sihanouk Hosp Ctr Hope, Infect Dis, Phnom Penh, Cambodia; [Francque, Sven] Univ Antwerp, Gastroenterol Hepatol, Antwerp, Belgium; [Francque, Sven] Univ Antwerp, Lab Expt Med & Paediat, Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp; University of Antwerp	De Weggheleire, A (corresponding author), Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium.	adeweggheleire@itg.be	Lynen, Lutgarde/AAT-9180-2020; Buyze, Jozefien/B-8550-2014; De Weggheleire, Anja/C-7345-2018; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Buyze, Jozefien/0000-0001-6780-380X; De Weggheleire, Anja/0000-0001-9377-4766; Lynen, Lutgarde/0000-0001-7183-4895; Florence, Eric/0000-0002-7004-9120	Flemish Government - Department of Economy, Science Innovation; Institute of Tropical Medicine Antwerp; ihanouk Hospital Center of Hope; Belgian Development Cooperation (DGDC)	Flemish Government - Department of Economy, Science Innovation; Institute of Tropical Medicine Antwerp; ihanouk Hospital Center of Hope; Belgian Development Cooperation (DGDC)	This work was supported by a research grant from the Flemish Government - Department of Economy, Science & Innovation and through the framework agreement between the Institute of Tropical Medicine Antwerp, Sihanouk Hospital Center of Hope and the Belgian Development Cooperation (DGDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarathamrongsin S, 2011, INTERVIROLOGY, V54, P10, DOI 10.1159/000318884; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; [Anonymous], BMJ, DOI DOI 10.1136/BMJ.327.7423.1075; [Anonymous], 2017, LANCET GASTROENTEROL, V2, P161; Bes M, 2009, TRANSFUSION, V49, P1296, DOI 10.1111/j.1537-2995.2009.02103.x; Chen M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150512; Chhorvann C, 2014, HIV RELATED RISK BEH; De Monte A, 2016, J CLIN VIROL, V78, P27, DOI 10.1016/j.jcv.2016.02.026; De Weggheleire A, J HEPATOLOGY, V64, pS715; EASL, 2016, REC TREATM HEP C; Filippini P, 2007, J MED VIROL, V79, P1679, DOI 10.1002/jmv.20992; Getchell JP, 2013, MMWR-MORBID MORTAL W, V62, P362; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Goyet S, 2014, AIDS BEHAV, V18, P495, DOI 10.1007/s10461-013-0486-0; Grint D, 2016, HIV MED; Hadlich E, 2007, J GASTROEN HEPATOL, V22, P1506, DOI 10.1111/j.1440-1746.2006.04614.x; Hammerstad SS, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00134; Holding R., 1998, EPIDEMICS DEVASTATIN; IDSA-AASLD, 2016, REC TEST MAN TREAT H; Lerolle N., 2012, Journal of AIDS and Clinical Research, V3, P161; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; Makuria AT, 2012, TRANSFUSION, V52, P1940, DOI 10.1111/j.1537-2995.2011.03524.x; Martinello M, 2016, AIDS REV, V18, P69; Murphy J., 2015, COUNTRY LOVE INJECTI; Ol HS, 2009, SE ASIAN J TROP MED, V40, P963; Owens DK, 1997, MED DECIS MAKING, V17, P409, DOI 10.1177/0272989X9701700406; Pepin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099677; Pepin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080948; Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5; Ranieri R, 2003, CLIN INFECT DIS, V36, P1086, DOI 10.1086/374247; Soeung SC, 2009, AM J TROP MED HYG, V81, P252, DOI 10.4269/ajtmh.2009.81.252; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Stenkvist J, 2014, J HEPATOL, V61, P957, DOI 10.1016/j.jhep.2014.06.014; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thursz M, 2014, NAT REV GASTRO HEPAT, V11, P28, DOI 10.1038/nrgastro.2013.179; van Griensven J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088552; Vong S, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-56; Vun MC, 2016, MMWR-MORBID MORTAL W, V65, P142, DOI 10.15585/mmwr.mm6506a2; World Health Organization, 2017, GUID HEP B C TEST; Yamada H, 2015, HEPATOL RES, V45, P480, DOI 10.1111/hepr.12367; Yu C, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw099	41	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183530	10.1371/journal.pone.0183530	http://dx.doi.org/10.1371/journal.pone.0183530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832660	Green Published, Green Submitted, gold			2022-12-26	WOS:000408355800062
J	Johnson, LM; Torres, C; Sykes, A; Gibson, DV; Baker, JN				Johnson, Liza-Marie; Torres, Carlos; Sykes, April; Gibson, Deborah V.; Baker, Justin N.			The bereavement experience of adolescents and early young adults with cancer: Peer and parental loss due to death is associated with increased risk of adverse psychological outcomes	PLOS ONE			English	Article							CHILDHOOD-CANCER; GRIEF; SURVIVORS; HEALTH; CARE; EXPOSURE; CHILDREN; YOUTH	Background Adolescents commonly experience loss due to death, and perceived closeness to the deceased can often increase the intensity of bereavement. Adolescents and early young adult (AeYA) oncology patients may recall previous losses or experience new losses, possibly of other children with cancer, while coping with their own increased risk of mortality. The bereavement experiences of AeYA patients are not well described in the literature. Methods and findings This analysis of bereavement sought to describe the prevalence and types of losses, the support following a death, and the impact of loss on AeYAs aged 13-21 years with malignant disease (or a hematologic disorder requiring allogeneic transplant). Participants were receiving active oncologic therapy or had completed therapy within the past 3 years. Participants completed a bereavement questionnaire and inventories on depression, anxiety, and somatization. The cross-sectional study enrolled 153 AeYAs (95% participation), most (88%) of whom had experienced a loss due to death. The most commonly reported losses were of a grandparent (58%) or friend (37%). Peer deaths were predominantly cancer related (66%). Many participants (39%) self-identified a loss as "very significant." As loss significance increased, AeYAs were more likely to report that it had changed their life "a lot/enormously" (P<0.0001), that they were grieving "slowly or never got over it" (P<0.0001), and that they felt a need for more professional help (P = 0.026). Peer loss was associated with increased risk of adverse psychological outcomes (P = 0.029), as was parental loss (P = 0.018). Conclusions Most AeYAs with serious illness experience the grief process as slow or ongoing. Peer or parental loss was associated with increased risk of negative mental health outcomes. Given the high prevalence of peer loss, screening for bereavement problems is warranted in AeYAs with cancer, and further research on grief and bereavement is needed in AeYAs with serious illness.	[Johnson, Liza-Marie; Torres, Carlos; Gibson, Deborah V.; Baker, Justin N.] St Jude Childrens Res Hosp, Div Qual Life & Palliat Care, 332 N Lauderdale St, Memphis, TN 38105 USA; [Torres, Carlos] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; [Sykes, April] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Memphis; St Jude Children's Research Hospital	Johnson, LM (corresponding author), St Jude Childrens Res Hosp, Div Qual Life & Palliat Care, 332 N Lauderdale St, Memphis, TN 38105 USA.	Liza.johnson@stjude.org	Torres, Carlos/GRS-7240-2022; Sykes, April/N-4407-2018; Johnson, Liza-Marie/N-8127-2018; Baker, Justin/N-8117-2018	Sykes, April/0000-0002-7667-8155; Johnson, Liza-Marie/0000-0002-7124-979X; Baker, Justin/0000-0002-6584-6483				Ayers T, 2004, DEATH STUD, V28, P491, DOI 10.1080/07481180490461188; Balk D.E., 2009, ADOLESCENT ENCOUNTER; Bleyer A, 2006, CANC EPIDEMIOLOGY OL; Boelen PA, 2015, PSYCHOL TRAUMA-US, V7, P382, DOI 10.1037/tra0000018; BRENT DA, 1992, J AM ACAD CHILD PSY, V31, P629, DOI 10.1097/00004583-199207000-00009; Brown G. W., 1986, DEPRESSION YOUNG PEO, P251; Cupit MC, 2015, WHY GOD SUFFERING CA, P138; Dyregrov A, 1999, SCAND J PSYCHOL, V40, P167, DOI 10.1111/1467-9450.00114; Ens C, 2005, DEATH STUD, V29, P171, DOI 10.1080/07481180590906192; Grenklo TB, 2013, J CLIN ONCOL, V31, P2886, DOI 10.1200/JCO.2012.46.6102; Harrison L, 2001, J ADOLESCENCE, V24, P159, DOI 10.1006/jado.2001.0379; Hinds PS, 2005, J CLIN ONCOL, V23, P9146, DOI 10.1200/JCO.2005.10.538; Hirooka K, 2017, J ADV NURS, V73, P955, DOI 10.1111/jan.13196; Hogan N., 1996, CONTINUING BONDS NEW, P235; Jonas-Simpson C, 2015, DEATH STUD, V39, P242, DOI 10.1080/07481187.2014.991954; Kazak AE, 2010, J CLIN ONCOL, V28, P2002, DOI 10.1200/JCO.2009.25.9564; MacPherson C., 2005, MORTALITY, V10, P113, DOI DOI 10.1080/13576270500102872; Martinson IM, 1991, J ADOLESCENT RES, V6, P54, DOI DOI 10.1177/074355489161005; McNeil J. N., 1991, J ADOLESCENT RES, V6, P132; Michel G, 2010, J CLIN ONCOL, V28, P1740, DOI 10.1200/JCO.2009.23.4534; Neimeyer RA, 2002, AM BEHAV SCI, V46, P235, DOI 10.1177/000276402236676; Nickerson B., 1991, J ADOLESCENT RES, V6, P70, DOI DOI 10.1177/074355489161006; Nitschke R, 2000, MED PEDIATR ONCOL, V34, P268; Noppe LD., 2004, J MENT HLTH COUNS, V26, P146, DOI [10.17744/mehc.26.2.py2tk0kmay1ukc3v, DOI 10.17744/MEHC.26.2.PY2TK0KMAY1UKC3V]; OBRIEN JM, 1991, ADOLESCENCE, V26, P431; Oltjenbruns KA, 1991, J ADOLESC RES, V6, P43; Prasad PK, 2015, J CLIN ONCOL, V33, P2545, DOI 10.1200/JCO.2014.57.7528; Prigerson HG, 2008, BRIT J PSYCHIAT, V193, P435, DOI 10.1192/bjp.bp.108.053157; Reynolds CR., 2004, BEHAV ASSESSMENT SYS, V2, DOI [10.1002/9780470479216.corpsy0114, DOI 10.1002/9780470479216.CORPSY0114]; Rheingold AA, 2004, J LOSS TRAUMA, V9, P1, DOI 10.1080/15325020490255250; Ringler LL, 2000, J ADOLESCENT RES, V15, P209, DOI 10.1177/0743558400152002; Servaty-Seib HL, 2006, OMEGA-J DEATH DYING, V54, P147; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; Sood B, 1992, MENTAL HLTH CARE, V2, P17; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Swihart J., 1992, SCHOOL COUNS, V40, P55; Trevino KM, 2011, J ADOLESC YOUNG ADUL, V1, P168, DOI 10.1089/jayao.2011.0024; Warnick AL, 2015, CURR OPIN SUPPORT PA, V9, P58, DOI 10.1097/SPC.0000000000000115	39	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0181024	10.1371/journal.pone.0181024	http://dx.doi.org/10.1371/journal.pone.0181024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832654	Green Published, gold, Green Submitted			2022-12-26	WOS:000408355800002
J	Kenawy, S; Hegazy, R; Hassan, A; El-Shenawy, S; Gomaa, N; Zaki, H; Attia, A				Kenawy, Sara; Hegazy, Rehab; Hassan, Azza; El-Shenawy, Siham; Gomaa, Nawal; Zaki, Hala; Attia, Amina			Involvement of insulin resistance in Dgalactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID-BETA; THERAPEUTIC TARGET; OXIDATIVE STRESS; INFLAMMATION; PROGRESSION; REDUCTIONS; IMPAIRMENT; METABOLISM; EXPRESSION	Age-related dementia is one of the most devastating disorders affecting the elderly. Recently, emerging data suggest that impaired insulin signaling is the major contributor in the development of Alzheimer's dementia (AD), which is the most common type of senile dementia. In the present study, we investigated the potential therapeutic effects of metformin (Met) and saxagliptin (Saxa), as insulin sensitizing agents, in a rat model of brain aging and AD using D-galactose (D-gal, 150 mg/kg/day, s.c. for 90 successive days). Six groups of adult male Wistar rats were used: normal, D-gal, Met (500 mg/kg/day, p.o), and Saxa (1 mg/kg/day, p.o) control groups, as well as D-gal/Met and D-gal/Sax treated groups. Impaired learning and memory function was observed in rats treated with D-gal using Morris water maze test. Biochemical and histopathological findings also revealed some characteristic changes of AD in the brain that include the increased content of acetylcholine, glutamate, and phosphorelated tau, as well as deposition of amyloid plaques and neurofibrillary tangles. Induction of insulin resistance in experimentally aged rats was evidenced by increased blood glycated hemoglobin, brain contents of insulin and receptors for advanced glycated end-products, as well as decreased brain insulin receptor level. Elevation of oxidative stress markers and TNF-alpha brain content was also demonstrated. Met and Saxa, with a preference to Met, restored the normal memory and learning functions in rats, improved D-galinduced state of insulin resistance, oxidative stress and inflammation, and ameliorated the AD biochemical and histopathological alterations in brain tissues. Our findings suggest that D-gal model of aging results in a diminishing of learning and memory function by producing a state of impaired insulin signaling that causes a cascade of deleterious events like oxidative stress, inflammation, and tau hyper-phosphorylation. Reversing of these harmful effects by the use of insulin-sensitizing drugs like Met and Saxa suggests their involvement in alleviation insulin resistance as the underlying pathology of AD and hence their potential use as anti-dementia drugs.	[Kenawy, Sara; Hegazy, Rehab; El-Shenawy, Siham; Gomaa, Nawal] Natl Res Ctr, Med Div, Pharmacol Dept, Giza, Egypt; [Hassan, Azza] Cairo Univ, Fac Vet Med, Pathol Dept, Giza, Egypt; [Zaki, Hala; Attia, Amina] Cairo Univ, Fac Pharm, Pharmacol & Toxicol Dept, Cairo, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Hegazy, R (corresponding author), Natl Res Ctr, Med Div, Pharmacol Dept, Giza, Egypt.	rehab_hegazy@hotmail.com		, Siham/0000-0002-8057-0331; Hegazy, Rehab/0000-0002-2586-2104; Zaki, Hala/0000-0001-9026-4015	National Research Center of Egypt; National Research Centre (Giza, Egypt)	National Research Center of Egypt(National Research Centre (NRC)); National Research Centre (Giza, Egypt)(National Research Centre (NRC))	SK received fund from the National Research Center of Egypt to perform the work in the current manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported and funded by the National Research Centre (Giza, Egypt).	Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bevan P, 2001, J CELL SCI, V114, P1429; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Bhutada P, PROTECTION CHOLINERG; BONAVIDA B, 1991, BIOTHERAPY, V3, P127, DOI 10.1007/BF02172085; Bordji K, 2011, REV NEUROSCIENCE, V22, P285, DOI 10.1515/RNS.2011.029; Bromley-Brits Kelley, 2011, J Vis Exp, DOI 10.3791/2920; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Chen F, 2016, NEUROPHARMACOLOGY, V101, P123, DOI 10.1016/j.neuropharm.2015.07.023; Chen HY, 2016, J ALZHEIMERS DIS, V51, P515, DOI 10.3233/JAD-151089; Chen YX, 2016, CURR TOP MED CHEM, V16, P485, DOI 10.2174/1568026615666150813142423; COCCHETTO DM, 1983, J PHARM SCI-US, V72, P465, DOI 10.1002/jps.2600720503; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Fried LP, 2016, GERONTOLOGIST, V56, pS167, DOI 10.1093/geront/gnw035; Grieb P, 2016, MOL NEUROBIOL, V53, P1741, DOI 10.1007/s12035-015-9132-3; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Huang WJ, 2016, BIOMED REP, V4, P519, DOI 10.3892/br.2016.630; Hunter S, 2013, MOL NEUROBIOL, V48, P556, DOI 10.1007/s12035-013-8445-3; Igel LI, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0568-3; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Kim Y, 2016, KIDNEY RES CLIN PRAC, V35, P69, DOI 10.1016/j.krcp.2016.02.004; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kosaraju J, SAXAGLIPTIN DIPEPTID; Kosaraju J, 2013, NEUROPHARMACOLOGY, V72, P291, DOI 10.1016/j.neuropharm.2013.04.008; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Li HY, 2016, J ETHNOPHARMACOL, V179, P162, DOI 10.1016/j.jep.2015.12.020; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li YN, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/320513; Liu YJ, 2015, J NEUROGENET, V29, P50, DOI 10.3109/01677063.2015.1067203; Maczurek A, 2008, ANN NY ACAD SCI, V1126, P147, DOI 10.1196/annals.1433.026; Manolopoulos KN, 2010, MOL PSYCHIATR, V15, P1046, DOI 10.1038/mp.2010.17; Marin MT, 2011, EUR J PHARMACOL, V660, P363, DOI 10.1016/j.ejphar.2011.03.052; Mcnay EC, 2011, NEUROBIOL LEARN MEM, V96, P432, DOI 10.1016/j.nlm.2011.08.005; Mondragon-Rodriguez S, 2010, EXPERT REV NEUROTHER, V10, P683, DOI 10.1586/ERN.10.27; Muir-Hunter SW, 2016, J NUTR HEALTH AGING, V20, P439, DOI 10.1007/s12603-015-0585-x; Novelle MG, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025932; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PEREZDELAMORA M, 1989, ANAL BIOCHEM, V180, P248, DOI 10.1016/0003-2697(89)90425-9; Rehman S.U., 2016, MOL NEUROBIOL, DOI [DOI 10.1007/S12035-015-9604-5, 10.1007/s12035-015-9604-5]; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Salazar JJ, 2016, J DIABETES COMPLICAT, V30, P746, DOI 10.1016/j.jdiacomp.2015.12.017; Snowdon DA, 1997, GERONTOLOGIST, V37, P150, DOI 10.1093/geront/37.2.150; Solini A, 2016, VASC PHARMACOL, V76, P62, DOI 10.1016/j.vph.2015.10.002; Son SM, 2016, J ALZHEIMERS DIS, V51, P1197, DOI 10.3233/JAD-151200; Stefanova NA, 2014, CELL CYCLE, V13, P898, DOI 10.4161/cc.28255; Tarpey MM, 2004, AM J PHYSIOL-REG I, V286, pR431, DOI 10.1152/ajpregu.00361.2003; Tramutola A., 2016, BRAIN RES B; Walker D, 2015, EXPERT OPIN INV DRUG, V24, P393, DOI 10.1517/13543784.2015.1001490; Watson GS, 2006, J NEUROL SCI, V245, P21, DOI 10.1016/j.jns.2005.08.017; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Zhang EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143814	52	41	41	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183565	10.1371/journal.pone.0183565	http://dx.doi.org/10.1371/journal.pone.0183565			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832656	Green Published, gold, Green Submitted			2022-12-26	WOS:000408355800064
J	Feng, GX; Li, J; Yang, Z; Zhang, SQ; Liu, YX; Zhang, WY; Ye, LH; Zhang, XD				Feng, G. X.; Li, J.; Yang, Z.; Zhang, S. Q.; Liu, Y. X.; Zhang, W. Y.; Ye, L. H.; Zhang, X. D.			Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; EXTRACELLULAR-MATRIX; CELL-CELL; EXPRESSION; MICRORNAS; PROLIFERATION; BIOMARKERS; METASTASIS; CIRRHOSIS; ENHANCE	Hepatitis B virus (HBV)-induced liver necrosis takes great part in liver cirrhosis progression. However, less is known about whether hepatitis B virus X protein (HBx) has effect on liver fibrosis. Here, we report that HBV leads to liver fibrosis and hepatocarcinogenesis through miR-30e targeting P4HA2. HBV transgenic mouse was treated by CCl4 to generate a model of liver fibrosis. A crucial enzyme catalyzing collagen formation, prolyl 4-hydroxylase subunit alpha 2 (P4HA2) was evaluated by immunohistochemistry, western blotting or quantitative reverse transcription-PCR analysis. The function of HBV-modulated P4HA2 in hepatoma cell growth in vitro and in vivo was analyzed by EdU, MTT, colony-forming assay and animal transplantation assay. HBV transgenic mice exhibited more collagen deposition in liver after intraperitoneal injection of CCl4. P4HA2 was dramatically augmented in liver samples of HBV transgenic mice, clinical liver cirrhosis and liver cancer patients. Mechanistically, HBx was capable of inducing P4HA2 through suppressing miR-30e, in which miR-30e could target P4HA2 mRNA 3' untranslated region in liver cancer cells. HBx inhibited the miR-30e expression through increasing methylation of CpG islands in its promoter mediated by EZH2-formed complexes. Functionally, HBx-elevated P4HA2 enhanced the collagen deposition in the liver in vivo and in vitro, leading to liver fibrosis and liver cancer progression. In conclusion, HBx promotes the development of liver fibrosis and hepatocellular carcinoma through miR-30e targeting P4HA2 mRNA. We provide novel perspective on how HBx induces liver fibrosis.	[Feng, G. X.; Li, J.; Yang, Z.; Zhang, S. Q.; Liu, Y. X.; Zhang, W. Y.; Zhang, X. D.] Nankai Univ, Dept Canc Res, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Ye, L. H.] Nankai Univ, Dept Biochem, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China	Nankai University; Nankai University	Zhang, WY; Zhang, XD (corresponding author), Nankai Univ, Dept Canc Res, Coll Life Sci, Tianjin 300071, Peoples R China.; Ye, LH (corresponding author), Nankai Univ, Dept Biochem, Coll Life Sci, Tianjin 300071, Peoples R China.	zhwybao@nankai.edu.cn; yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Feng, Guoxing/AAD-6163-2019		National Natural Science Foundation of China [81372186, 31470756, 31670769, 31670771]; National Basic Research Program of China (973 Program) [2015CB553905, 2015CB553703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the grants of National Natural Science Foundation of China (No. 81372186, 31470756, 31670769, 31670771) and National Basic Research Program of China (973 Program, No. 2015CB553905, 2015CB553703).	Bhattacharya S, 2016, AM J PATHOL, V186, P242, DOI 10.1016/j.ajpath.2015.10.003; Chakravarthi BVSK, 2014, ONCOTARGET, V5, P6654, DOI 10.18632/oncotarget.2208; Chang KP, 2011, J PROTEOME RES, V10, P4935, DOI 10.1021/pr200311p; Chen RJ, 2015, NEUROSCIENCE, V305, P36, DOI 10.1016/j.neuroscience.2015.07.045; Cushing L, 2015, BIOCHEM CELL BIOL, V93, P109, DOI 10.1139/bcb-2014-0095; de Martel C, 2015, HEPATOLOGY, V62, P1190, DOI 10.1002/hep.27969; Feng GL, 2016, PROCEEDINGS 2016 FIRST INTERNATIONAL CONFERENCE ON MULTIMEDIA AND IMAGE PROCESSING (ICMIP 2016), P1, DOI 10.1109/ICMIP.2016.13; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Haflidadottir BS, 2015, EUR UROL, V67, P42, DOI 10.1016/j.eururo.2014.08.067; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Jin ZX, 2011, HEPATOLOGY, V53, P219, DOI 10.1002/hep.23983; Joo SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09660; Karsdal MA, 2016, J HEPATOL, V64, P103, DOI 10.1016/j.jhep.2015.08.014; Kayashima H, 2015, SURGERY, V158, P1670, DOI 10.1016/j.surg.2015.06.001; Kriegel AJ, 2015, HYPERTENSION, V66, P793, DOI 10.1161/HYPERTENSIONAHA.115.05645; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Lin Cong, 2013, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V29, P704; McMillen P, 2015, CURR OPIN CELL BIOL, V36, P48, DOI 10.1016/j.ceb.2015.07.002; Park ES, 2013, HEPATOLOGY, V58, P762, DOI 10.1002/hep.26379; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; PIHLAJANIEMI T, 1991, J HEPATOL, V13, pS2, DOI 10.1016/0168-8278(91)90002-S; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Shan CL, 2011, CARCINOGENESIS, V32, P1190, DOI 10.1093/carcin/bgr106; Shi Xiao-Yan, 2011, Chin J Cancer, V30, P273; Sim JY, 2015, MOL BIOL CELL, V26, P2456, DOI 10.1091/mbc.E14-12-1618; Sinn DH, 2015, HEPATOLOGY, V62, P694, DOI 10.1002/hep.27889; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Su XQ, 2013, CHINESE J CANCER RES, V25, P235, DOI 10.3978/j.issn.1000-9604.2013.03.08; Sze KMF, 2013, HEPATOLOGY, V57, P131, DOI 10.1002/hep.25979; Tameda M, 2014, INT J ONCOL, V45, P541, DOI 10.3892/ijo.2014.2445; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang YH, 2016, ONCOL LETT, V11, P801, DOI 10.3892/ol.2015.3976; Wells RG, 2008, CLIN LIVER DIS, V12, P759, DOI 10.1016/j.cld.2008.07.008; Wong CM, 2012, HEPATOLOGY, V55, P1453, DOI 10.1002/hep.25512; Xiong GF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-1; Xu C, 2014, CANCER LETT, V345, P216, DOI 10.1016/j.canlet.2013.08.035; Yang SL, 2016, J GASTROENTEROL, V51, P722, DOI 10.1007/s00535-015-1146-0; Yi T, 2017, SCI REP, V7, P1; You X, 2014, ONCOGENE, V33, P449, DOI 10.1038/onc.2012.618; You XN, 2013, CARCINOGENESIS, V34, P1644, DOI 10.1093/carcin/bgt089; Zanotti S, 2015, BBA-MOL BASIS DIS, V1852, P1451, DOI 10.1016/j.bbadis.2015.04.013; Zhang R, 2015, INT J CORROS, V2015, DOI 10.1155/2015/823172; Zhang S, 2013, FEBS LETT, V587, P645, DOI 10.1016/j.febslet.2013.01.019; Zhang T, 2013, NEOPLASIA, V15, P1282, DOI 10.1593/neo.131362; Zhang W, 2014, MOL CANCER, V13, P1; Zhang Xiao-Dong, 2014, Cancer Biology Medicine, V11, P182, DOI 10.7497/j.issn.2095-3941.2014.03.004; Zhang Y, 2012, HEPATOLOGY, V56, p617A; Zhu MY, 2015, ONCOTARGET, V6, P12196, DOI 10.18632/oncotarget.2906	48	35	38	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 14	2017	36	50					6895	6905		10.1038/onc.2017.291	http://dx.doi.org/10.1038/onc.2017.291			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FQ0JM	28846110				2022-12-26	WOS:000418041800006
J	Gupta, P; Zhang, ZF; Sugiman-Marangos, SN; Tam, J; Raman, S; Julien, JP; Kroh, HK; Lacy, DB; Murgolo, N; Bekkari, K; Therien, AG; Hernandez, LD; Melnyk, RA				Gupta, Pulkit; Zhang, Zhifen; Sugiman-Marangos, Seiji N.; Tam, John; Raman, Swetha; Julien, Jean-Phillipe; Kroh, Heather K.; Lacy, D. Borden; Murgolo, Nicholas; Bekkari, Kavitha; Therien, Alex G.; Hernandez, Lorraine D.; Melnyk, Roman A.			Functional defects in Clostridium difficile TcdB toxin uptake identify CSPG4 receptor-binding determinants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGENS TPEL TOXIN; CRYSTAL-STRUCTURE; RHO-PROTEINS; MECHANISM; ANTIBODY; TRANSLOCATION; BEZLOTOXUMAB; ENTEROTOXIN; ACTOXUMAB; EPITOPES	Clostridium difficile is a major nosocomial pathogen that produces two exotoxins, TcdA and TcdB, with TcdB thought to be the primary determinant in human disease. TcdA and TcdB are large, multidomain proteins, each harboring a cytotoxic glucosyltransferase domain that is delivered into the cytosol from endosomes via a translocation domain after receptor-mediated endocytosis of toxins from the cell surface. Although there are currently no known host cell receptors for TcdA, three cell-surface receptors for TcdB have been identified: CSPG4, NECTIN3, and FZD1/2/7. The sites on TcdB that mediate binding to each receptor are not defined. Furthermore, it is not known whether the combined repetitive oligopeptide (CROP) domain is involved in or required for receptor binding. Here, in a screen designed to identify sites in TcdB that are essential for target cell intoxication, we identified a region at the junction of the translocation and the CROP domains that is implicated in CSPG4 binding. Using a series of C-terminal truncations, we show that the CSPG4-binding site on TcdB extends into the CROP domain, requiring three short repeats for binding and for full toxicity on CSPG4-expressing cells. Consistent with the location of the CSPG4-binding site on TcdB, we show that the anti-TcdB antibody bezlotoxumab, which binds partially within the first three short repeats, prevents CSPG4 binding to TcdB. In addition to establishing the binding region for CSPG4, this work ascribes for the first time a role in TcdB CROPs in receptor binding and further clarifies the relative roles of host receptors in TcdB pathogenesis.	[Gupta, Pulkit; Murgolo, Nicholas; Bekkari, Kavitha; Therien, Alex G.; Hernandez, Lorraine D.] Merck & Co Inc, Kenilworth, NJ 07033 USA; [Zhang, Zhifen; Sugiman-Marangos, Seiji N.; Tam, John; Raman, Swetha; Julien, Jean-Phillipe; Melnyk, Roman A.] Hosp Sick Children, Mol Med, Toronto, ON M5G 0A4, Canada; [Zhang, Zhifen; Julien, Jean-Phillipe; Melnyk, Roman A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Kroh, Heather K.; Lacy, D. Borden] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Kroh, Heather K.; Lacy, D. Borden] Vanderbilt Univ, Sch Med, Dept Microbiol, Nashville, TN 37212 USA; [Kroh, Heather K.; Lacy, D. Borden] Vanderbilt Univ, Sch Med, Dept Immunol, Nashville, TN 37212 USA	Merck & Company; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Vanderbilt University; Vanderbilt University; Vanderbilt University	Melnyk, RA (corresponding author), Hosp Sick Children, 686 Bay St, Toronto, ON M5G 0A4, Canada.	roman.melnyk@sickkids.ca	Therien, Alex/AAS-8437-2021; Lacy, D. Borden/AFQ-2203-2022; Melnyk, Roman/GQA-9908-2022	Sugiman-Marangos, Seiji/0000-0002-8475-5456; Julien, Jean-Philippe/0000-0001-7602-3995; Lacy, Borden/0000-0003-2273-8121	Canadian Institutes of Health Research; Merck, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002943] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Merck, Inc.(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Canadian Institutes of Health Research and by Merck, Inc. P.G., N.M., K.B., A.G.T., and L.D.H. are employees of Merck, Inc.	Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Chumbler NM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.2, 10.1038/nmicrobiol.2015.2]; Chumbler NM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003072; Farrow MA, 2013, P NATL ACAD SCI USA, V110, P18674, DOI 10.1073/pnas.1313658110; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Gerhard R, 2013, J MED MICROBIOL, V62, P1414, DOI 10.1099/jmm.0.057828-0; Guttenberg G, 2012, J BIOL CHEM, V287, P24929, DOI 10.1074/jbc.M112.347773; Haimes J., 2010, DEMONSTRATION DELTAD; Hernandez LD, 2017, J MOL BIOL, V429, P1030, DOI 10.1016/j.jmb.2017.02.010; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; LaFrance ME, 2015, P NATL ACAD SCI USA, V112, P7073, DOI 10.1073/pnas.1500791112; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Manse JS, 2015, FEBS LETT, V589, P3945, DOI 10.1016/j.febslet.2015.11.017; Olling A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017623; Orth P, 2014, J BIOL CHEM, V289, P18008, DOI 10.1074/jbc.M114.560748; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Schorch B, 2014, P NATL ACAD SCI USA, V111, P6431, DOI 10.1073/pnas.1323790111; Steele J, 2013, J INFECT DIS, V207, P323, DOI 10.1093/infdis/jis669; Tam J, 2015, CHEM BIOL, V22, P175, DOI 10.1016/j.chembiol.2014.12.010; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; Terada N, 2006, HISTOCHEM CELL BIOL, V126, P483, DOI 10.1007/s00418-006-0184-3; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wilcox M., 2015, IDWEEK 2015; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Yang ZY, 2015, INFECT IMMUN, V83, P822, DOI 10.1128/IAI.02897-14; Yuan PF, 2015, CELL RES, V25, P157, DOI 10.1038/cr.2014.169; Zhang ZF, 2014, P NATL ACAD SCI USA, V111, P3721, DOI 10.1073/pnas.1400680111	35	35	36	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17290	17301		10.1074/jbc.M117.806687	http://dx.doi.org/10.1074/jbc.M117.806687			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28842504	hybrid, Green Published			2022-12-26	WOS:000414009300012
J	Asemoloye, MD; Ahmad, R; Jonathan, SG				Asemoloye, Michael Dare; Ahmad, Rafiq; Jonathan, Segun Gbolagade			Synergistic rhizosphere degradation of gamma-hexachlorocyclohexane (lindane) through the combinatorial plant-fungal action	PLOS ONE			English	Article							ORGANOCHLORINE INSECTICIDE RESIDUES; SPHINGOMONAS-PAUCIMOBILIS; LIN GENES; GROUND-WATER; TECHNICAL HEXACHLOROCYCLOHEXANE; AEROBIC DEGRADATION; DEHALOGENASE GENE; SURFACE-WATER; CLONING; ISOMERS	Fungi are usually involved in degradation/deterioration of many anthropogenic wastes due to their verse enzyme secretions and adaptive capabilities. In this study, five dominant fungal strains were isolated from an aged lindane polluted site, they were all mixed (100 mg each) together with pent mushroom compost (SMC) and applied to lindane polluted soil (5 kg) at 10, 20, 30, 40% and control 0% (soil with no treatment), these were used to grow M. maximus Jacq for 3 months. To establish lindane degradation, deductions such as Degradation rate (K-1), Half-life (t(1/2)) and Degradation efficiency (DE) were made based on the analyzed lindane concentrations before and after the experiment. We also tested the presence and expressions of phosphoesterases (mpd and opd-A) and catechol 1,2-dioxygenases (efk2 and efk4) genes in the strains. The stains were identified as Aspergillus niger (KY693970); Talaromyces atroroseus (KY488464), Talaromyces purpurogenus (KY488468), Yarrowia lipolytica (KY488469) and Aspergillus flavus (KY693973) through morphological and molecular methods. Combined rhizospheric action of M. maximus and fungi speed up lindane degradation rate, initially detected lindane concentration of 45 mg/ kg was reduced to 11.26, 9.34 and 11.23 mg/kg in 20, 30 and 40% treatments respectively making 79.76, 85.93 and 88.67% degradation efficiencies. K-1 of 1.29 was recorded in control while higher K-1 of 1.60, 1.96 and 2.18 /day were recorded in 20, 30 and 40% treatments respectively. The best t(1/2) of 0.32 and 0.35 /day were recorded in 40 and 30% compared to control (0.54 /day). All the strains were also affirmed to possess the tested genes; opd was overexpressed in all the strains except KY693973 while mpd was overexpressed in KY693970, KY488464 but moderately expressed in KY488468, KY488469 and KY693973. However, efk genes were under-expressed in most of the strains except KY488469 and KY693973 which showed moderate expression of efk4. This work suggests that the synergistic association of the identified rhizospheric fungi and M. maximus roots could be used to remove lindane in soil at a limited time period and this combination could be used at large scale.	[Asemoloye, Michael Dare; Jonathan, Segun Gbolagade] Univ Ibadan, Dept Bot, Food & Environm Mycol Biotechnol Unit, Ibadan, Nigeria; [Ahmad, Rafiq] COMSATS Inst Informat Technol, Dept Environm Sci, Abbottabad, Pakistan	University of Ibadan; COMSATS University Islamabad (CUI)	Asemoloye, MD (corresponding author), Univ Ibadan, Dept Bot, Food & Environm Mycol Biotechnol Unit, Ibadan, Nigeria.; Ahmad, R (corresponding author), COMSATS Inst Informat Technol, Dept Environm Sci, Abbottabad, Pakistan.	asemoloyemike@gmail.com; drrafiq@ciit.net.pk	Ahmad, Rafiq/AAG-8217-2019; Dare, Asemoloye Michael/AAQ-4905-2021	Ahmad, Rafiq/0000-0003-1016-1142; Dare, Asemoloye Michael/0000-0003-4339-1251	TWAS-CIIT Postgraduate (Sandwich) Fellowship Program FR [3240287156]; Postgraduate School University of Ibadan Nigeria [128004]	TWAS-CIIT Postgraduate (Sandwich) Fellowship Program FR; Postgraduate School University of Ibadan Nigeria	This work was financed by the TWAS-CIIT Postgraduate (Sandwich) Fellowship Program FR number: 3240287156, 2015. The work was also financed by the honorarium given by the Postgraduate School University of Ibadan Nigeria through the Postgraduate Scholarship Scheme award given to the first author (University Postgraduate Scholar 128004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash PC, 2008, CHEMOSPHERE, V72, P79, DOI 10.1016/j.chemosphere.2008.01.056; Agency for Toxic Substances and Disease Registry (ATSDR), 1997, TOX PROF NICK, P1; Agnihotri NP, 1996, ENVIRON MONIT ASSESS, V40, P279, DOI 10.1007/BF00398873; Al-Nasrawi H., 2012, J BIOREMEDIATION BIO, V3, P4; ALVEY S, 1995, J ENVIRON QUAL, V24, P1156, DOI 10.2134/jeq1995.00472425002400060015x; Barber JL, 2005, SCI TOTAL ENVIRON, V349, P1, DOI 10.1016/j.scitotenv.2005.03.014; Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; BIDLEMAN TF, 1995, GEOPHYS RES LETT, V22, P219, DOI 10.1029/94GL02990; Bik HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038550; Boltner D, 2005, ENVIRON MICROBIOL, V7, P1329, DOI 10.1111/j.1462-5822.2005.00820.x; Bosma TNP, 1997, ENVIRON SCI TECHNOL, V31, P248, DOI 10.1021/es960383u; Brubaker WW, 1998, ENVIRON SCI TECHNOL, V32, P766, DOI 10.1021/es970650b; Cai M, 2002, J BACTERIOL, V184, P4672, DOI 10.1128/JB.184.17.4672-4680.2002; Pereira RC, 2008, ENVIRON POLLUT, V155, P350, DOI 10.1016/j.envpol.2007.11.009; Castro T. F., 1974, Soil Science and Plant Nutrition, V20, P363, DOI 10.1080/00380768.1974.10432607; Ceremonie H, 2006, FEMS MICROBIOL LETT, V257, P243, DOI 10.1111/j.1574-6968.2006.00188.x; Dams RI, 2007, CHEMOSPHERE, V68, P864, DOI 10.1016/j.chemosphere.2007.02.014; DEO PG, 1994, CRIT REV MICROBIOL, V20, P57, DOI 10.3109/10408419409113546; Dogra C, 2004, J BACTERIOL, V186, P2225, DOI 10.1128/JB.186.8.2225-2235.2004; Donald DB, 1997, ENVIRON TOXICOL CHEM, V16, P1867, DOI [10.1002/etc.5620160915, 10.1897/1551-5028(1997)016&lt;1867:ROGWOH&gt;2.3.CO;2]; Endo R, 2006, BIOSCI BIOTECH BIOCH, V70, P1029, DOI 10.1271/bbb.70.1029; Endo R, 2005, J BACTERIOL, V187, P847, DOI 10.1128/JB.187.3.847-853.2005; Fatoki OS, 2004, J ENVIRON SCI HEAL B, V39, P101, DOI 10.1081/PFC-120027442; Gulp Narain S., 2003, DOWN TO EARTH   0215, P27; Hanson DJ, 2005, CHEM ENG NEWS; Humphreys EH, 2008, ENVIRON HEALTH PERSP, V116, P297, DOI 10.1289/ehp.10668; Hussain S, 2009, CRIT REV ENV SCI TEC, V39, P843, DOI 10.1080/10643380801910090; IMAI R, 1989, AGR BIOL CHEM TOKYO, V53, P2015, DOI 10.1080/00021369.1989.10869597; IMAI R, 1991, J BACTERIOL, V173, P6811, DOI 10.1128/jb.173.21.6811-6819.1991; IWATA H, 1994, ENVIRON POLLUT, V85, P15, DOI 10.1016/0269-7491(94)90234-8; Jantunen LM, 1996, J GEOPHYS RES-ATMOS, V101, P28837, DOI 10.1029/96JD02352; John PJ, 2001, ENVIRON INT, V26, P231, DOI 10.1016/S0160-4120(00)00111-2; Jonathan SG, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/4602036; Kandalepas D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122378; KANNAN K, 1992, J AGR FOOD CHEM, V40, P518, DOI 10.1021/jf00015a032; Kostadinova N, 2009, BIOTECHNOL BIOTEC EQ, V23, P267, DOI 10.1080/13102818.2009.10818416; Kumari R, 2002, APPL ENVIRON MICROB, V68, P6021, DOI 10.1128/AEM.68.12.6021-6028.2002; Lal R, 2006, TRENDS BIOTECHNOL, V24, P121, DOI 10.1016/j.tibtech.2006.01.005; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Y. F., 1999, Science of the Total Environment, V232, P121, DOI 10.1016/S0048-9697(99)00114-X; Li YF, 2003, ENVIRON SCI TECHNOL, V37, P3493, DOI 10.1021/es034157d; MacDonald RW, 2000, SCI TOTAL ENVIRON, V254, P93, DOI 10.1016/S0048-9697(00)00434-4; Mackay Donald, 1997, ILLUSTRATED HDB PHYS; Manasiev J, 2008, Z NATURFORSCH C, V63, P133; Manickam N, 2007, J APPL MICROBIOL, V102, P1468, DOI 10.1111/j.1365-2672.2006.03209.x; MARTINEZTOLEDO MV, 1993, CHEMOSPHERE, V27, P2261, DOI 10.1016/0045-6535(93)90137-T; Miyauchi K, 1999, J BACTERIOL, V181, P6712, DOI 10.1128/JB.181.21.6712-6719.1999; Miyauchi K, 2002, APPL ENVIRON MICROB, V68, P1803, DOI 10.1128/AEM.68.4.1803-1807.2002; Miyauchi K, 1998, J BACTERIOL, V180, P1354, DOI 10.1128/JB.180.6.1354-1359.1998; Mohn WW, 2006, ENVIRON MICROBIOL, V8, P60, DOI 10.1111/j.1462-2920.2005.00865.x; Mougin C, 1996, PESTIC SCI, V47, P51, DOI 10.1002/(SICI)1096-9063(199605)47:1&lt;51::AID-PS391&gt;3.0.CO;2-V; Mukherjee I, 2002, ENVIRON MONIT ASSESS, V76, P185, DOI 10.1023/A:1015527929438; Murthy HMR, 2007, J HAZARD MATER, V149, P18, DOI 10.1016/j.jhazmat.2007.03.053; Nagata Y, 1999, J BACTERIOL, V181, P5409, DOI 10.1128/JB.181.17.5409-5413.1999; Nagata Y, 1999, J IND MICROBIOL BIOT, V23, P380, DOI 10.1038/sj.jim.2900736; NAGATA Y, 1993, J BACTERIOL, V175, P6403, DOI 10.1128/jb.175.20.6403-6410.1993; Nagata Y, 1997, APPL ENVIRON MICROB, V63, P3707, DOI 10.1128/AEM.63.9.3707-3710.1997; Nagata Y, 2007, APPL MICROBIOL BIOT, V76, P741, DOI 10.1007/s00253-007-1066-x; Naqvi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094177; Nawab A, 2003, BIORESOURCE TECHNOL, V88, P41, DOI 10.1016/S0960-8524(02)00263-8; Pan B, 2008, ENVIRON SCI POLLUT R, V15, P554, DOI 10.1007/s11356-008-0051-y; Paul B, 2006, APPL ENVIRON MICROB, P2358; Phillips TM, 2005, BIODEGRADATION, V16, P363, DOI 10.1007/s10532-004-2413-6; Prakash O, 2004, CURR SCI INDIA, V87, P73; Quintero JC, 2005, CHEMOSPHERE, V61, P528, DOI 10.1016/j.chemosphere.2005.02.010; Reyes-Cesar A, 2014, WORLD J MICROB BIOT, V30, P999, DOI 10.1007/s11274-013-1518-7; da Luz JMR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069386; Saez F, 2006, APPL MICROBIOL BIOT, V71, P563, DOI 10.1007/s00253-005-0182-8; SAHU SK, 1993, SOIL BIOL BIOCHEM, V25, P387, DOI 10.1016/0038-0717(93)90139-3; SENOO K, 1989, SOIL SCI PLANT NUTR, V35, P79, DOI 10.1080/00380768.1989.10434739; Shen L, 2004, ENVIRON SCI TECHNOL, V38, P965, DOI 10.1021/es034998k; Shi SJ, 2007, FEMS MICROBIOL LETT, V269, P110, DOI 10.1111/j.1574-6968.2006.00621.x; Siddaramappa R, 1975, CRIT REV MICROBIOL, V10, P125; Silambarasan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077170; Singh BK, 2000, PEST MANAG SCI, V56, P142, DOI 10.1002/1526-4998(200002)56:2<142::AID-PS104>3.0.CO;2-I; Sun JQ, 2009, WORLD J MICROB BIOT, V25, P259, DOI 10.1007/s11274-008-9888-y; Tariq MI, 2007, ENVIRON INT, V33, P1107, DOI 10.1016/j.envint.2007.07.012; Titus A, 2001, Indian J Environ Health, V43, P190; Turnbull GA, 2001, APPL ENVIRON MICROB, V67, P2270, DOI 10.1128/AEM.67.5.2270-2275.2001; Usman M, 2014, SCI TOTAL ENVIRON, V476, P434, DOI 10.1016/j.scitotenv.2014.01.027; Walker K, 1999, ENVIRON SCI TECHNOL, V33, P4373, DOI 10.1021/es990647n	81	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183373	10.1371/journal.pone.0183373	http://dx.doi.org/10.1371/journal.pone.0183373			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859100	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500014
J	Kumarasamy, V; Kuppusamy, UR; Jayalakshmi, P; Samudi, C; Ragavan, ND; Kumar, S				Kumarasamy, Vinoth; Kuppusamy, Umah Rani; Jayalakshmi, Pailoor; Samudi, Chandramathi; Ragavan, Nanthiney Devi; Kumar, Suresh			Exacerbation of colon carcinogenesis by Blastocystis sp	PLOS ONE			English	Article							OXIDATION PROTEIN PRODUCTS; COLORECTAL-CANCER RISK; ABERRANT CRYPTS; LIPID-PEROXIDATION; ANTIOXIDANT STATUS; RADICAL PRODUCTION; BREAST-CANCER; RAT COLON; IN-VITRO; HOMINIS	Colorectal cancer (CRC) is one the most commonly diagnosed cancers worldwide and the number is increasing every year. Despite advances in screening programs, CRC remains as the second leading cause of cancer deaths in the United States. Oxidative stress plays an important role in the molecular mechanisms of colorectal cancer (CRC) and has been shown to be associated with Blastocystis sp., a common intestinal microorganism. In the present study, we aimed to identify a role for Blastocystis sp. in exacerbating carcinogenesis using in vivo rat model. Methylene blue staining was used to identify colonic aberrant crypt foci (ACF) and adenomas formation in infected rats whilst elevation of oxidative stress biomarker levels in the urine and serum samples were evaluated using biochemical assays. Histological changes of the intestinal mucosa were observed and a significant number of ACF was found in Blastocystis sp. infected AOM-rats compared to the AOM-controls. High levels of urinary oxidative indices including advanced oxidative protein products (AOPP) and hydrogen peroxide were observed in Blastocystis sp. infected AOM-rats compared to the uninfected AOM-rats. Our study provides evidence that Blastocystis sp. has a significant role in enhancing AOM-induced carcinogenesis by resulting damage to the intestinal epithelium and promoting oxidative damage in Blastocystis sp. infected rats.	[Kumarasamy, Vinoth] MAHSA Univ, Fac Med, Dept Microbiol, Shah Alam, Malaysia; [Kuppusamy, Umah Rani] Univ Malaya, Dept Biomed Sci, Fac Med, Kuala Lumpur, Malaysia; [Jayalakshmi, Pailoor] Univ Malaya, Dept Pathol, Fac Med, Kuala Lumpur, Malaysia; [Samudi, Chandramathi] Univ Malaya, Dept Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Ragavan, Nanthiney Devi] Mahsa Univ, Dept Biomed Sci, Fac Med, Shah Alam, Malaysia; [Kumar, Suresh] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	Mahsa University; Universiti Malaya; Universiti Malaya; Universiti Malaya; Mahsa University; Universiti Malaya	Kumar, S (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	suresh@um.edu.my	Kumarasamy, Vinoth/AAQ-1554-2020; samudi@raju, Chandramathi/AAR-1595-2021; Samudi, Chandramathi/G-5937-2012; KUPPUSAMY, UMAH RANI/B-9981-2010	Kumarasamy, Vinoth/0000-0002-8895-1796; 	University Malaya High Impact Research Grant [UM.C/625/1/HIR/MOHE/MED/44]	University Malaya High Impact Research Grant	Funding for this study was provided by University Malaya High Impact Research Grant UM.C/625/1/HIR/MOHE/MED/44. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallahi OMS, 1999, LIVER, V19, P495, DOI 10.1111/j.1478-3231.1999.tb00082.x; Abdel-Hafeez EH, 2016, PARASITOL RES, V115, P2061, DOI 10.1007/s00436-016-4951-3; Adelstein BA, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-65; Ajjampur SSR, 2016, PARASITOL INT, V65, P772, DOI 10.1016/j.parint.2016.05.007; Anderson JC, 2012, CANCER CAUSE CONTROL, V23, P355, DOI 10.1007/s10552-011-9884-7; Banerjee D, 2003, CLIN CHIM ACTA, V334, P205, DOI 10.1016/S0009-8981(03)00236-5; Bartsch H, 2000, EUR J CANCER, V36, P1229, DOI 10.1016/S0959-8049(00)00095-2; Beaugerie L, 2013, GASTROENTEROLOGY, V145, P166, DOI 10.1053/j.gastro.2013.03.044; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Buxton D, 1998, VET RES, V29, P289; Chan KH, 2012, PARASITOL RES, V110, P2475, DOI 10.1007/s00436-011-2788-3; Chandramathi S, 2010, PARASITOLOGY, V137, P605, DOI 10.1017/S0031182009991351; Chandramathi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094567; Chandramathi S, 2012, T ROY SOC TROP MED H, V106, P267, DOI 10.1016/j.trstmh.2011.12.008; Chandramathi S, 2010, PARASITOL RES, V106, P941, DOI 10.1007/s00436-010-1764-7; Chen JZ, 2009, CANCER BIOL THER, V8, P1313, DOI 10.4161/cbt.8.14.8983; Demirci M, 2011, J HEALTH POPUL NUTR, V21, P72; Di Giacomo C, 2003, EXP BIOL MED, V228, P525, DOI 10.1177/15353702-0322805-17; El-Taweel Hend A., 2007, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V37, P189; Ellmerich S, 2000, CARCINOGENESIS, V21, P753, DOI 10.1093/carcin/21.4.753; Eroglu F, 2009, PARASITOL RES, V105, P1589, DOI 10.1007/s00436-009-1595-6; Escribano M, 2004, CLIN SCI, V106, P83, DOI 10.1042/CS20030192; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; FARLAND WH, 1978, J PARASITOL, V64, P564, DOI 10.2307/3279817; Fisseha B, 2017, EJHD, V13; GARDNER AL, 1991, AM J TROP MED HYG, V44, P49, DOI 10.4269/ajtmh.1991.44.49; Goh KL, 2005, ALIMENT PHARM THER, V22, P859, DOI 10.1111/j.1365-2036.2005.02646.x; Gosse F, 2005, CARCINOGENESIS, V26, P1291, DOI 10.1093/carcin/bgi074; Jayasekara H, 2016, ALCOHOL ALCOHOLISM, V51, P315, DOI 10.1093/alcalc/agv110; Jones MS, 2009, PARASITOL RES, V104, P341, DOI 10.1007/s00436-008-1198-7; Kamalvand G, 2004, FREE RADICAL BIO MED, V36, P657, DOI 10.1016/j.freeradbiomed.2003.12.011; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kosova F, 2007, ANN SURG ONCOL, V14, P2616, DOI 10.1245/s10434-007-9425-5; Kumarasamy V, 2013, PARASITOL RES, V112, P3551, DOI 10.1007/s00436-013-3538-5; Kuppusamy UR, 2005, CLIN CHIM ACTA, V351, P197, DOI 10.1016/j.cccn.2004.09.014; Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P1259; Lillehoj HS, 1998, AVIAN DIS, V42, P307, DOI 10.2307/1592481; Lim MX, 2014, INFECT IMMUN, V82, P4789, DOI 10.1128/IAI.02279-14; Marotta F, 2003, HEPATO-GASTROENTEROL, V50, P1914; Moe KT, 1997, PARASITOL RES, V83, P319, DOI 10.1007/s004360050256; Mohamed RT, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2114-8; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; PEREIRA MA, 1994, CARCINOGENESIS, V15, P1049, DOI 10.1093/carcin/15.5.1049; PRETLOW TP, 1992, CARCINOGENESIS, V13, P1509, DOI 10.1093/carcin/13.9.1509; Puthia MK, 2005, PARASITOL RES, V97, P386, DOI 10.1007/s00436-005-1461-0; Ray G, 2000, BREAST CANCER RES TR, V59, P163, DOI 10.1023/A:1006357330486; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Saygili EI, 2003, BIOCHEMISTRY-MOSCOW+, V68, P325, DOI 10.1023/A:1023010418230; SENAY H, 1990, J INFECT DIS, V162, P987, DOI 10.1093/infdis/162.4.987; Sigal LH, 1994, IMMUNOLOGY INFLAMMAT; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Steer H, 2007, ANN ROY COLL SURG, V89, P539, DOI 10.1308/003588407X202155; Stenzel DJ, 1996, CLIN MICROBIOL REV, V9, P563, DOI 10.1128/CMR.9.4.563; STOCKER R, 1986, BIOCHEM BIOPH RES CO, V134, P152, DOI 10.1016/0006-291X(86)90540-1; Stockmann M, 1998, AIDS, V12, P43, DOI 10.1097/00002030-199801000-00006; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Tesarova P, 2007, NEOPLASMA, V54, P219; UDKOW MP, 1993, J INFECT DIS, V168, P242, DOI 10.1093/infdis/168.1.242; Windsor J. D., 2007, BIOMEDICAL SCI, V51, P524; Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524; Wong KHS, 2008, PARASITOL RES, V102, P663, DOI 10.1007/s00436-007-0808-0; Wu Z., 2014, BIOMED RES INT; Wu Z., 2014, PLOS NEGLECT TROP D, V8, P27; Yoshikawa H, 2004, PARASITOL RES, V94, P391, DOI 10.1007/s00436-004-1230-5; Zaman V., 1994, JPMA (Journal of the Pakistan Medical Association), V44, P220	69	25	25	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183097	10.1371/journal.pone.0183097	http://dx.doi.org/10.1371/journal.pone.0183097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859095	gold, Green Published, Green Submitted			2022-12-26	WOS:000408740500011
J	Al-Obaid, K; Asadzadeh, M; Ahmad, S; Khan, Z				Al-Obaid, Khaled; Asadzadeh, Mohammad; Ahmad, Suhail; Khan, Ziauddin			Population structure and molecular genetic characterization of clinical Candida tropicalis isolates from a tertiary-care hospital in Kuwait reveal infections with unique strains	PLOS ONE			English	Article							RESISTANT ASPERGILLUS-FUMIGATUS; ANTIFUNGAL SUSCEPTIBILITY; INVASIVE CANDIDIASIS; TR34/L98H MUTATIONS; FUNGAL-INFECTION; EPIDEMIOLOGY; SURVEILLANCE; FLUCONAZOLE; DIAGNOSIS; ALBICANS	Candida tropicalis is a frequently isolated yeast species causing bloodstream, urinary tract and other infections particularly in patients admitted to intensive care units (ICUs) and those requiring prolonged urinary catheterization (UC) or receiving broad-spectrum antibiotics (BSA). This study investigated clinical characteristics and genetic relatedness among C. tropicalis strains isolated from patients at Al-Amiri Hospital in Kuwait. C. tropicalis strains (n = 63) isolated from blood, genito-urinary, respiratory (RT) and digestive (GIT) tracts and wound sites from 54 patients were used. All isolates were phenotypically identified and tested against six antifungal drugs by using Vitek 2 system. Molecular identification was performed by PCR amplification of rDNA. Fingerprinting was achieved by 6-loci-based multilocus sequence typing (MLST) and data were analyzed by BioNumerics software for phylogenetic relationships. Patients mean age was >65 years and >20% patients were hospitalized in ICUs. Most patients had underlying conditions that included UC, BSA, diabetes and RT/GIT abnormalities. Most candiduria cases had UC, ureteric stent or suprapubic catheters. All isolates were identified as C. tropicalis by Vitek 2 and by species-specific PCR. Sixty-two isolates were susceptible to all tested antifungal drugs. MLST identified 59 diploid sequence types (DSTs) including 54 newly-identified DSTs. C. tropicalis isolates from multiple sites of same patient usually belonged to different DSTs. Interestingly, 56 of 57 isolates from 48 patients belonged to unique genotypes. Only six isolates from six patients belonged to three DSTs (clusters), however, C. tropicalis strains in each cluster were isolated >3 months apart. Our data show diverse origins of C. tropicalis infections in Kuwait as most isolates were unique strains. There was no obvious correlation between cluster isolates with time of isolation and/or hospital ward of their origin. This study presents the first MLST analysis of C. tropicalis isolates from Middle East and may be useful for studying genetic relationships among global C. tropicalis strains.	[Al-Obaid, Khaled] Al Amiri Hosp, Dept Med Labs, Microbiol, Kuwait, Kuwait; [Asadzadeh, Mohammad; Ahmad, Suhail; Khan, Ziauddin] Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait	Amiri Hospital; Kuwait University	Ahmad, S (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait.	suhail_ah@hsc.edu.kw	Ahmad, Suhail/AAJ-5456-2021	asadzadeh, Mohammad/0000-0002-9151-1505; Alobaid, Khaled/0000-0002-7481-3587	Kuwait University Research Sector [MI02/15, SRUL02/13]	Kuwait University Research Sector	The study was funded by Kuwait University Research Sector grant MI02/15 and core facility grant SRUL02/13.	Afsarian MH, 2015, J MED MICROBIOL, V64, P248, DOI 10.1099/jmm.0.000015; Ahmad S, 2002, J CLIN MICROBIOL, V40, P2483, DOI 10.1128/JCM.40.7.2483-2489.2002; Ahmad S, 2004, INT J MED MICROBIOL, V294, P45, DOI 10.1016/j.ijmm.2004.01.002; Ahmad S, 2015, J ANTIMICROB CHEMOTH, V70, P412, DOI 10.1093/jac/dku410; Ahmad S, 2014, ENVIRON RES, V133, P20, DOI 10.1016/j.envres.2014.05.009; Ahmad S, 2014, J CLIN MICROBIOL, V52, P2223, DOI 10.1128/JCM.00408-14; Ahmad S, 2012, MED MYCOL, V50, P244, DOI 10.3109/13693786.2011.597446; Al-Sweih N, 2009, MYCOSES, V52, P518, DOI 10.1111/j.1439-0507.2008.01637.x; Alvarez-Lerma F, 2003, INTENS CARE MED, V29, P1069, DOI 10.1007/s00134-003-1807-y; Asadzadeh M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175269; Asadzadeh M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00247; Asadzadeh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142880; Asmundsdottir LR, 2008, CLIN INFECT DIS, V47, pE17, DOI 10.1086/589298; Binelli CA, 2006, CLIN MICROBIOL INFEC, V12, P538, DOI 10.1111/j.1469-0691.2006.01435.x; Sa MB, 2008, INT J ANTIMICROB AG, V32, pS155, DOI 10.1016/S0924-8579(08)70018-9; Bougnoux ME, 2008, INTENS CARE MED, V34, P292, DOI 10.1007/s00134-007-0865-y; Branco CC, 2004, MYCOPATHOLOGIA, V158, P49, DOI 10.1023/B:MYCO.0000038436.51918.d9; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Castanheira M, 2016, DIAGN MICR INFEC DIS, V85, P200, DOI 10.1016/j.diagmicrobio.2016.02.009; Chapman B, 2017, J ANTIMICROB CHEMOTH, V72, P1103, DOI 10.1093/jac/dkw422; Magri MMC, 2013, J CLIN MICROBIOL, V51, P268, DOI 10.1128/JCM.02366-12; Chen CY, 2003, ANN HEMATOL, V82, P93, DOI 10.1007/s00277-002-0588-7; Chen KW, 2009, INFECT GENET EVOL, V9, P912, DOI 10.1016/j.meegid.2009.06.011; Cliff PR, 2008, J HOSP INFECT, V69, P24, DOI 10.1016/j.jhin.2008.02.006; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI S; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Desnos-Ollivier M, 2008, EMERG INFECT DIS, V14, P557, DOI 10.3201/eid1404.071083; Fan X, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00464; Fan X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166156; Fan X, 2014, CHINESE MED J-PEKING, V127, P4226, DOI 10.3760/cma.j.issn.0366-6999.20142048; Gee SF, 2002, J CLIN MICROBIOL, V40, P556, DOI 10.1128/JCM.40.2.556-574.2002; Guinea J, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12539; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hou X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154385; Jang SJ, 2005, JPN J INFECT DIS, V58, P263; Kauffman CA, 2000, CLIN INFECT DIS, V30, P14, DOI 10.1086/313583; Kauffman CA, 2014, INFECT DIS CLIN N AM, V28, P61, DOI 10.1016/j.idc.2013.09.004; Khan ZU, 2008, ANTON LEEUW INT J G, V94, P343, DOI 10.1007/s10482-008-9251-1; Khan ZU, 2010, ANTON LEEUW INT J G, V97, P253, DOI 10.1007/s10482-009-9406-8; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lai HP, 2005, J FORMOS MED ASSOC, V104, P174; Leonard JT, 1998, BIOTECHNIQUES, V24, P314, DOI 10.2144/98242pf01; Mokaddas EM, 2007, J MED MICROBIOL, V56, P255, DOI 10.1099/jmm.0.46817-0; Moorhouse AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145888; Munoz P, 2011, CLIN MICROBIOL INFEC, V17, P1538, DOI 10.1111/j.1469-0691.2010.03338.x; Negri M, 2012, EUR J CLIN MICROBIOL, V31, P1399, DOI 10.1007/s10096-011-1455-z; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Pfaller MA, 2013, DIAGN MICR INFEC DIS, V77, P37, DOI 10.1016/j.diagmicrobio.2013.05.019; REX JH, 1995, ANTIMICROB AGENTS CH, V39, P40, DOI 10.1128/AAC.39.1.40; Rho J, 2004, J MICROBIOL, V42, P80; Suleyman G, 2016, INFECT DIS CLIN N AM, V30, P1023, DOI 10.1016/j.idc.2016.07.008; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5601, DOI 10.1128/JCM.43.11.5601-5613.2005; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5593, DOI 10.1128/JCM.43.11.5593-5600.2005; Voss A, 2001, CLIN MICROBIOL INFEC, V7, P523; Wang Jiun-Ling, 2004, Journal of Microbiology Immunology and Infection, V37, P236; Wang Y, 2016, INFECT GENET EVOL, V44, P418, DOI 10.1016/j.meegid.2016.07.026; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wu JY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42537; Wu Y, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0245-z; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047767; Xiao M, 2015, J ANTIMICROB CHEMOTH, V70, P802, DOI 10.1093/jac/dku460	61	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182292	10.1371/journal.pone.0182292	http://dx.doi.org/10.1371/journal.pone.0182292			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854190	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600009
J	Rashidian, H; Hadji, M; Marzban, M; Gholipour, M; Rahimi-Movaghar, A; Kamangar, F; Malekzadeh, R; Weiderpass, E; Rezaianzadeh, A; Moradi, A; Babhadi-Ashar, N; Ghiasvand, R; Khavari-Daneshvar, H; Haghdoost, AA; Zendehdel, K				Rashidian, Hamideh; Hadji, Maryam; Marzban, Maryam; Gholipour, Mahin; Rahimi-Movaghar, Afarin; Kamangar, Farin; Malekzadeh, Reza; Weiderpass, Elisabete; Rezaianzadeh, Abbas; Moradi, Abdolvahab; Babhadi-Ashar, Nima; Ghiasvand, Reza; Khavari-Daneshvar, Hossein; Haghdoost, Ali Akbar; Zendehdel, Kazem			Sensitivity of self-reported opioid use in case-control studies: Healthy individuals versus hospitalized patients	PLOS ONE			English	Article							POPULATION-CONTROLS; ESOPHAGEAL CANCER; HIGH-RISK; OPIUM; EPIDEMIOLOGY; PREVALENCE; ALCOHOL; BIAS; IRAN	Background Several case-control studies have shown associations between the risk of different cancers and self-reported opium use. Inquiring into relatively sensitive issues, such as the history of drug use, is usually prone to information bias. However, in order to justify the findings of these types of studies, we have to quantify the level of such a negative bias. In current study, we aimed to evaluate sensitivity of self-reported opioid use and suggest suitable types of control groups for case-control studies on opioid use and the risk of cancer. Methods In order to compare the validity of the self-reported opioid use, we cross-validated the response of two groups of subjects 1) 178 hospitalized patients and 2) 186 healthy individuals with the results of their tests using urine rapid drug screen (URDS) and thin layer chromatography (TLC). The questioners were asked by trained interviewers to maximize the validity of responses; healthy individuals were selected from the companions of patients in hospitals. Results Self-reported regular opioid use was 36.5% in hospitalized patients 19.3% in healthy individuals (p-value> 0.001). The reported frequencies of opioid use in the past 72 hours were 21.4% and 11.8% in hospitalized patients and healthy individuals respectively. Comparing their responses with the results of urine tests showed a sensitivity of 77% and 69% among hospitalized patients and healthy individuals for self-reports (p-value = 0.4). Having corrected based on the mentioned sensitivities; the frequency of opioid regular use was 47% and 28% in hospitalized patients and healthy individuals, respectively. Regular opioid use among hospitalized patients was significantly higher than in healthy individuals (p-value> 0.001). Conclusion Our findings showed that the level of opioid use under-reporting in hospitalized patients and healthy individuals was considerable but comparable. In addition, the frequency of regular opioid use among hospitalized patients was significantly higher than that in the general population. Altogether, it seems that, without corrections for these differences and biases, the results of many studies including case-control studies on opioid use might distort findings substantially.	[Rashidian, Hamideh] Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Hadji, Maryam; Khavari-Daneshvar, Hossein; Zendehdel, Kazem] Univ Tehran Med Sci, Canc Res Ctr, Canc Inst Iran, Tehran, Iran; [Marzban, Maryam] Shiraz Univ Med Sci, Student Res Ctr Comm, Shiraz, Iran; [Gholipour, Mahin; Moradi, Abdolvahab] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran; [Rahimi-Movaghar, Afarin; Babhadi-Ashar, Nima] Univ Tehran Med Sci, INCAS, Tehran, Iran; [Kamangar, Farin] Morgan State Univ, Dept Publ Hlth Anal, Sch Community Hlth & Policy, Baltimore, MD 21239 USA; [Malekzadeh, Reza] Univ Tehran Med Sci, Digest Oncol Res Ctr, Digest Dis Res Inst, Tehran, Iran; [Weiderpass, Elisabete] Inst Population Based Canc Res, Dept Res, Canc Registry Norway, Oslo, Norway; [Weiderpass, Elisabete] Arctic Univ Norway, Dept Community Med, Fac Hlth Sci, Univ Tromso, Tromso, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland; [Rezaianzadeh, Abbas] Shiraz Univ Med Sci, Colorectal Res Ctr, Shiraz, Iran; [Ghiasvand, Reza] Univ Oslo, Oslo Ctr Biostat & Epidemiol, Inst Basic Med Sci, Oslo, Norway; [Haghdoost, Ali Akbar] Kerman Univ Med Sci, Reg Knowledge Hub, Kerman, Iran; [Haghdoost, Ali Akbar] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran; [Zendehdel, Kazem] Univ Tehran Med Sci, Canc Biol Res Ctr, Canc Inst Iran, Tehran, Iran	Kerman University of Medical Sciences; Tehran University of Medical Sciences; Shiraz University of Medical Science; Golestan University of Medical Sciences; Tehran University of Medical Sciences; Morgan State University; Tehran University of Medical Sciences; University of Oslo; UiT The Arctic University of Tromso; Karolinska Institutet; Folkhalsan Research Center; Shiraz University of Medical Science; University of Oslo; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Tehran University of Medical Sciences	Zendehdel, K (corresponding author), Univ Tehran Med Sci, Canc Res Ctr, Canc Inst Iran, Tehran, Iran.; Zendehdel, K (corresponding author), Univ Tehran Med Sci, Canc Biol Res Ctr, Canc Inst Iran, Tehran, Iran.	kzendeh@tums.ac.ir	Weiderpass, Elisabete/M-4029-2016; Rahimi-Movaghar, Afarin/E-9505-2011; Hadji, Maryam/GPG-1218-2022; Gholipour, Mahin/AAZ-8062-2020; Malekzadeh, Reza/U-1382-2017; Haghdoost, Ali Akbar/C-2823-2009; Ghiasvand, Reza/H-4944-2019; marzban, maryam/A-5548-2018; Rezaeianzadeh, Abbas/R-2330-2018; Weiderpass, Elisabete/AAP-2747-2021; Gholipour, Mahin/AAB-6956-2019	Weiderpass, Elisabete/0000-0003-2237-0128; Rahimi-Movaghar, Afarin/0000-0002-5761-1668; Malekzadeh, Reza/0000-0002-9820-6335; Haghdoost, Ali Akbar/0000-0003-4628-4849; Ghiasvand, Reza/0000-0002-5466-7308; Rezaeianzadeh, Abbas/0000-0002-0067-0659; Weiderpass, Elisabete/0000-0003-2237-0128; Gholipour, Mahin/0000-0003-1551-9254; marzban, maryam/0000-0003-4333-4126; Zendehdel, Kazem/0000-0002-0269-4945	cancer research center of cancer institute of Iran [93-04-51-27867]	cancer research center of cancer institute of Iran	This study was supported by grant number 93-04-51-27867 from the cancer research center of cancer institute of Iran, to KZ. The funder involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abnet CC, 2004, CANCER EPIDEM BIOMAR, V13, P1068; Amin-Esmaeili M, 2016, ADDICTION, V111, P1836, DOI 10.1111/add.13453; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Farhoudian A, 2014, IRAN J PHARM RES, V13, P337; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Harrington D, 2007, COMP DRUG TESTING SE; Infante-Rivard C, 2003, AM J EPIDEMIOL, V157, P176, DOI 10.1093/aje/kwf174; Kamangar F, 2014, LANCET ONCOL, V15, pE69, DOI 10.1016/S1470-2045(13)70550-3; Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502; Lewallen S, 1998, Community Eye Health, V11, P57; Matson SC, 2011, ADOLESCENT MED TODAY, P291; Moeller KE, 2008, MAYO CLIN P; Najafipour H, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.157470; Nakhaee N, 2008, SUBST USE MISUSE, V43, P513, DOI 10.1080/10826080701772348; Nasrollahzadeh D, 2008, BRIT J CANCER, V98, P1857, DOI 10.1038/sj.bjc.6604369; Sadeghian S, 2007, EUR J CARDIOV PREV R, V14, P715, DOI 10.1097/HJR.0b013e328045c4e9; Sadeghian S, 2010, INT J CARDIOL, V141, P116, DOI 10.1016/j.ijcard.2008.11.063; Sadjadi A, 2010, MIDDLE EAST J CANCER, V1, P5; Schulz KF, 2002, LANCET, V359, P431, DOI 10.1016/S0140-6736(02)07605-5; Shakeri R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032711; Sharifi V, 2015, ARCH IRAN MED, V18, P76, DOI 015182/AIM.004; SHUSTER JJ, 1983, J CHRON DIS, V36, P315, DOI 10.1016/0021-9681(83)90116-9; STAVRAKY KM, 1983, J CHRON DIS, V36, P301, DOI 10.1016/0021-9681(83)90113-3; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Zhao JH, 2009, DRUG ALCOHOL REV, V28, P648, DOI 10.1111/j.1465-3362.2009.00077.x; Ziaaddini H., 2005, J APPL SCI, V5, P380, DOI [10.3923/jas.2005.380.382, DOI 10.3923/JAS.2005.380.382]	26	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183017	10.1371/journal.pone.0183017	http://dx.doi.org/10.1371/journal.pone.0183017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF1XX	28854228	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600027
J	Soon, B; Vicenzino, B; Schmid, AB; Coppieters, MW				Soon, Benjamin; Vicenzino, Bill; Schmid, Annina B.; Coppieters, Michel W.			Facilitatory and inhibitory pain mechanisms are altered in patients with carpal tunnel syndrome	PLOS ONE			English	Article							NOXIOUS CONDITIONING STIMULATION; HYPERTONIC SALINE; MODULATION; NEUROPATHY; SYMPTOMS; QUESTIONNAIRE; HYPERALGESIA; SENSITIVITY; HYPERSENSITIVITY; OSTEOARTHRITIS	Preliminary evidence from studies using quantitative sensory testing suggests the presence of central mechanisms in patients with carpal tunnel syndrome (CTS) as apparent by widespread hyperalgesia. Hallmarks of central mechanisms after nerve injuries include nociceptive facilitation and reduced endogenous pain inhibition. Methods to study nociceptive facilitation in CTS so far have been limited to quantitative sensory testing and the integrity of endogenous inhibition remains unexamined. The aim of this study was therefore to investigate changes in facilitatory and inhibitory processing in patients with CTS by studying hypersensitivity following experimentally induced pain (facilitatory mechanisms) and the efficacy of conditioned pain modulation (CPM, inhibitory mechanisms). Twenty-five patients with mild to moderate CTS and 25 age and sex matched control participants without CTS were recruited. Increased pain facilitation was evaluated via injection of hypertonic saline into the upper trapezius. Altered pain inhibition through CPM was investigated through cold water immersion of the foot as the conditioning stimulus and pressure pain threshold over the thenar and hypothenar eminence bilaterally as the test stimulus. The results demonstrated that patients with CTS showed a greater duration (p = 0.047), intensity (p = 0.044) and area (p = 0.012) of pain in response to experimentally induced pain in the upper trapezius and impaired CPM compared to the control participants (p = 0.006). Although typically considered to be driven by peripheral mechanisms, these findings indicate that CTS demonstrates characteristics of altered central processing with increased pain facilitation and reduced endogenous pain inhibition.	[Soon, Benjamin; Vicenzino, Bill; Schmid, Annina B.] Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Soon, Benjamin] Singapore Inst Technol, Singapore, Singapore; [Vicenzino, Bill; Coppieters, Michel W.] Univ Queensland, Sch Hlth & Rehabil Sci, Physiotherapy, Brisbane, Qld, Australia; [Schmid, Annina B.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Coppieters, Michel W.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands; [Coppieters, Michel W.] Griffith Univ, Fac Hlth, Menzies Hlth Inst Queensland, Gold Coast Campus, Gold Coast, Qld, Australia; [Coppieters, Michel W.] Griffith Univ, Fac Hlth, Sch Allied Hlth Sci, Gold Coast Campus, Gold Coast, Qld, Australia	University of Queensland; Singapore Institute of Technology; University of Queensland; University of Oxford; Vrije Universiteit Amsterdam; Griffith University; Menzies Health Institute Queensland; Griffith University	Coppieters, MW (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Physiotherapy, Brisbane, Qld, Australia.; Coppieters, MW (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands.; Coppieters, MW (corresponding author), Griffith Univ, Fac Hlth, Menzies Hlth Inst Queensland, Gold Coast Campus, Gold Coast, Qld, Australia.; Coppieters, MW (corresponding author), Griffith Univ, Fac Hlth, Sch Allied Hlth Sci, Gold Coast Campus, Gold Coast, Qld, Australia.	m.coppieters@griffith.edu.au	Coppieters, Michel/AAW-7326-2021; Schmid, Annina B/F-3070-2010; Vicenzino, Bill/A-8492-2011	Schmid, Annina B/0000-0001-7759-0211; Vicenzino, Bill/0000-0003-0253-5933; Coppieters, Michel/0000-0002-3958-4408	National Health and Medical Research Council (NHMRC) [511161]; Neil Hamilton Fairley Fellowship from the National Health and Medical Research Council; Swiss National Science Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Neil Hamilton Fairley Fellowship from the National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the National Health and Medical Research Council (NHMRC) grant 511161 to MC. AB Schmid is supported by a Neil Hamilton Fairley Fellowship from the National Health and Medical Research Council and an advanced postdoc.mobility fellowship from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt-Nielsen Lars, 2003, Curr Pain Headache Rep, V7, P355, DOI 10.1007/s11916-003-0034-0; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Arendt-Nielsen L, 2009, J PAIN, V10, P556, DOI 10.1016/j.jpain.2009.02.002; Bennell K, 2004, J ORTHOP RES, V22, P116, DOI 10.1016/S0736-0266(03)00162-1; Bialosky JE, 2011, MANUAL THER, V16, P602, DOI 10.1016/j.math.2011.06.003; de-la-Llave-Rincon AI, 2012, DISCOV MED, V13, P343; Edwards RR, 2005, NEUROLOGY, V65, P437, DOI 10.1212/01.wnl.0000171862.17301.84; Falla D, 2008, PAIN, V138, P217, DOI 10.1016/j.pain.2008.04.004; Fernandez de-las Penas C, 2010, J ORTHOP SPORT PHYS, V40, P751, DOI 10.2519/jospt.2010.3331; Fernandez-de-las-Penas C, 2010, ARTHRIT CARE RES, V62, P1055, DOI 10.1002/acr.20189; Fernandez-de-las-Penas C, 2009, BRAIN, V132, P1472, DOI 10.1093/brain/awp050; GravenNielsen T, 1997, PAIN, V69, P111, DOI 10.1016/S0304-3959(96)03243-5; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Huisstede BM, 2010, ARCH PHYS MED REHAB, V91, P1005, DOI 10.1016/j.apmr.2010.03.023; de la Llave-Rincon AI, 2009, EXP BRAIN RES, V198, P455, DOI 10.1007/s00221-009-1941-z; KATZ JN, 1990, ANN INTERN MED, V112, P321, DOI 10.7326/0003-4819-112-5-321; Knudsen L, 2009, EUR J PAIN, V13, P1023, DOI 10.1016/j.ejpain.2008.12.005; Kosek E, 2000, PAIN, V88, P69, DOI 10.1016/S0304-3959(00)00310-9; Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Leffler AS, 2000, EUR J PAIN, V4, P73, DOI 10.1053/eujp.1999.0160; Lemming D, 2012, J REHABIL MED, V44, P648, DOI 10.2340/16501977-1006; Leonard G, 2009, PAIN, V147, P217, DOI 10.1016/j.pain.2009.09.009; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; Lewis GN, 2012, J PAIN, V13, P936, DOI 10.1016/j.jpain.2012.07.005; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Mitchell LA, 2004, J PAIN, V5, P233, DOI 10.1016/j.jpain.2004.03.004; Nahman-Averbuch H, 2011, J PAIN SYMPTOM MANAG, V42, P229, DOI 10.1016/j.jpainsymman.2010.10.268; Nora DB, 2005, CLIN NEUROPHYSIOL, V116, P275, DOI 10.1016/j.clinph.2004.08.013; Nora DB, 2004, CLIN NEUROL NEUROSUR, V107, P64, DOI 10.1016/j.clineuro.2004.08.003; O'Neill S, 2007, EUR J PAIN, V11, P415, DOI 10.1016/j.ejpain.2006.05.009; Pickering G, 2014, PAIN RES MANAG, V19, pE19, DOI 10.1155/2014/507947; Pielsticker A, 2005, PAIN, V118, P215, DOI 10.1016/j.pain.2005.08.019; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Schmid AB, 2011, EUROPEAN J PAIN; Schmid AB, 2014, BRAIN, V137, P3186, DOI 10.1093/brain/awu288; Sjors A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-230; Tamburin S, 2011, J PAIN, V12, P205, DOI 10.1016/j.jpain.2010.06.010; Tamburin S, 2008, J NEUROL, V255, P1636, DOI 10.1007/s00415-008-0895-6; Tecchio F, 2002, HUM BRAIN MAPP, V17, P28, DOI 10.1002/hbm.10049; Tompra N, 2015, BRIT J SPORTS MED; Tuveson B, 2007, EUR J PAIN, V11, P452, DOI 10.1016/j.ejpain.2006.06.007; van Wijk G, 2010, J PAIN, V11, P408, DOI 10.1016/j.jpain.2009.10.009; Watson JC, 2012, NEUROL CLIN, V30, P457, DOI 10.1016/j.ncl.2011.12.001; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021; Zanette G, 2006, PAIN, V122, P264, DOI 10.1016/j.pain.2006.01.034; Zanette G, 2010, PAIN, V148, P227, DOI 10.1016/j.pain.2009.10.025	48	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183252	10.1371/journal.pone.0183252	http://dx.doi.org/10.1371/journal.pone.0183252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854251	Green Published, gold			2022-12-26	WOS:000408693600035
J	Sun, LM; Liao, K; Wang, DY				Sun, Lingmei; Liao, Kai; Wang, Dayong			Honokiol induces superoxide production by targeting mitochondrial respiratory chain complex I in Candida albicans	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; UNITED-STATES; GENE-EXPRESSION; EPIDEMIOLOGY; RESISTANCE; TRENDS; AGENTS; CELLS; MICE; ROS	Background Honokiol, a compound extracted from Magnolia officinalis, has antifungal activities by inducing mitochondrial dysfunction and triggering apoptosis in Candida albicans. However, the mechanism of honokiol-induced oxidative stress is poorly understood. The present investigation was designed to determine the specific mitochondrial reactive oxygen species (ROS)-generation component. Methods/results We found that honokiol induced mitochondrial ROS accumulation, mainly superoxide anions (O-2(center dot-)) measured by fluorescent staining method. The mitochondrial respiratory chain complex I (C I) inhibitor rotenone completely blocked O-2(center dot-) production and provided the protection from the killing action of honokiol. Moreover, respiratory activity and the C I enzyme activity was significantly reduced after honokiol treatment. The differential gene-expression profile also showed that genes involved in oxidoreductase activity, electron transport, and oxidative phosphorylation were upregulated. Conclusions The present work shows that honokiol may bind to mitochondrial respiratory chain C I, leading to mitochondrial dysfunction, accompanied by increased cellular superoxide anion and oxidative stress. General significance This work not only provides insights on the mechanism by which honokiol interferes with fungal cell, demonstrating previously unknown effects on mitochondrial physiology, but also raises a note of caution on the use of M. officinalis as a Chinese medicine due to the toxic for mitochondria and suggests the possibility of using honokiol as chemosensitizer.	[Sun, Lingmei] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Liao, Kai] Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Jiangsu, Peoples R China; [Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Sun, LM (corresponding author), Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China.; Wang, DY (corresponding author), Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China.	sunlingmei@seu.edu.cn; dayongw@seu.edu.cn			National Natural Science Foundation of China [81302814, 81703574]; Jiangsu Province Natural Science Foundation [20140624]; Fundamental Research Funds for the Central Universities [2242017K40096, 2242017K40093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was funded by the National Natural Science Foundation of China grants (81302814 - Dr. Lingmei Sun) and (81703574 - Kai Liao); Jiangsu Province Natural Science Foundation (20140624 - Kai Liao); Fundamental Research Funds for the Central Universities (2242017K40096 - Dr. Lingmei Sun); and Fundamental Research Funds for the Central Universities (2242017K40093 - Kai Liao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes PMDS, 2014, DIAGN MICR INFEC DIS, V79, P222, DOI 10.1016/j.diagmicrobio.2013.09.016; Alexander BD, 1997, DRUGS, V54, P657, DOI 10.2165/00003495-199754050-00002; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ayer A, 2014, FEMS YEAST RES, V14, P60, DOI 10.1111/1567-1364.12114; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; Bondaryk M, 2013, POSTEP DERM ALERGOL, V30, P293, DOI 10.5114/pdia.2013.38358; Dikalov S, 2008, BIOCHEM PHARMACOL, V76, P589, DOI 10.1016/j.bcp.2008.06.012; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Evdokimovsky EV, 2011, RADIAT ENVIRON BIOPH, V50, P181, DOI 10.1007/s00411-010-0329-6; FONZI WA, 1993, GENETICS, V134, P717; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Hahm ER, 2014, PROSTATE, V74, P1209, DOI 10.1002/pros.22837; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Jangra A, 2016, EUR J PHARMACOL, V770, P25, DOI 10.1016/j.ejphar.2015.11.047; Jiang C, 2013, J ANTIMICROB CHEMOTH, V68, P778, DOI 10.1093/jac/dks481; Jin J, 2010, LETT APPL MICROBIOL, V51, P351, DOI 10.1111/j.1472-765X.2010.02900.x; Johnson MD, 2010, CURR FUNGAL INFECT R, V4, P87, DOI 10.1007/s12281-010-0018-6; Kobayashi T, 2012, J CLIN MICROBIOL, V50, P1606, DOI 10.1128/JCM.06461-11; LEHAN P H, 1956, Antibiot Annu, P467; Li DM, 2016, CURR GENET, V62, P87, DOI 10.1007/s00294-015-0518-6; Lunnon K, 2017, NEUROBIOL AGING, V53, P36, DOI 10.1016/j.neurobiolaging.2016.12.029; Moreno-Sanchez R, 2013, FEBS J, V280, P927, DOI 10.1111/febs.12086; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Orr AL, 2013, FREE RADICAL BIO MED, V65, P1047, DOI 10.1016/j.freeradbiomed.2013.08.170; Pan J, 2016, MOL NUTR FOOD RES, V60, P1383, DOI 10.1002/mnfr.201501007; Pereira GC, 2007, J PHARMACOL EXP THER, V323, P636, DOI 10.1124/jpet.107.128017; Plaine A, 2008, FUNGAL GENET BIOL, V45, P1404, DOI 10.1016/j.fgb.2008.08.003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; She XD, 2015, CELL MICROBIOL, V17, P1350, DOI 10.1111/cmi.12438; She XD, 2013, CELL MICROBIOL, V15, P1572, DOI 10.1111/cmi.12135; Skrzypek MS, 2010, NUCLEIC ACIDS RES, V38, pD428, DOI 10.1093/nar/gkp836; Sun J, 2015, DRUG DES DEV THER, V9, P6327, DOI 10.2147/DDDT.S92777; Sun L., 2017, PLOS ONE, V12; Sun LM, 2015, J APPL MICROBIOL, V118, P826, DOI 10.1111/jam.12737; Tada R, 2013, CURR PHARM DESIGN, V19, P3738, DOI 10.2174/1381612811319200012; Teodoro GR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01420; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang XD, 2015, INT J CLIN EXP PATHO, V8, P7929; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40; Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xiao JJ, 2011, J CELL MOL MED, V15, P1166, DOI 10.1111/j.1582-4934.2010.01106.x; Zhang XT, 2000, MOL MICROBIOL, V36, P618, DOI 10.1046/j.1365-2958.2000.01877.x; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	45	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184003	10.1371/journal.pone.0184003	http://dx.doi.org/10.1371/journal.pone.0184003			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854218	gold, Green Submitted, Green Published			2022-12-26	WOS:000408693600077
J	Yu, Y; Song, EM; Lee, KE; Joo, YH; Kim, SE; Moon, CM; Kim, HY; Jung, SA; Jo, I				Yu, Yeonsil; Song, Eun Mi; Lee, Ko Eun; Joo, Yang-Hee; Kim, Seong-Eun; Moon, Chang Mo; Kim, Ha Yeong; Jung, Sung-Ae; Jo, Inho			Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; STROMAL CELLS; IN-VITRO; NECROSIS FACTOR; TISSUE-DAMAGE; MOUSE MODEL; MICE; DIFFERENTIATION; ADIPOSE; EXPRESSION	The therapeutic potential of tonsil-derived mesenchymal stem cells (TMSC) prepared from human tonsillar tissue has been studied in animal models for several diseases such as hepatic injury, hypoparathyroidism, diabetes and muscle dystrophy. In this study, we examined the therapeutic effects of TMSC in a dextran sulfate sodium (DSS)-induced colitis model. TMSC were injected in DSS-induced colitis mice via intraperitoneal injection twice (TMSC[x2]) or four times (TMSC[x4]). Control mice were injected with either phosphate-buffered saline or human embryonic kidney 293 cells. Body weight, stool condition and disease activity index (DAI) were examined daily. Colon length, histologic grading, and mRNA expression of pro-inflammatory cytokines, interleukin 1 beta (IL-1 beta), IL-6, IL-17 and tumor necrosis factor a, and anti-inflammatory cytokines, IL-10, IL-11 and IL-13, were also measured. Our results showed a significant improvement in survival rates and body weight gain in colitis mice injected with TMSC[x2] or TMSC[x4]. Injection with TMSC also significantly decreased DAI scores throughout the experimental period; at the end of experiment, almost complete reversal of DAI scores to normal was found in colitis mice treated with TMSC[x4]. Colon length was also significantly recovered in colitis mice treated with TMSC[x4]. However, histopathological alterations induced by DSS treatment were not apparently improved by injection with TMSC. Finally, treatment with TMSC[x4] significantly reversed the mRNA levels of IL-1 beta and IL-6, although expression of all pro-inflammatory cytokines tested was induced in colitis mice. Under our experimental conditions, however, no apparent alterations in the mRNA levels of all the anti-inflammatory cytokines tested were found. In conclusion, our findings demonstrate that multiple injections with TMSC produced a therapeutic effect in a mouse model of DSS-induced colitis.	[Yu, Yeonsil; Kim, Ha Yeong; Jo, Inho] Ewha Womans Univ, Dept Mol Med, Coll Med, Seoul, South Korea; [Song, Eun Mi; Lee, Ko Eun; Joo, Yang-Hee; Kim, Seong-Eun; Moon, Chang Mo; Jung, Sung-Ae] Ewha Womans Univ, Dept Internal Med, Coll Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Jo, I (corresponding author), Ewha Womans Univ, Dept Mol Med, Coll Med, Seoul, South Korea.; Jung, SA (corresponding author), Ewha Womans Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	jassa@ewha.ac.kr; inhojo@ewha.ac.kr	Jo, Inho/R-3581-2019	Kim, Ha Yeong/0000-0003-0561-4792; Jo, Inho/0000-0001-6060-6416	National Research Foundation of Korea [NRF] - Ministry of Science, ICT & Future Planning [2013R1A1A2014344, 2016R1A2B4006972]; Ministry of Education, Science and Technology [2013R1A1A2062781]	National Research Foundation of Korea [NRF] - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by Basic Science Research Program through the National Research Foundation of Korea [NRF] funded by the Ministry of Science, ICT & Future Planning [2013R1A1A2014344 and 2016R1A2B4006972 to SAJ] and by the Ministry of Education, Science and Technology [2013R1A1A2062781 to YY]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeri M, 2015, IMMUNOL LETT, V168, P191, DOI 10.1016/j.imlet.2015.06.018; Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Baars JE, 2012, INFLAMM BOWEL DIS, V18, P1634, DOI 10.1002/ibd.21925; Banerjee A, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0073-6; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Burger D, 2011, GASTROENTEROLOGY, V140, P1827, DOI 10.1053/j.gastro.2011.02.045; Burisch J, 2014, GUT, V63, P588, DOI 10.1136/gutjnl-2013-304636; Chatterjee D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00662; Chow JP, 2016, TISSUE ENG REGEN MED, V13, P701, DOI 10.1007/s13770-016-0018-x; Cohen LB, 2014, TRANSL RES, V163, P533, DOI 10.1016/j.trsl.2014.01.002; Colpaert S, 2001, ALIMENT PHARM THER, V15, P1827, DOI 10.1046/j.1365-2036.2001.01111.x; De Fazio L, 2014, WORLD J GASTROENTERO, V20, P2051, DOI 10.3748/wjg.v20.i8.2051; Buruiana FE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005109.pub3; He XW, 2012, DIGEST DIS SCI, V57, P3136, DOI 10.1007/s10620-012-2290-5; Janjanin S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2459; Gomez-Gomez GJ, 2015, WORLD J GASTROENTERO, V21, P11282, DOI 10.3748/wjg.v21.i40.11282; Jung KH, 2011, GASTROENTEROLOGY, V140, P998, DOI 10.1053/j.gastro.2010.11.047; Jung N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111867; Kang JW, 2012, J VET SCI, V13, P23, DOI 10.4142/jvs.2012.13.1.23; Kersting S, 2013, J INFLAMM RES, V6, P71, DOI 10.2147/JIR.S40092; Keubler LM, 2015, INFLAMM BOWEL DIS, V21, P1967, DOI 10.1097/MIB.0000000000000468; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; Kozuch PL, 2008, WORLD J GASTROENTERO, V14, P354, DOI 10.3748/wjg.14.354; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Li LM, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-16; McAlindon ME, 1998, GUT, V42, P214, DOI 10.1136/gut.42.2.214; Molendijk I, 2016, J CROHNS COLITIS; Park JS, 2015, J CLIN BIOCHEM NUTR, V57, P192, DOI 10.3164/jcbn.15-56; PARK M, 2015, SCI REP UK, V5; Park S, 2016, INT J MOL MED, V37, P1209, DOI 10.3892/ijmm.2016.2536; Park YS, 2016, ACTA BIOMATER, V35, P215, DOI 10.1016/j.actbio.2016.03.003; Park YS, 2015, BIOMATERIALS, V65, P140, DOI 10.1016/j.biomaterials.2015.06.044; Perez-Merino EM, 2015, VET J, V206, P391, DOI 10.1016/j.tvjl.2015.07.023; Ryu KH, 2014, EXP CELL RES, V326, P143, DOI 10.1016/j.yexcr.2014.06.007; Ryu KH, 2012, CYTOTHERAPY, V14, P1193, DOI 10.3109/14653249.2012.706708; Sala E, 2015, GASTROENTEROLOGY, V149, P163, DOI 10.1053/j.gastro.2015.03.013; Salam AGA, 2014, INT IMMUNOPHARMACOL, V22, P515, DOI 10.1016/j.intimp.2014.07.030; Samivel R, 2015, AM J RHINOL ALLERGY, V29, P262, DOI 10.2500/ajra.2015.29.4216; Seiffart V, 2015, CELL PHYSIOL BIOCHEM, V36, P1259, DOI 10.1159/000430295; Sisakhtnezhad S, 2017, EUR J CELL BIOL, V96, P13, DOI 10.1016/j.ejcb.2016.11.003; Suyama T, 2016, TISSUE ENG REGEN MED, V13, P527, DOI 10.1007/s13770-016-9124-z; Takac Boris, 2014, Coll Antropol, V38, P659; Thomson ABR, 2012, WORLD J GASTROENTERO, V18, P4823, DOI 10.3748/wjg.v18.i35.4823; Wang YH, 2017, EXP THER MED, V13, P203, DOI 10.3892/etm.2016.3941; Yanez R, 2010, EXP CELL RES, V316, P3109, DOI 10.1016/j.yexcr.2010.08.008; Yu Y, 2016, TISSUE ENG REGEN MED, V13, P162, DOI 10.1007/s13770-016-9134-x; Yu Y, 2014, J ANAT, V225, P510, DOI 10.1111/joa.12229; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190; Zhang YZ, 2014, WORLD J GASTROENTERO, V20, P91, DOI 10.3748/wjg.v20.i1.91; Zhou J, 2016, Zhonghua Yi Xue Za Zhi, V96, P1047, DOI 10.3760/cma.j.issn.0376-2491.2016.13.014	50	21	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183141	10.1371/journal.pone.0183141	http://dx.doi.org/10.1371/journal.pone.0183141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854223	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600030
J	Bolotin, S; Lim, G; Dang, V; Crowcroft, N; Gubbay, J; Mazzulli, T; Schabas, R				Bolotin, Shelly; Lim, Gillian; Dang, Vica; Crowcroft, Natasha; Gubbay, Jonathan; Mazzulli, Tony; Schabas, Richard			The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009-2014	PLOS ONE			English	Article							DIAGNOSIS; VIRUS; TRANSMISSION; TESTS	In Canada, measles was eliminated in 1998 and rubella in 2000. Effective measles and rubella surveillance is vital in elimination settings, hinging on reliable laboratory methods. However, low-prevalence settings affect the predictive value of laboratory tests. We conducted an analysis to determine the performance of measles and rubella IgM testing in a jurisdiction where both infections are eliminated. 21,299 test results were extracted from the Public Health Ontario Laboratories database and 1,239 reports were extracted from the Ontario Integrated Public Health Information System (iPHIS) from 2008 and 2010 for measles and rubella, respectively, to 2014. Deterministic linkage resulted in 658 linked measles records (2009-2014) and 189 linked rubella records (2010-2014). Sixty-six iPHIS measles entries were classified as confirmed cases, of which 53 linked to laboratory data. Five iPHIS rubella entries were classified as confirmed, all linked to IgM results. The positive predictive value was 17.4% for measles and 3.6% for rubella. Sensitivity was 79.2% for measles and 100.0% for rubella. Specificity was 65.7% for measles and 25.8% for rubella. Our study confirms that a positive IgM alone does not confirm a measles case in elimination settings. This has important implications for countries that are working towards measles and rubella elimination.	[Bolotin, Shelly; Lim, Gillian; Dang, Vica; Crowcroft, Natasha; Gubbay, Jonathan; Mazzulli, Tony] Publ Hlth Ontario, Toronto, ON, Canada; [Bolotin, Shelly; Crowcroft, Natasha] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Crowcroft, Natasha; Gubbay, Jonathan] Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, Toronto, ON, Canada; [Gubbay, Jonathan] Univ Toronto, Dept Pediat, Fac Med, Toronto, ON, Canada; [Gubbay, Jonathan] Hosp Sick Children, Div Infect Dis, Toronto, ON, Canada; [Mazzulli, Tony] Univ Toronto, Div Infect Dis, Dept Med, Fac Med, Toronto, ON, Canada; [Mazzulli, Tony] Mt Sinai Hosp, Toronto, ON, Canada; [Schabas, Richard] Hastings Prince Edward Publ Hlth, Belleville, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Bolotin, S (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Bolotin, S (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	shelly.bolotin@oahpp.ca	Gubbay, Jonathan/Q-8580-2019	Gubbay, Jonathan/0000-0003-0026-3786				ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; [Anonymous], 2013, Can Commun Dis Rep, V39, P1, DOI 10.14745/ccdr.v39i00a03; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; [Anonymous], 4 WHO GLOB MEASL RUB; Bellini WJ, 2003, J INFECT DIS, V187, pS283, DOI 10.1086/368040; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P396; Charlton CL, 2016, CURR TREAT OPT INFEC, V8, P329, DOI [10.1007/s40506-016-0090-8, DOI 10.1007/S40506-016-0090-8]; Ciccone FH, 2010, REV SOC BRAS MED TRO, V43, P234, DOI 10.1590/S0037-86822010000300004; CUTTS FT, 1995, REV MED VIROL, V5, P35, DOI 10.1002/rmv.1980050105; Dietz V, 2004, B WORLD HEALTH ORGAN, V82, P852; Dolin R, 2009, MANDELL DOUGLAS BENN; Government of Ontario, 1990, RSO; JENKERSON SA, 1995, NEW ENGL J MED, V332, P1103, DOI 10.1056/NEJM199504203321616; Khorrami SMS, 2015, J MED VIROL, V87, P1846, DOI 10.1002/jmv.24250; King A, 2004, J INFECT DIS, V189, pS236, DOI 10.1086/378499; KURTZ JB, 1985, LANCET, V2, P1356; Lim G, 2014, DOCUMENTING ELIMINAT, P40; Mausner J, 1985, EPIDEMIOLOGY INTRO T; Mayo Clinic, 2008, HOT TOP SER TEST RUB; Ontario Agency for Health Protection and Promotion, 2014, IMM COV REP SCH PUP; Ontario Ministry of Health and Long Term Care, 2014, INF DIS PROT 2014 AP; Ontario Ministry of Health and Long Term Care, 2013, INF DIS PROT 2013 AP; Preacher K.J., 2001, CALCULATION CHI SQUA; Public Health Agency of Canada, 2012, CAN IMM GUID; Public Health Agency of Canada (PHAC), 2011, EL MEASL RUB CONG RU; Shane A, 2014, Can Commun Dis Rep, V40, P219; Sherrard L, MEASLES ELIMINATION; Sowers SB, 2016, CLIN VACCINE IMMUNOL, V23, P707, DOI 10.1128/CVI.00268-16; Thomas HIJ, 1999, J CLIN VIROL, V14, P107, DOI 10.1016/S1386-6532(99)00051-7; Tipples GA, 2003, J CLIN MICROBIOL, V41, P4790, DOI 10.1128/JCM.41.10.4790-4792.2003; van Binnendijk RS, 2003, J INFECT DIS, V188, P898, DOI 10.1086/377103; Wolfe S, 2015, EPIDEMIOLOGY PREVENT; Woods CR, 2013, J PEDIATR INFECT DIS, V2, P87, DOI 10.1093/jpids/pis133; World Health Organization Regional Office for Europe, 2012, SURV GUID MEASL; World Health Organization (WHO), WHOIVB0701	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0181172	10.1371/journal.pone.0181172	http://dx.doi.org/10.1371/journal.pone.0181172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850604	gold, Green Published, Green Submitted			2022-12-26	WOS:000408544200001
J	Lu, YG; Aitken, RJ; Lin, MJ				Lu, Yonggang; Aitken, Robert John; Lin, Minjie			Ultrastructural investigation and in vitro recapitulation of spermatid differentiation in a potential bio-indicator species - The marine invertebrate Galeolaria gemineoa (Polychaeta: Serpulidae)	PLOS ONE			English	Article							ORYZIAS-LATIPES; MEIOTIC DIFFERENTIATION; FERTILIZATION BIOLOGY; REPRODUCTIVE-BIOLOGY; FUNCTIONAL SPERM; SPERMATOGENESIS; SPERMIOGENESIS; ANNELIDA; CAESPITOSA; MORPHOLOGY	Galeolaria gemineoa is a sessile broadcast-spawning marine invertebrate, whose spermatozoa have been regarded as a sensitive indicator for water quality monitoring. In this study, 10 steps of spermiogenesis have been identified at the ultrastructural level and this differentiation process has been recapitulated in vitro up to the point of spermiogenesis (step 7-9 spermatids). On completion of the second meiosis, newly formed spermatids were detached from the seminiferous epithelium and released to the lumen of each germinal chamber. These spermatids were present in pairs and interconnected by a cytoplasmic bridge throughout the entire spermiogenic process. On the basis of morphological events such as formation of the acrosome, elongation of the flagellum, and condensation of the nucleus, spermiogenesis has been temporally divided into Golgi phase, acrosomal phase and maturation phase. During the Golgi phase, proacrosomal vesicles appeared at the posterior pole of the spermatids and gradually fused into a proacrosomal vacuole. Simultaneously, the distal centriole docked onto the plasma membrane and gave rise to a formative flagellum. The acrosomal phase was characterised by differentiation of the acrosome, condensation of the chromatin and formation of a mitochondrial sheath surrounding the initial portion of the flagellum. During the maturation phase, the fully differentiated acrosome migrated to the anterior pole and excess cytoplasm was extruded from the spermatids in the form of residual bodies. In addition, we successfully induced step 1-3 spermatids to differentiate into the step 7-9 spermatids in both male germinal fluid and 10% foetal bovine serum in RPMI 1640 medium, but failed to replicate this process in female or boiled male germinal fluids. This finding supports our concept that spermatid differentiation in this species is dependent on intrinsic developmental programming and does not require input from accompanying nurse cells.	[Lu, Yonggang; Aitken, Robert John; Lin, Minjie] Univ Newcastle, Sch Environm & Life Sci, Fac Sci, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia	University of Newcastle	Aitken, RJ (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Fac Sci, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia.	John.Aitken@newcastle.edu.au	Aitken, Robert John/AAY-8238-2020; Lu, Yonggang/HHN-6203-2022	Aitken, Robert John/0000-0002-9152-156X; Lu, Yonggang/0000-0003-0198-8906	School of Environmental and Life Sciences, University of Newcastle, Australia	School of Environmental and Life Sciences, University of Newcastle, Australia	Funding provided by a special project grant (2013-2015) to ML by the School of Environmental and Life Sciences, University of Newcastle, Australia; http://www.newcastle.edu.au/about-uon/governance-and-leadership/faculties-and-schools/faculty-of-science-and-information-technology/school-of-environmental-and-life-sciences. The funder had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS JC, 1962, P LINN SOC N S W, V87, P185; BERTOUT M, 1983, J EXP ZOOL, V226, P151, DOI 10.1002/jez.1402260118; Blake EA, 2005, INVERTEBR BIOL, V124, P254, DOI 10.1111/j.1744-7410.2005.00022.x; Bochert R, 1996, ACTA ZOOL-STOCKHOLM, V77, P191, DOI 10.1111/j.1463-6395.1996.tb01263.x; Bremner J, 2008, J EXP MAR BIOL ECOL, V366, P37, DOI 10.1016/j.jembe.2008.07.007; Dean H.K., 2008, REV BIOL TROP, V56, P11, DOI [10.15517/rbt.v56i4.27162, DOI 10.15517/RBT.V56I4.27162]; ECKELBARGER KJ, 1984, J ULTRA MOL STRUCT R, V89, P146, DOI 10.1016/S0022-5320(84)80011-8; Eckelbarger KJ, 2005, J MAR BIOL ASSOC UK, V85, P1425, DOI 10.1017/S0025315405012609; ECKELBARGER KJ, 1987, MAR BIOL, V95, P415, DOI 10.1007/BF00409572; Eckelbarger KJ, 2002, BIOL BULL-US, V203, P134, DOI 10.2307/1543382; Edgar G.J., 2008, AUSTR MARINE LIFE PL, V2nd; Falkenberg LJ, 2016, MAR ENVIRON RES, V114, P51, DOI 10.1016/j.marenvres.2015.12.005; Gao Y, 2014, J OCEAN U CHINA, V13, P1071, DOI 10.1007/s11802-014-2309-y; Gherardi M, 2011, ITAL J ZOOL, V78, P174, DOI 10.1080/11250003.2010.529468; Giangrande A, 2000, MAR BIOL, V136, P847, DOI 10.1007/s002279900251; GRIER HJ, 1976, CELL TISSUE RES, V168, P419, DOI 10.1007/BF00215993; Halt MN, 2009, INVERTEBR SYST, V23, P205, DOI 10.1071/IS09003; Hunter Damien, 2012, Spermatogenesis, V2, P32; Hutchings P, 1998, BIODIVERS CONSERV, V7, P1133, DOI 10.1023/A:1008871430178; JAMIESON BGM, 1989, BIOL REV, V64, P93, DOI 10.1111/j.1469-185X.1989.tb00673.x; Kupriyanova EK, 2006, SCI MAR, V70, P309, DOI 10.3989/scimar.2006.70s3309; Levine H, 2017, HUM REPROD UPDATE, V23, P646, DOI 10.1093/humupd/dmx022; LIN M, 1993, J ANAT, V183, P525; Lin MJ, 2000, J ANAT, V196, P217, DOI 10.1046/j.1469-7580.2000.19620217.x; Lu YG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174907; Marshall DJ, 2005, J EVOLUTION BIOL, V18, P1244, DOI 10.1111/j.1420-9101.2005.00947.x; Marshall DJ, 2005, J EVOLUTION BIOL, V18, P735, DOI 10.1111/j.1420-9101.2004.00873.x; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Nagahama Y, 2007, CIB FDN S 182 GERML, P255; Parks JE, 2003, THERIOGENOLOGY, V59, P73, DOI 10.1016/S0093-691X(02)01275-X; Purschke G, 2005, ZOOMORPHOLOGY, V124, P137, DOI 10.1007/s00435-005-0001-x; Radashevsky VI, 2011, INVERTEBR REPROD DEV, V55, P168, DOI 10.1080/07924259.2011.553410; RICE SA, 1989, BIOL BULL, V176, P123, DOI 10.2307/1541579; RICE SA, 1981, ZOOMORPHOLOGY, V97, P1, DOI 10.1007/BF00310099; Rice SA, 1988, ULTRASTRUCTURE POLYC, V4, P309; Rouse GW, 2005, HYDROBIOLOGIA, V535, P167, DOI 10.1007/s10750-004-4390-5; Rouse GW, 1999, HYDROBIOLOGIA, V402, P215, DOI 10.1023/A:1003700827759; Rouse GW, 1998, INVERTEBRATE ZOOLOGY, P196; Saiki A, 1997, DEV GROWTH DIFFER, V39, P337, DOI 10.1046/j.1440-169X.1997.t01-2-00009.x; Sakai N, 2002, DEVELOPMENT, V129, P3359; Sasaki T, 2005, DEV GROWTH DIFFER, V47, P87, DOI 10.1111/j.1440-169x.2005.00785.x; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Schlegel P, 2014, MAR POLLUT BULL, V78, P213, DOI 10.1016/j.marpolbul.2013.10.040; Selim SA, 2005, MEDITERR MAR SCI, V6, P89, DOI 10.12681/mms.195; Simon CA, 2005, INVERTEBR BIOL, V124, P39, DOI 10.1111/j.1744-7410.2005.1241-05.x; Staub C, 2001, J ANDROL, V22, P911; Styan CA, 2008, EVOLUTION, V62, P3041, DOI 10.1111/j.1558-5646.2008.00521.x; Waring JS, 2006, J ENVIRON MONITOR, V8, P1149, DOI 10.1039/b612509n	48	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183986	10.1371/journal.pone.0183986	http://dx.doi.org/10.1371/journal.pone.0183986			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850628	Green Published, gold, Green Submitted			2022-12-26	WOS:000408544200051
J	Shukla, SK; Ye, Z; Sandberg, S; Reyes, I; Fritsche, TR; Keifer, M				Shukla, Sanjay K.; Ye, Zhan; Sandberg, Scott; Reyes, Iris; Fritsche, Thomas R.; Keifer, Matthew			The nasal microbiota of dairy farmers is more complex than oral microbiota, reflects occupational exposure, and provides competition for staphylococci	PLOS ONE			English	Article							GUT MICROBIOTA; AUREUS; MICROORGANISMS; ASSOCIATIONS; DIVERSITY; HEALTH	Allergic and autoimmune diseases had been attributed to lack of exposure to biodiversity, an important factor in regulating immune homeostasis in a healthy host. We posit that the microbiome of healthy dairy farmers (DF) will be richer than non-farmers (NF) living in urban settings due to exposure to a greater biodiversity in the dairy environment. However, no studies have investigated the relationships between microbiota of dairy farmers (DF) compared with urban non-farmers (NF). We compared the nasal and oral microbiota of dairy farmers (N_DF, O_DF, respectively) with nasal and oral microbiota of NF in the same geographical area. The N_DF showed high microbial diversity with hundreds of unique genera that reflected environmental/occupational exposures. The nasal and oral microbiomes clustered separately from each other using Principal Coordinate Analysis, and with DF harboring two-fold and 1.5-fold greater exclusive genera in their nose and mouth respectively, than did non-farmers. Additionally, the N_DF group had a lower burden of Staphylococcus spp. suggesting a correlation between higher microbial diversity and competition for colonization by staphylococci. The N_DF samples were negative for the mecA gene, a marker of methicillin-resistance in staphylococci. The lower burden of staphylococci was found to be independent of the abundance of Corynebacterium spp. Exposure to greater biodiversity could enhance microbial competition, thereby reducing colonization with opportunistic pathogens. Future studies will analyze whether exposure to livestock microbiomes offers protection from acute and chronic diseases.	[Shukla, Sanjay K.] Marshfield Clin Fdn Med Res & Educ, Res Inst, Ctr Human Genet, Mol Microbiol Lab, Marshfield, WI 54449 USA; [Ye, Zhan] Marshfield Clin Fdn Med Res & Educ, Res Inst, Biomed Informat Res Ctr, Marshfield, WI USA; [Sandberg, Scott; Reyes, Iris] Marshfield Clin Fdn Med Res & Educ, Res Inst, Natl Farm Med Ctr, Marshfield, WI USA; [Fritsche, Thomas R.] Marshfield Clin Fdn Med Res & Educ, Div Lab Med, Marshfield, WI USA; [Keifer, Matthew] VA Puget Sound, Seattle, WA USA	Marshfield Clinic; Marshfield Clinic; Marshfield Clinic; Marshfield Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Shukla, SK (corresponding author), Marshfield Clin Fdn Med Res & Educ, Res Inst, Ctr Human Genet, Mol Microbiol Lab, Marshfield, WI 54449 USA.	shukla.sanjay@mcrf.mfldclin.edu		Shukla, Sanjay/0000-0001-7267-8572	Marshfield Clinic Research Foundation (MCRF)	Marshfield Clinic Research Foundation (MCRF)	The study was funded by Marshfield Clinic Research Foundation (MCRF) and donations made to MCRF.	Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; Bassis CM, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-27; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Brugger SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005633; Camarinha-Silva A, 2014, ENVIRON MICROBIOL, V16, P2939, DOI 10.1111/1462-2920.12362; Campbell SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150502; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chen J, 2013, SCI REP, V6, P28484; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DOWD SE, 2008, BMC MICROBIOL, V8; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Espinosa-Gongora C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160331; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.24, 10.1038/nmicrobiol.2016.24]; Glurich I, 2013, ORAL DIS, V19, P1, DOI 10.1111/j.1601-0825.2012.01921.x; Glurich I, 2016, GENOMICS PERSONALIZE, P35; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Holman DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15557; John J, 2012, HOSP EPIDEMIOLOGY IN, P385; Kaspar U, 2016, ENVIRON MICROBIOL, V18, P2130, DOI 10.1111/1462-2920.12891; Lee SA, 2006, J OCCUP ENVIRON HYG, V3, P118, DOI 10.1080/15459620500524607; Lin Y, 2011, CLIN MED RES, V9, P7, DOI 10.3121/cmr.2010.944; Liu CM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400216; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; McGuinness SL, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1338-0; Naleway Allison L, 2004, Clin Med Res, V2, P5; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Normand AC, 2011, OCCUP ENVIRON MED, V68, P849, DOI 10.1136/oem.2010.061879; Pehrsson EC, 2016, NATURE, V533, P212, DOI 10.1038/nature17672; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rook GAW, 2010, CLIN EXP IMMUNOL, V160, P70, DOI 10.1111/j.1365-2249.2010.04133.x; Schaubeck M, 2016, GUT, V65, P225, DOI 10.1136/gutjnl-2015-309333; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Shukla SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145453; Shukla SK, 2015, TRENDS MOL MED, V21, P461, DOI 10.1016/j.molmed.2015.06.002; Shukla SK, 2004, ANTIMICROB AGENTS CH, V48, P3080, DOI 10.1128/AAC.48.8.3080-3085.2004; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; Wegienka G, 2015, IMMUNOL ALLERGY CLIN, V35, P1, DOI 10.1016/j.iac.2014.09.002; Wlasiuk G, 2012, CURR OPIN ALLERGY CL, V12, P461, DOI 10.1097/ACI.0b013e328357a3bc; Wos-Oxley ML, 2016, ENVIRON MICROBIOL, V18, P2259, DOI 10.1111/1462-2920.13378; Wos-Oxley ML, 2010, ISME J, V4, P839, DOI 10.1038/ismej.2010.15; Yan ML, 2013, CELL HOST MICROBE, V14, P631, DOI 10.1016/j.chom.2013.11.005; Zeissig S, 2014, NAT IMMUNOL, V15, P307, DOI 10.1038/ni.2847	51	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183898	10.1371/journal.pone.0183898	http://dx.doi.org/10.1371/journal.pone.0183898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850578	Green Published, Green Submitted, gold			2022-12-26	WOS:000408544200038
J	Zitouni, S; Mechall, F; Papin, C; Choquet, A; Roche, D; Baldin, V; Coux, O; Bonne-Andrea, C				Zitouni, Sihem; Mechall, Francisca; Papin, Catherine; Choquet, Armelle; Roche, Daniel; Baldin, Veronique; Coux, Olivier; Bonne-Andrea, Catherine			The stability of Fbw7 alpha in M-phase requires its phosphorylation by PKC	PLOS ONE			English	Article							FBW7 UBIQUITIN LIGASE; F-BOX PROTEIN; GLYCOGEN-SYNTHASE KINASE-3; CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; DEPENDENT DEGRADATION; SUBSTRATE DEGRADATION; C-MYC; FUNCTIONAL INTERACTION; STRUCTURAL BASIS	Fbw7 is a tumor suppressor often deleted or mutated in human cancers. It serves as the substrate-recruiting subunit of a SCF ubiquitin ligase that targets numerous critical proteins for degradation, including oncoproteins and master transcription factors. Cyclin E was the first identified substrate of the SCFFbw7 ubiquitin ligase. In human cancers bearing FBXW7-gene mutations, deregulation of cyclin E turnover leads to its aberrant expression in mitosis. We investigated Fbw7 regulation in Xenopus eggs, which, although arrested in a mitotic-like phase, naturally express high levels of cyclin E. Here, we report that Fbw7 alpha, the only Fbw7 isoform detected in eggs, is phosphorylated by PKC (protein kinase C) at a key residue (S18) in a manner coincident with Fbw7 alpha inactivation. We show that this PKC-dependent phosphorylation and inactivation of Fbw7 alpha also occurs in mitosis during human somatic cell cycles, and importantly is critical for Fbw7 alpha stabilization itself upon nuclear envelope breakdown. Finally, we provide evidence that S18 phosphorylation, which lies within the intrinsically disordered N-terminal region specific to the a-isoform reduces the capacity of Fbw7 alpha to dimerize and to bind cyclin E. Together, these findings implicate PKC in an evolutionarily-conserved pathway that aims to protect Fbw7 alpha from degradation by keeping it transiently in a resting, inactive state.	[Zitouni, Sihem; Mechall, Francisca; Roche, Daniel; Baldin, Veronique; Coux, Olivier; Bonne-Andrea, Catherine] Univ Montpellier, CNRS, UMR 5237, Ctr Rech Biol Cellulaire Montpellier, Montpellier, France; [Papin, Catherine] Univ Montpellier, CNRS, UMR 9002, Inst Genet Humaine, Montpellier, France; [Choquet, Armelle] Univ Montpellier, CNRS UMR 5203, Inst Genom Fonct, Montpellier, France; [Roche, Daniel] Univ Montpellier, CNRS, Inst Biol Computat, LIRMM, Montpellier, France; [Zitouni, Sihem] Inst Gulbenkian Ciencias, Oeiras, Portugal	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; Instituto Gulbenkian de Ciencia	Bonne-Andrea, C (corresponding author), Univ Montpellier, CNRS, UMR 5237, Ctr Rech Biol Cellulaire Montpellier, Montpellier, France.	catherine.bonne-andrea@crbm.cnrs.fr	BALDIN, Véronique/Y-8397-2019; Coux, Olivier/P-6847-2019; Coux, Olivier/B-3406-2010	BALDIN, Véronique/0000-0001-8523-0494; Coux, Olivier/0000-0001-8455-3849; Coux, Olivier/0000-0001-8455-3849; Choquet, armelle/0000-0002-6959-9387; Roche, Daniel/0000-0002-9204-1840; Zitouni, Sihem/0000-0003-3590-3931	Agence Universitaire de la Francophonie; Ligue Nationale Contre le Cancer; CNRS	Agence Universitaire de la Francophonie; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); CNRS(Centre National de la Recherche Scientifique (CNRS))	We are grateful to D. Fesquet and S. Boulon and to the past members of the Coux laboratory for their advice and suggestions. We thank D. Joubert for the gift of GFP-PKC constructs, S. Reed for the gift of pCMVFLAG-hCdc4 alpha, P. Richard from the animal facility for the production of rabbit polyclonal antibodies, Y. Boublik for baculovirus production, the Montpellier Ressources Imagerie (MRI) facility for assistance with immunofluorescence microscopy and J. Hutchins for checking the scientific English of the manuscript. S.Z. was supported by studentships from the Agence Universitaire de la Francophonie and the Ligue Nationale Contre le Cancer.; The project was supported by the CNRS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen V, 2010, ANTICANCER RES, V30, P3995; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Babu MM, 2016, BIOCHEM SOC T, V44, P1185, DOI 10.1042/BST20160172; Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Bengoechea-Alonso MT, 2010, ONCOGENE, V29, P5322, DOI 10.1038/onc.2010.278; Bengoechea-Alonso MT, 2010, P NATL ACAD SCI USA, V107, P11817, DOI 10.1073/pnas.0913367107; Busino L, 2012, NAT CELL BIOL, V14, P375, DOI 10.1038/ncb2463; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chevalier S, 1996, J CELL SCI, V109, P1173; Cizmecioglu O, 2012, J CELL SCI, V125, P981, DOI 10.1242/jcs.095075; Collazos A, 2006, MOL CELL BIOL, V26, P2247, DOI 10.1128/MCB.26.6.2247-2261.2006; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Cueille N, 1998, J VIROL, V72, P7255, DOI 10.1128/JVI.72.9.7255-7262.1998; Dashzeveg N, 2016, CANCER LETT, V377, P158, DOI 10.1016/j.canlet.2016.04.032; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; De Vita F, 2012, CELL CYCLE, V11, P1583, DOI 10.4161/cc.20003; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DOMINGUEZ I, 1992, MOL CELL BIOL, V12, P3776, DOI 10.1128/MCB.12.9.3776; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Durgan J, 2010, BIOCHEM J, V432, P77, DOI 10.1042/BJ20100799; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Ekholm-Reed S, 2013, MOL CELL BIOL, V33, P3627, DOI 10.1128/MCB.00535-13; Fikaris AJ, 2005, J BIOL CHEM, V280, P32107, DOI 10.1074/jbc.M504432200; Fisher DL, 1999, DEVELOPMENT, V126, P567; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Fujii Y, 2006, CANCER SCI, V97, P729, DOI 10.1111/j.1349-7006.2006.00239.x; Fukushima H, 2012, CELL REP, V1, P434, DOI 10.1016/j.celrep.2012.04.002; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Halet G, 2004, BBA-MOL CELL RES, V1742, P185, DOI 10.1016/j.bbamcr.2004.09.012; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Ji SR, 2015, CELL RES, V25, P561, DOI 10.1038/cr.2015.30; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kalive M, 2010, MOL REPROD DEV, V77, P95, DOI 10.1002/mrd.21112; Kannan MB, 2015, J BIOL CHEM, V290, P26292, DOI 10.1074/jbc.M115.666446; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kourtis N, 2015, NAT CELL BIOL, V17, P322, DOI 10.1038/ncb3121; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; McGuffin LJ, 2015, NUCLEIC ACIDS RES, V43, pW169, DOI 10.1093/nar/gkv236; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Mo JS, 2011, J CELL SCI, V124, P100, DOI 10.1242/jcs.073924; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Perez-Benavente B, 2013, ONCOGENE, V32, P2189, DOI 10.1038/onc.2012.235; Perez-Benavente B, 2013, ONCOTARGET, V4, P956, DOI 10.18632/oncotarget.1151; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; Rocher-Ros V, 2010, ONCOGENE, V29, P2950, DOI 10.1038/onc.2010.57; Sancho R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001586; Schulein C, 2011, FEBS LETT, V585, P2151, DOI 10.1016/j.febslet.2011.05.036; Schulein-Volk C, 2014, CELL REP, V9, P1099, DOI 10.1016/j.celrep.2014.09.057; Sionov RV, 2013, CELL CYCLE, V12, P3547, DOI 10.4161/cc.26591; Spruck CH, 2002, CANCER RES, V62, P4535; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Teixeira LK, 2015, CURR BIOL, V25, P1327, DOI 10.1016/j.cub.2015.03.022; Thomas Y, 2014, CELL CYCLE, V13, P3867, DOI 10.4161/15384101.2014.972882; Uversky VN, 2015, FEBS LETT, V589, P2498, DOI 10.1016/j.febslet.2015.06.004; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Wang LX, 2014, ONCOTARGET, V5, P2000, DOI 10.18632/oncotarget.1859; Wang R, 2013, CELL RES, V23, P803, DOI 10.1038/cr.2013.42; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Welcker M, 2013, GENE DEV, V27, P2531, DOI 10.1101/gad.229195.113; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Xu WS, 2016, SEMIN CANCER BIOL, V36, P62, DOI 10.1016/j.semcancer.2015.09.005; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zhang W, 2006, MOL CANCER RES, V4, P935, DOI 10.1158/1541-7786.MCR-06-0253; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	85	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183500	10.1371/journal.pone.0183500	http://dx.doi.org/10.1371/journal.pone.0183500			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850619	Green Published, Green Submitted, gold			2022-12-26	WOS:000408544200016
J	Muley, A; Odaka, Y; Lewkowich, IP; Vemaraju, S; Yamaguchi, TP; Shawber, C; Dickie, BH; Lang, RA				Muley, Ajit; Odaka, Yoshi; Lewkowich, Ian P.; Vemaraju, Shruti; Yamaguchi, Terry P.; Shawber, Carrie; Dickie, Belinda H.; Lang, Richard A.			Myeloid Wnt ligands are required for normal development of dermal lymphatic vasculature	PLOS ONE			English	Article							GROWTH-FACTOR-C; ENDOTHELIAL-CELL; LYMPHOVENOUS VALVES; VESSELS; MOUSE; MACROPHAGES; DISEASE; LYMPHANGIOGENESIS; SECRETION; PROTEINS	Resident tissue myeloid cells play a role in many aspects of physiology including development of the vascular systems. In the blood vasculature, myeloid cells use VEGFC to promote angiogenesis and can use Wnt ligands to control vascular branching and to promote vascular regression. Here we show that myeloid cells also regulate development of the dermal lymphatic vasculature using Wnt ligands. Using myeloid-specific deletion of the WNT transporter Wntless we show that myeloid Wnt ligands are active at two distinct stages of development of the dermal lymphatics. As lymphatic progenitors are emigrating from the cardinal vein and intersomitic vessels, myeloid Wnt ligands regulate both their numbers and migration distance. Later in lymphatic development, myeloid Wnt ligands regulate proliferation of lymphatic endothelial cells (LEC) and thus control lymphatic vessel caliber. Myeloid-specific deletion of WNT co-receptor Lrp5 or Wnt5a gain-of-function also produce elevated caliber in dermal lymphatic capillaries. These data thus suggest that myeloid cells produce Wnt ligands to regulate lymphatic development and use Wnt pathway co-receptors to regulate the balance of Wnt ligand activity during the macrophage-LEC interaction.	[Muley, Ajit; Shawber, Carrie] Columbia Univ, Med Ctr, Dept OB GYN, New York, NY USA; [Odaka, Yoshi; Vemaraju, Shruti; Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Visual Syst Grp, Div Pediat Ophthalmol, Cincinnati, OH 45229 USA; [Lewkowich, Ian P.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Yamaguchi, Terry P.] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA; [Dickie, Belinda H.] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Ctr Chronobiol, Cincinnati, OH 45229 USA; [Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Abrahamson Pediat Eye Inst, Cincinnati, OH 45229 USA; [Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Lang, Richard A.] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45267 USA	Columbia University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Lang, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Visual Syst Grp, Div Pediat Ophthalmol, Cincinnati, OH 45229 USA.; Dickie, BH (corresponding author), Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA.; Lang, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Chronobiol, Cincinnati, OH 45229 USA.; Lang, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Abrahamson Pediat Eye Inst, Cincinnati, OH 45229 USA.; Lang, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.; Lang, RA (corresponding author), Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45267 USA.	Belinda.HsiDickie@childrens.harvard.edu; Richard.Lang@cchmc.org	Odaka, Yoshinobu/AAY-6918-2021	Odaka, Yoshinobu/0000-0003-3966-5475; Lang, Richard/0000-0002-5212-254X	 [R01 EY021636]; NATIONAL CANCER INSTITUTE [ZIABC010345] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01 EY021636. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Andersson E, 2010, DEV DYNAM, V239, P237, DOI 10.1002/dvdy.22101; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Birner P, 2001, CLIN CANCER RES, V7, P93; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Buttler K, 2013, DEV BIOL, V381, P365, DOI 10.1016/j.ydbio.2013.06.028; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; Cha B, 2016, BMB REP, V49, P403, DOI 10.5483/BMBRep.2016.49.8.112; Cha B, 2016, GENE DEV, V30, P1454, DOI 10.1101/gad.282400.116; Cha KB, 2004, MECH DEVELOP, V121, P183, DOI 10.1016/j.mod.2003.12.002; Ching W, 2006, CELL, V125, P432, DOI 10.1016/j.cell.2006.04.018; Cueni LN, 2006, J INVEST DERMATOL, V126, P2167, DOI 10.1038/sj.jid.5700464; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Gale NW, 2002, COLD SPRING HARB SYM, V67, P267, DOI 10.1101/sqb.2002.67.267; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Gordon EJ, 2010, DEVELOPMENT, V137, P3899, DOI 10.1242/dev.050021; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; James JM, 2013, DEVELOPMENT, V140, P3903, DOI 10.1242/dev.095026; Jeltsch M, 2014, CIRCULATION; Karkkainen MJ, 2002, SEMIN CELL DEV BIOL, V13, P9, DOI 10.1006/scdb.2001.0286; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; KOCH AE, 1992, CLIN IMMUNOL IMMUNOP, V65, P23, DOI 10.1016/0090-1229(92)90243-H; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Martinez-Corral I, 2012, P NATL ACAD SCI USA, V109, P6223, DOI 10.1073/pnas.1115542109; Nicenboim J, 2015, NATURE, V522, P56, DOI 10.1038/nature14425; NUSSE R, 1992, J STEROID BIOCHEM, V43, P9, DOI 10.1016/0960-0760(92)90181-H; Oliver G, 2008, ANN NY ACAD SCI, V1131, P75, DOI 10.1196/annals.1413.006; Oliver G, 2010, DEVELOPMENT, V137, P363, DOI 10.1242/dev.035360; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Rao S, 2007, DEVELOPMENT, V134, P4449, DOI 10.1242/dev.012187; Rao S, 2013, NATURE, V494, P243, DOI 10.1038/nature11823; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Semenov MV, 2007, CELL, V131, P1378; Semo J, 2016, DEVELOPMENT, V143, P924, DOI 10.1242/dev.132431; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2011, GENE DEV, V25, P2187, DOI 10.1101/gad.16974811; Stefater JA, 2013, BLOOD, V121, P2574, DOI 10.1182/blood-2012-06-434621; Stefater JA, 2011, TRENDS MOL MED, V17, P743, DOI 10.1016/j.molmed.2011.07.009; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Ulvmar MH, 2016, CARDIOVASC RES, V111, P310, DOI 10.1093/cvr/cvw175; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Yang Y, 2012, BLOOD, V120, P2340, DOI 10.1182/blood-2012-05-428607; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; Yeo EJ, 2014, CANC RES; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Zhong ZD, 2012, J BONE MINER RES, V27, P1849, DOI 10.1002/jbmr.1715	67	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0181549	10.1371/journal.pone.0181549	http://dx.doi.org/10.1371/journal.pone.0181549			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846685	Green Published, Green Submitted, gold			2022-12-26	WOS:000408438600006
J	Schaekel, F; May, T; Seiler, J; Hartmann, M; Kreienbrock, L				Schaekel, Franziska; May, Thomas; Seiler, Julia; Hartmann, Maria; Kreienbrock, Lothar			Antibiotic drug usage in pigs in Germany-Are the class profiles changing?	PLOS ONE			English	Article							ANTIMICROBIAL AGENTS; PATTERNS	The development of antimicrobial resistance is triggered by the use of antibiotic drugs. Therefore, the consumption of antibiotics in livestock is monitored, and different measures may be applied if the usage of antibiotic drugs seems inappropriate. Unfortunately, the surveillance of antibiotic consumption is not standardised, and surveillance systems differ. In Germany, the food quality assurance system QS Qualita E t und Sicherheit GmbH (QS) began the documentation of antibiotic drug usage in pigs in 2012 in a private economic based database, and for its members, documentation has been mandatory in all pig age groups since 2014. In this investigation, we calculated the distribution of the antibiotics use per pig age group and half- year, and the percentage of the active substances used from overall treatments within German pig holdings from 1 July, 2013 to 30 June, 2015. In fattening pigs, the median of the treatment frequency is 4.3 in 2013-2 and exhibits a decreasing trend in this time period up to 2.1 in 2015-1. In weaners the median ranged between 11.3 in 2014-2 and 5.8 in 2013-2. The median of sucklers varies between 21.6 and 25.0. In sucklers and weaners, a clear temporal trend is not seen to date. The share of the active substances differs between the age groups. In fattening pigs, mostly tetracyclines and penicillines were used, occurring in approximately 60% of the total treatments. In weaners, amoxicillin and colistin have the highest shares of the treatment frequency, at approximately 60%. The treatment frequencies of macrolides and penicillines have the highest share in sucklers.	[Schaekel, Franziska; Hartmann, Maria; Kreienbrock, Lothar] Univ Vet Med, Dept Biometry Epidemiol & Informat Proc, WHO, Collaborating Ctr Res & Training Hlth Human Anim, Hannover, Germany; [May, Thomas; Seiler, Julia] Qualitat & Sicherheit GmbH, QS, Bonn, Germany	University of Veterinary Medicine Hannover, Foundation; World Health Organization	Schaekel, F (corresponding author), Univ Vet Med, Dept Biometry Epidemiol & Informat Proc, WHO, Collaborating Ctr Res & Training Hlth Human Anim, Hannover, Germany.	franziska.schaekel@tiho-hannover.de						Aarestrup Frank M., 2008, Animal Health Research Reviews, V9, P135, DOI 10.1017/S1466252308001503; [Anonymous], 2015, LEITL SORGF UMG ANT; [Anonymous], 2010, VER DAT INF ARZN DTS; AURES, 2014, RES OST AURES 2013 A; Bos MEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077525; Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001; DANMAP, 2016, DANMAP 2015 US ANT A; European Medicines Agency, 2013, EMA2864162012REV1; Hosoi Y, 2013, INT J ANTIMICROB AG, V41, P489, DOI 10.1016/j.ijantimicag.2013.01.002; Huber P.J., 2004, ROBUST STAT; Jensen VF, 2012, J VET PHARMACOL THER, V35, P33, DOI 10.1111/j.1365-2885.2011.01291.x; MARAN, 2015, MARAN MON ANT RES AN; Merle R, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-7; Merle R, 2012, PREV VET MED, V104, P34, DOI 10.1016/j.prevetmed.2011.10.013; Moreno MA, 2012, VET REC, V171, DOI 10.1136/vr.100818; Moreno MA, 2013, VET RECORD OPEN; Murphy D., 2017, EFSA J, V15, pe04666; NORM/NORM-VET -. NORM/NORM-VET, 2015, NORM NORM VET 2015 U; Persoons D, 2012, PREV VET MED, V105, P320, DOI 10.1016/j.prevetmed.2012.02.020; QS Qualitat und Sicherheit GmbH, 2016, GEM STARK PARTN 2016; QS Qualitat und Sicherheit GmbH, 2015, QS ANT BEI SCHWEIN M; QS Qualitat und Sicherheit GmbH, 2015, LEITF ANT SCHWEIN BO; QS Qualitat und Sicherheit GmbH, 2016, QS ANF GES MASSN WIR; SDa Autoriteit Diergeneesmiddelen, 2016, US ANT AGR LIV NETH; Sjolund M, 2016, PREV VET MED, V130, P41, DOI 10.1016/j.prevetmed.2016.06.003; Sjolund M, 2015, PREV VET MED, V121, P257, DOI 10.1016/j.prevetmed.2015.07.005; SVARM, 2015, SWEDRES SVARM 2015 C; Timmerman T, 2006, PREV VET MED, V74, P251, DOI 10.1016/j.prevetmed.2005.10.003; Trauffler M, 2014, BERL MUNCH TIERARZTL, V127, P375, DOI 10.2376/0005-9366-127-375; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; van Rennings L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119114; WHO, 2011, WHO CRIT IMP ANT HUM	32	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182661	10.1371/journal.pone.0182661	http://dx.doi.org/10.1371/journal.pone.0182661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841685	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700009
J	Feng, F; Li, XL; Yao, YJ; Liu, M				Feng, Fei; Li, Xianglan; Yao, Yunjun; Liu, Meng			Long-term spatial distributions and trends of the latent heat fluxes over the global cropland ecosystem using multiple satellite-based models	PLOS ONE			English	Article							WATER-VAPOR; EDDY-COVARIANCE; SOLAR-RADIATION; CARBON-DIOXIDE; CLIMATE-CHANGE; EVAPOTRANSPIRATION; FLUXNET; MODIS; VARIABILITY; MAIZE	Estimating cropland latent heat flux (LE) from continental to global scales is vital to modeling crop production and managing water resources. Over the past several decades, numerous LE models were developed, such as the moderate resolution imaging spectroradiometer LE (MOD16) algorithm, revised remote sensing-based Penman-Monteith LE algorithm (RRS), the Priestley-Taylor LE algorithm of the Jet Propulsion Laboratory (PT-JPL) and the modified satellite-based Priestley-Taylor LE algorithm (MS-PT). However, these LE models have not been directly compared over the global cropland ecosystem using various algorithms. In this study, we evaluated the performances of these four LE models using 34 eddy covariance (EC) sites. The results showed that mean annual LE for cropland varied from 33.49 to 58.97 W/m(2) among the four models. The interannual LE slightly increased during 1982-2009 across the global cropland ecosystem. All models had acceptable performances with the coefficient of determination (R-2) ranging from 0.4 to 0.7 and a root mean squared error (RMSE) of approximately 35 W/m(2). MS-PT had good overall performance across the cropland ecosystem with the highest R-2, lowest RMSE and a relatively low bias. The reduced performances of MOD16 and RRS, with R-2 ranging from 0.4 to 0.6 and RMSEs from 30 to 39 W/m(2), might be attributed to empirical parameters in the structure algorithms and calibrated coefficients.	[Feng, Fei; Li, Xianglan] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Yao, Yunjun; Liu, Meng] Beijing Normal Univ, Sch Geog, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Liu, Meng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Liu, Meng] Univ Chinese Acad Sci, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, XL (corresponding author), Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.; Yao, YJ (corresponding author), Beijing Normal Univ, Sch Geog, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.	xlli@bnu.edu.cn; boyyunjun@163.com			High-Tech Research and Development Program of China [2013AA122801]; Natural Science Fund of China [41205104, 41201331]; National Basic Research Program of China [2012CB955302]; Fundamental Research Funds for the Central Universities [2012LYB38]; youth talent support program of College of Global Change and Earth System Science [312231103]; High Resolution Earth Observation Systems of National Science and Technology Major Projects [05-Y30B02-9001-13/15-9]	High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); youth talent support program of College of Global Change and Earth System Science; High Resolution Earth Observation Systems of National Science and Technology Major Projects	This work was partially supported by the High-Tech Research and Development Program of China (Grant 2013AA122801), the Natural Science Fund of China (Grants 41205104 and, 41201331), the National Basic Research Program of China (Grant 2012CB955302), the Fundamental Research Funds for the Central Universities (Grant 2012LYB38), the youth talent support program of College of Global Change and Earth System Science (312231103) and the High Resolution Earth Observation Systems of National Science and Technology Major Projects (Grant 05-Y30B02-9001-13/15-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, 56 FAO, P300; Allen RG, 2000, J HYDROL, V229, P27, DOI 10.1016/S0022-1694(99)00194-8; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Behrangi A, 2014, INT J REMOTE SENS, V35, P2170, DOI 10.1080/01431161.2014.889866; Burba GG, 2005, AGR FOREST METEOROL, V135, P190, DOI 10.1016/j.agrformet.2005.11.017; Byun K, 2014, AGR FOREST METEOROL, V197, P169, DOI 10.1016/j.agrformet.2014.07.001; Chen Y, 2014, REMOTE SENS ENVIRON, V140, P279, DOI 10.1016/j.rse.2013.08.045; Churkina G, 1999, GLOBAL CHANGE BIOL, V5, P46, DOI 10.1046/j.1365-2486.1999.00006.x; Cleugh HA, 2007, REMOTE SENS ENVIRON, V106, P285, DOI 10.1016/j.rse.2006.07.007; Ding RS, 2015, HYDROL PROCESS, V29, P239, DOI 10.1002/hyp.10146; Ding RS, 2013, AGR FOREST METEOROL, V168, P140, DOI 10.1016/j.agrformet.2012.08.003; Ershadi A, 2014, AGR FOREST METEOROL, V187, P46, DOI 10.1016/j.agrformet.2013.11.008; Feng F, 2015, REMOTE SENS-BASEL, V7, P16733, DOI 10.3390/rs71215853; Fisher JB, 2008, REMOTE SENS ENVIRON, V112, P901, DOI 10.1016/j.rse.2007.06.025; Fung I, 1997, NATURE, V386, P659, DOI 10.1038/386659a0; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Gordon LJ, 2005, P NATL ACAD SCI USA, V102, P7612, DOI 10.1073/pnas.0500208102; Guo Z., 2006, J GEOPHYS RES-ATMOS, V111, pD22, DOI DOI 10.1029/2006JD007845; Kennedy AD, 2011, J CLIMATE, V24, P4541, DOI 10.1175/2011JCLI3978.1; Kustas WP, 2004, REMOTE SENS ENVIRON, V92, P535, DOI 10.1016/j.rse.2004.02.020; Leuning R, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006562; Liu CS, 2013, PROC SPIE, V8869, DOI 10.1117/12.2021713; Liu YL, 2015, J GEOPHYS RES-ATMOS, V120, P2647, DOI 10.1002/2014JD022531; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; McCabe MF, 2006, REMOTE SENS ENVIRON, V105, P271, DOI 10.1016/j.rse.2006.07.006; Misson Monson RK, 2005, AGR FOR METEOROL, V131, P1; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; MYNENI RB, 1994, REMOTE SENS ENVIRON, V49, P200, DOI 10.1016/0034-4257(94)90016-7; Nemanill R., 1997, INCREASED PLANT GROW; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Pereira LS, 1999, J IRRIG DRAIN ENG, V125, P45, DOI 10.1061/(ASCE)0733-9437(1999)125:2(45); Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Pinker RT, 2005, SCIENCE, V308, P850, DOI 10.1126/science.1103159; Pipunic RC, 2008, REMOTE SENS ENVIRON, V112, P1295, DOI 10.1016/j.rse.2007.02.038; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Rawlins MA, 2006, EARTH INTERACT, V10; Riediger Jan, 2014, Environmental Sciences Europe, V26, DOI 10.1186/s12302-014-0018-1; Sacks WJ, 2011, AGR FOREST METEOROL, V151, P882, DOI 10.1016/j.agrformet.2011.02.010; Schreiber L, 2001, PLANTA, V214, P274, DOI 10.1007/s004250100615; Singh RK, 2016, WATER-SUI, V8, DOI 10.3390/w8010009; Steduto P, 1998, AGR FOREST METEOROL, V89, P215, DOI 10.1016/S0168-1923(97)00082-8; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Twine TE, 2000, AGR FOREST METEOROL, V103, P279, DOI 10.1016/S0168-1923(00)00123-4; Valipour M, 2015, ARCH AGRON SOIL SCI, V61, P239, DOI 10.1080/03650340.2014.925107; Vinukollu RK, 2011, REMOTE SENS ENVIRON, V115, P801, DOI 10.1016/j.rse.2010.11.006; Wang KC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008351; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Yang FL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100031, 10.1371/journal.pone.0076458]; Yao YJ, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4619-y; Yao YJ, 2014, REMOTE SENS-BASEL, V6, P880, DOI 10.3390/rs6010880; Yao YJ, 2014, J GEOPHYS RES-ATMOS, V119, P4521, DOI 10.1002/2013JD020864; Yao YJ, 2013, AGR FOREST METEOROL, V171, P187, DOI 10.1016/j.agrformet.2012.11.016; Yuan WP, 2010, REMOTE SENS ENVIRON, V114, P1416, DOI 10.1016/j.rse.2010.01.022; Zhang K, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008800; Zhang XY, 2011, AGR WATER MANAGE, V98, P1097, DOI 10.1016/j.agwat.2011.02.003; Zhao L, 2013, J GEOPHYS RES-ATMOS, V118, P9552, DOI 10.1002/jgrd.50697; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	57	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183771	10.1371/journal.pone.0183771	http://dx.doi.org/10.1371/journal.pone.0183771			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837704	Green Submitted, gold, Green Published			2022-12-26	WOS:000408365000118
J	Chi, XZ; Lee, JW; Lee, YS; Park, IY; Ito, Y; Bae, SC				Chi, X-Z; Lee, J-W; Lee, Y-S; Park, I. Y.; Ito, Y.; Bae, S-C			Runx3 plays a critical role in restriction-point and defense against cellular transformation	ONCOGENE			English	Article							K-RAS ONCOGENE; GENE-EXPRESSION; LUNG-CANCER; P53; FAMILY; PROLIFERATION; SUPPRESSION; ACTIVATION; INDUCTION; CYCLE	The restriction (R)-point decision is fundamental to normal differentiation and the G(1)-S transition, and the decision-making machinery is perturbed in nearly all cancer cells. The mechanisms underlying the cellular context-dependent R-point decision remain poorly understood. We found that the R-point was dysregulated in Runx3(-/-) mouse embryonic fibroblasts (MEFs), which formed tumors in nude mice. Ectopic expression of Runx3 restored the R-point and abolished the tumorigenicity of Runx3-/-MEFs and K-Ras-activated Runx3(-/-) MEFs (Runx3(-/-); K-Ras(G12D/+)). During the R-point, Runx3 transiently formed a complex with pRb and Brd2 and induced Cdkn1a (p21(Waf1/Cip1/Sdi1); p21), a key regulator of the R-point transition. Cyclin D-CDK4/6 promoted dissociation of the pRb-Runx3-Brd2 complex, thus turning off p21 expression. However, cells harboring oncogenic K-Ras maintained the pRb-Runx3-Brd2 complex and p21 expression even after introduction of Cyclin D1. Thus, Runx3 plays a critical role in R-point regulation and defense against cellular transformation.	[Chi, X-Z; Lee, J-W; Lee, Y-S; Bae, S-C] Chungbuk Natl Univ, Dept Biochem, Sch Med, Cheongju 361763, South Korea; [Chi, X-Z; Lee, J-W; Lee, Y-S; Bae, S-C] Chungbuk Natl Univ, Inst Tumor Res, Cheongju 361763, South Korea; [Park, I. Y.] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea; [Ito, Y.] Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med, Singapore, Singapore	Chungbuk National University; Chungbuk National University; Chungbuk National University; National University of Singapore	Bae, SC (corresponding author), Chungbuk Natl Univ, Dept Biochem, Sch Med, Cheongju 361763, South Korea.; Bae, SC (corresponding author), Chungbuk Natl Univ, Inst Tumor Res, Cheongju 361763, South Korea.	scbae@chungbuk.ac.kr			National Research Foundation (NRF) of Korea [2014R1A3A2030690]; Basic Science Research Program [2014R1A1A2007204]; NRF - Ministry of Education of Korea [2013R1A1A2057659]; Rural Development Administration, Republic of Korea [PJ01226101]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Basic Science Research Program; NRF - Ministry of Education of Korea; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	S-C Bae is supported by a Creative Research Grant (2014R1A3A2030690) through the National Research Foundation (NRF) of Korea. J-W Lee is supported by the Basic Science Research Program (2014R1A1A2007204) Y-S Lee is supported by Basic Science Research Program (2013R1A1A2057659) through the NRF funded by the Ministry of Education of Korea. IY Park was supported by "Cooperative Research Program for Agriculture Science and Technology Development (PJ01226101)" Rural Development Administration, Republic of Korea.	Balmain A, 2002, NATURE, V417, P235, DOI 10.1038/417235a; Berns A, 2010, NATURE, V468, P519, DOI 10.1038/468519a; Blagosklonny MV, 2002, CELL CYCLE, V1, P100, DOI 10.4161/cc.1.2.107; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drosten M, 2016, J MOL MED, V94, P121, DOI 10.1007/s00109-015-1360-5; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; HARPER JW, 1993, CELL, V75, P805; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lee KS, 2010, ONCOGENE, V29, P3349, DOI 10.1038/onc.2010.79; Lee YS, 2013, CANCER CELL, V24, P603, DOI 10.1016/j.ccr.2013.10.003; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martinsson HS, 2005, EXP CELL RES, V305, P383, DOI 10.1016/j.yexcr.2005.01.023; MICHIELI P, 1994, CANCER RES, V54, P3391; Muzumdar MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12685; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Odell A, 2010, AGING-US, V2, P160, DOI 10.18632/aging.100129; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Weinberg Reditor, 2007, BIOL CANC; Whittle MC, 2015, CELL, V161, P1345, DOI 10.1016/j.cell.2015.04.048; ZETTERBERG A, 1991, COLD SH Q B, V56, P137; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	43	14	14	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 14	2017	36	50					6884	6894		10.1038/onc.2017.290	http://dx.doi.org/10.1038/onc.2017.290			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FQ0JM	28846108	Green Published, hybrid			2022-12-26	WOS:000418041800005
J	Xiao, B; Goh, JY; Xiao, L; Xian, HX; Lim, KL; Liou, YC				Xiao, Bin; Goh, Jian-Yuan; Xiao, Lin; Xian, Hongxu; Lim, Kah-Leong; Liou, Yih-Cherng			Reactive oxygen species trigger Parkin/PINK1 pathway-dependent mitophagy by inducing mitochondrial recruitment of Parkin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGED MITOCHONDRIA; OXIDATIVE STRESS; PINK1; UBIQUITIN; DEGRADATION; MUTATIONS; AUTOPHAGY; TRANSLOCATION; DISEASE; YEAST	Defective mitophagy linked to dysfunction in the proteins Parkin and PTEN-induced putative kinase 1 (PINK1) is implicated in the pathogenesis of Parkinson's disease. Although the mechanism by which Parkin mediates mitophagy in a PINK1-dependent manner is becoming clearer, the triggers for this mitophagy pathway remain elusive. Reactive oxygen species (ROS) have been suggested as such triggers, but this proposal remains controversial because ROS scavengers fail to retard mitophagy. Here we demonstrate that the role of ROS in mitophagy has been underappreciated as a result of the inefficiency of ROS scavengers to control ROS bursts after high-dose treatment with carbonyl cyanide m-chlorophenylhydrazone. Supporting this, combinatorial treatment with N-acetyl-L-cysteine and catalase substantially inhibited the ROS upsurge and PINK1-dependent Parkin translocation to mitochondria in response to carbonyl cyanide m-chlorophenylhydrazone treatment. In addition to the chemical mitophagy inducer, overexpression of voltage-dependent anion channel 1 (VDAC1) induced Parkin translocation to mitochondria, presumably by stimulating ROS generation. Similarly, combined N-acetyl-L-cysteine and catalase treatment also suppressed VDAC1-induced redistribution of Parkin. Alongside these observations, we also found that the elevated protein level of PINK1 was not necessary for Parkin translocation to mitochondria. Thus, our data suggest that ROS may act as a trigger for the induction of Parkin/PINK1-dependent mitophagy. In addition, our study casts doubt on the importance of protein quantity of PINK1 in the recruitment of Parkin to mitochondria.	[Xiao, Bin; Xiao, Lin; Xian, Hongxu; Liou, Yih-Cherng] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Goh, Jian-Yuan; Liou, Yih-Cherng] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, 14 Sci Dr 4, Singapore 117543, Singapore; [Lim, Kah-Leong] Natl Neurosci Inst, Singapore 308433, Singapore; [Lim, Kah-Leong] Natl Univ Singapore, Dept Physiol, Block MD9,2 Med Dr, Singapore 117597, Singapore	National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI); National University of Singapore	Liou, YC (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Liou, YC (corresponding author), Natl Univ Singapore, Grad Sch Integrat Sci & Engn, 14 Sci Dr 4, Singapore 117543, Singapore.	dbslyc@nus.edu.sg	Lim, Kah/L-5426-2019; Lim, Kah-Leong/AAY-3308-2020	Xian, Hongxu/0000-0002-8610-2029; Xiao, Bin/0000-0003-2986-4980; Lim, Kah-Leong/0000-0002-5440-2588	Ministry of Education Tier 1 Grant [R-154-000-A15-114]; NMRC Singapore Grant [NMRC/CBRG/0067/2014]	Ministry of Education Tier 1 Grant; NMRC Singapore Grant(National Medical Research Council, Singapore)	This work was supported by Ministry of Education Tier 1 Grant R-154-000-A15-114) and NMRC Singapore Grant NMRC/CBRG/0067/2014 (to Y.-C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Berezhnov AV, 2016, J BIOL CHEM, V291, P8701, DOI 10.1074/jbc.M115.691774; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Grenier K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00100; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kanki T, 2010, AUTOPHAGY, V6, P278, DOI 10.4161/auto.6.2.10901; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; KIM JW, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018556; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee S, 2015, J BIOL CHEM, V290, P904, DOI 10.1074/jbc.M114.606798; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lynch-Day MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009357; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McWilliams TG, 2017, CURR OPIN CELL BIOL, V45, P83, DOI 10.1016/j.ceb.2017.03.013; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Padman BS, 2013, AUTOPHAGY, V9, P1862, DOI 10.4161/auto.26557; Pellegrino MW, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0129-1; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Whitworth AJ, 2017, CURR OPIN GENET DEV, V44, P47, DOI 10.1016/j.gde.2017.01.016; Xiao B, 2017, BBA-MOL CELL RES, V1864, P1308, DOI 10.1016/j.bbamcr.2017.04.009; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	50	129	133	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16697	16708		10.1074/jbc.M117.787739	http://dx.doi.org/10.1074/jbc.M117.787739			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28848050	hybrid, Green Published			2022-12-26	WOS:000412414800029
J	Zhang, N; Huang, HJ; Tan, BH; Wei, YL; Xiong, QQ; Yan, Y; Hou, LL; Wu, NN; Siwko, S; Cimarelli, A; Xu, JR; Han, HH; Qian, M; Liu, MY; Du, B				Zhang, Na; Huang, Hongjun; Tan, Binghe; Wei, Yinglei; Xiong, Qingqing; Yan, Yan; Hou, Lili; Wu, Nannan; Siwko, Stefan; Cimarelli, Andrea; Xu, Jianrong; Han, Honghui; Qian, Min; Liu, Mingyao; Du, Bing			Leucine-rich repeat-containing G protein-coupled receptor 4 facilitates vesicular stomatitis virus infection by binding vesicular stomatitis virus glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LDL-RECEPTOR; HOST-CELLS; ENTRY; LGR4; MICE; INHIBITION; BULLET; HIV-1	Vesicular stomatitis virus (VSV) and rabies and Chandipura viruses belong to the Rhabdovirus family. VSV is a common laboratory virus to study viral evolution and host immune responses to viral infection, and recombinant VSV-based vectors have been widely used for viral oncolysis, vaccination, and gene therapy. Although the tropism of VSV is broad, and its envelope glycoprotein G is often used for pseudotyping other viruses, the host cellular components involved in VSV infection remain unclear. Here, we demonstrate that the host protein leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is essential for VSV and VSV-G pseudotyped lentivirus (VSVG-LV) to infect susceptible cells. Accordingly, Lgr4-deficient mice had dramatically decreased VSV levels in the olfactory bulb. Furthermore, Lgr4 knockdown in RAW 264.7 cells also significantly suppressed VSV infection, and Lgr4 overexpression in RAW 264.7 cells enhanced VSV infection. Interestingly, only VSV infection relied on Lgr4, whereas infections with Newcastle disease virus, influenza A virus (A/WSN/33), and herpes simplex virus were unaffected by Lgr4 status. Of note, assays of virus entry, cell ELISA, immunoprecipitation, and surface plasmon resonance indicated that VSV bound susceptible cells via the Lgr4 extracellular domain. Pretreating cells with an Lgr4 antibody, soluble LGR4 extracellular domain, or R-spondin 1 blocked VSV infection by competitively inhibiting VSV binding to Lgr4. Taken together, the identification of Lgr4 as a VSV-specific host factor provides important insights into understanding VSV entry and its pathogenesis and lays the foundation for VSV-based gene therapy and viral oncolytic therapeutics.	[Zhang, Na; Huang, Hongjun; Tan, Binghe; Wei, Yinglei; Xiong, Qingqing; Yan, Yan; Hou, Lili; Wu, Nannan; Qian, Min; Liu, Mingyao; Du, Bing] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Zhang, Na; Huang, Hongjun; Tan, Binghe; Wei, Yinglei; Xiong, Qingqing; Yan, Yan; Hou, Lili; Wu, Nannan; Qian, Min; Liu, Mingyao; Du, Bing] East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Siwko, Stefan; Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, Inst Biosci & Technol, Houston, TX 77030 USA; [Cimarelli, Andrea] CIRI, F-69364 Lyon, France; [Cimarelli, Andrea] INSERM, U1111, 46 Allee Italie, F-69364 Lyon, France; [Cimarelli, Andrea] Ecole Normale Super Lyon, 46 Allee Italie, F-69364 Lyon, France; [Cimarelli, Andrea] CNRS, UMR5308, 46 Allee Italie, F-69364 Lyon, France; [Cimarelli, Andrea] Univ Lyon 1, UMS3444, BioSci Gerland US8, F-69364 Lyon, France; [Xu, Jianrong] Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol, Sch Med, Shanghai 200025, Peoples R China; [Han, Honghui] Shanghai Bioray Labs Inc, Shanghai 200241, Peoples R China	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Shanghai Jiao Tong University	Liu, MY; Du, B (corresponding author), East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.; Liu, MY; Du, B (corresponding author), East China Normal Univ, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	myliu@bio.ecnu.edu.cn; bdu.ecnu@gmail.com		CIMARELLI, Andrea/0000-0003-0892-0488; Sweat, Yan/0000-0002-9903-8054; Siwko, Stefan/0000-0003-4260-2985	National Natural Science Foundation of China [31000398, 31570896, 81672811, 31770969]; Joint Research Institute for Science and Society (JoRISS) Grant [14JORISS01]; Science and Technology Commission of Shanghai Municipality Grant [15JC1401500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Research Institute for Science and Society (JoRISS) Grant; Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China Grants 31000398, 31570896, 81672811, and 31770969, Joint Research Institute for Science and Society (JoRISS) Grant 14JORISS01, and Science and Technology Commission of Shanghai Municipality Grant 15JC1401500. The authors declare that they have no conflicts of interest with the contents of this article.	Albertini AAV, 2012, VIRUSES-BASEL, V4, P117, DOI 10.3390/v4010117; Amirache F, 2014, BLOOD, V123, P1422, DOI 10.1182/blood-2013-11-540641; Bloor S, 2010, P NATL ACAD SCI USA, V107, P6970, DOI 10.1073/pnas.0908536107; Breitbach CJ, 2011, MOL THER, V19, P886, DOI 10.1038/mt.2011.26; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen Y, 2007, AM J PHYSIOL-RENAL, V293, pF680, DOI 10.1152/ajprenal.00209.2007; Cheng H, 2015, J VIROL, V89, P9932, DOI 10.1128/JVI.01337-15; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Ge P, 2010, SCIENCE, V327, P689, DOI 10.1126/science.1181766; GILLIES S, 1980, VIROLOGY, V107, P497, DOI 10.1016/0042-6822(80)90316-5; Gong X, 2015, ONCOGENE, V34, P4692, DOI 10.1038/onc.2014.417; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Hu BL, 2011, IMMUNOL REV, V239, P45, DOI 10.1111/j.1600-065X.2010.00967.x; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Kubo T, 2011, J ORTHOP RES, V29, P795, DOI 10.1002/jor.21307; Liang F, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0486-1; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Luo J, 2016, NAT MED, V22, P539, DOI 10.1038/nm.4076; Luo WJ, 2013, STEM CELLS, V31, P2492, DOI 10.1002/stem.1484; Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; Muik A, 2011, J VIROL, V85, P5679, DOI 10.1128/JVI.02511-10; Obuchi M, 2003, J VIROL, V77, P8843, DOI 10.1128/JVI.77.16.8843-8856.2003; Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Song QX, 2014, ACS NANO, V8, P2345, DOI 10.1021/nn4058215; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; SUPERTI F, 1987, J GEN VIROL, V68, P387, DOI 10.1099/0022-1317-68-2-387; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Xu K, 2013, STRUCTURE, V21, P1683, DOI 10.1016/j.str.2013.07.001; Yi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078144; Yi Y, 2011, CURR GENE THER, V11, P218	41	14	14	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16527	16538		10.1074/jbc.M117.802090	http://dx.doi.org/10.1074/jbc.M117.802090			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842478	Green Published, hybrid			2022-12-26	WOS:000412414800015
J	Cook, JB; Hendrickson, LM; Garwood, GM; Toungate, KM; Nania, CV; Morikawa, H				Cook, Jason B.; Hendrickson, Linzy M.; Garwood, Grant M.; Toungate, Kelsey M.; Nania, Christina V.; Morikawa, Hitoshi			Junk food diet-induced obesity increases D2 receptor autoinhibition in the ventral tegmental area and reduces ethanol drinking	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; HIGH-FAT DIET; DOPAMINE NEURONS; GENERAL-POPULATION; MENTAL-DISORDERS; ANIMAL-MODEL; RATS; REWARD; CONSUMPTION; ALCOHOL	Similar to drugs of abuse, the hedonic value of food is mediated, at least in part, by the mesostriatal dopamine (DA) system. Prolonged intake of either high calorie diets or drugs of abuse both lead to a blunting of the DA system. Most studies have focused on DAergic alterations in the striatum, but little is known about the effects of high calorie diets on ventral tegmental area (VTA) DA neurons. Since high calorie diets produce addictive-like DAergic adaptations, it is possible these diets may increase addiction susceptibility. However, high calorie diets consistently reduce psychostimulant intake and conditioned place preference in rodents. In contrast, high calorie diets can increase or decrease ethanol drinking, but it is not known how a junk food diet (cafeteria diet) affects ethanol drinking. In the current study, we administered a cafeteria diet consisting of bacon, potato chips, cheesecake, cookies, breakfast cereals, marshmallows, and chocolate candies to male Wistar rats for 3-4 weeks, producing an obese phenotype. Prior cafeteria diet feeding reduced homecage ethanol drinking over 2 weeks of testing, and transiently reduced sucrose and chow intake. Importantly, cafeteria diet had no effect on ethanol metabolism rate or blood ethanol concentrations following 2g/kg ethanol administration. In midbrain slices, we showed that cafeteria diet feeding enhances DA D2 receptor (D2R) autoinhibition in VTA DA neurons. These results show that junk food diet-induced obesity reduces ethanol drinking, and suggest that increased D2R autoinhibition in the VTA may contribute to deficits in DAergic signaling and reward hypofunction observed with obesity.	[Cook, Jason B.; Hendrickson, Linzy M.; Nania, Christina V.; Morikawa, Hitoshi] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Cook, Jason B.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Hendrickson, Linzy M.; Garwood, Grant M.; Toungate, Kelsey M.; Morikawa, Hitoshi] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Cook, Jason B.] NIEHS, In Vivo Neurobiol Lab, Neurobiol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cook, JB (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.; Cook, JB (corresponding author), Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA.; Cook, JB (corresponding author), NIEHS, In Vivo Neurobiol Lab, Neurobiol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	jason.cook@nih.gov			University of Texas at Austin, Division of Pharmacology and Toxicology, College of Pharmacy [R01 AA015521, F32AA021640, T32-AA007471]; National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015521, T32AA007471] Funding Source: NIH RePORTER	University of Texas at Austin, Division of Pharmacology and Toxicology, College of Pharmacy; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by R01 AA015521 (HM), F32AA021640 (LMH), and T32-AA007471 (University of Texas at Austin, Division of Pharmacology and Toxicology, College of Pharmacy). These grants were or are funded by the National Institute on Alcohol Abuse and Alcoholism. https://www.niaaa.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Avena NA, 2004, ALCOHOL, V34, P203, DOI 10.1016/j.alcohol.2004.09.006; Barry D, 2009, ADDICT BEHAV, V34, P51, DOI 10.1016/j.addbeh.2008.08.008; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Blum K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00919; Blum K, 2011, CURR PHARM DESIGN, V17, P1158, DOI 10.2174/138161211795656819; Branch SY, 2013, J NEUROSCI, V33, P13861, DOI 10.1523/JNEUROSCI.5099-12.2013; Carrillo CA, 2004, ALCOHOL, V34, P197, DOI 10.1016/j.alcohol.2004.08.009; CARROLL ME, 1979, SCIENCE, V205, P319, DOI 10.1126/science.36665; Davis C, 2004, APPETITE, V42, P131, DOI 10.1016/j.appet.2003.07.004; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; Diana Marco, 2011, Front Psychiatry, V2, P64, DOI 10.3389/fpsyt.2011.00064; Fredriksson I, 2016, NEUROPSYCHOPHARMACOL; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gantz SC, 2015, ELIFE, V4, DOI 10.7554/eLife.09358.001; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Geiger BM, 2008, FASEB J, V22, P2740, DOI 10.1096/fj.08-110759; Heyne A, 2009, ADDICT BIOL, V14, P373, DOI 10.1111/j.1369-1600.2009.00175.x; Hirth N, 2016, P NATL ACAD SCI USA, V113, P3024, DOI 10.1073/pnas.1506012113; Hryhorczuk C, 2016, NEUROPSYCHOPHARMACOL, V41, P811, DOI 10.1038/npp.2015.207; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kanarek RB, 1996, PHARMACOL BIOCHEM BE, V54, P719, DOI 10.1016/0091-3057(96)00012-3; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koyama S, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12004; Labouebe G, 2013, NAT NEUROSCI, V16, P300, DOI 10.1038/nn.3321; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Middaugh LD, 1999, ALCOHOL, V17, P175, DOI 10.1016/S0741-8329(98)00055-X; Moore RJ, 1998, SYNAPSE, V30, P88, DOI 10.1002/(SICI)1098-2396(199809)30:1<88::AID-SYN11>3.0.CO;2-L; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; PEKKANEN L, 1978, BRIT J NUTR, V40, P103, DOI 10.1079/BJN19780100; Perra S, 2011, NEUROPSYCHOPHARMACOL, V36, P993, DOI 10.1038/npp.2010.237; Pickering RP, 2007, J CLIN PSYCHIAT, V68, P998, DOI 10.4088/JCP.v68n0704; PUCAK ML, 1994, J PHARMACOL EXP THER, V271, P1181; Rada P, 2010, PHYSIOL BEHAV, V101, P394, DOI 10.1016/j.physbeh.2010.07.005; Roberts AJ, 2000, NEUROPSYCHOPHARMACOL, V22, P581, DOI 10.1016/S0893-133X(99)00167-0; ROLLS BJ, 1980, J PHYSIOL-LONDON, V298, P415, DOI 10.1113/jphysiol.1980.sp013091; ROSSETTI ZL, 1992, EUR J PHARMACOL, V221, P227, DOI 10.1016/0014-2999(92)90706-A; Scott KM, 2008, INT J OBESITY, V32, P192, DOI 10.1038/sj.ijo.0803701; Scott KA, 2008, J PSYCHOSOM RES, V64, P97, DOI 10.1016/j.jpsychores.2007.09.006; Sharpe AL, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu073; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Takase K, 2016, OBESITY, V24, P886, DOI 10.1002/oby.21441; Vikraman Sundeep, 2015, NCHS Data Brief, P1; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Volkow ND, 1996, ALCOHOL CLIN EXP RES, V20, P1594, DOI 10.1111/j.1530-0277.1996.tb05936.x; Wang Gene-Jack, 2002, Expert Opin Ther Targets, V6, P601, DOI 10.1517/14728222.6.5.601; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834; Wellman PJ, 2007, PHARMACOL BIOCHEM BE, V88, P89, DOI 10.1016/j.pbb.2007.07.008; WHITE FJ, 1984, LIFE SCI, V34, P1161, DOI 10.1016/0024-3205(84)90088-2	54	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183685	10.1371/journal.pone.0183685	http://dx.doi.org/10.1371/journal.pone.0183685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859110	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500030
J	Tarmann, L; Wackernagel, W; Ivastinovic, D; Schneider, M; Winkler, P; Langmann, G				Tarmann, Lisa; Wackernagel, Werner; Ivastinovic, Domagoj; Schneider, Mona; Winkler, Peter; Langmann, Gerald			Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas	PLOS ONE			English	Article							CHOROIDAL MELANOMAS; LASER PHOTOCOAGULATION; RADIATION; RADIOTHERAPY; FAILURE; MM	Background To report on radiation-related side effects and complications after ruthenium-106 plaque brachytherapy of uveal melanomas. Methods Medical records of 143 eyes with uveal melanoma, treated by ruthenium-106 brachytherapy between 1997 and 2012 at a single center, were analyzed. We evaluated the occurrence of radiation-related side effects on the anterior and posterior segment of the eye. The influence of patient, tumor and treatment parameters on outcome was analyzed by multivariate time to event analysis considering competing risks. Results The median overall follow-up was 37.9 months. After treatment, the estimated risk at 12, 24 and 48 months for developing anterior segment complications was 25.3%, 37.5% and 50.3% for cataract formation and 5.4%, 6.4% and 8.1% for secondary glaucoma, respectively. The estimated risk for the occurrence of posterior segment complications 12, 24 and 48 months after treatment was 3.1%, 6.7% and 18.3% for radiation retinopathy, 18.3%, 27.1% and 42.6% for radiation maculopathy and 16.5%, 21.0% and 32.8% for radiation neuropathy, respectively. The risk of an increase in retinal detachment after treatment was 14.7%, 14.7% and 17.4% at 12, 24 and 48 months, respectively. The risk of vitreous hemorrhage occurring after treatment was 6.2%, 8.1% and 12.7%, and the risk of tumor vasculopathy was 15.4%, 17.4% and 19.0%. Scleral necrosis was observed in one patient. Conclusion Radiation-related side effects and complications are common among patients treated with ruthenium brachytherapy for uveal melanoma. However, the risk for those largely depends on individual tumor parameters. Before treatment, patients should be informed of their specific risks to develop various side effects. Patient information before treatment should cover not only general information about the treatment and possible complications and side effects but should also give details on the specific risks of the patient in her individual situation. This also includes elucidating the patient's individual resources and expectations and her willingness for long-term regular follow-up examinations and secondary adjunct treatments.	[Tarmann, Lisa; Wackernagel, Werner; Ivastinovic, Domagoj; Schneider, Mona; Langmann, Gerald] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Winkler, Peter] Med Univ Graz, Dept Therapeut Radiol & Oncol, Graz, Austria	Medical University of Graz; Medical University of Graz	Wackernagel, W (corresponding author), Med Univ Graz, Dept Ophthalmol, Graz, Austria.	werner.wackernagel@medunigraz.at						ARCHER D B, 1991, Eye (London), V5, P239; Browne AW, 2015, BRACHYTHERAPY, V14, P718, DOI 10.1016/j.brachy.2015.04.010; Chang MY, 2013, BRIT J OPHTHALMOL, V97, P804, DOI 10.1136/bjophthalmol-2012-302490; Finger PT, 2005, BRIT J OPHTHALMOL, V89, P730, DOI 10.1136/bjo.2004.052159; Kaiserman N, 2009, BRIT J OPHTHALMOL, V93, P1167, DOI 10.1136/bjo.2009.157701; Kivela T, 2013, EYE, V27, P243, DOI 10.1038/eye.2012.256; LOMMATZSCH PK, 1994, GRAEF ARCH CLIN EXP, V232, P482, DOI 10.1007/BF00195358; Materin MA, 2012, RETINA-J RET VIT DIS, V32, P1601, DOI 10.1097/IAE.0b013e3182437e70; Naseripour M, 2016, J CONTEMP BRACHYTHER, V8, P66, DOI 10.5114/jcb.2016.57818; Rouberol F, 2004, AM J OPHTHALMOL, V137, P893, DOI 10.1016/j.ajo.2003.12.032; Salkola S, 2014, RETINA-J RET VIT DIS, V34, P2110, DOI 10.1097/IAE.0000000000000202; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Summanen P, 1996, BRIT J OPHTHALMOL, V80, P732, DOI 10.1136/bjo.80.8.732; Tarmann L, 2015, BRIT J OPHTHALMOLOGY; Wilkinson DA, 2008, BRIT J RADIOL, V81, P784, DOI 10.1259/bjr/76813976	15	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183833	10.1371/journal.pone.0183833	http://dx.doi.org/10.1371/journal.pone.0183833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859118	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500038
J	Adane, M; Mengistie, B; Kloos, H; Medhin, G; Mulat, W				Adane, Metadel; Mengistie, Bezatu; Kloos, Helmut; Medhin, Girmay; Mulat, Worku			Sanitation facilities, hygienic conditions, and prevalence of acute diarrhea among under-five children in slums of Addis Ababa, Ethiopia: Baseline survey of a longitudinal study	PLOS ONE			English	Article							SHARED SANITATION; ENVIRONMENTAL-FACTORS; INFORMAL SETTLEMENTS; HEALTH; MORTALITY; LATRINE; WATER; ENTEROPATHY; BANGLADESH; COUNTRIES	Background In developing countries, children under the age of five years who live in slums are highly vulnerable to diarrhea. However, there is a paucity of information on the relationship between sanitation facilities and hygienic conditions to acute diarrhea among under-five children in slum areas of Addis Ababa, Ethiopia. Therefore, this study examines the sanitation facilities and hygienic conditions in the slums of Addis Ababa and identifies the main factors significantly associated with acute diarrhea among children aged 0-50 months in those slums. Methods A community-based cross-sectional household survey was carried out between September and November 2014, that then served as the baseline survey of a longitudinal study. For this survey, 697 children aged 0-50 months were recruited from two slum districts in Addis Ababa. A pre-tested structured questionnaire and an observational checklist were used for data collection. Multivariable logistic regression analysis was used to identify sanitation facilities and hygiene-related factors that were significantly associated with acute diarrhea by controlling potential confounding effects of selected socio-demographic factors. Adjusted odds ratio (AOR) with corresponding 95% confidence interval (CI) was used to quantify the strength of association. Main findings The prevalence of acute diarrhea among children aged 0-50 months in the study area was 11.9% and 94.6% of the sanitation facilities were unimproved. Sharing of a sanitation facility by six or more households (AOR = 4.7; 95% CI: 2.4-9.4), proximity of sanitation facilities within 15 meters of homes (AOR = 6.6; 95% CI: 2.5-17.0), presence of feces (AOR = 3.9; 95% CI: 1.5-10.3) and flies (AOR = 2.5; 95% CI: 1.3-5.0) on the floor of and/or around sanitation facilities, and presence of uncollected garbage inside house compounds (AOR = 3.2; 95% CI: 1.2-8.4) were significantly associated with acute diarrhea. Conclusion This study reveals the slum environment to be high risk for diarrhea due to close proximity of sanitation facilities to homes, sharing of sanitation facilities, and poor hygiene of the sanitation facilities and housing compounds. We recommend the development of a comprehensive diarrheal disease prevention program that focuses on improving the cleanliness of the sanitation facilities and housing compounds. Increasing the number of improved sanitation facilities at an appropriate distance from houses is also essential in order to reduce the number of households that share one latrine.	[Adane, Metadel] Univ Addis Ababa, EIWR, Addis Ababa, Ethiopia; [Mengistie, Bezatu] Haramaya Univ, Coll Hlth & Med Sci, Haramaya, Ethiopia; [Kloos, Helmut] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Medhin, Girmay] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Mulat, Worku] Univ Connecticut, Dept Civil & Environm Engn, Storrs, CT USA	Addis Ababa University; Haramaya University; University of California System; University of California San Francisco; Addis Ababa University; University of Connecticut	Adane, M (corresponding author), Univ Addis Ababa, EIWR, Addis Ababa, Ethiopia.	metadel.adane2@gmail.com	Adane, Metadel/AFQ-9478-2022	Adane, Metadel/0000-0002-7039-4768; Medhin, Girmay/0000-0003-2146-4261	Ethiopian Institute of Water Resources of Addis Ababa University	Ethiopian Institute of Water Resources of Addis Ababa University	Ethiopian Institute of Water Resources of Addis Ababa University funded this research project. The funders had no role in study design, data collection and analysis, decisions to publish, interpretation of the data and preparation of the manuscript for publication.	Adane M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181516; Adane M, 2017, J HEALTH POPUL NUTR, V36, P1, DOI 10.1186/s41043-017-0085-1; Alam MZ, 2013, AM ACAD SCHOLARLY RE, V1, P1; Alemayehu Elias Yitbarek, 2008, THESIS; [Anonymous], 2013, MILL DEV GOALS REP 2; [Anonymous], 2008, PROGR DRINK WAT SAN; Azage M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144690; Azage M, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0090-z; Baker KK, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002010; Bartlett S, 2003, ENVIRON URBAN, V15, P57, DOI 10.1177/095624780301500220; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Berhe F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-187; Beyene A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1804-4; Boadi K.O., 2005, J HLTH POPULAT DEV C, V7, P15; Borah H, 2014, IND J SCI RES TECH, V2, P16; Carlton EJ, 2014, AM J EPIDEMIOL, V179, P344, DOI 10.1093/aje/kwt279; Central Statistical Agency, 2013, POP PROJ ETH REG WER; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency [Ethiopia] ICF, 2016, ETH DEM HLTH SURV 20; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Choyon K., 2012, CURR RES J SOC SCI, V4, P304; Collinet-Adler S, 2015, APPL ENVIRON MICROB, V81, P6053, DOI 10.1128/AEM.01236-15; Corbett JJ, 2015, J METHANE EMISSIONS, P1, DOI DOI 10.1155/2015/; de Melo MCN, 2008, BRAZ J INFECT DIS, V12, P89, DOI 10.1590/S1413-86702008000100019; Escamilla V, 2013, ANN ASSOC AM GEOGR, V103, P299, DOI 10.1080/00045608.2013.756257; Ezeh A, 2017, LANCET, V389, P547, DOI 10.1016/S0140-6736(16)31650-6; Fadel ME, 2014, ENVIRON MONIT ASSESS, V186, P665, DOI DOI 10.1007/S10661-013-3406-X; Federal Democratic Republic of Ethiopia, 2011, WAT SUPPL SAN HYG WA; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR; Ferdous F, 2013, AM J TROP MED HYG, V89, P223, DOI 10.4269/ajtmh.12-0743; Fetene N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156438; Fotso JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-218; Fotso Jean-Christophe, 2006, Int J Equity Health, V5, P9, DOI 10.1186/1475-9276-5-9; Fuller JA, 2014, AM J TROP MED HYG, V91, P173, DOI 10.4269/ajtmh.13-0503; Garenne M, 2010, ARCH DIS CHILD, V95, P464, DOI 10.1136/adc.2009.172585; Gebru T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-395; Gilmartin AA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0143; Gould WTS, 1998, HEALTH PLACE, V4, P171, DOI 10.1016/S1353-8292(98)00009-4; Guerrant RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158772; Heijnen M, 2014, TROP MED INT HEALTH, V19, P1334, DOI 10.1111/tmi.12375; Heijnen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093300; Hosmer JD, 2013, APPL LOGISTIC REGRES; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Irish S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067951; Kalakheti B, 2017, J LUMBINI MED COLL, V4, P94; Kelsey JL., 1996, METHODS OBSERVATIONA; Keusch GT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P371; Kimani-Murage EW, 2007, J URBAN HEALTH, V84, P829, DOI 10.1007/s11524-007-9199-x; Kirkwood BR, 2003, ESSENTIAL MED STAT; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Kwiringira J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3036-7; Leon DA, 2008, INT J EPIDEMIOL, V37, P4, DOI 10.1093/ije/dym271; Lindo S, 2012, WORLD GASTROENTEROLO, P1; McNamee R, 2003, OCCUP ENVIRON MED, V60, P227, DOI 10.1136/oem.60.3.227; Ministry of Urban Development and Housing of Ethiopia, 2015, STRAT SCAL SAF NET R; Mukabutera A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3435-9; Mutisya M, 2010, TROP MED INT HEALTH, V15, P132, DOI 10.1111/j.1365-3156.2009.02419.x; Nakagiri A, 2015, HABITAT INT, V49, P529, DOI 10.1016/j.habitatint.2015.07.005; Nelson KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103886; Nirgude S, 2014, INDIAN J APPL RES, V4, P11; Owolabi AA, 2012, AFR J MICROBIOL RES, V6, P3465, DOI 10.5897/AJMR11.1535; Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2; Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7; Semba RD, 2011, AM J TROP MED HYG, V84, P443, DOI 10.4269/ajtmh.2011.10-0244; Simiyu S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-4009-6; Spears D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073784; Strina A, 2003, AM J EPIDEMIOL, V157, P1032, DOI 10.1093/aje/kwg075; Sudipta Basa, 2015, Asian Journal of Biomedical and Pharmaceutical Sciences, V5, P8, DOI 10.15272/ajbps.v5i45.701; Tessema RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175233; Tumwebaze IK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1260; UN, 2019, IMPROVING SUSTAINABL; UN HABITAT, 2008, ETH ADD AB URB PROF; UN-Habitat , 2010, ETH CAS COND HOUS IN; Unger A, 2013, ARCH DIS CHILD, V98, P799, DOI 10.1136/archdischild-2011-301621; UNICEF, 2012, STAT WORLDS CHILDR 2; United Nations Human Settlements Programme (UN -Habitat), 2003, CHALL SLUMS GLOB REP; Uwizeye D, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-745; Vedachalam S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176272; Vedachalam S, 2015, ENVIRON URBAN, V27, P117, DOI 10.1177/0956247814560978; World Health Organization, 2005, TREATM DIARRH MAN PH; Worldwatch-Institue, 2007, OUR URB FUT, V24th edn ed.	82	48	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182783	10.1371/journal.pone.0182783	http://dx.doi.org/10.1371/journal.pone.0182783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF1XX	28854200	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600017
J	Hui, SYA; Sahota, DS; Lao, TT				Hui, Shuk Yi Annie; Sahota, Daljit S.; Lao, Terence T.			Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger	PLOS ONE			English	Article							PREGNANT-WOMEN; CHILDBEARING AGE; IMMUNE-RESPONSE; MMR VACCINATION; ANTIBODY-LEVELS; MEASLES; SUSCEPTIBILITY; IMMUNIZATION; SEROPREVALENCE; ELIMINATION	Objective This study compared the incidence of rubella seronegativity among gravidae of 25 year-old and younger, between those born in Hong Kong after 1983 when the two-dose rubella vaccination was implemented, versus gravidae born before, to examine the impact of the two-dose regimen. Methods In this retrospective cohort study, the incidence of antenatal rubella seronegativity in our parturients managed in1997-2015 was analysed by their age from <= 16 to 25 years, and the effect of year of birth was determined adjusting for confounding factors including teenage status, obstetric history, anthropometric factors, and health parameters including anaemia, thalassaemia trait and hepatitis B carrier status. Results Among the 12743 gravidae, the 6103 gravidae born after 1983 had overall higher rubella seronegativity (9.1% versus 4.4%, OR 2.061, 95% CI 1.797-2.364), with significant difference (p = 0.006) and inverse correlation (p<0.001) with age, in contrast to the 6640 gravidae born in/before 1983 whom there was significant difference (p = 0.027) but a positive correlation (p = 0.008) with age. For each year of age, the former had significantly higher incidence of rubella seronegativity except for those of <= 16 years. Regression analysis confirmed that birth after 1983 was independently associated with rubella seronegativity (aOR 2.207, 95% CI 1.902-2.562). Conclusion There was a significant trend between rubella seronegativity with age in young gravidae, but the pattern was opposite between gravidae born after versus in/before 1983, with the former having a higher incidence of seronegativity at all ages. Young women covered by the two-dose rubella immunisation programme have a paradoxically higher incidence of rubella seronegativity.	[Hui, Shuk Yi Annie; Sahota, Daljit S.; Lao, Terence T.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Sahota, Daljit S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, 1E, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Hui, SYA (corresponding author), Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	anniehui@cuhk.edu.hk	Hui, Shuk Yi Annie/H-6323-2019	Hui, Shuk Yi Annie/0000-0001-5042-4731; Sahota, Daljit/0000-0002-3755-2701				Bouthry E, 2016, J CLIN MICROBIOL, V54, P1720, DOI 10.1128/JCM.00383-16; Byrne L, 2012, VACCINE, V30, P161, DOI 10.1016/j.vaccine.2011.11.045; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Centre for Health Protection, CTR HLTH PROT; Chuang SK, 2002, B WORLD HEALTH ORGAN, V80, P585; Davidkin I, 2008, J INFECT DIS, V197, P950, DOI 10.1086/528993; Davidkin I, 2010, EXPERT REV VACCINES, V9, P1045, DOI [10.1586/erv.10.99, 10.1586/ERV.10.99]; *DEP HLTH HONG KON, 1995, PUBLIC HLTH EPIDEMIO, V4, P17; Fan D. S. P., 2005, Hong Kong Medical Journal, V11, P85; Francis BH, 2003, AM J PUBLIC HEALTH, V93, P1274, DOI 10.2105/AJPH.93.8.1274; Huerta M, 2004, PREV MED, V39, P1223, DOI 10.1016/j.ypmed.2004.04.036; Hyde TB, 2006, CLIN INFECT DIS, V43, pS146, DOI 10.1086/505947; Isa Y, 2014, BR J APPL SCI TECHNO, V4, P1230; Kakoulidou M, 2010, VACCINE, V28, P1002, DOI 10.1016/j.vaccine.2009.10.130; Kontio M, 2012, J INFECT DIS, V206, P1542, DOI 10.1093/infdis/jis568; Lam T, 2011, PUBLIC HLTH EPIDEMIO, V20, P31; Lao TTH, 2010, J VIRAL HEPATITIS, V17, P737, DOI 10.1111/j.1365-2893.2009.01236.x; Lao TT, 2015, VACCINE, V33, P4776, DOI 10.1016/j.vaccine.2015.07.105; Leung TY, 2012, BEST PRACT RES CL OB, V26, P37, DOI 10.1016/j.bpobgyn.2011.10.009; Levine H, 2012, VACCINE, V30, P7260, DOI 10.1016/j.vaccine.2012.09.075; Lin CC, 2011, BJOG-INT J OBSTET GY, V118, P706, DOI 10.1111/j.1471-0528.2011.02903.x; Matthews LA, 2011, EPIDEMIOL INFECT, V139, P1720, DOI 10.1017/S0950268810002748; Mazari L, 1998, MECH AGEING DEV, V104, P25, DOI 10.1016/S0047-6374(98)00047-5; MILLER E, 1987, BRIT MED J, V294, P737, DOI 10.1136/bmj.294.6574.737; O'Dwyer V, 2013, IR MED J; Plans P, 2015, EUR J CLIN MICROBIOL, V34, P1161, DOI 10.1007/s10096-015-2339-4; POLAND GA, 1994, ARCH INTERN MED, V154, P1815, DOI 10.1001/archinte.154.16.1815; Poland GA, 2012, VACCINE, V30, P103, DOI 10.1016/j.vaccine.2011.11.085; ROBERTST.IC, 1974, LANCET, V2, P368; Sathanandan D, 2005, AUST NZ J OBSTET GYN, V45, P435, DOI 10.1111/j.1479-828X.2005.00467.x; Skidmore S, 2014, EPIDEMIOL INFECT, V142, P1114, DOI 10.1017/S0950268813002045; Tookey PA, 2002, J PUBLIC HEALTH MED, V24, P211, DOI 10.1093/pubmed/24.3.211; Tsang T., 2006, DHSEBCD107; Van der Wielen M, 2006, VACCINE, V24, P5509, DOI 10.1016/j.vaccine.2006.04.016; Wang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091160; Wysokinska T, 2004, VACCINE, V22, P1899, DOI 10.1016/j.vaccine.2003.11.004	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183630	10.1371/journal.pone.0183630	http://dx.doi.org/10.1371/journal.pone.0183630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854204	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600050
J	Putz, I; Brock, O				Putz, Ines; Brock, Oliver			Elastic network model of learned maintained contacts to predict protein motion	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PRINCIPAL COMPONENT ANALYSIS; STRUCTURAL CLASSIFICATION; BIOMOLECULAR SIMULATION; CONFORMATIONAL-CHANGES; NATIVE ENSEMBLES; SINGLE-PARAMETER; DOMAIN MOTIONS; FLUCTUATIONS; FLEXIBILITY	We present a novel elastic network model, lmcENM, to determine protein motion even for localized functional motions that involve substantial changes in the protein's contact topology. Existing elastic network models assume that the contact topology remains unchanged throughout the motion and are thus most appropriate to simulate highly collective function-related movements. lmcENM uses machine learning to differentiate breaking from maintained contacts. We show that lmcENM accurately captures functional transitions unexplained by the classical ENM and three reference ENM variants, while preserving the simplicity of classical ENM. We demonstrate the effectiveness of our approach on a large set of proteins covering different motion types. Our results suggest that accurately predicting a "deformation-invariant" contact topology offers a promising route to increase the general applicability of ENMs. We also find that to correctly predict this contact topology a combination of several features seems to be relevant which may vary slightly depending on the protein. Additionally, we present case studies of two biologically interesting systems, Ferric Citrate membrane transporter FecA and Arachidonate 15-Lipoxygenase.	[Putz, Ines; Brock, Oliver] Tech Univ Berlin, Robot & Biol Lab, Dept Comp Sci & Elect Engn, Berlin, Germany	Technical University of Berlin	Brock, O (corresponding author), Tech Univ Berlin, Robot & Biol Lab, Dept Comp Sci & Elect Engn, Berlin, Germany.	oliver.brock@tu-berlin.de			Alexander von Humboldt Foundation; German Federal Ministry of Education and Research	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Alexander von Humboldt Foundation through an Alexander von Humboldt professorship awarded to Prof. Oliver Brock, http://www.humboldt-foundation.de/web/start.html (funded by the German Federal Ministry of Education and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2006, PROTEINS, V63, P1038, DOI 10.1002/prot.20907; Ahmed A, 2010, PROTEINS, V78, P3341, DOI 10.1002/prot.22841; Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; Amemiya T, 2011, J MOL BIOL, V408, P568, DOI 10.1016/j.jmb.2011.02.058; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Batson B., 2009, MILL SCAL MOL DYN SI, P1, DOI [10.1145/1654059.1654099, DOI 10.1145/1654059.1654099]; Best RB, 2006, P NATL ACAD SCI USA, V103, P10901, DOI 10.1073/pnas.0511156103; Bruce A., 2002, MOL BIOL CELL, V4th ed.; BRUSCHWEILER R, 1995, J CHEM PHYS, V102, P3396, DOI 10.1063/1.469213; Brylinski M, 2008, PROTEINS, V70, P363, DOI 10.1002/prot.21510; Buch I, 2010, J CHEM INF MODEL, V50, P397, DOI 10.1021/ci900455r; Burra PV, 2009, P NATL ACAD SCI USA, V106, P10505, DOI 10.1073/pnas.0812152106; Carnevale V, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/285206; Cavasotto CN, 2012, METHODS MOL BIOL, V819, P157, DOI 10.1007/978-1-61779-465-0_11; Cavasotto CN, 2005, J AM CHEM SOC, V127, P9632, DOI 10.1021/ja042260c; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Das A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003521; Dietzen M, 2012, J CHEM INF MODEL, V52, P844, DOI 10.1021/ci2004847; Dony N, 2013, INT J MOL SCI, V14, P11510, DOI 10.3390/ijms140611510; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; Eickholt J, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-38; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Frappier V, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003569; Fugebakk E, 2013, J CHEM THEORY COMPUT, V9, P5618, DOI 10.1021/ct400399x; Fuglebakk E, 2015, BBA-GEN SUBJECTS, V1850, P911, DOI 10.1016/j.bbagen.2014.09.021; Fuglebakk E, 2012, BIOINFORMATICS, V28, P2431, DOI 10.1093/bioinformatics/bts445; Geng Li, 2012, Statistical Analysis and Data Mining, V5, P265, DOI 10.1002/sam.11153; Globisch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060582; Gniewek P, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4710986; Gorska A, 2014, TRENDS PHARMACOL SCI, V35, P442, DOI 10.1016/j.tips.2014.06.007; Gur M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816375; Gur M, 2013, BIOPHYS J, V105, P1643, DOI 10.1016/j.bpj.2013.07.058; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hensen U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033931; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hinsen K, 2000, CHEM PHYS, V261, P25, DOI 10.1016/S0301-0104(00)00222-6; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Jamroz M, 2012, PROTEINS, V80, P1425, DOI 10.1002/prot.24040; Jeong JI, 2006, J MOL GRAPH MODEL, V24, P296, DOI 10.1016/j.jmgm.2005.09.006; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kim MH, 2015, J STRUCT BIOL, V190, P338, DOI 10.1016/j.jsb.2015.04.007; Kim MH, 2013, PROTEIN SCI, V22, P605, DOI 10.1002/pro.2244; Kirillova S, 2008, PROTEINS, V70, P131, DOI 10.1002/prot.21570; Kondrashov DA, 2007, STRUCTURE, V15, P169, DOI 10.1016/j.str.2006.12.006; Kondrashov DA, 2006, BIOPHYS J, V91, P2760, DOI 10.1529/biophysj.106.085894; Kovacs JA, 2004, PROTEINS, V56, P661, DOI 10.1002/prot.20151; Krebs WG, 2002, PROTEINS, V48, P682, DOI 10.1002/prot.10168; Kutzner C, 2015, J COMPUT CHEM, V36, P1990, DOI 10.1002/jcc.24030; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Leioatts N, 2012, J CHEM THEORY COMPUT, V8, P2424, DOI 10.1021/ct3000316; Lezon TR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000816; Li YQ, 2011, BIOINFORMATICS, V27, P3379, DOI 10.1093/bioinformatics/btr579; Lin TL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S3; Liu Y, 2012, MOL BIOL EVOL, V29, P2253, DOI 10.1093/molbev/mss097; Loapez-Blanco JR, 2014, NORMAL MODE ANAL TEC; Lovasz L, 2007, EIGENVALUES GRAPHS; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Marques O, 1995, PROTEINS, V23, P557, DOI 10.1002/prot.340230410; Marsh JA, 2014, BIOESSAYS, V36, P209, DOI 10.1002/bies.201300134; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Micheletti C, 2004, PROTEINS, V55, P635, DOI 10.1002/prot.20049; Micheletti C, 2013, PHYS LIFE REV, V10, P1, DOI 10.1016/j.plrev.2012.10.009; Monzon AM, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw038; Miller RJD, 2014, SCIENCE, V343, P1108, DOI 10.1126/science.1248488; Moritsugu K, 2007, BIOPHYS J, V93, P3460, DOI 10.1529/biophysj.107.111898; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ohmura I, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0387; Orellana L, 2010, J CHEM THEORY COMPUT, V6, P2910, DOI 10.1021/ct100208e; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petrone P, 2006, BIOPHYS J, V90, P1583, DOI 10.1529/biophysj.105.070045; Piggot TJ, 2013, BBA-BIOMEMBRANES, V1828, P284, DOI 10.1016/j.bbamem.2012.08.021; Lopez-Blanco JR, 2016, CURR OPIN STRUC BIOL, V37, P46, DOI 10.1016/j.sbi.2015.11.013; Rueda M, 2007, STRUCTURE, V15, P565, DOI 10.1016/j.str.2007.03.013; Schneider M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108438; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Shaw DE, 2014, INT CONF HIGH PERFOR, P41, DOI 10.1109/SC.2014.9; Song G, 2006, PROTEINS, V63, P197, DOI 10.1002/prot.20836; Srivastava A, 2012, PROTEINS, V80, P2692, DOI 10.1002/prot.24153; Stanley N, 2015, SILICO PHARM; Stein A, 2011, STRUCTURE, V19, P881, DOI 10.1016/j.str.2011.03.009; Stember JN, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3167410; Tama F, 2000, PROTEINS, V41, P1; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Wang GF, 2014, ANAL BIOANAL CHEM, V406, P2279, DOI 10.1007/s00216-013-7518-5; Wu TF, 2004, J MACH LEARN RES, V5, P975; Yang LW, 2009, BIOINFORMATICS, V25, P606, DOI 10.1093/bioinformatics/btp023; Yang L, 2008, STRUCTURE, V16, P321, DOI 10.1016/j.str.2007.12.011; Yang L, 2007, BIOPHYS J, V93, P920, DOI 10.1529/biophysj.106.095927; Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106; Yue WW, 2003, J MOL BIOL, V332, P353, DOI 10.1016/S0022-2836(03)00855-6	103	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183889	10.1371/journal.pone.0183889	http://dx.doi.org/10.1371/journal.pone.0183889			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854238	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600065
J	Costa, AG; Ramasawmy, R; Ibiapina, HNS; Sampaio, VS; Xabregas, LA; Brasil, LW; Tarrago, AM; Almeida, ACG; Kuehn, A; Vitor-Silva, S; Melo, GC; Siqueira, AM; Monteiro, WM; Lacerda, MVG; Malheiro, A				Costa, Allyson Guimaraes; Ramasawmy, Rajendranath; Santos Ibiapina, Hiochelson Najibe; Sampaio, Vanderson Souza; Xabregas, Lilyane Amorim; Brasil, Larissa Wanderley; Tarrago, Andrea Monteiro; Gomes Almeida, Anne Cristine; Kuehn, Andrea; Vitor-Silva, Sheila; Melo, Gisely Cardoso; Siqueira, Andre Machado; Monteiro, Wuelton Marcelo; Guimaraes Lacerda, Marcus Vinicius; Malheiro, Adriana			Association of TLR variants with susceptibility to Plasmodium vivax malaria and parasitemia in the Amazon region of Brazil	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MEROZOITE SURFACE PROTEIN-1; FALCIPARUM-MALARIA; CLINICAL-OUTCOMES; NIGERIAN CHILDREN; IMMUNE-RESPONSE; DENDRITIC CELLS; POLYMORPHISMS; RECOGNITION; GENE	Background Plasmodium vivax malaria (Pv-malaria) is still considered a neglected disease despite an alarming number of individuals being infected annually. Malaria pathogenesis occurs with the onset of the vector-parasite-host interaction through the binding of pathogen-associated molecular patterns (PAMPs) and receptors of innate immunity, such as toll-like receptors (TLRs). The triggering of the signaling cascade produces an elevated inflammatory response. Genetic polymorphisms in TLRs are involved in susceptibility or resistance to infection, and the identification of genes involved with Pv-malaria response is important to elucidate the pathogenesis of the disease and may contribute to the formulation of control and elimination tools. Methodology/Principal findings A retrospective case-control study was conducted in an intense transmission area of Pvmalaria in the state of Amazonas, Brazil. Genetic polymorphisms (SNPs) in different TLRs, TIRAP, and CD14 were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis in 325 patients infected with P. vivax and 274 healthy individuals without malaria history in the prior 12 months from the same endemic area. Parasite load was determined by qPCR. Simple and multiple logistic/linear regressions were performed to investigate association between the polymorphisms and the occurrence of Pvmalaria and parasitemia. The C/T (TLR5 R392StopCodon) and T/T (TLR9 - 1486C/T) genotypes appear to be risk factors for infection by P. vivax (TLR5: C/C vs. C/T [ OR: 2.116, 95% CI: 1.054 - 4.452, p = 0.031]; TLR9: C/C vs. T/T [ OR: 1.919, 95% CI: 1.159 - 3.177, p = 0.010]; respectively). Fever (COEF = 7599.46, 95% CI = 3063.80 - 12135.12, p = 0.001) and the C/C genotype of TLR9 - 1237C/T (COEF = 17006.63, 95% CI = 3472.83 - 30540.44, p = 0.014) were independently associated with increased parasitemia in patients with Pv-malaria. Conclusions Variants of TLRs may predispose individuals to infection by P. vivax. The TLR5 R392StopCodon and TLR9 - 1486C/T variants are associated with susceptibility to Pv-malaria. Furthermore, the TLR9 variant - 1237C/C correlates with high parasitemia.	[Costa, Allyson Guimaraes; Ramasawmy, Rajendranath; Santos Ibiapina, Hiochelson Najibe; Sampaio, Vanderson Souza; Brasil, Larissa Wanderley; Gomes Almeida, Anne Cristine; Melo, Gisely Cardoso; Siqueira, Andre Machado; Monteiro, Wuelton Marcelo; Guimaraes Lacerda, Marcus Vinicius; Malheiro, Adriana] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil; [Costa, Allyson Guimaraes; Ramasawmy, Rajendranath; Santos Ibiapina, Hiochelson Najibe; Sampaio, Vanderson Souza; Xabregas, Lilyane Amorim; Brasil, Larissa Wanderley; Gomes Almeida, Anne Cristine; Kuehn, Andrea; Vitor-Silva, Sheila; Melo, Gisely Cardoso; Monteiro, Wuelton Marcelo; Guimaraes Lacerda, Marcus Vinicius] Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Diretoria Ensino & Pesquisa, Manaus, Amazonas, Brazil; [Costa, Allyson Guimaraes; Tarrago, Andrea Monteiro; Malheiro, Adriana] Fundacao Hosp Hematol & Hemoterapia Amazonas HEMO, Lab Genom, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath; Tarrago, Andrea Monteiro; Malheiro, Adriana] Univ Fed Amazonas UFAM, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath] Univ Nilton Lins UNINILTONLINS, Manaus, Amazonas, Brazil; [Kuehn, Andrea] Barcelona Global Hlth Inst ISGLOBAL, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Siqueira, Andre Machado] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil; [Guimaraes Lacerda, Marcus Vinicius] FIOCRUZ Amazonia, Inst Pesquisas Leonidas & Maria Deane, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Universidade Federal de Amazonas; ISGlobal; CRESIB; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Costa, AG; Ramasawmy, R (corresponding author), Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil.; Costa, AG; Ramasawmy, R (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Diretoria Ensino & Pesquisa, Manaus, Amazonas, Brazil.; Costa, AG (corresponding author), Fundacao Hosp Hematol & Hemoterapia Amazonas HEMO, Lab Genom, Manaus, Amazonas, Brazil.; Ramasawmy, R (corresponding author), Univ Fed Amazonas UFAM, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.; Ramasawmy, R (corresponding author), Univ Nilton Lins UNINILTONLINS, Manaus, Amazonas, Brazil.	allyson.gui.costa@gmail.com; ramasawm@gmail.com; marcuslacerda.br@gmail.com; malheiroadriana@yahoo.com.br	Sampaio, Vanderson/M-4337-2015; Siqueira, Andre M/G-1340-2010; Sampaio, Vanderson/AAQ-1418-2020; melo, gisely/GZK-5350-2022; Ramasawmy, Rajendranath/V-4926-2019; Costa, Allyson Guimarães/AAD-3923-2021; Tarrago, Andrea/AAJ-3758-2021	Sampaio, Vanderson/0000-0001-7307-8851; Siqueira, Andre M/0000-0003-2208-0294; Sampaio, Vanderson/0000-0001-7307-8851; Costa, Allyson Guimarães/0000-0002-7312-6822; Tarrago, Andrea/0000-0003-3125-580X; Malheiro, Adriana/0000-0002-1107-8079	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [575788/2008-9]; Fundaco Cellex; Bill & Mellinda Gates Foundation (TransEPI Consortium); CAPES; CNPq; FAPEAM; PVS Program [PECTI-AM/PG#019/2013]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundaco Cellex; Bill & Mellinda Gates Foundation (TransEPI Consortium); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEAM; PVS Program	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant number 575788/2008-9), Fundaco Cellex (P. vivax Consortium) and Bill & Mellinda Gates Foundation (TransEPI Consortium). MVGL is a level 1 research fellow from CNPq. AM is a level 2 research fellow from CNPq. RR is a research fellow from FAPEAM (PVS Program - PECTI-AM/PG#019/2013). AGC, VSS, AMT, LWB, ACGA, HNSI and LAX have fellowship from CAPES, CNPq and FAPEAM (PhD, Master's and SI students). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2001, J IMMUNOL, V167, P5928, DOI 10.4049/jimmunol.167.10.5928; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2015, WORLD MALARIA REPORT, P238; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Antonelli LRV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004393; Areeshi MY, 2013, PLOS ONE, V8, P1; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Bargieri DY, 2010, VACCINE, V28, P2818, DOI 10.1016/j.vaccine.2010.02.004; Bargieri DY, 2008, VACCINE, V26, P6132, DOI 10.1016/j.vaccine.2008.08.070; Basu M, 2010, INFECT GENET EVOL, V10, P686, DOI 10.1016/j.meegid.2010.03.008; Brasil LW, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1754-7; Brazil, 2015, B EP, V46, P1; Brazilian Ministry of Health, 2005, MAN DIAGN LAB MAL; Brazilian Ministry of Health, 2010, GUIA PRAT TRAT MAL B; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Costa AG, 2017, REV SOC BRAS MED TRO, V50, P151, DOI 10.1590/0037-8682-0132-2017; da Costa AG, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/318250; Dhangadamajhi G, 2017, REV SOC BRAS MED TRO, V50, P153, DOI 10.1590/0037-8682-0475-2016; Franklin BS, 2007, MICROBES INFECT, V9, P881, DOI 10.1016/j.micinf.2007.03.007; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Giribaldi G, 2011, ASIAN PAC J TROP MED, V4, P925, DOI 10.1016/S1995-7645(11)60220-4; Gowda DC, 2007, TRENDS PARASITOL, V23, P596, DOI 10.1016/j.pt.2007.09.003; Greene JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-50; Gu L, 2016, NEUROL SCI, V37, P1537, DOI 10.1007/s10072-016-2607-9; Hahn WO, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1071-y; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heinzmann A, 2003, EUR J IMMUNOGENET, V30, P345, DOI 10.1046/j.1365-2370.2003.00414.x; Hisaeda H, 2008, J IMMUNOL, V180, P2496, DOI 10.4049/jimmunol.180.4.2496; Iwalokun BA, 2017, ASIAN PAC J TROP BIO, V7, P96, DOI 10.1016/j.apjtb.2016.11.015; Iwalokun BA, 2015, GENES ENVIRON, V37, DOI 10.1186/s41021-015-0002-z; Kar A, 2015, INFECT GENET EVOL, V36, P356, DOI 10.1016/j.meegid.2015.10.008; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Leoratti FMS, 2008, J INFECT DIS, V198, P772, DOI 10.1086/590440; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mayor A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-3; Mendonca VRR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-69; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Oakley MS, 2011, TRENDS PARASITOL, V27, P442, DOI 10.1016/j.pt.2011.06.004; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Omar AH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-168; Pan American Health Organization, 2014, SIT MAL REG AM 2000; Panigrahi S, 2016, IMMUNOL RES, V64, P291, DOI 10.1007/s12026-015-8749-7; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Ramasawmy R, 2009, J INFECT DIS, V199, P1838, DOI 10.1086/599212; Rosanas-Urgell A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-361; Rosas-Taraco AG, 2007, J INFECT DIS, V196, P1698, DOI 10.1086/522147; Sam-Agudu NA, 2010, AM J TROP MED HYG, V82, P548, DOI 10.4269/ajtmh.2010.09-0467; Sampaio VS, 2015, REV SOC BRAS MED TRO, V48, P4, DOI 10.1590/0037-8682-0275-2014; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Silva SV, 2016, MALAR J BIOMED CENTR, P1; Siqueira AM, 2016, AM J TROP MED HYG, V95, P87, DOI 10.4269/ajtmh.16-0204; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Val FF, 2014, MEM I OSWALDO CRUZ, V109, P522, DOI 10.1590/0074-0276140240; Wampfler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076316; Zafra G, 2008, MEM I OSWALDO CRUZ, V103, P27, DOI 10.1590/S0074-02762008000100004; Zakeri S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-77	72	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183840	10.1371/journal.pone.0183840	http://dx.doi.org/10.1371/journal.pone.0183840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850598	Green Published, gold			2022-12-26	WOS:000408544200031
J	Havlicek, J; Rivera-Milla, E; Slickers, P; Andres, S; Feuerriegel, S; Niemann, S; Merker, M; Labugger, I				Havlicek, Juliane; Rivera-Milla, Eric; Slickers, Peter; Andres, Soenke; Feuerriegel, Silke; Niemann, Stefan; Merker, Matthias; Labugger, Ines			An application of competitive reporter monitored amplification (CMA) for rapid detection of single nucleotide polymorphisms (SNPs)	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TECHNOLOGIES; RESISTANCE; MUTATIONS; FUTURE; DNA; PCR	Single nucleotide polymorphisms (SNPs) are essential parameters in molecular diagnostics and can be used for the early detection and clinical prognosis in various diseases. Available methods for SNP detection are still labor-intensive and require a complex laboratory infrastructure, which are not suitable for the usage in resource-limited settings. Thus, there is an urgent need for a simple, reliable and rapid approach. In this paper we modified the previously developed competitive reporter monitored amplification (CMA) technique for the detection of resistance mediating SNPs in Mycobacterium tuberculosis complex (MTBC) strains. As a proof-of-principle for the application of the CMA-based SNP assay in routine molecular tuberculosis diagnostic, we show that the assay recognizes resistance mediating SNPs for rifampicin, isoniazid and ethambutol from either isolated DNA or heat inactivated M. tuberculosis cell cultures. The CMA-based SNP assay can identify the most prevalent resistance mediating mutations in the genes rpoB, katG, embB, and the promotor region of inhA within one hour.	[Havlicek, Juliane; Rivera-Milla, Eric; Slickers, Peter; Labugger, Ines] Alere Technol GmbH, Jena, Germany; [Andres, Soenke] Res Ctr Borstel, Natl Reference Ctr Mycobacteria, Borstel, Germany; [Feuerriegel, Silke; Niemann, Stefan; Merker, Matthias] Res Ctr Borstel, Mol & Expt Mycobacteriol, Borstel, Germany; [Feuerriegel, Silke] German Ctr Infect Res, Partner Site Hamburg Lubeck Borstel, Borstel, Germany	Alere; Forschungszentrum Borstel; Forschungszentrum Borstel; German Center for Infection Research	Merker, M (corresponding author), Res Ctr Borstel, Mol & Expt Mycobacteriol, Borstel, Germany.	mmerker@fz-borstel.de	Niemann, Stefan/C-9327-2011; Merker, Matthias/P-7399-2015	Merker, Matthias/0000-0003-1386-2331; Niemann, Stefan/0000-0002-6604-0684	State of Thuringia, Germany [2013 FE 0098]	State of Thuringia, Germany	The study was supported by a grant from the State of Thuringia, Germany (2013 FE 0098). This funding source had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakravarti A, 2001, NATURE, V409, P822, DOI 10.1038/35057281; Chen XN, 1998, GENOME RES, V8, P549, DOI 10.1101/gr.8.5.549; Fahlyani BK, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.28895; Fernandes-Monteiro AG, 2015, HUM VACC IMMUNOTHER, V11, P1865, DOI 10.4161/21645515.2014.990854; Feuerriegel S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-90; Griffin TJ, 1999, P NATL ACAD SCI USA, V96, P6301, DOI 10.1073/pnas.96.11.6301; Hadjinicolaou AV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-97; Jani IV, 2016, J CLIN MICROBIOL, V54, P2104, DOI 10.1128/JCM.00362-16; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Krishnan P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162622; Kumar P, 2009, J MOL DIAGN, V11, P430, DOI 10.2353/jmoldx.2009.080135; Lai E, 2001, GENOME RES, V11, P927, DOI 10.1101/gr.192301; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; Masimba P, 2014, TROP MED INT HEALTH, V19, P664, DOI 10.1111/tmi.12289; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Park JH, 2012, J CLIN ONCOL, V30, P2157, DOI 10.1200/JCO.2011.40.1943; Phelan J, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0575-9; Rattan A, 1998, EMERG INFECT DIS, V4, P195, DOI 10.3201/eid0402.980207; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; Starks AM, 2009, ANTIMICROB AGENTS CH, V53, P1061, DOI 10.1128/AAC.01357-08; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Tyagi S, 1998, NAT BIOTECHNOL, V16, P49, DOI 10.1038/nbt0198-49; Ullrich T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035438; Valdivia HO, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1928-z; Walker TM, 2016, CLIN MICROBIOL INFEC; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wu S, 2014, ANAL CHEM, V86, P3461, DOI 10.1021/ac4040373	28	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183561	10.1371/journal.pone.0183561	http://dx.doi.org/10.1371/journal.pone.0183561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850612	Green Published, gold, Green Submitted			2022-12-26	WOS:000408544200020
J	Buscail, C; Sabate, JM; Bouchoucha, M; Torres, MJ; Alles, B; Hercberg, S; Benamouzig, R; Julia, C				Buscail, Camille; Sabate, Jean-Marc; Bouchoucha, Michel; Torres, Marion J.; Alles, Benjamin; Hercberg, Serge; Benamouzig, Robert; Julia, Chantal			Association between self-reported vegetarian diet and the irritable bowel syndrome in the French NutriNet cohort	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; LACTOSE-INTOLERANCE; MULTIPLE IMPUTATION; SEMI-VEGETARIAN; CROHNS-DISEASE; MEAT-EATERS; FOOD; FIBER; PREVALENCE; MANAGEMENT	Background There is growing interest in using diet counselling in the management of patients with irritable bowel syndrome (IBS). Among new emerging diets, vegetarian diets (VD) seem to be experiencing an important popularity, partly because of their alleged health benefits. A recent study performed among a rural Indian population showed that predominant VD could be associated with IBS. Objective This cross-sectional study aimed at assessing the association between the VD and IBS, among a large French cohort, the NutriNet-sante A study. Methods Subjects participating in the NutriNet-Sante A cohort study completed a questionnaire based on Rome III criteria (N = 41,682). Anthropometrics, socio-demographical and lifestyle data, including VD, were collected prior to the completion of Rome III questionnaire via self-administered questionnaires. Association between VD and IBS and its subtypes was investigated through multivariate logistic regression. Results The included subjects were mainly women (78.0%) and the mean age was 49.8 +/- 14.3 years. Among these individuals, 2,264 (5.4%) presented an IBS, and 805 (1.9%) reported a VD. Overall, VD was not associated with IBS or subtypes. A stable VD (i.e. self-declared at least three times) was associated with IBS (aOR 2.60 95% CI [1.37-4.91]), IBS mixed (aOR 2.97 95% CI [1.20-7.36]) and IBS diarrhoea (aOR 2.77 95% CI [1.01-7.59]). Conclusions This study suggests that a long term VD could be associated with IBS. Nevertheless, further studies are needed to confirm these results, and investigate the multiple aspects of the vegetarian diet, possibly related to the IBS.	[Buscail, Camille; Torres, Marion J.; Alles, Benjamin; Hercberg, Serge; Julia, Chantal] Univ Paris 13, Equipe Rech Epidemiol Nutr, Ctr Rech Epidemiol & Biostat CRESS, Inserm 1153,Inra U1125,Cnam,COMUE Sorbonne Paris, Bobigny, France; [Buscail, Camille; Hercberg, Serge; Julia, Chantal] Hop Avicenne, Dept Sante Publ, Bobigny, France; [Sabate, Jean-Marc; Bouchoucha, Michel; Benamouzig, Robert] Hop Avicenne, Serv Hepatogastroenterol, Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Buscail, C (corresponding author), Univ Paris 13, Equipe Rech Epidemiol Nutr, Ctr Rech Epidemiol & Biostat CRESS, Inserm 1153,Inra U1125,Cnam,COMUE Sorbonne Paris, Bobigny, France.; Buscail, C (corresponding author), Hop Avicenne, Dept Sante Publ, Bobigny, France.	c.buscail@eren.smbh.univ-paris13.fr	Alles, Benjamin/F-1006-2017; Serge, Hercberg/F-3038-2017; Buscail, Camille/J-7682-2016; BENAMOUZIG, Robert/W-8067-2019; Chantal, Julia/F-2805-2017	Alles, Benjamin/0000-0002-7970-171X; Serge, Hercberg/0000-0002-3168-1350; Buscail, Camille/0000-0002-6120-6497; Chantal, Julia/0000-0003-2006-5269; BENAMOUZIG, ROBERT/0000-0003-1952-6830; Torres, Marion J/0000-0002-7609-5531	French Ministry of Health; Institut de Veille Sanitaire; Institut National de la Sante et de la Recherche Medicale; Institut National de la Recherche Agronomique; Conservatoire National des Arts et Metiers; Sante publique France Institute; Fondation pour la Recherche Medicale and Paris 13 University	French Ministry of Health; Institut de Veille Sanitaire; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique; Conservatoire National des Arts et Metiers; Sante publique France Institute; Fondation pour la Recherche Medicale and Paris 13 University	The NutriNet-Sante Study is supported by the French Ministry of Health, the Institut de Veille Sanitaire, the Institut National de la Sante et de la Recherche Medicale, the Institut National de la Recherche Agronomique, the Conservatoire National des Arts et Metiers, the Sante publique France Institute and the Fondation pour la Recherche Medicale and Paris 13 University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Study sponsors had no part in study design, collection, analysis, and interpretation of data and the writing of the article and the decision to submit it for publication.	Austin GL, 2009, CLIN GASTROENTEROL H, V7, P706, DOI 10.1016/j.cgh.2009.02.023; Bijkerk CJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3154; Bijkerk CJ, 2004, ALIMENT PHARM THER, V19, P245, DOI 10.1111/j.0269-2813.2004.01862.x; Boettcher E, 2013, AM J GASTROENTEROL, V108, P728, DOI 10.1038/ajg.2013.97; Bommelaer G, 2002, GASTROEN CLIN BIOL, V26, P1118; Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7; Chiba M, 2010, WORLD J GASTROENTERO, V16, P2484, DOI 10.3748/wjg.v16.i20.2484; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Corazziari E, 2004, BEST PRACT RES CL GA, V18, P613, DOI 10.1016/j.bpg.2004.04.012; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027; Crowe FL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4131; Dapoigny M, 2004, EUR J GASTROEN HEPAT, V16, P995, DOI 10.1097/00042737-200410000-00008; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Dinu M., 2016, CRIT REV FOOD SCI NU; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1257, DOI 10.1053/j.gastro.2016.03.035; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Dugum M, 2016, CLEV CLIN J MED, V83, P655, DOI 10.3949/ccjm.83a.14159; El-Salhy M, 2012, INT J MOL MED, V29, P723, DOI 10.3892/ijmm.2012.926; El-Salhy M, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0022-3; Esteve-Saillard M, 2016, OCL OILS FAT CROP LI, V23, DOI 10.1051/ocl/2016015; Eswaran S, 2013, AM J GASTROENTEROL, V108, P718, DOI 10.1038/ajg.2013.63; Eswaran S, 2011, GASTROENTEROL CLIN N, V40, P141, DOI 10.1016/j.gtc.2010.12.012; Farre R, 2013, AM J GASTROENTEROL, V108, P698, DOI 10.1038/ajg.2013.24; Farup PG, 2004, SCAND J GASTROENTERO, V39, P645, DOI 10.1080/00365520410005405; Ferrocino I, 2015, PLOS ONE, V10; Ford AC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2313; Foundation Rome, 2006, J GASTROINTEST LIVER, V15, P307; Fraser GE, 2009, AM J CLIN NUTR, V90, P248, DOI 10.3945/ajcn.2009.27933; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; Ghoshal UC, 2016, J GASTROENTEROL HEPA; Gibson PR, 2015, GASTROENTEROLOGY, V148, P1158, DOI 10.1053/j.gastro.2015.02.005; Gibson PR, 2013, SYNDR DIAGN MANAG, P81; Gupta D, 2007, J GASTROEN HEPATOL, V22, P2261, DOI 10.1111/j.1440-1746.2007.04986.x; Hamm LR, 1999, AM J GASTROENTEROL, V94, P1279, DOI 10.1016/S0002-9270(99)00133-1; Hawkins Irana W, 2015, Front Nutr, V2, P21, DOI 10.3389/fnut.2015.00021; Hedenus F, 2014, CLIMATIC CHANGE, V124, P79, DOI 10.1007/s10584-014-1104-5; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Heizer WD, 2009, J AM DIET ASSOC, V109, P1204, DOI 10.1016/j.jada.2009.04.012; Hercberg S., 2012, MAX PORTIONS ALIMENT; Human Research Council, 2014, HRC; Janssen M, 2016, APPETITE, V105, P643, DOI 10.1016/j.appet.2016.06.039; Jorgensen B., 2015, POROI, V11, P1, DOI DOI 10.13008/2151-2957.1220; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Kwok CS, 2014, INT J CARDIOL, V176, P680, DOI 10.1016/j.ijcard.2014.07.080; Lacy BE, 2013, PHYSICIAN ANSWERS YO; Lassale C, 2016, J ACAD NUTR DIET, V116, P427, DOI 10.1016/j.jand.2015.09.017; Lassale C, 2015, BRIT J NUTR, V113, P953, DOI 10.1017/S0007114515000057; Lee Bo Ra, 2016, Clin Nutr Res, V5, P102, DOI 10.7762/cnr.2016.5.2.102; Leitzmann C., 2014, AM J CLIN NUTR; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lomer MCE, 2008, ALIMENT PHARM THER, V27, P93, DOI 10.1111/j.1365-2036.2007.03557.x; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; McEvoy CT, 2012, PUBLIC HEALTH NUTR, V15, P2287, DOI 10.1017/S1368980012000936; Moayyedi P, 2014, AM J GASTROENTEROL, V109, P1367, DOI 10.1038/ajg.2014.195; Monsbakken KW, 2006, EUR J CLIN NUTR, V60, P667, DOI 10.1038/sj.ejcn.1602367; Morcos A, 2009, J DIGEST DIS, V10, P237, DOI 10.1111/j.1751-2980.2009.00392.x; Mullee A, 2017, APPETITE, V114, P299, DOI 10.1016/j.appet.2017.03.052; Nagarajan N, 2015, EUR J GAS TROENTEROL, V1; NAIR P, 1994, DIGEST DIS, V12, P177, DOI 10.1159/000171451; Newport F., US 5 CONS THEMS VEG; Ostgaard H, 2012, MOL MED REP, V5, P1382, DOI 10.3892/mmr.2012.843; Panigrahi MK, 2013, J NEUROGASTROENTEROL, V19, P374, DOI 10.5056/jnm.2013.19.3.374; Parry SD, 2002, EUR J GASTROEN HEPAT, V14, P1225, DOI 10.1097/00042737-200211000-00010; Rao SSC, 2015, ALIMENT PHARM THER, V41, P1256, DOI 10.1111/apt.13167; Reddy KS, 2004, PUBLIC HLTH NUTR, V7; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; RIORDAN AM, 1993, LANCET, V342, P1131, DOI 10.1016/0140-6736(93)92121-9; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Sabate J, 2015, PUBLIC HEALTH NUTR, V18, P2067, DOI [10.1017/S1368980014002377, 10.1017/S1368980014003176]; Sabate J, 2014, AM J CLIN NUTR, V100, p476S, DOI 10.3945/ajcn.113.071522; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Shepherd SJ, 2013, AM J GASTROENTEROL, V108, P707, DOI 10.1038/ajg.2013.96; Simren M, 2001, DIGESTION, V63, P108, DOI 10.1159/000051878; Su YS, 2011, J STAT SOFTW, V45, P1; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Tuck CJ, 2014, EXPERT REV GASTROENT, V8, P819, DOI 10.1586/17474124.2014.917956; Turnbull GK, 2000, NUTRITION, V16, P665, DOI 10.1016/S0899-9007(00)00339-7; VEBU. Vegetarische und vegane Lebensmittel auf Erfolgskurs, 2016, VEG VEG LEB ERF; Wald A, 2008, NUTR CLIN PRACT, V23, P284, DOI 10.1177/0884533608318677; WHO, Q A CARC CONS RED ME; Wu GD, 2016, GUT, V65, P63, DOI 10.1136/gutjnl-2014-308209	85	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183039	10.1371/journal.pone.0183039	http://dx.doi.org/10.1371/journal.pone.0183039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841661	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700016
J	Islam, N; Miklavcic, SJ; Bradshaw-Hajek, BH; White, LR				Islam, Nazmul; Miklavcic, Stanley J.; Bradshaw-Hajek, Bronwyn H.; White, Lee R.			Convective and diffusive effects on particle transport in asymmetric periodic capillaries	PLOS ONE			English	Article							FLOW; PENETRATION; NUMBERS; CELLS	We present here results of a theoretical investigation of particle transport in longitudinally asymmetric but axially symmetric capillaries, allowing for the influence of both diffusion and convection. In this study we have focused attention primarily on characterizing the influence of tube geometry and applied hydraulic pressure on the magnitude, direction and rate of transport of particles in axi-symmetric, saw-tooth shaped tubes. Three initial value problems are considered. The first involves the evolution of a fixed number of particles initially confined to a central wave-section. The second involves the evolution of the same initial state but including an ongoing production of particles in the central wave-section. The third involves the evolution of particles a fully laden tube. Based on a physical model of convective-diffusive transport, assuming an underlying oscillatory fluid velocity field that is unaffected by the presence of the particles, we find that transport rates and even net transport directions depend critically on the design specifics, such as tube geometry, flow rate, initial particle configuration and whether or not particles are continuously introduced. The second transient scenario is qualitatively independent of the details of how particles are generated. In the third scenario there is no net transport. As the study is fundamental in nature, our findings could engender greater understanding of practical systems.	[Islam, Nazmul; Miklavcic, Stanley J.; Bradshaw-Hajek, Bronwyn H.; White, Lee R.] Univ South Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA 5001, Australia; [Islam, Nazmul] Khulna Univ, Math Discipline Sci Engn & Technol Sch, Khulna, Bangladesh	University of South Australia; Khulna University	Miklavcic, SJ (corresponding author), Univ South Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA 5001, Australia.	stan.miklavcic@unisa.edu.au	Hajek, Bronwyn H/H-5513-2011	Hajek, Bronwyn H/0000-0002-7892-4620; Islam, Nazmul/0000-0003-4053-9521; Miklavcic, Stanley/0000-0002-2361-246X	Australian Research Council [DP1096282]; Australian Research Council through its Discovery Grant Scheme [DP1096282]	Australian Research Council(Australian Research Council); Australian Research Council through its Discovery Grant Scheme(Australian Research Council)	LRW gratefully received funding in the form of Discovery Grant #DP1096282 from the Australian Research Council (http://www.arc.gov.au/) for the support of NI. The funders had no role in study, design, data collection and analysis,decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the support of the Australian Research Council through its Discovery Grant Scheme (DP1096282).	Ahualli S, 2007, J COLLOID INTERF SCI, V309, P342, DOI 10.1016/j.jcis.2007.02.006; Bandopadhyay A, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4947115; Bradshaw-Hajek BH, 2008, LANGMUIR, V24, P4512, DOI 10.1021/la703777g; Cross SE, 1999, PHARMACEUT RES, V16, P427, DOI 10.1023/A:1018834021066; Dancik Y, 2012, BRIT J CLIN PHARMACO, V73, P564, DOI 10.1111/j.1365-2125.2011.04128.x; DAVIS RH, 1985, ANNU REV FLUID MECH, V17, P91, DOI 10.1146/annurev.fl.17.010185.000515; FEDKIW P, 1977, AICHE J, V23, P255, DOI 10.1002/aic.690230307; GIDDINGS JC, 1993, SCIENCE, V260, P1456, DOI 10.1126/science.8502990; Herringer JW, 2017, AICHE J, V63, P2358, DOI 10.1002/aic.15569; Hewitt GF, 2010, J FLUID MECH, V660, P258, DOI 10.1017/S0022112010002697; Huang LR, 2004, SCIENCE, V304, P987, DOI 10.1126/science.1094567; Islam N, 2015, EUR J MECH B-FLUID, V53, P119, DOI 10.1016/j.euromechflu.2015.04.008; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; Jawadzadegan A., 2009, J MECH SCI TECHNOL, V23, P2456; Lee S, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4872035; Levich V.G., 1962, PHYSICOCHEMICAL HYDR; MCNEILL SC, 1992, PHARMACEUT RES, V9, P1422, DOI 10.1023/A:1015854728278; Miragotri S, 2011, INT J PHARMACEUT, V418, P115; MONTEIRORIVIERE NA, 1993, PHARMACEUT RES, V10, P1326, DOI 10.1023/A:1018973814456; MULLER M, 1995, J CONTROL RELEASE, V37, P49, DOI 10.1016/0168-3659(95)00063-E; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pozrikidis C., 1992, BOUNDARY INTEGRAL SI; Tripathi D, 2017, INT J HEAT MASS TRAN, V111, P138, DOI 10.1016/j.ijheatmasstransfer.2017.03.089	23	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183127	10.1371/journal.pone.0183127	http://dx.doi.org/10.1371/journal.pone.0183127			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841658	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000408370700019
J	Micic, D; Gaetano, JN; Rubin, JN; Cohen, RD; Sakuraba, A; Rubin, DT; Pekow, J				Micic, Dejan; Gaetano, John N.; Rubin, Jonah N.; Cohen, Russell D.; Sakuraba, Atsushi; Rubin, David T.; Pekow, Joel			Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease	PLOS ONE			English	Article							POPULATION-BASED COHORT; CROHNS-DISEASE; UNITED-STATES; RISK-FACTORS; CLOSTRIDIUM-DIFFICILE; ULCERATIVE-COLITIS; HEALTH-INSURANCE; HEART-FAILURE; RATES; CARE	Background Management of inpatients with inflammatory bowel disease (IBD) requires increasing resources. We aimed to identify factors associated with hospital readmissions among individuals with IBD. Materials & methods We collected data from the Healthcare Cost and Utilization Project Nationwide Readmissions Database 2013. We identified individuals with index hospitalizations for IBD. Patient-specific factors, comorbidities and hospitalization characteristics were extracted for the index hospitalization. We performed logistic regression modeling to create adjusted odds ratios (ORs) for 30-day hospital readmission. Subgroup analysis was performed based on disease type and performance of surgery. Results We analyzed a total of 55,942 index hospital discharges; 3037 patients (7.0%) were readmitted to the hospital within 30 days. Increasing patient age (> 65: OR: 0.45; 95% CI 0.39-0.53) was associated with a decreased risk of readmission, while a diagnosis of Crohn's disease (OR: 1.09; 95% CI 1.00-1.18) and male sex (OR: 1.16; 95% CI 1.07-1.25) were associated with an increased risk of readmission. The comorbidities of smoking (OR: 1.09; 95% CI 1.00-1.19), anxiety (OR: 1.17; 95% CI 1.01-1.36) and opioid dependence (OR: 1.40; 95% CI 1.06-1.86) were associated with an increased risk of 30-day readmission. Individual hospitalization characteristics and disease complications were significantly associated with readmission. Performance of a surgery during the index admission was associated with a decreased risk of readmission (OR: 0.57; 95% CI 0.33-0.96). Conclusion Analyzing data from a US publicly available all-payer inpatient healthcare database, we identified patient and hospitalization risk factors associated with 30-day readmission. Identifying patients at high risk for readmission may allow for interventions during or after the index hospitalization to decrease this risk.	[Micic, Dejan; Gaetano, John N.; Cohen, Russell D.; Sakuraba, Atsushi; Rubin, David T.; Pekow, Joel] Univ Chicago, Dept Internal Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA; [Rubin, Jonah N.] Univ Chicago, Dept Internal Med, Sect Hosp Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Micic, D (corresponding author), Univ Chicago, Dept Internal Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA.	dejan.micic@northwestern.edu	Sakuraba, Atsushi/ABD-6796-2020	Sakuraba, Atsushi/0000-0003-2519-6129; Pekow, Joel/0000-0002-4790-8994	National Institutes of Health [T32DK007074, K08DK090152, P30DK42086]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090152, P30DK042086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health [grant number T32DK007074, K08DK090152 (JP), P30DK42086]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegretti JR, 2015, INFLAMM BOWEL DIS, V21, P2583, DOI 10.1097/MIB.0000000000000537; Ananthakrishnan AN, 2008, GUT, V57, P205, DOI 10.1136/gut.2007.128231; Ananthakrishnan AN, 2008, AM J GASTROENTEROL, V103, P2789, DOI 10.1111/j.1572-0241.2008.02054.x; Ashton CM, 1997, MED CARE, V35, P1044, DOI 10.1097/00005650-199710000-00006; Barnes EL, 2017, INFLAMM BOWEL DIS, V23, P875, DOI 10.1097/MIB.0000000000001121; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P110, DOI 10.1111/j.1572-0241.2006.00330.x; Bewtra M, 2007, CLIN GASTROENTEROL H, V5, P597, DOI 10.1016/j.cgh.2007.01.015; Damle RN, 2016, J SURG RES, V200, P200, DOI 10.1016/j.jss.2015.06.052; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; Hazratjee N, 2013, AM J GASTROENTEROL, V108, P1024, DOI 10.1038/ajg.2012.343; Horton HA, 2014, ANTIMICROB AGENTS CH, V58, P5054, DOI 10.1128/AAC.02606-13; Horwitz L, 2014, J HOSP MED, V9, P743, DOI 10.1002/jhm.2271; Introduction to the HCUP Nationwide Readmissions Database (NRD), 2013, INTR HCUP NAT READM; Jennings JH, 2015, CHEST, V147, P1227, DOI 10.1378/chest.14-1123; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kulaylat AN, 2015, COLORECTAL DIS, V17, P891, DOI 10.1111/codi.12958; Lawrence Kosinski JVB, 2016, PROJECT SONAR REDUCT; Lichtenstein GR, 2005, GASTROENTEROLOGY, V128, P862, DOI 10.1053/j.gastro.2005.01.048; Loop MS, 2016, AM J CARDIOL, V118, P79, DOI 10.1016/j.amjcard.2016.04.015; Nguyen GC, 2008, INFLAMM BOWEL DIS, V14, P1105, DOI 10.1002/ibd.20429; Nguyen GC, 2007, INFLAMM BOWEL DIS, V13, P1408, DOI 10.1002/ibd.20200; Nguyen GC, 2014, CLIN GASTROENTEROL H, V12, P1897, DOI 10.1016/j.cgh.2014.02.042; Oddone EZ, 1996, J GEN INTERN MED, V11, P597, DOI 10.1007/BF02599027; Park KT, 2016, AM J GASTROENTEROL, V111, P15, DOI 10.1038/ajg.2015.207; Poojary P, 2017, INFLAMM BOWEL DIS, V23, P347, DOI 10.1097/MIB.0000000000001041; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P402, DOI 10.1053/j.gastro.2003.11.014; Silverstein MD, 1999, GASTROENTEROLOGY, V117, P49, DOI 10.1016/S0016-5085(99)70549-4; Singh G, 2016, CHEST, V149, P905, DOI 10.1378/chest.15-0449; Tapper EB, 2016, CLIN GASTROENTEROL H, V14, P1181, DOI 10.1016/j.cgh.2016.04.009; Villani A, 2014, J TELEMED TELECARE, V20, P468, DOI 10.1177/1357633X14555644	31	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182900	10.1371/journal.pone.0182900	http://dx.doi.org/10.1371/journal.pone.0182900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837634	Green Submitted, Green Published, gold			2022-12-26	WOS:000408365000033
J	Nehemia, A; Kochzius, M				Nehemia, Alex; Kochzius, Marc			Reduced genetic diversity and alteration of gene flow in a fiddler crab due to mangrove degradation	PLOS ONE			English	Article							POPULATION-STRUCTURE; LARVAL DISPERSAL; UCA-ANNULIPES; MANAGEMENT; TESTS; RECRUITMENT; OCYPODIDAE; CONTEMPORARY; BOTTLENECKS; VARIABILITY	The fiddler crab Austruca occidentalis is a dominant species in mangrove forests along the East African coast. It enhances soil aeration and, through its engineering activities, makes otherwise-inaccessible food available for other marine organisms. Despite its importance, the habitat of A. occidentalis is threatened by human activities. Clearing the mangroves for salt farming and selective logging of mangroves trees continue to jeopardise mangrove ecosystems in the Western Indian Ocean. This study aims to use partial mitochondrial COI gene sequences and nuclear microsatellites to determine whether salt farming activities in mangroves have a negative impact on the genetic diversity and gene flow of A. occidentalis collected along the Tanzania coast. The level of genetic diversity for both mitochondrial DNA and nuclear microsatellites are relatively lower in samples from salt ponds compared to natural mangrove sites. Analysis of molecular variance (AMOVA) among all populations showed low but significant differentiation (COI: F-st = 0.022, P < 0.05; microsatellites: F-st = 0.022, P < 0.001). A hierarchical AMOVA indicates lower but significant genetic differentiation among populations from salt ponds and natural mangroves sites (COI: F-ct = 0.033, P < 0.05; microsatellites: F-ct = 0.018, P = < 0.01). These results indicate that salt farming has a significant negative impact on the genetic diversity of A. occidentalis. Since higher genetic diversity contributes to a stable population, restoring the cleared habitats might be the most effective measures for the conservation of genetic diversity and hence adaptive potential to environmental change in this species.	[Nehemia, Alex; Kochzius, Marc] VUB, Marine Biol Ecol & Biodivers, Pl Laan 2, Brussels, Belgium; [Nehemia, Alex] Sokoine Univ Agr, Dept Biol Sci, Morogoro, Tanzania	Vrije Universiteit Brussel; Sokoine University of Agriculture	Nehemia, A (corresponding author), VUB, Marine Biol Ecol & Biodivers, Pl Laan 2, Brussels, Belgium.; Nehemia, A (corresponding author), Sokoine Univ Agr, Dept Biol Sci, Morogoro, Tanzania.	alexander_nehemiah@yahoo.co.uk	Kochzius, Marc/AAN-3799-2021	Kochzius, Marc/0000-0001-8953-4719; NEHEMIA, ALEX/0000-0001-5471-7080	CARIBU programme (Erasmus Mundus Action 2) [2013-2618]; Leopold III-Fund [LF/JVG/vm/15.65]; Vrije Universiteit Brussel [NSE-TG-2015-25]	CARIBU programme (Erasmus Mundus Action 2); Leopold III-Fund; Vrije Universiteit Brussel	This study was funded by the CARIBU programme (Erasmus Mundus Action 2) (Grant number 2013-2618), Leopold III-Fund (Grant number: LF/JVG/vm/15.65), and the doctoral school of the Vrije Universiteit Brussel (Grant number: NSE-TG-2015-25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuodha PAW, 2001, HYDROBIOLOGIA, V458, P255, DOI 10.1023/A:1013130916811; Araujo ES, 2015, ARCH BIOL SCI, V67, P1369, DOI 10.2298/ABS141205115A; Arif I. A., 2009, Animal Biodiversity and Conservation, V32, P9; Atkinson SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151992; Auld JR, 2010, BIOL LETTERS, V6, P222, DOI 10.1098/rsbl.2009.0726; Banks SC, 2013, TRENDS ECOL EVOL, V28, P670, DOI 10.1016/j.tree.2013.08.005; Bartolini F, 2011, MAR ENVIRON RES, V71, P53, DOI 10.1016/j.marenvres.2010.10.002; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bosire JO, 2014, BIOGEOSCIENCES, V11, P2623, DOI 10.5194/bg-11-2623-2014; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Britto FB, 2011, GENET MOL RES, V10, P4084, DOI 10.4238/2011.November.9.2; Casariego AM, 2004, MAR BIOL, V145, P259, DOI 10.1007/s00227-004-1325-7; Cervini M, 2006, GENET MOL BIOL, V29, P486, DOI 10.1590/S1415-47572006000300015; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Crook DA, 2015, SCI TOTAL ENVIRON, V534, P52, DOI 10.1016/j.scitotenv.2015.04.034; DiBattista JD, 2008, CONSERV GENET, V9, P141, DOI 10.1007/s10592-007-9317-z; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Evans BS, 2004, MAR ECOL PROG SER, V270, P163, DOI 10.3354/meps270163; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2007, 153 FAO, P77; Faulks LK, 2011, EVOL APPL, V4, P589, DOI 10.1111/j.1752-4571.2011.00183.x; Fauvelot C, 2009, MAR BIOL, V156, P2313, DOI 10.1007/s00227-009-1259-1; Fratini S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158582; Fu YX, 1997, GENETICS, V147, P915; Garcia-Cisneros A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33269; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gonzalez EB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163052; Goode MG, 2007, BIOINFORMATICS, V23, P1553, DOI 10.1093/bioinformatics/btm128; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Haig SM, 1998, ECOLOGY, V79, P413, DOI 10.1890/0012-9658(1998)079[0413:MCTC]2.0.CO;2; Halpern BS, 2004, MAR ECOL PROG SER, V276, P197, DOI 10.3354/meps276197; Hamilton SE, GLOB ECOL BIOGEOGR, V25, P729; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hui M, 2016, MAR ECOL, V38, P1; Kairo JG, 2001, S AFR J BOT, V67, P383, DOI 10.1016/S0254-6299(15)31153-4; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kinnear M, 2009, J CRUSTACEAN BIOL, V29, P273, DOI 10.1651/08-3049R.1; Kirui KB, 2013, OCEAN COAST MANAGE, V83, P19, DOI 10.1016/j.ocecoaman.2011.12.004; Koch V, 2005, MAR ECOL PROG SER, V291, P177, DOI 10.3354/meps291177; Kochzius M, 2008, MOL ECOL, V17, P3775, DOI 10.1111/j.1365-294X.2008.03803.x; Kristensen E, 2008, AQUAT BOT, V89, P201, DOI 10.1016/j.aquabot.2007.12.005; Leese F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-19; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; LIINGILIE A. S., 2015, MEDITERRANEAN J BIOS, V1, P27; Litulo C, 2004, HYDROBIOLOGIA, V525, P167, DOI 10.1023/B:HYDR.0000038864.38435.6a; Litulo Carlos, 2004, Western Indian Ocean Journal of Marine Science, V3, P87; Mahongo S.B., 2014, J OCEANOGRAPHY MARIN, V5, P1, DOI DOI 10.5897/JOMS2013.0100; Fernandez-Palacios JM, 2016, GLOBAL ECOL BIOGEOGR, V25, P817, DOI 10.1111/geb.12320; Mokhtari M, 2008, ESTUAR COAST SHELF S, V76, P273, DOI 10.1016/j.ecss.2007.07.010; Mokhtari M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117467; Mwandya AW, 2009, ESTUAR COAST SHELF S, V82, P193, DOI 10.1016/j.ecss.2008.12.010; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nehemia A, 2017, J MOLLUS STUD, V83, P1, DOI 10.1093/mollus/eyw040; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Otwoma LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165552; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pini J, 2011, CORAL REEFS, V30, P399, DOI 10.1007/s00338-011-0718-6; Ragionieri L, 2010, ESTUAR COAST SHELF S, V86, P179, DOI 10.1016/j.ecss.2009.11.002; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Ridgway Tyrone, 2005, Western Indian Ocean Journal of Marine Science, V4, P1; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg MS, 2002, BIOL J LINN SOC, V75, P147, DOI 10.1046/j.1095-8312.2002.00012.x; Rumisha C, 2012, MAR POLLUT BULL, V64, P521, DOI 10.1016/j.marpolbul.2011.12.025; SEMESI AK, 1992, HYDROBIOLOGIA, V247, P1, DOI 10.1007/BF00008199; Silva IC, 2010, MAR BIOL, V157, P1113, DOI 10.1007/s00227-010-1393-9; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; SWALLOW JC, 1991, J GEOPHYS RES-OCEANS, V96, P22245, DOI 10.1029/91JC01942; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Varela ES, 2009, MOL ECOL RESOUR, V9, P1395, DOI 10.1111/j.1755-0998.2009.02674.x; Vasconcelos RP, 2014, ICES J MAR SCI, V71, P638, DOI 10.1093/icesjms/fst136; Walters BB, 2008, AQUAT BOT, V89, P220, DOI 10.1016/j.aquabot.2008.02.009; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; Wang Y., 2003, MAR GEOD, V26, P35, DOI [10.1080/01490410390181243, DOI 10.1080/01490410306708, https://doi.org/10.1080/01490410306708]; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wieman AC, 2014, MAR BIOL, V161, P173, DOI 10.1007/s00227-013-2327-0; Wilson GA, 2003, GENETICS, V163, P1177; WOODROFFE CD, 1991, J BIOGEOGR, V18, P479, DOI 10.2307/2845685	88	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182987	10.1371/journal.pone.0182987	http://dx.doi.org/10.1371/journal.pone.0182987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837577	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000039
J	Sanches, PG; op 't Veld, RC; de Graaf, W; Strijkers, GJ; Grull, H				Sanches, Pedro Gomes; op 't Veld, Roel C.; de Graaf, Wolter; Strijkers, Gustav J.; Gruell, Holger			Novel axolotl cardiac function analysis method using magnetic resonance imaging	PLOS ONE			English	Article							SPINAL-CORD REGENERATION; HEART; SALAMANDER; SURVIVAL; BIOLOGY; DISEASE	The salamander axolotl is capable of complete regeneration of amputated heart tissue. However, non-invasive imaging tools for assessing its cardiac function were so far not employed. In this study, cardiac magnetic resonance imaging is introduced as a non-invasive technique to image heart function of axolotls. Three axolotls were imaged with magnetic resonance imaging using a retrospectively gated Fast Low Angle Shot cine sequence. Within one scanning session the axolotl heart was imaged three times in all planes, consecutively. Heart rate, ejection fraction, stroke volume and cardiac output were calculated using three techniques: (1) combined long-axis, (2) short-axis series, and (3) ultrasound (control for heart rate only). All values are presented as mean +/- standard deviation. Heart rate (beats per minute) among different animals was 32.2+/-6.0 (long axis), 30.4+/-5.5 (short axis) and 32.7+/-4.9 (ultrasound) and statistically similar regardless of the imaging method (p > 0.05). Ejection fraction (%) was 59.6+/-10.8 (long axis) and 48.1+/-11.3 (short axis) and it differed significantly (p = 0.019). Stroke volume (mu l/beat) was 133.7+/-33.7 (long axis) and 93.2+/-31.2 (short axis), also differed significantly (p = 0.015). Calculations were consistent among the animals and over three repeated measurements. The heart rate varied depending on depth of anaesthesia. We described a new method for defining and imaging the anatomical planes of the axolotl heart and propose one of our techniques (long axis analysis) may prove useful in defining cardiac function in regenerating axolotl hearts.	[Sanches, Pedro Gomes; op 't Veld, Roel C.; de Graaf, Wolter; Strijkers, Gustav J.; Gruell, Holger] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR Grp, Eindhoven, Netherlands; [op 't Veld, Roel C.] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, Nijmegen, Netherlands; [Strijkers, Gustav J.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [Gruell, Holger] Univ Hosp Cologne, Dept Radiol, Cologne, Germany	Eindhoven University of Technology; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Cologne	Grull, H (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR Grp, Eindhoven, Netherlands.; Grull, H (corresponding author), Univ Hosp Cologne, Dept Radiol, Cologne, Germany.	holger.gruell@uk-koeln.de	Veld, Roel C op 't/A-4941-2016	Strijkers, Gustav/0000-0001-6700-5058; Grull, Holger/0000-0002-0993-9300	UniversiteitsFonds Eindhoven; Eindhoven University of Technology	UniversiteitsFonds Eindhoven; Eindhoven University of Technology	This study was funded by the UniversiteitsFonds Eindhoven (Health-Anniversary Awards UFe 2011) and the Eindhoven University of Technology (both awarded to HG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakermans AJ, 2015, PROG NUCL MAG RES SP, V88-89, P1, DOI 10.1016/j.pnmrs.2015.03.001; Cano-Martínez Agustina, 2010, Arch. Cardiol. Méx., V80, P79; Chernoff EAG, 2003, DEV DYNAM, V226, P295, DOI 10.1002/dvdy.10240; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Davies F, 1941, PHILOS T ROY SOC B, V231, P99, DOI 10.1098/rstb.1941.0005; ECKERT RL, 1989, ENVIRON HEALTH PERSP, V80, P109, DOI 10.2307/3430736; Feder M. E., 1992, ENV PHYSL AMPHIBIANS; Fritsche R, 1997, AM ZOOL, V37, P23; Heijman E, 2007, NMR BIOMED, V20, P439, DOI 10.1002/nbm.1110; HOYT RW, 1984, J EXP ZOOL, V230, P491, DOI 10.1002/jez.1402300318; KRAMER K, 1993, J PHARMACOL TOXICOL, V30, P209, DOI 10.1016/1056-8719(93)90019-B; Kropf N, 2010, J NEUROSURG, V112, P880, DOI 10.3171/2008.10.JNS08222; Lee V.S., 2006, CARDIOVASCULAR MRI P; LINDBLOM D, 1990, J AM COLL CARDIOL, V15, P566, DOI 10.1016/0735-1097(90)90627-2; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nakamura R, 2016, DEV GROWTH DIFFER; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Phillips A M, 2005, Injury, V36 Suppl 3, pS5, DOI 10.1016/j.injury.2005.07.027; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; Shahbaba B., 2012, BIOSTATISTICS R INTR; Steward MM, 2013, CURR TOP MICROBIOL, V367, P163, DOI 10.1007/82_2012_302; Uygur A, 2016, DEV CELL, V36, P362, DOI 10.1016/j.devcel.2016.01.018; van Nierop BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055424	27	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183446	10.1371/journal.pone.0183446	http://dx.doi.org/10.1371/journal.pone.0183446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837595	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000069
J	Camera, DM; Burniston, JG; Pogson, MA; Smiles, WJ; Hawley, JA				Camera, Donny M.; Burniston, Jatin G.; Pogson, Mark A.; Smiles, William J.; Hawley, John A.			Dynamic proteome profiling of individual proteins in human skeletal muscle after a high-fat diet and resistance exercise	FASEB JOURNAL			English	Article						muscle protein synthesis; abundance; metabolism; adaptation; protein degradation	MYOFIBER HYPERTROPHY; OLDER-ADULTS; PHOSPHORYLATION; MYOFIBRILLAR; METABOLISM; EXPRESSION; YOUNG; RATES; MICE; TIME	It is generally accepted that muscle adaptation to resistance exercise (REX) training is underpinned by contraction-induced, increased rates of protein synthesis and dietary protein availability. By using dynamic proteome profiling (DPP), we investigated the contribution of both synthesis and breakdown to changes in abundance on a protein-by-protein basis inhuman skeletal muscle. Age-matched, overweight males consumed 9 d of a high-fat, low-carbohydrate diet during which time they either undertook 3 sessions of REX or performed no exercise. Precursor enrichment and the rate of incorporation of deuterium oxide into newly synthesized muscle proteins were determined by mass spectrometry. Ninety proteins were included in the DPP, with 28 proteins exhibiting significant responses to REX. The most common pattern of response was an increase in turnover, followed by an increase in abundance with no detectable increase in protein synthesis. Here, we provide novel evidence that demonstrates that the contribution of synthesis and breakdown to changes in protein abundance induced by REX differ on a protein by-protein basis. We also highlight the importance of the degradation of individual muscle proteins after exercise in human skeletal muscle.	[Camera, Donny M.; Smiles, William J.; Hawley, John A.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Exercise & Nutr, Fitzroy, Vic, Australia; [Burniston, Jatin G.; Hawley, John A.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool, Merseyside, England; [Pogson, Mark A.] Liverpool John Moores Univ, Dept Appl Math, Liverpool, Merseyside, England	Australian Catholic University; Liverpool John Moores University; Liverpool John Moores University	Hawley, JA (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Fitzroy, Vic 3165, Australia.	hawley@acu.edu.au	Camera, Donny/J-1571-2018; Burniston, Jatin G/B-7833-2008; Burniston, Jatin/AAB-8831-2020; Hawley, John A/U-3814-2018; Pogson, Mark/D-9558-2016	Camera, Donny/0000-0002-6494-9472; Burniston, Jatin G/0000-0001-7303-9318; Burniston, Jatin/0000-0001-7303-9318; Hawley, John A/0000-0002-0886-9881; Smiles, William/0000-0002-6846-689X; Pogson, Mark/0000-0002-2116-7200	Australian Catholic University Collaborative Research Network [2013000443]	Australian Catholic University Collaborative Research Network	The authors thank the study participants for their efforts and dedication. This work was supported by an Australian Catholic University Collaborative Research Network Grant to J.A.H. (2013000443). The authors declare no conflicts of interest.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Balagopal P, 2001, AM J PHYSIOL-ENDOC M, V280, pE203, DOI 10.1152/ajpendo.2001.280.2.E203; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE514; Bloch RJ, 2003, EXERC SPORT SCI REV, V31, P73, DOI 10.1097/00003677-200304000-00004; Brook MS, 2015, FASEB J, V29, P4485, DOI 10.1096/fj.15-273755; Burniston JG, 2014, PROTEOMICS, V14, P2339, DOI 10.1002/pmic.201400118; Camera DM, 2015, MED SCI SPORT EXER, V47, P82, DOI 10.1249/MSS.0000000000000390; Camera DM, 2012, J APPL PHYSIOL, V113, P206, DOI 10.1152/japplphysiol.00395.2012; Camera DM, 2010, MED SCI SPORT EXER, V42, P1843, DOI 10.1249/MSS.0b013e3181d964e4; CHESLEY A, 1992, J APPL PHYSIOL, V73, P1383, DOI 10.1152/jappl.1992.73.4.1383; COMMERFORD SL, 1983, RADIAT RES, V94, P151, DOI 10.2307/3575870; Hawley J. A., 1985, J APPL PHYSIOL, V110, P834; HAWLEY JA, 1992, EUR J APPL PHYSIOL, V65, P79, DOI 10.1007/BF01466278; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Hesketh S, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4010012; Hipkiss AR, 2011, AGEING RES REV, V10, P498, DOI 10.1016/j.arr.2011.05.003; Kasumov T, 2013, ARTERIOSCL THROM VAS, V33, P1994, DOI 10.1161/ATVBAHA.113.301700; Koopman R, 2006, EUR J APPL PHYSIOL, V96, P525, DOI 10.1007/s00421-005-0118-0; Kosek DJ, 2006, J APPL PHYSIOL, V101, P531, DOI 10.1152/japplphysiol.01474.2005; Lam MPY, 2014, J CLIN INVEST, V124, P1734, DOI 10.1172/JCI73787; Leber Y, 2016, HUM MOL GENET, V25, P2776, DOI 10.1093/hmg/ddw135; Lehti M, 2009, J APPL PHYSIOL, V106, P1419, DOI 10.1152/japplphysiol.90660.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Macrae K, 2013, J LIPID RES, V54, P2366, DOI 10.1194/jlr.M036996; Malik ZA, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030290; Mayhew DL, 2009, J APPL PHYSIOL, V107, P1655, DOI 10.1152/japplphysiol.91234.2008; McCabe BJ, 2006, ANAL BIOCHEM, V350, P171, DOI 10.1016/j.ab.2006.01.020; Meplan C, 2016, FASEB J, V30, P2812, DOI 10.1096/fj.201600251R; Mertens I, 2006, INT J OBESITY, V30, P1308, DOI 10.1038/sj.ijo.0803189; Mitchell CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089431; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Noh HS, 2016, AUTOPHAGY, V12, P2183, DOI 10.1080/15548627.2016.1219013; Paulsen G, 2012, EUR J APPL PHYSIOL, V112, P1773, DOI 10.1007/s00421-011-2132-8; Paulsen G, 2009, J APPL PHYSIOL, V107, P570, DOI 10.1152/japplphysiol.00209.2009; Phillips SM, 2005, J AM COLL NUTR, V24, p134S, DOI 10.1080/07315724.2005.10719454; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204; R Core Team, 2016, LANG ENV STAT COMP; Sanger JW, 2017, HANDB EXP PHARMACOL, V235, P39, DOI 10.1007/164_2016_53; Shankaran M, 2016, AM J PHYSIOL-ENDOC M, V310, pE405, DOI 10.1152/ajpendo.00257.2015; Shankaran M, 2016, J CLIN INVEST, V126, P288, DOI 10.1172/JCI79639; Sollanek KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171007; Stefanyk LE, 2010, CURR OPIN CLIN NUTR, V13, P255, DOI 10.1097/MCO.0b013e328338236e; Tachtsis B, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00144; TESCH PA, 1986, EUR J APPL PHYSIOL, V55, P362, DOI 10.1007/BF00422734; Ulbricht A, 2015, AUTOPHAGY, V11, P538, DOI 10.1080/15548627.2015.1017186; Volek JS., 2011, ART SCI LOW CARBOHYD; Wagenmakers AJM, 1999, P NUTR SOC, V58, P987, DOI 10.1017/S0029665199001305; Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x; Wilkinson DJ, 2017, J PHYSIOL-LONDON, V595, P2873, DOI 10.1113/JP272277; Williamson D, 2003, J PHYSIOL-LONDON, V547, P977, DOI 10.1113/jphysiol.2002.036673; Woolstenhulme MT, 2006, J APPL PHYSIOL, V100, P1876, DOI 10.1152/japplphysiol.01592.2005; Wretman C, 2001, J PHYSIOL-LONDON, V535, P155, DOI 10.1111/j.1469-7793.2001.00155.x; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195	57	29	31	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5478	5494		10.1096/fj.201700531R	http://dx.doi.org/10.1096/fj.201700531R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28855275	Green Accepted			2022-12-26	WOS:000416588300030
J	Wang, MM; Tang, L; Liu, DH; Ying, QL; Ye, SD				Wang, Manman; Tang, Ling; Liu, Dahai; Ying, Qi-Long; Ye, Shoudong			The transcription factor Gbx2 induces expression of Kruppel-like factor 4 to maintain and induce naive pluripotency of embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; differentiation; embryonic stem cell; Kruppel-like factor 4 (KLF4); reprogramming; Gbx2; self-renewal	LEUKEMIA INHIBITORY FACTOR; SELF-RENEWAL; SIGNALING PATHWAYS; STAT3 ACTIVATION; MOUSE EMBRYOS; GROUND-STATE; NANOG; DIFFERENTIATION; OCT4; GENE	The transcription factor Gbx2 (gastrulation brain homeobox 2) is a direct target of the LIF/STAT3 signaling pathway, maintains mouse embryonic stem cell (mESC) self-renewal, and facilitates mouse epiblast stem cell (mEpiSC) reprogramming to naive pluripotency. However, the mechanism by which Gbx2 mediates its effects on pluripotency remains unknown. Here, using an RNA-Seq approach, we identified Klf4 (Kruppel-like factor 4) as a direct target of Gbx2. Functional studies indicated that Klf4 mediates the self-renewal-promoting effects of Gbx2, because knockdown of Klf4 expression abrogated the ability of Gbx2 to maintain the undifferentiated state of mESCs. We also found that Gbx2 largely depends on Klf4 to reprogram mEpiSCs to a mESC-like state. In summary, our study has uncovered a mechanism by which Gbx2 maintains and induces naive pluripotency. These findings expand our understanding of the pluripotency control network and may inform the development of culture conditions for improved ESC maintenance and differentiation.	[Wang, Manman; Tang, Ling; Liu, Dahai; Ye, Shoudong] Anhui Univ, Sch Life Sci, Ctr Stem Cell & Translat Med, Hefei 230601, Anhui, Peoples R China; [Ying, Qi-Long] Univ Southern Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	Anhui University; University of Southern California	Ye, SD (corresponding author), Anhui Univ, Sch Life Sci, Ctr Stem Cell & Translat Med, Hefei 230601, Anhui, Peoples R China.	shdye@126.com			Natural Science Foundation of China [31501191, 31671535]; Anhui Province Grant [1508085SQC204]; Scientific Research Startup Fund of Anhui University [J01006068, J01006045]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Province Grant; Scientific Research Startup Fund of Anhui University	This work was supported by Natural Science Foundation of China Grants 31501191 and 31671535, Anhui Province Grant 1508085SQC204, and Scientific Research Startup Fund of Anhui University Grants J01006068 and J01006045. The authors declare that they have no conflicts of interest with the contents of this article.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chapman G, 1997, GENOMICS, V46, P223, DOI 10.1006/geno.1997.4969; Chen HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8095; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Huang GY, 2015, CELL MOL LIFE SCI, V72, P1741, DOI 10.1007/s00018-015-1833-2; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3403; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ohtsuka S., 2015, JAK STAT, V4, DOI DOI 10.1080/21623996.2015; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Roeseler DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047366; Russell R, 2015, STEM CELL REP, V5, P1155, DOI 10.1016/j.stemcr.2015.11.003; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Tai CI, 2013, J CELL SCI, V126, P1093, DOI 10.1242/jcs.118273; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wang XC, 2012, INT J ONCOL, V41, P1181, DOI 10.3892/ijo.2012.1568; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ye SD, 2016, J CELL SCI, V129, P269, DOI 10.1242/jcs.177675; Ye SD, 2014, CURR OPIN GENET DEV, V28, P10, DOI 10.1016/j.gde.2014.08.002; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	43	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17121	17128		10.1074/jbc.M117.803254	http://dx.doi.org/10.1074/jbc.M117.803254			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28848051	Green Published, hybrid			2022-12-26	WOS:000413140600031
J	Yanagisawa, S; Frasch, WD				Yanagisawa, Seiga; Frasch, Wayne D.			Protonation-dependent stepped rotation of the F-type ATP synthase c-ring observed by single-molecule measurements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; bioenergetics; F0F1-ATPase; proton transport; single-molecule biophysics	ESCHERICHIA-COLI; ALPHA-SUBUNIT; F-1-ATPASE; RESOLUTION; F1FO-ATPASE; F1-ATPASE; MOTORS; MUSCLE; F-1	The two opposed rotary molecular motors of the F0F1-ATP synthase work together to provide the majority of ATP in biological organisms. Rotation occurs in 120 degrees power strokes separated by dwells when F-1 synthesizes or hydrolyzes ATP. F-0 and F-1 complexes connect via a central rotor stalk and a peripheral stator stalk. A major unresolved question is the mechanism in which the interaction between subunit-a and rotating subunit-c-ring in the F-0 motor uses the flux of H+ across the membrane to induce clockwise rotation against the force of counterclockwise rotation driven by the F-1-ATPase. In single-molecule measurements of F0F1 embedded in lipid bilayer nanodiscs, we observed that the ability of the F-0 motor to form transient dwells increases with decreasing pH. Transient dwells can halt counterclockwise rotation powered by the F-1-ATPase in steps equivalent to the rotation of single c-subunits in the c-ring of F-0, and can push the common axle shared by the two motors clockwise by as much as one c-subunit. Because the F-0 proton half-channels that access the periplasm and the cytoplasm are exposed to the same pH, these data are consistent with the conclusion that the periplasmic half-channel is more easily protonated in a manner that halts ATPase-driven rotation by blocking ATPase-dependent proton pumping. The fit of transient dwell occurrence to the sum of three Gaussian curves suggests that the asymmetry of the three ATPase-dependent 120 degrees power strokes imposed by the relative positions of the central and peripheral stalks affects c-subunit stepping efficiency.	[Yanagisawa, Seiga; Frasch, Wayne D.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Frasch, WD (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	frasch@asu.edu			National Institutes of Health [R01 GM097510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institutes of Health Grant R01 GM097510 (to W. D. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; CAIN BD, 1988, J BIOL CHEM, V263, P6606; CAIN BD, 1989, J BIOL CHEM, V264, P3292; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; ENGELBRECHT S, 1989, EUR J BIOCHEM, V181, P485, DOI 10.1111/j.1432-1033.1989.tb14750.x; Etzold C, 1997, EUR J BIOCHEM, V243, P336, DOI 10.1111/j.1432-1033.1997.0336a.x; Fillingame R. H., 2014, BIOCHIM BIOPHYS ACTA, V1837, P1062; FISCHER S, 1994, EUR J BIOCHEM, V225, P167, DOI 10.1111/j.1432-1033.1994.00167.x; Hornung T, 2011, METHODS MOL BIOL, V778, P273, DOI 10.1007/978-1-61779-261-8_18; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; KUSHMERICK MJ, 1992, AM J PHYSIOL, V263, pC598, DOI 10.1152/ajpcell.1992.263.3.C598; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; LIGHTOWLERS RN, 1987, BIOCHIM BIOPHYS ACTA, V894, P399, DOI 10.1016/0005-2728(87)90118-6; Martin J, 2015, J BIOL CHEM, V290, P10717, DOI 10.1074/jbc.M115.646430; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; Morales-Rios E, 2015, P NATL ACAD SCI USA, V112, P13231, DOI 10.1073/pnas.1517542112; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Sobti M, 2016, ELIFE, V5, DOI 10.7554/eLife.21598; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Spetzler D, 2012, ADV PHOTOSYNTH RESP, V34, P561, DOI 10.1007/978-94-007-1579-0_22; Spetzler D, 2009, BIOCHEMISTRY-US, V48, P7979, DOI 10.1021/bi9008215; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; VIK SB, 1988, J BIOL CHEM, V263, P6599; WILKEMOUNTS S, 1994, ARCH BIOCHEM BIOPHYS, V309, P363, DOI 10.1006/abbi.1994.1125; Zhou AN, 2015, ELIFE, V4, DOI 10.7554/eLife.10180	29	12	11	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17093	17100		10.1074/jbc.M117.799940	http://dx.doi.org/10.1074/jbc.M117.799940			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842481	hybrid, Green Published			2022-12-26	WOS:000413140600028
J	Merkley, ED; Sego, LH; Lin, A; Leiser, OP; Kaiser, BLD; Adkins, JN; Keim, PS; Wagner, DM; Kreuzer, HW				Merkley, Eric D.; Sego, Landon H.; Lin, Andy; Leiser, Owen P.; Kaiser, Brooke L. Deatherage; Adkins, Joshua N.; Keim, Paul S.; Wagner, David M.; Kreuzer, Helen W.			Protein abundances can distinguish between naturally-occurring and laboratory strains of Yersinia pestis, the causative agent of plague	PLOS ONE			English	Article							NITROGEN ASSIMILATION; ESCHERICHIA-COLI; PROTEOMICS; EXPRESSION; TEMPERATURE; BIOMARKERS; SEQUENCE; SYSTEM	The rapid pace of bacterial evolution enables organisms to adapt to the laboratory environment with repeated passage and thus diverge from naturally-occurring environmental ("wild") strains. Distinguishing wild and laboratory strains is clearly important for biodefense and bioforensics; however, DNA sequence data alone has thus far not provided a clear signature, perhaps due to lack of understanding of how diverse genome changes lead to convergent phenotypes, difficulty in detecting certain types of mutations, or perhaps because some adaptive modifications are epigenetic. Monitoring protein abundance, a molecular measure of phenotype, can overcome some of these difficulties. We have assembled a collection of Yersinia pestis proteomics datasets from our own published and unpublished work, and from a proteomics data archive, and demonstrated that protein abundance data can clearly distinguish laboratory-adapted from wild. We developed a lasso logistic regression classifier that uses binary (presence/absence) or quantitative protein abundance measures to predict whether a sample is laboratory-adapted or wild that proved to be similar to 98% accurate, as judged by replicated 10-fold cross-validation. Protein features selected by the classifier accord well with our previous study of laboratory adaptation in Y. pestis. The input data was derived from a variety of unrelated experiments and contained significant confounding variables. We show that the classifier is robust with respect to these variables. The methodology is able to discover signatures for laboratory facility and culture medium that are largely independent of the signature of laboratory adaptation. Going beyond our previous laboratory evolution study, this work suggests that proteomic differences between laboratory-adapted and wild Y. pestis are general, potentially pointing to a process that could apply to other species as well. Additionally, we show that proteomics datasets (even archived data collected for different purposes) contain the information necessary to distinguish wild and laboratory samples. This work has clear applications in biomarker detection as well as biodefense.	[Merkley, Eric D.; Lin, Andy; Leiser, Owen P.; Kaiser, Brooke L. Deatherage; Kreuzer, Helen W.] Pacific Northwest Natl Lab, Chem & Biol Signature Sci, Richland, WA 99352 USA; [Sego, Landon H.] Pacific Northwest Natl Lab, Appl Stat & Computat Modeling, Richland, WA USA; [Lin, Andy] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Leiser, Owen P.; Keim, Paul S.; Wagner, David M.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ USA; [Adkins, Joshua N.] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Washington; University of Washington Seattle; Northern Arizona University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Merkley, ED (corresponding author), Pacific Northwest Natl Lab, Chem & Biol Signature Sci, Richland, WA 99352 USA.	eric.merkley@pnnl.gov	Leiser, Owen/ABA-8089-2021	Leiser, Owen/0000-0003-1190-5596; Lin, Andy/0000-0003-0072-612X; Wagner, David/0000-0003-2684-6007; Merkley, Eric/0000-0002-5486-4723	Defense Threat Reduction Agency [DTRA10027IA]; Department of Defense Combating Terrorism Technology Support Office (IFS) [N4175615MP50173]; NIAID NIH/DHHS Interagency [Y1-AI-8401]; NIGMS Grant [GM094623]; United States Department of Energy [DE-AC06-76RL0]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008401, R22AI008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094623] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Department of Defense Combating Terrorism Technology Support Office (IFS); NIAID NIH/DHHS Interagency; NIGMS Grant; United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research is part of the Signature Discovery Initiative at Pacific Northwest National Laboratory (PNNL), conducted under the Laboratory Directed Research and Development Program at PNNL. The Defense Threat Reduction Agency provided funding for the original serial passaging experiment and the culturing of the additional wild isolates under DTRA10027IA. The Department of Defense Combating Terrorism Technology Support Office (IFS) provided funding for the collection of some of our unpublished data under N4175615MP50173 to PNNL. Selected mass spectrometry data from the W.R. Wiley Environmental and Molecular Sciences Laboratory (EMSL) proteomics database was provided via NIAID NIH/DHHS Interagency agreement Y1-AI-8401 and NIGMS Grant GM094623. PNNL is a multi-program national laboratory operated by Battelle Memorial Institute for the United States Department of Energy under contract DE-AC06-76RL0. The funders authorized publication, but had no role in study design, data collection and analysis, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; Amidan BG, 2014, J PROTEOME RES, V13, P2215, DOI 10.1021/pr401143e; Ansong C, 2013, MOL BIOSYST, V9, P44, DOI 10.1039/c2mb25287b; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; Bender RA, 2010, J BACTERIOL, V192, P4801, DOI 10.1128/JB.00266-10; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P725; Chromy BA, 2005, J BACTERIOL, V187, P8172, DOI 10.1128/JB.187.23.8172-8180.2005; Colman RE, 2009, EMERG INFECT DIS, V15, P1623, DOI 10.3201/eid1510.090188; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dammeier S, 2016, J PROTEOME RES, V15, P182, DOI 10.1021/acs.jproteome.5b00704; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Farrell A, 2014, J PROTEOME RES, V13, P3144, DOI 10.1021/pr500219b; FOWLER JM, 1994, INFECT IMMUN, V62, P5234, DOI 10.1128/IAI.62.12.5234-5241.1994; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Griss J, 2015, PROTEOM CLIN APPL, V9, P437, DOI 10.1002/prca.201400107; Hastie T, 2009, ELEMENTS STAT LEARNI, VSecond, P119; Hinnebusch BJ, 2008, CURR TOP MICROBIOL, V322, P229; Huang T, 2013, COMPUT BIOL CHEM, V43, P46, DOI 10.1016/j.compbiolchem.2012.12.008; Kamath KS, 2015, PROTEOM CLIN APPL, V9, P134, DOI 10.1002/prca.201400122; Kiebel GR, 2006, PROTEOMICS, V6, P1783, DOI 10.1002/pmic.200500500; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Leiser OP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142997; Lin A, 2015, J MICROBIOL METH, V112, P3, DOI 10.1016/j.mimet.2015.01.015; Lowell JL, 2005, J CLIN MICROBIOL, V43, P650, DOI 10.1128/JCM.43.2.650-656.2005; Ma NL, 2013, INT J MOL SCI, V14, P7515, DOI 10.3390/ijms14047515; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; Myers-Morales T, 2007, APPL ENVIRON MICROB, V73, P5750, DOI 10.1128/AEM.02968-06; Ojala M, 2010, J MACH LEARN RES, V11, P1833; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15796; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Payne SH, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.41; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pieper R, 2009, MICROBIOL-SGM, V155, P498, DOI 10.1099/mic.0.022160-0; Pieper R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-30; R Core Team, 2013, R LANG ENV STAT COMP; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Sarovich DS, 2010, J MICROBIOL METH, V82, P95, DOI 10.1016/j.mimet.2010.03.019; Saxer G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004872; Schrimpe-Rutledge AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033903; Sebbane F, 2001, INFECT IMMUN, V69, P170, DOI 10.1128/IAI.69.1.170-176.2001; Sego L, 2015, GLMNETLRC LASSO ELAS; Teran LM, 2015, J PROTEOME RES, V14, P38, DOI 10.1021/pr500935s; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Vaudel M, 2016, PROTEOMICS, V16, P214, DOI 10.1002/pmic.201500295; Viola RE, 2008, MICROBIOL-SGM, V154, P1271, DOI 10.1099/mic.0.2007/015529-0; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106	53	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183478	10.1371/journal.pone.0183478	http://dx.doi.org/10.1371/journal.pone.0183478			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854255	Green Published, gold, Green Submitted			2022-12-26	WOS:000408693600047
J	Ryan, JP; Green, JR; Espinoza, E; Hearn, AR				Ryan, John P.; Green, Jonathan R.; Espinoza, Eduardo; Hearn, Alex R.			Association of whale sharks (Rhincodon typus) with thermo-biological frontal systems of the eastern tropical Pacific	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; SATELLITE TRACKING; INSTABILITY WAVES; FORAGING BEHAVIOR; CHRISTMAS ISLAND; OCEAN-COLOR; PRODUCTIVITY; ZOOPLANKTON; GALAPAGOS; ECOLOGY	Satellite tracking of 27 whale sharks in the eastern tropical Pacific, examined in relation to environmental data, indicates preferential occupancy of thermo-biological frontal systems. In these systems, thermal gradients are caused by wind-forced circulation and mixing, and biological gradients are caused by associated nutrient enrichment and enhanced primary productivity. Two of the frontal systems result from upwelling, driven by divergence in the current systems along the equator and the west coast of South America; the third results from wind jet dynamics off Central America. All whale sharks were tagged near Darwin Island, Galapagos, within the equatorial Pacific upwelling system. Occupancy of frontal habitat is pronounced in synoptic patterns of shark locations in relation to serpentine, temporally varying thermal fronts across a zonal expanse >4000 km. 80% of shark positions in northern equatorial upwelling habitat and 100% of positions in eastern boundary upwelling habitat were located within the upwelling front. Analysis of equatorial shark locations relative to thermal gradients reveals occupancy of a transition point in environmental stability. Equatorial subsurface tag data show residence in shallow, warm (>22 degrees C) water 94% of the time. Surface zonal current speeds for all equatorial tracking explain only 16% of the variance in shark zonal movement speeds, indicating that passive drifting is not a primary determinant of movement patterns. Movement from equatorial to eastern boundary frontal zones occurred during boreal winter, when equatorial upwelling weakens seasonally. Off Peru sharks tracked upwelling frontal positions within similar to 100-350 km from the coast. Off Central America, the largest tagged shark (12.8 m TL) occupied an oceanic front along the periphery of the Panama wind jet. Seasonal movement from waning equatorial upwelling to productive eastern boundary habitat is consistent with underlying trophic dynamics. Persistent shallow residence in thermo-biological frontal zones suggests the role of physical-biological interactions that concentrate food resources.	[Ryan, John P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Green, Jonathan R.] Charles Darwin Fdn, Puerto Ayora, Puerto Ayora, Galapagos Islan, Ecuador; [Espinoza, Eduardo] Galapagos Natl Pk Directorate, Puerto Ayora, Galapagos Islan, Ecuador; [Hearn, Alex R.] Univ San Francisco Quito, Galapagos Sci Ctr, Quito, Ecuador	Monterey Bay Aquarium Research Institute	Ryan, JP (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	ryjo@mbari.org	Hearn, Alex/AAK-6461-2020	Ryan, John Phillip/0000-0001-7954-5369	David and Lucile Packard Foundation / Monterey Bay Aquarium Research Institute; Blake, Kymberly and George Rapier Charitable Trust; Galapagos Conservation Trust	David and Lucile Packard Foundation / Monterey Bay Aquarium Research Institute(The David & Lucile Packard Foundation); Blake, Kymberly and George Rapier Charitable Trust; Galapagos Conservation Trust	David and Lucile Packard Foundation / Monterey Bay Aquarium Research Institute (www.mbari.org); Blake, Kymberly and George Rapier Charitable Trust; Galapagos Conservation Trust (http://galapagesconservation.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aca EQ, 2011, ASIA LIFE SCI, V20, P361; Acuna-Marrero D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115946; Afonso P, 2014, PLOS ONE, V9; Archer D, 1997, DEEP-SEA RES PT II, V44, P1827, DOI 10.1016/S0967-0645(97)00031-3; Argos, 2016, ARGOS USERS MANUAL W; Ayon P, 2008, PROG OCEANOGR, V79, P208, DOI 10.1016/j.pocean.2008.10.023; BARBER RT, 1991, LIMNOL OCEANOGR, V36, P1803, DOI 10.4319/lo.1991.36.8.1803; Bertrand A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6239; Bonjean F, 2002, J PHYS OCEANOGR, V32, P2938, DOI 10.1175/1520-0485(2002)032<2938:DMAAOT>2.0.CO;2; Castillo J, 1996, ICES J MAR SCI, V53, P139, DOI 10.1006/jmsc.1996.0014; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Chavez FP, 1995, DAHL WS ENV, V18, P313; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Chelton DB, 2000, GEOPHYS RES LETT, V27, P1239, DOI 10.1029/1999GL011047; Clingham E, 2016, PEER J PREPRINTS; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; ESR (Earth & Space Research), 2009, OSCAR 3 DEGR RES OC; Evans W, 2009, DEEP-SEA RES PT I, V56, P178, DOI 10.1016/j.dsr.2008.08.008; Feldman G.C., 1986, TIDAL MIXING PLANKTO, P77, DOI 10.1007/978-1-4612-4966-5_3; Flament PJ, 1996, NATURE, V383, P610, DOI 10.1038/383610a0; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; Gunn JS, 1999, MAR BIOL, V135, P553, DOI 10.1007/s002270050656; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; Hearn A.R., 2013, ANIM BIOTELEMETRY, V1, P1, DOI [10.1186/2050-3385-1-11, DOI 10.1186/2050-3385-1-11]; Hearn AR, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2991-y; Hearn AR D, 2014, GALAPAGOS MARINE RES, P23; Hobbs JPA, 2009, CORAL REEFS, V28, P577, DOI 10.1007/s00338-009-0491-y; Holmes RM, 2014, J PHYS OCEANOGR, V44, P995, DOI 10.1175/JPO-D-13-0157.1; Hsu HH, 2007, FISH RES, V84, P25, DOI 10.1016/j.fishres.2006.11.030; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Klemas V, 2013, FISH RES, V148, P124, DOI 10.1016/j.fishres.2012.02.027; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; Kukuyev EI, 1995, J ICHTHYOL, V36, P203; Lalli M. C., 1997, BIOL OCEANOGRAPHY IN; Large WG, 2009, CLIM DYNAM, V33, P341, DOI 10.1007/s00382-008-0441-3; Lumpkin R, 2013, J GEOPHYS RES-OCEANS, V118, P2992, DOI 10.1002/jgrc.20210; McClain CR, 2002, DEEP-SEA RES PT II, V49, P2533, DOI 10.1016/S0967-0645(02)00047-4; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Meekan MG, 2009, MAR FRESHWATER RES, V60, P607, DOI 10.1071/MF08254; Muller-Karger FE, 2000, J GEOPHYS RES-OCEANS, V105, P1271, DOI 10.1029/1999JC900257; NASA Goddard Space Flight Center, 2017, VIS INFR IM RAD SUIT; Palacios DM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016232; Palacios DM, 2004, DEEP-SEA RES PT II, V51, P43, DOI 10.1016/j.dsr2.2003.08.001; Pennington JT, 2006, PROG OCEANOGR, V69, P285, DOI 10.1016/j.pocean.2006.03.012; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez P, 1995, BIOL PESQUERIA TIBUR, V16, P23; Ramirez-Macias D, 2017, PEERJ, V5, DOI 10.7717/peerj.3271; Ramirez-Macias Deni, 2012, Endangered Species Research, V18, P115, DOI 10.3354/esr00437; Rohner CA, 2011, J FISH BIOL, V78, P378, DOI 10.1111/j.1095-8649.2010.02861.x; Rohner CA, 2015, J PLANKTON RES, V37, P352, DOI 10.1093/plankt/fbv010; Rowat D, 2008, ENVIRON BIOL FISH, V82, P215, DOI 10.1007/s10641-007-9280-z; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Ryan JP, 2002, PROG OCEANOGR, V55, P263, DOI 10.1016/S0079-6611(02)00137-4; Santos AMP, 2000, FISH RES, V49, P1, DOI 10.1016/S0165-7836(00)00201-0; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V390, P84, DOI 10.1016/j.jembe.2010.05.009; Strutton PG, 2001, GEOPHYS RES LETT, V28, P2005, DOI 10.1029/2000GL012166; Thys Tierney M., 2017, Journal of Marine Biology, P7097965; Thys TM, 2015, J EXP MAR BIOL ECOL, V471, P64, DOI 10.1016/j.jembe.2015.05.005; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Watkins JM, 1996, DEEP-SEA RES PT II, V43, P1257, DOI 10.1016/0967-0645(96)00008-2; WHITE JR, 1995, DEEP-SEA RES PT II, V42, P715, DOI 10.1016/0967-0645(95)00033-M; WOLFSON FH, 1983, J FISH BIOL, V22, P647, DOI 10.1111/j.1095-8649.1983.tb04224.x; WYRTKI K, 1981, J PHYS OCEANOGR, V11, P1205, DOI 10.1175/1520-0485(1981)011<1205:AEOEUI>2.0.CO;2; Xie SP, 2005, J CLIMATE, V18, P5, DOI 10.1175/JCLI-3249.1; YODER JA, 1994, NATURE, V371, P689, DOI 10.1038/371689a0	68	15	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182599	10.1371/journal.pone.0182599	http://dx.doi.org/10.1371/journal.pone.0182599			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854201	Green Submitted, gold, Green Published			2022-12-26	WOS:000408693600012
J	Stephens, SE; Liachenko, S; Ingels, NB; Wenk, JF; Jensen, MO				Stephens, Sam E.; Liachenko, Serguei; Ingels, Neil B.; Wenk, Jonathan F.; Jensen, Morten O.			High resolution imaging of the mitral valve in the natural state with 7 Tesla MRI	PLOS ONE			English	Article							CHORDAL FORCE DISTRIBUTION; SADDLE-SHAPED ANNULUS; IN-VITRO; PAPILLARY-MUSCLE; ANNULOPLASTY RINGS; LEAFLET; REGURGITATION; MECHANICS; TENDINEAE; GEOMETRY	Imaging techniques of the mitral valve have improved tremendously during the last decade, but challenges persist. The delicate changes in annulus shape and papillary muscle position throughout the cardiac cycle have significant impact on the stress distribution in the leaflets and chords, thus preservation of anatomically accurate positioning is critical. The aim of this study was to develop an in vitro method and apparatus for obtaining high-resolution 3D MRI images of porcine mitral valves in both the diastolic and systolic configurations with physiologically appropriate annular shape, papillary muscle positions and orientations, specific to the heart from which the valve was harvested. Positioning and mounting was achieved through novel, customized mounting hardware consisting of papillary muscle and annulus holders with geometries determined via pre-mortem ultrasonic intra-valve measurements. A semi-automatic process was developed and employed to tailor Computer Aided Design models of the holders used to mount the valve. All valve mounting hardware was 3D printed using a stereolithographic printer, and the material of all fasteners used were brass for MRI compatibility. The mounted valves were placed within a clear acrylic case, capable of holding a zero-pressure and pressurized liquid bath of a MRI-compatible fluid. Obtaining images from the valve submerged in liquid fluid mimics the natural environment surrounding the valve, avoiding artefacts due to tissue surface tension mismatch and gravitational impact on tissue shape when not neutrally buoyant. Fluid pressure was supplied by reservoirs held at differing elevations and monitored and controlled to within +/- 1mmHg to ensure that the valves remained steady. The valves were scanned in a 7 Tesla MRI system providing a voxel resolution of at least 80 mu m. The systematic approach produced 3D datasets of high quality which, when combined with physiologically accurate positioning by the apparatus, can serve as an important input for validated computational models.	[Stephens, Sam E.] Univ Arkansas, Dept Mech Engn, Fayetteville, AR 72701 USA; [Stephens, Sam E.; Ingels, Neil B.; Jensen, Morten O.] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA; [Liachenko, Serguei] US FDA, Div Neurotoxicol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Wenk, Jonathan F.] Univ Kentucky, Dept Mech Engn, Lexington, KY 40506 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; US Food & Drug Administration (FDA); University of Kentucky	Jensen, MO (corresponding author), Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA.	mojensen@uark.edu		Liachenko, Serguei/0000-0002-0683-5442; Stephens, Sam/0000-0002-2312-9523	Arkansas Research Alliance; National Center for Toxicological Research [E9999928]; National Science Foundation [CMMI-1538754]; Div Of Civil, Mechanical, & Manufact Inn [1538754] Funding Source: National Science Foundation	Arkansas Research Alliance; National Center for Toxicological Research; National Science Foundation(National Science Foundation (NSF)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This study was supported by the Arkansas Research Alliance, received by MJ, http://aralliance.org/; the National Center for Toxicological Research, protocol number E9999928, received by SL, https://www.fda.gov/nctr/; and the National Science Foundation, grant number CMMI-1538754, received by JFW, https://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askov JB, 2013, J THORAC CARDIOV SUR, V145, P1635, DOI 10.1016/j.jtcvs.2012.07.062; Bloodworth CH, 2017, ANN BIOMED ENG, V45, P496, DOI 10.1007/s10439-016-1734-z; Cochran RP, 1998, ANN THORAC SURG, V66, pS155, DOI 10.1016/S0003-4975(98)01100-X; Dagum P, 2001, J THORAC CARDIOV SUR, V122, P665, DOI 10.1067/mtc.2001.116313; He SQ, 2000, J HEART VALVE DIS, V9, P495; He SQ, 2003, J HEART VALVE DIS, V12, P300; Hyare H, 2008, P INT SOC MAGNETIC R; Jensen MOJ, 2001, ANN BIOMED ENG, V29, P406, DOI 10.1114/1.1366672; Jensen MOJ, 2001, J HEART VALVE DIS, V10, P111; Jensen MO, 2008, CIRCULATION, V118, pS250, DOI 10.1161/CIRCULATIONAHA.107.746776; Jensen MO, 2011, J THORAC CARDIOV SUR, V142, P697, DOI 10.1016/j.jtcvs.2011.01.022; Jimenez JH, 2005, ANN BIOMED ENG, V33, P557, DOI 10.1007/s10439-005-1512-9; Jimenez JH, 2005, J HEART VALVE DIS, V14, P295; Jimenez JH, 2003, ANN BIOMED ENG, V31, P1171, DOI 10.1114/1.1616929; Jimenez JH, 2007, J THORAC CARDIOV SUR, V134, P1562, DOI 10.1016/j.jtcvs.2007.08.037; Khalighi AH, 2017, ANN BIOMED ENG, V45, P378, DOI 10.1007/s10439-016-1775-3; KUNZELMAN KS, 1992, J CARDIAC SURG, V7, P71, DOI 10.1111/j.1540-8191.1992.tb00777.x; Lai DT, 2001, J HEART VALVE DIS, V10, P767; LEVINE RA, 1989, CIRCULATION, V80, P589, DOI 10.1161/01.CIR.80.3.589; Padala M, 2009, ANN THORAC SURG, V88, P1499, DOI 10.1016/j.athoracsur.2009.06.042; Rabbah JP, 2013, ANN BIOMED ENG, V41, P305, DOI 10.1007/s10439-012-0651-z; Rahmani A, 2013, J HEART VALVE DIS, V22, P28; Salgo IS, 2002, CIRCULATION, V106, P711, DOI 10.1161/01.CIR.0000025426.39426.83; Timek TA, 2004, CIRCULATION, V110, pII79, DOI 10.1161/01.CIR.0000138975.05902.a5; Timek TA, 2002, J THORAC CARDIOV SUR, V123, P881, DOI 10.1067/mtc.2002.122296; Toma M, 2016, BIOMECH MODEL MECHAN, V15, P1619, DOI 10.1007/s10237-016-0786-1; Toma M, 2016, ANN BIOMED ENG, V44, P942, DOI 10.1007/s10439-015-1385-5; Votta E, 2008, PHILOS T R SOC A, V366, P3411, DOI 10.1098/rsta.2008.0095	28	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184042	10.1371/journal.pone.0184042	http://dx.doi.org/10.1371/journal.pone.0184042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854273	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600080
J	Tao, Y; Xu, CL; Yuan, CF; Wang, HH; Lin, BR; Zhuo, K; Liao, JL				Tao, Ye; Xu, Chunling; Yuan, Chunfen; Wang, Honghong; Lin, Borong; Zhuo, Kan; Liao, Jinling			Meloidogyne aberrans sp nov (Nematoda: Meloidogynidae), a new root-knot nematode parasitizing kiwifruit in China	PLOS ONE			English	Article							CYST-FORMING NEMATODES; N. SP NEMATODA; MOLECULAR-IDENTIFICATION; GENUS MELOIDOGYNE; RIBOSOMAL-RNA; KIWI FRUIT; HETERODERIDAE; HYPSOPERINE; TYLENCHIDA; ETHIOPICA	High infection rates of roots of wild kiwifruit (Actinidia chinensis Planch) and soil infestation by a root-knot nematode were found in Anshun, GuiZhou Province, China. Morphology, esterase phenotype and molecular analyses confirmed that this nematode was different from previously described root-knot nematodes. In this report, the species is described, illustrated and named Meloidogyne aberrans sp. nov. The new species has a unique combination of characters. A prominent posterior protuberance, round and faint perineal pattern and a medium-length stylet (13.6-15.5 mu m) characterized the females. Second-stage juveniles (J2) were characterized by a smooth lip region with distinctly protruded medial lips and a depression in outline at the oral aperture, a relatively long stylet (15.9-16.8 mu m), four incisures in the lateral field and a very short, even poorly defined, hyaline tail terminus (2.2-5.5 mu m). More incisures (11-15) existed in the lateral field of males, and the stylet and spicules of males were 18.2-19.6 mu m and 22.7-36.8 mu m long respectively. Egg masses were typically produced within the roots of kiwifruit. The new species had a rare Est phenotype, S2. Phylogenetic trees inferred from SSU, LSU D2D3, ITS, and partial coxII-16S rRNA revealed that M. aberrans sp. nov. was within the Meloidogyne clade and was distinguished from all described root-knot nematodes. Moreover, from histopathological observations, M. aberrans sp. nov. induced the formation of multinucleate giant cells.	[Tao, Ye; Xu, Chunling; Yuan, Chunfen; Wang, Honghong; Lin, Borong; Zhuo, Kan; Liao, Jinling] South China Agr Univ, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China; [Wang, Honghong; Liao, Jinling] Guangdong Ecoengn Polytech, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Zhuo, K; Liao, JL (corresponding author), South China Agr Univ, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China.; Liao, JL (corresponding author), Guangdong Ecoengn Polytech, Guangzhou, Guangdong, Peoples R China.	zhuokan@scau.edu.cn; jlliao@scau.edu.cn			National Key Basic Research Program of China (973 Program) [2013CB127501, 2013C6127502]; National Natural Science Foundation of China [31171824, 31471750]; Special Fund for Agro-scientific Research in Public Interest of China [201103018]; Planning Project for Science and Technology in Guangdong Province [2010A202507001-68]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in Public Interest of China; Planning Project for Science and Technology in Guangdong Province	This work was supported by grants from the National Key Basic Research Program of China (973 Program, Nos. 2013CB127501; 2013C6127502), National Natural Science Foundation of China (Nos. 31171824; 31471750), the Special Fund for Agro-scientific Research in Public Interest of China (No. 201103018), and Planning Project for Science and Technology in Guangdong Province (No. 2010A202507001-68). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyazi F, 2013, TURK ENTOMOL DERG-TU, V37, P449; ALLEN MW, 1951, P HELM SOC WASH, V18, P47; Araki Masaaki, 1992, Japanese Journal of Nematology, V22, P11; Bachand GD, 2001, J PHYTOPATHOL, V149, P415, DOI 10.1046/j.1439-0434.2001.00647.x; Caboni P, 2012, J AGR FOOD CHEM, V60, P1146, DOI 10.1021/jf2044586; Carneiro RMDG, 2007, NEMATOLOGY, V9, P635, DOI 10.1163/156854107782024794; Carneiro RMDG, 2004, NEMATOLOGY, V6, P109, DOI 10.1163/156854104323072982; Castillo P, 2003, PHYTOPATHOLOGY, V93, P1093, DOI 10.1094/PHYTO.2003.93.9.1093; Castillo P, 1998, PLANT PATHOL, V47, P370, DOI 10.1046/j.1365-3059.1998.00240.x; Castillo P, 2009, PLANT PATHOL, V58, P606, DOI 10.1111/j.1365-3059.2008.01991.x; Chitwood BG, 1887, HELMINTHOL SOC WASH, V16, P90; COETZEE V, 1956, NATURE, V177, P899, DOI 10.1038/177899a0; Conceicao IL, 2012, EUR J PLANT PATHOL, V134, P451, DOI 10.1007/s10658-012-0027-0; DAS V M, 1960, Z Parasitenkd, V19, P553; De Ley IT, 2007, NEMATOLOGY, V9, P405, DOI 10.1163/156854107781352052; Eisenback J. D., 1985, ADV TREATISE MELOIDO, VII, P79; Eisenback Jonathan D., 1991, P191; Esbenshade PR, 1985, ADV TREATISE MELOIDO, P79; ESSER RP, 1976, P HELM SOC WASH, V43, P138; Feng Z X, 2001, PLANT NEMATOLOGY; Franklin M. T., 1971, P139; Gaur H. S., 1993, Annals of Plant Protection Sciences, V1, P18; GOLDEN A. M., 1971, Plant parasitic nematodes. Vol. 1. Morphology, anatomy, taxonomy, and ecology., P191; HANDOO ZA, 1993, J NEMATOL, V25, P628; Hartman K. M., 1985, An advanced treatise on Meloidogyne.Volume II: Methodology., P69; HAYGOOD RA, 1990, PLANT DIS, V74, P81, DOI 10.1094/PD-74-0081F; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hu MX, 2011, PHYTOPATHOLOGY, V101, P1270, DOI 10.1094/PHYTO-04-11-0095; Huang GZ, 2005, MOL PLANT PATHOL, V6, P23, DOI 10.1111/j.1364-3703.2004.00257.x; Huang Wei, 2012, Guizhou Agricultural Sciences, P184; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt David J., 2009, P55, DOI 10.1079/9781845934927.0055; Janssen T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172190; Jepson S.B., 1987, IDENTIFICATION ROOT; Khan M. L., 2000, Indian Journal of Nematology, V30, P245; Kiewnick S, 2014, EUR J PLANT PATHOL, V140, P97, DOI 10.1007/s10658-014-0446-1; Knight KWL, 2001, NEW ZEAL J CROP HORT, V29, P267, DOI 10.1080/01140671.2001.9514188; Kofoid CA, 1919, J AMER MED ASSOC, V72, P567, DOI 10.1001/jama.1919.02610080033010; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Li S. J., 1991, Acta Agriculturae Universitatis Henanensis, V25, P251; Li TQ., 2014, TILL CULTIVATION, V34, P68; Liang C.F., 1983, GUIHAIA, V3, P229; LOPEZ R, 1984, TURRIALBA, V34, P275; LUC M, 1988, Revue de Nematologie, V11, P159; LUC MICHEL, 1963, NEMATOLOGICA, V9, P471; Ma KC, 2007, ACTA HORTIC, P719, DOI 10.17660/ActaHortic.2007.753.94; Maafi ZT, 2003, NEMATOLOGY, V5, P99, DOI 10.1163/156854102765216731; MAAS PWT, 1978, NEMATOLOGICA, V24, P305, DOI 10.1163/187529278X00272; Maleita CM, 2016, PLANT DIS, V100, P1725, DOI 10.1094/PDIS-01-16-0112-RE; Mundo-Ocampo M, 2008, NEMATOLOGY, V10, P611, DOI 10.1163/156854108785787190; Neal J. C., 1889, BULLETIN, V20; Philippi I., 1996, Fitopatologia, V31, P96; PINOCHET J, 1990, NEMATROPICA, V20, P31; Plantard O, 2007, J NEMATOL, V39, P127; POGOSYAN E E, 1971, Doklady Akademii Nauk Armyanskoi SSR, V53, P306; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POWERS TO, 1993, J NEMATOL, V25, P1; RAU GJ, 1965, P HELM SOC WASH, V32, P159; ROCCUZZO G, 1993, FUND APPL NEMATOL, V16, P151; SHER SA, 1968, NEMATOLOGICA, V14, P243, DOI 10.1163/187529268X00471; Siddiqi M.R, 1986, TYLENCHIDA PARASITES; Siddiqi M.R., 2000, TYLENCHIDA PARASITES; Siddiqi Mohammad Rafiq, 1992, Afro-Asian Journal of Nematology, V1, P212; SLEDGE EB, 1964, P HELM SOC WASH, V31, P83; Somavilla L, 2011, TROP PLANT PATHOL, V36, P89, DOI 10.1590/S1982-56762011000200004; Somavilla Lucia, 2009, Nematologia Brasileira, V33, P252; SPAULL VW, 1977, NEMATOLOGICA, V23, P177, DOI 10.1163/187529277X00525; Subbotin SA, 2000, NEMATOLOGY, V2, P153, DOI 10.1163/156854100509042; Subbotin SA, 2006, NEMATOLOGY, V8, P455, DOI 10.1163/156854106778493420; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEPPER HB, 1993, J PLANT PHYSIOL, V142, P722, DOI 10.1016/S0176-1617(11)80909-0; TEPPER HB, 1992, J PLANT PHYSIOL, V140, P241, DOI 10.1016/S0176-1617(11)80942-9; THORNE G, 1969, P HELM SOC WASH, V36, P98; Treub M., 1885, ONDERZOEKINGEN SEREH, V2, P1; Waliullah M. I. S., 2005, Indian Journal of Nematology, V35, P227; WHITEHEAD A G, 1968, Transactions of the Zoological Society of London, V31, P263; Whitehead A. G, 1959, NEMATOLOGICA, V4, P272; Yang QP, 2014, HUBEI AGR SCI, V53, P2307; [张计育 Zhang Jiyu], 2014, [中国农学通报, Chinese Agricultural Science Bulletin], V30, P48; Zhang SS., 1993, J FUJ AGR COLL, V22, P433; Zheng YQ, 2002, J WUHAN BOT RES, V21, P444; Zhuo K, 2010, ZOOTAXA, P39	83	10	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182627	10.1371/journal.pone.0182627	http://dx.doi.org/10.1371/journal.pone.0182627			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854186	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600013
J	Rao, S; Nandineni, MR				Rao, Soumya; Nandineni, Madhusudan R.			Genome sequencing and comparative genomics reveal a repertoire of putative pathogenicity genes in chilli anthracnose fungus Colletotrichum truncatum	PLOS ONE			English	Article							PROVIDES INSIGHTS; CAUSAL AGENT; PHI-BASE; ANNOTATION; PROTEIN; PEPPER; ALIGNMENT; DATABASE; IDENTIFICATION; TOPOLOGY	Colletotrichum truncatum, a major fungal phytopathogen, causes the anthracnose disease on an economically important spice crop chilli (Capsicum annuum), resulting in huge economic losses in tropical and sub-tropical countries. It follows a subcuticular intramural infection strategy on chilli with a short, asymptomatic, endophytic phase, which contrasts with the intracellular hemibiotrophic lifestyle adopted by most of the Colletotrichum species. However, little is known about the molecular determinants and the mechanism of pathogenicity in this fungus. A high quality whole genome sequence and gene annotation based on transcriptome data of an Indian isolate of C. truncatum from chilli has been obtained. Analysis of the genome sequence revealed a rich repertoire of pathogenicity genes in C. truncatum encoding secreted proteins, effectors, plant cell wall degrading enzymes, secondary metabolism associated proteins, with potential roles in the host-specific infection strategy, placing it next only to the Fusarium species. The size of genome assembly, number of predicted genes and some of the functional categories were similar to other sequenced Colletotrichum species. The comparative genomic analyses with other species and related fungi identified some unique genes and certain highly expanded gene families of CAZymes, proteases and secondary metabolism associated genes in the genome of C. truncatum. The draft genome assembly and functional annotation of potential pathogenicity genes of C. truncatum provide an important genomic resource for understanding the biology and lifestyle of this important phytopathogen and will pave the way for designing efficient disease control regimens.	[Rao, Soumya; Nandineni, Madhusudan R.] Ctr DNA Fingerprinting & Diagnost CDFD, Lab Genom & Profiling Applicat, Hyderabad, Telangana, India; [Rao, Soumya] Manipal Univ, Grad Studies, Manipal, Karnataka, India; [Nandineni, Madhusudan R.] Ctr DNA Fingerprinting & Diagnost CDFD, Lab DNA Fingerprinting Serv, Hyderabad, Telangana, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Nandineni, MR (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Lab Genom & Profiling Applicat, Hyderabad, Telangana, India.; Nandineni, MR (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Lab DNA Fingerprinting Serv, Hyderabad, Telangana, India.	nandineni@cdfd.org.in		Nandineni, Madhusudan Reddy/0000-0002-8933-4503; Rao, Soumya/0000-0002-3836-4745	core grants of CDFD; University Grants Commission (UGC), India	core grants of CDFD; University Grants Commission (UGC), India(University Grants Commission, India)	This study was supported by the core grants of CDFD. No additional funding was received for this study. SR was the recipient of Junior and Senior Research Fellowships of the University Grants Commission (UGC), India towards the pursuit of a Ph.D. degree of the Manipal University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Jaramillo VDA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059078; Auyong A.S.M., 2015, J PLANT PATHOL MICRO, V6, P259, DOI [10.4172/2157-7471.1000259, DOI 10.4172/2157-7471.1000259]; Auyong ASM, 2012, J BASIC MICROB, V52, P372, DOI 10.1002/jobm.201100250; Bailey J. A., 1992, Colletotrichum: biology, pathology and control., P88; Baroncelli R., 2014, GENOME ANNOUNC, V2, DOI DOI 10.1128/GENOMEA.00112-14; Baroncelli R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2917-6; Baroncelli R, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00540-14; Bhadauria V, 2013, EUKARYOT CELL, V12, P2, DOI 10.1128/EC.00192-12; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Buiate EAS, 2017, BMC GENOMICS BMC GEN, P1; Campbell Michael S, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0411s48; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; Crouch J., 2014, GENOMICS PLANT ASS F, P69, DOI DOI 10.1007/978-3-662-44053-7_3; Damm U, 2009, FUNGAL DIVERS, V39, P45; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dong SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005704; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eilbeck K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-67; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gan P, 2016, GENOME BIOL EVOL, V8, P1467, DOI 10.1093/gbe/evw089; Gan P, 2013, NEW PHYTOL, V197, P1236, DOI 10.1111/nph.12085; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guyon K, 2014, BMC GENOMICS, P15; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hacquard S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11362; Han JH, 2016, GENOM DATA, V8, P45, DOI 10.1016/j.gdata.2016.03.007; Heard S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130534; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jayawardena RS, 2016, MYCOSPHERE, V7, P1192, DOI 10.5943/mycosphere/si/2c/9; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Kleemann Jochen, 2012, PLoS Pathog, V8, pe1002643, DOI 10.1371/journal.ppat.1002643; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Kombrink A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003769; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Latunde-Dada AO, 2001, MOL PLANT PATHOL, V2, P187, DOI 10.1046/j.1464-6722.2001.00069.x; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Lewis S.E., 2003, GENOME BIOL, V3, P1, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lyu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15565; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; MANANDHAR JB, 1995, PLANT DIS, V79, P380, DOI 10.1094/PD-79-0380; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Meinken J., 2014, COMPUT MOL BIOL, V4, P1, DOI [10.5376/cmb.2014.04.0007, DOI 10.5376/CMB.2014.04.0007]; Montri P, 2009, PLANT DIS, V93, P17, DOI 10.1094/PDIS-93-1-0017; Nelson David R., 2009, Human Genomics, V4, P59; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Ranathunge NP, 2012, AUSTRALAS PLANT PATH, V41, P463, DOI 10.1007/s13313-012-0156-0; Ranathunge Nalika Priyanwada, 2016, Journal of Plant Protection Research, V56, P157, DOI 10.1515/jppr-2016-0026; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Sanz-Martin JM, 2016, MOL PLANT PATHOL, V17, P1048, DOI 10.1111/mpp.12347; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Selin C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00600; Shenoy BD, 2007, FUNGAL DIVERS, V27, P197; Shiller J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00980; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Sperschneider J, 2016, NEW PHYTOL, V210, P743, DOI 10.1111/nph.13794; Squissato V, 2015, MED MYCOL CASE REP, V9, P1, DOI 10.1016/j.mmcr.2015.06.001; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Takahara H, 2016, NEW PHYTOL, V211, P1323, DOI 10.1111/nph.13994; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Than PP, 2008, PLANT PATHOL, V57, P562, DOI 10.1111/j.1365-3059.2007.01782.x; Than PP, 2008, J ZHEJIANG UNIV-SC B, V9, P764, DOI 10.1631/jzus.B0860007; Todd RB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-214; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Xue MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002869; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zampounis A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00821-16; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	106	28	28	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183567	10.1371/journal.pone.0183567	http://dx.doi.org/10.1371/journal.pone.0183567			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846714	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600035
J	Wild, HM; Heckemann, RA; Studholme, C; Hammers, A				Wild, Heather M.; Heckemann, Rolf A.; Studholme, Colin; Hammers, Alexander			Gyri of the human parietal lobe: Volumes, spatial extents, automatic labelling, and probabilistic atlases	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; POSITRON EMISSION TOMOGRAPHY; COMPUTERIZED BRAIN ATLAS; LEFT ANGULAR GYRUS; 1ST-EPISODE SCHIZOPHRENIA; CORTICAL GYRIFICATION; INTRACRANIAL VOLUME; STEREOTAXIC SPACE; MRI SEGMENTATION; MYELIN CONTENT	Accurately describing the anatomy of individual brains enables interlaboratory communication of functional and developmental studies and is crucial for possible surgical interventions. The human parietal lobe participates in multimodal sensory integration including language processing and also contains the primary somatosensory area. We describe detailed protocols to subdivide the parietal lobe, analyze morphological and volumetric characteristics, and create probabilistic atlases in MNI152 stereotaxic space. The parietal lobe was manually delineated on 3D T1 MR images of 30 healthy subjects and divided into four regions: supramarginal gyrus (SMG), angular gyrus (AG), superior parietal lobe (supPL) and postcentral gyrus (postCG). There was the expected correlation of male gender with larger brain and intracranial volume. We examined a wide range of anatomical features of the gyri and the sulci separating them. At least a rudimentary primary intermediate sulcus of Jensen (PISJ) separating SMG and AG was identified in nearly all (59/60) hemispheres. Presence of additional gyri in SMG and AG was related to sulcal features and volumetric characteristics. The parietal lobe was slightly (2%) larger on the left, driven by leftward asymmetries of the postCG and SMG. Intersubject variability was highest for SMG and AG, and lowest for postCG. Overall the morphological characteristics tended to be symmetrical, and volumes also tended to covary between hemispheres. This may reflect developmental as well as maturation factors. To assess the accuracy with which the labels can be used to segment newly acquired (unlabelled) T1-weighted brain images, we applied multi-atlas label propagation software (MAPER) in a leave-one-out experiment and compared the resulting automatic labels with the manually prepared ones. The results showed strong agreement (mean Jaccard index 0.69, corresponding to a mean Dice index of 0.82, average mean volume error of 0.6%). Stereotaxic probabilistic atlases of each subregion were obtained. They illustrate the physiological brain torque, with structures in the right hemisphere positioned more anteriorly than in the left, and right/left positional differences of up to 10 mm. They also allow an assessment of sulcal variability, e.g. low variability for parietooccipital fissure and cingulate sulcus. Illustrated protocols, individual label sets, probabilistic atlases, and a maximum-probability atlas which takes into account surrounding structures are available for free download under academic licences.	[Wild, Heather M.; Heckemann, Rolf A.; Hammers, Alexander] Neurodis Fdn, Lyon, France; [Wild, Heather M.] Univ Claude Bernard Lyon 1, Univ Lyon, INSERM, Stem Cell & Brain Res Inst,U1208, Bron, France; [Heckemann, Rolf A.] Univ Gothenburg, Sahlgrenska Univ Hosp, MedTech West, Gothenburg, Sweden; [Studholme, Colin] Univ Washington, Dept Pediat, Div Neonatol, Seattle, WA 98195 USA; [Hammers, Alexander] Kings Coll London, Div Imaging Sci & Biomed Engn, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Sahlgrenska University Hospital; University of Gothenburg; University of Washington; University of Washington Seattle; University of London; King's College London	Hammers, A (corresponding author), Neurodis Fdn, Lyon, France.; Hammers, A (corresponding author), Kings Coll London, Div Imaging Sci & Biomed Engn, London, England.	alexander.hammers@kcl.ac.uk	Heckemann, Rolf Andreas/H-9022-2019; Hammers, Alexander/D-9982-2015	Heckemann, Rolf Andreas/0000-0003-3582-3683; Hammers, Alexander/0000-0001-9530-4848	AH-Deutsche Forschungsgemeinschaft [DFG HA 3013/1-1]; AH Medical Research Council [G9901497, G108/585]; AH The Neurodis Foundation; AH King's College London; RAH Dunhill Medical Trust [R62/1107]; RAH The Neurodis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055064] Funding Source: NIH RePORTER; MRC [G108/585] Funding Source: UKRI; Medical Research Council [G108/585] Funding Source: researchfish	AH-Deutsche Forschungsgemeinschaft; AH Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AH The Neurodis Foundation; AH King's College London; RAH Dunhill Medical Trust; RAH The Neurodis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors received no specific funding for this work. However, undertaking such research was part of the general brief of other funding during which data for this study was either acquired or analyzed: AH-Deutsche Forschungsgemeinschaft (DFG HA 3013/1-1), AH Medical Research Council (G9901497 to M.J. Koepp, AH Medical Research Council (G108/585 to AH), AH The Neurodis Foundation (salary funding Chair of Excellence in Functional Neuroimaging), AH King's College London (salary funding Professor (Honorary Consultant) of Imaging and Neuroscience), RAH Dunhill Medical Trust (R62/1107), RAH The Neurodis Foundation (salary funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan RL, 2007, NEUROIMAGE, V38, P261, DOI 10.1016/j.neuroimage.2007.06.004; Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Amiez C, 2014, CEREB CORTEX, V24, P563, DOI 10.1093/cercor/bhs329; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; BAJCSY R, 1983, J COMPUT ASSIST TOMO, V7, P618, DOI 10.1097/00004728-198308000-00008; BERGIN PS, 1994, NEUROLOGY, V44, P1770, DOI 10.1212/WNL.44.9.1770-b; BOHM C, 1983, AM J NEURORADIOL, V4, P731; Bonnici HM, 2007, NEUROIMAGE, V35, P648, DOI 10.1016/j.neuroimage.2006.11.031; Brodmann K, 1909, VERGLEICHENDE LOKALI; Brownsett SLE, 2010, CEREB CORTEX, V20, P517, DOI 10.1093/cercor/bhp120; Cappelletti M, 2010, J COGNITIVE NEUROSCI, V22, P331, DOI 10.1162/jocn.2009.21246; Carreiras M, 2010, NEUROIMAGE, V49, P1741, DOI 10.1016/j.neuroimage.2009.09.058; Carter RM, 2012, SCIENCE, V337, P109, DOI 10.1126/science.1219681; Caspers S, 2012, PLOS ONE, P7; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Caspers S, 2011, NEUROIMAGE, V58, P362, DOI 10.1016/j.neuroimage.2011.06.027; Cattaneo Z, 2009, NEUROIMAGE, V44, P563, DOI 10.1016/j.neuroimage.2008.09.003; Crespo-Facorro B, 2000, PSYCHIAT RES-NEUROIM, V100, P97, DOI 10.1016/S0925-4927(00)00072-X; Crespo-Facorro B, 2000, PSYCHIAT RES, P100; DANN R, 1989, J COMPUT ASSIST TOMO, V13, P603, DOI 10.1097/00004728-198907000-00009; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; EVANS AC, 1988, J CEREBR BLOOD F MET, V8, P513, DOI 10.1038/jcbfm.1988.92; Evans AC, 1991, J CEREB BLOOD FLOW M, P11; Ferro A, 2015, PSYCHIAT RES-NEUROIM, V231, P42, DOI 10.1016/j.pscychresns.2014.10.023; Gautam P, 2015, BEHAV BRAIN RES, V287, P331, DOI 10.1016/j.bbr.2015.03.018; GEE JC, 1993, J COMPUT ASSIST TOMO, V17, P225, DOI 10.1097/00004728-199303000-00011; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Greitz T, 1991, J COMPUT ASSIST TOMO, P15; Hammers A, 2002, HUM BRAIN MAPP, V15, P165, DOI 10.1002/hbm.10016; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hammers A, 2007, NEUROIMAGE, V36, P38, DOI 10.1016/j.neuroimage.2007.02.031; Hammers A, 2007, HUM BRAIN MAPP, V28, P34, DOI 10.1002/hbm.20254; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Herve PY, 2012, NEUROIMAGE, V61, P1255, DOI 10.1016/j.neuroimage.2012.03.073; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; Horn H, 2009, BRIT J PSYCHIAT, V194, P130, DOI 10.1192/bjp.bp.107.045633; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Huffman Kelly, 2012, Frontiers in Genetics, V3, P212, DOI 10.3389/fgene.2012.00212; Hyatt CJ, 2012, BIOL PSYCHIAT, V72, P207, DOI 10.1016/j.biopsych.2011.11.017; Joseph R., 2000, NEUROPSYCHIATRY NEUR; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; Kennedy H, 2012, PROG BRAIN RES, V195, P341, DOI 10.1016/B978-0-444-53860-4.00016-7; Lemieux L, 2003, MAGN RESON MED, V49, P872, DOI 10.1002/mrm.10436; Li G, 2014, J NEUROSCI, V34, P4228, DOI 10.1523/JNEUROSCI.3976-13.2014; Liu T, 2012, PLOS ONE, P7; Makropoulos A, 2014, IEEE T MED IMAGING, V33, P1818, DOI 10.1109/TMI.2014.2322280; Malone IB, 2015, NEUROIMAGE, V104, P366, DOI 10.1016/j.neuroimage.2014.09.034; Markov NT, 2013, SCIENCE, V342, P578, DOI 10.1126/science.1238406; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Nierenberg J, 2005, AM J PSYCHIAT, V162, P1539, DOI 10.1176/appi.ajp.162.8.1539; Ochiai T, 2004, NEUROIMAGE, V22, P706, DOI 10.1016/j.neuroimage.2004.01.023; Ono M, 1990, ATLAS CEREBRAL SULCI; Palaniyappan L, 2012, EUR ARCH PSY CLIN N, V262, P579, DOI 10.1007/s00406-012-0314-y; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Rizzo G, 1997, NEUROIMAGE, V6, P59, DOI 10.1006/nimg.1997.0277; Roux FE, 2003, J NEUROSURG, V99, P716, DOI 10.3171/jns.2003.99.4.0716; Ruschel M, 2014, CEREB CORTEX, V24, P2436, DOI 10.1093/cercor/bht098; Salamon N, 2005, SURG RADIOL ANAT, V27, P431, DOI 10.1007/s00276-005-0022-7; Schaer M, 2012, JOVE-J VIS EXP, DOI 10.3791/3417; Seghier ML, 2010, J NEUROSCI, V30, P16809, DOI 10.1523/JNEUROSCI.3377-10.2010; SEITZ RJ, 1990, J CEREBR BLOOD F MET, V10, P443, DOI 10.1038/jcbfm.1990.87; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Shaw P, 2012, BIOL PSYCHIAT, V72, P191, DOI 10.1016/j.biopsych.2012.01.031; Soran B, 2012, IEEE ENG MED BIO, P3219, DOI 10.1109/EMBC.2012.6346650; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Studholme C., RVIEW; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sugiura L, 2011, CEREB CORTEX, V21, P2374, DOI 10.1093/cercor/bhr023; Torrey EF, 2007, SCHIZOPHR RES, V97, P215, DOI 10.1016/j.schres.2007.08.023; Tzourio-Mazoyer N, 2015, BRAIN STRUCT FUNCT, V220, P1585, DOI 10.1007/s00429-014-0746-4; Ulmer S., 2010, FMRI; VanEssen DC, 1997, J NEUROSCI, V17, P7079; VONBONIN G, 1951, T AM NEUROL ASSOC, P1; White T, 2003, BIOL PSYCHIAT, V54, P418, DOI 10.1016/S0006-3223(03)00065-9; Wu SS, 2009, CEREB CORTEX, V19, P2930, DOI 10.1093/cercor/bhp063; Xu XM, 2012, NEUROSCI LETT, V526, P33, DOI 10.1016/j.neulet.2012.08.004; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou SY, 2007, SCHIZOPHR RES, V89, P35, DOI 10.1016/j.schres.2006.08.032	87	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0180866	10.1371/journal.pone.0180866	http://dx.doi.org/10.1371/journal.pone.0180866			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846692	Green Published, Green Submitted, gold			2022-12-26	WOS:000408438600005
J	Kuck, P; Wilkinson, M; Gross, C; Foster, PG; Wagele, JW				Kueck, Patrick; Wilkinson, Mark; Gross, Christian; Foster, Peter G.; Waegele, Johann W.			Can quartet analyses combining maximum likelihood estimation and Hennigian logic overcome long branch attraction in phylogenomic sequence data?	PLOS ONE			English	Article							SITE RATE VARIATION; RNA-POLYMERASE-II; MISSING DATA; EVOLUTIONARY TREES; COMPOSITIONAL HETEROGENEITY; DATA SETS; INFERENCE; LIFE; PARSIMONY; ACCURACY	Systematic biases such as long branch attraction can mislead commonly relied upon model-based (i.e. maximum likelihood and Bayesian) phylogenetic methods when, as is usually the case with empirical data, there is model misspecification. We present PhyQuart, a new method for evaluating the three possible binary trees for any quartet of taxa. PhyQuart was developed through a process of reciprocal illumination between a priori considerations and the results of extensive simulations. It is based on identification of site-patterns that can be considered to support a particular quartet tree taking into account the Hennigian distinction between apomorphic and plesiomorphic similarity, and employing corrections to the raw observed frequencies of site-patterns that exploit expectations from maximum likelihood estimation. We demonstrate through extensive simulation experiments that, whereas maximum likeilihood estimation performs well in many cases, it can be outperformed by PhyQuart in cases where it fails due to extreme branch length asymmetries producing long-branch attraction artefacts where there is only very minor model misspecification.	[Kueck, Patrick; Waegele, Johann W.] Zool Forsch Museum Alexander Koenig, D-53113 Bonn, Germany; [Kueck, Patrick; Wilkinson, Mark; Gross, Christian; Foster, Peter G.] Nat Hist Museum, London SW7 5BD, England; [Gross, Christian] Delft Univ Technol, NL-2628 CD Delft, Netherlands	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Natural History Museum London; Delft University of Technology	Kuck, P (corresponding author), Zool Forsch Museum Alexander Koenig, D-53113 Bonn, Germany.; Kuck, P (corresponding author), Nat Hist Museum, London SW7 5BD, England.	patrick_kueck@web.de		Foster, Peter/0000-0003-0194-9237; Gross, Christian/0000-0002-9482-4259	John Templeton Foundation [43915]; PK's IEF Marie Curie Fellowship	John Templeton Foundation; PK's IEF Marie Curie Fellowship	This work was funded in part by PK's IEF Marie Curie Fellowship and by a grant (43915) from the John Templeton Foundation to MW.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Anderson FE, 2004, MOL PHYLOGENET EVOL, V33, P440, DOI 10.1016/j.ympev.2004.06.015; Arabi J, 2010, CR BIOL, V333, P438, DOI 10.1016/j.crvi.2010.01.018; Ashkenazy H, 2014, GENOME BIOL EVOL, V6, P3199, DOI 10.1093/gbe/evu252; Bapteste E, 2002, P NATL ACAD SCI USA, V290, P972; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bininda-Emonds ORP, 2004, PHYLOGENOMIC SUPERTR; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Brinkmann H, 2008, J SYST EVOL, V46, P274, DOI 10.3724/SP.J.1002.2008.08038; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; Cracraft J., 2004, ASSEMBLING TREE LIFE; Dacks JB, 2002, MOL BIOL EVOL, V19, P830, DOI 10.1093/oxfordjournals.molbev.a004140; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dress A, 1996, DISCRETE APPL MATH, V71, P95, DOI 10.1016/S0166-218X(96)00059-5; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Dunn KA, 2003, MOL PHYLOGENET EVOL, V27, P259, DOI 10.1016/S1055-7903(02)00442-6; EMBLEY TM, 1993, SYST APPL MICROBIOL, V16, P25; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fernandez R, 2015, BIORXIV, P1; Fischer M, 2009, J THEOR BIOL, V256, P247, DOI 10.1016/j.jtbi.2008.09.031; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; Foster PG, 2009, PHILOS T R SOC B, V364, P2197, DOI 10.1098/rstb.2009.0034; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Fuellen G, 2001, BIOINFORMATICS, V17, P1168, DOI 10.1093/bioinformatics/17.12.1168; Gaucher EA, 2005, MOL PHYLOGENET EVOL, V37, P928, DOI 10.1016/j.ympev.2005.03.027; GAUT BS, 1995, MOL BIOL EVOL, V12, P152, DOI 10.1093/oxfordjournals.molbev.a040183; Gee H, 2003, NATURE, V425, P782, DOI 10.1038/425782a; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haldane J.B.S., 1927, POSSIBLE WORLDS OTHE; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Harvey P. H., 1996, NEW USES NEW PHYLOGE; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; HENNIG W, 1965, ANNU REV ENTOMOL, V10, P97, DOI 10.1146/annurev.en.10.010165.000525; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; HUELSENBECK JP, 1991, SYST ZOOL, V40, P458, DOI 10.2307/2992240; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Kocot K. M., 2016, SYST BIOL; Kuck P, 2015, CLADISTICS, V0, P1; Kuck P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036593; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P1455, DOI 10.1073/pnas.91.4.1455; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Laumer CE, 2015, CURR BIOL, V25, P2000, DOI 10.1016/j.cub.2015.06.068; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Nesnidal MP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-253; Nesnidal MP, 2010, MOL BIOL EVOL, V27, P2095, DOI 10.1093/molbev/msq097; Nishihara H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r199; Nosenko T, 2013, MOL PHYLOGENET EVOL, V67, P223, DOI 10.1016/j.ympev.2013.01.010; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Omilian AR, 2001, MOL BIOL EVOL, V18, P2201, DOI 10.1093/oxfordjournals.molbev.a003767; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Pisani D, 2004, SYST BIOL, V53, P978, DOI 10.1080/10635150490888877; PISANI D, 2009, TIMETREE LIFE; Podsiadlowski L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-284; Poe S, 2003, SYST BIOL, V52, P423, DOI 10.1080/10635150390197046; Poe S, 1998, MOL BIOL EVOL, V15, P1086, DOI 10.1093/oxfordjournals.molbev.a026008; Pol D, 2001, CLADISTICS, V17, P266, DOI 10.1111/j.1096-0031.2001.tb00123.x; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Privman E, 2012, MOL BIOL EVOL, V29, P1, DOI 10.1093/molbev/msr177; Rannala B, 1998, SYST BIOL, V47, P702, DOI 10.1080/106351598260680; Rosenberg MS, 2003, MOL BIOL EVOL, V20, P610, DOI 10.1093/molbev/msg067; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Roure B, 2013, MOL BIOL EVOL, V30, P197, DOI 10.1093/molbev/mss208; Sanderson MJ, 2000, MOL BIOL EVOL, V17, P782, DOI 10.1093/oxfordjournals.molbev.a026357; Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318; Sharma PP, 2014, MOL BIOL EVOL, P1; Simmons MP, 2012, CLADISTICS, V28, P208, DOI 10.1111/j.1096-0031.2011.00375.x; Simmons MP, 2012, MOL PHYLOGENET EVOL, V62, P472, DOI 10.1016/j.ympev.2011.10.017; Simmons MP, 2011, MOL PHYLOGENET EVOL, V61, P177, DOI 10.1016/j.ympev.2011.06.003; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Snir S, 2012, MOL PHYLOGENET EVOL, V62, P1, DOI 10.1016/j.ympev.2011.06.021; Soltis PS, 2001, TAXON, V50, P663, DOI 10.2307/1223700; Struck TH, 2014, MOL BIOL EVOL, V31, P1833, DOI 10.1093/molbev/msu143; Sullivan J, 2001, SYST BIOL, V50, P723, DOI 10.1080/106351501753328848; SULLIVAN J, 1995, MOL BIOL EVOL, V12, P988; Sullivan Jack, 1997, Journal of Mammalian Evolution, V4, P77, DOI 10.1023/A:1027314112438; Susko E, 2005, J MOL EVOL, V61, P351, DOI 10.1007/s00239-004-0352-9; Susko E, 2015, SYST BIOL, V64, P243, DOI 10.1093/sysbio/syu099; Swofford D.L., 1996, PHYLOGENETIC INFEREN; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Telford MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0479; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; Wilkinson M, 1998, SYST BIOL, V47, P673, DOI 10.1080/106351598260662; Wilkinson M, 2006, SYSTEMATIC ASS SPECI; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Williams TA, 2012, P ROY SOC B-BIOL SCI, V279, P4870, DOI 10.1098/rspb.2012.1795; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	113	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183393	10.1371/journal.pone.0183393	http://dx.doi.org/10.1371/journal.pone.0183393			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841676	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700029
J	Pui, M; Nicol, AM; Brauer, M; Palad, F; Carlsten, C				Pui, Mandy; Nicol, Anne-Marie; Brauer, Michael; Palad, Farshad; Carlsten, Christopher			A qualitative study of the knowledge, attitudes, and behaviors of people exposed to diesel exhaust at the workplace in British Columbia, Canada	PLOS ONE			English	Article							AIR-POLLUTION; PARTICULATE MATTER; WORKERS	Purpose To identify exposure-related knowledge, attitudes and behaviors of individuals occupationally exposed to diesel exhaust (DE); to reveal strengths, knowledge gaps and misperceptions therein. Methods A Mental Models approach was used to gather information about current scientific understanding of DE exposure hazards and the ways in which exposure can be reduced. Thirty individuals in British Columbia who were regularly exposed to occupational DE were interviewed. The audio was recorded and transcribed. Data was grouped together and examined to draw out themes around DE awareness, hazard assessment and risk reduction behaviors. These themes were then compared and contrasted with existing grey and research literature in order to reveal strengths, gaps and misperceptions regarding DE exposure. Results Study participants were aware and concerned about their exposure to DE but had incomplete and sometimes incorrect understanding of exposure pathways, health effects, and effective strategies to reduce their exposures. The perceived likelihood of exposure to DE was significantly greater compared to that of other work hazards (p<0.01), whereas the difference for their perceived severity of consequences was not significant. There was no universally perceived main source of information regarding DE, and participants generally distrusted sources of information based on their past experience with the source. Most of the actions that were taken to address DE exposure fell into the area of administrative controls such as being aware of sources of DE and avoiding these sources. Conclusions This study of the knowledge, attitude, and behavior of those occupationally exposed to DE found, most notably, that more education and training and the creation of a health effects inventory regarding DE exposure were desired.	[Pui, Mandy; Brauer, Michael; Carlsten, Christopher] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Nicol, Anne-Marie; Palad, Farshad] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Brauer, Michael; Carlsten, Christopher] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of British Columbia; Simon Fraser University; University of British Columbia	Pui, M; Carlsten, C (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.; Carlsten, C (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	dieselworkers@gmail.com; carlsten@mail.ubc.ca	Brauer, Michael/Y-2810-2019	Brauer, Michael/0000-0002-9103-9343				Alfaro-Moreno E, 2007, CURR OPIN PULM MED, V13, P98, DOI 10.1097/MCP.0b013e328013f47e; Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x; Baranowski T, 2003, OBESITY RES, V11; Brook RD, 2010, OCCUP ENV MED; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Bull ER D S, 2014, BMJ OPEN, V4; Calderon-Garciduenas L, 2008, BRAIN COGNITION, V68, P117, DOI 10.1016/j.bandc.2008.04.008; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Canada H, 2013, FUELS AIR POLLUTION; Canada S., EMPLOYMENT IND SEX C; CAREX, 2014, PROF EST BURN; Carlsten C, 2007, THROMB RES; CCOHS, 2012, HLTH SAF REP, V10; CCOHS, 2008, OH S LEG CAN BAS RES; Centre CP, 2012, REDUCING EXPOSURES O; Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011; CupeBC, HLTH SAF MATT BRIT; Demers P., 2007, CARCINOGEN SURVEILLA; Freire C, 2010, J EPIDEMIOL COMMUN H, V64, P223, DOI 10.1136/jech.2008.084574; GAMBLE J, 1987, ENVIRON RES, V44, P6, DOI 10.1016/S0013-9351(87)80082-8; Gupta A, 2006, AM J IND MED, V49, P423, DOI 10.1002/ajim.20312; Kim J, 2014, OCCUP ENV MED S1, V71; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Miller PG, 2015, AM J DRUG ALCOHOL AB, V41, P16, DOI 10.3109/00952990.2014.966199; Morgan M. G., 2002, RISK COMMUNICATION M; Nicol AM HA, 2008, EUR SAF REL C VAL SP; NIOSH, MIN TOP DIES EXH 201; NTP, 12 REP CARC DIES EXH; Organization WH, 2008, AD COMM SOC MOB TB C, P116; OSHA, 2015, SAF HAZ; OSHA Occupational Safety and Health Administration, 2013, HAZ AL DIES EXH DIES; Sadhra S, 2002, OCCUP ENVIRON MED, V59, P689, DOI 10.1136/oem.59.10.689; Santos MS, 2007, CHEST, V131, P1768, DOI 10.1378/chest.06-2487; Society CC, 2015, LUNG CANC STAT CAN; STEENLAND K, 1992, AM J IND MED, V21, P887, DOI 10.1002/ajim.4700210612; Strauss A., 1998, BASICS QUALITATIVE R; Wood M, 2012, RISK ANAL, V32, P1349, DOI 10.1111/j.1539-6924.2012.01832.x; WorkSafeBC, WORKSAFEBC 2012 STAT; WorkSafeBC, 2010, OHS REG GUID 5; Zaksek M, 2004, RISK ANAL, V24, P1503, DOI 10.1111/j.0272-4332.2004.00545.x	42	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182890	10.1371/journal.pone.0182890	http://dx.doi.org/10.1371/journal.pone.0182890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841707	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700014
J	Chen, YF; Ding, JP; Yan, HJ; Lu, J; Ding, P; Chen, GH; Li, JJ; Huan, XP; Yang, HT; Tang, WM; Fu, GF				Chen, Yuan-Fang; Ding, Jian-Ping; Yan, Hong-Jing; Lu, Jing; Ding, Ping; Chen, Guo-Hong; Li, Jian-Jun; Huan, Xi-Ping; Yang, Hai-Tao; Tang, Wei-Ming; Fu, Geng-Feng			The current status of syphilis prevention and control in Jiangsu province, China: A cross-sectional study	PLOS ONE			English	Article							MULTILEVEL; EPIDEMIC	Objective To analyze the midterm evaluation data from the National Syphilis Prevention and Control Plan (2010-2020) and evaluate the current status of syphilis prevention and control in Jiangsu province, China. Methods We collected data via (1) field surveys conducted in 2015 and (2) data recorded in existing syphilis surveillance systems. We conducted descriptive statistical analysis to evaluate the current landscape of syphilis control initiatives and their potential effect in syphilis control. Results The incidence of all cases of syphilis decreased from 2010 (32.3 per 100,000) to 2015 (30.1 per 100,000), with an annual growth of -1.17% (x(trend)(2) = -7.52, P<0.001) in Jiangsu province. The incidence of primary and secondary syphilis and congenital syphilis both decreased significantly from 2010 to 2015. The average awareness rate of syphilis knowledge among professional personnel was 95.4% (3781/3963). Rural residents had the lowest awareness rate (83.5%, 1875/2245) and commercial sex workers had the highest awareness rate (92.1%, 7804/8474) in 2015. Only 47.8% (33908/70894) of patients received provider-initiated syphilis counseling and testing (PISTC) services in sexually transmitted disease (STD) clinics, but 94.5% (87927/93020) of all syphilis patients received free testing for syphilis. Overall, 97.2% (9378/9648) of syphilis reported cases of syphilis at medical institutions were confirmed to be accurate, and 92.2% (5850/6345) of patients diagnosed with syphilis at medical institutions received treatment with penicillin. Conclusion The syphilis incidence rate in Jiangsu has decreased in recent years, but remains at a high level. It is essential to promote PISTC services to improve knowledge of syphilis and rates of testing and treatment in Jiangsu province.	[Chen, Yuan-Fang; Ding, Jian-Ping; Yan, Hong-Jing; Lu, Jing; Ding, Ping; Chen, Guo-Hong; Li, Jian-Jun; Huan, Xi-Ping; Fu, Geng-Feng] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Yang, Hai-Tao] Jiangsu Inst Parasit Dis, Wuxi, Peoples R China; [Tang, Wei-Ming] Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention	Fu, GF (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.; Tang, WM (corresponding author), Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China.	weimingtangscience@gmail.com; fugf@jscdc.cn						Azeredo CM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011571; Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Champredon D, 2016, EPIDEMIOL INFECT, V144, P3244, DOI 10.1017/S0950268816001643; Chen XS, 2013, CHINESE MED J-PEKING, V126, P2774, DOI 10.3760/cma.j.issn.0366-6999.20123559; China Ministry of Health, 2010, NOT MIN HLTH ISS NAT; Chivriga V., 2016, SUBSIDIZING AGR REPU, P37; Fu GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118863; Han Y., 2013, CHINESE J HUMAN SEXU, V22, P37; Hongcheng S, 2016, CHIN J AIDS STD, V22, P32, DOI DOI 10.13419/J.CNKI.AIDS.2016.01.11; Hu Yu-Feng, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P876; Huang SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121814; Ma P, 2012, JIANGSU J PREVENTIVE, V23, P34; Patton ME, 2014, MMWR-MORBID MORTAL W, V63, P402; Qin JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102203; Song X, 2017, CHINA RURAL HLTH, P59; Sun YP, 2016, MED INFORM, V29, P285; Tang WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085985; Taylor MM, 2016, B WORLD HEALTH ORGAN, V94, P559, DOI 10.2471/BLT.16.173310; Tucker JD, 2011, CURR OPIN INFECT DIS, V24, P50, DOI 10.1097/QCO.0b013e32834204bf; Wang Jian, 2016, Chinese Journal of Dermatology, V49, P364; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; Wong NS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-4004-y; World Health Organisation, 2021, SEXUALLY TRANSMITTED; Wu XB, 2012, SEX TRANSM INFECT, V88, P325, DOI 10.1136/sextrans-2011-050397; Xia JH, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0760-0; Xu JG, 2013, INT J LAB MED, V34, P3182; Yang HT, 2014, CLIN INFECT DIS, V58, P1753, DOI 10.1093/cid/ciu175; Zhang JX, 2011, J THERM SCI, V20, P1, DOI 10.1007/s11630-011-0426-0; Zhang WY, 2016, J DERMATOLOGY VENERE, V38, P1002; Zhao Y, 2007, MODERN PREVENTIVE ME, V34, P1956; [邹亚明 Zou Yaming], 2016, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V37, P142; 樊尚荣(编译), 2015, [中国全科医学, Chinese General Practice], V18, P3260	32	4	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183409	10.1371/journal.pone.0183409	http://dx.doi.org/10.1371/journal.pone.0183409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837587	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000064
J	Kainuma, S; Miyagawa, S; Fukushima, S; Tsuchimochi, H; Sonobe, T; Fujii, Y; Pearson, JT; Saito, A; Harada, A; Toda, K; Shirai, M; Sawa, Y				Kainuma, Satoshi; Miyagawa, Shigeru; Fukushima, Satsuki; Tsuchimochi, Hirotsugu; Sonobe, Takashi; Fujii, Yutaka; Pearson, James T.; Saito, Atsuhiro; Harada, Akima; Toda, Koichi; Shirai, Mikiyasu; Sawa, Yoshiki			Influence of coronary architecture on the variability in myocardial infarction induced by coronary ligation in rats	PLOS ONE			English	Article							CELL-SHEET TECHNIQUE; HEART-FAILURE; ISCHEMIC CARDIOMYOPATHY; ARTERY LIGATION; THERAPY; MODEL; LOCATION; MOUSE; MICE; SIZE	It has been shown that the size of myocardial infarction in rats created by coronary ligation technique is not uniform, varying from 4% to 65%. We hypothesized that infarct size variability induced by coronary artery ligation might be caused by coronary artery branching pattern. Coronary artery angiography was performed in 50 normal Lewis rats and in chronic myocardial infarction models in which coronary artery was ligated immediately below the left atrial appendage or 2mm distal to the left atrial appendage (n = 25 for each), followed by histological analysis. Unlike the human, the rats had a single major septal artery arising from the proximal part of the left coronary artery (n = 30) or right coronary artery (n = 20). There were three branching patterns of left circumflex artery (LCX): 33 (66%) had LCX branching peripherally from a long left main coronary artery (LMCA), while the remainder 17 (34%) had the LCX branching from the proximal part of the septal artery or a short LMCA. The rats with distal coronary ligation presented myocardial infarction localized to an anterior territory irrespective of LCX branching pattern. In the rats with proximal coronary ligation, 64% (n = 16) had broad myocardial infarction involving the anterior and lateral territories, while the remainder (36%, n = 9) had myocardial infarction localized to an anterior territory with the intact LCX arising proximally from a short LMCA. The interventricular septum was spared from infarction in all rats because of its anatomical location. Infarct size variations were caused not only by ligation site but also by varying LCX branching patterns. There are potential risks to create different sizes of myocardial infarction, particularly when targeting a broad range of myocardial infarction. The territory of the septal artery always appears to be spared from myocardial infarction induced by the coronary ligation technique.	[Kainuma, Satoshi; Miyagawa, Shigeru; Fukushima, Satsuki; Saito, Atsuhiro; Harada, Akima; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Tsuchimochi, Hirotsugu; Sonobe, Takashi; Fujii, Yutaka; Pearson, James T.; Shirai, Mikiyasu] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cardiac Physiol, Suita, Osaka, Japan; [Pearson, James T.] Monash Univ, Dept Physiol, Clayton, Vic, Australia	Osaka University; National Cerebral & Cardiovascular Center - Japan; Monash University	Sawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan.	sawa-p@surg1.med.osaka-u.ac.jp	Sonobe, Takashi/Q-6600-2016; Tsuchimochi, Hirotsugu/D-8224-2011; Fukushima, Satsuki/ABE-6582-2020; Pearson, James/B-4631-2012	Sonobe, Takashi/0000-0003-3589-0405; Tsuchimochi, Hirotsugu/0000-0001-7591-2520; Fukushima, Satsuki/0000-0002-9481-8860; Pearson, James/0000-0002-3318-5406; Miyagawa, Shigeru/0000-0003-0015-6569	Ministry of Health, Labour and Welfare of Japan; JSPS KAKENHI [26670616]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Research on Regenerative Medicine for Clinical Application from the Ministry of Health, Labour and Welfare of Japan. The work was supported by JSPS KAKENHI Grant (26670616): https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26670616/.	Ahn D, 2004, AM J PHYSIOL-HEART C, V286, pH1201, DOI 10.1152/ajpheart.00862.2003; Bayat H, 2002, BASIC RES CARDIOL, V97, P206, DOI 10.1007/s003950200013; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; GELTMAN EM, 1979, CIRCULATION, V60, P805, DOI 10.1161/01.CIR.60.4.805; Imanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069302; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; Kainuma S, 2015, MOL THER, V23, P374, DOI 10.1038/mt.2014.225; Klocke R, 2007, CARDIOVASC RES, V74, P29, DOI 10.1016/j.cardiores.2006.11.026; Kumar D, 2005, CORONARY ARTERY DIS, V16, P41, DOI 10.1097/00019501-200502000-00008; Liu YH, 1997, AM J PHYSIOL-HEART C, V272, pH722, DOI 10.1152/ajpheart.1997.272.2.H722; MACLEAN D, 1978, J CLIN INVEST, V61, P541, DOI 10.1172/JCI108965; Matsuda T, 2014, CIRC J, V78, P222, DOI 10.1253/circj.CJ-13-0534; Narita T, 2013, INT J CARDIOL, V168, P261, DOI 10.1016/j.ijcard.2012.09.081; Narita T, 2013, MOL THER, V21, P860, DOI 10.1038/mt.2013.9; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; POMBO JF, 1971, CIRCULATION, V43, P480, DOI 10.1161/01.CIR.43.4.480; Shudo Y, 2011, TRANSPLANTATION, V92, pE34, DOI 10.1097/TP.0b013e31822d875c; Tano N, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002815; Tanol N, 2014, MOL THER, V22, P1864, DOI 10.1038/mt.2014.110; Uchinaka A, 2010, CELL TRANSPLANT, V19, P573; Uchinaka A, 2014, TISSUE ENG PT A, V20, P3073, DOI [10.1089/ten.tea.2013.0763, 10.1089/ten.TEA.2013.0763]; WILSON RB, 1970, ARCH PATHOL, V89, P457	22	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183323	10.1371/journal.pone.0183323	http://dx.doi.org/10.1371/journal.pone.0183323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837679	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000059
J	Li, J; Zhong, R; Palva, ET				Li, Jing; Zhong, Rusen; Palva, E. Tapio			WRKY70 and its homolog WRKY54 negatively modulate the cell wall-associated defenses to necrotrophic pathogens in Arabidopsis	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; OXIDATIVE CROSS-LINKING; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; SALICYLIC-ACID; DISEASE RESISTANCE; BOTRYTIS-CINEREA; PLANT; STRESS; SUPPRESSION	Previous studies have identified the Arabidopsis thaliana transcription factor WRKY70 as a node of convergence for salicylic acid (SA) and jasmonic acid (JA)-mediated defense signal pathways and, together with its closest homolog WRKY54, as a negative regulator of SA biosynthesis. Here, we demonstrate that WRKY70 together with WRKY54 negatively affect the response of Arabidopsis to the necrotrophic pathogens Pectobacterium carotovorum and Botrytis cinerea, but not to the hemibiotroph Pseudomonas syringae pv tomato (Pst) DC3000, as revealed by mutants studies. Unstressed wrky54wrky70 double mutants exhibited increased levels of SA, accumulation of hydrogen peroxide (H2O2) and up-regulated expression of both SA and JA/ethylene (ET) responsive defense related genes. Additionally, protein cross-linking in cell wall was promoted by endogenous SA, suggesting involvement of wall-associated defenses against necrotrophs. This response to necrotrophs was compromised by introducing the sid2-1 allele impairing SA biosynthesis and leading to reduction of H2O2 content and of defense gene expression. The data suggest that the elevated SA level in the wrky54wrky70 double mutant results in moderate accumulation of H2O2, in promoting cell wall fortification and consequently enhanced resistance to necrotrophs but is not sufficient to trigger hypersensitive reaction (HR)-like cell death and resistance to biotrophs/hemibiotrophs like Pst DC3000.	[Li, Jing; Zhong, Rusen] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan, Hubei, Peoples R China; [Palva, E. Tapio] Univ Helsinki, Dept Biosci, Viikki Bioctr, Div Genet, Helsinki, Finland	Wuhan University of Technology; University of Helsinki	Li, J (corresponding author), Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan, Hubei, Peoples R China.	celery_wh@126.com			Academy of Finland Center of Excellence programme; Academy of Finland [257644]; European Research Area in Plant Genomics [ERAPGFP/06.023a]; Fundamental Research Funds for the Central Universities [WUT:2017IVA115, 2017IB006]	Academy of Finland Center of Excellence programme(Academy of Finland); Academy of Finland(Academy of Finland); European Research Area in Plant Genomics; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by the Academy of Finland Center of Excellence programme, the project of Academy of Finland (257644) and the European Research Area in Plant Genomics (ERAPGFP/06.023a) and the Fundamental Research Funds for the Central Universities (WUT:2017IVA115 and 2017IB006) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Antico Christopher J, 2012, [Frontiers in Biology, 生物学前沿], V7, P48; Asselbergh B, 2007, PLANT PHYSIOL, V144, P1863, DOI 10.1104/pp.107.099226; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Bolwell GP, 2009, SIGNAL COMMUN PLANTS, P113, DOI 10.1007/978-3-642-00390-5_7; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; BRISSON LF, 1994, PLANT CELL, V6, P1703, DOI 10.1105/tpc.6.12.1703; Brown I, 1998, PLANT J, V15, P333, DOI 10.1046/j.1365-313X.1998.00215.x; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Coego A, 2005, PLANT CELL, V17, P2123, DOI 10.1105/tpc.105.032375; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Davidsson PR, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00191; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Draper J, 1997, TRENDS PLANT SCI, V2, P162, DOI 10.1016/S1360-1385(97)01030-3; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Federici L, 2006, TRENDS PLANT SCI, V11, P65, DOI 10.1016/j.tplants.2005.12.005; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; He P, 2007, CELL MICROBIOL, V9, P1385, DOI 10.1111/j.1462-5822.2007.00944.x; Hwang BH, 2012, PLANT CELL TISS ORG, V103; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Li J, 2013, NEW PHYTOL, V200, P455, DOI 10.1111/nph.12378; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; PALVA TK, 1994, MOL PLANT MICROBE IN, V7, P356, DOI 10.1094/MPMI-7-0356; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Survila M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01945; Temme N, 2009, MOL PLANT MICROBE IN, V22, P987, DOI 10.1094/MPMI-22-8-0987; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Toth IK, 2005, CURR OPIN PLANT BIOL, V8, P424, DOI 10.1016/j.pbi.2005.04.001; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Vidal S, 1997, PLANT J, V11, P115, DOI 10.1046/j.1365-313X.1997.11010115.x; vonTiedemann A, 1997, PHYSIOL MOL PLANT P, V50, P151; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	55	46	47	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183731	10.1371/journal.pone.0183731	http://dx.doi.org/10.1371/journal.pone.0183731			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837631	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000106
J	Muenks, AG; Stiers, KM; Beamer, LJ				Muenks, Andrew G.; Stiers, Kyle M.; Beamer, Lesa J.			Sequence-structure relationships, expression profiles, and disease-associated mutations in the paralogs of phosphoglucomutase 1	PLOS ONE			English	Article							ACETYLGLUCOSAMINE-PHOSPHATE MUTASE; D-PHOSPHOHEXOMUTASE SUPERFAMILY; PGM3; DEFICIENCY; PROTEIN; MUSCLE; IDENTIFICATION; DEFECTS; GENE; PHOSPHOPENTOMUTASE	The key metabolic enzyme phosphoglucomutase 1 (PGM1) controls glucose homeostasis in most human cells. Four proteins related to PGM1, known as PGM2, PGM2L1, PGM3 and PGM5, and referred to herein as paralogs, are encoded in the human genome. Although all members of the same enzyme superfamily, these proteins have distinct substrate preferences and different functional roles. The recent association of PGM1 and PGM3 with inherited enzyme deficiencies prompts us to revisit sequence-structure and other relationships among the PGM1 paralogs, which are understudied despite their importance in human biology. Using currently available sequence, structure, and expression data, we investigated evolutionary relationships, tissue-specific expression profiles, and the amino acid preferences of key active site motifs. Phylogenetic analyses indicate both ancient and more recent divergence between the different enzyme sub-groups comprising the human paralogs. Tissue-specific protein and RNA expression profiles show widely varying patterns for each paralog, providing insight into function and disease pathology. Multiple sequence alignments confirm high conservation of key active site regions, but also reveal differences related to substrate specificity. In addition, we find that sequence variants of PGM2, PGM2L1, and PGM5 verified in the human population affect residues associated with disease-related mutants in PGM1 or PGM3. This suggests that inherited diseases related to dysfunction of these paralogs will likely occur in humans.	[Muenks, Andrew G.; Stiers, Kyle M.; Beamer, Lesa J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Beamer, LJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	beamerl@missouri.edu		Stiers, Kyle/0000-0001-5542-022X; Beamer, Lesa/0000-0001-5689-200X	National Institutes of Health [T32 GM008396-26]; American Heart Society [17PRE33400210]; Patton Trust of the Kansas City Area Life Sciences Research Foundation; National Science Foundation [MCB-1409898]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1409898] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Society; Patton Trust of the Kansas City Area Life Sciences Research Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KMS was supported by National Institutes of Health training grant T32 GM008396-26 and a predoctoral fellowship 17PRE33400210 from the American Heart Society. This work was supported by grants to LJB from the Patton Trust of the Kansas City Area Life Sciences Research Foundation and the National Science Foundation (MCB-1409898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei I, 2001, CURRENT PROTOCOLS HU; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Beamer L.J., 2015, J INHERIT METAB DIS, V38; BELKIN AM, 1994, J CELL SCI, V107, P159; BELKIN AM, 1994, J CELL SCI, V107, P1993; BELKIN AM, 1995, J BIOL CHEM, V270, P6328, DOI 10.1074/jbc.270.11.6328; Charif D, 2007, THE SEQINR PACKAGE; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; Gaudet P, 2011, BRIEF BIOINFORM, V12, P449, DOI 10.1093/bib/bbr042; Gururaj A, 2004, ONCOGENE, V23, P8118, DOI 10.1038/sj.onc.1207969; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee Y, 2014, J BIOL CHEM, V289, P32010, DOI 10.1074/jbc.M114.597914; Li CY, 2000, GENE, V242, P97, DOI 10.1016/S0378-1119(99)00543-0; LOWRY OH, 1969, J BIOL CHEM, V244, P910; Lundin KE, 2015, CLIN IMMUNOL, V161, P366, DOI 10.1016/j.clim.2015.10.002; Maliekal P, 2007, J BIOL CHEM, V282, P31844, DOI 10.1074/jbc.M706818200; MCALPINE PJ, 1970, ANN HUM GENET, V34, P169, DOI 10.1111/j.1469-1809.1970.tb00230.x; Mehra-Chaudhary R, 2011, PROTEINS, V79, P1215, DOI 10.1002/prot.22957; Mio T, 2000, BBA-GENE STRUCT EXPR, V1492, P369, DOI 10.1016/S0167-4781(00)00120-2; Moiseeva E., 2004, EUROPEAN J BIOCH, V235, P103; Molt S, 2014, J CELL SCI, V127, P3578, DOI 10.1242/jcs.152157; Nishitani Y, 2006, J BIOL CHEM, V281, P19740, DOI 10.1074/jbc.M600801200; Pacheco-Cuellar G, 2017, J BONE MINE IN PRESS; Pang H, 2002, ANN HUM GENET, V66, P139, DOI 10.1017/S0003480002001033; Perez B, 2013, J INHERIT METAB DIS, V36, P535, DOI 10.1007/s10545-012-9525-7; PUTT W, 1993, BIOCHEM J, V296, P417, DOI 10.1042/bj2960417; QUICK CB, 1974, EUR J BIOCHEM, V42, P511, DOI 10.1111/j.1432-1033.1974.tb03366.x; Regni C, 2004, STRUCTURE, V12, P55, DOI 10.1016/j.str.2003.11.015; ROBERT X, 2014, NUCLEIC ACIDS RES, V42, P320, DOI DOI 10.1093/NAR/GKU316; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stiers KM, 2017, ADV PROTEIN CHEM STR, P265; Stiers KM, 2017, FEBS J, V284, P937, DOI 10.1111/febs.14025; Stiers KM, 2016, J MOL BIOL, V428, P1493, DOI 10.1016/j.jmb.2016.02.032; Stojkovic T, 2009, NEW ENGL J MED, V361, P425, DOI 10.1056/NEJMc0901158; Stray-Pedersen A, 2014, AM J HUM GENET, V95, P96, DOI 10.1016/j.ajhg.2014.05.007; Tegtmeyer LC, 2014, NEW ENGL J MED, V370, P533, DOI 10.1056/NEJMoa1206605; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Willems AP, 2016, BBA-GEN SUBJECTS, V1860, P1640, DOI 10.1016/j.bbagen.2015.12.017; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013	48	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183563	10.1371/journal.pone.0183563	http://dx.doi.org/10.1371/journal.pone.0183563			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837627	Green Submitted, gold, Green Published			2022-12-26	WOS:000408365000082
J	Aguilera, O; Luz, Z; Carrillo-Briceno, JD; Kocsis, L; Vennemann, TW; de Toledo, PM; Nogueira, A; Amorim, KB; Moraes-Santos, H; Polck, MR; Ruivo, MD; Linhares, AP; Monteiro-Neto, C				Aguilera, Orangel; Luz, Zoneibe; Carrillo-Briceno, Jorge D.; Kocsis, Laszlo; Vennemann, Torsten W.; de Toledo, Peter Mann; Nogueira, Afonso; Amorim, Kamilla Borges; Moraes-Santos, Heloisa; Polck, Marcia Reis; Ruivo, Maria de Lourdes; Linhares, Ana Paula; Monteiro-Neto, Cassiano			Neogene sharks and rays from the Brazilian 'Blue Amazon'	PLOS ONE			English	Article							SPOTTED EAGLE RAY; MOVEMENT PATTERNS; EARLY MIOCENE; POPULATION-STRUCTURE; FISH ASSEMBLAGE; SEA-LEVEL; ISOTOPIC COMPOSITION; CARCHARHINUS-LEUCAS; STRONTIUM ISOTOPES; RHINOPTERA-BONASUS	The lower Miocene Pirabas Formation in the North of Brazil was deposited under influence of the proto-Amazon River and is characterized by large changes in the ecological niches from the early Miocene onwards. To evaluate these ecological changes, the elasmobranch fauna of the fully marine, carbonate-rich beds was investigated. A diverse fauna with 24 taxa of sharks and rays was identified with the dominant groups being carcharhiniforms and myliobatiforms. This faunal composition is similar to other early Miocene assemblages from the proto-Carribbean bioprovince. However, the Pirabas Formation has unique features compared to the other localities; being the only Neogene fossil fish assemblage described from the Atlantic coast of Tropical Americas. Phosphate oxygen isotope composition of elasmobranch teeth served as proxies for paleotemperatures and paleoecology. The data are compatible with a predominantly tropical marine setting with recognized inshore and offshore habitats with some probable depth preferences (e.g., Aetomylaeus groups). Paleohabitat of taxa particularly found in the Neogene of the Americas (+Carcharhinus ackermannii, +Aetomylaeus cubensis) are estimated to have been principally coastal and shallow waters. Larger variation among the few analyzed modern selachians reflects a larger range for the isotopic composition of recent seawater compared to the early Miocene. This probably links to an increased influence of the Amazon River in the coastal regions during the Holocene.	[Aguilera, Orangel; Monteiro-Neto, Cassiano] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Rio De Janeiro, Brazil; [Aguilera, Orangel; Luz, Zoneibe; Nogueira, Afonso] Univ Fed Para, Inst Geociencias, Belem, Para, Brazil; [Carrillo-Briceno, Jorge D.] Univ Zurich, Palaeontol Inst & Museum, Zurich, Canton Of Zuric, Switzerland; [Kocsis, Laszlo] Univ Brunei Darussalam, Fac Sci, Geol Grp, Jalan Tungku, Gadong, Brunei; [Luz, Zoneibe; Vennemann, Torsten W.] Univ Lausanne, Inst Dynam Surface Terrestre, Lausanne, Vaud, Switzerland; [de Toledo, Peter Mann] Inst Nacl Pesquisas Espaciais, Sao Paulo, Brazil; [Amorim, Kamilla Borges] Univ Sao Paulo, Inst Astron Geofis & Ciencias Atmosfer, Sao Paulo, Brazil; [Moraes-Santos, Heloisa; Ruivo, Maria de Lourdes; Linhares, Ana Paula] Museu Paraense Emilio Goeldi, Coordenacao Ciencias Terra & Ecol, Belem, Para, Brazil; [Polck, Marcia Reis] Dept Nacl Prod Mineral, Rio De Janeiro, RJ, Brazil	Universidade Federal Fluminense; Universidade Federal do Para; University of Zurich; University Brunei Darussalam; University of Lausanne; Instituto Nacional de Pesquisas Espaciais (INPE); Universidade de Sao Paulo; Museu Paraense Emilio Goeldi	Luz, Z (corresponding author), Univ Fed Para, Inst Geociencias, Belem, Para, Brazil.; Luz, Z (corresponding author), Univ Lausanne, Inst Dynam Surface Terrestre, Lausanne, Vaud, Switzerland.	zoneibe.luz@gmail.com	Aguilera, Orangel/D-5055-2013; Toledo, Peter M/P-3618-2015	Toledo, Peter M/0000-0003-4265-2624; Borges Amorim, Kamilla/0000-0002-5031-402X; Luz, Zoneibe/0000-0002-8920-7694; NOGUEIRA, AFONSO/0000-0002-5225-9255; Aguilera, Orangel/0000-0003-4418-8351; Kocsis, Laszlo/0000-0003-4613-1850	National Counsel of Technological and Scientific Development (CNPq); Museum Paraense Emilio Goeldi (MPEG); Departamento Nacional de Producao Mineral (DNPM); Universidade Federal Fluminense (UFF); Universidade Federal do Para (UFPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [ICAAF 111/2014]; Instituto Nacional de Ciencia e Tecnologia (INCT) in Brazil; Palaeontological Institute and Museum at the University of Zurich; University of Lausanne	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Museum Paraense Emilio Goeldi (MPEG); Departamento Nacional de Producao Mineral (DNPM); Universidade Federal Fluminense (UFF); Universidade Federal do Para (UFPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia (INCT) in Brazil; Palaeontological Institute and Museum at the University of Zurich; University of Lausanne	This research was supported by the National Counsel of Technological and Scientific Development (CNPq) (http//www.cnpq.br, to O.A.), the Museum Paraense Emilio Goeldi (MPEG) (http://www.museu-goeldi.br/, to O.A., H.M-S, M.L. R., A.P.L.), the Departamento Nacional de Producao Mineral (DNPM) (http://www.dnpm.gov.br/, to M.R.P), the Universidade Federal Fluminense (UFF) (http://www.uff.br/, to O.A., C.M.-N.), the Universidade Federal do Para (UFPA) (http://www.portal.ufpa.br,to O.A., A.N., K.B.A.), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (http://www.capes.gov.br/, to Z.L.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://ww.fapespa.pa.gov.br/, ICAAF 111/2014, to A.N.), Instituto Nacional de Ciencia e Tecnologia (INCT) (http://inct.cnpq.br/home/, to P.T., Z.L.) in Brazil and the Palaeontological Institute and Museum at the University of Zurich (http://www.pim.uzh.ch, to J.C-B.) as well as the University of Lausanne for the financial support of the isotopic analyses.	Agassiz L., 1835, NEUES JB MINERALOGIE, V1835, P290; Aguilera O, 2001, J PALEONTOL, V75, P732, DOI 10.1666/0022-3360(2001)075<0732:AECUFA>2.0.CO;2; Aguilera O. A., 2016, PALAEO ICHTHYOLOGICA, V14, P7; Aguilera OA, 2010, PECES FOSILES CARIBE; Aguilera O, 2014, J S AM EARTH SCI, V56, P422, DOI 10.1016/j.jsames.2014.09.021; Aguilera Orangel, 2013, Swiss Journal of Palaeontology, V132, P99, DOI 10.1007/s13358-013-0051-5; Aguilera Orangel A., 2010, P129; Aguilera Orangel Antonio, 2013, Swiss Journal of Palaeontology, V132, P45, DOI 10.1007/s13358-013-0052-4; Aguilera Socorro Orangel, 2012, Boletim do Museu Paraense Emilio Goeldi Ciencias Naturais, V7, P29; Aguilera Socorro Orangel Antonio, 2011, Swiss Journal of Palaeontology, V130, P217, DOI 10.1007/s13358-011-0020-9; Cabrera DA, 2012, AMEGHINIANA, V49, P126, DOI 10.5710/AMGH.v49i1(469); Alvan A., 2006, 13 C PER GEOL LIM 17, P595; Bezerra ISAA, 2015, BRAZ J GEOL, V45, P63, DOI 10.1590/2317-4889201530124; Ameghino Florentino, 1906, Anales del Museo Nacional Buenos Aires Ser 3, V8, P1; Amiot R, 2008, PALAEOGEOGR PALAEOCL, V264, P85, DOI 10.1016/j.palaeo.2008.04.001; Andrianavalona TH, 2015, PLOS BIOL, V10, P1; [Anonymous], 1999, LEIPZIGER GEOWISSENS, P9; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Antunes M. T, 1970, Revta Fac. Cienc. Univ. Lisb. (Cienc. nat.), V16, P119; Antunes MT, 1964, NEOCRETA CICO CENOZO; Antunes MT, 1970, REV FAC CIENCIAS LIS, V16, P1; Apolin J., 2004, PUBLICACION ESPECIAL, V6, P401; Argyriou T, 2015, J AFR EARTH SCI, V102, P86, DOI 10.1016/j.jafrearsci.2014.11.008; Arratia Gloria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P9; Barker A. S., 2006, IUCN RED LIST THREAT; BARRICK RE, 1993, PALEOCEANOGRAPHY, V8, P845, DOI 10.1029/93PA01412; Bassin C., 2000, EOS T AGU, V81, pF897, DOI DOI 10.1007/S00015-005-1168-3; Bassos-Hull K, 2014, ENVIRON BIOL FISH, V97, P1039, DOI 10.1007/s10641-014-0294-z; Billups K, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000567; Blainville H, 1816, B SOC PHILOMATHIQUE, V8, P121; Blake C.C., 1862, GEOLOGIST, V5, P316; Boessenecker Robert W., 2011, PalArch's Journal of Vertebrate Palaeontology, V8, P1; Bohme M, 2003, PALAEOGEOGR PALAEOCL, V195, P389, DOI 10.1016/S0031-0182(03)00367-5; Bonaparte C.L., 1838, NOUVELLES ANN SCI NA, V2, P195; Bor T, 2012, MIOCENE CHONDRICHTHY, P21; Buchmann F, 1997, NOTAS TE CNICAS, V10, P7; Cadenat J., 1963, Bull Inst franY Afr noire, V25A, P526; Campos D.A., 1984, LEXICO ESTRATIGRAFIC; Cappetta H., 2012, HDB PALEOICHTHYOLOGY; Cappetta H., 1970, SELACIENS MIOCENE RE; Carlson JK, 2014, AQUAT CONSERV, V24, P104, DOI 10.1002/aqc.2382; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Carr BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145396; Carrillo-Briceno JD, 2016, PALAEONTOL ELECTRON, V19, P1; Carrillo-Briceno JD, 2016, AMEGHINIANA, V53, P77, DOI 10.5710/AMGH.26.10.2015.2931; Carrillo-Briceno JD, 2015, J S AM EARTH SCI, V60, P56, DOI 10.1016/j.jsames.2015.02.001; Carrillo-Briceno JD, 2014, J S AM EARTH SCI, V51, P76, DOI 10.1016/j.jsames.2014.01.001; Carrillo-Briceno JD, 2013, REV CHIL HIST NAT, V86, P191, DOI 10.4067/S0716-078X2013000200008; CASE G R, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V171, P75; CASIER E, 1958, MEMOIRES SUISSES PAL, V74, P1, DOI DOI 10.1111/J.1463-6395.2011.00502.X; Chapman DD, 2015, ANNU REV MAR SCI, V7, P547, DOI 10.1146/annurev-marine-010814-015730; Cicimurri David J., 2014, PalArch's Journal of Vertebrate Palaeontology, V11, P1; Coates AG, 2004, GEOL SOC AM BULL, V116, P1327, DOI 10.1130/B25275.1; Coates AG, 2003, GEOL SOC AM BULL, V115, P271, DOI 10.1130/0016-7606(2003)115<0271:ENHOTC>2.0.CO;2; Coates AG, 2013, B MAR SCI, V89, P801, DOI 10.5343/bms.2012.1076; Collins AB, 2007, J FISH BIOL, V71, P1159, DOI 10.1111/j.1095-8649.2007.01590.x; Collins AB, 2008, ESTUAR COAST, V31, P1174, DOI 10.1007/s12237-008-9100-5; COMPAGNO L.J.V., 1998, FAO SPECIES IDENTI 1, V3, P1410; COMPAGNO L.J.V., 1999, FAO SPECIES IDENTIFI, P1467; Compagno L.J.V., 2005, SHARKS WORLD; COMPAGNO LJV, 1977, AM ZOOL, V17, P303; Compagno LJV, 1973, ZOOL J LINN SOC S1, P15; Cope E. D., 1867, P ACAD NAT SCI PHILA, V19, P138; Costa S., 2009, B MUS PARA EMILIO GO, V4, P221; Costa SARF, 2011, THESIS U FEDERAL PAR; Cuvier G., 1829, REGNE ANIMAL DISTRIB; DACULSI G, 1980, ARCH ORAL BIOL, V25, P145, DOI 10.1016/0003-9969(80)90013-8; Dartevelle E., 1943, ANN MUSEE CONGO BE A, V2, P1; Dera G, 2009, EARTH PLANET SC LETT, V286, P198, DOI 10.1016/j.epsl.2009.06.027; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Domeier M. L., 2013, Animal Biotelemetry, V1, P1; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Donovan Stephen K., 2001, Bulletin of the Mizunami Fossil Museum, V28, P211; Ebert D. A., 2003, SHARKS RAYS CHIMAERA; Ebert DA, 2013, FAO SPECIES CATA LOG; Ebert DA, 2013, SHARK WORLD; Enault S, 2015, ZOOL J LINN SOC-LOND, V174, P549, DOI 10.1111/zoj.12244; Enault S, 2013, ZOOL J LINN SOC-LOND, V169, P144, DOI 10.1111/zoj.12059; Feldheim KA, 2014, MOL ECOL, V23, P110, DOI 10.1111/mec.12583; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; Fischer J, 2014, HIST BIOL, V26, P710, DOI 10.1080/08912963.2013.838953; Fischer J, 2013, CHEM GEOL, V342, P44, DOI 10.1016/j.chemgeo.2013.01.022; Fischer J, 2012, PALAEOGEOGR PALAEOCL, V353, P60, DOI 10.1016/j.palaeo.2012.07.002; Froese R., 2016, WORLD WIDE WEB ELECT; Garman S., 1913, Memoirs of the Museum of Comparative Zoology at Harvard College Cambridge, V36; Garman Samuel, 1908, Bulletin of the Museum of Comparative Zoology at Harvard College, V51; Geoffroy Saint-Hilare E., 1817, EMPEREUR NAPOLE GRAN, V1, P18; Gill, 1872, ARRANGEMENT FAMILIES; Gill T.N., 1862, P ACAD NAT SCI PHILA, V14, P329; Gillette D.D., 1984, Journal of Vertebrate Paleontology, V4, P172; Glikman LS., 1964, SHARKS PALEOGENE THE; Goes A.M., 1990, B MUSEU PARAENSE CT, V2, P3; Gonzalez-Barba G., 2000, 17 S GEOL LAT RES EX, V18, P1; Gorini C, 2014, TERRA NOVA, V26, P179, DOI 10.1111/ter.12083; Gray J., 1834, ILLUSTRATIONS INDIAN; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Halfar J, 2005, GEOLOGY, V33, P481, DOI 10.1130/G21462.1; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hasse K, 1879, MORPHOLOGISCHE PALAO, V1; HERMAN J, 1991, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V61, P73; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Horton B.K., 2010, GSAT, V20, P4, DOI [10.1130/GSATG76A.1, DOI 10.1130/GSATG76A.1]; HULBERT RC, 2001, FOSSIL VERTEBRATES F; Iturralde-Vinent M., 1996, Journal of the Geological Society of Jamaica, V31, P7; Iturralde-Vinent M, 1998, REV SOC MEXICANA PAL, V8, P135; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Jackson JBC, 2013, B MAR SCI, V89, P779, DOI 10.5343/bms.2012.1096; Jordan D.S., 1896, B US NAT MUS, V47, P1, DOI [10.5962/bhl.title.39714, DOI 10.5962/BHL.TITLE.46755]; Jordan DS, 1888, P ACAD NAT SCI PHILA, V39, P387; Jorgensen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047819; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Karr JD, 2002, OCEANOL ACTA, V25, P71, DOI 10.1016/S0399-1784(02)01183-0; Kindlimann R., 1990, B LIMA, V69, P91; Kocsis L, 2009, PALAEOGEOGR PALAEOCL, V271, P117, DOI 10.1016/j.palaeo.2008.10.003; Kocsis L, 2015, ENVIRON BIOL FISH, V98, P1609, DOI 10.1007/s10641-015-0386-4; Kocsis L, 2014, PALAEOGEOGR PALAEOCL, V394, P74, DOI 10.1016/j.palaeo.2013.11.002; Kocsis L, 2011, CHIMIA, V65, P787, DOI 10.2533/chimia.2011.787; KOLODNY Y, 1983, EARTH PLANET SC LETT, V64, P398, DOI 10.1016/0012-821X(83)90100-0; Kominz MA, 2008, BASIN RES, V20, P211, DOI 10.1111/j.1365-2117.2008.00354.x; Kruckow T., 1990, Courier Forschungsinstitut Senckenberg, V119, P1; Kyne PM, 2003, AETOMYLAEUS NICHOFII; Landau B, 2008, PALAEOGEOGR PALAEOCL, V257, P445, DOI 10.1016/j.palaeo.2007.10.019; Laurito C. A, 1999, SELACEOS FOSILES LOC; Laurito Cesar A., 2008, Revista Geologica de America Central, V39, P65; Lecuyer C, 1996, PALAEOGEOGR PALAEOCL, V126, P61, DOI 10.1016/S0031-0182(96)00070-3; LECUYER C, 1993, PALAEOGEOGR PALAEOCL, V105, P235, DOI 10.1016/0031-0182(93)90085-W; Lecuyer C, 2013, CHEM GEOL, V347, P217, DOI 10.1016/j.chemgeo.2013.03.008; Leite F.P.R., 2004, NOGENO AMAZO NIA ORI, P55; Lessa R, 1999, MAR FRESHWATER RES, V50, P383, DOI 10.1071/MF98127; Lessa Rosangela, 1997, Cybium, V21, P123; Leuzinger L, 2015, BIOGEOSCIENCES, V12, P6945, DOI 10.5194/bg-12-6945-2015; Long Douglas J., 1993, Tertiary Research, V14, P117; LONGINEL.A, 1973, EARTH PLANET SC LETT, V20, P337, DOI 10.1016/0012-821X(73)90007-1; LONGINELLI A, 1973, EARTH PLANET SC LETT, V19, P373, DOI 10.1016/0012-821X(73)90088-5; Lowe Christopher G., 2006, Atoll Research Bulletin, P281; Lucuyer C., 2004, HDB STABLE ISOTOPE A, P482, DOI [DOI 10.1016/B978-044451114-0/50024-7, 10.1016/B978-044451114-0/50024-7]; Cione AL, 2011, BIOL J LINN SOC, V103, P423, DOI 10.1111/j.1095-8312.2011.01685.x; Marsili S, 2007, RIV ITAL PALEONTOL S, V113, P79, DOI 10.13130/2039-4942/6360; Matsubara K., 1936, Dobutsugaku Zasshi Tokyo, V48, P380; Maury C. J., 1925, MONOGRAFIA SERVICO G, V4; MOLLER IJ, 1975, ARCH ORAL BIOL, V20, P797, DOI 10.1016/0003-9969(75)90056-4; Montes C, 2015, SCIENCE, V348, P226, DOI 10.1126/science.aaa2815; Moura RL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501252; Muller George Friedrich, 1760, KONIGLICH PREUSSISCH; Muller J, 1839, SYSTEMATISCHE BESCHR; NISHDA K, 1990, Memoirs of the Faculty of Fisheries Hokkaido University, V37, P1; O'Dea A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600883; Pellegrini M, 2008, PALAEOGEOGR PALAEOCL, V266, P119, DOI 10.1016/j.palaeo.2008.03.017; Pimiento C, 2013, J PALEONTOL, V87, P755, DOI 10.1666/12-117; Pimiento C, 2013, J S AM EARTH SCI, V42, P159, DOI 10.1016/j.jsames.2012.11.005; Pindell J., 2009, GEOLOGY EVOLUTION RE; Pindell J. L., 1995, AAPG MEMOIR, V62, P101; Poey F., 1876, ANALES SOC ESPANOLA, V5, P373; Portell RW, 2008, CARIBB J SCI, V44, P279; Posner A. S., 1984, Phosphate Minerals, P330; Puceat E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000823; Puceat E, 2007, GEOLOGY, V35, P107, DOI 10.1130/G23103A.1; Purdy RW, 2001, SM C PALEOB, V90, P71; Ranzani C, 1839, DISS PRIMA NOVI COMM, V4, P65; Reinecke Thomas, 2011, Palaeontos, V20, P1; Reis MAF., 2005, ANUARIO I GEOCIENC, V28, P31; Nogueira ACR, 2013, J S AM EARTH SCI, V46, P89, DOI 10.1016/j.jsames.2013.05.004; Rossetti D.F., 2004, NE OGENO AMAZO NIA O, P13; Rossetti DD, 2001, J S AM EARTH SCI, V14, P77; Rossetti DF, 2015, SEDIMENT GEOL, V330, P1, DOI 10.1016/j.sedgeo.2015.10.001; Rossetti DF, 2013, EARTH-SCI REV, V123, P87, DOI 10.1016/j.earscirev.2013.04.005; Ruppell W, 1837, FISCHE ROTHEN MEERES; Santos R, 1971, B MUSEU PARAENSE EMI, V16, P1; Santos R, 1960, MONOGRAFIA DIVISAO G; Schwarzhans Werner, 2013, Palaeo Ichthyologica, V13, P83; Sellas AB, 2015, J HERED, V106, P266, DOI 10.1093/jhered/esv011; Shephard GE, 2010, NAT GEOSCI, V3, P870, DOI [10.1038/ngeo1017, 10.1038/NGEO1017]; Skinner H.C.W, 2003, TREATISE GEOCHEMISTR, V8, P117; Soares Junior A.V., 2011, GEOCIE NCIAS UNESP, V30, P669; Suarez M, 2003, 10 C GEOL CHIL; Suarez M., 2006, CAINOZOIC RES, V4, P3; Underwood C. J., 2004, CAINOZOIC RES, V3, P157; Underwood CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122553; Vennemann TW, 2001, GEOCHIM COSMOCHIM AC, V65, P1583, DOI 10.1016/S0016-7037(00)00629-3; Voigt M., 2011, FIELD GUIDE SHARKS G; White C, 1887, CONTRIBUICAO PALEONT; White W. T., 2006, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2006.RLTS.T60120A12307534.en; White WT, 2014, ZOOTAXA, V3860, P149, DOI 10.11646/zootaxa.3860.2.3; Whitley G. P., 1929, Australian Zoologist, V5, P353; Whitley G. P., 1940, FISHES AUSTR 1; Woodward A, 1889, RITISH MUSEUM NATURA; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P2245, DOI 10.1016/j.gca.2003.11.009; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P1, DOI 10.1016/S0016-7037(03)00278-3	190	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182740	10.1371/journal.pone.0182740	http://dx.doi.org/10.1371/journal.pone.0182740			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832664	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000408355800031
J	Hung, CY; Wu, WT; Chang, KV; Wang, TG; Han, DS				Hung, Chen-Yu; Wu, Wei-Ting; Chang, Ke-Vin; Wang, Tyng-Guey; Han, Der-Sheng			Predicting the length of hospital stay of post-acute care patients in Taiwan using the Chinese version of the continuity assessment record and evaluation item set	PLOS ONE			English	Article							INDWELLING URINARY CATHETERS; OF-STAY; ACUTE STROKE; DISCHARGE DESTINATION; ISCHEMIC-STROKE; POSTACUTE CARE; REHABILITATION; EXPERIENCE; ADMISSION; DURATION	Background The Chinese version of the Continuity Assessment Record and Evaluation (CARE-C) item set was developed to facilitate the assessment of post-acute care (PAC) patients in Taiwan. Considering that the length of hospital stay (LOS) has a significant effect on the total healthcare cost, determining whether the CARE-C scores could predict the LOS of PAC patients is of great interest to the PAC providers. Methods This prospective trial included PAC patients with stroke or central nervous system injuries. The demographic data and CARE-C scores were collected after admission and before discharge. A multivariable stepwise linear regression model was used to identify the predictors of the LOS using age, sex, tube placement status, CARE-C component scores at admission, and score differences between admission and discharge as independent variables. Results This study included 178 patients (66 women and 112 men), with a mean age of 61.9 +/- 15.6 years. Indwelling urinary catheter placement status at admission (beta = 0.241, p = 0.002) was a positive predictor of the LOS, whereas age (beta = -0.189, p = 0.010), core transfer subscale score at admission (beta = -0.176, p = 0.020), and difference in continence subscale score (beta = -0.203, p = 0.008) were negative predictors of the LOS. The model explained 14% of the total variance. Conclusions Indwelling urinary catheter placement status at admission, age, core transfer subscale score at admission, and difference in the CARE-C continence subscale score were identified as predictors of the LOS. The explanatory power of these predictors might be limited due to the regulations of Taiwan's National Health Insurance.	[Hung, Chen-Yu; Wu, Wei-Ting; Chang, Ke-Vin; Han, Der-Sheng] Natl Taiwan Univ Hosp, BeiHu Branch, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chang, Ke-Vin; Han, Der-Sheng] Natl Taiwan Univ Hosp, BeiHu Branch, Community & Geriatr Med Res Ctr, Taipei, Taiwan; [Chang, Ke-Vin; Wang, Tyng-Guey; Han, Der-Sheng] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chang, Ke-Vin; Wang, Tyng-Guey; Han, Der-Sheng] Natl Taiwan Univ, Coll Med, Dept Phys Med & Rehabil, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Han, DS (corresponding author), Natl Taiwan Univ Hosp, BeiHu Branch, Dept Phys Med & Rehabil, Taipei, Taiwan.; Han, DS (corresponding author), Natl Taiwan Univ Hosp, BeiHu Branch, Community & Geriatr Med Res Ctr, Taipei, Taiwan.; Han, DS (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Han, DS (corresponding author), Natl Taiwan Univ, Coll Med, Dept Phys Med & Rehabil, Taipei, Taiwan.	dshan1121@yahoo.com.tw		HAN, DER-SHENG/0000-0001-7642-8060; WANG, TYNG-GUEY/0000-0003-3298-4916	Taiwanese Society of Physical Medicine and Rehabilitation; Bureau of National Health Insurance [F1030033722]	Taiwanese Society of Physical Medicine and Rehabilitation; Bureau of National Health Insurance	This study was sponsored by the Taiwanese Society of Physical Medicine and Rehabilitation, and the Bureau of National Health Insurance grant No. F1030033722. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atalay A, 2009, INT J REHABIL RES, V32, P48, DOI 10.1097/MRR.0b013e32830d3689; Beckers V, 2012, ACTA NEUROL BELG, V112, P19, DOI 10.1007/s13760-012-0026-0; Bettger JAP, 2007, ARCH PHYS MED REHAB, V88, P1526, DOI 10.1016/j.apmr.2007.06.768; Bogousslavsky J, 1996, ARCH NEUROL-CHICAGO, V53, P265, DOI 10.1001/archneur.1996.00550030077025; Bohannon R W, 1994, J Stroke Cerebrovasc Dis, V4, P235, DOI 10.1016/S1052-3057(10)80097-7; Chang KC, 2002, STROKE, V33, P2670, DOI 10.1161/01.STR.0000034396.68980.39; Chang KV, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001828; Cowey E, 2012, CLIN REHABIL, V26, P470, DOI 10.1177/0269215511426160; DeJong G, 2014, ARCH PHYS MED REHAB, V95, P218, DOI 10.1016/j.apmr.2013.10.014; Deutsch A, 2012, CONTINUITY ASSESSMEN; Elwood D, 2009, PM&R, V1, P147, DOI 10.1016/j.pmrj.2008.10.010; Gage B., 2012, DEV TESTING CONTINUI; GALSKI T, 1993, STROKE, V24, P1794, DOI 10.1161/01.STR.24.12.1794; Holloway RG, 1996, NEUROLOGY, V46, P854; Holroyd-Leduc JM, 2007, J AM GERIATR SOC, V55, P227, DOI 10.1111/j.1532-5415.2007.01064.x; Hsieh CY, 2014, INT J STROKE, V9, pE3, DOI 10.1111/ijs.12232; Huang YC, 2013, J STROKE CEREBROVASC, V22, pE152, DOI 10.1016/j.jstrokecerebrovasdis.2012.10.014; Jorgensen HS, 1997, STROKE, V28, P1138, DOI 10.1161/01.STR.28.6.1138; Lin CL, 2009, J FORMOS MED ASSOC, V108, P653, DOI 10.1016/S0929-6646(09)60386-7; Saint S, 2000, AM J MED, V109, P476, DOI 10.1016/S0002-9343(00)00531-3; SHAH S, 1990, STROKE, V21, P241, DOI 10.1161/01.STR.21.2.241; Shieh G, 2014, BEHAV RES METHODS, V46, P808, DOI 10.3758/s13428-013-0415-1; Taiwo W, 2016, DISABIL REHABIL, P1; Tan WS, 2009, ARCH PHYS MED REHAB, V90, P1202, DOI 10.1016/j.apmr.2009.01.027; Wee JYM, 2005, AM J PHYS MED REHAB, V84, P604, DOI 10.1097/01.phm.0000171005.08744.ab; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wu CH, 2013, NEUROUROL URODYNAM, V32, P480, DOI 10.1002/nau.22317; Yeh HJ, 2017, ARCH PHYS MED REHAB, V98, P707, DOI 10.1016/j.apmr.2016.08.468	28	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183612	10.1371/journal.pone.0183612	http://dx.doi.org/10.1371/journal.pone.0183612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832680	Green Submitted, gold, Green Published			2022-12-26	WOS:000408355800070
J	Malhotra, N; Karthikeyan, S; Chakraborti, PK				Malhotra, Neha; Karthikeyan, Subramanian; Chakraborti, Pradip K.			Phosphorylation of mycobacterial phosphodiesterase by eukaryotic-type Ser/Thr kinase controls its two distinct and mutually exclusive functionalities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; PROTEIN-KINASE; CAMP; TUBERCULOSIS; ACTIVATION; PKNA; IDENTIFICATION; BIOSYNTHESIS; MECHANISMS; PATHWAY	Phosphorylation-mediated negative feedback regulation of cAMP levels by phosphodiesterase is well-established in eukaryotic cells. However, such a mechanism remains unexplored in prokaryotes. We report here the involvement of eukaryotic-type Ser/Thr kinases, particularly PknA in trans-phosphorylating phosphodiesterase from Mycobacterium tuberculosis (mPDE), that resulted in decreased enzyme turnover rate compared with its unphosphorylated counterpart. To elucidate the role of mPDE phosphorylation in hydrolyzing cellular cAMP, we utilized a phosphodiesterase knock-out Escherichia coli strain, Delta cpdA, where interference of endogenous eukaryotic-type Ser/Thr kinases could be excluded. Interestingly, the mPDE-complemented Delta cpdA strain showed enhanced cAMP levels in the presence of PknA, and this effect was antagonized by PknA-K42N, a kinase-dead variant. Structural analysis of mPDE revealed that four Ser/Thr residues (Ser-20, Thr-22, Thr-182, and Thr-240) were close to the active site, indicating their possible role in phosphorylation-mediated alteration in enzymatic activity. Mutation of these residues one at a time to alanine or a combination of all four (mPDE-4A) affected catalytic activity of mPDE. Moreover, mPDE-4A protein in kinase assays exhibited reduction in its phosphorylation compared with mPDE. In consonance, phosphoproteins obtained after co-expression of PknA with mPDE/S20A/T240A/4A displayed decreased phospho-signal intensities in immunoblotting with anti-phosphoserine/ phosphothreonine antibodies. Furthermore, unlike mPDE, phospho-ablated mPDE-T309A protein exhibited impaired cell wall localization in Mycobacterium smegmatis, whereas mPDE-4A behaved similarly as wild type. Taken together, our findings establish mutually exclusive dual functionality of mPDE upon PknA-mediated phosphorylation, where Ser-20/Thr-240 influence enzyme activity and Thr-309 endorses its cell wall localization.	[Malhotra, Neha; Karthikeyan, Subramanian; Chakraborti, Pradip K.] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Chakraborti, PK (corresponding author), Jamia Hamdarad Hamdard Univ, Dept Biotechnol, Sch Chem & Life Sci, New Delhi 110062, India.	pradip@imtech.res.in		Malhotra, Neha/0000-0002-5545-7986	Council of Scientific and Industrial Research (CSIR) [BSC-104]; Department of Science and Technology (JC Bose National Fellowship), New Delhi, India [SR/S2/JCB-87/2012]; CSIR, New Delhi, India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (JC Bose National Fellowship), New Delhi, India; CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by research grants from network project (BSC-104) of the Council of Scientific and Industrial Research (CSIR) and the Department of Science and Technology (JC Bose National Fellowship to P. K. C., SR/S2/JCB-87/2012, Science and Engineering Research Board), New Delhi, India. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Senior Research Fellowship from CSIR, New Delhi, India.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Dar HH, 2010, BIOCHEM J, V430, P539, DOI 10.1042/BJ20100026; Dave JA, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-30; DeLano WL, 2011, PYMOL MOL GRAPHICS S; Dhiman RK, 2004, J LIPID RES, V45, P1140, DOI 10.1194/jlr.M400047-JLR200; Dong HL, 2015, BREAST CANCER RES TR, V152, P17, DOI 10.1007/s10549-015-3445-9; Fuchs EL, 2010, J BACTERIOL, V192, P3553, DOI 10.1128/JB.00363-10; Gancedo JM, 2013, BIOL REV, V88, P645, DOI 10.1111/brv.12020; Gerbaud Pascale, 2016, Biologie Aujourd hui, V210, P139, DOI 10.1051/jbio/2016017; Gibbons HS, 2007, J BACTERIOL, V189, P5090, DOI 10.1128/JB.00163-07; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Kalivoda EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071267; Liang W, 2007, MICROBIOL-SGM, V153, P2964, DOI 10.1099/mic.0.2007/006668-0; Malhotra N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00123; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Midha M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036094; Oberholzer M, 2015, MBIO, V6, DOI 10.1128/mBio.01954-14; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; PERLMAN RL, 1969, NATURE, V223, P810, DOI 10.1038/223810a0; Plattner F, 2015, NAT NEUROSCI, V18, P1094, DOI 10.1038/nn.4066; Prisic S, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0006-2013; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; Thakur M, 2008, J BIOL CHEM, V283, P8023, DOI 10.1074/jbc.M707535200; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Wang L, 2000, J BIOL CHEM, V275, P7224, DOI 10.1074/jbc.275.10.7224; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Yang W, 2001, PROTEIN EXPRES PURIF, V22, P472, DOI 10.1006/prep.2001.1453; Zaveri A, 2013, CURR SCI INDIA, V105, P666; Zheng JM, 2007, MOL MICROBIOL, V63, P1360, DOI 10.1111/j.1365-2958.2007.05611.x	42	1	1	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17362	17374		10.1074/jbc.M117.784124	http://dx.doi.org/10.1074/jbc.M117.784124			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28855253	Green Published, hybrid			2022-12-26	WOS:000414009300018
J	Jia, ZH; Jia, Y; Guo, FJ; Chen, J; Zhang, XW; Cui, MH				Jia, Zan-Hui; Jia, Yan; Guo, Feng-Jun; Chen, Jun; Zhang, Xi-Wen; Cui, Man-Hua			Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; PROSTATE-CANCER; ACTIVATION; INTERLEUKIN-6; GROWTH; MATRIX-METALLOPROTEINASE-9; INHIBITION; BIOLOGY; CELLS; MODEL	Ovarian cancer's poor progression is closely associated with overexpression of matrix metalloproteinase 9 (MMP-9), which belongs to the class of enzymes believed to be involved in the degradation of extracellular matrix. However, the mechanisms underlying regulation of MMP-9 are not completely understood. STAT (signal transducer and activator of transcription) family of transcription factors is well known to be engaged in diverse cellular functions. Activation of STAT3 has been observed in a number of cancers, promoting tumorigenesis and metastasis via transcriptional activation of its target genes. In this study, we tested our hypothesis that STAT3 regulates MMP-9 gene expression in epithelial ovarian cancer. Using epithelial ovarian cancer cell lines as in vitro model, we show an abundance of phosphorylated STAT3 at Tyr705 (p-STAT3) in SKOV3 cell line. We further show that MMP-9 gene promoter was significantly enriched by p-STAT3, and IL-6 treatment led to a significant increase of MMP-9 at mRNA and protein levels, in addition to an association of p-STAT3 with MMP-9 gene. By using luciferase reporter assay, we determined that the STAT3 DNA responsive element of MMP-9 was sufficient to regulate transcriptional activity of a heterologous promoter. These results suggest that the phosphorylation of STAT3 regulates MMP-9 production in ovarian cancer, which might be responsible for its invasiveness and metastasis.	[Jia, Zan-Hui; Jia, Yan; Guo, Feng-Jun; Chen, Jun; Zhang, Xi-Wen; Cui, Man-Hua] Jilin Univ, Hosp 2, Dept Obstet & Gynecol, Changchun, Jilin, Peoples R China	Jilin University	Jia, ZH (corresponding author), Jilin Univ, Hosp 2, Dept Obstet & Gynecol, Changchun, Jilin, Peoples R China.	zhjcc90@gmail.com			Science and Technology Agency of Jilin Province [20150414020GH]	Science and Technology Agency of Jilin Province	This work was supported by Science and Technology Agency of Jilin Province (20150414020GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Barton BE, 2004, MOL CANCER THER, V3, P11; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Di Stefano V, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa9806; Gastl G, 2001, Methods Mol Med, V39, P121, DOI 10.1385/1-59259-071-3:121; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Gupta SC, 2013, BIOCHEM PHARMACOL, V85, P898, DOI 10.1016/j.bcp.2012.12.018; Hibi M, 1996, J MOL MED-JMM, V74, P1, DOI 10.1007/BF00202068; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kojima H, 1996, ONCOGENE, V12, P547; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lou W, 2000, PROSTATE, V42, P239, DOI 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Nadiminty N, 2006, P NATL ACAD SCI USA, V103, P7264, DOI 10.1073/pnas.0509808103; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Uno M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088347; Urzua U, 2012, HORM METAB RES, V44, P656, DOI 10.1055/s-0032-1304617; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu LJ, 2015, PLACENTA, V36, P581, DOI 10.1016/j.placenta.2015.02.013; Zou MH, 2016, CELL ONCOL, V39, P47, DOI 10.1007/s13402-015-0251-7	30	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183622	10.1371/journal.pone.0183622	http://dx.doi.org/10.1371/journal.pone.0183622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859117	gold, Green Published, Green Submitted			2022-12-26	WOS:000408740500026
J	Baker, J; White, N; Mengersen, K; Rolfe, M; Morgan, GG				Baker, Jannah; White, Nicole; Mengersen, Kerrie; Rolfe, Margaret; Morgan, Geoffrey G.			Joint modelling of potentially avoidable hospitalisation for five diseases accounting for spatiotemporal effects: A case study in New South Wales, Australia	PLOS ONE			English	Article							CARE SENSITIVE CONDITIONS; CONGESTIVE-HEART-FAILURE; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS; RISK; HYPERTENSION; PREVALENCE; MORTALITY	Background Three variant formulations of a spatiotemporal shared component model are proposed that llow examination of changes in shared underlying factors over time. Methods Models are evaluated within the context of a case study examining hospitalisation rates for five chronic diseases for residents of a regional area in New South Wales: type II diabetes mellitus (DMII), chronic obstructive pulmonary disease (COPD), coronary arterial disease (CAD), hypertension (HT) and congestive heart failure (CHF) between 2001-2006. These represent ambulatory care sensitive (ACS) conditions, often used as a proxy for avoidable hospitalisations. Using a selected model, the effects of socio-economic status (SES) as a shared component are estimated and temporal patterns in the influence of the residual shared spatial component are examined. Results Choice of model depends upon the application. In the featured application, a model allowing for changing influence of the shared spatial component over time was found to have the best fit and was selected for further analyses. Hospitalisation rates were found to be increasing for COPD and DMII, decreasing for CHF and stable for CAD and HT. SES was substantively associated with hospitalisation rates, with differing degrees of influence for each disease. In general, most of the spatial variation in hospitalisation rates was explained by disease-specific spatial components, followed by the residual shared spatial component. Conclusion Appropriate selection of a joint disease model allows for the examination of temporal patterns of disease outcomes and shared underlying spatial factors, and distinction between different shared spatial factors.	[Baker, Jannah; White, Nicole; Mengersen, Kerrie] Queensland Univ Technol, Australian Res Council Ctr Excellence Math & Stat, Brisbane, Qld, Australia; [Baker, Jannah; White, Nicole; Mengersen, Kerrie] Cooperat Res Ctr Spatial Informat, Melbourne, Vic, Australia; [Baker, Jannah] George Inst Global Hlth, Sydney, NSW, Australia; [Rolfe, Margaret; Morgan, Geoffrey G.] Univ Sydney, Univ Ctr Rural Hlth North Coast, Lismore, NSW, Australia; [Rolfe, Margaret] Univ Sydney, Sch Publ Hlth, Fac Med, Sydney, NSW, Australia; [Morgan, Geoffrey G.] Mid North Coast Local Hlth Dist, North Coast Publ Hlth Unit, Port Macquarie, NSW 2444, Australia	Queensland University of Technology (QUT); George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney	Baker, J (corresponding author), Queensland Univ Technol, Australian Res Council Ctr Excellence Math & Stat, Brisbane, Qld, Australia.; Baker, J (corresponding author), Cooperat Res Ctr Spatial Informat, Melbourne, Vic, Australia.; Baker, J (corresponding author), George Inst Global Hlth, Sydney, NSW, Australia.	jbaker1@georgeinstitute.org.au	Mengersen, Kerrie/AHC-4096-2022	Baker, Jannah/0000-0002-2208-6584; Mengersen, Kerrie/0000-0001-8625-9168; White, Nicole/0000-0002-9292-0773; Morgan, Geoffrey/0000-0003-4046-2405	Cooperative Research Centre for Spatial Information; Australian Commonwealth's Cooperative Research Centres Programme	Cooperative Research Centre for Spatial Information(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Commonwealth's Cooperative Research Centres Programme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The authors were financially supported in this work by the Cooperative Research Centre for Spatial Information, whose activities are funded by the Australian Commonwealth's Cooperative Research Centres Programme. The funding source had no involvement in study design, in the collection, analysis or interpretation of data, in the writing of the report and in the decision to submit this article for publication.	Australian Bureau of Statistics, 2012, QUICKST 2012; Australian Bureau of Statistics, 2013, SOC IND AR 2013; Baker James, 2017, THESIS; Bartnik M, 2004, EUR HEART J, V25, P1880, DOI 10.1016/j.ehj.2004.07.027; Besag J, 1991, ANN I STAT MATH, V43, P59; Best N, 2005, STAT METHODS MED RES, V14, P35, DOI 10.1191/0962280205sm388oa; Best N, 2009, EPIDEMIOLOGY, V20, P400, DOI 10.1097/EDE.0b013e31819d90f9; BILLINGS J, 1990, HEALTH AFFAIR, V9, P158, DOI 10.1377/hlthaff.9.4.158; Blustein J, 1998, HEALTH AFFAIR, V17, P177, DOI 10.1377/hlthaff.17.2.177; Byrd L, 2009, GERIATR NURS, V30, P365, DOI 10.1016/j.gerinurse.2009.08.007; Clancy CM, 2005, HEALTH SERV RES, V40, P953, DOI 10.1111/j.1475-6773.2005.00442.x; Dabney AR, 2005, STAT METHODS MED RES, V14, P83, DOI 10.1191/0962280205sm340oa; Diabetes UK, 2012, DIABETES IN THE UK 2; Downing A, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-41; Earnest A, 2010, HEALTH PLACE, V16, P684, DOI 10.1016/j.healthplace.2010.02.006; HealthStats NSW, 2016, DIAB HOSP TYP DIAB A; Held L, 2005, STAT METHODS MED RES, V14, P61, DOI 10.1191/0962280205sm389oa; Held L, 2006, STAT METHODS MED RES, V15, P465, DOI 10.1177/0962280206071642; Holden SH, 2010, DIABETES OBES METAB, V15, P844, DOI DOI 10.1111/D0M.12123; International Diabetes Federation, 2014, IDF DIABETES ATLAS S; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kim H, 2001, J AM STAT ASSOC, V96, P1506, DOI 10.1198/016214501753382408; Kirby SE, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-216; Knorr-Held L, 2001, J R STAT SOC A STAT, V164, P73, DOI 10.1111/1467-985X.00187; Laditka JN, 2005, HEALTH SERV RES, V40, P1148, DOI 10.1111/j.1475-6773.2005.00403.x; Longman JM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-373; Mahaki B, 2017, ARXIV PREPRINT ARXIV; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Mezzetti M, 2012, STAT METHOD APPL-GER, V21, P49, DOI 10.1007/s10260-011-0177-9; Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879; Page Anthea, 2007, ATLAS OF AVOIDABLE H; Purdy S, 2010, AVOIDING HOSPITAL AD; R Project, 2015, R PROJECT STAT COMPU; Rana JS, 2004, DIABETES CARE, V27, P2478, DOI 10.2337/diacare.27.10.2478; Richardson S, 2006, STAT METHODS MED RES, V15, P385, DOI 10.1191/0962280206sm458oa; Roos LL, 2005, HEALTH SERV RES, V40, P1167, DOI 10.1111/j.1475-6773.2005.00407.x; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Tzala E, 2008, STAT METHODS MED RES, V17, P97, DOI 10.1177/0962280207081243	40	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183653	10.1371/journal.pone.0183653	http://dx.doi.org/10.1371/journal.pone.0183653			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF1XX	28854280	gold, Green Submitted, Green Published			2022-12-26	WOS:000408693600053
J	Pergolini, I; Morales-Oyarvide, V; Mino-Kenudson, M; Honselmann, KC; Rosenbaum, MW; Nahar, S; Kem, M; Ferrone, CR; Lillemoe, KD; Bardeesy, N; Ryan, DP; Thayer, SP; Warshaw, AL; Fernandez-del Castillo, C; Liss, AS				Pergolini, Ilaria; Morales-Oyarvide, Vicente; Mino-Kenudson, Mari; Honselmann, Kim C.; Rosenbaum, Matthew W.; Nahar, Sabikun; Kem, Marina; Ferrone, Cristina R.; Lillemoe, Keith D.; Bardeesy, Nabeel; Ryan, David P.; Thayer, Sarah P.; Warshaw, Andrew L.; Fernandez-del Castillo, Carlos; Liss, Andrew S.			Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival	PLOS ONE			English	Article							CANCER; MODELS; CARCINOMA; PLATFORM; CHEMORESISTANCE; RESISTANCE; PATHWAYS; GROWTH; MICE	Patient-derived xenograft (PDX) tumors are powerful tools to study cancer biology. However, the ability of PDX tumors to model the biological and histological diversity of pancreatic ductal adenocarcinoma (PDAC) is not well known. In this study, we subcutaneously implanted 133 primary and metastatic PDAC tumors into immunodeficient mice. Fifty-seven tumors were successfully engrafted and even after extensive passaging, the histology of poorly-, moderately-, and well-differentiated tumors was maintained in the PDX models. Moreover, the fibroblast and collagen contents in the stroma of patient tumors were recapitulated in the corresponding PDX models. Analysis of the clinicopathological features of patients revealed xenograft tumor engraftment was associated with lymphovascular invasion (P = 0.001) and worse recurrence-free (median, 7 vs. 16 months, log-rank P = 0.047) and overall survival (median, 13 vs. 21 months, log-rank P = 0.038). Among successful engraftments, median time of growth required for reimplantation into new mice was 151 days. Reflective of the inherent biological diversity between PDX tumors with rapid (<151 days) and slow growth, differences in their growth were maintained during extensive passaging. Rapid growth was additionally associated with lymph node metastasis (P = 0.022). The association of lymphovascular invasion and lymph node metastasis with PDX formation and rapid growth may reflect an underlying biological mechanism that allows these tumors to adapt and grow in a new environment. While the ability of PDX tumors to mimic the cellular and non-cellular features of the parental tumor stroma provides a valuable model to study the interaction of PDAC cells with the tumor microenvironment, the association of successful engraftment with adverse clinicopathological features suggests PDX models over represent more aggressive forms of this disease.	[Pergolini, Ilaria; Morales-Oyarvide, Vicente; Honselmann, Kim C.; Nahar, Sabikun; Ferrone, Cristina R.; Lillemoe, Keith D.; Thayer, Sarah P.; Warshaw, Andrew L.; Fernandez-del Castillo, Carlos; Liss, Andrew S.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Pergolini, Ilaria; Morales-Oyarvide, Vicente; Honselmann, Kim C.; Nahar, Sabikun; Ferrone, Cristina R.; Lillemoe, Keith D.; Thayer, Sarah P.; Warshaw, Andrew L.; Fernandez-del Castillo, Carlos; Liss, Andrew S.] Massachusetts Gen Hosp, Andrew L Warshaw MD Inst Pancreat Canc Res, Boston, MA 02114 USA; [Pergolini, Ilaria; Morales-Oyarvide, Vicente; Honselmann, Kim C.; Rosenbaum, Matthew W.; Nahar, Sabikun; Kem, Marina; Ferrone, Cristina R.; Lillemoe, Keith D.; Thayer, Sarah P.; Warshaw, Andrew L.; Fernandez-del Castillo, Carlos; Liss, Andrew S.] Harvard Med Sch, Boston, MA 02115 USA; [Pergolini, Ilaria] Univ Politecn Marche, Dept Surg, Ancona, Italy; [Mino-Kenudson, Mari; Rosenbaum, Matthew W.; Kem, Marina] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bardeesy, Nabeel; Ryan, David P.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Marche Polytechnic University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Liss, AS (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.; Liss, AS (corresponding author), Massachusetts Gen Hosp, Andrew L Warshaw MD Inst Pancreat Canc Res, Boston, MA 02114 USA.; Liss, AS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	aliss@mgh.harvard.edu	Castillo, Carlos Fenandez-del/AAO-2602-2020; Honselmann, Kim/AAU-6684-2021; Liss, Andrew/L-9696-2019	Honselmann, Kim/0000-0002-5699-2286; 	National Institutes of Health (SPT) [P01CA117969]; NATIONAL CANCER INSTITUTE [R01CA169086, P01CA117969] Funding Source: NIH RePORTER	National Institutes of Health (SPT)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant number P01CA117969 is from the National Institutes of Health (SPT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Cirri P, 2011, AM J CANCER RES, V1, P482; Delitto D, 2015, AM J PATHOL, V185, P1297, DOI 10.1016/j.ajpath.2015.01.016; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Duda DG, 2004, CANCER RES, V64, P5920, DOI 10.1158/0008-5472.CAN-04-1268; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Herreros-Villanueva M, 2012, WORLD J GASTROENTERO, V18, P1286, DOI 10.3748/wjg.v18.i12.1286; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Huang YS, 2016, CLIN CANCER RES, V22, P4259, DOI 10.1158/1078-0432.CCR-15-2068; Hwang CI, 2016, J PATHOL, V238, P197, DOI 10.1002/path.4651; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jun E, 2016, ANTICANCER RES, V36, P517; Kadaba R, 2013, J PATHOL, V230, P107, DOI 10.1002/path.4172; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Lim KH, 2012, ONCOLOGIST, V17, P192, DOI 10.1634/theoncologist.2011-0268; Linnebacher M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-362; Mattie Mike, 2013, Neoplasia, V15, P1138; Miyamoto H, 2004, PANCREAS, V28, P38, DOI 10.1097/00006676-200401000-00006; Muerkoster SS, 2008, INT J CANCER, V123, P1751, DOI 10.1002/ijc.23703; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Oh BY, 2015, ONCOTARGET, V6, P16059, DOI 10.18632/oncotarget.3863; Perez-Torras S, 2011, CELL ONCOL, V34, P511, DOI 10.1007/s13402-011-0049-1; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sorio C, 2001, VIRCHOWS ARCH, V438, P154, DOI 10.1007/s004280000343; Thomas RM, 2015, ANN SURG ONCOL, V22, P1884, DOI 10.1245/s10434-014-4241-1; Walters DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077065; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115	32	42	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182855	10.1371/journal.pone.0182855	http://dx.doi.org/10.1371/journal.pone.0182855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854237	Green Submitted, Green Published, gold			2022-12-26	WOS:000408693600020
J	Yu, BG; Oh, JH; Kim, Y; Kim, TW				Yu, Byung Gyu; Oh, Je Hyeok; Kim, Yeomyung; Kim, Tae Wook			Accurate measurement of chest compression depth using impulse-radio ultra-wideband sensor on a mattress	PLOS ONE			English	Article							FLEXIBLE PRESSURE SENSOR; CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; FEEDBACK; MANNEQUIN; SURVIVAL; QUALITY; BED	Objective We developed a new chest compression depth (CCD) measuring technology using radar and impulse-radio ultra-wideband (IR-UWB) sensor. This study was performed to determine its accuracy on a soft surface. Methods Four trials, trial 1: chest compressions on the floor using an accelerometer device; trial 2: chest compressions on the floor using an IR-UWB sensor; trial 3: chest compressions on a foam mattress using an accelerometer device; trial 4: chest compressions on a foam mattress using an IR-UWB sensor, were performed in a random order. In all the trials, a cardiopulmonary resuscitation provider delivered 50 uninterrupted chest compressions to a manikin. Results The CCD measured by the manikin and the device were as follows: 57.42 +/- 2.23 and 53.92 +/- 2.92 mm, respectively in trial 1 (p < 0.001); 56.29 +/- 1.96 and 54.16 +/- 3.90 mm, respectively in trial 2 (p < 0.001); 55.61 +/- 1.57 and 103.48 +/- 10.48 mm, respectively in trial 3 (p < 0.001); 57.14 +/- 3.99 and 55.51 +/- 3.39 mm, respectively in trial 4 (p = 0.012). The gaps between the CCD measured by the manikin and the devices (accelerometer device vs. IR-UWB sensor) on the floor were not different (3.50 +/- 2.08 mm vs. 3.15 +/- 2.27 mm, respectively, p = 0.136). However, the gaps were significantly different on the foam mattress (48.53 +/- 5.65 mm vs. 4.10 +/- 2.47 mm, p < 0.001). Conclusion The IR-UWB sensor could measure the CCD accurately both on the floor and on the foam mattress.	[Yu, Byung Gyu; Kim, Yeomyung; Kim, Tae Wook] Yonsei Univ, Sch Elect & Elect Engn, Seoul, South Korea; [Oh, Je Hyeok] Chung Ang Univ, Coll Med, Dept Emergency Med, Seoul, South Korea	Yonsei University; Chung Ang University; Chung Ang University Hospital	Kim, TW (corresponding author), Yonsei Univ, Sch Elect & Elect Engn, Seoul, South Korea.	taewook.kim@yonsei.ac.kr	Oh, Je Hyeok/D-4755-2015; Kim, Tae Wook/G-4974-2012	Oh, Je Hyeok/0000-0002-5211-3838; 	National Research Foundation of Korea (NRF) - Korea government [NRF-2013R1A2A2A05005818]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-2013R1A2A2A05005818). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beesems SG, 2014, RESUSCITATION, V85, P1439, DOI 10.1016/j.resuscitation.2014.08.005; Bhanji F, 2015, CIRCULATION, V132, pS242, DOI 10.1161/CIR.0000000000000277; Kim Y, 2017, IEEE SENS J, V17, P3174, DOI 10.1109/JSEN.2017.2680454; Minami K, 2016, AM J EMERG MED, V34, P899, DOI 10.1016/j.ajem.2016.02.052; Minami K, 2016, RESUSCITATION, V99, pE11, DOI 10.1016/j.resuscitation.2015.11.022; Oh J, 2012, RESUSCITATION, V83, P500, DOI 10.1016/j.resuscitation.2011.09.028; Perkins GD, 2009, RESUSCITATION, V80, P79, DOI 10.1016/j.resuscitation.2008.08.011; Perkins GD, 2005, RESUSCITATION, V64, P103, DOI 10.1016/j.resuscitation.2004.08.011; Skorning M, 2010, RESUSCITATION, V81, P53, DOI 10.1016/j.resuscitation.2009.10.005; Talikowska M, 2015, RESUSCITATION, V96, P66, DOI 10.1016/j.resuscitation.2015.07.036; Truszewski Z, 2016, AM J EMERG MED, V34, P381, DOI 10.1016/j.ajem.2015.11.003; Vadeboncoeur T, 2014, RESUSCITATION, V85, P182, DOI 10.1016/j.resuscitation.2013.10.002; Wutzler A, 2015, RESUSCITATION, V87, P81, DOI 10.1016/j.resuscitation.2014.10.004	13	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183971	10.1371/journal.pone.0183971	http://dx.doi.org/10.1371/journal.pone.0183971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854262	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600071
J	Adekunbi, DA; Li, XF; Li, SY; Adegoke, OA; Iranloye, BO; Morakinyo, AO; Lightman, SL; Taylor, PD; Poston, L; O'Byrne, KT				Adekunbi, Daniel A.; Li, Xiao Feng; Li, Shengyun; Adegoke, Olufeyi A.; Iranloye, Bolanle O.; Morakinyo, Ayodele O.; Lightman, Stafford L.; Taylor, Paul D.; Poston, Lucilla; O'Byrne, Kevin T.			Role of amygdala kisspeptin in pubertal timing in female rats	PLOS ONE			English	Article							HYPOTHALAMIC KISS1 EXPRESSION; LUTEINIZING-HORMONE SURGE; MESSENGER-RNA EXPRESSION; MEDIAL AMYGDALA; GENE-EXPRESSION; ARCUATE NUCLEUS; REPRODUCTIVE FUNCTION; SEXUAL-BEHAVIOR; NEURONS; BRAIN	To investigate the mechanism by which maternal obesity disrupts reproductive function in offspring, we examined Kiss1 expression in the hypothalamic arcuate (ARC) and anteroventral periventricular (AVPV) nuclei, and posterodorsal medial amygdala (MePD) of pre-pubertal and young adult offspring. Sprague-Dawley rats were fed either a standard or energy-dense diet for six weeks prior to mating and throughout pregnancy and lactation. Male and female offspring were weaned onto normal diet on postnatal day (pnd) 21. Brains were collected on pnd 30 or 100 for qRT-PCR to determine Kiss1 mRNA levels. Maternal obesity increased Kiss1 mRNA expression in the MePD of pre-pubertal male and female offspring, whereas Kiss1 expression was not affected in the ARC or AVPV at this age. Maternal obesity reduced Kiss1 expression in all three brain regions of 3 month old female offspring, but only in MePD of males. The role of MePD kisspeptin on puberty, estrous cyclicity and pre-ovulatory LH surges was assessed directly in a separate group of post-weanling and young adult female rats exposed to a normal diet throughout their life course. Bilateral intra-MePD cannulae connected to osmotic mini-pumps for delivery of kisspeptin receptor antagonist (Peptide 234 for 14 days) were chronically implanted on pnd 21 or 100. Antagonism of MePD kisspeptin delayed puberty onset, disrupted estrous cyclicity and reduced the incidence of LH surges. These data show that the MePD plays a key role in pubertal timing and ovulation and that maternal obesity may act via amygdala kisspeptin signaling to influence reproductive function in the offspring.	[Adekunbi, Daniel A.; Li, Xiao Feng; Li, Shengyun; Taylor, Paul D.; Poston, Lucilla; O'Byrne, Kevin T.] Kings Coll London, Fac Life Sci & Med, Div Womens Hlth, London, England; [Adekunbi, Daniel A.; Adegoke, Olufeyi A.; Iranloye, Bolanle O.; Morakinyo, Ayodele O.] Univ Lagos, Dept Physiol, Coll Med, Lagos, Nigeria; [Lightman, Stafford L.] Univ Bristol, Henry Wellcome Lab Integrat Neurosci & Endocrinol, Bristol, Avon, England	University of London; King's College London; University of Lagos; University of Bristol	O'Byrne, KT (corresponding author), Kings Coll London, Fac Life Sci & Med, Div Womens Hlth, London, England.	kevin.obyrne@kcl.ac.uk	Adekunbi, Daniel/HII-7074-2022; li, xiaofeng/GXF-9442-2022	Iranloye, Bolanle/0000-0001-7498-0193; Lightman, Stafford/0000-0002-8546-9646; O'Byrne, Kevin/0000-0002-2548-4182; Morakinyo, Femi/0000-0002-1577-2412; Adekunbi, Daniel/0000-0001-5456-3392; Taylor, Paul David/0000-0002-4740-4307; Poston, Lucilla/0000-0003-1100-2821	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J002232/1]; Medical Research Council (MRC) [MR/N022637/1]; BBSRC [BB/J002232/1] Funding Source: UKRI; MRC [MR/N022637/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J002232/1] Funding Source: researchfish; Medical Research Council [MR/N022637/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.sc.uk/) Grant# BB/J002232/1 to Kevin O'Byrne, Stafford Lightman, Lucilla Poston and the Medical Research Council (MRC) (https://www.mrc.ac.uki/) Grant # MR/N022637/1 to Kevin O'Byrne, Stafford Lightman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers-Wolthers CHJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179156; Ambrosetti V, 2016, ENDOCRINE, V53, P258, DOI 10.1007/s12020-016-0858-0; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Cadiz-Moretti B, 2016, BRAIN STRUCT FUNCT, V221, P1033, DOI 10.1007/s00429-014-0954-y; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Cheong Y, 2014, FERTIL STERIL, V102, P899, DOI 10.1016/j.fertnstert.2014.06.015; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; Colledge WH, 2009, TRENDS ENDOCRIN MET, V20, P115, DOI 10.1016/j.tem.2008.10.005; Comninos AN, 2017, J CLIN INVEST, V127, P709, DOI 10.1172/JCI89519; Comninos AN, 2016, BRAIN STRUCT FUNCT, V221, P2035, DOI 10.1007/s00429-015-1024-9; Connor KL, 2012, J PHYSIOL-LONDON, V590, P2167, DOI 10.1113/jphysiol.2011.223305; Cooke BM, 2011, J NEUROENDOCRINOL, V23, P65, DOI 10.1111/j.1365-2826.2010.02075.x; Cooke BM, 2006, NEUROSCIENCE, V138, P997, DOI 10.1016/j.neuroscience.2005.06.018; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Deardorff J, 2013, MATERN CHILD HLTH J, V17, P1391, DOI 10.1007/s10995-012-1139-z; Donato Jose Jr, 2011, Front Endocrinol (Lausanne), V2, P57, DOI 10.3389/fendo.2011.00057; Donato J, 2011, J CLIN INVEST, V121, P355, DOI 10.1172/JCI45106; Donato J, 2010, PHYSIOL BEHAV, V99, P67, DOI 10.1016/j.physbeh.2009.10.012; Franssen D, 2016, ENDOCRINOLOGY, V157, P1740, DOI 10.1210/en.2015-1937; Grachev P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044344; Gresham R, 2016, NEUROSCI LETT, V627, P13, DOI 10.1016/j.neulet.2016.05.042; HilakiviClarke L, 1997, P NATL ACAD SCI USA, V94, P9372, DOI 10.1073/pnas.94.17.9372; Hounsgaard ML, 2014, ANDROLOGY-US, V2, P198, DOI 10.1111/j.2047-2927.2013.00171.x; Hu MH, 2015, ENDOCRINOLOGY, V156, P2619, DOI 10.1210/en.2014-1655; Iwasa T, 2010, J PHYSIOL-LONDON, V588, P821, DOI 10.1113/jphysiol.2009.183558; Jacobs S, 2014, PHYSIOL BEHAV, V129, P280, DOI 10.1016/j.physbeh.2014.03.003; Kim J, 2011, ENDOCRINOLOGY, V152, P2020, DOI 10.1210/en.2010-1498; King BM, 2006, AM J PHYSIOL-REG I, V291, pR1201, DOI 10.1152/ajpregu.00199.2006; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Knox AMI, 2009, J NEUROENDOCRINOL, V21, P683, DOI 10.1111/j.1365-2826.2009.01885.x; Kubo A, 2016, AM J EPIDEMIOL, V184, P7, DOI 10.1093/aje/kww006; Kumar D, 2014, J NEUROSCI, V34, P3756, DOI 10.1523/JNEUROSCI.5123-13.2014; Kurian JR, 2012, ENDOCRINOLOGY, V153, P3331, DOI 10.1210/en.2012-1221; Li XF, 2015, ENDOCRINOLOGY, V156, P3725, DOI 10.1210/en.2015-1366; Li XF, 2010, J PHYSL, V588, p821 ; Li XF, 2012, ENDOCRINOLOGY, V153, P4422, DOI 10.1210/en.2012-1223; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Neal-Perry G, 2009, ENDOCRINOLOGY, V150, P3699, DOI 10.1210/en.2008-1667; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Pardo-Bellver C, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00033; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Pineda R, 2016, NEUROENDOCRINOLOGY; Popa SM, 2008, ANNU REV PHYSIOL, V70, P213, DOI 10.1146/annurev.physiol.70.113006.100540; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Rodriguez-Gonzalez GL, 2015, INT J OBESITY, V39, P549, DOI 10.1038/ijo.2014.209; Ruth KS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24710; Santos M, 2015, AM J PHYSIOL-REG I, V308, pR219, DOI 10.1152/ajpregu.00398.2014; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Sloboda DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006744; Smith JT, 2006, J NEUROSCI, V26, P6687, DOI 10.1523/JNEUROSCI.1618-06.2006; Smith JT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097758; Smith JT, 2009, PEPTIDES, V30, P94, DOI 10.1016/j.peptides.2008.08.013; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Stephens SBZ, 2016, ENDOCRINOLOGY, V157, P4021, DOI 10.1210/en.2016-1431; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takumi K, 2015, NEUROSCI RES, V100, P21, DOI 10.1016/j.neures.2015.06.004; Takumi K, 2011, J MOL NEUROSCI, V43, P138, DOI 10.1007/s12031-010-9430-1; Vida B, 2010, J NEUROENDOCRINOL, V22, P1032, DOI 10.1111/j.1365-2826.2010.02045.x; Zhang C, 2009, ENDOCRINOLOGY, V150, P2388, DOI 10.1210/en.2008-1313	64	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183596	10.1371/journal.pone.0183596	http://dx.doi.org/10.1371/journal.pone.0183596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846730	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600040
J	Marchant, A; Le Coupanec, A; Joly, C; Perthame, E; Sertour, N; Garnier, M; Godard, V; Ferquel, E; Choumet, V				Marchant, Axelle; Le Coupanec, Alain; Joly, Claire; Perthame, Emeline; Sertour, Natacha; Garnier, Martine; Godard, Vincent; Ferquel, Elisabeth; Choumet, Valerie			Infection of Ixodes ricinus by Borrelia burgdorferi sensu lato in peri-urban forests of France	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; FRAGMENT-LENGTH-POLYMORPHISM; TAMIAS-SIBIRICUS-BARBERI; LYME-DISEASE SPIROCHETE; INTERGENIC SPACER; MOLECULAR CHARACTERIZATION; DEER DENSITY; SP-NOV.; TICKS; HOST	Lyme borreliosis is the most common tick-borne disease in the northern hemisphere. In Europe, it is transmitted by Ixodes ticks that carry bacteria belonging to the Borrelia burgdorferi sensu lato complex. The objective of this work was to explore eco-epidemiological factors of Lyme borreliosis in peri-urban forests of France (Se A nart, Notre-Dame and Rambouillet). We investigated whether the introduction of Tamias sibiricus in Se A nart could alter the density of infected ticks. Moreover, the density and tick infection were investigated according to the tree species found in various patches of Se A nart forest. For this purpose, ticks were sampled during 3 years. In the Se A nart forest, the density of nymph and adult ticks showed no significant difference between 2008, 2009 and 2011. The nymph density varied significantly as a function of the month of collection. Regarding the nymphs, a higher rate of infection and infected density were found in 2009. Plots with chipmunks (C) presented a lower density of both nymphs and adult ticks than plots without chipmunks (NC) did. A higher rate of infection of nymphs with Borrelia was seen in C plots. The prevalence of the various species of Borrelia was also found to vary between C and NC plots with the year of the collect. The presence of chestnut trees positively influenced the density of both nymphs and adults. The infected nymph density showed a significant difference depending on the peri-urban forest studied, Se A nart being higher than Rambouillet. The prevalence of Borrelia species also differed between the various forests studied. Concerning the putative role that Tamias sibiricus may play in the transmission of Borrelia, our results suggest that its presence is correlated with a higher rate of infection of questing ticks by Borrelia genospecies and if its population increases, it could play a significant role in the risk of transmission of Lyme borreliosis.	[Marchant, Axelle; Le Coupanec, Alain; Joly, Claire; Sertour, Natacha; Garnier, Martine; Ferquel, Elisabeth; Choumet, Valerie] Inst Pasteur, Ctr Natl Reference Borrelia, Paris, France; [Perthame, Emeline] Inst Pasteur, Bioinformat & Biostat Hub C3BI, USR IP CNRS Bioinformat & Biostat 3756, Paris, France; [Godard, Vincent] Univ Paris 08, CNRS, UMR7533, LADYSS, St Denis, France; [Ferquel, Elisabeth; Choumet, Valerie] Inst Pasteur, Unite Environm & Risques Infect, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-VIII; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Choumet, V (corresponding author), Inst Pasteur, Ctr Natl Reference Borrelia, Paris, France.; Choumet, V (corresponding author), Inst Pasteur, Unite Environm & Risques Infect, Paris, France.	vchoumet@pasteur.fr		Choumet, Valerie/0000-0003-4714-1006	Institut National de Veille Sanitaire (INVS); Ilede-France Region under a Partnerships for Citizens for Research and Innovation [PICRI] contract	Institut National de Veille Sanitaire (INVS); Ilede-France Region under a Partnerships for Citizens for Research and Innovation [PICRI] contract	This work was supported by Institut National de Veille Sanitaire (INVS) and by the Ilede-France Region under a Partnerships for Citizens for Research and Innovation [PICRI] contract and a call for projects validated by the Scientific Council of the Maison des Sciences de l'Homme Paris Nord.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Beytout J, 2007, VECTOR-BORNE ZOONOT, V7, P507, DOI 10.1089/vbz.2006.0633; Bonnet S, 2015, TICKS TICK-BORNE DIS, V6, P393, DOI 10.1016/j.ttbdis.2015.03.008; Cagnacci F, 2012, INT J PARASITOL, V42, P365, DOI 10.1016/j.ijpara.2012.02.012; Casjens SR, 2011, J BACTERIOL, V193, P6995, DOI 10.1128/JB.05951-11; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Ceballos LA, 2014, EXP APPL ACAROL, V64, P121, DOI 10.1007/s10493-014-9794-y; Chao LL, 2010, J MED MICROBIOL, V59, P254, DOI 10.1099/jmm.0.016626-0; Chao LL, 2002, AM J TROP MED HYG, V67, P504, DOI 10.4269/ajtmh.2002.67.504; Chapuis JL, 2005, REV ECOL-TERRE VIE, V60, P239; Chu Chen-yi, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P681; Classens, 1988, FRANCE DORIGINES GIB, V5, P359; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; CRAINE NG, 1995, FOLIA PARASIT, V42, P73; De Sousa R, 2012, APPL ENVIRON MICROB, V78, P3767, DOI 10.1128/AEM.07945-11; Derdakova M, 2003, APPL ENVIRON MICROB, V69, P509, DOI 10.1128/AEM.69.1.509-516.2003; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Dubska L, 2009, APPL ENVIRON MICROB, V75, P596, DOI 10.1128/AEM.01674-08; Ferquel E, 2006, APPL ENVIRON MICROB, V72, P3074, DOI 10.1128/AEM.72.4.3074-3078.2006; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; FISH D, 1990, J WILDLIFE DIS, V26, P339, DOI 10.7589/0090-3558-26.3.339; Gassner F, 2011, VECTOR-BORNE ZOONOT, V11, P523, DOI 10.1089/vbz.2010.0026; Gomez-Diaz E, 2011, ENVIRON MICROBIOL, V13, P2453, DOI 10.1111/j.1462-2920.2011.02515.x; Guner ES, 2003, J MED MICROBIOL, V52, P807, DOI 10.1099/jmm.0.05205-0; Halperin JJ, 2016, J NEUROL; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; Hanincova K, 2003, PARASITOLOGY, V126, P11, DOI 10.1017/S0031182002002548; Hanincova K, 2003, APPL ENVIRON MICROB, V69, P2825, DOI 10.1128/AEM.69.5.2825-2830.2003; Jacquot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088581; Jouda F, 2004, VECTOR-BORNE ZOONOT, V4, P23, DOI 10.1089/153036604773082960; Kiewra D, 2017, TICKS TICK-BORNE DIS, V8, P362, DOI 10.1016/j.ttbdis.2016.12.011; Kjelland V, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-59; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 1998, APPL ENVIRON MICROB, V64, P1169; Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998; KURTENBACH K, 1994, INFECT IMMUN, V62, P5344, DOI 10.1128/IAI.62.12.5344-5352.1994; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; LeFleche A, 1997, INT J SYST BACTERIOL, V47, P921; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; MARCONI RT, 1992, J CLIN MICROBIOL, V30, P628, DOI 10.1128/JCM.30.3.628-632.1992; Maresca B, LA FRE A QUENTATION; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; Marsot M, 2012, INT J PARASITOL, V42, P781, DOI 10.1016/j.ijpara.2012.05.010; Marsot M, 2011, APPL ENVIRON MICROB, V77, P5716, DOI 10.1128/AEM.01846-10; Marsot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055377; Masuzawa T, 2005, INT J MED MICROBIOL, V294, P455, DOI 10.1016/j.ijmm.2004.09.008; McCabe GJ, 2004, VECTOR-BORNE ZOONOT, V4, P143, DOI 10.1089/1530366041210765; OLSEN B, 1995, APPL ENVIRON MICROB, V61, P3082; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Perret JL, 2004, J MED ENTOMOL, V41, P361, DOI 10.1603/0022-2585-41.3.361; Pichon B, 2006, VECTOR-BORNE ZOONOT, V6, P382, DOI 10.1089/vbz.2006.6.382; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; Pisanu B, 2014, TICKS TICK-BORNE DIS, V5, P1, DOI 10.1016/j.ttbdis.2013.07.007; POSTIC C, 1994, AM J PHYSIOL, V266, pE548, DOI 10.1152/ajpendo.1994.266.4.E548; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Postic D, 1999, J CLIN MICROBIOL, V37, P3010, DOI 10.1128/JCM.37.9.3010-3012.1999; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Poupon MA, 2006, APPL ENVIRON MICROB, V72, P976, DOI 10.1128/AEM.72.1.976-979.2006; Reye AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054476; Richter D, 2006, INT J SYST EVOL MICR, V56, P873, DOI 10.1099/ijs.0.64050-0; Richter D, 2004, APPL ENVIRON MICROB, V70, P6414, DOI 10.1128/AEM.70.11.6414-6419.2004; Richter D, 2012, VECTOR-BORNE ZOONOT, V12, P21, DOI 10.1089/vbz.2011.0668; Rijpkema Sjoerd G. T., 1997, Clin Microbiol Infect, V3, P109; Rudenko N, 2011, TICKS TICK-BORNE DIS, V2, P123, DOI 10.1016/j.ttbdis.2011.04.002; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P487, DOI 10.1111/j.1469-0691.2011.03492.x; Tagliapietra V, 2011, VET PARASITOL, V183, P114, DOI 10.1016/j.vetpar.2011.07.022; Ullmann AJ, 2003, J PARASITOL, V89, P1256, DOI 10.1645/Ge-3081RN; Vandenesch A, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.34.20883; Vassallo M, 2000, EXP APPL ACAROL, V24, P941, DOI 10.1023/A:1010669003887; Vennestrom J, 2008, PARASITOL INT, V57, P32, DOI 10.1016/j.parint.2007.07.004; Vor T, 2010, EXP APPL ACAROL, V51, P405, DOI 10.1007/s10493-010-9337-0; Vourc'h G, 2016, TICKS TICK-BORNE DIS, V7, P644, DOI 10.1016/j.ttbdis.2016.02.008; Vourc'h G, 2007, VECTOR-BORNE ZOONOT, V7, P637, DOI 10.1089/vbz.2007.0111; Wang GQ, 1999, CLIN MICROBIOL REV, V12, P633, DOI 10.1128/CMR.12.4.633; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10; Zhang F, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-157	78	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183543	10.1371/journal.pone.0183543	http://dx.doi.org/10.1371/journal.pone.0183543			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846709	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600033
J	Oh, H; Custead, R; Wang, YY; Barlow, S				Oh, Hyuntaek; Custead, Rebecca; Wang, Yingying; Barlow, Steven			Neural encoding of saltatory pneumotactile velocity in human glabrous hand	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; MEDIAN NERVE-STIMULATION; POSTERIOR PARIETAL CORTEX; MOVING TACTILE STIMULI; FUNCTIONAL MRI; HAIRY SKIN; DIRECTIONAL SENSITIVITY; CYTOARCHITECTONIC MAPS; MOTOR CORTEX; FMRI	Neurons in the somatosensory cortex are exquisitely sensitive to mechanical stimulation of the skin surface. The location, velocity, direction, and adaptation of tactile stimuli on the skin's surface are discriminable features of somatosensory processing, however the representation and processing of dynamic tactile arrays in the human somatosensory cortex are poorly understood. The principal aim of this study was to map the relation between dynamic saltatory pneumatic stimuli at discrete traverse velocities on the glabrous hand and the resultant pattern of evoked BOLD response in the human brain. Moreover, we hypothesized that the hand representation in contralateral Brodmann Area (BA) 3b would show a significant dependence on stimulus velocity. Saltatory pneumatic pulses (60 ms duration, 9.5 ms rise/fall) were repetitively sequenced through a 7-channel TAC-Cell array at traverse velocities of 5, 25, and 65 cm/s on the glabrous hand initiated at the tips of D2 (index finger) and D3 (middle finger) and sequenced towards the D1 (thumb). The resulting hemodynamic response was sampled during 3 functional MRI scans (BOLD) in 20 neurotypical right-handed adults at 3T. Results from each subject were inserted to the one-way ANOVA within-subjects and one sample t-test to evaluate the group main effect of all three velocities stimuli and each of three different velocities, respectively. The stimulus evoked BOLD response revealed a dynamic representation of saltatory pneumotactile stimulus velocity in a network consisting of the contralateral primary hand somatosensory cortex (BA3b), associated primary motor cortex (BA4), posterior insula, and ipsilateral deep cerebellum. The spatial extent of this network was greatest at the 5 and 25 cm/s pneumotactile stimulus velocities.	[Oh, Hyuntaek; Barlow, Steven] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA; [Custead, Rebecca; Wang, Yingying; Barlow, Steven] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE USA; [Oh, Hyuntaek; Custead, Rebecca; Wang, Yingying; Barlow, Steven] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA; [Oh, Hyuntaek] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Baylor College of Medicine	Oh, H (corresponding author), Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA.; Oh, H (corresponding author), Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA.; Oh, H (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	hyuntaek.oh@huskers.unl.edu	Wang, Yingying/I-2705-2018	Wang, Yingying/0000-0001-6502-1388	Barkley Trust Foundation (SM Barlow - PI)	Barkley Trust Foundation (SM Barlow - PI)	This work was supported by the internal grant from Barkley Trust Foundation (SM Barlow - PI). There was no additional external funding received for this study.	Ackerley R, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00051; Backes WH, 2000, CLIN NEUROPHYSIOL, V111, P1738, DOI 10.1016/S1388-2457(00)00420-X; Bertolasi L, 1998, J PHYSIOL-LONDON, V511, P947, DOI 10.1111/j.1469-7793.1998.947bg.x; Besle J, 2013, J NEUROPHYSIOL, V109, P2293, DOI 10.1152/jn.00499.2012; Blakemore SJ, 1999, NEUROIMAGE, V10, P448, DOI 10.1006/nimg.1999.0478; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Blakemore SJ, 2001, NEUROREPORT, V12, P1879, DOI 10.1097/00001756-200107030-00023; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Brodoehl S, 2013, BEHAV BRAIN RES, V238, P259, DOI 10.1016/j.bbr.2012.10.038; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Bursztyn LLCD, 2006, CURR BIOL, V16, P2440, DOI 10.1016/j.cub.2006.10.051; Caspers S, 2013, CEREB CORTEX, V23, P615, DOI 10.1093/cercor/bhs048; Chen TL, 2008, NEUROIMAGE, V40, P1765, DOI 10.1016/j.neuroimage.2008.01.020; Custead R, 2015, BRAIN RES, V1622, P81, DOI 10.1016/j.brainres.2015.06.025; Dallmann CJ, 2015, J NEUROPHYSIOL, V114, P3131, DOI 10.1152/jn.00621.2015; Dean J, 2006, CLIN PHYSIOL FUNCT I, V26, P314, DOI 10.1111/j.1475-097X.2006.00689.x; DREYER DA, 1978, SENS PROCESS, V2, P71; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; ESSICK GK, 1995, J NEUROSCI, V15, P848; ESSICK GK, 1988, SOMATOSENS MOT RES, V6, P21, DOI 10.3109/08990228809144639; Ferretti A, 2007, HUM BRAIN MAPP, V28, P645, DOI 10.1002/hbm.20292; FOX PT, 1985, P NATL ACAD SCI USA, V82, P7462, DOI 10.1073/pnas.82.21.7462; Franklin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134518; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gleeson BT, 2010, IEEE T HAPTICS, V3, P177, DOI [10.1109/TOH.2010.20, 10.1109/ToH.2010.20]; Hagen MC, 2002, EUR J NEUROSCI, V16, P957, DOI 10.1046/j.1460-9568.2002.02139.x; Huang RS, 2007, NEUROIMAGE, V34, P1060, DOI 10.1016/j.neuroimage.2006.10.024; Iggo A., 2012, SOMATOSENSORY SYSTEM, V2; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Kampe KKW, 2000, HUM BRAIN MAPP, V9, P106, DOI 10.1002/(SICI)1097-0193(200002)9:2<106::AID-HBM5>3.0.CO;2-Y; Karkhanis AN, 2014, J PHYSIOL-LONDON, V592, P3625, DOI 10.1113/jphysiol.2014.270942; KEYSON DV, 1995, PERCEPT PSYCHOPHYS, V57, P738, DOI 10.3758/BF03213278; Kim SG, 1997, MAGNET RESON MED, V37, P631, DOI 10.1002/mrm.1910370427; Ktiada R, 2003, NEUROREPORT, V14, P719, DOI 10.1097/01.wnr.0000065508.53896.aa; LEE CJ, 1992, CEREB CORTEX, V2, P81, DOI 10.1093/cercor/2.2.81; Lin YY, 2003, CAN J NEUROL SCI, V30, P31, DOI 10.1017/S0317167100002407; Loken LS, 2011, BRAIN RES, V1417, P9, DOI 10.1016/j.brainres.2011.08.011; Martuzzi R, 2014, HUM BRAIN MAPP, V35, P213, DOI 10.1002/hbm.22172; McGlone F, 2012, EUR J NEUROSCI, V35, P1782, DOI 10.1111/j.1460-9568.2012.08092.x; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; OLAUSSON H, 1993, J PHYSIOL-LONDON, V464, P545, DOI 10.1113/jphysiol.1993.sp019650; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Papadelis C, 2011, NEUROIMAGE, V54, P60, DOI 10.1016/j.neuroimage.2010.07.054; Pei YC, 2014, J NEUROPHYSIOL, V112, P3023, DOI 10.1152/jn.00391.2014; Popescu EA, 2013, HUM BRAIN MAPP, V34, P1415, DOI 10.1002/hbm.21519; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Sanchez-Panchuelo RM, 2012, J NEUROSCI, V32, P15815, DOI 10.1523/JNEUROSCI.2501-12.2012; Schweisfurth M. A., 2014, FRONTIERS HUMAN NEUR, V8; Small SL, 2002, BRAIN, V125, P1544, DOI 10.1093/brain/awf148; Tommerdahl M, 2006, J NEUROSCI, V26, P5970, DOI 10.1523/JNEUROSCI.5270-05.2006; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Venkatesan L, 2010, BRAIN RES, V1348, P63, DOI 10.1016/j.brainres.2010.06.015; VERRILLO RT, 1986, J ACOUST SOC AM, V80, P528, DOI 10.1121/1.394047; Weibull A, 2008, MAGN RESON IMAGING, V26, P1342, DOI 10.1016/j.mri.2008.04.007; WHITSEL BL, 1978, FED PROC, V37, P2223; WHITSEL BL, 1986, SOMATOSENS MOT RES, V3, P185, DOI 10.3109/07367228609144583; Wienbruch C, 2006, NEUROSCI LETT, V398, P183, DOI 10.1016/j.neulet.2006.01.025; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363	67	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183532	10.1371/journal.pone.0183532	http://dx.doi.org/10.1371/journal.pone.0183532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841675	Green Submitted, Green Published, gold			2022-12-26	WOS:000408370700039
J	Brenes-Soto, A; Dierenfeld, ES; Janssens, GPJ				Brenes-Soto, Andrea; Dierenfeld, Ellen S.; Janssens, Geert P. J.			Colouration in amphibians as a reflection of nutritional status: The case of tree frogs in Costa Rica	PLOS ONE			English	Article							NUPTIAL COLORATION; BODY CONDITION; REPRODUCTIVE SUCCESS; DIETARY CAROTENOIDS; SIZE; HEMATOLOGY; SIGNALS; PLASMA; VALUES; TRANSFORMATIONS	Colouration has been considered a cue for mating success in many species; ornaments in males often are related to carotenoid mobilization towards feathers and/or skin and can signal general health and nutrition status. However, there are several factors that can also link with status, such as physiological blood parameters and body condition, but there is not substantial evidence which supports the existence of these relationships and interactions in anurans. This study evaluated how body score and blood values interact with colouration in free-range Agalychnis callidryas and Agalychnis annae males. We found significant associations between body condition and plasmatic proteins and haematocrit, as well as between body condition and colour values from the chromaticity diagram. We also demonstrated that there is a significant relation between the glucose and plasmatic protein values that were reflected in the ventral colours of the animals, and haematocrit inversely affected most of those colour values. Significant differences were found between species as well as between populations of A. callidryas, suggesting that despite colour variation, there are also biochemical differences within animals from the same species located in different regions. These data provide information on underlying factors for colouration of male tree frogs in nature, provide insights about the dynamics of several nutrients in the amphibian model and how this could affect the reproductive output of the animals.	[Brenes-Soto, Andrea; Janssens, Geert P. J.] Univ Ghent, Fac Vet Med, Anim Nutr Lab, Merelbeke, Belgium; [Brenes-Soto, Andrea] Univ Costa Rica, Dept Anim Sci, San Jose, Costa Rica; [Dierenfeld, Ellen S.] Ellen S Dierenfeld LLC, St Louis, MO USA	Ghent University; Universidad Costa Rica	Brenes-Soto, A (corresponding author), Univ Ghent, Fac Vet Med, Anim Nutr Lab, Merelbeke, Belgium.; Brenes-Soto, A (corresponding author), Univ Costa Rica, Dept Anim Sci, San Jose, Costa Rica.	andrea.brenessoto@ugent.be	Janssens, Geert/C-2264-2008		Research Department, University of Costa Rica [739- B2-076]; Ellen S. Dierenfeld, LLC; University of Costa Rica	Research Department, University of Costa Rica; Ellen S. Dierenfeld, LLC; University of Costa Rica	The work was supported by Research Department, University of Costa Rica, Project No. 739- B2-076, www.vinv.ucr.ac.cr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ellen S. Dierenfeld is affiliated to Ellen S. Dierenfeld, LLC. Ellen S. Dierenfeld, LLC. provided support in the form of salary for author ESD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the "author contributions" section.; The authors would like to thank Yolanda Matamoros, from Simon Bolivar Zoo, Santiago Parra from San Isidro de Dota and the staff from El Zota Biological Station for the access to the collection sites. We would also like to thank Jesenia Vasquez Vargas, research assistant, Jose Hernandez and Randall Arguedas for the technical assistance and the University of Costa Rica for the financial support in the development of the study.	Aiello S.E., 2012, MERK VET MANUAL; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; [Anonymous], 2012, BOL CIENT NUS HIS NA, V1, P233; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; Bell BD, 2004, BIOL CONSERV, V120, P189, DOI 10.1016/j.biocon.2004.02.011; Berg J. M., 2008, BIOQUIMICA; Blount JD, 2004, ARCH BIOCHEM BIOPHYS, V430, P10, DOI 10.1016/j.abb.2004.03.039; Bray RE, 2001, PROCEEDINGS OF THE AZA NUTRITION ADVISORY GROUP FOURTH CONFERENCE ON ZOO AND WILDLIFE NUTRITION, P25; Brenes-Soto A, 2014, ZOO BIOL, V33, P544, DOI 10.1002/zoo.21175; Briggs VS, 2008, ETHOLOGY, V114, P489, DOI 10.1111/j.1439-0310.2008.01490.x; BROWDER LW, 1968, J HERED, V59, P163, DOI 10.1093/oxfordjournals.jhered.a107674; Zenklusen MCC, 2011, REV BIOL TROP, V59, P17; Cathers T, 1997, J ZOO WILDLIFE MED, V28, P171; Chang SH, 1974, J KOREAN CHEM SOC, V18, P289; Chelonians Flanagan J., 2015, ZOO WILD ANIMAL MED, P27; Coppo J, 2004, FACENA, V20, P73; Coppo JA, 2005, REV BIOL TROP, V53, P545; COPPO JA, 2001, FISIOLOGIA COMPARADA; COSTANZO JP, 1993, J EXP BIOL, V181, P245; CZECZUGA B, 1980, COMP BIOCHEM PHYS B, V65, P623, DOI 10.1016/0305-0491(80)90170-4; Das MK, 2014, ISRN, V2014, P1, DOI DOI 10.1093/imrn/rns215; Davis AK, 2008, HERPETOL J, V18, P83; Dickinson VM, 2002, J WILDLIFE DIS, V38, P143, DOI 10.7589/0090-3558-38.1.143; Duellman WE, 2001, HYLID FROGS MIDDLE A; Dugas MB, 2013, ZOO BIOL, V32, P655, DOI 10.1002/zoo.21102; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fioranelli S, 2005, COM CIENT TECNOL, V003, P1; FROST SK, 1984, J MORPHOL, V179, P229, DOI 10.1002/jmor.1051790303; GATTEN RE, 1969, COMP BIOCHEM PHYSIOL, V30, P1019, DOI 10.1016/0010-406X(69)91039-1; Gomez D, 2010, BEHAVIOUR, V147, P1753, DOI 10.1163/000579510X534227; GROSS J, 1966, BIOCHEM J, V101, P747, DOI 10.1042/bj1010747; Gul C, 2011, ACTA HERPETOL, V6, P137; Hadfield CA, 2006, J EXOT PET MED, V15, P255, DOI 10.1053/j.jepm.2006.09.004; Hettyey A, 2009, AMPHIBIA-REPTILIA, V30, P37, DOI 10.1163/156853809787392784; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; Hill GE, 1999, AM NAT, V154, P589, DOI 10.1086/303264; Hill GE, 2014, INTEGR COMP BIOL, V54, P645, DOI 10.1093/icb/icu029; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; IGA T, 1975, J EXP ZOOL, V192, P331, DOI 10.1002/jez.1401920306; Jacobs L, 2016, BIOL J LINN SOC; Jain NC, 1993, ESSENTIALS VET HEMAT; Johnson JD, 2013, BIOCHIMIE, V95, P436, DOI 10.1016/j.biochi.2012.10.021; Kaneko JJ, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P1; Kelber A, 2006, J EXP BIOL, V209, P781, DOI 10.1242/jeb.02060; Kelleher SR, 2017, ANIM BEHAV, V129, P161, DOI 10.1016/j.anbehav.2017.05.013; Khachik F, 2002, INVEST OPHTH VIS SCI, V43, P3383; KING RB, 1993, J EXP ZOOL, V267, P40, DOI 10.1002/jez.1402670107; KISTLER A, 1980, INT J BIOCHEM, V12, P395, DOI 10.1016/0020-711X(80)90119-6; KRINSKY NI, 1994, PURE APPL CHEM, V66, P1003, DOI 10.1351/pac199466051003; LEENDERS T., 2001, GUIDE AMPHIBIANS REP; Lutz T., 2009, ENCICLOPEDIA NUTR CL; Mader DR, 1996, REPTILE MED SURG; Matias-Ferrer N, 2015, HERPETOL J, V25, P169; McDonald P., 2010, ANIM NUTR; McGraw KJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P484, DOI 10.1086/383506; McGraw KJ, 2002, COMP BIOCHEM PHYS B, V131, P261, DOI 10.1016/S1096-4959(01)00500-0; Merton D., 2012, SMALL ANIMAL CLIN PH; MORTON RA, 1949, BIOCHEM J, V45, P612, DOI 10.1042/bj0450612; Murray R. K., 2012, HARPERS ILLUSTRATED; Newman SH, 1997, COLON WATERBIRD, V20, P492, DOI 10.2307/1521600; Ogilvy V, 2012, ANIM CONSERV, V15, P480, DOI 10.1111/j.1469-1795.2012.00536.x; OLSSON M, 1994, ANIM BEHAV, V48, P607, DOI 10.1006/anbe.1994.1280; Olvera-Novoa MA, 2007, AQUACULTURE, V266, P191, DOI 10.1016/j.aquaculture.2007.02.013; PACKARD GC, 1976, AM MIDL NAT, V96, P482, DOI 10.2307/2424090; Patrick L, 2009, REV BIOL TROP, V57, P313; Pinto F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073234; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; READING CJ, 1995, OECOLOGIA, V102, P453, DOI 10.1007/BF00341357; Ready M, 2010, LEAF LIT, V3, P14; Reppert A, 2011, PROC NUT ADV G, P40; Robertson J. S., 2008, THESIS; Robertson JM, 2009, MOL ECOL, V18, P1375, DOI 10.1111/j.1365-294X.2009.04126.x; Sarna T, 2006, PIGMENTARY SYSTEM PH, P311; Savage J.M., 2002, AMPHIBIANS REPTILES; SCHIEDT K, 1985, PURE APPL CHEM, V57, P685, DOI 10.1351/pac198557050685; Sefc KM, 2014, COMP BIOCHEM PHYS A, V173, P42, DOI 10.1016/j.cbpa.2014.03.006; Shirakata Yoshinori, 2006, Chugokugakuen Journal, V5, P17; SINGH K, 1978, ANAT ANZEIGER, V143, P161; Smith H, 2006, EUROP SOC EVOL BIOL, V20, P310; Somsueb P, 2001, AQUAC RES, V32, P33, DOI 10.1046/j.1355-557x.2001.00033.x; Stegen JC, 2004, CAN J ZOOL, V82, P889, DOI 10.1139/Z04-068; Stuart S. N., 2008, THREATENED AMPHIBIAN; SUGA T, 1988, J NAT PROD, V51, P713, DOI 10.1021/np50058a008; Sztatecsny M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1587, DOI 10.1007/s00265-012-1412-6; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x; Zhu B, 2016, PLOS ONE, V11, P1; Zoran DL, 2002, J AM VET MED ASSOC, V221, P1559, DOI 10.2460/javma.2002.221.1559; IUCN RED LIST THREAT	91	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182020	10.1371/journal.pone.0182020	http://dx.doi.org/10.1371/journal.pone.0182020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837604	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000014
J	Kuravi, SJ; Yates, CM; Foster, M; Harrison, P; Hazeldine, J; Hampson, P; Watson, C; Belli, A; Midwinter, M; Nash, GB				Kuravi, Sahithi J.; Yates, Clara M.; Foster, Mark; Harrison, Paul; Hazeldine, Jon; Hampson, Peter; Watson, Chris; Belli, Antonio; Midwinter, Mark; Nash, Gerard B.			Changes in the pattern of plasma extracellular vesicles after severe trauma	PLOS ONE			English	Article							CELL-DERIVED MICROPARTICLES; PROCOAGULANT MICROPARTICLES; CIRCULATING MICROPARTICLES; PLATELET MICROPARTICLES; ORGAN DYSFUNCTION; GLYCOPROTEIN IB; FLOW-CYTOMETRY; MICROVESICLES; BLOOD; STANDARDIZATION	Background Extracellular vesicles (EV) released into the circulation after traumatic injury may influence complications. We thus evaluated the numbers of EV in plasma over 28 days after trauma and evaluated their pro-coagulant and inflammatory effects. Methods and findings 37 patients suffering trauma with an injury severity score > 15 were studied along with 24 healthy controls. Plasma samples were isolated by double centrifugation (2000g 20min; 13000g 2min) from blood collected from within an hour up to 28 days after injury. Plasma EV were counted and sized using nanoparticle tracking analysis (NTA); counts and cellular origins were also determined by flow cytometry (FC) using cell-specific markers. Functional effects were tested in a procoagulant phospholipid assay and in flow-based, leukocyte adhesion assay after endothelial cells (EC) were treated with EV. We found that EV concentrations measured by NTA were significantly increased in trauma patients compared to healthy controls, and remained elevated over days. In addition, or FC showed that patients with trauma had higher numbers of EV derived from platelets (CD41+), leukocytes (CD45+) and endothelial EC (CD144+). The increases were evident throughout the 28-day follow-up. However, the FC count represented <1% of the count detected by NTA, and only 1-2% of EV identified using NTA had a diameter > 400nm. The procoagulant phospholipid activity assay showed that patient plasma accelerated coagulation on day 1 and day 3 after trauma, with coagulation times correlated with EV counts. Furthermore, treatment of EC for 24 hours with plasma containing EV tended to increase the recruitment of peripheral flowing blood mononuclear cells. Conclusions EV counted by FC represent a small sub-population of the total load detected by NTA. Both methods however indicate a significant increase in plasma EV after severe traumatic injury that have pro-coagulant and pro-inflammatory effects that may influence outcomes.	[Kuravi, Sahithi J.; Yates, Clara M.; Nash, Gerard B.] Univ Birmingham, Inst Cardiovasc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Kuravi, Sahithi J.; Yates, Clara M.; Foster, Mark; Hazeldine, Jon; Belli, Antonio; Midwinter, Mark; Nash, Gerard B.] Univ Hosp Birmingham NHS Fdn Trust, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Harrison, Paul; Hazeldine, Jon; Hampson, Peter; Belli, Antonio] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Watson, Chris] Queen Elizabeth Hosp, Dept Haematol, Birmingham, W Midlands, England; [Midwinter, Mark] Univ Queensland, Fac Med, Rural Clin Sch Bundaberg, Bundaberg, Qld, Australia	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Queensland	Nash, GB (corresponding author), Univ Birmingham, Inst Cardiovasc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England.; Nash, GB (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England.	g.nash@bham.ac.uk	Nash, Gerard B/E-4182-2010; Harrison, Paul/AAN-1916-2021; Belli, Antonio/I-3799-2015; Hazeldine, Jon/T-5725-2019	Nash, Gerard B/0000-0002-5935-2831; Harrison, Paul/0000-0003-4610-8909; Belli, Antonio/0000-0002-3211-9933; 	National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC) [RRAK 12708]; University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; Royal Centre for Defence Medicine; Scar Free Foundation	National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC); University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; Royal Centre for Defence Medicine; Scar Free Foundation	SK, CY, JH, AB were funded by the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC, grant number RRAK 12708), a partnership between University Hospitals Birmingham NHS Foundation Trust, the University of Birmingham and the Royal Centre for Defence Medicine. PH was funded by Scar Free Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SR, 2011, J IMMUNOL, V187, P1432, DOI 10.4049/jimmunol.1100299; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; ANDERSON BO, 1990, J TRAUMA, V30, pS44; Ayers L, 2011, THROMB RES, V127, P370, DOI 10.1016/j.thromres.2010.12.014; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; BODE AP, 1994, TRANSFUSION, V34, P690, DOI 10.1046/j.1537-2995.1994.34894353465.x; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; BUTTRUM SM, 1993, BLOOD, V82, P1165; Chandler WL, 2011, J THROMB HAEMOST, V9, P1216, DOI 10.1111/j.1538-7836.2011.04283.x; CIPOLLE MD, 1993, CRIT CARE CLIN, V9, P261, DOI 10.1016/S0749-0704(18)30196-9; COOKE BM, 1993, MICROVASC RES, V45, P33, DOI 10.1006/mvre.1993.1004; Curry N, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25625; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Flaumenhaft R, 2010, SEMIN THROMB HEMOST, V36, P881, DOI 10.1055/s-0030-1267042; Flaumenhaft R, 2009, BLOOD, V113, P1112, DOI 10.1182/blood-2008-06-163832; Fujimi S, 2003, J TRAUMA, V54, P114, DOI 10.1097/00005373-200301000-00014; Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671; Gardiner EE, 2014, TRANSFUS MED REV, V28, P56, DOI 10.1016/j.tmrv.2014.03.001; Giannoudis PV, 1998, BRIT J SURG, V85, P986; Giannoudis PV, 2004, J BONE JOINT SURG BR, V86B, P313, DOI 10.1302/0301-620X.86B3.15035; Giannoudis PV, 1998, ACTA ORTHOP SCAND, V69, P184, DOI 10.3109/17453679809117625; Hazeldine J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002338; HOLME PA, 1994, THROMB HAEMOSTASIS, V72, P666; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; Key NS, 2010, THROMB RES, V125, pS42, DOI 10.1016/j.thromres.2010.01.035; Lacroix R, 2013, J THROMB HAEMOST, V11, P1190, DOI 10.1111/jth.12207; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Leroyer AS, 2008, J INTERN MED, V263, P528, DOI 10.1111/j.1365-2796.2008.01957.x; Matijevic N, 2014, THROMB RES, V134, P652, DOI 10.1016/j.thromres.2014.07.023; Matijevic N, 2011, THROMB RES, V128, P35, DOI 10.1016/j.thromres.2011.02.011; Mause SF, 2005, ARTERIOSCL THROM VAS, V25, P1512, DOI 10.1161/01.ATV.0000170133.43608.37; Mesri C, 1998, J IMMUNOL, V161, P4382; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Morel O, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-15; Morel O, 2005, REV MED INTERNE, V26, P791, DOI 10.1016/j.revmed.2005.03.015; Morel O, 2008, PLATELETS, V19, P9, DOI 10.1080/09537100701817232; MURPHY S, 1969, NEW ENGL J MED, V280, P1094, DOI 10.1056/NEJM196905152802004; Ogura H, 2001, J TRAUMA, V50, P801, DOI 10.1097/00005373-200105000-00005; Padilla Foster M., 2016, THESIS; Park MS, 2012, SURGERY, V151, P831, DOI 10.1016/j.surg.2011.12.022; Rose S, 1996, ZBL CHIR, V121, P896; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; Van der Pol E, 2012, J THROMB HAEMOST, V10, P919, DOI 10.1111/j.1538-7836.2012.04683.x; van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x; WINOKUR R, 1995, BLOOD, V85, P1796, DOI 10.1182/blood.V85.7.1796.bloodjournal8571796; Yuana Y, 2011, THROMB HAEMOSTASIS, V105, P396, DOI 10.1160/TH10-09-0595	51	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183640	10.1371/journal.pone.0183640	http://dx.doi.org/10.1371/journal.pone.0183640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837705	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000093
J	Makhanova, N; Morgan, AP; Kayashima, Y; Makhanov, A; Hiller, S; Zhilicheva, S; Xu, LQ; de Villena, FPM; Maeda, N				Makhanova, Natalia; Morgan, Andrew P.; Kayashima, Yukako; Makhanov, Andrei; Hiller, Sylvia; Zhilicheva, Svetlana; Xu, Longquan; de Villena, Fernando Pardo-Manuel; Maeda, Nobuyo			Genetic architecture of atherosclerosis dissected by QTL analyses in three F2 intercrosses of apolipoprotein E-null mice on C57BL6/J, DBA/2J and 129S6/SvEvTac backgrounds	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; IDENTIFICATION; ASSOCIATION; LESIONS; CROSS	Quantitative trait locus (QTL) analyses of intercross populations between widely used mouse inbred strains provide a powerful approach for uncovering genetic factors that influence susceptibility to atherosclerosis. Epistatic interactions are common in complex phenotypes and depend on genetic backgrounds. To dissect genetic architecture of atherosclerosis, we analyzed F2 progeny from a cross between apolipoprotein E-null mice on DBA/2J (DBA-apoE) and C57BL/6J (B6-apoE) genetic backgrounds and compared the results with those from two previous F2 crosses of apolipoprotein E-null mice on 129S6/SvEvTac (129-apoE) and DBA-apoE backgrounds, and B6-apoE and 129-apoE backgrounds. In these round-robin crosses, in which each parental strain was crossed with two others, large-effect QTLs are expected to be detectable at least in two crosses. On the other hand, observation of QTLs in one cross only may indicate epistasis and/or absence of statistical power. For atherosclerosis at the aortic arch, Aath4 on chromosome (Chr)2:66 cM follows the first pattern, with significant QTL peaks in (DBAx129)F2 and (B6xDBA)F2 mice but not in (B6x129)F2 mice. We conclude that genetic variants unique to DBA/2J at Aath4 confer susceptibility to atherosclerosis at the aortic arch. A similar pattern was observed for Aath5 on chr10:35 cM, verifying that the variants unique to DBA/2J at this locus protect against arch plaque development. However, multiple loci, including Aath1 (Chr1:49 cM), and Aath2 (Chr1:70 cM) follow the second type of pattern, showing significant peaks in only one of the three crosses (B6-apoE x 129-apoE). As for atherosclerosis at aortic root, the majority of QTLs, including Ath29 (Chr9:33 cM), Ath44 (Chr1:68 cM) and Ath45 (Chr2:83 cM), was also inconsistent, being significant in only one of the three crosses. Only the QTL on Chr7:37 cM was consistently suggestive in two of the three crosses. Thus QTL analysis of round-robin crosses revealed the genetic architecture of atherosclerosis.	[Makhanova, Natalia; Kayashima, Yukako; Hiller, Sylvia; Zhilicheva, Svetlana; Xu, Longquan; Maeda, Nobuyo] Univ North Carolina Chapel Hill, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Morgan, Andrew P.; de Villena, Fernando Pardo-Manuel] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC USA; [Morgan, Andrew P.; de Villena, Fernando Pardo-Manuel] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Makhanov, Andrei] Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Georgia; Georgia Institute of Technology	Maeda, N (corresponding author), Univ North Carolina Chapel Hill, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	nobuyo@med.unc.edu			National Institutes of Health (NIH) [HL042630]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a National Institutes of Health (NIH) grant HL042630 (PI: N. Maeda). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Beavis W. D., 1994, P 49 ANN CORN SORGH, P250; Beavis WD, 1998, MOL DISSECTION COMPL, P145, DOI DOI 10.1093/MP/SSR111; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Broman K., 2009, A GUIDE TO QTL MAPPI; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Colinayo VV, 2003, MAMM GENOME, V14, P464, DOI 10.1007/s00335-002-2187-2; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Irvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024052; Kayashima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117478; Kayashima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088274; Kenney-Hunt JP, 2008, GENETICS, V178, P2275, DOI 10.1534/genetics.107.084434; Kenney-Hunt JP, 2006, MAMM GENOME, V17, P526, DOI 10.1007/s00335-005-0160-6; Kessler T, 2016, EMBO MOL MED, V8, P688, DOI 10.15252/emmm.201506174; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lalani SR, 2013, HUM MOL GENET, V22, P4339, DOI 10.1093/hmg/ddt283; Maeda N, 2007, ATHEROSCLEROSIS, V195, P75, DOI 10.1016/j.atherosclerosis.2006.12.006; Mann MRW, 1999, HUM MOL GENET, V8, P1867, DOI 10.1093/hmg/8.10.1867; Morgan AP, 2016, GENETICS, V204, P267, DOI 10.1534/genetics.116.191007; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Sen S, 2007, MAMM GENOME, V18, P87, DOI 10.1007/s00335-006-0090-y; STEWARTPHILLIPS JL, 1989, CLIN INVEST MED, V12, P121; Teupser D, 2006, P NATL ACAD SCI USA, V103, P123, DOI 10.1073/pnas.0509570102; Tomita H, 2010, CIRC RES, V106, P1052, DOI 10.1161/CIRCRESAHA.109.207175; Treusch S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004913; Wang JR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S3-S13; Wang SS, 2007, ARTERIOSCL THROM VAS, V27, P2671, DOI 10.1161/ATVBAHA.107.148106; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; Wang XS, 2005, AM J HUM GENET, V77, P1, DOI 10.1086/431656; WARNICK GR, 1985, CLIN CHEM, V31, P217; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182882	10.1371/journal.pone.0182882	http://dx.doi.org/10.1371/journal.pone.0182882			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837567	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000031
J	Deng, XL; Wang, Y; Xiao, GS				Deng, Xiu-Ling; Wang, Yan; Xiao, Guo-Sheng			Effects of equol on multiple K+ channels stably expressed in HEK 293 cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ISOFLAVONE METABOLITE EQUOL; CARDIAC POTASSIUM CHANNELS; TRANSIENT OUTWARD CURRENT; PIG VENTRICULAR MYOCYTES; FACTOR RECEPTOR KINASE; HUMAN ATRIAL MYOCYTES; ANTIOXIDANT ACTIVITY; TYROSINE KINASE; SOY ISOFLAVONES	The present study investigated the effects of equol on cardiovascular K+ channel currents. The cardiovascular K+ channel currents were determined in HEK 293 cells stably expressing cloned differential cardiovascular K+ channels with conventional whole-cell patch voltage-clamp technique. We found that equol inhibited hKv1.5 (IC50: 15.3 mu M), hKv4.3 (IC50: 29.2 mu M and 11.9 mu M for hKv4.3 peak current and charge area, respectively), I-Ks (IC50: 24.7 mu M) and I-hERG (IC50: 31.6 and 56.5 mu M for I-hERG.tail and I-hERG.step, respectively), but not hKir2.1 current, in a concentration-dependent manner. Interestingly, equol increased BKCa current with an EC50 of 0.1 mu M. It had no significant effect on guinea pig ventricular action potentials at concentrations of <= 3 mu M. These results demonstrate that equol inhibits several cardiac K+ currents at relatively high concentrations, whereas it increases BKCa current at very low concentrations, suggesting that equol is a safe drug candidate for treating patients with cerebral vascular disorders.	[Deng, Xiu-Ling] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Xian, Shaanxi, Peoples R China; [Wang, Yan; Xiao, Guo-Sheng] Xiamen Univ, Xiamen Cardiovasc Hosp, Xiamen, Fujian, Peoples R China	Xi'an Jiaotong University; Xiamen University	Deng, XL (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Xian, Shaanxi, Peoples R China.; Xiao, GS (corresponding author), Xiamen Univ, Xiamen Cardiovasc Hosp, Xiamen, Fujian, Peoples R China.	dengxl@mail.xjtu.edu.cn; xgs71@163.com			National Nature Science Foundation of China [81570214, 81370191]; Collaborative Grant for Study on Prevention and Control of Major Chronic Non-infectious Diseases of the 13th Five-Year National Research Plan from Ministry of Science and Technology, China; Key Cardiovascular Laboratory Fund from Department of Xiamen Science and Technology, Xiamen, China [3502Z20150050]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Grant for Study on Prevention and Control of Major Chronic Non-infectious Diseases of the 13th Five-Year National Research Plan from Ministry of Science and Technology, China; Key Cardiovascular Laboratory Fund from Department of Xiamen Science and Technology, Xiamen, China	This work was supported in part by grants (No.81570214, No.81370191) from National Nature Science Foundation of China, a Collaborative Grant for Study on Prevention and Control of Major Chronic Non-infectious Diseases of the 13th Five-Year National Research Plan from Ministry of Science and Technology, China and a Key Cardiovascular Laboratory Fund (3502Z20150050) from Department of Xiamen Science and Technology, Xiamen, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grants (No.81570214, No.81370191) from National Nature Science Foundation of China, a Collaborative Grant for Study on Prevention and Control of Major Chronic Non-infectious Diseases of the 13th Five-Year National Research Plan from Ministry of Science and Technology, China and a Key Cardiovascular Laboratory Fund (3502Z20150050) from Department of Xiamen Science and Technology, Xiamen, China.	Amberg GC, 2003, AM J PHYSIOL-CELL PH, V284, pC583, DOI 10.1152/ajpcell.00301.2002; Atkinson C, 2005, EXP BIOL MED, V230, P155, DOI 10.1177/153537020523000302; Blair RM, 2003, J NUTR, V133, P2262, DOI 10.1093/jn/133.7.2262; Choi EJ, 2014, MOL MED REP, V9, P328, DOI 10.3892/mmr.2013.1752; CLARK RB, 1995, BRIT J PHARMACOL, V115, P335, DOI 10.1111/j.1476-5381.1995.tb15882.x; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Dong MQ, 2010, BBA-BIOMEMBRANES, V1798, P995, DOI 10.1016/j.bbamem.2010.01.010; Farkas AS, 2010, DRUGS, V70, P573, DOI 10.2165/11535230-000000000-00000; Feng JL, 1997, CIRC RES, V80, P572, DOI 10.1161/01.RES.80.4.572; Giudicessi JR, 2011, HEART RHYTHM, V8, P1024, DOI 10.1016/j.hrthm.2011.02.021; Guo KP, 2010, BRIT J NUTR, V104, P118, DOI 10.1017/S0007114510000279; Hazim S, 2016, AM J CLIN NUTR, V103, P694, DOI 10.3945/ajcn.115.125690; Hedlund TE, 2003, PROSTATE, V54, P68, DOI 10.1002/pros.10137; Jackman KA, 2007, CURR MED CHEM, V14, P2824, DOI 10.2174/092986707782360178; Jackman KA, 2007, BRAIN RES, V1141, P99, DOI 10.1016/j.brainres.2007.01.007; Kim HJ, 2011, AM J PHYSIOL-CELL PH, V300, pC567, DOI 10.1152/ajpcell.00031.2010; Ko EA, 2009, VASC PHARMACOL, V50, P51, DOI 10.1016/j.vph.2008.09.004; Legette LL, 2014, J AGR FOOD CHEM, V62, P1294, DOI 10.1021/jf400097m; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Li GR, 2002, J MOL CELL CARDIOL, V34, P1185, DOI 10.1006/jmcc.2002.2053; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Li GR, 2008, CIRCULATION, V117, P2449, DOI 10.1161/CIRCULATIONAHA.108.769554; Li GR, 2010, ADV PHARMACOL, V59, P93, DOI 10.1016/S1054-3589(10)59004-5; Li GR, 2009, CARDIOVASC RES, V81, P286, DOI 10.1093/cvr/cvn322; Liew R, 2003, J PHARMACOL EXP THER, V304, P985, DOI 10.1124/jpet.102.042986; Liu H, 2007, J MOL CELL CARDIOL, V42, P760, DOI 10.1016/j.yjmcc.2006.10.013; Magee PJ, 2014, EUR J NUTR, V53, P345, DOI 10.1007/s00394-013-0520-z; Magee PJ, 2011, P NUTR SOC, V70, P10, DOI 10.1017/S0029665110003940; Mahmoud AM, 2014, J STEROID BIOCHEM, V140, P116, DOI 10.1016/j.jsbmb.2013.12.010; Ohkura Y, 2015, J CARDIOVASC PHARM, V65, P500, DOI 10.1097/FJC.0000000000000220; OYAMA Y, 1992, JPN J PHARMACOL, V58, P185, DOI 10.1254/jjp.58.185; Peretz A, 1999, J PHYSIOL-LONDON, V519, P373, DOI 10.1111/j.1469-7793.1999.0373m.x; Remillard CV, 2007, AM J PHYSIOL-CELL PH, V292, pC1837, DOI 10.1152/ajpcell.00405.2006; Rowlands DJ, 2011, HYPERTENSION, V57, P833, DOI 10.1161/HYPERTENSIONAHA.110.162198; Rufer CE, 2006, J AGR FOOD CHEM, V54, P2926, DOI 10.1021/jf053112o; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Setchell KDR, 2005, AM J CLIN NUTR, V81, P1072; Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188; Setchell KDR, 2010, J NUTR, V140, p1363S, DOI 10.3945/jn.109.119784; Turner R, 2004, FREE RADICAL RES, V38, P209, DOI 10.1080/10715760310001641854; Veerman CC, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1002, DOI 10.1161/CIRCEP.113.000239; Wu HJ, 2011, J MOL CELL CARDIOL, V51, P966, DOI 10.1016/j.yjmcc.2011.08.022; Wu W, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059749, 10.1371/journal.pone.0059016]; Yang L, 2015, ANESTHESIOLOGY, V122, P571, DOI 10.1097/ALN.0000000000000495; Yu W, 2016, PHARMACOL RES, V107, P186, DOI 10.1016/j.phrs.2016.03.015; Yu W, 2014, CURR NEUROVASC RES, V11, P367, DOI 10.2174/1567202611666140908094517; Yuan JP, 2007, MOL NUTR FOOD RES, V51, P765, DOI 10.1002/mnfr.200600262; Zhang DY, 2008, CELL SIGNAL, V20, P1815, DOI 10.1016/j.cellsig.2008.06.006; Zhang DY, 2011, BBA-BIOMEMBRANES, V1808, P1993, DOI 10.1016/j.bbamem.2011.04.015; Zhang HT, 2010, EUR J PHARMACOL, V630, P100, DOI 10.1016/j.ejphar.2009.12.032; Zhang YH, 2012, CARDIOVASC RES, V93, P424, DOI 10.1093/cvr/cvr347	52	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183708	10.1371/journal.pone.0183708	http://dx.doi.org/10.1371/journal.pone.0183708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832658	Green Submitted, Green Published, gold			2022-12-26	WOS:000408355800089
J	Roy, G; Zhang, S; Li, L; Higham, E; Wu, H; Marelli, M; Bowen, MA				Roy, Gargi; Zhang, Shu; Li, Lina; Higham, Eileen; Wu, Herren; Marelli, Marcello; Bowen, Michael A.			Development of a fluorescent reporter system for monitoring ER stress in Chinese hamster ovary cells and its application for therapeutic protein production	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR XBP-1; B-CELLS; SECRETORY CAPACITY; QUALITY-CONTROL; MESSENGER-RNA; CHO-CELLS; DIFFERENTIATION; ATF6; IRE1	Mammalian cell expression systems have become a workhorse for the production of biotherapeutic proteins. As such, there is an ever increasing demand for higher productivity from these expression platforms to reduce manufacturing costs. While great advances have been made in the optimization of culture conditions and cell line selection to improve productivity, protein mis-folding remains a common limitation to high levels of production of therapeutic proteins. Accumulation of mis- and unfolded protein in the endoplasmic reticulum (ER) causes ER stress and initiates the unfolded protein response (UPR) that results in an activation of protein folding machinery, translation attenuation in an effort to proper folding of the newly synthesized peptides or may even lead to apoptosis if the correct folding is not restored. As a result, UPR associated apoptosis often results in lower protein expression. To better understand the molecular mechanisms in these pathways, we developed a reporter construct that detects Inositol-requiring enzyme 1 (IRE1)-alpha mediated splicing of X-box binding protein 1 (XBP1) to monitor the course of UPR activation in cell lines expressing monoclonal antibodies. Using this reporter we observed a clear activation of UPR in cells treated with known ER stress causing pharmacological agents, such as Tunicamycin (Tm) and Thapsigargin (Tg), as well as in stable IgG expressing cells during fed-batch cultures. Furthermore, we developed a stress metric that we term as ER stress index (ERSI) to gauge basal ER stress in cells which we used as a predictive tool for isolation of high IgG expressing cell lines. This reporter system, with its ability to monitor the stress involved in recombinant protein expression, has utility to assist in devising engineering strategies for improved production of biotherapeutic drugs.	[Roy, Gargi; Zhang, Shu; Wu, Herren; Marelli, Marcello; Bowen, Michael A.] MedImmune LLC, Antibody Discovery & Prot Engn, Gaithersburg, MD USA; [Li, Lina; Higham, Eileen] MedImmune LLC, Cell Culture & Fermentat Sci, Gaithersburg, MD USA; [Zhang, Shu] Gilead Sci, Biol Dev, San Diego, CA USA; [Higham, Eileen] Juno Therapeut, Proc Dev, Seattle, WA USA; [Bowen, Michael A.] Juno Therapeut, Analyt Dev, Seattle, WA USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; Gilead Sciences	Roy, G; Bowen, MA (corresponding author), MedImmune LLC, Antibody Discovery & Prot Engn, Gaithersburg, MD USA.; Bowen, MA (corresponding author), Juno Therapeut, Analyt Dev, Seattle, WA USA.	royg@medimmune.com; m.bowen@miami.edu		Marelli, Marcello/0000-0001-7095-8263	Medlmmune LLC	Medlmmune LLC	This study received funding from Medlmmune LLC. Medlmmune provided support in the form of salaries for authors [GR, SZ, LL, EH, HW, MM, MAB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Becker E, 2008, J BIOTECHNOL, V135, P217, DOI 10.1016/j.jbiotec.2008.03.008; Cain K, 2013, BIOTECHNOL PROGR, V29, P697, DOI 10.1002/btpr.1693; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Cudna RE, 2003, BIOTECHNOL BIOENG, V81, P56, DOI 10.1002/bit.10445; Du ZM, 2013, BIOTECHNOL BIOENG, V110, P2184, DOI 10.1002/bit.24877; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Evans K, 2015, BIOTECHNOL PROGR, V31, P1172, DOI 10.1002/btpr.2145; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Gunn KE, 2003, FASEB J, V17, pC209; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kober L, 2012, BIOTECHNOL BIOENG, V109, P2599, DOI 10.1002/bit.24527; Ku SCY, 2010, BIOTECHNOL PROGR, V26, P517, DOI 10.1002/btpr.322; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LYTTON J, 1991, J BIOL CHEM, V266, P17067; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Paschen W, 2001, J NEUROCHEM, V79, P719, DOI 10.1046/j.1471-4159.2001.00623.x; Prashad K, 2015, CYTOTECHNOLOGY, V67, P237, DOI 10.1007/s10616-013-9678-8; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Tigges M, 2006, METAB ENG, V8, P264, DOI 10.1016/j.ymben.2006.01.006; Tirosh B, 2005, J EXP MED, V202, P505, DOI 10.1084/jem.20050575; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848	37	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183694	10.1371/journal.pone.0183694	http://dx.doi.org/10.1371/journal.pone.0183694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832690	Green Published, gold, Green Submitted			2022-12-26	WOS:000408355800084
J	Sletta, KY; Tveitaras, MK; Lu, N; Engelsen, AST; Reed, RK; Garmann-Johnsen, A; Stuhr, L				Sletta, Kristine Yttersian; Tveitaras, Maria K.; Lu, Ning; Engelsen, Agnete S. T.; Reed, Rolf K.; Garmann-Johnsen, Annette; Stuhr, Linda			Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts	PLOS ONE			English	Article							HYPERBARIC-OXYGEN; MESENCHYMAL TRANSITION; GENE-EXPRESSION; PROSTATE-CANCER; N-CADHERIN; LUNG; CELLS; HYPEROXIA; PATTERNS; OUTCOMES	Background Tumor hypoxia is relevant for tumor growth, metabolism, resistance to chemotherapy and metastasis. We have previously shown that hyperoxia, using hyperbaric oxygen treatment (HBOT), attenuates tumor growth and shifts the phenotype from mesenchymal to epithelial (MET) in the DMBA-induced mammary tumor model. This study describes the effect of HBOT on tumor growth, angiogenesis, chemotherapy efficacy and metastasis in a triple negative MDA-MB-231 breast cancer model, and evaluates tumor growth using a triple positive BT-474 breast cancer model. Materials and methods 5 x 10(5) cancer cells were injected s.c. in the groin area of NOD/SCID female mice. The BT474 group was supplied with Progesterone and Estradiol pellets 2-days prior to tumor cell injection. Mice were divided into controls (1 bar, pO(2) = 0.2 bar) or HBOT (2.5 bar, pO(2) = 2.5 bar, 90 min, every third day until termination of the experiments). Treatment effects were determined by assessment of tumor growth, proliferation (Ki67-staining), angiogenesis (CD31-staining), metastasis (immunostaining), EMT markers (western blot), stromal components collagen type I, Itgb1 and FSP1 (immunostaining) and chemotherapeutic efficacy (5FU). Results HBOT significantly suppressed tumor growth in both the triple positive and negative tumors, and both MDA-MB-231 and BT-474 showed a decrease in proliferation after HBOT. No differences were found in angiogenesis or 5FU efficacy between HBOT and controls. Nevertheless, HBOT significantly reduced both numbers and total area of the metastastatic lesions, as well as reduced expression of N-cadherin, Axl and collagen type I measured in the MDA-MB-231 model. No change in stromal Itgb1 and FSP1 was found in either tumor model. Conclusion Despite the fact that behavior and prognosis of the triple positive and negative subtypes of cancer are different, the HBOT had a similar suppressive effect on tumor growth, indicating that they share a common oxygen dependent anti-tumor mechanism. Furthermore, HBOT significantly reduced the number and area of metastatic lesions in the triple negative model as well as a significant reduction in the EMT markers N-cadherin, Axl and density of collagen type I.	[Sletta, Kristine Yttersian; Tveitaras, Maria K.; Lu, Ning; Engelsen, Agnete S. T.; Reed, Rolf K.; Stuhr, Linda] Univ Bergen, Dept Biomed, Bergen, Norway; [Tveitaras, Maria K.; Engelsen, Agnete S. T.; Reed, Rolf K.; Stuhr, Linda] Univ Bergen, Ctr Canc Biomarkers CCBIO, Bergen, Norway; [Tveitaras, Maria K.] Haukeland Hosp, Matrix Biol, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Stuhr, L (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.; Stuhr, L (corresponding author), Univ Bergen, Ctr Canc Biomarkers CCBIO, Bergen, Norway.	linda.stuhr@uib.no	Engelsen, Agnete Svendsen Tenfjord/AAB-6652-2020; Reed, Rolf K./B-9422-2017	Engelsen, Agnete Svendsen Tenfjord/0000-0003-0375-3406; Reed, Rolf K./0000-0002-2633-6595	Research Council of Norway through its Centre of Excellence funding scheme [223250]; Norwegian Cancer Society, Helse Vest RHF	Research Council of Norway through its Centre of Excellence funding scheme; Norwegian Cancer Society, Helse Vest RHF	This work was partly supported by the Research Council of Norway through its Centre of Excellence funding scheme, project number 223250. The study was also supported by the Norwegian Cancer Society, Helse Vest RHF.	ALAGOZ T, 1995, CANCER, V75, P2313, DOI 10.1002/1097-0142(19950501)75:9<2313::AID-CNCR2820750921>3.0.CO;2-6; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Conklin MW, 2012, CELL ADHES MIGR, V6, P249, DOI 10.4161/cam.20567; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Ferreira BI, 2017, MEDCHEMCOMM, V8, P53, DOI 10.1039/c6md00394j; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Granowitz EV, 2005, ANTICANCER RES, V25, P3833; Haroon ATMY, 2007, UNDERSEA HYPERBAR M, V34, P83; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalns J, 1998, ANTICANCER RES, V18, P363; Kluft O., 1965, HYPERBARIC OXYGEN EX; Lash GE, 2002, GROWTH FACTORS, V20, P189, DOI 10.1080/0897719021000069560; Li MC, 2016, ONCOL REP, V36, P521, DOI 10.3892/or.2016.4766; LINDENSCHMIDT RC, 1986, CARCINOGENESIS, V7, P1581, DOI 10.1093/carcin/7.9.1581; Liu ZJ, 2015, J ZHEJIANG UNIV-SC B, V16, P32, DOI 10.1631/jzus.B1400221; Luo WR, 2012, HISTOPATHOLOGY, V61, P237, DOI 10.1111/j.1365-2559.2012.04212.x; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; MESTROVIC J, 1990, CLIN EXP METASTAS, V8, P113, DOI 10.1007/BF00117784; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mimeault M, 2013, J CELL MOL MED, V17, P30, DOI 10.1111/jcmm.12004; Moen I, 2011, DRUG THERAPY STUDIES, P10; Moen I, 2012, TARGET ONCOL, V7, P233, DOI 10.1007/s11523-012-0233-x; Moen I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-21; Moen I, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-446; Moen I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006381; Nerenberg Paul S., 2007, Cancer Genomics & Proteomics, V4, P319; Ohguri T, 2009, INT J HYPERTHER, V25, P160, DOI 10.1080/02656730802610357; Park SJ, 2016, ONCOL LETT, V11, P1895, DOI 10.3892/ol.2016.4115; Petre PM, 2003, J THORAC CARDIOV SUR, V125, P85, DOI 10.1067/mtc.2003.90; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Raa A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-23; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2015, CLIN SCI, V129, P1037, DOI 10.1042/CS20150451; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stepien K, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0814-0; Stuhr LEB, 2004, CANCER LETT, V210, P35, DOI 10.1016/j.canlet.2004.02.012; Stuhr LEB, 2007, J NEURO-ONCOL, V85, P191, DOI 10.1007/s11060-007-9407-2; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang Z, CURR DRUG TARGETS, V11, P745; Wu XY, 2015, ONCOTARGET, V6, P29143, DOI 10.18632/oncotarget.5020	43	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183254	10.1371/journal.pone.0183254	http://dx.doi.org/10.1371/journal.pone.0183254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832662	Green Published, gold, Green Submitted			2022-12-26	WOS:000408355800053
J	Diehl, K; Dinges, LA; Helm, O; Ammar, N; Plundrich, D; Arlt, A; Rocken, C; Sebens, S; Schafer, H				Diehl, K.; Dinges, L-A; Helm, O.; Ammar, N.; Plundrich, D.; Arlt, A.; Roecken, C.; Sebens, S.; Schaefer, H.			Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells	ONCOGENE			English	Article							KEAP1-NRF2 PATHWAY; OXIDATIVE STRESS; PROTEASOME ACTIVITY; KEAP1/NRF2 PATHWAY; PROTEIN EXPRESSION; SIGNALING PATHWAY; BREAST CANCERS; NRF2; FIBROBLASTS; ACTIVATION	Malignant tumors, such as colorectal cancer (CRC), are heterogeneous diseases characterized by distinct metabolic phenotypes. These include Warburg-and reverse Warburg phenotypes depending on differential distribution of the lactate carrier proteins monocarboxylate transporter-4 and -1 (MCT4 and MCT1). Here, we elucidated the role of the antioxidant transcription factor nuclear factor E2-related factor-2 (Nrf2) as the key regulator of cellular adaptation to inflammatory/environmental stress in shaping the metabolism toward a reverse Warburg phenotype in malignant and premalignant colonic epithelial cells. Immunohistochemistry of human CRC tissues revealed reciprocal expression of MCT1 and MCT4 in carcinoma and stroma cells, respectively, accompanied by strong epithelial Nrf2 activation. In colorectal tissue from inflammatory bowel disease patients, MCT1 and Nrf2 were coexpressed as well, relating to CD68+inflammatory infiltrates. Indirect coculture of human NCM460 colonocytes with M1- but not M2 macrophages induces MCT1 as well as G6PD, LDHB and TALDO expression, whereas MCT4 expression was decreased. Nrf2 knockdown or reactive oxygen species (ROS) scavenging blocked these coculture effects in NCM460 cells. Likewise, Nrf2 knockdown inhibited similar effects of tBHQ-mediated Nrf2 activation on NCM460 and HCT15 CRC cells. M1 coculture or Nrf2 activation/overexpression greatly altered the lactate uptake but not glucose uptake and mitochondrial activities in these cells, reflecting the reverse Warburg phenotype. Depending on MCT1-mediated lactate uptake, Nrf2 conferred protection from TRAIL-induced apoptosis in NCM460 and HCT15 cells. Moreover, metabolism-dependent clonal growth of HCT15 cells was induced by Nrf2-dependent activation of MCT1-driven lactate exchange. These findings indicate that Nrf2 has an impact on the metabolism already in premalignant colonic epithelial cells exposed to inflammatory M1 macrophages, an effect accompanied by growth and survival alterations. Favoring the reverse Warburg effect, these Nrf2-dependent alterations add to malignant transformation of the colonic epithelium.	[Diehl, K.; Arlt, A.; Schaefer, H.] Lab Mol Gastroenterol, Dept Internal Med 1, UKSH Campus Kiel, Kiel, Germany; [Dinges, L-A; Helm, O.; Ammar, N.; Plundrich, D.; Sebens, S.; Schaefer, H.] Univ Kiel, Inst Expt Canc Res, UKSH Campus Kiel,Bldg 17,Arnold Heller Str 3, D-24105 Kiel, Germany; [Roecken, C.] Univ Kiel, Inst Pathol, UKSH Campus Kiel, Kiel, Germany; [Roecken, C.; Sebens, S.] Comprehens Canc Ctr Kiel, Biomat Bank, UKSH Campus Kiel, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Schafer, H (corresponding author), Univ Kiel, Inst Expt Canc Res, UKSH Campus Kiel,Bldg 17,Arnold Heller Str 3, D-24105 Kiel, Germany.	hschaef@1med.uni-kiel.de	Sebens, Susanne/C-1222-2010; Röcken, Christoph/A-9239-2010; Arlt, Alexander/G-7308-2019; Schäfer, Heiner/C-1055-2011	Röcken, Christoph/0000-0002-6989-8002; Arlt, Alexander/0000-0002-6160-1059; Schafer, Heiner/0000-0001-6936-9090	Wilhelm-Sander-Stiftung [2015.011.01]; German-Cancer-Aid [111555]; Cluster of Excellence 'Inflammation at Interfaces'	Wilhelm-Sander-Stiftung; German-Cancer-Aid(Deutsche Krebshilfe); Cluster of Excellence 'Inflammation at Interfaces'	We thank Maike Witt-Ramdohr and Iris Kosmol (both from the Institute of Experimental Cancer Research), and Sandra Kruger and Deniza Hajzeri (both from the Institute of Pathology) for excellent technical assistance. We also thank Dr Jens Dischinger for supporting with radioactivity experiments. Financial support by the Wilhelm-Sander-Stiftung (2015.011.01 to HS), the German-Cancer-Aid (111555 to KD) and the Cluster of Excellence 'Inflammation at Interfaces' (to HS, AA and SS) is greatly acknowledged.	Alvarez Z, 2016, CEREB CORTEX, V26, P1046, DOI 10.1093/cercor/bhu281; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Bolanos JP, 2016, J NEUROCHEM, V139, P115, DOI 10.1111/jnc.13486; Chartoumpekis DV, 2015, BIOCHEM SOC T, V43, P639, DOI 10.1042/BST20150049; Fang ZS, 2016, BBA-MOL CELL RES, V1863, P2245, DOI 10.1016/j.bbamcr.2016.05.016; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Ferro S, 2016, ONCOTARGET, V7, P70639, DOI 10.18632/oncotarget.12156; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Folmes CDL, 2016, SEMIN CELL DEV BIOL, V52, P68, DOI 10.1016/j.semcdb.2016.02.010; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Ganan-Gomez I, 2013, FREE RADICAL BIO MED, V65, P750, DOI 10.1016/j.freeradbiomed.2013.06.041; Geismann C, 2014, ONCOTARGETS THER, V7, P1497, DOI 10.2147/OTT.S36624; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; Hadjiagapiou C, 2005, AM J PHYSIOL-GASTR L, V288, pG1118, DOI 10.1152/ajpgi.00312.2004; Hai T, 1999, GENE EXPRESSION, V7, P321; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Hashimoto Y, 2002, NUCLEIC ACIDS RES, V30, P2398, DOI 10.1093/nar/30.11.2398; Hawkins KE, 2016, CELL REP, V14, P1883, DOI 10.1016/j.celrep.2016.02.003; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu TH, 2013, J BIOMED RES, V27, P283, DOI 10.7555/JBR.27.20130069; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Ji LL, 2014, INT J CLIN EXP PATHO, V7, P1124; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Kruse ML, 2016, INFLAMM BOWEL DIS, V22, P2593, DOI 10.1097/MIB.0000000000000925; Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035; Lambert DW, 2002, BRIT J CANCER, V86, P1262, DOI 10.1038/sj.bjc.6600264; Lee Minjong, 2015, World J Biol Chem, V6, P148, DOI 10.4331/wjbc.v6.i3.148; Leinonen HM, 2015, BIOCHEM SOC T, V43, P645, DOI 10.1042/BST20150048; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Li LN, 2015, PHARMACOL THERAPEUT, V150, P33, DOI 10.1016/j.pharmthera.2015.01.004; Martinez-Outschoorn UE, 2011, INT J BIOCHEM CELL B, V43, P1045, DOI 10.1016/j.biocel.2011.01.023; Martins SF, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2566-9; McCullagh KJA, 1996, AM J PHYSIOL-ENDOC M, V271, pE143, DOI 10.1152/ajpendo.1996.271.1.E143; Menendez JA, 2016, STEM CELL REP, V6, P273, DOI 10.1016/j.stemcr.2015.12.012; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Montal ED, 2015, MOL CELL, V60, P571, DOI 10.1016/j.molcel.2015.09.025; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Nakajima EC, 2013, MOL CARCINOGEN, V52, P329, DOI 10.1002/mc.21863; Nakayama Y, 2012, EXP THER MED, V3, P25, DOI 10.3892/etm.2011.361; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pinheiro C, 2008, VIRCHOWS ARCH, V452, P139, DOI 10.1007/s00428-007-0558-5; Pinheiro C, 2012, J BIOENERG BIOMEMBR, V44, P127, DOI 10.1007/s10863-012-9428-1; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sanita P, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-154; Schafer H, 2013, ONCOGENE, V32, P180, DOI 10.1038/onc.2012.44; Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Shan T, 2017, ONCOL REP, V37, P1971, DOI 10.3892/or.2017.5479; Sivridis E, 2005, J CLIN PATHOL, V58, P1033, DOI 10.1136/jcp.2005.026260; Slocum SL, 2016, ARCH BIOCHEM BIOPHYS, V591, P57, DOI 10.1016/j.abb.2015.11.040; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Upadhyay M, 2013, PHARMACOL THERAPEUT, V137, P318, DOI 10.1016/j.pharmthera.2012.11.003; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Visconti R, 2009, IDRUGS, V12, P240; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P1772, DOI 10.4161/cc.10.11.15659; Winiarska K, 2003, METABOLISM, V52, P739, DOI 10.1016/S0026-0495(03)00035-0; Witkiewicz AK, 2012, CELL CYCLE, V11, P1108, DOI 10.4161/cc.11.6.19530; Witkiewicz AK, 2011, CELL CYCLE, V10, P1794, DOI 10.4161/cc.10.11.15675; Wong CC, 2017, ONCOGENE, V36, P3359, DOI 10.1038/onc.2016.485; Xu XD, 2015, ONCOL RES TREAT, V38, P117, DOI 10.1159/000375435; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yoshida GJ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0221-y	70	32	36	3	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					39	51		10.1038/onc.2017.299	http://dx.doi.org/10.1038/onc.2017.299			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28846107				2022-12-26	WOS:000422625000005
J	Lachmann, PJ; Lay, E; Seilly, DJ				Lachmann, Peter J.; Lay, Elizabeth; Seilly, David J.			Experimental confirmation of the C3 tickover hypothesis by studies with an Ab (S77) that inhibits tickover in whole serum	FASEB JOURNAL			English	Article						complement; alternative pathway; C3 feedback loop	COMPLEMENT CONVERTASE FORMATION; INACTIVATOR KAF; C-3 CONVERTASE; PATHWAY; ACTIVATION	The complement component 3 (C3) tickover hypothesis was put forward in the early 1970s to account for the spontaneous activation of the alternative complement pathway that occurs after the genetic absence or in vitro depletion of Factor I, the enzyme that is essential for the breakdown of C3b. The hypothesis was widely accepted, but experimental demonstration of the tickover was elusive. A phage Ab against C3b that inhibited the alternative complement pathway, but not the classical pathway, was described in 2009. Studies using this Ab in a variety of assays have now demonstrated that it acts primarily by inhibiting tickover, thereby confirming that tickover really exists.	[Lachmann, Peter J.; Lay, Elizabeth; Seilly, David J.] Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England	University of Cambridge	Lachmann, PJ (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	pjl1000@cam.ac.uk	Lachmann, P J/I-7968-2019	Lachmann, P J/0000-0003-2849-3524	Gyroscope Therapeutics (London, United Kingdom)	Gyroscope Therapeutics (London, United Kingdom)	Some financial contribution was made towards this work by Gyroscope Therapeutics (London, United Kingdom). The authors acknowledge the invaluable secretarial help of Barbara King (University of Cambridge) in the preparation of this paper, and Scott Stawicki, Kenneth Katschke, and Menno van Lookeren Campagne (all from Genentech, Inc., San Francisco, CA, USA) for generating S77. The authors declare no conflicts of interest.	ABRAMSON N, 1971, J IMMUNOL, V107, P19; ALPER CA, 1970, J CLIN INVEST, V49, P1975, DOI 10.1172/JCI106417; Bexborn F, 2008, MOL IMMUNOL, V45, P2370, DOI 10.1016/j.molimm.2007.11.003; FISHELSON Z, 1982, J IMMUNOL, V129, P2603; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Gordon J, 1926, BIOCHEM J, V20, P1028, DOI 10.1042/bj0201028; Janssen BJC, 2009, EMBO J, V28, P2469, DOI 10.1038/emboj.2009.184; Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200; Lachmann PJ, 2016, CLIN EXP IMMUNOL, V183, P150, DOI 10.1111/cei.12714; Lachmann P. J., 1974, SCHER S IMM 1973 PER, V12, P262; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; LACHMANN PJ, 1980, IMMUNOLOGY, V41, P503; LACHMANN PJ, 1975, CLIN EXP IMMUNOL, V21, P109; NICOL PAE, 1973, IMMUNOLOGY, V24, P259; Nilsson B, 2012, IMMUNOBIOLOGY, V217, P1106, DOI 10.1016/j.imbio.2012.07.008; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Weir D.M., 1978, HDB EXPT IMMUNOLOGY	17	18	18	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					123	129		10.1096/fj.201700734	http://dx.doi.org/10.1096/fj.201700734			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855277				2022-12-26	WOS:000419172700013
J	Mizugishi, K; Yamashita, K				Mizugishi, Kiyomi; Yamashita, Kouhei			Neutrophil extracellular traps are critical for pregnancy loss in sphingosine kinase-deficient mice on 129Sv/C57BL/6 background	FASEB JOURNAL			English	Article						DSC; histone citrullination; innate immunity; peptidylarginine deiminase; sphingolipid	SYSTEMIC-LUPUS-ERYTHEMATOSUS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; THROMBOSIS; ACTIVATION; SPHINGOSINE-1-PHOSPHATE; PREECLAMPSIA; 1-PHOSPHATE; CERAMIDE; DISEASE	Exaggerated maternal immune responses must be strictly controlled to ensure a successful pregnancy. Neutrophil extracellular traps (NETs) have recently been implicated as a potential mechanism for promoting inflammation in pregnancy-related disorders. In this study, we demonstrated that NETs play a key role in the pathogenesis of sphingosine kinase (Sphk)-mediated pregnancy loss. Perturbing the sphingolipid pathway by disrupting Sphk genes during pregnancy led to excessive NET formation exclusively at the fetomaternal interface and early fetal death. Neutrophils that formed NETs were characterized by histone hypercitrullination and peptidylarginine deiminase 4 (PAD4) overexpression. In addition, thrombus formation was enhanced in the decidua, but not in the plasma, of Sphk-deficient mice. Blocking NET formation with a PAD4 inhibitor protected Sphk-deficient mice from pregnancy loss. The PAD4 inhibition significantly reduced the expression of hypercitrullinated histone inneutrophils and ameliorated vascular injury in the decidua of Sphk-deficient mice. Moreover, NET formation was induced in human neutrophils stimulated with Sphk-deficient human decidual cells. Together, these findings indicate that targeting NETs might be a novel therapeutic strategy to treat idiopathic pregnancy loss in humans.	[Mizugishi, Kiyomi; Yamashita, Kouhei] Kyoto Univ Hosp, Dept Hematol & Oncol, Kyoto, Japan	Kyoto University	Mizugishi, K (corresponding author), Kyoto Univ Hosp, Dept Hematol & Oncol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kiyomim@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [15K09711, 15K09499]; Grants-in-Aid for Scientific Research [15K09711] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank H. Kohda and K. Furuta (Center for Anatomical Studies, Graduate School of Medicine, Kyoto University, Kyoto, Japan) for technical assistance. This work was supported, in part, by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (15K09711 to K.M. and 15K09499 to K.Y.). The authors declare no conflicts of interest.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Arai Y, 2013, BIOL BLOOD MARROW TR, V19, P1683, DOI 10.1016/j.bbmt.2013.09.005; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brunnert D, 2014, MOL HUM REPROD, V20, P1016, DOI 10.1093/molehr/gau051; Carmona-Rivera C, 2015, ANN RHEUM DIS, V74, P1417, DOI 10.1136/annrheumdis-2013-204837; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Dobierzewska A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175118; Dobierzewska A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157221; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; El-Benna J, 2016, IMMUNOL REV, V273, P180, DOI 10.1111/imr.12447; Erpenbeck L, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140293; Fuchs TA, 2012, ARTERIOSCL THROM VAS, V32, P1777, DOI 10.1161/ATVBAHA.111.242859; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Girardi G, 2004, J CLIN INVEST, V113, P646, DOI 10.1172/JCI200418817C1; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Hahn S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00362; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Kan R, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-19; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kim JW, 2005, BIOORGAN MED CHEM, V13, P3475, DOI 10.1016/j.bmc.2005.02.053; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lewis HD, 2016, CURR OPIN CHEM BIOL, V33, P169, DOI 10.1016/j.cbpa.2016.06.020; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Meng H, 2017, ARTHRITIS RHEUMATOL, V69, P655, DOI 10.1002/art.39938; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Mizugishi K, 2015, J BIOL CHEM, V290, P2053, DOI 10.1074/jbc.M114.628867; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Pyne Nigel J., 2015, Advances in Biological Regulation, V60, P151, DOI 10.1016/j.jbior.2015.09.001; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Sokolove J, 2013, ARTHRITIS RHEUM-US, V65, P1719, DOI 10.1002/art.37961; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Yalavarthi S, 2015, ARTHRITIS RHEUMATOL, V67, P2990, DOI 10.1002/art.39247; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	43	15	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5577	5591		10.1096/fj.201700399RR	http://dx.doi.org/10.1096/fj.201700399RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842426				2022-12-26	WOS:000416588300038
J	Barta, ML; Shearer, JP; Arizmendi, O; Tremblay, JM; Mehzabeen, N; Zheng, Q; Battaile, KP; Lovell, S; Tzipori, S; Picking, WD; Shoemaker, CB; Picking, WL				Barta, Michael L.; Shearer, Jonathan P.; Arizmendi, Olivia; Tremblay, Jacqueline M.; Mehzabeen, Nurjahan; Zheng, Qi; Battaile, Kevin P.; Lovell, Scott; Tzipori, Saul; Picking, William D.; Shoemaker, Charles B.; Picking, Wendy L.			Single-domain antibodies pinpoint potential targets within Shigella invasion plasmid antigen D of the needle tip complex for inhibition of type III secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEM NEEDLE; PROTEIN SECRETION; IPAD; FLEXNERI; MODEL; NANOBODIES; CHALLENGE; PATHOGENS; APPARATUS; FEATURES	Numerous Gram-negative pathogens infect eukaryotes and use the type III secretion system (T3SS) to deliver effector proteins into host cells. One important T3SS feature is an extracellular needle with an associated tip complex responsible for assembly of a pore-forming translocon in the host cell membrane. Shigella spp. cause shigellosis, also called bacillary dysentery, and invade colonic epithelial cells via the T3SS. The tip complex of Shigella flexneri contains invasion plasmid antigen D (IpaD), which initially regulates secretion and provides a physical platform for the translocon pore. The tip complex represents a promising therapeutic target for many important T3SS-containing pathogens. Here, in an effort to further elucidate its function, we created a panel of single-VH domain antibodies (VHHs) that recognize distinct epitopes within IpaD. These VHHs recognized the in situ tip complex and modulated the infectious properties of Shigella. Moreover, structural elucidation of several IpaD-VHH complexes provided critical insights into tip complex formation and function. Of note, one VHH heterodimer could reduce Shigella hemolytic activity by >80%. Our observations along with previous findings support the hypothesis that the hydrophobic translocator (IpaB in Shigella) likely binds to a region within the tip protein that is structurally conserved across all T3SS-possessing pathogens, suggesting potential therapeutic avenues for managing infections by these pathogens.	[Barta, Michael L.; Arizmendi, Olivia; Zheng, Qi; Picking, William D.; Picking, Wendy L.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA; [Shearer, Jonathan P.; Tremblay, Jacqueline M.; Tzipori, Saul; Shoemaker, Charles B.] Tufts Clin & Translat Sci Inst, Dept Infect Dis & Global Hlth, North Grafton, MA 02111 USA; [Mehzabeen, Nurjahan; Lovell, Scott] Univ Kansas, Del Shankel Struct Biol Ctr, Prot Struct Lab, Lawrence, KS 66047 USA; [Battaile, Kevin P.] Hauptman Woodward Med Res Inst, IMCA CAT, Argonne, IL 60439 USA	University of Kansas; University of Kansas; Hauptman Woodward Medical Research Institute	Picking, WL (corresponding author), Univ Kansas, 2030 Becker Dr, Lawrence, KS 66047 USA.	wendy.picking@ku.edu		Arizmendi, Olivia/0000-0002-7182-0255; Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [P30 GM110761]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the University of Kansas Protein Structure Laboratory was supported by National Institutes of Health P30 GM110761 (NIGMS). Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barta ML, 2012, PROTEINS, V80, P935, DOI 10.1002/prot.23251; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Cheung M, 2015, MOL MICROBIOL, V95, P31, DOI 10.1111/mmi.12843; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; de Marco A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0320-7; De Tavernier E, 2016, J BIOL CHEM, V291, P15243, DOI 10.1074/jbc.M115.684241; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickenson NE, 2013, BIOCHEMISTRY-US, V52, P8790, DOI 10.1021/bi400755f; Dickenson NE, 2011, BIOCHEMISTRY-US, V50, P172, DOI 10.1021/bi101365f; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diepold A, 2014, FEMS MICROBIOL REV, V38, P802, DOI 10.1111/1574-6976.12061; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Epler CR, 2012, J MOL BIOL, V420, P29, DOI 10.1016/j.jmb.2012.03.025; Epler CR, 2009, INFECT IMMUN, V77, P2754, DOI 10.1128/IAI.00190-09; Espina M, 2007, PROTEIN SCI, V16, P704, DOI 10.1110/ps.062645007; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P, 2012, SCIENCE, V336, P986, DOI 10.1126/science.1222162; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gazi AD, 2009, CELL MICROBIOL, V11, P719, DOI 10.1111/j.1462-5822.2009.01297.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gu J, 2009, MICROBES INFECT, V11, P835, DOI 10.1016/j.micinf.2009.04.024; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kaur K, 2016, CHEMBIOCHEM, V17, P745, DOI 10.1002/cbic.201500556; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kuhn P, 2016, PROTEOM CLIN APPL, V10, P922, DOI 10.1002/prca.201600002; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lunelli M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002163; Maass DR, 2007, J IMMUNOL METHODS, V324, P13, DOI 10.1016/j.jim.2007.04.008; Medhekar B, 2009, MOL MICROBIOL, V71, P492, DOI 10.1111/j.1365-2958.2008.06543.x; MENARD R, 1993, J BACTERIOL, V175, P5899; Moayeri M, 2015, J BIOL CHEM, V290, P6584, DOI 10.1074/jbc.M114.627943; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Rathinavelan T, 2014, J MOL BIOL, V426, P2958, DOI 10.1016/j.jmb.2014.06.009; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rossmann FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118405; Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998; Sawa T, 2014, MICROBIOL IMMUNOL, V58, P267, DOI 10.1111/1348-0421.12147; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Vrentas CE, 2016, J BIOL CHEM, V291, P21596, DOI 10.1074/jbc.M116.749184; WATARAI M, 1995, EMBO J, V14, P2461, DOI 10.1002/j.1460-2075.1995.tb07243.x; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196; Yip CK, 2005, NAT STRUCT MOL BIOL, V12, P75, DOI 10.1038/nsmb879; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	59	9	10	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16677	16687		10.1074/jbc.M117.802231	http://dx.doi.org/10.1074/jbc.M117.802231			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842484	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000412414800027
J	Pavlidou, T; Rosina, M; Fuoco, C; Gerini, G; Gargioli, C; Castagnoli, L; Cesareni, G				Pavlidou, Theodora; Rosina, Marco; Fuoco, Claudia; Gerini, Giulia; Gargioli, Cesare; Castagnoli, Luisa; Cesareni, Gianni			Regulation of myoblast differentiation by metabolic perturbations induced by metformin	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELL-CYCLE REGULATORS; SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; AMPK ACTIVATION; MOLECULAR-MECHANISMS; MYOD; EXPRESSION; P38; PHOSPHORYLATION	The metabolic perturbation caused by calorie restriction enhances muscle repair by playing a critical role in regulating satellite cell availability and activity in the muscles of young and old mice. To clarify the underlying mechanisms we asked whether myoblast replication and differentiation are affected by metformin, a calorie restriction-mimicking drug. C2C12, a mouse myoblast cell line, readily differentiate in vitro and fuse to form myotubes. However, when incubated with metformin, C2C12 slow their replication and do not differentiate. Interestingly, lower doses of metformin promote myogenic differentiation. We observe that metformin treatment modulates the expression of cyclins and cyclin inhibitors thereby inducing a cell cycle perturbation that causes a delay in the G2/M transition. The effect of metformin treatment is reversible since after drug withdrawal, myoblasts can re-enter the cell cycle and/or differentiate, depending on culture conditions. Myoblasts cultured under metformin treatment fail to up-regulate MyoD and p21cip1, a key step in cell cycle exit and terminal differentiation. Although the details of the molecular mechanisms underlying the effect of the drug on myoblasts still need to be clarified, we propose that metformin negatively affects myogenic differentiation by inhibiting irreversible exit from the cell cycle through reduction of MyoD and p21cip1 levels.	[Pavlidou, Theodora; Rosina, Marco; Fuoco, Claudia; Gerini, Giulia; Gargioli, Cesare; Castagnoli, Luisa; Cesareni, Gianni] Tor Vergata Univ, Mol Genet Lab, Dept Biol, Rome, Italy; [Cesareni, Gianni] Fdn Santa Lucia, IRCCS, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Rome Tor Vergata; IRCCS Santa Lucia	Gargioli, C; Castagnoli, L; Cesareni, G (corresponding author), Tor Vergata Univ, Mol Genet Lab, Dept Biol, Rome, Italy.; Cesareni, G (corresponding author), Fdn Santa Lucia, IRCCS, Rome, Italy.	cesare.gargioli@uniroma2.it; castagnoli@uniroma2.it; cesareni@uniroma2.it	Fuoco, Claudia/AAB-2268-2019; Cesareni, Gianni/AAW-1382-2020; Rosina, Marco/Y-7510-2019	Rosina, Marco/0000-0003-0952-1710; Castagnoli, Luisa/0000-0001-5283-8671; GERINI, Giulia/0000-0002-9229-5103; Fuoco, Claudia/0000-0001-8372-305X	Italian Ministry of Education [RBAP11LP2W]; DEPTH of the European Research Council [322749]; Italian Association for Cancer Research [IG 2013 N.14135]	Italian Ministry of Education; DEPTH of the European Research Council; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Oncodiet project of the Italian Ministry of Education (RBAP11LP2W) to GC; DEPTH project of the European Research Council (grant agreement 322749) to GC; and Italian Association for Cancer Research Grant N (IG 2013 N.14135) to GC.	Averous J, 2012, EXP CELL RES, V318, P217, DOI 10.1016/j.yexcr.2011.10.015; Boonstra J., 2003, REGULATION G1 PHASE; Carnac G, 2000, CURR BIOL, V10, P543, DOI 10.1016/S0960-9822(00)00471-1; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chakkalakal JV, 2014, DEVELOPMENT, V141, P1649, DOI 10.1242/dev.100842; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Frith-Terhune A, 1998, MOL CELLS, V8, P637; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; GUO K, 1995, MOL CELL BIOL, V15, P3823; Gurung R, 2012, J CELL BIOCHEM, V113, P209, DOI 10.1002/jcb.23346; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; Janjetovic K, 2011, EUR J PHARMACOL, V668, P373, DOI 10.1016/j.ejphar.2011.07.004; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Langone F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114018; Ljubicic V, 2013, TRENDS MOL MED, V19, P614, DOI 10.1016/j.molmed.2013.07.002; Ljubicic V, 2011, HUM MOL GENET, V20, P3478, DOI 10.1093/hmg/ddr265; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Miyake M, 2012, CELL TISSUE RES, V349, P615, DOI 10.1007/s00441-012-1422-8; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Perdiguero E, 2007, CELL CYCLE, V6, P1298, DOI 10.4161/cc.6.11.4315; Perfetto L, 2015, NUCLEIC ACIDS RES; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Rodriguez-Lirio A, 2015, LEUK RES TREATMENT, V2015; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Scholzen T, 2002, J PATHOL, V196, P135, DOI 10.1002/path.1016; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Williamson DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE304, DOI 10.1152/ajpendo.91007.2008; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yoshida N, 1998, J CELL SCI, V111, P769; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18	54	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0182475	10.1371/journal.pone.0182475	http://dx.doi.org/10.1371/journal.pone.0182475			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859084	gold, Green Published, Green Submitted			2022-12-26	WOS:000408740500004
J	Hopp, BH; Arvidson, RS; Adams, ME; Razak, KA				Hopp, Bradley H.; Arvidson, Ryan S.; Adams, Michael E.; Razak, Khaleel A.			Arizona bark scorpion venom resistance in the pallid bat, Antrozous pallidus	PLOS ONE			English	Article							CHANNEL ALPHA-SUBUNIT; GATED SODIUM-CHANNELS; SNAKE-VENOMS; MOLECULAR-BASIS; VOLTAGE SENSOR; RECEPTOR-SITES; BETA-TOXIN; DOMAIN; CHIROPTERA; LOOP	The pallid bat (Antrozous pallidus), a gleaning bat found in the western United States and Mexico, hunts a wide variety of ground-dwelling prey, including scorpions. Anecdotal evidence suggests that the pallid bat is resistant to scorpion venom, but no systematic study has been performed. Here we show with behavioral measures and direct injection of venom that the pallid bat is resistant to venom of the Arizona bark scorpion, Centruroides sculpturatus. Our results show that the pallid bat is stung multiple times during a hunt without any noticeable effect on behavior. In addition, direct injection of venom at mouse LD50 concentrations (1.5 mg/kg) has no effect on bat behavior. At the highest concentration tested (10 mg/kg), three out of four bats showed no effects. One of the four bats showed a transient effect suggesting that additional studies are required to identify potential regional variation in venom tolerance. Scorpion venom is a cocktail of toxins, some of which activate voltage-gated sodium ion channels, causing intense pain. Dorsal root ganglia (DRG) contain nociceptive neurons and are principal targets of scorpion venom toxins. To understand if mutations in specific ion channels contribute to venom resistance, a pallid bat DRG transcriptome was generated. As sodium channels are a major target of scorpion venom, we identified amino acid substitutions present in the pallid bat that may lead to venom resistance. Some of these substitutions are similar to corresponding amino acids in sodium channel isoforms responsible for reduced venom binding activity. The substitution found previously in the grasshopper mouse providing venom resistance to the bark scorpion is not present in the pallid bat, indicating a potentially novel mechanism for venom resistance in the bat that remains to be identified. Taken together, these results indicate that the pallid bat is resistant to venom of the bark scorpion and altered sodium ion channel function may partly underlie such resistance.	[Hopp, Bradley H.; Adams, Michael E.; Razak, Khaleel A.] Univ Calif Riverside, Grad Neurosci Program, Riverside, CA 92521 USA; [Arvidson, Ryan S.; Adams, Michael E.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Arvidson, Ryan S.; Adams, Michael E.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Razak, Khaleel A.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Razak, KA (corresponding author), Univ Calif Riverside, Grad Neurosci Program, Riverside, CA 92521 USA.; Razak, KA (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.	Khaleel@ucr.edu	Adams, Michael/ABF-6728-2020	Adams, Michael/0000-0003-0519-6113	UC Riverside Academic Senate; Office of Research and Economic Development; National Science Foundation [IOS1252769]	UC Riverside Academic Senate; Office of Research and Economic Development; National Science Foundation(National Science Foundation (NSF))	This study was funded by the UC Riverside Academic Senate and Office of Research and Economic Development and the National Science Foundation (IOS1252769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlettaz R, 1997, J ANIM ECOL, V66, P897, DOI 10.2307/6005; BARCHAN D, 1992, P NATL ACAD SCI USA, V89, P7717, DOI 10.1073/pnas.89.16.7717; BELL GP, 1982, BEHAV ECOL SOCIOBIOL, V10, P217, DOI 10.1007/BF00299688; Borges A, 2004, TOXICON, V43, P671, DOI 10.1016/j.toxicon.2004.02.022; BROOKE AP, 1994, J MAMMAL, V75, P212, DOI 10.2307/1382253; CAHALAN MD, 1975, J PHYSIOL-LONDON, V244, P511, DOI 10.1113/jphysiol.1975.sp010810; CATANESE JJ, 1992, BIOCHEMISTRY-US, V31, P410, DOI 10.1021/bi00117a015; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; DEPLATER G, 1995, TOXICON, V33, P157, DOI 10.1016/0041-0101(94)00150-7; DEWIT CA, 1982, TOXICON, V20, P709, DOI 10.1016/0041-0101(82)90119-2; Fet V, 2000, CATALOG SCORPIONS WO; GORDON D, 1992, BIOCHEMISTRY-US, V31, P7622, DOI 10.1021/bi00148a025; Gordon D, 2004, NEUROTOX 03 NEUROTOX; GUILER E R, 1970, Australian Journal of Zoology, V18, P63, DOI 10.1071/ZO9700063; Gur M, 2011, J BIOL CHEM, V286, P35209, DOI 10.1074/jbc.M111.259507; Gurevitz M, 2012, TOXICON, V60, P502, DOI 10.1016/j.toxicon.2012.03.022; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hatt R. T., 1923, J MAMMAL, V4, P260, DOI 10.1093/jmammal/4.4.260-a; HEATWOLE H, 1995, COPEIA, P136; Holderied M, 2011, J COMP PHYSIOL A, V197, P425, DOI 10.1007/s00359-010-0608-3; Johnston DS, 2001, J MAMMAL, V82, P362, DOI 10.1644/1545-1542(2001)082<0362:IAPLVI>2.0.CO;2; KILMON JA, 1976, TOXICON, V14, P337, DOI 10.1016/0041-0101(76)90032-5; Lack JB, 2010, ACTA CHIROPTEROL, V12, P401, DOI 10.3161/150811010X537981; Leipold E, 2004, MOL PHARMACOL, V65, P685, DOI 10.1124/mol.65.3.685; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Lenhart PA, 2010, SOUTHWEST NAT, V55, P110, DOI 10.1894/CLG-21.1; LoVecchio F, 2003, J TOXICOL-CLIN TOXIC, V41, P937, DOI 10.1081/CLT-120026514; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; Moraes ER, 2011, NEUROTOX RES, V19, P102, DOI 10.1007/s12640-009-9144-8; ONEILL MG, 1989, AUST J ECOL, V14, P19; OVADIA M, 1977, TOXICON, V15, P541, DOI 10.1016/0041-0101(77)90105-2; PEREZ JC, 1978, TOXICON, V16, P375, DOI 10.1016/0041-0101(78)90158-7; PORAN NS, 1987, TOXICON, V25, P767, DOI 10.1016/0041-0101(87)90127-9; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; ROSS ANTHONY, 1961, JOUR MAMMOL, V42, P66, DOI 10.2307/1377243; Rowe AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023783; Rowe AH, 2006, ANIM BEHAV, V71, P725, DOI 10.1016/j.anbehav.2005.08.003; Rowe AH, 2008, TOXICON, V52, P597, DOI 10.1016/j.toxicon.2008.07.004; Rowe AH, 2013, SCIENCE, V342, P441, DOI 10.1126/science.1236451; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simao FA, 2015, BIOINFORMATICS, DOI DOI 10.1093/BIOINFORMATICS/BTV351; Simard J.M., 1992, NATURAL TOXINS TOXIC, P236; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; STAHNKE H L, 1971, Entomological News, V82, P281; TEJEDOR FJ, 1988, P NATL ACAD SCI USA, V85, P8742, DOI 10.1073/pnas.85.22.8742; THOMSEN WJ, 1989, P NATL ACAD SCI USA, V86, P10161, DOI 10.1073/pnas.86.24.10161; VAUGHAN TA, 1976, J MAMMAL, V57, P227, DOI 10.2307/1379685; Voss RS, 2012, BIOL REV, V87, P822, DOI 10.1111/j.1469-185X.2012.00222.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	51	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183215	10.1371/journal.pone.0183215	http://dx.doi.org/10.1371/journal.pone.0183215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854259	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600034
J	Shahhoseini, Z; Sarvi, M				Shahhoseini, Zahra; Sarvi, Majid			Collective movements of pedestrians: How we can learn from simple experiments with non-human (ant) crowds	PLOS ONE			English	Article							EXIT CHOICES; BEHAVIOR; ESCAPE; DYNAMICS; FASTER; ARCHITECTURE; FLOW	Introduction Understanding collective behavior of moving organisms and how interactions between individuals govern their collective motion has triggered a growing number of studies. Similarities have been observed between the scale-free behavioral aspects of various systems (i.e. groups of fish, ants, and mammals). Investigation of such connections between the collective motion of non-human organisms and that of humans however, has been relatively scarce. The problem demands for particular attention in the context of emergency escape motion for which innovative experimentation with panicking ants has been recently employed as a relatively inexpensive and non-invasive approach. However, little empirical evidence has been provided as to the relevance and reliability of this approach as a model of human behaviour. Methods This study explores pioneer experiments of emergency escape to tackle this question and to connect two forms of experimental observations that investigate the collective movement at macroscopic level. A large number of experiments with human and panicking ants are conducted representing the escape behavior of these systems in crowded spaces. The experiments share similar architectural structures in which two streams of crowd flow merge with one another. Measures such as discharge flow rates and the probability distribution of passage headways are extracted and compared between the two systems. Findings Our findings displayed an unexpected degree of similarity between the collective patterns emerged from both observation types, particularly based on aggregate measures. Experiments with ants and humans commonly indicated how significantly the efficiency of motion and the rate of discharge depend on the architectural design of the movement environment. Practical applications Our findings contribute to the accumulation of evidence needed to identify the boarders of applicability of experimentation with crowds of non-human entities as models of human collective motion as well as the level of measurements (i.e. macroscopic or microscopic) and the type of contexts at which reliable inferences can be drawn. This particularly has implications in the context of experimenting evacuation behaviour for which recruiting human subjects may face ethical restrictions. The findings, at minimum, offer promise as to the potential benefit of piloting such experiments with non-human crowds, thereby forming better-informed hypotheses.	[Shahhoseini, Zahra; Sarvi, Majid] Univ Melbourne, Ctr Disaster Management & Publ Safety, Sch Engn, Melbourne, Vic, Australia	University of Melbourne	Shahhoseini, Z (corresponding author), Univ Melbourne, Ctr Disaster Management & Publ Safety, Sch Engn, Melbourne, Vic, Australia.	zahra.shahhoseini@unimelb.edu.au	sarvi, majid/A-2397-2009		Arc Linkage project [LP120200361]; Public Transport Victoria (PTV); Department of Economic Development, Jobs, Transport and Resources (DEDJTR) Powered	Arc Linkage project(Australian Research Council); Public Transport Victoria (PTV); Department of Economic Development, Jobs, Transport and Resources (DEDJTR) Powered	The study was financially supported by Arc Linkage project LP120200361, jointly provided by Public Transport Victoria (PTV) and Department of Economic Development, Jobs, Transport and Resources (DEDJTR) Powered.	Altshuler E, 2005, AM NAT, V166, P643, DOI 10.1086/498139; Boari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081082; Boltes M., 2013, MODELING SIMULATION, P67; Boltes M, 2013, NEUROCOMPUTING, V100, P127, DOI 10.1016/j.neucom.2012.01.036; Burd M, 2002, AM NAT, V159, P283, DOI 10.1086/338541; Burd M, 2010, ECOL ENTOMOL, V35, P464, DOI 10.1111/j.1365-2311.2010.01202.x; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Deutsch A, 2012, INTERFACE FOCUS, V2, P689, DOI 10.1098/rsfs.2012.0048; Dias C, 2015, TRANSPORT RES REC, P65, DOI 10.3141/2490-08; Dias C, 2013, SAFETY SCI, V60, P87, DOI 10.1016/j.ssci.2013.07.005; Gago PA, 2013, TRAFFIC GRANULAR FLO, V11, P317; Garcimartin A, 2014, TRANSP RES PROC, V2, P760, DOI 10.1016/j.trpro.2014.09.085; Giardina I, 2008, HFSP J, V2, P205, DOI 10.2976/1.2961038; Haghani M, 2017, TRANSPORTATION RES B; Haghani M, 2017, J ENVIRON PSYCHOL, V51, P141, DOI 10.1016/j.jenvp.2017.03.013; Haghani M, 2017, PHYSICA A, V475, P24, DOI 10.1016/j.physa.2017.02.010; Haghani M, 2017, ANIM BEHAV, V124, P47, DOI 10.1016/j.anbehav.2016.11.024; Haghani M, 2016, J ADV TRANSPORT, V50, P1870, DOI 10.1002/atr.1434; Haghani M, 2017, TRANSPORT RES B-METH, V95, P238, DOI 10.1016/j.trb.2016.10.019; Haghani M, 2016, TRANSPORT RES REC, P67, DOI 10.3141/2560-08; Haghani M, 2016, FIRE SAFETY J, V85, P1, DOI 10.1016/j.firesaf.2016.07.003; Haghani M, 2015, J CHOICE MODEL, V16, P58, DOI 10.1016/j.jocm.2015.09.006; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Helbing D, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168001; Li G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114517; Lin P, 2016, PHYSICA A, V452, P157, DOI 10.1016/j.physa.2016.02.017; Moussaid M, 2009, P ROYAL SOC LONDON B; Moussaid M, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0414; Moussaid M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33417; Parisi DR, 2015, SAFETY SCI, V72, P274, DOI 10.1016/j.ssci.2014.09.014; Pastor JM, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062817; Pinter-Wollman N, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0111; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Saloma C, 2003, P NATL ACAD SCI USA, V100, P11947, DOI 10.1073/pnas.2031912100; Saloma C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118508; Shahhoseini Z, 2016, TRANSPORT RES REC, P81, DOI 10.3141/2561-10; Shiwakoti N, 2011, TRANSPORT RES B-METH, V45, P1433, DOI 10.1016/j.trb.2011.05.016; Shiwakoti N, 2009, TRANSPORT RES REC, P31, DOI 10.3141/2137-04; Sobhani A, 2014, TRANSP RES PROC, V2, P745, DOI 10.1016/j.trpro.2014.09.083; Soria SA, 2012, SAFETY SCI, V50, P1584, DOI 10.1016/j.ssci.2012.03.010; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Thielicke W., 2014, J OPEN RES STW, V2, P30, DOI [10.5334/JORS.BL, DOI 10.5334/JORS.BL]; Wang SJ, 2016, PHYSICA A, V457, P239, DOI 10.1016/j.physa.2016.03.083; Wang SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131784; Zhang J, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/06/P06004; Zuriguel I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.030301; Zuriguel I, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.032302; Zuriguel I, 2014, SCI REP-UK, V4, DOI 10.1038/srep07324	48	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182913	10.1371/journal.pone.0182913	http://dx.doi.org/10.1371/journal.pone.0182913			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854221	gold, Green Published			2022-12-26	WOS:000408693600023
J	Torralvo, K; Botero-Arias, R; Magnusson, WE				Torralvo, Kelly; Botero-Arias, Robinson; Magnusson, William E.			Temporal variation in black-caiman-nest predation in varzea of central Brazilian amazonia	PLOS ONE			English	Article								On the Amazon floodplain, the main predators of black caiman (Melanosuchus niger) eggs are jaguars (Panthera onca), tegu lizards (Tupinambis teguixim), capuchin monkeys (Sapajus macrocephalus) and humans (Homo sapiens). In this study, we investigated the relationship between predator attacks on nests and incubation period, and evaluated the influence of initial predation on subsequent predation in the Mamiraua A Sustainable Development Reserve. We also evaluated the influence of presence of females near the nests and manipulation of nests on the occurrence of attacks. We compared results from data obtained with camera traps and vestiges left by predators on estimates of rates of predation by different predators. Egg predation was recorded in 32% of the 658 black caiman nests monitored during two years. Our results suggest that the probability of predation on black caiman eggs is relatively constant throughout the incubation period and that predation on eggs was lower when adults, presumably females, were present. Careful opening of nests and handling of eggs did not increase the number of attacks on black caiman nests. Nest opening by a predator appeared to increase the chances of a subsequent attack because most of the attacks on nests occurred soon after a predator first opened the nest. However, attacks by another species of predator do not appear to be necessary to initiate attacks by any other species of predator. Results based on camera traps and vestiges differed, but use of vestiges was adequate for identifying the principal predators on eggs in black caiman nests and, in many circumstances, the vestiges may be better for estimating predation by humans. In this study, opening nests and handling eggs did not increase the number of attacks on black caiman nests.	[Torralvo, Kelly] Natl Inst Amazonian Res, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Torralvo, Kelly; Botero-Arias, Robinson] Mamiraua Inst Sustainable Dev, Tefe, Amazonas, Brazil; [Botero-Arias, Robinson] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Magnusson, William E.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; State University System of Florida; University of Florida; Institute Nacional de Pesquisas da Amazonia	Torralvo, K (corresponding author), Natl Inst Amazonian Res, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.; Torralvo, K (corresponding author), Mamiraua Inst Sustainable Dev, Tefe, Amazonas, Brazil.	kellytorralvo@hotmail.com			Institute de Desenvolvimento Sustentavel Mamiraua (IDSM) of the Projeto AQUAVERT, through the Petrobras Ambiental; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Institute de Desenvolvimento Sustentavel Mamiraua (IDSM) of the Projeto AQUAVERT, through the Petrobras Ambiental; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was carried out with the financial and logistical support of the Institute de Desenvolvimento Sustentavel Mamiraua (IDSM) (http://www.mamiraua.org.br/pt-br) of the Projeto AQUAVERT, through the Petrobras Ambiental and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Botero-Arias R, 2013, CONSTRUINDO BASES SI, V3; Campos Z, 2014, J NAT HIST, P1; CAMPOS Z, 2010, CROCODILES, P49; CHARNOV EL, 1976, AM NAT, V110, P247, DOI 10.1086/283062; Clark RG, 1997, J AVIAN BIOL, V28, P31, DOI 10.2307/3677091; Combrink X, 2016, BEHAV PROCESS, V133, P31, DOI 10.1016/j.beproc.2016.10.014; Da Silveira R, 2010, J HERPETOL, V44, P418, DOI 10.1670/08-340.1; Goncalves FA, 2007, REV BRAS ZOOL, V24, P1063, DOI 10.1590/S0101-81752007000400025; HERRON JC, 1990, J HERPETOL, V24, P314, DOI 10.2307/1564402; HUNT RH, 1991, J HERPETOL, V25, P448, DOI 10.2307/1564768; Kotler B, 1992, ANN ZOOL FENN, P465; Larriera A, 2000, HERPETOL NAT HIST, V7, P73; LEGLER JOHN M., 1954, HERPETOLOGICA, V10, P137; Barao-Nobrega JAL, 2016, HERPETOL J, V26, P65; Barao-Nobrega L, 2014, J HERPETOL, V48, P338, DOI 10.1670/13-081; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; Medem F., 1963, REV ACAD COLOMB CIEN, P5; Ramalho EE., 2010, UAKARI, V5, P61, DOI DOI 10.4322/ACTALB.2011.023; Simoncini MS, 2016, PHYLLOMEDUSA, V15, P137, DOI 10.11606/issn.2316-9079.v15i2p137-146; Somaweera R, 2011, ECOL RES, V26, P957, DOI 10.1007/s11284-011-0853-0; Staton M.A., 1977, WILDLIFE RES REPORT, P1; Thorbjarnarson J, 2000, NAT HIST, V109, P70; Vergne AL, 2008, CURR BIOL, V18, pR513, DOI 10.1016/j.cub.2008.04.011; Vergne AL, 2011, ZOOLOGY, V114, P313, DOI 10.1016/j.zool.2011.07.003; Villamarin F, 2008, P 19 WORK M CROC SPE; Villamarin F, 2011, BIOL CONSERV, V144, P913, DOI 10.1016/j.biocon.2010.12.012; Villamarin-Jurado F, 2007, J HERPETOL, V41, P164, DOI 10.1670/0022-1511(2007)41[164:NOTBCM]2.0.CO;2; Zar J. H., 1996, BIOSTATISTICAL ANAL	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183476	10.1371/journal.pone.0183476	http://dx.doi.org/10.1371/journal.pone.0183476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854258	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600046
J	Gaoue, OG; Kouagou, M; Natta, AK; Gado, C				Gaoue, Orou G.; Kouagou, M'Mouyohoun; Natta, Armand K.; Gado, Choukouratou			Response of a tropical tree to non-timber forest products harvest and reduction in habitat size	PLOS ONE			English	Article							LAND-USE TYPE; POPULATION-STRUCTURE; UNDERSTORY HERB; SEMIARID SAVANNA; FRAGMENTATION; IMPACT; SUSTAINABILITY; DEMOGRAPHY; DYNAMICS; BARK	Non-timber forest products (NTFPs) are widely harvested by local people for their livelihood. Harvest often takes place in human disturbed ecosystems. However, our understanding of NTFPs harvesting impacts in fragmented habitats is limited. We assessed the impacts of fruit harvest, and reduction in habitat size on the population structures of Pentadesma butyracea Sabine (Clusiaceae) across two contrasting ecological regions (dry vs. moist) in Benin. In each region, we selected three populations for each of the three fruit harvesting intensities (low, medium and high). Harvesting intensities were estimated as the proportion of fruits harvested per population. Pentadesma butyracea is found in gallery forests along rivers and streams. We used the width of gallery forests as a measure of habitat size. We found negative effects of fruit harvest on seedling and adult density but no significant effect on population size class distribution in both ecological regions. The lack of significant effect of fruit harvest on population structure may be explained by the ability of P. butyracea to compensate for the negative effect of fruit harvesting by increasing clonal reproduction. Our results suggest that using tree density and population structure to assess the ecological impacts of harvesting clonal plants should be done with caution.	[Gaoue, Orou G.] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Gaoue, Orou G.; Kouagou, M'Mouyohoun; Natta, Armand K.; Gado, Choukouratou] Univ Parakou, Fac Agron, Parakou, Benin; [Gaoue, Orou G.] Univ Johannesburg, Dept Geog Environm Management & Energy Studies, APK Campus, Johannesburg, South Africa	University of Hawaii System; University of Hawaii Manoa; University of Johannesburg	Gaoue, OG (corresponding author), Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA.; Gaoue, OG (corresponding author), Univ Parakou, Fac Agron, Parakou, Benin.; Gaoue, OG (corresponding author), Univ Johannesburg, Dept Geog Environm Management & Energy Studies, APK Campus, Johannesburg, South Africa.	ogaoue@utk.edu	Gaoue, Orou G./B-4932-2011	Gaoue, Orou G./0000-0002-0946-2741	University of Hawaii at Manoa, Colleges of Natural Sciences	University of Hawaii at Manoa, Colleges of Natural Sciences	OGG was supported by a start-up grant from the University of Hawaii at Manoa, Colleges of Natural Sciences.; We are grateful to Josias Obonte, Emma Yeropa and Raoufou Salifou for field assistance and anonymous reviewers for valuable comments on this manuscript. OGG was supported by start-up grant from the University of Hawaii at Manoa, Colleges of Natural Sciences.	Adomou AC, 2007, ACTA BOT GALLICA, V154, P221, DOI 10.1080/12538078.2007.10516053; [Anonymous], 2005, THESIS WAGENINGEN U; Avocevou-Ayisso C, 2009, FOREST ECOL MANAG, V257, P1930, DOI 10.1016/j.foreco.2009.01.043; Ayisso C, 2011, THESIS; Barton K., 2015, MUMIN MULTIMODEL INF; Bawa KS, 2004, BIOTROPICA, V36, P437, DOI 10.1111/j.1744-7429.2004.tb00341.x; Bernal R, 1998, J APPL ECOL, V35, P64, DOI 10.1046/j.1365-2664.1998.00280.x; Botha J, 2004, BIODIVERS CONSERV, V13, P1675, DOI 10.1023/B:BIOC.0000029333.72945.b0; Bruna EM, 2005, AM J BOT, V92, P2101, DOI 10.3732/ajb.92.12.2101; Bruna EM, 2002, CONSERV BIOL, V16, P1256, DOI 10.1046/j.1523-1739.2002.99494.x; Bufford JL, 2015, ECOL APPL, V25, P1319, DOI 10.1890/14-0953.1; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Campbell G, 2008, FOLIA PRIMATOL, V79, P15, DOI 10.1159/000108383; Chase MJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2354; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; Emanuel PL, 2005, FOREST ECOL MANAG, V214, P91, DOI 10.1016/j.foreco.2005.03.066; Endress BA, 2006, FOREST ECOL MANAG, V234, P181, DOI 10.1016/j.foreco.2006.07.020; Ewedje EEBK, 2012, GENET RESOUR CROP EV, V59, P625, DOI 10.1007/s10722-012-9802-1; Feeley KJ, 2007, J TROP ECOL, V23, P191, DOI 10.1017/S0266467406003919; Gagnon PR, 2011, BIOL CONSERV, V144, P830, DOI 10.1016/j.biocon.2010.11.015; Gaoue O, 2017, DRYAD DIGIT REPOS; Gaoue OG, 2017, BIOTROPICA IN PRESS; Gaoue OG, 2007, BIOL CONSERV, V137, P424, DOI 10.1016/j.biocon.2007.02.020; Gaoue OG, 2016, J APPL ECOL, V53, P112, DOI 10.1111/1365-2664.12553; Gaoue OG, 2013, J ECOL, V101, P1563, DOI 10.1111/1365-2745.12140; Gaoue OG, 2011, ECOL APPL, V21, P1604, DOI 10.1890/10-0422.1; Gaoue OG, 2011, J APPL ECOL, V48, P844, DOI 10.1111/j.1365-2664.2011.01977.x; Gaoue OG, 2010, CONSERV BIOL, V24, P605, DOI 10.1111/j.1523-1739.2009.01345.x; Gelman A., 2007, DATA ANAL USING REGR; Ghimire SK, 2008, J APPL ECOL, V45, P41, DOI 10.1111/j.1365-2664.2007.01375.x; Groenendijk P, 2012, J APPL ECOL, V49, P164, DOI 10.1111/j.1365-2664.2011.02078.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; HALL P, 1993, ECON BOT, V47, P234, DOI 10.1007/BF02862289; Honnay O, 2005, OIKOS, V108, P427, DOI 10.1111/j.0030-1299.2005.13569.x; Ipavec A, 2007, PACHYDERM, P36; Kolb A, 2005, J ECOL, V93, P1226, DOI 10.1111/j.1365-2745.2005.01049.x; Kolb A, 2010, ECOLOGY, V91, P3210, DOI 10.1890/09-2207.1; Laurance WF, 2001, CONSERV BIOL, V15, P1529, DOI 10.1046/j.1523-1739.2001.01093.x; LIEBERMAN D, 1987, BIOTROPICA, V19, P365, DOI 10.2307/2388635; Mandle L, 2012, J ECOL, V100, P997, DOI 10.1111/j.1365-2745.2012.01982.x; Natta A. K., 2003, THESIS; Natta Armand K., 2002, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V124, P55, DOI 10.1127/0006-8152/2002/0124-0055; Peres CA, 2003, SCIENCE, V302, P2112, DOI 10.1126/science.1091698; Peters C.M., 1999, NONWOOD FOREST PRODU, P19; R Core Team, 2013, R LANG ENV STAT COMP; Ribeiro MBN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102187; Salzmann U, 2005, HOLOCENE, V15, P190, DOI 10.1191/0959683605hl799rp; Schmidt IB, 2011, J APPL ECOL, V48, P815, DOI 10.1111/j.1365-2664.2011.01999.x; Schumann K, 2011, BIOL CONSERV, V144, P2369, DOI 10.1016/j.biocon.2011.06.018; Schumann K, 2010, FOREST ECOL MANAG, V260, P2035, DOI 10.1016/j.foreco.2010.09.009; Scoles R, 2012, FOREST ECOL MANAG, V265, P71, DOI 10.1016/j.foreco.2011.10.027; Sinsin B, 2002, FOLIA PRIMATOL, V73, P116, DOI 10.1159/000064789; Sinsin Brice, 2003, Cahiers Agricultures, V12, P75; Sparovek G, 2002, AGR ECOSYST ENVIRON, V90, P169, DOI 10.1016/S0167-8809(01)00195-5; Tabarelli M, 2004, BIODIVERS CONSERV, V13, P1419, DOI 10.1023/B:BIOC.0000019398.36045.1b; Tehou AC, 2000, MAMMALIA, V64, P29, DOI 10.1515/mamm.2000.64.1.29; Ticktin T, 2004, BIOL CONSERV, V120, P461, DOI 10.1016/j.biocon.2004.03.019; Ticktin T, 2004, J APPL ECOL, V41, P11, DOI 10.1111/j.1365-2664.2004.00859.x; Ticktin T, 2012, J APPL ECOL, V49, P774, DOI 10.1111/j.1365-2664.2012.02156.x; Varghese A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119634; Varghese A, 2008, ECOL SOC, V13; Wadt LHO, 2005, FOREST ECOL MANAG, V211, P371, DOI 10.1016/j.foreco.2005.02.061; Zambrano J, 2014, BIOTROPICA, V46, P556, DOI 10.1111/btp.12144	63	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183964	10.1371/journal.pone.0183964	http://dx.doi.org/10.1371/journal.pone.0183964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850624	Green Submitted, Green Published, gold			2022-12-26	WOS:000408544200049
J	Hermetet, C; Dubois, F; Gaudy-Graffin, C; Bacq, Y; Royer, B; Gaborit, C; D'Alteroche, L; Desenclos, JC; Roingeard, P; Grammatico-Guillon, L				Hermetet, Coralie; Dubois, Frederic; Gaudy-Graffin, Catherine; Bacq, Yannick; Royer, Bernard; Gaborit, Christophe; D'Alteroche, Louis; Desenclos, Jean Claude; Roingeard, Philippe; Grammatico-Guillon, Leslie			Continuum of hepatitis C care in France: A 20-year cohort study	PLOS ONE			English	Article							VIRUS-INFECTION; RISK-FACTORS; POPULATION; SOFOSBUVIR; RECOMMENDATIONS; EPIDEMIOLOGY; PROGRESSION; LEDIPASVIR; FIBROSIS; TRIAL	Background Hepatitis C virus (HCV)-infected patients require a specific continuum of care (CoC) from HCV screening to treatment. We assessed CoC of HCV-infected patients in a longitudinal study. Methods We established a cohort of subjects undergoing HCV screening (high alanine aminotransferase levels or risk factors) during preventive consultations at a French regional medical center from 1993 to 2013. Patients were considered to be HCV-infected if HCV RNA was detected in their serum. CoC was assessed as described by Viner et al. (Hepatology 2015): Stage 1, HCV screening; Stage 2, HCV RNA testing; Stage 3, continuing care; Stage 4, antiviral treatment. Cox multivariate analysis was performed to identify factors favoring CoC, defined as at least one course of antiviral treatment. Results In total, 12,993 HCV tests were performed and 478 outpatients were found to be HCV-seropositive. We included 417 seropositive patients, after excluding false positives and patients lost to follow-up. The baseline characteristics of the patients were: sex ratio (M/F) 1.4; mean age 38.5 years; intravenous drug use (IDU) in 55%; and 28% in unstable social situations, estimated by the EPICES deprivation score. Antiviral treatment was initiated for 179 (42.9%) of the 379 (90.9%) patients attending specialist consultations. CoC was associated with screening after 1997 (HR 2.0, 95% CI 1.4-2.9), age > 45 years (HR 1.5, 95% CI 1.02-2.3), patient acceptance of care (HR 9.3, 95% CI 5.4 -16.10), specialist motivation for treatment (HR 10.9, 95% CI 7.4-16.0), and absence of cancer (HR 6.7, 95% CI 1.6-27.9). Other comorbid conditions, such as depression and IDU, were not associated with CoC. Conclusions Our 20-year cohort study reveals the real-life continuum of care for HCV-infected patients in France. The number of patients involved in HCV care after positive testing was substantial due to the organization of healthcare in France. An improved CoC along with new direct-acting antivirals should help to decrease chronic HCV infection.	[Hermetet, Coralie; Gaborit, Christophe; Grammatico-Guillon, Leslie] Univ Tours, CHRU Tours, SIMEES, Lab Sante Publ, Tours, France; [Dubois, Frederic; Gaudy-Graffin, Catherine; Roingeard, Philippe; Grammatico-Guillon, Leslie] Univ Tours, INSERM, U966, Tours, France; [Dubois, Frederic; Gaudy-Graffin, Catherine; Roingeard, Philippe; Grammatico-Guillon, Leslie] CHRU Tours, Tours, France; [Dubois, Frederic; Gaudy-Graffin, Catherine] CHRU Tours, Serv Bacteriol Virol Hyg, Tours, France; [Dubois, Frederic; Royer, Bernard] UC IRSA, Dept 37, La Riche, France; [Bacq, Yannick; D'Alteroche, Louis] CHRU Tours, Serv Hepatogastroenterol, Tours, France; [Desenclos, Jean Claude] InVS, Direct Sci, St Maurice, France; [Roingeard, Philippe] CHRU Tours, Lab Biol Cellulaire, Tours, France	CHU Tours; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; CHU Tours; CHU Tours; Institute of Public Health Surveillance; CHU Tours	Grammatico-Guillon, L (corresponding author), Univ Tours, CHRU Tours, SIMEES, Lab Sante Publ, Tours, France.; Grammatico-Guillon, L (corresponding author), Univ Tours, INSERM, U966, Tours, France.; Grammatico-Guillon, L (corresponding author), CHRU Tours, Tours, France.	leslie.guillon@univ-tours.fr		Grammatico-Guillon, Leslie/0000-0001-7934-8912				Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Almasio PL, 2011, DIGEST LIVER DIS, V43, P589, DOI 10.1016/j.dld.2010.12.004; Bansal S, 2015, WORLD J HEPATOL, V7, P806, DOI 10.4254/wjh.v7.i5.806; Brody H, 2011, NATURE, V474, pCP17; Brouard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126920; Castera L, 2003, GUT, V52, P1531, DOI 10.1136/gut.52.10.1531; Chavalitdhamrong D, 2006, WORLD J GASTROENTERO, V12, P5532, DOI 10.3748/wjg.v12.i34.5532; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Delarocque-Astagneau E, 2010, J VIRAL HEPATITIS, V17, P435, DOI 10.1111/j.1365-2893.2009.01196.x; Desenclos JC, 1997, GASTROEN CLIN BIOL, V21, pS25; Dubois F, 1997, HEPATOLOGY, V25, P1490, DOI 10.1002/hep.510250630; Edlin BR, 2013, HEPATOLOGY, V57, P1644, DOI 10.1002/hep.26194; Gaudy C, 2005, J CLIN MICROBIOL, V43, P1722, DOI 10.1128/JCM.43.4.1722-1726.2005; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Marcellin P, 2002, HEPATOLOGY, V36, pS47, DOI 10.1053/jhep.2002.36993; Marcellin P, 2008, J HEPATOL, V48, P200, DOI 10.1016/j.jhep.2007.09.010; Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734; Mishra P, 2015, HEPATOLOGY, V62, P1298, DOI 10.1002/hep.27880; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Negro F, 2014, DIGEST LIVER DIS, V46, pS158, DOI 10.1016/j.dld.2014.09.023; Noell BC, 2015, DRUG DES DEV THER, V9, P2367, DOI 10.2147/DDDT.S65255; Pol S, 2014, MED MAL INFECT; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Vermeiren APA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051194; Viner K, 2015, HEPATOLOGY, V61, P783, DOI 10.1002/hep.27584; Zhou K, LANCET INFECT DIS	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183232	10.1371/journal.pone.0183232	http://dx.doi.org/10.1371/journal.pone.0183232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850623	gold, Green Published, Green Submitted			2022-12-26	WOS:000408544200012
J	Wang, MZ; Kong, J; Meng, XH; Luan, S; Luo, K; Sui, J; Chen, BL; Cao, JW; Shi, XL				Wang, Mingzhu; Kong, Jie; Meng, Xianhong; Luan, Sheng; Luo, Kun; Sui, Juan; Chen, Baolong; Cao, Jiawang; Shi, Xiaoli			Evaluation of genetic parameters for growth and cold tolerance traits in Fenneropenaeus chinensis juveniles	PLOS ONE			English	Article							OREOCHROMIS-NILOTICUS; NILE TILAPIA; BODY-WEIGHT; PRAWN	In this study, genetic parameters were obtained for growth and cold tolerance of 99 Fenneropenaeus chinensis juvenile families by means of indoor artificial cooling (starting from 14 degrees C, 2 degrees C/d). A linear mixed model was fitted to estimate variance components using the ASReml software package. Heritabilities estimated for body weight (BW) and body length (BL) of F. chinensis juveniles were 0.078 +/- 0.124 and 0.131 +/- 0.133, respectively. The estimates of heritability were low in magnitude for both traits. The differences between the heritabilities estimated for the two growth traits were not significant with each other, and the heritabilities were not significantly different from zero (P>0.05). The phenotypic and genetic correlation coefficients between BW and BL were as high as 0.9408 +/- 0.0040 and 0.9562 +/- 0.0551, respectively, and both were significantly different from zero (P < 0.01). The heritabilities of temperature at death (TAD) and cooling degree hours (CDH) were 0.265 +/- 0.091 and 0.077 +/- 0.058, respectively. The heritability estimates for TAD was moderate and significantly different from zero (P < 0.01). The correlation analysis indicated that the phenotypic correlation coefficient between TAD and CDH was - 0.5470 +/- 0.0174, and the genetic correlation coefficient was - 0.6707 +/- 0.3635. In the analysis of growth traits and cold tolerance traits, the values of phenotypic correlation coefficient were floating between - 0.1055 and 0.1098, both were significantly different from zero (P < 0.05), while the genetic correlation had a larger range (0.0526 similar to 0.9914), and all were not significantly different from zero (P > 0.05). In this study, there was a low correlation between growth and cold tolerance traits, indicating that growth traits and cold tolerance traits should be considered collectively in the breeding program of shrimp.	[Wang, Mingzhu; Kong, Jie; Meng, Xianhong; Luan, Sheng; Luo, Kun; Sui, Juan; Chen, Baolong; Cao, Jiawang; Shi, Xiaoli] Chinese Acad Fishery Sci, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Wang, Mingzhu; Kong, Jie; Meng, Xianhong; Luan, Sheng; Luo, Kun; Sui, Juan; Chen, Baolong; Cao, Jiawang; Shi, Xiaoli] Qingdao Natl Lab & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Wang, Mingzhu; Meng, Xianhong] Shanghai Ocean Univ, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University	Meng, XH (corresponding author), Chinese Acad Fishery Sci, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.; Meng, XH (corresponding author), Qingdao Natl Lab & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.; Meng, XH (corresponding author), Shanghai Ocean Univ, Shanghai, Peoples R China.	mengxianhong@ysfri.ac.cn			Central Public-interest Scientific Institution Basal Research Fund, CAFS [2016HY-ZD04]; National Natural Science Foundation of China [41676148]; Key R&D Program of Shandong province [2016ZDJS06A07]; Taishan Scholar Program for Seed Industry	Central Public-interest Scientific Institution Basal Research Fund, CAFS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key R&D Program of Shandong province; Taishan Scholar Program for Seed Industry	This project was financially supported by the Central Public-interest Scientific Institution Basal Research Fund, CAFS (no. 2016HY-ZD04), National Natural Science Foundation of China (no. 41676148), Key R&D Program of Shandong province (2016ZDJS06A07), and The Taishan Scholar Program for Seed Industry.	Charo-Karisa H, 2005, AQUACULTURE, V249, P115, DOI 10.1016/j.aquaculture.2005.04.029; Cnaani A, 2000, AQUACULT INT, V8, P289, DOI 10.1023/A:1009299109614; He YuYing, 2011, Agricultural Science & Technology - Hunan, V12, P613; Huang Fu-You, 2008, Zhongguo Haiyang Daxue Xuebao, V38, P269; Jiang X, 2013, J FISHERY SCI CHINA, P544; Kong Jie, 2012, Journal of Fisheries of China, V36, P1854; LI J, 2015, BOUND VALUE PRO 0110; Li Jian, 2005, Journal of Fisheries of China, V29, P1; Li WJ, 2016, ACTA OCEANOL SIN, V35, P12, DOI 10.1007/s13131-016-0845-6; Li WJ, 2015, AQUACULTURE, V441, P8, DOI 10.1016/j.aquaculture.2015.02.013; Liu BaoSuo, 2011, Journal of Fisheries of China, V35, P1601; Liu RY, 2004, 4 SESS ABSTR WORLD C, P1; Lu Qi-xi, 2011, Guangxi Shifan Daxue Xuebao Ziran Kexue Ban, V29, P104; Moore SS, 1999, AQUACULTURE, V173, P19, DOI 10.1016/S0044-8486(98)00461-X; Nguyen NH, 2007, AQUACULTURE, V272, pS38, DOI 10.1016/j.aquaculture.2007.08.013; Perry GML, 2005, AQUACULTURE, V250, P120, DOI 10.1016/j.aquaculture.2005.04.042; [田永胜 TIAN Yongsheng], 2008, [海洋水产研究, Marine Fisheries Research], V29, P1; Wang QY., 2013, PRINCIPLES PRACTICES, P42; Zhang TS, 2011, ACTA OCEANOL SIN, V30, P78, DOI 10.1007/s13131-011-0093-8	19	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183801	10.1371/journal.pone.0183801	http://dx.doi.org/10.1371/journal.pone.0183801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850577	Green Published, Green Submitted, gold			2022-12-26	WOS:000408544200026
J	Li, JK; Cui, GW; Hu, GF; Wang, MJ; Zhang, P; Qin, LG; Shang, C; Zhang, HL; Zhu, XC; Qu, MN				Li, Jikai; Cui, Guowen; Hu, Guofu; Wang, Mingjun; Zhang, Pan; Qin, Ligang; Shang, Chen; Zhang, Hailing; Zhu, Xiaocen; Qu, Mingnan			Proteome dynamics and physiological responses to short-term salt stress in Leymus chinensis leaves	PLOS ONE			English	Article							CHLOROPHYLL BIOSYNTHESIS; TRANSGENIC EXPRESSION; ARABIDOPSIS-THALIANA; POSIDONIA-OCEANICA; SALINITY; TOLERANCE; DROUGHT; GENE; GROWTH; PHOTOSYNTHESIS	Salt stress is becoming an increasing threat to global agriculture. In this study, physiological and proteomics analysis were performed using a salt-tolerant grass species, Leymus chinensis (L. chinensis). The aim of this study is to understand the potential mechanism of salt tolerance in L. chinensis that used for crop molecular breeding. A series of short-term (<48 h) NaCl treatments (0 similar to 700 mM) were conducted. Physiological data indicated that the root and leaves growth were inhibited, chlorophyll contents decreased, while hydraulic conductivity, proline, sugar and sucrose were accumulated under salt stress. For proteomic analysis, we obtained 274 differentially expressed proteins in response to NaCl treatments. GO analysis revealed that 44 out of 274 proteins are involved in the biosynthesis of amino acids and carbon metabolism. Our findings suggested that L. chinensis copes with salt stress by stimulating the activities of POD, SOD and CAT enzymes, speeding up the reactions of later steps of citrate cycle, and synthesis of proline and sugar. In agreement with our physiological data, proteomic analysis also showed that salt stress depress the expression of photosystem relevant proteins, Calvin cycle, and chloroplast biosynthesis.	[Li, Jikai; Cui, Guowen; Hu, Guofu; Wang, Mingjun; Zhang, Pan; Qin, Ligang] Northeast Agr Univ, Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Li, Jikai; Shang, Chen; Zhang, Hailing] Heilongjiang Acad Agr Sci, Inst Grass Res, Harbin, Heilongjiang, Peoples R China; [Zhu, Xiaocen; Qu, Mingnan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Heilongjiang Academy of Agricultural Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cui, GW (corresponding author), Northeast Agr Univ, Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China.	cgw603@163.com			Ministry of Science and Technology [2016YFC0500607]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	National key research and development project(2016YFC0500607) funded by Ministry of Science and Technology(http://www.most.gov.cn): Rapid recovery and efficient utilization techniques of degraded meadow in cold regions of black soil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National key research and development project, Ministry of Science and Technology (2016YFC0500607),"Rapid recovery and efficient utilization techniques of degraded meadow in cold regions of black soil".	Abdul Qados A.M.S., 2011, J SAUDI SOC AGR SCI, V10, P7, DOI [10.1016/j.jssas.2010.06.002, DOI 10.1016/J.JSSAS.2010.06.002]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Carillo P, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P21; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheng TL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00030; Clayton WD, 1986, GRASSES OF THE WORLD; Ellouzi H, 2014, PLANTA, V240, P1299, DOI 10.1007/s00425-014-2154-7; Elmore JM, 2011, MOL PLANT, V4, P416, DOI 10.1093/mp/ssq083; Ghosh D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00006; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hakim AK, 2012, MOL CELLULAR PROTEOM, V11; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; HIRASAWA T, 1991, JPN J CROP SCI, V60, P174, DOI 10.1626/jcs.60.174; ILAG LL, 1994, PLANT CELL, V6, P265, DOI 10.1105/tpc.6.2.265; Jia H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144808; Jin H, 2006, PLANT SCI, V175, P784; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Koch MS, 2007, AQUAT BOT, V86, P14, DOI 10.1016/j.aquabot.2006.08.003; Liu A, 2016, ECOTOXICOLOGY; Liu ZJ, 2017, J PLANT PHYSIOL, V211, P90, DOI 10.1016/j.jplph.2016.12.014; Luo JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138974; Lv DW, 2014, J PROTEOME RES, V13, P2381, DOI 10.1021/pr401184v; Lyon BR, 2011, PLANT PHYSIOL, V157, P1926, DOI 10.1104/pp.111.185025; Marin-Guirao L, 2011, ESTUAR COAST SHELF S, V92, P286, DOI 10.1016/j.ecss.2011.01.003; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; Pang Cai-Hong, 2008, V69, P231, DOI 10.1007/978-3-540-72954-9_9; Peng XJ, 2011, PLANT CELL REP, V30, P1493, DOI 10.1007/s00299-011-1058-2; Piro A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00464; PREMACHANDRA GS, 1992, J EXP BOT, V43, P1569, DOI 10.1093/jxb/43.12.1569; Qureshi MI, 2013, PHYTOCHEMISTRY, V95, P215, DOI 10.1016/j.phytochem.2013.06.026; Rai S, 2014, J PROTEOMICS, V98, P254, DOI 10.1016/j.jprot.2013.12.020; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Sanchez-Romera B, 2014, PLANT CELL ENVIRON, V37, P995, DOI 10.1111/pce.12214; Sandoval-Gil JM, 2012, ESTUAR COAST SHELF S, V115, P260, DOI 10.1016/j.ecss.2012.09.008; Sandoval-Gil JM, 2014, MAR ENVIRON RES, V95, P39, DOI 10.1016/j.marenvres.2013.12.011; Shi HT, 2013, J PROTEOME RES, V12, P4951, DOI 10.1021/pr400479k; Shi HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053422; Sobhanian H, 2010, J PROTEOME RES, V9, P2882, DOI 10.1021/pr900974k; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Tang X, 2014, CRIT REV BIOTECHNOL, P16; Turan S, 2015, PHYSIOL PLANTARUM, V153, P477, DOI 10.1111/ppl.12250; Wang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096765; Wang SH, 2014, PLANT CELL, V26, P4875, DOI 10.1105/tpc.114.133116; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wohlbach DJ, 2008, PLANT CELL, V20, P1101, DOI 10.1105/tpc.107.055871; Yu JJ, 2011, J PROTEOME RES, V10, P3852, DOI 10.1021/pr101102p; Zhao Q, 2013, P NATL ACAD SCI USA, V110, P13660, DOI 10.1073/pnas.1312234110; Zheng LY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00678	54	15	18	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							0183615	10.1371/journal.pone.0183615	http://dx.doi.org/10.1371/journal.pone.0183615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846722	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600041
J	Walabyeki, J; Adamson, J; Buckley, HL; Sinclair, H; Atkin, K; Graham, H; Whitaker, K; Wardle, J; Macleod, U				Walabyeki, Julie; Adamson, Joy; Buckley, Hannah L.; Sinclair, Helena; Atkin, Karl; Graham, Hilary; Whitaker, Katriina; Wardle, Jane; Macleod, Una			Experience of, awareness of and help-seeking for potential cancer symptoms in smokers and non-smokers: A cross-sectional study	PLOS ONE			English	Article							LUNG-CANCER; RISK-FACTORS; PUBLIC AWARENESS; SMOKING; DELAY; DIAGNOSIS; AUSTRALIA; KNOWLEDGE; BEHAVIOR; IMPACT	Background Presenting to primary care with potential cancer symptoms is contingent on one's ability to recognize potentially serious symptoms. We investigated differences between smokers and non-smokers in symptoms experienced, awareness and consulting of potential respiratory, head and neck cancer symptoms. Methods Smokers and non-smokers aged over 50 from Yorkshire general practice lists were sent a postal questionnaire asking about symptoms, consulting and awareness of cancer symptoms. Data were analysed using STATA14. Results Response rate after one reminder was 30.5% (1205/3954). Smoking status was associated with experience of cough (p<0.001), breathlessness (p = 0.002) and tiredness (p = 0.004) with smokers (25.8% of population) more likely than never-smokers (53.6% of population) to experience all three symptoms (cough OR = 2.56; 95% CI[1.75-3.75], breathlessness OR = 2.39; 95%CI[1.43-4.00], tiredness OR = 1.57; 95% CI[1.12-2.19]). Smoking status was associated with awareness of breathlessness as a potential cancer symptom (p = 0.035) and consulting for cough (p = 0.011) with smokers less likely to consult than never-smokers (OR = 0.37; 95%CI[0.17-0.80]). Conclusion Our findings suggest that current smokers are more likely to experience cough, breathlessness and tiredness, but are less likely to consult for cough than never-smokers. To increase cancer awareness and promote consulting among smokers, innovative interventions improving symptom recognition and empowering smokers to seek help are required.	[Walabyeki, Julie; Sinclair, Helena; Macleod, Una] Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Adamson, Joy] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Buckley, Hannah L.; Atkin, Karl; Graham, Hilary] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Whitaker, Katriina] Univ Surrey, Sch Hlth Sci, Guildford, Surrey, England; [Wardle, Jane] UCL, Hlth Behav Res Ctr, London, England; [Buckley, Hannah L.] Univ Leeds, Leeds Inst Clin Trials Res, Leeds, W Yorkshire, England	University of Hull; University of York - UK; Newcastle University - UK; University of York - UK; University of Surrey; University of London; University College London; University of Leeds	Walabyeki, J (corresponding author), Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England.	Julie.Walabyeki@hyms.ac.uk	Whitaker, Katriina/AAA-6593-2020	Whitaker, Katriina/0000-0002-0947-1840; Adamson, Joy/0000-0002-9860-0850	National Awareness and Early Diagnosis Initiative (NAEDI); CRUK [C1294/A13905]; NIHR CRN; Cancer Research UK (CRUK); Cancer Research UK [13905] Funding Source: researchfish	National Awareness and Early Diagnosis Initiative (NAEDI); CRUK(Cancer Research UK); NIHR CRN; Cancer Research UK (CRUK)(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The work was supported by the National Awareness and Early Diagnosis Initiative (NAEDI)-Project Award, CRUK; Ref: C1294/A13905. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the study participants, pilot study volunteers; participating practices; Dr Trish Green and Ms Claire Ward, who helped with the questionnaire packs preparation; HYMS IT team; Dr Judith Dyson for her contribution and our collaborators, Dr Gill Greenwood (Consultant in Oral Medicine and special care dentistry), Professor Nick Stafford (ENT surgery, University of Hull) and Dr Gavin Anderson (Department of Respiratory Medicine, Hull and East Yorkshire Hospitals. We acknowledge the support of the NIHR CRN and our funders, National Awareness and Early Diagnosis Initiative (NAEDI)-Project Award, Cancer Research UK (CRUK).	Blakely T, 2013, CANCER CAUSE CONTROL, V24, P1243, DOI 10.1007/s10552-013-0204-2; Brindle L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001977; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Crane M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3051-8; Cromme SK, 2016, BRIT J GEN PRACT, V66, pE474, DOI 10.3399/bjgp16X685621; de Almeida AA, 2014, J BRAS PNEUMOL, V40, P286, DOI 10.1590/S1806-37132014000300012; Department of Health (DoH), 2007, CANC REF STRAT; Elliott AM, 2012, BMC FAMILY PRACTICE, V13, P1; Forbes LJL, 2014, BRIT J CANCER, V111, P581, DOI 10.1038/bjc.2014.304; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; Friedemann Smith C, 2016, SMOKERS ARE LESS NON; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Health and Social Care Information Centre (HSCIC), 2015, STAT SMOK, P1; Hoseini M, 2016, ENVIRON SCI POLLUT R, V23, P25065, DOI 10.1007/s11356-016-7619-8; Ironmonger L, 2015, Br J Cancer, V112, P207, DOI 10.1038/bjc.2014.596; Kotz D, 2012, ADDICTION, V107, P995, DOI 10.1111/j.1360-0443.2011.03739.x; Lee YCA, 2013, INT J CANCER, V133, P2688, DOI 10.1002/ijc.28288; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; McLachlan S, 2015, FAM PRACT, V32, P568, DOI 10.1093/fampra/cmv048; Moffat J, 2015, BRIT J CANCER, V112, pS14, DOI 10.1038/bjc.2015.31; Office of National Statistics (ONS), 2016, STAT B, P1; ONS, 2013, CANC REG STAT, V2015, P1; Osborne J., 2011, DEALING MISSING INCO, P105; PHE, 2016, RESP S AW BE CLEAR C; Public Health England (PHE), 2016, LOC TOB CONTR PROF E; Quaife SL, 2014, BRIT J CANCER, V110, P12, DOI 10.1038/bjc.2013.684; Richards MA, 2009, BRIT J CANCER, V101, pS125, DOI 10.1038/sj.bjc.6605402; Robb K, 2009, BRIT J CANCER, V101, pS18, DOI 10.1038/sj.bjc.6605386; Simon AE, 2012, THORAX, V67, P426, DOI 10.1136/thoraxjnl-2011-200898; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Smith SM, 2009, THORAX, V64, P523, DOI 10.1136/thx.2008.096560; Stubbings S, 2009, BRIT J CANCER, V101, pS13, DOI 10.1038/sj.bjc.6605385; The National Institute for Health and Care Excellence (NICE), 2015, NICE GUID, VNG12, P1; Tynan Michael A., 2012, Morbidity and Mortality Weekly Report, V61, P565; Vander Weg MW, 2012, NICOTINE TOB RES, V14, P123, DOI 10.1093/ntr/ntr141; Wagland R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165677; Walter FM, 2015, BRIT J CANCER, V112, pS6, DOI 10.1038/bjc.2015.30; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Whitaker KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114028	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183647	10.1371/journal.pone.0183647	http://dx.doi.org/10.1371/journal.pone.0183647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846706	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600043
J	Zangooei, MH; Habibi, J				Zangooei, Mohammad Hossein; Habibi, Jafar			Hybrid multiscale modeling and prediction of cancer cell behavior	PLOS ONE			English	Article							AGENT-BASED MODEL; TUMOR-GROWTH; AUTOMATON MODEL; SOLID TUMOR; MULTICELLULAR PATTERNS; MATHEMATICAL-MODEL; HETEROGENEITY; ANGIOGENESIS; PHENOTYPES; CONTINUUM	Background Understanding cancer development crossing several spatial-temporal scales is of great practical significance to better understand and treat cancers. It is difficult to tackle this challenge with pure biological means. Moreover, hybrid modeling techniques have been proposed that combine the advantages of the continuum and the discrete methods to model multiscale problems. Methods In light of these problems, we have proposed a new hybrid vascular model to facilitate the multiscale modeling and simulation of cancer development with respect to the agent-based, cellular automata and machine learning methods. The purpose of this simulation is to create a dataset that can be used for prediction of cell phenotypes. By using a proposed Q-learning based on SVR-NSGA-II method, the cells have the capability to predict their phenotypes autonomously that is, to act on its own without external direction in response to situations it encounters. Results Computational simulations of the model were performed in order to analyze its performance. The most striking feature of our results is that each cell can select its phenotype at each time step according to its condition. We provide evidence that the prediction of cell phenotypes is reliable. Conclusion Our proposed model, which we term a hybrid multiscale modeling of cancer cell behavior, has the potential to combine the best features of both continuum and discrete models. The in silico results indicate that the 3D model can represent key features of cancer growth, angiogenesis, and its related micro-environment and show that the findings are in good agreement with biological tumor behavior. To the best of our knowledge, this paper is the first hybrid vascular multiscale modeling of cancer cell behavior that has the capability to predict cell phenotypes individually by a self-generated dataset.	[Zangooei, Mohammad Hossein; Habibi, Jafar] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran	Sharif University of Technology	Habibi, J (corresponding author), Sharif Univ Technol, Dept Comp Engn, Tehran, Iran.	jhabibi@sharif.edu	Zangooei, Mohammad Hossein/AAD-9441-2021; Zangooei, Mohammad Hossein/AAJ-6094-2020	Zangooei, Mohammad Hossein/0000-0002-1471-3584				Alarcon T, 2003, J THEOR BIOL, V225, P257, DOI 10.1016/S0022-5193(03)00244-3; Alemani D, 2012, J IMMUNOL METHODS, V376, P55, DOI 10.1016/j.jim.2011.11.009; Anderson AR, 2014, CANCER RES, V66, P1366; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2007, SINGLE CELL BASED MO, P3; AndersonAR ChaplainMA, 2000, J THEORETICAL MED, V2, P129, DOI DOI 10.1080/10273660008833042; Athale C, 2005, J THEOR BIOL, V233, P469, DOI 10.1016/j.jtbi.2004.10.019; Brown JM, 2007, METHOD ENZYMOL, V435, P297, DOI 10.1016/S0076-6879(07)35015-5; Butler J, 2014, SIMULATING CANC GROW, P67; Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0; Cai Y, 2011, J THEOR BIOL, V279, P90, DOI 10.1016/j.jtbi.2011.02.017; Chaplain MAJ, 2000, J NEURO-ONCOL, V50, P37, DOI 10.1023/A:1006446020377; Chapuis A., 2015, COMPUTATIONAL BIOMEC, P25; Chen L, 2012, FRONT ARCHIT RES, V1, P166, DOI 10.1016/j.foar.2012.03.003; Cristini V., 2010, MULTISCALE MODELING; de Pillis LG, 2005, CANCER RES, V65, P7950, DOI 10.1158/0008-5472.CAN-05-0564; Deacon N, 2014, COMPUTATIONAL BIOMEC, P27; Deisboeck TS, 2011, ANNU REV BIOMED ENG, V13, P127, DOI 10.1146/annurev-bioeng-071910-124729; DEMICHELI R, 1980, EUR J CANCER, V16, P1603, DOI 10.1016/0014-2964(80)90034-1; Edgar LT, 2013, COMPUT METHOD BIOMEC, V16, P790, DOI 10.1080/10255842.2012.662678; Freedman HI, 2009, NONLINEAR ANAL-REAL, V10, P2709, DOI 10.1016/j.nonrwa.2008.08.001; Gerlee P, 2007, J THEOR BIOL, V246, P583, DOI 10.1016/j.jtbi.2007.01.027; Gerlee P, 2013, CANCER RES, V73, P2407, DOI 10.1158/0008-5472.CAN-12-4355; Ghaffari A, 2014, J APPL MATH, DOI 10.1155/2014/363109; Hatzikirou H, 2010, COMPUT MATH APPL, V59, P2326, DOI 10.1016/j.camwa.2009.08.041; Jinghua W, 2014, J HEAT TRANSFER AM S, V136, P71101; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; KUZNETSOV VA, 1994, B MATH BIOL, V56, P295, DOI 10.1007/BF02460644; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Lejon A, 2015, VARIANCE REDUCED SIM; Lollini Pier-Luigi, 2008, P363, DOI 10.1007/978-0-8176-4713-1_14; Macal CM, 2007, PROCEEDINGS OF THE 2007 WINTER SIMULATION CONFERENCE, VOLS 1-5, P83; Macklin P, 2012, J THEOR BIOL, V301, P122, DOI 10.1016/j.jtbi.2012.02.002; Mallet DG, 2006, J THEOR BIOL, V239, P334, DOI 10.1016/j.jtbi.2005.08.002; Mansury Y, 2006, J THEOR BIOL, V238, P146, DOI 10.1016/j.jtbi.2005.05.027; Olsen MM, 2013, PROCEDIA COMPUT SCI, V18, P1016, DOI 10.1016/j.procs.2013.05.267; Osborne JM, 2010, PHILOS T R SOC A, V368, P5013, DOI 10.1098/rsta.2010.0173; Owen MR, 2011, CANCER RES, V71, P2826, DOI 10.1158/0008-5472.CAN-10-2834; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Perfahl H, 2013, BIOANALYSIS-ADV MAT, V2, P29, DOI 10.1007/978-1-4614-4376-6_3; Perry SW, 2002, J NEUROVIROL, V8, P611, DOI 10.1080/13550280290101021; Piccolo E, 2002, ONCOGENE, V21, P6520, DOI 10.1038/sj.onc.1205821; Poleszczuk Jan, 2014, Appl Math (Irvine), V5, P144; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; QI AS, 1993, J THEOR BIOL, V161, P1, DOI 10.1006/jtbi.1993.1035; Rangamani P, 2007, BIOTECHNOL BIOENG, V97, P1216, DOI 10.1002/bit.21307; Reis EA, 2009, PHYSICA A, V388, P1303, DOI 10.1016/j.physa.2008.11.038; Rejniak KA, 2011, WIRES SYST BIOL MED, V3, P115, DOI 10.1002/wsbm.102; Schaller G, 2006, PHILOS T R SOC A, V364, P1443, DOI 10.1098/rsta.2006.1780; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Sherratt JA, 2001, J MATH BIOL, V43, P291, DOI 10.1007/s002850100088; Shrestha SMB, 2013, INT J NUMER METH BIO, V29, P542, DOI 10.1002/cnm.2539; Song JF, 2008, OPT EXPRESS, V16, P15304, DOI 10.1364/OE.16.015304; Sun XQ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-218; Trappey CV, 2008, ADV ENG INFORM, V22, P421, DOI 10.1016/j.aei.2008.05.007; Wang J, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-41; Wang ZH, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-50; Wang ZH, 2009, BIOINFORMATICS, V25, P2389, DOI 10.1093/bioinformatics/btp416; WODARZ D, 2009, PLOS ONE, V4; Wolfram S, 1994, CELLULAR AUTOMATA CO; Zangooei MH, 2014, NEUROCOMPUTING, V136, P14, DOI 10.1016/j.neucom.2014.01.042; Zhang L, 2009, MATH COMPUT MODEL, V49, P307, DOI 10.1016/j.mcm.2008.05.011; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034; Zhang L, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-46; Zhang L, 2009, MATH COMPUT SIMULAT, V79, P2021, DOI 10.1016/j.matcom.2008.09.007	65	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183810	10.1371/journal.pone.0183810	http://dx.doi.org/10.1371/journal.pone.0183810			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846712	Green Submitted, Green Published, gold			2022-12-26	WOS:000408438600051
J	Fu, XW; Feng, HQ; Liu, ZF; Wu, KM				Fu, Xiaowei; Feng, Hongqiang; Liu, Zhongfang; Wu, Kongming			Trans-regional migration of the beet armyworm, Spodoptera exigua (Lepidoptera: Noctuidae), in North-East Asia	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; CNAPHALOCROCIS-MEDINALIS LEPIDOPTERA; NILAPARVATA-LUGENS HOMOPTERA; AUTUMN MIGRATION; BOHAI SEA; SEASONAL MIGRATION; RETURN MIGRATION; INSECT MIGRATION; PIED PIPER; RADAR	The beet armyworm, Spodoptera exigua (Hubner) (Lepidoptera: Noctuidae), is a serious polyphagous insect pest worldwide. This species is known as a long-distance migrant, and previous studies on its migration have been mostly carried out in regions where it can over-winter. However, what pattern of seasonal migration this species exhibits in regions where it cannot overwinter (i.e., the 'summer breeding region') remains unknown. Here, we present data from 14-years of monitoring on a small remote island located in the center of the Bohai Strait, in northern China, by means of searchlight trapping and ovarian dissection. We found that the population size of this overseas migration varied significantly among years, with very large migrations in 2005, 2007, 2009, and 2014 that resulted in annual total catches of more than ten thousand individuals. In addition, nightly catches exhibited a significant inter-month variability, with the vast majority of S. exigua moths being trapped in August and September, (81.1 +/- 3.6%), making S. exigua one of the most frequently encountered species in that period. The mean time from the earliest trap capture to the latest capture within a given year was 113 +/- 22 d (range 57 d [2003] to 138 d [2008]). The sex ratio (females: males) was significantly less than 1:1 in each month, but the proportion of females showed an upward trend from June to October. The majority of trapped females in summer were mated (94.4 +/- 10.7% in June, 80.0 +/- 6.4% in July) and sexually mature (88.9 +/- 11.1% in June, 61.8 +/- 12.3% in July), suggesting the onset of mating and/or sexual maturation does not terminate the migration behavior in this species. These findings provide a good starting point for study of the trans-regional migration of S. exigua across different climate zones.	[Fu, Xiaowei; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Feng, Hongqiang] Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou, Henan, Peoples R China; [Liu, Zhongfang] Shanxi Acad Agr Sci, Inst Plant Protect, Taiyuan, Shanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Henan Academy of Agricultural Sciences; Shanxi Agricultural University	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	wukongming@caas.cn		Feng, Hongqiang/0000-0002-1171-248X	National Natural Sciences Foundation of China [31601630]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Sciences Foundation of China (grant number: 31601630).; We would like to thank Chao Li, Jianglong Guo, Xiao Wu, Hong Chang, Limei He and Shengyuan Zhao from the Institute of Plant Protection, Chinese Academy of Agricultural Sciences and Long Cao, Lei Yang, Kangle Fan, Doudou Wang and Lili Song from the College of Plant Protection, Henan Agricultural University, for their contributions in searchlight trapping and ovarian dissections. English editing was done by Van Driesche Scientific Editing. This research was supported by the National Natural Sciences Foundation of China (grant number: 31601630).	Aarvik L., 1981, Fauna Norvegica Series B, V28, P90; Ahmad M, 2010, CROP PROT, V29, P1428, DOI 10.1016/j.cropro.2010.07.025; ALI A, 1992, ENVIRON ENTOMOL, V21, P780, DOI 10.1093/ee/21.4.780; [Anonymous], DPS DATA PROCESSING; Berzitis EA, 2014, GLOBAL CHANGE BIOL, V20, P2778, DOI 10.1111/gcb.12557; Carde RT, 2008, CURR BIOL, V18, pR472, DOI 10.1016/j.cub.2008.04.018; Chapman JW, 2012, P NATL ACAD SCI USA, V109, P14924, DOI 10.1073/pnas.1207255109; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Dingle H., 2014, MIGRATION BIOL LIFE, P352; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; DRAKE VA, 1988, ANNU REV ENTOMOL, V33, P183, DOI 10.1146/annurev.en.33.010188.001151; Ehler LE, 2004, BIOCONTROL, V49, P121, DOI 10.1023/B:BICO.0000017364.20596.38; FARROW RA, 1987, AUST J ZOOL, V35, P1, DOI 10.1071/ZO9870001; Feng HQ, 2005, B ENTOMOL RES, V95, P361, DOI 10.1079/BER2005367; Feng HQ, 2008, ENVIRON ENTOMOL, V37, P774, DOI 10.1603/0046-225X(2008)37[774:AMOMSL]2.0.CO;2; Feng HQ, 2007, AGR FOREST ENTOMOL, V9, P103, DOI 10.1111/j.1461-9563.2007.00326.x; Feng HQ, 2006, ECOL ENTOMOL, V31, P511, DOI 10.1111/j.1365-2311.2006.00813.x; Feng HQ, 2009, J ECON ENTOMOL, V102, P95, DOI 10.1603/029.102.0114; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; Feng HQ, 2004, ENVIRON ENTOMOL, V33, P1253, DOI 10.1603/0046-225X-33.5.1253; Feng HQ, 2003, B ENTOMOL RES, V93, P115, DOI 10.1079/BER2002221; Chaves LF, 2010, J MED ENTOMOL, V47, P291, DOI 10.1603/ME09250; FRENCH RA, 1969, J ANIM ECOL, V38, P199, DOI 10.2307/2746; Fu XW, 2014, B ENTOMOL RES, V104, P601, DOI 10.1017/S0007485314000376; Fu XW, 2015, J ECON ENTOMOL, V108, P525, DOI 10.1093/jee/tov019; Fu XW, 2014, CROP PROT, V64, P143, DOI 10.1016/j.cropro.2014.06.021; Fu XW, 2014, J ECON ENTOMOL, V107, P1399, DOI 10.1603/EC13380; GILMORE E. C., 1958, AGRON JOUR, V50, P611; Guo JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131639; Han LZ, 2009, J APPL ENTOMOL, V133, P262, DOI 10.1111/j.1439-0418.2008.01353.x; Hu CX, 2015, CLIMATIC CHANGE, V132, P337, DOI 10.1007/s10584-015-1427-x; Jiang XF., 2010, J CHANGJIANG VEG, V18, P36; Johnson C.G., 1969, MIGRATION DISPERSAL; JOHNSON CG, 1963, NATURE, V198, P423, DOI 10.1038/198423a0; Karimi-Malati A, 2014, J ASIA-PAC ENTOMOL, V17, P349, DOI 10.1016/j.aspen.2014.03.002; Karimi-Malati A, 2014, ENVIRON ENTOMOL, V43, P795, DOI 10.1603/EN11272; Kim Y, 2000, ENVIRON ENTOMOL, V29, P868, DOI 10.1603/0046-225X-29.5.868; KIMURA S, 1991, ANN REPORT SOC PLANT, V42, P148; Kwon Min, 2006, Journal of Asia-Pacific Entomology, V9, P361, DOI 10.1016/S1226-8615(08)60315-5; Long Y, 2012, ENVIRON ENTOMOL, V41, P1231, DOI 10.1603/EN12143; MCNEIL JN, 1987, INSECT SCI APPL, V8, P591, DOI 10.1017/S1742758400022657; Mehrkhou F, 2012, ENVIRON ENTOMOL, V41, P326, DOI 10.1603/EN10255; Mikkola K, 2003, ENTOMOL FENNICA, V14, P15; Pan Lei, 2014, Chinese Journal of Applied Entomology, V51, P974, DOI 10.7679/j.issn.2095-1353.2014.117; RILEY JR, 1994, B ENTOMOL RES, V84, P389, DOI 10.1017/S0007485300032521; RILEY JR, 1995, B ENTOMOL RES, V85, P397, DOI 10.1017/S0007485300036130; Roff DA, 2007, BIOSCIENCE, V57, P155, DOI 10.1641/B570210; Saeed S, 2010, J PEST SCI, V83, P165, DOI 10.1007/s10340-009-0283-8; *SAS I INC, 2001, JMP START STAT; Serafim Jr. M., 2003, Braz. J. Biol., V63, P349, DOI 10.1590/S1519-69842003000200020; Shi BK, 2014, J INTEGR AGR, V13, P1520, DOI 10.1016/S2095-3119(14)60804-2; Showers WB, 1997, ANNU REV ENTOMOL, V42, P393, DOI 10.1146/annurev.ento.42.1.393; STINNER RE, 1983, ANNU REV ENTOMOL, V28, P319, DOI 10.1146/annurev.en.28.010183.001535; Su JY, 2014, CROP PROT, V61, P58, DOI 10.1016/j.cropro.2014.03.013; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; TAYLOR RAJ, 1986, J ANIM ECOL, V55, P1103, DOI 10.2307/4436; WADA T, 1988, ENTOMOL EXP APPL, V46, P141, DOI 10.1007/BF00190844; Wang Xianhui, 2003, Acta Phytophylacica Sinica, V30, P261; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; WILLIAMS CB, 1957, ANNU REV ENTOMOL, V2, P163, DOI 10.1146/annurev.en.02.010157.001115; Wu Kong-Ming, 2002, Acta Ecologica Sinica, V22, P1075; Wu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132904; Yan NS, 2001, CHINESE TOBACCO SCI, V2, P25; Yin JianLi, 2010, Plant Diseases and Pests, V1, P52; Zanuncio JC, 1998, FOREST ECOL MANAG, V108, P85, DOI 10.1016/S0378-1127(98)00215-1; Zhai Bao-Ping, 1993, Acta Ecologica Sinica, V13, P356; Zhang AY, 2001, J HEZE TEACHERS COLL, V23, P23; Zhang B., 2008, CHINESE AGR SCI B, V24, P427; Zhang Xiao-Ming, 2015, Chinese Journal of Applied Entomology, V52, P237, DOI 10.7679/j.issn.2095-1353.2015.025; Zhao XY, 2016, B ENTOMOL RES, V106, P740, DOI 10.1017/S000748531600047X; Zheng XL, 2011, J ENTOMOL RES SOC, V13, P39; Zhou C, 2011, PHYTOPARASITICA, V39, P315, DOI 10.1007/s12600-011-0157-5; Ziter C, 2012, GLOBAL CHANGE BIOL, V18, P2771, DOI 10.1111/j.1365-2486.2012.02748.x	74	14	18	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183582	10.1371/journal.pone.0183582	http://dx.doi.org/10.1371/journal.pone.0183582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841696	Green Submitted, Green Published, gold			2022-12-26	WOS:000408370700043
J	Huang, FQ; Spangler, JR; Huang, AY				Huang, Faqing; Spangler, Joseph Rankin; Huang, Allen Yang			In vivo cloning of up to 16 kb plasmids in E-coli is as simple as PCR	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; DNA-MOLECULES; PRODUCTS; CONSTRUCTION; YEAST; EFFICIENT; VECTORS; VITRO	The precise assembly of defined DNA sequences into plasmids is an essential task in bioscience research. While a number of molecular cloning techniques have been developed, many methods require specialized expensive reagents or laborious experimental procedure. Not surprisingly, conventional cloning techniques based on restriction digestion and ligation are still commonly used in routine DNA cloning. Here, we describe a simple, fast, and economical cloning method based on RecA-and RecET-independent in vivo recombination of DNA fragments with overlapping ends using E. coli. All DNA fragments were prepared by a 2-consecutive PCR procedure with Q5 DNA polymerase and used directly for transformation resulting in 95% cloning accuracy and zero background from parental template plasmids. Quantitative relationships were established between cloning efficiency and three factors -the length of overlapping nucleotides, the number of DNA fragments, and the size of target plasmids -which can provide general guidance for selecting in vivo cloning parameters. The method may be used to accurately assemble up to 5 DNA fragments with 25 nt overlapping ends into relatively small plasmids, and 3 DNA fragments into plasmids up to 16 kb in size. The whole cloning procedure may be completed within 2 days by a researcher with little training in cloning. The combination of high accuracy and zero background eliminates the need for screening a large number of colonies. The method requires no enzymes other than Q5 DNA polymerase, has no sequence restriction, is highly reliable, and represents one of the simplest, fastest, and cheapest cloning techniques available. Our method is particularly suitable for common cloning tasks in the lab where the primary goal is to quickly generate a plasmid with a pre-defined sequence at low costs.	[Huang, Faqing; Spangler, Joseph Rankin] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Huang, Allen Yang] Oak Grove High Sch, Hattiesburg, MS USA	University of Southern Mississippi	Huang, FQ (corresponding author), Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	Faqing.Huang@usm.edu		Spangler, Joseph/0000-0002-0673-1459	University of Southern Mississippi; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	University of Southern Mississippi; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by a Development Fund from the University of Southern Mississippi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ballard lab and the Cullen lab for providing pIk [36] and pk-Dcr [37] for use as the templates for the construction of pIkB, pDcEG, and pDSADE. We would like to acknowledge the Mississippi INBRE program supported by the National Institutes of Health for using its facilities.	Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Benoit RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153158; Brand LA, 2005, J BIOL CHEM, V280, P20185, DOI 10.1074/jbc.C500044200; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Cao PG, 2014, PLASMID, V76, P40, DOI 10.1016/j.plasmid.2014.09.002; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; Coleman Tricia M, 2005, RNA Biol, V2, P129, DOI 10.4161/rna.2.4.2285; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; Garcia-Nafria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27459; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Jacobus AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119221; Joska TM, 2014, J MICROBIOL METH, V100, P46, DOI 10.1016/j.mimet.2013.11.013; Kelwick Richard, 2014, Front Bioeng Biotechnol, V2, P60, DOI 10.3389/fbioe.2014.00060; Kennedy EM, 2015, P NATL ACAD SCI USA, V112, pE6945, DOI 10.1073/pnas.1513421112; Kostylev M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137466; Lee DF, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw436; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LOBBAN PE, 1973, J MOL BIOL, V78, P453, DOI 10.1016/0022-2836(73)90468-3; Lovett ST, 2002, GENETICS, V160, P851; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Muyrers J P, 2000, Genet Eng (N Y), V22, P77; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; Shao Zengyi, 2014, Curr Protoc Chem Biol, V6, P65, DOI 10.1002/9780470559277.ch130191; Strauss E, 2002, J BIOL CHEM, V277, P48205, DOI 10.1074/jbc.M204560200; Trehan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19121; van Leeuwen J, 2015, COLD SPRING HARB PRO, V2015; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; WATT VM, 1985, P NATL ACAD SCI USA, V82, P4768, DOI 10.1073/pnas.82.14.4768; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	40	19	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183974	10.1371/journal.pone.0183974	http://dx.doi.org/10.1371/journal.pone.0183974			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837659	Green Submitted, Green Published, gold			2022-12-26	WOS:000408365000138
J	Mahabadi, AA; Balcer, B; Dykun, I; Forsting, M; Schlosser, T; Heusch, G; Rassaf, T				Mahabadi, Amir Abbas; Balcer, Bastian; Dykun, Iryna; Forsting, Michael; Schlosser, Thomas; Heusch, Gerd; Rassaf, Tienush			Cardiac computed tomography-derived epicardial fat volume and attenuation independently distinguish patients with and without myocardial infarction	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; VISCERAL ABDOMINAL FAT; ADIPOSE-TISSUE VOLUME; HEINZ NIXDORF RECALL; PERICARDIAL FAT; CORONARY-ARTERY; PLASMA-PROTEIN; ASSOCIATION; CT; ADIPONECTIN	Background and objective Epicardial adipose tissue (EAT) volume is associated with coronary plaque burden and adverse events. We aimed to determine, whether CT-derived EAT attenuation in addition to EAT volume distinguishes patients with and without myocardial infarction. Methods and results In 94 patients with confirmed or suspected coronary artery disease (aged 66.9+/-14.7years, 61%male) undergoing cardiac CT imaging as part of clinical workup, EAT volume was retrospectively quantified from non-contrast cardiac CT by delineation of the pericardium in axial images. Mean attenuation of all pixels from EAT volume was calculated. Patients with type-I myocardial infarction (n = 28) had higher EAT volume (132.9 +/- 111.9ml vs. 109.7 +/- 94.6ml, p = 0.07) and CT-attenuation (-86.8 +/- 5.8HU vs. -89.0 +/- 3.7HU, p = 0.03) than patients without type-I myocardial infarction, while EAT volume and attenuation were only modestly inversely correlated (r = -0.24, p = 0.02). EAT volume increased per standard deviation of age (18.2 [6.2-30.2] ml, p = 0.003), BMI (29.3 [18.4-40.2] ml, p<0.0001), and with presence of diabetes (44.5 [16.7-72.3] ml, p = 0.0002), while attenuation was higher in patients with lipid-lowering therapy (2.34 [0.08-4.61] HU, p = 0.04). In a model containing volume and attenuation, both measures of EAT were independently associated with the occurrence of type-I myocardial infarction (OR [95% CI]: 1.79 [1.10-2.94], p = 0.02 for volume, 2.04 [1.18-3.53], p = 0.01 for attenuation). Effect sizes remained stable for EAT attenuation after adjustment for risk factors (1.44 [0.77-2.68], p = 0.26 for volume; 1.93 [1.11-3.39], p = 0.02 for attenuation). Conclusion CT-derived EAT attenuation, in addition to volume, distinguishes patients with vs. without myocardial infarction and is increased in patients with lipid-lowering therapy. Our results suggest that assessment of EAT attenuation could render complementary information to EAT volume regarding coronary risk burden.	[Mahabadi, Amir Abbas; Balcer, Bastian; Dykun, Iryna; Rassaf, Tienush] Univ Clin Essen, West German Heart & Vasc Ctr Essen, Dept Cardiol & Vasc Med, Essen, Germany; [Forsting, Michael; Schlosser, Thomas] Univ Clin Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Heusch, Gerd] Univ Clin Essen, Inst Pathophysiol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Mahabadi, AA (corresponding author), Univ Clin Essen, West German Heart & Vasc Ctr Essen, Dept Cardiol & Vasc Med, Essen, Germany.	amir-abbas.mahabadi@uk-essen.de	Heusch, Gerd/ABE-6675-2020; Mahabadi, Amir/ABE-6057-2020					Arita Y, 2002, CIRCULATION, V105, P2893, DOI 10.1161/01.CIR.0000018622.84402.FF; Baba S, 2010, J NUCL MED, V51, P246, DOI 10.2967/jnumed.109.068775; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hell MM, 2016, J CARDIOVASC COMPUT, V10, P141, DOI 10.1016/j.jcct.2016.01.009; Hell MM, 2016, J CARDIOVASC COMPUT, V10, P52, DOI 10.1016/j.jcct.2015.07.011; Jain SH, 2009, DIABETES CARE, V32, P903, DOI 10.2337/dc08-1733; Jungen C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14155; Jungen C, 2016, AM J CASE REP, V17, P280, DOI 10.12659/AJCR.897412; Konishi M, 2010, ATHEROSCLEROSIS, V213, P649, DOI 10.1016/j.atherosclerosis.2010.10.007; Laine P, 1999, CIRCULATION, V99, P361, DOI 10.1161/01.CIR.99.3.361; Mahabadi AA, 2016, JACC IN PRESS; Mahabadi AA, 2014, JACC-CARDIOVASC IMAG, V7, P909, DOI 10.1016/j.jcmg.2014.07.002; Mahabadi AA, 2014, EUR HEART J-CARD IMG, V15, P863, DOI 10.1093/ehjci/jeu006; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Mahabadi AA, 2010, ATHEROSCLEROSIS, V211, P195, DOI 10.1016/j.atherosclerosis.2010.02.013; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Moebus S, 2009, DIABETOLOGIA, V52, P81, DOI 10.1007/s00125-008-1173-y; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Schlett CL, 2012, ATHEROSCLEROSIS, V222, P129, DOI 10.1016/j.atherosclerosis.2012.02.029; Torriani M, 2015, OBES SURG, V25, P381, DOI 10.1007/s11695-014-1485-6	27	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183514	10.1371/journal.pone.0183514	http://dx.doi.org/10.1371/journal.pone.0183514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837682	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000075
J	Potkin, SG; Loze, JY; Forray, C; Baker, RA; Sapin, C; Peters-Strickland, T; Beillat, M; Nylander, AG; Hertel, P; Schmidt, SN; Ettrup, A; Eramo, A; Hansen, K; Naber, D				Potkin, Steven G.; Loze, Jean-Yves; Forray, Carlos; Baker, Ross A.; Sapin, Christophe; Peters-Strickland, Timothy; Beillat, Maud; Nylander, Anna-Greta; Hertel, Peter; Schmidt, Simon Nitschky; Ettrup, Anders; Eramo, Anna; Hansen, Karina; Naber, Dieter			Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study	PLOS ONE			English	Article							LIFE SCALE	Schizophrenia is a chronic disease with negative impact on patients' employment status and quality of life. This post-hoc analysis uses data from the QUALIFY study to elucidate the relationship between work readiness and health-related quality of life and functioning. QUALIFY was a 28-week, randomized study (NCT01795547) comparing the treatment effectiveness of aripiprazole once-monthly 400 mg and paliperidone palmitate once-monthly using the Heinrichs-Carpenter Quality-of-Life Scale as the primary endpoint. Also, patients' capacity to work and work readiness (Yes/No) was assessed with the Work Readiness Questionnaire. We categorized patients, irrespective of treatment, by work readiness at baseline and week 28: No to Yes (n = 41), Yes to Yes (n = 49), or No at week 28 (n = 118). Quality-of-Life Scale total, domains, and item scores were assessed with a mixed model of repeated measures. Patients who shifted from No to Yes in work readiness showed robust improvements on Quality-of-Life Scale total scores, significantly greater than patients not ready to work at week 28 (least squares mean difference: 11.6+/-2.6, p<0.0001). Scores on Quality-of-Life Scale instrumental role domain and items therein-occupational role, work functioning, work levels, work satisfaction-significantly improved in patients shifting from No to Yes in work readiness (vs patients No at Week 28). Quality-of-Life Scale total scores also significantly predicted work readiness at week 28. Overall, these results highlight a strong association between improvements in health-related quality of life and work readiness, and suggest that increasing patients' capacity to work is an achievable and meaningful goal in the treatment of impaired functioning in schizophrenia.	[Potkin, Steven G.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Loze, Jean-Yves] Otsuka Pharmaceut Europe Ltd, Wexham, England; [Forray, Carlos] Lundbeck LLC, Paramus, NJ USA; [Baker, Ross A.; Peters-Strickland, Timothy] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA; [Sapin, Christophe; Beillat, Maud; Hansen, Karina] Lundbeck SAS, Issy Les Moulineaux, France; [Nylander, Anna-Greta; Hertel, Peter; Schmidt, Simon Nitschky; Ettrup, Anders] H Lundbeck & Co AS, Valby, Denmark; [Eramo, Anna] Lundbeck LLC, Deerfield, IL USA; [Naber, Dieter] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany	University of California System; University of California Irvine; Otsuka Pharmaceutical; Lundbeck Corporation; Lundbeck Corporation - France; Lundbeck Corporation; University of Hamburg; University Medical Center Hamburg-Eppendorf	Potkin, SG (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA.	sgpotkin@uci.edu		Ettrup, Anders/0000-0002-8926-3012	H. Lundbeck A/S; Otsuka Pharmaceutical Development & Commercialization, Inc.	H. Lundbeck A/S; Otsuka Pharmaceutical Development & Commercialization, Inc.(Otsuka Pharmaceutical)	This work was supported by H. Lundbeck A/S and Otsuka Pharmaceutical Development & Commercialization, Inc. Authors Forray C, Sapin C, Beillat M, Nylander AG, Hertel P, Schmidt SN, Ettrup A, Eramo A, and Hansen K are employed by H. Lundbeck A/S; authors Baker RA and Peters Strickland T are employed by Otsuka Pharmaceutical Development & Commercialization, Inc.; and author Loze JY is employed by Otsuka Pharmaceutical Europe Ltd. The specific roles of these authors are articulated in the 'author contributions' section. The funders provided support in the form of salaries for these authors, and were involved in the study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Bilker WB, 2003, NEUROPSYCHOPHARMACOL, V28, P773, DOI 10.1038/sj.npp.1300093; Emsley R, 2013, SCHIZOPHR RES, V148, P117, DOI 10.1016/j.schres.2013.05.016; Falissard B, 2016, INT J METH PSYCH RES, V25, P101, DOI 10.1002/mpr.1483; Fiszdon JM, 2008, SCHIZOPHR RES, V105, P105, DOI 10.1016/j.schres.2008.06.010; Guy W., 1976, CDEU ASSESSMENT MANU; Hasan A, 2013, WORLD J BIOL PSYCHIA, V14, P2, DOI 10.3109/15622975.2012.739708; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Karagianis J, 2009, INT J CLIN PRACT, V63, P1578, DOI 10.1111/j.1742-1241.2009.02191.x; Karow A, 2014, DIALOGUES CLIN NEURO, V16, P185; Kuhnigk O, 2012, J PSYCHIATR PRACT, V18, P321, DOI 10.1097/01.pra.0000419816.75752.65; LEIDY NK, 1994, NURS RES, V43, P196; Leucht S, 2006, NEUROPSYCHOPHARMACOL, V31, P2318, DOI 10.1038/sj.npp.1301147; Lewis SW, 2006, SCHIZOPHRENIA BULL, V32, P715, DOI 10.1093/schbul/sbj067; Naber D, 2015, SCHIZOPHR RES, V168, P498, DOI 10.1016/j.schres.2015.07.007; Potkin SG, 2016, INT J NEURO IN PRESS; Potkin SG, 2016, CNS SPECTRUMS, V21, P199, DOI 10.1017/S1092852914000352; Thornicroft G, 2004, SCHIZOPHR RES, V69, P125, DOI 10.1016/S0920-9964(03)00191-9	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183475	10.1371/journal.pone.0183475	http://dx.doi.org/10.1371/journal.pone.0183475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837593	gold, Green Submitted, Green Published			2022-12-26	WOS:000408365000070
J	Yang, T; Kersigo, J; Wu, S; Fritzsch, B; Bassuk, AG				Yang, Tian; Kersigo, Jennifer; Wu, Shu; Fritzsch, Bernd; Bassuk, Alexander G.			Prickle1 regulates neurite outgrowth of apical spiral ganglion neurons but not hair cell polarity in the murine cochlea	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; LIM DOMAIN PROTEIN; PLANAR POLARITY; INNER-EAR; GENE-EXPRESSION; MOUSE PRICKLE1; PCP PATHWAY; MICE; VANGL2; IDENTIFICATION	In the mammalian organ of Corti (OC), the stereocilia on the apical surface of hair cells (HCs) are uniformly organized in a neural to abneural axis (or medial-laterally). This organization is regulated by planar cell polarity (PCP) signaling. Mutations of PCP genes, such as Vangl2, Dvl1/2, Celsr1, and Fzd3/6, affect the formation of HC orientation to varying degrees. Prickle1 is a PCP signaling gene that belongs to the prickle / espinas / testin family. Prickle1 protein is shown to be asymmetrically localized in the HCs of the OC, and this asymmetric localization is associated with loss of PCP in Smurf mutants, implying that Prickle1 is involved in HC PCP development in the OC. A follow-up study found no PCP polarity defects after loss of Prickle1 (Prickle1(-/-)) in the cochlea. We show here strong Prickle1 mRNA expression in the spiral ganglion by in situ hybridization and beta-Gal staining, and weak expression in the OC by beta-Gal staining. Consistent with this limited expression in the OC, cochlear HC PCP is unaffected in either Prickle1(C251X/C251X) mice or Prickle1(f/f); Pax2-cre conditional null mice. Meanwhile, type II afferents of apical spiral ganglion neurons (SGN) innervating outer hair cells (OHC) have unusual neurite growth. In addition, afferents from the apex show unusual collaterals in the cochlear nuclei that overlap with basal turn afferents. Our findings argue against the role of Prickle1 in regulating hair cell polarity in the cochlea. Instead, Prickle1 regulates the polarity-related growth of distal and central processes of apical SGNs.	[Yang, Tian; Kersigo, Jennifer; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Wu, Shu; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Yang, T; Fritzsch, B (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.; Bassuk, AG (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	tian-yang@uiowa.edu; bernd-fritzsch@uiowa.edu; alexander-bassuk@uiowa.edu		Bassuk, Alexander/0000-0002-4067-2157; Fritzsch, Bernd/0000-0002-4882-8398	NIH [R01 DC005590, P30 DC 010362, NS064159-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH: R01 DC005590 and P30 DC 010362 to BF, NS064159-01A1 to AGB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appler JM, 2013, J NEUROSCI, V33, P3679, DOI 10.1523/JNEUROSCI.4703-12.2013; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Bekman E, 2002, MECH DEVELOP, V119, pS77, DOI 10.1016/S0925-4773(03)00095-9; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Copley CO, 2013, J NEUROSCI, V33, P14001, DOI 10.1523/JNEUROSCI.1307-13.2013; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A., 2016, PRIMARY AUDITORY NEU; Duncan JS, 2017, DEV BIOL, V423, P126, DOI 10.1016/j.ydbio.2017.01.020; Duncan JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062046; Elkon R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9549; Elliott KL, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00025; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Fantetti KN, 2011, HEARING RES, V278, P86, DOI 10.1016/j.heares.2011.04.005; Feng J, 2016, CEREB CORTEX, V26, P3323, DOI 10.1093/cercor/bhw132; Fritzsch B, 2015, CELL TISSUE RES, P368; Fritzsch B, 2016, METHODS MOL BIOL, V1427, P243, DOI 10.1007/978-1-4939-3615-1_14; Fritzsch B, 2016, SPRINGER HANDB AUDIT, V52, P49, DOI 10.1007/978-1-4939-3031-9_3; Fritzsch B, 2013, EVOL DEV, V15, P63, DOI 10.1111/ede.12015; Fritzsch B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009377; Giese AP, 2012, DEVELOPMENT, V139, P3775, DOI 10.1242/dev.074229; Goodrich LV, 2016, SPRINGER HANDB AUDIT, V52, P11, DOI 10.1007/978-1-4939-3031-9_2; Hudspeth AJ, 2014, NAT REV NEUROSCI, V15, P600, DOI 10.1038/nrn3786; Jahan I, 2015, BIOESSAYS, V37, P1016, DOI 10.1002/bies.201500044; Jahan I, 2015, DEVELOPMENT, V142, P2810, DOI 10.1242/dev.123091; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Katoh M, 2003, INT J MOL MED, V11, P249; Koundakjian EJ, 2007, J NEUROSCI, V27, P14078, DOI 10.1523/JNEUROSCI.3765-07.2007; Liu CQ, 2014, BIOL OPEN, V3, P861, DOI 10.1242/bio.20148375; Liu CQ, 2013, HUM MOL GENET, V22, P2234, DOI 10.1093/hmg/ddt075; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Lu CC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004823; Lu XW, 2016, WIRES DEV BIOL, V5, P85, DOI 10.1002/wdev.202; Mao YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094580; Mapp OM, 2011, DEVELOPMENT, V138, P2121, DOI 10.1242/dev.060442; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Muniak MA, 2016, SPRINGER HANDB AUDIT, V52, P157, DOI 10.1007/978-1-4939-3031-9_6; Muniak MA, 2013, J COMP NEUROL, V521, P1510, DOI 10.1002/cne.23238; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Okpodu S, 2012, INVEST OPHTHALMOL, V53, P3961; Okuda H, 2007, FEBS LETT, V581, P4754, DOI 10.1016/j.febslet.2007.08.075; Paemka L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080737; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Ren DD, 2013, DEV DYNAMICS; Rudnicki A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-484; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Shimojo M, 2006, J NEUROCHEM, V96, P1130, DOI 10.1111/j.1471-4159.2005.03608.x; Shimojo M, 2003, MOL CELL BIOL, V23, P9025, DOI 10.1128/MCB.23.24.9025-9031.2003; Sienknecht UJ, 2008, J COMP NEUROL, V510, P378, DOI 10.1002/cne.21791; Tao H, 2011, AM J HUM GENET, V88, P138, DOI 10.1016/j.ajhg.2010.12.012; Tao H, 2009, P NATL ACAD SCI USA, V106, P14426, DOI 10.1073/pnas.0901332106; Tarchini B, 2016, DEVELOPMENT, V143, P3926, DOI 10.1242/dev.139089; Teufel A, 2005, INT J MOL MED, V15, P513; Tonniges J, 2010, J MICROSC-OXFORD, V239, P117, DOI 10.1111/j.1365-2818.2009.03363.x; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang W, 2016, NATURE COMMUNICATION, V7; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Yang T, 2013, MOL GENETICS GENOMIC; Yang T, 2014, CELL TISSUE RES, V357, P549, DOI 10.1007/s00441-014-1925-6; Yang T, 2013, DEV DYNAM, V242, P1293, DOI 10.1002/dvdy.24025; Yin HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031988; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	70	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183773	10.1371/journal.pone.0183773	http://dx.doi.org/10.1371/journal.pone.0183773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837644	Green Submitted, Green Published, gold			2022-12-26	WOS:000408365000119
J	Wang, XJ; Zhang, X; Chu, ESH; Chen, XT; Kang, W; Wu, F; To, KF; Wong, VWS; Chan, HLY; Chan, MTV; Sung, JJY; Wu, WKK; Yu, J				Wang, Xiaojuan; Zhang, Xiang; Chu, Eagle S. H.; Chen, Xiaoting; Kang, Wei; Wu, Feng; To, Ka-Fai; Wong, Vincent W. S.; Chan, Henry L. Y.; Chan, Matthew T. V.; Sung, Joseph J. Y.; Wu, William K. K.; Yu, Jun			Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis	FASEB JOURNAL			English	Article						NAFLD; autophagy; lysosome; asparagine synthetase	STRESS; HEPATOCYTES; ASPARAGINE; FLUX	Autophagic impairment is implicated in nonalcoholic fatty liver disease (NAFLD), but the molecular mechanism is unclear. We found that autophagic flux was significantly inhibited in 3 murine models of NAFLD. Interestingly, the number of acidic organelles and the level of mature cathepsin D were reduced, suggesting defective lysosome acidification. Asparagine synthetase (ASNS) was induced by endoplasmic reticulum stress, leading to the generation of asparagine, which inhibited lysosome acidification. Both steatotic-and asparaginetreated hepatocytes showed reduced lysosomal acidity and retention of lysosomal calcium. Knockdown ofASNS in steatotic hepatocytes restored autophagic flux. As a potential biomarker, increased serum p62/sequestosome 1 (SQSTM1) level was an independent risk factor for patients with steatosis and lobular inflammation. Impaired autophagy inNAFLDis elicited by defective lysosome acidification, which is caused byASNS-induced asparagine synthesis under endoplasmic reticulum stress and subsequent retention of lysosomal calcium. p62/SQSTM1 could be used as a noninvasive biomarker in the diagnosis ofNAFLDpatients.	[Wang, Xiaojuan; Zhang, Xiang; Chu, Eagle S. H.; Wu, Feng; Wong, Vincent W. S.; Chan, Henry L. Y.; Sung, Joseph J. Y.; Wu, William K. K.; Yu, Jun] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Inst Digest Dis,Dept Med & Therapeut,State Key La, Hong Kong, Hong Kong, Peoples R China; [Chen, Xiaoting; Chan, Matthew T. V.; Wu, William K. K.] Chinese Univ Hong Kong, Dept Anesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; [Kang, Wei; Wu, Feng; To, Ka-Fai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wu, WKK (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anesthesia & Intens Care, 04C14 Main Clin Block & Trauma Ctr, Shatin, Hong Kong, Peoples R China.; Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	wukakei@cuhk.edu.hk; junyu@cuhk.edu.hk	Sung, Joseph J. Y./R-3203-2018; Wong, Vincent WS/K-3864-2014; Wu, William K.K./A-3277-2009; wu, william/HII-5817-2022; ZHANG, Xiang/N-7918-2015; KANG, Wei/C-5451-2016; Yu, Jun/D-8569-2015; Chan, Henry Lik-Yuen/B-9636-2008; Chan, Matthew/J-2884-2013; Wong, Grace LH/L-8586-2014	Sung, Joseph J. Y./0000-0003-3125-5199; Wong, Vincent WS/0000-0003-2215-9410; Wu, William K.K./0000-0002-5662-5240; ZHANG, Xiang/0000-0002-3222-5824; KANG, Wei/0000-0002-4651-677X; Yu, Jun/0000-0001-5008-2153; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Chan, Matthew/0000-0002-3574-7855; Wong, Grace LH/0000-0002-2863-9389; WANG, Echo/0000-0001-6229-5690	National Basic Research Program of China (973 Program) [2013CB531401]; Theme-Based Research Scheme of the Hong Kong Research Grants Council [T12-403-11]; Collaborative Research Fund [HKU3/CRF11R, CUHK3/CRF/12R]; Early Career Scheme of the Research Grant Council Hong Kong [24115815]; Shenzhen Science and Technology Programme of the Shenzhen Science and Technology Innovation Commission [JCYJ20150630165236956, JCYC20140905151710921]; Natural Science Foundation of Guangdong Province of the Department of Science and Technology [2015A030313886]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Theme-Based Research Scheme of the Hong Kong Research Grants Council; Collaborative Research Fund; Early Career Scheme of the Research Grant Council Hong Kong; Shenzhen Science and Technology Programme of the Shenzhen Science and Technology Innovation Commission; Natural Science Foundation of Guangdong Province of the Department of Science and Technology	The authors thank G.C. Farrell (Australian National University Medical School, Canberra, ACT, Australia) for providing the foz/foz mice. This work was supported by the National Basic Research Program of China (973 Program; 2013CB531401), Theme-Based Research Scheme of the Hong Kong Research Grants Council (T12-403-11), Collaborative Research Fund (HKU3/CRF11R, CUHK3/CRF/12R), Early Career Scheme (24115815) of the Research Grant Council Hong Kong, Shenzhen Science and Technology Programme of the Shenzhen Science and Technology Innovation Commission (JCYJ20150630165236956, JCYC20140905151710921), and the Natural Science Foundation of Guangdong Province of the Department of Science and Technology (2015A030313886). The authors declare no conflict of interest.	B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Bernales S, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00005; Coen K, 2012, J CELL BIOL, V198, P23, DOI 10.1083/jcb.201201076; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; Fukuo Y, 2014, HEPATOL RES, V44, P1026, DOI 10.1111/hepr.12282; Giatromanolaki A, 2010, J CLIN PATHOL, V63, P867, DOI 10.1136/jcp.2010.079525; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lin CW, 2013, J HEPATOL, V58, P993, DOI 10.1016/j.jhep.2013.01.011; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Porter K, 2013, AUTOPHAGY, V9, P581, DOI 10.4161/auto.23568; Rikiishi Hidemi, 2012, Int J Cell Biol, V2012, P317645, DOI 10.1155/2012/317645; Shen JY, 2012, J HEPATOL, V56, P1363, DOI 10.1016/j.jhep.2011.12.025; Shi B, 2017, AUTOPHAGY, V13, P285, DOI 10.1080/15548627.2016.1261238; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yu J, 2010, GASTROENTEROLOGY, V138, P694, DOI 10.1053/j.gastro.2009.09.058; Zhang XQ, 2014, WORLD J GASTROENTERO, V20, P1768, DOI 10.3748/wjg.v20.i7.1768; Zois CE, 2011, AUTOPHAGY, V7, P1371, DOI 10.4161/auto.7.11.16664	25	46	48	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					37	51		10.1096/fj.201601393R	http://dx.doi.org/10.1096/fj.201601393R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28842428				2022-12-26	WOS:000419172700006
J	Roy, K; Jerman, S; Jozsef, L; McNamara, T; Onyekaba, G; Sun, ZX; Marin, EP				Roy, Kasturi; Jerman, Stephanie; Jozsef, Levente; McNamara, Thomas; Onyekaba, Ginikanwa; Sun, Zhaoxia; Marin, Ethan P.			Palmitoylation of the ciliary GTPase ARL13b is necessary for its stability and its role in cilia formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; MEMBRANE LOCALIZATION; TRANSPORT; ACYLATION; PDE6D; NPHP3; SITE; FORM	Primary cilia are hairlike extensions of the plasma membrane of most mammalian cells that serve specialized signaling functions. To traffic properly to cilia, multiple cilia proteins rely on palmitoylation, the post-translational attachment of a saturated 16-carbon lipid. However, details regarding the mechanism of how palmitoylation affects cilia protein localization and function are unknown. Herein, we investigated the protein ADP-ribosylation factor-like GTPase 13b (ARL13b) as a model palmitoylated ciliary protein. Using biochemical, cellular, and in vivo studies, we found that ARL13b palmitoylation occurs in vivo in mouse kidneys and that it is required for trafficking to and function within cilia. Myristoylation, a 14-carbon lipid, is shown to largely substitute for palmitoylation with regard to cilia localization of ARL13b, but not with regard to its function within cilia. The functional importance of palmitoylation results in part from a dramatic increase in ARL13b stability, which is not observed with myristoylation. Additional results show that blockade of depalmitoylation slows the degradation of ARL13b that occurs during cilia resorption, raising the possibility that the sensitivity of ARL13b stability to palmitoylation may be exploited by the cell to accelerate degradation of ARL13b by depalmitoylating it. Together, the results show that palmitoylation plays a unique and critical role in controlling the localization, stability, abundance, and thus function of ARL13b. Pharmacological manipulation of protein palmitoylation may be a strategy to alter cilia function.	[Roy, Kasturi; Jozsef, Levente; McNamara, Thomas; Onyekaba, Ginikanwa; Marin, Ethan P.] Yale Univ, Sch Med, Dept Internal Med, Sect Nephrol, New Haven, CT 06520 USA; [Jerman, Stephanie; Sun, Zhaoxia] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Marin, EP (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Nephrol, New Haven, CT 06520 USA.	ethan.marin@yale.edu	Roy, Kasturi/I-2244-2019	Roy, Kasturi/0000-0003-2504-3114	National Institutes of Health [R01HL125885, K08 HL103831]; PKD Foundation [213G16A]; American Society of Nephrology; Pilot and Feasibility Award from the Yale Polycystic Kidney Disease Program [P30 DK090744]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL103831, R01HL125885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PKD Foundation; American Society of Nephrology; Pilot and Feasibility Award from the Yale Polycystic Kidney Disease Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01HL125885 and PKD Foundation Grant 213G16A (to Z. S.), by an American Society of Nephrology Gottschalk Award and National Institutes of Health Grant K08 HL103831, and by Pilot and Feasibility Award P30 DK090744 from the Yale Polycystic Kidney Disease Program (to E. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blanc Mathieu, 2015, F1000Res, V4, P261, DOI 10.12688/f1000research.6464.1; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cevik S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003977; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Dallavilla T, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004774; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; Follit JA, 2010, J CELL BIOL, V188, P21, DOI 10.1083/jcb.200910096; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Gotthardt K, 2015, ELIFE, V4, DOI 10.7554/eLife.11859; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Li Y, 2012, J BIOL CHEM, V287, P523, DOI 10.1074/jbc.M111.306183; Li YY, 2016, J AM SOC NEPHROL, V27, P3628, DOI 10.1681/ASN.2015091004; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mick DU, 2015, DEV CELL, V35, P497, DOI 10.1016/j.devcel.2015.10.015; Nakata K, 2012, CYTOSKELETON, V69, P221, DOI 10.1002/cm.21014; PELLMAN D, 1985, NATURE, V314, P374, DOI 10.1038/314374a0; Prodromou NV, 2012, J CELL SCI, V125, P4297, DOI 10.1242/jcs.100545; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao KN, 2016, HUM MOL GENET, V25, P4533, DOI 10.1093/hmg/ddw281; Ren WY, 2013, ADIPOCYTE, V2, P17, DOI 10.4161/adip.22117; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Thomas S, 2014, HUM MUTAT, V35, P137, DOI 10.1002/humu.22470; Tyler KM, 2009, J CELL SCI, V122, P859, DOI 10.1242/jcs.037721; Wan JM, 2013, CHEM BIOL, V20, P1421, DOI 10.1016/j.chembiol.2013.09.018; Wei XC, 2014, ARTERIOSCL THROM VAS, V34, P346, DOI 10.1161/ATVBAHA.113.302848; Westerfield M., 2000, ZEBRAFISH BOOK AGUID; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111	41	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17703	17717		10.1074/jbc.M117.792937	http://dx.doi.org/10.1074/jbc.M117.792937			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28848045	Green Published, hybrid			2022-12-26	WOS:000414013000011
J	Dong, SL; Baranwal, S; Garcia, A; Serrano-Gomez, SJ; Eastlack, S; Iwakuma, T; Mercante, D; Mauvais-Jarvis, F; Alahari, SK				Dong, Shengli; Baranwal, Somesh; Garcia, Anapatricia; Serrano-Gomez, Silvia J.; Eastlack, Steven; Iwakuma, Tomoo; Mercante, Donald; Mauvais-Jarvis, Franck; Alahari, Suresh K.			Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); calorimetry; cell metabolism; cell migration; glucose; obesity	RICH REPEAT PROTEINS; GLUCOSE-METABOLISM; BINDING PROTEIN; CELL-MIGRATION; BREAST-CANCER; TRANSCRIPTIONAL ACTIVITY; INSULIN-RESISTANCE; HEPATIC STEATOSIS; FATTY-ACID; IQGAP1	Nischarin (Nisch) is a key protein functioning as a molecular scaffold and thereby hosting interactions with several protein partners. To explore the physiological importance of Nisch, here we generated Nisch loss-of-function mutant mice and analyzed their metabolic phenotype. Nisch-mutant embryos exhibited delayed development, characterized by small size and attenuated weight gain. We uncovered the reason for this phenotype by showing that Nisch binds to and inhibits the activity of AMP-activated protein kinase (AMPK), which regulates energy homeostasis by suppressing anabolic and activating catabolic processes. The Nisch mutations enhanced AMPK activation and inhibited mechanistic target of rapamycin signaling in mouse embryonic fibroblasts as well as in muscle and liver tissues of mutant mice. Nisch-mutant mice also exhibited increased rates of glucose oxidation with increased energy expenditure, despite reduced overall food intake. Moreover, the Nisch-mutant mice had reduced expression of liver markers of gluconeogenesis associated with increased glucose tolerance. As a result, these mice displayed decreased growth and body weight. Taken together, our results indicate that Nisch is an important AMPK inhibitor and a critical regulator of energy homeostasis, including lipid and glucose metabolism.	[Dong, Shengli; Baranwal, Somesh; Serrano-Gomez, Silvia J.; Eastlack, Steven; Alahari, Suresh K.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Mercante, Donald] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Biostat, New Orleans, LA 70112 USA; [Baranwal, Somesh] Cent Univ Punjab, Ctr Biochem & Microbial Sci, City Campus Mansa Rd, Bathinda 151001, India; [Garcia, Anapatricia] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Serrano-Gomez, Silvia J.] Pontificia Univ Javeriana, Bogota 11001000, Colombia; [Iwakuma, Tomoo] Univ Kansas, Dept Canc Biol, Med Ctr, Kansas City, KS 66160 USA; [Mauvais-Jarvis, Franck] Tulane Univ, Sch Med, Div Endocrinol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Central University of Punjab; Emory University; Pontificia Universidad Javeriana; University of Kansas; University of Kansas Medical Center; Tulane University	Alahari, SK (corresponding author), Louisiana Sch Med, Biochem, CSRB 406, New Orleans, LA 70112 USA.	salaha@lsuhsc.edu			Louisiana State University School of Medicine; Fred G. Brazda Foundation; National Institutes of Health [R01 DK074970, DK107444]; NATIONAL CANCER INSTITUTE [R01CA174735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107444, R01DK074970] Funding Source: NIH RePORTER	Louisiana State University School of Medicine; Fred G. Brazda Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Louisiana State University School of Medicine and the Fred G. Brazda Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants R01 DK074970 and DK107444.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Baranwal S, 2011, J NATL CANCER I, V103, P1513, DOI 10.1093/jnci/djr350; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Chawla B, 2017, J BIOL CHEM, V292, P3273, DOI 10.1074/jbc.M116.752642; Crescenti A, 2015, J NUTR BIOCHEM, V26, P912, DOI 10.1016/j.jnutbio.2015.03.003; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Henriksson E, 2015, J CELL SCI, V128, P472, DOI 10.1242/jcs.153932; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jain P, 2013, J BIOL CHEM, V288, P15495, DOI 10.1074/jbc.M112.418103; Jha S, 2009, J IMMUNOL, V183, P7623, DOI 10.4049/jimmunol.0902425; Kimura T, 2013, MOL CELL BIOL, V33, P4834, DOI 10.1128/MCB.00895-13; Kohan AB, 2009, BIOCHEM BIOPH RES CO, V388, P117, DOI 10.1016/j.bbrc.2009.07.130; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liangpunsakul S, 2013, J INVEST MED, V61, P270, DOI 10.2310/JIM.0b013e31827c2795; Liao YL, 2005, CARDIOVASC RES, V67, P705, DOI 10.1016/j.cardiores.2005.04.018; Liu XN, 2014, MOL CANCER THER, V13, P596, DOI 10.1158/1535-7163.MCT-13-0579; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Marini C, 2013, CELL CYCLE, V12, P3490, DOI 10.4161/cc.26461; Maziveyi M, 2015, CANCER RES, V75, P4252, DOI 10.1158/0008-5472.CAN-15-1395; Meng XY, 2016, J BIOL CHEM, V291, P10625, DOI 10.1074/jbc.M116.713768; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Ota S, 2009, BIOCHEM BIOPH RES CO, V388, P311, DOI 10.1016/j.bbrc.2009.07.164; PETRESCU I, 1979, ANAL BIOCHEM, V96, P279, DOI 10.1016/0003-2697(79)90582-7; Piletz JE, 2000, DNA CELL BIOL, V19, P319, DOI 10.1089/10445490050043290; Rittmeyer EN, 2008, J CELL SCI, V121, P391, DOI 10.1242/jcs.016881; Sayedyahossein S, 2016, J BIOL CHEM, V291, P19261, DOI 10.1074/jbc.M116.732529; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shan TZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36561; Smith AC, 2005, J PHYSIOL-LONDON, V565, P537, DOI 10.1113/jphysiol.2004.081679; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Tran L, 2015, ANN PHARMACOTHER, V49, P540, DOI 10.1177/1060028014558289; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; WIESE TJ, 1991, COMP BIOCHEM PHYS B, V100, P297, DOI 10.1016/0305-0491(91)90378-Q; Zhang L, 2013, CNS NEUROSCI THER, V19, P978, DOI 10.1111/cns.12192; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	54	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16833	16846		10.1074/jbc.M117.784256	http://dx.doi.org/10.1074/jbc.M117.784256			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842496	Green Published, hybrid			2022-12-26	WOS:000413140600006
J	Nance, N; Pendo, P; Masanja, J; Ngilangwa, DP; Webb, K; Noronha, R; McCoy, SI				Nance, Nerissa; Pendo, Prosper; Masanja, Joseph; Ngilangwa, David Paul; Webb, Karen; Noronha, Rita; McCoy, Sandra I.			Short-term effectiveness of a community health worker intervention for HIV-infected pregnant women in Tanzania to improve treatment adherence and retention in care: A cluster-randomized trial	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; OUTCOMES; PROGRAM; RATES	Introduction Community health workers (CHWs) are lay workers who have the potential to enhance services to prevent mother-to-child HIV transmission (PMTCT) and improve the health of women living with HIV infection. We conducted a cluster-randomized trial of an intervention to integrate CHWs with 'Option B+' PMTCT services in Shinyanga Region, Tanzania. Methods The intervention was implemented for 11 months and included four integrated components: 1) formal linkage of CHWs to health facilities; 2) CHW-led antiretroviral therapy (ART) adherence counseling; 3) loss to follow-up tracing by CHWs; and 4) distribution of Action Birth Cards (ABCs), a birth planning tool. We cluster-randomized 32 facilities offering PMTCT services, within strata of size, to the intervention (n = 15) or comparison (standard of care, n = 17) groups. Intervention effectiveness was determined with a difference-indifferences strategy based on clinical and pharmacy data from HIV-infected postpartum women at baseline (births in 2014) and endline (births April-Oct 2015). The primary outcome was retention in care between 60 and 120 days postpartum. Secondary outcomes included ART initiation, timing of ART initiation (as measured by week of gestation), and ART adherence 90 days postpartum, measured using the medication possession ratio (MPR >= 95%). Results Intervention and comparison facilities were similar at baseline. Data were collected from 1,152 and 678 mother-infant pairs at baseline and endline, respectively. There were no significant differences in retention in care, ART initiation, or timing of ART initiation between the intervention and control groups. Adherence (MPR >= 95%) at 90 days postpartum was 11.3 percentage points higher in the intervention group in ITT analyses (95% CI: -0.7, 23.3, p = 0.06), though this effect was attenuated after adjusting for baseline imbalance (9.5 percentage points, 95% CI: -2.9, 22.0, p = 0.13). Among only sites that had the greatest fidelity to the intervention, however, we found a stronger effect on adherence (13.6 percentage points, 95% CI: 2.5, 24.6). Conclusions Despite being feasible and acceptable, the CHW-based intervention did not have strong effects on most PMTCT indicators. CHW involvement in PMTCT programs may improve ART adherence among HIV-infected postpartum women, however, and success appears heavily dependent on program implementation.	[Nance, Nerissa; McCoy, Sandra I.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Pendo, Prosper] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania; [Masanja, Joseph; Ngilangwa, David Paul] Amref Hlth Africa, Dar Es Salaam, Tanzania; [Webb, Karen] OPHID, Harare, Zimbabwe; [Noronha, Rita] Jhpiego, Baltimore, MD USA	University of California System; University of California Berkeley; African Medical & Research Foundation (AMREF); Jhpiego	Nance, N (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	nerissanance@berkeley.edu			International Initiative for Impact Evaluation(3ie)	International Initiative for Impact Evaluation(3ie)	This study was funded by the International Initiative for Impact Evaluation(3ie). http://www.3ieimpact.org/.	Andersen C, 2014, UNPUB; [Anonymous], QUALTR SURV SOFTW; Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Beeson L., 2016, 21 INT AIDS C JUL 18; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Geldsetzer P, 2016, J INT AIDS SOC, P19; Gertler PJ, 2011, IMPACT EVALUATION IN PRACTICE, P1, DOI 10.1596/978-0-8213-8541-8; Goga AE, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020405; Goldman JD, 2008, AIDS RES HUM RETROV, V24, P1031, DOI 10.1089/aid.2008.0035; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Hellevik O, 2009, QUAL QUANT, V43, P59, DOI 10.1007/s11135-007-9077-3; Hong S, 2012, 19 C RETR OPP INF SE; Igumbor JO, 2011, AIDS CARE, V23, P231, DOI 10.1080/09540121.2010.498909; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Kwesigabo G, 2012, J PUBLIC HEALTH POL, V33, pS35, DOI 10.1057/jphp.2012.55; Loomba Foundation, 2015, GLOB WID REP 2015 GL; McCoy SI, 2016, 21 INT AIDS C JUL 17; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; MoHSW, 2012, TANZ EL MOTH CHILD T, P108; Mubita B., 2016, 21 INT AIDS C JUL 18; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; National Bureau of Statistics (NBS), 2010, TANZ DEM HLTH SURV 2; Slater Mackenzie, 2010, Paediatr Drugs, V12, P1, DOI 10.2165/11316130-000000000-00000; Stata Corp, 2013, STATA STAT SOFTW REL; StataCorp, STATA MAN SVY COMM; StataCorp, STATA MAN LON COMM; The United Republic of Tanzania, 2014, GLOB AIDS RESP COUNT; Thurston B., 21 INT AIDS C DURB S; Torpey KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002204; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; UNICEF Health Section, 2014, ACC HEALTHC COM HLTH; Webb K., 2014, 20 INT AIDS C 2014 J; WHO World Health Organizations, 2010, WHO PMTCT STRAT VIS; Woldesenbet S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132425; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization Global Health Observatory (GHO), 2014, DENS PHYS TOT NUMB P; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	42	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0181919	10.1371/journal.pone.0181919	http://dx.doi.org/10.1371/journal.pone.0181919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2PY	28859083	Green Published, gold			2022-12-26	WOS:000408740500003
J	Bjarnason, TA; Hafthorsson, SO; Kristinsdottir, LB; Oskarsdottir, ES; Aspelund, T; Sigurdsson, S; Gudnason, V; Andersen, K				Bjarnason, Thorarinn A.; Hafthorsson, Steinar O.; Kristinsdottir, Linda B.; Oskarsdottir, Erna S.; Aspelund, Thor; Sigurdsson, Sigurdur; Gudnason, Vilmundur; Andersen, Karl			Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; TYPE-2 DIABETES-MELLITUS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; EUROPEAN-SOCIETY; FASTING GLUCOSE; HEART-DISEASE; PREVALENCE; CARDIOLOGY; INSULIN	Background Type 2 diabetes and prediabetes are established risk factors for atherosclerosis. The aim of this study was to evaluate the atherosclerotic plaque burden in the carotid arteries of patients with acute coronary syndrome according to their glycemic status. Methods Patients with acute coronary syndrome and no previous history of type 2 diabetes were consecutively included in the study. Glucose metabolism was evaluated with fasting glucose in plasma, HbA1c and a standard two-hour oral glucose tolerance test. Atherosclerotic plaque in the carotid arteries was evaluated with a standardized ultrasound examination where total plaque area was measured and patients classified as having no plaque or a significant plaque formation. Results A total of 245 acute coronary syndrome patients (male 78%, 64 years (SD: 10.9)) were included. The proportion diagnosed with normal glucose metabolism, prediabetes and type 2 diabetes was 28.6%, 64.1% and 7.3%, respectively. A significant atherosclerotic plaque was found in 48.5%, 66.9% and 72.2% of patients with normal glucose metabolism, prediabetes and type 2 diabetes, respectively. An incremental increase in total plaque area was found from normal glucose metabolism to prediabetes (25.5%) and from normal glucose metabolism to type 2 diabetes (35.9%) (p=0.04). When adjusted for conventional cardiovascular risk factors the OR of having significant atherosclerotic plaque in the carotid arteries was 2.17 (95% CI 1.15.4.15) for patients with newly diagnosed dysglycemia compared to patients with normal glucose metabolism. When additionally adjusted for the 2-hour plasma glucose after glucose loading (2hPG) the OR attenuated to 1.77 (95% CI 0.83.3.84). Conclusion Newly detected dysglycemia is an independent predictor of significant atherosclerotic plaque in the carotid arteries with oral glucose tolerance test as a major determinant of carotid plaque burden in this group of individuals with acute coronary syndrome.	[Bjarnason, Thorarinn A.; Andersen, Karl] Natl Univ Hosp Iceland, Landspitali, Dept Med, Div Cardiol, Reykjavik, Iceland; [Bjarnason, Thorarinn A.; Hafthorsson, Steinar O.; Kristinsdottir, Linda B.; Oskarsdottir, Erna S.; Aspelund, Thor; Sigurdsson, Sigurdur; Andersen, Karl] Univ Iceland, Sch Hlth Sci, Reykjavik, Iceland; [Aspelund, Thor; Sigurdsson, Sigurdur; Gudnason, Vilmundur; Andersen, Karl] Icelandic Heart Assoc, Kopavogur, Iceland	Landspitali National University Hospital; University of Iceland; Icelandic Heart Association	Andersen, K (corresponding author), Natl Univ Hosp Iceland, Landspitali, Dept Med, Div Cardiol, Reykjavik, Iceland.; Andersen, K (corresponding author), Univ Iceland, Sch Hlth Sci, Reykjavik, Iceland.; Andersen, K (corresponding author), Icelandic Heart Assoc, Kopavogur, Iceland.	andersen@landspitali.is	Gudnason, Vilmundur/AAE-7126-2019; Aspelund, Thor/K-7022-2019	Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433	Landspitali University Hospital Research Fund; University of Iceland Research Fund	Landspitali University Hospital Research Fund; University of Iceland Research Fund	TAB received grants from Landspitali University Hospital Research Fund (http://www.landspitali.is/visindi-og-menntun/visindastarfsemi/visindasjodur-lsh/) and the University of Iceland Research Fund (http://sjodir.hi.is/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; American Diabetes A, 2012, DIAGN CLASS DIAB MEL; [Anonymous], 2015, LANCET DIABETEENDO; Baber U, 2015, J AM COLL CARDIOL, V65, P1065, DOI 10.1016/j.jacc.2015.01.017; Bartnik M, 2004, EUR HEART J, V25, P1990, DOI 10.1016/j.ehj.2004.09.021; Bergsveinsson Johannes, 2007, Laeknabladid, V93, P397; Bjarnason TA, 2016, EUROPEAN HEART J ACU; Bjornsdottir G., 2014, J VASC ULTRASOUND, V38, P198; Cohen GI, 2013, JACC-CARDIOVASC IMAG, V6, P1160, DOI 10.1016/j.jcmg.2013.06.007; Davis TME, 2013, CIRCULATION, V127, P980, DOI 10.1161/CIRCULATIONAHA.112.000908; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Demmer RT, 2013, AM J EPIDEMIOL, V178, P1106, DOI 10.1093/aje/kwt088; FERRANNINI E, 1988, METABOLISM, V37, P79, DOI 10.1016/0026-0495(88)90033-9; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Gyberg V, 2015, EUR HEART J, V36, P1171, DOI 10.1093/eurheartj/ehv008; Hanefeld M, 2004, STROKE, V35, P1073, DOI 10.1161/01.STR.0000125864.01546.f2; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Mellbin LG, 2010, EUR J CARDIOV PREV R, V17, pS9, DOI 10.1097/01.hjr.0000368192.24732.2f; Oren A, 2003, ARCH INTERN MED, V163, P1787, DOI 10.1001/archinte.163.15.1787; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Plichart M, 2011, ATHEROSCLEROSIS, V219, P917, DOI 10.1016/j.atherosclerosis.2011.09.024; R Core Team, 2013, R LANG ENV STAT COMP; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Ryden L, 2014, DIABETES VASC DIS RE, V11, P133, DOI 10.1177/1479164114525548; Sturlaugsdottir R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012457; Tamita K, 2007, CIRC J, V71, P834, DOI 10.1253/circj.71.834; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183839	10.1371/journal.pone.0183839	http://dx.doi.org/10.1371/journal.pone.0183839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854264	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600060
J	Burlina, P; Billings, S; Joshi, N; Albayda, J				Burlina, Philippe; Billings, Seth; Joshi, Neil; Albayda, Jemima			Automated diagnosis of myositis from muscle ultrasound: Exploring the use of machine learning and deep learning methods	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; TEXTURE ANALYSIS; FOLLOW-UP; ULTRASONOGRAPHY; POLYMYOSITIS; SEGMENTATION; ECHOGENICITY; THICKNESS; DISEASES; TOOL	Objective To evaluate the use of ultrasound coupled with machine learning (ML) and deep learning (DL) techniques for automated or semi-automated classification of myositis. Methods Eighty subjects comprised of 19 with inclusion body myositis (IBM), 14 with polymyositis (PM), 14 with dermatomyositis (DM), and 33 normal (N) subjects were included in this study, where 3214 muscle ultrasound images of 7 muscles (observed bilaterally) were acquired. We considered three problems of classification including (A) normal vs. affected (DM, PM, IBM); (B) normal vs. IBM patients; and (C) IBM vs. other types of myositis (DM or PM). We studied the use of an automated DL method using deep convolutional neural networks (DL-DCNNs) for diagnostic classification and compared it with a semi-automated conventional ML method based on random forests (ML-RF) and "engineered" features. We used the known clinical diagnosis as the gold standard for evaluating performance of muscle classification. Results The performance of the DL-DCNN method resulted in accuracies +/- standard deviation of 76.2% +/- 3.1% for problem (A), 86.6% +/- 2.4% for (B) and 74.8% +/- 3.9% for (C), while the ML-RF method led to accuracies of 72.3% +/- 3.3% for problem (A), 84.3% +/- 2.3% for (B) and 68.9% +/- 2.5% for (C). Conclusions This study demonstrates the application of machine learning methods for automatically or semi-automatically classifying inflammatory muscle disease using muscle ultrasound. Compared to the conventional random forest machine learning method used here, which has the drawback of requiring manual delineation of muscle/fat boundaries, DCNN-based classification by and large improved the accuracies in all classification problems while providing a fully automated approach to classification.	[Burlina, Philippe; Billings, Seth; Joshi, Neil] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Albayda, Jemima] Johns Hopkins Sch Med, Div Rheumatol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University; Johns Hopkins Medicine	Albayda, J (corresponding author), Johns Hopkins Sch Med, Div Rheumatol, Baltimore, MD 21205 USA.	jalbayd1@jhmi.edu			Johns Hopkins University School of Medicine Precision Award; Donald B. and Dorothy L. Stabler Discovery Fund; Johns Hopkins University Applied Physics Laboratory, Science and Technology, Research and Development Fund	Johns Hopkins University School of Medicine Precision Award; Donald B. and Dorothy L. Stabler Discovery Fund; Johns Hopkins University Applied Physics Laboratory, Science and Technology, Research and Development Fund	The Johns Hopkins University School of Medicine Precision Award funded JA and PB; The Donald B. and Dorothy L. Stabler Discovery Fund funded JA; The Johns Hopkins University Applied Physics Laboratory, Science and Technology, Research and Development Fund funded PB, SB and NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts IMP, 2010, MUSCLE NERVE, V41, P32, DOI 10.1002/mus.21458; Banerjee A, 2007, INT GEOSCI REMOTE SE, P3817; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Bhansing KJ, 2015, MUSCLE NERVE, V52, P534, DOI 10.1002/mus.24595; Billings S, 2016, 23 INT C PATT REC IC; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; Brandsma R, 2014, ULTRASOUND MED BIOL, V40, P2345, DOI 10.1016/j.ultrasmedbio.2014.03.027; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burlina P, 2016, I S BIOMED IMAGING, P184, DOI 10.1109/ISBI.2016.7493240; Burlina P, 2011, IEEE ENG MED BIO, P3962, DOI 10.1109/IEMBS.2011.6090984; Burlina P, 2017, COMPUT BIOL MED, V82, P80, DOI 10.1016/j.compbiomed.2017.01.018; Burlina PM, 2015, 2015 IEEE 14TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), P871, DOI 10.1109/ICMLA.2015.140; Caresio C, 2017, ULTRASOUND MED BIOL, V43, P195, DOI 10.1016/j.ultrasmedbio.2016.08.032; Feeny AK, 2015, COMPUT BIOL MED, V65, P124, DOI 10.1016/j.compbiomed.2015.06.018; Felzenszwalb PF, 2009, IEEE T PATTERN ANAL, V32; Goodwin DW, 2011, RHEUM DIS CLIN N AM, V37, P245, DOI 10.1016/j.rdc.2011.01.007; Habers GEA, 2015, MUSCLE NERVE, V52, P540, DOI 10.1002/mus.24564; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Index (CDASI) Cutaneous Assessment Tool (CAT) Dermatomyositis Skin Severity Index (DSSI), 2011, ARTHRITIS CARE RES, V63; Jansen M, 2012, NEUROMUSCULAR DISORD, V22, P306, DOI 10.1016/j.nmd.2011.10.020; Konig T, 2015, INT J COMPUT ASS RAD, V10, P1493, DOI 10.1007/s11548-014-1133-6; Krizhevsky A., 2011, ESANN; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Makhzani Alireza, 2015, ABS151105644 CORR; Malattia C, 2014, ANN RHEUM DIS, V73, P1083, DOI 10.1136/annrheumdis-2012-202915; Martinez-Paya JJ, 2017, ULTRASONIC IMAGING; Molinari F, 2015, ULTRASOUND MED BIOL, V41, P2520, DOI 10.1016/j.ultrasmedbio.2015.04.021; Nodera H, 2016, EUR J NEUROL, V23, P588, DOI 10.1111/ene.12899; Noto YI, 2014, MUSCLE NERVE, V49, P745, DOI 10.1002/mus.24056; Oelze ML, 2016, IEEE T ULTRASON FERR, V63, P336, DOI 10.1109/TUFFC.2015.2513958; Olsen Nancy J, 2005, Curr Rheumatol Rep, V7, P106, DOI 10.1007/s11926-005-0062-3; Pillen S, 2007, NEUROMUSCULAR DISORD, V17, P509, DOI 10.1016/j.nmd.2007.03.008; Pillen S, 2008, MUSCLE NERVE, V37, P679, DOI 10.1002/mus.21015; Pillen S, 2016, HAND CLINIC, V136, P843, DOI 10.1016/B978-0-444-53486-6.00042-9; Pillen S, 2015, MUSCLE NERVE, V52, P319, DOI 10.1002/mus.24613; Pinal-Fernandez I, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-210198; REIMERS CD, 1993, J NEUROL SCI, V116, P82, DOI 10.1016/0022-510X(93)90093-E; Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Scholten RR, 2003, MUSCLE NERVE, V27, P693, DOI 10.1002/mus.10384; Schulze M, 2009, AM J ROENTGENOL, V192, P1708, DOI 10.2214/AJR.08.1764; Sermanet P., 2013, OVERFEAT INTEGRATED; Sogawa K, 2017, RADIOLOGY, V283, P492, DOI 10.1148/radiol.2016160826; Srivastava T, 2012, NEUROLOGY, V79, P358, DOI 10.1212/WNL.0b013e3182604395; Vapnik V., 1998, STAT LEARNING THEORY; Vyas S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.057008; Wu JS, 2010, NEUROLOGY, V75, P526, DOI 10.1212/WNL.0b013e3181eccf8f; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zaidman CM, 2008, MUSCLE NERVE, V38, P893, DOI 10.1002/mus.21052; Zaidman CM, 2017, ANN NEUROL, V81, P633, DOI 10.1002/ana.24904; Zaidman CM, 2016, J CLIN NEUROPHYSIOL, V33, P103, DOI 10.1097/WNP.0000000000000245	55	61	62	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184059	10.1371/journal.pone.0184059	http://dx.doi.org/10.1371/journal.pone.0184059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854220	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600082
J	Eid, R; Zhou, DR; Arab, NTT; Boucher, E; Young, PG; Mandato, CA; Greenwood, MT				Eid, Rawan; Zhou, David R.; Arab, Nagla T. T.; Boucher, Eric; Young, Paul G.; Mandato, Craig A.; Greenwood, Michael T.			Heterologous expression of anti-apoptotic human 14-3-3 beta/alpha enhances iron-mediated programmed cell death in yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HYDROGEN-PEROXIDE; DNA-REPLICATION; HUMAN FERRITIN; BCL-2 FAMILY; STRESS; COPPER; OVEREXPRESSION; AUTOPHAGY; PROTEIN	The induction of Programmed Cell Death (PCD) requires the activation of complex responses involving the interplay of a variety of different cellular proteins, pathways, and processes. Uncovering the mechanisms regulating PCD requires an understanding of the different processes that both positively and negatively regulate cell death. Here we have examined the response of normal as well as PCD resistant yeast cells to different PCD inducing stresses. As expected cells expressing the pro-survival human 14-3-3 beta/alpha sequence show increased resistance to numerous stresses including copper and rapamycin. In contrast, other stresses including iron were more lethal in PCD resistant 14-3-3 beta/alpha expressing cells. The increased sensitivity to PCD was not iron and 14-3-3 beta/alpha specific since it was also observed with other stresses (hydroxyurea and zinc) and other pro-survival sequences (human TC-1 and H-ferritin). Although microscopical examination revealed little differences in morphology with iron or copper stresses, cells undergoing PCD in response to high levels of prolonged copper treatment were reduced in size. This supports the interaction some forms of PCD have with the mechanisms regulating cell growth. Analysis of iron-mediated effects in yeast mutant strains lacking key regulators suggests that a functional vacuole is required to mediate the synergistic effects of iron and 14-3-3 beta/alpha on yeast PCD. Finally, mild sub-lethal levels of copper were found to attenuate the observed inhibitory effects of iron. Taken together, we propose a model in which a subset of stresses like iron induces a complex process that requires the cross-talk of two different PCD inducing pathways.	[Eid, Rawan; Arab, Nagla T. T.; Greenwood, Michael T.] Royal Mil Coll Canada, Dept Chem & Chem Engn, Kingston, ON, Canada; [Eid, Rawan; Arab, Nagla T. T.; Young, Paul G.] Queens Univ, Dept Biol, Kingston, ON, Canada; [Zhou, David R.; Boucher, Eric; Mandato, Craig A.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	Royal Military College - Canada; Queens University - Canada; McGill University	Greenwood, MT (corresponding author), Royal Mil Coll Canada, Dept Chem & Chem Engn, Kingston, ON, Canada.	michael.greenwood@rmc.ca		Boucher, Eric/0000-0002-3940-0437; Greenwood, Michael/0000-0003-0890-3434; Eid, Rawan Waleed Khaled/0000-0002-4443-1879	Natural Sciences and Engineering Research Council of Canada [217502-2009 RGPIN]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada 217502-2009 RGPIN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea M, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00057; Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Balakumar P, 2008, PHARMACOL RES, V57, P403, DOI 10.1016/j.phrs.2008.05.006; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Bleackley MR, 2011, BIOMETALS, V24, P785, DOI 10.1007/s10534-011-9451-4; Botstein D, 2011, GENETICS, V189, P695, DOI 10.1534/genetics.111.130765; Bou-Abdallah F, 2010, BBA-GEN SUBJECTS, V1800, P719, DOI 10.1016/j.bbagen.2010.03.021; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Buttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197; Busca A, 2009, CURR GENOMICS, V10, P306, DOI 10.2174/138920209788920967; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Castells-Roca L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148204; Chang SJ, 2008, NEUROSCI LETT, V441, P134, DOI 10.1016/j.neulet.2008.06.005; Clapp C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.90; Clapp C, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00059; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Eid R, 2016, BIOCH BIOPHYSICA ACT; Eid R, 2016, EXP CELL RES, V342, P52, DOI 10.1016/j.yexcr.2016.02.010; Eid R, 2014, FEMS YEAST RES, V14, P495, DOI 10.1111/1567-1364.12121; Eisenberg T, 2010, APOPTOSIS, V15, P257, DOI 10.1007/s10495-009-0453-4; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Goralska M, 2001, INVEST OPHTH VIS SCI, V42, P1721; Hartwell LH, 2002, BIOSCIENCE REP, V22, P373, DOI 10.1023/A:1020918107706; Ho YH, 2015, CURR GENET, V61, P503, DOI 10.1007/s00294-015-0491-0; Horowitz A, 2013, BBA-MOL CELL RES, V1833, P3186, DOI 10.1016/j.bbamcr.2013.09.004; Jacob AK, 1997, SURGERY, V122, P243, DOI 10.1016/S0039-6060(97)90015-5; Jones NK, 2015, MICROB CELL, V2, P247, DOI 10.15698/mic2015.07.213; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim H, 2012, J BIOL CHEM, V287, P19029, DOI 10.1074/jbc.M112.363390; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Liang QL, 2007, MOL BIOL CELL, V18, P4741, DOI 10.1091/mbc.E07-05-0431; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; MAJNO G, 1995, AM J PATHOL, V146, P3; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Matsuyama S, 1999, CURR OPIN MICROBIOL, V2, P618, DOI 10.1016/S1369-5274(99)00031-4; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Munoz JP, 2010, FREE RADICAL BIO MED, V48, P526, DOI 10.1016/j.freeradbiomed.2009.11.017; Nishida K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001269; Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268; Pereira C, 2008, BBA-MOL CELL RES, V1783, P1286, DOI 10.1016/j.bbamcr.2008.03.010; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Priault M, 2003, FEMS YEAST RES, V4, P15, DOI 10.1016/S1567-1356(03)00143-0; Rudolf E, 2010, BIOMETALS, V23, P339, DOI 10.1007/s10534-010-9302-8; Schonthal AH, 2009, CANCER LETT, V275, P163, DOI 10.1016/j.canlet.2008.07.005; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Seo HY, 2003, APPL MICROBIOL BIOT, V63, P57, DOI 10.1007/s00253-003-1350-3; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Silva RD, 2011, CURR PHARM DESIGN, V17, P246; Spincemaille P, 2014, BBA-MOL CELL RES, V1843, P1207, DOI 10.1016/j.bbamcr.2014.03.004; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; Swiecilo A, 2016, CELL STRESS CHAPERON, V21, P187, DOI 10.1007/s12192-016-0667-7; Szczypka MS, 1997, SACCHAROMYCES CEREVI; Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001; Thiruchelvam M, 2005, J BIOL CHEM, V280, P22530, DOI 10.1074/jbc.M500417200; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Vasilikos L, 2017, IMMUNOL CELL BIOL; Wang YC, 2015, EXP NEUROL, V272, P26, DOI 10.1016/j.expneurol.2015.04.009; Williams D, 2011, BBA-MOL CELL RES, V1813, P315, DOI 10.1016/j.bbamcr.2010.11.021; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Wright ME, 2000, FEBS LETT, V481, P13, DOI 10.1016/S0014-5793(00)01962-1; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yang Z, 2006, FEMS YEAST RES, V6, P751, DOI 10.1111/j.1567-1364.2006.00052.x; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zhang CG, 2014, PROTEIN CELL, V5, P750, DOI 10.1007/s13238-014-0083-7	78	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184151	10.1371/journal.pone.0184151	http://dx.doi.org/10.1371/journal.pone.0184151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854230	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600089
J	Sumankuuro, J; Crockett, J; Wang, SY				Sumankuuro, Joshua; Crockett, Judith; Wang, Shaoyu			Maternal health care initiatives: Causes of morbidities and mortalities in two rural districts of Upper West Region, Ghana	PLOS ONE			English	Article							STILLBIRTHS	Background Maternal and neonatal morbidities and mortalities have received much attention over the years in sub-Saharan Africa; yet addressing them remains a profound challenge, no more so than in the nation of Ghana. This study focuses on finding explanations to the conditions which lead to maternal and neonatal morbidities and mortalities in rural Ghana, particularly the Upper West Region. Method Mixed methods approach was adopted to investigate the medical and non-medical causes of maternal and neonatal morbidities and mortalities in two rural districts of the Upper West Region of Ghana. Survey questionnaires, in-depth interviews and focus group discussions were employed to collect data from: a) 80 expectant mothers (who were in their second and third trimesters, excluding those in their ninth month), b) 240 community residents and c) 13 healthcare providers (2 district directors of health services, 8 heads of health facilities and 3 nurses). Result Morbidity and mortality during pregnancy is attributed to direct causes such urinary tract infection (48%), hypertensive disorders (4%), mental health conditions (7%), nausea (4%) and indirect related sicknesses such as anaemia (11%), malaria, HIV/AIDS, oedema and hepatitis B (26%). Socioeconomic and cultural factors are identified as significant underlying causes of these complications and to morbidity and mortality during labour and the postnatal period. Birth asphyxia and traditional beliefs and practices were major causes of neonatal deaths. Conclusion These findings provide focused targets and open a window of opportunity for the community-based health services run by Ghana Health Service to intensify health education and promotion programmes directed at reducing risky economic activities and other cultural beliefs and practices affecting maternal and neonatal morbidity and mortality.	[Sumankuuro, Joshua; Crockett, Judith; Wang, Shaoyu] Charles Sturt Univ, Fac Sci, Sch Community Hlth, Orange, NSW, Australia	Charles Sturt University	Sumankuuro, J (corresponding author), Charles Sturt Univ, Fac Sci, Sch Community Hlth, Orange, NSW, Australia.	jsumankuuro@csu.edu.au	Dangal, Ganesh/O-1989-2017; Sumankuuro, Joshua/AAD-9951-2019; Wang, Shaoyu/M-5948-2015	Dangal, Ganesh/0000-0002-5834-5525; Sumankuuro, Joshua/0000-0002-8967-1091; Wang, Shaoyu/0000-0001-8674-8965; Crockett, Judith/0000-0003-2039-4345	Ghana Education Trust Fund (GETFUND) Doctorate Studentship	Ghana Education Trust Fund (GETFUND) Doctorate Studentship	This research was funded by Ghana Education Trust Fund (GETFUND) Doctorate Studentship to JS, http://www.getfund.gov.gh/. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aborigo RA, 2014, AFR J REPROD HEALTH, V18, P78; Aboulghar M, 2016, HUM REPROD, V31, P1631, DOI 10.1093/humrep/dew154; Acosta DF, 2012, REV ESC ENFERM USP, V46, P1328; Alabi AA, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.881; Anyait A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-132; Asamoah BO, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-159; Bayu H, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.28082; Cofie LE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0604-2; [Daffiama/ Bussie/ Issa Service LG], 2014, DAFF BUSS ISS DISTR; Der E M, 2013, Ghana Med J, V47, P158; Ekabua J., 2011, ISRN OBSTET GYNECOL, V2011, P1, DOI [10. 5402/ 2011/ 560641, DOI 10.5402/2011/560641]; Engmann C, 2012, TROP MED INT HEALTH, V17, P272, DOI 10.1111/j.1365-3156.2011.02931.x; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Galaa SZ, 2016, GHANA J DEV STUDIES, V13, P80, DOI [10. 4314/gjds. v13i1. 5, DOI 10.4314/GJDS.V13I1.5]; Illah Evance, 2013, Afr J Reprod Health, V17, P119; Masuy-Stroobant G., 2002, DETERMINANTS INFANT, P15; MoH/ GHS, 2010, HLTH SECT MED TERM D; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; [NDA Government L], 2014, PROF NAODWL DISTR AS; Otolorin E, 2015, INT J GYNECOL OBSTET, V130, pS46, DOI 10.1016/j.ijgo.2015.03.007; Rahman A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001442; Rishworth A, 2016, SOC SCI MED, V148, P8, DOI 10.1016/j.socscimed.2015.11.018; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Storm F, 2014, LANCET GLOB HEALTH, V2, pE566, DOI 10.1016/S2214-109X(14)70297-9; Sychareun V, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1031-8; Udofia Emilia A, 2013, Afr J Reprod Health, V17, P27; UNDP/ NDPC, 2012, 2010 MILL DEV GOALS; [UNFPA United Nations Population Fund G], 2014, FACTS SHEET, P2; UNICEF, 2019, MAT MORT; WHO. UNICEF UNFPA World Bank Group Division atUNP, 2015, TRENDS MAT MORT 1990; Witter S, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-16	31	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183644	10.1371/journal.pone.0183644	http://dx.doi.org/10.1371/journal.pone.0183644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854248	Green Submitted, gold, Green Published			2022-12-26	WOS:000408693600052
J	Balmer, P; Bauer, A; Pujar, S; McGarvey, KM; Welle, M; Galichet, A; Muller, EJ; Pruitt, KD; Leeb, T; Jagannathan, V				Balmer, Pierre; Bauer, Anina; Pujar, Shashikant; McGarvey, Kelly M.; Welle, Monika; Galichet, Arnaud; Mueller, Eliane J.; Pruitt, Kim D.; Leeb, Tosso; Jagannathan, Vidhya			A curated catalog of canine and equine keratin genes	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; DIFFERENTIATION; SEQUENCE	Keratins represent a large protein family with essential structural and functional roles in epithelial cells of skin, hair follicles, and other organs. During evolution the genes encoding keratins have undergone multiple rounds of duplication and humans have two clusters with a total of 55 functional keratin genes in their genomes. Due to the high similarity between different keratin paralogs and species-specific differences in gene content, the currently available keratin gene annotation in species with draft genome assemblies such as dog and horse is still imperfect. We compared the National Center for Biotechnology Information (NCBI) (dog annotation release 103, horse annotation release 101) and Ensembl (release 87) gene predictions for the canine and equine keratin gene clusters to RNA-seq data that were generated from adult skin of five dogs and two horses and from adult hair follicle tissue of one dog. Taking into consideration the knowledge on the conserved exon/intron structure of keratin genes, we annotated 61 putatively functional keratin genes in both the dog and horse, respectively. Subsequently, curators in the RefSeq group at NCBI reviewed their annotation of keratin genes in the dog and horse genomes (Annotation Release 104 and Annotation Release 102, respectively) and updated annotation and gene nomenclature of several keratin genes. The updates are now available in the NCBI Gene database (https://www.ncbi.nlm.nih.gov/gene).	[Balmer, Pierre] Univ Bern, Vetsuisse Fac, Div Clin Dermatol, Dept Clin Vet Med, Bern, Switzerland; [Balmer, Pierre; Bauer, Anina; Welle, Monika; Galichet, Arnaud; Mueller, Eliane J.; Leeb, Tosso; Jagannathan, Vidhya] Univ Bern, Vetsuisse Fac, Dermfocus, Bern, Switzerland; [Bauer, Anina; Leeb, Tosso; Jagannathan, Vidhya] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Pujar, Shashikant; Pruitt, Kim D.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Welle, Monika; Mueller, Eliane J.] Univ Bern, Inst Anim Pathol, Vetsuisse Fac, Bern, Switzerland; [Galichet, Arnaud; Mueller, Eliane J.] Univ Bern, Dept Clin Res Mol Dermatol & Stem Cell Res, Bern, Switzerland; [Mueller, Eliane J.] Bern Univ Hosp, Inselspital, Dermatol Clin, Bern, Switzerland	University of Bern; University of Bern; University of Bern; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Bern; University of Bern; University of Bern; University Hospital of Bern	Jagannathan, V (corresponding author), Univ Bern, Vetsuisse Fac, Dermfocus, Bern, Switzerland.; Jagannathan, V (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	vidhya.jagannathan@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Jagannathan, Vidhya/P-1055-2019; Welle, Monika Maria/ABF-6113-2021	Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Pujar, Shashikant/0000-0001-7132-5513; Pruitt, Kim/0000-0001-7950-1374; Bauer, Anina/0000-0002-6765-4012	Swiss National Science Foundation [CRSI13_160738 / 1]; Intramural Research Program of the NIH, National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Intramural Research Program of the NIH, National Library of Medicine; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by a grant from the Swiss National Science Foundation (CRSI13_160738 / 1). Work carried out by NCBI authors was funded by the Intramural Research Program of the NIH, National Library of Medicine.	Avci P, 2013, EXPERT OPIN DRUG DIS, V8, P331, DOI 10.1517/17460441.2013.761202; Bray DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132706; Carter RA, 2010, J ANIM SCI, V88, P3843, DOI 10.2527/jas.2010-2964; Coleman SJ, 2010, ANIM GENET, V41, P121, DOI 10.1111/j.1365-2052.2010.02118.x; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; Hoeppner MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091172; Homberg M, 2014, INT REV CEL MOL BIO, V311, P265, DOI 10.1016/B978-0-12-800179-0.00007-6; Hutton E, 1998, J CELL BIOL, V143, P487, DOI 10.1083/jcb.143.2.487; Knobel M, 2015, CELL TISSUE RES, V360, P583, DOI 10.1007/s00441-014-2105-4; KUGA T, 2016, SCI REP UK, V6; Lemke JR, 2014, DERMATOLOGY, V229, P55, DOI 10.1159/000362200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loschke F, 2015, CURR OPIN CELL BIOL, V32, P56, DOI 10.1016/j.ceb.2014.12.006; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Oshima RG, 2007, EXP CELL RES, V313, P1981, DOI 10.1016/j.yexcr.2007.04.007; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Paramio JM, 1999, MOL CELL BIOL, V19, P3086; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; REIS A, 1994, NAT GENET, V6, P174, DOI 10.1038/ng0294-174; Schweizer J, 2007, EXP CELL RES, V313, P2010, DOI 10.1016/j.yexcr.2007.02.032; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vaidya MM, 2007, J BIOSCIENCES, V32, P629, DOI 10.1007/s12038-007-0062-8; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang FR, 2016, METHOD ENZYMOL, V568, P303, DOI 10.1016/bs.mie.2015.09.032	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0180359	10.1371/journal.pone.0180359	http://dx.doi.org/10.1371/journal.pone.0180359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846680	Green Submitted, gold, Green Published			2022-12-26	WOS:000408438600003
J	Ganie, SA; Pani, DR; Mondal, TK				Ganie, Showkat Ahmad; Pani, Dipti Ranjan; Mondal, Tapan Kumar			Genome-wide analysis of DUF221 domaincontaining gene family in Oryza species and identification of its salinity stress-responsive members in rice	PLOS ONE			English	Article							SATIVA L.; EXPRESSION ANALYSIS; ABIOTIC STRESS; ABSCISIC-ACID; DEHYDRATION STRESS; ARABIDOPSIS; DROUGHT; SALT; DUPLICATION; MICRORNAS	DUF221 domain-containing genes (DDP genes) play important roles in developmental biology, hormone signalling transduction, and responses to abiotic stress. Therefore to understand their structural and evolutionary relationship, we did a genome-wide analysis of this important gene family in rice. Further, through comparative genomics, DDP genes from Oryza sativa subsp. (indica), nine different wild species of rice and Arabidopsis were also identified. We also found an expansion of the DDP gene families in rice and Arabidopsis which is due to the segmental duplication events in some of the gene family members. In general, a highly purifying selection was found acting on all the deduced paralogous and orthologous DDP gene pairs. The data from microarray and subsequent qRT-PCR analysis revealed that although several OsDDPs were differentially regulated under salinity stress, yet OsDDP6 was upregulated at all the developmental stages in salt tolerant rice genotype, FL478. Interestingly, OsDDP6 was found to be involved in proline metabolism pathway as indicated by protein network analysis. The diverse gene structures, varied transmembrane topologies and the differential expression patterns implied the functional diversity in DDP genes. Therefore, the comprehensive evolutionary analysis of DDP genes from different Oryza species and Arabidopsis performed in this study will provide the basis for further functional validation studies vis-a-vis DDP genes of rice and other plant species.	[Ganie, Showkat Ahmad; Mondal, Tapan Kumar] ICAR Natl Bur Plant Genet Resources, Div Genom Resources, Pusa Campus, New Delhi, India; [Pani, Dipti Ranjan] NBPGR Base Ctr, ICAR Natl Rice Res Inst Campus, Cuttack, Orissa, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Mondal, TK (corresponding author), ICAR Natl Bur Plant Genet Resources, Div Genom Resources, Pusa Campus, New Delhi, India.	mondaltk@rediffmail.com	Ganie, Showkat/M-1659-2019	Ganie, Showkat/0000-0002-8654-9840; MONDAL, TAPAN/0000-0001-6702-2990	Department of Biotechnology, Govt. of India, New Delhi	Department of Biotechnology, Govt. of India, New Delhi(Department of Biotechnology (DBT) India)	The authors are grateful to Dr K. V. Bhat, Head, Division of Genomic Resources and Director, NBPGR, New Delhi for providing the facility. SAG is grateful to Department of Biotechnology, Govt. of India, New Delhi for providing the fellowship.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Aneja M, 1999, PLANT GROWTH REGUL, V27, P149, DOI 10.1023/A:1006153502897; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Buchanan-Wollaston V, 2007, ANN BOT, V101, P197, DOI [DOI 10.1093/AOB/MCM286, 10.1093/aob/mcm286]; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chen F, 2006, DNA RES, V13, P53, DOI 10.1093/dnares/dsl001; Chen JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2596; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Deng PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137990; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Fernandez-Aguado M, 2013, APPL MICROBIOL BIOT, V97, P795, DOI 10.1007/s00253-012-4256-0; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Ganie SA, 2016, PHYSIOL MOL BIOL PLA, V22, P107, DOI 10.1007/s12298-016-0342-6; Ganie SA, 2016, FUNCT INTEGR GENOMIC, V16, P1, DOI 10.1007/s10142-015-0460-1; Ganie SA, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0207-7; Ganie SA, 2014, PLANT SYST EVOL, V300, P1741, DOI 10.1007/s00606-014-0999-7; Goodacre NF, 2014, MBIO, V5, DOI 10.1128/mBio.00744-13; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gu ZM, 2008, GENE, V415, P1, DOI 10.1016/j.gene.2008.02.011; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hauser R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002815; Hashimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062589; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hou CC, 2014, CELL RES, V24, P632, DOI 10.1038/cr.2014.14; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Jami SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047801; Jamsheer KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134328; Jia L, 2004, PLANT PHYSIOL, V134, P575, DOI 10.1104/pp.103.027201; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kumar G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-107; Kushwaha HR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li YS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0653-8; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Liu LP, 2013, MICROB PATHOGENESIS, V64, P6, DOI 10.1016/j.micpath.2013.06.001; Liu QP, 2012, FUNCT INTEGR GENOMIC, V12, P649, DOI 10.1007/s10142-012-0282-3; Liu SP, 2010, J PLANT BIOL, V53, P444, DOI 10.1007/s12374-010-9135-6; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Molla KA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0498-1; Mondal TK, 2014, PLANT MOL BIOL REP, V32, P605, DOI 10.1007/s11105-013-0664-2; Mondal TK, 2014, GENE, V535, P204, DOI 10.1016/j.gene.2013.11.033; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Mustafiz A, 2011, FUNCT INTEGR GENOMIC, V11, P293, DOI 10.1007/s10142-010-0203-2; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Pani DR, 2013, J INDIAN SOC COASTAL, V31, p11 ; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Rai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032658; Rajendran K, 2009, PLANT CELL ENVIRON, V32, P237, DOI 10.1111/j.1365-3040.2008.01916.x; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rengasamy P, 2010, FUNCT PLANT BIOL, V37, P613, DOI 10.1071/FP09249; Rohila JS, 2007, J INTEGR PLANT BIOL, V49, P751, DOI 10.1111/j.1744-7909.2007.00501.x; Ruan SL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-34; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shaik R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049331; Sharma M, 2014, DNA RES, V21, P267, DOI 10.1093/dnares/dst056; Sharoni AM, 2012, MOL GENET GENOMICS, V287, P1, DOI 10.1007/s00438-011-0659-3; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Singh AK, 2015, RICE, V8, DOI 10.1186/s12284-015-0054-5; Soni P, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24738; SUNKAR R, 2008, BMC PLANT BIOL, V8; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Szarzynska B, 2009, NUCLEIC ACIDS RES, V37, P3083, DOI 10.1093/nar/gkp189; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathi AK, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0414-8; Trivellini A, 2011, J EXP BOT, V62, P5437, DOI 10.1093/jxb/err218; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; Vij S, 2006, MOL GENET GENOMICS, V276, P565, DOI 10.1007/s00438-006-0165-1; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wagner A, 2002, GENOME BIOL, V3; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Warthmann N, 2008, MOL BIOL EVOL, V25, P892, DOI 10.1093/molbev/msn029; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Xing Wang, 2013, Australian Journal of Crop Science, V7, P289; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; YI QM, 1995, HEREDITAS, V122, P135, DOI 10.1111/j.1601-5223.1995.00135.x; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yuan F, 2014, NATURE, V514, P367, DOI 10.1038/nature13593; Yue R, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0118751	109	23	28	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182469	10.1371/journal.pone.0182469	http://dx.doi.org/10.1371/journal.pone.0182469			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846681	gold, Green Submitted, Green Published			2022-12-26	WOS:000408438600010
J	Kwak, YK; Lee, SW; Kay, CS; Park, HH				Kwak, Yoo-Kang; Lee, Sea-Won; Kay, Chul Seung; Park, Hee Hyun			Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose	PLOS ONE			English	Article							CERVICAL-CANCER; CLINICAL-OUTCOMES; CONCURRENT CHEMOTHERAPY; RADICAL SURGERY; CARCINOMA; WOMEN; IRRADIATION; IMPACT; CISPLATIN; UTERUS	This retrospective study was performed to evaluate and compare gastrointestinal (GI) toxicities caused by conventional radiotherapy (cRT) and intensity modulated radiotherapy (IMRT) in 136 cancer patients treated with pelvic radiotherapy (RT) with moderate radiation dose in a single institution. A matched-pair analysis of the two groups was performed; each group included 68 patients. Conventional RT was delivered using the four-field box technique and IMRT was delivered with helical tomotherapy. The median daily dose was 1.8 Gy and the median total dose was 50.4 Gy (range 25.2-56 Gy). Primary end point was GI toxicity during and after RT. Secondary end point was factors that affect toxicity. Patients treated with IMRT had lower incidence of grade >= 2 acute GI toxicity compared to the patients treated with cRT (p = 0.003). The difference remained significant in multivariate analysis (p = 0.01). The incidence of chronic GI toxicity was not statistically different between the two groups, but the cRT group had higher incidence of grade 3 chronic GI toxicity. Based on our results, IMRT can reduce GI toxicity compared to cRT in the treatment of pelvic radiotherapy even with moderate radiation dose and this will enhance patients' quality of life and treatment compliance.	[Kwak, Yoo-Kang; Lee, Sea-Won] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea; [Kay, Chul Seung; Park, Hee Hyun] Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Kay, CS (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea.	k41645@chol.com		Kwak, Yoo-Kang/0000-0002-7615-7819				Barker CL, 2009, BRIT J CANCER, V100, P1558, DOI 10.1038/sj.bjc.6605050; Barraclough LH, 2012, RADIOTHER ONCOL, V103, P327, DOI 10.1016/j.radonc.2012.04.018; Brixey CJ, 2002, INT J RADIAT ONCOL, V54, P1388, DOI 10.1016/S0360-3016(02)03801-4; Buchali A, 1999, RADIOTHER ONCOL, V52, P29, DOI 10.1016/S0167-8140(99)00068-7; Chan P, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-13; Chen MF, 2007, INT J RADIAT ONCOL, V67, P1438, DOI 10.1016/j.ijrobp.2006.11.005; Denham JW, 1999, RADIOTHER ONCOL, V51, P43, DOI 10.1016/S0167-8140(99)00027-4; Du XL, 2012, GYNECOL ONCOL, V125, P151, DOI 10.1016/j.ygyno.2011.12.432; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Gandhi AK, 2013, INT J RADIAT ONCOL, V87, P542, DOI 10.1016/j.ijrobp.2013.06.2059; Gilbert A, 2015, INT J RADIAT ONCOL, V92, P555, DOI 10.1016/j.ijrobp.2015.02.021; Huh SJ, 2004, RADIOTHER ONCOL, V71, P73, DOI 10.1016/j.radonc.2004.01.005; Kidd EA, 2010, INT J RADIAT ONCOL, V77, P1085, DOI 10.1016/j.ijrobp.2009.06.041; Krol R, 2014, INT J COLORECTAL DIS, V29, P273, DOI 10.1007/s00384-013-1784-8; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Lengele B, 2009, RADIOTHER ONCOL, V92, P22, DOI 10.1016/j.radonc.2008.11.007; Lukka H, 2002, CLIN ONCOL-UK, V14, P203, DOI 10.1053/clon.2002.0076; Mell LK, 2008, INT J RADIAT ONCOL, V71, P1504, DOI 10.1016/j.ijrobp.2008.04.046; Mundt AJ, 2002, INT J RADIAT ONCOL, V52, P1330, DOI 10.1016/S0360-3016(01)02785-7; Mundt AJ, 2001, GYNECOL ONCOL, V82, P456, DOI 10.1006/gyno.2001.6250; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Ray A, 2013, ASIA-PAC J CLIN ONCO, V9, P280, DOI 10.1111/ajco.12049; Roeske JC, 2003, RADIOTHER ONCOL, V69, P201, DOI 10.1016/j.radonc.2003.05.001; Roeske JC, 2000, INT J RADIAT ONCOL, V48, P1613, DOI 10.1016/S0360-3016(00)00771-9; Taylor A, 2007, CLIN ONCOL-UK, V19, P542, DOI 10.1016/j.clon.2007.05.002; van de Bunt L, 2008, RADIOTHER ONCOL, V88, P233, DOI 10.1016/j.radonc.2007.12.017; YEOH E, 1993, AM J MED, V95, P397, DOI 10.1016/0002-9343(93)90309-D; Yeoh EEK, 2004, AM J GASTROENTEROL, V99, P361, DOI 10.1111/j.1572-0241.2004.04037.x; Yeoh EEK, 2000, INT J RADIAT ONCOL, V47, P915, DOI 10.1016/S0360-3016(00)00487-9; Yeoh EK, 2012, INT J RADIAT ONCOL, V84, pE593, DOI 10.1016/j.ijrobp.2012.06.032	31	16	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183339	10.1371/journal.pone.0183339	http://dx.doi.org/10.1371/journal.pone.0183339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846718	Green Published, Green Submitted, gold			2022-12-26	WOS:000408438600025
J	Kalu, AW; Telele, NF; Gebreselasie, S; Fekade, D; Abdurahman, S; Marrone, G; Sonnerborg, A				Kalu, Amare Worku; Telele, Nigus Fikrie; Gebreselasie, Solomon; Fekade, Daniel; Abdurahman, Samir; Marrone, Gaetano; Sonnerborg, Anders			Prediction of coreceptor usage by five bioinformatics tools in a large Ethiopian HIV-1 subtype C cohort	PLOS ONE			English	Article							CD4 CELL COUNT; ANTIRETROVIRAL THERAPY; GENOTYPIC ALGORITHMS; PHENOTYPIC ASSAYS; TROPISM; IMPACT; EPIDEMIOLOGY; PROGRESSION; RECOVERY; CCR5	Background Genotypic tropism testing (GTT) has been developed largely on HIV-1 subtype B. Although a few reports have analysed the utility of GTT in other subtypes, more studies using HIV-1 subtype C (HIV-1C) are needed, considering the huge contribution of HIV-1C to the global epidemic. Methods Plasma was obtained from 420 treatment-naive HIV-1C infected Ethiopians recruited 2009 - 2011. The V3 region was sequenced and the coreceptor usage was predicted by five tools: Geno2Pheno clinical- and clonal-models, PhenoSeq-C, C-PSSM and Raymond's algorithm. The impact of baseline tropism on antiretroviral treatment (ART) outcome was evaluated. Results Of 352 patients with successful baseline V3 sequences, the proportion of predicted R5 virus varied between the methods by 12.5% (78.1%-90.6%). However, only 58.2% of the predictions were concordant and only 1.7% were predicted to be X4-tropic across the five methods. Compared pairwise, the highest concordance was between C-PSSM and Geno2Pheno clonal (86.4%). In bivariate intention to treat (ITT) analysis, R5 infected patients achieved treatment success more frequently than X4 infected at month six as predicted by Geno2Pheno clinical (77.8% vs 58.7%, P = 0.004) and at month 12 by C-PSSM (61.9% vs 46.6%, P = 0.038). However, in the multivariable analysis adjusted for age, gender, baseline CD4 and viral load, only tropism as predicted by C-PSSM showed an impact on month 12 (P = 0.04, OR 2.47, 95% CI 1.06-5.79). Conclusion Each of the bioinformatics models predicted R5 tropism with comparable frequency but there was a large discordance between the methods. Baseline tropism had an impact on outcome of first line ART at month 12 in multivariable ITT analysis but only based on prediction by C-PSSM which thus possibly could be used for predicting outcome of ART in HIV-1C infected Ethiopians.	[Kalu, Amare Worku; Telele, Nigus Fikrie; Sonnerborg, Anders] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden; [Kalu, Amare Worku; Telele, Nigus Fikrie; Gebreselasie, Solomon] Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Fekade, Daniel] Addis Ababa Univ, Dept Internal Med, Addis Ababa, Ethiopia; [Abdurahman, Samir] Publ Hlth Agcy Sweden, Solna, Sweden; [Marrone, Gaetano; Sonnerborg, Anders] Karolinska Inst, Dept Med Huddinge, Unit Infect Dis, Stockholm, Sweden	Karolinska Institutet; Addis Ababa University; Addis Ababa University; Public Health Agency of Sweden; Karolinska Institutet	Kalu, AW (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden.; Kalu, AW (corresponding author), Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia.	Amare.worku.kalu@ki.se	Sönnerborg, Anders/W-2011-2019; Kalu, Amare/O-5143-2018	Sönnerborg, Anders/0000-0001-8928-3374; Kalu, Amare/0000-0003-3950-6992	Swedish Research Council; Swedish Institutet; EDCTP; EuResist consortium; CDC Cooperative Agreement [5U2GPS00085 8]; European and Developing Clinical Trial Partnership; Swedish Civil Contingencies Agency; Swedish Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institutet; EDCTP; EuResist consortium; CDC Cooperative Agreement(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); European and Developing Clinical Trial Partnership; Swedish Civil Contingencies Agency; Swedish Institute	Samples and data were collected by the Advanced Clinical Monitoring of Antiretroviral Treatment in Ethiopia, funded by CDC Cooperative Agreement 5U2GPS00085 8. Part of this work has been supported by the European and Developing Clinical Trial Partnership, the Swedish Research Council, the Swedish Civil Contingencies Agency and the Swedish Institute.; We acknowledge Addis Ababa University (AAU) College of Health Sciences, particularly Dr Ahmed Raja (CED) and Dr Dawit Wondimagegn; the ACM steering committee, particularly Dr Achamyeleh Alebachew. We also acknowledge support from the Swedish Research Council, the Swedish Institutet, the EDCTP and the EuResist consortium.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Bader J, 2017, CLIN INFECT DIS, V64, P295, DOI 10.1093/cid/ciw737; Braun P, 2007, EUR J MED RES, V12, P463; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Cashin K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08543; Ceresola ER, 2015, J ANTIMICROB CHEMOTH, V70, P1391, DOI 10.1093/jac/dku573; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Crous S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-203; Dauwe K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1217-0; DELWART EL, 1995, PCR METH APPL, V4, pS202; Fox J, 2010, AIDS, V24, P2397, DOI 10.1097/QAD.0b013e32833cbb5b; Garrido C, 2008, J CLIN MICROBIOL, V46, P887, DOI 10.1128/JCM.01611-07; Gijsbers EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076255; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Gupta S, 2015, INTERVIROLOGY, V58, P1, DOI 10.1159/000369017; Hoffmann C, 2007, EUR J MED RES, V12, P385; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; JOHANSSON B, 1995, AIDS RES HUM RETROV, V11, P761, DOI 10.1089/aid.1995.11.761; Kalu AW, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2163-1; Lanca AM, 2012, MEM I OSWALDO CRUZ, V107, P96, DOI 10.1590/S0074-02762012000100014; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Neogi U, 2014, PLOS ONE, V9; Neogi U, 2014, AIDS, V28, P2319, DOI 10.1097/QAD.0000000000000419; Neogi U, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-24; Neogi Ujjwal, 2009, AIDS Res Ther, V6, P28, DOI 10.1186/1742-6405-6-28; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5; Raymond S, 2016, JAIDS-J ACQ IMM DEF, V72, P376, DOI 10.1097/QAI.0000000000000984; Raymond S, 2010, JAIDS-J ACQ IMM DEF, V53, P167, DOI 10.1097/QAI.0b013e3181c8413b; Resistance UKCGoHD, 2014, AIDS, V28, P773; Riemenschneider M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24883; Sallam M, 2017, INFECT GENET EVOL, V49, P157, DOI 10.1016/j.meegid.2017.01.004; Sechet M, 2015, INTERVIROLOGY, V58, P155, DOI 10.1159/000398798; Seclen E, 2011, J CLIN MICROBIOL, V49, P3380, DOI 10.1128/JCM.00908-11; Seclen E, 2011, J INFECT DIS, V204, P139, DOI 10.1093/infdis/jir218; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; Teklu AM, 2017, ETHIOP J HEALTH SCI, V27, P3, DOI [10.4314/ejhs.v27i1.2S, 10.4314/ejhs.v27i1.2s]; Trabaud MA, 2012, J MED VIROL, V84, P402, DOI 10.1002/jmv.23209; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c	41	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182384	10.1371/journal.pone.0182384	http://dx.doi.org/10.1371/journal.pone.0182384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841646	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700006
J	Dimitriadis, Z; Scholtz, W; Ensminger, SM; Piper, C; Bitter, T; Wiemer, M; Vlachojannis, M; Borgermann, J; Faber, L; Horstkotte, D; Gummert, J; Scholtz, S				Dimitriadis, Zisis; Scholtz, Werner; Ensminger, Stephan M.; Piper, Cornelia; Bitter, Thomas; Wiemer, Marcus; Vlachojannis, Marios; Boergermann, Jochen; Faber, Lothar; Horstkotte, Dieter; Gummert, Jan; Scholtz, Smita			Impact of sheath diameter of different sheath types on vascular complications and mortality in transfemoral TAVI approaches using the Proglide closure device	PLOS ONE			English	Article							AORTIC-VALVE IMPLANTATION; END-POINT DEFINITIONS; ACCESS SITE CLOSURE; ANEURYSM REPAIR; TRANSCATHETER; REPLACEMENT; MULTICENTER; STENOSIS; REGISTRY; OUTCOMES	Objective Evaluation of the impact of the sheath diameter on vascular complications and mortality in transfemoral aortic valve implantation. Method Between 2012 and 2014, 183 patients underwent the procedure using a sheath diameter of 18-24 F. This collective was divided into two groups: group 1, with a sheath diameter of 18F (G1, n = 94), consisted of patients with 18F Medtronic Sentrant and 18 F Direct Flow sheaths, and group 2 with a sheath diameter of 19-24 F (G2, n = 89) consisted of patients with Edwards expandable e-sheath and Solopath sheaths. Perclose-Proglide (R) was used as a closure device in all patients. Results G1 had significantly more female patients (64.9% vs. 46.1% in G2, p = 0.01) and the average BMI was lower (26 +/- 4.5% vs. 27.4 +/- 4.7%, p = 0.03). There was no significant difference in the incidence of major and minor vascular complications (G1: 12.8% vs. G2: 12.4%, p = 0.9). 30-day mortality was similar in both groups (G1: 6.4 +/- 2.5% [95% CI: 0.88-0.98], G2: 3.7 +/- 1.9% [95% CI: 0.92-0.99]. The Kaplan Meier analysis of survival revealed no significant differences either. Conclusion The difference in sheath diameter had no effect on either incidence or severity of vascular complications. There was no impact on mortality either.	[Dimitriadis, Zisis; Scholtz, Werner; Piper, Cornelia; Bitter, Thomas; Vlachojannis, Marios; Faber, Lothar; Horstkotte, Dieter; Scholtz, Smita] Ruhr Univ Bochum, Clin Cardiol, Herz & Diabet Zentrum NRW, Bad Oeynhausen, Germany; [Ensminger, Stephan M.; Boergermann, Jochen; Gummert, Jan] Ruhr Univ Bochum, Clin Thorac & Cardiovasc Surg, Herz & Diabet Zentrum NRW, Bad Oeynhausen, Germany; [Wiemer, Marcus] Ruhr Univ Bochum, Johannes Wesling Klinikum Minden, Dept Cardiol & Crit Care Med, Minden, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Dimitriadis, Z (corresponding author), Ruhr Univ Bochum, Clin Cardiol, Herz & Diabet Zentrum NRW, Bad Oeynhausen, Germany.	akleemeyer@hdz-nrw.de	Ensminger, Stephan Prof. Dr./AAQ-2141-2021; Faber, Lothar/AAJ-1135-2020	Ensminger, Stephan Prof. Dr./0000-0002-9508-3261; 				Abdel-Wahab M, 2015, TRENDS CARDIOVAS MED, V25, P154, DOI 10.1016/j.tcm.2014.10.001; Agarwal S, 2015, HEART, V101, P169, DOI 10.1136/heartjnl-2014-306254; Barbanti M, 2013, EUROINTERVENTION, V9, P929, DOI 10.4244/EIJV9I8A156; Barbash IM, 2015, EUR HEART J, V36, P3370, DOI 10.1093/eurheartj/ehv417; Borz B, 2014, CATHETER CARDIO INTE, V83, pE227, DOI 10.1002/ccd.25390; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Eisenack M, 2009, J ENDOVASC THER, V16, P708, DOI 10.1583/08-2622.1; Eltchaninoff H, 2012, ARCH CARDIOVASC DIS, V105, P132, DOI 10.1016/j.acvd.2012.02.002; Eltchaninoff H, 2011, EUR HEART J, V32, P191, DOI 10.1093/eurheartj/ehq261; Etezadi V, 2011, J VASC INTERV RADIOL, V22, P142, DOI 10.1016/j.jvir.2010.10.008; Genereux P, 2012, J AM COLL CARDIOL, V60, P1043, DOI 10.1016/j.jacc.2012.07.003; Greason KL, 2013, J CARDIAC SURG, V28, P348, DOI 10.1111/jocs.12140; Griese DP, 2013, CATHETER CARDIO INTE, V82, pE734, DOI 10.1002/ccd.25053; Hayashida K, 2012, JACC-CARDIOVASC INTE, V5, P207, DOI 10.1016/j.jcin.2011.09.020; Hayashida K, 2011, JACC-CARDIOVASC INTE, V4, P851, DOI 10.1016/j.jcin.2011.03.019; Howell M, 2002, CATHETER CARDIO INTE, V55, P281, DOI 10.1002/ccd.10072; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1016/j.jacc.2012.09.001, 10.1093/ejcts/ezs533]; Kodali S, 2016, EUR HEART J; Krishnaswamy A, 2014, CATHETER CARDIO INTE, V84, P844, DOI 10.1002/ccd.25488; Lefevre T, 2011, EUR HEART J, V32, P148, DOI 10.1093/eurheartj/ehq427; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Manoharan G, 2015, JACC-CARDIOVASC INTE, V8, P1359, DOI 10.1016/j.jcin.2015.05.015; Masson JB, 2009, JACC-CARDIOVASC INTE, V2, P811, DOI 10.1016/j.jcin.2009.07.005; McCabe JM, 2016, AM J CARDIOL; Nelson PR, 2014, J VASC SURG, V59, P1181, DOI 10.1016/j.jvs.2013.10.101; Ramlawi Basel, 2012, Methodist Debakey Cardiovasc J, V8, P22; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Sari C, 2015, PERFUSION-UK, V30, P666, DOI 10.1177/0267659115578002; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Steinberger JD, 2015, TECH VASC INTERV RAD, V18, P93, DOI 10.1053/j.tvir.2015.04.007; Tchetche D, 2010, EUROINTERVENTION, V5, P659, DOI 10.4244/EIJV5I6A109; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545; Van Mieghem NM, 2014, EUROINTERVENTION, V9, P1317, DOI 10.4244/EIJV9I11A222; Van Mieghem NM, 2010, EUROINTERVENTION, V5, P673, DOI 10.4244/EIJV5I6A111; Walther T, 2015, J AM COLL CARDIOL, V65, P2173, DOI 10.1016/j.jacc.2015.03.034; Webb J, 2011, EUR HEART J, V32, P140, DOI 10.1093/eurheartj/ehq453; Zahn R, 2011, EUR HEART J, V32, P198, DOI 10.1093/eurheartj/ehq339	38	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183658	10.1371/journal.pone.0183658	http://dx.doi.org/10.1371/journal.pone.0183658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837613	Green Submitted, Green Published, gold			2022-12-26	WOS:000408365000095
J	Donchenko, EK; Pechnikova, EV; Mishyna, MY; Manukhova, TI; Sokolova, OS; Nikitin, NA; Atabekov, JG; Karpova, OV				Donchenko, Ekaterina K.; Pechnikova, Evgeniya V.; Mishyna, Maryia Yu.; Manukhova, Tatiana I.; Sokolova, Olga S.; Nikitin, Nikolai A.; Atabekov, Joseph G.; Karpova, Olga V.			Structure and properties of virions and virus-like particles derived from the coat protein of Alternanthera mosaic virus	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; POTEXVIRUS; IDENTIFICATION; PORTULACA; BINDING; PHLOX	Plant viruses and their virus-like particles (VLPs) have a lot of advantages for biotechnological applications including complete safety for humans. Alternanthera mosaic virus (AltMV) is a potentially promising object for design of novel materials. The 3D structures of AltMV virions and its VLPs were obtained by single particle EM at similar to 13 angstrom resolution. The comparison of the reconstructions and a trypsin treatment revealed that AltMV CPs possesses a different fold in the presence (virions) and absence of viral RNA (VLPs). For the first time, the structure of morphologically similar virions and virus-like particles based on the coat protein of a helical filamentous plant virus is shown to be different. Despite this, both AltMV virions and VLPs are stable in a wide range of conditions. To provide a large amount of AltMV for biotechnology usage the isolation procedure was modified.	[Donchenko, Ekaterina K.; Manukhova, Tatiana I.; Sokolova, Olga S.; Nikitin, Nikolai A.; Atabekov, Joseph G.; Karpova, Olga V.] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia; [Pechnikova, Evgeniya V.] Russian Acad Sci, Lab Electron Microscopy, VA Shoubnikov Inst Crystallog, Moscow, Russia; [Pechnikova, Evgeniya V.] Kurchatov Inst, Nano Bio Informat Cognit Sociohumanist NBICS Sci, Natl Res Ctr, Moscow, Russia; [Mishyna, Maryia Yu.] Tel Hai Coll, Dept Food Sci, Upper Galilee, Israel; [Pechnikova, Evgeniya V.] Thermo Fisher Sci, Mat & Struct Anal, Eindhoven, Netherlands	Lomonosov Moscow State University; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; National Research Centre - Kurchatov Institute; Tel Hai Academy College; Thermo Fisher Scientific	Donchenko, EK (corresponding author), Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia.	donchenko@mail.bio.msu.ru	Sokolova, Olga S/G-7794-2016; Karpova, Olga V/H-2475-2013; Maryia, Mishyna/A-9409-2016; Nikitin, Nikolai/D-6520-2013; Manukhova, Tatiana/AAS-3685-2021; Sokolova, Olga/AAM-8289-2020; Donchenko (Petrova), Ekaterina/D-7561-2012	Karpova, Olga V/0000-0002-0605-9033; Nikitin, Nikolai/0000-0001-9626-2336; Manukhova, Tatiana/0000-0001-9498-1257; Sokolova, Olga/0000-0003-4678-232X; Mishyna, Maryia/0000-0001-9079-8156; Donchenko (Petrova), Ekaterina/0000-0002-5872-3928	Russian Science Foundation [14-24-00007]; Russian Foundation for Basic Research [16-34-00658_mol_a]; 'Thermo Fisher Scientific'; Russian Science Foundation [17-24-00002] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); 'Thermo Fisher Scientific'; Russian Science Foundation(Russian Science Foundation (RSF))	This work (study design, data collection and analysis) was funded by the Russian Science Foundation (Grant No. 14-24-00007) to JGA. www.rscf.ru. Building the 3D reconstructions was funded by Russian Foundation for Basic Research (Grant No. 16-34-00658_mol_a to EP). www.rfbr.ru. Currently one of the authors (Pechnikova E.V.) is employed by a commercial company 'Thermo Fisher Scientific'. The presented cryo-EM results were obtained in V.A. Shoubnikov Institute of Crystallography RAS and National Research Centre 'Kurchatov Institute', where Pechnikova E.V. was employed at that time. 'Thermo Fisher Scientific' provided support in the form of salary for author [Pechnikova E.V.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agirrezabala X, 2015, ELIFE, V4, DOI 10.7554/eLife.11795; Baker CA, 2006, PLANT DIS, V90, P833, DOI 10.1094/PD-90-0833C; BANCROFT JB, 1979, VIROLOGY, V98, P121, DOI 10.1016/0042-6822(79)90531-2; Brunt A. A., 1997, PLANT VIRUSES ONLINE; Ciuffo M, 2004, PLANT PATHOL, V53, P515, DOI 10.1111/j.1365-3059.2004.01040.x; Clare DK, 2015, STRUCTURE, V23, P1815, DOI 10.1016/j.str.2015.06.028; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; DiMaio F, 2015, NAT STRUCT MOL BIOL, V22, P642, DOI 10.1038/nsmb.3054; Duarte L. M. L., 2008, Revista Brasileira de Horticultura Ornamental, V14, P59; ERICKSON JW, 1976, VIROLOGY, V72, P514, DOI 10.1016/0042-6822(76)90180-X; ERICKSON JW, 1978, VIROLOGY, V90, P36, DOI 10.1016/0042-6822(78)90330-6; Geering ADW, 1999, ARCH VIROL, V144, P577, DOI 10.1007/s007050050526; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Hammond J, 2006, ARCH VIROL, V151, P477, DOI 10.1007/s00705-005-0646-2; Hammond J, 2006, ACTA HORTIC, P71, DOI 10.17660/ActaHortic.2006.722.8; Ivanov PA, 2011, VIRUS GENES, V42, P268, DOI 10.1007/s11262-010-0556-6; Iwabuchi N, 2016, GENOME ANNOUNC, V5; Karpova OV, 2006, MOL BIOL+, V40, P703; Lebel ME, 2017, J IMMUNOL, V198, P292, DOI 10.4049/jimmunol.1601271; Lebel ME, 2016, NANO LETT, V16, P1826, DOI 10.1021/acs.nanolett.5b04877; Lockhart BE, 2008, PLANT DIS, V92, P1473, DOI 10.1094/PDIS-92-10-1473B; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mukhamedzhanova Anna A, 2011, Open Virol J, V5, P136, DOI 10.2174/1874357901105010136; Nikitin N. A., 2016, Moscow University Biological Sciences Bulletin, V71, P128, DOI 10.3103/S0096392516030081; Nikitin N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142415; Rodionova NP, 2003, J MOL BIOL, V333, P565, DOI 10.1016/j.jmb.2003.08.058; Savard C, 2012, VACCINE, V30, P2535, DOI 10.1016/j.vaccine.2012.01.085; Savard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021522; Semenyuk PI, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1522, DOI 10.1134/S0006297916120130; Smith KM., 1972, TXB PLANT VIRUS DIS, V3; Steele JFC, 2017, WIRES NANOMED NANOBI, V9, DOI 10.1002/wnan.1447; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang J, 2010, AUSTRALAS PLANT DIS, V5, P25, DOI 10.1071/DN10010; Tremblay MH, 2006, FEBS J, V273, P14, DOI 10.1111/j.1742-4658.2005.05033.x; Trifonova E. A., 2015, MOSC U BIOL SCI B, V70, P194, DOI [10.3103/S0096392515040094, DOI 10.3103/S0096392515040094]; Trifonova EA, 2017, ANTIVIR RES, V144, P27, DOI 10.1016/j.antiviral.2017.05.006; Yang SQ, 2012, J MOL BIOL, V422, P263, DOI 10.1016/j.jmb.2012.05.032	38	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183824	10.1371/journal.pone.0183824	http://dx.doi.org/10.1371/journal.pone.0183824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837650	Green Submitted, gold, Green Published			2022-12-26	WOS:000408365000128
J	Dong, HD; Lv, Y; Sreevatsan, S; Zhao, DM; Zhou, XM				Dong, Haodi; Lv, Yue; Sreevatsan, Srinand; Zhao, Deming; Zhou, Xiangmei			Differences in pathogenicity of three animal isolates of Mycobacterium species in a mouse model	PLOS ONE			English	Article							IL-1-BETA PRODUCTION; TUBERCULOSIS; BOVIS; VIRULENCE; MPB83; MPB70; STRAINS; CATTLE; PARATUBERCULOSIS; INFLAMMASOME	Animal mycobacterioses are among the most important zoonoses worldwide. These are generally caused by either Mycobacterium tuberculosis (MTB), M. bovis (MBO) or M. avium (MAV). To test the hypothesis that different species of pathogenic mycobacteria isolated from varied anatomic locations or animal species differ in virulence and pathogenicity, we performed experiments with three mycobacteria strains (NTSE-3(MTB), NTSE-4(MBO) and NTSE-5 (MAV)) obtained from animal species. Spoligotyping analysis was used to confirm both MTB and MBO strains while the MAV strain was confirmed by 16s rDNA sequencing. BALB/c mice were intranasally infected with the three strains at low and high CFU doses to evaluate variations in pathogenicity. Clinical and pathological parameters were assessed. Infected mice were euthanized at 80 days post-inoculation (dpi). Measures of lung and body weights indicated that the MBO infected group had higher mortality, more weight loss, higher bacterial burden and more severe lesions in lungs than the other two groups. Cytokine profiles showed higher levels of TNF-alpha for MBO versus MTB, while MAV had the highest amounts of IFN-beta in vitro and in vivo. In vitro levels of other cytokines such as IL-1 beta, IL-10, IL-12, IL-17, and IFN-beta showed that Th1 cells had the strongest response in MBO infected mice and that Th2 cells were inhibited. We found that the level of virulence among the three isolates decreased in the following order MBO> MTB> MAV.	[Dong, Haodi; Lv, Yue; Zhao, Deming; Zhou, Xiangmei] China Agr Univ, Minist Agr, Key Lab Anim Epidemiol, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Dong, Haodi; Lv, Yue; Zhao, Deming; Zhou, Xiangmei] China Agr Univ, Coll Vet Med, Beijing, Peoples R China; [Sreevatsan, Srinand] Univ Minnesota, Coll Vet Med, Vet Populat Med Dept, St Paul, MN 55108 USA	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; University of Minnesota System; University of Minnesota Twin Cities	Zhou, XM (corresponding author), China Agr Univ, Minist Agr, Key Lab Anim Epidemiol, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Zhou, XM (corresponding author), China Agr Univ, Coll Vet Med, Beijing, Peoples R China.	zhouxm@cau.edu.cn	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403	National Science & Technology Pillar Program [2015BAI09B01]; National Natural Science Foundation of China [31572487]; MoSTRCUK international cooperation project [2013DFG32500]; State Key Lab of Agrobiotechnology Project [2012SKLAB0614]; CAU Foreign Experts Major Projects [2012z018]; High-end Foreign Experts Recruitment Program [GDT20161100071]	National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MoSTRCUK international cooperation project; State Key Lab of Agrobiotechnology Project; CAU Foreign Experts Major Projects; High-end Foreign Experts Recruitment Program	This work was supported by National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (No. 2015BAI09B01), National Natural Science Foundation of China (Project No. 31572487), the MoSTRCUK international cooperation project (Project No. 2013DFG32500), Funding of State Key Lab of Agrobiotechnology (Project No. 2012SKLAB0614), 2016 CAU Foreign Experts Major Projects (Project No: 2012z018) High-end Foreign Experts Recruitment Program (Project No: GDT20161100071).	Ameni G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076891; [Anonymous], 1896, T ASSOC AM PHYSICIAN, V11, P75; Appelberg R, 2006, IMMUNOL RES, V35, P179, DOI 10.1385/IR:35:3:179; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Cervantes-Villagrana AR, 2013, VACCINE, V31, P676, DOI 10.1016/j.vaccine.2012.11.042; CHATTERJEE D, 1989, INFECT IMMUN, V57, P322, DOI 10.1128/IAI.57.2.322-330.1989; Cheng CC, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-1; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Di Paolo NC, 2015, IMMUNITY, V43, P1125, DOI 10.1016/j.immuni.2015.11.016; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gonzalo-Asensio J, 2014, P NATL ACAD SCI USA, V111, P11491, DOI 10.1073/pnas.1406693111; HARBOE M, 1995, SCAND J IMMUNOL, V42, P46, DOI 10.1111/j.1365-3083.1995.tb03624.x; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; JARNAGIN JL, 1983, AM J VET RES, V44, P1920; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Koch R, 1901, Br Med J, V2, P189; Kolb J, 2014, INT J MED MICROBIOL, V304, P941, DOI 10.1016/j.ijmm.2014.06.001; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Logan KE, 2008, TUBERCULOSIS, V88, P437, DOI 10.1016/j.tube.2008.05.005; Marassi CD, 2011, ACTA TROP, V118, P101, DOI 10.1016/j.actatropica.2011.02.015; McNab FW, 2014, J IMMUNOL, V193, P3600, DOI 10.4049/jimmunol.1401088; Medina E, 2006, TUBERCULOSIS, V86, P20, DOI 10.1016/j.tube.2005.04.003; Michel AL, 2010, VET MICROBIOL, V140, P371, DOI 10.1016/j.vetmic.2009.08.029; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; Ocepek M, 2005, J CLIN MICROBIOL, V43, P3555, DOI 10.1128/JCM.43.7.3555-3557.2005; Olsen A, 2016, MBIO, V7, DOI 10.1128/mBio.01023-15; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Pruvot M, 2014, PREV VET MED, V117, P95, DOI 10.1016/j.prevetmed.2014.09.003; Raviglione M, 2016, INFECT DIS REP, V8, P33, DOI 10.4081/idr.2016.6570; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rivas-Santiago B, 2015, IMMUNOTHERAPY-UK, V7, P207, DOI [10.2217/IMT.14.119, 10.2217/imt.14.119]; Said-Salim B, 2006, MOL MICROBIOL, V62, P1251, DOI 10.1111/j.1365-2958.2006.05455.x; Shah S, 2013, J IMMUNOL, V191, P3514, DOI 10.4049/jimmunol.1301331; Singh VK, 2014, TUBERCULOSIS, V94, P252, DOI 10.1016/j.tube.2014.02.001; Srivastava K, 2008, INDIAN J MED RES, V128, P26; Verdugo C, 2014, PREV VET MED, V117, P436, DOI 10.1016/j.prevetmed.2014.09.009; Wedlock DN, 2003, TUBERCULOSIS, V83, P339, DOI 10.1016/S1472-9792(03)00055-6; Whelan AO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008527; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zarden CFO, 2013, TROP ANIM HEALTH PRO, V45, P1203, DOI 10.1007/s11250-012-0347-2; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183666	10.1371/journal.pone.0183666	http://dx.doi.org/10.1371/journal.pone.0183666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837698	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000097
J	Guimaraes-e-Silva, AS; Silva, SD; da Silva, RCR; Pinheiro, VCS; Rebelo, JMM; Melo, MN				Guimaraes-e-Silva, Antonia Suely; Silva, Soraia de Oliveira; Ribeiro da Silva, Rosa Cristina; Soares Pinheiro, Valeria Cristina; Macario Rebelo, Jose Manuel; Melo, Maria Norma			Leishmania infection and blood food sources of phlebotomines in an area of Brazil endemic for visceral and tegumentary leishmaniasis	PLOS ONE			English	Article							DIPTERA PSYCHODIDAE PHLEBOTOMINAE; SAND FLIES; CUTANEOUS LEISHMANIASIS; VIANNIA LAINSONI; NATURAL INFECTION; MIXED INFECTION; EQUUS-CABALLUS; MARANHAO STATE; AMAZON REGION; MINAS-GERAIS	The aims of the study were to determine the blood feeding preferences of sandflies and to identify species of Leishmania that infected phlebotomines in Caxias, Maranhao, Brazil, an area that is highly endemic for leishmaniasis. Sandflies were captured in light traps located in the peridomiciliary environments of randomly selected houses in urban and rural settings between 1800 and 0600 hours on new moon days between March 2013 and February 2015. DNA extracts from 982 engorged female sandflies were submitted to fragment length polymorphism analysis to identify infecting species of Leishmania, and blood sources were identified for 778 of these specimens. Infection by Leishmania infantum was detected in Lutzomyia longipalpis, Lu. whitmani and Lu. termitophila; L. infantum/L. braziliensis in Lu. longipalpis, Lu. whitmani and Lu. trinidadensis; L. shawi in Lu. longipalpis; L. mexicana in Lu. longipalpis; L. braziliensis in Lu. longipalpis and Lu. whitmani; L. guyanensis in Lu. longipalpis and Lu. termitophila; L. amazonensis in Lu. longipalpis and L. lainsoni or L. naiffi in Lu. longipalpis, while Lu. longipalpis and Lu. trinidadensis were infected with unidentified Leishmania sp. Blood sources were identified in 573 individual phlebotomines and the preferred hosts were, in decreasing order, chicken, dog, rodent and human with lower preferences for pig, horse, opossum and cattle. Lu. longipalpis and Lu. whitmani performed mixed feeding on man, dog and rodent, while Lu. longipalpis was the most opportunistic species, feeding on the blood of all hosts surveyed, but preferably on dog/chicken, dog/rodent and rodent/chicken. Our findings reveal the concomitant circulation of Leishmania species that cause visceral leishmaniasis and tegumentary leishmaniasis in the study area, and explain the occurrence of autochthonous human cases of both clinical forms of leishmaniasis in Caxias, Maranhao. The results support our hypothesis that, in the municipality of Caxias, transmission of Leishmania occurs in close proximity to humans.	[Guimaraes-e-Silva, Antonia Suely; Ribeiro da Silva, Rosa Cristina; Soares Pinheiro, Valeria Cristina] Univ Estadual Maranhao, Lab Entomol Med LABEM, Ctr Estudos Super Caxias, Caxias, Maranhao, Brazil; [Silva, Soraia de Oliveira; Melo, Maria Norma] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Biol Leishmania, Dept Parasitol, Belo Horizonte, MG, Brazil; [Macario Rebelo, Jose Manuel] Univ Fed Maranhao, Lab Entomol & Vetores, Dept Biol, Sao Luis, Maranhao, Brazil	Universidade Estadual do Maranhao; Universidade Federal de Minas Gerais; Universidade Federal do Maranhao	Melo, MN (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Biol Leishmania, Dept Parasitol, Belo Horizonte, MG, Brazil.	melo@icb.ufmg.br	Silva, Rosa/AGH-4018-2022; Pinheiro, Valeria Cristina Soares/W-8389-2019	Ribeiro da Silva, Rosa Cristina/0000-0002-7184-0408	Conselho de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao	Conselho de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA))	This work is supported by Conselho de Desenvolvimento Cientifico e Tecnologico, MNM; Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao, JMMR.	AGUILAR C M, 1984, Memorias do Instituto Oswaldo Cruz, V79, P181, DOI 10.1590/S0074-02761984000200005; Alexander B, 2002, EMERG INFECT DIS, V8, P1480, DOI 10.3201/eid0812.010485; de Souza AAA, 2016, PARASITE, V23, DOI 10.1051/parasite/2016022; Felipe IMA, 2011, MEM I OSWALDO CRUZ, V106, P207, DOI 10.1590/S0074-02762011000200015; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Andrade JD, 2009, NEOTROP ENTOMOL, V38, P688, DOI 10.1590/S1519-566X2009000500022; [Anonymous], 2015, GLOB HLTH OBS IND ES; AZEVEDO ACR, 1990, MEM I OSWALDO CRUZ, V85, P251, DOI 10.1590/S0074-02761990000200021; Barata RA, 2005, REV SOC BRAS MED TRO, V38, P421, DOI 10.1590/S0037-86822005000500012; Barbosa David Soeiro, 2010, Ciencia Animal Brasileira, V11, P653, DOI 10.5216/cab.v11i3.5933; Bastrenta B, 2002, ACTA TROP, V83, P249, DOI 10.1016/S0001-706X(02)00129-8; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; BIAGI F, 1972, T ROY SOC TROP MED H, V66, P943, DOI 10.1016/0035-9203(72)90132-0; Brandao SP, 2003, T ROY SOC TROP MED H, V97, P291, DOI 10.1016/S0035-9203(03)90146-5; BRAZIL R P, 1987, Memorias do Instituto Oswaldo Cruz, V82, P145, DOI 10.1590/S0074-02761987000100025; BRAZIL RP, 1991, MEM I OSWALDO CRUZ, V86, P497, DOI 10.1590/S0074-02761991000400029; Brilhante AF, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0041-8; Cabrera MAA, 2003, REV I MED TROPICAL, V25, P79; Carvalho GML, 2008, VECTOR-BORNE ZOONOT, V8, P407, DOI 10.1089/vbz.2007.0180; Casanova C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002443; Costa J M, 1992, Rev Soc Bras Med Trop, V25, P115, DOI 10.1590/S0037-86821992000200005; CRONIN T M, 1987, Paleontological Society Memoir, P1; Sales KGD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0840-3; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; de Carvalho MR, 2010, ACTA TROP, V116, P108, DOI 10.1016/j.actatropica.2010.03.009; Dos Santos SO, 1998, MED VET ENTOMOL, V12, P315, DOI 10.1046/j.1365-2915.1998.00104.x; El Tai NO, 2000, T ROY SOC TROP MED H, V94, P575, DOI 10.1016/S0035-9203(00)90093-2; Figueredo LA, 2012, REV BRAS PARASITOL V, V21, P418, DOI 10.1590/S1984-29612012005000010; Filho SP, 2006, VET PARASITOL, V140, P54; Galati Eunice Aparecida Bianchi, 2003, Revista de Patologia Tropical, V32, P235; Gil LHS, 2003, MEM I OSWALDO CRUZ, V98, P751, DOI 10.1590/S0074-02762003000600007; Governo do Estado do Atlas do, GOV EST MAR ATL MAR; Haouas N, 2007, AM J TROP MED HYG, V77, P1054, DOI 10.4269/ajtmh.2007.77.1054; Instituto Brasileiro de Geografia e Estat o A stica (IBGE), CENS DEM; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Lainson R., 2010, TOPLEY WILSONS MICRO, DOI 10.1002/9780470688618; Lainson R, 2005, TOPLEY WILSONS MICRO, V5, P313; Lainson Ralph, 2010, Revista Pan-Amazonica de Saude, V1, P13; Lana RS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/385493; Lins RMMA, 2002, INSECT MOL BIOL, V11, P117, DOI 10.1046/j.1365-2583.2002.00315.x; LUCAS CM, 1994, AM J TROP MED HYG, V51, P533, DOI 10.4269/ajtmh.1994.51.533; Madeira Maria de Fátima, 2003, Rev. Soc. Bras. Med. Trop., V36, P551, DOI 10.1590/S0037-86822003000500002; Madeira MF, 2006, T ROY SOC TROP MED H, V100, P442, DOI 10.1016/j.trstmh.2005.07.011; Marco JD, 2001, MEM I OSWALDO CRUZ, V96, P649, DOI 10.1590/S0074-02762001000500009; Marcondes M., 2013, Brazilian Journal of Veterinary Research and Animal Science, V50, P341, DOI 10.11606/issn.2318-3659.v50i5p341-352; Savani ESMM, 2009, VET PARASITOL, V160, P18, DOI 10.1016/j.vetpar.2008.10.090; MAYRINK W, 1979, ANN TROP MED PARASIT, V73, P123, DOI 10.1080/00034983.1979.11687239; Michalsky Érika Monteiro, 2011, Rev. Soc. Bras. Med. Trop., V44, P58, DOI 10.1590/S0037-86822011000100014; Ministerio da Saude do Brasil, 2007, MAN VIG LEISHM TEG A; Missawa Nanci Akemi, 2011, Rev. Soc. Bras. Med. Trop., V44, P76, DOI 10.1590/S0037-86822011000100017; Oliveira-Pereira YN, 2008, CAD SAUDE PUBLICA, V24, P2183, DOI 10.1590/S0102-311X2008000900024; Paiva BR, THESIS; Quaresma PF, 2012, MEM I OSWALDO CRUZ, V107, P480, DOI 10.1590/S0074-02762012000400007; Rangel EF, 2009, MEM I OSWALDO CRUZ, V104, P937, DOI 10.1590/S0074-02762009000700001; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Soares VYR, 2014, MEM I OSWALDO CRUZ, V109, P379, DOI 10.1590/0074-0276130405; Salomon OD, 2010, ACTA TROP, V113, P84, DOI 10.1016/j.actatropica.2009.08.024; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANTOS FR, 1993, HUM GENET, V90, P655; Saraiva L, 2010, MEM I OSWALDO CRUZ, V105, P1033, DOI 10.1590/S0074-02762010000800013; Scarpassa VM, 2015, OVERVIEW TROPICAL DI; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Shaw JJ, 2002, WORLD CL PARASITES, V4, P11; Shaw JJ, 1999, MEMOIRS ENTOMOLOGY; Silva LB, 2015, REV PATOL TROP, V44, P181; Silveira F.T., 1989, Revista da Sociedade Brasileira de Medicina Tropical, V22, P125, DOI 10.1590/S0037-86821989000300003; SILVEIRA FT, 1984, REV INST MED TROP SP, V26, P272, DOI 10.1590/S0036-46651984000500008; SILVEIRA FT, 1991, MEM I OSWALDO CRUZ, V86, P127, DOI 10.1590/S0074-02761991000100021; SILVEIRA FT, 1991, REV I MED TROP, V33, P18, DOI 10.1590/S0036-46651991000100004; Nasciment MDSB, 2013, REV SOC BRAS MED TRO, V46, P555, DOI 10.1590/0037-8682-0150-2013; Soares IR, 2013, VET PARASITOL, V197, P665, DOI 10.1016/j.vetpar.2013.06.014; Soares Maria Regiane Araujo, 2010, Cad Saude Publica, V26, P2409, DOI 10.1590/S0102-311X2010001200019; Steuber S, 2005, PARASITOL RES, V97, P247, DOI 10.1007/s00436-005-1410-y; Tanure A, 2015, REV INST MED TROP SP, V57, P321, DOI 10.1590/S0036-46652015000400008; Tolezano JE, 2007, VET PARASITOL, V149, P280, DOI 10.1016/j.vetpar.2007.07.008; YOSHIDA ELA, 1990, MEM I OSWALDO CRUZ, V85, P133, DOI 10.1590/S0074-02761990000100026; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	77	25	25	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0179052	10.1371/journal.pone.0179052	http://dx.doi.org/10.1371/journal.pone.0179052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837565	gold, Green Submitted, Green Published			2022-12-26	WOS:000408365000002
J	Hallengren, M; Astrand, P; Eksborg, S; Barle, H; Frostell, C				Hallengren, Mikael; Astrand, Per; Eksborg, Staffan; Barle, Hans; Frostell, Claes			Septic shock and the use of norepinephrine in an intermediate care unit: Mortality and adverse events	PLOS ONE			English	Article							GOAL-DIRECTED RESUSCITATION; SEVERE SEPSIS; HOSPITAL MORTALITY; DETERMINANTS; MANAGEMENT; THERAPY; ACCESS	Background Septic shock is associated with high mortality. Aged and multimorbid patients are not always eligible for intensive care units. Norepinephrine is an accepted treatment for hypotension in septic shock. It is unknown whether norepinephrine has a place in treatment outside an intensive care unit and when given peripherally. Objectives To describe mortality, Acute Physiology And Chronic Health Evaluation (APACHE-II), time to mean arterial pressure >65 mmHg, and adverse events in patients with septic shock receiving norepinephrine peripherally in an intermediate care unit. Methods From a retrospective chart review of 91 patients with septic shock treated with norepinephrine for hypotension, ward mortality, 30-, 60- and 90-day mortality, standardized mortality ratio (SMR) and adverse events (necrosis and arrhythmia) were analysed. Administration route via peripheral venous catheter or central venous catheter was registered. Results Median age was 81 (43-96) years and median APACHE-II score was 26 (12-42). Observed ward mortality was 27.5% (SMR 0.443, 95% CI: 0.287-0.654), and 30-day and 90-day mortality were 47.2% and 58.2%, respectively. Conclusions Elderly patients with septic shock treated with norepinephrine displayed a better survival in the ward and at 30 days than expected. Our retrospective study did not indicate frequent complications when administering norepinephrine via a peripheral venous catheter.	[Hallengren, Mikael; Barle, Hans; Frostell, Claes] Karolinska Inst, Danderyd Hosp, Div Anaesthesia & Intens Care, Dept Clin Sci, Stockholm, Sweden; [Astrand, Per] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Internal Med, Stockholm, Sweden; [Eksborg, Staffan] Karolinska Inst, Astrid Lindgren Childrens Hosp, Karolinska Univ Hosp Solna, Dept Womens & Childrens Hlth,Childhood Canc Res U, Stockholm, Sweden; [Frostell, Claes] Claes Frostell Res & Consulting AB, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Hallengren, M (corresponding author), Karolinska Inst, Danderyd Hosp, Div Anaesthesia & Intens Care, Dept Clin Sci, Stockholm, Sweden.	mikael.hallengren@sll.se		Hallengren, Mikael/0000-0002-1481-8511; Eksborg, Staffan/0000-0001-7326-9471	Claes Frostell Research and Consulting AB; Karolinska Institute to Karolinska Institute Danderyds Hospital (KIDS); Karolinska Institute; Claes Frostell Research Consulting AB; Claes Frostell Research and Consulting AB; Karolinska Institute to Karolinska Institute Danderyds Hospital (KIDS); Karolinska Institute; Claes Frostell Research Consulting AB	Claes Frostell Research and Consulting AB; Karolinska Institute to Karolinska Institute Danderyds Hospital (KIDS); Karolinska Institute(Karolinska Institutet); Claes Frostell Research Consulting AB; Claes Frostell Research and Consulting AB; Karolinska Institute to Karolinska Institute Danderyds Hospital (KIDS); Karolinska Institute(Karolinska Institutet); Claes Frostell Research Consulting AB	This study was funded in part by Claes Frostell Research and Consulting AB - (1) Fee for IRB, (2) Fee for English proofreading, (3) The publication fee in case of acceptance in PLOS ONE. Data Collection was in part supported by the following educational funds to MH as part of his medical studies. The educational funds were paid as a bench fee from Karolinska Institute to Karolinska Institute Danderyds Hospital (KIDS) for expenses when accepting and supervising a master thesis at the institution. There is no grant name, number or URL, however we have a certificate from Karolinska Institute explaining the bench fee. It is uploaded as a separate file named S2 File. This will hopefully explain in full extent the bench fee from Karolinska Institute and further questions can be answered by contact information in the certificate. No additional funding was received for this study. Claes Frostell is the owner of Claes Frostell Research & Consulting AB. Claes Frostell Research & Consulting AB provided support in the form of part time salary for author CF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; [Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Bai XW, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0532-y; Cecconi M, 2014, MINERVA ANESTESIOL, V80, P701; Dalegrave Daniele, 2012, Rev. bras. ter. intensiva, V24, P362, DOI 10.1590/S0103-507X2012000400012; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hodzic Samir, 2014, Med Arch, V68, P300, DOI 10.5455/medarh.2014.68.300-303; Kato R, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0085-5; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kumar R, 2011, INDIAN PEDIATR, V48, P277, DOI 10.1007/s13312-011-0055-4; Labelle A, 2012, CRIT CARE MED, V40, P2016, DOI 10.1097/CCM.0b013e318250aa72; Lampin ME, 2012, ACTA PAEDIATR, V101, pe426, DOI 10.1111/j.1651-2227.2012.02725.x; LIDDELL FDK, 1984, J EPIDEMIOL COMMUN H, V38, P85, DOI 10.1136/jech.38.1.85; Loubani OM, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.01.014; Marik P, 2016, BRIT J ANAESTH, V116, P339, DOI 10.1093/bja/aev349; McEvoy C, 2013, CURR INFECT DIS REP, V15, P400, DOI 10.1007/s11908-013-0361-1; Morimatsu H, 2004, RESUSCITATION, V62, P249, DOI 10.1016/j.resuscitation.2004.03.016; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Omar S, 2011, ANAESTH INTENS CARE, V39, P449, DOI 10.1177/0310057X1103900316; Pavon A, 2013, CRIT CARE MED, V41, P2600, DOI 10.1097/CCM.0b013e31829a6e89; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Rai SS, 2010, CRIT CARE RESUSC, V12, P177; Ricard JD, 2013, CRIT CARE MED, V41, P2108, DOI 10.1097/CCM.0b013e31828a42c5; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rogers G, 2000, INT J SPORTS MED, V21, P90; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Turner DA, 2010, PEDIATR EMERG CARE, V26, P563, DOI 10.1097/PEC.0b013e3181ea71e1; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	29	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183073	10.1371/journal.pone.0183073	http://dx.doi.org/10.1371/journal.pone.0183073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837628	Green Published, gold			2022-12-26	WOS:000408365000046
J	Li, Z; Tang, Y; Tang, N; Feng, Q; Zhong, H; Liu, YM; Wang, LM; He, F				Li, Zhen; Tang, Yan; Tang, Na; Feng, Qian; Zhong, Hua; Liu, Yong-min; Wang, La-mei; He, Fang			High anti-human cytomegalovirus antibody levels are associated with the progression of essential hypertension and target organ damage in Han Chinese population	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BLOOD-PRESSURE; OXIDATIVE STRESS; INFECTION; RISK; ATHEROSCLEROSIS; MECHANISMS; MORTALITY; ETIOLOGY; DISEASE	Human cytomegalovirus (CMV) infection is associated with hypertension and has been linked with the pathogenesis of increased arterial blood pressure (BP). Currently, whether CMV infection is associated with the progression of hypertension and hypertensive target organ damage (TOD) remains to be identified. We aimed to examine the relationship between CMV infection and the progression of hypertension and hypertensive TOD, which could provide clues on the possible mediating mechanisms, in the Han Chinese population. A total of 372 patients with hypertension and 191 healthy controls (Han participants from Xinjiang, China) were included in the study. Enzyme-linked immunosorbent assay (ELISA) and qPCR were used to detect CMV infection. C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) titers were also analyzed using an ELISA kit. Moreover, cardiovascular disease markers were evaluated by echocardiography, carotid ultrasonography, and tomographic scans. Essential hypertension (EH) patients exhibited a marked increase in CMV IgG antibody, CRP, TNF-alpha, and IL-6 levels. Higher grade of hypertension and hypertensive TOD had higher CMV IgG antibody and CRP levels. The CMV IgG antibody titers were positively correlated with arterial BP, greater grade of hypertension and hypertensive TOD, and CRP and IL-6 levels. The higher quartile of CMV IgG titer and CRP level were associated with the incidence of hypertension and the progression of hypertension and hypertensive TOD. In the Han Chinese population, high CMV IgG titers are associated with the progression of hypertension and hypertensive TOD. CMV IgG titer >4.25 U could be an independent predictor of hypertension and progression of hypertension, while that >4.85 U could be an independent risk factor for hypertensive TOD. The underlying mechanism may be largely mediated by chronic inflammation.	[Li, Zhen; Tang, Na; Feng, Qian; Zhong, Hua; Liu, Yong-min; He, Fang] Shihezi Univ, Coll Med, Dept Pathophysiol, Key Lab Educ Minist Xinjiang Endem & Ethn Dis, Shihezi, Peoples R China; [Li, Zhen] Shihezi Univ, Coll Med, Affiliated Hosp 1, Dept Emergency & Crit Care Med, Shihezi, Peoples R China; [Tang, Yan] Shihezi Univ, Coll Med, Affiliated Hosp 1, Dept Geriatr, Shihezi, Peoples R China; [Wang, La-mei] Shihezi Univ, Coll Med, Ctr Med Funct Expt, Shihezi, Peoples R China	Shihezi University; Shihezi University; Shihezi University; Shihezi University	He, F (corresponding author), Shihezi Univ, Coll Med, Dept Pathophysiol, Key Lab Educ Minist Xinjiang Endem & Ethn Dis, Shihezi, Peoples R China.	fangf2002shz@126.com	Liu, Yong/GWQ-6163-2022		National Natural Science Foundation of China [U1403123]; Ministry of Major Science & Technology of Shihezi University [gxjs2013-zdgg04, gxjs2013-zdgg04-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Major Science & Technology of Shihezi University	This project was supported by the Joint Funds of the National Natural Science Foundation of China (No.U1403123) and the Ministry of Major Science & Technology of Shihezi University (No. gxjs2013-zdgg04, No.gxjs2013-zdgg04-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Chen YM, 2014, J MICROBIOL IMMUNOL, V47, P345, DOI 10.1016/j.jmii.2013.01.011; Cheng J, 2009, PLOS PATHOG, V5, P4713; Chobanian AV, 1996, ARCH INTERN MED, V156, P1952, DOI 10.1001/archinte.156.17.1952; Choudhary A, 2015, INDIAN J MED MICR S2, V33, P135; COSENTINO F, 1994, HYPERTENSION, V23, P229, DOI 10.1161/01.HYP.23.2.229; Delitala AP, 2015, NUTR METAB CARDIOVAS, V25, P1104, DOI 10.1016/j.numecd.2015.09.001; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Dumortier J, 2008, J VIROL, V82, P6524, DOI 10.1128/JVI.00502-08; Ehret GB, 2016, NATURE GENETICS, V48; Martinez-Rodriguez JE, 2013, ARTERIOSCL THROM VAS, V33, P2653, DOI 10.1161/ATVBAHA.113.302163; Gandhi MK, 2003, BLOOD REV, V17, P259, DOI 10.1016/S0268-960X(03)00028-6; Gaytant MA, 2002, OBSTET GYNECOL SURV, V57, P245, DOI 10.1097/00006254-200204000-00024; Gomez-Hernandez A, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/1216783; Gu Dong-feng, 2003, Zhonghua Yufang Yixue Zazhi, V37, P84; Guetta E, 1997, CIRC RES, V81, P8, DOI 10.1161/01.RES.81.1.8; Haarala A, 2012, CLIN EXP IMMUNOL, V167, P309, DOI 10.1111/j.1365-2249.2011.04513.x; Huang LC, 2016, J ATHEROSCLEROSIS TH; Huang ZR, 2012, CNS NEUROSCI THER, V18, P457, DOI 10.1111/j.1755-5949.2012.00326.x; Hui J, 2016, WIEN KLIN WOCHENSCHR, V128, P586, DOI 10.1007/s00508-016-0977-x; IKEDA U, 1991, AM J PHYSIOL, V260, pH1713, DOI 10.1152/ajpheart.1991.260.5.H1713; Jeong SH, 2016, GLOBAL AUTEUR: THE POLITICS OF AUTHORSHIP IN 21ST CENTURY CINEMA, P1; Jeong SJ, 2015, CLIN CHIM ACTA, V445, P65, DOI 10.1016/j.cca.2015.03.015; Kunes J, 2009, PHYSIOL RES, V58, pS33, DOI 10.33549/physiolres.931913; Labarrere CA, 2004, AM J MED, V117, P499, DOI 10.1016/j.amjmed.2004.03.039; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lee SY, 2011, INT J NANOMED, V6, P179, DOI 10.2147/IJN.S12760; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Lin WR, 2002, NEUROBIOL DIS, V9, P82, DOI 10.1006/nbdi.2001.0465; Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259; Mancia G, 2013, BLOOD PRESSURE, V25, P1751; MCVOY MA, 1989, J INFECT DIS, V160, P1, DOI 10.1093/infdis/160.1.1; Mehta SK, 2000, J INFECT DIS, V182, P1761, DOI 10.1086/317624; Muhlestein JB, 2000, CIRCULATION, V102, P20; Mundkur LA, 2012, HEART, V98, P982, DOI 10.1136/heartjnl-2012-301850; Patel R, 2006, J VASC SURG, V43, P364, DOI 10.1016/j.jvs.2005.10.032; Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103; Popovic M, 2012, J THROMB THROMBOLYS, V33, P160, DOI 10.1007/s11239-011-0662-x; Priviero FBM, 2009, AM J HYPERTENS, V22, P493, DOI 10.1038/ajh.2009.18; Prosch S, 2001, J BIOL CHEM, V276, P40712, DOI 10.1074/jbc.M009815200; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Rust P, 2016, IMPACT SALT INTAKE P; Sachetelli S, 2006, KIDNEY INT, V69, P1016, DOI 10.1038/sj.ki.5000210; Savva GM, 2013, AGING CELL, V12, P381, DOI 10.1111/acel.12059; Shamran HA, 2015, BIOMED RES INT, V2015, P1; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Soderberg-Naucler C, 2006, J INTERN MED, V259, P219, DOI 10.1111/j.1365-2796.2006.01618.x; Tang N, 2014, MED SCI MONITOR, V20, P2508, DOI 10.12659/MSM.892861; van der Meer IM, 2002, STROKE, V33, P2750, DOI 10.1161/01.STR.0000044168.00485.02; Vecchione C, 2009, HYPERTENSION, V54, P150, DOI 10.1161/HYPERTENSIONAHA.108.128124; Wall NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055686; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; WANG H., 2015, EURASIP J WIREL COMM, V2015, P1, DOI DOI 10.1016/J.TPLANTS.2015.04.003; Yaiw KC, 2013, HERPESVIRIDAE, V4, P1; Young W, 2000, CIRC RES, V86, P906, DOI 10.1161/01.RES.86.8.906; Zhang J, 2015, MED SCI MONITOR, V21, P4102, DOI 10.12659/MSM.896071; Zhang MM, 2011, MED HYPOTHESES, V76, P682, DOI 10.1016/j.mehy.2011.01.032; Zheng L, 2016, CIRCULATION J OFFICI	60	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181440	10.1371/journal.pone.0181440	http://dx.doi.org/10.1371/journal.pone.0181440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837559	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000007
J	Van Kampen, JM; Kay, DG				Van Kampen, Jackalina M.; Kay, Denis G.			Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer's disease	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; AMYLOID-BETA DEPOSITION; A-BETA; GROWTH-FACTOR; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; OXIDATIVE STRESS; DOWN-REGULATION; HOST-DEFENSE; NEPRILYSIN	Progranulin (PGRN) is a multifunctional protein that is widely expressed throughout the brain, where it has been shown to act as a critical regulator of CNS inflammation and also functions as an autocrine neuronal growth factor, important for long-term neuronal survival. PGRN has been shown to activate cell signaling pathways regulating excitoxicity, oxidative stress, and synaptogenesis, as well as amyloidogenesis. Together, these critical roles in the CNS suggest that PGRN has the potential to be an important therapeutic target for the treatment of various neurodegenerative disorders, particularly Alzheimer's disease (AD). AD is the leading cause of dementia and is marked by the appearance of extracellular plaques consisting of aggregates of amyloid-beta (A beta), as well as neuroinflammation, oxidative stress, neuronal loss and synaptic atrophy. The ability of PGRN to target multiple key features of AD pathophysiology suggests that enhancing its expression may benefit this disease. Here, we describe the application of PGRN gene transfer using in vivo delivery of lentiviral expression vectors in a transgenic mouse model of AD. Viral vector delivery of the PGRN gene effectively enhanced PGRN expression in the hippocampus of Tg2576 mice. This elevated PGRN expression significantly reduced amyloid plaque burden in these mice, accompanied by reductions in markers of inflammation and synaptic atrophy. The overexpression of PGRN was also found to increase activity of neprilysin, a key amyloid beta degrading enzyme. PGRN regulation of neprilysin activity could play a major role in the observed alterations in plaque burden. Thus, PGRN may be an effective therapeutic target for the treatment of AD.	[Van Kampen, Jackalina M.; Kay, Denis G.] Neurodyn Inc, Charlottetown, PE, Canada; [Van Kampen, Jackalina M.] Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE, Canada; [Van Kampen, Jackalina M.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Kay, Denis G.] Univ Prince Edward Isl, Dept Pathol & Microbiol, Charlottetown, PE, Canada	University of Prince Edward Island; Mayo Clinic; University of Prince Edward Island	Van Kampen, JM (corresponding author), Neurodyn Inc, Charlottetown, PE, Canada.; Van Kampen, JM (corresponding author), Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE, Canada.; Van Kampen, JM (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	jvankampen@neurodyn.ca		Van Kampen, Jackalina/0000-0002-8351-4757	Atlantic Canada Opportunities Agency	Atlantic Canada Opportunities Agency	This work was supported by Atlantic Canada Opportunities Agency (http://www.acoa-apeca.gc.ca/Eng/Pages/Home.aspx) (DK). The funding organizations, Atlantic Canada Opportunities Agency and Neurodyn Inc., did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Akiyama H, 2001, BRAIN RES, V902, P277, DOI 10.1016/S0006-8993(01)02390-3; Apelt J, 2003, NEUROSCI LETT, V339, P183, DOI 10.1016/S0304-3940(03)00030-2; Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Barua NU, 2012, J ALZHEIMERS DIS, V32, P43, DOI 10.3233/JAD-2012-120658; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Cerpa W, 2009, DRUG NEWS PERSPECT, V22, P579, DOI [10.1358/dnp.2009.10.1436817, 10.1358/dnp.2009.22.10.1443391]; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cote M, 2015, NEUROBIOL DIS, V82, P99, DOI 10.1016/j.nbd.2015.05.017; Cruts Marc, 2006, Current Alzheimer Research, V3, P485, DOI 10.2174/156720506779025251; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Devos D, 2013, NEUROBIOL DIS, V50, P42, DOI 10.1016/j.nbd.2012.09.007; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Gao X, 2010, PROTEIN CELL, V1, P552, DOI 10.1007/s13238-010-0067-1; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Gass J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-33; Guo A, 2010, BRAIN RES; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2002, CANCER RES, V62, P5590; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Irwin D, 2009, J NEUROL SCI, V276, P9, DOI 10.1016/j.jns.2008.08.024; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Kang KA, 2010, INT J MOL SCI, V11, P4348, DOI 10.3390/ijms11114348; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kelley BJ, 2010, ARCH NEUROL-CHICAGO, V67, P171, DOI 10.1001/archneurol.2010.113; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Kleinberger G, 2010, J NEUROCHEM, V115, P735, DOI 10.1111/j.1471-4159.2010.06961.x; Knowles RB, 1998, J NEUROPATH EXP NEUR, V57, P1122, DOI 10.1097/00005072-199812000-00003; Long ZM, 2015, CNS NEUROSCI THER, V21, P887, DOI 10.1111/cns.12445; Malaspina A, 2001, J NEUROCHEM, V77, P132, DOI 10.1046/j.1471-4159.2001.t01-1-00231.x; Maqbool M, 2016, EUR J MED CHEM, V107, P63, DOI 10.1016/j.ejmech.2015.10.018; Marr RA, 2003, J NEUROSCI, V23, P1992; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Martens LH, 2012, J CLIN INVEST; Marzo A, 2016, CURR BIOL, V26, P2551, DOI 10.1016/j.cub.2016.07.024; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; McGeer PL, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P271; McGeer PL, 2001, NEUROBIOL AGING, V22, P799, DOI 10.1016/S0197-4580(01)00289-5; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Nedachi T, 2011, NEUROSCIENCE, V185, P106, DOI 10.1016/j.neuroscience.2011.04.037; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Pereson S, 2009, J PATHOL, V219, P173, DOI 10.1002/path.2580; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Petoukhov E, 2013, J CELL SCI, V126, P5412, DOI 10.1242/jcs.132076; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Qian YS, 2015, EUR J PHARMACOL, V764, P298, DOI 10.1016/j.ejphar.2015.07.028; Qin R, 2011, TOXICOL LETT, V202, P1, DOI 10.1016/j.toxlet.2011.01.001; Revuelta GJ, 2008, AM J ALZHEIMERS DIS, V23, P488, DOI 10.1177/1533317508321910; Rosa E, 2015, NEUROBIOL AGING, V36, P2406, DOI 10.1016/j.neurobiolaging.2015.04.014; Rosen EY, 2011, NEURON, V71, P1030, DOI 10.1016/j.neuron.2011.07.021; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Schwab C, 2010, BBA-MOL BASIS DIS, V1802, P889, DOI 10.1016/j.bbadis.2009.10.013; Seira O, 2014, MOL NEUROBIOL, V49, P931, DOI 10.1007/s12035-013-8571-y; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sereno L, 2009, NEUROBIOL DIS, V35, P359, DOI 10.1016/j.nbd.2009.05.025; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Shruster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040843; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tao J, 2012, BRAIN RES, V1436, P130, DOI 10.1016/j.brainres.2011.11.063; Tapia L, 2011, J NEUROSCI, V31, P11126, DOI 10.1523/JNEUROSCI.6244-10.2011; Van Kampen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097032; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Yang YZ, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-14; Yao YM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-21; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang YR, 2016, J STAT MECH-THEORY E, P1, DOI 10.1088/1742-5468/2016/11/113207; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	91	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182896	10.1371/journal.pone.0182896	http://dx.doi.org/10.1371/journal.pone.0182896			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837568	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000032
J	Cascella, R; Fani, G; Capitini, C; Rusmini, P; Poletti, A; Cecchi, C; Chiti, F				Cascella, Roberta; Fani, Giulia; Capitini, Claudia; Rusmini, Paola; Poletti, Angelo; Cecchi, Cristina; Chiti, Fabrizio			Quantitative assessment of the degradation of aggregated TDP-43 mediated by the ubiquitin proteasome system and macroautophagy	FASEB JOURNAL			English	Article						ALS; FTLD-U; UPS; protein aggregation; motor neuron disease	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN B8 HSPB8; MOLECULAR CHAPERONES; SELECTIVE AUTOPHAGY; MUTATIONS; MECHANISMS; BINDING; BAG3; QUANTIFICATION	Amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positive inclusions are neurodegenerative disorders that share the cytosolic deposition of TDP-43 (TARDNA-binding protein 43) in the CNS. TDP-43 is well known as being actively degraded by both the proteasome and macroautophagy. The well-documented decrease in the efficiency of these clearance systems in aging and neurodegeneration, as well as the genetic evidence that many of the familial forms of TDP-43 proteinopathies involve genes that are associated with them, suggest that a failure of these protein degradation systems is a major factor that contributes to the onset of TDP-43-associated disorders. Here, we inserted preformed human TDP-43 aggregates in the cytosol of murine NSC34 and N2a cells in diffuse form and observed their degradation under conditions in which exogenous TDP-43 is not expressed and endogenous nuclear TDP-43 is not recruited, thereby allowing a time zero to be established in TDP-43 degradation and to observe its disposal kinetically and analytically. TDP-43 degradation was observed in the absence and presence of selective inhibitors and small interfering RNAs against the proteasome and autophagy. We found that cytosolic diffuse aggregates of TDP-43 can be distinguished in 3 different classes on the basis of their vulnerability to degradation, which contributed to the definition-with previous reports-of a total of 6 distinct classes of misfolded TDP-43 species that range from soluble monomer to undegradable macroaggregates. We also found that the proteasome and macroautophagy-degradable pools of TDP-43 are fully distinguishable, rather than in equilibrium between them on the time scale required for degradation, and that a significant crosstalk exists between the 2 degradation processes.	[Cascella, Roberta; Fani, Giulia; Capitini, Claudia; Cecchi, Cristina; Chiti, Fabrizio] Univ Florence, Dept Expt & Clin Biomed Sci, Vle GB Morgagni 50, I-50134 Florence, Italy; [Rusmini, Paola; Poletti, Angelo] Univ Milan, Ctr Eccellenza Malattie Neurodegenerat, Dipartimento Sci Farmacol & Biomol, Milan, Italy	University of Florence; University of Milan	Chiti, F (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, Vle GB Morgagni 50, I-50134 Florence, Italy.	fabrizio.chiti@unifi.it	Poletti, Angelo/A-9016-2011	Poletti, Angelo/0000-0002-8883-0468; Cecchi, Cristina/0000-0001-8387-7737; RUSMINI, PAOLA/0000-0001-9989-0733; Capitini, Claudia/0000-0003-2834-1424	Accademia Nazionale dei Lincei (Rome, Italy) [47/2014/A]	Accademia Nazionale dei Lincei (Rome, Italy)	This work was supported by the Accademia Nazionale dei Lincei (Rome, Italy) (47/2014/A). The authors thank Neil Cashman (University of British Columbia, Vancouver, BC, Canada) for providing the NSC34 cell line. The authors declare no conflicts of interest.	Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x; Bang Y, 2014, NEUROSCI LETT, V566, P263, DOI 10.1016/j.neulet.2014.02.056; Behl C, 2016, TRENDS PHARMACOL SCI, V37, P672, DOI 10.1016/j.tips.2016.04.007; Brandmeir NJ, 2008, ACTA NEUROPATHOL, V115, P123, DOI 10.1007/s00401-007-0315-5; Caccamo A, 2015, HUM MOL GENET, V24, P4625, DOI 10.1093/hmg/ddv193; Capitini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086720; Cappelli S, 2016, BIOL CHEM, V397, P401, DOI 10.1515/hsz-2015-0250; Cascella R, 2016, J BIOL CHEM, V291, P19437, DOI 10.1074/jbc.M116.737726; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Crippa V, 2016, HUM MOL GENET, V25, P3908, DOI 10.1093/hmg/ddw232; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Cristofani R, 2017, AUTOPHAGY, V13, P1280, DOI 10.1080/15548627.2017.1308985; Dantuma NP, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00070, 10.3389/fnmol.2014.00070]; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Diehl-Schmid J, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0489-x; Evangelisti E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32721; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Gamerdinger M, 2011, J MOL MED, V89, P1175, DOI 10.1007/s00109-011-0795-6; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Halliday G, 2012, ACTA NEUROPATHOL, V124, P373, DOI 10.1007/s00401-012-1030-4; Huang CC, 2014, J CELL SCI, V127, P3024, DOI 10.1242/jcs.136150; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kim SH, 2012, HUM MOL GENET, V21, P4845, DOI 10.1093/hmg/dds321; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McKinnon C, 2014, ANTIOXID REDOX SIGN, V21, P2302, DOI 10.1089/ars.2013.5802; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pandey UB, 2007, AUTOPHAGY, V3, P643, DOI 10.4161/auto.5050; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Ruegsegger C, 2016, BRAIN RES, V1648, P571, DOI 10.1016/j.brainres.2016.03.032; Rusmini P, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00176; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Sturner E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00177; Tashiro Y, 2012, J BIOL CHEM, V287, P42984, DOI 10.1074/jbc.M112.417600; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; van Eersel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022850; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33	55	24	24	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5609	5624		10.1096/fj.201700292RR	http://dx.doi.org/10.1096/fj.201700292RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842427				2022-12-26	WOS:000416588300040
J	Cheng, JH; Zhong, YH; Chen, S; Sun, Y; Huang, LT; Kang, YJ; Chen, BZ; Chen, G; Wang, FL; Tian, YP; Liu, WJ; Feng, GS; Lu, ZX				Cheng, Jianghong; Zhong, Yanhong; Chen, Shuai; Sun, Yan; Huang, Lantang; Kang, Yujia; Chen, Baozhen; Chen, Gang; Wang, Fengli; Tian, Yingpu; Liu, Wenjie; Feng, Gen-Sheng; Lu, Zhongxian			Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways	FASEB JOURNAL			English	Article						HCC; knockout mouse; IL-6; Jak2/Stat3 signaling pathway; therapeutic target	MAMMARY EPITHELIAL-CELLS; GRB2-ASSOCIATED BINDER 2; OVARIAN-CANCER; SCAFFOLDING ADAPTER; LIVER-CANCER; FATTY LIVER; EXPRESSION; PROMOTES; GROWTH; OVEREXPRESSION	Ourprevious studies have found that Growth factor receptor-bound protein2-associated binding protein 2 (Gab2)-a docking protein-governs the development of fatty liver disease. Here, we further demonstrate that Gab2mediates hepatocarcinogenesis. Compared with a faint expression in para-carcinoma tissue, Gab2 was highly expressed in similar to 60-70% of human hepatocellular carcinoma (HCC) specimens. Deletion of Gab2 dramatically suppressed diethylnitrosamine-induced HCC in mice. The oncogenic effects of Gab2 in HepG2 cells were promoted by Gab2 overexpression but were rescued by Gab2 knockdown. Furthermore, Gab2 knockout in HepG2 cells restrained cell proliferation, migration and tumor growth in nude mice. Signaling pathway analysis with protein kinase inhibitors demonstrated that oncogenic regulation by Gab2 in hepatic cells involved multiple signaling molecules, including ERK, Akt, and Janus kinases (Jaks), especially those that mediate inflammatory signaling. IL-6 signaling was increased by Gab2 overexpression and impaired by Gab2 deletion via regulation of Jak2 and signal transducer and activator of transcription 3 phosphorylation and the expression of downstream genes, such as Bcl-2 (B-cell lymphoma 2), c-Myc, MMP7 (matrix metalloproteinase-7), and cyclin D1 in vitro and in vivo. These data indicate that Gab2 mediates the pathologic progression of HCC by integrating multiple signaling pathways and suggest that Gab2 might be a powerful therapeutic target for HCC.	[Cheng, Jianghong; Zhong, Yanhong; Chen, Shuai; Sun, Yan; Huang, Lantang; Kang, Yujia; Wang, Fengli; Tian, Yingpu; Liu, Wenjie; Lu, Zhongxian] Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Pharmaceut Sci, Zhuangjin Hall,Room 319, Xiamen 361005, Peoples R China; [Chen, Baozhen; Chen, Gang] Fujian Prov Tumor Hosp, Dept Pathol, Fuzhou, Fujian, Peoples R China; [Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, Div Biol Sci, La Jolla, CA 92093 USA	Xiamen University; University of California System; University of California San Diego	Lu, ZX (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Pharmaceut Sci, Zhuangjin Hall,Room 319, Xiamen 361005, Peoples R China.	zhongxian@xmu.edu.cn	Lu, ZX/G-4586-2010		National Natural Science Foundation of China [81470111, 30772546]; National Basic Research Program of China [2013CB945503, 2010CB945004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grants 81470111 and 30772546) and the National Basic Research Program of China (Grants 2013CB945503 and 2010CB945004). The authors declare no conflicts of interest.	Abreu MTH, 2011, MOL BIOL CELL, V22, P105, DOI 10.1091/mbc.E10-03-0185; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Berasain C, 2014, J GASTROENTEROL, V49, P9, DOI 10.1007/s00535-013-0907-x; Bhala N, 2013, CURR PHARM DESIGN, V19, P5169, DOI 10.2174/13816128113199990336; Bocanegra M, 2010, ONCOGENE, V29, P774, DOI 10.1038/onc.2009.364; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Boudot C, 2002, CELL SIGNAL, V14, P869, DOI 10.1016/S0898-6568(02)00036-0; Breitkopf SB, 2016, SCI REP-UK, V6, DOI 10.1038/srep20471; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Chauhan Ranjit, 2016, Biomark Cancer, V8, P37, DOI 10.4137/BIC.S34413; Chen S, 2016, J MOL CELL BIOL, V8, P492, DOI 10.1093/jmcb/mjw028; Chen YM, 2016, TUMOR BIOL, V37, P10861, DOI 10.1007/s13277-016-4909-1; Chernoff KA, 2009, CLIN CANCER RES, V15, P4288, DOI 10.1158/1078-0432.CCR-09-0280; Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522; Davis SJ, 2015, MOL CANCER THER, V14, P1495, DOI 10.1158/1535-7163.MCT-15-0039; Ding CB, 2015, MOL MED REP, V12, P4007, DOI 10.3892/mmr.2015.3951; Duckworth C, 2016, ONCOGENE, V35, P4036, DOI 10.1038/onc.2015.472; Enguita-German M, 2014, WORLD J HEPATOL, V6, P716, DOI 10.4254/wjh.v6.i10.716; Fleuren EDG, 2010, INT J CANCER, V127, P1486, DOI 10.1002/ijc.25172; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Gu SQ, 2016, BLOOD, V127, P1803, DOI 10.1182/blood-2015-06-653006; Halbach S, 2016, LEUKEMIA, V30, P1942, DOI 10.1038/leu.2016.92; Halbach S, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0129-y; Hu X, 2016, CLIN LAB, V62, P1087, DOI 10.7754/Clin.Lab.2015.151008; Joshi K, 2016, CLIN LIVER DIS, V20, P563, DOI 10.1016/j.cld.2016.02.012; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Lee SH, 2007, PATHOLOGY, V39, P326, DOI 10.1080/00313020701329773; Liu H, 2014, P NATL ACAD SCI USA, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0113875; Liu XM, 2016, ONCOL REP, V36, P1385, DOI 10.3892/or.2016.4971; Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Moriguchi M, 2016, CLIN J GASTROENTEROL, V9, P184, DOI 10.1007/s12328-016-0670-7; Nagao T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084746; Pan XL, 2010, NEUROSCI BULL, V26, P241, DOI 10.1007/s12264-010-1109-7; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Scaiewicz V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081065; Sha F, 2013, P NATL ACAD SCI USA, V110, P14924, DOI 10.1073/pnas.1303640110; Shi LH, 2013, ACTA ONCOL, V52, P1739, DOI 10.3109/0284186X.2012.750032; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; Strazzabosco M, 2012, GASTROENTEROLOGY, V143, P1430, DOI 10.1053/j.gastro.2012.10.025; Sun L, 2016, MOL CARCINOGEN, V55, P40, DOI 10.1002/mc.22256; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; Teal HE, 2006, ONCOGENE, V25, P2433, DOI 10.1038/sj.onc.1209288; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Tian LQ, 2016, MOL MED REP, V13, P4279, DOI 10.3892/mmr.2016.5076; Vaughan TY, 2011, AM J BLOOD RES, V1, P130; Wang WJ, 2015, INT J CLIN EXP PATHO, V8, P10575; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; WRIGHT TL, 1993, LANCET, V342, P1340, DOI 10.1016/0140-6736(93)92250-W; Wu J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0229-3; Xia CX, 2015, CELL PHYSIOL BIOCHEM, V37, P677, DOI 10.1159/000430386; Xie GZ, 2012, INT J ONCOL, V40, P1171, DOI 10.3892/ijo.2011.1275; Xu XL, 2011, INT J BIOL SCI, V7, P496, DOI 10.7150/ijbs.7.496; Yajima I, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/354191; Yang Y, 2013, ONCOGENE, V32, P3627, DOI 10.1038/onc.2012.367; Zhang XC, 2013, MOL CELL BIOL, V33, P1657, DOI 10.1128/MCB.01353-12; Zhang X, 2015, WORLD J HEPATOL, V7, P1282, DOI 10.4254/wjh.v7.i9.1282	58	17	18	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5530	+		10.1096/fj.201700120RR	http://dx.doi.org/10.1096/fj.201700120RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842424	Green Published			2022-12-26	WOS:000416588300034
J	Ning, YJ; Feng, K; Min, YQ; Deng, F; Hu, ZH; Wang, HL				Ning, Yun-Jia; Feng, Kuan; Min, Yuan-Qin; Deng, Fei; Hu, Zhihong; Wang, Hualin			Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOCYTOPENIA SYNDROME VIRUS; NF-KAPPA-B; SEVERE FEVER; RIG-I; ADAPTER PROTEIN; BUNYAVIRIDAE PHLEBOVIRUS; NONSTRUCTURAL PROTEIN; UNITED-STATES; IKK-EPSILON; INNATE	Heartland virus (HRTV) is a pathogenic phlebovirus related to the severe fever with thrombocytopenia syndrome virus (SFTSV), another phlebovirus causing life-threatening disease in humans. Previous findings have suggested that SFTSV can antagonize the host interferon (IFN) system via viral nonstructural protein (NSs)-mediated sequestration of antiviral signaling proteins into NSs-induced inclusion bodies. However, whether and how HRTV counteracts the host innate immunity is unknown. Here, we report that HRTV NSs (HNSs) also antagonizes IFN and cytokine induction and bolsters viral replication, although no noticeable inclusion body formation was observed in HNSs-expressing cells. Furthermore, HNSs inhibited the virus-triggered activation of IFN-beta promoter by specifically targeting the IFN-stimulated response element but not the NF-kappa B response element. Consistently, HNSs blocked the phosphorylation and nuclear translocation of IFN regulatory factor 3 (IRF3, an IFN-stimulated response element-activating transcription factor). Reporter gene assays next showed that HNSs blockades the antiviral signaling mediated by RIG-I-like receptors likely at the level of TANK-binding kinase 1 (TBK1). Indeed, HNSs strongly interacts with TBK1 as indicated by confocal microscopy and pulldown analyses, and we also noted that the scaffold dimerization domain of TBK1 is required for the TBK1-HNSs interaction. Finally, pulldown assays demonstrated that HNSs expression dose-dependently diminishes a TBK1-IRF3 interaction, further explaining the mechanism for HNSs function. Collectively, these data suggest that HNSs, an antagonist of host innate immunity, interacts with TBK1 and thereby hinders the association of TBK1 with its substrate IRF3, thus blocking IRF3 activation and transcriptional induction of the cellular antiviral responses.	[Ning, Yun-Jia; Feng, Kuan; Min, Yuan-Qin; Deng, Fei; Hu, Zhihong; Wang, Hualin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China; [Feng, Kuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, HL (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China.	h.wang@wh.iov.cn	Hu, Zhihong/AAS-2215-2020	Hu, Zhihong/0000-0002-1560-0928	National Natural Science Foundation of China [31621061, 31600144]; strategic priority research program of the Chinese Academy of Sciences [XDPB0301]; National Basic Research Program (973 Program) of China [2013CB911101]; Science and Technology Basic Work Program [2013FY113500]; National Key Research and Development Program of China [2016YFC1200400, 2016YFE0113500]; European Union's Horizon 2020 project European Virus Archive goes global (EVAg) [653316]; Hubei Provincial Natural Science Foundation of China [2016CFB124]; "One-Three-Five" Research Program of Wuhan Institute of Virology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); strategic priority research program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program (973 Program) of China(National Basic Research Program of China); Science and Technology Basic Work Program; National Key Research and Development Program of China; European Union's Horizon 2020 project European Virus Archive goes global (EVAg); Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "One-Three-Five" Research Program of Wuhan Institute of Virology	This work was supported by the National Natural Science Foundation of China (31621061 and 31600144), the strategic priority research program of the Chinese Academy of Sciences (XDPB0301), the National Basic Research Program (973 Program) of China (2013CB911101), the Science and Technology Basic Work Program (2013FY113500), the National Key Research and Development Program of China (2016YFC1200400 and 2016YFE0113500), European Union's Horizon 2020 project European Virus Archive goes global (EVAg, Grant 653316), the Hubei Provincial Natural Science Foundation of China (2016CFB124), and the "One-Three-Five" Research Program of Wuhan Institute of Virology. The authors declare that they have no conflicts of interest with the contents of this article.	Bosco-Lauth AM, 2016, EMERG INFECT DIS, V22, P2070, DOI 10.3201/eid2212.160472; Bosco-Lauth AM, 2015, AM J TROP MED HYG, V92, P1163, DOI 10.4269/ajtmh.14-0702; Chen H, 2013, J MOL CELL BIOL, V5, P111, DOI 10.1093/jmcb/mjt006; Denic S, 2011, CASE REP INFECT DIS, V2011, DOI 10.1155/2011/204056; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Errett JS, 2015, VIROL SIN, V30, P163, DOI 10.1007/s12250-015-3604-5; Fill MMA, 2017, CLIN INFECT DIS, V64, P510, DOI 10.1093/cid/ciw766; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gowen BB, 2017, J VIROL, V91, DOI 10.1128/JVI.01942-16; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DY, 2015, CURR OPIN VIROL, V12, P26, DOI 10.1016/j.coviro.2015.02.005; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Matsuno K, 2015, J VIROL, V89, P594, DOI 10.1128/JVI.02704-14; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mourya DT, 2014, J VIROL, V88, P3605, DOI 10.1128/JVI.02617-13; Muehlenbachs A, 2014, CLIN INFECT DIS, V59, P845, DOI 10.1093/cid/ciu434; Ning YJ, 2015, J VIROL, V89, P4227, DOI 10.1128/JVI.00154-15; Ning YJ, 2014, J MOL CELL BIOL, V6, DOI 10.1093/jmcb/mju015; Pastula DM, 2014, MMWR-MORBID MORTAL W, V63, P270; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; Ran Y, 2016, J MOL CELL BIOL, V8, P31, DOI 10.1093/jmcb/mjv068; Riemersma KK, 2015, EMERG INFECT DIS, V21, P1830, DOI 10.3201/eid2110.150380; Santiago FW, 2014, J VIROL, V88, P4572, DOI 10.1128/JVI.03021-13; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sparrer KMJ, 2015, CURR OPIN MICROBIOL, V26, P1, DOI 10.1016/j.mib.2015.03.001; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Sun LJ, 2010, CELL, V140, P436, DOI 10.1016/j.cell.2010.01.041; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748; Wang J, 2014, EMERG INFECT DIS, V20, P1040, DOI 10.3201/eid2006.140003; Wang YY, 2012, CELL HOST MICROBE, V12, P129, DOI 10.1016/j.chom.2012.07.006; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107; Wu XD, 2014, FASEB J, V28, P2504, DOI 10.1096/fj.13-243857; Wu XD, 2014, J VIROL, V88, P3067, DOI 10.1128/JVI.03510-13; Wuerth JD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060174; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	54	25	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16722	16733		10.1074/jbc.M117.805127	http://dx.doi.org/10.1074/jbc.M117.805127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28848048	Green Published, hybrid			2022-12-26	WOS:000412414800031
J	Busch, AA; Kunert, G; Heckel, DG; Pauchet, Y				Busch, Andre A.; Kunert, Grit; Heckel, David G.; Pauchet, Yannick			Evolution and functional characterization of CAZymes belonging to subfamily 10 of glycoside hydrolase family 5 (GH5_10) in two species of phytophagous beetles	PLOS ONE			English	Article							MULBERRY LONGICORN BEETLE; WALL DEGRADING ENZYMES; MOLECULAR-CLONING; ANTARCTIC SPRINGTAIL; ENZYMATIC-ACTIVITY; BETA-MANNANASE; CDNA CLONING; BLUE MUSSEL; EXPRESSION; CELLULASE	Hemicelluloses, such as xyloglucan, xylan and mannans, consist of a heterogeneous array of plant-derived polysaccharides that form the plant cell wall. These polysaccharides differ from each other in their structure and physiochemical properties, but they share a beta-(1,4)linked sugar backbone. Hemicelluloses can be hydrolyzed by plant-cell-wall-degrading enzymes (PCWDEs), which are widely distributed in phytopathogenic microbes. Recently, it has become apparent that phytophagous beetles also produce their own PCWDEs. Our previous work identified genes encoding putative mannanases belonging to the subfamily 10 of glycoside hydrolase (GH) family 5 (GH5_10) in the genomes of the leaf beetle, Gastrophysa viridula (Chrysomelidae, Chrysomelinae; one gene), and of the bean beetle, Callosobruchus maculatus (Chrysomelidae, Bruchinae; four genes). In contrast to proteins from other GH5 subfamilies, GH5_10 proteins are patchily distributed within the tree of life and have so far hardly been investigated. We addressed the following questions: Are beetle-derived GH5_10s active PCWDEs? How did they evolve? What is their physiological function? Using heterologous protein expression and enzymatic assays, we show that the G. viridula GH5_10 protein is an endo-beta-1,4-mannanase. We also demonstrate that only one out of four C. maculatus GH5_10 proteins is an endo-beta-1,4-mannanase, which has additional activity on carboxymethyl cellulose. Unexpectedly, another C. maculatus GH5_10 protein has evolved to use xylan instead of mannans as a substrate. RNAi experiments in G. viridula indicate (i) that the sole GH5_10 protein is responsible for breaking down mannans in the gut and (ii) that this breakdown may rather be accessory and may facilitate access to plant cell content, which is rich in nitrogen and simple sugars. Phylogenetic analyses indicate that coleopteran-derived GH5_10 proteins cluster together with Chelicerata-derived ones. Interestingly, other insect-derived GH5_10 proteins cluster elsewhere, suggesting insects have several independent evolutionary origins.	[Busch, Andre A.; Heckel, David G.; Pauchet, Yannick] Max Planck Inst Chem Ecol, Entomol, Jena, Germany; [Kunert, Grit] Max Planck Inst Chem Ecol, Biochem, Jena, Germany	Max Planck Society; Max Planck Society	Pauchet, Y (corresponding author), Max Planck Inst Chem Ecol, Entomol, Jena, Germany.	ypauchet@ice.mpg.de	Heckel, David G/K-2138-2013; Kunert, Grit/H-4271-2014; Pauchet, Yannick/AAU-9751-2021	Heckel, David G/0000-0001-8991-2150; Kunert, Grit/0000-0002-9969-8044; Pauchet, Yannick/0000-0002-2918-8946	Max-Planck-Gesellschaft	Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by Max-Planck-Gesellschaft (YP, AB, GK, DGH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna R, 2012, P NATL ACAD SCI USA, V109, P4197, DOI 10.1073/pnas.1121190109; Angelov A, 2010, J BACTERIOL, V192, P6492, DOI 10.1128/JB.01023-10; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Buckeridge MS, 2010, PLANT PHYSIOL, V154, P1017, DOI 10.1104/pp.110.158642; Buckeridge MS, 2000, PLANT PHYSIOL BIOCH, V38, P141, DOI 10.1016/S0981-9428(00)00162-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chi YH, 2009, INSECT MOL BIOL, V18, P97, DOI 10.1111/j.1365-2583.2008.00854.x; Cosgrove DJ, 2014, CURR OPIN PLANT BIOL, V22, P122, DOI 10.1016/j.pbi.2014.11.001; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Crawley M.J., 2007, R BOOK; Rodriguez-Gacio MDC, 2012, J EXP BOT, V63, P3975, DOI 10.1093/jxb/ers096; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dodd D, 2010, J BIOL CHEM, V285, P30261, DOI 10.1074/jbc.M110.141788; Feiz L, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-10; FOONG FCF, 1992, J BACTERIOL, V174, P1403, DOI 10.1128/jb.174.4.1403-1409.1992; Girard C, 1999, INSECT BIOCHEM MOLEC, V29, P1129, DOI 10.1016/S0965-1748(99)00104-6; Iakiviak M, 2011, APPL ENVIRON MICROB, V77, P7541, DOI 10.1128/AEM.06088-11; Iseli C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000579; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Kim MK, 2014, PROTEINS, V82, P3217, DOI 10.1002/prot.24655; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Kirsch R, 2014, INSECT BIOCHEM MOLEC, V52, P33, DOI 10.1016/j.ibmb.2014.06.008; Kirsch Roy, 2012, BMC Genomics, V13, P587, DOI 10.1186/1471-2164-13-587; Kuwar SS, 2015, INSECT BIOCHEM MOLEC, V59, P18, DOI 10.1016/j.ibmb.2015.01.016; Larsson AM, 2006, J MOL BIOL, V357, P1500, DOI 10.1016/j.jmb.2006.01.044; Lee SJ, 2004, COMP BIOCHEM PHYS B, V139, P107, DOI 10.1016/j.cbpc.2004.06.015; Lee SJ, 2005, COMP BIOCHEM PHYS B, V140, P551, DOI 10.1016/j.cbpc.2004.12.003; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malgas S, 2015, WORLD J MICROB BIOT, V31, P1167, DOI 10.1007/s11274-015-1878-2; Marvaldi AE, 2009, ZOOL SCR, V38, P63, DOI 10.1111/j.1463-6409.2008.00360.x; Matheson N.K., 1990, METHODS PLANT BIOCH, V2, P371, DOI DOI 10.1016/B978-0-12-461012-5.50017-3; McKenna DD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1088-8; Meier H., 1982, Encyclopedia of plant physiology. New series. Volume 13 A. Plant carbohydrates. I. Intracellular carbohydrates [Loewus, F.A.; Tanner, W. (Editors)], P418; Nogueira FCS, 2012, PROTEOMICS, V12, P2704, DOI 10.1002/pmic.201200039; Ootsuka S, 2006, J BIOTECHNOL, V125, P269, DOI 10.1016/j.jbiotec.2006.03.008; Padilla-Hurtado Beatriz, 2012, BMC Research Notes, V5, DOI 10.1186/1756-0500-5-23; Pauchet Y, 2014, INSECT MOL BIOL, V23, P286, DOI 10.1111/imb.12081; Pauchet Y, 2014, INSECT BIOCHEM MOLEC, V49, P1, DOI 10.1016/j.ibmb.2014.03.004; Pauchet Y, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1021; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2014, R A LANGUAGE AND ENV; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Scherbukhin VD, 1999, APPL BIOCHEM MICRO+, V35, P229; SINHA R. N., 1959, ANN ENT SOC AMER, V52, P763; Song JM, 2008, COMP BIOCHEM PHYS B, V151, P32, DOI 10.1016/j.cbpb.2008.05.005; Soni H., 2013, ADV ENZYME BIOTECHNO, P41, DOI DOI 10.1007/978-81-322-1094-8_4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valencia A, 2013, GENE, V513, P260, DOI 10.1016/j.gene.2012.10.046; Vega FE, 2015, SCI REP-UK, V5, DOI 10.1038/srep12525; Wei YD, 2006, COMP BIOCHEM PHYS B, V145, P220, DOI 10.1016/j.cbpb.2006.07.007; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Xu BZ, 2002, J BIOTECHNOL, V92, P267, DOI 10.1016/S0168-1656(01)00367-4; Zahura UA, 2011, COMP BIOCHEM PHYS B, V159, P227, DOI 10.1016/j.cbpb.2011.05.001; Zuur A, 2009, MIXED EFFECTS MODELS	56	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0184305	10.1371/journal.pone.0184305	http://dx.doi.org/10.1371/journal.pone.0184305			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854242	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600090
J	Masson, JJR; Murphy, AJ; Lee, MKS; Ostrowski, M; Crowe, SM; Palmer, CS				Masson, Jesse J. R.; Murphy, Andrew J.; Lee, Man K. S.; Ostrowski, Matias; Crowe, Suzanne M.; Palmer, Clovis S.			Assessment of metabolic and mitochondrial dynamics in CD4+and CD8+T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy	PLOS ONE			English	Article							CD4(+) T-CELLS; MEMORY DIFFERENTIATION; EFFECTOR FUNCTION; MEMBRANE PERMEABILIZATION; RESERVOIR PERSISTENCE; AEROBIC GLYCOLYSIS; GLUCOSE-UPTAKE; IMMUNOMETABOLISM; SUBSETS; ACTIVATION	Metabolism plays a fundamental role in supporting the growth, proliferation and effector functions of T cells. We investigated the impact of HIV infection on key processes that regulate glucose uptake and mitochondrial biogenesis in subpopulations of CD4+ and CD8+ T cells from 18 virologically-suppressed HIV-positive individuals on combination antiretroviral therapy (cART; median CD4+ cell count: 728 cells/mu l) and 13 HIV seronegative controls. Mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) production were also analysed in total CD4+ and CD8+ T cells. Among HIV+/cART individuals, expression of glucose transporter (Glut1) and mitochondrial density were highest within central memory and naive CD4+ T cells, and lowest among effector memory and transitional memory T cells, with similar trends in HIV-negative controls. Compared to HIV-negative controls, there was a trend towards higher percentage of circulating CD4+Glut1+ T cells in HIV+/cART participants. There were no significant differences in mitochondrial dynamics between subject groups. Glut1 expression was positively correlated with mitochondrial density and MMP in total CD4+ T cells, while MMP was also positively correlated with ROS production in both CD4+ and CD8+ T cells. Our study characterizes specific metabolic features of CD4+ and CD8+ T cells in HIV-negative and HIV+/cART individuals and will invite future studies to explore the immunometabolic consequences of HIV infection.	[Masson, Jesse J. R.] James Cook Univ, Cairns, Australia; [Masson, Jesse J. R.; Crowe, Suzanne M.; Palmer, Clovis S.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Murphy, Andrew J.; Lee, Man K. S.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Ostrowski, Matias] Fac Med, Inst Invest Biomed Retrovirus & SIDA, Buenos Aires, DF, Argentina; [Crowe, Suzanne M.; Palmer, Clovis S.] Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia; [Palmer, Clovis S.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia	James Cook University; Burnet Institute; Baker Heart and Diabetes Institute; Monash University; University of Melbourne	Palmer, CS (corresponding author), Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia.; Palmer, CS (corresponding author), Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia.; Palmer, CS (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	cpalmer@burnet.edu.au	Palmer, Clovis/P-1986-2019	Palmer, Clovis/0000-0002-5031-6922; Murphy, Andrew/0000-0001-7039-7777; Ostrowski, Matias/0000-0002-3982-1338	Australian Centre for HIV and Hepatitis Virology Research (ACH2); University of Washington Center for AIDS Research (CFAR); NIH - NIH Institutes and Centers (NIAID) [A1027757]; NCI; NIMH; NIDA; NICHD; NHLBI; NIA; CNIHR; ACH2 grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	Australian Centre for HIV and Hepatitis Virology Research (ACH2); University of Washington Center for AIDS Research (CFAR); NIH - NIH Institutes and Centers (NIAID); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CNIHR; ACH2 grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the Australian Centre for HIV and Hepatitis Virology Research (ACH2) and a 2010 developmental grant (CNIHR) from the University of Washington Center for AIDS Research (CFAR), an NIH funded program under award number A1027757 which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA). C.S.P. is a recipient of the CNIHR and ACH2 grant.	Almeida L, 2016, SEMIN IMMUNOL, P30106; Autran B, 2016, AIDS, V30, P2896, DOI 10.1097/QAD.0000000000001284; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Cao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104104; Capel E, 2012, ANTIVIR THER, V17, P549, DOI 10.3851/IMP1988; Chang CH, 2016, NAT IMMUNOL, V17, P364, DOI 10.1038/ni.3415; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; Cretenet G, 2016, SCI REP-UK, V6, DOI 10.1038/srep24129; Dagenais-Lussier X, 2015, CYTOKINE GROWTH F R, V26, P603, DOI 10.1016/j.cytogfr.2015.09.001; Dimeloe S, 2016, J IMMUNOL, V196, P106, DOI 10.4049/jimmunol.1501766; Fraser KA, 2013, IMMUNITY, V39, P171, DOI 10.1016/j.immuni.2013.07.003; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Gibellini L, 2017, AIDS, V31, P1387, DOI 10.1097/QAD.0000000000001510; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Gumbi PP, 2011, J VIROL, V85, P13333, DOI 10.1128/JVI.05671-11; Haas R., 2016, TRENDS BIOCHEM SCI, P26; Howell JJ, 2017, CELL METAB, V25, P463, DOI 10.1016/j.cmet.2016.12.009; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jung MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30887; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Lecoeur H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.21; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Maekawa Y, 2015, NAT MED, V21, P55, DOI 10.1038/nm.3758; Matheson NJ, 2016, CURR OPIN VIROL, V19, P65, DOI 10.1016/j.coviro.2016.06.014; Mathieu C, 2015, EUR J IMMUNOL, V45, P3324, DOI 10.1002/eji.201546000; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Murray PJ, 2015, CELL METAB, V22, P190, DOI 10.1016/j.cmet.2015.06.014; Nemes E, 2006, AIDS, V20, P2021, DOI 10.1097/01.aids.0000247575.41622.b1; Ngo DC, 2015, MOL BIOL REP, V42, P819, DOI 10.1007/s11033-015-3857-y; Palmer C, 2008, HEPATOLOGY, V48, P374, DOI 10.1002/hep.22387; Palmer CS, 2016, AIDS, V30, P2895, DOI 10.1097/QAD.0000000000001114; Palmer CS, 2016, INT REV IMMUNOL, V35, P477, DOI 10.3109/08830185.2015.1082178; Palmer CS, 2016, J IMMUNOL, V196, P4437, DOI 10.4049/jimmunol.1600120; Palmer CS, 2016, EBIOMEDICINE, V6, P31, DOI 10.1016/j.ebiom.2016.02.012; Palmer CS, 2014, AIDS, V28, P297, DOI 10.1097/QAD.0000000000000128; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Xu Y, 2016, J CLIN INVEST, V126, P2678, DOI 10.1172/JCI85834; Yap M, 2016, AM J TRANSPLANT, V16, P999, DOI 10.1111/ajt.13581; Yu FT, 2017, JAIDS-J ACQ IMM DEF, V74, P206, DOI 10.1097/qai.0000000000001175; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhang LJ, 2016, CELL REP, V14, P1206, DOI 10.1016/j.celrep.2015.12.095	56	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183931	10.1371/journal.pone.0183931	http://dx.doi.org/10.1371/journal.pone.0183931			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854263	Green Published, gold, Green Accepted			2022-12-26	WOS:000408693600067
J	Aftab, SMA; Ahmad, KA				Aftab, S. M. A.; Ahmad, K. A.			CFD study on NACA 4415 airfoil implementing spherical and sinusoidal Tubercle Leading Edge	PLOS ONE			English	Article							HYDRODYNAMIC CHARACTERISTICS; FLOW	The Humpback whale tubercles have been studied for more than a decade. Tubercle Leading Edge (TLE) effectively reduces the separation bubble size and helps in delaying stall. They are very effective in case of low Reynolds number flows. The current Computational Fluid Dynamics (CFD) study is on NACA 4415 airfoil, at a Reynolds number 120,000. Two TLE shapes are tested on NACA 4415 airfoil. The tubercle designs implemented on the airfoil are sinusoidal and spherical. A parametric study is also carried out considering three amplitudes (0.025c, 0.05c and 0.075c), the wavelength (0.25c) is fixed. Structured mesh is utilized to generate grid and Transition SST turbulence model is used to capture the flow physics. Results clearly show spherical tubercles outperform sinusoidal tubercles. Furthermore experimental study considering spherical TLE is carried out at Reynolds number 200,000. The experimental results show that spherical TLE improve performance compared to clean airfoil.	[Aftab, S. M. A.; Ahmad, K. A.] Univ Putra Malaysia, Dept Aerosp Engn, Serdang 43400, Malaysia; [Ahmad, K. A.] King Saud Univ, Mech Engn Dept, Coll Engn, POB 800, Riyadh 11421, Saudi Arabia	Universiti Putra Malaysia; King Saud University	Ahmad, KA (corresponding author), Univ Putra Malaysia, Dept Aerosp Engn, Serdang 43400, Malaysia.; Ahmad, KA (corresponding author), King Saud Univ, Mech Engn Dept, Coll Engn, POB 800, Riyadh 11421, Saudi Arabia.	aekamarul@upm.edu.my	arifin, kamarul/AAL-2920-2020	Aftab, Syed/0000-0003-2583-571X; arifin, kamarul/0000-0002-4065-4266	Ministry of Science, Technology and Innovation (MOSTI), Malaysia through the e-science fund [04-01-04-SF2206]	Ministry of Science, Technology and Innovation (MOSTI), Malaysia through the e-science fund	The authors would like to acknowledge the support provided by the Ministry of Science, Technology and Innovation (MOSTI), Malaysia, for providing funds through the e-science fund, grant no 04-01-04-SF2206, for the current research.; The authors would like to acknowledge the support provided by the Ministry of Science, Technology and Innovation (MOSTI), Malaysia, for providing funds through the e-science fund, grant no 04-01-04-SF2206, for the current research. The authors are also grateful for the facilities provided by the College of Engineering Research Center at King Saud University, for this work.	Aftab SMA, 2016, PROG AEROSP SCI, V84, P48, DOI 10.1016/j.paerosci.2016.03.002; Aftab SMA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153755; Aftab S. M. A., 2014, Applied Mechanics and Materials, V629, P30, DOI 10.4028/www.scientific.net/AMM.629.30; [Anonymous], [No title captured]; Borg Jonathan, 2012, EFFECT LEADING EDGE; Chen H, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1761-1; Chen H, 2013, SCI CHINA TECHNOL SC, V56, P772, DOI 10.1007/s11431-013-5143-3; Corsini A, 2013, J FLUID ENG-T ASME, V135, DOI 10.1115/1.4024115; Fouatih OM, 2016, EUR J MECH B-FLUID, V56, P82, DOI 10.1016/j.euromechflu.2015.11.006; Gawad A. F. A., 2012, INT MECH ENG C EXP; Gawad A. F. A., 2013, TRANSACTION CONTROL, V2; Goruney T, 2009, EXP FLUIDS, V47, P321, DOI 10.1007/s00348-009-0666-x; Johari H, 2007, AIAA J, V45, P2634, DOI 10.2514/1.28497; Kartikawati N.K., 2014, PRASTYONO BUDIDAYA D, P1; Kim MJ, 2012, INT J NAV ARCH OCEAN, V4, P447, DOI 10.3744/JNAOE.2012.4.4.447; Kouh J. S., 2011, FLUCOME 2011, P1; Langtry RB, 2009, AIAA J, V47, P2894, DOI 10.2514/1.42362; Lohry Mark W., 2013, 31st AIAA Applied Aerodynamics Conference, P1; Miklosovic DS, 2007, J AIRCRAFT, V44, P1404, DOI 10.2514/1.30303; Pope A, 1966, LOW SPEED WIND TUNNE; Rostamzadeh N., 2012, P 18 AUSTR FLUID MEC, P1; Skillen A, 2015, AIAA J, V53, P464, DOI 10.2514/1.J053142; Swanson T., 6 AIAA THEOR FLUID M, P1; Wisuda, 2012, UPM EXTERNAL BALANCE; Yoon HS, 2011, COMPUT FLUIDS, V49, P276, DOI 10.1016/j.compfluid.2011.06.010; Zhang LH, 2013, ADV MATER RES-SWITZ, V602-604, P1761, DOI 10.4028/www.scientific.net/AMR.602-604.1761; Zhang MM, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1710-z; Zhang MM, 2013, AIAA J, V51, P1960, DOI 10.2514/1.J052319; Zhang MM, 2014, FLUID STRUCTURE SOUN, P107, DOI [10.1007/978-3-642-40371-2_15, DOI 10.1007/978-3-642-40371-2_15]	30	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183456	10.1371/journal.pone.0183456	http://dx.doi.org/10.1371/journal.pone.0183456			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850622	Green Published, Green Submitted, gold			2022-12-26	WOS:000408544200014
J	Aguera, A; Ahn, IY; Guillaumot, C; Danis, B				Aguera, Antonio; Ahn, In-Young; Guillaumot, Charlene; Danis, Bruno			A Dynamic Energy Budget (DEB) model to describe Laternula elliptica (King, 1832) seasonal feeding and metabolism	PLOS ONE			English	Article							WESTERN ANTARCTIC PENINSULA; GEORGE-ISLAND; CLIMATE-CHANGE; POTTER COVE; SEA-ICE; COVARIATION METHOD; LARVAL DEVELOPMENT; MARIAN COVE; BIVALVE; BRODERIP	Antarctic marine organisms are adapted to an extreme environment, characterized by a very low but stable temperature and a strong seasonality in food availability arousing from variations in day length. Ocean organisms are particularly vulnerable to global climate change with some regions being impacted by temperature increase and changes in primary production. Climate change also affects the biotic components of marine ecosystems and has an impact on the distribution and seasonal physiology of Antarctic marine organisms. Knowledge on the impact of climate change in key species is highly important because their performance affects ecosystem functioning. To predict the effects of climate change on marine ecosystems, a holistic understanding of the life history and physiology of Antarctic key species is urgently needed. DEB (Dynamic Energy Budget) theory captures the metabolic processes of an organism through its entire life cycle as a function of temperature and food availability. The DEB model is a tool that can be used to model lifetime feeding, growth, reproduction, and their responses to changes in biotic and abiotic conditions. In this study, we estimate the DEB model parameters for the bivalve Laternula elliptica using literatureextracted and field data. The DEB model we present here aims at better understanding the biology of L. elliptica and its levels of adaptation to its habitat with a special focus on food seasonality. The model parameters describe a metabolism specifically adapted to low temperatures, with a low maintenance cost and a high capacity to uptake and mobilise energy, providing this organism with a level of energetic performance matching that of related species from temperate regions. It was also found that L. elliptica has a large energy reserve that allows enduring long periods of starvation. Additionally, we applied DEB parameters to time-series data on biological traits (organism condition, gonad growth) to describe the effect of a varying environment in food and temperature on the organism condition and energy use. The DEB model developed here for L. elliptica allowed us to improve benchmark knowledge on the ecophysiology of this key species, providing new insights in the role of food availability and temperature on its life cycle and reproduction strategy.	[Aguera, Antonio; Guillaumot, Charlene; Danis, Bruno] Univ Libre Bruxelles, Lab Biol Marine CP160 15, Brussels, Belgium; [Ahn, In-Young] Korea Polar Res Inst KOPRI, Incheon, South Korea	Universite Libre de Bruxelles; Korea Polar Research Institute (KOPRI)	Aguera, A (corresponding author), Univ Libre Bruxelles, Lab Biol Marine CP160 15, Brussels, Belgium.	antonio.aguera@gmail.com	Danis, Bruno/AAS-8444-2021; Agüera, Antonio/O-5498-2017	Danis, Bruno/0000-0002-9037-7623; Agüera, Antonio/0000-0003-0076-1849	project vERSO from Belgian Office of Science, BELSPO [BR/132/A1/vERSO]; KOPRI [PE17070]; Belgian Science Policy Office (BELSPO [BR/132/A1/vERSO]; Korea Polar Research Institute [PE17070]	project vERSO from Belgian Office of Science, BELSPO; KOPRI(Korea Polar Research Institute of Marine Research Placement (KOPRI)); Belgian Science Policy Office (BELSPO(Belgian Federal Science Policy Office); Korea Polar Research Institute(Korea Polar Research Institute of Marine Research Placement (KOPRI))	This work is funded by the project vERSO (from the Belgian Office of Science, BELSPO contract no BR/132/A1/vERSO). This fund covered the time invested by the researchers at the University Libre de Bruxelles on this work. Marian Cove field data used was provided and previously published by author I-YA. Marian Cove data collection was funded by KOPRI (PE17070).; This is contribution no. 19 to the vERSO project (www.versoproject.be), funded by the Belgian Science Policy Office (BELSPO, contract no BR/132/A1/vERSO). Original data collection funded by the Korea Polar Research Institute (PE17070).	Aguera A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140078; Aguera A, 2015, OIKOS, V124, P1367, DOI 10.1111/oik.01949; Aguera A, 2015, J SEA RES, V99, P9, DOI 10.1016/j.seares.2015.01.003; Ahn I-Y, 2016, 1 RECORD MASSIVE BLO, V51, P273; Ahn In-Young, 2001, Ocean and Polar Research, V23, P419; Ahn In-Young, 1994, Memoirs of National Institute of Polar Research Special Issue, V50, P1; Ahn In-Young, 1997, P142; Ahn IY, 2003, MAR ECOL PROG SER, V257, P99, DOI 10.3354/meps257099; AHN IY, 1993, J EXP MAR BIOL ECOL, V171, P75, DOI 10.1016/0022-0981(93)90141-A; Ahn IY, 1998, J EXP MAR BIOL ECOL, V224, P253, DOI 10.1016/S0022-0981(97)00201-3; [Anonymous], 2014, R LANG ENV STAT COMP; Ansell AD, 1997, J MOLLUS STUD, V63, P285, DOI 10.1093/mollus/63.2.285; Barnes DKA, 2011, NAT CLIM CHANGE, V1, P365, DOI 10.1038/NCLIMATE1232; Barnes DKA, 2011, CURR BIOL, V21, pR451, DOI 10.1016/j.cub.2011.04.012; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bers AV, 2013, CLIMATIC CHANGE, V116, P789, DOI 10.1007/s10584-012-0523-4; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bigatti G, 2001, J SHELLFISH RES, V20, P283; Brey T, 2011, J MARINE SYST, V88, P542, DOI 10.1016/j.jmarsys.2011.07.004; Brockington S, 2001, POLAR BIOL, V24, P523, DOI 10.1007/s003000100251; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bylenga CH, 2015, MAR ECOL PROG SER, V536, P187, DOI 10.3354/meps11436; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; Elzhov T.V., 2013, MINPACK LM R INTERFA; Gedan KB, 2010, OECOLOGIA, V164, P479, DOI 10.1007/s00442-010-1661-x; Guy CI, 2014, POLAR BIOL, V37, P541, DOI 10.1007/s00300-014-1456-3; Holling C. S., 1959, Canadian Entomologist, V91, P385; Hunt BM, 2003, ANTARCT SCI, V15, P333, DOI 10.1017/S0954102003001342; Jusup M, 2014, J SEA RES, V94, P144, DOI 10.1016/j.seares.2014.09.002; Jusup M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021903; Kang DH, 2003, INVERTEBR REPROD DEV, V44, P71, DOI 10.1080/07924259.2003.9652555; Kearney M, 2012, FUNCT ECOL, V26, P167, DOI 10.1111/j.1365-2435.2011.01917.x; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Khim BK, 2007, ESTUAR COAST SHELF S, V73, P111, DOI 10.1016/j.ecss.2006.12.015; Kooijman SALM, 2014, J SEA RES, V94, P128, DOI 10.1016/j.seares.2014.06.005; KOOIJMAN SALM, 1986, J THEOR BIOL, V121, P269, DOI 10.1016/S0022-5193(86)80107-2; Kooijman SALM, 2010, DYNAMIC ENERGY BUDGE; Kowalke J, 1998, ENERGIEUMSATZE BETHI; Lika K, 2011, J SEA RES, V66, P270, DOI 10.1016/j.seares.2011.07.010; Lika K, 2011, J SEA RES, V66, P278, DOI 10.1016/j.seares.2011.09.004; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; MCCLINTOCK JB, 1994, MAR ECOL PROG SER, V111, P191, DOI 10.3354/meps111191; Meredith MP, 2017, DEEP-SEA RES PT II, V139, P40, DOI 10.1016/j.dsr2.2016.04.019; Momo F, 2002, ECOL MODEL, V155, P43, DOI 10.1016/S0304-3800(02)00081-9; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Morley SA, 2012, MAR ECOL PROG SER, V450, P81, DOI 10.3354/meps09577; Osterling ME, 2010, J APPL ECOL, V47, P759, DOI 10.1111/j.1365-2664.2010.01827.x; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Peck LS, 2007, MAR BIOL, V150, P1191, DOI 10.1007/s00227-006-0428-8; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Peck LS, 2002, POLAR BIOL, V25, P31, DOI 10.1007/s003000100308; Peck LS, 2002, PHYSIOL BIOCHEM ZOOL, V75, P123, DOI 10.1086/340990; Pecquerie L, 2012, MAR ECOL PROG SER, V447, P151, DOI 10.3354/meps09492; Pecquerie L, 2009, J SEA RES, V62, P93, DOI 10.1016/j.seares.2009.06.002; Philipp EER, 2011, ANTARCT SCI, V23, P127, DOI 10.1017/S0954102010000970; Sahade R, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500050; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Tation M, 2008, POLAR BIOL, V31, P509, DOI 10.1007/s00300-007-0379-7; Turner J, 2014, POLAR REC, V50, P237, DOI 10.1017/S0032247413000296; Urban HJ, 1998, ANTARCT SCI, V10, P153, DOI 10.1017/S0954102098000200; van der Meer J, 2006, J SEA RES, V56, P85, DOI 10.1016/j.seares.2006.03.001; van der Veer HW, 2006, J SEA RES, V56, P107, DOI 10.1016/j.seares.2006.03.005; Wood S.N., 2016, MIXED GAM COMPUTATIO; Zuur A. F., 2012, BEGINNERS GUIDE GEN	66	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183848	10.1371/journal.pone.0183848	http://dx.doi.org/10.1371/journal.pone.0183848			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850607	Green Published, Green Submitted, gold			2022-12-26	WOS:000408544200032
J	Alshareeda, AT; Sakaguchi, K; Abumaree, M; Zin, NKM; Shimizu, T				Alshareeda, Alaa T.; Sakaguchi, Katsuhisa; Abumaree, Mohammed; Zin, Nur Khatijah Mohd; Shimizu, Tatsuya			The potential of cell sheet technique on the development of hepatocellular carcinoma in rat models	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; B SHORT-TERM; CANCER; HEPATITIS; TRANSPLANTATION; ANGIOGENESIS; FAILURE; GROWTH; EPIDEMIOLOGY; PROMOTE	Background Hepatocellular carcinoma (HCC) is considered the 3rd leading cause of death by cancer worldwide with the majority of patients were diagnosed in the late stages. Currently, there is no effective therapy. The selection of an animal model that mimics human cancer is essential for the identification of prognostic/predictive markers, candidate genes underlying cancer induction and the examination of factors that may influence the response of cancers to therapeutic agents and regimens. In this study, we developed a HCC nude rat models using cell sheet and examined the effect of human stromal cells (SCs) on the development of the HCC model and on different liver parameters such as albumin and urea. Methods Transplanted cell sheet for HCC rat models was fabricated using thermo-responsive culture dishes. The effect of human umbilical cord mesenchymal stromal cells (UC-MSCs) and human bone marrow mesenchymal stromal cells (BM-MSCs) on the developed tumour was tested. Furthermore, development of tumour and detection of the liver parameter was studied. Additionally, angiogenesis assay was performed using Matrigel. Results HepG2 cells requires five days to form a complete cell sheet while HepG2 co-cultured with UC-MSCs or BM-MSCs took only three days. The tumour developed within 4 weeks after transplantation of the HCC sheet on the liver of nude rats. Both UC-MSCs and BM-MSCs improved the secretion of liver parameters by increasing the secretion of albumin and urea. Comparatively, the UC-MSCs were more effective than BM-MSCs, but unlike BM-MSCs, UC-MSCs prevented liver tumour formation and the tube formation of HCC. Conclusions Since this is a novel study to induce liver tumour in rats using hepatocellular carcinoma sheet and stromal cells, the data obtained suggest that cell sheet is a fast and easy technique to develop HCC models as well as UC-MSCs have therapeutic potential for liver diseases. Additionally, the data procured indicates that stromal cells enhanced the fabrication of HepG2 cell sheets. This provides the foundation for future research using stromal cells in preclinical and clinical investigations.	[Alshareeda, Alaa T.; Abumaree, Mohammed] King Abdul Aziz Med City, Minist Natl Guard Hlth Affairs, King Abdullah Int Med Res Ctr, Stem Cells & Regenerat Med Dept, Riyadh, Saudi Arabia; [Alshareeda, Alaa T.; Sakaguchi, Katsuhisa; Zin, Nur Khatijah Mohd; Shimizu, Tatsuya] Tokyo Women Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Sakaguchi, Katsuhisa; Zin, Nur Khatijah Mohd] Waseda Univ, Sch Sci & Engn, Tokyo, Japan; [Abumaree, Mohammed] King Saud bin Abdulaziz Univ Hlth Sci, Minist Natl Guard Hlth Affairs, King Abdulaziz Med City, Coll Sci & Hlth Profess, Riyadh, Saudi Arabia	King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs; Tokyo Women's Medical University; Waseda University; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs	Alshareeda, AT (corresponding author), King Abdul Aziz Med City, Minist Natl Guard Hlth Affairs, King Abdullah Int Med Res Ctr, Stem Cells & Regenerat Med Dept, Riyadh, Saudi Arabia.; Alshareeda, AT (corresponding author), Tokyo Women Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan.	al-shareedaal@ngha.med.sa	Tatsuya, Shimizu/AAN-5675-2021; Sakaguchi, Katsuhisa/P-7252-2018; Zin, Nur Khatijah Mohd/Y-8180-2019	Sakaguchi, Katsuhisa/0000-0002-8610-8455; Zin, Nur Khatijah Mohd/0000-0002-5584-3019; Alshareeda, Alaa/0000-0001-7242-3836	Japan Agency for Medical Research and development, AMED	Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This research is supported by the "Three-dimensional tissues and organs based on cell sheets engineering" from Japan Agency for Medical Research and development, AMED.	Akimoto K, 2013, STEM CELLS DEV, V22, P1370, DOI 10.1089/scd.2012.0486; Altimari A, 2003, DIGEST LIVER DIS, V35, P332, DOI 10.1016/S1590-8658(03)00077-X; Burra P, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-88; Chen B, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S2-S5; Chow AKM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078675; Coleman ML, 2002, CELL DEATH DIFFER, V9, P493, DOI 10.1038/sj.cdd.4400987; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; DRISCOLL JS, 1984, CANCER TREAT REP, V68, P63; Fan ST, 1999, ANN SURG, V229, P322, DOI 10.1097/00000658-199903000-00004; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Forner A, 2006, CRIT REV ONCOL HEMAT, V60, P89, DOI 10.1016/j.critrevonc.2006.06.001; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gauthier A, 2013, HEPATOL RES, V43, P147, DOI 10.1111/j.1872-034X.2012.01113.x; Gudima S, 2008, J VIROL, V82, P7276, DOI 10.1128/JVI.00576-08; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Houlihan DD, 2011, HEPATOLOGY, V54, P1891, DOI 10.1002/hep.24722; Jain S, 2010, AM J TRANSL RES, V2, P105; Kansu E, 2012, HEMATOLOGY, V17, pS159, DOI 10.1179/102453312X13336169156735; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Lis R, 2011, INT J CANCER, V128, P715, DOI 10.1002/ijc.25619; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marra M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-171; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Murakami T, 2014, LIVER CANCER, V3, P85, DOI 10.1159/000343864; Muto J, 2015, HEPATOL RES, V45, P1, DOI 10.1111/hepr.12310; Nishida N, 2006, VASC HEALTH RISK MAN, V2, P213, DOI 10.2147/vhrm.2006.2.3.213; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Okumura T, 2009, LAB INVEST, V89, P1410, DOI 10.1038/labinvest.2009.88; OTA K, 1995, TRANSPLANT P, V27, P83; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; Qiao L, 2008, ACTA PHARMACOL SIN, V29, P333, DOI 10.1111/j.1745-7254.2008.00751.x; Santos NP, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695923; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Shlomai A, 2014, SEMIN CANCER BIOL, V26, P78, DOI 10.1016/j.semcancer.2014.01.004; Wei T, 2013, HEPATOLOGY, V58, P451, DOI 10.1002/hep.26143; Yu JM, 2008, STEM CELLS DEV, V17, P463, DOI 10.1089/scd.2007.0181; Zhang T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt221; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004	41	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0184004	10.1371/journal.pone.0184004	http://dx.doi.org/10.1371/journal.pone.0184004			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850615	Green Submitted, Green Published, gold			2022-12-26	WOS:000408544200052
J	Fernando, MR; Jiang, C; Krzyzanowski, GD; Ryan, WL				Fernando, M. Rohan; Jiang, Chao; Krzyzanowski, Gary D.; Ryan, Wayne L.			New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes	PLOS ONE			English	Article							VESICLES	Cell-free DNA (cfDNA) in blood is used as a source of genetic material for noninvasive prenatal and cancer diagnostic assays in clinical practice. Recently we have started a project for new biomarker discovery with a view to developing new noninvasive diagnostic assays. While reviewing literature, it was found that exosomes may be a rich source of biomarkers, because exosomes play an important role in human health and disease. While characterizing exosomes found in human blood plasma, we observed the presence of cfDNA in plasma exosomes. Plasma was obtained from blood drawn into K3EDTA tubes. Exosomes were isolated from cell-free plasma using a commercially available kit. Sizing and enumeration of exosomes were done using electron microscopy and NanoSight particle counter. NanoSight and confocal microscopy was used to demonstrate the association between dsDNA and exosomes. DNA extracted from plasma and exosomes was measured by a fluorometric method and a droplet digital PCR (ddPCR) method. Size of extracellular vesicles isolated from plasma was heterogeneous and showed a mean value of 92.6 nm and a mode 39.7 nm. A large proportion of extracellular vesicles isolated from plasma were identified as exosomes using a fluorescence probe specific for exosomes and three protein markers, Hsp70, CD9 and CD63, that are commonly used to identify exosome fraction. Fluorescence dye that stain dsDNA showed the association between exosomes and dsDNA. Plasma cfDNA concentration analysis showed more than 93% of amplifiable cfDNA in plasma is located in plasma exosomes. Storage of a blood sample showed significant increases in exosome count and exosome DNA concentration. This study provide evidence that a large proportion of plasma cfDNA is localized in exosomes. Exosome release from cells is a metabolic energy dependent process, thus suggesting active release of cfDNA from cells as a source of cfDNA in plasma.	[Fernando, M. Rohan; Jiang, Chao; Krzyzanowski, Gary D.] Univ Nebraska, Med Ctr, Dept Obstet & Gynecol, Omaha, NE 68182 USA; [Fernando, M. Rohan; Krzyzanowski, Gary D.; Ryan, Wayne L.] CFGenome, Dept Res & Dev, Omaha, NE 68130 USA	University of Nebraska System; University of Nebraska Medical Center	Fernando, MR (corresponding author), Univ Nebraska, Med Ctr, Dept Obstet & Gynecol, Omaha, NE 68182 USA.; Fernando, MR (corresponding author), CFGenome, Dept Res & Dev, Omaha, NE 68130 USA.	mrohan.fernando@unmc.edu			University of Nebraska Foundation	University of Nebraska Foundation	The authors did not get any specific funding for this project. The project was funded by the general funds provided to the laboratory by the University of Nebraska Foundation. Dr. W. L. Ryan is Professor Emeritus, University of Nebraska Medical Center, who has been associated with the department for more than 40 years. As one of the collaborators, WLR was involved in designing the experiments and writing the manuscript. During the time this project was done (September 2014 to March 2016), MRF, CJ and GDK were full-time employees of the University of Nebraska Medical Center. In August 2016, WLR, MRF and GDK started CFGenome, a startup company located in Omaha NE. MRF is the CEO of CFGenome and GDK is an employee. MRF has applied for 2 patents which are unrelated to this project.	Anitei M, 2010, MOL MEMBR BIOL, V27, P443, DOI 10.3109/09687688.2010.522601; Arbabi A, 2016, BIOINFORMATICS, V32, P1662, DOI 10.1093/bioinformatics/btw178; Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hahn S, 2010, CLIN CHEM, V56, P1210, DOI 10.1373/clinchem.2010.149609; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Jiang PY, 2016, TRENDS GENET, V32, P360, DOI 10.1016/j.tig.2016.03.009; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Menck K, 2017, JOVE-J VIS EXP, DOI 10.3791/55057; Norton SE, 2013, J CLIN LAB ANAL, V27, P305, DOI 10.1002/jcla.21603; Orlando KA, 2006, EXP CELL RES, V312, P5, DOI 10.1016/j.yexcr.2005.09.012; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Thierry AR, 2016, CANCER METAST REV, V35, P347, DOI 10.1007/s10555-016-9629-x; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yu SCY, 2014, P NATL ACAD SCI USA, V111, P8583, DOI 10.1073/pnas.1406103111	21	153	156	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183915	10.1371/journal.pone.0183915	http://dx.doi.org/10.1371/journal.pone.0183915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850588	Green Submitted, Green Published, gold			2022-12-26	WOS:000408544200041
J	Hansoti, B; Jenson, A; Kironji, AG; Katz, J; Levin, S; Rothman, R; Kelen, GD; Wallis, LA				Hansoti, Bhakti; Jenson, Alexander; Kironji, Antony G.; Katz, Joanne; Levin, Scott; Rothman, Richard; Kelen, Gabor D.; Wallis, Lee A.			SCREEN: A simple layperson administered screening algorithm in low resource international settings significantly reduces waiting time for critically ill children in primary healthcare clinics	PLOS ONE			English	Article							CHILDHOOD ILLNESS; MANAGEMENT	Background In low resource settings, an inadequate number of trained healthcare workers and high volumes of children presenting to Primary Healthcare Centers (PHC) result in prolonged waiting times and significant delays in identifying and evaluating critically ill children. The Sick Children Require Emergency Evaluation Now (SCREEN) program, a simple six-question screening algorithm administered by lay healthcare workers, was developed in 2014 to rapidly identify critically ill children and to expedite their care at the point of entry into a clinic. We sought to determine the impact of SCREEN on waiting times for critically ill children post real world implementation in Cape Town, South Africa. Methods and findings This is a prospective, observational implementation-effectiveness hybrid study that sought to determine: (1) the impact of SCREEN implementation on waiting times as a primary outcome measure, and (2) the effectiveness of the SCREEN tool in accurately identifying critically ill children when utilised by the QM and adherence by the QM to the SCREEN algorithm as secondary outcome measures. The study was conducted in two phases, Phase I control (pre-SCREEN implementation-three months in 2014) and Phase II (post-SCREEN implementation-two distinct three month periods in 2016). In Phase I, 1600 (92.38%) of 1732 children presenting to 4 clinics, had sufficient data for analysis and comprised the control sample. In Phase II, all 3383 of the children presenting to the 26 clinics during the sampling time frame had sufficient data for analysis. The proportion of critically ill children who saw a professional nurse within 10 minutes increased tenfold from 6.4% to 64% (Phase I to Phase II) with the median time to seeing a professional nurse reduced from 100.3 minutes to 4.9 minutes, (p <.001, respectively). Overall layperson screening compared to Integrated Management of Childhood Illnesses (IMCI) designation by a nurse had a sensitivity of 94.2% and a specificity of 88.1%, despite large variance in adherence to the SCREEN algorithm across clinics. Conclusions The SCREEN program when implemented in a real-world setting can significantly reduce waiting times for critically ill children in PHCs, however further work is required to improve the implementation of this innovative program.	[Hansoti, Bhakti; Jenson, Alexander; Kironji, Antony G.; Levin, Scott; Rothman, Richard; Kelen, Gabor D.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA; [Hansoti, Bhakti; Katz, Joanne] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Wallis, Lee A.] Univ Cape Town, Div Emergency Med, Cape Town, South Africa	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town	Hansoti, B (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA.; Hansoti, B (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	bhansot1@jhmi.edu		Hansoti, Bhakti/0000-0003-0188-9764; Katz, Joanne/0000-0002-5997-7823; Wallis, Lee/0000-0003-2711-3139	Thrasher Research Fund Award, Early Career Award [12783]	Thrasher Research Fund Award, Early Career Award	This study is funded by the Thrasher Research Fund Award, Early Career Award # 12783 (https://www.thrasherresearch.org/SitePages/early-career-award.aspx).	Amaral J, 2005, HEALTH POLICY PLANN, V20, pI42, DOI 10.1093/heapol/czi058; Armagan E, 2008, EUR J EMERG MED, V15, P338, DOI 10.1097/MEJ.0b013e3283034222; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Chopra M, 2005, ARCH DIS CHILD, V90, P397, DOI 10.1136/adc.2004.059147; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Dawes M, 2010, LANCET, V375, P784, DOI 10.1016/S0140-6736(09)62166-8; Goga AE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-503; Gove S, 1999, ARCH DIS CHILD, V81, P473, DOI 10.1136/adc.81.6.473; Hansoti B, 2017, PEDIAT EMERGENCY CAR; Hansoti B, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000036; Hodkinson P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145473; Hodkinson PW, 2015, DEV PATIENT CENTRED; Kai J, 1996, BRIT MED J, V313, P983; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2001, AM J PUBLIC HEALTH, V91, P1625, DOI 10.2105/AJPH.91.10.1625; Sokhela Dudu G, 2013, Curationis, V36, pE1, DOI 10.4102/curationis.v36i1.60; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Tulloch J, 1999, LANCET, V354, pS16; Van den Bruel Ann, 2006, BMC Fam Pract, V7, P23, DOI 10.1186/1471-2296-7-23; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; WHO, 2011, IMCI SERV TRAIN; World Health Organization, 2011, CHILD MORT	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183520	10.1371/journal.pone.0183520	http://dx.doi.org/10.1371/journal.pone.0183520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE9SU	28850617	gold, Green Submitted, Green Published			2022-12-26	WOS:000408544200018
J	Bodson, J; Wilson, A; Warner, EL; Kepka, D				Bodson, Julia; Wilson, Andrew; Warner, Echo L.; Kepka, Deanna			Religion and HPV vaccine-related awareness, knowledge, and receipt among insured women aged 18-26 in Utah	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; YOUNG-ADULT WOMEN; UNITED-STATES; PARENTS; CANCER; ADOLESCENTS; STUDENTS	Introduction We investigate the associations between religious practice and human papillomavirus (HPV) vaccine-related awareness, knowledge, and receipt among young women in Utah. Methods We surveyed 326 insured women aged 18-26 by mail. Fisher's Exact Tests and multivariable logistic regression models were used to evaluate the relations between religious practice and HPV vaccine-related outcomes. Data collection occurred January-December 2013; analyses were conducted June-September 2015. Results Multivariable analyses reveal that when controlling for age, educational attainment, and marital status, participants who practiced an organized religion were significantly less likely to have heard of HPV (aOR = 0.25, p = 0.0123), to have heard of the HPV vaccine (aOR = 0.41, p = 0.0368), to know how HPV is spread (aOR = 0.45, p = 0.0074), to have received a provider recommendation for the HPV vaccine (aOR = 0.36, p = 0.0332), and to have received at least one (aOR = 0.50, p = 0.0073) or all three (aOR = 0.47, p = 0.0026) doses of the HPV vaccine. Bivariate analyses produce parallel results. Conclusions Results indicate that religious young women in Utah are not only under-vaccinated, but are also under-informed about HPV and the HPV vaccine. These results suggest that suboptimal vaccine coverage among religious young women may present a serious health risk for the community. Strategies for educational interventions targeted to this population are discussed.	[Bodson, Julia; Warner, Echo L.; Kepka, Deanna] Huntsman Canc Inst, Canc Control & Populat Sci, Salt Lake City, UT 84103 USA; [Wilson, Andrew] Univ Utah, Dept Family & Prevent Med, Salt Lake City, UT USA; [Warner, Echo L.; Kepka, Deanna] Univ Utah, Coll Nursing, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Bodson, J (corresponding author), Huntsman Canc Inst, Canc Control & Populat Sci, Salt Lake City, UT 84103 USA.	Julia.Bodson@hci.utah.edu	Warner, Echo/K-4068-2018	Warner, Echo/0000-0002-7844-3309; Wilson, Andrew/0000-0003-3679-9232	Huntsman Cancer Institute; Huntsman Cancer Foundation	Huntsman Cancer Institute; Huntsman Cancer Foundation	This project was supported in part by Huntsman Cancer Institute and Huntsman Cancer Foundation. The funding source had no involvement in study design; in the collection, analysis, and interpretation of the data; in the writing of the report; or in the decision to submit the article for publication.	Chen D., 2015, DESERET NEWS; Constantine NA, 2007, J ADOLESCENT HEALTH, V40, P108, DOI 10.1016/j.jadohealth.2006.10.007; Davidson L., 2012, SALT LAKE TRIBUNE; Dillman DA, 2009, E COMMUNICATION; Finer LB, 2013, PEDIATRICS, V131, P886, DOI 10.1542/peds.2012-3495; Gehrke R, 2016, MORMON CHURCH OPPOSI; Gerend MA, 2011, WOMEN HEALTH, V51, P25, DOI 10.1080/03630242.2011.540744; Hariri S, 2011, J INFECT DIS, V204, P566, DOI 10.1093/infdis/jir341; Healthy People 2020, 2010, PICS OBJECTIVES IMM; Krakow MM, 2015, WOMEN HEALTH ISS, V25, P105, DOI 10.1016/j.whi.2014.11.006; Lefkowitz ES, 2014, WOMEN HEALTH, V54, P487, DOI 10.1080/03630242.2014.903552; Litton AG, 2011, J PEDIATR ADOL GYNEC, V24, P166, DOI 10.1016/j.jpag.2011.01.004; Manhart LE, 2011, VACCINE, V29, P5238, DOI 10.1016/j.vaccine.2011.05.024; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Poulson RL, 1998, J AM COLL HEALTH, V46, P227, DOI 10.1080/07448489809600227; Rambout L, 2014, PREV MED, V58, P22, DOI 10.1016/j.ypmed.2013.10.009; Ratanasiripong NT, 2012, J AM COLL HEALTH, V60, P461, DOI 10.1080/07448481.2012.684365; Reagan-Steiner S, 2016, MMWR-MORBID MORTAL W, V65, P850, DOI 10.15585/mmwr.mm6533a4; Reynolds D., 2014, J CHRIST NURS, V31, P172; Rimer B. K., 2014, ACCELERATING HPV VAC; Sadigh G, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18456; Shelton RC, 2013, J RELIG HEALTH, V52, P1120, DOI 10.1007/s10943-011-9553-x; Thomas TL, 2013, J ADOLESCENT HEALTH, V52, pS60, DOI 10.1016/j.jadohealth.2012.08.011; Thomas TL, 2012, J NURS SCHOLARSHIP, V44, P358, DOI 10.1111/j.1547-5069.2012.01479.x; Thompson VLS, 2012, J HEALTH CARE POOR U, V23, P290, DOI 10.1353/hpu.2012.0007; Williams WW, 2012, MMWR-MORBID MORTAL W, V2014, P95; Wilson AR, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0323-5; Zimet GD, 2008, ANNU REV MED, V59, P223, DOI 10.1146/annurev.med.59.092806.131644	28	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183725	10.1371/journal.pone.0183725	http://dx.doi.org/10.1371/journal.pone.0183725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841681	Green Published, Green Submitted, gold			2022-12-26	WOS:000408370700054
J	Kilbride, P; Lamb, S; Gibbons, S; Bundy, J; Erro, E; Selden, C; Fuller, B; Morris, J				Kilbride, Peter; Lamb, Stephen; Gibbons, Stephanie; Bundy, James; Erro, Eloy; Selden, Clare; Fuller, Barry; Morris, John			Cryopreservation and re-culture of a 2.3 litre biomass for use in a bioartificial liver device	PLOS ONE			English	Article							HUMAN HEPATOCYTES; CHAIN DELIVERY; STEM-CELLS; SPHEROIDS; ALGINATE; SCALE; TRANSPLANTATION; VITRIFICATION; TEMPERATURES; STRATEGY	For large and complex tissue engineered constructs to be available on demand, long term storage using methods, such as cryopreservation, are essential. This study optimised parameters such as excess media concentration and warming rates and used the findings to enable the successful cryopreservation of 2.3 litres of alginate encapsulated liver cell spheroids. This volume of biomass is typical of those required for successful treatment of Acute Liver Failure using our Bioartificial Liver Device. Adding a buffer of medium above the biomass, as well as slow (0.6 E C/min) warming rates was found to give the best results, so long as the warming through the equilibrium melting temperature was rapid. After 72 h post thaw-culture, viable cell number, glucose consumption, lactate production, and alpha-fetoprotein production had recovered to pre-freeze values in the 2.3 litre biomass (1.00 +/- 0.05, 1.19 +/- 0.10, 1.23 +/- 0.18, 2.03 +/- 0.04 per ml biomass of the pre-cryopreservation values respectively). It was also shown that further improvements in warming rates of the biomass could reduce recovery time to < 48 h. This is the first example of a biomass of this volume being successfully cryopreserved in a single cassette and re-cultured. It demonstrates that a bioartificial liver device can be cryopreserved, and has wider applications to scale-up large volume cryopreservation.	[Kilbride, Peter; Lamb, Stephen; Morris, John] Gen Elect Healthcare, Asymptote, Cambridge, England; [Kilbride, Peter; Gibbons, Stephanie; Bundy, James; Erro, Eloy; Selden, Clare] UCL, Inst Liver & Digest Hlth, Royal Free Hosp Campus, London, England; [Fuller, Barry] UCL, Dept Surg, Royal Free Hosp Campus, London, England	General Electric; University of London; University College London; University of London; University College London	Kilbride, P (corresponding author), Gen Elect Healthcare, Asymptote, Cambridge, England.; Kilbride, P (corresponding author), UCL, Inst Liver & Digest Hlth, Royal Free Hosp Campus, London, England.	peter.kilbride.11@ucl.ac.uk		Selden, Angela/0000-0003-2648-443X; Erro Barbarin, Eloy/0000-0002-3558-4216	Medical Research Council (UK) Industrial Case Studentship [9203]; Asymptote Ltd.; Innovate UK [101103]; Liver Group Charity; Wellcome Trust	Medical Research Council (UK) Industrial Case Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asymptote Ltd.; Innovate UK(UK Research & Innovation (UKRI)Innovate UK); Liver Group Charity; Wellcome Trust(Wellcome TrustEuropean Commission)	Peter Kilbride was funded through a Medical Research Council (UK) Industrial Case Studentship 9203. Funding for this work was provided by Asymptote Ltd. and Innovate UK (101103). Stephanie Gibbons was funded by the Liver Group Charity, and James Bundy & Eloy Erro were funded by the Wellcome Trust. The funder provided support in the form of salaries for authors [MRC - PK, Wellcome - JB, CS and EE, Liver Group Charity - SG, Asymptote - JM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ABLETT S, 1992, J CHEM SOC FARADAY T, V88, P789, DOI 10.1039/ft9928800789; AKHTAR T, 1979, CRYOBIOLOGY, V16, P424, DOI 10.1016/0011-2240(79)90055-5; Alexandre E, 2002, CRYOBIOLOGY, V44, P103, DOI 10.1016/S0011-2240(02)00011-1; [Anonymous], CRYOBIOLOGY; Baust JM, 2000, IN VITRO CELL DEV-AN, V36, P262; Baust JM, 2009, BIOPRESERV BIOBANK, V7, P3, DOI 10.1089/bio.2009.0701.jmb; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Borel Rinkes IH, 1992, CELL TRANSPLANT, V1, P281; Brockbank KGN, 2006, ADV BIOPRESERVATION, P157; Campbell BK, 2014, HUM REPROD, V29, P1749, DOI 10.1093/humrep/deu144; Coward SM, 2005, ARTIF ORGANS, V29, P152, DOI 10.1111/j.1525-1594.2005.29026.x; Day JG, 2007, CRYOPRESERVATION FRE, Vxi; Erro E, 2013, BIORESEARCH OPEN ACC, V2, P1, DOI 10.1089/biores.2012.0286; Evans S, 2000, CRYOBIOLOGY, V40, P126, DOI 10.1006/cryo.2000.2232; Fahy GM, 2006, REJUV RES, V9, P279, DOI 10.1089/rej.2006.9.279; Fahy GM, 2009, ORGANOGENESIS, V5, P167, DOI 10.4161/org.5.3.9974; Guibert EE, 2011, TRANSFUS MED HEMOTH, V38, P125, DOI 10.1159/000327033; Khush KK, 2015, AM J TRANSPLANT, V15, P642, DOI 10.1111/ajt.13055; Kilbride P, 2016, CRYOBIOLOGY; Kilbride P, 2016, BIORESEARCH OPEN ACC, V5, P146, DOI 10.1089/biores.2016.0017; Kilbride P, 2014, CRYOBIOLOGY, V69, P367, DOI 10.1016/j.cryobiol.2014.09.003; KORBER C, 1988, Q REV BIOPHYS, V21, P229, DOI 10.1017/S0033583500004303; Lee WM, 2012, SEMIN RESP CRIT CARE, V33, P36, DOI 10.1055/s-0032-1301733; Li Y, 2012, BIORESEARCH OPEN ACC, V1, P205, DOI 10.1089/biores.2012.0224; Malpique R, 2010, TISSUE ENG PART C-ME, V16, P965, DOI 10.1089/ten.TEC.2009.0660; Marasco SF, 2011, J HEART LUNG TRANSPL, V30, P414, DOI 10.1016/j.healun.2010.10.002; Massie IR, 2012, DEV OPTIMISED CRYOPR; Massie I, 2014, TISSUE ENG PART C-ME, V20, P693, DOI [10.1089/ten.tec.2013.0571, 10.1089/ten.TEC.2013.0571]; Massie I, 2011, TISSUE ENG PART C-ME, V17, P765, DOI [10.1089/ten.tec.2010.0394, 10.1089/ten.TEC.2010.0394]; Massie I, 2013, TISSUE ENG PART C-ME, V19, P189, DOI [10.1089/ten.tec.2012.0307, 10.1089/ten.TEC.2012.0307]; Mazur P, 1970, CIBA FDN S FROZ CELL; MCGANN LE, 1981, CRYOBIOLOGY, V18, P469, DOI 10.1016/0011-2240(81)90205-4; Meryman HT, 1966, CRYOBIOLOGY, Vxiv; Milenkovic M, 2011, J ASSIST REPROD GEN, V28, P7, DOI 10.1007/s10815-010-9477-5; Morris GJ, 2013, CRYOBIOLOGY, V66, P85, DOI 10.1016/j.cryobiol.2012.11.007; MUNN CS, 1986, RADIOLOGY, V159, P731, DOI 10.1148/radiology.159.3.3517957; Nyberg SL, 2014, PATHOBIOLOGY OF HUMAN DISEASE: A DYNAMIC ENCYCLOPEDIA OF DISEASE MECHANISMS, P1800, DOI 10.1016/B978-0-12-386456-7.04205-2; Petrowsky H, 2015, TRANSPLANTATION LIVE, P582, DOI DOI 10.1016/B978-1-4557-0268-8.00044-0; RAPATZ G., 1960, BIODYNAMICA, V8, P195; Rasmussen D, 1968, PHASE DIAGRAM SYSTEM; RUGGERA PS, 1990, CRYOBIOLOGY, V27, P465, DOI 10.1016/0011-2240(90)90035-3; Santos-Sousa CA, 2015, INT J MORPHOL, V33, P1293, DOI 10.4067/S0717-95022015000400017; Selden C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082312; Serra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023212; Sputtek A, 2011, CYTOTHERAPY, V13, P481, DOI 10.3109/14653249.2010.529891; Stephenne X, 2010, WORLD J GASTROENTERO, V16, P1, DOI 10.3748/wjg.v16.i1.1; Terry C, 2010, LIVER TRANSPLANT, V16, P229, DOI 10.1002/lt.21983; Wang T, 2014, CRYOBIOLOGY, V68, P234, DOI 10.1016/j.cryobiol.2014.02.002; Wusteman M, 2004, CRYOBIOLOGY, V48, P179, DOI 10.1016/j.cryobiol.2004.01.002	49	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183385	10.1371/journal.pone.0183385	http://dx.doi.org/10.1371/journal.pone.0183385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841674	Green Submitted, Green Published, gold			2022-12-26	WOS:000408370700028
J	Kraaijenbrink, C; Vegter, RJK; Hensen, AHR; Wagner, H; van der Woude, LHV				Kraaijenbrink, Cassandra; Vegter, Riemer J. K.; Hensen, Alexander H. R.; Wagner, Heiko; van der Woude, Lucas H. V.			Different cadences and resistances in sub-maximal synchronous handcycling in able-bodied men: Effects on efficiency and force application	PLOS ONE			English	Article							SPONTANEOUSLY CHOSEN CRANK; WHEELCHAIR; REHABILITATION; PROPULSION; CAPACITY; ARM	Background With the introduction of an add-on handcycle, a crank system that can be placed in front of a wheelchair, handcycling was made widely available for daily life. With it, people go into town more easily, e.g. to do groceries; meet up with friends, etc. They have more independency and can be socially active. Our aim is to explore some settings of the handcycle, so that it can be optimally used as a transportation device. Therefore, the effects of cadence and added resistance on gross mechanical efficiency and force application during sub-maximal synchronous handcycling were investigated. We hypothesized that a cadence of 52 rpm with a higher resistance (35 W) would lead to a higher gross mechanical efficiency and a more tangential force application than a higher cadence of 70 rpm and no extra resistance (15 W). Methods Twelve able-bodied men rode in an instrumented add-on handcycle on a motorized level treadmill at 1.94 m/s. They performed three sessions of three four-minute blocks of steady state exercise. Gear (70, 60 and 52 rpm) was changed in-between the blocks and resistance (rolling resistance +0 W, +10 W, +20 W) was changed across sessions, both in a counterbalanced order. 3D force production, oxygen uptake and heart rate were measured continuously. Gross mechanical efficiency (ME) and fraction of effective force (FEF) were calculated as main outcomes. The effects of cadence and resistance were analyzed using a repeated measures ANOVA (P<0.05) with Bonferroni-corrected post-hoc pairwise comparisons. Results With a decrease in cadence a slight increase in ME (70 rpm: 5.5 (0.2)%, 60 rpm: 5.7 (0.2)%, 52 rpm: 5.8 (0.2)%, P = 0.008, eta(2)(p) = 0.38), while an increase in FEF (70 rpm: 58.0 (3.2)%, 60 rpm: 66.0 (2.8)%, 52 rpm: 71.3 (2.3)%, P<0.001,eta(2)(p) = 0.79) is seen simultaneously. Also with an increase in resistance an increase in ME (+0 W: 4.0 (0.2)%, +10 W: 6.0 (0.3)%, +20 W: 7.0 (0.2)%, P<0.001,eta(2)(p) = 0.92) and FEF (+0 W: 59.0 (2.9)%, +10 W: 66.1 (3.4)%, +20 W: 70.2 (2.4)%, P<0.001,eta(2)(p) = 0.56) was found. Interpretation A cadence of 52 rpm against a higher resistance of about 35 W leads to a more optimal direction of forces and is more mechanically efficient than propelling at a higher cadence or lower resistance. Therefore, changing gears on a handcycle is important, and it is advised to keep the linear hand velocity relatively low for locomotion purposes.	[Kraaijenbrink, Cassandra; Vegter, Riemer J. K.; Hensen, Alexander H. R.; van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Kraaijenbrink, Cassandra; Wagner, Heiko] Univ Munster, Dept Movement Sci, Inst Sport Sci, Munster, North Rhine Wes, Germany; [van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands	University of Groningen; University of Munster; University of Groningen	Kraaijenbrink, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.; Kraaijenbrink, C (corresponding author), Univ Munster, Dept Movement Sci, Inst Sport Sci, Munster, North Rhine Wes, Germany.	kraaijen@uni-muenster.de	van der Woude, Lucas H/E-7986-2018; JK, Vegter Riemer/N-3385-2013; Wagner, Heiko/D-9677-2013	van der Woude, Lucas H/0000-0002-8472-334X; JK, Vegter Riemer/0000-0002-4294-6086; Wagner, Heiko/0000-0002-5470-5044; Kraaijenbrink, Cassandra/0000-0003-3763-7278				Arnet U, 2012, PROPULSION STYLE MEC, P88; Arnet U, 2013, J APPL BIOMECH, V29, P687, DOI 10.1123/jab.29.6.687; Bergman BC, 1999, J APPL PHYSIOL, V87, pU33; Bertucci W, 2005, J BIOMECH, V38, P1003, DOI 10.1016/j.jbiomech.2004.05.037; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Dallmeijer AJ, 2004, INT J SPORTS MED, V25, P622, DOI 10.1055/s-2004-817879; Dallmeijer AJ, 2004, SPINAL CORD, V42, P91, DOI 10.1038/sj.sc.3101566; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Foss O, 2004, EUR J APPL PHYSIOL, V92, P443, DOI 10.1007/s00421-004-1175-5; GARBY L, 1987, ACTA PHYSIOL SCAND, V129, P443, DOI 10.1111/j.1365-201X.1987.tb10613.x; Groen WG, 2010, DISABIL REHABIL, V32, P2165, DOI 10.3109/09638288.2010.505677; Hansen EA, 2002, J BIOMECH, V35, P277, DOI 10.1016/S0021-9290(01)00182-8; Hettinga F J, 2010, Phys Med Rehabil Clin N Am, V21, P127, DOI 10.1016/j.pmr.2009.07.010; Marais G, 2002, INT J SPORTS MED, V23, P120, DOI 10.1055/s-2002-20131; Marais G, 2002, ERGONOMICS, V45, P631, DOI 10.1080/00140130210151821; Mascher D, RESP EXCHANGE RATIO; POWERS SK, 1984, J APPL PHYSIOL, V56, P495, DOI 10.1152/jappl.1984.56.2.495; Romkes J, 1999, BIOMEDICAL ASPECTS M, V5; Rossato M, 2008, INT J SPORTS MED, V29, P746, DOI 10.1055/s-2008-1038375; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Valent L, 2010, DISABIL REHABIL, V32, P2191, DOI 10.3109/09638288.2010.509461; Valent LJ, 2008, ARCH PHYS MED REHAB, V89, P1016, DOI 10.1016/j.apmr.2007.10.034; Valent LJM, 2009, PHYS THER, V89, P1051, DOI 10.2522/ptj.20080340; van der Woude LHV, 2000, J MED ENG TECHNOL, V24, P242, DOI 10.1080/030919000300037168; van der Woude LHV, 2001, AM J PHYS MED REHAB, V80, P765, DOI 10.1097/00002060-200110000-00012; van Drongelen S, 2011, MED ENG PHYS, V33, P1167, DOI 10.1016/j.medengphy.2011.04.018; VANDERWOUDE LHV, 1986, ERGONOMICS, V29, P1561, DOI 10.1080/00140138608967269; VEEGER D, 1989, Journal of Rehabilitation Research and Development, V26, P37; VEEGER HEJ, 1992, MED SCI SPORT EXER, V24, P100; Vercruyssen F, 2010, J SCI MED SPORT, V13, P225, DOI 10.1016/j.jsams.2008.12.631; Verellen J, 2004, MED SCI SPORT EXER, V36, P1826, DOI 10.1249/01.MSS.0000142367.04918.5A	31	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183502	10.1371/journal.pone.0183502	http://dx.doi.org/10.1371/journal.pone.0183502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841704	Green Submitted, gold, Green Published			2022-12-26	WOS:000408370700037
J	Zhai, Q; Xue, GX; Li, M				Zhai, Qing; Xue, Guo-xi; Li, Meng			DNA barcoding-based sexual association of Sovia lucasii and S. lii (Lepidoptera: Hesperiidae), with description of a new subspecies	PLOS ONE			English	Article							BUTTERFLIES; DIMORPHISM	Both sexes of two sympatric and sexually dimorphic species, Sovia lucasii (Mabille, 1876) and S. lii Xue, 2015, are associated based on DNA barcoding using the COI (mitochondrial cytochrome coxidase I) gene. The females are thus identified for the first time, and their wing patterns and genitalia are described and illustrated for the convenience of morphological identification hereafter. A new subspecies, S. lucasii minor ssp. nov., from the northeastern and eastern parts of the Sichuan Basin of China, is reported. External and genital differences between the new taxon and the nominate subspecies, which is distributed in western Sichuan and newly discovered in northwestern Guangxi, are illustrated and discussed.	[Zhai, Qing] Henan Agr Univ, Coll Plant Protect, Zhengzhou, Henan, Peoples R China; [Xue, Guo-xi; Li, Meng] Zhengzhou Univ Light Ind, Sch Food & Bioengn, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Zhengzhou University of Light Industry	Zhai, Q (corresponding author), Henan Agr Univ, Coll Plant Protect, Zhengzhou, Henan, Peoples R China.	zhaiqingjn@163.com			National Natural Science Foundation of China [41401067, 31401810]; China Postdoctoral Science Foundation [2016M602935XB]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Funding provided by National Natural Science Foundation of China, No. 41401067 (GX), URL: https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list; National Natural Science Foundation of China, No. 31401810 (ML), URL: https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list; and Project Funded by China Postdoctoral Science Foundation, No. 2016M602935XB (QZ), URL: http://jj. chinapostdoctor.org.cn/V1/Program3/Info_Show2.aspx?InfoID=bf5f0be7-56e6-41e2-b07d-a-6dca6e23f3a &InfoCategoryID=2&Show=0&rnd=2e6b1dba-fc97-4e49-8187-da0e67b602dc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Editing committee of geomorphic atlas of the People's Republic of China, 2009, GEOM ATL PEOPL REP C; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Laguerre Michel, 2016, Journal of Insect Biodiversity, V4, DOI [10.12976/jib/2016.4.21, 10.12976/jib/2016.4.11]; Li WC, 2016, SYST BIODIVERS, V14, P303, DOI 10.1080/14772000.2016.1140246; Lukhtanov VA, 2016, SYST BIODIVERS, V14, P599, DOI 10.1080/14772000.2016.1203371; Moraes SD, 2017, SYST BIODIVERS, V15, P259, DOI 10.1080/14772000.2016.1250835; Przybylowicz L, 2015, ZOOL J LINN SOC-LOND, V173, P22, DOI 10.1111/zoj.12198; Rand DB, 2000, MOL PHYLOGENET EVOL, V17, P85, DOI 10.1006/mpev.2000.0820; Shirozu T., 1960, BUTTERFLIES FORMOSA, P481; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Corley MFV, 2017, ZOOTAXA, V4221, P594, DOI 10.11646/zootaxa.4221.5.7; Xue GX, 2015, ZOOTAXA, V3985, P583, DOI 10.11646/zootaxa.3985.4.7; Xue GX, 2016, ENTOMOL FENNICA, V27, P70, DOI 10.33338/ef.59125	17	9	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183847	10.1371/journal.pone.0183847	http://dx.doi.org/10.1371/journal.pone.0183847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841714	Green Submitted, Green Published, gold			2022-12-26	WOS:000408370700063
J	Barykina, NV; Subach, OM; Piatkevich, KD; Jung, EE; Malyshev, AY; Smirnov, IV; Bogorodskiy, AO; Borshchevskiy, VI; Varizhuk, AM; Pozmogova, GE; Boyden, ES; Anokhin, KV; Enikolopov, GN; Subach, FV				Barykina, Natalia V.; Subach, Oksana M.; Piatkevich, Kiryl D.; Jung, Erica E.; Malyshev, Aleksey Y.; Smirnov, Ivan V.; Bogorodskiy, Andrey O.; Borshchevskiy, Valentin I.; Varizhuk, Anna M.; Pozmogova, Galina E.; Boyden, Edward S.; Anokhin, Konstantin V.; Enikolopov, Grigori N.; Subach, Fedor V.			Green fluorescent genetically encoded calcium indicator based on calmodulin/M13-peptide from fungi	PLOS ONE			English	Article							CA2+ INDICATORS; PROTEINS; ZEBRAFISH; TRANSGENESIS; CALMODULIN; NEURONS; MECHANISM; SENSORS; DESIGN	Currently available genetically encoded calcium indicators (GECIs) utilize calmodulins (CaMs) or troponin C from metazoa such as mammals, birds, and teleosts, as calcium-binding domains. The amino acid sequences of the metazoan calcium-binding domains are highly conserved, which may limit the range of the GECI key parameters and cause undesired interactions with the intracellular environment in mammalian cells. Here we have used fungi, evolutionary distinct organisms, to derive CaM and its binding partner domains and design new GECI with improved properties. We applied iterative rounds of molecular evolution to develop FGCaMP, a novel green calcium indicator. It includes the circularly permuted version of the enhanced green fluorescent protein (EGFP) sandwiched between the fungal CaM and a fragment of CaM-dependent kinase. FGCaMP is an excitation-ratiometric indicator that has a positive and an inverted fluorescence response to calcium ions when excited at 488 and 405 nm, respectively. Compared with the GCaMP6s indicator in vitro, FGCaMP has a similar brightness at 488 nm excitation, 7-fold higher brightness at 405 nm excitation, and 1.3-fold faster calcium ion dissociation kinetics. Using site-directed mutagenesis, we generated variants of FGCaMP with improved binding affinity to calcium ions and increased the magnitude of FGCaMP fluorescence response to low calcium ion concentrations. Using FGCaMP, we have successfully visualized calcium transients in cultured mammalian cells. In contrast to the limited mobility of GCaMP6s and G-GECO1.2 indicators, FGCaMP exhibits practically 100% molecular mobility at physiological concentrations of calcium ion in mammalian cells, as determined by photobleaching experiments with fluorescence recovery. We have successfully monitored the calcium dynamics during spontaneous activity of neuronal cultures using FGCaMP and utilized whole-cell patch clamp recordings to further characterize its behavior in neurons. Finally, we used FGCaMP in vivo to perform structural and functional imaging of zebrafish using wide-field, confocal, and light-sheet microscopy.	[Barykina, Natalia V.; Subach, Oksana M.; Bogorodskiy, Andrey O.; Borshchevskiy, Valentin I.; Enikolopov, Grigori N.; Subach, Fedor V.] Moscow Inst Phys & Technol, Moscow, Russia; [Barykina, Natalia V.; Anokhin, Konstantin V.] PK Anokhin Inst Normal Physiol RAMS, Moscow, Russia; [Subach, Oksana M.; Anokhin, Konstantin V.] Natl Res Ctr Kurchatov Inst, Moscow, Russia; [Piatkevich, Kiryl D.; Jung, Erica E.; Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA; [Malyshev, Aleksey Y.; Smirnov, Ivan V.] RAS, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Smirnov, Ivan V.] NI Pirogov Russian Natl Res Med Univ, Medicobiol Fac, Moscow, Russia; [Varizhuk, Anna M.; Pozmogova, Galina E.] Fed Med Biol Agcy, Fed Res & Clin Ctr Phys Chem Med, Moscow, Russia; [Varizhuk, Anna M.] RAS, Engelhardt Inst Mol Biol, Moscow, Russia; [Boyden, Edward S.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Anokhin, Konstantin V.] Lomonosov Moscow State Univ, Moscow, Russia; [Enikolopov, Grigori N.] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Enikolopov, Grigori N.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA	Moscow Institute of Physics & Technology; Russian Academy of Medical Sciences; Anokhin Institute of Normal Physiology; National Research Centre - Kurchatov Institute; Massachusetts Institute of Technology (MIT); Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; Pirogov Russian National Research Medical University; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Massachusetts Institute of Technology (MIT); Lomonosov Moscow State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Enikolopov, GN; Subach, FV (corresponding author), Moscow Inst Phys & Technol, Moscow, Russia.; Enikolopov, GN (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.; Enikolopov, GN (corresponding author), SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA.	Grigori.Enikolopov@stonybrookmedicine.edu; subach.fv@mipt.ru	Anokhin, Konstantin V./K-7983-2014; Subach, Fedor/AAA-5320-2021; Enikolopov, Grigori/P-5731-2019; Bogorodskiy, Andrey/R-7690-2016; Borshchevskiy, Valentin I./F-2287-2014; Galina, Pozmogova/S-6204-2017; Varizhuk, Anna/Y-7558-2019; Смирнов, Иван/AAO-2062-2020; Malyshev, Aleksey/R-8471-2018	Anokhin, Konstantin V./0000-0003-4437-6002; Subach, Fedor/0000-0003-2720-7821; Enikolopov, Grigori/0000-0001-8178-8917; Bogorodskiy, Andrey/0000-0002-7589-7823; Borshchevskiy, Valentin I./0000-0003-4398-9712; Galina, Pozmogova/0000-0001-9458-4972; Varizhuk, Anna/0000-0001-9359-8651; Смирнов, Иван/0000-0002-6192-7008; Malyshev, Aleksey/0000-0002-4633-7691; Barykina, Natalia/0000-0001-5835-8388	RSF [16-15-10323, 16-15-00291, 18-44-04015, 14-25-00013, 16-15-00294]; RFBR [15-04-03383, 17-29-01037]; HHMI-Simons Faculty Scholars Program, NIH [2R01DA029639]; NIH [1DP1NS087724, 1R01GM104948]; Russian Ministry of Education and Science [11.G34.31.0071]; National Institute of Aging [R01AG040209]; New York State Stem Cell Science (NYSTEM) [C029569]; Russian Science Foundation [17-15-00058, 17-25-00005, 16-15-00291] Funding Source: Russian Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS087724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029639] Funding Source: NIH RePORTER	RSF(Russian Science Foundation (RSF)); RFBR(Russian Foundation for Basic Research (RFBR)); HHMI-Simons Faculty Scholars Program, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New York State Stem Cell Science (NYSTEM); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by RSF grant No 16-15-10323 to F.V.S. (developing the FGCaMP indicator), RFBR grant No 15-04-03383 to F.V.S. (rAAVs isolation), by RSF grant No 16-15-00291 to A.Y.M. (experiments with patch clamp), by RSF grant No18-44-04015 to V.I.B. (FRAP experiments), by RSF grant No14-25-00013 to G.E. P. (stop-flow studies), HHMI-Simons Faculty Scholars Program, NIH grants 2R01DA029639, NIH Director's Pioneer Award 1DP1NS087724, and 1R01GM104948, and the IET Harvey Prize to E.S. B. (in vivo imaging in zebrafish), by RSF grant No. 14-15-00685 to K.V.A. (isolation and imaging of neuronal cultures) and by grants from RSF (grant No 16-15-00294), RFBR (grant No 17-29-01037), the Russian Ministry of Education and Science (grant 11.G34.31.0071), the National Institute of Aging (R01AG040209), and New York State Stem Cell Science (NYSTEM) (C029569) to G.N.E.	Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; [Anonymous], 2008, NATURE METHODS, V6, P1; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Barykina NV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34447; BROCARD JB, 1993, NEURON, V11, P751, DOI 10.1016/0896-6273(93)90084-5; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Helassa N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15978; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kimura Y, 2008, DEVELOPMENT, V135, P3001, DOI 10.1242/dev.024802; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051286; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Panier T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00065; PORUMB T, 1994, PROTEIN ENG, V7, P109, DOI 10.1093/protein/7.1.109; Renaud O, 2011, NAT PROTOC, V6, P1897, DOI 10.1038/nprot.2011.408; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Subedi A, 2014, METHODS, V66, P433, DOI 10.1016/j.ymeth.2013.06.012; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Zhao YX, 2014, INTEGR BIOL-UK, V6, P714, DOI 10.1039/c4ib00039k; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zou J, 2007, BIOCHEMISTRY-US, V46, P12275, DOI 10.1021/bi7007307	35	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183757	10.1371/journal.pone.0183757	http://dx.doi.org/10.1371/journal.pone.0183757			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837632	gold, Green Published, Green Submitted			2022-12-26	WOS:000408365000112
J	Sumi, M; Sato, S; Nakamura, T				Sumi, Misa; Sato, Shuntaro; Nakamura, Takashi			Extranodal spread of primary and secondary metastatic nodes: The dominant risk factor of survival in patients with head and neck squamous cell carcinoma	PLOS ONE			English	Article							EXTRACAPSULAR SPREAD; PROGNOSTIC-FACTOR; CANCER; CLASSIFICATION; PROPOSAL; HYPOXIA; EXTENT	Extranodal spread (ENS) in patients with head and neck squamous cell carcinoma (HNSCC) can greatly influence the prognostic outcomes. However, the relative risks of ENS in the primary (1st) and secondary (2nd) metastatic nodes (mets) are not well documented. We retrospectively analyzed the hazard ratios (HRs) of ENS in the 1st and 2nd mets from 516 HNSCC patients who had undergone primary tumor excision. The impact of clinically and/or histologically confirmed ENS-positive mets on prognosis in terms of cancer-specific survival was analyzed. Cox proportional hazard regression analysis indicated that ENS-positive 1st met (adjusted HR = 3.15; 95% CI, 1.40-7.56; p = 0.006) and ENS-positive 2nd met (adjusted HR = 4.03; 95% CI, 1.41-16.96; p = 0.007) significantly and independently predicted poor prognosis; however, other variables including primary site, met size or numbers, and met location in the contralateral side of the primary lesion, did not. Cumulative incidence function and Cox analyses indicated that differences in ENS profiles of 1st and 2nd mets stratified HNSCC patients with varying risks of poor outcome; HRs relative to patients with ENS-positive 1st met (-)/ENS-positive 2nd met (-) were 4.02 (95% CI, 1.78-8.24; p = 0.002), 8.29 (95% CI, 4.58-14.76; p < 0.001), and 25.80 (95% CI, 10.15-57.69; p < 0.001) for patients with ENS-positive 1st met (+)/ENS-positive 2nd met (-), ENS-positive 1st met (-)/ENS-positive 2nd met (+), and ENS-positive 1st met (+)/ENS-positive 2nd met (+) patients, respectively. Kaplan-Meier analysis indicated that the 2nd met that appeared in the neck side with a history of 1st met and neck dissection had a higher risk of ENS than the 2nd met in the neck side without the history (p = 0.003). These results suggested that ENS is a dominant prognostic predictor of HNSCC patients, with double-positive ENS in the 1st and 2nd mets predicting the most devastating outcome.	[Sumi, Misa; Nakamura, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan; [Sato, Shuntaro] Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, Japan	Nagasaki University; Nagasaki University	Nakamura, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan.	taku@nagasaki-u.ac.jp	Sato, Shuntaro/AAN-8048-2020	Sato, Shuntaro/0000-0002-6055-3649	Grants-in-Aid for Scientific Research [15K11078] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ahn TS, 2015, ANN SURG ONCOL, V22, P3745, DOI 10.1245/s10434-014-4359-1; Amin MB, 2017, AJCC CANC STAGING MA; Amit M, 2013, ANN SURG ONCOL, V20, P3575, DOI 10.1245/s10434-013-3044-0; Anniko M, 2010, EUR MAN MED, P1, DOI 10.1007/978-3-540-68940-9; Chang J, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3461; Cochran AJ, 2006, NAT REV IMMUNOL, V6, P659, DOI 10.1038/nri1919; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; de Juan J, 2013, JAMA OTOLARYNGOL, V139, P483, DOI 10.1001/jamaoto.2013.2666; Greenberg JS, 2003, CANCER, V97, P1464, DOI 10.1002/cncr.11202; Katayama I, 2012, EUR J RADIOL, V81, P3326, DOI 10.1016/j.ejrad.2012.06.018; King AD, 2004, EUR J RADIOL, V52, P264, DOI 10.1016/j.ejrad.2004.03.004; Langendijk JA, 2005, CANCER-AM CANCER SOC, V104, P1408, DOI 10.1002/cncr.21340; LEEMANS CR, 1994, CANCER-AM CANCER SOC, V73, P187, DOI 10.1002/1097-0142(19940101)73:1<187::AID-CNCR2820730132>3.0.CO;2-J; Luchini C, 2016, SURG ONCOL, V25, P60, DOI 10.1016/j.suronc.2015.09.005; Pereira ER, 2015, SEMIN CELL DEV BIOL, V38, P98, DOI 10.1016/j.semcdb.2015.01.008; Puri Sajeev K, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P119, DOI 10.1097/00020840-200304000-00010; Shingaki S, 2003, AM J SURG, V185, P278, DOI 10.1016/S0002-9610(02)01378-8; Silva SD, 2014, CLIN EXP METASTAS, V31, P307, DOI 10.1007/s10585-013-9629-y; Sinha P, 2012, CANCER-AM CANCER SOC, V118, P3519, DOI 10.1002/cncr.26671; Sumi M, 2011, J MAGN RESON IMAGING, V33, P830, DOI 10.1002/jmri.22454; Van den Eynden GG, 2007, HISTOPATHOLOGY, V51, P440, DOI 10.1111/j.1365-2559.2007.02761.x; Vaupel P, 2014, ADV EXP MED BIOL, V812, P19, DOI 10.1007/978-1-4939-0620-8_3; Wreesmann VB, 2016, HEAD NECK-J SCI SPEC, V38, pE1192, DOI 10.1002/hed.24190; Xing Y, 2016, CANCER-AM CANCER SOC, V122, P534, DOI 10.1002/cncr.29780	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183611	10.1371/journal.pone.0183611	http://dx.doi.org/10.1371/journal.pone.0183611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837620	Green Submitted, gold, Green Published			2022-12-26	WOS:000408365000087
J	Weissmueller, NT; Marsay, L; Schiffter, HA; Carlisle, RC; Rollier, CS; Prud'homme, RK; Pollard, AJ				Weissmueller, Nikolas T.; Marsay, Leanne; Schiffter, Heiko A.; Carlisle, Robert C.; Rollier, Christine S.; Prud'homme, Robert K.; Pollard, Andrew J.			Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; BALLISTIC DELIVERY; ANTIBODY-RESPONSES; INFLUENZA VACCINE; PARTICLE-SIZE; HUMAN SKIN; IMMUNOGENICITY; IMMUNIZATION; MICROPARTICLES; FORMULATION	Powder-injectors use gas propulsion to deposit lyophilised drug or vaccine particles in the epidermal and sub epidermal layers of the skin. We prepared dry-powder (T-g = 45.2 +/- 0.5 degrees C) microparticles (58.1 mu m) of a MenY-CRM197 glyconjugate vaccine (0.5% wt.) for intradermal needle-free powder injection (NFPI). SFD used ultrasound atomisation of the liquid vaccine-containing excipient feed, followed by lyophilisation above the glass transition temperature (T-g' = -29.9 +/- 0.3 degrees C). This resulted in robust particles (density similar to 0.53 +/-0.09 g/cm(3)) with a narrow volume size distribution (mean diameter 58.1 mu m, and span = 1.2), and an impact parameter (rho vr similar to 11.5 kg/m.s) sufficient to breach the Stratum corneum (sc). The trehalose, manitol, dextran (10 kDa), dextran (150 kDa) formulation, or TMDD (3:3:3:1), protected the MenY-CRM197 glyconjugate during SFD with minimal loss, no detectable chemical degradation or physical aggregation. In a capsular group Y Neisseria meningitidis serum bactericidal assay (SBA) with human serum complement, the needle free vaccine, which contained no alum adjuvant, induced functional protective antibody responses in vivo of similar magnitude to the conventional vaccine injected by hypodermic needle and syringe and containing alum adjuvant. These results demonstrate that needle-free vaccination is both technically and immunologically valid, and could be considered for vaccines in development.	[Weissmueller, Nikolas T.; Marsay, Leanne; Rollier, Christine S.; Pollard, Andrew J.] Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, Oxfordshire, England; [Weissmueller, Nikolas T.; Marsay, Leanne; Rollier, Christine S.; Pollard, Andrew J.] NIHR Oxford Biomed Res Inst, Oxford, Oxfordshire, England; [Weissmueller, Nikolas T.; Prud'homme, Robert K.] Princeton Univ, Dept Biol & Chem Engn, Princeton, NJ 08544 USA; [Weissmueller, Nikolas T.; Schiffter, Heiko A.; Carlisle, Robert C.] BUBBL, Inst Biomed Engn, Oxford, Oxfordshire, England; [Schiffter, Heiko A.] Univ Appl Sci, Dept Appl Nat Sci, Cologne, North Rhine Wes, Germany	University of Oxford; Princeton University; University of Oxford	Weissmueller, NT (corresponding author), Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, Oxfordshire, England.; Weissmueller, NT (corresponding author), NIHR Oxford Biomed Res Inst, Oxford, Oxfordshire, England.; Weissmueller, NT (corresponding author), Princeton Univ, Dept Biol & Chem Engn, Princeton, NJ 08544 USA.; Weissmueller, NT (corresponding author), BUBBL, Inst Biomed Engn, Oxford, Oxfordshire, England.	ntw@princeton.edu		Weissmueller, Nikolas/0000-0003-4589-9286; Schiffter-Weinle, Heiko Alexander/0000-0003-0407-3242	Oxford Martin School, University of Oxford	Oxford Martin School, University of Oxford	This work was supported by the Oxford Martin School, University of Oxford. URL: http://www.oxfordmartin.ox.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2008, INT J PHARMACEUT, V364, P227, DOI 10.1016/j.ijpharm.2008.08.032; Bal SM, 2010, J CONTROL RELEASE, V148, P266, DOI 10.1016/j.jconrel.2010.09.018; Berti F, 2004, BIOPHYS J, V86, P3, DOI 10.1016/S0006-3495(04)74078-3; Blanchard-Rohner G, 2011, EXPERT REV VACCINES, V10, P673, DOI 10.1586/erv.11.14; Borrow R, 2006, VACCINE, V24, P5093, DOI 10.1016/j.vaccine.2006.03.091; Borrow R, 2000, FEMS IMMUNOL MED MIC, V28, P79, DOI 10.1111/j.1574-695X.2000.tb01460.x; Broker M, 2016, HUM VACC IMMUNOTHER, V12, P1808, DOI 10.1080/21645515.2016.1153206; Burkoth TL, 1999, CRIT REV THER DRUG, V16, P331, DOI 10.1615/CritRevTherDrugCarrierSyst.v16.i4.10; Chen Dexiang, 2002, Expert Rev Vaccines, V1, P265, DOI 10.1586/14760584.1.3.265; Chen DX, 2004, VIRUS RES, V103, P147, DOI 10.1016/j.virusres.2004.02.027; Chen DX, 2003, VACCINE, V21, P2830, DOI 10.1016/S0264-410X(03)00175-0; Chen DX, 2000, NAT MED, V6, P1187, DOI 10.1038/80538; Chiu SS, 2009, VACCINE, V27, P4834, DOI 10.1016/j.vaccine.2009.05.066; Costantino HR, 2002, J PHARM SCI-US, V91, P388, DOI 10.1002/jps.10059; Costantino HR, 2000, PHARMACEUT RES, V17, P1374, DOI 10.1023/A:1007570030368; De Gregorio E, 2014, NAT REV IMMUNOL, V14, P505, DOI 10.1038/nri3694; Dean HJ, 2004, VACCINE, V23, P681, DOI 10.1016/j.vaccine.2004.06.041; Dean HJ, 2003, COMP IMMUNOL MICROB, V26, P373, DOI 10.1016/S0147-9571(03)00021-3; GHEESLING LL, 1994, J CLIN MICROBIOL, V32, P1475, DOI 10.1128/JCM.32.6.1475-1482.1994; Granoff DM, 1998, CLIN DIAGN LAB IMMUN, V5, P479, DOI 10.1128/CDLI.5.4.479-485.1998; Hancock BC, 1997, J PHARM SCI, V86, P1, DOI 10.1021/js9601896; Ho MM, 2000, VACCINE, V19, P716, DOI 10.1016/S0264-410X(00)00261-9; Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17; Johnson KA, 1997, ADV DRUG DELIVER REV, V26, P3, DOI 10.1016/S0169-409X(97)00506-1; Karande P, 2004, NAT BIOTECHNOL, V22, P192, DOI 10.1038/nbt928; Kelly DF, 2004, IMMUNOLOGY, V113, P163, DOI 10.1111/j.1365-2567.2004.01971.x; Kendall M, 2004, J BIOMECH, V37, P1733, DOI 10.1016/j.jbiomech.2004.01.032; Kendall M, 2004, J INVEST DERMATOL, V122, P739, DOI 10.1111/j.0022-202X.2004.22320.x; Kendall MAF, 2002, SHOCK WAVES, V12, P23, DOI 10.1007/s001930200126; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; LEVI G, 1995, FOOD RES INT, V28, P145, DOI 10.1016/0963-9969(95)90798-F; Levine MM, 2003, NAT MED, V9, P99, DOI 10.1038/nm0103-99; Lieberman JM, 1996, JAMA-J AM MED ASSOC, V275, P1499, DOI 10.1001/jama.275.19.1499; Liu Y, 2007, MED ENG PHYS, V29, P390, DOI 10.1016/j.medengphy.2006.05.015; Maa YF, 2004, J PHARM SCI-US, V93, P1912, DOI 10.1002/jps.20104; Maa YF, 2003, PHARMACEUT RES, V20, P969, DOI 10.1023/A:1024493719236; Maa YF, 1998, J PHARM SCI, V87, P152, DOI 10.1021/js970308x; Maury M, 2005, EUR J PHARM BIOPHARM, V59, P565, DOI 10.1016/j.ejpb.2004.10.002; McIntosh EDG, 2015, VACCINE, V33, P4414, DOI 10.1016/j.vaccine.2015.07.019; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Moginger U, 2016, SCI REP-UK, V6, DOI 10.1038/srep20488; Mvundura M, 2015, VACCINE, V33, P2697, DOI 10.1016/j.vaccine.2015.03.084; Nail Steven L, 2002, Pharm Biotechnol, V14, P281; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Perrett KP, 2009, PEDIATR INFECT DIS J, V28, P186, DOI 10.1097/INF.0b013e31818e037d; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Ratanji KD, 2014, J IMMUNOTOXICOL, V11, P99, DOI 10.3109/1547691X.2013.821564; Rochelle C, 2007, J PHARM SCI-US, V96, P2296, DOI 10.1002/jps.20861; Rubinstein LJ, 1998, INFECT IMMUN, V66, P5450, DOI 10.1128/IAI.66.11.5450-5456.1998; Schiffter H., 2007, EUR PHARM REV, V3, P67; Schiffter H, 2010, J R SOC INTERFACE, V7, pS483, DOI 10.1098/rsif.2010.0114.focus; Snape MD, 2008, JAMA-J AM MED ASSOC, V299, P173, DOI 10.1001/jama.2007.29-c; Sonner C, 2002, J PHARM SCI-US, V91, P2122, DOI 10.1002/jps.10204; Tang XL, 2004, PHARM RES-DORDR, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75; WAHL M, 1987, SCAND J INFECT DIS, V19, P617, DOI 10.3109/00365548709117195; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Weissmueller NT, 2015, CLIN VACCINE IMMUNOL, V22, P586, DOI 10.1128/CVI.00121-15; Weissmueller NT, 2013, EXPERT REV VACCINES, V12, P687, DOI [10.1586/ERV.13.48, 10.1586/erv.13.48]; Wilburn SQ, 2004, INT J OCCUP ENV HEAL, V10, P451, DOI 10.1179/oeh.2004.10.4.451; World Health Organization, 2004, SAF INJ GLOB FACTS F; Zhang L, 2015, EXPERT REV VACCINES, V14, P1509, DOI 10.1586/14760584.2015.1081067	62	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183427	10.1371/journal.pone.0183427	http://dx.doi.org/10.1371/journal.pone.0183427			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837693	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000065
J	Hosokawa, Y; Masaki, N; Takei, S; Horikawa, M; Matsushita, S; Sugiyama, E; Ogura, H; Shiiya, N; Setou, M				Hosokawa, Yuko; Masaki, Noritaka; Takei, Shiro; Horikawa, Makoto; Matsushita, Shoko; Sugiyama, Eiji; Ogura, Hiroyuki; Shiiya, Norihiko; Setou, Mitsutoshi			Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues	PLOS ONE			English	Article							MASS-SPECTROMETRY; PROGRESSION; SURVIVAL	Triple-negative breast cancer (TNBC) is one of the breast cancer subtype that displays a high risk of early recurrence and short overall survival. Improvement of the prognosis of patients with TNBC requires identifying a predictive factor of recurrence, which would make it possible to provide beneficial personalized treatment. However, no clinically reliable predictive factor is currently known. In this study, we investigated the predictive factor of recurrence in TNBC using matrix-assisted laser desorption/ionization-imaging mass spectrometry for lipid profiling of breast cancer specimens obtained from three and six patients with recurrent and non-recurrent TNBC, respectively. The signal for phosphatidylcholine (PC) (32:1) at m/z 732.5 was significantly higher in the recurrence group compared to the non-recurrence group (P = 0.024). PC (32:1) was more abundant in the cancer epithelial area than it was in the surrounding stroma, suggesting that abnormal lipid metabolism was associated with malignant transformation. Our results indicate PC (32:1) as a candidate predictive factor of TNBC recurrence. A future prospective study investigating whether personalized therapy based on PC (32:1) intensity improves the prognosis of patients with TNBC is recommended.	[Hosokawa, Yuko; Ogura, Hiroyuki; Shiiya, Norihiko] Hamamatsu Univ, Sch Med, Dept Surg 1, Higashi Ku, Hamamatsu, Shizuoka, Japan; [Hosokawa, Yuko; Masaki, Noritaka; Takei, Shiro; Horikawa, Makoto; Matsushita, Shoko; Sugiyama, Eiji; Setou, Mitsutoshi] Hamamatsu Univ, Sch Med, Int Mass Imaging Ctr, Higashi Ku, Hamamatsu, Shizuoka, Japan; [Hosokawa, Yuko; Masaki, Noritaka; Takei, Shiro; Horikawa, Makoto; Matsushita, Shoko; Sugiyama, Eiji; Setou, Mitsutoshi] Hamamatsu Univ, Sch Med, Dept Cellular & Mol Anat, Higashi Ku, Hamamatsu, Shizuoka, Japan; [Setou, Mitsutoshi] Preeminent Med Photon Educ & Res Ctr, Higashi Ku, Hamamatsu, Shizuoka, Japan; [Setou, Mitsutoshi] Univ Hong Kong, Dept Anat, 6-F,William MW Mong Block,Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Setou, Mitsutoshi] RIKEN, Ctr Mol Imaging Sci, Chuo Ku, Kobe, Hyogo, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; University of Hong Kong; RIKEN	Setou, M (corresponding author), Hamamatsu Univ, Sch Med, Int Mass Imaging Ctr, Higashi Ku, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Hamamatsu Univ, Sch Med, Dept Cellular & Mol Anat, Higashi Ku, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Preeminent Med Photon Educ & Res Ctr, Higashi Ku, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Univ Hong Kong, Dept Anat, 6-F,William MW Mong Block,Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.; Setou, M (corresponding author), RIKEN, Ctr Mol Imaging Sci, Chuo Ku, Kobe, Hyogo, Japan.	setou@hama-med.ac.jp	Horikawa, Makoto/GSE-0110-2022	Horikawa, Makoto/0000-0002-5094-7070	MEXT/JSPS KAKENHI [JP15H05898B1]; Imaging Platform Grant [967]; Advanced Research and Development Programs for Medical Innovation (CREST) from Japan Agency for Medical Research and Development, AMED [921910520]; MEXT/JSPS KAKENHI [JP15H05898B1]; Imaging Platform Grant [967]; Advanced Research and Development Programs for Medical Innovation (CREST) from Japan Agency for Medical Research and Development, AMED [921910520]; Grants-in-Aid for Scientific Research [15H05898, 15H05897] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Imaging Platform Grant; Advanced Research and Development Programs for Medical Innovation (CREST) from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Imaging Platform Grant; Advanced Research and Development Programs for Medical Innovation (CREST) from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI Grant Number JP15H05898B1, Imaging Platform Grant Number 967, and Advanced Research and Development Programs for Medical Innovation (CREST) from Japan Agency for Medical Research and Development, AMED Grant Number 921910520 to M. Setou. The funders had no role in study design, data collection, analysis, and preparation of the manuscript.	Abalsamo L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3151; Abdelzaher E, 2015, TUMOR BIOL, V36, P5473, DOI 10.1007/s13277-015-3214-8; Abramson VG, 2014, CURR BREAST CANCER R, V6, P154, DOI 10.1007/s12609-014-0152-1; Baumann J, 2013, BBA-MOL CELL BIOL L, V1831, P1509, DOI 10.1016/j.bbalip.2013.03.011; Berry KAZ, 2011, CHEM REV, V111, P6491, DOI 10.1021/cr200280p; Delvolve AM, 2011, ANAL METHODS-UK, V3, P1729, DOI 10.1039/c1ay05107e; Fleisher B, 2016, BREAST CANCER-TARGET, V8, P183, DOI 10.2147/BCTT.S114659; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; He MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11298; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Holder AM, 2013, BREAST CANCER RES TR, V137, P319, DOI 10.1007/s10549-012-2354-4; Hsu FF, 2003, J AM SOC MASS SPECTR, V14, P352, DOI 10.1016/S1044-0305(03)00064-3; Ide Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061204; Iorio E, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00205; Kang HS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-465; Kim H. Y., 2016, ONCOTARGET; Kurabe N, 2013, CANCER SCI, V104, P1295, DOI 10.1111/cas.12221; Mao XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21043; Moessinger C, 2014, BMC CELL BIOL, V15, DOI 10.1186/s12860-014-0043-3; Morita Y, 2013, J HEPATOL, V59, P292, DOI 10.1016/j.jhep.2013.02.030; Peck B, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0146-8; Peltier S, 2008, INT J MOL MED, V22, P559, DOI 10.3892/ijmm_00000056; Ridgway ND, 2013, CRIT REV BIOCHEM MOL, V48, P20, DOI 10.3109/10409238.2012.735643; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wahba HA, 2015, CANCER BIOL MED, V12, P106, DOI 10.7497/j.issn.2095-3941.2015.0030; Waki ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026721	26	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183724	10.1371/journal.pone.0183724	http://dx.doi.org/10.1371/journal.pone.0183724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832678	Green Submitted, gold, Green Published			2022-12-26	WOS:000408355800095
J	Kumar, R; Nurse, P; Bahng, S; Lee, CM; Marians, KJ				Kumar, Rupesh; Nurse, Pearl; Bahng, Soon; Lee, Chong M.; Marians, Kenneth J.			The MukB-topoisomerase IV interaction is required for proper chromosome compaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA structure; DNA topoisomerase; DNA topology; nucleic acid enzymology	ESCHERICHIA-COLI CHROMOSOME; GREEN FLUORESCENT PROTEIN; DNA-REPLICATION; CONDENSIN MUKB; IN-VIVO; SEGREGATION; ORGANIZATION; COMPLEX; CELLS; TRANSCRIPTION	The bacterial condensin MukB and the cellular decatenating enzyme topoisomerase IV interact. This interaction stimulates intramolecular reactions catalyzed by topoisomerase IV, supercoiled DNA relaxation, and DNA knotting but not intermolecular reactions such as decatenation of linked DNAs. We have demonstrated previously that MukB condenses DNA by sequestering negative supercoils and stabilizing topologically isolated loops in the DNA. We show here that the MukB-topoisomerase IV interaction stabilizes MukB on DNA, increasing the extent of DNA condensation without increasing the amount of MukB bound to the DNA. This effect does not require the catalytic activity of topoisomerase IV. Cells carrying a mukB mutant allele that encodes a protein that does not interact with topoisomerase IV exhibit severe nucleoid decompaction leading to chromosome segregation defects. These findings suggest that the MukB-topoisomerase IV complex may provide a scaffold for DNA condensation.	[Kumar, Rupesh; Nurse, Pearl; Bahng, Soon; Lee, Chong M.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu	Kumar, Rupesh/A-2077-2019	Kumar, Rupesh/0000-0001-5661-8828	National Institutes of Health Cancer Center Core Support Grant from NCI [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Core Support Grant from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Memorial Sloan Kettering Cancer Center was recipient of National Institutes of Health Cancer Center Core Support Grant P30CA008748 from NCI.	ADAMS DE, 1992, CELL, V71, P277, DOI 10.1016/0092-8674(92)90356-H; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Bahng S, 2016, J BIOL CHEM, V291, P23999, DOI 10.1074/jbc.M116.749994; Bakshi S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00636; Corcoran CP, 2010, J BACTERIOL, V192, P4790, DOI 10.1128/JB.00531-10; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; El Sayyed H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006025; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Hammel M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600650; Hayama R, 2013, J BIOL CHEM, V288, P7653, DOI 10.1074/jbc.M112.418087; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; Helgesen E, 2016, J BACTERIOL, V198, P1305, DOI 10.1128/JB.00919-15; HIRAGA S, 1989, J BACTERIOL, V171, P1496, DOI 10.1128/jb.171.3.1496-1505.1989; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KATO J, 1992, J BIOL CHEM, V267, P25676; Kumar R, 2017, J BIOL CHEM, V292, P16904, DOI 10.1074/jbc.M117.803312; Lee C, 2013, J BIOL CHEM, V288, P31503, DOI 10.1074/jbc.M113.494237; Li YY, 2010, P NATL ACAD SCI USA, V107, P18832, DOI 10.1073/pnas.1008678107; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Murphy LD, 1997, J STRUCT BIOL, V119, P321, DOI 10.1006/jsbi.1997.3883; Nicolas E, 2014, MBIO, V5, DOI 10.1128/mBio.01001-13; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Nolivos S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10466; Ohsumi K, 2001, MOL MICROBIOL, V40, P835, DOI 10.1046/j.1365-2958.2001.02447.x; PENG H, 1993, P NATL ACAD SCI USA, V90, P8571, DOI 10.1073/pnas.90.18.8571; PENG H, 1993, J BIOL CHEM, V268, P24481; Peng H., 1995, THESIS; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Pong H, 1999, METH MOL B, V94, P163; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Vos SM, 2013, EMBO J, V32, P2950, DOI 10.1038/emboj.2013.218; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wiggins PA, 2010, P NATL ACAD SCI USA, V107, P4991, DOI 10.1073/pnas.0912062107; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873; Yazdi NH, 2012, MOL MICROBIOL, V86, P1318, DOI 10.1111/mmi.12071; Zawadzki P, 2015, CELL REP, V13, P2587, DOI 10.1016/j.celrep.2015.11.034	46	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16921	16932		10.1074/jbc.M117.803346	http://dx.doi.org/10.1074/jbc.M117.803346			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842485	Green Published, hybrid			2022-12-26	WOS:000413140600013
J	Batmaz, AU; de Mathelin, M; Dresp-Langley, B				Batmaz, Anil U.; de Mathelin, Michel; Dresp-Langley, Birgitta			Seeing virtual while acting real: Visual display and strategy effects on the time and precision of eye-hand coordination	PLOS ONE			English	Article							PERFORMANCE; ADAPTATION; SYSTEMS; INFORMATION; LAPAROSCOPY; MONITOR; IMPACT; SPACE; PERCEPTION; JUDGMENTS	Effects of different visual displays on the time and precision of bare-handed or tool-mediated eye-hand coordination were investigated in a pick-and-place-task with complete novices. All of them scored well above average in spatial perspective taking ability and performed the task with their dominant hand. Two groups of novices, four men and four women in each group, had to place a small object in a precise order on the centre of five targets on a Realworld Action Field (RAF), as swiftly as possible and as precisely as possible, using a tool or not (control). Each individual session consisted of four visual display conditions. The order of conditions was counterbalanced between individuals and sessions. Subjects looked at what their hands were doing 1) directly in front of them ("natural" top-down view) 2) in top-down 2D fisheye view 3) in top-down undistorted 2D view or 4) in 3D stereoscopic top-down view (head-mounted OCULUS DK 2). It was made sure that object movements in all image conditions matched the real-world movements in time and space. One group was looking at the 2D images with the monitor positioned sideways (sub-optimal); the other group was looking at the monitor placed straight ahead of them (near-optimal). All image viewing conditions had significantly detrimental effects on time (seconds) and precision (pixels) of task execution when compared with "natural" direct viewing. More importantly, we find significant trade-offs between time and precision between and within groups, and significant interactions between viewing conditions and manipulation conditions. The results shed new light on controversial findings relative to visual display effects on eye-hand coordination, and lead to conclude that differences in camera systems and adaptive strategies of novices are likely to explain these.	[Batmaz, Anil U.; de Mathelin, Michel] Univ Strasbourg, ICube Lab Robot Dept, 1 Pl Hop, Strasbourg, France; [Dresp-Langley, Birgitta] CNRS, ICube Lab Cognit Sci Dept, 1 Pl Hop, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dresp-Langley, B (corresponding author), CNRS, ICube Lab Cognit Sci Dept, 1 Pl Hop, Strasbourg, France.	birgitta.dresp@unistra.fr	Batmaz, Anil Ufuk/ABE-7803-2021; Dresp-Langley, Birgitta/F-8243-2013	Batmaz, Anil Ufuk/0000-0001-7948-8093; Dresp-Langley, Birgitta/0000-0002-2860-6472	Initiative d'Excellence de l'Universite de Strasbourg; CNRS [MI-AAP 2015]	Initiative d'Excellence de l'Universite de Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS))	The project is funded by the Initiative d'Excellence de l'Universite de Strasbourg (Project award to B Dresp-Langley) and the CNRS (MI-AAP 2015 to B Dresp).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balslev D, 2007, J COGNITIVE NEUROSCI, V19, P1535, DOI 10.1162/jocn.2007.19.9.1535; Batmaz Anil Ufuk, 2016, BMC Psychol, V4, P55; Batmaz AU, 2016, PERCEPTION S, V45, P196; Bhayani Sam B, 2005, Rev Urol, V7, P211; Blavier A, 2014, COGN TECHNOL WORK, V16, P509, DOI 10.1007/s10111-014-0281-3; Bogner MS, 1994, HUMAN ERROR MED; BONNET C, 1993, BEHAV RES METH INS C, V25, P2, DOI 10.3758/BF03204443; Bonnet C, 1990, COGNITIVE BIASES, P309; Boumenir Y, 2010, PERCEPT MOTOR SKILL, V111, P1; Breedveld P, 2001, MINIM INVASIV THER, V10, P155; Buess GF, 1996, CHIRURG, V67, P1041, DOI 10.1007/s001040050101; Chan ACW, 1997, SURG ENDOSC-ULTRAS, V11, P438, DOI 10.1007/s004649900385; Derossis AM, 1999, CAN J SURG, V42, P293; Det MJ, 1990, SURG ENDOSC, V23, P1279; Dresp-Langley B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01565; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fogassi L, 2004, HDB MULTISENSORY PRO, P425; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; Gallagher AG, 2005, AM J SURG, V189, P76, DOI 10.1016/j.amjsurg.2004.04.008; Gallagher AG, 2011, IMPROVING MED OUTCOM; Graziano Michael S. A., 1995, P1021; Hanna GB, 1998, ANN SURG, V227, P481, DOI 10.1097/00000658-199804000-00005; Haveran LA, 2007, SURG ENDOSC, V21, P980, DOI 10.1007/s00464-007-9360-3; Hegarty M, 2004, INTELLIGENCE, V32, P175, DOI 10.1016/j.intell.2003.12.001; Held R, 2009, OPTOMETRY VISION SCI, V86, P595, DOI 10.1097/OPX.0b013e3181a72999; Henriques DYP, 2012, J MOTOR BEHAV, V44, P435, DOI 10.1080/00222895.2012.659232; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Huber JW, 2003, ERGONOMICS, V46, P999, DOI 10.1080/0014013031000109197; Humphreys GW, 2004, VIS COGN, V11, P401, DOI 10.1080/13506280344000310; Jenmalm P, 2000, J NEUROPHYSIOL, V84, P2984, DOI 10.1152/jn.2000.84.6.2984; Jones DB, 1996, SURG LAPAROSC ENDOSC, V6, P191, DOI 10.1097/00019509-199606000-00005; Kanhere A, 2013, J MICROELECTROMECHAN, V22, P1057; Kersten-Oertel M, 2012, COMPARISON DEPTH ENH; Kersten-Oertel M, 2014, EVALUATION DEPTH ENH; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Kumler J, 2000, P SOC PHOTO-OPT INS, V4093, P360, DOI 10.1117/12.405226; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Luce RD, 1986, RESPONSE TIMES THEIR; Luger T, 2015, ERGONOMICS, V58, P1851, DOI 10.1080/00140139.2015.1043356; Maithel SK, 2005, SURG ENDOSC, V19, P406, DOI 10.1007/s00464-004-8177-6; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Maravita A, 2001, NEUROPSYCHOLOGIA, V39, P580, DOI 10.1016/S0028-3932(00)00150-0; Masia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007004; MCCLELLAND JL, 1979, PSYCHOL REV, V86, P287, DOI 10.1037/0033-295X.86.4.287; MEYER DE, 1988, PSYCHOL REV, V95, P183, DOI 10.1037/0033-295X.95.2.183; Mueller MD, 1999, SURG ENDOSC-ULTRAS, V13, P469, DOI 10.1007/s004649901014; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ollmann RT, 1977, ATTENTION PERFORM, VVI, P99; Preston C, 2010, CONSCIOUS COGN, V19, P986, DOI 10.1016/j.concog.2010.04.005; Robertson CM, 2008, INT SYM MIX AUGMENT, P73, DOI 10.1109/ISMAR.2008.4637328; Sakata S, 2017, BRIT J SURG, V104, P1097, DOI 10.1002/bjs.10528; Sakata S, 2016, ANN SURG, V263, P234, DOI 10.1097/SLA.0000000000001504; Salomonczyk D, 2013, EXP BRAIN RES, V228, P313, DOI 10.1007/s00221-013-3564-7; Sarlegna F, 2003, EXP BRAIN RES, V151, P524, DOI 10.1007/s00221-003-1504-7; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Silvestri C, 2010, DESIGN STUD, V31, P363, DOI 10.1016/j.destud.2010.03.001; Slachevsky A, 2001, J COGNITIVE NEUROSCI, V13, P332, DOI 10.1162/08989290151137386; Sommer Robert, 1969, PERSONAL SPACE BEHAV, P12; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Stein BE, 2002, NEUROSCIENTIST, V8, P306, DOI 10.1177/107385840200800406; Stoet G., 2013, BMC PSYCHOL, V1, DOI [10.1186/2050-7283-1-18, DOI 10.1186/2050-7283-1-18]; Storz P, 2012, SURG ENDOSC, V26, P1454, DOI 10.1007/s00464-011-2055-9; Studeli T, 2007, P WWCS 2007 COMP SYS; Taffinder N, 1999, SURG ENDOSC-ULTRAS, V13, P1087, DOI 10.1007/s004649901179; Tanagho YS, 2012, J LAPAROENDOSC ADV S, V22, P865, DOI 10.1089/lap.2012.0220; Uhrich ML, 2002, SURG ENDOSC, V16, P635, DOI 10.1007/s00464-001-8151-5; Votanopoulos K, 2008, WORLD J SURG, V32, P110, DOI 10.1007/s00268-007-9253-6; Wilson MR, 2011, SURG ENDOSC, V25, P2268, DOI 10.1007/s00464-010-1546-4; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	70	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183789	10.1371/journal.pone.0183789	http://dx.doi.org/10.1371/journal.pone.0183789			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2PY	28859092	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500034
J	Guellati, FZ; Touati, H; Tambosco, K; Quiblier, C; Humbert, JF; Bensouilah, M				Guellati, Fatma Zohra; Touati, Hassen; Tambosco, Kevin; Quiblier, Catherine; Humbert, Jean-Francois; Bensouilah, Mourad			Unusual cohabitation and competition between Planktothrix rubescens and Microcystis sp (cyanobacteria) in a subtropical reservoir (Hammam Debagh) located in Algeria	PLOS ONE			English	Article							FRESH-WATER BODIES; TOXIC CYANOBACTERIUM; CLIMATE-CHANGE; LAKE; PHYTOPLANKTON; BLOOMS; QUANTIFICATION; APHANIZOMENON; TEMPERATURE; AERUGINOSA	Succession in bloom-forming cyanobacteria belonging to distant functional groups in freshwater ecosystems is currently an undescribed phenomenon. However in the Hammam Debagh reservoir (Algeria), P. rubescens and Microcystis sp. co-occur and sometimes proliferate. With the aim of identifying the main factors and processes involved in this unusual cohabitation, water samples were collected monthly from February 2013 to June 2015 at the subsurface at four sampling stations and along the entire water column at one sampling station. In addition, the composition of the cyanobacterial communities was estimated by Illumina sequencing of a 16S rRNA gene fragment from samples collected over one year (October 2013-November 2014). This molecular approach showed that the Hammam Debagh reservoir displays high species richness (89 species) but very low diversity due to the high dominance of Microcystis in this community. Furthermore, it appears that Planktothrix rubescens and Microcystis sp. coexisted (from September to January) but proliferated alternately (Spring 2015 for P. rubescens and Spring 2014 and Autumn 2014/2015 for Microcystis). The main factors and processes explaining these changes in bloom-forming species seem to be related to the variation in the depth of the lake during the mixing period and to the water temperatures during the winter prior to the bloom season in spring.	[Guellati, Fatma Zohra; Touati, Hassen; Bensouilah, Mourad] Univ Badji Mokhtar, Ecobiol Milieux Marins & Litoraux, Fac Sci, BP 12 El Hadjar, Annaba, Algeria; [Guellati, Fatma Zohra; Tambosco, Kevin; Humbert, Jean-Francois] UPEC, IRD Paris 7, Inst Ecol & Sci Environm Paris iEES, CNRS,UMR 7618,UPMC,INRA, Paris, France; [Quiblier, Catherine] Museum Natl Hist Nat, CNRS, UMR 7245, Paris, France; [Quiblier, Catherine] Univ Paris Diderot, Paris, France	Universite Badji Mokhtar - Annaba; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); INRAE; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite	Guellati, FZ (corresponding author), Univ Badji Mokhtar, Ecobiol Milieux Marins & Litoraux, Fac Sci, BP 12 El Hadjar, Annaba, Algeria.; Guellati, FZ; Humbert, JF (corresponding author), UPEC, IRD Paris 7, Inst Ecol & Sci Environm Paris iEES, CNRS,UMR 7618,UPMC,INRA, Paris, France.	guellati.fatma@yahoo.fr; jean-francois.humbert@upmc.fr		GUELLATI, Fatma Zohra/0000-0001-7237-4341; Humbert, Jean-Francois/0000-0002-1519-5651				Amarouche-Yala S, 2014, EXTREMOPHILES, V18, P1035, DOI 10.1007/s00792-014-0680-7; Anagnostidis, 2005, CYANOPROKARYOTA 2; [Anonymous], 1966, MONOGR OCEANOGR METH, DOI DOI 10.1007/S13398-014-0173-7.2; Briand JF, 2005, MICROB ECOL, V50, P418, DOI 10.1007/s00248-005-0186-z; Brient L, 2008, J ENVIRON MONITOR, V10, P248, DOI 10.1039/B714238B; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; D'Alelio D, 2011, FRESHWATER BIOL, V56, P1481, DOI 10.1111/j.1365-2427.2011.02584.x; Dolman A. M., 2012, PLoS ONE, V7, pe38757, DOI 10.1371/journal.pone.0038757; Douma M, 2010, ENVIRON MONIT ASSESS, V160, P439, DOI 10.1007/s10661-008-0708-5; Dunton PG, 2005, FEMS MICROBIOL LETT, V247, P37, DOI 10.1016/j.femsle.2005.04.026; El Herry S, 2009, J LIMNOL, V68, P242, DOI 10.4081/jlimnol.2009.242; El-Shehawy R, 2012, WATER RES, V46, P1420, DOI 10.1016/j.watres.2011.11.021; Ernst B, 2009, HARMFUL ALGAE, V8, P329, DOI 10.1016/j.hal.2008.07.006; Fathalli A, 2011, SYST APPL MICROBIOL, V34, P303, DOI 10.1016/j.syapm.2010.12.003; Gallina N, 2011, J LIMNOL, V70, P186, DOI 10.4081/jlimnol.2011.186; Halstvedt CB, 2007, J PLANKTON RES, V29, P471, DOI 10.1093/plankt/fbm036; Harke MJ, 2016, HARMFUL ALGAE, V54, P4, DOI 10.1016/j.hal.2015.12.007; Holland DP, 2009, J MICROBIOL METH, V77, P214, DOI 10.1016/j.mimet.2009.02.005; ISO Standards Compendium, 1994, ISO STAND COMP ENV W; Jacquet S, 2005, HARMFUL ALGAE, V4, P651, DOI 10.1016/j.hal.2003.12.006; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; Komarek J, 1999, CYANOPROKARYOTA 1; KONOPKA A, 1981, APPL ENVIRON MICROB, V42, P102, DOI 10.1128/AEM.42.1.102-108.1981; Laborde JP, 2010, CURR SCI, P8; Lawrence I, 2000, TECHNICAL REPORT; Lindenschmidt KE, 1998, J PLANKTON RES, V20, P1927, DOI 10.1093/plankt/20.10.1927; Mariani MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17964; McDonald KE, 2013, LAKE RESERV MANAGE, V29, P103, DOI 10.1080/10402381.2013.800172; Messineo V, 2006, TOXICON, V48, P160, DOI 10.1016/j.toxicon.2006.04.006; Michalak AM, 2016, NATURE, V535, P349, DOI 10.1038/535349a; Micheletti S, 1998, NEW PHYTOL, V139, P233, DOI 10.1046/j.1469-8137.1998.00196.x; Nasri H, 2007, ENVIRON TOXICOL, V22, P347, DOI 10.1002/tox.20275; Nurnberg GK, 2003, LAKE RESERV MANAGE, V19, P307; Oberhaus L, 2007, J PHYCOL, V43, P1191, DOI 10.1111/j.1529-8817.2007.00414.x; Ostermaier V, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-100; Oudra B, 2002, ENVIRON TOXICOL, V17, P32, DOI 10.1002/tox.10029; Oudra B, 2001, TOXICON, V39, P1375, DOI 10.1016/S0041-0101(01)00093-9; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Pobel D, 2011, WATER RES, V45, P1005, DOI 10.1016/j.watres.2010.10.011; Quiblier C, 2008, WATER RES, V42, P1023, DOI 10.1016/j.watres.2007.09.030; Recknagel F, 2016, HYDROBIOLOGIA, V778, P61, DOI 10.1007/s10750-015-2442-7; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; Saoudi A., 2015, ADV ENV BIOL, V9, P109; Schauer M, 2003, AQUAT MICROB ECOL, V31, P163, DOI 10.3354/ame031163; Sitoki L, 2012, HYDROBIOLOGIA, V691, P109, DOI 10.1007/s10750-012-1062-8; Soares MCS, 2012, LIMNOLOGICA, V42, P197, DOI 10.1016/j.limno.2011.11.002; Tan B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01027; Torres CD, 2016, MICROB ECOL, V71, P802, DOI 10.1007/s00248-015-0719-z; Van Wichelen J, 2016, HARMFUL ALGAE, V55, P97, DOI 10.1016/j.hal.2016.02.009; Via-Ordorika L, 2004, SYST APPL MICROBIOL, V27, P592, DOI 10.1078/0723202041748163; Wu WJ, 2010, FRESEN ENVIRON BULL, V19, P846; Xu Y, 2008, ENVIRON POLLUT, V156, P162, DOI 10.1016/j.envpol.2007.12.027	53	14	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183540	10.1371/journal.pone.0183540	http://dx.doi.org/10.1371/journal.pone.0183540			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859113	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500021
J	Parikh, AM; Coletta, AM; Yu, ZH; Rauch, GM; Cheung, JP; Court, LE; Klopp, AH				Parikh, Aaroh M.; Coletta, Adriana M.; Yu, Z. Henry; Rauch, Gaiane M.; Cheung, Joey P.; Court, Laurence E.; Klopp, Ann H.			Development and validation of a rapid and robust method to determine visceral adipose tissue volume using computed tomography images	PLOS ONE			English	Article							ABDOMINAL FAT; CANCER; SOFTWARE; OBESITY; HEALTH; WOMEN; RISK; CT	Background Visceral adiposity is a risk factor for many chronic diseases. Existing methods to quantify visceral adipose tissue volume using computed tomographic (CT) images often use a single slice, are manual, and are time consuming, making them impractical for large population studies. We developed and validated a method to accurately, rapidly, and robustly measure visceral adipose tissue volume using CT images. Methods In-house software, Medical Executable for the Efficient and Robust Quantification of Adipose Tissue (MEERQAT), was developed to calculate visceral adipose tissue volume using a series of CT images within a manually identified region of interest. To distinguish visceral and subcutaneous adipose tissue, ellipses are drawn through the rectus abdominis and transverse abdominis using manual and automatic processes. Visceral and subcutaneous adipose tissue volumes are calculated by counting the numbers of voxels corresponding to adipose tissue in the region of interest. MEERQAT's ellipse interpolation method was validated by comparing visceral adipose volume from 10 patients' CT scans with corresponding results from manually delineated scans. Accuracy of visceral adipose quantification was tested using a phantom consisting of animal fat and tissues. Robustness of the method was tested by determining intra-observer and inter-observer coefficients of variation (CV). Results The mean difference in visceral adipose tissue volume between manual and elliptical delineation methods was -0.54 +/- 4.81%. In the phantom, our measurement differed from the known adipose volume by <= 7.5% for all scanning parameters. Mean inter-observer CV for visceral adipose tissue volume was 0.085, and mean intra-observer CV for visceral adipose tissue volume was 0.059. Conclusions We have developed and validated a robust method of accurately and quickly determining visceral adipose tissue volume in any defined region of interest using CT imaging.	[Parikh, Aaroh M.] Rice Univ, Dept Phys & Astron, Houston, TX USA; [Coletta, Adriana M.] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA; [Yu, Z. Henry; Cheung, Joey P.; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Yu, Z. Henry; Klopp, Ann H.] Christiana Care Hlth Syst, Dept Radiat Oncol, Newark, DE USA; [Rauch, Gaiane M.] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA; [Klopp, Ann H.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Parikh, Aaroh M.] Baylor Coll Med, Sch Med, Houston, TX 77030 USA	Rice University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Christiana Care Health System; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Klopp, AH (corresponding author), Christiana Care Hlth Syst, Dept Radiat Oncol, Newark, DE USA.; Klopp, AH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	aklopp@mdanderson.org		Court, Laurence/0000-0002-3241-6145; Coletta, Adriana/0000-0002-2503-2792; , Zhiqian/0000-0002-2441-4457	Cancer Prevention & Research Institute of Texas [RP140609]; American Cancer Society [126516-RSG-14-159-01-CCE]; National Cancer Institute of the National Institutes of Health [R25CA057730]; Center for Energy Balance in Cancer Prevention and Survivorship (Duncan Family Institute) at MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R25CA057730] Funding Source: NIH RePORTER	Cancer Prevention & Research Institute of Texas; American Cancer Society(American Cancer Society); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Energy Balance in Cancer Prevention and Survivorship (Duncan Family Institute) at MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work in this paper was partially funded by the Cancer Prevention & Research Institute of Texas (Grant ID: RP140609), the American Cancer Society (Grant ID: 126516-RSG-14-159-01-CCE), National Cancer Institute of the National Institutes of Health Award Number R25CA057730 (PI: ShineChang, PhD) for providing support for AMC, and the Center for Energy Balance in Cancer Prevention and Survivorship (Duncan Family Institute) at MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Erica Goodoff from the Department of Scientific Publications at M.D. Anderson Cancer Center for reviewing the manuscript. The authors would also like to specially thank Gerardo Garza for providing the fresh animal parts for this study. We would also like to thank the National Cancer Institute of the National Institutes of Health Award Number R25CA057730 (PI: Shine Chang, PhD) for providing support for AMC.	Arsenault BJ, 2010, INT J OBESITY, V34, P340, DOI 10.1038/ijo.2009.229; Awad S, 2012, CLIN NUTR, V31, P74, DOI 10.1016/j.clnu.2011.08.008; Chung H, 2009, P SOC PHOTO-OPT INS, P7261; Demerath EW, 2007, INT J OBESITY, V31, P285, DOI 10.1038/sj.ijo.0803409; Guiu B, 2010, GUT, V59, P341, DOI 10.1136/gut.2009.188946; Irlbeck T, 2010, INT J OBESITY, V34, P781, DOI 10.1038/ijo.2009.279; Irving BA, 2007, OBESITY, V15, P370, DOI 10.1038/oby.2007.573; Ladoire S, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2010-0227; Makrogiannis S, 2013, ACAD RADIOL, V20, P1413, DOI 10.1016/j.acra.2013.08.007; Maurovich-Horvat P, 2007, INT J OBESITY, V31, P500, DOI 10.1038/sj.ijo.0803454; Molarius A, 1998, INT J OBESITY, V22, P719, DOI 10.1038/sj.ijo.0800660; Nemoto M, 2014, J OBES, V2014, DOI 10.1155/2014/495084; Ng AC, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.12; Ohshima Shunsuke, 2008, Nihon Hoshasen Gijutsu Gakkai Zasshi, V64, P1177; Poirier P, 2005, HYPERTENSION, V45, P363, DOI 10.1161/01.HYP.0000155463.90018.dc; Prizment AE, 2010, CANCER EPIDEM BIOMAR, V19, P2229, DOI 10.1158/1055-9965.EPI-10-0522; Schmandt RE, 2011, AM J OBSTET GYNECOL, V205, P518, DOI 10.1016/j.ajog.2011.05.042; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Yoshikawa K, 2011, SURG ENDOSC, V25, P3825, DOI 10.1007/s00464-011-1798-7; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; Zhao BS, 2006, J COMPUT ASSIST TOMO, V30, P777, DOI 10.1097/01.rct.0000228164.08968.e8	21	16	17	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183515	10.1371/journal.pone.0183515	http://dx.doi.org/10.1371/journal.pone.0183515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859115	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500019
J	Tsuda, T; Kaibori, M; Hishikawa, H; Nakatake, R; Okumura, T; Ozeki, E; Hara, I; Morimoto, Y; Yoshii, K; Kon, M				Tsuda, Takumi; Kaibori, Masaki; Hishikawa, Hidehiko; Nakatake, Richi; Okumura, Tadayoshi; Ozeki, Eiichi; Hara, Isao; Morimoto, Yuji; Yoshii, Kengo; Kon, Masanori			Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosome has antineoplastic effects for hepatocellular carcinoma	PLOS ONE			English	Article							SPINAL METASTASIS; DELAYS PARALYSIS; CANCER; SORAFENIB; TUMORS	Background Anticancer agents and operating procedures have been developed for hepatocellular carcinoma (HCC) patients, but their prognosis remains poor. It is necessary to develop novel diagnostic and therapeutic strategies for HCC to improve its prognosis. Lactosome is a core-shell-type polymeric micelle, and enclosing labeling or anticancer agents into this micelle enables drug delivery. In this study, we investigated the diagnostic and therapeutic efficacies of indocyanine green (ICG)-loaded lactosome for near-infrared fluorescence (NIF) imaging and photodynamic therapy (PDT) for HCC. Methods The human HCC cell line HuH-7 was treated with ICG or ICG-lactosome, followed by PDT, and the cell viabilities were measured (in vitro PDT efficiency). For NIF imaging, HuH-7 cells were subcutaneously transplanted into BALB/c nude mice, followed by intravenous administration of ICG or ICG-lactosome. The transplanted animals were treated with PDT, and the antineoplastic effects were analyzed (in vivo PDT efficiency). Results PDT had toxic effects on HuH-7 cells treated with ICG-lactosome, but not ICG alone. NIF imaging revealed that the fluorescence of tumor areas in ICG-lactosome-treated animals was higher than that of contralateral regions at 24 h after injection and thereafter. PDT exerted immediate and continuous phototoxic effects in the transplanted mice treated with ICG-lactosome. Conclusions Our results demonstrate that ICG-lactosome accumulated in xenograft tumors, and that PDT had antineoplastic effects on these malignant implants. NIF imaging and PDT with ICG-lactosome could be useful diagnostic and/or therapeutic strategies for HCC.	[Tsuda, Takumi; Kaibori, Masaki; Hishikawa, Hidehiko; Nakatake, Richi; Okumura, Tadayoshi; Kon, Masanori] Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan; [Ozeki, Eiichi; Hara, Isao] Shimadzu Co Ltd, Technol Res Lab, Kyoto, Japan; [Morimoto, Yuji] Natl Def Med Coll, Dept Integrat Physiol & Bionano Med, Tokorozawa, Saitama, Japan; [Yoshii, Kengo] Kyoto Prefectural Univ Med, Dept Math & Stat Med Sci, Kyoto, Japan	Kansai Medical University; Shimadzu Corporation; National Defense Medical College - Japan; Kyoto Prefectural University of Medicine	Kaibori, M (corresponding author), Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan.	Kaibori@hirakata.kmu.ac.jp	MORIMOTO, YUJI/F-2912-2019	MORIMOTO, YUJI/0000-0001-6494-413X	Japan Society for the Promotion of Science (KAKENHI) [15K10175]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (KAKENHI; grant number 15K10175).; This study was supported by the Japan Society for the Promotion of Science (KAKENHI; grant number 15K10175).	Alter M, 2015, J DTSCH DERMATOL GES, V13, P863, DOI 10.1111/ddg.12798; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Cancer Registry and Statistics, CANC REG STAT; CHERRICK GR, 1960, J CLIN INVEST, V39, P592, DOI 10.1172/JCI104072; Engel E, 2008, INVEST OPHTH VIS SCI, V49, P1777, DOI 10.1167/iovs.07-0911; Funayama T, 2013, PHOTODIAGN PHOTODYN, V10, P374, DOI 10.1016/j.pdpdt.2013.03.002; Funayama Toru, 2012, Open Biomed Eng J, V6, P80, DOI 10.2174/1874120701206010080; Funayama T, 2012, PHOTOMED LASER SURG, V30, P47, DOI 10.1089/pho.2011.3080; Hara E, 2014, ACS MED CHEM LETT, V5, P873, DOI 10.1021/ml500112u; Harris K, 2017, CHEST, V151, P674, DOI 10.1016/j.chest.2016.05.025; Hirano T, 2007, J JPN SOC LASER SURG, V28, P122, DOI DOI 10.2530/jslsm.28.122; Ishizawa T, 2009, CANCER-AM CANCER SOC, V115, P2491, DOI 10.1002/cncr.24291; Kaibori M, 2016, CANC IMAGING, V6, P16; Kaneko J, 2014, J GASTROENTEROL, V49, P110, DOI 10.1007/s00535-013-0775-4; Lee YH, 2016, PLOS ONE, V11; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Makino A, 2007, CHEM LETT, V36, P1220, DOI 10.1246/cl.2007.1220; Makino A, 2012, J CONTROL RELEASE, V161, P821, DOI 10.1016/j.jconrel.2012.05.006; Makino A, 2009, BIOMATERIALS, V30, P5156, DOI 10.1016/j.biomaterials.2009.05.046; Mao AW, 2016, GASTROINTEST TUMORS, V3, P59, DOI 10.1159/000447512; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Oinuma T, 2015, LASER THER, V25, P87; Oleinick NL, 2002, PHOTOCH PHOTOBIO SCI, V1, P1, DOI 10.1039/b108586g; Schenkman Emmanuel, 2004, ScientificWorldJournal, V4 Suppl 1, P387; Tsujimoto H, 2015, ANN SURG ONCOL, V22, pS923, DOI 10.1245/s10434-015-4594-0; Tsujimoto H, 2014, CANCER SCI, V105, P1626, DOI 10.1111/cas.12553; Tsukanishi T, 2014, J PHOTOPOLYM SCI TEC, V27, P449, DOI 10.2494/photopolymer.27.449; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429	30	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183527	10.1371/journal.pone.0183527	http://dx.doi.org/10.1371/journal.pone.0183527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859104	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500020
J	Zeynalov, E; Jones, SM; Elliott, JP				Zeynalov, Emil; Jones, Susan M.; Elliott, J. Paul			Therapeutic time window for conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice	PLOS ONE			English	Article							VASOPRESSIN; RECEPTOR; V-1	Background Ischemic stroke is often complicated by brain edema, disruption of blood-brain barrier (BBB), and uncontrolled release of arginine-vasopressin (AVP). Conivaptan, a V1a and V2 receptor antagonist, reduces brain edema and minimizes damage to the blood-brain barrier after stroke. Most stroke patients do not receive treatment immediately after the onset of brain ischemia. Delays in therapy initiation may worsen stroke outcomes. Therefore, we designed a translational study to explore the therapeutic time window for conivaptan administration. Methods Mice were treated with conivaptan beginning 3, 5, or 20 hours after 60-minute focal middle cerebral artery occlusion. Treatments were administered by continuous IV infusion for a total of 48 hours. Brain edema and blood-brain barrier (BBB) disruption were evaluated at endpoint. Results Conivaptan therapy initiated at 3 hours following ischemia reduced edema in the ipsilateral hemisphere, which corresponded with improvements in neurological deficits. Stroke-triggered BBB disruption was also reduced in mice when conivaptan treatments were initiated at 3 hours of reperfusion. However, 5 and 20-hour delays of conivaptan administration failed to reduce edema or protect BBB. Conclusion Timing of conivaptan administration is important for successful reduction of brain edema and BBB disruption. Our experimental data open new possibilities to repurpose conivaptan, and make an important "bench-to-bedside translation" of the results into clinical practice.	[Zeynalov, Emil; Jones, Susan M.] Swedish Med Ctr, Neurotrauma Res, Englewood, CO 80110 USA; [Elliott, J. Paul] Colorado Brain & Spine Inst, Englewood, CO USA; [Zeynalov, Emil; Jones, Susan M.] Swedish Med Ctr, Neurotrauma Res Dept, Englewood, CO 80110 USA		Zeynalov, E (corresponding author), Swedish Med Ctr, Neurotrauma Res, Englewood, CO 80110 USA.; Zeynalov, E (corresponding author), Swedish Med Ctr, Neurotrauma Res Dept, Englewood, CO 80110 USA.	emil.zeynalov@healthonecares.com		Zeynalov, Emil/0000-0002-1259-3136; Jones, Susan/0000-0002-9801-1239	Swedish Medical center	Swedish Medical center	This research was supported by a grant from Swedish Medical center to Dr. J. Paul Elliott.	[Anonymous], 2004, Drugs R D, V5, P94; Chelko SP, 2013, J VASC RES, V50, P478, DOI 10.1159/000355265; Figueroa SA, 2015, CNS DRUGS, V29, P17, DOI 10.1007/s40263-014-0210-2; Hedna VS, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0213-0; Heiss WD, 2016, CEREBROVASC DIS, V41, P1, DOI 10.1159/000441627; Lv S, 2010, LIVER INT, V30, P1198, DOI 10.1111/j.1478-3231.2010.02211.x; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; O'Donnell ME, 2005, AM J PHYSIOL-CELL PH, V289, pC283, DOI 10.1152/ajpcell.00001.2005; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Vantyghem MC, 2011, ANN ENDOCRINOL-PARIS, V72, P500, DOI 10.1016/j.ando.2011.10.001; Villabona Carles, 2010, Endocrinol Nutr, V57 Suppl 2, P41, DOI 10.1016/S1575-0922(10)70021-8; Wun T, 1996, BRIT J HAEMATOL, V92, P968, DOI 10.1046/j.1365-2141.1996.436975.x; Zeynalov E, 2006, J CEREBR BLOOD F MET, V26, P414, DOI 10.1038/sj.jcbfm.9600196; Zeynalov E, 2008, CRIT CARE MED, V36, P2634, DOI 10.1097/CCM.0b013e3181847853; Zeynalov E, 2016, JOVE-J VIS EXP, DOI 10.3791/54170; Zeynalov E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136121; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4	18	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183985	10.1371/journal.pone.0183985	http://dx.doi.org/10.1371/journal.pone.0183985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854286	Green Published, gold, Green Submitted			2022-12-26	WOS:000408693600075
J	Bosl, A; Spitzmuller, A; Jasarevic, Z; Rauch, S; Jager, S; Offner, F				Boesl, Andreas; Spitzmueller, Andreas; Jasarevic, Zerina; Rauch, Stefanie; Jaeger, Silke; Offner, Felix			MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer	PLOS ONE			English	Article							70-GENE PROGNOSIS SIGNATURE; DISTANT RECURRENCE; PAM50 RISK; ASSAY; SCORE; INFORMATION; VALIDATION; PREDICTION; HALLMARKS; WOMEN	Introduction Correct risk assessment of disease recurrence in patients with early breast cancer is critically important to detect patients who may be spared adjuvant chemotherapy. In clinical practice this is increasingly done based on the results of gene expression assays. In the present study we compared the concordance of the 70-gene signature MammaPrint (MP) with the 12 gene assay EndoPredict (EP). Methods Representative tissue of 48 primary tumours was analysed with the MP during routine diagnostic purposes. Corresponding formalin-fixed, paraffin-embedded tissue was thereafter analysed by the EP test. Risk categories of both tests were compared. Results 41 of 48 tumours could be directly compared by both tests. Of the 17 MP low risk cases, only 9 were considered low risk by EP (53% agreement) and of the 24 MP high risk cases, 18 were high risk by EP (75% agreement). Discrepancies occurred in 14 of 41 cases (34.1%). There was only a weak and non-significant correlation between the MP and EP test with an overall concordance of only 66%. The original therapeutic recommendation was based on the MP and would have been changed in 38% of the patients following EP test results. 4 patients developed distant metastases. The respective tumours of these patients were all classified as high risk by the EP, but only 3 were classified as high risk by the MP. Conclusion Both tests resulted in different treatment recommendations for a significant proportion of patients and cannot be used interchangeably. The results underscore the urgent need for further comparative analyses of multi-genomic tests to avoid misclassification of disease recurrence risk in breast cancer patients.	[Boesl, Andreas; Jasarevic, Zerina; Offner, Felix] Acad Teaching Hosp Feldkirch, Inst Pathol, Dept Mol Diagnost, Feldkirch, Austria; [Spitzmueller, Andreas] Tech Univ Munich, Dept Genome Oriented Bioinformat, Freising Weihenstephan, Germany; [Rauch, Stefanie] Acad Teaching Hosp Feldkirch, Dept Surg, Feldkirch, Austria; [Jaeger, Silke] Univ Appl Sci, FH Campus Vienna, Vienna, Austria	Technical University of Munich	Bosl, A (corresponding author), Acad Teaching Hosp Feldkirch, Inst Pathol, Dept Mol Diagnost, Feldkirch, Austria.	Andreas.Boesl@lkhf.at						Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Alvarado MD, 2015, ADV THER, V32, P1237, DOI 10.1007/s12325-015-0269-2; Bueno-de-Mesquita JM, 2009, BREAST CANCER RES TR, V117, P483, DOI 10.1007/s10549-008-0191-2; Buus R, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw149; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Coates AS, 2015, ANN ONCOL, P1; Cobain EF, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0340-x; Dabbs D, 2014, J CLIN ONCOL, V32, p5s; Denkert C, 2012, VIRCHOWS ARCH, V460, P251, DOI 10.1007/s00428-012-1204-4; Dombard Y, 2015, ONCOLOGIST, V20, P351, DOI 10.1634/theoncologist.2014-0268; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Drukker CA, 2013, INT J CANCER, V133, P929, DOI 10.1002/ijc.28082; Dubsky P, 2013, BRIT J CANCER, V109, P2959, DOI 10.1038/bjc.2013.671; Dubsky P, 2013, ANN ONCOL, V24, P640, DOI 10.1093/annonc/mds334; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Gluck S, 2013, BREAST CANCER RES TR, V139, P759, DOI 10.1007/s10549-013-2572-4; Gyorffy B, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0514-2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kelly CM, 2012, ONCOLOGIST, V17, P492, DOI 10.1634/theoncologist.2012-0007; Knauer M, 2010, BREAST CANCER RES TR, V120, P655, DOI 10.1007/s10549-010-0814-2; Kos Z, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3688; Kronenwett R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-456; Maroun R, 2015, J CLIN ONCOL, V33; Martin M, 2012, CANCER RES, V272, P210; Martin M, 2016, BREAST CANCER RES TR, V156, P81, DOI 10.1007/s10549-016-3725-z; Mehta R, 2011, CLIN BREAST CANCER, V11, P20, DOI 10.3816/CBC.2011.n.004; Mook S, 2010, ANN ONCOL, V21, P717, DOI 10.1093/annonc/mdp388; Mook S, 2009, BREAST CANCER RES TR, V116, P295, DOI 10.1007/s10549-008-0130-2; Morris SR, 2007, REV ENDOCR METAB DIS, V8, P185, DOI 10.1007/s11154-007-9035-3; Muller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068252; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2011, BREAST, V20, pS87, DOI 10.1016/S0960-9776(11)70301-0; R Core Team, 2021, R LANGUAGE ENV STAT; Sapino A, 2014, J MOL DIAGN, V16, P190, DOI 10.1016/j.jmoldx.2013.10.008; Senkus E, 2015, ANN ONCOL, P26; Sinn P, 2013, GEBURTSH FRAUENHEILK, V73, P932, DOI 10.1055/s-0033-1350831; Tian S, 2010, BIOMARK INSIGHTS, V5, P129, DOI 10.4137/BMI.S6184; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Varga Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058483; Weigelt B, 2012, ANN ONCOL S10, V23; Witmer BS, 2008, CLIN CANCER RES, V14, P2988, DOI 10.1158/1078-0432.CCR-07-4723; Wolff AC, 2014, AM SOC CLIN ONCOLOGY, V31, P3997; Zhao X, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-211	47	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183458	10.1371/journal.pone.0183458	http://dx.doi.org/10.1371/journal.pone.0183458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850621	gold, Green Submitted, Green Published			2022-12-26	WOS:000408544200015
J	Kobayashi, T; Miyashita, T; Murayama, T; Toyoshima, YY				Kobayashi, Takuya; Miyashita, Takuya; Murayama, Takashi; Toyoshima, Yoko Y.			Dynactin has two antagonistic regulatory domains and exerts opposing effects on dynein motility	PLOS ONE			English	Article							MICROTUBULE-BINDING DOMAIN; CAP-GLY DOMAIN; CYTOPLASMIC DYNEIN; MOTOR DOMAIN; PLUS ENDS; K-LOOP; PROCESSIVITY; P150(GLUED); TRANSPORT; COMPLEX	Dynactin is a dynein-regulating protein that increases the processivity of dynein movement on microtubules. Recent studies have shown that a tripartite complex of dynein-dynactin-Bicaudal D2 is essential for highly processive movement. To elucidate the regulation of dynein motility by dynactin, we focused on two isoforms (A and B) of dynactin 1 (DCTN1), the largest subunit of dynactin that contains both microtubule- and dynein-binding domains. The only difference between the primary structures of the two isoforms is that DCTN1B lacks the K-rich domain, a cluster of basic residues. We measured dynein motility by single molecule observation of recombinant dynein and dynactin. Whereas the tripartite complex containing DCTN1A exhibited highly processive movement, the complex containing DCTN1B dissociated from microtubules with no apparent processive movement. This inhibitory effect of DCTN1B was caused by reductions of the microtubule-binding affinities of both dynein and dynactin, which was attributed to the coiled-coil 1 domain of DCTN1. In DCTN1A, the K-rich domain antagonized these inhibitory effects. Therefore, dynactin has two antagonistic domains and promotes or suppresses dynein motility to accomplish correct localization and functions of dynein within a cell.	[Kobayashi, Takuya; Miyashita, Takuya; Toyoshima, Yoko Y.] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Murayama, Takashi] Juntendo Univ, Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Juntendo University	Toyoshima, YY (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	cyytoyo@mail.ecc.u-tokyo.ac.jp			JSPS KAKENHI [15H01310, 16H04772]; Grants-in-Aid for Scientific Research [16H04772, 16K08507] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 15H01310 and 16H04772 to YYT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN V, 1994, CURR BIOL, V4, P1000, DOI 10.1016/S0960-9822(00)00225-6; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Brocard CB, 2005, TRAFFIC, V6, P386, DOI 10.1111/j.1600-0854.2005.00283.x; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Dixit R, 2008, J BIOL CHEM, V283, P33611, DOI 10.1074/jbc.M804840200; Duellberg C, 2014, NAT CELL BIOL, V16, P804, DOI 10.1038/ncb2999; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Hendricks AG, 2012, CURR BIOL, V22, P632, DOI 10.1016/j.cub.2012.02.023; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Holzbaur ELF, 2010, ENCY NEUROSCI, P1181; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kobayashi T, 2006, BIOCHEM BIOPH RES CO, V340, P23, DOI 10.1016/j.bbrc.2005.11.145; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007827; Kobayashi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003822; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Kumar S, 2001, EMBO REP, V2, P939, DOI 10.1093/embo-reports/kve202; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; Lazarus JE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001611; Li SL, 2002, J BIOL CHEM, V277, P48596, DOI 10.1074/jbc.M208512200; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Munch C, 2005, ANN NEUROL, V58, P777, DOI 10.1002/ana.20631; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Newsway V, 2010, MOVEMENT DISORD, V25, P767, DOI 10.1002/mds.22950; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Pensato S, 2010, BIOPOLYMERS, V93, P434, DOI 10.1002/bip.21357; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shrum CK, 2009, P NATL ACAD SCI USA, V106, P2647, DOI 10.1073/pnas.0806677106; Siglin AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059453; Siller KH, 2008, DEV BIOL, V319, P1, DOI 10.1016/j.ydbio.2008.03.018; Tokito MK, 1998, BBA-GENE STRUCT EXPR, V1442, P432, DOI 10.1016/S0167-4781(98)00195-X; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Tripathy SK, 2014, NAT CELL BIOL, V16, P1192, DOI 10.1038/ncb3063; Urnavicius L, 2015, SCIENCE, V347, P1441, DOI 10.1126/science.aaa4080; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Yan S, 2013, J MOL BIOL, V425, P4249, DOI 10.1016/j.jmb.2013.04.027; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Zhapparova ON, 2009, TRAFFIC, V10, P1635, DOI 10.1111/j.1600-0854.2009.00976.x	50	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183672	10.1371/journal.pone.0183672	http://dx.doi.org/10.1371/journal.pone.0183672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850609	gold, Green Submitted, Green Published			2022-12-26	WOS:000408544200023
J	Korza, G; Abini-Agbomson, S; Setlow, B; Shen, A; Setlow, P				Korza, George; Abini-Agbomson, Stephen; Setlow, Barbara; Shen, Aimee; Setlow, Peter			Levels of L-malate and other low molecular weight metabolites in spores of Bacillus species and Clostridium difficile	PLOS ONE			English	Article							BACTERIAL SPORULATION; MEGATERIUM SPORES; DIPICOLINIC ACID; AMINO-ACIDS; MOTHER CELL; GERMINATION; BETA-POLY(L-MALATE); FORESPORE; SUBTILIS	Dormant spores of Bacillus species lack ATP and NADH and contain notable levels of only a few other common low mol wt energy reserves, including 3-phosphoglyceric acid (3PGA), and glutamic acid. Recently, Bacillus subtilis spores were reported to contain similar to 30 mu mol of L-malate/g dry wt, which also could serve as an energy reserve. In present work, L-malate levels were determined in the core of dormant spores of B. subtilis, Bacillus cereus, Bacillus megaterium and Clostridium difficile, using both an enzymatic assay and C-13-NMR on extracts prepared by several different methods. These assays found that levels of L-malate in B. cereus and B. megaterium spores were <= 0.5 mu mol/g dry wt, and <= 1 mu mol/g dry wt in B. subtilis spores, and levels of L-lactate and pyruvate in B. megaterium and B. subtilis spores were < 0.5 mu mol/g dry wt. Levels of L-malate in C. difficile spores were <= 1 mu mol/g dry wt, while levels of 3PGA were similar to 7 mu mol/g; the latter value was determined by P-31-NMR, and is in between the 3PGA levels in B. megaterium and B. subtilis spores determined previously. C-13-NMR analysis of spore extracts further showed that B. megaterium, B. subtilis and C. difficile contained significant levels of carbonate/bicarbonate in the spore core. Low mol wt carbon-containing small molecules present at > 3 mu mol/g dry spores are: i) dipicolinic acid, carbonate/bicarbonate and 3PGA in B. megaterium, B. subtilis and C. difficile; ii) glutamate in B. megaterium and B. subtilis; iii) arginine in B. subtilis; and iv) at least one unidentified compound in all three species.	[Korza, George; Abini-Agbomson, Stephen; Setlow, Barbara; Setlow, Peter] UConn Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Shen, Aimee] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Tufts University	Setlow, P (corresponding author), UConn Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA.	setlow@nso2.uchc.edu		Abini-Agbomson, Stephen/0000-0003-0148-6498; Shen, Aimee/0000-0002-9786-5742	Short Term Innovative Research (STIR) from Army Research Office [W91NF-16-1-0024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108684] Funding Source: NIH RePORTER	Short Term Innovative Research (STIR) from Army Research Office; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Short Term Innovative Research (STIR) award to PS from the Army Research Office (www.arl.army.mil), and a research grant (W91NF-16-1-0024 to PS, also from the Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagyan I, 1998, GENE, V212, P179, DOI 10.1016/S0378-1119(98)00172-3; BERGERE JL, 1975, ANN INST PASTEUR MIC, VA126, P421; Camp AH, 2009, GENE DEV, V23, P1014, DOI 10.1101/gad.1781709; Clements MO, 1968, J BACTERIOL, V180, P1787; Doan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000566; FISCHER H, 1989, BIOCHEMISTRY-US, V28, P5219, DOI 10.1021/bi00438a045; Ghosh S, 2015, J BACTERIOL, V197, P992, DOI 10.1128/JB.02520-14; HAUSENBAUER JM, 1977, J BACTERIOL, V129, P1148, DOI 10.1128/JB.129.2.1148-1150.1977; HODSON PH, 1965, J BACTERIOL, V90, P1503, DOI 10.1128/JB.90.5.1503-.1965; Loshon CA, 2006, J BACTERIOL, V188, P3153, DOI 10.1128/JB.188.8.3153-3158.2006; LOSHON CA, 1993, CAN J MICROBIOL, V39, P259, DOI 10.1139/m93-036; Magge A, 2008, J BACTERIOL, V190, P4798, DOI 10.1128/JB.00477-08; Meisner J, 2008, P NATL ACAD SCI USA, V105, P15100, DOI 10.1073/pnas.0806301105; NELSON DL, 1970, J BIOL CHEM, V245, P1137; NELSON DL, 1970, J BIOL CHEM, V245, P1128; Nelson DL, 1969, SPORES 4, P59; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Paidhungat M, 2000, J BACTERIOL, V182, P5505, DOI 10.1128/JB.182.19.5505-5512.2000; Paidhungat M., 2002, BACILLUS SUBTILIS IT, P537, DOI DOI 10.1128/9781555817992.CH37; PELEG Y, 1990, APPL ENVIRON MICROB, V56, P2777, DOI 10.1128/AEM.56.9.2777-2783.1990; PERRY JJ, 1956, J BACTERIOL, V72, P295, DOI 10.1128/JB.72.3.295-300.1956; Pinchai N, 2006, FEBS J, V273, P1046, DOI 10.1111/j.1742-4658.2006.05131.x; Schmidt A, 1996, EUR J CELL BIOL, V70, P373; SCOTT IR, 1978, BIOCHEM J, V174, P627, DOI 10.1042/bj1740627; Setlow B, 1996, J BACTERIOL, V178, P3486, DOI 10.1128/jb.178.12.3486-3495.1996; SETLOW B, 1977, J BACTERIOL, V132, P744, DOI 10.1128/JB.132.2.744-746.1977; SETLOW P, 1970, J BIOL CHEM, V245, P3637; Setlow P, 2013, J APPL MICROBIOL, V115, P1251, DOI 10.1111/jam.12343; SETLOW P, 1994, J APPL BACTERIOL, V76, pS49, DOI 10.1111/j.1365-2672.1994.tb04357.x; SETLOW P, 1975, J BIOL CHEM, V250, P623; SETLOW P, 1970, J BIOL CHEM, V245, P3645; Setlow P, 2012, FOOD MICROBIOLOGY FU, V4th, P45; Sinai L, 2015, MOL CELL, V57, P695, DOI 10.1016/j.molcel.2014.12.019; SINGH RP, 1977, J BACTERIOL, V130, P1130, DOI 10.1128/JB.130.3.1130-1138.1977; SZULMAJSTER JEKISIEL, 1965, P162; Wang SW, 2015, J BACTERIOL, V197, P2361, DOI 10.1128/JB.00200-15; Willibald B, 1999, EUR J BIOCHEM, V265, P1085, DOI 10.1046/j.1432-1327.1999.00834.x	37	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0182656	10.1371/journal.pone.0182656	http://dx.doi.org/10.1371/journal.pone.0182656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850573	Green Published, gold, Green Submitted			2022-12-26	WOS:000408544200005
J	Ribeiro, PPC; Silva, DMD; de Assis, CF; Correia, RTP; Damasceno, KSFDC				Cabral Ribeiro, Penha Patricia; de Lima e Silva, Denise Maria; de Assis, Cristiane Fernandes; Pinto Correia, Roberta Targino; da Silva Chaves Damasceno, Karla Suzanne Florentino			Bioactive properties of faveleira (Cnidoscolus quercifolius) seeds, oil and press cake obtained during oilseed processing	PLOS ONE			English	Article							IN-VITRO ANTIOXIDANT; PHENOLIC-COMPOUNDS; ANTIMICROBIAL ACTIVITIES; FATTY-ACIDS; L.; CAPACITY; EXTRACTS; QUALITY; FLAX; IDENTIFICATION	To the best of our knowledge, this is the first report in the literature concerning the bioactive properties of faveleira products. This work focuses on the physicochemical evaluation of faveleira oil, as well as it investigates the bioactive properties of faveleira seeds, faveleira oil and the press cake obtained during the oilseed processing. The seeds were cold pressed and the following tests were performed: physicochemical characteristics (acidity, peroxide values, moisture and volatile matter, density and viscosity) and fatty acid profile of faveleira oil; total phenolic and flavonoid content of faveleira seed and press cake; antibacterial activity of seed, oil and press cake; and antioxidant activity (DPPH radical scavenging activity, reducing power assay, total antioxidant capacity, superoxide radical scavenging assay and oxygen radical absorbance capacity) of seed, oil and press cake. Our work demonstrated that the faveleira seed oil has low acidity (0.78 +/- 0.03% oleic acid) and peroxide value (1.13 +/- 0.12 mEq/1000g), associated with the relevant concentration of linoleic acid (53.56%). It was observed that important phenolics (398.89 +/- 6.34 mg EAG/100 g), especially flavonoids (29.81 +/- 0.71 mg RE/g) remain in the press cake, which indicates that the by-product of the faveleira oilseed production constitutes a rich residual source of bioactive compounds. No bacterial growth inhibition was detected, but all samples including faveleira seeds, press cake, oil and its fractions have potent antioxidant activities, mainly the press cake, with oxygen radical absorbance capacity of 28.39 +/- 4.36 mu M TE/g. Our results also show that faveleira oil has potential to be used as edible oil and the press cake should be used to contain the most antioxidants from seed.	[Cabral Ribeiro, Penha Patricia; de Lima e Silva, Denise Maria; da Silva Chaves Damasceno, Karla Suzanne Florentino] Univ Fed Rio Grande do Norte, Dept Nutr, Natal, Rio Grande Do N, Brazil; [de Assis, Cristiane Fernandes] Univ Fed Rio Grande do Norte, Sch Pharm, Natal, Rio Grande Do N, Brazil; [Pinto Correia, Roberta Targino] Univ Fed Rio Grande do Norte, Dept Chem Engn, Natal, Rio Grande Do N, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Ribeiro, PPC (corresponding author), Univ Fed Rio Grande do Norte, Dept Nutr, Natal, Rio Grande Do N, Brazil.	penhapatriciar@hotmail.com	Assis, Cristiane Fernandes de/AAY-9213-2021; Hoskin, Roberta/W-2785-2019	Assis, Cristiane Fernandes de/0000-0001-7595-5395; Hoskin, Roberta/0000-0003-0900-4983; Florentino da Silva Chaves Damasceno, Karla Suzanne/0000-0001-6884-1023; Cabral Ribeiro, Penha Patricia/0000-0002-4867-5248				Abu Bakar MF, 2009, FOOD CHEM, V113, P479, DOI 10.1016/j.foodchem.2008.07.081; Alves CQ, 2010, QUIM NOVA, V33, P2202, DOI 10.1590/S0100-40422010001000033; [Anonymous], 1994, FATS OILS HUM NUTR; AOCS, 2014, OFFICIAL METHODS REC; AOCS, 2003, OFFICIAL METHODS REC; Arranz S, 2008, EUR FOOD RES TECHNOL, V227, P425, DOI 10.1007/s00217-007-0737-2; Basu S, 2012, INDIAN J BIOCHEM BIO, V49, P115; Belhadj F, 2016, FOOD CHEM, V204, P29, DOI 10.1016/j.foodchem.2016.02.111; Chirinos R, 2013, FOOD CHEM, V141, P1732, DOI 10.1016/j.foodchem.2013.04.078; Christodouleas DC, 2015, FOOD ANAL METHOD, V8, P1294, DOI 10.1007/s12161-014-0005-6; Condelli N, 2015, FOOD CHEM, V177, P233, DOI 10.1016/j.foodchem.2015.01.001; Dasgupta N, 2004, FOOD CHEM, V88, P219, DOI 10.1016/j.foodchem.2004.01.036; Dorni C, 2017, FATTY ACID PROFILE E; Ferronatto Regina, 2007, Rev. bras. farmacogn., V17, P224, DOI 10.1590/S0102-695X2007000200016; Fujita A, 2013, FOOD RES INT, V54, P495, DOI 10.1016/j.foodres.2013.07.025; Ganske F., 2006, ORAC ASSAY FLUORSTAR; Gao F, 2016, J FOOD COMPOS ANAL, V45, P26, DOI 10.1016/j.jfca.2015.09.004; Candela CG, 2011, NUTR HOSP, V26, P323, DOI [10.1590/S0212-16112011000200013, 10.3305/nh.2011.26.2.5117]; Hartman L., 1973, Laboratory Practice, V22 [7] 475-476, P494; Islam T, 2016, LWT-FOOD SCI TECHNOL, V72, P423, DOI 10.1016/j.lwt.2016.05.005; Karaman S, 2015, J AGR FOOD CHEM, V63, P2305, DOI 10.1021/jf504390t; Kim J, 2010, FOOD CHEM, V118, P398, DOI 10.1016/j.foodchem.2009.05.011; Kumaran A, 2007, LWT-FOOD SCI TECHNOL, V40, P344, DOI 10.1016/j.lwt.2005.09.011; de Medeiros EJL, 2013, J THERM ANAL CALORIM, V112, P1515, DOI 10.1007/s10973-012-2653-3; Li X, 2014, J FOOD NUTR RES, V2, P244; Lopez-Huertas E, 2010, PHARMACOL RES, V61, P200, DOI 10.1016/j.phrs.2009.10.007; Paredes PF, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7930563; Makni M, 2008, FOOD CHEM TOXICOL, V46, P3714, DOI 10.1016/j.fct.2008.09.057; Marques FG, 2015, REV BRAS FARMACOGN, V25, P522, DOI 10.1016/j.bjp.2015.07.019; Matthaus B, 2002, J AGR FOOD CHEM, V50, P3444, DOI 10.1021/jf011440s; Medeiros E, 2014, MOLECULES, V19, P992, DOI 10.3390/molecules19010992; Mohamed AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060269; National Committee for Clinical Laboratory Standards, 2009, PERF STAND ANT DISK; Nobrega EM, 2014, J FOOD PROCESS PRES, P1; Ribeiro SAO, 2016, LWT-FOOD SCI TECHNOL, V65, P464, DOI 10.1016/j.lwt.2015.08.053; Ogbunugafor H. A., 2011, Pakistan Journal of Nutrition, V10, P409; Onivogui G, 2016, ASIAN PAC J TROP BIO, V6, P20, DOI 10.1016/j.apjtb.2015.09.023; Sobrinho TJSP, 2011, AFR J PHARM PHARMACO, V5, P2310, DOI 10.5897/AJPP11.608; Perez-Jimenez J, 2006, FOOD RES INT, V39, P791, DOI 10.1016/j.foodres.2006.02.003; do Prado ACP, 2013, IND CROP PROD, V45, P64, DOI 10.1016/j.indcrop.2012.11.042; Raj CA, 2012, CHIN J NAT MEDICINES, V10, P263, DOI 10.3724/SP.J.1009.2012.00263; Roleira FMF, 2015, FOOD CHEM, V183, P235, DOI 10.1016/j.foodchem.2015.03.039; Santos JCO, 2005, J THERM ANAL CALORIM, V79, P271, DOI 10.1007/s10973-005-0048-4; Santoso H, 2014, PROCEDIA CHEM, V9, P248, DOI 10.1016/j.proche.2014.05.030; Saravanan S, 2014, FOOD SCI HUM WELL, V3, P56, DOI DOI 10.1016/J.FSHW.2014.05.001; Schmidt S, 2005, CZECH J FOOD SCI, V23, P93, DOI 10.17221/3377-CJFS; Shahidi F, 2015, J FUNCT FOODS, V18, P757, DOI 10.1016/j.jff.2015.01.047; Silva SI, 2014, BIOMASS BIOENERG, V69, P124, DOI 10.1016/j.biombioe.2014.07.010; Slatnar A, 2014, FOOD RES INT, V64, P783, DOI 10.1016/j.foodres.2014.08.009; Souza BB, 2012, AGROPECUARIA CIENTIF, V8, P1; Tabart J, 2009, FOOD CHEM, V113, P1226, DOI 10.1016/j.foodchem.2008.08.013; Teh SS, 2015, FOOD CHEM, V187, P460, DOI 10.1016/j.foodchem.2015.04.043; Teh SS, 2013, J FOOD COMPOS ANAL, V30, P26, DOI 10.1016/j.jfca.2013.01.004; Thanonkaew A, 2012, LWT-FOOD SCI TECHNOL, V48, P231, DOI 10.1016/j.lwt.2012.03.018; Wang J, 2008, INT J BIOL MACROMOL, V42, P127, DOI 10.1016/j.ijbiomac.2007.10.003; Yang J, 2009, LWT-FOOD SCI TECHNOL, V42, P1, DOI 10.1016/j.lwt.2008.07.007	56	14	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183935	10.1371/journal.pone.0183935	http://dx.doi.org/10.1371/journal.pone.0183935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846740	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600058
J	Caparros-Gonzalez, RA; Romero-Gonzalez, B; Strivens-Vilchez, H; Gonzalez-Perez, R; Martinez-Augustin, O; Peralta-Ramirez, MI				Caparros-Gonzalez, Rafael A.; Romero-Gonzalez, Borja; Strivens-Vilchez, Helen; Gonzalez-Perez, Raquel; Martinez-Augustin, Olga; Isabel Peralta-Ramirez, Maria			Hair cortisol levels, psychological stress and psychopathological symptoms as predictors of postpartum depression	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; POSTNATAL DEPRESSION; SPANISH VERSION; PREGNANCY; RISK; ANXIETY; SCALE; DYSREGULATION; VALIDATION; DISTRESS	Postpartum depression affects a huge number of women and has detrimental consequences. Knowing the factors associated with postpartum depression during pregnancy can help its prevention. Although there is evidence surrounding behavioral or psychological predictors of postpartum depression, there is a lack of evidence of biological forecasters. The aim of this study was to analyze the sociodemographic, obstetric, and psychological variables along with hair cortisol levels during the first, second, and third trimesters of pregnancy that could predict postpartum depression symptoms. A sample of 44 pregnant women was assessed during 3 trimesters of pregnancy and the postpartum period using psychological questionnaires and hair cortisol levels. Participants were divided into 2 groups: a group with postpartum depression symptoms and a group with no postpartum depression symptoms. Results showed significant positive differences between groups in the first trimester regarding the Somatization subscale of the SCL-90-R (p<.05). In the second trimester, significant differences were found in the Somatization, Depression, Anxiety, and GSI subscales (p<.05). In the third trimester significant differences between both groups were found regarding pregnancy-specific stress. We found significant positive differences between groups regarding hair cortisol levels in the first and the third trimester. Hair cortisol levels could predict 21.7% of the variance of postpartum depression symptoms. In conclusion, our study provided evidence that psychopathological symptoms, pregnancy-specific stress, and hair cortisol levels can predict postpartum depression symptoms at different time-points during pregnancy. These findings can be applied in future studies and improve maternal care in clinical settings.	[Caparros-Gonzalez, Rafael A.; Romero-Gonzalez, Borja; Isabel Peralta-Ramirez, Maria] Univ Granada, Fac Psychol, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain; [Caparros-Gonzalez, Rafael A.] Hosp Poniente, Dept Gynecol & Obstet, El Ejido, Spain; [Strivens-Vilchez, Helen] Gongora Primary Hlth Ctr, Midwifery Dept, Granada, Spain; [Gonzalez-Perez, Raquel] Univ Granada, Inst Invest Biosanitaria Ibs GRANADA, Dept Pharmacol, CIBERehd,Sch Pharm, Granada, Spain; [Martinez-Augustin, Olga] Univ Granada, Inst Invest Biosanitaria Ibs GRANADA, Dept Biochem & Mol Biol 2, CIBERehd,Sch Pharm, Granada, Spain	University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada	Caparros-Gonzalez, RA; Romero-Gonzalez, B (corresponding author), Univ Granada, Fac Psychol, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain.; Caparros-Gonzalez, RA (corresponding author), Hosp Poniente, Dept Gynecol & Obstet, El Ejido, Spain.; Gonzalez-Perez, R (corresponding author), Univ Granada, Inst Invest Biosanitaria Ibs GRANADA, Dept Pharmacol, CIBERehd,Sch Pharm, Granada, Spain.	rcg477@correo.ugr.es; borjaps@correo.ugr.es; raquel.gonzalez@ciberehd.or	Peralta, Maria Isabel MI/I-3920-2015; Caparros-Gonzalez, Rafael A./P-1519-2015; Romero-Gonzalez, Borja/ABF-5918-2020; Augustin, Olga Martínez/K-6720-2014; Romero-Gonzalez, Borja/X-7551-2018	Peralta, Maria Isabel MI/0000-0001-8201-8906; Caparros-Gonzalez, Rafael A./0000-0002-0565-1123; Romero-Gonzalez, Borja/0000-0002-6350-1836; Augustin, Olga Martínez/0000-0001-8291-3468; Romero-Gonzalez, Borja/0000-0002-6350-1836	Spanish Ministry of Science and Innovation [PSI2015-63494-P]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study is a part of a Doctoral Thesis and was supported by the I+D Project "PSI2015-63494-P" of the Spanish Ministry of Science and Innovation. URL of the funder's website: http://panwww.idi.mineco.gob.es/portal/site/MICINNI/menuitem.00d7c011ca2a3753222b7d1001432ea0/?vgnextoid=33881f4368aef110VgnVCM1000001034e20aRCRD. The funder's role was providing funding for data collection and analysis, and preparation of the manuscript.	Abell JG, 2016, PSYCHONEUROENDOCRINO, V73, P148, DOI 10.1016/j.psyneuen.2016.07.214; Alderdice F, 2013, J REPROD INFANT PSYC, V31, P431, DOI 10.1080/02646838.2013.835039; Alderdice F, 2012, J PSYCHOSOM OBST GYN, V33, P62, DOI 10.3109/0167482X.2012.673040; Andalusian Ministry of Health, 2010, PREGNANCY HEALTH DOC; Andy Field, 2009, DISCOVERING STAT USI; Becker M, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0664-7; Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Bergman K, 2010, BIOL PSYCHIAT, V67, P1026, DOI 10.1016/j.biopsych.2010.01.002; BOYCE P, 1993, AUST NZ J PSYCHIAT, V27, P472, DOI 10.3109/00048679309075805; Braig S, 2016, PAEDIATR PERINAT EP, V30, P97, DOI 10.1111/ppe.12255; Caparros-Caparros B, 2007, INT J CLIN HLTH PSYC, V7, P781; Caparros-Gonzalez RA, 2015, J REPROD INFANT PSYC, V33, pE36; Chen Z, 2013, J CHROMATOGR B, V929, P187, DOI 10.1016/j.jchromb.2013.04.026; Clout D, 2015, J AFFECT DISORDERS, V188, P60, DOI 10.1016/j.jad.2015.08.054; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; D'Anna-Hernandez KL, 2011, PHYSIOL BEHAV, V104, P348, DOI 10.1016/j.physbeh.2011.02.041; de Rezende MG, 2016, J AFFECT DISORDERS, V193, P249, DOI 10.1016/j.jad.2015.12.065; Derogatis L. R., 1975, SCL 90 R ADM SCORING; Diego MA, 2004, PSYCHIATRY, V67, P63, DOI 10.1521/psyc.67.1.63.31251; Duthie L, 2013, NEUROENDOCRINOLOGY, V98, P106, DOI 10.1159/000354702; Fan FL, 2009, INT J GYNECOL OBSTET, V105, P46, DOI 10.1016/j.ijgo.2008.12.001; Figueiredo B, 2009, ARCH WOMEN MENT HLTH, V12, P143, DOI 10.1007/s00737-009-0059-4; Garcia-Esteve L, 2003, J AFFECT DISORDERS, V75, P71, DOI 10.1016/S0165-0327(02)00020-4; Glynn LM, 2013, NEUROPEPTIDES, V47, P363, DOI 10.1016/j.npep.2013.10.007; HARRIS B, 1989, BRIT J PSYCHIAT, V154, P813, DOI 10.1192/bjp.154.6.813; Iliadis SI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135471; Institutional Review Board (IRB). Office for Human Research Protection, 2016, INF CONS ASS CAP CON; Jolley SN, 2007, BIOL RES NURS, V8, P210, DOI 10.1177/1099800406294598; Katon W, 2014, J WOMENS HEALTH, V23, P753, DOI 10.1089/jwh.2014.4824; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Lobel M., 2016, ENCY MENTAL HLTH, V3, P318, DOI [DOI 10.1016/B978-0-12-397045-9.00164-6, 10.1016/B978-0-12-397045-9.00164-6]; Manenschijn L, 2011, STEROIDS, V76, P1032, DOI 10.1016/j.steroids.2011.04.005; Maroto-Navarro G, 2005, INT J CLIN HLTH PSYC, V5, P305, DOI DOI 10.1016/J.JAD.2010.01.069; Mastorakos G, 2003, ANN NY ACAD SCI, V997, P136, DOI 10.1196/annals.1290.016; Meyer J, 2014, JOVE-J VIS EXP, DOI 10.3791/50882; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Milgrom J, 2011, J AFFECT DISORDERS, V130, P385, DOI 10.1016/j.jad.2010.10.045; National Institute for Health and Care Excelence, 2016, ANT POSTN MENT HLTH; Nierop A, 2006, PSYCHOSOM MED, V68, P931, DOI 10.1097/01.psy.0000244385.93141.3b; O'Hara MW, 2013, ANNU REV CLIN PSYCHO, V9, P379, DOI 10.1146/annurev-clinpsy-050212-185612; Ramirez FP, 2013, J TRANSCULT NURS, V24, P348, DOI 10.1177/1043659613493328; Perez-Ramirez F, 2016, J REPROD INFANT PSYC; Puente C, 2016, HEALTH CARE WOMEN IN, V37, P97; Putnam K, 2015, LANCET PSYCHIAT, V2, P59, DOI 10.1016/S2215-0366(14)00055-8; Remor E, 2006, SPAN J PSYCHOL, V9, P86, DOI 10.1017/S1138741600006004; Reuland DS, 2009, ANN FAM MED, V7, P455, DOI 10.1370/afm.981; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Russell E, 2015, THER DRUG MONIT, V37, P71, DOI 10.1097/FTD.0000000000000148; Saligheh M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00597; Sandman C.A., 2016, FETAL DEV, P229, DOI [10.1007/978-3-319-22023-9_13, DOI 10.1007/978-3-319-22023-9_13]; Sauve B, 2007, CLIN INVEST MED, V30, pE183, DOI 10.25011/cim.v30i5.2894; Schetter CD, 2012, CURR OPIN PSYCHIATR, V25, P141, DOI 10.1097/YCO.0b013e3283503680; Scheyer K, 2016, ARCH WOMEN MENT HLTH, V19, P317, DOI 10.1007/s00737-015-0563-7; Senturk MB, 2016, J MATERN-FETAL NEO M, P1; Seth S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0915-y; Sockol LE, 2013, CLIN PSYCHOL REV, V33, P1205, DOI 10.1016/j.cpr.2013.10.004; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; Suhitharan T, 2016, NEUROPSYCH DIS TREAT, V12, P1333, DOI 10.2147/NDT.S105918; Turkcapar AF, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0532-1; Vanston CM, 2005, NEUROREPORT, V16, P779, DOI 10.1097/00001756-200505120-00024; Vliegen N, 2014, HARVARD REV PSYCHIAT, V22, P1, DOI 10.1097/HRP.0000000000000013; Wikenius E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161804; Wosu AC, 2013, ANN EPIDEMIOL, V23, P797, DOI 10.1016/j.annepidem.2013.09.006; Yali AM, 1999, J PSYCHOSOM OBST GYN, V20, P39, DOI 10.3109/01674829909075575; Yim IS, 2015, ANNU REV CLIN PSYCHO, V11, P99, DOI 10.1146/annurev-clinpsy-101414-020426	66	79	80	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182817	10.1371/journal.pone.0182817	http://dx.doi.org/10.1371/journal.pone.0182817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846691	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600015
J	Sciezynska, A; Ruszkowska, E; Szulborski, K; Rydz, K; Wierzbowska, J; Kosinska, J; Rekas, M; Ploski, R; Szaflik, JP; Oldak, M				Sciezynska, Aneta; Ruszkowska, Ewelina; Szulborski, Kamil; Rydz, Katarzyna; Wierzbowska, Joanna; Kosinska, Joanna; Rekas, Marek; Ploski, Rafal; Szaflik, Jacek Pawel; Oldak, Monika			Processing of OPA1 with a novel N-terminal mutation in patients with autosomal dominant optic atrophy: Escape from nonsense-mediated decay	PLOS ONE			English	Article							MESSENGER-RNA DECAY; TRANSCRIPTS; GENE; PENETRANCE; NEUROPATHY; EXPRESSION; FAMILIES; DISEASE; CODONS	Autosomal Dominant Optic Atrophy (ADOA) is the most common dominantly inherited optic neuropathy. In the majority of patients it is caused by OPA1 mutations and those predicted to introduce a premature termination codon (PTC) are frequently detected. Transcripts containing PTC may be degraded by nonsense-mediated mRNA decay (NMD), however very little is known about an effect of OPA1 mutations on NMD activation. Here, using a combination of linkage analysis and DNA sequencing, we have identified a novel c. 91C>T OPA1 mutation with a putative premature stop codon (Q31*), which segregated with ADOA in two Polish families. At the mRNA level we found no changes in the amount of OPA1 transcript among mutation carriers vs. non-carriers. Specific allele quantification revealed a considerable level of the OPA1 mutant transcript. Our study identifies a novel pathogenic OPA1 mutation and shows that it is located in the transcript region not prone for NMD activation. The data emphasizes the importance of analyzing how mutated genes are being processed in the cell. This gives an insight into the molecular mechanism of a genetic disease and promotes development of innovative therapeutic approaches.	[Sciezynska, Aneta; Ruszkowska, Ewelina; Rydz, Katarzyna; Oldak, Monika] Med Univ Warsaw, Dept Histol & Embryol, Warsaw, Poland; [Szulborski, Kamil; Szaflik, Jacek Pawel] Med Univ Warsaw, Dept Ophthalmol, Warsaw, Poland; [Wierzbowska, Joanna; Rekas, Marek] Mil Inst Med, Dept Ophthalmol, Warsaw, Poland; [Kosinska, Joanna; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Military Institute of Aviation Medicine; Medical University of Warsaw	Oldak, M (corresponding author), Med Univ Warsaw, Dept Histol & Embryol, Warsaw, Poland.	monika.oldak@wum.edu.pl	Ścieżyńska, Aneta/AAA-3378-2022	Kosinska, Joanna/0000-0003-3767-6584; Oldak, Monika/0000-0002-4216-9141; Machnicka, Katarzyna/0000-0003-2357-6742; Rekas, Marek/0000-0003-0429-6649; Ploski, Rafal/0000-0001-6286-5526; Sciezynska, Aneta/0000-0003-0438-2678; Wierzbowska, Joanna/0000-0002-6993-7518	Narodowe Centrum Nauki (National Science Center of Poland, NCN) [N N402 591540 (5915/B/P01/2011/40)]	Narodowe Centrum Nauki (National Science Center of Poland, NCN)	The work was supported by Narodowe Centrum Nauki (National Science Center of Poland, NCN) grant no. N N402 591540 (5915/B/P01/2011/40)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Cohen L, 2016, GENET RES, V98, DOI 10.1017/S0016672316000070; Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038; Ferre M, 2009, HUM MUTAT, V30, pE692, DOI 10.1002/humu.21025; Fuhrmann N, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-25; Harries LW, 2004, DIABETES, V53, P500, DOI 10.2337/diabetes.53.2.500; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Nguyen LS, 2014, NEUROSCI BIOBEHAV R, V46, P175, DOI 10.1016/j.neubiorev.2013.10.016; Lenaers G, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-46; Li Y, 2008, MOL VIS, V14, P2451; Miller JN, 2014, MUTAT RES-REV MUTAT, V762, P52, DOI 10.1016/j.mrrev.2014.05.001; Neu-Yilik G, 2008, ADV GENET, V62, P185, DOI 10.1016/S0065-2660(08)00604-4; Nyiko T, 2009, PLANT MOL BIOL, V71, P367, DOI 10.1007/s11103-009-9528-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ranieri M, 2012, J NEUROL SCI, V315, P146, DOI 10.1016/j.jns.2011.12.002; Rodningen OK, 1999, HUM MUTAT, V13, P186, DOI 10.1002/(SICI)1098-1004(1999)13:3<186::AID-HUMU2>3.0.CO;2-K; Schimpf S, 2008, HUM MUTAT, V29, P106, DOI 10.1002/humu.20607; Schrijver I, 2002, AM J HUM GENET, V71, P223, DOI 10.1086/341581; Silva AL, 2006, RNA, V12, P2160, DOI 10.1261/rna.201406; Skidd PM, 2013, SEMIN OPHTHALMOL, V28, P422, DOI 10.3109/08820538.2013.825296; Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007	24	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183866	10.1371/journal.pone.0183866	http://dx.doi.org/10.1371/journal.pone.0183866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841713	Green Published, gold, Green Submitted			2022-12-26	WOS:000408370700065
J	An, XY; Sendra, VG; Liadi, I; Ramesh, B; Romain, G; Haymaker, C; Martinez-Paniagua, M; Lu, YB; Radvanyi, LG; Roysam, B; Varadarajan, N				An, Xingyue; Sendra, Victor G.; Liadi, Ivan; Ramesh, Balakrishnan; Romain, Gabrielle; Haymaker, Cara; Martinez-Paniagua, Melisa; Lu, Yanbin; Radvanyi, Laszlo G.; Roysam, Badrinath; Varadarajan, Navin			Single-cell profiling of dynamic cytokine secretion and the phenotype of immune cells	PLOS ONE			English	Article							CD8(+) T-CELLS; NK CELLS; INTERFERON-GAMMA; TUMOR-CELLS; IFN-GAMMA; ACTIVATION; DIFFERENTIATION; HETEROGENEITY; INHIBITION; RESISTANCE	Natural killer (NK) cells are a highly heterogeneous population of innate lymphocytes that constitute our first line of defense against several types of tumors and microbial infections. Understanding the heterogeneity of these lymphocytes requires the ability to integrate their underlying phenotype with dynamic functional behaviors. We have developed and validated a single-cell methodology that integrates cellular phenotyping and dynamic cytokine secretion based on nanowell arrays and bead-based molecular biosensors. We demonstrate the robust passivation of the polydimethylsiloxane (PDMS)-based nanowells arrays with polyethylene glycol (PEG) and validated our assay by comparison to enzyme-linked immunospot (ELISPOT) assays. We used numerical simulations to optimize the molecular density of antibodies on the surface of the beads as a function of the capture efficiency of cytokines within an open-well system. Analysis of hundreds of individual human peripheral blood NK cells profiled ex vivo revealed that CD56(dim)CD16(+) NK cells are immediate secretors of interferon gamma (IFN-gamma) upon activation by phorbol 12-myristate 13-acetate (PMA) and iono-mycin (< 3 h), and that there was no evidence of cooperation between NK cells leading to either synergistic activation or faster IFN-gamma secretion. Furthermore, we observed that both the amount and rate of IFN-gamma secretion from individual NK cells were donor-dependent. Collectively, these results establish our methodology as an investigational tool for combining phenotyping and real-time protein secretion of individual cells in a high-throughput manner.	[An, Xingyue; Sendra, Victor G.; Liadi, Ivan; Ramesh, Balakrishnan; Romain, Gabrielle; Martinez-Paniagua, Melisa; Varadarajan, Navin] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Haymaker, Cara; Radvanyi, Laszlo G.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Lu, Yanbin; Roysam, Badrinath] Univ Houston, Dept Elect & Comp Engn, Houston, TX USA	University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston	Varadarajan, N (corresponding author), Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA.	nvaradar@central.uh.edu		Haymaker, Cara/0000-0002-1317-9287; An, Xingyue/0000-0001-9912-0683	NIH [R01CA174385]; CPRIT [RP130570]; MRA Award [509800]; Welch Foundation [E1774]; Owens Foundation, CDMRP [CA160591]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; MRA Award; Welch Foundation(The Welch Foundation); Owens Foundation, CDMRP	This publication was supported by the NIH (R01CA174385), CPRIT (RP130570); MRA Award (509800); Welch Foundation (E1774), Owens Foundation, CDMRP (CA160591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker PSA, 2016, CANCER IMMUNOL IMMUN, V65, P477, DOI 10.1007/s00262-016-1792-y; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Cao J, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9101-x; Chen Y, 2009, J IMMUNOL METHODS, V340, P65, DOI 10.1016/j.jim.2008.09.024; Chokkalingam V, 2013, LAB CHIP, V13, P4740, DOI 10.1039/c3lc50945a; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Dundua A, 2016, MACROMOL RAPID COMM, V37, P2030, DOI 10.1002/marc.201600473; Ekins RP, 1998, CLIN CHEM, V44, P2015; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Gerbitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034552; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a; Haymaker CL, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1014246; Heyes CD, 2007, MOL BIOSYST, V3, P419, DOI 10.1039/b700055n; Konry T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03179; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Liadi I, 2015, CANCER IMMUNOL RES, V3, P473, DOI 10.1158/2326-6066.CIR-14-0195; Liadi I, 2013, JOVE-J VIS EXP, DOI 10.3791/50058; Liu YP, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4946870; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lu Y, 2015, P NATL ACAD SCI USA, V112, pE607, DOI 10.1073/pnas.1416756112; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; Marie R, 2006, LANGMUIR, V22, P10103, DOI 10.1021/la060198m; Martinon F, 2009, HUM GENE THER, V20, P1291, DOI 10.1089/hum.2009.044; Mempel TR, 2010, METHODS MOL BIOL, V616, P181, DOI 10.1007/978-1-60761-461-6_12; Nie S, 2014, LAB CHIP, V14, P1087, DOI 10.1039/c3lc51303c; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Qin ZH, 2003, CANCER RES, V63, P4095; Reefman E, 2010, J IMMUNOL, V184, P4852, DOI 10.4049/jimmunol.0803954; Rezvani K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00578; Romain G, 2014, BLOOD, V124, P3241, DOI 10.1182/blood-2014-04-569061; Romee R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2341; Sakamoto N, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0632-8; Schneider F, 2009, SENSOR ACTUAT A-PHYS, V151, P95, DOI 10.1016/j.sna.2009.01.026; SOMANCHI SS, 2011, JOVE-J VIS EXP, V48, P2540, DOI DOI 10.3791/2540; Son KJ, 2016, ANALYST, V141, P679, DOI 10.1039/c5an01648g; Torres AJ, 2014, ANAL CHEM, V86, P11562, DOI 10.1021/ac4030297; Varadarajan N, 2012, P NATL ACAD SCI USA, V109, P3885, DOI 10.1073/pnas.1111205109; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wong I, 2009, MICROFLUID NANOFLUID, V7, P291, DOI 10.1007/s10404-009-0443-4; Yu XL, 2015, LANGMUIR, V31, P5891, DOI 10.1021/acs.langmuir.5b01085; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482; Zaretsky I, 2012, LAB CHIP, V12, P5007, DOI 10.1039/c2lc40808b; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	46	26	26	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181904	10.1371/journal.pone.0181904	http://dx.doi.org/10.1371/journal.pone.0181904			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837583	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000013
J	Markus, B; Szabo, K; Pfliegler, WP; Petrenyi, K; Boros, E; Pocsi, I; Tozser, J; Csosz, E; Dombradi, V				Markus, Bernadett; Szabo, Krisztina; Pfliegler, Walter P.; Petrenyi, Katalin; Boros, Eniko; Pocsi, Istvan; Tozser, Jozsef; Csosz, Eva; Dombradi, Viktor			Proteomic analysis of protein phosphatase Z1 from Candida albicans	PLOS ONE			English	Article							CELL-WALL INTEGRITY; ELONGATION-FACTOR 2; SACCHAROMYCES-CEREVISIAE; SALT TOLERANCE; IN-VIVO; YEAST; TRANSLATION; BIOFILMS; GENE; PPZ1	Protein phosphatase Z is a "novel type" fungus specific serine/threonine protein phosphatase. Previously our research group identified the CaPPZ1 gene in the opportunistic pathogen Candida albicans and reported that the gene deletion had several important physiological consequences. In order to reveal the protein targets and the associated mechanisms behind the functions of the phosphatase a proteomic method was adopted for the comparison of the cappz1 deletion mutant and the genetically matching QMY23 control strain. Proteins extracted from the control and deletion mutant strains were separated by two-dimensional gel electrophoresis and the protein spots were stained with RuBPS and Pro-Q Diamond in order to visualize the total proteome and the phosphoproteome, respectively. The alterations in spot intensities were determined by densitometry and were analysed with the Delta2D (Decodon) software. Spots showing significantly different intensities between the mutant and control strains were excised from the gels and were digested with trypsin. The resulting peptides were identified by LC-MS/MS mass spectrometry. As many as 15 protein spots were found that exhibited significant changes in their intensity upon the deletion of the phosphatase and 20 phosphoproteins were identified in which the level of phosphorylation was modified significantly in the mutant. In agreement with previous findings we found that the affected proteins function in protein synthesis, oxidative stress response, regulation of morphology and metabolism. Among these proteins we identified two potential CaPpz1 substrates (Eft2 and Rpp0) that may regulate the elongation step of translation. RT-qPCR experiments revealed that the expression of the genes coding for the affected proteins was not altered significantly. Thus, the absence of CaPpz1 exerted its effects via protein synthesis/degradation and phosphorylation/dephosphorylation. In addition, our proteomics data strongly suggested a role for CaPpz1 in biofilm formation, was confirmed experimentally. Thus our unbiased proteomic approach lead to the discovery of a novel function for this phosphatase in C. albicans.	[Markus, Bernadett; Tozser, Jozsef; Csosz, Eva] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Prote Core Facil, Debrecen, Hungary; [Szabo, Krisztina; Petrenyi, Katalin; Dombradi, Viktor] Univ Debrecen, Dept Med Chem, Fac Med, Debrecen, Hungary; [Pfliegler, Walter P.; Boros, Eniko; Pocsi, Istvan] Univ Debrecen, Fac Sci & Technol, Dept Biotechnol & Microbiol, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen	Csosz, E (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Prote Core Facil, Debrecen, Hungary.; Dombradi, V (corresponding author), Univ Debrecen, Dept Med Chem, Fac Med, Debrecen, Hungary.	cseva@med.unideb.hu; dombradi@med.unideb.hu	Tozser, Jozsef/A-7840-2008; Pfliegler, Walter P./D-1114-2018	Tozser, Jozsef/0000-0003-0274-0056; Pfliegler, Walter P./0000-0001-6723-4416; Csosz, Eva/0000-0003-4373-2175; Szabo, Krisztina/0000-0002-8461-9294	National Research, Development and Innovation Office [NKFIH K108989]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by the National Research, Development and Innovation Office NKFIH K108989 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks are due to Dr Alexander Johnson (University of California, San Francisco, USA) for the QMY23 control strain. The authors are indebted for the expert technical assistance of Ms Andrea Farkas Tankane (University of Debrecen, Debrecen, Hungary). This work was supported by the National Research, Development and Innovation Office-NKFIH K108989 grant.	Adam C, 2012, MICROBIOL-SGM, V158, P1258, DOI 10.1099/mic.0.057075-0; [Anonymous], 1995, J BIOL CHEM, V270, P13036; Arino J, 2002, EUR J BIOCHEM, V269, P1072, DOI 10.1046/j.0014-2956.2002.02753.x; Balcells L, 1997, EUR J BIOCHEM, V250, P476, DOI 10.1111/j.1432-1033.1997.0476a.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casado C, 2012, FUNGAL GENET BIOL, V49, P708; Chen E, 2016, AM SOC MICROBIOLOGY, V7; Clotet J, 1999, MOL CELL BIOL, V19, P2408; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Daniels KJ, 2013, EUKARYOT CELL, V12, P1389, DOI 10.1128/EC.00127-13; de Nadal E, 2001, J BIOL CHEM, V276, P14829, DOI 10.1074/jbc.M010824200; Dominguez JM, 1998, ANTIMICROB AGENTS CH, V42, P2279, DOI 10.1128/AAC.42.9.2279; Garcia-Gimeno MA, 2003, J BIOL CHEM, V278, P47744, DOI 10.1074/jbc.M306157200; Gauci Victoria J, 2011, J Chem Biol, V4, P3, DOI 10.1007/s12154-010-0043-5; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; Karkowska-Kuleta J, 2014, MOL ORAL MICROBIOL, V29, P270, DOI 10.1111/omi.12078; Kovacs L, 2010, J BASIC MICROB, V50, pS74, DOI 10.1002/jobm.200900434; LEE KS, 1993, MOL CELL BIOL, V13, P5843, DOI 10.1128/MCB.13.9.5843; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Hernaez ML, 2010, J PROTEOMICS, V73, P1404, DOI 10.1016/j.jprot.2010.02.008; Martinez JP, 2016, FEMS YEAST RES, V16; Mendoza A, 1999, GENE, V229, P183, DOI 10.1016/S0378-1119(99)00024-4; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; Minhas A, 2012, J BIOL CHEM, V287, P7301, DOI 10.1074/jbc.M111.299438; Mironova L J, 2007, GENES CELLS, V12, P435; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Muszkieta L, 2014, CELL MICROBIOL, V16, P1784, DOI 10.1111/cmi.12326; Nagy G, 2014, APPL MICROBIOL BIOT, V98, P5185, DOI 10.1007/s00253-014-5696-5; Nobile CJ, 2015, ANNU REV MICROBIOL, V69, P71, DOI 10.1146/annurev-micro-091014-104330; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Perez A, 2006, FEMS YEAST RES, V6, P1074, DOI 10.1111/j.1567-1364.2006.00131.x; Petrenyi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160965; POSAS F, 1995, FEBS LETT, V368, P39, DOI 10.1016/0014-5793(95)00593-X; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rodriguez-Gabriel MA, 1998, BIOCHEMISTRY-US, V37, P16620, DOI 10.1021/bi981396i; Serrano R J, 2002, EMBO J, V21, P920; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szoor B, 1998, BBA-PROTEIN STRUCT M, V1388, P260, DOI 10.1016/S0167-4838(98)00201-5; Tsui C, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw018; Vialas V, 2012, PROTEOMICS, V12, P2331, DOI 10.1002/pmic.201100588	43	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183176	10.1371/journal.pone.0183176	http://dx.doi.org/10.1371/journal.pone.0183176			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837603	gold, Green Accepted, Green Published			2022-12-26	WOS:000408365000050
J	Moore, RC; Paolillo, EW; Heaton, A; Fazeli, PL; Jeste, DV; Moore, DJ				Moore, Raeanne C.; Paolillo, Emily W.; Heaton, Anne; Fazeli, Pariya L.; Jeste, Dilip V.; Moore, David J.			Clinical utility of the UCSD Performance-Based Skills Assessment D Brief (UPSA-B) in adults living with HIV: Associations with neuropsychological impairment and patient-reported everyday functioning difficulties	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIRETROVIRAL THERAPY; IMPACT; SCHIZOPHRENIA; DEPENDENCE; CAPACITY; SPECIFICITY; SENSITIVITY; DYSFUNCTION; VALIDATION	Objective Requiring only 10-15 minutes to complete, the UCSD Performance-Based Skills Assessment (UPSA-B) has high clinical utility as a brief measure of functional capacity. This study aimed to validate the UPSA-B in adults living with HIV/AIDS (HIV+), and identify whether the UPSA-B can be used as an indicator of functional dependence in this population. Method One hundred and three HIV+ adults and 91 HIV-adults completed a comprehensive neuropsychological and neuromedical battery, including a self-report measure of functional status (IADL Dependence vs. IADL Independence), an objective measure of functional capacity (UPSA-B), and a self-report measure of mood states including a subscale related to cognitive difficulties (Profile of Mood States [POMS]-Confusion/Bewilderment subscale). Results HIV+ participants had significantly lower UPSA-B scores than their HIV-counterparts (p = 0.02), although this fell to a trend (p = 0.08) when including covariates. Among the HIV+ group, higher UPSA-B scores were related to better neuropsychological ability, but unrelated to self-reported functional independence. Conversely, UPSA-B scores were unrelated to participant-reported cognitive difficulties on the POMS Confusion/Bewilderment subscale. An ROC curve was generated to determine the optimal UPSA-B value for discriminating between normal neuropsychological functioning versus neuropsychological impairment, with results indicating an optimal cutoff of 79. The UPSA-B identified HIV+ persons with cognitive impairment with 70.9% accuracy. Conclusions The UPSA-B was able to differentiate neuropsychological impairment from no impairment among HIV+ participants and holds promise as a clinical screening tool in this population. However, indicators of functional disability among adults living with HIV is still not well understood and is likely multifactorial in nature. These data highlight the complex interplay between objective functional capacity, neurocognitive ability, subjective cognitive symptoms, and functional dependence.	[Moore, Raeanne C.; Heaton, Anne; Jeste, Dilip V.; Moore, David J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Moore, Raeanne C.] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Paolillo, Emily W.] Univ Calif San Diego, San Diego State Univ, San Diego Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Fazeli, Pariya L.] Univ Alabama Birmingham, UAB Sch Nursing, Birmingham, AL USA; [Jeste, Dilip V.] Univ Calif San Diego, Stein Inst Res Aging, San Diego, CA 92103 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; California State University System; San Diego State University; University of California System; University of California San Diego; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego	Moore, RC (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.; Moore, RC (corresponding author), VA San Diego Healthcare Syst, San Diego, CA 92161 USA.	r6moore@ucsd.edu	Moore, Raeanne/ABC-6648-2020	Fazeli, Pariya/0000-0001-6629-0010	National Institute of Mental Health [R01 MH099987, P30MH062512, K23 MH107260, R00 AG048762, T32 AA013525]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH107260, P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG048762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA031098] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute of Mental Health (grant number R01 MH099987, P30MH062512, K23 MH107260 (salary support to RCM), R00 AG048762 (salary support to PLF), T32 AA013525 (stipend support to EWP)). The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, National Institutes of Health, nor the United States Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bangsberg David R, 2007, Curr HIV/AIDS Rep, V4, P65, DOI 10.1007/s11904-007-0010-0; Blackstone K, 2012, CLIN NEUROPSYCHOL, V26, P894, DOI 10.1080/13854046.2012.694479; Blackstone K, 2013, J ADDICT MED, V7, P255, DOI 10.1097/ADM.0b013e318293653d; Bowie CR, 2006, AM J PSYCHIAT, V163, P418, DOI 10.1176/appi.ajp.163.3.418; Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214; Cattie JE, 2012, J CLIN EXP NEUROPSYC, V34, P906, DOI 10.1080/13803395.2012.692772; Doyle KL, 2013, J NEUROVIROL, V19, P565, DOI 10.1007/s13365-013-0218-2; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Garcia-Portilla MP, 2013, SCHIZOPHR RES, V150, P421, DOI 10.1016/j.schres.2013.07.049; Gorman AA, 2009, NEUROPSYCHOL REV, V19, P186, DOI 10.1007/s11065-009-9095-0; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; HEATON RK, 1994, PSYCHOSOM MED, V56, P8, DOI 10.1097/00006842-199401000-00001; Henry BL, 2010, ADDICT BEHAV, V35, P593, DOI 10.1016/j.addbeh.2010.01.013; Hutchinson AB, 2006, JAIDS-J ACQ IMM DEF, V43, P451, DOI 10.1097/01.qai.0000243090.32866.4e; Kamat R, 2012, ARCH CLIN NEUROPSYCH, V27, P520, DOI 10.1093/arclin/acs055; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Marcotte TD, 1999, J INT NEUROPSYCH SOC, V5, P579, DOI 10.1017/S1355617799577011; Mausbach BT, 2008, J PSYCHIATR RES, V42, P320, DOI 10.1016/j.jpsychires.2006.12.008; Mausbach BT, 2007, SCHIZOPHRENIA BULL, V33, P1364, DOI 10.1093/schbul/sbm014; Mausbach BT, 2011, SCHIZOPHR RES, V132, P165, DOI 10.1016/j.schres.2011.07.022; Mausbach BT, 2010, BIPOLAR DISORD, V12, P45, DOI 10.1111/j.1399-5618.2009.00787.x; Mausbach BT, 2009, SCHIZOPHRENIA BULL, V35, P307, DOI 10.1093/schbul/sbn152; McNair D., 1981, MANUAL PROFILE MOOD; Moore RC, 2015, SCHIZOPHR RES, V169, P121, DOI 10.1016/j.schres.2015.09.017; Moore RC, 2015, SCHIZOPHR RES, V164, P187, DOI 10.1016/j.schres.2015.02.014; Moore RC, 2013, SCHIZOPHR RES, V144, P87, DOI 10.1016/j.schres.2012.12.028; Moore RC, 2016, AM J GERIAT PSYCHIAT, V25, P829; Morgan EE, 2014, PSYCHIAT RES, V220, P527, DOI 10.1016/j.psychres.2014.07.008; Olsson AK, 2012, PSYCHIAT RES, V197, P290, DOI 10.1016/j.psychres.2011.11.002; Patterson TL, 2001, SCHIZOPHRENIA BULL, V27, P235, DOI 10.1093/oxfordjournals.schbul.a006870; Sadek JR, 2007, J CLIN EXP NEUROPSYC, V29, P266, DOI 10.1080/13803390600659384; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Sumiyoshi Chika, 2014, Schizophr Res Cogn, V1, P137, DOI 10.1016/j.scog.2014.08.002; Thames AD, 2011, J CLIN EXP NEUROPSYC, V33, P200, DOI 10.1080/13803395.2010.499357; Thames AD, 2011, CLIN NEUROPSYCHOL, V25, P224, DOI 10.1080/13854046.2010.539577; Thurlow J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-18; Woods SP, 2008, NEUROPSYCHOLOGY, V22, P110, DOI 10.1037/0894-4105.22.1.110; Zlatar ZZ, 2014, J GERIATR PSYCH NEUR, V27, P181, DOI 10.1177/0891988714524628	42	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183614	10.1371/journal.pone.0183614	http://dx.doi.org/10.1371/journal.pone.0183614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837678	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000088
J	Smit, NW; ten Sande, JN; Parvizi, M; van Amersfoorth, SCM; Plantinga, JA; van Spreuwel-Goossens, CAFM; van Dongen, EMWM; van Dessel, PFHM; Kluijtmans, SGJM; Meijborg, VMF; de Bakker, JMT; Harmsen, MC; Coronel, R				Smit, Nicoline W.; ten Sande, Judith N.; Parvizi, Mojtaba; van Amersfoorth, Shirley C. M.; Plantinga, Josee A.; van Spreuwel-Goossens, Carolien A. F. M.; van Dongen, Elisabeth M. W. M.; van Dessel, Pascal F. H. M.; Kluijtmans, Sebastianus G. J. M.; Meijborg, Veronique M. F.; de Bakker, Jacques M. T.; Harmsen, Martin C.; Coronel, Ruben			Recombinant human collagen-based microspheres mitigate cardiac conduction slowing induced by adipose tissue-derived stromal cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; RANDOMIZED PHASE-1 TRIAL; HEART; CARDIOMYOCYTES; REPAIR; TRANSPLANTATION; REGENERATION; RETENTION	Background Stem cell therapy to improve cardiac function after myocardial infarction is hampered by poor cell retention, while it may also increase the risk of arrhythmias by providing an arrhythmogenic substrate. We previously showed that porcine adipose tissue-derived-stromal cells (pASC) induce conduction slowing through paracrine actions, whereas rat ASC (rASC) and human ASC (hASC) induce conduction slowing by direct coupling. We postulate that biomaterial microspheres mitigate the conduction slowing influence of pASC by interacting with paracrine signaling. Aim To investigate the modulation of ASC-loaded recombinant human collagen-based microspheres, on the electrophysiological behavior of neonatal rat ventricular myocytes (NRVM). Method Unipolar extracellular electrograms, derived from microelectrode arrays (8x8 electrodes) containing NRVM, co-cultured with ASC or ASC loaded microspheres, were used to determine conduction velocity (CV) and conduction heterogeneity. Conditioned medium (Cme) of (co)cultures was used to assess paracrine mechanisms. Results Microspheres did not affect CV in control (NRVM) monolayers. In co-cultures of NRVM and rASC, hASC or pASC, CV was lower than in controls (14.4+/-1.0, 13.0+/-0.6 and 9.0+/-1.0 vs. 19.5+/-0.5 cm/s respectively, p<0.001). Microspheres loaded with either rASC or hASC still induced conduction slowing compared to controls (13.5+/-0.4 and 12.6+/-0.5 cm/s respectively, p<0.001). However, pASC loaded microspheres increased CV of NRVM compared to pASC and NRMV co-cultures (16.3+/-1.3 cm/s, p<0.001) and did not differ from controls (p = NS). Cme of pASC reduced CV in control monolayers of NRVM (10.3+/-1.1 cm/s, p<0.001), similar to Cme derived from pASC-loaded microspheres (11.1+/-1.7 cm/s, p = 1.0). The presence of microspheres in monolayers of NRVM abolished the CV slowing influence of Cme pASC (15.9+/-1.0 cm/s, p = NS vs. control). Conclusion The application of recombinant human collagen-based microspheres mitigates indirect paracrine conduction slowing through interference with a secondary autocrine myocardial factor.	[Smit, Nicoline W.; ten Sande, Judith N.; van Amersfoorth, Shirley C. M.; van Dessel, Pascal F. H. M.; Meijborg, Veronique M. F.; de Bakker, Jacques M. T.; Coronel, Ruben] Univ Amsterdam, Acad Med Ctr Amsterdam, Dept Clin & Expt Cardiol, Ctr Heart, Amsterdam, Netherlands; [Smit, Nicoline W.; ten Sande, Judith N.; Meijborg, Veronique M. F.] Holland Heart House, Netherlands Heart Inst, Utrecht, Netherlands; [Parvizi, Mojtaba; Plantinga, Josee A.; Harmsen, Martin C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [van Spreuwel-Goossens, Carolien A. F. M.; van Dongen, Elisabeth M. W. M.; Kluijtmans, Sebastianus G. J. M.] Fujifilm Mfg Europe BV, Tilburg, Netherlands; [Coronel, Ruben] Fdn Univ Bordeaux, Inst Rythmol & Modelisat Cardiaque LIRYC, Bordeaux, France	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Fujifilm Corporation; CHU Bordeaux	Smit, NW (corresponding author), Univ Amsterdam, Acad Med Ctr Amsterdam, Dept Clin & Expt Cardiol, Ctr Heart, Amsterdam, Netherlands.; Smit, NW (corresponding author), Holland Heart House, Netherlands Heart Inst, Utrecht, Netherlands.	n.w.smit@amc.uva.nl	Coronel, Ruben/AAZ-8948-2020; Parvizi, Mojtaba/Q-1543-2019; Harmsen, Martin/R-4579-2019; Harmsen, Martin C/F-3197-2016	Coronel, Ruben/0000-0001-9433-6119; Harmsen, Martin/0000-0002-7128-2741; Harmsen, Martin C/0000-0002-7128-2741; Meijborg, Veronique/0000-0002-2358-0170	ICARUS of the BioMedical Materials program [P5.01]; LeDucq (SHAPEHEART network)	ICARUS of the BioMedical Materials program; LeDucq (SHAPEHEART network)	The financial contributions of ICARUS of the BioMedical Materials program (project-P5.01) and the LeDucq (SHAPEHEART network) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askar SFA, 2013, CIRC-ARRHYTHMIA ELEC, V6, P380, DOI 10.1161/CIRCEP.111.000215; Bagno LL, 2015, CELL TRANSPLANT; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Cartledge JE, 2015, CARDIOVASC RES, V105, P260, DOI 10.1093/cvr/cvu264; Chang MG, 2006, CIRCULATION, V113, P1832, DOI 10.1161/CIRCULATIONAHA.105.593038; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; de Jong R, 2014, CIRC-CARDIOVASC INTE, V7, P673, DOI 10.1161/CIRCINTERVENTIONS.114.001580; DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915; Hamdi H, 2014, CELL TRANSPLANT, V23, P87, DOI 10.3727/096368912X658836; Hasan A, 2016, MACROMOL BIOSCI, V16, P958, DOI 10.1002/mabi.201500396; Heubach JF, 2004, J PHYSIOL-LONDON, V554, P659, DOI 10.1113/jphysiol.2003.055806; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; KLEBER AG, 1986, CIRCULATION, V73, P189, DOI 10.1161/01.CIR.73.1.189; LAMMERS WJEP, 1990, AM J PHYSIOL, V259, pH1254, DOI 10.1152/ajpheart.1990.259.4.H1254; Lan L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173814; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; MARUYAMA T, 1991, AM J PHYSL, V261, P66880; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Mumcuoglu D dML, 2016, DEV INJECTABLE BMP 2, P1; Oedayrajsingh-Varma MJ, 2006, CYTOTHERAPY, V8, P166, DOI 10.1080/14653240600621125; Panda NC, 2014, J INTERV CARD ELECTR, V41, P117, DOI 10.1007/s10840-014-9940-9; Parvizi M, 2016, BIOTECHNOL J, V11, P932, DOI 10.1002/biot.201500519; Parvizi M, 2016, J BIOMED MATER RES A, V104, P503, DOI 10.1002/jbm.a.35588; Pedrotty DM, 2009, CARDIOVASC RES, V83, P688, DOI 10.1093/cvr/cvp164; Potse M, 2002, COMPUT METH PROG BIO, V69, P225, DOI 10.1016/S0169-2607(02)00014-7; Price MJ, 2006, INT J CARDIOL, V111, P231, DOI 10.1016/j.ijcard.2005.07.036; Przybyt E, 2013, CURR STEM CELL RES T, V8, P270, DOI 10.2174/1574888X11308040002; Roche ET, 2014, BIOMATERIALS, V35, P6850, DOI 10.1016/j.biomaterials.2014.04.114; SHEETS MF, 1988, CIRC RES, V63, P386, DOI 10.1161/01.RES.63.2.386; Sundelacruz S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003737; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Ten Sande JN, 2016, STEM CELLS TRANSL ME; Tirziu D, 2010, CIRCULATION, V122, P928, DOI 10.1161/CIRCULATIONAHA.108.847731; Tuin A, 2010, TISSUE ENG PT A, V16, P1811, DOI [10.1089/ten.tea.2009.0592, 10.1089/ten.TEA.2009.0592]; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Weeke-Klimp A, 2010, J MOL CELL CARDIOL, V49, P606, DOI 10.1016/j.yjmcc.2010.07.007; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367	39	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183481	10.1371/journal.pone.0183481	http://dx.doi.org/10.1371/journal.pone.0183481			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837600	Green Published, gold, Green Submitted			2022-12-26	WOS:000408365000071
J	Watanabe, T; Shibasaki, M; Maruyama, F; Sekizaki, T; Nakagawa, I				Watanabe, Takayasu; Shibasaki, Masaki; Maruyama, Fumito; Sekizaki, Tsutomu; Nakagawa, Ichiro			Investigation of potential targets of Porphyromonas CRISPRs among the genomes of Porphyromonas species	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; HORIZONTAL TRANSFER; GENE-TRANSFER; CAS SYSTEMS; SMALL RNA; SP NOV.; CD-HIT; GINGIVALIS; SEQUENCE; BACTERIA	The oral bacterial species Porphyromonas gingivalis, a periodontal pathogen, has plastic genomes that may be driven by homologous recombination with exogenous deoxyribonucleic acid (DNA) that is incorporated by natural transformation and conjugation. However, bacteriophages and plasmids, both of which are main resources of exogenous DNA, do not exist in the known P. gingivalis genomes. This could be associated with an adaptive immunity system conferred by clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated (cas) genes in P. gingivalis as well as innate immune systems such as a restriction-modification system. In a previous study, few immune targets were predicted for P. gingivalis CRISPR/Cas. In this paper, we analyzed 51 P. gingivalis genomes, which were newly sequenced, and publicly available genomes of 13 P. gingivalis and 46 other Porphyromonas species. We detected 6 CRISPR/Cas types (classified by sequence similarity of repeat) in P. gingivalis and 12 other types in the remaining species. The Porphyromonas CRISPR spacers with potential targets in the genus Porphyromonas were approximately 23 times more abundant than those with potential targets in other genus taxa (1,720/6,896 spacers vs. 74/6,896 spacers). Porphyromonas CRISPR/Cas may be involved in genome plasticity by exhibiting selective interference against intra-and interspecies nucleic acids.	[Watanabe, Takayasu; Sekizaki, Tsutomu] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Lab Food Borne Pathogen Microbiol,Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan; [Shibasaki, Masaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Implantol & Regenerat Dent Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan; [Maruyama, Fumito; Nakagawa, Ichiro] Kyoto Univ, Grad Sch Med, Dept Microbiol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); Kyoto University	Watanabe, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Lab Food Borne Pathogen Microbiol,Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	atakawat@mail.ecc.u-tokyo.ac.jp	Maruyama, Fumito/AAK-5928-2020; Sekizaki, Tsutomu/AAB-1816-2021	Maruyama, Fumito/0000-0003-2347-616X; Sekizaki, Tsutomu/0000-0002-8899-2504; Watanabe, Takayasu/0000-0001-5487-8191	Japan Society for the Promotion of Science (Tokyo, Japan) KAKENHI Grant [JP12J05796, JP14J02840, JP26861544, JP16K08015]	Japan Society for the Promotion of Science (Tokyo, Japan) KAKENHI Grant	This work was supported by the Japan Society for the Promotion of Science (Tokyo, Japan) KAKENHI Grant Numbers JP12J05796, JP14J02840, JP26861544, and JP16K08015 (to TW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-230; Alkhnbashi OS, 2014, BIOINFORMATICS, V30, pI489, DOI 10.1093/bioinformatics/btu459; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baltrus DA, 2009, GENOME DYNAM, V6, P75, DOI 10.1159/000235764; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burmistrz M, 2015, J BACTERIOL, V197, P2631, DOI 10.1128/JB.00261-15; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Chakraborty S, 2010, MOL PHYLOGENET EVOL, V56, P878, DOI 10.1016/j.ympev.2010.05.020; COYKENDALL AL, 1980, INT J SYST BACTERIOL, V30, P559, DOI 10.1099/00207713-30-3-559; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cugini C, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.19804; Darmon E, 2014, MICROBIOL MOL BIOL R, V78, P1, DOI 10.1128/MMBR.00035-13; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Dziarski R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146162; Eggerth AH, 1933, J BACTERIOL, V25, P389, DOI 10.1128/JB.25.4.389-413.1933; ENERSEN M, 2011, J ORAL MICROBIOL, P3; Fournier D, 2001, INT J SYST EVOL MICR, V51, P1179, DOI 10.1099/00207713-51-3-1179; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Goessweiner-Mohr N, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0004-2013; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Jorth P, 2012, MBIO, V3, DOI 10.1128/mBio.00309-12; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Koehler A, 2003, MICROBIOL-SGM, V149, P2407, DOI 10.1099/mic.0.26267-0; Kong Y, 2013, GENOME BIOL EVOL, V5, P1611, DOI 10.1093/gbe/evt116; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; McLean JS, 2013, GENOME RES, V23, P867, DOI 10.1101/gr.150433.112; Mell JC, 2014, J BACTERIOL, V196, P1471, DOI 10.1128/JB.01293-13; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Naito M, 2011, MICROBIOL-SGM, V157, P2022, DOI 10.1099/mic.0.047803-0; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogier JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-568; Ohyama A, 2006, J COMPUT AIDED CHEM, V7, P102, DOI 10.2751/jcac.7.102; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Phillips P, 2014, FEMS MICROBIOL LETT, V351, P202, DOI 10.1111/1574-6968.12320; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Sakamoto M, 2006, INT J SYST EVOL MICR, V56, P1599, DOI 10.1099/ijs.0.64192-0; Salmond GPC, 2015, NAT REV MICROBIOL, V13, P777, DOI 10.1038/nrmicro3564; SALYERS AA, 1995, MICROBIOL REV, V59, P579, DOI 10.1128/MMBR.59.4.579-590.1995; Samson JE, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.PLAS-0034-2014; Schoen C, 2009, VACCINE, V27, pB103, DOI 10.1016/j.vaccine.2009.04.064; Serbanescu MA, 2015, J BACTERIOL, V197, P749, DOI 10.1128/JB.02333-14; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Suominen I, 2003, INT J SYST EVOL MICR, V53, P1369, DOI 10.1099/ijs.0.02277-0; Tribble GD, 2007, J BACTERIOL, V189, P6382, DOI 10.1128/JB.00460-07; Tribble GD, 2013, FUTURE MICROBIOL, V8, P607, DOI [10.2217/FMB.13.30, 10.2217/fmb.13.30]; Tribble GD, 2012, MBIO, V3, DOI 10.1128/mBio.00231-11; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Vos M, 2009, TRENDS MICROBIOL, V17, P226, DOI 10.1016/j.tim.2009.03.001; Watanabe T, 2013, GENOME BIOL EVOL, V5, P1099, DOI 10.1093/gbe/evt075; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; WYSS C, 1992, J CLIN MICROBIOL, V30, P2225, DOI 10.1128/JCM.30.9.2225-2229.1992; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zou SM, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0177-y	68	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183752	10.1371/journal.pone.0183752	http://dx.doi.org/10.1371/journal.pone.0183752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837670	Green Submitted, gold, Green Published			2022-12-26	WOS:000408365000110
J	Almasud, AA; Giles, KH; Miklavcic, JJ; Martins, KJB; Baracos, VE; Putman, CT; Guan, LL; Mazurak, VC				Almasud, Alaa A.; Giles, Kaitlin H.; Miklavcic, John J.; Martins, Karen J. B.; Baracos, Vickie E.; Putman, Charles T.; Guan, Leluo L.; Mazurak, Vera C.			Fish oil mitigates myosteatosis and improves chemotherapy efficacy in a preclinical model of colon cancer	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SKELETAL-MUSCLE DEPLETION; TRANSCRIPTION FACTORS; PROGNOSTIC-FACTOR; RATS BEARING; PPAR-GAMMA; MASS; SUPPLEMENTATION; PROGRESSION; EXPRESSION	Background This study aimed to assess whether feeding a diet containing fish oil was efficacious in reducing tumor-and subsequent chemotherapy-associated myosteatosis, and improving tumor response to treatment. Methods Female Fischer 344 rats were fed either a control diet for the entire study (control), or switched to a diet containing fish oil (2.0 g/100 g of diet) one week prior to tumor implantation (long term fish oil) or at the start of chemotherapy (adjuvant fish oil). Chemotherapy (irinotecan plus 5-fluorouracil) was initiated 2 weeks after tumor implantation (cycle-1) and 1 week thereafter (cycle-2). Reference animals received no tumor or treatment and only consumed the control diet. All skeletal muscle measures were conducted in the gastrocnemius. To assess myosteatosis, lipids were assessed histologically by Oil Red O staining and total triglyceride content was quantified by gas chromatography. Expression of adipogenic transcription factors were assessed at the mRNA level by real-time RT-PCR. Results Feeding a diet containing fish oil significantly reduced tumor-and subsequent chemotherapy-associated increases in skeletal muscle neutral lipid (p<0.001) and total triglyceride content (p<0.03), and expression of adipogenic transcription factors (p<0.01) compared with control diet fed animals. The adjuvant fish oil diet was as effective as the long term fish oil diet in mitigating chemotherapy-associated skeletal muscle fat content, and in reducing tumor volume during chemotherapy compared with control fed animals (p<0.01). Conclusion Long term and adjuvant fish oil diets are equally efficacious in reducing chemotherapy-associated myosteatosis that may be occurring by reducing expression of transcription factors involved in adipogenesis/lipogenesis, and improving tumor-response to chemotherapy in a neoplastic model.	[Almasud, Alaa A.; Giles, Kaitlin H.; Miklavcic, John J.; Martins, Karen J. B.; Mazurak, Vera C.] Univ Alberta, Dept Agr Food & Nutrit Sci, Alberta Inst Human Nutr, Edmonton, AB, Canada; [Baracos, Vickie E.] Univ Alberta, Dept Oncol, Palliat Care Med, Edmonton, AB, Canada; [Putman, Charles T.] Univ Alberta, Fac Med & Dent, Neurosci & Mental Hlth Inst, Exercise Biochem Lab,Fac Phys Educ & Recreat, Edmonton, AB, Canada; [Guan, Leluo L.] Univ Alberta, Dept Agr Food & Nutr Sci, Funct Genom & Microbiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Mazurak, VC (corresponding author), Univ Alberta, Dept Agr Food & Nutrit Sci, Alberta Inst Human Nutr, Edmonton, AB, Canada.	vera.mazurak@ualberta.ca	; Mazurak, Vera/J-5136-2014	Almasud, Alaa/0000-0003-0758-9818; Miklavcic, John/0000-0001-7676-1939; Mazurak, Vera/0000-0002-7724-6354	Canadian Institutes of Health Research [259704]; Ministry of Highly Educated of Saudi Arabia Scholarship; Saudi Arabian Cultural Bureau; University of Alberta	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Highly Educated of Saudi Arabia Scholarship; Saudi Arabian Cultural Bureau; University of Alberta(University of Alberta)	This study was funded by the Canadian Institutes of Health Research (259704). Alaa Almasud was funded by the Ministry of Highly Educated of Saudi Arabia Scholarship, Saudi Arabian Cultural Bureau. Kaitlin Giles was funded by the Queen Elizabeth II scholarship from the University of Alberta.; Financial funding support for this research was supported by a grant from the Canadian Institutes of Health Research (Operating grant 259704). The authors of this manuscript would like to thank Yanhong Chen and Rebecca Kong from Dr. Guan's Lab for technical assistance. Abha Dunichand-Hoedl is also acknowledged for her expertise in assisting with the animal experiments.	An L, 2012, BIOCHEM BIOPH RES CO, V428, P405, DOI 10.1016/j.bbrc.2012.10.068; Antoun S, 2013, CANCER-AM CANCER SOC, V119, P3377, DOI 10.1002/cncr.28218; Antoun S, 2010, J CLIN ONCOL, V28, P1054, DOI 10.1200/JCO.2009.24.9730; Baracos VE, 2004, NUTR RES REV, V17, P177, DOI 10.1079/NRR200488; Blauwhoff-Buskermolen S, 2016, J CLIN ONCOL, V34, P1339, DOI 10.1200/JCO.2015.63.6043; Bougnoux P, 2009, BRIT J CANCER, V101, P1978, DOI 10.1038/sj.bjc.6605441; Brey CW, 2009, INT J BIOL SCI, V5, P622; Chircop M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00304; Conklin Kenneth A, 2002, Altern Med Rev, V7, P4; Ewaschuk JB, 2014, APPL PHYSIOL NUTR ME, V39, P654, DOI 10.1139/apnm-2013-0423; FOLCH J, 1957, J BIOL CHEM, V226, P497; Grounds MD, 2014, AM J PATHOL, V184, P1668, DOI 10.1016/j.ajpath.2014.02.005; Hajjaji N, 2013, CANCER TREAT REV, V39, P473, DOI 10.1016/j.ctrv.2012.07.001; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hu SM, 2012, MOL ENDOCRINOL, V26, P977, DOI 10.1210/me.2011-1253; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Lee SJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/327167; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liu MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05538; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchildon F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145583; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Miyamoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129742; Morland S. L., 2016, Journal of Nutrition & Intermediary Metabolism, V5, P107, DOI 10.1016/j.jnim.2016.05.001; Moro C, 2008, AM J PHYSIOL-ENDOC M, V294, pE203, DOI 10.1152/ajpendo.00624.2007; Murphy RA, 2011, CANCER-AM CANCER SOC, V117, P3774, DOI 10.1002/cncr.25933; Murphy RA, 2011, CANCER-AM CANCER SOC, V117, P1775, DOI 10.1002/cncr.25709; Murphy RA, 2010, J NUTR, V140, P1602, DOI 10.3945/jn.110.123521; Piotrowska M, 2012, ACTA PHYSL, V205, P145; Pratt VC, 2002, BRIT J CANCER, V87, P1370, DOI 10.1038/sj.bjc.6600659; Rollins KE, 2016, CLIN NUTR, V35, P1103, DOI 10.1016/j.clnu.2015.08.005; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Stephens NA, 2011, J CACHEXIA SARCOPENI, V2, P111, DOI 10.1007/s13539-011-0030-x; Todorcevic M, 2016, J CLIN MED, V5, DOI 10.3390/jcm5010003; Xue HY, 2007, CLIN CANCER RES, V13, P7146, DOI 10.1158/1078-0432.CCR-07-0823; Xue HY, 2009, BRIT J NUTR, V102, P434, DOI 10.1017/S0007114508199482	37	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183576	10.1371/journal.pone.0183576	http://dx.doi.org/10.1371/journal.pone.0183576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832677	Green Published, gold, Green Submitted			2022-12-26	WOS:000408355800066
J	Huang, ZJ; Lu, Q; Wang, J; Chen, X; Mao, XY; He, ZL				Huang, Zhujian; Lu, Qin; Wang, Jun; Chen, Xian; Mao, Xiaoyun; He, Zhenli			Inhibition of the bioavailability of heavy metals in sewage sludge biochar by adding two stabilizers	PLOS ONE			English	Article							SOILS; SPECIATION; HYPERACCUMULATOR; REMEDIATION; PYROLYSIS; PB	Agricultural application of sewage sludge (SS) after carbonization is a plausible way for disposal. Despite its benefits of improving soil fertility and C sequestration, heavy metals contained in sewage sludge biochars (SSB) are still a concern. In this study, two types of heavy metal stabilizers were chosen: fulvic acid (FA) and phosphogypsum (with CaSO4, CS, as the main component). The two stabilizers were incorporated into SS prior to 350 degrees C carbonization for 1 h at the rates of 1%, 2%, or 4%. The obtained SSBs were then analyzed by Fourier transform infrared spectroscopy (FTIR) and X-ray photoelectron spectroscopy (XPS). Total and available concentrations of four heavy metals, i.e., Zn, Pb, Cd, and Ni, in the SSBs were determined. In addition, a series of pot soil culture experiments was conducted to investigate the effects of stabilizers incorporation into SSB on heavy metal bioavailability and the uptake by plants (corn as an indicator) and plant biomass yield, with SS and SSB (no stabilizers) as controls. The results showed that incorporation of both FA and CS increased functional groups such as carboxyl, phenol, hydroxyl, amine and quinine groups in the SSBs. The percentage of heavy metals in sulfuric and oxidizable state and residual state of SSBs were significantly increased after carbonization, and hence the mobility of the heavy metals in SSBs was decreased. The introduction of the stabilizers (i.e., FA or CS) significantly lowered the total and available concentrations of Zn, Pb, Cd, and Ni. The reduction in available heavy metal concentration increased with incorporation rate of the stabilizers from 1% to 4%. In the treatments with FA or CS incorporated SSB, less heavy metals were taken up by plants and more plant biomass yields were obtained. The mitigating effects were more pronounced at higher rates of FA or CS stabilizer. These findings provide a way to lower bioavailability of heavy metals in SS or SSB for land application or horticulture as a peat substitute.	[Huang, Zhujian; Lu, Qin; Wang, Jun; Chen, Xian; Mao, Xiaoyun] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Huang, Zhujian] Guangdong Prov Key Lab Environm Pollut Control &, Guangzhou, Guangdong, Peoples R China; [He, Zhenli] Univ Florida, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL USA	South China Agricultural University; State University System of Florida; University of Florida	Mao, XY (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China.	xymao@scau.edu.cn	He, Zhenli/A-4773-2008		Natural Science Foundation of China [51509093]; Science and Technology Project of Guangdong Province [20166020242005, 20156020215012, 2014A050503065, 2017A020216025]; Science and Technology Project of Guangzhou City [201508030039, 201504282153571]; Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology [2016K0014]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangdong Province; Science and Technology Project of Guangzhou City; Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology	This work was supported by the grants (51509093) from Natural Science Foundation of China, the grants (20166020242005, 20156020215012, 2014A050503065 and 2017A020216025) from the Science and Technology Project of Guangdong Province, the grants (201508030039 and 201504282153571) from the Science and Technology Project of Guangzhou City and the grant (2016K0014) from the Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology.	Angelova V, 2004, J PLANT NUTR, V27, P757, DOI 10.1081/PLN-120030609; Hossain MK, 2010, CHEMOSPHERE, V78, P1167, DOI 10.1016/j.chemosphere.2010.01.009; Huang ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159802; Huang ZJ, 2016, APPL SURF SCI, V370, P209, DOI 10.1016/j.apsusc.2016.02.126; Koppolu L, 2003, BIOMASS BIOENERG, V24, P69, DOI 10.1016/S0961-9534(02)00074-0; Luo F, 2014, ENVIRON SCI POLLUT R, V21, P8707, DOI 10.1007/s11356-014-2797-8; Ma LQ, 1999, WATER AIR SOIL POLL, V110, P1, DOI 10.1023/A:1005025708044; Macias F, 2017, PROCED EARTH PLAN SC, V17, P666, DOI 10.1016/j.proeps.2016.12.178; Mahmoud E, 2015, LAND DEGRAD DEV, V26, P819, DOI 10.1002/ldr.2288; Mendez A, 2017, BIOL AGRIC HORTIC, V33, P40, DOI 10.1080/01448765.2016.1185645; Mendez A, 2012, CHEMOSPHERE, V89, P1354, DOI 10.1016/j.chemosphere.2012.05.092; Rijkenberg MJA, 2010, SCI TOTAL ENVIRON, V408, P1212, DOI 10.1016/j.scitotenv.2009.11.053; Shin W, 2016, J SOIL SEDIMENT, V16, P726, DOI 10.1007/s11368-015-1279-z; Sun Y, 2014, INT J PHYTOREMEDIAT, V16, P496, DOI 10.1080/15226514.2013.798617; Sun YB, 2016, FRONT ENV SCI ENG, V10, P85, DOI 10.1007/s11783-014-0689-2; Szolnoki Z, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1737-4; Tang WW, 2014, SCI TOTAL ENVIRON, V468, P1014, DOI 10.1016/j.scitotenv.2013.09.044; Umoren I. U., 2007, Environmentalist, V27, P241, DOI 10.1007/s10669-007-9001-3; Walter I, 2006, ENVIRON POLLUT, V139, P507, DOI 10.1016/j.envpol.2005.05.020; Wang Jun, 2015, Journal of South China Agricultural University, V36, P54; Xu DB, 2012, PEDOSPHERE, V22, P815, DOI 10.1016/S1002-0160(12)60067-8; Xue T, 2013, PEDOSPHERE, V23, P265, DOI 10.1016/S1002-0160(13)60015-6; Yin HB, 2016, CHEM ENG J, V285, P112, DOI 10.1016/j.cej.2015.09.108; Zanini S, 2005, SURF COAT TECH, V200, P953, DOI 10.1016/j.surfcoat.2005.01.093; Zhang SQ, 2017, CHEMOSPHERE, V166, P334, DOI 10.1016/j.chemosphere.2016.09.095	25	25	25	9	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183617	10.1371/journal.pone.0183617	http://dx.doi.org/10.1371/journal.pone.0183617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832651	gold, Green Published, Green Submitted			2022-12-26	WOS:000408355800072
J	Kojima, M; Gimenes, JA; Chan, TW; Eliceiri, BP; Baird, A; Costantini, TW; Coimbra, R				Kojima, Mitsuaki; Gimenes-Junior, Joao A.; Chan, Theresa W.; Eliceiri, Brian P.; Baird, Andrew; Costantini, Todd W.; Coimbra, Raul			Exosomes in postshock mesenteric lymph are key mediators of acute lung injury triggering the macrophage activation via Toll-like receptor 4	FASEB JOURNAL			English	Article						extracellular vesicles; microvesicles; hemorrhagic shock; SIRS; trauma	HEMORRHAGIC-SHOCK; TRAUMA/HEMORRHAGIC SHOCK; INFLAMMATORY RESPONSE; ALVEOLAR MACROPHAGES; DUCT LIGATION; GUT INJURY; CELLS; TRAUMA; MECHANISM; ORGAN	Acute lunginjury (ALI) is a common cause of morbidity inpatients after severe injury due to dysregulated inflammation, which is believed to be driven by gut-derived inflammatory mediators carried via mesenteric lymph (ML). We have previously demonstrated that nano-sized extracellular vesicles, called exosomes, secreted into ML after trauma/hemorrhagic shock (T/HS) have the potential to activate immune cells in vitro. Here, we assess the function of ML exosomes in the development of T/HS-induced ALI and the role of TLR4 in the ML exosome-mediated inflammatory response. ML exosomes isolated from rats subjected to T/HS stimulated NF-kappa B activation and caused proinflammatory cytokine production in alveolar macrophages. In vivo experiments revealed that intravenous injection of exosomes harvested after T/HS, but not before shock, caused recruitment of inflammatory cells in the lung, increased vascular permeability, and induced histologic ALI in naive mice. The exosome-depleted supernatant of ML had no effect on in vitro and in vivo inflammatory responses. We also demonstrated that both pharmacologic inhibition and genetic knockout of TLR4 completely abolished ML exosome-induced cytokine production in macrophages. Thus, our findings define the critical role of exosomes secreted into ML as a critical mediator of T/HS-induced ALI through macrophage TLR4 activation.	[Kojima, Mitsuaki; Gimenes-Junior, Joao A.; Chan, Theresa W.; Eliceiri, Brian P.; Baird, Andrew; Costantini, Todd W.; Coimbra, Raul] Univ Calif San Diego Hlth Sci, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, San Diego, CA USA	University of California System; University of California San Diego	Coimbra, R (corresponding author), Univ Calif San Diego, Sch Med, 200 W Arbor Dr,8896, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Gimenes-Junior, Joao A/F-4439-2014; Kojima, Mitsuaki/AFO-6200-2022; Coimbra, Raul/AAP-3019-2020	Gimenes-Junior, Joao A/0000-0002-2958-1174; Coimbra, Raul/0000-0002-3759-6851; Eliceiri, Brian/0000-0003-1811-1916				Adams CA, 2002, SHOCK, V18, P513, DOI 10.1097/00024382-200212000-00005; Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Bonjoch L, 2016, J PATHOL, V240, P235, DOI 10.1002/path.4771; Bretz NP, 2013, J BIOL CHEM, V288, P36691, DOI 10.1074/jbc.M113.512806; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chow A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05750; D'Alessandro A, 2014, SHOCK, V42, P509, DOI 10.1097/SHK.0000000000000259; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Dayal SD, 2002, J TRAUMA, V52, P1048, DOI 10.1097/00005373-200206000-00005; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Deitch EA, 2001, SURGERY, V129, P39, DOI 10.1067/msy.2001.109119; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010; Fanous MYZ, 2007, J PANCREAS, V8, P374; Gambim MH, 2007, CRIT CARE, V11, DOI 10.1186/cc6133; Gonzalez RJ, 2001, SURGERY, V130, P198, DOI 10.1067/msy.2001.115824; Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Imai T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26238; Jiang H, 2014, SHOCK, V42, P271, DOI 10.1097/SHK.0000000000000212; Jordan JR, 2008, J APPL PHYSIOL, V104, P1161, DOI 10.1152/japplphysiol.00022.2007; Kao S, 2015, EXP LUNG RES, V41, P163, DOI 10.3109/01902148.2014.983282; Kim YS, 2015, J IMMUNOL, V194, P3361, DOI 10.4049/jimmunol.1402268; Kojima M, 2017, J TRAUMA ACUTE CARE, V82, P42, DOI 10.1097/TA.0000000000001296; Levy G, 2013, SHOCK, V39, P39, DOI 10.1097/SHK.0b013e31827b450d; Lowry DM, 2014, J SURG RES, V192, P12, DOI 10.1016/j.jss.2014.06.012; Mastronardi ML, 2011, CRIT CARE MED, V39, P1739, DOI 10.1097/CCM.0b013e3182190b4b; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; McGhan LJ, 2012, INJURY, V43, P129, DOI 10.1016/j.injury.2011.05.032; Mircescu MM, 2009, J INFECT DIS, V200, P647, DOI 10.1086/600380; Moon HG, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.282; Moore EE, 2010, AM J SURG, V200, P681, DOI 10.1016/j.amjsurg.2010.05.010; Morishita K, 2015, AM J PHYSIOL-GASTR L, V309, pG202, DOI 10.1152/ajpgi.00097.2015; Morishita K, 2015, J TRAUMA ACUTE CARE, V78, P52, DOI 10.1097/TA.0000000000000489; Morishita K, 2013, J TRAUMA ACUTE CARE, V75, P767, DOI 10.1097/TA.0b013e3182a924f2; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Nolan JP, 2013, CYTOM PART A, V83A, P301, DOI 10.1002/cyto.a.22255; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Reino DC, 2012, SHOCK, V38, P107, DOI 10.1097/SHK.0b013e318257123a; Rocha DM, 2016, ATHEROSCLEROSIS, V244, P211, DOI 10.1016/j.atherosclerosis.2015.11.015; Sakamoto W, 2017, MOL MED REP, V15, P1989, DOI 10.3892/mmr.2017.6259; SKLAR MD, 1985, J CELL PHYSIOL, V125, P403, DOI 10.1002/jcp.1041250307; Sodar BW, 2016, SCI REP-UK, V6, DOI 10.1038/srep24316; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Such J, 2002, HEPATOLOGY, V36, P135, DOI 10.1053/jhep.2002.33715; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Upperman JS, 1998, SHOCK, V10, P407, DOI 10.1097/00024382-199812000-00005; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; Welton JL, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27269; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Yi J, 2015, SHOCK, V44, P336, DOI 10.1097/SHK.0000000000000431; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zughaier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009165; Zughaier SM, 2011, J LEUKOCYTE BIOL, V89, P469, DOI 10.1189/jlb.0610369	57	61	74	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					97	110		10.1096/fj.201700488R	http://dx.doi.org/10.1096/fj.201700488R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855278				2022-12-26	WOS:000419172700011
J	Lee, SH; Yu, J; Hwang, GH; Kim, S; Kim, HS; Ye, S; Kim, K; Park, J; Park, DY; Cho, YK; Kim, JS; Bae, S				Lee, S. H.; Yu, J.; Hwang, G-H; Kim, S.; Kim, H. S.; Ye, S.; Kim, K.; Park, J.; Park, D. Y.; Cho, Y-K; Kim, J-S; Bae, S.			CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR	ONCOGENE			English	Article							CIRCULATING TUMOR DNA; LIQUID BIOPSY; RNA; MUTATIONS; CANCER; CAS9; BREAST; CELLS; QUANTIFICATION; ENDONUCLEASES	Circulating tumor DNA (ctDNA) has emerged as a tumor-specific biomarker for the early detection of various cancers. To date, several techniques have been devised to enrich the extremely small amounts of ctDNA present in plasma, but they are still insufficient for cancer diagnosis, especially at the early stage. Here, we developed a novel method, CUT (CRISPR-mediated, Ultrasensitive detection of Target DNA)-PCR, which uses CRISPR endonucleases to enrich and detect the extremely small amounts of tumor DNA fragments among the much more abundant wild-type DNA fragments by specifically eliminating the wild-type sequences. We computed that by using various orthologonal CRISPR endonucleases such as SpCas9 and FnCpf1, the CUT-PCR method would be applicable to 80% of known cancer-linked substitution mutations registered in the COSMIC database. We further verified that CUT-PCR together with targeted deep sequencing enables detection of a broad range of oncogenes with high sensitivity (<0.01%) and accuracy, which is superior to conventional targeted deep sequencing. In the end, we successfully applied CUT-PCR to detect sequences with oncogenic mutations in the ctDNA of colorectal cancer patients' blood, suggesting that our technique could be adopted for diagnosing various types of cancer at early stages.	[Lee, S. H.; Kim, S.; Kim, H. S.; Ye, S.; Kim, K.; Kim, J-S] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea; [Yu, J.] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Hwang, G-H; Bae, S.] Hanyang Univ, Dept Chem, Room 36-316,222 Wangsimni Ro, Seoul 133791, South Korea; [Kim, H. S.; Kim, J-S] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Park, J.; Cho, Y-K] Inst Basic Sci, Ctr Soft & Living Matter, Ulsan, South Korea; [Park, D. Y.] Pusan Natl Univ, Sch Med, Dept Pathol, Busan, South Korea; [Park, D. Y.] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Cho, Y-K] Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Ulsan, South Korea; [Bae, S.] Hanyang Univ, Res Inst Convergence Basic Sci, Seoul, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Hanyang University; Seoul National University (SNU); Institute for Basic Science - Korea (IBS); Pusan National University; Pusan National University; Pusan National University Hospital; Ulsan National Institute of Science & Technology (UNIST); Hanyang University	Bae, S (corresponding author), Hanyang Univ, Dept Chem, Room 36-316,222 Wangsimni Ro, Seoul 133791, South Korea.	sangsubae@hanyang.ac.kr	Park, Juhee/P-5219-2017; Kim, Kyoungmi/AAR-3964-2020; Yu, Jihyeon/U-4150-2019; KIM, Jin-Soo/M-6918-2013; Cho, Yoon-Kyoung/E-9082-2010; Cho, Yoon-Kyoung/ABF-9355-2021; Bae, Sangsu/E-5324-2017; Kim, Sang-Tae/U-9457-2018	Park, Juhee/0000-0002-8109-6387; Kim, Kyoungmi/0000-0003-0941-806X; Yu, Jihyeon/0000-0003-0247-7753; KIM, Jin-Soo/0000-0003-4847-1306; Cho, Yoon-Kyoung/0000-0001-6423-1834; Cho, Yoon-Kyoung/0000-0001-6423-1834; Bae, Sangsu/0000-0003-3615-8566; Kim, Sang-Tae/0000-0003-1645-6021	Ministry of Health and Welfare; Korea Healthcare technology R&D Project, Ministry for Health and Welfare Affairs [HI16C1012, HI12C1845]; Institute for Basic Science [IBS-R021-D1]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Korea Healthcare technology R&D Project, Ministry for Health and Welfare Affairs; Institute for Basic Science	We express our gratitude to all of the patients and healthy volunteers who contributed blood samples for this study. The biological specimens for this study were provided by the Pusan National University hospital, a member of the National Biobank of Korea, which is supported by the Ministry of Health and Welfare. All samples were obtained with informed consent according to the institutional review board-approved protocols. The deep-sequencing data are available at the NCBI Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra) under accession number SRX1970116. This work was supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health and Welfare Affairs (HI16C1012) to SB, (HI12C1845) to JP, DP and YC and Institute for Basic Science (IBS-R021-D1) to J-SK.	Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cheng FF, 2016, ONCOTARGET, V7, P48832, DOI 10.18632/oncotarget.9453; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Mattos-Arruda L, 2016, MOL ONCOL, V10, P464, DOI 10.1016/j.molonc.2015.12.001; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Freidin MB, 2015, CLIN CHEM, V61, P1299, DOI 10.1373/clinchem.2015.242453; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kruglyak KM, 2014, EXPERT REV MOL DIAGN, V14, P635, DOI 10.1586/14737159.2014.916213; Lee SH, 2016, BMB REP, V49, P201, DOI 10.5483/BMBRep.2016.49.4.042; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Narayan A, 2012, CANCER RES, V72, P3492, DOI 10.1158/0008-5472.CAN-11-4037; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Park JT, 2015, ONCOGENE, V34, P2801, DOI 10.1038/onc.2014.223; Park JY, 2013, NAT BIOTECHNOL, V31, P990, DOI 10.1038/nbt.2743; Park J, 2017, BIOINFORMATICS, V33, P286, DOI 10.1093/bioinformatics/btw561; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Song C, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw650; Sorber L, 2017, LUNG CANCER, V107, P100, DOI 10.1016/j.lungcan.2016.04.026; Tsao SCH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11198; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xu XR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623509; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405	43	56	57	7	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 7	2017	36	49					6823	6829		10.1038/onc.2017.281	http://dx.doi.org/10.1038/onc.2017.281			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FP0IK	28846115	hybrid, Green Published			2022-12-26	WOS:000417282500008
J	Ames, H; Njang, DM; Glenton, C; Fretheim, A; Kaufman, J; Hill, S; Oku, A; Cliff, J; Cartier, Y; Bosch-Capblanch, X; Rada, G; Muloliwa, AM; Oyo-Ita, A; Kum, AP; Lewin, S				Ames, Heather; Njang, Diangha Mabel; Glenton, Claire; Fretheim, Atle; Kaufman, Jessica; Hill, Sophie; Oku, Afiong; Cliff, Julie; Cartier, Yuri; Bosch-Capblanch, Xavier; Rada, Gabriel; Muloliwa, Artur Manuel; Oyo-Ita, Angela; Kum, Awah Paschal; Lewin, Simon			Stakeholder perceptions of communication about vaccination in two regions of Cameroon: A qualitative case study	PLOS ONE			English	Article							CHILDHOOD VACCINATION; MMR; COMPLEXITY; ATTITUDES; VACCINES; BARRIERS; CHILDREN	Background Understanding stakeholders' (parents', communities' and health workers') perspectives of communication about childhood vaccination, including their preferences for its format, delivery and content, is an important step towards designing better communication strategies and ensuring more informed parents. Our objectives were to explore stakeholders' views, experiences and preferences for childhood vaccination communication in Cameroon. Methods In 2014, in the Central and North West Regions of Cameron, we gathered qualitative data for our case study using the following methods: semi structured interviews; observations and informal conversations during routine immunization clinics and three rounds of the National Polio Immunization Campaign; document analysis of reports and mass media communications about vaccination; and a survey of parents. We conducted a thematic analysis of the qualitative data to identify themes relating to views, experiences and perceptions of vaccination information and its delivery. Survey data were analysed using simple descriptive statistics. Results All of the parents interviewed felt that vaccinating their child was important, and trusted the information provided by health workers. However, many parents wanted more information. Parents did not always feel that they could ask questions during vaccination appointments. All participants felt that health workers and vaccination clinics were important sources of information. Social mobilisation activities such as door-to-door visits and announcements during religious services were important and accepted ways of communicating information, especially during vaccination campaigns. Information communicated through mass media and text messages was also seen as important. In general, stakeholders believed that more consistent messaging about routine vaccination through community channels would be helpful to remind parents of the importance of routine vaccination during ongoing rounds of vaccination campaigns against polio. Conclusions This study confirms that parents regard information about childhood vaccination as important, but that health services need to be organized in ways that prioritize and facilitate communication, particularly about routine vaccination.	[Ames, Heather; Glenton, Claire; Fretheim, Atle; Lewin, Simon] Norwegian Inst Publ Hlth, Global Hlth Unit, Oslo, Norway; [Njang, Diangha Mabel; Kum, Awah Paschal; Lewin, Simon] Univ Yaounde I, Dept Anthropol, Yaounde, Central Provinc, Cameroon; [Fretheim, Atle] Univ Oslo, Inst Hlth & Soc, N-0318 Oslo, Norway; [Kaufman, Jessica; Hill, Sophie] La Trobe Univ, Sch Psychol & Publ Hlth, Ctr Hlth Commun & Participat, Melbourne, Vic, Australia; [Oku, Afiong; Oyo-Ita, Angela] Univ Calabar, Calabar Municipal, Cross River Sta, Nigeria; [Cliff, Julie] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Cartier, Yuri] Int Union Hlth Promot & Educ, St Denis, Reunion, France; [Bosch-Capblanch, Xavier] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Bosch-Capblanch, Xavier] Univ Basel, Basel, Switzerland; [Rada, Gabriel] Pontificia Univ Catolica Chile, Evidence Based Healthcare Programme, Santiago, Chile; [Muloliwa, Artur Manuel] Direccao Prov Saude Nampula, Dept Saude, Nampula, Mozambique; [Lewin, Simon] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa	Norwegian Institute of Public Health (NIPH); University of Yaounde I; University of Oslo; La Trobe University; University of Calabar; Eduardo Mondlane University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Pontificia Universidad Catolica de Chile; South African Medical Research Council	Ames, H (corresponding author), Norwegian Inst Publ Hlth, Global Hlth Unit, Oslo, Norway.	heather.melanie.ames@gmail.com	Lewin, Simon/HCH-1959-2022; Bosch-Capblanch, Xavier/ABD-7059-2020; Glenton, Claire/GSE-3606-2022; Ames, Heather Melanie R/AFT-1164-2022	Bosch-Capblanch, Xavier/0000-0002-4469-0395; Glenton, Claire/0000-0002-7558-7737; 	Research Council of Norway [220873]; South African Medical Research Council; Department for International Development (DFID) [201400] Funding Source: researchfish	Research Council of Norway(Research Council of Norway); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID)	The Research Council of Norway (Project 220873) funds the Communicate to Vaccinate 2 project. SL receives additional funding from the South African Medical Research Council.r The Research Council of Norway (Project 220873) funds the Communicate to Vaccinate 2 project. SL receives additional funding from the South African Medical Research Council.	Ames H, 2015, BMC PUBLIC HEALTH, V15, P1; Ames H., 2011, QUALITATIVE STUDY IN; Ames HG, 2016, COCHRANE DATABASE SY; Anderson LM, 2011, RES SYNTH METHODS, V2, P33, DOI 10.1002/jrsm.32; [Anonymous], 2011, INDEPENDENT MONITORI; Baxter P, 2008, QUAL REP, V13, P544; Bosch-Capblanch X, 2012, TROP MED INT HEALTH, V17, P697, DOI 10.1111/j.1365-3156.2012.02989.x; Brown S, 2014, MCN-AM J MATERN-CHIL, V39, P357, DOI 10.1097/NMC.0000000000000081; Cameroon DHS, 2011, HLTH SURVEY MULTIPLE; Casiday R, 2006, VACCINE, V24, P177, DOI 10.1016/j.vaccine.2005.07.063; Cleland J, 1992, HLTH TRANSITION REV, P1; Feldman-Savelsberg P, 2000, MED ANTHROPOL Q, V14, P159, DOI 10.1525/maq.2000.14.2.159; GAVI, 2014, CAMEROON PROTECT ITS; Ghinai I, 2013, GLOB PUBLIC HEALTH, V8, P1138, DOI 10.1080/17441692.2013.859720; Gulland A., 2014, BMJ, V348; Hadjikoumi I, 2006, ARCH DIS CHILD, V91, P621, DOI 10.1136/adc.2005.088898; Harvey H, 2015, VACCINE, V33, P2862, DOI 10.1016/j.vaccine.2015.04.085; Hill S., 2011, KNOWLEDGEABLE PATIEN, DOI [10.1002/9781444346855, DOI 10.1002/9781444346855]; Jheeta M, 2008, B WORLD HEALTH ORGAN, V86, P419, DOI 10.2471/BLT.07.047159; Julie Muloliwa AC, 2016, GLOBAL HLTH IN PRESS; Kaufman J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010038.pub2; Kharbanda EO, 2009, AM J PUBLIC HEALTH, V99, P2176, DOI 10.2105/AJPH.2009.161364; Miles M. B., 2019, SAGE, DOI DOI 10.1080/1034912X.2016.1228856; Mills E, 2005, J CLIN EPIDEMIOL, V58, P1081, DOI 10.1016/j.jclinepi.2005.09.002; Ministry of Public Health DoFH Expanded Programme on Immunization Central Technical Group, 2011, COMPR MULT PLAN EXP; Moturi EK, 2014, MMWR-MORBID MORTAL W, V63, P468; Munoz DC, 2015, INT J PUBLIC HEALTH, P1; Obregon R, 2010, J HEALTH COMMUN, V15, P25, DOI 10.1080/10810731003695367; Oku A, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30337; Oyo-Ita A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008145.pub2; Pearce A, 2008, BMJ-BRIT MED J, V336, P754, DOI 10.1136/bmj.39489.590671.25; Saeterdal I, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010232.pub2; SAGE Working Group on Vaccine Hesitancy, 2014, REP SAG WORK GROUP V; Taylor JA, 2002, PEDIATRICS, V110, P1110, DOI 10.1542/peds.110.6.1110; UNICEF, 2011, UNICEF ANN REP 2010; Wei J, 2011, J TELEMED TELECARE, V17, P41, DOI 10.1258/jtt.2010.100322; WHO, 2009, LESS LEARN IMPL ACT; WHO, 2012, TABL 2 SUMM WHO POS; Woo EJ, 2004, AM J PUBLIC HEALTH, V94, P990, DOI 10.2105/AJPH.94.6.990	39	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183721	10.1371/journal.pone.0183721	http://dx.doi.org/10.1371/journal.pone.0183721			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2PY	28859101	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500032
J	Subotic, A; Ting, WKC; Cusimano, MD				Subotic, Arsenije; Ting, Windsor Kwan-Chun; Cusimano, Michael D.			Characteristics of the King-Devick test in the assessment of concussed patients in the subacute and later stages after injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; VISUAL SCREENING TOOL; BASE-LINE ASSOCIATIONS; AMATEUR RUGBY UNION; ICE HOCKEY PLAYERS; EYE-MOVEMENTS; SLEEP-DEPRIVATION; YOUTH; INTERFERENCE; ATTENTION	Although the King-Devick (K-D) test has been used frequently in assessing sports related concussion early after injury, its characteristics over time after injury and in patients with prolonged persistent symptoms are unknown. The purpose of this paper was to: evaluate the ability of the K-D Test to distinguish patients seen early after concussion from those with symptoms persisting more than 3 months compared to controls, assess changes in the K-D test times over time after concussion, and determine the relationship of K-D times to the Stroop Color and Word Test scores. We performed cross-sectional comparisons of patients with recent concussive brain injury (acute group) and those with symptoms persisting more than 3 months to healthy controls on the K-D test, the Sports Concussion Assessment Tool 3 (SCAT3), and the Stroop Color and Word Test. Longitudinal comparisons of the acute group over time within the first month after injury were also made. Post-concussive syndrome (PCS) patients had significantly higher K-D times compared to controls (p = 0.01), while the acute group did not differ from controls(p = 0.33). K-D times at the second visit for the acute group were similar to those of controls (54.7 vs. 49.6, p = 0.31). While SCAT3 scores improved over time in the acute group, the K-D scores did not change between the first and second visit (55.2 vs. 54.7, p = 0.94). K-D scores correlated significantly with the Stroop scores for all three participant groups. The K-D test is likely useful very early after concussion in conjunction with baseline scores, and while scores in PCS patients remain elevated, they can be confounded by factors such as pre-morbid depression and medication use. High correlations with Stroop scores also suggest that performance on the K-D test can by proxy provide additional insight about cognitive function and predict performance on more cognitively demanding tasks.	[Subotic, Arsenije; Ting, Windsor Kwan-Chun; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Dept Surg, Injury Prevent Res Off, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Cusimano, MD (corresponding author), St Michaels Hosp, Div Neurosurg, Dept Surg, Injury Prevent Res Off, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Univ Toronto, Toronto, ON, Canada.	injuryprevention@smh.ca	Cusimano, Michael/GWR-1025-2022; Cusimano, Michael/X-4059-2019; Ting, Windsor Kwan-Chun/I-4013-2014	Ting, Windsor Kwan-Chun/0000-0003-4293-9617; Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research [MOP 123371]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We would like to thank the Canadian Institutes of Health Research MOP 123371 for the study funding. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, NEUROL CLIN PRACT, DOI DOI 10.1212/CPJ.000000000; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Duenas M, 2014, SURG NEUROL INT, V5, P91, DOI DOI 10.4103/2152-7806.134364; Fransson PA, 2008, J VESTIBUL RES-EQUIL, V18, P209; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Hoshizaki B, 2013, J NEUROL NEUROPHYSIO; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Naber M, PSYCHOL, V7, P822; Olk B, 2013, PSYCHOL RES-PSYCH FO, V77, P106, DOI 10.1007/s00426-011-0405-9; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; STROOP JR, 1992, J EXP PSYCHOL GEN, V121, P15; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955; Wright RM, J NEUROTRAUMA, V30, P102	39	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183092	10.1371/journal.pone.0183092	http://dx.doi.org/10.1371/journal.pone.0183092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2PY	28859119	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500010
J	Terrao, MC; de Vasconcelos, EJR; Defina, TA; Myler, PJ; Cruz, AK				Terrao, Monica Cristina; Rosas de Vasconcelos, Elton Jose; Defina, Tania Aquino; Myler, Peter J.; Cruz, Angela Kaysel			Disclosing 3 ' UTR cis-elements and putative partners involved in gene expression regulation in Leishmania spp.	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; RNA; BINDING; DONOVANI; FAMILY; DIFFERENTIATION; TRANSFECTION; NUCLEOTIDE; STABILITY; SEQUENCES	To identify putative cis-elements involved in gene expression regulation in Leishmania, we previously conducted an in silico investigation to find conserved intercoding sequences (CICS) in the genomes of L. major, L. infantum, and L. braziliensis. Here, the CICS databank was explored to search for sequences that were present in the untranslated regions (UTRs) of groups of genes showing similar expression profiles during in vitro differentiation. Using a selectable marker as a reporter gene, flanked by either an intact 3' UTR or a UTR lacking the conserved element, the regulatory role of a CICS was confirmed. We observed that the pattern of modulation of the mRNA levels was altered in the absence of the CICS. We also identified putative CICS RNA-binding proteins. This study suggests that the publicly available CICS database is a useful tool for identifying regulatory cis-elements for Leishmania genes and suggests the existence of post-transcriptional regulons in Leishmania.	[Terrao, Monica Cristina; Rosas de Vasconcelos, Elton Jose; Defina, Tania Aquino; Cruz, Angela Kaysel] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Cell & Mol Biol, Ribeirao Preto, Brazil; [Myler, Peter J.] Ctr Infect Dis Res, 307 Westlake Ave, Seattle, WA USA; [Myler, Peter J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Myler, Peter J.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA	Universidade de Sao Paulo; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cruz, AK (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Cell & Mol Biol, Ribeirao Preto, Brazil.	akcruz@fmrp.usp.br	Vasconcelos, Elton/O-5593-2014; Cruz, Angela Kaysel/N-8445-2014; Myler, Peter John/AAR-9535-2021	Vasconcelos, Elton/0000-0001-5130-6622; Cruz, Angela Kaysel/0000-0002-4260-4713; 	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/50219-9, 2008/04969-8]	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2013/50219-9 to AKC, 2008/04969-8 to MCT). AKC is a senior investigator of the Brazilian Research Council, CNPq.; We thank Viviane Ambrosio for their technical assistance. This work was supported by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2013/50219-9 to AKC, 2008/04969-8 to MCT). AKC is a senior investigator of the Brazilian Research Council, CNPq.	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; COBURN CM, 1991, MOL BIOCHEM PARASIT, V46, P169, DOI 10.1016/0166-6851(91)90210-W; Conn GL, 1998, CURR OPIN STRUC BIOL, V8, P278, DOI 10.1016/S0959-440X(98)80059-6; Coughlin BC, 2000, J BIOL CHEM, V275, P12051, DOI 10.1074/jbc.275.16.12051; D'Orso I, 2001, J BIOL CHEM, V276, P15783, DOI 10.1074/jbc.M010959200; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dupe A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137243; Dupe A, 2014, MOL MICROBIOL, V91, P548, DOI 10.1111/mmi.12478; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; HYNES TR, 1991, PROTEINS, V10, P92, DOI 10.1002/prot.340100203; Jankowsky E, 2015, NAT REV MOL CELL BIO, V16, P533, DOI 10.1038/nrm4032; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Klaff P, 1996, PLANT MOL BIOL, V32, P89, DOI 10.1007/BF00039379; Langst G, 2015, GENES-BASEL, V6, P299, DOI 10.3390/genes6020299; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; LEBOWITZ JH, 1991, GENE, V103, P119, DOI 10.1016/0378-1119(91)90402-W; Mani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022463; Muller M, 2010, NUCLEIC ACIDS RES, V38, P5867, DOI 10.1093/nar/gkq349; Rosenzweig D, 2008, PROTEOMICS, V8, P1843, DOI 10.1002/pmic.200701043; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Smith M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-240; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; Vasconcelos EJR, 2012, MOL BIOCHEM PARASIT, V183, P140, DOI 10.1016/j.molbiopara.2012.02.009; Wu Y, 2000, MOL BIOCHEM PARASIT, V110, P345, DOI 10.1016/S0166-6851(00)00290-5; Yu MC, 1998, MOL BIOCHEM PARASIT, V94, P265, DOI 10.1016/S0166-6851(98)00083-8	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183401	10.1371/journal.pone.0183401	http://dx.doi.org/10.1371/journal.pone.0183401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859096	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500016
J	Conley, KR; Sutherland, KR				Conley, Keats R.; Sutherland, Kelly R.			Particle shape impacts export and fate in the ocean through interactions with the globally abundant appendicularian Oikopleura dioica	PLOS ONE			English	Article							LOW-REYNOLDS-NUMBER; SUBMICROMETER PARTICLES; RETENTION EFFICIENCY; BACTERIAL COMMUNITY; CLEARANCE RATES; VANHOEFFENI; SIZE; HOUSE; FLOW; MICROORGANISMS	Marine microbes exhibit highly varied, often non-spherical shapes that have functional significance for essential processes, including nutrient acquisition and sinking rates. There is a surprising absence of data, however, on how cell shape affects grazing, which is crucial for predicting the fate of oceanic carbon. We used synthetic spherical and prolate spheroid microbeads to isolate the effect of particle length-to-width ratios on grazing and fate in the ocean. Here we show that the shape of microbe-sized particles affects predation by the appendicularian Oikopleura dioica, a globally abundant marine grazer. Using incubation experiments, we demonstrate that shape affects how particles are retained in the house and that the minimum particle diameter is the key variable determining how particles are ingested. High-speed videography revealed the mechanism behind these results: microbesized spheroids oriented with the long axis parallel to fluid streamlines, matching the speed and tortuosity of spheres of equivalent width. Our results suggest that the minimum particle diameter determines how elongated prey interact with the feeding-filters of appendicularians, which may help to explain the prevalence of ellipsoidal cells in the ocean, since a cell's increased surface-to-volume ratio does not always increase predation. We provide the first evidence that grazing by appendicularians can cause non-uniform export of different shaped particles, thereby influencing particle fate.	[Conley, Keats R.; Sutherland, Kelly R.] Univ Oregon, Dept Biol, Oregon Inst Marine Biol, Eugene, OR 97403 USA	University of Oregon	Conley, KR (corresponding author), Univ Oregon, Dept Biol, Oregon Inst Marine Biol, Eugene, OR 97403 USA.	keatsconley@gmail.com		Conley, Keats/0000-0002-2966-1844; Sutherland, Kelly/0000-0001-6832-6515	National Science Foundation award from the Division of Ocean Sciences [OCE-1537201]; Sloan Research Fellowship; Oregon Sea Grant Robert E. Malouf Marine Studies Scholarship; Julie and Rocky Dixon Graduate Innovation Award	National Science Foundation award from the Division of Ocean Sciences; Sloan Research Fellowship(Alfred P. Sloan Foundation); Oregon Sea Grant Robert E. Malouf Marine Studies Scholarship; Julie and Rocky Dixon Graduate Innovation Award	Funding was provided by National Science Foundation award from the Division of Ocean Sciences (OCE-1537201, https://www.nsf.gov/div/index.isp?div=OCE) and a Sloan Research Fellowship (https://sloan.org/fellowships, to K.R.S.). K.R.C. was supported in part by an Oregon Sea Grant 2014 Robert E. Malouf Marine Studies Scholarship (http://seagrant.oregonstate.edu/education/sea-grant-scholars/fellowships-internships/robert-e-malouf-marine-studies-scholarship) and a Julie and Rocky Dixon Graduate Innovation Award (https://gradschool.uoregon.edu/dixon-innovation-award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fattah AI, 2002, J COLLOID INTERF SCI, V246, P410, DOI 10.1006/jcis.2001.7922; Acuna JL, 1996, LIMNOL OCEANOGR, V41, P1800; ALLDREDGE AL, 1981, LIMNOL OCEANOGR, V26, P247, DOI 10.4319/lo.1981.26.2.0247; ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; Alldredge AL., 2005, RESPONSE MARINE ECOS, P309, DOI DOI 10.1093/PLANKT/FBI133; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; BEDO AW, 1993, B MAR SCI, V53, P2; Bergkvist J, 2012, LIMNOL OCEANOGR, V57, P318, DOI 10.4319/lo.2012.57.1.0318; Bochdansky AB, 1999, MAR BIOL, V133, P37, DOI 10.1007/s002270050440; BORSHEIM KY, 1984, OECOLOGIA, V63, P286, DOI 10.1007/BF00379891; BRETHERTON FP, 1962, J FLUID MECH, V14, P284, DOI 10.1017/S002211206200124X; Champion JA, 2007, P NATL ACAD SCI USA, V104, P11901, DOI 10.1073/pnas.0705326104; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Christaki U, 1998, LIMNOL OCEANOGR, V43, P458, DOI 10.4319/lo.1998.43.3.0458; Corno G, 2006, APPL ENVIRON MICROB, V72, P78, DOI 10.1128/AEM.72.1.78-86.2006; Dagg M.J., 2005, RESPONSE MARINE ECOS, P293; Dagg MJ, 1996, J MAR RES, V54, P149, DOI 10.1357/0022240963213466; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; DEIBEL D, 1992, MAR ECOL PROG SER, V81, P25, DOI 10.3354/meps081025; Dusenbery DB, 1998, J BACTERIOL, V180, P5978, DOI 10.1128/JB.180.22.5978-5983.1998; FENAUX R, 1986, ZOOMORPHOLOGY, V106, P224, DOI 10.1007/BF00312043; Fernandez D, 2004, MAR ECOL PROG SER, V266, P89, DOI 10.3354/meps266089; GONZALEZ HE, 1994, POLAR BIOL, V14, P331; Gorsky G., 1998, P161; Guasto JS, 2012, ANNU REV FLUID MECH, V44, P373, DOI 10.1146/annurev-fluid-120710-101156; Humphries S, 2009, P NATL ACAD SCI USA, V106, P7882, DOI 10.1073/pnas.0809063106; Jeffery GB, 1922, P R SOC LOND A-CONTA, V102, P161, DOI 10.1098/rspa.1922.0078; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; JONASZ M, 1987, LIMNOL OCEANOGR, V32, P1059, DOI 10.4319/lo.1987.32.5.1059; Jorgensen CB, 1984, MAR ECOL PROG SER, V15, P283; Jurgens K, 1999, APPL ENVIRON MICROB, V65, P1241; Kim MC, 2010, LAB CHIP, V10, P2464, DOI 10.1039/c003627g; KOEHL MAR, 1981, LIMNOL OCEANOGR, V26, P1062, DOI 10.4319/lo.1981.26.6.1062; Leblanc K, 2012, EARTH SYST SCI DATA, V4, P149, DOI 10.5194/essd-4-149-2012; LEWIS WM, 1976, SCIENCE, V192, P885, DOI 10.1126/science.192.4242.885; Lopez-Urrutia A, 1999, MAR ECOL PROG SER, V191, P195, DOI 10.3354/meps191195; Loth E, 2008, POWDER TECHNOL, V182, P342, DOI 10.1016/j.powtec.2007.06.001; Marcos, 2011, P NATL ACAD SCI USA, V108, P3860, DOI 10.1073/pnas.1014576108; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Montagnes DJS, 2008, AQUAT MICROB ECOL, V53, P83, DOI 10.3354/ame01229; MORRIS CC, 1993, MAR BIOL, V115, P445, DOI 10.1007/BF00349843; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Pabst W., 2007, CHARACTERIZATION PAR; PACE ML, 1987, MAR ECOL PROG SER, V40, P185, DOI 10.3354/meps040185; Padisak J, 2003, HYDROBIOLOGIA, V500, P243, DOI 10.1023/A:1024613001147; PEDLEY TJ, 1987, PROC R SOC SER B-BIO, V231, P47, DOI 10.1098/rspb.1987.0035; Perry J. J., 1997, MICROBIOLOGY DYNAMIC; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Robison BH, 2005, SCIENCE, V308, P1609, DOI 10.1126/science.1109104; RUBENSTEIN DI, 1977, AM NAT, V111, P981, DOI 10.1086/283227; Sato R, 2003, MAR ECOL PROG SER, V259, P163, DOI 10.3354/meps259163; Sato R, 2008, J PLANKTON RES, V30, P299, DOI 10.1093/plankt/fbn001; Scheiner S., 2001, DESIGN ANAL ECOLOGIC; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sutherland KR, 2010, P NATL ACAD SCI USA, V107, P15129, DOI 10.1073/pnas.1003599107; Taguchi S, 1982, COASTAL SHELF SCI, V14, P545; Ting CS, 2007, J BACTERIOL, V189, P4485, DOI 10.1128/JB.01948-06; Tiselius P, 2003, MAR BIOL, V142, P253, DOI 10.1007/s00227-002-0961-z; Troedsson C, 2007, LIMNOL OCEANOGR, V52, P416, DOI 10.4319/lo.2007.52.1.0416; TURLEY CM, 1986, MAR ECOL PROG SER, V33, P59, DOI 10.3354/meps033059; URBAN JL, 1993, MAR BIOL, V117, P607, DOI 10.1007/BF00349772; Vargas CA, 2002, MAR ECOL PROG SER, V241, P125, DOI 10.3354/meps241125; Visser AW, 2000, J PLANKTON RES, V22, P761, DOI 10.1093/plankt/22.4.761; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Zimon A.D., 2012, ADHESION DUST POWDER	66	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183105	10.1371/journal.pone.0183105	http://dx.doi.org/10.1371/journal.pone.0183105			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854260	Green Published, Green Submitted, gold			2022-12-26	WOS:000408693600029
J	Chaudhary, JK; Rath, PC				Chaudhary, Jitendra Kumar; Rath, Pramod C.			Microgrooved-surface topography enhances cellular division and proliferation of mouse bone marrow-derived mesenchymal stem cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; STROMAL CELLS; NEURONAL DIFFERENTIATION; SIGNALING PATHWAY; DISEASE; CULTURE; PROGENITORS; EXPRESSION; COLONIES; PROTOCOL	Mesenchymal stem cells' (MSCs) fate is largely determined by the various topographical features and a range of extracellular matrix (ECM) components present in their niches. Apart from maintaining structural stability, they regulate cell morphology, division, proliferation, migration and differentiation among others. Traditional MSC cultures, which are mainly based on two-dimensional smooth surfaces of culture dishes and plates, do not provide topographical cues similar to in vivo three-dimensional niches, impacting various cellular processes. Therefore, we culture the mouse bone marrow-derived MSCs on microgrooved bearing surface, partially mimicking in vivo reticulated niche, to study its effect on morphology, pluripotency factor-associated stemness, cell division and rate of proliferation. Following culture, morphological features, and MSC-specific marker gene expression, such as CD29, CD44, Sca-1 along with HSC (Haematopoietic stem cell)-specific markers like CD34, CD45, CD11b were evaluated by microscopy and immunophenotyping, respectively. HSC is another type of bone marrow stem cell population, which concertedly interacts with MSC during various functions, including haematopoiesis. In addition, mesenchymal stem cells were further analyzed for gene expression of pluripotency-associated transcription factors such as Oct3/4, Sox-2, Nanog and Myc, as well as differentiated into adipocytes, osteocytes and chondrocytes. Our results show that microgrooved surface-cultured mesenchymal stem cells (MMSCs) expressed higher levels of expected cell surface and pluripotencyassociated markers and proliferated more rapidly (2-3xfold) with higher percentage of cells in S/G2-M-phase, consequently giving rise to higher cell yield compared to standard culture flask-grown cells (MSCs), taken as control. Furthermore, both MSCs and MMSCs showed considerable accumulation of intracellular lipid-droplets, higher alkaline phosphatase activity and secretion of extracellular matrix that are characteristics of adipogenesis, osteogenesis and chondrogenesis, respectively.	[Chaudhary, Jitendra Kumar; Rath, Pramod C.] Jawaharlal Nehru Univ, Sch Life Sci, Mol Biol Lab, New Delhi, India	Jawaharlal Nehru University, New Delhi	Rath, PC (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Mol Biol Lab, New Delhi, India.	pcrath@mail.jnu.ac.in	RATH, PRAMOD/AAP-5565-2020	CHAUDHARY, JITENDRA/0000-0001-8499-9656	School of Life Sciences, J.N.U. from the University Grants Commission (UGC) Research Network Resource Centre (RNRC); DRS; Department of Science and Technology (DST) FIST & PURSE, Government of India; University Grants Commission (UGC) Research Network Resource Centre (RNRC)	School of Life Sciences, J.N.U. from the University Grants Commission (UGC) Research Network Resource Centre (RNRC); DRS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Science and Technology (DST) FIST & PURSE, Government of India; University Grants Commission (UGC) Research Network Resource Centre (RNRC)	This work was supported by the School of Life Sciences, J.N.U. from the University Grants Commission (UGC) Research Network Resource Centre (RNRC) and DRS as well as the Department of Science and Technology (DST) FIST & PURSE, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Central Instrumentation Facility (CIF), SLS and Advanced Instrumentation Research Facility (AIRF), JNU, New Delhi, and ICMR-JRF/SRF to J.K.C. The financial support to the School of Life Sciences, J.N.U. from the University Grants Commission (UGC) Research Network Resource Centre (RNRC) and DRS as well as the Department of Science and Technology (DST) FIST & PURSE, Government of India are gratefully acknowledged.	Anjos-Afonso F., 2008, CURR PROTOC STEM CEL, V7, p2B. 3.1; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Bao J, 2016, INT J MOL MED, V38, P457, DOI 10.3892/ijmm.2016.2638; Binrui C, 2016, ACCOUNTS CHEM RES, V49, P1111; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Chaudhary JK, 2017, J CELL SCI THERAPY, V8, P261, DOI DOI 10.4172/2157-7013.1000261; Chen DD, 2017, J NEUROSCI RES, V95, P907, DOI 10.1002/jnr.23879; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Czapla J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158745; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Gerlach JC, 2012, STEM CELLS DEV, V21, P3258, DOI 10.1089/scd.2012.0296; GOSHIMA J, 1991, CLIN ORTHOP RELAT R, V262, P298; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Li LR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37894; Liu Y, 2017, COLLOID SURFACE B, V154, P1, DOI 10.1016/j.colsurfb.2017.02.035; Matsubara T, 2004, BIOCHEM BIOPH RES CO, V313, P503, DOI 10.1016/j.bbrc.2003.11.143; Mishra RR, 2012, MOL BIOL REP, V39, P7389, DOI 10.1007/s11033-012-1571-6; Mishra RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028433; Munneke JM, 2016, TRANSPLANTATION, V100, P2309, DOI 10.1097/TP.0000000000001029; Nadri N, 2007, IN VITRO CELL DEV, V43, P276; Oh SH, 2015, CELL TRANSPLANT, V24, P1097, DOI 10.3727/096368914X679237; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prat M, 2017, METHODS MOL BIOL, V1553, P169, DOI 10.1007/978-1-4939-6756-8_13; Rakian R, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0235-6; Ranzoni AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep39656; Reichert D, 2015, SCI REP-UK, V5, DOI 10.1038/srep15680; Rodrigues M., 2010, CURR STEM CELL RES T, V1, P32, DOI DOI 10.1186/SCRT32; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Trivanovic D, 2015, LIFE SCI, V141, P61, DOI 10.1016/j.lfs.2015.09.019; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Wang SJ, 2016, STEM CELLS DEV, V25, P1195, DOI 10.1089/scd.2016.0055; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Yan YH, 2016, LIFE SCI, V166, P131, DOI 10.1016/j.lfs.2016.10.004; Zhou YX, 2016, STEM CELL REV REP, V12, P560, DOI 10.1007/s12015-016-9671-7; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	41	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182128	10.1371/journal.pone.0182128	http://dx.doi.org/10.1371/journal.pone.0182128			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846679	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600009
J	Harikrishnan, H; Singh, KKB; Ismail, A				Harikrishnan, Hemavathy; Singh, Kirnpal Kaur Banga; Ismail, Asma			Outer membrane proteins analysis of Shigella sonnei and evaluation of their antigenicity in Shigella infected individuals	PLOS ONE			English	Article							DYSENTERIAE TYPE-1; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; ACUTE DIARRHEA; FLEXNERI 2A; SERUM	Bacillary dysentery caused by infection with Shigella spp. remains as serious and common health problem throughout the world. It is a highly multi drug resistant organism and rarely identified from the patient at the early stage of infection. S. sonnei is the most frequently isolated species causing shigellosis in industrialized countries. The antigenicity of outer membrane protein of this pathogen expressed during human infection has not been identified to date. We have studied the antigenic outer membrane proteins expressed by S. sonnei, with the aim of identifying presence of specific IgA and IgG in human serum against the candidate protein biomarkers. Three antigenic OMPs sized 33.3, 43.8 and 100.3 kDa were uniquely recognized by IgA and IgG from patients with S. sonnei infection, and did not cross-react with sera from patients with other types of infection. The antigenic proteome data generated in this study are a first for OMPs of S. sonnei, and they provide important insights of human immune responses. Furthermore, numerous prime candidate proteins were identified which will aid the development of new diagnostic tools for the detection of S. sonnei.	[Harikrishnan, Hemavathy; Singh, Kirnpal Kaur Banga] Univ Sains Malaysia, Sch Med Sci, Dept Med Microbiol & Parasitol, Hlth Campus, Kelantan, Malaysia; [Ismail, Asma] Univ Sains Malaysia, Off Vice Chancellor, George Town, Malaysia; [Ismail, Asma] Univ Sains Malaysia, Inst Res Mol Med INFORMM, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Singh, KKB (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Med Microbiol & Parasitol, Hlth Campus, Kelantan, Malaysia.	kiren@usm.my	Singh, Kirnpal Kaur Banga/A-5761-2010; Singh, Kirnpal Kaur Banga/ABC-5192-2020; HARIKRISHNAN, HEMAVATHY/AAK-7007-2020; Banga Singh, Kirnpal Kaur/ABC-5195-2020	Singh, Kirnpal Kaur Banga/0000-0002-9958-5760; Singh, Kirnpal Kaur Banga/0000-0002-9958-5760; Banga Singh, Kirnpal Kaur/0000-0002-9958-5760	Research University Cluster [1001/PSKBP/8630012]; Institute for Postgraduate Studies, Universiti Sains Malaysia	Research University Cluster; Institute for Postgraduate Studies, Universiti Sains Malaysia(Universiti Sains Malaysia)	This research was supported by a Research University Cluster Grant (1001/PSKBP/8630012) titled "Molecular approaches to fundamental studies on biomarkers and development of sustainable rapid nanobiodiagnostics to enteric diseases for low resource settings" (2011-2013) to KK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a Research University Cluster Grant (1001/PSKBP/8630012) titled "Molecular approaches to fundamental studies on biomarkers and development of sustainable rapid nanobiodiagnostics to enteric diseases for low resource settings" (2011-2013). We gratefully acknowledge the Institute for Postgraduate Studies, Universiti Sains Malaysia, for providing the fellowship assistance and the Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, for providing facilities and specimens.	Arya D, 1977, Indian J Pathol Microbiol, V20, P15; Ashkenazi Shai, 2004, Semin Pediatr Infect Dis, V15, P246, DOI 10.1053/j.spid.2004.07.005; Biswas T, 2000, FEMS IMMUNOL MED MIC, V29, P129; Faruque SM, 2002, APPL ENVIRON MICROB, V68, P3908, DOI 10.1128/AEM.68.8.3908-3913.2002; Harikrishnan H, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-38; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; Islam AHMS, 2011, DIAGN MICR INFEC DIS, V69, P38, DOI 10.1016/j.diagmicrobio.2010.09.008; ISLAM D, 1995, INFECT IMMUN, V63, P2054, DOI 10.1128/IAI.63.5.2054-2061.1995; ISMAIL A, 1991, BIOCHEM BIOPH RES CO, V181, P301, DOI 10.1016/S0006-291X(05)81417-2; KANTELE AM, 1988, J INFECT DIS, V158, P1011, DOI 10.1093/infdis/158.5.1011; LI A, 1994, SCAND J INFECT DIS, V26, P435, DOI 10.3109/00365549409008617; Liston A, 2016, TRENDS IMMUNOL, V37, P637, DOI 10.1016/j.it.2016.08.002; Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468; LORY S, 1985, CURR TOP MICROBIOL, V118, P53; MoezArdalan K, 2003, J HEALTH POPUL NUTR, V21, P96; Mukhopadhaya A, 2003, VACCINE, V21, P3043, DOI 10.1016/S0264-410X(03)00111-7; Niyogi SK, 2005, J MICROBIOL, V43, P133; OBERHELMAN RA, 1991, INFECT IMMUN, V59, P2341, DOI 10.1128/IAI.59.7.2341-2350.1991; Ojha SC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/412370; Ozuah P O, 1998, Pediatr Rev, V19, P100, DOI 10.1542/pir.19-3-100; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; Raqib R, 2003, INFECT IMMUN, V71, P2684, DOI 10.1128/IAI.71.5.2684-2692.2003; Rasolofo-Razanamparany V, 2001, INFECT IMMUN, V69, P5230, DOI 10.1128/IAI.69.9.5230-5234.2001; Robin G, 1997, J INFECT DIS, V175, P1128, DOI 10.1086/516452; ROY S, 1994, MICROBIOS, V79, P55; Sansonetti P, 1996, RES IMMUNOL, V147, P595, DOI 10.1016/S0923-2494(97)85227-3; Sansonetti PJ, 2001, AM J PHYSIOL-GASTR L, V280, pG319, DOI 10.1152/ajpgi.2001.280.3.G319; Turner SA, 2003, ANTIMICROB AGENTS CH, V47, P727, DOI 10.1128/AAC.47.2.727-734.2003; Warren BR, 2006, CRIT REV FOOD SCI, V46, P551, DOI 10.1080/10408390500295458	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182878	10.1371/journal.pone.0182878	http://dx.doi.org/10.1371/journal.pone.0182878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846684	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000408438600018
J	Lutter, M; Bahl, E; Hannah, C; Hofammann, D; Acevedo, S; Cui, HX; McAdams, CJ; Michaelson, JJ				Lutter, Michael; Bahl, Ethan; Hannah, Claire; Hofammann, Dabney; Acevedo, Summer; Cui, Huxing; McAdams, Carrie J.; Michaelson, Jacob J.			Novel and ultra-rare damaging variants in neuropeptide signaling are associated with disordered eating behaviors	PLOS ONE			English	Article							DIET-INDUCED OBESITY; MESOLIMBIC DOPAMINE SYSTEM; GLUCAGON-LIKE PEPTIDE-1; ANOREXIA-NERVOSA; TNF-ALPHA; GENETIC-VARIANTS; BULIMIA-NERVOSA; FOOD-INTAKE; MICE; NEUROTENSIN	Objective Eating disorders develop through a combination of genetic vulnerability and environmental stress, however the genetic basis of this risk is unknown. Methods To understand the genetic basis of this risk, we performed whole exome sequencing on 93 unrelated individuals with eating disorders (38 restricted-eating and 55 binge-eating) to identify novel damaging variants. Candidate genes with an excessive burden of predicted damaging variants were then prioritized based upon an unbiased, data-driven bioinformatic analysis. One top candidate pathway was empirically tested for therapeutic potential in a mouse model of binge-like eating. Results An excessive burden of novel damaging variants was identified in 186 genes in the restricted-eating group and 245 genes in the binge-eating group. This list is significantly enriched (OR = 4.6, p<0.0001) for genes involved in neuropeptide/ neurotrophic pathways implicated in appetite regulation, including neurotensin-, glucagon-like peptide 1-and BDNF-signaling. Administration of the glucagon-like peptide 1 receptor agonist exendin-4 significantly reduced food intake in a mouse model of 'binge-like' eating. Conclusions These findings implicate ultra-rare and novel damaging variants in neuropeptide/neurotropic factor signaling pathways in the development of eating disorder behaviors and identify glucagon-like peptide 1-receptor agonists as a potential treatment for binge eating.	[Lutter, Michael] Eating Recovery Ctr Dallas, Plano, TX USA; [Bahl, Ethan; Hannah, Claire; Hofammann, Dabney; Michaelson, Jacob J.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Acevedo, Summer; McAdams, Carrie J.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [Cui, Huxing] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa	Michaelson, JJ (corresponding author), Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA.	jacob-michaelson@uiowa.edu	McAdams, Carrie J./M-6822-2017	McAdams, Carrie J./0000-0002-4768-6703; Cui, Huxing/0000-0002-8627-8534; Michaelson, Jacob/0000-0001-9713-0992	Klarman Family Foundation Grants Program in Eating Disorder Research; University of Iowa Foundation, Department of Psychiatry; NIMH grants [MH093684, MH105527]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER	Klarman Family Foundation Grants Program in Eating Disorder Research; University of Iowa Foundation, Department of Psychiatry; NIMH grants; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the Klarman Family Foundation Grants Program in Eating Disorder Research (ML), University of Iowa Foundation, Department of Psychiatry (ML), and NIMH grants MH093684 (CJM), and MH105527 (JJM).	ALLEN GV, 1995, NEUROSCIENCE, V69, P533, DOI 10.1016/0306-4522(95)00261-G; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avena NM, 2012, NEUROPHARMACOLOGY, V63, P87, DOI 10.1016/j.neuropharm.2011.11.010; Bannerman E, 2001, CLIN NUTR, V20, P399, DOI 10.1054/clnu.2001.0463; Bataille D, 2014, DIABETES RES CLIN PR, V106, P1, DOI 10.1016/j.diabres.2014.06.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boraska V., 2014, MOL PSYCHIAT; BrainSpan, 2014, BRAINSPAN ATL DEV HU; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bulik CM, 2006, ARCH GEN PSYCHIAT, V63, P305, DOI 10.1001/archpsyc.63.3.305; Cao XH, 2014, J CLIN INVEST, V124, P4351, DOI 10.1172/JCI74726; Cochet-Bissuel M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00132; Cui HX, 2013, J CLIN INVEST, V123, P4706, DOI 10.1172/JCI71400; Czyzyk TA, 2012, FASEB J, V26, P3483, DOI 10.1096/fj.12-208041; Czyzyk TA, 2010, OBESITY, V18, P1710, DOI 10.1038/oby.2010.46; Dalvi PS, 2012, ENDOCRINOLOGY, V153, P2208, DOI 10.1210/en.2011-1795; Dossat AM, 2015, INT J EAT DISORDER, V48, P199, DOI 10.1002/eat.22264; Dubern B, 2008, PEDIATR RES, V63, P211, DOI 10.1203/PDR.0b013e31815ed62b; Eddy KT, 2008, AM J PSYCHIAT, V165, P245, DOI 10.1176/appi.ajp.2007.07060951; Egecioglu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069010; Fichter MM, 2007, INT J EAT DISORDER, V40, pS61, DOI 10.1002/eat.20443; Foster DJ, 2016, NEURON, V91, P1244, DOI 10.1016/j.neuron.2016.08.017; Friry C, 2002, BIOCHEM BIOPH RES CO, V290, P1161, DOI 10.1006/bbrc.2001.6308; Gu GB, 2013, J COMP NEUROL, V521, P2235, DOI 10.1002/cne.23282; Huo LH, 2008, ENDOCRINOLOGY, V149, P492, DOI 10.1210/en.2007-0633; Ishiguro H, 2010, SYNAPSE, V64, P92, DOI 10.1002/syn.20714; Khalil RB, 2011, EAT WEIGHT DISORD-ST, V16, pE300; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li J, 2016, NATURE, V533, P411, DOI 10.1038/nature17662; Liao GY, 2013, MOL METAB, V2, P491, DOI 10.1016/j.molmet.2013.08.002; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marcora SM, 2006, AM J CLIN NUTR, V84, P1463, DOI 10.1093/ajcn/84.6.1463; Mason BL, 2013, TRK B SIGNALING IN D; Mendez IA, 2015, NEUROPSYCHOPHARMACOL, V40, P2103, DOI 10.1038/npp.2015.67; Milos G, 2005, BRIT J PSYCHIAT, V187, P573, DOI 10.1192/bjp.187.6.573; Naessen S, 2011, AM J CLIN NUTR, V94, P967, DOI 10.3945/ajcn.111.014837; NHLBI, 2014, EX VAR SERV; Opland D, 2013, MOL METAB, V2, P423, DOI 10.1016/j.molmet.2013.07.008; Patel HJ, 2017, LIFE SCI, V170, P56, DOI 10.1016/j.lfs.2016.11.033; Pinheiro AP, 2010, AM J MED GENET B, V153B, P1070, DOI 10.1002/ajmg.b.31082; R Core Team, 2013, R LANG ENV STAT COMP; Ribases M, 2005, MOL PSYCHIATR, V10, P851, DOI 10.1038/sj.mp.4001670; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Robert SA, 2015, OBES RES CLIN PRACT, V9, P301, DOI 10.1016/j.orcp.2015.03.005; Santis S, 2009, N-S ARCH PHARMACOL, V379, P181, DOI 10.1007/s00210-008-0346-z; Shin JH, 2015, P NATL ACAD SCI USA, V112, P8124, DOI 10.1073/pnas.1508846112; Sodersten P, 2016, NEUROSCI BIOBEHAV R, V60, P26, DOI 10.1016/j.neubiorev.2015.11.003; Solmi M, 2015, PSYCHONEUROENDOCRINO, V51, P237, DOI 10.1016/j.psyneuen.2014.09.031; Solmi M, 2013, INT J EAT DISORDER, V46, P639, DOI 10.1002/eat.22153; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Wang K, 2010, NUCLEIC ACIDS RES, V38, pe164, DOI DOI 10.1093/nar/gkq603; Xue B, 2017, NEUROPHARMACOLOGY, V112, P57, DOI 10.1016/j.neuropharm.2016.04.005; Zeeland AASV, 2014, MOL PSYCHIATR, V19, P724, DOI 10.1038/mp.2013.91; Zhang H. Y., 2016, ADDICT BIOL	59	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0181556	10.1371/journal.pone.0181556	http://dx.doi.org/10.1371/journal.pone.0181556			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846695	Green Published, Green Submitted, gold			2022-12-26	WOS:000408438600007
J	Li, MZ; Chen, K; Liu, FT; Su, FX; Li, SR; Zhu, LL				Li, Mingzhu; Chen, Kai; Liu, Fengtao; Su, Fengxi; Li, Shunrong; Zhu, Liling			Nipple sparing mastectomy in breast cancer patients and long-term survival outcomes: An analysis of the SEER database	PLOS ONE			English	Article							CONSERVING SURGERY; FOLLOW-UP; SUBCUTANEOUS MASTECTOMY; ONCOLOGICAL SAFETY; RECONSTRUCTION; EXPERIENCE; INVOLVEMENT; POPULATION; RECURRENCE; MANAGEMENT	Purpose To determine the prevalence of nipple-sparing mastectomy (NSM) and its long-term survival outcomes in breast cancer patients. Method We used the Surveillance, Epidemiology, and End Results database and identified 2,440 breast cancer patients who received NSM during 1998-2013. We used chi-square and binary logistic regression to identify factors associated with the use of radiotherapy after NSM. We used Kaplan-Meier analysis to estimate cancer-specific survival (CSS) and overall survival (OS). We used the log-rank test and Cox regression to identify factors associated with CSS and OS. Results The median age of the population was 50 years. There were 725 (29.7%), 1064 (43.6%) and 651 (26.7%) patients who had Tis, T1 and T2-3 disease and 1943 (79.6%), 401 (16.4%) and 96 (3.9%) patients who had N0, N1 and N2-3 disease, respectively. The rates of RT use were 61.4%, 39.6% and 10.9% in patients with N2-3 disease, N1 or T3/N0 disease and Tis/ T1-2N0 disease, respectively. Elderly age, African American race, and higher T-stage and N-stage were associated with receiving radiotherapy. For patients diagnosed between 1998-2010 (N = 763), the median follow-up was 69 months. The 5-and 10-yr CSS were 96.9% and 94.9%, respectively. The 5- and 10-yr OS were 94.1% and 88.0%, respectively. Ethnicity, T-stage and N-stage were factors independently associated with CSS, and age and T-stage were factors independently associated with OS. Conclusions The use of NSM has increased, and it is oncologically safe for breast cancer patients.	[Li, Mingzhu] Fujian Med Univ, Quanzhou Hosp 1, Quanzhou, Fujian, Peoples R China; [Chen, Kai; Liu, Fengtao; Su, Fengxi; Li, Shunrong; Zhu, Liling] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China; [Chen, Kai; Liu, Fengtao; Su, Fengxi; Li, Shunrong; Zhu, Liling] Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China; [Zhu, Liling] Yale Univ, Dept Biostat, Yale Sch Publ Hlth, New Haven, CT 06520 USA	Fujian Medical University; Sun Yat Sen University; Sun Yat Sen University; Yale University	Li, SR; Zhu, LL (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China.; Li, SR; Zhu, LL (corresponding author), Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China.; Zhu, LL (corresponding author), Yale Univ, Dept Biostat, Yale Sch Publ Hlth, New Haven, CT 06520 USA.	lishr@mail.sysu.edu.cn; liling.zhu@yale.edu			National Natural Science Foundation of China [81402201/81372817]; National Natural Science Foundation of Guangdong Province [2014A030310070]; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [[2013]163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology	The authors have no conflicts of interest or financial disclosures. This study was supported by the National Natural Science Foundation of China (grant# 81402201/81372817), National Natural Science Foundation of Guangdong Province (grant# 2014A030310070), and grant [2013]163 from Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology.; The authors have no conflicts of interest or financial disclosures. This study was supported by the National Natural Science Foundation of China (Grant# 81402201/81372817), National Natural Science Foundation of Guangdong Province (Grant# 2014A030310070), and Grant [2013]163 from Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology.	Adam H, 2014, EJSO-EUR J SURG ONC, V40, P1209, DOI 10.1016/j.ejso.2014.07.037; Agarwal S, 2015, ANN SURG ONCOL, V22, P46, DOI 10.1245/s10434-014-3932-y; Agarwal S, 2014, AM J SURG, V208, P93, DOI 10.1016/j.amjsurg.2013.09.030; Alperovich M, 2016, BREAST J, V22, P18, DOI 10.1111/tbj.12517; Amara D, 2015, ANN SURG ONCOL, V22, P3803, DOI 10.1245/s10434-015-4646-5; Benediktsson KP, 2008, EJSO-EUR J SURG ONC, V34, P143, DOI 10.1016/j.ejso.2007.06.010; Caruso F, 2006, EJSO-EUR J SURG ONC, V32, P937, DOI 10.1016/j.ejso.2006.05.013; Chen K, 2015, ONCOTARGET, V6, P40127, DOI 10.18632/oncotarget.5394; De La Cruz L, 2015, ANN SURG ONCOL, V22, P3241, DOI 10.1245/s10434-015-4739-1; Eisenberg REK, 2014, BREAST J, V20, P15, DOI 10.1111/tbj.12199; Frasier LL, 2016, JAMA ONCOL, V2, P95, DOI 10.1001/jamaoncol.2015.3717; Gerber B, 2009, ANN SURG, V249, P461, DOI 10.1097/SLA.0b013e31819a044f; Jagsi R, 2012, CANCER-AM CANCER SOC, V118, P333, DOI 10.1002/cncr.26295; Jensen JA, 2011, ANN SURG ONCOL, V18, P1665, DOI 10.1245/s10434-010-1475-4; MACMILLAN RD, 1994, BRIT J SURG, V81, P56, DOI 10.1002/bjs.1800810119; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Moo TA, 2016, ANN SURG ONCOL, V23, P3221, DOI 10.1245/s10434-016-5366-1; Munhoz AM, 2013, BREAST CANCER RES TR, V140, P545, DOI 10.1007/s10549-013-2634-7; NCCN, 2016, VERSION I, P1; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petit JY, 2009, BREAST CANCER RES TR, V117, P333, DOI 10.1007/s10549-008-0304-y; Poruk KE, 2015, AM J SURG, V209, P212, DOI 10.1016/j.amjsurg.2014.04.001; Sakurai T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0481-3; Shi AP, 2012, BREAST CARE, V7, P131, DOI 10.1159/000337640; Tang R, 2016, J AM COLL SURGEONS, V222, P1149, DOI 10.1016/j.jamcollsurg.2016.02.016; van Maaren MC, 2016, LANCET ONCOL, V17, P1158, DOI 10.1016/S1470-2045(16)30067-5; Voltura AM, 2008, ANN SURG ONCOL, V15, P3396, DOI 10.1245/s10434-008-0102-0	27	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183448	10.1371/journal.pone.0183448	http://dx.doi.org/10.1371/journal.pone.0183448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841691	Green Submitted, Green Published, gold			2022-12-26	WOS:000408370700033
J	Kulp, JL; Cloudsdale, IS; Kulp, JL; Guarnieri, F				Kulp, John L., III; Cloudsdale, Ian S.; Kulp, John L., Jr.; Guarnieri, Frank			Hot-spot identification on a broad class of proteins and RNA suggest unifying principles of molecular recognition	PLOS ONE			English	Article							PANCREATIC TRYPSIN-INHIBITOR; FRAGMENT-BASED APPROACH; ENSEMBLE MONTE-CARLO; BINDING-SITES; HIV-1 PROTEASE; CRYSTAL-STRUCTURES; X-RAY; DRUG DISCOVERY; LEAD DISCOVERY; LENNARD-JONES	Chemically diverse fragments tend to collectively bind at localized sites on proteins, which is a cornerstone of fragment-based techniques. A central question is how general are these strategies for predicting a wide variety of molecular interactions such as small molecule-protein, protein-protein and protein-nucleic acid for both experimental and computational methods. To address this issue, we recently proposed three governing principles, (1) accurate prediction of fragment-macromolecule binding free energy, (2) accurate prediction of water-macromolecule binding free energy, and (3) locating sites on a macromolecule that have high affinity for a diversity of fragments and low affinity for water. To test the generality of these concepts we used the computational technique of Simulated Annealing of Chemical Potential to design one small fragment to break the RecA-RecA protein-protein interaction and three fragments that inhibit peptide-deformylase via water-mediated multi-body interactions. Experiments confirm the predictions that 6-hydroxydopamine potently inhibits RecA and that PDF inhibition quantitatively tracks the water-mediated binding predictions. Additionally, the principles correctly predict the essential bound waters in HIV Protease, the surprisingly extensive binding site of elastase, the pinpoint location of electron transfer in dihydrofolate reductase, the HIV TAT-TAR protein-RNA interactions, and the MDM2-MDM4 differential binding to p53. The experimental confirmations of highly non-obvious predictions combined with the precise characterization of a broad range of known phenomena lend strong support to the generality of fragment-based methods for characterizing molecular recognition.	[Kulp, John L., III; Cloudsdale, Ian S.; Kulp, John L., Jr.] Conifer Point Pharmaceut, Doylestown, PA USA; [Kulp, John L., III] Baruch S Blumberg Inst, Dept Chem, Doylestown, PA USA; [Guarnieri, Frank] PAKA Pulm Pharmaceut, Acton, MA 01720 USA		Guarnieri, F (corresponding author), PAKA Pulm Pharmaceut, Acton, MA 01720 USA.	frankguarnieri@yahoo.com		Kulp, John/0000-0003-2586-9207	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health [R43GM109549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM109549] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Guarnieri is an employee of PAKA Pulmonary Pharmaceuticals and affiliated with Virginia Commonwealth University. Dr. Kulp III is an employee of Conifer Point Pharmaceuticals and an employee of the nonprofit, The Baruch S. Blumberg Institute. Dr. Kulp JR and Dr. Cloudsdale are employees of Conifer Point Pharmaceuticals. PAKA provided support in the form of salary for Dr. Guarnieri, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Conifer Point provided salary support for Dr. Kulp III and Dr. Kulp JR and these individuals had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Specific roles are articulated in the 'authors contributions' section. Part of the research reported in this publication was supported by National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health under award number R43GM109549.	ADAMS DJ, 1975, MOL PHYS, V29, P307, DOI 10.1080/00268977500100221; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; ALBER T, 1976, NATURE, V263, P297, DOI 10.1038/263297a0; Allen KN, 1996, J PHYS CHEM-US, V100, P2605, DOI 10.1021/jp952516o; Amano M, 2013, ANTIMICROB AGENTS CH, V57, P2036, DOI 10.1128/AAC.02189-12; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; BERNDT KD, 1992, J MOL BIOL, V227, P757, DOI 10.1016/0022-2836(92)90222-6; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Bohnuud T, 2012, NUCLEIC ACIDS RES, V40, P7644, DOI 10.1093/nar/gks519; Boularot A, 2007, J MED CHEM, V50, P10, DOI 10.1021/jm060910c; Bradbury MW, 2011, J MOL BIOL, V412, P412, DOI 10.1016/j.jmb.2011.07.034; Buhrman G, 2011, J MOL BIOL, V413, P773, DOI 10.1016/j.jmb.2011.09.011; CHEN ZG, 1994, J BIOL CHEM, V269, P26344; Cheng YK, 1998, NATURE, V392, P696, DOI 10.1038/33653; Chessari G, 2009, DRUG DISCOV TODAY, V14, P668, DOI 10.1016/j.drudis.2009.04.007; Chilingaryan Z, 2012, INT J MOL SCI, V13, P12857, DOI 10.3390/ijms131012857; Chuang GY, 2009, BIOPHYS J, V97, P2846, DOI 10.1016/j.bpj.2009.09.004; Corey R, 2014, ANTIMICROB AGENTS CH, V58, P6518, DOI 10.1128/AAC.03360-14; Cui PX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07453; Czapinska H, 2000, J MOL BIOL, V295, P1237, DOI 10.1006/jmbi.1999.3445; Czarna A, 2009, CELL CYCLE, V8, P1176, DOI 10.4161/cc.8.8.8185; DANISHEFSKY AT, 1993, PROTEIN SCI, V2, P577; Davidson A, 2011, NUCLEIC ACIDS RES, V39, P248, DOI 10.1093/nar/gkq713; Davies TG, 2016, J MED CHEM, V59, P3991, DOI 10.1021/acs.jmedchem.6b00228; De Zutter JK, 2001, STRUCTURE, V9, P47, DOI 10.1016/S0969-2126(00)00552-9; Dennis S, 2002, P NATL ACAD SCI USA, V99, P4290, DOI 10.1073/pnas.062398499; DORSEY BD, 1994, J MED CHEM, V37, P3443, DOI 10.1021/jm00047a001; Eakin AE, 2012, ANTIMICROB AGENTS CH, V56, P1240, DOI 10.1128/AAC.05485-11; Edink E, 2011, J AM CHEM SOC, V133, P5363, DOI 10.1021/ja110571r; Egger J, 2013, J AM CHEM SOC, V135, P9820, DOI 10.1021/ja4029582; Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109; Feki A, 2004, CRIT REV ONCOL HEMAT, V52, P103, DOI 10.1016/j.critrevonc.2004.07.002; Gable JE, 2016, CHEMMEDCHEM, V11, P862, DOI 10.1002/cmdc.201500526; Golden MS, 2013, J AM CHEM SOC, V135, P6242, DOI 10.1021/ja400914z; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Guan JY, 2013, J AM CHEM SOC, V135, P5859, DOI 10.1021/ja401323m; Guarnieri F, 1996, J AM CHEM SOC, V118, P8493, DOI 10.1021/ja961482a; Guarnieri F., 2012, DICHOTOMY UNDERSTAND, P4; Guarnieri F., 2015, DESIGNING ORALLY AVA, V1289, P211; Guarnieri F, 2004, U.S. Patent, Patent No. 6735530; Guarnieri Frank, 2015, Methods Mol Biol, V1289, P185, DOI 10.1007/978-1-4939-2486-8_14; Guarnieri F, 2010, P NATL ACAD SCI USA, V107, P10661, DOI 10.1073/pnas.1001349107; Hall DH, 2011, J AM CHEM SOC, V133, P20668, DOI 10.1021/ja207914y; Hao GF, 2012, J AM CHEM SOC, V134, P11168, DOI 10.1021/ja3001908; Hay DA, 2014, J AM CHEM SOC, V136, P9308, DOI 10.1021/ja412434f; HOUSSET D, 1991, J MOL BIOL, V220, P757, DOI 10.1016/0022-2836(91)90115-M; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; HUGHES DL, 1982, J MOL BIOL, V162, P645, DOI 10.1016/0022-2836(82)90393-X; Huguet F, 2012, CHEMMEDCHEM, V7, P1020, DOI 10.1002/cmdc.201200076; Indiani C, 2013, P NATL ACAD SCI USA, V110, P5410, DOI 10.1073/pnas.1303301110; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Katada T, 2012, BIOL PHARM BULL, V35, P2103, DOI 10.1248/bpb.b212024; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Kulp JL, 2012, J COMPUT AID MOL DES, V26, P583, DOI 10.1007/s10822-012-9546-1; Kulp JL, 2011, J AM CHEM SOC, V133, P10740, DOI 10.1021/ja203929x; Kumar M, 2002, BIOCHEM BIOPH RES CO, V294, P395, DOI 10.1016/S0006-291X(02)00482-5; Lax A, 2012, CURR TOP MICROBIOL, V361, P131, DOI 10.1007/82_2012_236; Lee AM, 2007, ANAL BIOCHEM, V367, P247, DOI 10.1016/j.ab.2007.04.021; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu FL, 2006, J MOL BIOL, V358, P1191, DOI 10.1016/j.jmb.2006.02.076; Liu LK, 2014, J MED CHEM, V57, P2714, DOI 10.1021/jm5000276; Liu ZG, 2013, BIOCHEM BIOPH RES CO, V430, P1022, DOI 10.1016/j.bbrc.2012.12.045; Marcellino D, 2010, J NEURAL TRANSM, V117, P681, DOI 10.1007/s00702-010-0400-0; Mashalidis EH, 2013, NAT PROTOC, V8, P2309, DOI 10.1038/nprot.2013.130; Massari S, 2013, CURR PHARM DESIGN, V19, P1860, DOI 10.2174/1381612811319100010; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; MATTOS C, 1994, NAT STRUCT BIOL, V1, P55, DOI 10.1038/nsb0194-55; Mattos C, 2006, J MOL BIOL, V357, P1471, DOI 10.1016/j.jmb.2006.01.039; Mattos C, 1996, NAT BIOTECHNOL, V14, P595, DOI 10.1038/nbt0596-595; Mehler EL, 1999, BIOPHYS J, V77, P3, DOI 10.1016/S0006-3495(99)76868-2; MEYER EF, 1986, J MOL BIOL, V189, P533, DOI 10.1016/0022-2836(86)90322-0; MEZEI M, 1987, MOL PHYS, V61, P565, DOI 10.1080/00268978700101321; Mikuni J, 2010, ANAL BIOCHEM, V402, P26, DOI 10.1016/j.ab.2010.03.019; Miller RM, 2013, J AM CHEM SOC, V135, P5298, DOI 10.1021/ja401221b; MIRANKER A, 1991, PROTEINS, V11, P29, DOI 10.1002/prot.340110104; Moffett K, 2011, BIOORG MED CHEM LETT, V21, P7155, DOI 10.1016/j.bmcl.2011.09.078; Moore WR, 2005, CURR OPIN DRUG DISC, V8, P355; Mousseau Guillaume, 2012, Biology (Basel), V1, P668, DOI 10.3390/biology1030668; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Murray K, 2007, PEPTIDE SCI, V88, P657; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; Peterson EJR, 2012, ASSAY DRUG DEV TECHN, V10, P260, DOI 10.1089/adt.2011.0409; Pierce J A, 1969, Trans Assoc Am Physicians, V82, P87; Popowicz GM, 2011, ANGEW CHEM INT EDIT, V50, P2680, DOI 10.1002/anie.201003863; Prashar V, 2010, BIOCHEM BIOPH RES CO, V396, P1018, DOI 10.1016/j.bbrc.2010.05.049; Qin LY, 2014, J AM CHEM SOC, V136, P18023, DOI 10.1021/ja509223m; Raman EP, 2015, J AM CHEM SOC, V137, P2608, DOI 10.1021/ja512054f; Raman EP, 2013, J CHEM INF MODEL, V53, P3384, DOI 10.1021/ci4005628; Randhawa H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-321; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; Rojas A, 2013, CELL SIGNAL, V25, P609, DOI 10.1016/j.cellsig.2012.11.022; Rouhana J, 2013, J MED CHEM, V56, P8497, DOI 10.1021/jm4009357; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Scott DE, 2013, CHEMBIOCHEM, V14, P332, DOI 10.1002/cbic.201200521; Sexton Jonathan Z, 2010, Curr Chem Genomics, V4, P34, DOI 10.2174/1875397301004010034; Sheth A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.112; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Siegert P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003385; Silvestre HL, 2013, P NATL ACAD SCI USA, V110, P12984, DOI 10.1073/pnas.1304045110; Singleton SF, 2007, TETRAHEDRON, V63, P3553, DOI 10.1016/j.tet.2006.10.092; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; TURINO GM, 1969, SCIENCE, V165, P709, DOI 10.1126/science.165.3894.709; Vallee M, 2014, SCIENCE, V343, P94, DOI 10.1126/science.1243985; Van Molle I, 2012, CHEM BIOL, V19, P1300, DOI 10.1016/j.chembiol.2012.08.015; Waaijers S, 2013, J PROTEOME RES, V12, P3181, DOI 10.1021/pr400047p; Wang ZM, 1998, BBA-PROTEIN STRUCT M, V1384, P335, DOI 10.1016/S0167-4838(98)00027-2; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wigle TJ, 2007, BIOORG MED CHEM LETT, V17, P3249, DOI 10.1016/j.bmcl.2007.04.013; Wigle TJ, 2009, J BIOMOL SCREEN, V14, P1092, DOI 10.1177/1087057109342126; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a; Winter A, 2016, MOL CANCER THER, V15, P3, DOI 10.1158/1535-7163.MCT-15-0446; Winter A, 2012, Q REV BIOPHYS, V45, P383, DOI 10.1017/S0033583512000108; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; WLODAWER A, 1987, J MOL BIOL, V193, P145, DOI 10.1016/0022-2836(87)90633-4; WLODAWER A, 1987, J MOL BIOL, V198, P469, DOI 10.1016/0022-2836(87)90294-4; Yedidi RS, 2012, BIOCHEM BIOPH RES CO, V421, P413, DOI 10.1016/j.bbrc.2012.03.096; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	121	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183327	10.1371/journal.pone.0183327	http://dx.doi.org/10.1371/journal.pone.0183327			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837642	Green Published, Green Submitted, gold			2022-12-26	WOS:000408365000060
J	Purcell, KM; Craig, JK; Nance, JM; Smith, MD; Bennear, LS				Purcell, Kevin M.; Craig, J. Kevin; Nance, James M.; Smith, Martin D.; Bennear, Lori S.			Fleet behavior is responsive to a large-scale environmental disturbance: Hypoxia effects on the spatial dynamics of the northern Gulf of Mexico shrimp fishery	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; SOUTHEASTERN UNITED-STATES; BROWN SHRIMP; FARFANTEPENAEUS-AZTECUS; MANAGEMENT IMPLICATIONS; ELECTRONIC LOGBOOK; CONTINENTAL-SHELF; MENHADEN FISHERY; DISSOLVED-OXYGEN; FISHING EFFORT	The northwestern Gulf of Mexico shelf experiences one of the largest seasonal hypoxic zones in the western hemisphere. Hypoxia (dissolved oxygen, DO <= 2.0 mg.L-1) is most severe from May to August during the height of the Gulf shrimp fishery, but its effects on the fishery are not well known. Prior studies indicate that hypoxia alters the spatial dynamics of shrimp and other species through habitat loss and aggregation in nearby oxygenated refuge habitats. We hypothesized that hypoxia-induced changes in the distribution of shrimp also alter the spatial dynamics of the Gulf shrimp fleet. We integrated data on the geographic distribution of shrimp tows and bottom DO to evaluate the effects of hypoxia on spatial patterns in shrimping effort. Our analyses indicate that shrimping effort declines in low DO waters on both the Texas and Louisiana shelf, but that considerable effort still occurs in low DO waters off Louisiana, likely because riverine nutrients fuel both benthic production and low bottom DO in the same general regions. The response of the shrimp fleet to hypoxia on the Louisiana shelf was complex with shifts in effort inshore, offshore, westward, and eastward of the hypoxic zone, as well as to an oxygenated area between two hypoxia regimes associated with the Mississippi and the Atchafalaya River outflows. In contrast, effort on the Texas shelf mostly shifted offshore in response to low DO but also shifted inshore in some years. Spatial patterns in total shrimping effort were driven primarily by the number of shrimp tows, consistent with aggregation of the fleet outside of hypoxic waters, though tow duration also declined in low DO waters. Overall, our results demonstrate that hypoxia alters the spatial dynamics of the Gulf shrimp fishery with potential consequences for harvest interactions and the economic condition of the fishery.	[Purcell, Kevin M.; Craig, J. Kevin] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort Lab, Beaufort, NC 28516 USA; [Nance, James M.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Galveston Lab, Galveston, TX USA; [Smith, Martin D.; Bennear, Lori S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Purcell, Kevin M.] Harrisburg Univ Sci & Technol, Harrisburg, PA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Duke University	Craig, JK (corresponding author), Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort Lab, Beaufort, NC 28516 USA.	kevin.craig@noaa.gov		Craig, Joseph/0000-0002-0148-4989	National Oceanic and Atmospheric administration (NOM) Center [NA09NOS4780186]	National Oceanic and Atmospheric administration (NOM) Center	Financial support for this project was provided by the National Oceanic and Atmospheric administration (NOM) Center for Sponsored Coastal Ocean Research under award # NA09NOS4780186. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed herein are those of the authors and do not necessarily reflect the view of NOAA or any of its sub-agencies.	[Anonymous], 2009, CONT SHELF RES, V29, P1464; ArreguinSanchez F, 1996, REV FISH BIOL FISHER, V6, P221; Bacheler NM, 2010, FISH OCEANOGR, V19, P107, DOI 10.1111/j.1365-2419.2009.00531.x; Bartolino V, 2012, MAR ECOL PROG SER, V444, P251, DOI 10.3354/meps09434; Bianchi TS, 2010, SCI TOTAL ENVIRON, V408, P1471, DOI 10.1016/j.scitotenv.2009.11.047; Branch TA, 2006, CAN J FISH AQUAT SCI, V63, P1647, DOI 10.1139/F06-072; Chesney EJ, 2000, ECOL APPL, V10, P350; Ciannelli L, 2012, P ROY SOC B-BIOL SCI, V279, P3635, DOI 10.1098/rspb.2012.0849; Condrey R, 2005, CLIMATE CHANGE FISHE, P89; Craig JK, 2010, FISH OCEANOGR, V19, P301, DOI 10.1111/j.1365-2419.2010.00545.x; Craig JK, 2013, ESTUAR COAST, V36, P268, DOI 10.1007/s12237-012-9577-9; Craig JK, 2012, MAR ECOL PROG SER, V445, P75, DOI 10.3354/meps09437; Craig JK, 2005, CAN J FISH AQUAT SCI, V62, P1295, DOI 10.1139/F05-036; Craig JK, 2005, MAR ECOL PROG SER, V294, P79, DOI 10.3354/meps294079; Davies TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114037; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DiMarco SF, 2012, AQUAT GEOCHEM, V18, P159, DOI 10.1007/s10498-011-9156-x; DiMarco SF, 2010, J MARINE SYST, V80, P25, DOI 10.1016/j.jmarsys.2009.08.005; Drexler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064458; Eales James, 1986, MAR RESOUR ECON, V2, P331, DOI [10.1086/mre.2.4.42628909, DOI 10.1086/MRE.2.4.42628909]; ELDRIDGE PJ, 1988, MAR FISH REV, V50, P29; Froehlich HE, 2014, ESTUAR COAST, V37, P449, DOI 10.1007/s12237-013-9676-2; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Gallaway BJ, 2003, N AM J FISH MANAGE, V23, P787, DOI 10.1577/M02-105; Gallaway BJ, 2003, N AM J FISH MANAGE, V23, P581, DOI 10.1577/1548-8675(2003)023<0581:DOASEL>2.0.CO;2; Gezelius SS, 2007, HUM ECOL, V35, P587, DOI 10.1007/s10745-006-9096-z; Gillis DM, 2006, CAN J FISH AQUAT SCI, V63, P254, DOI 10.1139/F05-211; Gillis DM, 2001, ICES J MAR SCI, V58, P61, DOI 10.1006/jmsc.2000.0990; Greene RM, 2009, ECOL APPL, V19, P1161, DOI 10.1890/08-0035.1; Gruss A, 2014, FISH RES, V159, P11, DOI 10.1016/j.fishres.2014.05.005; Gunter G., 1963, J MISS ACAD SCI, V9, P286; HARPER DE, 1991, GEOL SOC SPEC PUBL, P49, DOI 10.1144/GSL.SP.1991.058.01.04; HASTIE T, 1993, J ROY STAT SOC B MET, V55, P757; Haynie AC, 2010, J ENVIRON ECON MANAG, V59, P165, DOI 10.1016/j.jeem.2009.11.001; Hazen EL, 2009, MAR ECOL PROG SER, V375, P195, DOI 10.3354/meps07791; Hetland RD, 2008, J MARINE SYST, V70, P49, DOI 10.1016/j.jmarsys.2007.03.002; Holland DS, 2000, LAND ECON, V76, P133, DOI 10.2307/3147262; Huang L, 2014, AM ECON REV, V104, P4071, DOI 10.1257/aer.104.12.4071; Huang L, 2012, MAR RESOUR ECON, V27, P3, DOI 10.5950/0738-1360-27.1.3; Huang L, 2010, MAR COAST FISH, V2, P232, DOI 10.1577/C09-048.1; Iverson K, 2009, J MAR ED, V25; Langseth BJ, 2016, FISH RES, V181, P186, DOI 10.1016/j.fishres.2016.04.013; Langseth BJ, 2014, MAR COAST FISH, V6, P223, DOI 10.1080/19425120.2014.949017; Ludsin SA, 2009, J EXP MAR BIOL ECOL, V381, pS121, DOI 10.1016/j.jembe.2009.07.016; Michael PE, 2015, FISH OCEANOGR, V24, P478, DOI 10.1111/fog.12123; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Nance James M., 1994, North American Journal of Fisheries Management, V14, P522, DOI 10.1577/1548-8675(1994)014<0522:FOITER>2.3.CO;2; Nance JM, 1993, NMFSSEFSC337; Obenour DR, 1985, ENV SCI TECHNOL, V47; PATELLA F, 1975, MAR FISH REV, V37, P22; Poos JJ, 2010, ICES J MAR SCI, V67, P155, DOI 10.1093/icesjms/fsp219; Prince ED, 2010, FISH OCEANOGR, V19, P448, DOI 10.1111/j.1365-2419.2010.00556.x; Rabalais NN, 2007, ECOL APPL, V17, pS129, DOI 10.1890/06-0644.1; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Rabalais NN, 2002, BIOSCIENCE, V52, P129, DOI 10.1641/0006-3568(2002)052[0129:BSIPGO]2.0.CO;2; Rester J. K., 2011, SEAMAP ENV BIOL ATLA; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Smith MD, 2014, MAR RESOUR ECON, V29, P111, DOI 10.1086/676826; Smith MD, 2010, B MAR SCI, V86, P461; Smith MD, 2006, CAN J FISH AQUAT SCI, V63, P153, DOI 10.1139/F05-205; Smith MD, 2005, J ENVIRON ECON MANAG, V50, P319, DOI 10.1016/j.jeem.2005.04.001; Smith MD, 2017, P NATL ACAD SCI; Soykan CU, 2014, ECOL APPL, V24, P71, DOI 10.1890/12-0826.1; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Sun J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159626; Switzer TS, 2009, J EXP MAR BIOL ECOL, V381, pS51, DOI 10.1016/j.jembe.2009.07.011; Sys K, 2016, ICES J MAR SCI, V73, P1485, DOI 10.1093/icesjms/fsw008; Thronson A, 2008, ESTUAR COAST, V31, P802, DOI 10.1007/s12237-008-9056-5; Turner RE, 2008, ENVIRON SCI TECHNOL, V42, P2323, DOI 10.1021/es071617k; Tyler RM, 2007, MAR ECOL PROG SER, V333, P257, DOI 10.3354/meps333257; van Putten IE, 2012, FISH FISH, V13, P216, DOI 10.1111/j.1467-2979.2011.00430.x; Wang XLL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053381; Wannamaker CM, 2000, J EXP MAR BIOL ECOL, V249, P145, DOI 10.1016/S0022-0981(00)00160-X; Wilen JE, 2002, B MAR SCI, V70, P553; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Zhang HY, 2009, J EXP MAR BIOL ECOL, V381, pS80, DOI 10.1016/j.jembe.2009.07.014; Zimmerman RJ, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P293	78	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183032	10.1371/journal.pone.0183032	http://dx.doi.org/10.1371/journal.pone.0183032			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837674	Green Published, gold			2022-12-26	WOS:000408365000043
J	Rosager, AM; Sorensen, MD; Dahlrot, RH; Hansen, S; Schonberg, DL; Rich, JN; Lathia, JD; Kristensen, BW				Rosager, Ann Mari; Sorensen, Mia D.; Dahlrot, Rikke H.; Hansen, Steinbjorn; Schonberg, David L.; Rich, Jeremy N.; Lathia, Justin D.; Kristensen, Bjarne W.			Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value	PLOS ONE			English	Article							IRON-METABOLISM; ADJUVANT TEMOZOLOMIDE; BREAST-CANCER; GLIOBLASTOMA; GLIOMA; MARKER; CELLS; RADIOTHERAPY; HOMEOSTASIS; CONCOMITANT	Astrocytic brain tumors are the most frequent primary brain tumors. Treatment with radio- and chemotherapy has increased survival making prognostic biomarkers increasingly important. The aim of the present study was to investigate the expression and prognostic value of transferrin receptor-1 (TfR1) as well as ferritin heavy (FTH) and light (FTL) chain in astrocytic brain tumors. A cohort of 111 astrocytic brain tumors (grade II-IV) was stained immunohistochemically with antibodies against TfR1, FTH, and FTL and scored semi-quantitatively. Double-immunofluorescence stainings were established to determine the phenotype of cells expressing these markers. We found that TfR1, FTH, and FTL were expressed by tumor cells in all grades. TfR1 increased with grade (p<0.001), but was not associated with prognosis in the individual grades. FTH and FTL were expressed by tumor cells and cells with microglial/macrophage morphology. Neither FTH nor FTL increased with malignancy grade, but low FTH expression by both tumor cells (p = 0.03) and microglia/macrophages (p = 0.01) correlated with shorter survival in patients anaplastic astrocytoma. FTL-positive microglia/macrophages were frequent in glioblastomas, and high FTL levels correlated with shorter survival in the whole cohort (p = 0.01) and in patients with anaplastic astrocytoma (p = 0.02). Double-immunofluorescence showed that TfR1, FTH, and FTL were co-expressed to a limited extent with the stem cell-related marker CD133. FTH and FTL were also co-expressed by IBA-1-positive microglia/macrophages. In conclusion, TfR1 was highly expressed in glioblastomas and associated with shorter survival in the whole cohort, but not in the individual malignancy grades. Low levels of FTH-positive tumor cells and microglia/macrophages were associated with poor survival in anaplastic astrocytomas, while high amounts of FTL-positive microglia/macrophages had a negative prognostic value. The results suggest that regulation of the iron metabolism in astrocytic brain tumors is complex involving both autocrine and paracrine signaling.	[Rosager, Ann Mari; Sorensen, Mia D.; Kristensen, Bjarne W.] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Rosager, Ann Mari; Sorensen, Mia D.; Hansen, Steinbjorn; Kristensen, Bjarne W.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Dahlrot, Rikke H.; Hansen, Steinbjorn] Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Schonberg, David L.; Rich, Jeremy N.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Lathia, Justin D.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sorensen, MD (corresponding author), Odense Univ Hosp, Dept Pathol, Odense, Denmark.; Sorensen, MD (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	mia.soerensen@rsyd.dk	Kristensen, Bjarne Winther/AAX-5491-2020; Lathia, Justin/AHB-8296-2022; Rich, Jeremy/AAM-1445-2021; Kristensen, Bjarne Winther/A-6690-2012	Kristensen, Bjarne Winther/0000-0002-6352-0826; Kristensen, Bjarne Winther/0000-0002-6352-0826; Rosager, Ann Mari/0000-0003-2353-7612; Hansen, Steinbjorn/0000-0001-5651-6493; Dahlrot, Rikke/0000-0003-1538-4361	Odense University Hospital Research Funds; University of Southern Denmark; Agnete Lovgren's legat; Familien Hede Nielsen's Foundation; Meta and Hakon Bagger's Foundation; Else and Mogens Wendell-Wedellsborg Foundation	Odense University Hospital Research Funds; University of Southern Denmark; Agnete Lovgren's legat; Familien Hede Nielsen's Foundation; Meta and Hakon Bagger's Foundation; Else and Mogens Wendell-Wedellsborg Foundation	This work was supported by the Odense University Hospital Research Funds, University of Southern Denmark, Agnete Lovgren's legat, Familien Hede Nielsen's Foundation, Meta and Hakon Bagger's Foundation, and Else and Mogens Wendell-Wedellsborg Foundation.	Arai H, 2012, BRAIN TUMOR PATHOL, V29, P160, DOI 10.1007/s10014-012-0081-5; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bradshaw A, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00021; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen K, 2008, J NEURO-ONCOL, V90, P157, DOI 10.1007/s11060-008-9648-8; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; Connor JR, 2001, PEDIATR NEUROL, V25, P118, DOI 10.1016/S0887-8994(01)00303-4; CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Dahlrot RH, 2014, INT J CLIN EXP PATHO, V7, P3739; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Debinski W, 2008, DRUG DEVELOP RES, V69, P407, DOI 10.1002/ddr.20272; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Gautam P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046153; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Huang JY, 2013, FASEB J, V27, P2845, DOI 10.1096/fj.12-216929; KANEKO Y, 1989, ACTA NEUROPATHOL, V79, P129, DOI 10.1007/BF00294369; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Kim JS, 2011, J VET SCI, V12, P1, DOI 10.4142/jvs.2011.12.1.1; Kolenda J, 2011, J NEURO-ONCOL, V103, P43, DOI 10.1007/s11060-010-0357-8; KONDO K, 1990, CHEST, V97, P1367, DOI 10.1378/chest.97.6.1367; Laske DW, 1997, NAT MED, V3, P1362, DOI 10.1038/nm1297-1362; Lathia JD, 2014, CELL REP, V6, P117, DOI 10.1016/j.celrep.2013.11.043; Lathia JD, 2012, ANN NEUROL, V72, P766, DOI 10.1002/ana.23674; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Liu NQ, 2014, MOL CELL PROTEOMICS, V13, P1814, DOI 10.1074/mcp.M113.037176; PANACCIO M, 1987, IMMUNOL CELL BIOL, V65, P461, DOI 10.1038/icb.1987.55; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Prutki M, 2006, CANCER LETT, V238, P188, DOI 10.1016/j.canlet.2005.07.001; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Schonberg D. L., 2013, MOL ASPECTS MED; Schonberg DL, 2015, CANCER CELL, V28, P441, DOI 10.1016/j.ccell.2015.09.002; SHINDELMAN JE, 1981, INT J CANCER, V27, P329, DOI 10.1002/ijc.2910270311; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; The WHO, 2020, CLASSIFICATION TUMOU; Torti Suzy V., 2013, Critical Reviews in Oncogenesis, V18, P435; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Tortorella S, 2014, J MEMBRANE BIOL, V247, P291, DOI 10.1007/s00232-014-9637-0; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weaver M, 2003, J NEURO-ONCOL, V65, P3, DOI 10.1023/A:1026246500788; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149361; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Zhang X, 2006, GLIA, V54, P795, DOI 10.1002/glia.20416	49	32	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182954	10.1371/journal.pone.0182954	http://dx.doi.org/10.1371/journal.pone.0182954			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837569	gold, Green Submitted, Green Published			2022-12-26	WOS:000408365000036
J	Jung, KB; Lee, H; Son, YS; Lee, JH; Cho, HS; Lee, MO; Oh, JH; Lee, J; Kim, S; Jung, CR; Kim, J; Son, MY				Jung, Kwang Bo; Lee, Hana; Son, Ye Seul; Lee, Ji Hye; Cho, Hyun-Soo; Lee, Mi-Ok; Oh, Jung-Hwa; Lee, Jaemin; Kim, Seokho; Jung, Cho-Rok; Kim, Janghwan; Son, Mi-Young			In vitro and in vivo imaging and tracking of intestinal organoids from human induced pluripotent stem cells	FASEB JOURNAL			English	Article						KLF5; ISX; fluorescence imaging; reporter system; human intestine	GENE-EXPRESSION; TISSUE; DIFFERENTIATION; MODEL; TRANSPLANTATION; DISEASE; CARDIOMYOCYTES; EPITHELIUM; GUT	Human intestinal organoids (hIOs) derived from human pluripotent stem cells (hPSCs) have immense potential as a source of intestines. Therefore, an efficient system is needed for visualizing the stage of intestinal differentiation and further identifying hIOs derived from hPSCs. Here, 2 fluorescent biosensors were developed based on human induced pluripotent stem cell (hiPSC) lines that stably expressed fluorescent reporters driven by intestine-specific gene promoters Kruppel-like factor 5 monomeric Cherry (KLF5(mCherry)) and intestine-specific homeobox enhanced green fluorescence protein (ISXeGFP). Then hIOs were efficiently induced from those transgenic hiPSC lines in which mCherry- or eGFP-expressing cells, which appeared during differentiation, could be identified in intact living cells in real time. Reporter gene expression had no adverse effects on differentiation into hIOs and proliferation. Using our reporter system to screen for hIO differentiation factors, we identified DMH1 as an efficient substitute for Noggin. Transplanted hIOs under the kidney capsule were tracked with fluorescence imaging(FLI) and confirmed histologically. After orthotopic transplantation, the localization of the hIOs in the small intestine could be accurately visualized using FLI. Our study establishes a selective system for monitoring the in vitro differentiation and for tracking the in vivo localization of hIOs and contributes to further improvement of cell-based therapies and preclinical screenings in the intestinal field.	[Jung, Kwang Bo; Lee, Hana; Son, Ye Seul; Lee, Ji Hye; Cho, Hyun-Soo; Jung, Cho-Rok; Kim, Janghwan; Son, Mi-Young] KRIBB, Stem Cell Res Ctr, Daejeon 34141, South Korea; [Lee, Mi-Ok] KRIBB, Immunotherapy Covergence Res Ctr, Daejeon, South Korea; [Lee, Jaemin; Kim, Seokho] KRIBB, Aging Res Inst, Daejeon, South Korea; [Jung, Kwang Bo; Lee, Hana; Son, Ye Seul; Cho, Hyun-Soo; Kim, Seokho; Jung, Cho-Rok; Kim, Janghwan; Son, Mi-Young] Korea Univ Sci & Technol, KRIBB Sch Biosci, Dept Funct Genom, Daejeon, South Korea; [Oh, Jung-Hwa] Korea Inst Toxicol, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Institute of Toxicology	Kim, J; Son, MY (corresponding author), KRIBB, Stem Cell Res Ctr, Daejeon 34141, South Korea.	janghwan.kim@kribb.re.kr; myson@kribb.re.kr		, cho-rok/0000-0002-4474-6563	National Research Foundation of Korea - Ministry of Science, Information and Communications Technologies (ICT), and Future Planning [2016R1A2B4013501]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	National Research Foundation of Korea - Ministry of Science, Information and Communications Technologies (ICT), and Future Planning; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This work was supported by the National Research Foundation of Korea, funded by the Ministry of Science, Information and Communications Technologies (ICT), and Future Planning (Grant 2016R1A2B4013501), and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Aurora M, 2016, DEV BIOL, V420, P230, DOI 10.1016/j.ydbio.2016.06.006; Bitar KN, 2012, NEUROGASTROENT MOTIL, V24, P7, DOI 10.1111/j.1365-2982.2011.01843.x; Bitar KN, 2014, GASTROENTEROLOGY, V146, P1614, DOI 10.1053/j.gastro.2014.03.044; Brugmann SA, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt362; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chinen J, 2010, J ALLERGY CLIN IMMUN, V125, pS324, DOI 10.1016/j.jaci.2009.11.014; Choi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086358; Den Hartogh SC, 2015, STEM CELLS, V33, P56, DOI 10.1002/stem.1842; Desai CS, 2012, INDIAN J GASTROENTER, V31, P217, DOI 10.1007/s12664-012-0243-8; Finkbeiner SR, 2015, STEM CELL REP, V4, P1140, DOI 10.1016/j.stemcr.2015.04.010; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Forster R, 2014, STEM CELL REP, V2, P838, DOI 10.1016/j.stemcr.2014.05.001; Howell JC, 2011, REGEN MED, V6, P743, DOI [10.2217/RME.11.90, 10.2217/rme.11.90]; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Jung KB, 2017, MOL BIOSYST, V13, P1565, DOI 10.1039/c7mb00174f; Kim DS, 2017, HEPATOLOGY, V66, P1662, DOI 10.1002/hep.29324; Kwak JE, 2015, BIOCHEM BIOPH RES CO, V457, P554, DOI 10.1016/j.bbrc.2015.01.023; Lavon N, 2004, DIFFERENTIATION, V72, P230, DOI 10.1111/j.1432-0436.2004.07205002.x; Lavon N, 2006, STEM CELLS, V24, P1923, DOI 10.1634/stemcells.2005-0397; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Noisa P, 2010, STEM CELL REV REP, V6, P438, DOI 10.1007/s12015-010-9159-9; Richmond CA, 2010, PROG MOL BIOL TRANSL, V96, P207, DOI 10.1016/S1877-1173(10)96009-2; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Sinagoga KL, 2015, EMBO J, V34, P1149, DOI 10.15252/embj.201490686; Son MY, 2017, NEUROPATH APPL NEURO, V43, P584, DOI 10.1111/nan.12396; Son MY, 2017, STEM CELLS DEV, V26, P133, DOI 10.1089/scd.2016.0181; Son MY, 2015, J PATHOL, V237, P98, DOI 10.1002/path.4551; Son MY, 2015, PROTEOMICS, V15, P2220, DOI 10.1002/pmic.201400510; Son MY, 2014, HUM MOL GENET, V23, P1802, DOI 10.1093/hmg/ddt571; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Wells JM, 2014, DEVELOPMENT, V141, P752, DOI 10.1242/dev.097386; Widjaja-Adhi MAK, 2015, HUM MOL GENET, V24, P3206, DOI 10.1093/hmg/ddv072; Woo DH, 2016, CELL STEM CELL, V19, P397, DOI 10.1016/j.stem.2016.05.024; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zietek T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16831	38	28	28	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					111	122		10.1096/fj.201700504R	http://dx.doi.org/10.1096/fj.201700504R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855280				2022-12-26	WOS:000419172700012
J	Caorsi, VZ; Both, C; Cechin, S; Antunes, R; Borges-Martins, M				Caorsi, Valentina Zaffaroni; Both, Camila; Cechin, Sonia; Antunes, Rogger; Borges-Martins, Marcio			Effects of traffic noise on the calling behavior of two Neotropical hylid frogs	PLOS ONE			English	Article							ANTHROPOGENIC NOISE; GREAT TITS; COMMUNICATION; ANURAN; SOUNDS; VOCALIZATION; ASSEMBLAGE; MASKING; BIRDS; SONG	Anthropogenic disturbance has been pointed to as one of the major causes of the world's biodiversity crisis. Among them, noise pollution is a potential underestimated threat, projected to increase in the next decades accompanying urban expansion. Rising levels of noise pollution may result in negative impacts on species highly dependent on acoustic communication. Amphibians have long served as model organisms for investigating animal acoustic communication because their reproduction depends on transmitting and receiving acoustic signals. A few studies have investigated the effects of anthropogenic noise on anurans, but there is still limited knowledge on how it affects them. In this study, we test the effect of two intensities of traffic noise on calling males of two Neotropical treefrogs species. We expect to record more changes in call parameters, to avoid masking effect, at higher intensity noise treatments, and in the species with higher call/noise frequency overlap. We performed a set of field playback experiments exposing male frogs to road noise at two different intensities (65dB and 75dB). Focal species are Boana bischoffi (high call/noise frequency overlap) and B. leptolineata (low call/noise frequency overlap). Both species changed acoustic parameters during or after the exposure to traffic noise. Advertisement call rate of B. bischoffi decreased during road noise, and dominant frequency decreased over time. Call length of B. leptolineata increased or decreased, depending on the order of noise intensity. We also observed spatial displacement in both species, which moved away from the noise source. Our results provide evidence that traffic noise affects anuran calling behavior, and noise intensity is an important factor affecting how species respond.	[Caorsi, Valentina Zaffaroni; Antunes, Rogger; Borges-Martins, Marcio] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Zool, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil; [Both, Camila; Cechin, Sonia] Univ Fed Santa Maria, Programa Posgrad Biodiversidade Anim, Santa Maria, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Santa Maria (UFSM)	Caorsi, VZ (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Zool, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil.	valenzc@gmail.com	Borges-Martins, Marcio/I-3274-2012; Caorsi, Valentina Zaffaroni/AAD-1093-2019; Cechin, Sonia T. Z./D-6259-2013	Borges-Martins, Marcio/0000-0001-9328-5794; Both, Camila/0000-0002-4590-7242; Zaffaroni-Caorsi, Valentina/0000-0003-4166-9600	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [3471301]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 401076/2014-8, 312968/2013-2]; Universidade Federal do Rio Grande do Sul Postgraduate program in Animal Biology; Explorers Club	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do Rio Grande do Sul Postgraduate program in Animal Biology; Explorers Club	This work was supported by research fellowships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br / CAPES No.3471301), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br / CNPq 401076/2014-8; 312968/2013-2), and finally the Universidade Federal do Rio Grande do Sul Postgraduate program in Animal Biology (www.ufrgs.br/ppgban) and The Explorers Club (explorers.org / New York, USA) for financial support of the equipment and field activities.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2021, LANG ENV STAT COMP; Barrass A., 1985, THESIS; Bee MA, 2007, ANIM BEHAV, V74, P1765, DOI 10.1016/j.anbehav.2007.03.019; Bioacoustics Research Program, 2011, RAV PRO INT SOUND AN; Bradbury Jack W., 1998, pi; Brumm H, 2010, ENCY ANIMAL BEHAV, P89, DOI DOI 10.1016/B978-0-08-045337-8.00289-8; Brumm H., 2013, ANIMAL COMMUNICATION, P187, DOI 10.1007/978-3-642-41494-7; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Cunnington GM, 2010, ACTA OECOL, V36, P463, DOI 10.1016/j.actao.2010.06.002; Engbrecht NJ, 2015, COPEIA, V103, P1048, DOI 10.1643/CH-14-148; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; FORREST TG, 1994, AM ZOOL, V34, P644; Francis CD, 2013, FRONT ECOL ENVIRON, V11, P305, DOI 10.1890/120183; Gerhardt H. Carl, 2001, P73; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gil D, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P1; Goutte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078020; Halfwerk W, 2016, BEHAV ECOL, V27, P669, DOI 10.1093/beheco/arv204; Hamer AJ, 2011, ECOL APPL, V21, P378, DOI 10.1890/10-0390.1; Herrera-Montes MI, 2011, URBAN ECOSYST, V14, P415, DOI 10.1007/s11252-011-0158-7; Horn AG, 2013, ANIMAL COMMUNICATION THEORY: INFORMATION AND INFLUENCE, P43; Hoskin CJ, 2010, ECOL SOC, V15, DOI 10.5751/es-03272-150315; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Kaiser K, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cou061; Kaiser K, 2011, BEHAVIOUR, V148, P215, DOI 10.1163/000579510X551660; Kaiser K, 2009, BEHAVIOUR, V146, P1053, DOI 10.1163/156853909X404457; Kruger DJD, 2016, ECOL RES, V31, P393, DOI 10.1007/s11284-016-1349-8; Kwet A, 2001, FROSCHE BRASILIANISC; Lengagne T, 2008, BIOL CONSERV, V141, P2023, DOI 10.1016/j.biocon.2008.05.017; Lukanov S, 2014, NORTH-WEST J ZOOL, V10, P359; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; McCauley RD, 2003, J ACOUST SOC AM, V113, P638, DOI 10.1121/1.1527962; MCGREGOR PK, 1992, ANIM BEHAV, V43, P987, DOI 10.1016/0003-3472(92)90012-X; Medeiros CI, 2016, BIOL INVASIONS, V19, P1; NARINS PM, 1990, BIOSCIENCE, V40, P268, DOI 10.2307/1311263; NARINS PM, 1995, SCI AM, V273, P78, DOI 10.1038/scientificamerican0895-78; Oksanen J., 2013, PACKAGE VEGAN, V2, P1; PARRIS KM, 2009, ECOL SOC, V14; Pellet J, 2004, CONSERV BIOL, V18, P1599, DOI 10.1111/j.1523-1739.2004.0421a.x; Pombal Jose P. Jr., 2010, Arquivos do Museu Nacional Rio de Janeiro, V68, P135; Popper AN, 2003, FISHERIES, V28, P24, DOI 10.1577/1548-8446(2003)28[24:EOASOF]2.0.CO;2; Richardson W.J., 2013, MARINE MAMMALS NOISE; Roca IT, 2016, BEHAV ECOL, V27, P1269, DOI 10.1093/beheco/arw060; RYAN MJ, 1988, AM ZOOL, V28, P885; Samarra FIP, 2009, BEHAVIOUR, V146, P1635, DOI 10.1163/156853909X463713; Shannon G, 2016, BIOL REV, V91, P982, DOI 10.1111/brv.12207; Shen J-X, 2016, LOMBARD EFFECT MALE; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Stuart S. N., 2008, THREATENED AMPHIBIAN; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Sun JWC, 2005, BIOL CONSERV, V121, P419, DOI 10.1016/j.biocon.2004.05.017; Tressler J, 2009, J COMP PHYSIOL A, V195, P923, DOI 10.1007/s00359-009-0468-x; Troianowski M, 2017, CONSERV BIOL; Tyack P, 2003, MAR TECHNOL SOC J, V37, P41, DOI 10.4031/002533203787537087; Vargas-Salinas F, 2014, URBAN ECOSYST, V17, P945, DOI 10.1007/s11252-014-0374-z; Velez A., 2013, ANIMAL COMMUNICATION, P133, DOI 10.1007/978-3-642-41494-7_6; Wells KD., 2008, ECOLOGY BEHAV AMPHIB	58	22	25	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0183342	10.1371/journal.pone.0183342	http://dx.doi.org/10.1371/journal.pone.0183342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	28854253	gold, Green Published, Green Submitted			2022-12-26	WOS:000408693600039
J	Bailey, MA; Na, HN; Duthie, MS; Gillis, TP; Lahiri, R; Parish, T				Bailey, Mai Ann; Na, Hana; Duthie, Malcolm S.; Gillis, Thomas P.; Lahiri, Ramanuj; Parish, Tanya			Nitazoxanide is active against Mycobacterium leprae	PLOS ONE			English	Article							LEPROSY PATIENTS; CLINICAL-TRIAL; MULTIDRUG THERAPY; DRUG-RESISTANCE; MULTIBACILLARY LEPROSY; LEPROMATOUS LEPROSY; MOLECULAR-DETECTION; RELAPSE RATE; MINOCYCLINE; OFLOXACIN	Nitazoxanide (NTZ) is an anti-parasitic drug that also has activity against bacteria, including Mycobacterium tuberculosis. Our data using both radiorespirometry and live-dead staining in vitro demonstrate that NTZ similarly has bactericidal against M. leprae. Further, gavage of M. leprae-infected mice with NTZ at 25mg/kg provided anti-mycobacterial activity equivalent to rifampicin (RIF) at 10 mg/kg. This suggests that NTZ could be considered for leprosy treatment.	[Bailey, Mai Ann; Duthie, Malcolm S.; Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA; [Na, Hana; Gillis, Thomas P.; Lahiri, Ramanuj] Healthcare Syst Bur, Dept Hlth & Human Serv, Hlth Resources & Serv Adm, Natl Hansens Dis Program, Baton Rouge, LA USA; [Bailey, Mai Ann] Amgen Inc, San Francisco, CA USA	United States Health Resources & Service Administration (HRSA); Amgen	Parish, T (corresponding author), Infect Dis Res Inst, Seattle, WA USA.	tanya.parish@idri.org	; Parish, Tanya/A-8912-2014	Lahiri, Ramanuj/0000-0001-5922-8307; Duthie, Malcolm/0000-0002-8515-5516; Parish, Tanya/0000-0001-7507-0423	New York Community Trust Heiser Foundation	New York Community Trust Heiser Foundation	This work was funded by a grant from New York Community Trust Heiser Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2007, BRIT J CLIN PHARMACO, V63, P387, DOI 10.1111/j.1365-2125.2007.02873.x; Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; Burgos J, 2011, LEPROSY REV, V82, P253; Cambau E, 2002, CLIN INFECT DIS, V34, P39, DOI 10.1086/324623; Cellona RV, 2003, INT J LEPROSY, V71, P308, DOI 10.1489/1544-581X(2003)071&lt;0308:LEOYWM&gt;2.0.CO;2; CHAN GP, 1994, ANTIMICROB AGENTS CH, V38, P515, DOI 10.1128/AAC.38.3.515; Consigny S, 2000, ANTIMICROB AGENTS CH, V44, P2919, DOI 10.1128/AAC.44.10.2919-2921.2000; Costa MB, 2001, INT J LEPROSY, V69, P177; Silva BJD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006103; de Carvalho LPS, 2009, J MED CHEM, V52, P5789, DOI 10.1021/jm9010719; de Caryalho LPS, 2011, ACS MED CHEM LETT, V2, P849, DOI 10.1021/ml200157f; Di Santo N, 2014, MUTAT RES-FUND MOL M, V768, P16, DOI 10.1016/j.mrfmmm.2014.05.005; FAJARDO TT, 1995, INT J LEPROSY, V63, P8; FRANZBLAU SG, 1987, ANTIMICROB AGENTS CH, V31, P780, DOI 10.1128/AAC.31.5.780; GELBER RH, 1992, BRIT MED J, V304, P91, DOI 10.1136/bmj.304.6819.91; Gelber RH, 2004, INT J LEPROSY, V72, P493, DOI 10.1489/1544-581X(2004)72&lt;493:TRRIML&gt;2.0.CO;2; GELBER RH, 1994, EUR J CLIN MICROBIOL, V13, P942, DOI 10.1007/BF02111496; GELBER RH, 1994, INT J LEPROSY, V62, P568; GELBER RH, 1995, INT J LEPROSY, V63, P259; Girdhar BK, 2000, LEPROSY REV, V71, P144; GROSSET JH, 1990, INT J LEPROSY, V58, P281; GROSSET JH, 1989, INT J LEPROSY, V57, P607; Hoffman PS, 2007, ANTIMICROB AGENTS CH, V51, P868, DOI 10.1128/AAC.01159-06; Honrado ER, 2008, DERMATOL CLIN, V26, P221, DOI 10.1016/j.det.2007.11.007; Ji B, 1991, Acta Leprol, V7, P321; Ji B, 2000, LEPROSY REV, V71, pS81; Ji BH, 2006, ANTIMICROB AGENTS CH, V50, P1921, DOI [10.1128/AAC.00052-06, 10.1128/AAC.50.4.1558-1560.2006]; JI BH, 1994, ANTIMICROB AGENTS CH, V38, P662, DOI 10.1128/AAC.38.4.662; Ji BH, 1997, ANTIMICROB AGENTS CH, V41, P1953, DOI 10.1128/AAC.41.9.1953; Ji BH, 1996, ANTIMICROB AGENTS CH, V40, P2137, DOI 10.1128/AAC.40.9.2137; Lahiri R, 2005, J MED MICROBIOL, V54, P235, DOI 10.1099/jmm.0.45700-0; Lam KKY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002691; Ma YL, 2017, DNA CELL BIOL, V36, P1, DOI 10.1089/dna.2016.3446; Maeda S, 2001, ANTIMICROB AGENTS CH, V45, P3635, DOI 10.1128/AAC.45.12.3635-3639.2001; Malathi Munisamy, 2013, Indian J Dermatol, V58, P93, DOI 10.4103/0019-5154.108029; Manjunatha UH, 2006, ANTIMICROB AGENTS CH, V50, P3350, DOI 10.1128/AAC.00488-06; Matsuoka M, 2003, INT J LEPROSY, V71, P240, DOI 10.1489/1544-581X(2003)71&lt;240:ASCOMM&gt;2.0.CO;2; Matsuoka M, 2000, INT J LEPROSY, V68, P452; Matsuoka M, 2007, LEPROSY REV, V78, P343; Norman G, 2004, INT J LEPROSY, V72, P1, DOI 10.1489/1544-581X(2004)072&lt;0001:RIMPTW&gt;2.0.CO;2; Ortiz JJ, 2001, ALIMENT PHARM THER, V15, P1409, DOI 10.1046/j.1365-2036.2001.01066.x; Raju MS, 2015, LEPROSY REV, V86, P6; Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014; Rossignol JFA, 2001, J INFECT DIS, V184, P103, DOI 10.1086/321008; SHEPARD CC, 1972, AM J TROP MED HYG, V21, P446, DOI 10.4269/ajtmh.1972.21.446; SHEPARD CC, 1974, AM J TROP MED HYG, V23, P1120, DOI 10.4269/ajtmh.1974.23.1120; Shigyo K, 2013, ANTIMICROB AGENTS CH, V57, P2834, DOI 10.1128/AAC.02542-12; Truman RW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000328; Truman RW, 2001, INT J LEPROSY, V69, P1; WHO, 2011, M SENT SURV DRUG RES; Williams DL, 2004, LEPROSY REV, V75, P118; You EY, 2005, J INFECTION, V50, P6, DOI 10.1016/j.jinf.2004.03.012	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0184107	10.1371/journal.pone.0184107	http://dx.doi.org/10.1371/journal.pone.0184107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850614	Green Submitted, Green Published, gold			2022-12-26	WOS:000408544200057
J	Huang, WY; Hsin, IL; Chen, DR; Chang, CC; Kor, CT; Chen, TY; Wu, HM				Huang, Wan-Yu; Hsin, I-Lun; Chen, Dar-Ren; Chang, Chia-Chu; Kor, Chew-Teng; Chen, Ting-Yu; Wu, Hung-Ming			Circulating interleukin-8 and tumor necrosis factor-alpha are associated with hot flashes in healthy postmenopausal women	PLOS ONE			English	Article							VASOMOTOR SYMPTOMS; GENE-EXPRESSION; NEUROKININ-B; MENOPAUSE; INFLAMMATION; INVOLVEMENT; SECRETION; SEROTONIN; ESTROGENS; NEURONS	Introduction Hot flashes have been postulated to be linked to systemic inflammation. This study aimed to investigate the relationship between hot flashes, pro-inflammatory factors, and leukocytes in healthy, non-obese postmenopausal women. Participants and design In this cross-sectional study, a total of 202 women aged 45-60 years were stratified into one of four groups according to their hot-flash status: never experienced hot flashes (Group N), mild hot flashes (Group m), moderate hot flashes (Group M), and severe hot flashes (Group S). Variables measured in this study included clinical parameters, hot flash experience, leukocytes, and fasting plasma levels of nine circulating cytokines/chemokines measured by using multiplex assays. Multiple linear regression analysis was used to evaluate the associations of hot flashes with these pro-inflammatory factors. Settings The study was performed in a hospital medical center. Results The mean values of leukocyte number were not different between these four groups. The hot flash status had a positive tendency toward increased levels of circulating IL-6 (P-trend = 0.049), IL-8 (P-trend < 0.001), TNF-alpha (P-trend = 0.008), and MIP1 beta (P-trend = 0.04). Multivariate linear regression analysis revealed that hot-flash severity was significantly associated with IL-8 (P-trend < 0.001) and TNF alpha (P-trend = 0.007) among these nine cytokines/chemokines after adjustment for age, menopausal duration, BMI and FSH.Multivariate analysis further revealed that severe hot flashes were strongly associated with a higher IL-8 (% difference, 37.19%; 95% confidence interval, 14.98,63.69; P < 0.001) and TNF alpha ( 51.27%; 6.64,114.57; P < 0.05). Conclusion The present study provides evidence that hot flashes are associated with circulating IL-8 and TNF-alpha in healthy postmenopausal women. It suggests that hot flashes might be related to low-grade systemic inflammation.	[Huang, Wan-Yu] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Hsin, I-Lun; Chen, Ting-Yu; Wu, Hung-Ming] Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan; [Chen, Dar-Ren] Changhua Christian Hosp, Comprehens Breast Canc Ctr, Changhua, Taiwan; [Chang, Chia-Chu] Changhua Christian Hosp, Dept Nephrol, Changhua, Taiwan; [Kor, Chew-Teng] Changhua Christian Hosp, Internal Med Res Ctr, Div Stat, Changhua, Taiwan; [Wu, Hung-Ming] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Wu, Hung-Ming] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan	National Cheng Kung University; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; China Medical University Taiwan	Wu, HM (corresponding author), Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan.; Wu, HM (corresponding author), Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan.; Wu, HM (corresponding author), China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan.	18288@cch.org.tw	Chen, Ting-Yu/AAD-8375-2021	Hsin, I-Lun/0000-0003-4711-3582	Ministry of Science and Technology, Taiwan [MOST 105-2314-6-371-004]; Changhua Christian Hospital Research Foundation, Changhua City, Taiwan [105-CCH-PRJ-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital Research Foundation, Changhua City, Taiwan	This study was funded by grant MOST 105-2314-6-371-004 from the Ministry of Science and Technology, Taiwan, and by grants 105-CCH-PRJ-006 from the Changhua Christian Hospital Research Foundation, Changhua City, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez A, 2002, CIRC RES, V91, P1142, DOI 10.1161/01.RES.0000046018.23605.3E; Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Avis NE, 2015, JAMA INTERN MED, V175, P531, DOI 10.1001/jamainternmed.2014.8063; Bechlioulis A, 2010, J CLIN ENDOCR METAB, V95, P1199, DOI 10.1210/jc.2009-2262; Berendsen HHG, 2000, MATURITAS, V36, P155, DOI 10.1016/S0378-5122(00)00151-1; Chakrabarti S, 2008, IUBMB LIFE, V60, P376, DOI 10.1002/iub.48; Chedraui P, 2011, GYNECOL ENDOCRINOL, V27, P685, DOI 10.3109/09513590.2010.521270; De Miguel C, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0507-z; Domingueti CP, 2016, J DIABETES COMPLICAT, V30, P738, DOI 10.1016/j.jdiacomp.2015.12.018; Figueroa-Vega N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120990; Freedman RR, 1999, AM J OBSTET GYNECOL, V181, P66, DOI 10.1016/S0002-9378(99)70437-0; FUJISHIMA S, 1993, J CELL PHYSIOL, V154, P478, DOI 10.1002/jcp.1041540305; Goncalves RB, 2011, INFLAMM RES, V60, P409, DOI 10.1007/s00011-011-0308-7; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Huang WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176430; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Karaoulanis SE, 2012, ANN GEN PSYCHIATR, V11, DOI 10.1186/1744-859X-11-9; Kobashi C, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-25; KRONENBERG F, 1987, CAN J PHYSIOL PHARM, V65, P1312, DOI 10.1139/y87-208; Lewis JE, 2005, MATURITAS, V50, P209, DOI 10.1016/j.maturitas.2004.06.015; Malutan A, 2013, ACTA ENDOCRINOL-BUCH, V9, P133, DOI 10.4183/aeb.2013.133; McLarnon JG, 2016, J ALZHEIMERS DIS PAR, V6, P5; Muka T, 2016, JAMA CARDIOL, V1, P767, DOI 10.1001/jamacardio.2016.2415; Noguchi M, 2008, ENDOCRINOLOGY, V149, P2899, DOI 10.1210/en.2007-1521; Ohayon MM, 2006, ARCH INTERN MED, V166, P1262, DOI 10.1001/archinte.166.12.1262; Orleans RJ, 2014, NEW ENGL J MED, V370, P1777, DOI 10.1056/NEJMp1402080; PACIFICI R, 1989, P NATL ACAD SCI USA, V86, P2398, DOI 10.1073/pnas.86.7.2398; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Prague JK, 2017, LANCET, V389, P1809, DOI 10.1016/S0140-6736(17)30823-1; Rance NE, 2013, FRONT NEUROENDOCRIN, V34, P211, DOI 10.1016/j.yfrne.2013.07.003; RANCE NE, 1991, ENDOCRINOLOGY, V128, P2239, DOI 10.1210/endo-128-5-2239; Salmi P, 1998, PHARMACOL TOXICOL, V82, P122, DOI 10.1111/j.1600-0773.1998.tb01410.x; SHEARD MH, 1967, NATURE, V216, P495, DOI 10.1038/216495a0; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Soules MR, 2001, J WOMEN HEALTH GEN-B, V10, P843, DOI 10.1089/152460901753285732; Stearns V, 2002, LANCET, V360, P1851, DOI 10.1016/S0140-6736(02)11774-0; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Szmuilowicz ED, 2011, MENOPAUSE, V18, P603, DOI 10.1097/gme.0b013e3182014849; Thurston RC, 2008, CIRCULATION, V118, P1234, DOI 10.1161/CIRCULATIONAHA.108.776823; Thurston RC, 2011, OBSTET GYN CLIN N AM, V38, P489, DOI 10.1016/j.ogc.2011.05.006; Thurston RC, 2012, J CLIN ENDOCR METAB, V97, P3487, DOI 10.1210/jc.2012-1410; Thurston RC, 2012, OBSTET GYNECOL, V119, P753, DOI 10.1097/AOG.0b013e31824a09ec; Thurston RC, 2011, MENOPAUSE, V18, P1044, DOI 10.1097/gme.0b013e31821f5d39; Thurston RC, 2011, MENOPAUSE, V18, P352, DOI 10.1097/gme.0b013e3181fa27fd; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Yasui T, 2006, J CLIN ENDOCR METAB, V91, P4805, DOI 10.1210/jc.2006-1100	48	17	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0184011	10.1371/journal.pone.0184011	http://dx.doi.org/10.1371/journal.pone.0184011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846735	Green Published, gold, Green Submitted			2022-12-26	WOS:000408438600065
J	Chiacchio, T; Delogu, G; Vanini, V; Cuzzi, G; De Maio, F; Pinnetti, C; Sampaolesi, A; Antinori, A; Goletti, D				Chiacchio, Teresa; Delogu, Giovanni; Vanini, Valentina; Cuzzi, Gilda; De Maio, Flavio; Pinnetti, Carmela; Sampaolesi, Alessandro; Antinori, Andrea; Goletti, Delia			Immune characterization of the HBHA-specific response in Mycobacterium tuberculosisinfected patients with or without HIV infection	PLOS ONE			English	Article							HEPARIN-BINDING HEMAGGLUTININ; T-CELL RESPONSES; EFFECTOR MEMORY PHENOTYPE; ACTIVE TUBERCULOSIS; PROTECTIVE IMMUNITY; INTERFERON-GAMMA; IFN-GAMMA; INDIVIDUALS; LYMPHOCYTES; ANTIGEN	RD1-based Interferon-. Release Assays (IGRAs) cannot distinguish latent from active tuberculosis (TB) disease. Conversely, a positive response to heparin-binding haemagglutinin (HBHA)-based IGRAs, among TB-infected subjects, correlates with Mycobacterium tuberculosis (Mtb) containment and low risk of TB progression. The aim of this study was to characterize HBHA-immune responses in HIV-infected and uninfected subjects with active TB or latent TB infection (LTBI). Methods 49 subjects were prospectively enrolled: 22 HIV-uninfected (13 TB, 9 LTBI) and 27 HIVinfected (12 HIV-TB, 15 HIV-LTBI). Whole blood and peripheral blood mononuclear cells were stimulated with HBHA and RD1 antigens. Interferon (IFN). release was evaluated by ELISA whereas cytokine profile [IFN gamma, tumor necrosis (TNF) alpha, interleukin (IL) 2] and phenotype (CD45RA, CCR7) by flow cytometry. Results Among LTBI individuals, HBHA stimulation induced IFN. release in all the HIV-uninfected, while, only 4/ 15 HIV-infected responded. Within the active TB, only 5/ 13 HIV-uninfected and 1/ 12 HIV-TB patients responded. Interestingly, by cytometry we showed that CD4 (+) T-cells response to HBHA was significantly impaired in the HIV-infected subjects with TB or LTBI compared to the HIV-uninfected subjects. The phenotype of HBHA-specific CD4 T-cells showed a predominantly central memory (CM) and effector memory (EM) phenotype without differences among the groups. Differently, HBHA-specific CD8 (+) T-cells, showed mainly a CM and naive phenotype in LTBI group while TB, HIV-LTBI and HIV-TB groups were characterized by EM or terminally differentiated phenotypes. Interestingly, differently than whatobserved for RD1, the cytokine profile of HBHA-specific T-cells evaluated by cytometry showed that the CD4 (+) T-cells were mostly monofunctional. Conversely, CD8-specific Tcells were mostly monofunctional for both HBHA and RD1 stimulations. Conclusions These results characterize the impact of HIV infection in CD4- and CD8-specific response to HBHA in both LTBI and TB patients. HIV infection impairs the CD4 response to HBHA and likely this may lead to an impairment of TB control.	[Chiacchio, Teresa; Vanini, Valentina; Cuzzi, Gilda; Goletti, Delia] L Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy; [Delogu, Giovanni; De Maio, Flavio] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Gemelli, Inst Microbiol, Rome, Italy; [Pinnetti, Carmela; Sampaolesi, Alessandro; Antinori, Andrea] L Spallanzani Natl Inst Infect Dis INMI, Dept Clin & Clin Res, IRCCS, Rome, Italy	IRCCS Lazzaro Spallanzani; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Lazzaro Spallanzani	Goletti, D (corresponding author), L Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy.	delia.goletti@inmi.it	De Maio, Flavio/AAL-7355-2021; goletti, delia/AAM-6577-2020; Antinori, Andrea/K-7125-2016; De Maio, Flavio/J-9452-2018; De Maio, Flavio/AAD-1076-2022	De Maio, Flavio/0000-0002-4744-9820; Antinori, Andrea/0000-0003-2121-4684; De Maio, Flavio/0000-0002-4744-9820; Goletti, Delia/0000-0001-8360-4376	Italian Ministry of Health [RF-2011-02349395, 97/RF-2011-02348713, 54/GR-2011-02350886]; European Union: EC IDEA [FP7-HEALTH-2009-241642]; EC HORIZON TBVAC [643381]	Italian Ministry of Health(Ministry of Health, Italy); European Union: EC IDEA; EC HORIZON TBVAC	This work was supported by the Italian Ministry of Health: RF-2011-02349395, 97/RF-2011-02348713, 54/GR-2011-02350886 (http:// www.salute.gov.it/imgs/C_17_pagineAree_3878_ listaFile_itemName_23_jile.pdf) and the European Union: EC FP7 IDEA (FP7-HEALTH-2009-241642) http://cordis.europa.eu/project/rcn/94020_it.html; EC HORIZON2020 TBVAC2020 (contract no. 643381) http://www.tbvi.eu/for-partners/tbvac2020/tbvac2020-project-description/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belay M, 2016, J INFECTION, V72, P189, DOI 10.1016/j.jinf.2015.09.040; Beveridge NER, 2008, TUBERCULOSIS, V88, P631, DOI 10.1016/j.tube.2008.06.005; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chiacchio T, 2014, J INFECTION, V69, P533, DOI 10.1016/j.jinf.2014.06.009; Corbiere V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043285; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Delogu G, 2016, SCAND J IMMUNOL, V84, P344, DOI 10.1111/sji.12493; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Delogu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018315; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Goletti D, 2014, J RHEUMATOL, V91, P24, DOI DOI 10.3899/jrheum.140099; Goletti D, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-11; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Houben RMGJ, 2011, INT J TUBERC LUNG D, V15, P24; Launois P, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/640309; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mascart F, 2015, EXPERT REV VACCINES, V14, P1573, DOI 10.1586/14760584.2015.1102638; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Nusbaum RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21522; Parra M, 2004, INFECT IMMUN, V72, P6799, DOI 10.1128/IAI.72.12.6799-6805.2004; Petruccioli E, 2017, TUBERCULOSIS, V106, P38, DOI 10.1016/j.tube.2017.06.002; Petruccioli E, 2016, EUR RESPIR J, V48, P1751, DOI 10.1183/13993003.01012-2016; Petruccioli E, 2016, J INFECTION, V73, P588, DOI 10.1016/j.jinf.2016.09.008; Petruccioli E, 2013, J INFECTION, V66, P475, DOI 10.1016/j.jinf.2013.02.004; Podlekareva DN, 2016, LANCET HIV, V3, pE120, DOI 10.1016/S2352-3018(15)00252-0; Pokrovskiy V, 2014, J INT AIDS SOC, V17, P10, DOI 10.7448/IAS.17.4.19502; Pollock KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146905; Pollock KM, 2013, J INFECT DIS, V208, P952, DOI 10.1093/infdis/jit265; Ronacher K, 2015, IMMUNOL REV, V264, P121, DOI 10.1111/imr.12257; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Sester M, 2014, AM J RESP CRIT CARE, V190, P1168, DOI 10.1164/rccm.201405-0967OC; Smits K, 2015, J CLIN CELL IMMUNOL, V6, P341; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stylianou E, 2014, EUR J IMMUNOL, V44, P440, DOI 10.1002/eji.201343887; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Temmerman ST, 2005, J INFECT DIS, V192, P226, DOI 10.1086/430930; Vanini V, 2012, J INFECTION, V65, P49, DOI 10.1016/j.jinf.2012.03.017; Vincenti D, 2007, CLIN EXP IMMUNOL, V150, P91, DOI 10.1111/j.1365-2249.2007.03462.x; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Wyndham-Thomas C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0796-0; Wyndham-Thomas C, 2014, CLIN VACCINE IMMUNOL, V21, P321, DOI 10.1128/CVI.00651-13; Zanetti S, 2005, CLIN DIAGN LAB IMMUN, V12, P1135, DOI 10.1128/CDLI.12.9.1135-1138.2005	50	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183846	10.1371/journal.pone.0183846	http://dx.doi.org/10.1371/journal.pone.0183846			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837654	Green Submitted, Green Published, gold			2022-12-26	WOS:000408365000131
J	Palmer-Young, EC; Alison, H; Alexander, JK; Donnelly, D; Jonathan, A; Connon, SJ; Weston, I; Kimberly, S; Irwin, RE; Adler, LS				Palmer-Young, Evan C.; Hogeboom, Alison; Kaye, Alexander J.; Donnelly, Dash; Andicoechea, Jonathan; Connon, Sara June; Weston, Ian; Skyrm, Kimberly; Irwin, Rebecca E.; Adler, Lynn S.			Context-dependent medicinal effects of anabasine and infection-dependent toxicity in bumble bees	PLOS ONE			English	Article							BOMBUS-TERRESTRIS; CRITHIDIA-BOMBI; SECONDARY METABOLITES; INTESTINAL PATHOGEN; COMBINED PESTICIDE; NECTAR-NICOTINE; PARASITE; HOST; HONEYBEES; INSECT	Background Floral phytochemicals are ubiquitous in nature, and can function both as antimicrobials and as insecticides. Although many phytochemicals act as toxins and deterrents to consumers, the same chemicals may counteract disease and be preferred by infected individuals. The roles of nectar and pollen phytochemicals in pollinator ecology and conservation are complex, with evidence for both toxicity and medicinal effects against parasites. However, it remains unclear how consistent the effects of phytochemicals are across different parasite lineages and environmental conditions, and whether pollinators actively self-medicate with these compounds when infected. Approach Here, we test effects of the nectar alkaloid anabasine, found in Nicotiana, on infection intensity, dietary preference, and survival and performance of bumble bees (Bombus impatiens). We examined variation in the effects of anabasine on infection with different lineages of the intestinal parasite Crithidia under pollen-fed and pollen-starved conditions. Results We found that anabasine did not reduce infection intensity in individual bees infected with any of four Crithidia lineages that were tested in parallel, nor did anabasine reduce infection intensity in microcolonies of queenless workers. In addition, neither anabasine nor its isomer, nicotine, was preferred by infected bees in choice experiments, and infected bees consumed less anabasine than did uninfected bees under no-choice conditions. Furthermore, anabasine exacerbated the negative effects of infection on bee survival and microcolony performance. Anabasine reduced infection in only one experiment, in which bees were deprived of pollen and post-pupal contact with nestmates. In this experiment, anabasine had antiparasitic effects in bees from only two of four colonies, and infected bees exhibited reduced-rather than increased-phytochemical consumption relative to uninfected bees. Conclusions Variation in the effect of anabasine on infection suggests potential modulation of tritrophic interactions by both host genotype and environmental variables. Overall, our results demonstrate that Bombus impatiens prefer diets without nicotine and anabasine, and suggest that the medicinal effects and toxicity of anabasine may be context dependent. Future research should identify the specific environmental and genotypic factors that determine whether nectar phytochemicals have medicinal or deleterious effects on pollinators.	[Palmer-Young, Evan C.] Univ Massachusetts, Organism & Evolutionary Biol, Amherst, MA 01003 USA; [Palmer-Young, Evan C.; Hogeboom, Alison; Connon, Sara June; Weston, Ian; Skyrm, Kimberly; Adler, Lynn S.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Kaye, Alexander J.; Donnelly, Dash; Andicoechea, Jonathan; Irwin, Rebecca E.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA; [Connon, Sara June; Irwin, Rebecca E.] North Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Hogeboom, Alison] Colorado State Univ, Dept Bioagr & Pest Sci, Ft Collins, CO 80523 USA; [Kaye, Alexander J.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Andicoechea, Jonathan] Univ Minnesota, STEM Educ Ctr, St Paul, MN 55108 USA; [Skyrm, Kimberly] Massachusetts Dept Agr Resources, Apiary Program, Amherst, MA USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Dartmouth College; University of North Carolina; North Carolina State University; Colorado State University; Tufts University; University of Minnesota System; University of Minnesota Twin Cities	Palmer-Young, EC (corresponding author), Univ Massachusetts, Organism & Evolutionary Biol, Amherst, MA 01003 USA.; Palmer-Young, EC (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	ecp52@cornell.edu	Palmer-Young, Evan/AFL-1225-2022	Palmer-Young, Evan/0000-0002-9258-2073	National Science Foundation (NSF) [NSFDEB-1258096]; NSF GRFP [DGE-0907995]; NSF DDIG [NSFDEB-1501907]; Cooperative State Research, Education, and Extension Service (CSREES) [USDA-AFRI 2013-02536]; National Institute of Food and Agriculture Predoctoral Fellowship [USDA-AFRI-2016-67011-24698]; Garden Club of America Centennial Pollinator Fellowship (ECPY); National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA); Division Of Environmental Biology [1638866] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF DDIG(National Science Foundation (NSF)); Cooperative State Research, Education, and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Institute of Food and Agriculture Predoctoral Fellowship; Garden Club of America Centennial Pollinator Fellowship (ECPY); National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the National Science Foundation (NSF: nsf.gov) under NSFDEB-1258096 (to LSA and RED), NSF GRFP (DGE-0907995 to ECPY), and NSF DDIG (NSFDEB-1501907 to ECPY and LSA); by the National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA: usda.gov) Cooperative State Research, Education, and Extension Service (CSREES) Grant USDA-AFRI 2013-02536 (to LSA and RED; by a National Institute of Food and Agriculture Predoctoral Fellowship (USDA-AFRI-2016-67011-24698 to EPY), and by the Garden Club of America (www.gcamerica.org) Centennial Pollinator Fellowship (ECPY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Adler LS, 2012, ECOL LETT, V15, P1140, DOI 10.1111/j.1461-0248.2012.01838.x; Adler LS, 2012, OECOLOGIA, V168, P1033, DOI 10.1007/s00442-011-2153-3; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anthony WE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142496; Archer CR, 2014, FUNCT ECOL, V28, P913, DOI 10.1111/1365-2435.12226; Arnold SEJ, 2014, J CHEM ECOL, V40, P878, DOI 10.1007/s10886-014-0467-4; BAKER HG, 1977, APIDOLOGIE, V8, P349, DOI 10.1051/apido:19770405; Baracchi David, 2015, F1000Res, V4, P73, DOI 10.12688/f1000research.6262.2; Barribeau SM, 2014, P NATL ACAD SCI USA, V111, P3496, DOI 10.1073/pnas.1318628111; Barribeau SM, 2013, INFECT GENET EVOL, V20, P249, DOI 10.1016/j.meegid.2013.09.014; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Biller OM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144668; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BREER H, 1987, J INSECT PHYSIOL, V33, P771, DOI 10.1016/0022-1910(87)90025-4; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brunner FS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0128; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Ceja-Navarro JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8618; Cisarovsky G, 2014, ENTOMOL EXP APPL, V152, P209, DOI 10.1111/eea.12218; Conroy TJ, 2016, ENVIRON ENTOMOL, V45, P1212, DOI 10.1093/ee/nvw099; Costa C, 2010, APIDOLOGIE, V41, P141, DOI 10.1051/apido/2009070; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dobson HEM, 2000, PLANT SYST EVOL, V222, P63, DOI 10.1007/BF00984096; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; du Rand EE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11779; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Fauser-Misslin A, 2014, J APPL ECOL, V51, P450, DOI 10.1111/1365-2664.12188; Fox J., 2018, R COMPANION APPL REG, VThird; Gegear RJ, 2005, ANIM BEHAV, V70, P209, DOI 10.1016/j.anbehav.2004.09.025; Gherman BI, 2014, BEHAV ECOL SOCIOBIOL, V68, P1777, DOI 10.1007/s00265-014-1786-8; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gillespie S, 2010, ECOL ENTOMOL, V35, P737, DOI 10.1111/j.1365-2311.2010.01234.x; Goldberg F, 1999, J PHYSIOL-LONDON, V514, P759, DOI 10.1111/j.1469-7793.1999.759ad.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Graystock P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1371; Hartmann T, 1996, ENTOMOL EXP APPL, V80, P177, DOI 10.1007/BF00194753; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Heinrich B., 2004, BUMBLEBEE EC; Huang M, 2012, NEW PHYTOL, V193, P997, DOI 10.1111/j.1469-8137.2011.04001.x; Hurst V, 2014, J COMP PHYSIOL A, V200, P881, DOI 10.1007/s00359-014-0932-0; Imhoof B, 1999, INSECT SOC, V46, P233, DOI 10.1007/s000400050139; Irwin RE, 2004, ECOLOGY, V85, P1503, DOI 10.1890/03-0390; Junker RR, 2013, J CHEM ECOL, V39, P810, DOI 10.1007/s10886-013-0325-9; Karban R, 1997, ECOLOGY, V78, P603, DOI 10.1890/0012-9658(1997)078[0603:TPAHPC]2.0.CO;2; Kassambara A., 2016, SURVMINER DRAWING SU; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kohler A, 2012, J INSECT PHYSIOL, V58, P918, DOI 10.1016/j.jinsphys.2012.04.007; Kohler A, 2012, J INSECT PHYSIOL, V58, P286, DOI 10.1016/j.jinsphys.2011.12.002; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Lefevre T, 2012, J ANIM ECOL, V81, P70, DOI 10.1111/j.1365-2656.2011.01901.x; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; LIPA JJ, 1988, ACTA PROTOZOOL, V27, P287; Logan A, 2005, PARASITOLOGY, V130, P637, DOI 10.1017/S0031182005007304; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; Manson JS, 2009, ECOL ENTOMOL, V34, P421, DOI 10.1111/j.1365-2311.2009.01100.x; Marxer M, 2016, EVOL BIOL, P1; Oddoze C, 1998, J CHROMATOGR B, V708, P95, DOI 10.1016/S0378-4347(97)00632-4; Otterstatter MC, 2006, PARASITOLOGY, V133, P749, DOI 10.1017/S003118200600120X; Otterstatter MC, 2007, OECOLOGIA, V154, P411, DOI 10.1007/s00442-007-0834-8; Palmer-Young EC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37087; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson CH, 1936, J ECON ENTOMOL, V29, P850, DOI 10.1093/jee/29.5.850; Richardson LL, 2016, ECOLOGY, V97, P325, DOI 10.1890/15-0263.1; Richardson LL, 2015, P R SOC LOND B, V282; Rosenkranz V, 2008, MOLECULES, V13, P2462, DOI 10.3390/molecules13102462; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Sadd BM, 2013, PARASITE IMMUNOL, V35, P339, DOI 10.1111/pim.12043; Sadd BM, 2011, EVOLUTION, V65, P2995, DOI 10.1111/j.1558-5646.2011.01345.x; Sattelle DB, 2005, BIOESSAYS, V27, P366, DOI 10.1002/bies.20207; Schiestl FP, 1999, P ENTOMOL SOC WASH, V101, P880; Schmid-Hempel R, 1998, FUNCT ECOL, V12, P22, DOI 10.1046/j.1365-2435.1998.00153.x; Schmid-Hempel R, 2014, J ANIM ECOL, V83, P823, DOI 10.1111/1365-2656.12185; Schmid-Hempel R, 2011, INFECT GENET EVOL, V11, P564, DOI 10.1016/j.meegid.2011.01.002; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; Schwarz RS, 2015, J EUKARYOT MICROBIOL, V62, P567, DOI 10.1111/jeu.12209; SHYKOFF JA, 1991, APIDOLOGIE, V22, P117, DOI 10.1051/apido:19910204; Singaravelan N, 2006, J CHEM ECOL, V32, P49, DOI 10.1007/s10886-006-9350-2; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; SOLOWAY SB, 1976, ENVIRON HEALTH PERSP, V14, P109, DOI 10.2307/3428368; Tadmor-Melamed H, 2004, FUNCT ECOL, V18, P844, DOI 10.1111/j.0269-8463.2004.00929.x; Thany SH, 2003, INSECT MOL BIOL, V12, P255, DOI 10.1046/j.1365-2583.2003.00409.x; Therneau T.M., 2015, R PACKAGE COXME MIXE; Thomson JD, 2015, ARTHROPOD-PLANT INTE, V9, P1, DOI 10.1007/s11829-014-9350-z; Thorburn L., 2015, F1000RESEARCH, V4, P880, DOI DOI 10.12688/F1000RESEARCH.6870.2; Tognazzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049137; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tseng M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106401; Tyler Elizabeth R, 2006, BMC Physiol, V6, P6, DOI 10.1186/1472-6793-6-6; Ujvary I., 1999, NICOTINOID INSECTICI, P29, DOI [10.1007/978-4-431-67933-2_2, DOI 10.1007/978-4-431-67933-2_2]; Vannette RL, 2016, ECOLOGY, V97, P1410, DOI 10.1890/15-0858.1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilke CO, 2016, CRAN REP; Wink M, 2002, CHEMOECOLOGY, V12, P29, DOI 10.1007/s00049-002-8324-2; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 2001, INT CLASS FUNCT DIS; Yamamoto Izuru, 1999, NICOTINOID INSECTICI, P3, DOI DOI 10.1007/978-4-431-67933-2_1; Yothers MA, 1940, J ECON ENTOMOL, V33, P800, DOI 10.1093/jee/33.5.800	105	9	9	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183729	10.1371/journal.pone.0183729	http://dx.doi.org/10.1371/journal.pone.0183729			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832668	Green Published, gold, Green Submitted			2022-12-26	WOS:000408355800096
J	Tsai, YC; Chen, HM; Hsiao, SM; Chen, CS; Lin, MY; Chiu, YW; Hwang, SJ; Kuo, MC				Tsai, Yi-Chun; Chen, Hui-Mei; Hsiao, Shih-Ming; Chen, Cheng-Sheng; Lin, Ming-Yen; Chiu, Yi-Wen; Hwang, Shang-Jyh; Kuo, Mei-Chuan			Association of physical activity with cardiovascular and renal outcomes and quality of life in chronic kidney disease	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; OLDER-ADULTS; HANDGRIP STRENGTH; CKD; PERFORMANCE; PREDICTOR; HEMODIALYSIS; DISABILITY; SURVIVAL; EXERCISE	Patients with chronic kidney disease (CKD) are more readily prone to have impaired physical activity than the general population. The aim of this study is to examine the relationship between physical activity and adverse clinical outcomes and quality of life (QOL) in CKD. One hundred and sixty-one patients with CKD stages 1-5 was enrolled from February 2013 to September 2013 and followed up until June 2016. Physical activity was measured using high handgrip strength, 30-second chair stand, and 2-minute step. The QOL was assessed using the Taiwan version of the World Health Organization Quality of Life-BREF. Clinical outcomes included commencing dialysis, major adverse cardiovascular events (MACEs), and first hospitalization. Of all participants, 1 kgf increase in handgrip strength was significantly associated with 0.13 score increase in total scores of QOL and 0.05 score increase in physical domain of QOL in adjusted analysis. One time increase in 30-second chair stand was significantly correlated with 0.14 score increase in psychological domain of QOL. Over a mean follow-up period of 29.1-11.2 months, 37 (23.0%) reached commencing dialysis, 11 (6.8%) had MACEs, and 50(31.1%) had first hospitalization. High handgrip strength (hazard ratio (HR): 0.89, 95% CI: 0.84-0.96) and high 2-minute step (HR: 0.04, 95% CI: 0.01-0.95) were significantly associated with decreased risk for commencing dialysis in multivariate analysis. Thirty-second chair-stand was negatively associated with MACEs (HR: 0.65, 95% CI: 0.47-0.89) and first hospitalization (HR: 0.84, 95% CI: 0.74-0.95). In conclusion, physical activity is a potential predictor of QOL and adverse clinical outcomes in patients with CKD.	[Tsai, Yi-Chun] Kaohsiung Med Univ Hosp, Div Gen Med, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Lin, Ming-Yen; Chiu, Yi-Wen; Hwang, Shang-Jyh; Kuo, Mei-Chuan] Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Hui-Mei; Chen, Cheng-Sheng] Kaohsiung Med Univ, Grad Med, Kaohsiung, Taiwan; [Chen, Hui-Mei] Kaohsiung Med Univ, Dept Occupat Therapy, Coll Hlth Sci, Kaohsiung, Taiwan; [Hsiao, Shih-Ming] Kaohsiung Med Univ Hosp, Dept Nursing, Kaohsiung, Taiwan; [Chen, Cheng-Sheng] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lin, Ming-Yen; Chiu, Yi-Wen; Hwang, Shang-Jyh; Kuo, Mei-Chuan] Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Kuo, MC (corresponding author), Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan.; Kuo, MC (corresponding author), Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan.	mechku@cc.kmu.edu.tw	Lin, Ming Yen/A-8637-2010	Lin, Ming Yen/0000-0002-8194-4833; Chen, Hui-Mei/0000-0002-3712-5144	Kaohsiung Medical University Hospital [KMUH-98-P18]	Kaohsiung Medical University Hospital	This research was supported by a grant from the Kaohsiung Medical University Hospital (KMUH-98-P18). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddhu S, 2009, CLIN J AM SOC NEPHRO, V4, P1901, DOI 10.2215/CJN.01970309; Bharakhada N, 2012, AM J KIDNEY DIS, V60, P583, DOI 10.1053/j.ajkd.2012.04.024; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Centers for Disease Control and Prevention (CDC), NAT HLTH NUTR EX SUR; Chang KV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117167; Chang YT, 2011, NEPHROL DIAL TRANSPL, V26, P3588, DOI 10.1093/ndt/gfr013; Chen IR, 2014, CLIN J AM SOC NEPHRO, V9, P1183, DOI 10.2215/CJN.09810913; Garg AX, 2001, KIDNEY INT, V60, P1867, DOI 10.1046/j.1523-1755.2001.00001.x; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Haider S, 2016, QUAL LIFE RES, V25, P3129, DOI 10.1007/s11136-016-1349-8; Hiraki K, 2013, CLIN EXP NEPHROL, V17, P225, DOI 10.1007/s10157-012-0681-8; Hsiao SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165400; Johansen KL, 2012, AM J KIDNEY DIS, V59, P126, DOI 10.1053/j.ajkd.2011.10.008; Johansen KL, 2000, KIDNEY INT, V57, P2564, DOI 10.1046/j.1523-1755.2000.00116.x; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lopes AA, 2014, CLIN J AM SOC NEPHRO, V9, P1702, DOI 10.2215/CJN.12371213; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Pedrosa R, 2009, BRAZ J PHYS THER, V13, P252, DOI 10.1590/S1413-35552009005000030; Ro YS, 2017, RESUSCITATION, V115, P44, DOI 10.1016/j.resuscitation.2017.03.041; Roshanravan B, 2013, J AM SOC NEPHROL, V24, P822, DOI 10.1681/ASN.2012070702; Slee AD, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-36; Stump CS, 2011, CARDIORENAL MED, V1, P164, DOI 10.1159/000329929; Yao G, 2002, J FORMOS MED ASSOC, V101, P342	27	34	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183642	10.1371/journal.pone.0183642	http://dx.doi.org/10.1371/journal.pone.0183642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832653	Green Submitted, Green Published, gold			2022-12-26	WOS:000408355800075
